PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bernardo, AD; Lopes, SMCD				Bernardo, Ana de Melo; Lopes, Susana M. Chuva de Sousa			The Involvement of the Proamnion in the Development of the Anterior Amnion Fold in the Chicken	PLOS ONE			English	Article							EMBRYO; IMPLANTATION; PROLIFERATION; EVOLUTION; CULTURE; VITRO; MODEL	The amnion was one of the most important evolutionary novelties in the animal kingdom, allowing independence of water for reproduction and subsequent exploration of terrestrial habitats, and is therefore an important structure to understand evolution. We have studied chicken amniogenesis using ex ovo culture systems and 3D-reconstructions of serially sectioned chicken embryos. We provide evidence for a transient depression of the head in the proamnion, forming a pouch, that positions the extraembryonic membranes dorsal to the head and that is fundamental for the correct formation of the amnion and chorion membranes. When this "sinking" process in the proamnion was blocked, the amnion/chorion did not form, even though the growth of the embryo per se seemed unaffected. Here, we give insight in the role of the proamnion in amniogenesis.	[Bernardo, Ana de Melo; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lopes, SMCD (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.	lopes@lumc.nl		de Melo Bernardo, Ana/0000-0002-7918-5911	European Commission [Leonardo da Vinci 2011-1-PT1-LEO02-08199]; Netherlands organization of Scientific Research (NWO) [ASPASIA 015.007.037]; Interuniversity Attraction Poles-Phase VII [IUAP/PAI P7/14]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Interuniversity Attraction Poles-Phase VII	This research was supported by the European Commission's Lifelong Learning Programme (Leonardo da Vinci 2011-1-PT1-LEO02-08199) to AMB and by the Netherlands organization of Scientific Research (NWO) (ASPASIA 015.007.037) and the Interuniversity Attraction Poles-Phase VII (IUAP/PAI P7/14) to AMB and SMCSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSTONE FB, 1948, J MORPHOL, V83, P359, DOI 10.1002/jmor.1050830303; Beneden E. Van, 1884, Arch. Biol., Vv, P369; Bernardo AD, 2012, BIOL OPEN, V1, P1146, DOI 10.1242/bio.20122592; Blomberg L, 2008, REPRODUCTION, V135, P181, DOI 10.1530/REP-07-0355; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029; Gilbert S.F., 2010, DEV BIOL; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hirota S., 1894, Journal Coll Japan, Vvi, P337; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Lillie FR, 1903, BIOL BULL-US, V5, P92, DOI 10.2307/1535515; Mess A, 2003, J EXP ZOOL PART A, V299A, P78, DOI 10.1002/jez.a.10292; MILLER SA, 1994, ANAT RECORD, V238, P225, DOI 10.1002/ar.1092380209; Mitsukuri K., 1891, Journal of the College of Science Japan, Viv, P1; Nagai H, 2011, GENESIS, V49, P46, DOI 10.1002/dvg.20690; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NICOLET G, 1963, EXPERIENTIA, V19, P165, DOI 10.1007/BF02171616; OVERTON J, 1989, CELL TISSUE RES, V257, P141; Patten DM, 1951, EARLY EMBRYOLOGY CHI; Pereira PNG, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-48; Pourquie O, 2004, MECH DEVELOP, V121, P1069, DOI 10.1016/j.mod.2004.05.002; RASWEILER JJ, 1979, J REPROD FERTIL, V56, P403; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; ROSENQUIST GC, 1971, DEV BIOL, V26, P323, DOI 10.1016/0012-1606(71)90131-X; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; Shore T. W., 1889, Journal of Anatomy and Physiology, Vxxiv, P1; SMITH SM, 1994, DEV DYNAM, V200, P14, DOI 10.1002/aja.1002000103; Soukup V, 2013, J ANAT, V222, P79, DOI 10.1111/j.1469-7580.2012.01540.x; Stern CD, 1997, INT J DEV BIOL, V41, P379; Tipping N, 2011, ANAT REC, V294, P1143, DOI 10.1002/ar.21407; WATERMAN RE, 1980, ANAT RECORD, V197, P441, DOI 10.1002/ar.1091970408; [No title captured]	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92672	10.1371/journal.pone.0092672	http://dx.doi.org/10.1371/journal.pone.0092672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647352	Green Published, gold			2022-12-25	WOS:000333348500151
J	Shcherbik, SV; Pearce, NC; Levine, ML; Klimov, AI; Villanueva, JM; Bousse, TL				Shcherbik, Svetlana V.; Pearce, Nicholas C.; Levine, Marnie L.; Klimov, Alexander I.; Villanueva, Julie M.; Bousse, Tatiana L.			Rapid Strategy for Screening by Pyrosequencing of Influenza Virus Reassortants - Candidates for Live Attenuated Vaccines	PLOS ONE			English	Article							GENOME COMPOSITION; INACTIVATED VACCINES; RESTRICTION ANALYSIS; WILD-TYPE; H3N2; PCR; EFFICACY; H1N1; RECOMBINANTS; RESISTANCE	Background: Live attenuated influenza vaccine viruses (LAIVs) can be generated by classical reassortment of gene segments between a cold adapted, temperature sensitive and attenuated Master Donor Virus (MDV) and a seasonal wild-type (wt) virus. The vaccine candidates contain hemagglutinin (HA) and neuraminidase (NA) genes derived from the circulating wt viruses and the remaining six genes derived from the MDV strains. Rapid, efficient selection of the viruses with 6: 2 genome compositions from the large number of genetically different viruses generated during reassortment is essential for the biannual production schedule of vaccine viruses. Methodology/Principal Findings: This manuscript describes a new approach for the genotypic analysis of LAIV reassortant virus clones based on pyrosequencing. LAIV candidate viruses were created by classical reassortment of seasonal influenza A (H3N2) (A/Victoria/361/2011, A/Ohio/02/2012, A/Texas/50/2012) or influenza A (H7N9) (A/Anhui/1/2013) wt viruses with the MDV A/Leningrad/134/17/57(H2N2). Using strain-specific pyrosequencing assays, mixed gene variations were detected in the allantoic progenies during the cloning procedure. The pyrosequencing analysis also allowed for estimation of the relative abundance of segment variants in mixed populations. This semi-quantitative approach was used for selecting specific clones for the subsequent cloning procedures. Conclusions/Significance: The present study demonstrates that pyrosequencing analysis is a useful technique for rapid and reliable genotyping of reassortants and intermediate clones during the preparation of LAIV candidates, and can expedite the selection of vaccine virus candidates.	[Shcherbik, Svetlana V.; Pearce, Nicholas C.; Levine, Marnie L.; Klimov, Alexander I.; Villanueva, Julie M.; Bousse, Tatiana L.] Ctr Dis Control & Prevent, Virol Surveillance & Diag Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Shcherbik, Svetlana V.; Pearce, Nicholas C.; Levine, Marnie L.] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Bousse, TL (corresponding author), Ctr Dis Control & Prevent, Virol Surveillance & Diag Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tbousse@cdc.gov		Pearce, Neil/0000-0002-9938-7852	U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA)	U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA)	The research study was supported by U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson ME, 2005, J CLIN VIROL, V33, P25, DOI 10.1016/j.jcv.2004.09.022; ALEKSANDROVA GI, 1977, VOP VIRUSOL+, P387; Alexandrova GIK, 1994, LIVE INFLUENZA VACCI; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; An WQ, 2009, CHINESE MED J-PEKING, V122, P2880, DOI 10.3760/cma.j.issn.0366-6999.2009.23.015; Arvia R, 2012, J VIROL METHODS, V184, P113, DOI 10.1016/j.jviromet.2012.05.018; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Cha TA, 1997, ANAL BIOCHEM, V252, P24, DOI 10.1006/abio.1997.2269; COUCH RB, 1993, ANN NY ACAD SCI, V685, P803, DOI 10.1111/j.1749-6632.1993.tb35946.x; COX NJ, 1979, VIROLOGY, V97, P190, DOI 10.1016/0042-6822(79)90386-6; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Deng YM, 2013, J CLIN VIROL, V58, P94, DOI 10.1016/j.jcv.2013.04.018; Deng YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023400; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Desheva Yu. A., 2007, Voprosy Virusologii, V52, P16; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Duwe S, 2008, J VIROL METHODS, V153, P134, DOI 10.1016/j.jviromet.2008.07.017; Duwe SC, 2011, ANTIVIR RES, V89, P115, DOI 10.1016/j.antiviral.2010.11.001; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Elahi E, 2003, J VIROL METHODS, V109, P171, DOI 10.1016/S0166-0934(03)00068-5; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GHENDON YZ, 1981, J GEN VIROL, V53, P215, DOI 10.1099/0022-1317-53-2-215; GHENDON YZ, 1984, INFECT IMMUN, V44, P730, DOI 10.1128/IAI.44.3.730-733.1984; Ha SH, 2006, J VIROL METHODS, V134, P154, DOI 10.1016/j.jviromet.2005.12.011; Kendal AP, 1997, EUR J EPIDEMIOL, V13, P591, DOI 10.1023/A:1007327505862; KENDAL AP, 1977, J GEN VIROL, V37, P145, DOI 10.1099/0022-1317-37-1-145; Kiseleva I V, 2011, Mol Gen Mikrobiol Virusol, P29; Kiseleva IV, 2011, VOP VIRUSOL+, V56, P28; Kiseleva I. V., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P40; KLIMOV AI, 1992, VIROLOGY, V186, P795, DOI 10.1016/0042-6822(92)90050-Y; KLIMOV AI, 1995, J VIROL METHODS, V52, P41, DOI 10.1016/0166-0934(94)00133-2; Lee EY, 2010, J VIROL METHODS, V165, P133, DOI 10.1016/j.jviromet.2009.10.022; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; MEDVEDEVA TE, 1983, ACTA VIROL, V27, P311; Mello FCA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-96; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Rudenko LG, 1996, B WORLD HEALTH ORGAN, V74, P77; Sakamoto S, 1996, J VIROL METHODS, V56, P161, DOI 10.1016/0166-0934(95)01909-X; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; SMORODINTSEN AA, 1965, IND MED SURG, V34, P53; TREANOR JJ, 1992, ANN INTERN MED, V117, P625, DOI 10.7326/0003-4819-117-8-625; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Vodeiko GM, 2003, VACCINE, V21, P3867, DOI 10.1016/S0264-410X(03)00312-8; Wareing MD, 2002, VACCINE, V20, P2082, DOI 10.1016/S0264-410X(02)00056-7; Watanabe T, 2013, NATURE; WHO, 2011, MAN LAB DIAGN VIR SU; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	51	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92580	10.1371/journal.pone.0092580	http://dx.doi.org/10.1371/journal.pone.0092580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647786	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500147
J	Tamagnini, F; Scullion, S; Brown, JT; Randall, AD				Tamagnini, Francesco; Scullion, Sarah; Brown, Jonathan T.; Randall, Andrew D.			Low Concentrations of the Solvent Dimethyl Sulphoxide Alter Intrinsic Excitability Properties of Cortical and Hippocampal Pyramidal Cells	PLOS ONE			English	Article							NEUROTOXICITY; INFUSION; PLASTICITY	Dimethylsulfoxide (DMSO) is a widely used solvent in biology. It has many applications perhaps the most common of which is in aiding the preparation of drug solutions from hydrophobic chemical entities. Recent studies have suggested that this molecule may be able to induce apoptosis in neural tissues urging caution regarding its introduction into humans, for example as part of stem cell transplants. Here we have used in vitro electrophysiological methods applied to murine brain slices to examine whether a few hours treatment with 0.05% DMSO (a concentration regarded by many as innocuous) alters intrinsic excitability properties of neurones. We investigated pyramidal neurones in two distinct brain regions, namely area CA1 of the hippocampus and layer 2 of perirhinal cortex. In the former there was no effect on resting potential but input resistance was decreased by DMSO pre-treatment. In line with this action potential count for any level of depolarizing current stimulus was reduced by similar to 25% following DMSO treatment. I-h-mediated "sag" was also increased in CA1 pyramids and action potential waveform analysis demonstrated that DMSO treatment moved action potential threshold towards resting potential. In perirhinal cortex a decreased action potential output for various depolarizing current stimuli was also seen. In these cells action potential threshold was unaltered by DMSO but a significant increase in action potential width was apparent. These data indicate that pre-treatment with this widely employed solvent can elicit multifaceted neurophysiological changes in mammalian neurones at concentrations below those frequently encountered in the published literature.	[Tamagnini, Francesco; Scullion, Sarah; Brown, Jonathan T.; Randall, Andrew D.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Tamagnini, Francesco; Brown, Jonathan T.; Randall, Andrew D.] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Exeter, Devon, England	University of Bristol; University of Exeter	Randall, AD (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	A.D.Randall@Bristol.ac.uk		Brown, Jonathan T/0000-0001-5269-7661; Randall, Andrew/0000-0001-8852-3671; Tamagnini, Francesco/0000-0002-8741-5094	Medical Research Council (UK); Alzheimers Research UK [ARUK-SRF2012-6] Funding Source: researchfish; Medical Research Council [G1100623] Funding Source: researchfish; MRC [G1100623] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (UK) who provided funds for staff salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authier N, 2002, TOXICOL LETT, V132, P117, DOI 10.1016/S0378-4274(02)00052-8; Bliss T., 2007, HIPPOCAMPUS BOOK, P133; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; Chen YJ, 2012, ALCOHOL CLIN EXP RES, V36, P2036, DOI 10.1111/j.1530-0277.2012.01826.x; FOSSOM LH, 1985, NEUROTOXICOLOGY, V6, P17; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Higman MA, 2000, BONE MARROW TRANSPL, V26, P797, DOI 10.1038/sj.bmt.1702589; Hoyt R, 2000, BONE MARROW TRANSPL, V25, P1285, DOI 10.1038/sj.bmt.1702443; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Junior AM, 2008, BONE MARROW TRANSPL, V41, P95, DOI 10.1038/sj.bmt.1705883; Kealy J, 2011, PROG NEUROBIOL, V93, P522, DOI 10.1016/j.pneurobio.2011.03.002; KEUNG YK, 1994, BONE MARROW TRANSPL, V14, P363; Mueller LP, 2007, EUR J HAEMATOL, V78, P527, DOI 10.1111/j.1600-0609.2007.00851.x; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; Novarino G, 2004, J NEUROSCI, V24, P5322, DOI 10.1523/JNEUROSCI.1170-04.2004; Randall AD, 2012, NEUROBIOL AGING, V33, P2715, DOI 10.1016/j.neurobiolaging.2011.12.030; Renner S, 2011, FUTURE MED CHEM, V3, P751, DOI [10.4155/fmc.11.15, 10.4155/FMC.11.15]; STYLER MJ, 1992, BONE MARROW TRANSPL, V10, P435; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Tateno T, 2011, J NEUROPHYSIOL, V106, P1901, DOI 10.1152/jn.00162.2011; Windrum P, 2005, BONE MARROW TRANSPL, V36, P601, DOI 10.1038/sj.bmt.1705100; Windrum P, 2003, BONE MARROW TRANSPL, V31, P315, DOI 10.1038/sj.bmt.1703848; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; Yu ZW, 1998, MOL MEMBR BIOL, V15, P59, DOI 10.3109/09687689809027519	27	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92557	10.1371/journal.pone.0092557	http://dx.doi.org/10.1371/journal.pone.0092557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647720	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000333348500143
J	Tang, DL; Lee, J; Muirhead, L; Li, TY; Qu, LR; Yu, J; Perera, F				Tang, Deliang; Lee, Joan; Muirhead, Loren; Li, Ting Yu; Qu, Lirong; Yu, Jie; Perera, Frederica			Molecular and Neurodevelopmental Benefits to Children of Closure of a Coal Burning Power Plant in China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; NEUROTROPHIC FACTOR; PRENATAL EXPOSURE; BDNF; LTP; AIR; PHOSPHORYLATION; EXPRESSION; POLLUTANTS; PLASTICITY	Polycyclic aromatic hydrocarbons (PAH) are major toxic air pollutants released during incomplete combustion of coal. PAH emissions are especially problematic in China because of their reliance on coal-powered energy. The prenatal period is a window of susceptibility to neurotoxicants. To determine the health benefits of reducing air pollution related to coal-burning, we compared molecular biomarkers of exposure and preclinical effects in umbilical cord blood to neurodevelopmental outcomes from two successive birth cohorts enrolled before and after a highly polluting, coal-fired power plant in Tongliang County, China had ceased operation. Women and their newborns in the two successive cohorts were enrolled at the time of delivery. We measured PAH-DNA adducts, a biomarker of PAH-exposure and DNA damage, and brain-derived neurotrophic factor (BDNF), a protein involved in neuronal growth, in umbilical cord blood. At age two, children were tested using the Gesell Developmental Schedules (GDS). The two cohorts were compared with respect to levels of both biomarkers in cord blood as well as developmental quotient (DQ) scores across 5 domains. Lower levels of PAH-DNA adducts, higher concentrations of the mature BDNF protein (mBDNF) and higher DQ scores were seen in the 2005 cohort enrolled after closure of the power plant. In the two cohorts combined, PAH-DNA adducts were inversely associated with mBDNF as well as scores for motor (p = 0.05), adaptive (p = 0.022), and average (p = 0.014) DQ. BDNF levels were positively associated with motor (p = 0.018), social (p = 0.001), and average (p = 0.017) DQ scores. The findings indicate that the closure of a coal-burning plant resulted in the reduction of PAH-DNA adducts in newborns and increased mBDNF levels that in turn, were positively associated with neurocognitive development. They provide further evidence of the direct benefits to children's health as a result of the coal plant shut down, supporting clean energy and environmental policies in China and elsewhere.	[Tang, Deliang; Lee, Joan; Muirhead, Loren; Qu, Lirong; Yu, Jie; Perera, Frederica] Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Li, Ting Yu] Chongqing Med Univ, Dept Pediat, Chongqing, Peoples R China	Columbia University; Chongqing Medical University	Tang, DL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	dt14@columbia.edu		Perera, Frederica/0000-0002-1364-9250	Energy Foundation; Rockefeller Brothers Fund; Schmidt Foundation	Energy Foundation; Rockefeller Brothers Fund; Schmidt Foundation	This study was supported by the Energy Foundation, the Rockefeller Brothers Fund and the Schmidt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WADE EC MOD CHIN WOR; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chow JC, 2006, J ENVIRON SCI HEAL A, V41, P517, DOI 10.1080/10934520600564253; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Gomez-Pinilla F, 2005, EXP NEUROL, V192, P235, DOI 10.1016/j.expneurol.2004.12.001; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hudon L, 1998, AM J OBSTET GYNECOL, V179, P858, DOI 10.1016/S0002-9378(98)70178-4; Jedrychowski Wieslaw, 2003, Int J Occup Med Environ Health, V16, P21; Kandel ER, 2004, BIOSCIENCE REP, V24, P475, DOI 10.1007/s10540-005-2742-7; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li Z, 2012, TOXICOL SCI, V125, P233, DOI 10.1093/toxsci/kfr261; LIJINSKY W, 1991, MUTAT RES, V259, P251, DOI 10.1016/0165-1218(91)90121-2; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Millman A, 2008, PEDIATRICS, V122, P620, DOI 10.1542/peds.2007-3143; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Perera F, 2012, ENVIRON RES, V114, P40, DOI 10.1016/j.envres.2011.12.011; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Perera F, 2008, ENVIRON HEALTH PERSP, V116, P1396, DOI 10.1289/ehp.11480; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Sheng L, 2010, TOXICOL SCI, V118, P625, DOI 10.1093/toxsci/kfq304; Su TC, 2006, EUR J CARDIOV PREV R, V13, P849, DOI 10.1097/01.hjr.0000219116.25415.c4; Tang DL, 2008, ENVIRON HEALTH PERSP, V116, P674, DOI 10.1289/ehp.10471; Toledo-Rodriguez M, 2010, AM J MED GENET B, V153B, P1350, DOI 10.1002/ajmg.b.31109; Wormley DD, 2004, CELL MOL BIOL, V50, P715; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1	42	36	37	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91966	10.1371/journal.pone.0091966	http://dx.doi.org/10.1371/journal.pone.0091966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647528	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500064
J	Gardini, AC; Capelli, L; Ulivi, P; Giannini, M; Freier, E; Tamberi, S; Scarpi, E; Passardi, A; Zoli, W; Ragazzini, A; Amadori, D; Frassineti, GL				Gardini, Andrea Casadei; Capelli, Laura; Ulivi, Paola; Giannini, Massimo; Freier, Eva; Tamberi, Stefano; Scarpi, Emanuela; Passardi, Alassandro; Zoli, Wainer; Ragazzini, Angela; Amadori, Dino; Frassineti, Giovanni Luca			KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)	PLOS ONE			English	Article							COLORECTAL-CANCER; MUTATIONAL STATUS; CETUXIMAB; CHEMORADIOTHERAPY; EGFR	Anti-EGFR therapy appears to be a potential treatment option for squamous cell anal carcinoma (SCAC). KRAS mutation is a rare event in SCAC, indicating the absence of the principal mechanism of resistance to this type of therapy. However, no information is available from the literature regarding the status of BRAF or PIK3CA in this cancer type. We analysed KRAS, BRAF and PIK3CA status in SCAC patients in relation to the clinical-pathological characteristics of patients and to the presence of the human papilloma virus (HPV). One hundred and three patients were treated with the Nigro scheme for anal cancer from March 2001 to August 2012. Fifty patients were considered for the study as there was insufficient paraffin-embedded tumour tissue to perform molecular analysis the remaining 53. DNA was extracted from paraffin-embedded sections. KRAS, BRAF and PIK3CA gene status and HPV genotype were evaluated by pyrosequencing. KRAS and BRAF genes were wild-type in all cases. Conversely, PIK3CA gene was found to be mutated in 11 (22%) cases. In particular, 8 mutations occurred in exon 9 and 3 in exon 20 of the PIK3CA gene. These findings suggest that SCAC could potentially respond to an anti-EGFR drug. PIK3CA mutation may be involved in the process of carcinogenesis in some cases of SCAC.	[Gardini, Andrea Casadei; Capelli, Laura; Ulivi, Paola; Scarpi, Emanuela; Passardi, Alassandro; Zoli, Wainer; Ragazzini, Angela; Amadori, Dino; Frassineti, Giovanni Luca] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Giannini, Massimo] Macerata Hosp, Radiotherapy Unit, Macerata, Italy; [Freier, Eva; Tamberi, Stefano] Degli Infermi Hosp, Oncol Unit, Faenza, Italy	IRCCS Meldola (IRST)	Gardini, AC (corresponding author), Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy.	casadeigardini@gmail.com	gardini, Andrea Casadei/L-4859-2019; Gardini, Andrea Casadei/F-1830-2016; Passardi, Alessandro/AAH-4786-2019; Capelli, Laura/AAB-9682-2019; Scarpi, Emanuela/AAD-7036-2019; Gardini, Andrea/AAA-6985-2022	gardini, Andrea Casadei/0000-0001-6289-7202; Gardini, Andrea Casadei/0000-0001-6289-7202; Passardi, Alessandro/0000-0002-7099-240X; Scarpi, Emanuela/0000-0001-7230-9267; Ulivi, Paola/0000-0002-4334-9662; Tamberi, Stefano/0000-0002-7087-9116; Frassineti, Giovanni Luca/0000-0002-0277-5622				Bamba Takeo, 2012, Gan To Kagaku Ryoho, V39, P311; Barmettler H, 2012, CASE REP ONCOL, V5, P428, DOI 10.1159/000341371; Bruckman KC, 2010, ORAL SURG ORAL MED O, V110, P632, DOI 10.1016/j.tripleo.2010.05.002; COX DR, 1972, J R STAT SOC B, V34, P187; Das P, 2007, INT J RADIAT ONCOL, V68, P794, DOI 10.1016/j.ijrobp.2006.12.052; Deutsch E, 2013, ANN ONCOL, V24, P2834, DOI 10.1093/annonc/mdt368; Edge SB, 2010, AJCC CANC STAGING MA; Kaplan EL, 2005, J AM STAT ASSOC, V24, P341; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Lukan N, 2009, ONCOLOGY-BASEL, V77, P293, DOI 10.1159/000259615; McIntyre JB, 2013, GYNECOL ONCOL, V128, P409, DOI 10.1016/j.ygyno.2012.12.019; Olivatto LO, 2006, J CLIN ONCOL S243; Paliga A, 2012, BRIT J CANCER, V107, P1864, DOI 10.1038/bjc.2012.479; Pochylski T, 2003, EUR J OBSTET GYN R B, V111, P68, DOI 10.1016/S0301-2115(03)00205-7; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Skamperle M, 2013, ACTA DERMATOVEN ALP, V21, P1, DOI 10.2478/v10162-012-0024-1; Ulivi P, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-87; Van Damme N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-189; Yhim HY, 2011, INT J CANCER, V129, P1752, DOI 10.1002/ijc.25825; Zampino MG, 2009, CANCER CHEMOTH PHARM, V65, P197, DOI 10.1007/s00280-009-1117-3	21	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92071	10.1371/journal.pone.0092071	http://dx.doi.org/10.1371/journal.pone.0092071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642661	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900075
J	Gonzalo, V; Lozano, JJ; Alonso-Espinaco, V; Moreira, L; Munoz, J; Pellise, M; Castellvi-Bel, S; Bessa, X; Andreu, M; Xicola, RM; Llor, X; Ruiz-Ponte, C; Carracedo, A; Jover, R; Castells, A; Balaguer, F				Gonzalo, Victoria; Jose Lozano, Juan; Alonso-Espinaco, Virginia; Moreira, Leticia; Munoz, Jenifer; Pellise, Maria; Castellvi-Bel, Sergi; Bessa, Xavier; Andreu, Montserrat; Xicola, Rosa M.; Llor, Xavier; Ruiz-Ponte, Clara; Carracedo, Angel; Jover, Rodrigo; Castells, Antoni; Balaguer, Francesc		Spanish Gastroenterological Assoc	Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DNA METHYLATION; MICROSATELLITE INSTABILITY; HYPERPLASTIC POLYPOSIS; PROMOTER METHYLATION; MICE; PREDISPOSITION; TUMORIGENESIS; EXPRESSION; PROGNOSIS	Epigenetics are thought to play a major role in the carcinogenesis of multiple sporadic colorectal cancers (CRC). Previous studies have suggested concordant DNA hypermethylation between tumor pairs. However, only a few methylation markers have been analyzed. This study was aimed at describing the epigenetic signature of multiple CRC using a genome-scale DNA methylation profiling. We analyzed 12 patients with synchronous CRC and 29 age-, sex-, and tumor location-paired patients with solitary tumors from the EPICOLON II cohort. DNA methylation profiling was performed using the Illumina Infinium HM27 DNA methylation assay. The most significant results were validated by Methylight. Tumors samples were also analyzed for the CpG Island Methylator Phenotype (CIMP); KRAS and BRAF mutations and mismatch repair deficiency status. Functional annotation clustering was performed. We identified 102 CpG sites that showed significant DNA hypermethylation in multiple tumors with respect to the solitary counterparts (difference in beta value >= 0.1). Methylight assays validated the results for 4 selected genes (p = 0.0002). Eight out of 12(66.6%) multiple tumors were classified as CIMP-high, as compared to 5 out of 29(17.2%) solitary tumors (p = 0.004). Interestingly, 76 out of the 102 (74.5%) hypermethylated CpG sites found in multiple tumors were also seen in CIMP-high tumors. Functional analysis of hypermethylated genes found in multiple tumors showed enrichment of genes involved in different tumorigenic functions. In conclusion, multiple CRC are associated with a distinct methylation phenotype, with a close association between tumor multiplicity and CIMP-high. Our results may be important to unravel the underlying mechanism of tumor multiplicity.	[Gonzalo, Victoria; Alonso-Espinaco, Virginia; Moreira, Leticia; Munoz, Jenifer; Pellise, Maria; Castellvi-Bel, Sergi; Castells, Antoni; Balaguer, Francesc] Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain; [Jose Lozano, Juan] CIBERehd, Bioinformat Unit, Barcelona, Catalonia, Spain; [Bessa, Xavier; Andreu, Montserrat] Hosp del Mar, Dept Gastroenterol, Barcelona, Catalonia, Spain; [Xicola, Rosa M.; Llor, Xavier] Univ Illinois, Dept Med, Chicago, IL USA; [Xicola, Rosa M.; Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Ruiz-Ponte, Clara; Carracedo, Angel] Univ Compostela, Hosp Clin, Genom Med Grp, Galician Publ Fdn Genom Med FPGMX,CIBERER, Galicia, Spain; [Jover, Rodrigo] Hosp Gen Univ, Gastroenterol Unit, Alicante, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; General University Hospital of Alicante	Balaguer, F (corresponding author), Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain.	fprunes@clinic.cat	Rodrigo, Luis/A-6278-2010; Jover, Rodrigo/ABC-3258-2021; Ruiz-Ponte, Clara/I-3849-2015; Felis, Carmen Pinol/C-6397-2011; Carracedo, Angel/D-4257-2012; Bujanda, Luis/AAB-2485-2021; RIESTRA, SABINO/N-2897-2019; Andreu, Montserrat/D-9911-2015; Pellise, Maria/ABC-3246-2021; Enriquez-Navascues, Jose M/AAG-8632-2020; Moreira, Leticia/AAN-9863-2021; CUBIELLA, JOAQUIN/G-7692-2017; BALAGUER, FRANCESC/G-2389-2016; Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Carballo, Fernando/M-4668-2016	Rodrigo, Luis/0000-0003-1717-9345; Jover, Rodrigo/0000-0003-3742-3413; Ruiz-Ponte, Clara/0000-0002-2200-0162; Felis, Carmen Pinol/0000-0003-0626-1298; Carracedo, Angel/0000-0003-1085-8986; Bujanda, Luis/0000-0002-4353-9968; Andreu, Montserrat/0000-0003-4286-1098; Enriquez-Navascues, Jose M/0000-0002-6486-1489; Moreira, Leticia/0000-0002-4518-8591; CUBIELLA, JOAQUIN/0000-0002-9994-4831; Castells, Antoni/0000-0001-8431-2033; Lozano, Juan Jose/0000-0001-7613-3908; Carballo, Fernando/0000-0003-1152-1517; Alenda, Cristina/0000-0002-0560-1759; Poca Sans, Maria/0000-0002-0235-1395; Pinol, Virginia/0000-0003-3669-6989; ESTEVE, MARIA/0000-0002-3178-7008; Bessa Caserras, Xavier/0000-0003-4680-1228; Fernandez-Banares, Fernando/0000-0002-1489-504X; Castellvi-Bel, Sergi/0000-0003-1217-5097; Sanchez Hernandez, Eloy/0000-0003-2493-8303; Pellise, Maria/0000-0001-9739-4998; ESTEVE, MARIA/0000-0001-7716-0027; Balaguer, Francesc/0000-0002-0206-0539	Hospital Clinic of Barcelona; Ministerio de Economi-a y Competitividad [SAF 2007-64873, SAF2010-19273]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III [PI10/00384]	Hospital Clinic of Barcelona; Ministerio de Economi-a y Competitividad(Spanish Government); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Hospital Clinic of Barcelona (Josep Font grant), Ministerio de Economi-a y Competitividad (SAF 2007-64873 and SAF2010-19273), Fundacion Cientifica de la Asociacion Espanola contra el Cancer, and Instituto de Salud Carlos III (PI10/00384). "Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Union Europea. Una manera de hacer Europa''. CIBEREHD is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Catalano V, 2011, HISTOPATHOLOGY, V58, P669, DOI 10.1111/j.1365-2559.2011.03818.x; Chan AOO, 2002, AM J PATHOL, V160, P529, DOI 10.1016/S0002-9440(10)64872-9; Chen HS, 2000, DIS COLON RECTUM, V43, P1093, DOI 10.1007/BF02236556; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Giraldez MD, 2010, CLIN CANCER RES, V16, P5402, DOI 10.1158/1078-0432.CCR-10-1491; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ferracin M, 2008, J PATHOL, V214, P594, DOI 10.1002/path.2318; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Gonzalo Victoria, 2008, Gastroenterol Hepatol, V31, P37; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Joensuu EI, 2008, CANCER RES, V68, P4597, DOI 10.1158/0008-5472.CAN-07-6645; Kamiyama H, 2012, ONCOGENE, V31, P5029, DOI 10.1038/onc.2011.652; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; Latournerie M, 2008, BRIT J SURG, V95, P1528, DOI 10.1002/bjs.6382; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lorenzi T, 2013, INT J CANC; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Mullany SA, 2011, CLIN CANCER RES, V17, P427, DOI 10.1158/1078-0432.CCR-09-3069; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2006, MODERN PATHOL, V19, P1083, DOI 10.1038/modpathol.3800618; Pedroni M, 1999, INT J CANCER, V81, P1; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Pinol V, 2004, DIS COLON RECTUM, V47, P1192, DOI 10.1007/s10350-004-0562-7; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164; Zauber P, 2013, J MOL DIAGN, V15, P652, DOI 10.1016/j.jmoldx.2013.03.009; Zuo XS, 2012, J NATL CANCER I, V104, P709, DOI 10.1093/jnci/djs187	42	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91033	10.1371/journal.pone.0091033	http://dx.doi.org/10.1371/journal.pone.0091033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643221	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900011
J	Narayan, EJ; Hero, JM				Narayan, Edward J.; Hero, Jean-Marc			Acute Thermal Stressor Increases Glucocorticoid Response but Minimizes Testosterone and Locomotor Performance in the Cane Toad (Rhinella marina)	PLOS ONE			English	Article							CORTICOSTERONE METABOLITE RESPONSES; BASE-LINE CORTICOSTERONE; SHORT-TERM CAPTURE; URINARY CORTICOSTERONE; CLIMATE-CHANGE; REPEATABILITY; TEMPERATURE; WILD; ELEVATION; PATTERNS	Climatic warming is a global problem and acute thermal stressor in particular could be considered as a major stressor for wildlife. Cane toads (Rhinella marina) have expanded their range into warmer regions of Australia and they provide a suitable model species to study the sub-lethal impacts of thermal stressor on the endocrine physiology of amphibians. Presently, there is no information to show that exposure to an acute thermal stressor could initiate a physiological stress (glucocorticoid) response and secondly, the possible effects on reproductive hormones and performance. Answering these questions is important for understanding the impacts of extreme temperature on amphibians. In this study, we experimented on cane toads from Queensland, Australia by acclimating them to mildly warm temperature (25 degrees C) and then exposing to acute temperature treatments of 30 degrees, 35 degrees or 40 degrees C (hypothetical acute thermal stressors). We measured acute changes in the stress hormone corticosterone and the reproductive hormone testosterone using standard capture and handling protocol and quantified the metabolites of both hormones non-invasively using urinary enzyme-immunoassays. Furthermore, we measured performance trait (i.e. righting response score) in the control acclimated and the three treatment groups. Corticosterone stress responses increased in all toads during exposure to an acute thermal stressor. Furthermore, exposure to a thermal stressor also decreased testosterone levels in all toads. The duration of the righting response (seconds) was longer for toads that were exposed to 40 degrees C than to 30 degrees, 35 degrees or 25 degrees C. The increased corticosterone stress response with increased intensity of the acute thermal stressor suggests that the toads perceived this treatment as a stressor. Furthermore, the results also highlight a potential trade-off with performance and reproductive hormones. Ultimately, exposure acute thermal stressors due to climatic variability could impact amphibians at multiple ecophysiological levels through impacts on endocrine physiology, performance and potentially fitness traits (e. g. reproductive output).	[Narayan, Edward J.; Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Nathan, Qld 4111, Australia	Griffith University	Narayan, EJ (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Nathan, Qld 4111, Australia.	e.narayan@ga.griffith.edu.au	Narayan, Edward/E-8238-2016	Narayan, Edward/0000-0003-2719-0900	Griffith University	Griffith University(Griffith University)	This research was supported by funding to EJN provided by the Griffith University New Researcher Grant 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; CALLARD GV, 1975, J COMP PHYSIOL, V99, P271, DOI 10.1007/BF00710367; Coumou D, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034018; Cunningham SJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080036, 10.1371/journal.pone.0082492]; GALINA ZH, 1983, PHARMACOL BIOCHEM BE, V19, P251, DOI 10.1016/0091-3057(83)90048-5; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Jessop TS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1444; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kindermann C, 2013, COMP BIOCHEM PHYS A, V165, P223, DOI 10.1016/j.cbpa.2013.03.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Laurance WF, 2011, BIOL CONSERV, V144, P1472, DOI 10.1016/j.biocon.2011.01.016; LEBOULENGER F, 1978, GEN COMP ENDOCR, V36, P327, DOI 10.1016/0016-6480(78)90114-4; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan E, 2010, AUST J ZOOL, V58, P189, DOI 10.1071/ZO10010; Narayan EJ, 2014, J THERM BIOL, V41, P72, DOI 10.1016/j.jtherbio.2014.02.011; Narayan EJ, 2013, J EXP ZOOL PART A, V319, P471, DOI 10.1002/jez.1810; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Narayan EJ, 2013, GEN COMP ENDOCR, V191, P225, DOI 10.1016/j.ygcen.2013.06.018; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V165, P304, DOI 10.1016/j.cbpa.2013.03.033; Narayan EJ, 2012, GEN COMP ENDOCR, V179, P345, DOI 10.1016/j.ygcen.2012.09.017; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V164, P21, DOI 10.1016/j.cbpa.2012.10.001; Narayan EJ, 2012, GEN COMP ENDOCR, V178, P301, DOI 10.1016/j.ygcen.2012.06.014; Narayan EJ, 2011, AUST J ZOOL, V59, P264, DOI 10.1071/ZO11070; Narayan EJ, 2012, GEN COMP ENDOCR, V175, P284, DOI 10.1016/j.ygcen.2011.11.023; Narayan EJ, 2011, GEN COMP ENDOCR, V174, P238, DOI 10.1016/j.ygcen.2011.09.004; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Narayan EJ, 2010, GEN COMP ENDOCR, V166, P172, DOI 10.1016/j.ygcen.2009.10.003; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Preest MR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P641, DOI 10.1086/590371; Shukla P.R., 2022, CLIMATE CHANGE 2013; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SUMPTER JP, 1985, GEN COMP ENDOCR, V59, P257, DOI 10.1016/0016-6480(85)90377-6; Sutherst RW, 1996, CONSERV BIOL, V10, P294, DOI 10.1046/j.1523-1739.1996.10010294.x; Todd BD, 2011, P ROY SOC B-BIOL SCI, V278, P2191, DOI 10.1098/rspb.2010.1768; Tyler M. J., 1989, AUSTR FROGS; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385	41	24	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92090	10.1371/journal.pone.0092090	http://dx.doi.org/10.1371/journal.pone.0092090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643017	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900083
J	Arula, T; Groger, J; Ojaveer, H; Simm, M				Arula, Timo; Groeger, Joachim; Ojaveer, Henn; Simm, Mart			Shifts in the Spring Herring (Clupea harengus membras) Larvae and Related Environment in the Eastern Baltic Sea over the Past 50 Years	PLOS ONE			English	Article							REGIME SHIFTS; NORTH-SEA; TROPHIC INTERACTIONS; MARINE ECOSYSTEMS; CLIMATE-CHANGE; MISMATCH; CIRCULATION; MECHANISMS; MANAGEMENT; PREDATION	Because of the high management relevance, commercial fish related aspects have often been central in marine ecosystem investigations. The iterative shiftogram method was applied to detect occurrence, type and timing of shifts in the single and multivariate time series linked to the spring spawning herring larvae in the Gulf of Riga (Baltic Sea). Altogether nineteen larval herring and related environmental variables were utilized during the period of 1957-2010. All the time series investigated, either single or multivariate, exhibited one or more shifts with variable type and timing. Multivariate shiftogram based on all time series identified two distinct states (1957-1983 and 1992-2010) in studied variables, separated by a smooth transition period lasting almost ten years. The observed shift was mainly related to hydroclimate and not to phenology or biota. Significantly increased variability was found in larval herring and recruitment abundances after the shift. While the shift in hydroclimate (1985-1991) was followed by the shift in phenology (1991-1997), the shift in biota occurred remarkably later (2003). It is likely that the dynamics in biota were affected by other drivers than those investigated in the current paper.	[Arula, Timo; Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Groeger, Joachim] Thunen Inst Sea Fisheries, Hamburg, Germany; [Groeger, Joachim] Univ Rostock, Inst Biosci, D-18055 Rostock, Germany; [Simm, Mart] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia	University of Tartu; Estonian Marine Institute; Johann Heinrich von Thunen Institute; University of Rostock; University of Tartu; Estonian Marine Institute	Arula, T (corresponding author), Univ Tartu, Estonian Marine Inst, Parnu, Estonia.	timo.arula@ut.ee	Ojaveer, Henn/K-2160-2016; arula, timo/G-8710-2017	Ojaveer, Henn/0000-0003-2742-6063; arula, timo/0000-0001-9621-1168	Estonian Ministry of Education and Research [SF0180005s10]; Institutional research funding of the Estonian Research Council [IUT02-20]; Estonian Science Foundation [8254, 8747]; European Community [266445]; project on The status of marine biodiversity and its potential futures in the Estonian coastal sea of Environmental protection and - technology programme of European Regional Fund [3.2.0802.11-0029]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Institutional research funding of the Estonian Research Council(Estonian Research Council); Estonian Science Foundation; European Community(European Commission); project on The status of marine biodiversity and its potential futures in the Estonian coastal sea of Environmental protection and - technology programme of European Regional Fund	This work was partially financed by the Estonian Ministry of Education and Research (grantSF0180005s10), Institutional research funding IUT02-20 of the Estonian Research Council and by the Estonian Science Foundation (grants 8254, 8747). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). The study has been supported by the project on The status of marine biodiversity and its potential futures in the Estonian coastal sea 3.2.0802.11-0029 of Environmental protection and - technology programme of European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Arula T, 2012, J SEA RES, V68, P33, DOI 10.1016/j.seares.2011.12.003; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Choi JS, 2005, OCEANOGR MAR BIOL, V43, P47; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Diekmann R, 2010, INTEGRATED ECOSYSTEM; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Greve W, 2005, ICES J MAR SCI, V62, P1216, DOI 10.1016/j.icesjms.2005.03.011; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; HELCOM, 1988, GUID BALT MON PROGR; HELCOM, 2009, BALT SEA ENV P, V116A; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; ICES, 2012, REP ICES HELCOM WORK; ICES, 2011, REP BALT FISH ASS WO; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kotta J, 2009, ESTUAR COAST SHELF S, V84, P509, DOI 10.1016/j.ecss.2009.07.014; Kraberg AC, 2011, MAR POLLUT BULL, V62, P7, DOI 10.1016/j.marpolbul.2010.09.010; Laur K, 2014, ESTUAR COAST SHELF S, V136, P112, DOI 10.1016/j.ecss.2013.11.011; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lehtiniemi M, 2008, MAR ECOL PROG SER, V362, P193, DOI 10.3354/meps07441; Lindegren M, 2010, MAR ECOL PROG SER, V402, P239, DOI 10.3354/meps08454; Link JS, 2002, N AM J FISH MANAGE, V22, P550, DOI 10.1577/1548-8675(2002)022<0550:EIBEAG>2.0.CO;2; McQuatters-Gollop A, 2007, LIMNOL OCEANOGR, V52, P635, DOI 10.4319/lo.2007.52.2.0635; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2011, MAR ECOL PROG SER, V431, P293, DOI 10.3354/meps09205; Ojaveer E, 2011, FISH RES, V107, P159, DOI 10.1016/j.fishres.2010.11.001; Ojaveer E, 1988, BALTIC HERRINGS BIOL; Ojaveer H, 1999, ICES J MAR SCI, V56, P33, DOI 10.1006/jmsc.1999.0609; Omstedt A, 2011, GUIDE TO PROCESS BASED MODELING OF LAKES AND COASTAL SEAS, P1, DOI 10.1007/978-3-642-17728-6; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rannak L, 1971, RAPP P VERB REU CONS, P77; Rannak L, 1979, 1979J9 ICES CM, V9; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schlittgen R., 2001, ANGEW ZEITREIHENANAL; Schwing FB, 2009, REGIME SHIFTS PHYS F, P709; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106	48	11	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91304	10.1371/journal.pone.0091304	http://dx.doi.org/10.1371/journal.pone.0091304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637830	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100027
J	Chan, SHJ; Norregaard, L; Solem, C; Jensen, PR				Chan, Siu Hung Joshua; Norregaard, Lasse; Solem, Christian; Jensen, Peter Ruhdal			Acetate Kinase Isozymes Confer Robustness in Acetate Metabolism	PLOS ONE			English	Article							PYRUVATE-FORMATE-LYASE; ACETYL-COENZYME-A; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; METHANOSARCINA-THERMOPHILA; BACILLUS-STEAROTHERMOPHILUS; ACTIVE-SITE; GROWTH; PURIFICATION; EXPRESSION	Acetate kinase (ACK) (EC no: 2.7.2.1) interconverts acetyl-phosphate and acetate to either catabolize or synthesize acetyl-CoA dependent on the metabolic requirement. Among all ACK entries available in UniProt, we found that around 45% are multiple ACKs in some organisms including more than 300 species but surprisingly, little work has been done to clarify whether this has any significance. In an attempt to gain further insight we have studied the two ACKs (AckA1, AckA2) encoded by two neighboring genes conserved in Lactococcus lactis (L. lactis) by analyzing protein sequences, characterizing transcription structure, determining enzyme characteristics and effect on growth physiology. The results show that the two ACKs are most likely individually transcribed. AckA1 has a much higher turnover number and AckA2 has a much higher affinity for acetate in vitro. Consistently, growth experiments of mutant strains reveal that AckA1 has a higher capacity for acetate production which allows faster growth in an environment with high acetate concentration. Meanwhile, AckA2 is important for fast acetate-dependent growth at low concentration of acetate. The results demonstrate that the two ACKs have complementary physiological roles in L. lactis to maintain a robust acetate metabolism for fast growth at different extracellular acetate concentrations. The existence of ACK isozymes may reflect a common evolutionary strategy in bacteria in an environment with varying concentrations of acetate.	[Chan, Siu Hung Joshua; Norregaard, Lasse; Solem, Christian; Jensen, Peter Ruhdal] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark	Solem, C (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark.	cso@food.dtu.dk; perj@food.dtu.dk	jensen, Peter Ruhdal/AAC-4891-2019; Chan, Siu Hung Joshua/N-9777-2016	Jensen, Peter Ruhdal/0000-0003-2080-2070; Solem, Christian/0000-0002-3898-280X; Chan, Siu Hung Joshua/0000-0002-7707-656X	Danish research council for Nature and Universe (FNU) [10-085115]	Danish research council for Nature and Universe (FNU)(Danish Natural Science Research Council)	This work was supported by the Danish research council for Nature and Universe (FNU; Grant #10-085115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; ANDERSCH W, 1983, EUR J APPL MICROBIOL, V18, P327, DOI 10.1007/BF00504740; Andersen HW, 2001, J BACTERIOL, V183, P3458, DOI 10.1128/JB.183.11.3458-3467.2001; BOWMAN CM, 1976, J BIOL CHEM, V251, P3117; Brondsted L, 1999, APPL ENVIRON MICROB, V65, P752; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001; Buss KA, 1997, PROTEIN SCI, V6, P2659; Chittori S, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-24; Contiero J, 2000, J IND MICROBIOL BIOT, V24, P421, DOI 10.1038/sj.jim.7000014; de Felipe FL, 2009, APPL MICROBIOL BIOT, V82, P1115, DOI 10.1007/s00253-009-1897-8; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; Eckhardt TH, 2013, J BACTERIOL, V195, P1081, DOI 10.1128/JB.02043-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez M, 2002, J BACTERIOL, V184, P82, DOI 10.1128/JB.184.1.82-90.2002; FOX DK, 1986, J BIOL CHEM, V261, P3487; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GRUNDY FJ, 1993, J BACTERIOL, V175, P7348, DOI 10.1128/JB.175.22.7348-7355.1993; HARWOOD CS, 1982, J BACTERIOL, V152, P246; Henriksen CM, 2001, APPL MICROBIOL BIOT, V56, P767, DOI 10.1007/s002530100694; Hertzberger RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057235; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; ISHIKAWA H, 1995, J CHEM ENG JPN, V28, P517, DOI 10.1252/jcej.28.517; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Jensen PR, 1993, APPL ENVIRON MICROB, V59, P4263; JOHANSEN E, 1992, J DAIRY SCI, V75, P1186, DOI 10.3168/jds.S0022-0302(92)77865-5; KAHANE I, 1979, J BACTERIOL, V137, P764, DOI 10.1128/JB.137.2.764-772.1979; KAKUDA H, 1994, BIOSCI BIOTECH BIOCH, V58, P2232, DOI 10.1271/bbb.58.2232; Knorr R, 2001, MICROBIOL RES, V156, P267, DOI 10.1078/0944-5013-00114; Koebmann BJ, 2002, APPL ENVIRON MICROB, V68, P4274, DOI 10.1128/AEM.68.9.4274-4282.2002; Koebmann B, 2008, BIOTECHNOL APPL BIOC, V50, P25, DOI 10.1042/BA20070132; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Lin WLR, 1998, TETRAHEDRON, V54, P15915, DOI 10.1016/S0040-4020(98)01001-1; Melchiorsen CR, 2000, J BACTERIOL, V182, P4783, DOI 10.1128/JB.182.17.4783-4788.2000; Melchiorsen CR, 2002, APPL MICROBIOL BIOT, V58, P338, DOI 10.1007/s00253-001-0892-5; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073907; Miles RD, 2002, J BIOL CHEM, V277, P22547, DOI 10.1074/jbc.M105921200; Miles RD, 2001, J BIOL CHEM, V276, P45059, DOI 10.1074/jbc.M108355200; Miller J.H., 1972, EXPT MOL GENETICS; NAKAJIMA H, 1978, J BIOCHEM, V84, P193, DOI 10.1093/oxfordjournals.jbchem.a132108; Sambrook J., 2002, MOL CLONING LAB MANU; Singh-Wissmann K, 1998, J BACTERIOL, V180, P1129, DOI 10.1128/JB.180.5.1129-1134.1998; SKOOG K, 1992, APPL ENVIRON MICROB, V58, P2552, DOI 10.1128/AEM.58.8.2552-2558.1992; SNOEP JL, 1993, FEMS MICROBIOL LETT, V114, P279, DOI 10.1016/0378-1097(93)90284-9; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; Solem C, 2007, J BACTERIOL, V189, P6727, DOI 10.1128/JB.00902-07; SPECTOR LB, 1980, P NATL ACAD SCI-BIOL, V77, P2626, DOI 10.1073/pnas.77.5.2626; THOMAS TD, 1979, J BACTERIOL, V138, P109, DOI 10.1128/JB.138.1.109-117.1979; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	56	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92256	10.1371/journal.pone.0092256	http://dx.doi.org/10.1371/journal.pone.0092256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638105	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100135
J	Chen, LH; Advani, SL; Thai, K; Kabir, MG; Sood, MM; Gibson, IW; Yuen, DA; Connelly, KA; Marsden, PA; Kelly, DJ; Gilbert, RE; Advani, A				Chen, Li-Hao; Advani, Suzanne L.; Thai, Kerri; Kabir, M. Golam; Sood, Manish M.; Gibson, Ian W.; Yuen, Darren A.; Connelly, Kim A.; Marsden, Philip A.; Kelly, Darren J.; Gilbert, Richard E.; Advani, Andrew			SDF-1/CXCR4 Signaling Preserves Microvascular Integrity and Renal Function in Chronic Kidney Disease	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL-CELLS; UP-REGULATION; EXPRESSION; GROWTH; VEGF; INJURY; GLOMERULOSCLEROSIS; PATHOGENESIS; ACETYLATION	The progressive decline of renal function in chronic kidney disease (CKD) is characterized by both disruption of the microvascular architecture and the accumulation of fibrotic matrix. One angiogenic pathway recently identified as playing an essential role in renal vascular development is the stromal cell-derived factor-1 alpha (SDF-1)/CXCR4 pathway. Because similar developmental processes may be recapitulated in the disease setting, we hypothesized that the SDF-1/CXCR4 system would regulate microvascular health in CKD. Expression of CXCR4 was observed to be increased in the kidneys of subtotally nephrectomized (SNx) rats and in biopsies from patients with secondary focal segmental glomerulosclerosis (FSGS), a rodent model and human correlate both characterized by aberration of the renal microvessels. A reno-protective role for local SDF-1/CXCR4 signaling was indicated by i) CXCR4-dependent glomerular eNOS activation following acute SDF-1 administration; and ii) acceleration of renal function decline, capillary loss and fibrosis in SNx rats treated with chronic CXCR4 blockade. In contrast to the upregulation of CXCR4, SDF-1 transcript levels were decreased in SNx rat kidneys as well as in renal fibroblasts exposed to the pro-fibrotic cytokine transforming growth factor beta (TGF-beta), the latter effect being attenuated by histone deacetylase inhibition. Increased renal SDF-1 expression was, however, observed following the treatment of SNx rats with the ACE inhibitor, perindopril. Collectively, these observations indicate that local SDF-1/CXCR4 signaling functions to preserve microvascular integrity and prevent renal fibrosis. Augmentation of this pathway, either purposefully or serendipitously with either novel or existing therapies, may attenuate renal decline in CKD.	[Chen, Li-Hao; Advani, Suzanne L.; Thai, Kerri; Kabir, M. Golam; Yuen, Darren A.; Connelly, Kim A.; Marsden, Philip A.; Gilbert, Richard E.; Advani, Andrew] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Chen, Li-Hao; Advani, Suzanne L.; Thai, Kerri; Kabir, M. Golam; Yuen, Darren A.; Connelly, Kim A.; Marsden, Philip A.; Gilbert, Richard E.; Advani, Andrew] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Sood, Manish M.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Gibson, Ian W.] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada; [Kelly, Darren J.] St Vincents Hosp, Dept Med, Melbourne, Vic, Australia	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Manitoba; Children's Hospital Research Institute of Manitoba; St Vincent's Hospital Melbourne	Advani, A (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	advania@smh.ca	Sood, Manish M/H-3134-2019	Sood, Manish M/0000-0002-9146-2344; Kelly, Darren/0000-0003-4850-3929; Gibson, Ian/0000-0003-3505-0262	CIHR [MOP-97791]; Canadian Diabetes Association (CDA) [OG-3-10-2949-AA]; CIHR Frederick Banting and Charles Best Graduate Scholarship; Banting and Best Diabetes Centre Graduate Studentship; Canadian Diabetes Association	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA); CIHR Frederick Banting and Charles Best Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre Graduate Studentship; Canadian Diabetes Association	These studies were supported by grants from CIHR (grant MOP-97791) and the Canadian Diabetes Association (CDA, OG-3-10-2949-AA) to Dr. Advani. Mr. Chen was supported by a CIHR Frederick Banting and Charles Best Graduate Scholarship and a Banting and Best Diabetes Centre Graduate Studentship. Dr. Advani is a Canadian Diabetes Association Clinician Scientist and this work was supported, in part, by the Canadian Diabetes Association. Dr. Gilbert is a Canada Research Chair in Diabetes Complications. Dr. Yuen is a KRESCENT New Investigator and Canadian Diabetes Association Clinician Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Advani A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024695; Advani A, 2011, AM J PATHOL, V178, P2205, DOI 10.1016/j.ajpath.2011.01.044; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; BURLINGTON H, 1973, P SOC EXP BIOL MED, V142, P143, DOI 10.3181/00379727-142-36977; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chabane N, 2009, J CELL BIOCHEM, V106, P453, DOI 10.1002/jcb.22027; Chu PY, 2011, CIRC-HEART FAIL, V4, P651, DOI 10.1161/CIRCHEARTFAILURE.110.960831; Dai SJ, 2010, J MOL CELL CARDIOL, V49, P587, DOI 10.1016/j.yjmcc.2010.07.010; Daly AJ, 2008, ORAL ONCOL, V44, P646, DOI 10.1016/j.oraloncology.2007.08.012; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fine LG, 1998, KIDNEY INT, pS74; Floege J, 2009, J AM SOC NEPHROL, V20, P1659, DOI 10.1681/ASN.2009060621; Fogo AB, 2005, CURR OPIN NEPHROL HY, V14, P201, DOI 10.1097/01.mnh.0000165883.08675.ab; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gilbert RE, 1999, AM J PATHOL, V155, P429, DOI 10.1016/S0002-9440(10)65139-5; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Johnson RJ, 1997, AM J PATHOL, V151, P1179; Kanda S, 2003, J BIOL CHEM, V278, P257, DOI 10.1074/jbc.M204771200; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Kelly DJ, 2003, NEPHROL DIAL TRANSPL, V18, P1286, DOI 10.1093/ndt/gfg176; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Sameermahmood Z, 2008, INVEST OPHTH VIS SCI, V49, P3305, DOI 10.1167/iovs.07-0456; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543	48	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92227	10.1371/journal.pone.0092227	http://dx.doi.org/10.1371/journal.pone.0092227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637920	Green Published, gold			2022-12-25	WOS:000333254100130
J	Feng, J; Zhang, H; Strelkov, SE; Hwang, SF				Feng, Jie; Zhang, Hui; Strelkov, Stephen E.; Hwang, Sheau-Fang			The LmSNF1 Gene Is Required for Pathogenicity in the Canola Blackleg Pathogen Leptosphaeria maculans	PLOS ONE			English	Article							PHOMA STEM CANKER; INDUCED POINT MUTATIONS; CELL-WALL DEGRADATION; SNF1 PROTEIN-KINASE; RICE BLAST FUNGUS; BRASSICA-NAPUS; OILSEED RAPE; FILAMENTOUS FUNGI; SACCHAROMYCES-CEREVISIAE; AVIRULENCE GENE	Leptosphaeria maculans is a fungal pathogen causing blackleg in canola. Its virulence has been attributed, among other factors, to the activity of hydrolytic cell wall degrading enzymes (CWDEs). Studies on the pathogenicity function of CWDEs in plant pathogenic fungi have been difficult due to gene redundancy. In microorganisms many CWDE genes are repressed by glucose and derepressed by the function of the sucrose non-fermenting protein kinase 1 gene (SNF1). To address the molecular function of SNF1 in L. maculans, the ortholog of SNF1 (LmSNF1) was cloned and functionally characterized using a gene knockout strategy. Growth of the LmSNF1 knockout strains was severely disrupted, as was sporulation, spore germination and the ability to attach on the plant surface. When inoculated on canola cotyledons, the LmSNF1 knockout strains could not cause any symptoms, indicating the loss of pathogenicity. The expression of 11 selected CWDE genes and a pathogenicity gene (LopB) was significantly down-regulated in the LmSNF1 knockout strains. In conclusion, knockout of LmSNF1 prevents L. maculans from properly derepressing the production of CWDEs, compromises the utilization of certain carbon sources, and impairs fungal pathogenicity on canola.	[Feng, Jie; Hwang, Sheau-Fang] Alberta Agr & Rural Dev, Crop Diversificat Ctr North, Edmonton, AB, Canada; [Zhang, Hui] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Strelkov, Stephen E.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Alberta	Hwang, SF (corresponding author), Alberta Agr & Rural Dev, Crop Diversificat Ctr North, Edmonton, AB, Canada.	sheau-fang.hwang@gov.ab.ca			SaskCanola; Agriculture and Agri-Food Canada under the Growing Forward 2 Program	SaskCanola; Agriculture and Agri-Food Canada under the Growing Forward 2 Program	Financial support was received from SaskCanola and Agriculture and Agri-Food Canada under the Growing Forward 2 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Both M, 2005, PLANT CELL, V17, P2107, DOI 10.1105/tpc.105.032631; CARLSON M, 1981, GENETICS, V98, P25; Carver TLW, 2006, ANNU PLANT REV, V23, P368; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cho Y, 2009, MOL MICROBIOL, V72, P1316, DOI 10.1111/j.1365-2958.2009.06689.x; Choi J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S7; DEISING H, 1992, PLANT CELL, V4, P1101, DOI 10.1105/tpc.4.9.1101; Dilmaghani A, 2009, PLANT PATHOL, V58, P1044, DOI 10.1111/j.1365-3059.2009.02149.x; Elliott CE, 2008, MOL PLANT, V1, P471, DOI 10.1093/mp/ssn014; Elliott CE, 2006, MOL PLANT MICROBE IN, V19, P588, DOI 10.1094/MPMI-19-0588; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Fairhead C, 1998, GENE, V223, P33, DOI 10.1016/S0378-1119(98)00171-1; Feng J, 2005, MICROBIOL-SGM, V151, P3911, DOI 10.1099/mic.0.28261-0; Feng J, 2011, PLANT PATHOL, V60, P698, DOI 10.1111/j.1365-3059.2011.02434.x; Feng J, 2010, CAN J PLANT PATHOL, V32, P396, DOI 10.1080/07060661.2010.508620; Feng J, 2011, MICROBIOL RES, V166, P618, DOI 10.1016/j.micres.2010.12.002; Feng J, 2009, MOL PLANT MICROBE IN, V22, P1601, DOI 10.1094/MPMI-22-12-1601; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Fitt BDL, 2008, PLANT PATHOL, V57, P652, DOI 10.1111/j.1365-3059.2008.01841.x; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Fu HT, 2013, FUNGAL BIOL-UK, V117, P673, DOI 10.1016/j.funbio.2013.07.003; Fudal I, 2007, MOL PLANT MICROBE IN, V20, P459, DOI 10.1094/MPMI-20-4-0459; Garcia-Maceira FI, 2000, MOL PLANT MICROBE IN, V13, P359, DOI 10.1094/MPMI.2000.13.4.359; Goodwin PH, 2002, FEMS MICROBIOL LETT, V215, P169, DOI 10.1111/j.1574-6968.2002.tb11387.x; Gout L, 2006, MOL MICROBIOL, V60, P67, DOI 10.1111/j.1365-2958.2006.05076.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horwitz BA, 1999, FUNGAL GENET BIOL, V26, P19, DOI 10.1006/fgbi.1998.1094; Howlett BJ, 2004, CAN J PLANT PATHOL, V26, P245; Idnurm A, 2003, FUNGAL GENET BIOL, V39, P31, DOI 10.1016/S1087-1845(02)00588-1; Idnurm A, 2002, EUKARYOT CELL, V1, P719, DOI 10.1128/EC.1.5.719-724.2002; JOHNSON RD, 1994, PLANT PATHOL, V43, P269, DOI 10.1111/j.1365-3059.1994.tb02685.x; Jonkers W, 2009, MOL MICROBIOL, V74, P1100, DOI 10.1111/j.1365-2958.2009.06922.x; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Nadal M, 2010, PHYTOPATHOLOGY, V100, P1364, DOI 10.1094/PHYTO-01-10-0011; Osherov N, 2001, FEMS MICROBIOL LETT, V199, P153, DOI 10.1111/j.1574-6968.2001.tb10667.x; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Parlange F, 2009, MOL MICROBIOL, V71, P851, DOI 10.1111/j.1365-2958.2008.06547.x; Remy E, 2009, MOL PLANT MICROBE IN, V22, P725, DOI 10.1094/MPMI-22-6-0725; Remy E, 2008, NEW PHYTOL, V179, P1105, DOI 10.1111/j.1469-8137.2008.02522.x; Remy E, 2008, FUNGAL GENET BIOL, V45, P1122, DOI 10.1016/j.fgb.2008.04.008; RIKKERINK EHA, 1994, CURR GENET, V25, P202, DOI 10.1007/BF00357163; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Sambrook J, 2001, MOL CLONING LAB MANU; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vacher S, 2003, GENE, V310, P113, DOI 10.1016/S0378-1119(03)00525-0; Van de Wouw AP, 2014, MOL PLANT PATHOL, V15, P523, DOI 10.1111/mpp.12105; Van de Wouw APV, 2009, FUNGAL GENET BIOL, V46, P695, DOI 10.1016/j.fgb.2009.06.004; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wu SC, 1997, MOL PLANT MICROBE IN, V10, P700, DOI 10.1094/MPMI.1997.10.6.700; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yi M, 2008, FUNGAL GENET BIOL, V45, P1172, DOI 10.1016/j.fgb.2008.05.003; Zhang TY, 2013, APPL MICROBIOL BIOT, V97, P5433, DOI 10.1007/s00253-012-4593-z	65	19	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92503	10.1371/journal.pone.0092503	http://dx.doi.org/10.1371/journal.pone.0092503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638039	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100151
J	Kitano, K; Usui, S; Ootsuji, H; Takashima, S; Kobayashi, D; Murai, H; Furusho, H; Nomura, A; Kaneko, S; Takamura, M				Kitano, Katsunori; Usui, Soichiro; Ootsuji, Hiroshi; Takashima, Shin-ichiro; Kobayashi, Daisuke; Murai, Hisayoshi; Furusho, Hiroshi; Nomura, Ayano; Kaneko, Shuichi; Takamura, Masayuki			Rho-Kinase Activation in Leukocytes Plays a Pivotal Role in Myocardial Ischemia/Reperfusion Injury	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CARDIAC-HYPERTROPHY; NEUTROPHIL DEPLETION; ISCHEMIA-REPERFUSION; APOPTOSIS; INHIBITION; EXPRESSION; ALPHA; SUPPRESSION; DYSFUNCTION	The Rho/Rho-kinase pathway plays an important role in many cardiovascular diseases such as hypertension, atherosclerosis, heart failure, and myocardial infarction. Although previous studies have shown that Rho-kinase inhibitors reduce ischemia/reperfusion (I/R) injury and cytokine production, the role of Rho-kinase in leukocytes during I/R injury is not well understood. Mice were subjected to 30-min ischemia and reperfusion. Rho-kinase activity was significantly greater in leukocytes subjected to myocardial I/R compared to the sham-operated mice. Administration of fasudil, a Rho-kinase inhibitor, significantly reduced the I/R-induced expression of the proinflammatory cytokines interleukin (IL)-6, C-C motif chemoattractant ligand 2 (CCL2), and tumor necrosis factor (TNF)-alpha, in leukocytes, compared with saline as the vehicle. Furthermore, fasudil decreased I/R-induced myocardial infarction/area at risk (IA) and I/R-induced leukocyte infiltration in the myocardium. Interestingly, IA in fasudil-administered mice with leukocyte depletion was similar to that in fasudil-administered mice. I/R also resulted in remarkable increases in the mRNA expression levels of the proinflammatory cytokines TNF-alpha, IL-6, and CCL2 in the heart. Inhibition of Rho-kinase activation in leukocytes has an important role in fasudil-induced cardioprotective effects. Hence, inhibition of Rho-kinase may be an additional therapeutic intervention for the treatment of acute coronary syndrome.	[Kitano, Katsunori; Usui, Soichiro; Ootsuji, Hiroshi; Takashima, Shin-ichiro; Kobayashi, Daisuke; Murai, Hisayoshi; Furusho, Hiroshi; Nomura, Ayano; Kaneko, Shuichi; Takamura, Masayuki] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan	Kanazawa University	Usui, S (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	usuiso@m-kanazawa.jp; skaneko@m-kanazawa.jp	USUI, Soichiro/GQH-4849-2022; FURUSHO, Hiroshi/L-3710-2015	FURUSHO, Hiroshi/0000-0002-8428-4615; Usui, Soichiro/0000-0003-1752-8082	Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-24591092, C-25461049, B-25860590]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (C-24591092 to SU, C-25461049 to MT), and a Grant-in-aid for Young Scientists (B-25860590 to HO) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, BLOOD, V107, P2004, DOI 10.1182/blood-2005-06-2345; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Bolger AP, 2002, AM J CARDIOL, V90, P384, DOI 10.1016/S0002-9149(02)02494-3; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Feske SK, 2009, BRAIN RES, V1257, P89, DOI 10.1016/j.brainres.2008.12.045; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; Hasan Z, 2012, SHOCK, V37, P282, DOI 10.1097/SHK.0b013e3182426be4; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; Kin H, 2006, J SURG RES, V135, P170, DOI 10.1016/j.jss.2006.02.019; Lawson CA, 1997, J CLIN INVEST, V99, P1729, DOI 10.1172/JCI119337; Liu YH, 2012, J VIROL, V86, P1372, DOI 10.1128/JVI.06245-11; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Nakayama M, 2008, ATHEROSCLEROSIS, V198, P426, DOI 10.1016/j.atherosclerosis.2007.09.006; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Ohtani K, 2012, HYPERTENS RES, V35, P287, DOI 10.1038/hr.2011.183; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Ootsuji H, 2010, CIRC-CARDIOVASC GENE, V3, P68, DOI 10.1161/CIRCGENETICS.108.795484; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pfohl M, 1999, ATHEROSCLEROSIS, V142, P389, DOI 10.1016/S0021-9150(98)00242-1; Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Shibata M, 1997, J INTERF CYTOK RES, V17, P145, DOI 10.1089/jir.1997.17.145; Shimokawa H, 2002, J CARDIOVASC PHARM, V40, P749; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Tousoulis D, 2007, INT J CARDIOL, V115, P203, DOI 10.1016/j.ijcard.2006.03.011; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093	38	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92242	10.1371/journal.pone.0092242	http://dx.doi.org/10.1371/journal.pone.0092242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638037	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100132
J	Owais, M; Kazmi, S; Tufail, S; Zubair, S				Owais, Mohammad; Kazmi, Shadab; Tufail, Saba; Zubair, Swaleha			An Alternative Chemical Redox Method for the Production of Bispecific Antibodies: Implication in Rapid Detection of Food Borne Pathogens	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODIES; LISTERIA-MONOCYTOGENES; MODEL; ERYTHROCYTES; PROTEINS; DISEASE; GHOSTS; BLOOD	Bi-functional antibodies with the ability to bind two unrelated epitopes have remarkable potential in diagnostic and biosensing applications. In the present study, bispecific antibodies that recognize human red blood cell (RBC) and the food borne pathogen Listeria monocytogenes (L. monocytogenes) were engineered. The procedure involves initial reduction of a mixture of anti-RBC and anti-Listeria antibodies followed by gradual re-oxidation of the reduced disulphides. This facilitates association of the separated antibody chains and formation of hybrid immunoglobulins with affinity for the L. monocytogenes and human RBC. The bispecific antibodies caused the agglutination of the RBCs only in the presence of L. monocytogenes cells. The agglutination process necessitated the specific presence of L. monocytogenes and the red colored clumps formed were readily visible with naked eyes. The RBC agglutination assay described here provides a remarkably simple approach for the rapid and highly specific screening of various pathogens in their biological niches.	[Owais, Mohammad; Kazmi, Shadab; Tufail, Saba] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Zubair, S (corresponding author), Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India.	swalehazubair@yahoo.com		Kazmi, Shadab/0000-0002-1860-0624; Mohammad, Owais/0000-0001-7377-7388	Indian Council of Agriculture Research [NF/PHT-3028/2012-13]	Indian Council of Agriculture Research	The financial assistance was provided by Indian Council of Agriculture Research (www.icar.nic.in) against project sanction (NF/PHT-3028/2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2004, CLIN INFECT DIS, V38, pS115, DOI 10.1086/381577; Banada Padmapriya P, 2008, PRINCIPLES BACTERIAL, VIII, P567; BHUNIA AK, 2006, SCI HOMELAND SECURIT, P109; BRATCHER RL, 1974, J IMMUNOL, V112, P1337; Carlring J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022533; [CDC Department of Health and Human Services], 2006, E COLI O; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; De Jonge J, 1998, J IMMUNOL, V161, P1454; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Gasanov U, 2005, FEMS MICROBIOL REV, V29, P851, DOI 10.1016/j.femsre.2004.12.002; Guttikonda Sujatha, 2004, J Pharm Pharm Sci, V7, P7; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351; Iglesias BF, 2005, RES VET SCI, V79, P19, DOI 10.1016/j.rvsc.2004.10.004; Kendall PA, 2006, CLIN INFECT DIS, V42, P1298, DOI 10.1086/503262; Likhite Neah, 2011, J Biomol Tech, V22, P37; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Menard S, 1989, Int J Biol Markers, V4, P131; Mujahid S, 2007, ELECTROPHORESIS, V28, P3998, DOI 10.1002/elps.200600858; Muller S, 1998, INFECT IMMUN, V66, P3128; Ohk SH, 2010, J APPL MICROBIOL, V109, P808, DOI 10.1111/j.1365-2672.2010.04709.x; Orcutt KD, 2010, PROTEIN ENG DES SEL, V23, P221, DOI 10.1093/protein/gzp077; PORATH J, 1983, ARCH BIOCHEM BIOPHYS, V225, P543, DOI 10.1016/0003-9861(83)90065-6; Shen JQ, 2006, J BIOL CHEM, V281, P10706, DOI 10.1074/jbc.M513415200; SINGHAL A, 1986, BIOCHIM BIOPHYS ACTA, V880, P72, DOI 10.1016/0304-4165(86)90121-2; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034	29	10	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91255	10.1371/journal.pone.0091255	http://dx.doi.org/10.1371/journal.pone.0091255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637674	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100023
J	Cui, HHL; Ditiatkovski, M; Kesani, R; Bobryshev, YV; Liu, YY; Geyer, M; Mukhamedova, N; Bukrinsky, M; Sviridov, D				Cui, Huanhuan L.; Ditiatkovski, Michael; Kesani, Rajitha; Bobryshev, Yuri V.; Liu, Yingying; Geyer, Matthias; Mukhamedova, Nigora; Bukrinsky, Michael; Sviridov, Dmitri			HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis	FASEB JOURNAL			English	Article						HIV; cholesterol; metabolic syndrome; vessels; macrophages; reverse cholesterol transport	HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; TRANSGENIC MICE; PLASMA HDL; T-CELLS; INFECTION; DISEASE; INFLAMMATION; MACROPHAGES; TRANSPORTER	Patients with HIV are at an increased risk of cardiovascular disease. In this study we investigated the effect of Nef, a secreted HIV protein responsible for the impairment of cholesterol efflux, on the development of atherosclerosis in two animal models. ApoE(-/-) mice fed a high-fat diet and C57BL/6 mice fed a high-fat, high-cholesterol diet were injected with recombinant Nef (40 ng/injection) or vehicle, and the effects of Nef on development of atherosclerosis, inflammation, and dyslipidemia were assessed. In apoE(-/-) mice, Nef significantly increased the size of atherosclerotic lesions and caused vessel remodeling. Nef caused elevation of total cholesterol and triglyceride levels in the plasma while reducing high-density lipoprotein cholesterol levels. These changes were accompanied by a reduction of ABCA1 abundance in the liver, but not in the vessels. In C57BL/6 mice, Nef caused a significant number of lipid-laden macrophages presented in adventitia of the vessels; these cells were absent from the vessels of control mice. Nef caused sharp elevations of plasma triglyceride levels and body weight. Taken together, our findings suggest that Nef causes dyslipidemia and accumulation of cholesterol in macrophages within the vessel wall, supporting the role of Nef in pathogenesis of atherosclerosis in HIV-infected patients.	[Cui, Huanhuan L.; Ditiatkovski, Michael; Kesani, Rajitha; Liu, Yingying; Mukhamedova, Nigora; Sviridov, Dmitri] Baker Heart & Diabet Inst, Melbourne, Vic 8008, Australia; [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Geyer, Matthias] CAESAR, Bonn, Germany; [Bukrinsky, Michael] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA	Baker Heart and Diabetes Institute; University of New South Wales Sydney; Center of Advanced European Studies & Research (CAESAR); George Washington University	Sviridov, D (corresponding author), Baker Heart & Diabet Inst, POB 6492, Melbourne, Vic 8008, Australia.	dmitri.sviridov@bakeridi.edu.au	Sviridov, Dmitri/E-7943-2010; liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022	Geyer, Matthias/0000-0002-7718-5002	National Health and Medical Research Council of Australia [GNT1019847, GNT1036352]; U.S. National Institutes of Health (NIH) [HL093818]; Victorian government's OIS program; District of Columbia Developmental Center for AIDS Research (DC D-CFAR); NIH [1P30AI087714]; May Stewart Bursary; Elizabeth Mary Sweet Scholarship (Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093818, R01HL101274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian government's OIS program; District of Columbia Developmental Center for AIDS Research (DC D-CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); May Stewart Bursary; Elizabeth Mary Sweet Scholarship (Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Health and Medical Research Council of Australia (GNT1019847, GNT1036352) and the U.S. National Institutes of Health (NIH; HL093818), and in part by the Victorian government's OIS program and the District of Columbia Developmental Center for AIDS Research (DC D-CFAR), an NIH-funded program (1P30AI087714). H. L. C. was supported by The May Stewart Bursary and The Elizabeth Mary Sweet Scholarship (Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne). D. S. is a fellow of the National Health and Medical Research Council of Australia. The authors declare no conflicts of interest.	Asztalos BF, 2010, J INFECT DIS, V202, P614, DOI 10.1086/654817; Asztalos BF, 2003, AM J CARDIOL, V91, p12E, DOI 10.1016/S0002-9149(02)03383-0; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Bentzon JF, 2003, ARTERIOSCL THROM VAS, V23, P257, DOI 10.1161/01.ATV.0000051387.70962.79; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; D'Souza W, 2010, CIRC RES, V107, P217, DOI 10.1161/CIRCRESAHA.110.216507; Ditiatkovski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068802; Dubrovsky L, 2012, BIOCHEM BIOPH RES CO, V419, P95, DOI 10.1016/j.bbrc.2012.01.137; Duffy P, 2009, J SURG RES, V156, P257, DOI 10.1016/j.jss.2009.02.005; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Glesby Marshall J, 2005, Curr HIV/AIDS Rep, V2, P68, DOI 10.1007/s11904-005-0021-7; Hanna Z, 2004, VIROLOGY, V327, P273, DOI 10.1016/j.virol.2004.06.028; Huang MB, 2004, J VIROL, V78, P11084, DOI 10.1128/JVI.78.20.11084-11096.2004; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kay DG, 2002, AM J PATHOL, V161, P321, DOI 10.1016/S0002-9440(10)64184-3; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Pourabdollah M, 2013, HEART LUNG CIRC, V22, P19, DOI 10.1016/j.hlc.2012.07.051; Quehenberger O, 2005, J LIPID RES, V46, P1582, DOI 10.1194/jlr.R500008-JLR200; Rose H, 2006, METABOLISM, V55, P90, DOI 10.1016/j.metabol.2005.07.012; Rose H, 2008, ATHEROSCLEROSIS, V199, P79, DOI 10.1016/j.atherosclerosis.2007.10.018; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Sudano I, 2006, AM HEART J, V151, P1147, DOI 10.1016/j.ahj.2005.07.030; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Yamashita A, 2008, HISTOL HISTOPATHOL, V23, P127, DOI 10.14670/HH-23.127; Yu BL, 2010, OBES REV, V11, P560, DOI 10.1111/j.1467-789X.2009.00699.x	33	34	35	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2828	2839		10.1096/fj.13-246876	http://dx.doi.org/10.1096/fj.13-246876			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24642731	Green Published			2022-12-25	WOS:000337949400009
J	Beaudry, JT; Krause, MA; Diakite, SAS; Fay, MP; Joshi, G; Diakite, M; White, NJ; Fairhurst, RM				Beaudry, Jeanette T.; Krause, Michael A.; Diakite, Seidina A. S.; Fay, Michael P.; Joshi, Gyan; Diakite, Mahamadou; White, Nicholas J.; Fairhurst, Rick M.			Ex-Vivo Cytoadherence Phenotypes of Plasmodium falciparum Strains from Malian Children with Hemoglobins A, S, and C	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; SEVERE MALARIA; VAR GENES; PROTECTION; DISEASE; POPULATION; EXPRESSION; VARIANTS; DISPLAY	Sickle hemoglobin (Hb) S and HbC may protect against malaria by reducing the expression of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) on the surface of parasitized red blood cells (RBCs), thereby weakening their cytoadherence to microvascular endothelial cells (MVECs) and impairing their activation of MVECs to produce pathological responses. Therefore, we hypothesized that parasites causing malaria in HbAS or HbAC heterozygotes have overcome this protective mechanism by expressing PfEMP1 variants which mediate relatively strong binding to MVECs. To test this hypothesis, we performed 31 cytoadherence comparisons between parasites from HbAA and HbAS (or HbAC) Malian children with malaria. Ring-stage parasites from HbAA and HbAS (or HbAC) children were cultivated to trophozoites, purified, and then inoculated in parallel into the same wildtype uninfected RBCs. After one cycle of invasion and maturation to the trophozoite stage expressing PfEMP1, parasite strains were compared for binding to MVECs. In this assay, there were no significant differences in the binding of parasites from HbAS and HbAC children to MVECs compared to those from HbAA children (HbAS, fold-change = 1.46, 95% CI 0.97-2.19, p = 0.07; HbAC, fold-change = 1.19, 95% CI 0.77-1.84, p = 0.43). These data suggest that in-vitro reductions in cytoadherence by HbS and HbC may not be selecting for expression of high-avidity PfEMP1 variants in vivo. Future studies that identify PfEMP1 domains or amino-acid motifs which are selectively expressed in parasites from HbAS children may provide further insights into the mechanism of malaria protection by the sickle-cell trait.	[Beaudry, Jeanette T.; Krause, Michael A.; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Beaudry, Jeanette T.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Diakite, Seidina A. S.; Diakite, Mahamadou] Univ Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Fay, Michael P.; Joshi, Gyan] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Dis Res Unit, Bangkok, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Fairhurst, RM (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov	Fay, Michael P/A-2974-2008; White, Nick/AAC-6527-2019	Fay, Michael P/0000-0002-8643-9625; White, Nick/0000-0002-1897-1978; Diakite, Seidina A. S./0000-0003-1193-6501	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI001062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92185	10.1371/journal.pone.0092185	http://dx.doi.org/10.1371/journal.pone.0092185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647281	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500096
J	Chandy, SJ; Naik, GS; Charles, R; Jeyaseelan, V; Naumova, EN; Thomas, K; Lundborg, CS				Chandy, Sujith J.; Naik, Girish S.; Charles, Reni; Jeyaseelan, Visalakshi; Naumova, Elena N.; Thomas, Kurien; Lundborg, Cecilia Stalsby			The Impact of Policy Guidelines on Hospital Antibiotic Use over a Decade: A Segmented Time Series Analysis	PLOS ONE			English	Article							INFECTIOUS-DISEASES-SOCIETY; ANTIMICROBIAL RESISTANCE; INDIA; CARE; EPIDEMIOLOGY; INTERVENTION; SURVEILLANCE; REDUCTION; PNEUMONIA; OUTBREAK	Introduction: Antibiotic pressure contributes to rising antibiotic resistance. Policy guidelines encourage rational prescribing behavior, but effectiveness in containing antibiotic use needs further assessment. This study therefore assessed the patterns of antibiotic use over a decade and analyzed the impact of different modes of guideline development and dissemination on inpatient antibiotic use. Methods: Antibiotic use was calculated monthly as defined daily doses (DDD) per 100 bed days for nine antibiotic groups and overall. This time series compared trends in antibiotic use in five adjacent time periods identified as 'Segments,' divided based on differing modes of guideline development and implementation: Segment 1- Baseline prior to antibiotic guidelines development; Segment 2- During preparation of guidelines and booklet dissemination; Segment 3- Dormant period with no guidelines dissemination; Segment 4- Booklet dissemination of revised guidelines; Segment 5- Booklet dissemination of revised guidelines with intranet access. Regression analysis adapted for segmented time series and adjusted for seasonality assessed changes in antibiotic use trend. Results: Overall antibiotic use increased at a monthly rate of 0.95 (SE = 0.18), 0.21 (SE = 0.08) and 0.31 (SE = 0.06) for Segments 1, 2 and 3, stabilized in Segment 4 (0.05; SE = 0.10) and declined in Segment 5 (-0.37; SE = 0.11). Segments 1, 2 and 4 exhibited seasonal fluctuations. Pairwise segmented regression adjusted for seasonality revealed a significant drop in monthly antibiotic use of 0.401 (SE = 0.089; p<0.001) for Segment 5 compared to Segment 4. Most antibiotic groups showed similar trends to overall use. Conclusion: Use of overall and specific antibiotic groups showed varied patterns and seasonal fluctuations. Containment of rising overall antibiotic use was possible during periods of active guideline dissemination. Wider access through intranet facilitated significant decline in use. Stakeholders and policy makers are urged to develop guidelines, ensure active dissemination and enable accessibility through computer networks to contain antibiotic use and decrease antibiotic pressure.	[Chandy, Sujith J.; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Chandy, Sujith J.; Naik, Girish S.] Christian Med Coll & Hosp, Dept Pharmacol & Clin Pharmacol, Vellore, Tamil Nadu, India; [Charles, Reni] Christian Med Coll & Hosp, Dept Pharm, Vellore, Tamil Nadu, India; [Jeyaseelan, Visalakshi] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Naumova, Elena N.] Tufts Univ, Sch Engn, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Naumova, Elena N.] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Thomas, Kurien] Christian Med Coll & Hosp, Dept Med, Vellore, Tamil Nadu, India	Karolinska Institutet; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Tufts University; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Chandy, SJ (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	sjchandycmc@gmail.com	Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734; Naik, Girish S/0000-0002-2832-0001; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Erasmus Mundus External Cooperation Window Lot 15, India	Erasmus Mundus External Cooperation Window Lot 15, India	No specific funding was received for this study, but SJC received a scholarship from Erasmus Mundus External Cooperation Window Lot 15, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Amitabh V, 2012, LUNG INDIA, V29, P248, DOI 10.4103/0970-2113.99109; [Anonymous], 2008, ALTERN MED REV, V13, P165; Ansari F, 2003, J ANTIMICROB CHEMOTH, V52, P842, DOI 10.1093/jac/dkg459; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Gagliotti C, 2011, EURO SURVEILL B EUR, VMar 16; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Joshi S, 2013, INDIAN J MED RES, V137, P363; Kaul S, 2007, Indian J Med Microbiol, V25, P230; Kaur J, 2013, J CLIN DIAGN RES, V7, P576, DOI 10.7860/JCDR/2013/4765.2831; Knobler SL, 2003, WHO GLOBAL STRATEGY; Kumar S, 2012, Indian J Community Med, V37, P158, DOI 10.4103/0970-0218.99914; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lofgren E, 2007, LECT NOTES COMPUT SC, V4506, P114; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; Mathai E, 2008, TROP MED INT HEALTH, V13, P41, DOI 10.1111/j.1365-3156.2007.01969.x; Meyer E, 2007, J ANTIMICROB CHEMOTH, V59, P1148, DOI 10.1093/jac/dkm088; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; Pagkalis S, 2011, DRUGS, V71, P2277, DOI 10.2165/11597020-000000000-00000; Pathak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038641; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Tangden T, 2011, J ANTIMICROB CHEMOTH, V66, P1161, DOI 10.1093/jac/dkr053; Thursky KA, 2006, INT J QUAL HEALTH C, V18, P224, DOI 10.1093/intqhc/mzi095; Williams A, 2011, J PHARM BIOALLIED SC, V3, P531, DOI 10.4103/0975-7406.90108; World Health Organization, TOP 10 CAUS DEATH	33	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92206	10.1371/journal.pone.0092206	http://dx.doi.org/10.1371/journal.pone.0092206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647339	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500097
J	Chao, JQ; Jin, J; Wang, D; Han, R; Zhu, RS; Zhu, YG; Li, SQ				Chao, Jinquan; Jin, Jie; Wang, Dong; Han, Ran; Zhu, Renshan; Zhu, Yingguo; Li, Shaoqing			Cytological and Transcriptional Dynamics Analysis of Host Plant Revealed Stage-Specific Biological Processes Related to Compatible Rice-Ustilaginoidea virens Interaction	PLOS ONE			English	Article							DISEASE RESISTANCE; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; ORYZA-SATIVA; GENE; DEFENSE; PATHOGEN; PHOSPHORYLATION; EXPRESSION; STRATEGIES	Rice false smut, a fungal disease caused by Ustilaginoidea virens is becoming a severe detriment to rice production worldwide. However, little is known about the molecular response of rice to attacks by the smut pathogen. In this article, we define the initial infection process as having three stages: initial colonization on the pistil (stage 1, S1), amplification on the anther (stage 2, S2) and sporulation in the anther chambers (stage 3, S3). Based on the transcriptome of rice hosts in response to U. virens in two separate years, we identified 126, 204, and 580 specific regulated genes in their respective stages S1, S2, and S3, respectively, by excluding common expression patterns in other openly biotic/abiotic databases using bioinformatics. As the disease progresses, several stage-specific biological processes (BP) terms were distinctively enriched: "Phosphorylation" in stage S1, "PCD" in S2, and "Cell wall biogenesis" in S3, implying a concise signal cascade indicative of the tactics that smut pathogens use to control host rice cells during infection. 113 regulated genes were coexpressed among the three stages. They shared highly conserved promoter cis-element in the promoters in response to the regulation of WRKY and Myb for up-regulation, and ABA and Ca2+ for down regulation, indicating their potentially critical roles in signal transduction during rice-U. virens interaction. We further analyzed seven highly regulated unique genes; four were specific to pollen development, implying that pollen-related genes play critical roles in the establishment of rice susceptibility to U. virens. To my knowledge, this is the first report about probing of molecular response of rice to smut pathogen infection, which will greatly expand our understanding of the molecular events surrounding infection by rice false smut.	[Chao, Jinquan; Jin, Jie; Han, Ran; Zhu, Renshan; Zhu, Yingguo; Li, Shaoqing] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Wang, Dong] Univ Nebraska, Dept Stat, Lincoln, NE USA	Wuhan University; University of Nebraska System; University of Nebraska Lincoln	Li, SQ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	shaoqingli@whu.edu.cn			Transgenic Research and Development Program [2011ZX08001-004-002]; 863 Program [2011AA10A101]; Natural Science Foundation of China [31370363]	Transgenic Research and Development Program; 863 Program(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the Transgenic Research and Development Program (2011ZX08001-004-002), 863 Program (2011AA10A101) and Natural Science Foundation (31370363) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T, 2012, J GEN PLANT PATHOL, V78, P255, DOI 10.1007/s10327-012-0389-3; Atia MMM, 2004, Z PFLANZENK PFLANZEN, V111, P71; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baek KH, 2008, PLANT PATHOLOGY J, V24, P367, DOI 10.5423/PPJ.2008.24.4.367; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Burdon JJ, 2009, SCIENCE, V324, P755, DOI 10.1126/science.1171663; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Diola V, 2013, FUNCT INTEGR GENOMIC, V13, P379, DOI 10.1007/s10142-013-0330-7; Divon HH, 2007, FEMS MICROBIOL LETT, V266, P65, DOI 10.1111/j.1574-6968.2006.00504.x; EBELL LF, 1969, PHYTOCHEMISTRY, V8, P227, DOI 10.1016/S0031-9422(00)85818-5; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Gao Li, 2013, Plant J, V75, P903, DOI 10.1111/tpj.12270; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grand X, 2012, PLANT BIOTECHNOL J, V10, P840, DOI 10.1111/j.1467-7652.2012.00703.x; Guo XiaoYi, 2012, Journal of Agricultural Science and Technology A, V2, P1211; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Jin GH, 2013, J PLANT PHYSIOL, V170, P321, DOI 10.1016/j.jplph.2012.09.008; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; KOISO Y, 1994, J ANTIBIOT, V47, P765, DOI 10.7164/antibiotics.47.765; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Leterrier M, 2005, PLANT PHYSIOL, V138, P2111, DOI 10.1104/pp.105.066225; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Li YuSheng, 2011, Acta Agronomica Sinica, V37, P778, DOI 10.3724/SP.J.1006.2011.00788; Mao CZ, 2006, PLANT MOL BIOL, V61, P141, DOI 10.1007/s11103-005-6184-1; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-262; Qi YH, 2004, PLANTA, V219, P450, DOI 10.1007/s00425-004-1245-2; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rea AC, 2010, J EXP BOT, V61, P1897, DOI 10.1093/jxb/erp393; RUFTY TW, 1983, PLANT PHYSIOL, V72, P474, DOI 10.1104/pp.72.2.474; Rush M C, 2000, Plant Dis, V84, P100, DOI 10.1094/PDIS.2000.84.1.100D; Schroud P., 2005, ARK AGR EXP STAT RES, V540, P143; Schulze-Lefert P, 2003, ANNU REV PHYTOPATHOL, V41, P641, DOI 10.1146/annurev.phyto.41.061002.083300; Seah S, 2001, THEOR APPL GENET, V102, P600, DOI 10.1007/s001220051686; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Sun XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076879; Tang YX, 2013, PLANT PATHOL, V62, P1, DOI 10.1111/j.1365-3059.2012.02629.x; TeBeest D, 2010, PHYTOPATHOLOGY, V100, P125; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yap YK, 2005, PLANT PHYSIOL, V139, P127, DOI 10.1104/pp.105.065656; Yin YH, 2002, P NATL ACAD SCI USA, V99, P9090, DOI 10.1073/pnas.152330799; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zhang DB, 2011, J GENET GENOMICS, V38, P379, DOI 10.1016/j.jgg.2011.08.001; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	53	27	33	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91391	10.1371/journal.pone.0091391	http://dx.doi.org/10.1371/journal.pone.0091391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646527	Green Published, gold			2022-12-25	WOS:000333348500035
J	McCartney, JA; Stevens, NJ; O'Connor, PM				McCartney, Jacob A.; Stevens, Nancy J.; O'Connor, Patrick M.			The Earliest Colubroid-Dominated Snake Fauna from Africa: Perspectives from the Late Oligocene Nsungwe Formation of Southwestern Tanzania	PLOS ONE			English	Article							RUKWA RIFT BASIN; RED SANDSTONE GROUP; REVISED CLASSIFICATION; EARLY EOCENE; PHYLOGENY; SERPENTES; PALEOGENE; NUCLEAR; MIOCENE; MITOCHONDRIAL	The extant snake fauna has its roots in faunal upheaval occurring across the Paleogene - Neogene transition. On northern continents, this turnover is well established by the late early Miocene. However, this transition is poorly documented on southern landmasses, particularly on continental Africa, where no late Paleogene terrestrial snake assemblages are documented south of the equator. Here we describe a newly discovered snake fauna from the Late Oligocene Nsungwe Formation in the Rukwa Rift Basin of Tanzania. The fauna is small but diverse with eight identifiable morphotypes, comprised of three booids and five colubroids. This fauna includes Rukwanyoka holmani gen. et sp. nov., the oldest boid known from mainland Africa. It also provides the oldest fossil evidence for the African colubroid clade Elapidae. Colubroids dominate the fauna, comprising more than 75% of the recovered material. This is likely tied to local aridification and/or seasonality and mirrors the pattern of overturn in later snake faunas inhabiting the emerging grassland environments of Europe and North America. The early emergence of colubroid dominance in the Rukwa Rift Basin relative to northern continents suggests that the pattern of overturn that resulted in extant faunas happened in a more complex fashion on continental Africa than was previously realized, with African colubroids becoming at least locally important in the late Paleogene, either ahead of or as a consequence of the invasion of colubrids. The early occurrence of elapid snakes in the latest Oligocene of Africa suggests the clade rapidly spread from Asia to Africa, or arose in Africa, before invading Europe.	[McCartney, Jacob A.] SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA; [McCartney, Jacob A.; Stevens, Nancy J.; O'Connor, Patrick M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [McCartney, Jacob A.; Stevens, Nancy J.; O'Connor, Patrick M.] Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Stevens, NJ (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Irvine Hall, Athens, OH 45701 USA.	stevensn@ohio.edu	OConnor, Patrick M/I-9383-2012; Stevens, Nancy J/E-6928-2013	OConnor, Patrick M/0000-0002-6762-3806; 	National Geographic Society (CRE); LSB Leakey Foundation; Ohio University African Studies Program; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; National Science Foundation [EAR 0617561, EAR/IF 0933619, BCS 1127164]; Direct For Social, Behav & Economic Scie [1127164] Funding Source: National Science Foundation; Directorate For Geosciences [1349825] Funding Source: National Science Foundation	National Geographic Society (CRE)(National Geographic Society); LSB Leakey Foundation; Ohio University African Studies Program; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by: National Geographic Society (CRE), LSB Leakey Foundation, Ohio University African Studies Program, Ohio University Research Council, Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee, and the National Science Foundation (EAR 0617561; EAR/IF 0933619; BCS 1127164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2008, MOL PHYLOGENET EVOL, V46, P576, DOI 10.1016/j.ympev.2007.10.024; Andrews C. W., 1901, Geological Magazine (2), VDec. iv, P436; Andrews CW., 1924, GEOLOGICAL SURVEY NI, V7, P39; Andrews CW., 1906, DESCRIPTIVE CATALOGU; Antunes MT, 1964, NEOCRETACICO CENOZOI; Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; AUFFENBERG W., 1959, BREVIORA MUS COMP ZOOL [HARVARD], V114, P1; Auffenberg W., 1958, American Museum Novitates, VNo. 1874, P1; AUFFENBERG WALTER, 1963, TULANE STUD ZOOL, V10, P131; Auge M, 1997, GEOLOGIE FRANCE, V1, P22; Auge Marc, 2006, Annales de Paleontologie, V92, P235, DOI 10.1016/j.annpal.2005.09.001; BAILON S, 1994, CIFEG OCCASIONAL PUB, V29, P129; BOGERT CHARLES M., 1964, SENCKENBERG BIOL, V45, P509; Bogert CM, 1941, B AM MUS NAT HIST, V57, P1; Boie F, 1827, ISIS OKEN, V20, P508; CUNDALL D, 1993, ZOOL J LINN SOC-LOND, V109, P275, DOI 10.1006/zjls.1993.1039; Depuret C., 1890, PALEONTOLOGIE, V3, P1; Dowling H. G., 1959, Copeia, V1953, P38; ESTES R, 1970, Forma et Functio, V3, P139; Feldmann RM, 2007, NEUES JAHRB GEOL P-A, V244, P71, DOI 10.1127/0077-7749/2007/0244-0071; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gottfried M, 2007, J VERTEBR PALEONTOL, V27, p83A; Gower DJ, 2005, J ZOOL SYST EVOL RES, V43, P315, DOI 10.1111/j.1439-0469.2005.00315.x; Gray JE., 1825, ANN PHILOS, V2, P193; Guicking D, 2006, BIOL J LINN SOC, V87, P127, DOI 10.1111/j.1095-8312.2006.00561.x; Guo P, 2012, MOL PHYLOGENET EVOL, V63, P825, DOI 10.1016/j.ympev.2012.02.021; Head Jason J., 2007, Kirtlandia, V56, P177; Head JJ, 2005, J VERTEBR PALEONTOL, V25, P246, DOI 10.1671/0272-4634(2005)025[0246:FROSSF]2.0.CO;2; Hendey Q. B., 1969, S AFRICAN ARCHAEOLOG, V24, P96; Hoffstetter R., 1961, Bull Mus Hist nat Paris, V33, P326; Hoffstetter R., 1972, Annales Paleont (Vert), V58, P81; Hoffstetter R., 1969, P201; Hoffstetter R., 1939, ARCH MUS HIST NAT LY, V15, P1; HOFFSTETTER ROBERT, 1946, BULL MUS NATION HIST NAT [PARIS], V18, P132; Holman, 2000, FOSSIL SNAKES N AM O; Holman J.A., 1984, Journal of Vertebrate Paleontology, V3, P223; Holman J. Alan, 1999, Acta Zoologica Cracoviensia, V42, P447; Holman J. Alan, 1993, Tertiary Research, V14, P151; HOLMAN JA, 1977, HERPETOLOGICA, V33, P391; HOLMAN JA, 1977, HERPETOLOGICA, V33, P443; Ikeda Tadahiro, 2007, Current Herpetology, V26, P13, DOI 10.3105/1345-5834(2007)26[13:ACMSOT]2.0.CO;2; Ivanov M, 2002, ACTA PALAEONTOL POL, V47, P513; Ivanov Martin, 2001, Palaeontologische Zeitschrift, V74, P563; Ivanov Martin, 2000, Geodiversitas, V22, P559; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jacobs BF, 2004, PALAEOGEOGR PALAEOCL, V213, P115, DOI 10.1016/j.palaeo.2004.07.007; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Kelly CMR, 2011, MOL PHYLOGENET EVOL, V58, P415, DOI 10.1016/j.ympev.2010.11.010; Kluge A. G., 1991, MISCELLANEOUS PUBLIC, V178, P1; Kuch U, 2006, NATURWISSENSCHAFTEN, V93, P84, DOI 10.1007/s00114-005-0065-y; LaDuke T.C., 1991, CONTRIBUTIONS SCI NA, V424, P1, DOI [10.5962/p.226807, DOI 10.5962/P.226807]; Lawson R, 2005, MOL PHYLOGENET EVOL, V37, P581, DOI 10.1016/j.ympev.2005.07.016; Lawson R, 2004, J ZOOL, V263, P285, DOI 10.1017/S0952836904005278; Lee MSY, 2007, SYST BIODIVERS, V5, P371, DOI 10.1017/S1477200007002290; Lee MSY, 2002, BIOL REV, V77, P333, DOI 10.1017/S1464793102005924; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; List J. C., 1966, Illinois Biological Monographs, VNo. 36, P1; Madden CT, 1972, PALEOBIOS, V14, P1; MALNATE E V, 1972, Zoologische Mededelingen (Leiden), V47, P225; MCDOWELL S B, 1968, Journal of the Linnean Society of London Zoology, V47, P561; Meylan P.A., 1987, P78; Mlynarski M., 1982, Estudios Geologicos (Madrid), V38, P103; Nagy ZT, 2005, AFRICAN BIODIVERSITY: MOLECULES, ORGANISMS, ECOSYSTEMS, P221, DOI 10.1007/0-387-24320-8_20; Nopcsa F, 1923, PALAEONTOGRAPHICA, V55, P97; O'Connor PM, 2006, J AFR EARTH SCI, V44, P277, DOI 10.1016/j.jafrearsci.2005.11.022; Oppel M., 1811, ORDNUNGEN FAMILIEN G; Parmley Dennis, 2003, Acta Zoologica Cracoviensia, V46, P1; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2013, MOL PHYLOGENET EVOL, V66, P969, DOI 10.1016/j.ympev.2012.12.004; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rage, 1974, PALAEOVERTEBRATA, V6, P274; Rage J.C., 1973, Fossil Vertebr Afr, V3, P1; Rage J.-C., 1979, Bulletin de la Societe Geologique de France, V21, P329; Rage J.C., 1999, Palaeontologia Africana, V35, P85; RAGE J. C., 1984, SERPENTES HDB PALAOH, V11; RAGE J-C, 1981, Geobios (Villeurbanne), V14, P537, DOI 10.1016/S0016-6995(81)80127-1; RAGE J-C, 1988, Acta Zoologica Cracoviensia, V31, P457; RAGE J-C, 1987, P51; RAGE JC, 1983, CR ACAD SCI III-VIE, V296, P1029; Rage JC, 2005, CR PALEVOL, V4, P428, DOI 10.1016/j.crpv.2005.04.001; RAGE JC, 1975, CR ACAD SCI D NAT, V281, P515; Rage JC, 2003, GEODIVERSITAS, V25, P695; RAGE JC, 1992, CR ACAD SCI II, V314, P1085; Rage JC, 2008, ACTA PALAEONTOL POL, V53, P391, DOI 10.4202/app.2008.0303; Rage JC, 2013, ANN PALEONTOL, V99, P217, DOI 10.1016/j.annpal.2013.04.001; Rage Jean-Claude, 2003, Geological Survey of Namibia Memoir, V19, P43; Rage JC, 2010, GEOBIOS-LYON, V43, P253, DOI 10.1016/j.geobios.2009.08.002; Rasband WS, 1997, IMAGEJ; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2004, CRETACEOUS RES, V25, P749, DOI 10.1016/j.cretres.2004.06.007; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Sanders KL, 2010, MOL PHYLOGENET EVOL, V56, P857, DOI 10.1016/j.ympev.2010.04.031; SAVITZKY AH, 1980, EVOLUTION, V34, P1194, DOI 10.1111/j.1558-5646.1980.tb04065.x; Scanferla Agustin, 2013, PLoS ONE, V8, P1; Scanlon JD, 2006, NATURE, V439, P839, DOI 10.1038/nature04137; Scanlon JD, 2003, GEOBIOS-LYON, V36, P573, DOI 10.1016/S0016-6995(03)00056-1; Simons V, 2008, J VERTEBR PALEONTOL, V28, p143A; Smith KT, 2013, ZOOL ANZ, V252, P157, DOI 10.1016/j.jcz.2012.05.006; Sood MS, 1941, P INDIAN ACAD SCI B, V14, P191; Stevens N, 2006, J VERTEBR PALEONTOL, V26, p128A; Stevens NJ, 2009, J VERTEBR PALEONTOL, V29, P972, DOI 10.1671/039.029.0302; Stevens NJ, 2009, J VERTEBR PALEONTOL, V29, P631, DOI 10.1671/039.029.0219; Stevens NJ, 2005, J VERTEBR PALEONTOL, V25, P986, DOI 10.1671/0272-4634(2005)025[0986:AAPHFT]2.0.CO;2; Stevens NJ, 2006, J PALEONTOL, V80, P407, DOI 10.1666/0022-3360(2006)080[0407:MRPFTP]2.0.CO;2; Stevens NJ, 2010, J VERTEBR PALEONTOL, V30, p171A; Stevens NJ, 2013, NATURE, P1; Stevens NJ, 2008, E SIMONS SEARCH ORIG; SZYNDLAR Z, 1991, Estudios Geologicos (Madrid), V47, P103; SZYNDLAR Z, 1994, J VERTEBR PALEONTOL, V14, P24, DOI 10.1080/02724634.1994.10011536; Szyndlar Z, 2003, NONERYCINE BOOIDEA O; Szyndlar Zbigniew, 1996, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V240, P145; Szyndlar Z, 2012, B SOC GEOL FR, V183, P661, DOI 10.2113/gssgfbull.183.6.661; Szyndlar Zbigniew, 1993, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V192, P1; Szyndlar Z, 2009, PALAEONTOL Z, V83, P55, DOI 10.1007/s12542-009-0009-5; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; THIREAU MICHEL, 1967, BULL MUS NAT HIST NATUR, V39, P454; THOMAS H, 1991, B SOC GEOL FR, V162, P713; Tihen JA, 1964, SENCKENBERG BIOL, V45, P265; Underwood G., 1976, Linnean Soc Symp Ser, V3, P151; UNDERWOOD G, 1993, ZOOL J LINN SOC-LOND, V107, P3, DOI 10.1006/zjls.1993.1002; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal Nicolas, 2007, P27; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Vidal Nicolas, 2009, P390; WHISTLER DP, 1989, HERPETOLOGICA, V45, P350; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115	128	40	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90415	10.1371/journal.pone.0090415	http://dx.doi.org/10.1371/journal.pone.0090415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646522	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500014
J	Moreira, FC; Assumpcao, M; Hamoy, IG; Darnet, S; Burbano, R; Khayat, A; Goncalves, AN; Alencar, DO; Cruz, A; Magalhaes, L; Araujo, W; Silva, A; Santos, S; Demachki, S; Assumpcao, P; Ribeiro-dos-Santos, A				Moreira, Fabiano Cordeiro; Assumpcao, Monica; Hamoy, Igor G.; Darnet, Sylvain; Burbano, Rommel; Khayat, Andre; Goncalves, Andre Nicolau; Alencar, Dayse O.; Cruz, Aline; Magalhaes, Leandro; Araujo, Wilson, Jr.; Silva, Artur; Santos, Sidney; Demachki, Samia; Assumpcao, Paulo; Ribeiro-dos-Santos, Andrea			MiRNA Expression Profile for the Human Gastric Antrum Region Using Ultra-Deep Sequencing	PLOS ONE			English	Article							CANCER-CELL-LINES; MICRORNA TARGETS; SMALL RNAS; PROTEIN; ADHESION; FAMILY; APOPTOSIS; TISSUES; GENES; ROLES	Background: MicroRNAs are small non-coding nucleotide sequences that regulate gene expression. These structures are fundamental to several biological processes, including cell proliferation, development, differentiation and apoptosis. Identifying the expression profile of microRNAs in healthy human gastric antrum mucosa may help elucidate the miRNA regulatory mechanisms of the human stomach. Methodology/Principal Findings: A small RNA library of stomach antrum tissue was sequenced using high-throughput SOLiD sequencing technology. The total read count for the gastric mucosa antrum region was greater than 618,000. After filtering and aligning using with MirBase, 148 mature miRNAs were identified in the gastric antrum tissue, totaling 3,181 quality reads; 63.5% (2,021) of the reads were concentrated in the eight most highly expressed miRNAs (hsa-mir-145, hsa-mir-29a, hsa-mir-29c, hsa-mir-21, hsa-mir-451a, hsa-mir-192, hsa-mir-191 and hsa-mir-148a). RT-PCR validated the expression profiles of seven of these highly expressed miRNAs and confirmed the sequencing results obtained using the SOLiD platform. Conclusions/Significance: In comparison with other tissues, the antrum's expression profile was unique with respect to the most highly expressed miRNAs, suggesting that this expression profile is specific to stomach antrum tissue. The current study provides a starting point for a more comprehensive understanding of the role of miRNAs in the regulation of the molecular processes of the human stomach.	[Moreira, Fabiano Cordeiro; Assumpcao, Monica; Hamoy, Igor G.; Darnet, Sylvain; Burbano, Rommel; Khayat, Andre; Goncalves, Andre Nicolau; Alencar, Dayse O.; Cruz, Aline; Magalhaes, Leandro; Silva, Artur; Santos, Sidney; Assumpcao, Paulo; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Hamoy, Igor G.] Univ Fed Rural Amazonia, Capanema, PA, Brazil; [Burbano, Rommel; Khayat, Andre; Santos, Sidney; Demachki, Samia; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Nucleo Pesquisa Oncol, BR-66059 Belem, Para, Brazil; [Araujo, Wilson, Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Reg Hemoterapia, BR-14049 Ribeirao Preto, SP, Brazil; [Demachki, Samia] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil; [Assumpcao, Monica; Assumpcao, Paulo] Fed Univ Para, Hosp Univ Joao de Barros Barreto, BR-66059 Belem, Para, Brazil; [Cruz, Aline] Secretaria Estadual Saude Estado Para, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Para; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal do Para	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	akelyufpa@gmail.com	Santos, Ândrea Ribeiro dos/B-6061-2013; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Hamoy, Igor/S-5230-2019; DARNET, Sylvain Henri/G-4912-2012; Silva, Artur/E-1474-2014; Luiz Silva, Artur da Costa da/AAI-3516-2021; Khayat, Andre/AAF-2415-2019; Silva Jr, Wilson Araújo/E-9487-2011; Burbano, Rommel R/C-4149-2012; Moreira, Fabiano/I-2817-2015; CTC USP, CEPID 13 18/J-8951-2014; Aquime Goncalves, Andre Nicolau/Q-8326-2018	Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Hamoy, Igor/0000-0002-7412-4263; DARNET, Sylvain Henri/0000-0001-6351-0903; Silva, Artur/0000-0002-4082-1132; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Burbano, Rommel R/0000-0002-4872-234X; Cruz Ramos, Aline MP/0000-0001-8812-2923; Magalhaes, Leandro/0000-0002-2399-7769; Moreira, Fabiano/0000-0002-2799-3546; CTC USP, CEPID 13 18/0000-0002-7123-9524; Aquime Goncalves, Andre Nicolau/0000-0001-5264-8368	CNPq/Brazil [162605/2011- 0]; CNPq/Produtividade; Governo do Para/SEDECT/FAPESPA; PROPESP/UFPA-FADESP	CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Produtividade; Governo do Para/SEDECT/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPESP/UFPA-FADESP	IGH is supported by Pos-Doc Junior (PDJ) fellowship from CNPq/Brazil (162605/2011- 0); ANDREA RIBEIRO-DOS-SANTOS supported by CNPq/Produtividade; SS supported by CNPq/Produtividade; ROMMEL BURBANO supported by CNPq/Produtividade; Governo do Para/SEDECT/FAPESPA, PROPESP/UFPA-FADESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2012, BIOCHEM BIOPH RES CO, V425, P908, DOI 10.1016/j.bbrc.2012.08.009; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callahan JW, 2009, J PROTEOMICS, V72, P23, DOI 10.1016/j.jprot.2008.11.007; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Gao JL, 2012, MOL BIOL REP, V39, P8883, DOI 10.1007/s11033-012-1755-0; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Gulmann C, 2004, WORLD J GASTROENTERO, V10, P17; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; HUNTRISS JD, 1993, NUCLEIC ACIDS RES, V21, P4047, DOI 10.1093/nar/21.17.4047; ICHIYANAGI S, 1992, GASTROENTEROL JPN, V27, P559; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Philipps DL, 2008, DEV BIOL, V317, P72, DOI 10.1016/j.ydbio.2008.02.018; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Ricarte Filho Júlio C.M., 2006, Arq Bras Endocrinol Metab, V50, P1102, DOI 10.1590/S0004-27302006000600018; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Sanna MG, 2002, J BIOL CHEM, V277, P30454, DOI 10.1074/jbc.M203312200; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	41	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92300	10.1371/journal.pone.0092300	http://dx.doi.org/10.1371/journal.pone.0092300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647245	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500109
J	Ding, PJ; Yang, Y; Cheng, LY; Zhang, XJ; Cheng, LM; Li, CZ; Cai, JH				Ding, Peijian; Yang, Yang; Cheng, Luyang; Zhang, Xuejun; Cheng, Limin; Li, Caizhen; Cai, Jianhui			The Relationship between Seven Common Polymorphisms from Five DNA Repair Genes and the Risk for Breast Cancer in Northern Chinese Women	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; ANGIOTENSIN-ALDOSTERONE SYSTEM; HAN CHINESE; XRCC1 GENE; ASSOCIATION; METAANALYSIS; EPISTASIS; SUSCEPTIBILITY; HYPERTENSION; POPULATION	Background: Converging evidence supports the central role of DNA damage in progression to breast cancer. We therefore in this study aimed to assess the potential interactions of seven common polymorphisms from five DNA repair genes (XRCC1, XRCC2, XRCC3, XPA and APEX1) in association with breast cancer among Han Chinese women. Methodology/Principal Findings: This was a case-control study involving 606 patients diagnosed with sporadic breast cancer and 633 age-and ethnicity-matched cancer-free controls. The polymerase chain reaction - ligase detection reaction method was used to determine genotypes. All seven polymorphisms were in accordance with Hardy-Weinberg equilibrium in controls. Differences in the genotypes and alleles of XRCC1 gene rs25487 and XPA gene rs1800975 were statistically significant between patients and controls, even after the Bonferroni correction (P<0.05/7). Accordingly, the risk for breast cancer was remarkably increased for rs25487 (OR = 1.28; 95% CI: 1.07-1.51; P = 0.006), but decreased for rs1800975 (OR = 0.77; 95% CI: 0.67-0.90; P = 0.001) under an additive model at a Bonferroni corrected alpha of 0.05/7. Allele combination analysis showed higher frequencies of the most common combination C-G-G-C-G-G-G (alleles in order of rs1799782, rs25487, rs3218536, rs861539, rs1800975, rs1760944 and rs1130409) in controls than in patients (P-Sim = 0.002). In further interaction analysis, two-locus model including rs1800975 and rs25487 was deemed as the overall best model with the maximal testing accuracy of 0.654 and the cross-validation consistency of 10 out of 10 (P = 0.001). Conclusion: Our findings provide clear evidence that XRCC1 gene rs25487 and XPA gene rs1800975 might exert both independent and interactive effects on the development of breast cancer among northern Chinese women.	[Ding, Peijian; Cai, Jianhui] Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Ding, Peijian; Cai, Jianhui] Hebei Gen Hosp, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Ding, Peijian; Cai, Jianhui] Hebei Gen Hosp, Dept Oncol & Immunotherapy, Shijiazhuang, Hebei, Peoples R China; [Ding, Peijian; Yang, Yang; Cheng, Luyang; Zhang, Xuejun; Cheng, Limin] Chengde Med Coll, Affiliated Hosp, Dept Surg, Chengde, Hebei, Peoples R China; [Li, Caizhen] Hebei Eracon Biotech Co Ltd, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Chengde Medical University	Cai, JH (corresponding author), Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China.	jianhuicai2001@163.com			Nature Science Foundation of Hebei Province [C20100118]	Nature Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was financially supported by the Nature Science Foundation of Hebei Province (Grant No. C20100118). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mutairi FM, 2013, ASIAN PAC J CANCER P, V14, P3809, DOI 10.7314/APJCP.2013.14.6.3809; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Gage M, 2012, J SURG ONCOL, V105, P444, DOI 10.1002/jso.21856; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han W, 2012, CANCER-AM CANCER SOC, V118, P594, DOI 10.1002/cncr.26220; Holmberg E, 2001, BRIT J CANCER, V85, P362, DOI 10.1054/bjoc.2001.1868; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; Loizidou MA, 2008, BREAST CANCER RES TR, V112, P575, DOI 10.1007/s10549-007-9881-4; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Niu WQ, 2012, MOL CELL ENDOCRINOL, V358, P9, DOI 10.1016/j.mce.2012.02.010; Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; Parshad R, 1996, BRIT J CANCER, V74, P1, DOI 10.1038/bjc.1996.307; Pasche Boris, 2008, V141, P1; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Przybylowska-Sygut K, 2013, CLIN BREAST CANCER, V13, P61, DOI 10.1016/j.clbc.2012.09.019; Qi Y, 2008, EUR J EPIDEMIOL, V23, P143, DOI 10.1007/s10654-007-9208-0; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Sangrajrang S, 2008, BREAST CANCER RES TR, V111, P279, DOI 10.1007/s10549-007-9773-7; Sangrajrang S, 2007, BIOMARKERS, V12, P523, DOI 10.1080/13547500701395602; Webb PM, 2005, CANCER EPIDEM BIOMAR, V14, P319, DOI 10.1158/1055-9965.EPI-04-0335; Wu KS, 2011, ASIAN PAC J CANCER P, V12, P2237; Zhou B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-521	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92083	10.1371/journal.pone.0092083	http://dx.doi.org/10.1371/journal.pone.0092083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642895	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900080
J	Murtagh, N; Gatersleben, B; Uzzell, D				Murtagh, Niamh; Gatersleben, Birgitta; Uzzell, David			20:60:20-Differences in Energy Behaviour and Conservation between and within Households with Electricity Monitors	PLOS ONE			English	Article							FEEDBACK; CONSUMPTION; LABOR	The introduction of electricity monitors (in-home displays; IHDs), which show accurate and up-to-the-minute energy usage, is expected to lead to reduction in consumption. Studies of feedback on domestic electricity use have generally supported this view. However, such studies also demonstrate wide variation between households. Examining the heterogeneity of responses is essential for understanding the actual and potential effectiveness of IHDs and in order to target interventions effectively. To explore differences between households' responses to IHDs, we conducted a qualitative study with 21 households who had an IHD for more than six months. Of the 21, only four households continued to refer to the IHD and the findings suggest that attempts to reduce energy consumption were situated in wider social and physical contexts. Further, the participants demonstrated energy saving behaviour before and outside of IHD usage. The patterns of energy behaviours and attempts at electricity conservation could best be understood by categorising the households into three types: the Monitor Enthusiasts (20%), the Aspiring Energy Savers (60%) and the Energy Non-Engaged (20%). The factors of importance in energy behaviour differed between the categories. Financial savings contributed to efforts to reduce energy use but only up to boundaries which varied considerably between households. Social practices and social relationships appeared to constrain what actions households were prepared to undertake, illuminating aspects of inter-household variation. Within the household, all energy users were not equal and we found that women were particularly influential on energy use through their primary responsibility for domestic labour on behalf of the household. The implications of the findings for environmental campaigning are discussed.	[Murtagh, Niamh; Gatersleben, Birgitta; Uzzell, David] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England	University of Surrey	Murtagh, N (corresponding author), UCL Bartlett Sch Construct & Project Management, London, England.	n.murtagh@ucl.ac.uk	Uzzell, David/G-4097-2011; Gatersleben, Birgitta/AAV-5158-2021	Uzzell, David/0000-0001-7590-0079; Gatersleben, Birgitta/0000-0002-5841-0577	Digital Economy Programme of the Research Councils UK, a cross-council initiative led by EPSRC; AHRC under the REDUCE [EP/I000232/1]; ESRC under the REDUCE [EP/I000232/1]; MRC under the REDUCE [EP/I000232/1]; EPSRC [EP/I000232/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000232/1] Funding Source: researchfish	Digital Economy Programme of the Research Councils UK, a cross-council initiative led by EPSRC; AHRC under the REDUCE; ESRC under the REDUCE; MRC under the REDUCE; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research was funded by the Digital Economy Programme of the Research Councils UK, a cross-council initiative led by EPSRC (www.epsrc.ac.uk) and contributed to by AHRC, ESRC and MRC, under the REDUCE project grant (no EP/I000232/1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; AECOM, 2011, EN DEM RES PROJ FIN; Aune M, 2007, ENERG POLICY, V35, P5457, DOI 10.1016/j.enpol.2007.05.007; BITTLE RG, 1979, J ENVIRON SYST, V9, P275, DOI 10.2190/91AA-P97G-JF92-T7EJ; Brandon G, 1999, J ENVIRON PSYCHOL, V19, P75, DOI 10.1006/jevp.1998.0105; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Brookings JB, 2006, PSYCHOL REP, V98, P407, DOI 10.2466/PRO.98.2.407-413; Bulkeley H, 2000, PUBLIC UNDERST SCI, V9, P313, DOI 10.1088/0963-6625/9/3/307; Burgess J, 2008, ENERG POLICY, V36, P4454, DOI 10.1016/j.enpol.2008.09.039; CapGemini, 2008, DEM RES DEC BREAKTH; Carlsson-Kanyama A, 2007, ENERGY POLICY, V35; Carrico A. R., 2011, J ENERGY ENV LAW, V2, P61; Cockburn C., 1994, BRINGING TECHNOLOGY; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Darby S., 2006, ORTHOD FR, V86, P221, DOI [10.1051/orthodfr/2015025, DOI 10.1051/ORTHODFR/2015025]; Darby S, 2010, BUILD RES INF, V38, P442, DOI 10.1080/09613218.2010.492660; DECC, 2013, EN CONS UK; DECC, 2013, 2012 UK GREENH GAS E; DEFRA, 2007, FREM ENV BEH; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Dietz T, 2013, DAEDALUS-US, V142, P78, DOI 10.1162/DAED_a_00186; Dixon J, 2004, THEOR PSYCHOL, V14, P167, DOI 10.1177/0959354304042015; EEA, 2012, FIN EN CONS SECT MAR; Ehrhardt-Martinez K., 2010, ADV METERING INITIAT; Emmons R. A., 1996, PSYCHOL ACTION LINKI, P313; Evans D, 2011, GEOFORUM, V42, P550, DOI 10.1016/j.geoforum.2011.03.008; Faruqui A, 2010, J REGUL ECON, V38, P193, DOI 10.1007/s11149-010-9127-y; Faruqui A, 2010, ENERGY, V35, P1598, DOI 10.1016/j.energy.2009.07.042; Faulkner W., 1985, SMOTHERED INVENTION; Ferraro PJ, 2013, RESOUR ENERGY ECON, V35, P356, DOI 10.1016/j.reseneeco.2013.04.001; Fishbein M, 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Frey BS., 1999, J CONSUMER POLICY, V22, P395, DOI [DOI 10.1023/A:1006256117094, 10.1023/A:1006256117094]; Gatersleben B, 2010, ARCHIT SCI REV, V53, P37, DOI 10.3763/asre.2009.0101; Glucksmann M., 2007, EQUAL OPPORTUNITIES, V26, P96, DOI DOI 10.1108/02610150710732186; Gram-Hanssen K, 2011, J CONSUM CULT, V11, P61, DOI 10.1177/1469540510391725; Gronhoj A, 2011, INT J CONSUM STUD, V35, P138, DOI 10.1111/j.1470-6431.2010.00967.x; Hargreaves T, 2013, ENERG POLICY, V52, P126, DOI 10.1016/j.enpol.2012.03.027; Hargreaves T, 2010, ENERG POLICY, V38, P6111, DOI 10.1016/j.enpol.2010.05.068; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; Jain RK, 2012, ENERG BUILDINGS, V48, P8, DOI 10.1016/j.enbuild.2011.12.033; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, DOI 10.1080/13504620220145401, 10.1080/13504620220145401]; Little B. R., 2017, PERSONAL PROJECT PUR; Marteau TM., 2002, GETTING RES FINDINGS, P68, DOI [10.1002/9780470755891.CH5, DOI 10.1002/9780470755891.CH5]; Murtagh N, 2013, INDIVIDUAL ENERGY US; Murtagh N, 2012, TRANSPORT RES F-TRAF, V15, P514, DOI 10.1016/j.trf.2012.05.002; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schleich J, 2013, ENERG POLICY, V61, P1097, DOI 10.1016/j.enpol.2013.05.012; Schwartz D, 2013, P NATL ACAD SCI; Schwartz-Cowan R., 1983, MORE WORK MOTHER IRO; Shove E, 2008, BUILDING RES INFORM, V36; Shove Elizabeth, 2003, COMFORT CLEANLINESS; Shui B, 2004, REESTIMATION REFLECT; STERN PC, 1994, J SOC ISSUES, V50, P65, DOI 10.1111/j.1540-4560.1994.tb02420.x; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torriti J, 2010, ENERGY, V35, P1575, DOI 10.1016/j.energy.2009.05.021; van Dam SS, 2010, BUILD RES INF, V38, P458, DOI 10.1080/09613218.2010.494832; VANHOUWELINGEN JH, 1989, J CONSUM RES, V16, P98, DOI 10.1086/209197; Wajcman J, 2010, CAMB J ECON, V34, P134; Wallenborn G, 2011, INT J CONSUM STUD, V35, P146, DOI 10.1111/j.1470-6431.2010.00985.x; Warde A., 2005, J CONSUM CULT, V5, P131, DOI DOI 10.1177/1469540505053090; Wilhite H, 1999, ADV CONSUM RES, V26, P281; Wilk R., 2001, J CONSUM CULT, V1, P245, DOI DOI 10.1177/146954050100100211; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	64	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92019	10.1371/journal.pone.0092019	http://dx.doi.org/10.1371/journal.pone.0092019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642946	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900062
J	Howard, JD; Sarojini, H; Wan, R; Chien, SF				Howard, Jeffrey D.; Sarojini, Harshini; Wan, Rong; Chien, Sufan			Rapid Granulation Tissue Regeneration by Intracellular ATP Delivery-A Comparison with Regranex	PLOS ONE			English	Article							DIABETIC FOOT ULCERS; GROWTH-FACTOR; RABBIT EAR; MACROPHAGE PROLIFERATION; HYPERBARIC-OXYGEN; SKIN WOUNDS; GEL; ANGIOGENESIS; BECAPLERMIN; METABOLISM	This study tests a new intracellular ATP delivery technique for tissue regeneration and compares its efficacy with that of Regranex. Twenty-seven adult New Zealand white rabbits each underwent minimally invasive surgery to render one ear ischemic. Eight wounds were then created: four on the ischemic and four on the normal ear. Two wounds on one side of each ear were treated with Mg-ATP encapsulated lipid vesicles (ATP-vesicles) while the two wounds on the other side were treated with Regranex. Wound healing time was shorter when ATP-vesicles were used. The most striking finding was that new tissue growth started to appear in less than 1 day when ATP-vesicles were used. The growth continued and covered the wound area within a few days, without the formation of a provisional matrix. Regranex-treated wounds did not have this growth pattern. In wounds treated by ATP-vesicles, histologic studies revealed extremely rich macrophage accumulation, along with active proliferating cell nuclear antigen (PCNA) and positive BrdU staining, indicating in situ macrophage proliferation. Human macrophage culture suggested direct collagen production. These results support an entirely new healing process, which seems to have combined the conventional hemostasis, inflammation, and proliferation phases into a single one, thereby eliminating the lag time usually seen during healing process.	[Howard, Jeffrey D.; Sarojini, Harshini; Wan, Rong; Chien, Sufan] Univ Louisville, Dept Surg, Louisville, KY 40292 USA	University of Louisville	Chien, SF (corresponding author), Univ Louisville, Dept Surg, Louisville, KY 40292 USA.	sufanc@aim.com	Sarojini, Harshini/AAD-4870-2019	Sarojini, Harshini/0000-0002-3103-9712	National Institutes of Health [RO1DK74566, R44AR52984, R43HL114235, R43GM106639]; KSTC [KSTC-184-512-12-138]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL114235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR052984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM106639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSTC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health grants RO1DK74566, R44AR52984, R43HL114235, and R43GM106639, and KSTC match funding KSTC-184-512-12-138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JP, 1980, LANCET, V1, P1153; Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019; Berendt AR, 2006, CLIN INFECT DIS, V43, P193, DOI 10.1086/505223; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Cheng B, 2007, J DERMATOL SCI, V45, P193, DOI 10.1016/j.jdermsci.2006.11.014; Chiang B, 2007, AM J SURG, V193, P213, DOI 10.1016/j.amjsurg.2006.08.069; Chien, 2006, RECENT RES DEV BIOPH, V5, P1; Chien S, 2012, JOVE-J VIS EXP, V2012, P1; Chien S, 2007, WOUND REPAIR REGEN, V15, P928, DOI 10.1111/j.1524-475X.2007.00285.x; Chien S, 2007, WOUND REPAIR REGEN, V15, pA39; Chien SF, 2010, METHODS MOL BIOL, V605, P377, DOI 10.1007/978-1-60327-360-2_26; Chvapil M, 1988, J Burn Care Rehabil, V9, P279, DOI 10.1097/00004630-198805000-00009; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Cohen MA, 2001, J AM ACAD DERMATOL, V45, P857, DOI 10.1067/mjd.2001.117721; Coleman R, 2011, ACTA HISTOCHEM, V113, P231, DOI 10.1016/j.acthis.2010.02.002; COOPER GM, 1997, CELL MOL APPROACH; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Edwards JS, 2010, KNOWL MAN RES PRACT, V8, P1, DOI 10.1057/kmrp.2009.39; Fang RC, 2008, BIOL-TARGETS THER, V2, P1; Game FL, 2012, DIABETES-METAB RES, V28, P119, DOI 10.1002/dmrr.2246; Greener B, 2005, J Wound Care, V14, P59; Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160; Howes EL, 1943, SURG GYNECOL OBSTET, V76, P738; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; IM MJC, 1970, J SURG RES, V10, P459, DOI 10.1016/0022-4804(70)90070-3; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kloeters O, 2007, WOUND REPAIR REGEN, V15, pS40, DOI 10.1111/j.1524-475X.2007.00224.x; Landsman A, 2010, J AM PODIAT MED ASSN, V100, P155, DOI 10.7547/1000155; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lindblad, 1992, WOUND HEALING BIOCH, P248; Lindblad WJ, 2006, WOUND REPAIR REGEN, V14, P515, DOI 10.1111/j.1743-6109.2006.00171.x; Lubkowska A, 2012, J Biol Regul Homeost Agents, V26, p3S; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012; Niinikoski J, 2003, WOUND REPAIR REGEN, V11, P458, DOI 10.1046/j.1524-475X.2003.11610.x; Ovington LG, 2004, CHRONIC WOUND CARE P, P83; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, DOI 10.1038/nri3016; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Peng XY, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-12; PUISIEUX F, 1994, J DRUG TARGET, V2, P443, DOI 10.3109/10611869408996820; Randolph GJ, 2011, SCIENCE, V332, P1268, DOI 10.1126/science.1208480; Roy S, 2011, WOUND REPAIR REGEN, V19, P753, DOI 10.1111/j.1524-475X.2011.00740.x; Saulis AS, 2002, PLAST RECONSTR SURG, V110, P177, DOI 10.1097/00006534-200207000-00029; SAWYER RT, 1982, LAB INVEST, V46, P165; Schaffer Michael, 2002, Int J Low Extrem Wounds, V1, P104, DOI 10.1177/1534734602001002005; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Senet P, 2011, ARCH DERMATOL, V147, P926, DOI 10.1001/archdermatol.2011.84; SILVER IA, 1980, WOUND HEALING WOUND, P11; Simons M, 2005, J AM COLL CARDIOL, V46, P835, DOI 10.1016/j.jacc.2005.06.008; Smith DG, 1999, FOOT ANKLE INT, V20, P258, DOI 10.1177/107110079902000409; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; Tacke Frank, 2011, Hepatology, V54, P2267, DOI 10.1002/hep.24714; Toledo-Pereyra L.H., 2010, ORGAN PROCUREMENT PR, P82; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; VAAGE J, 1991, BRIT J CANCER, V63, P758, DOI 10.1038/bjc.1991.169; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; Van den BJ, 2012, J LEUKOCYTE BIOL, V91, P1; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Villiers E, 2006, VET CLIN PATH, V35, P55, DOI 10.1111/j.1939-165X.2006.tb00089.x; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Wang J, 2008, WOUND REPAIR REGEN, V16, pA56; Wang JP, 2010, AM J SURG, V199, P823, DOI 10.1016/j.amjsurg.2009.05.040; Wang JP, 2009, ANN PLAS SURG, V62, P180, DOI 10.1097/SAP.0b013e31817fe47e; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Werdin F, 2009, EPLASTY, V9, P169; WILLIAMSBOYCE PK, 1986, J ANAT, V149, P55; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zamora DO, 2013, ANGIOGENESIS, V16, P745, DOI 10.1007/s10456-013-9352-y	71	27	27	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91787	10.1371/journal.pone.0091787	http://dx.doi.org/10.1371/journal.pone.0091787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637626	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100061
J	Lin, IP; Hsu, YS; Kang, SW; Hsieh, MH; Wang, JY				Lin, I-Ping; Hsu, Yu-Shen; Kang, Ssu-Wei; Hsieh, Miao-His; Wang, Jiu-Yao			Escherichia coli Heat-Labile Detoxified Enterotoxin Modulates Dendritic Cell Function and Attenuates	PLOS ONE			English	Article							CHOLERA-TOXIN; DC-SIGN; MUCOSAL ADJUVANTICITY; ALVEOLAR MACROPHAGE; AIRWAY INFLAMMATION; TH2 CELLS; ACTIVATION; ASTHMA; DIFFERENTIATION; IMMUNOGENICITY	Various mutant forms of Escherichia coli heat-labile enterotoxin (LT) have been used as a mucosal adjuvant for vaccines, as it enhances immune responses to specific antigens including antigen-specific IgA antibodies when administrated intranasally or orally. We hypothesized that a detoxified mutant form of LT, LTS61K, could modulate dendritic cell (DC) function and alleviate allergen-induced airway inflammation. Two protocols, preventative and therapeutic, were used to evaluate the effects of LTS61K in a Dermatophagoides pteronyssinus (Der p)-sensitized and challenged murine model of asthma. LTS61K or Der p-primed bone marrow-derived dendritic cells (BMDCs) were also adoptively transferred into Der p-sensitized and challenged mice. Intranasal inoculations with LTS61K or LTS61K/Der p decreased allergen-induced airway inflammation and alleviated systemic T(H)2-type immune responses. Bronchoalveolar lavage fluid (BALF) and sera from LTS61K/Der p-treated mice also had higher concentrations of Der p-specific immunoglobulin (Ig) A than those of other groups. In vitro, BMDCs stimulated with Der p underwent cellular maturation and secreted proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)alpha In contrast, Der p-stimulated BMDCs that were pretreated with LTS61K showed decreased IL-6 and TNF alpha production and were less mature. Intratracheal adoptive transfer of LTS61K- or LTS61K/Der p-primed BMDCs into Der p-sensitized mice reduced inflammatory cell infiltration and T(H)2-type chemokines in BALF and alleviated airway inflammation in treated mice. LTS61K influenced DC maturation and decreased inflammatory cytokine production. Moreover, LTS61K/Der p induced increased Der p-specific IgA production to decrease allergic T(H)2 cytokine responses and alleviated airway inflammation in Der p-sensitized mice. These results suggest that the immunomodulatory effects of LTS61K may have clinical applications for allergy and asthma treatment.	[Lin, I-Ping; Hsieh, Miao-His; Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Inst Microbiol & Immunol, Tainan 70101, Taiwan; [Lin, I-Ping; Hsu, Yu-Shen; Kang, Ssu-Wei] Dev Ctr Biotechnol, Taipei, Taiwan; [Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan; [Wang, Jiu-Yao] China Med Univ, Sch Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan	Wang, JY (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Microbiol & Immunol, Tainan 70101, Taiwan.	a122@mail.ncku.edu.tw			Development Center for Biotechnology [101AN201]; National Cheng Kung University [98S153, 99S047, 101S082]	Development Center for Biotechnology; National Cheng Kung University	This work was supported by the Development Center for Biotechnology, grant number 101AN201, and research grants No. 98S153, 99S047, 101S082 from National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Aydogan M, 2007, PEDIAT ALLERG IMM-UK, V18, P320, DOI 10.1111/j.1399-3038.2007.00527.x; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Chen CL, 2006, J ALLERGY CLIN IMMUN, V118, P105, DOI 10.1016/j.jaci.2006.02.047; Chen CL, 2003, J IMMUNOL, V170, P528, DOI 10.4049/jimmunol.170.1.528; Donaldson DS, 2012, MUCOSAL IMMUNOL; Douce G, 1998, VACCINE, V16, P1065, DOI 10.1016/S0264-410X(98)80100-X; ELSON CO, 1984, J IMMUNOL, V132, P2736; Fahlen-Yrlid L, 2009, J IMMUNOL, V183, P5032, DOI 10.4049/jimmunol.0803992; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Huang HJ, 2011, MUCOSAL IMMUNOL, V4, P519, DOI 10.1038/mi.2011.17; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Liu CF, 2010, CLIN EXP ALLERGY, V40, P111, DOI [10.1111/j.1365-2222.2009.03367.x, 10.1111/j.1365-2222.2010.03549.x]; Liu CF, 2005, CLIN EXP ALLERGY, V35, P1615, DOI 10.1111/j.1365-2222.2005.02387.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MARINARO M, 1995, J IMMUNOL, V155, P4621; Negri DRM, 2009, INFECT IMMUN, V77, P1924, DOI 10.1128/IAI.01559-08; Petrovska L, 2003, VACCINE, V21, P1445, DOI 10.1016/S0264-410X(02)00696-5; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Schwarze J, 1998, AM J RESP CRIT CARE, V158, P519, DOI 10.1164/ajrccm.158.2.9801014; Soriani M, 2002, MICROBIOL-SGM, V148, P667, DOI 10.1099/00221287-148-3-667; Van Rijt LS, 2005, CLIN EXP ALLERGY, V35, P1125, DOI 10.1111/j.1365-2222.2005.02321.x; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yu CK, 2003, J IMMUNOL, V171, P3808, DOI 10.4049/jimmunol.171.7.3808; Zhou FM, 2009, CLIN VACCINE IMMUNOL, V16, P471, DOI 10.1128/CVI.00311-08	37	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90293	10.1371/journal.pone.0090293	http://dx.doi.org/10.1371/journal.pone.0090293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637787	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100006
J	Navarro-Castilla, A; Mata, C; Ruiz-Capillas, P; Palme, R; Malo, JE; Barja, I				Navarro-Castilla, Alvaro; Mata, Cristina; Ruiz-Capillas, Pablo; Palme, Rupert; Malo, Juan E.; Barja, Isabel			Are Motorways Potential Stressors of Roadside Wood Mice (Apodemus sylvaticus) Populations?	PLOS ONE			English	Article							FECAL CORTICOSTEROID LEVELS; PHYSIOLOGICAL STRESS; HABITAT USE; PEROMYSCUS-MANICULATUS; TOURIST PRESSURE; SEASONAL-CHANGES; WILD POPULATION; SMALL MAMMALS; RESPONSES; ECOLOGY	Linear infrastructures represent one of the most important human impacts on natural habitats and exert several effects on mammal populations. Motorways are recognized as a major cause of habitat fragmentation and degradation and of biodiversity loss. However, it is unknown whether motorways lead to increased physiological stress reactions in wild animal populations. We analysed faecal corticosterone metabolites (FCM) in wild populations of wood mice (Apodemus sylvaticus) living in a well-preserved Mediterranean agro-pastoral woodland at different distances (verge, 500 m and 1000 m) from the AP-51 motorway in Spain. Wood mice were captured with Sherman live traps, and fresh faecal samples from 424 individuals were collected and analyzed in the laboratory. The quantification of FCM was performed by a 5 alpha-pregnane-3 beta, 11 beta, 21-triol-20-one enzyme immunoassay. Results showed that females had higher FCM levels than males, and these levels were higher in breeding females. In addition, FCM levels were positively correlated with body weight of individuals. Wood mice captured where cattle were present showed higher FCM levels than individuals living where cattle were not detected. FCM levels were higher in non-breeding individuals living close to the motorway compared with FCM levels in those individuals captured further from the motorway. This is the first study showing evidence of the motorways' impact on physiological stress reactions in wild wood mice populations. Understanding how free-living animals are influenced by human interventions could help to understand other subtle changes observed in wild animal populations. Since mice are used world-wide as research models these results could open new perspectives testing human influence on the natural environment and trade-offs of species in degraded ecosystems.	[Navarro-Castilla, Alvaro; Barja, Isabel] Univ Autonoma Madrid, Zool Unit, Dept Biol, Madrid, Spain; [Mata, Cristina; Malo, Juan E.] Univ Autonoma Madrid, Terr Ecol Grp, Dept Ecol, Madrid, Spain; [Ruiz-Capillas, Pablo] Obrascon Huarte Lain SA, Direcc Innovac & Sostenibilidad, Madrid, Spain; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Biochem, Vienna, Austria	Autonomous University of Madrid; Autonomous University of Madrid; University of Veterinary Medicine Vienna	Navarro-Castilla, A (corresponding author), Univ Autonoma Madrid, Zool Unit, Dept Biol, Madrid, Spain.	alvaro.navarrocastilla@uam.es	Malo, Juan E/K-8305-2014; Arrazola, Juan Esteban Malo/Q-4819-2019; Palme, Rupert/A-3499-2008; Mata, Cristina/ABF-1169-2021; Barja, Isabel/B-8303-2016; Navarro-Castilla, Álvaro/M-7315-2018	Malo, Juan E/0000-0002-6033-5035; Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Palme, Rupert/0000-0001-9466-3662; Mata, Cristina/0000-0002-6206-1015; Barja, Isabel/0000-0002-8354-5342; Navarro-Castilla, Álvaro/0000-0003-0928-3978	CENIT-OASIS; CDTI of the Spanish Ministry of Science and Innovation [REMEDINAL-2 S-2009/AMB/1783, CCG10-UAM/AMB-5325]; Comunidad de Madrid; European Social Fund; Universidad Autonoma de Madrid; Ministerio de Educacion y Ciencia of Spain	CENIT-OASIS; CDTI of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid(Comunidad de Madrid); European Social Fund(European Social Fund (ESF)); Universidad Autonoma de Madrid; Ministerio de Educacion y Ciencia of Spain(Spanish Government)	This research has been funded by the projects: CENIT-OASIS supported by CDTI of the Spanish Ministry of Science and Innovation, REMEDINAL-2 S-2009/AMB/1783 and CCG10-UAM/AMB-5325 (Comunidad de Madrid together with the European Social Fund and Universidad Autonoma de Madrid). A. Navarro-Castilla was supported by a FPU grant from the Ministerio de Educacion y Ciencia of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews A., 1990, Australian Zoologist, V52, P130; ANGELSTAM P, 1987, OIKOS, V50, P123, DOI 10.2307/3565408; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Barja I, 2007, J STEROID BIOCHEM, V104, P136, DOI 10.1016/j.jsbmb.2007.03.008; Bauman D. E., 2000, Ruminant physiology: digestion, metabolism, growth and reproduction, P311, DOI 10.1079/9780851994635.0311; BIRNEY EC, 1976, ECOLOGY, V57, P1043, DOI 10.2307/1941069; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Crist MR, 2005, J APPL ECOL, V42, P181, DOI 10.1111/j.1365-2664.2005.00996.x; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Eccard JA, 2000, J ARID ENVIRON, V46, P103, DOI 10.1006/jare.2000.0659; ELTON CHARLES, 1939, JOUR WILDLIFE MANAGEMENT, V3, P332, DOI 10.2307/3796305; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frid A, 2002, CONSERV ECOL, V6; Gotz AA, 2007, PHYSIOL BEHAV, V90, P108, DOI 10.1016/j.physbeh.2006.09.014; Good T, 2003, PHYSIOL BEHAV, V80, P405, DOI 10.1016/j.physbeh.2003.09.006; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; GORMAN ML, 1993, J ZOOL, V229, P385, DOI 10.1111/j.1469-7998.1993.tb02643.x; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; GREEN R, 1979, J ZOOL, V188, P357; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Harper JM, 2004, AM MIDL NAT, V152, P400, DOI 10.1674/0003-0031(2004)152[0400:FCLIFP]2.0.CO;2; Harper JM, 2001, GEN COMP ENDOCR, V123, P337, DOI 10.1006/gcen.2001.7682; HAUGER RL, 1994, ENDOCRINOLOGY, V134, P1528, DOI 10.1210/en.134.3.1528; HESKE EJ, 1991, SOUTHWEST NAT, V36, P89, DOI 10.2307/3672121; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; KIKKAWA J, 1964, J ANIM ECOL, V33, P259, DOI 10.2307/2631; KLEIN DR, 1971, SCIENCE, V173, P393, DOI 10.1126/science.173.3995.393; Lode T, 2000, AMBIO, V29, P163, DOI 10.1579/0044-7447-29.3.163; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Moberg G.P., 1985, P27; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; MOEN AN, 1982, NEW YORK FISH GAME J, V29, P176; Monclus R, 2009, OECOLOGIA, V158, P615, DOI 10.1007/s00442-008-1201-0; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Munoz A, 2009, BASIC APPL ECOL, V10, P151, DOI 10.1016/j.baae.2008.01.003; Navarro-Castilla A, 2014, MAMM BIOL, V79, P36, DOI 10.1016/j.mambio.2013.08.004; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Parris KM, 2009, ECOL SOC, V14; Penn DJ, 2007, P NATL ACAD SCI USA, V104, P553, DOI 10.1073/pnas.0609301103; Pineiro A, 2012, WILDLIFE RES, V39, P532, DOI 10.1071/WR10218; POLLARD E, 1970, J APPL ECOL, V7, P549, DOI 10.2307/2401977; PRESTON CR, 1990, CONDOR, V92, P107, DOI 10.2307/1368388; PUTMAN RJ, 1989, BIOL CONSERV, V47, P13, DOI 10.1016/0006-3207(89)90017-7; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reck H, 1993, STRASSEN LEBENSRAUME; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Reijnen R, 1995, THESIS DLO I FOR NAT; Rico A, 2007, FOLIA ZOOL, V56, P1; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Roff Derek A., 1992; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Russell ES, 1966, BIOL LAB MOUSE, P685; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Saunders SC, 2002, BIOL CONSERV, V103, P209, DOI 10.1016/S0006-3207(01)00130-6; Schradin C, 2008, HORM BEHAV, V53, P573, DOI 10.1016/j.yhbeh.2008.01.003; Schwabl H, 1999, GEN COMP ENDOCR, V116, P403, DOI 10.1006/gcen.1999.7379; Sheffield LM, 2001, CAN J ZOOL, V79, P380, DOI 10.1139/cjz-79-3-380; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Spellerberg IF, 2002, ECOLOGICAL EFFECTS R, DOI DOI 10.1201/9781482279931; Stewart PM, 2003, WILLIAMS TXB ENDOCRI, P491; Strier KB, 2003, AM J PRIMATOL, V61, P85, DOI 10.1002/ajp.10109; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317, DOI 10.1152/ajpendo.1996.271.2.E317; Tchabovsky AV, 2001, J ETHOL, V19, P105, DOI 10.1007/s101640170006; Tester JR, 1961, STUDY CERTAIN PLANT; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Thiel D, 2011, IBIS, V153, P122, DOI 10.1111/j.1474-919X.2010.01083.x; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; van der Ree R, 2011, ECOL SOC, V16; VICKERY WL, 1992, ECOGRAPHY, V15, P205, DOI 10.1111/j.1600-0587.1992.tb00026.x; Walker BG, 2005, CONSERV BIOL, V19, P1571, DOI 10.1111/j.1523-1739.2005.00104.x; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520; WINGFIELD JC WINGFIELD JC, 2001, HDB PHYSL AM PHYSL S HDB PHYSL AM PHYSL S, V4 4, p211 211; WINNER WE, 1994, ECOL APPL, V4, P651, DOI 10.2307/1941998; Ylonen H, 2006, BEHAV ECOL SOCIOBIOL, V60, P350, DOI 10.1007/s00265-006-0171-7; [No title captured]	93	32	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91942	10.1371/journal.pone.0091942	http://dx.doi.org/10.1371/journal.pone.0091942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637740	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100085
J	Nogales-Gadea, G; Ramos-Fransi, A; Suarez-Calvet, X; Navas, M; Rojas-Garcia, R; Mosquera, JL; Diaz-Manera, J; Querol, L; Gallardo, E; Illa, I				Nogales-Gadea, Gisela; Ramos-Fransi, Alba; Suarez-Calvet, Xavier; Navas, Miquel; Rojas-Garcia, Ricard; Luis Mosquera, Jose; Diaz-Manera, Jordi; Querol, Luis; Gallardo, Eduard; Illa, Isabel			Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PROGNOSTIC MARKERS; SUBTLE DIFFERENCES; T-CELLS; BIOMARKERS; EXPRESSION; GENERATION; ANTIGEN; CANCER; PLASMA	Myasthenia gravis (MG) is an autoimmune disease characterized by the presence of autoantibodies, mainly against the acetylcholine receptor (AChR). The mechanisms triggering and maintaining this chronic disease are unknown. MiRNAs are regulatory molecules that play a key role in the immune system and are altered in many autoimmune diseases. The aim of this study was to evaluate miRNA profiles in serum of 61 AChR MG patients. We studied serum from patients with early onset MG (n = 22), late onset MG (n = 27) and thymoma (n = 12), to identify alterations in the specific subgroups. In a discovery cohort, we analysed 381 miRNA arrays from 5 patients from each subgroup, and 5 healthy controls. The 15 patients had not received any treatment. We found 32 miRNAs in different levels in MG and analysed 8 of these in a validation cohort that included 46 of the MG patients. MiR15b, miR122, miR-140-3p, miR185, miR192, miR20b and miR-885-5p were in lower levels in MG patients than in controls. Our study suggests that different clinical phenotypes in MG share common altered mechanisms in circulating miRNAs, with no additional contribution of the thymoma. MG treatment intervention does not modify the profile of these miRNAs. Novel insights into the pathogenesis of MG can be reached by the analysis of circulating miRNAs since some of these miRNAs have also been found low in MG peripheral mononuclear cells, and have targets with important roles in B cell survival and antibody production.	[Nogales-Gadea, Gisela; Ramos-Fransi, Alba; Suarez-Calvet, Xavier; Navas, Miquel; Rojas-Garcia, Ricard; Diaz-Manera, Jordi; Querol, Luis; Gallardo, Eduard; Illa, Isabel] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, E-08193 Barcelona, Spain; [Nogales-Gadea, Gisela; Ramos-Fransi, Alba; Suarez-Calvet, Xavier; Navas, Miquel; Rojas-Garcia, Ricard; Diaz-Manera, Jordi; Querol, Luis; Gallardo, Eduard; Illa, Isabel] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerat CIBERNED, Madrid, Spain; [Luis Mosquera, Jose] Univ Barcelona, Dept Stat, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBERNED; Instituto de Salud Carlos III; University of Barcelona	Nogales-Gadea, G (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, E-08193 Barcelona, Spain.	gnogales@santpau.cat; iilla@santpau.cat	Nogales-Gadea, Gisela/N-4004-2014; ILLA, Isabel/AAD-1816-2019; Suárez-Calvet, Xavier/AAF-8273-2021; Querol, Luis/H-2119-2015; Mosquera, Jose Luis/O-9456-2015	Nogales-Gadea, Gisela/0000-0002-7414-212X; Suárez-Calvet, Xavier/0000-0002-5314-6607; Querol, Luis/0000-0002-4289-8264; Mosquera, Jose Luis/0000-0002-7852-4993; RAMOS-FRANSI, ALBA/0000-0002-4114-4575; Gallardo, Eduard/0000-0002-3942-3436; Diaz-Manera, Jordi/0000-0003-2941-7988; Navas Madronal, Miquel/0000-0003-2984-1471	Fondo de Investigaciones Sanitarias (Fondo de Investigaciones [FIS] Intrasalud [09/1964]; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain [FIS CD10/00027, FIS CM09/00017]	Fondo de Investigaciones Sanitarias (Fondo de Investigaciones [FIS] Intrasalud; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This project was supported with a research grant from Fondo de Investigaciones Sanitarias (Fondo de Investigaciones [FIS] Intrasalud; 09/1964; principal investigator, I. I.). GNG and LQ are supported by FIS CD10/00027 and FIS CM09/00017 grants from Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almehmadi M, 2014, IMMUNOLOGY; Aragones JM, 2003, NEUROLOGY, V60, P1024, DOI 10.1212/01.WNL.0000050461.05432.C5; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baj-Krzyworzeka M, 2007, IMMUNOL LETT, V113, P76, DOI 10.1016/j.imlet.2007.07.014; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Berrih-Aknin S., 2014, J AUTOIMMUN; Berrih-Aknin S, 2009, ANN NEUROL, V66, P521, DOI 10.1002/ana.21628; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; Chen W, 2014, EUR J HAEMATOL; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng ZA, 2013, J CLIN IMMUNOL, V33, P567, DOI 10.1007/s10875-012-9834-5; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Csuka D, 2012, EUR J NEUROL, V19, P842, DOI 10.1111/j.1468-1331.2011.03636.x; Davis TE, 2013, ARTHRITIS RHEUM-US, V65, P1882, DOI 10.1002/art.37966; Deitiker PR, 2006, AUTOIMMUNITY, V39, P277, DOI 10.1080/08916930600738581; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; EYMARD B, 1995, REV NEUROL-FRANCE, V151, P6; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Gertel-Lapter S, 2013, AUTOIMMUN REV, V12, P894, DOI 10.1016/j.autrev.2013.03.009; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giraud M, 2007, NATURE, V448, P934, DOI 10.1038/nature06066; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hock M, 2013, J IMMUNOL, V190, P2345, DOI 10.4049/jimmunol.1201591; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ionita CM, 2013, PEDIATR NEUROL, V48, P95, DOI 10.1016/j.pediatrneurol.2012.07.008; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; Khella HWZ, 2013, AM J KIDNEY DIS, V61, P798, DOI 10.1053/j.ajkd.2012.09.018; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LANIER LL, 1989, J EXP MED, V169, P2233, DOI 10.1084/jem.169.6.2233; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leite MI, 2007, AM J PATHOL, V171, P893, DOI 10.2353/ajpath.2007.070240; Leuenberger N, 2013, ANAL BIOANAL CHEM, V405, P9617, DOI 10.1007/s00216-013-7340-0; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Liang H, 2013, WILEY INTERDISCIP RE; Lu J, 2013, NEUROSCI LETT; Macha MA, 2014, CURR PHARM DES; Melms A, 2006, ACTA NEUROL SCAND, V113, P12, DOI 10.1111/j.1600-0404.2006.00636.x; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mo MH, 2012, J CANCER, V3, P432, DOI 10.7150/jca.4919; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Rainer J, 2009, LEUKEMIA, V23, P746, DOI 10.1038/leu.2008.370; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sanders DB, 2013, MUSCLE NERVE; Sangokoya C, 2010, METHODS MOL BIOL, V667, P193, DOI 10.1007/978-1-60761-811-9_13; Setzer F, 2006, PLATELETS, V17, P571, DOI 10.1080/09537100600760244; SHIFENG H, 2013, PLOS ONE, V0008; Shiono H, 1997, EUR J IMMUNOL, V27, P805, DOI 10.1002/eji.1830270402; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stacy S, 2010, J IMMUNOL, V184, P6067, DOI 10.4049/jimmunol.0901618; Suzuki S, 2011, J NEUROIMMUNOL, V230, P148, DOI 10.1016/j.jneuroim.2010.10.023; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; THORLACIUS S, 1989, ACTA NEUROL SCAND, V80, P290, DOI 10.1111/j.1600-0404.1989.tb03881.x; Toiyama Y, 2013, ANN SURG; Tsai HL, 2013, TRANSL RES, V162, P258, DOI 10.1016/j.trsl.2013.07.009; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Z, 2013, MOL CELL BIOCH; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Yang BZ, 1998, CLIN IMMUNOL IMMUNOP, V86, P45, DOI 10.1006/clin.1997.4451; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zheng Hong, 2013, Cancer Biology Medicine, V10, P123, DOI 10.7497/j.issn.2095-3941.2013.03.001; Zivkovic SA, 2012, J NEUROL, V259, P2167, DOI 10.1007/s00415-012-6478-6	87	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91927	10.1371/journal.pone.0091927	http://dx.doi.org/10.1371/journal.pone.0091927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637658	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100082
J	Bohovych, I; Donaldson, G; Christianson, S; Zahayko, N; Khalimonchuk, O				Bohovych, Iryna; Donaldson, Garrett; Christianson, Sara; Zahayko, Nataliya; Khalimonchuk, Oleh			Stress-triggered Activation of the Metalloprotease Oma1 Involves Its C-terminal Region and Is Important for Mitochondrial Stress Protection in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetics; Metalloprotease; Mitochondria; Oxidative Stress; Yeast; Mitochondrial Stress; Oma1; Proteases	M-AAA PROTEASE; SACCHAROMYCES-CEREVISIAE; CYTOCHROME-OXIDASE; QUALITY-CONTROL; STRUCTURAL INSIGHT; RHOMBOID PROTEASE; ESCHERICHIA-COLI; STATIONARY-PHASE; OXIDATIVE STRESS; MAMMALIAN-CELLS	Background: Oma1 is a conserved membrane-bound protease that forms a high molecular mass complex. Results: Oma1 activity is induced by stress stimuli and required for survival. The activation is linked to changes in Oma1 oligomer stability and involves its C-terminal region. Conclusion: Oma1 function is activated by mitochondrial stress and is important for stress tolerance. Significance: Novel insights into Oma1 function and a potential stress activation mechanism are provided. Functional integrity of mitochondria is critical for optimal cellular physiology. A suite of conserved mitochondrial proteases known as intramitochondrial quality control represents one of the mechanisms assuring normal mitochondrial function. We previously demonstrated that ATP-independent metalloprotease Oma1 mediates degradation of hypohemylated Cox1 subunit of cytochrome c oxidase and is active in cytochrome c oxidase-deficient mitochondria. Here we show that Oma1 is important for adaptive responses to various homeostatic insults and preservation of normal mitochondrial function under damage-eliciting conditions. Changes in membrane potential, oxidative stress, or chronic hyperpolarization lead to increased Oma1-mediated proteolysis. The stress-triggered induction of Oma1 proteolytic activity appears to be associated with conformational changes within the Oma1 homo-oligomeric complex, and these alterations likely involve C-terminal residues of the protease. Substitutions in the conserved C-terminal region of Oma1 impair its ability to form a labile proteolytically active complex in response to stress stimuli. We demonstrate that Oma1 genetically interacts with other inner membrane-bound quality control proteases. These findings indicate that yeast Oma1 is an important player in IM protein homeostasis and integrity by acting in concert with other intramitochondrial quality control components.	[Khalimonchuk, Oleh] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Nebraska Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Khalimonchuk, O (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.	okhalimonchuk2@unl.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health [P20 RR-017675, P30GM103335, ES03817]; University of Nebraska-Lincoln Lyman Award; University of Nebraska UCARE program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES003817, R01ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108975, P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska-Lincoln Lyman Award; University of Nebraska UCARE program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR-017675 and P30GM103335 (to the Nebraska Redox Biology Center) and ES03817. This work was also supported by a University of Nebraska-Lincoln Lyman Award (to O.K.) and funds from the University of Nebraska UCARE program (to G. D. and S.C.).	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Baker M.J., 2011, COLD SPRING HARB PER, V3; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Biswas T, 2010, STRUCTURE, V18, P1353, DOI 10.1016/j.str.2010.06.017; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P587, DOI 10.1001/archneurol.2010.351; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Leroy I, 2010, FEBS LETT, V584, P3153, DOI 10.1016/j.febslet.2010.05.060; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Lopez-Pelegrin M, 2013, J BIOL CHEM, V288, P21279, DOI 10.1074/jbc.M113.476580; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Ocampo A, 2010, FASEB J, V24, P1431, DOI 10.1096/fj.09-148601; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Shimohata N, 2002, GENES CELLS, V7, P653, DOI 10.1046/j.1365-2443.2002.00554.x; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b	63	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13259	13272		10.1074/jbc.M113.542910	http://dx.doi.org/10.1074/jbc.M113.542910			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648523	Green Published, hybrid			2022-12-25	WOS:000335522800026
J	Abel, EV; Kim, EJ; Wu, JJ; Hynes, M; Bednar, F; Proctor, E; Wang, LD; Dziubinski, ML; Simeone, DM				Abel, Ethan V.; Kim, Edward J.; Wu, Jingjiang; Hynes, Mark; Bednar, Filip; Proctor, Erica; Wang, Lidong; Dziubinski, Michele L.; Simeone, Diane M.			The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer	PLOS ONE			English	Article							PROSPECTIVE IDENTIFICATION; BREAST-CANCER; TUMOR; DIFFERENTIATION; CLEAVAGE	Background: Pancreatic cancer stem cells (CSCs) represent a small subpopulation of pancreatic cancer cells that have the capacity to initiate and propagate tumor formation. However, the mechanisms by which pancreatic CSCs are maintained are not well understood or characterized. Methods: Expression of Notch receptors, ligands, and Notch signaling target genes was quantitated in the CSC and non-CSC populations from 8 primary human pancreatic xenografts. A gamma secretase inhibitor (GSI) that inhibits the Notch pathway and a shRNA targeting the Notch target gene Hes1 were used to assess the role of the Notch pathway in CSC population maintenance and pancreatic tumor growth. Results: Notch pathway components were found to be upregulated in pancreatic CSCs. Inhibition of the Notch pathway using either a gamma secretase inhibitor or Hes1 shRNA in pancreatic cancer cells reduced the percentage of CSCs and tumorsphere formation. Conversely, activation of the Notch pathway with an exogenous Notch peptide ligand increased the percentage of CSCs as well as tumorsphere formation. In vivo treatment of orthotopic pancreatic tumors in NOD/SCID mice with GSI blocked tumor growth and reduced the CSC population. Conclusion: The Notch signaling pathway is important in maintaining the pancreatic CSC population and is a potential therapeutic target in pancreatic cancer.	[Abel, Ethan V.; Wu, Jingjiang; Hynes, Mark; Bednar, Filip; Proctor, Erica; Wang, Lidong; Dziubinski, Michele L.; Simeone, Diane M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Kim, Edward J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Translat Oncol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	simeone@umich.edu	Kim, Edward/W-2366-2019		Randy Pausch Family AACR-PANCAN Innovation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	Randy Pausch Family AACR-PANCAN Innovation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Randy Pausch Family AACR-PANCAN Innovation Award (DMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Parisi M J, 1998, Cell Res, V8, P15; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Wang ZW, 2011, ANTICANCER RES, V31, P1105; Yabuuchi S, 2013, CANCER LETT, V335, P41, DOI 10.1016/j.canlet.2013.01.054; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yen WC, 2012, CLIN CANCER RES, V18, P5374, DOI 10.1158/1078-0432.CCR-12-0736; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0	33	109	118	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91983	10.1371/journal.pone.0091983	http://dx.doi.org/10.1371/journal.pone.0091983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647545	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500065
J	Dong, XP; Hao, YT; Wei, YC; Yin, QW; Du, JJ; Zhao, XG				Dong, Xiaopeng; Hao, Yingtao; Wei, Yucheng; Yin, Qiuwei; Du, Jiajun; Zhao, Xiaogang			Response to First-Line Chemotherapy in Patients with Non-Small Cell Lung Cancer According to RRM1 Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PHASE-III TRIAL; GEMCITABINE; ERCC1; CISPLATIN; RESISTANCE; SURVIVAL; PLATINUM; EFFICACY; REPAIR	Background: The response to cytotoxic chemotherapy varies greatly in patients with advanced non-small cell lung cancer (NSCLC), and molecular markers may be useful in determining a preferable therapeutic approach for individual patients. This retrospective study was performed to evaluate the predictive value of ribonucleotide reductase regulatory subunit M1 (RRM1) on the therapeutic efficacy of platinum-based chemotherapy in patients with NSCLC. Methods: Patients with advanced NSCLC who received platinum doublet chemotherapy (n = 229) were included in this retrospective study, and their clinical outcomes were analyzed according to RRM1 expression. Results: In patients receiving gemcitabine-based therapy, the disease control rate (DCR) and progression-free survival (PFS) of patients with RRM1-negative tumors were significantly higher than in patients with RRMI-positive tumors (P=0.041 and P=0.01, respectively), and multivariate analysis showed that RRM1 expression was an independent prognostic factor (P=0.013). No similar differences were found in patients receiving docetaxel-or vinorelbine-based therapy. In RRM1-positive patients, the DCRs for docetaxel and vinorelbine were higher than for gemcitabine (P=0.047 and P=0.047, respectively), and docetaxel and vinorelbine showed a longer PFS than gemcitabine-based chemotherapy (P=0.012 and P=0.007). No similar differences were found among patients with RRM1-negative tumors. Conclusions: Negative RRM1 expression in advanced NSCLC is associated with a higher response rate to gemcitabine-based chemotherapy. In patients with RRM1-positive tumors, docetaxel and vinorelbine showed a higher therapeutic efficacy than gemcitabine-based therapy. Additional prospective studies are needed to investigate the predictive meaning of RRM1 in the response to chemotherapy.	[Dong, Xiaopeng; Hao, Yingtao; Zhao, Xiaogang] Shandong Univ, Hosp 2, Dept Thorac Surg, Jinan 250100, Peoples R China; [Wei, Yucheng] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Peoples R China; [Yin, Qiuwei] Shandong Univ, Qilu Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China; [Du, Jiajun] Shandong Prov Hosp, Dept Thorac Surg, Jinan, Peoples R China	Shandong University; Qingdao University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhao, XG (corresponding author), Shandong Univ, Hosp 2, Dept Thorac Surg, Jinan 250100, Peoples R China.	dxp3260@sohu.com						Bepler G, 2008, J THORAC ONCOL, V3, P1112, DOI 10.1097/JTO.0b013e3181874936; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bepler G, 2013, J CLIN ONCOL, V31, P2404, DOI 10.1200/JCO.2012.46.9783; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Gong WY, 2012, LUNG CANCER, V75, P374, DOI 10.1016/j.lungcan.2011.08.003; Kelly K, 2001, J CLIN ONCOL, V19, P3210, DOI 10.1200/JCO.2001.19.13.3210; Oguri T, 2006, MOL CANCER THER, V5, P1800, DOI 10.1158/1535-7163.MCT-06-0025; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Papadaki C, 2012, J THORAC ONCOL, V7, P663, DOI 10.1097/JTO.0b013e318244bdd4; Park JH, 2012, LUNG CANCER, V77, P433, DOI 10.1016/j.lungcan.2012.03.020; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Roth JA, 2011, CLIN LUNG CANCER, V12, P393, DOI 10.1016/j.cllc.2011.04.005; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Simon GR, 2007, INT J BIOCHEM CELL B, V39, P1318, DOI 10.1016/j.biocel.2007.05.006; Simon GR, 2012, CANCER-AM CANCER SOC, V118, P2525, DOI 10.1002/cncr.26522; Simon GR, 2008, FUTURE ONCOL, V4, P51, DOI 10.2217/14796694.4.1.51; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Sun JM, 2011, J THORAC ONCOL, V6, P1392, DOI 10.1097/JTO.0b013e3182208ea8	23	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92320	10.1371/journal.pone.0092320	http://dx.doi.org/10.1371/journal.pone.0092320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647522	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500115
J	Narayan, EJ; Graham, C; McCallum, H; Hero, JM				Narayan, Edward J.; Graham, Clara; McCallum, Hamish; Hero, Jean-Marc			Over-Wintering Tadpoles of Mixophyes fasciolatus Act as Reservoir Host for Batrachochytrium dendrobatidis	PLOS ONE			English	Article							WILD FROGS; CHYTRIDIOMYCOSIS; DISEASE; PATHOGEN; DECLINE; TRANSMISSION; PREVALENCE; TIME; SUSCEPTIBILITY; POPULATIONS	Batrachochytrium dendrobatidis (Bd), a cutaneous amphibian fungus that causes the lethal disease chytridiomycosis, has been implicated as a cause of many amphibian declines. Bd can tolerate low temperatures with an optimum thermal range from 17-24 degrees C. It has been shown that Bd infection may result in species extinction, avoiding the transmission threshold presented by density dependent transmission theory. Prevalence of Bd during autumn and winter has been shown to be as low as 0% in some species. It is currently unclear how Bd persists in field conditions and what processes result in carry-over between seasons. It has been hypothesised that overwintering tadpoles may host Bd between breeding seasons. The Great Barred Frog (Mixophyes fasciolatus) is a common, stable and widespread species in Queensland, Australia, and is known to carry Bd. Investigation into Bd infection of different life stages of M. fasciolatus during seasonally low prevalence may potentially reveal persistence and carry-over methods between seasons. Metamorphs, juveniles, and adults were swabbed for Bd infection over three months (between March and May, 2011) at 5 sites of varying altitude (66 m-790 m). A total of 93 swabs were analysed using Polymerase Chain Reaction (PCR) real-time analysis. PCR analysis showed 6 positive (1 excluded), 4 equivocal and 83 negative results for infection with Bd. Equivocal results were assumed to be negative using the precautionary principle. The 5 positive results consisted of 4 emerging (Gosner stage 43-45) metamorphs and 1 adult M. fasciolatus. Fisher's exact test on prevalence showed that the prevalence was significantly different between life stages. All positive results were sampled at high altitudes (790 m); however prevalence was not significantly different between altitudes. Infection of emerging metamorphs suggests that individuals were infected as tadpoles. We hypothesise that M. fasciolatus tadpoles carry Bd through seasons. Thus, Mixophyes fasciolatus may act as disease reservoirs at multiple life stages.	[Narayan, Edward J.; Graham, Clara; McCallum, Hamish; Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Res Inst, Nathan, Qld 4111, Australia	Griffith University	Narayan, EJ (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Nathan, Qld 4111, Australia.	e.narayan@ga.griffith.edu.au	McCallum, Hamish/E-1638-2013; Narayan, Edward/E-8238-2016	McCallum, Hamish/0000-0002-3493-0412; Narayan, Edward/0000-0003-2719-0900	Griffith University Environmental Futures Centre	Griffith University Environmental Futures Centre	This research was supported by the Griffith University Environmental Futures Centre, as part of CG's honours thesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen D, 2010, GLOBAL BD MAPPING PR; Anstis M., 2007, TADPOLES S E AUSTR G; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger S, 2005, HORM BEHAV, V47, P419, DOI 10.1016/j.yhbeh.2004.11.011; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Daszak P, 2004, HERPETOL J, V14, P201; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; HERO J-M, 1989, Herpetological Review, V20, P66; Hero Jean-Marc, 2006, Pacific Conservation Biology, V12, P313; Hero JM, 2004, HERPETOL J, V14, P175; Hero JM, 2005, J ZOOL, V267, P221, DOI 10.1017/S0952836905007296; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P141, DOI 10.3354/dao071141; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McDonald K, 1999, REV DECLINING FROGS, P14; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Parris KM, 2002, WILDLIFE RES, V29, P469, DOI 10.1071/WR01107; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stratford Danial S., 2010, Australian Zoologist, V35, P189; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207	48	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92499	10.1371/journal.pone.0092499	http://dx.doi.org/10.1371/journal.pone.0092499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647532	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500137
J	Otis, JS; Niccoli, S; Hawdon, N; Sarvas, JL; Frye, MA; Chicco, AJ; Lees, SJ				Otis, Jeffrey S.; Niccoli, Sarah; Hawdon, Nicole; Sarvas, Jessica L.; Frye, Melinda A.; Chicco, Adam J.; Lees, Simon J.			Pro-Inflammatory Mediation of Myoblast Proliferation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; SATELLITE CELL-PROLIFERATION; HUMAN SKELETAL-MUSCLE; PROINFLAMMATORY CYTOKINE EXPRESSION; LEUKEMIA INHIBITORY FACTOR; STIMULATES IL-6 PRODUCTION; PROTEIN-KINASE-C; TNF-ALPHA; GENE-EXPRESSION	Skeletal muscle satellite cell function is largely dictated by the surrounding environment following injury. Immune cell infiltration dominates the extracellular space in the injured area, resulting in increased cytokine concentrations. While increased pro-inflammatory cytokine expression has been previously established in the first 3 days following injury, less is known about the time course of cytokine expression and the specific mechanisms of cytokine induced myoblast function. Therefore, the expression of IL-1 beta and IL-6 at several time points following injury, and their effects on myoblast proliferation, were examined. In order to do this, skeletal muscle was injured using barium chloride in mice and tissue was collected 1, 5, 10, and 28 days following injury. Mechanisms of cytokine induced proliferation were determined in cell culture using both primary and C2C12 myoblasts. It was found that there is a similar to 20-fold increase in IL-1 beta ( p <= 0.05) and IL-6 ( p = 0.06) expression 5 days following injury. IL-1b increased proliferation of both primary and C2C12 cells similar to 25%. IL-1 beta stimulation also resulted in increased NF-kappa B activity, likely contributing to the increased proliferation. These data demonstrate for the first time that IL-1 beta alone can increase the mitogenic activity of primary skeletal muscle satellite cells and offer insight into the mechanisms dictating satellite cell function following injury.	[Niccoli, Sarah; Hawdon, Nicole; Sarvas, Jessica L.; Lees, Simon J.] Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada; [Sarvas, Jessica L.; Lees, Simon J.] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Chicco, Adam J.; Lees, Simon J.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Frye, Melinda A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Otis, Jeffrey S.] Georgia State Univ, Dept Kinesiol & Hlth, Atlanta, GA 30303 USA	Northern Ontario School of Medicine; Lakehead University; Colorado State University; Colorado State University; University System of Georgia; Georgia State University	Lees, SJ (corresponding author), Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada.	simon.lees@nosm.ca			National Institutes of Health (National Institute on Aging [R03 AG-034352]; National Institute of Alcohol Abuse and Alcoholism [K01 017190]; Northern Ontario Heritage Fund Corporation; NATIONAL INSTITUTE ON AGING [R03AG034352] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Northern Ontario Heritage Fund Corporation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (National Institute on Aging R03 AG-034352, P. I., Simon J. Lees; National Institute of Alcohol Abuse and Alcoholism K01 017190, P. I., Jeffrey S. Otis) and the Northern Ontario Heritage Fund Corporation (P. I., Simon J. Lees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; ALMEKINDERS LC, 1986, AM J SPORT MED, V14, P303, DOI 10.1177/036354658601400411; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; BARLOW Y, 1992, BRIT MED BULL, V48, P698, DOI 10.1093/oxfordjournals.bmb.a072572; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; BETHEA JR, 1992, J CELL PHYSIOL, V152, P264, DOI 10.1002/jcp.1041520207; Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Catanzaro R, 2012, J BIOL REG HOMEOS AG, V26, P337; Chabaud M, 1998, J IMMUNOL, V161, P409; Chevrel G, 2005, ANN RHEUM DIS, V64, P1257, DOI 10.1136/ard.2004.032359; Clary CR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-30; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Cornelison DDW, 2008, J CELL BIOCHEM, V105, P663, DOI 10.1002/jcb.21892; Cumberbatch M, 2006, J EXP MED, V203, P953, DOI 10.1084/jem.20052367; de Almeida P, 2013, LASERS MED SCI; Dekeyser GJ, 2013, REGEN MED RES, V1, DOI 10.1186/2050-490X-1-2; Dumke BR, 2011, AM J PHYSL CELL PHYS; ELIAS JA, 1990, J IMMUNOL, V145, P161; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Hamada K, 2004, FASEB J, V18, P264, DOI 10.1096/fj.03-1286fje; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Isumi Y, 1999, FEBS LETT, V463, P110, DOI 10.1016/S0014-5793(99)01615-4; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Jozsi AC, 2000, MECH AGEING DEV, V120, P45, DOI 10.1016/S0047-6374(00)00178-0; Jump SS, 2009, EXP PHYSIOL, V94, P739, DOI 10.1113/expphysiol.2008.046136; Kafoury Ramzi M, 2005, Int J Environ Res Public Health, V2, P107, DOI 10.3390/ijerph2005010107; KHAN I, 1995, GASTROENTEROLOGY, V108, P1720, DOI 10.1016/0016-5085(95)90133-7; Knofler M, 1997, FEBS LETT, V405, P213, DOI 10.1016/S0014-5793(97)00190-7; Krause MP, 2013, ACTA PHYSIOL, V208, P180, DOI 10.1111/apha.12099; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Lee JG, 2013, BIOL CELL, V105, P175, DOI 10.1111/boc.201200077; Lee TS, 2006, WORLD J GASTROENTERO, V12, P716, DOI 10.3748/wjg.v12.i5.716; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Lees SJ, 2009, AGING CELL, V8, P26, DOI 10.1111/j.1474-9726.2008.00445.x; Lees SJ, 2006, AM J PHYSIOL-CELL PH, V290, pC609, DOI 10.1152/ajpcell.00408.2005; Lees SJ, 2008, AMJPHYSIOL CELL PHYS; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEE DW, 1993, J IMMUNOL, V151, P970; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Mendias CL, 2004, MUSCLE NERVE, V30, P497, DOI 10.1002/mus.20102; Merrick MA, 2002, J ATHL TRAINING, V37, P209; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nozaki M, 2012, MUSCLE NERVE, V46, P70, DOI 10.1002/mus.23280; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Onozaki K, 2013, YAKUGAKU ZASSHI, V133, P645, DOI 10.1248/yakushi.13-00064; Otis Jeffrey S, 2008, AIDS Res Ther, V5, P8, DOI 10.1186/1742-6405-5-8; Otis JS, 2007, MUSCLE NERVE, V36, P842, DOI 10.1002/mus.20883; Otis JS, 2010, ALCOHOL ALCOHOLISM, V45, P495, DOI 10.1093/alcalc/agq066; Otis JS, 2009, ALCOHOL CLIN EXP RES, V33, P1450, DOI 10.1111/j.1530-0277.2009.00975.x; Ozes ON, 1999, NATURE, V401, P82; Parikh AA, 1997, SHOCK, V8, P249, DOI 10.1097/00024382-199710000-00003; Parise G, 2008, MUSCLE NERVE, V37, P611, DOI 10.1002/mus.20995; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Prelovsek O, 2006, AM J PHYSIOL-REG I, V291, pR1651, DOI 10.1152/ajpregu.00020.2006; Przybyla B, 2006, EXP GERONTOL, V41, P320, DOI 10.1016/j.exger.2005.12.007; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rathbone CR, 2008, MUSCLE NERVE, V37, P84, DOI 10.1002/mus.20897; Rathbone CR, 2009, EUR J CELL BIOL, V88, P35, DOI 10.1016/j.ejcb.2008.08.003; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; SIRONI M, 1989, J IMMUNOL, V142, P549; Soltow QA, 2010, J MUSCLE RES CELL M, V31, P215, DOI 10.1007/s10974-010-9227-4; Spangelo BL, 2000, ANN NY ACAD SCI, V917, P597; Sung MS, 2012, INFLAMMATION, V35, P1585, DOI 10.1007/s10753-012-9473-2; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Trenerry MK, 2008, REJUV RES, V11, P717, DOI 10.1089/rej.2007.0643; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788	100	65	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92363	10.1371/journal.pone.0092363	http://dx.doi.org/10.1371/journal.pone.0092363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647690	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500122
J	Rahman, MM; Alkhouri, H; Tang, F; Che, WC; Ge, Q; Ammit, AJ				Rahman, Md. Mostafizur; Alkhouri, Hatem; Tang, Francesca; Che, Wenchi; Ge, Qi; Ammit, Alaina J.			Sphingosine 1-Phosphate Induces Neutrophil Chemoattractant IL-8: Repression by Steroids	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; NF-KAPPA-B; P38 MAPK; UP-REGULATION; TNF-ALPHA; CELLS; ASTHMA; SECRETION; CYTOKINES; RANTES	The bioactive sphingolipid sphingosine 1-phosphate (S1P) is found in increased amounts in the airways of asthmatics. S1P can regulate airway smooth muscle functions associated with asthmatic inflammation and remodeling, including cytokine secretion. To date however, whether S1P induces secretion of an important chemokine responsible for neutrophilia in airway inflammation - IL-8 - was unexplored. The aim of this study was to investigate whether S1P induces IL-8 gene expression and secretion to enhance neutrophil chemotaxis in vitro, as well as examine the molecular mechanisms responsible for repression by the corticosteroid dexamethasone. We show that S1P upregulates IL-8 secretion from ASM cells and enhance neutrophil chemotaxis in vitro. The corticosteroid dexamethasone significantly represses IL-8 mRNA expression and protein secretion in a concentration- and time-dependent manner. Additionally, we reveal that S1P-induced IL-8 secretion is p38 MAPK and ERK-dependent and that these key phosphoproteins act on the downstream effector mitogen-and stress-activated kinase 1 (MSK1) to control secretion of the neutrophil chemoattractant cytokine IL-8. The functional relevance of this in vitro data was demonstrated by neutrophil chemotaxis assays where S1P-induced effects can be significantly attenuated by pretreatment with dexamethasone, pharmacological inhibition of p38 MAPK- or ERK-mediated pathways, or by knocking down MSK-1 with siRNA. Taken together, our study reveals the molecular pathways responsible for IL-8 secretion from ASM cells in response to S1P and indicates ways in which the impact on IL-8-driven neutrophilia may be lessened.	[Rahman, Md. Mostafizur; Alkhouri, Hatem; Che, Wenchi; Ammit, Alaina J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Tang, Francesca; Ge, Qi] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Ammit, AJ (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	alaina.ammit@sydney.edu.au	Alkhouri, Hatem/AAG-3390-2021; Ge, Qi/D-3988-2013; Tang, Francesca/H-4833-2016	Alkhouri, Hatem/0000-0002-5569-704X; Ammit, Alaina/0000-0003-0555-2544	Endeavour Postgraduate Award; National Health and Medical Research Council of Australia	Endeavour Postgraduate Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by an Endeavour Postgraduate Award (to MMR) and funded by project grants from the National Health and Medical Research Council of Australia (to AJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Ammit AJ, 1997, AM J RESP CRIT CARE, V155, P1123, DOI 10.1164/ajrccm.155.3.9116997; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Amrani Y, 1999, J IMMUNOL, V163, P2128; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Baines KJ, 2009, EXP LUNG RES, V35, P554, DOI 10.1080/01902140902777490; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; Catley MC, 2006, MOL PHARMACOL, V70, P697, DOI 10.1124/mol.106.023150; Che W, 2013, AM J RESP CELL MOL B; Che WC, 2012, BBA-MOL CELL RES, V1823, P1658, DOI 10.1016/j.bbamcr.2012.06.011; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; John M, 1997, J IMMUNOL, V158, P1841; Johnson PRA, 1995, PULM PHARMACOL, V8, P43, DOI 10.1006/pulp.1995.1006; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; Kaur M, 2013, J PHARMACOL EXP THER, V347, P173, DOI 10.1124/jpet.112.201855; Lai WQ, 2011, BIOSCIENCE REP, V31, P145, DOI 10.1042/BSR20100087; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Manetsch M, 2012, BRIT J PHARMACOL, V166, P2049, DOI 10.1111/j.1476-5381.2012.01923.x; Manetsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059635; Manetsch M, 2012, AM J PHYSIOL-LUNG C, V302, pL838, DOI 10.1152/ajplung.00317.2011; Manetsch M, 2012, CELL SIGNAL, V24, P907, DOI 10.1016/j.cellsig.2011.12.013; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Moutzouris JP, 2010, BBA-MOL CELL RES, V1803, P416, DOI 10.1016/j.bbamcr.2009.12.007; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Newcomb DC, CURRENT OPINION IMMU; Olivera A, 2011, ADV EXP MED BIOL, V716, P123, DOI 10.1007/978-1-4419-9533-9_8; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Simpson JL, 2013, EUROPEAN RESP J; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	35	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92466	10.1371/journal.pone.0092466	http://dx.doi.org/10.1371/journal.pone.0092466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647471	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500135
J	Shi, L; Chen, XS; Tang, WY; Li, ZY; Liu, J; Gao, F; Sang, JL				Shi, Lei; Chen, Xuesi; Tang, Wenying; Li, Zhenyi; Liu, Jin; Gao, Feng; Sang, Jianli			Combination of FACS and Homologous Recombination for the Generation of Stable and High-Expression Engineered Cell Lines	PLOS ONE			English	Article							TRANSGENE EXPRESSION; CHO-CELLS; STRATEGIES; EFFICIENT; PROTEINS	Traditionally, cell line generation requires several months and involves screening of over several hundred cell clones for high productivity before dozens are selected as candidate cell lines. Here, we have designed a new strategy for the generation of stable and high-expression cell lines by combining homologous recombination (HR) and fluorescence-activated cell sorting (FACS). High expression was indicated by the expression of secreted green fluorescent protein (SEGFP). Parental cell lines with the highest expression of SEGFP were then selected by FACS and identified by stability analysis. Consequently, HR vectors were constructed using the cassette for SEGFP as the HR region. After transfecting the HR vector, the cells with negative SEGFP expression were enriched by FACS. The complete exchange between SEGFP and target gene (TNFR-Fc) cassettes was demonstrated by DNA analysis. Compared with the traditional method, by integrating the cassette containing the gene of interest into the pre-selected site, the highest producing cells secreted a more than 8-fold higher titer of target protein. Hence, this new strategy can be applied to isolated stable cell lines with desirable expression of any gene of interest. The stable cell lines can rapidly produce proteins for researching protein structure and function and are even applicable in drug discovery.	[Shi, Lei; Chen, Xuesi; Liu, Jin; Gao, Feng; Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Shi, Lei; Tang, Wenying; Li, Zhenyi; Gao, Feng] AutekBio Inc, R&D Dept, Beijing, Peoples R China	Beijing Normal University	Gao, F (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China.	feng_gao@autekbio.com; jlsang@bnu.edu.cn	Chen, Xuesi/ABB-5039-2020		National "Twelfth Five-Year Plan" from the Ministry of Health [2011ZX09506-007]	National "Twelfth Five-Year Plan" from the Ministry of Health	This work was supported by The National "Twelfth Five-Year Plan" from the Ministry of Health (2011ZX09506-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bort JAH, 2010, BIOTECHNOL J, V5, P1090, DOI 10.1002/biot.201000095; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Dreesen IAJ, 2011, BIOTECHNOL BIOENG, V108, P853, DOI 10.1002/bit.22990; Grandjean M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr436; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Huang Y, 2007, J IMMUNOL METHODS, V322, P28, DOI 10.1016/j.jim.2007.01.022; IMARC Group, 2012, SKUIMRC4880703; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Khoo SHG, 2009, BIOTECHNOL BIOENG, V102, P188, DOI 10.1002/bit.22041; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Koduri RK, 2001, GENE, V280, P87, DOI 10.1016/S0378-1119(01)00772-7; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Matasci M., 2008, DRUG DISCOV TODAY TE, V5, pe37, DOI DOI 10.1016/J.DDTEC.2008.12.003; Mattanovich D, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-12; Nair Ayyappan R, 2011, BMC Res Notes, V4, P178, DOI 10.1186/1756-0500-4-178; Peng J, 2005, RETARGETING PRESET R; Pichler J, 2011, BIOTECHNOL BIOENG, V108, P386, DOI 10.1002/bit.22946; Pichler J, 2009, J BIOTECHNOL, V141, P80, DOI 10.1016/j.jbiotec.2009.03.001; Porter AJ, 2010, BIOTECHNOL PROGR, V26, P1446, DOI 10.1002/btpr.442; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Seth G, 2007, CURR OPIN BIOTECH, V18, P557, DOI 10.1016/j.copbio.2007.10.012; Sleiman RJ, 2008, BIOTECHNOL BIOENG, V99, P578, DOI 10.1002/bit.21612; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wilke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027829; Yanez RJ, 1999, SOMAT CELL MOLEC GEN, V25, P27, DOI 10.1023/B:SCAM.0000007137.28557.73	28	4	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91712	10.1371/journal.pone.0091712	http://dx.doi.org/10.1371/journal.pone.0091712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646904	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500046
J	Walters, BJ; Lin, WW; Diao, SY; Brimble, M; Iconaru, LI; Dearman, J; Goktug, A; Chen, TS; Zuo, J				Walters, Brandon J.; Lin, Wenwei; Diao, Shiyong; Brimble, Mark; Iconaru, Luigi I.; Dearman, Jennifer; Goktug, Asli; Chen, Taosheng; Zuo, Jian			High-Throughput Screening Reveals Alsterpaullone, 2-Cyanoethyl as a Potent p27(Kip1) Transcriptional Inhibitor	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; HAIR-CELLS; STEM-CELLS; CANCER; EXPRESSION; GENE; COCHLEA; ORGAN; CORTI	p27(Kip1) is a cell cycle inhibitor that prevents cyclin dependent kinase (CDK)/cyclin complexes from phosphorylating their targets. p27(Kip1) is a known tumor suppressor, as the germline loss of p27(Kip1) results in sporadic pituitary formation in aged rodents, and its presence in human cancers is indicative of a poor prognosis. In addition to its role in cancer, loss of p27(Kip1) results in regenerative phenotypes in some tissues and maintenance of stem cell pluripotency, suggesting that p27(Kip1) inhibitors could be beneficial for tissue regeneration. Because p27(Kip1) is an intrinsically disordered protein, identifying direct inhibitors of the p27(Kip1) protein is difficult. Therefore, we pursued a high-throughput screening strategy to identify novel p27(Kip1) transcriptional inhibitors. We utilized a luciferase reporter plasmid driven by the p27(Kip1) promoter to transiently transfect HeLa cells and used cyclohexamide as a positive control for non-specific inhibition. We screened a "bioactive'' library consisting of 8,904 (4,359 unique) compounds, of which 830 are Food and Drug Administration (FDA) approved. From this screen, we successfully identified 111 primary hits with inhibitory effect against the promoter of p27(Kip1). These hits were further refined using a battery of secondary screens. Here we report four novel p27(Kip1) transcriptional inhibitors, and further demonstrate that our most potent hit compound (IC50 = 200 nM) Alsterpaullone 2-cyanoethyl, inhibits p27(Kip1) transcription by preventing FoxO3a from binding to the p27(Kip1) promoter. This screen represents one of the first attempts to identify inhibitors of p27(Kip1) and may prove useful for future tissue regeneration studies.	[Walters, Brandon J.; Diao, Shiyong; Brimble, Mark; Iconaru, Luigi I.; Dearman, Jennifer; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Lin, Wenwei; Goktug, Asli; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Brimble, Mark] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Bath	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org	Chen, Taosheng/I-6351-2013; Lin, Wenwei/D-9241-2018	Chen, Taosheng/0000-0001-6420-3809; Lin, Wenwei/0000-0001-8754-6150; Brimble, Mark/0000-0001-7182-9818; Walters, Brandon/0000-0002-8073-6573	Office of Naval Research [N000140911014, N000141210191, N000141210775]; National Institutes of Health [DC06471, GM086415, CA21765]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; The Hartwell Individual Biomedical Research Award; HHF emerging research grant; Garwood Fellowship; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC013879] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); The Hartwell Individual Biomedical Research Award; HHF emerging research grant; Garwood Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Office of Naval Research: N000140911014, N000141210191, and N000141210775 (JZ); National Institutes of Health: DC06471 (JZ), GM086415 (TC), and CA21765 (St. Jude); The American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; JZ is a recipient of The Hartwell Individual Biomedical Research Award; BW is a recipient of the HHF emerging research grant; LI is a recipient of the Garwood Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertagnolli MM, 2009, CLIN CANCER RES, V15, P2116, DOI 10.1158/1078-0432.CCR-08-2674; Bottini C, 2009, INT J ONCOL, V34, P69, DOI 10.3892/ijo_00000130; Chang BL, 2004, CANCER RES, V64, P1997, DOI 10.1158/0008-5472.CAN-03-2340; Chen P, 1999, DEVELOPMENT, V126, P1581; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Herbst J, 2009, ASSAY DRUG DEV TECHN, V7, P294, DOI 10.1089/adt.2008.184; Karnezis AN, 2001, J CLIN INVEST, V108, P383, DOI 10.1172/JCI11933; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Leonardi R, 2010, CHEM BIOL, V17, P892, DOI 10.1016/j.chembiol.2010.06.006; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Liu ZY, 2012, J NEUROSCI, V32, P10530, DOI 10.1523/JNEUROSCI.0686-12.2012; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Maass JC, 2013, JARO-J ASSOC RES OTO, V14, P495, DOI 10.1007/s10162-013-0383-2; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Menchon C, 2011, CELL CYCLE, V10, P1435, DOI 10.4161/cc.10.9.15421; Minami S, 1997, FEBS LETT, V411, P1, DOI 10.1016/S0014-5793(97)00660-1; Minoda R, 2007, HEARING RES, V232, P44, DOI 10.1016/j.heares.2007.06.005; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tolle N, 2011, CURR TOP MED CHEM, V11, P1320, DOI 10.2174/156802611795589601; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Walters BJ, 2013, HEARING RES, V297, P68, DOI 10.1016/j.heares.2012.11.009; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371	38	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91173	10.1371/journal.pone.0091173	http://dx.doi.org/10.1371/journal.pone.0091173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646893	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500025
J	Zhou, WP; Hui, DF; Shen, WJ				Zhou, Weiping; Hui, Dafeng; Shen, Weijun			Effects of Soil Moisture on the Temperature Sensitivity of Soil Heterotrophic Respiration: A Laboratory Incubation Study	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ECOSYSTEM RESPIRATION; MICROBIAL COMMUNITIES; EXTRACTION METHOD; WATER-CONTENT; DECOMPOSITION; RESPONSES; BIOMASS; CO2; PATTERNS	The temperature sensitivity (Q(10)) of soil heterotrophic respiration (Rh) is an important ecological model parameter and may vary with temperature and moisture. While Q(10) generally decreases with increasing temperature, the moisture effects on Q(10) have been controversial. To address this, we conducted a 90-day laboratory incubation experiment using a subtropical forest soil with a full factorial combination of five moisture levels (20%, 40%, 60%, 80%, and 100% water holding capacity - WHC) and five temperature levels (10, 17, 24, 31, and 38 degrees C). Under each moisture treatment, R-h was measured several times for each temperature treatment to derive Q(10) based on the exponential relationships between R-h and temperature. Microbial biomass carbon (MBC), microbial community structure and soil nutrients were also measured several times to detect their potential contributions to the moisture-induced Q(10) variation. We found that Q(10) was significantly lower at lower moisture levels (60%, 40% and 20% WHC) than at higher moisture level (80% WHC) during the early stage of the incubation, but became significantly higher at 20% WHC than at 60% WHC and not significantly different from the other three moisture levels during the late stage of incubation. In contrast, soil R-h had the highest value at 60% WHC and the lowest at 20% WHC throughout the whole incubation period. Variations of Q(10) were significantly associated with MBC during the early stages of incubation, but with the fungi-to-bacteria ratio during the later stages, suggesting that changes in microbial biomass and community structure are related to the moisture-induced Q(10) changes. This study implies that global warming's impacts on soil CO2 emission may depend upon soil moisture conditions. With the same temperature rise, wetter soils may emit more CO2 into the atmosphere via heterotrophic respiration.	[Zhou, Weiping; Shen, Weijun] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhou, Weiping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tennessee State University	Shen, WJ (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	shenweij@scbg.ac.cn	Shen, Weijun/G-2942-2010	Shen, Weijun/0000-0001-7574-8839; Hui, Dafeng/0000-0002-5284-2897	Natural Science Foundation of China [31130011, 31290222]; Natural Science Foundation of Guangdong Province, China [S2012020011084]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This study was financially supported by the Natural Science Foundation of China (31130011 and 31290222), and the Natural Science Foundation of Guangdong Province, China (S2012020011084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo CBM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001006; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; CARLYLE JC, 1988, J ECOL, V76, P654, DOI 10.2307/2260565; Chen DM, 2009, FOREST ECOL MANAG, V257, P2088, DOI 10.1016/j.foreco.2009.02.018; Christ MJ, 1996, SOIL BIOL BIOCHEM, V28, P1191, DOI 10.1016/0038-0717(96)00120-4; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Craine JM, 2011, SOIL BIOL BIOCHEM, V43, P455, DOI 10.1016/j.soilbio.2010.10.011; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Yuste JC, 2010, BIOGEOCHEMISTRY, V98, P127, DOI 10.1007/s10533-009-9381-1; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Deng Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041493, 10.1371/journal.pone.0038737]; DORICH RA, 1983, SOIL SCI SOC AM J, V47, P833, DOI 10.2136/sssaj1983.03615995004700040042x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gray SB, 2011, SOIL SCI SOC AM J, V75, P2217, DOI 10.2136/sssaj2011.0135; Guggenberger G, 1999, SOIL SCI SOC AM J, V63, P1188, DOI 10.2136/sssaj1999.6351188x; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; He ZL, 1997, BIOL FERT SOILS, V24, P421, DOI 10.1007/s003740050267; HOLLAND EA, 1987, ECOLOGY, V68, P425, DOI 10.2307/1939274; Huang WJ, 2013, PLANT SOIL, V364, P181, DOI 10.1007/s11104-012-1355-8; Hui DF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002297; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Li ZA, 2001, PLANT SOIL, V229, P105, DOI 10.1023/A:1004832013143; LINN DM, 1984, SOIL SCI SOC AM J, V48, P794, DOI 10.2136/sssaj1984.03615995004800040019x; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P1031, DOI 10.1016/S0038-0717(99)00017-6; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; NAKAS JP, 1979, APPL ENVIRON MICROB, V38, P454, DOI 10.1128/AEM.38.3.454-460.1979; OBERBAUER SF, 1992, OECOLOGIA, V92, P568, DOI 10.1007/BF00317851; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Richardson J, 2012, SOIL BIOL BIOCHEM, V46, P89, DOI 10.1016/j.soilbio.2011.11.008; SCHNURER J, 1986, MICROBIAL ECOL, V12, P217, DOI 10.1007/BF02011206; Shen WJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000685; Shen WJ, 2009, GLOBAL CHANGE BIOL, V15, P2274, DOI 10.1111/j.1365-2486.2009.01857.x; Solomon S., 2007, CONTRIBUTION WORKING, P996; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tuomi M, 2008, ECOL MODEL, V211, P182, DOI 10.1016/j.ecolmodel.2007.09.003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053914; Williams MA, 2007, SOIL BIOL BIOCHEM, V39, P2750, DOI 10.1016/j.soilbio.2007.05.025; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zak DR, 1996, ECOL APPL, V6, P257, DOI 10.2307/2269568; Zhou T, 2009, SCI CHINA SER C, V52, P982, DOI 10.1007/s11427-009-0125-1	64	63	67	3	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92531	10.1371/journal.pone.0092531	http://dx.doi.org/10.1371/journal.pone.0092531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647610	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500140
J	Fa, M; Staniszewski, A; Saeed, F; Francis, YI; Arancio, O				Fa, Mauro; Staniszewski, Agnieszka; Saeed, Faisal; Francis, Yitshak I.; Arancio, Ottavio			Dynamin 1 Is Required for Memory Formation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; RELEASE PROBABILITY; TRANSMITTER RELEASE; AMYLOID-BETA; ENDOCYTOSIS; ISOFORMS; INHIBITION; CALMODULIN; MODULATION	Dynamin 1-3 isoforms are known to be involved in endocytotic processes occurring during synaptic transmission. No data has directly linked dynamins yet with normal animal behavior. Here we show that dynamin pharmacologic inhibition markedly impairs hippocampal-dependent associative memory. Memory loss was associated with changes in synaptic function occurring during repetitive stimulation that is thought to be linked with memory induction. Synaptic fatigue was accentuated by dynamin inhibition. Moreover, dynamin inhibition markedly reduced long-term potentiation, post-tetanic potentiation, and neurotransmitter released during repetitive stimulation. Most importantly, the effect of dynamin inhibition onto memory and synaptic plasticity was due to a specific involvement of the dynamin 1 isoform, as demonstrated through a genetic approach with siRNA against this isoform to temporally block it. Taken together, these findings identify dynamin 1 as a key protein for modulation of memory and release evoked by repetitive activity.	[Fa, Mauro; Staniszewski, Agnieszka; Saeed, Faisal; Francis, Yitshak I.; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University	Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	oa1@columbia.edu	arancio, ottavio/AAB-7959-2019; Fa, Mauro/F-5515-2011; Fà, Mauro/AAH-2749-2020	Fa, Mauro/0000-0002-8348-0382; Fà, Mauro/0000-0002-8348-0382; Saeed, Faisal/0000-0003-1194-2792; arancio, ottavio/0000-0001-6335-164X	NIH [R01NS049442]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH # R01NS049442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Bartolome-Martin D, 2012, J CELL SCI, V125, P422, DOI 10.1242/jcs.090878; Bayazitov IT, 2007, J NEUROSCI, V27, P11510, DOI 10.1523/JNEUROSCI.3077-07.2007; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Casoli T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.012; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; DeAndrade MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035518; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Guo CH, 2010, BEHAV GENET, V40, P680, DOI 10.1007/s10519-010-9374-9; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hou QL, 2004, EUR J NEUROSCI, V20, P1593, DOI 10.1111/j.1460-9568.2004.03600.x; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kamal A, 2011, BRAIN RES, V1410, P33, DOI 10.1016/j.brainres.2011.06.059; Kasuya J, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.011.2009; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Lou XL, 2008, P NATL ACAD SCI USA, V105, P17555, DOI 10.1073/pnas.0809621105; Lu JZ, 2008, BIOCHEM BIOPH RES CO, V371, P315, DOI 10.1016/j.bbrc.2008.04.077; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Neher Erwin, 2010, Front Synaptic Neurosci, V2, P144, DOI 10.3389/fnsyn.2010.00144; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Otis T, 1996, J NEUROSCI, V16, P7496; Owen GR, 2012, CELL MOL NEUROBIOL, V32, P919, DOI 10.1007/s10571-012-9836-0; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Virmani T, 2006, J NEUROSCI, V26, P2197, DOI 10.1523/JNEUROSCI.4500-05.2006; Wu XS, 2009, J NEUROSCI, V29, P11038, DOI 10.1523/JNEUROSCI.2367-09.2009; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; Yao LJ, 2012, P NATL ACAD SCI USA, V109, P291, DOI 10.1073/pnas.1100608109; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	55	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91954	10.1371/journal.pone.0091954	http://dx.doi.org/10.1371/journal.pone.0091954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643165	gold, Green Submitted, Green Published			2022-12-25	WOS:000333259900050
J	Jensvoll, H; Blix, K; Brkkan, SK; Hansen, JB				Jensvoll, Hilde; Blix, Kristine; Brkkan, Sigrid K.; Hansen, John-Bjarne			Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromso Study	PLOS ONE			English	Article							P-SELECTIN; THROMBOSIS; MODEL; CHEMOTHERAPY; METASTASIS; VALIDATION; ACTIVATION; THROMBOCYTOSIS; TROUSSEAU; DISEASE	Background: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease. We investigated whether pre-cancer platelet count alone or together with high leukocyte count was associated with risk of venous thromboembolism in subjects who did and did not develop cancer during follow-up in a population-based cohort study. Methods: Platelet count and other baseline characteristics were measured in 25160 initially cancer-free subjects who participated in the Tromso Study in 1994-1995. Incident cancer and symptomatic venous thromboembolism events were registered up to December 31 st, 2009. Multivariable Cox regression models were used to calculate hazard ratio for venous thromboembolism across categories of platelet count (<40 th, 40-80 th, and >80 th percentile) with 95% confidence interval. Results: During follow-up, 2082 subjects were diagnosed with cancer. Platelet count was measured on average 8.3 years before the cancer diagnosis. There were 129 venous thromboembolism events in the cancer cohort (13.5 per 1000 person-years) and 377 in the non-cancer cohort (1.2 per 1000 person-years). In cancer patients, pre-cancer platelet count above the 80 th percentile (>= 295x10(9) /L) was associated with a 2-fold higher risk of venous thromboembolism (Hazard ratio: 1.98, 95% confidence interval 1.21-3.23) compared to platelet count below the 40 th percentile (<235x10(9) /L). Concomitant high platelet and leukocyte counts showed a synergistic effect on the VTE risk. In cancer-free subjects, no association was found. Comment: In conclusion, pre-cancer platelet count was associated with risk of symptomatic venous thromboembolism in cancer patients, but not in cancer-free subjects. Our findings suggest that platelet count and platelet-leukocyte interactions may play a role in the pathogenesis of cancer-related venous thromboembolism.	[Jensvoll, Hilde; Blix, Kristine; Brkkan, Sigrid K.; Hansen, John-Bjarne] Univ Tromso, Univ Hosp North Norway, Dept Clin Med, Hematol Res Grp,Div Internal Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway	Jensvoll, H (corresponding author), Univ Tromso, Univ Hosp North Norway, Dept Clin Med, Hematol Res Grp,Div Internal Med, Tromso, Norway.	hilde.jensvoll@uit.no		Braekkan, Sigrid/0000-0002-9678-9696	Northern Norway Regional Health Authority	Northern Norway Regional Health Authority	All authors are supported by research funding from the Northern Norway Regional Health Authority (URL: http://www.helse-nord.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Blix K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073447; Braekkan SK, 2010, J THROMB HAEMOST, V8, P157, DOI 10.1111/j.1538-7836.2009.03498.x; Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Cerletti C, 2012, THROMB RES, V129, P263, DOI 10.1016/j.thromres.2011.10.010; Chen M, 2006, ARCH IMMUNOL THER EX, V54, P75, DOI 10.1007/s00005-006-0010-6; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Elting LS, 2004, ARCH INTERN MED, V164, P1653, DOI 10.1001/archinte.164.15.1653; Garner C, 2000, BLOOD, V95, P342; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Ho KM, 2012, J THROMB HAEMOST, V10, P1768, DOI 10.1111/j.1538-7836.2012.04846.x; Horsted F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001275; Kashuk JL, 2010, SURGERY, V148, P667, DOI 10.1016/j.surg.2010.07.013; Khorana AA, 2005, CANCER-AM CANCER SOC, V104, P2822, DOI 10.1002/cncr.21496; Khorana AA, 2003, J THROMB HAEMOST, V1, P2463, DOI 10.1111/j.1538-7836.2003.00501.x; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Kunicki TJ, 2012, CURR OPIN HEMATOL, V19, P371, DOI 10.1097/MOH.0b013e3283567526; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Mandala M, 2010, ANN ONCOL, V21, P871, DOI 10.1093/annonc/mdp354; Merkow RP, 2011, ANN SURG, V254, P131, DOI 10.1097/SLA.0b013e31821b98da; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Ploquin A, 2012, BRIT J CANCER, V107, P1025, DOI 10.1038/bjc.2012.371; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Salim A, 2009, J TRAUMA, V66, P1349, DOI 10.1097/TA.0b013e318191b8af; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Severinsen MT, 2009, J THROMB HAEMOST, V7, P1297, DOI 10.1111/j.1538-7836.2009.03490.x; Severinsen MT, 2010, EUR J INTERN MED, V21, P268, DOI 10.1016/j.ejim.2010.03.013; Shao BJ, 2011, BLOOD, V118, P4015, DOI 10.1182/blood-2011-07-368514; Simanek R, 2010, J THROMB HAEMOST, V8, P114, DOI 10.1111/j.1538-7836.2009.03680.x; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Togna GI, 2000, THROMB RES, V99, P503, DOI 10.1016/S0049-3848(00)00294-2; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van der Bom JG, 2009, J THROMB HAEMOST, V7, P399, DOI 10.1111/j.1538-7836.2008.03267.x; von Bruhl ML, 2012, J EXP MED; Woller SC, 2011, AM J MED, V124, P947, DOI 10.1016/j.amjmed.2011.06.004	39	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92011	10.1371/journal.pone.0092011	http://dx.doi.org/10.1371/journal.pone.0092011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642868	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900060
J	Lanteri, MC; Diamond, MS; Law, JP; Chew, GM; Wu, SQ; Inglis, HC; Wong, D; Busch, MP; Norris, PJ; Ndhlovu, LC				Lanteri, Marion C.; Diamond, Michael S.; Law, Jacqueline P.; Chew, Glen M.; Wu, Shiquan; Inglis, Heather C.; Wong, Derek; Busch, Michael P.; Norris, Philip J.; Ndhlovu, Lishomwa C.			Increased Frequency of Tim-3 Expressing T Cells Is Associated with Symptomatic West Nile Virus Infection	PLOS ONE			English	Article							BLOCKADE; EXHAUSTION; IMMUNITY; CD4(+)	More than a decade after West Nile virus (WNV) entered North America, and despite a significant increase in reported cases during the 2012 and 2013 seasons, no treatment or vaccine for humans is available. Although antiviral T cells contribute to the control of WNV, little is known about their regulation during acute infection. We analyzed the expression of Tim-3 and PD-1, two recently identified T cell negative immune checkpoint receptors, over the course of WNV infection. Symptomatic WNV+ donors exhibited higher frequencies of Tim-3(+) cells than asymptomatic subjects within naive/early differentiated CD28(+/-)CD57(-)CD4(+) and differentiated CD28(-)CD57(-)CD8(+) T cells. Our study links Tim-3-expression on T cells during acute WNV infection with the development of symptomatic disease, suggesting Tim-3 and its ligands could be targeted therapeutically to alter anti-WNV immunity and improve disease outcome.	[Lanteri, Marion C.; Law, Jacqueline P.; Wu, Shiquan; Inglis, Heather C.; Wong, Derek; Busch, Michael P.; Norris, Philip J.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Chew, Glen M.; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Busch, Michael P.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Hawaii System; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanteri, MC (corresponding author), Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.	mlanteri@bloodsystems.org; lndhlovu@hawaii.edu	n, l/AAX-3992-2020; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Ndhlovu, Lishomwa/0000-0001-5427-4187	Centers for Disease Control and Prevention [R01 C1000214]; National Heart Lung and Blood Institute [RC2HL101]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Centers for Disease Control and Prevention R01 C1000214 and National Heart Lung and Blood Institute RC2HL101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; Cho Josalyn L, 2012, J Immunol, V189, P2879, DOI 10.4049/jimmunol.1102483; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; Lai L, 2011, TRANSFUSION; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mujib S., 2012, J IMMUNOL; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Pfeiffer IA, 2013, IMMUNOBIOLOGY, V218, P1392, DOI 10.1016/j.imbio.2013.07.005; Qiu YQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002984; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Tobler LH, 2008, J INFECT DIS, V198, P979, DOI 10.1086/591466; Wang Y, 2004, IMMUNOL CELL BIOL, V82, P170, DOI 10.1046/j.0818-9641.2004.01227.x; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92134	10.1371/journal.pone.0092134	http://dx.doi.org/10.1371/journal.pone.0092134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642562	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900092
J	McCann, JC; Wiley, LM; Forbes, TD; Rouquette, FM; Tedeschi, LO				McCann, Joshua C.; Wiley, Leanne M.; Forbes, T. David; Rouquette, Francis M., Jr.; Tedeschi, Luis O.			Relationship between the Rumen Microbiome and Residual Feed Intake-Efficiency of Brahman Bulls Stocked on Bermudagrass Pastures	PLOS ONE			English	Article							PREVOTELLA-RUMINICOLA; BACTERIAL COMMUNITY; GENETIC DIVERSITY; RUMINAL BACTERIA; PURE CULTURES; COWS; SPECIFICITY; SEQUENCES; DIGESTION; DIET	Residual feed intake (RFI) testing has increased selection pressure on biological efficiency in cattle. The objective of this study was to assess the association of the rumen microbiome in inefficient, positive RFI (p-RFI) and efficient, negative RFI (n-RFI) Brahman bulls grazing 'Coastal' bermudagrass [Cynodondactylon (L.) Pers.] under two levels of forage allowance (high and low stocking intensity). Sixteen Brahman bulls were previously fed in confinement for 70 d to determine the RFI phenotype. Bulls were then allotted 60 d stocking on bermudagrass pastures to estimate RFI using the n-alkane technique. At the conclusion of the grazing period, rumen liquid samples were collected from each bull by stomach tube to evaluate the rumen microbiome. Extraction of DNA, amplification of the V4-V6 region of the 16S rRNA gene, and 454 pyrosequencing were performed on each sample. After denoising the sequences, chimera checking, and quality trimming, 4,573 6 1,287 sequences were generated per sample. Sequences were then assigned taxonomy from the Greengenes database using the RDP classifier. Overall, 67.5 and 22.9% of sequences were classified as Bacteroidetes and Firmicutes, respectively. Within the phylum Bacteroidetes, Prevotella was the most predominant genus and was observed in greater relative abundance in p-RFI bulls compared with n-RFI bulls (P = 0.01). In contrast, an unidentified Bacteroidales family was greater in relative abundance for n-RFI bulls than p-RFI (26.7 vs. 19.1%; P = 0.03). Ruminococcaceae was the third most abundant family in our samples, but it was not affected by RFI phenotype. No effect of stocking intensity was observed for bacterial taxa, but there was a tendency for alpha diversity and operational taxonomic unit richness to increase with lower stocking intensity. Results suggested the rumen microbiome of p-RFI Brahman bulls has greater levels of Prevotella, but the bacterial community composition was unaffected by stocking intensity.	[McCann, Joshua C.; Wiley, Leanne M.; Tedeschi, Luis O.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Forbes, T. David] Texas A&M Agrilife Res, Uvalde, TX USA; [Rouquette, Francis M., Jr.] Texas A&M Agrilife Res, Overton, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Tedeschi, LO (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	luis.tedeschi@tamu.edu			Texas A&M AgriLife Research	Texas A&M AgriLife Research	This work was supported by Texas A&M AgriLife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VG, 2011, GRASS FORAGE SCI, V66, P2, DOI 10.1111/j.1365-2494.2010.00780.x; Arthur PF, 2005, AUST J EXP AGR, V45, P985, DOI 10.1071/EA05052; Arthur PF, 2001, J ANIM SCI, V79, P2805; ATTWOOD GT, 1995, J APPL BACTERIOL, V79, P22, DOI 10.1111/j.1365-2672.1995.tb03119.x; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; BRYANT MP, 1961, APPL MICROBIOL, V9, P91, DOI 10.1128/AEM.9.2.91-95.1961; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; COTTA MA, 1992, APPL ENVIRON MICROB, V58, P48, DOI 10.1128/AEM.58.1.48-54.1992; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; DEHORITY BA, 1991, P NUTR SOC, V50, P149, DOI 10.1079/PNS19910026; Dove H, 2006, NAT PROTOC, V1, P1680, DOI 10.1038/nprot.2006.225; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Durunna ON, 2011, J ANIM SCI, V89, P158, DOI 10.2527/jas.2009-2514; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Hernandez-Sanabria E, 2010, APPL ENV MICROBIOL; Hernandez-Sanabria E, 2012, APPL ENVIRON MICROB, V78, P1203, DOI 10.1128/AEM.05114-11; HUNTER RA, 1985, BRIT J NUTR, V53, P637, DOI 10.1079/BJN19850073; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lawrence P, 2011, J ANIM SCI, V89, P3248, DOI 10.2527/jas.2010-3774; Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089; McCann JC, 2013, THESIS TEXAS A M U C; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer AM, 2008, J ANIM SCI, V86, P2670, DOI 10.2527/jas.2007-0642; Nkrumah JD, 2006, J ANIM SCI, V84, P145; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Ramsey R., 2005, Journal of Agricultural and Applied Economics, V37, P91, DOI 10.1017/S1074070800007124; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; RUSSELL JB, 1980, APPL ENVIRON MICROB, V39, P604, DOI 10.1128/AEM.39.3.604-610.1980; Shannon C., 1964, MATH THEORY COMMUNIC; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Thoetkiattikul H, 2013, CURR MICROBIOL, V67, P130, DOI 10.1007/s00284-013-0336-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Whitford MF, 1998, ANAEROBE, V4, P153, DOI 10.1006/anae.1998.0155; Wiley LM, 2013, THESIS TEXAS A M U C	47	67	72	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91864	10.1371/journal.pone.0091864	http://dx.doi.org/10.1371/journal.pone.0091864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642871	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900041
J	Mukherjee, K; Edgett, BA; Burrows, HW; Castro, C; Griffin, JL; Schwertani, AG; Gurd, BJ; Funk, CD				Mukherjee, Kamalika; Edgett, Brittany A.; Burrows, Harrison W.; Castro, Cecilia; Griffin, Julian L.; Schwertani, Adel Giaid; Gurd, Brendon J.; Funk, Colin D.			Whole Blood Transcriptomics and Urinary Metabolomics to Define Adaptive Biochemical Pathways of High-Intensity Exercise in 50-60 Year Old Masters Athletes	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; CDNA-MICROARRAY ANALYSIS; GENE-EXPRESSION; SKELETAL-MUSCLE; SYSTEMS BIOLOGY; PHYSICAL-ACTIVITY; ADAPTATIONS; LIPIN-1; METABOLISM; PHYSIOLOGY	Exercise is beneficial for a variety of age-related disorders. However, the molecular mechanisms mediating the beneficial adaptations to exercise in older adults are not well understood. The aim of the current study was to utilize a dual approach to characterize the genetic and metabolic adaptive pathways altered by exercise in veteran athletes and age-matched untrained individuals. Two groups of 50-60 year old males: competitive cyclists (athletes, n = 9; VO2peak 59.1 +/- 5.2 ml.kg(-1).min(-1); peak aerobic power 383 +/- 39 W) and untrained, minimally active individuals (controls, n = 8; VO2peak 35.9 +/- 9.7 ml.kg(-1).min(-1); peak aerobic power 230 +/- 57 W) were examined. All participants completed an acute bout of submaximal endurance exercise, and blood and urine samples pre-and post-exercise were analyzed for gene expression and metabolic changes utilizing genome-wide DNA microarray analysis and NMR spectroscopy-based metabolomics, respectively. Our results indicate distinct differences in gene and metabolite expression involving energy metabolism, lipids, insulin signaling and cardiovascular function between the two groups. These findings may lead to new insights into beneficial signaling pathways of healthy aging and help identify surrogate markers for monitoring exercise and training load.	[Mukherjee, Kamalika; Burrows, Harrison W.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Edgett, Brittany A.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Castro, Cecilia; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Castro, Cecilia; Griffin, Julian L.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Schwertani, Adel Giaid] McGill Univ, Div Cardiol, Ctr Hlth, Montreal, PQ, Canada	Queens University - Canada; Queens University - Canada; University of Cambridge; University of Cambridge; McGill University	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Monleon, Daniel/A-5078-2010; Mukherjee, Kamalika/O-5148-2019	Monleon, Daniel/0000-0002-4803-1573; Edgett, Brittany/0000-0002-8232-0432; Mukherjee, Kamalika/0000-0002-0372-830X; Funk, Colin/0000-0001-7029-4233	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	CDF holds a Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; Burke MF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001188; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; de Jonge XAKJ, 2003, SPORTS MED, V33, P833; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Eggermont L, 2006, NEUROSCI BIOBEHAV R, V30, P562, DOI 10.1016/j.neubiorev.2005.10.004; Enea C, 2010, ANAL BIOANAL CHEM, V396, P1167, DOI 10.1007/s00216-009-3289-4; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Greenhaff PL, 2011, J PHYSIOL-LONDON, V589, P1031, DOI 10.1113/jphysiol.2010.201525; Groussard C, 2003, EUR J APPL PHYSIOL, V89, P14, DOI 10.1007/s00421-002-0767-1; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Higashida K, 2008, BIOCHEM BIOPH RES CO, V374, P587, DOI 10.1016/j.bbrc.2008.07.079; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Jung HJ, 2011, BIOORG MED CHEM LETT, V21, P1052, DOI 10.1016/j.bmcl.2010.12.002; Ka T, 2003, J RHEUMATOL, V30, P1036; Kawai T, 2007, CLIN J SPORT MED, V17, P375, DOI 10.1097/JSM.0b013e31814c3e4f; Kayashima T, 2011, CANCER SCI, V102, P1137, DOI 10.1111/j.1349-7006.2011.01936.x; Keller P, 2007, BIOCHEM SOC T, V35, P1306, DOI 10.1042/BST0351306; Kohut ML, 2004, EXERC IMMUNOL REV, V10, P6; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Kurapati R, 2012, HUM MOL GENET, V21, P1706, DOI 10.1093/hmg/ddr605; Larner Joseph, 2002, Int J Exp Diabetes Res, V3, P47, DOI 10.1080/15604280212528; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li CG, 2008, INT J CANCER, V123, P273, DOI 10.1002/ijc.23510; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Magaudda L, 2004, BASIC APPL MYOL, V14, P17; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Nieratschker V, 2011, EXPERT REV NEUROTHER, V11, P937, DOI [10.1586/ern.11.84, 10.1586/ERN.11.84]; Oue N, 2009, INT J CANCER, V125, P2383, DOI 10.1002/ijc.24624; PARDEE AB, 1949, J BIOL CHEM, V178, P241; Pears MR, 2007, METABOLOMICS, V3, P121, DOI 10.1007/s11306-007-0051-9; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Pereira CD, 2012, DIABETES OBES METAB, V14, P869, DOI 10.1111/j.1463-1326.2012.01582.x; Prior BM, 2003, EXERC SPORT SCI REV, V31, P26, DOI 10.1097/00003677-200301000-00006; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Rivera-Brown AM, 2012, PM&R, V4, P797, DOI 10.1016/j.pmrj.2012.10.007; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Saltin B, 1998, ACTA PHYSIOL SCAND, V162, P421, DOI 10.1046/j.1365-201X.1998.0293e.x; Sattelmair JR, 2009, CLIN GERIATR MED, V25, P677, DOI 10.1016/j.cger.2009.07.004; Simpson RJ, 2012, AGEING RES REV, V11, P404, DOI 10.1016/j.arr.2012.03.003; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094; Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Van der Borght K, 2009, HIPPOCAMPUS, V19, P928, DOI 10.1002/hipo.20545; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; West GB, 2009, J GERONTOL A-BIOL, V64, P205, DOI 10.1093/gerona/gln066; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wolach B, 2005, MED SCI SPORT EXER, V37, P949, DOI 10.1249/01.mss.0000171614.68897.8a; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Yarasheski KE, 2003, J GERONTOL A-BIOL, V58, P918; Yoshioka M, 2003, FASEB J, V17, P1812, DOI 10.1096/fj.02-1200com; Zeibig J, 2005, EUR J APPL PHYSIOL, V95, P96, DOI 10.1007/s00421-005-1334-3; Zhang YL, 2013, INT J MOL SCI, V14, P11096, DOI 10.3390/ijms140611096; Zieker D, 2005, PHYSIOL GENOMICS, V23, P287, DOI 10.1152/physiolgenomics.00096.2005; Zieker D, 2005, EXERC IMMUNOL REV, V11, P86	68	37	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92031	10.1371/journal.pone.0092031	http://dx.doi.org/10.1371/journal.pone.0092031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643011	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900064
J	Boyer, S; Foray, C; Dehecq, JS				Boyer, Sebastien; Foray, Coralie; Dehecq, Jean-Sebastien			Spatial and Temporal Heterogeneities of Aedes albopictus Density in La Reunion Island: Rise and Weakness of Entomological Indices	PLOS ONE			English	Article							CHIKUNGUNYA-VIRUS; ENVIRONMENTAL-FACTORS; SOURCE REDUCTION; EMILIA-ROMAGNA; AEGYPTI; MOSQUITO; DENGUE; DIPTERA; VECTOR; CULICIDAE	Following the 2006 Chikungunya disease in La Reunion, questions were raised concerning the monitoring survey of Aedes albopictus populations and the entomological indexes used to evaluate population abundance. The objectives of the present study were to determine reliable productivity indexes using a quantitative method to improve entomological surveys and mosquito control measures on Aedes albopictus. Between 2007 and 2011, 4 intervention districts, 24 cities, 990 areas and over 850,000 houses were used to fulfil those objectives. Four indexes including the classical Stegomyia index (House Index, Container Index, Breteau Index) plus an Infested Receptacle Index were studied in order to determine whether temporal (year, month, week) and/or spatial (districts, cities, areas) heterogeneities existed. Temporal variations have been observed with an increase of Ae. albopictus population density over the years, and a seasonality effect with a highest population during the hot and wet season. Spatial clustering was observed at several scales with an important autocorrelation at the area scale. Moreover, the combination among these results and the breeding site productivity obtained during these 5 years allowed us to propose recommendations to monitor Aedes albopictus by eliminating not the most finding sites but the most productive ones. As the other strategies failed in La Reunion, this new approach should should work better.	[Boyer, Sebastien] Univ Montpellier I, Ctr Natl Rech Sci CNRS 5290, MIVEGEC, IRD,UMR 224, Montpellier, France; [Boyer, Sebastien] Univ Montpellier 2, Montpellier, France; [Boyer, Sebastien; Foray, Coralie] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France; [Boyer, Sebastien] Inst Pasteur Madagascar, Unite Entomol Med, Antananarivo, Madagascar; [Dehecq, Jean-Sebastien] Agence Reg Sante Ocen Indien ARS OI, Serv Lutte Antivecorielle, GIP Serv Prophylaxie Renforcee, St Denis, Reunion, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Boyer, S (corresponding author), Univ Montpellier I, Ctr Natl Rech Sci CNRS 5290, MIVEGEC, IRD,UMR 224, Montpellier, France.	drsebastien.boyer@gmail.com		Boyer, Sebastien/0000-0002-2946-586X	French Ministry of Health; FEDER Convergence Reunion programme	French Ministry of Health; FEDER Convergence Reunion programme	This work was financially supported by the French Ministry of Health and the FEDER Convergence Reunion 2007-2013 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albieri A, 2010, B INSECTOL, V63, P209; Aldstadt J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000940; Alfonzo D, 2005, J MED ENTOMOL, V42, P278, DOI 10.1603/0022-2585(2005)042[0278:ECOTAH]2.0.CO;2; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; Beketov MA, 2010, J MED ENTOMOL, V47, P129, DOI 10.1603/ME09150; Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059; CHAMBERS DM, 1986, J AM MOSQUITO CONTR, V2, P539; Chase JM, 2003, ECOLOGY, V84, P580, DOI 10.1890/0012-9658(2003)084[0580:CGTAS]2.0.CO;2; D'Ortenzio E, 2011, EMERG INFECT DIS, V17, P309, DOI 10.3201/eid1702.101056; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Focks D, 2006, TDRIRMDEN06156 WHO; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; FOCKS DA, 2003, WHOTDRIDEDEN031; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Hamon J., 1954, Naturaliste Malgache Tananarive, V5, P35; Kumar NP, 2007, CURR SCI INDIA, V93, P1412; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; NILSSON AN, 1995, HYDROBIOLOGIA, V308, P183, DOI 10.1007/BF00006870; Organizacion Mundial de la Salud (OMS), 1995, DENGUE DENGUE HEMORR, V548; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Setbon M, 2008, POPULATION, V63, P555, DOI 10.3917/popu.803.0555; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Yebakima A, 1996, B SOC PATHOL EXOT, V89, P161	41	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91170	10.1371/journal.pone.0091170	http://dx.doi.org/10.1371/journal.pone.0091170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637507	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100019
J	Cereda, A; Hitchcock, A; Symes, MD; Cronin, L; Bibby, TS; Jones, AK				Cereda, Angelo; Hitchcock, Andrew; Symes, Mark D.; Cronin, Leroy; Bibby, Thomas S.; Jones, Anne K.			A Bioelectrochemical Approach to Characterize Extracellular Electron Transfer by Synechocystis sp PCC6803	PLOS ONE			English	Article							PCC 6803; MICROBIAL ELECTROSYNTHESIS; ELECTRICITY PRODUCTION; BACTERIAL NANOWIRES; FUEL-CELLS; BPV SYSTEM; SHEWANELLA; STRAIN; CYANOBACTERIA; SOLAR	Biophotovoltaic devices employ photosynthetic organisms at the anode of a microbial fuel cell to generate electrical power. Although a range of cyanobacteria and algae have been shown to generate photocurrent in devices of a multitude of architectures, mechanistic understanding of extracellular electron transfer by phototrophs remains minimal. Here we describe a mediatorless bioelectrochemical device to measure the electrogenic output of a planktonically grown cyanobacterium, Synechocystis sp. PCC6803. Light dependent production of current is measured, and its magnitude is shown to scale with microbial cell concentration and light intensity. Bioelectrochemical characterization of a Synechocystis mutant lacking Photosystem II demonstrates conclusively that production of the majority of photocurrent requires a functional water splitting aparatus and electrons are likely ultimately derived from water. This shows the potential of the device to rapidly and quantitatively characterize photocurrent production by genetically modified strains, an approach that can be used in future studies to delineate the mechanisms of cyanobacterial extracellular electron transport.	[Cereda, Angelo; Jones, Anne K.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Hitchcock, Andrew; Bibby, Thomas S.] Univ Southampton, Southampton, Hants, England; [Symes, Mark D.; Cronin, Leroy] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland	Arizona State University; Arizona State University-Tempe; University of Southampton; University of Glasgow	Jones, AK (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	jonesak@asu.edu	Symes, Mark/L-9810-2015; Hitchcock, Andrew/AAM-2855-2020; Cronin, Leroy/AAW-8067-2020; Cronin, Leroy/B-7752-2008	Symes, Mark/0000-0001-8067-5240; Hitchcock, Andrew/0000-0001-6572-434X; Cronin, Leroy/0000-0001-8035-5757; Cronin, Leroy/0000-0001-8035-5757; Bibby, Thomas/0000-0003-1743-473X	NSF [1105033]; BBSRC [BB/I02447X/1, BB/I024437/1]; BBSRC [BB/M011267/1] Funding Source: UKRI; EPSRC [EP/F016360/1, EP/H024107/1, EP/J00135X/1, EP/K023004/1, EP/J015156/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02447X/1, BB/I024437/1, BB/M011267/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F016360/1, EP/J00135X/1, EP/H024107/1, EP/K023004/1, EP/J015156/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by the NSF (www.nsf.gov) to AKJ (1105033) and the BBSRC (www.bbsrc.ac.uk) to TSB (BB/I02447X/1) and LC (BB/I024437/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombelli P, 2013, APPL MICROBIOL BIOT, V97, P429, DOI 10.1007/s00253-012-4473-6; Bombelli P, 2012, PHYS CHEM CHEM PHYS, V14, P12221, DOI 10.1039/c2cp42526b; Bombelli P, 2011, ENERG ENVIRON SCI, V4, P4690, DOI 10.1039/c1ee02531g; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Bradley RW, 2012, BIOCHEM SOC T, V40, P1302, DOI 10.1042/BST20120118; Bradley RW, 2013, PHYS CHEM CHEM PHYS, DOI [10.1039/C1033CP52438H, DOI 10.1039/C1033CP52438H]; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; de Schamphelaire L, 2008, ENVIRON SCI TECHNOL, V42, P3053, DOI 10.1021/es071938w; Desloover J, 2012, BIOCHEM SOC T, V40, P1233, DOI 10.1042/BST20120111; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Helder M, 2010, BIORESOURCE TECHNOL, V101, P3541, DOI 10.1016/j.biortech.2009.12.124; Howitt CA, 2001, PLANTA, V214, P46, DOI 10.1007/s004250100578; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Liu HA, 2010, ANGEW CHEM INT EDIT, V49, P6596, DOI 10.1002/anie.201000315; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Madiraju KS, 2012, BIORESOURCE TECHNOL, V110, P214, DOI 10.1016/j.biortech.2012.01.065; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; McCormick AJ, 2013, ENERG ENVIRON SCI, V6, P2682, DOI 10.1039/c3ee40491a; McCormick AJ, 2011, ENERG ENVIRON SCI, V4, P4699, DOI 10.1039/c1ee01965a; McLean JS, 2010, ENVIRON SCI TECHNOL, V44, P2721, DOI 10.1021/es903043p; Nealson KH, 2011, MRS BULL, V36, P380, DOI 10.1557/mrs.2011.69; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Pirbadian S, 2012, PHYS CHEM CHEM PHYS, V14, P13802, DOI 10.1039/c2cp41185g; Pisciotta JM, 2011, APPL MICROBIOL BIOT, V91, P377, DOI 10.1007/s00253-011-3239-x; Pisciotta JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010821; Pojidaeva E, 2004, J BACTERIOL, V186, P3991, DOI 10.1128/JB.186.12.3991-3999.2004; Rabaey K, 2011, CURR OPIN BIOTECH, V22, P371, DOI 10.1016/j.copbio.2011.01.010; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rosenbaum M, 2010, ELECTROANAL, V22, P844, DOI 10.1002/elan.200800005; Strik DPBTB, 2011, TRENDS BIOTECHNOL, V29, P41, DOI 10.1016/j.tibtech.2010.10.001; Vermaas W, 1996, J APPL PHYCOL, V8, P263, DOI 10.1007/BF02178569; VERMAAS WFJ, 1986, P NATL ACAD SCI USA, V83, P9474, DOI 10.1073/pnas.83.24.9474; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zou YJ, 2009, BIOTECHNOL BIOENG, V104, P939, DOI 10.1002/bit.22466	40	44	44	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91484	10.1371/journal.pone.0091484	http://dx.doi.org/10.1371/journal.pone.0091484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637387	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333254100037
J	Tenge, VR; Knowles, J; Johnson, JL				Tenge, Victoria R.; Knowles, Jared; Johnson, Jill L.			The Ribosomal Biogenesis Protein Utp21 Interacts with Hsp90 and Has Differing Requirements for Hsp90-Associated Proteins	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; SMALL-SUBUNIT PROCESSOME; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; HEAT-SHOCK; IN-VIVO; TETRATRICOPEPTIDE REPEAT; CELLULAR FUNCTIONS; STEROID-RECEPTOR; CLIENT PROTEINS	The molecular chaperone Hsp90 buffers the effects of genetic variation by assisting the stabilization and folding of multiple clients critical for cell signaling and growth. We identified an interaction of Hsp90 and associated proteins with the essential nucleolar protein, Utp21, part of a large complex required for biogenesis of the small ribosomal subunit. The utp21-S602F mutation, which causes minor defects in otherwise wild-type yeast, exhibited severe or lethal growth defects when combined with mutations in Hsp90 or co-chaperones. WT Utp21 and Utp21-S602F exhibited similar interactions with Hsp90, and steady-state levels of WT Utp21 were reduced upon Hsp90 mutation or inhibition. Mutations in the human homolog of UTP21, WDR36, have been associated with adult-onset primary open-angle glaucoma, a leading cause of blindness worldwide. Three different mutant forms of Utp21 analogous to glaucoma-associated WDR36 mutations exhibit reduced levels in yeast cells expressing mutations in Hsp90 or associated chaperones, suggesting that Hsp90 and co-chaperones buffer the effects of those mutations.	[Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; Univ Idaho, Ctr Reprod Biol, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Johnson, JL (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	jilljohn@uidaho.edu		Tenge, Victoria/0000-0002-9429-7161	National Science Foundation [MCB-0744522]; INBRE Program, NIH [P20 RR016454, P20 GM103408]; Div Of Molecular and Cellular Bioscience [0744522] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); INBRE Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was primarily funded by a grant to JLJ from the National Science Foundation, MCB-0744522. JK was a Brigham Young University-Idaho Summer Research intern supported by the INBRE Program, NIH Grant Nos. P20 RR016454 (National Center for Research Resources) and P20 GM103408 (National Institute of General Medical Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chi ZL, 2010, HUM MOL GENET, V19, P3806, DOI 10.1093/hmg/ddq299; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Fan BJ, 2009, MOL VIS, V15, P646; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2007, ARCH OPHTHALMOL-CHIC, V125, P434, DOI 10.1001/archopht.125.3.434-b; Flom G, 2006, GENETICS, V172, P41, DOI 10.1534/genetics.105.045815; Flom G, 2005, CURR GENET, V47, P368, DOI 10.1007/s00294-005-0580-6; Flom GA, 2012, CURR GENET, V58, P149, DOI 10.1007/s00294-012-0373-7; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Footz T, 2011, MOL VIS, V17, P1957; Footz TK, 2009, HUM MOL GENET, V18, P1276, DOI 10.1093/hmg/ddp027; Franzosa EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028211; Gallenberger M, 2011, HUM MOL GENET, V20, P422, DOI 10.1093/hmg/ddq478; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hauser MA, 2006, INVEST OPHTH VIS SCI, V47, P2542, DOI 10.1167/iovs.05-1476; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; Johnson JL, 2000, MOL CELL BIOL, V20, P3027, DOI 10.1128/MCB.20.9.3027-3036.2000; Koga F, 2009, ANTICANCER RES, V29, P797; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; SIKORSKI RS, 1989, GENETICS, V122, P19; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zuehlke AD, 2012, GENETICS, V191, P805, DOI 10.1534/genetics.112.140319	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92569	10.1371/journal.pone.0092569	http://dx.doi.org/10.1371/journal.pone.0092569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647762	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500145
J	Wang, KY				Wang, Kuo-Ying			How Change of Public Transportation Usage Reveals Fear of the SARS Virus in a City	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; PANDEMIC INFLUENZA; STRATEGIES; OUTBREAK	The outbreaks of the severe acute respiratory syndrome (SARS) epidemic in 2003 resulted in unprecedented impacts on people's daily life. One of the most significant impacts to people is the fear of contacting the SARS virus while engaging daily routine activity. Here we use data from daily underground ridership in Taipei City and daily reported new SARS cases in Taiwan to model the dynamics of the public fear of the SARS virus during the wax and wane of the SARS period. We found that for each reported new SARS case there is an immediate loss of about 1200 underground ridership (the fresh fear). These daily loss rates dissipate to the following days with an e-folding time of about 28 days, reflecting the public perception on the risk of contacting SARS virus when traveling with the underground system (the residual fear). About 50% of daily ridership was lost during the peak of the 2003 SARS period, compared with the loss of 80% daily ridership during the closure of the underground system after Typhoon Nari, the loss of 50-70% ridership due to the closure of the governmental offices and schools during typhoon periods, and the loss of 60% daily ridership during Chinese New Year holidays.	Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan	National Central University	Wang, KY (corresponding author), Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan.	kuoying@mail.atm.ncu.edu.tw			National Central University	National Central University	This work was funded by National Central University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beech H, 2003, TIME, V161; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P680; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P461; Chen YC, 2004, EMERG INFECT DIS, V10, P782, DOI 10.3201/eid1005.030579; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2005, EMERG INFECT DIS, V11, P278, DOI 10.3201/eid1102.040190; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; Hsueh Po-Ren, 2005, Journal of Microbiology Immunology and Infection, V38, P82; Liu JT, 2005, HEALTH ECON, V14, P83, DOI 10.1002/hec.911; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mamelund SE, 2004, POPULATION, V59, P269, DOI 10.2307/3654955; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084592; Normile D, 2013, SCIENCE, V339, P1269, DOI [10.1126/science.339.6125.1269, 10.1126/science.339.6125.1272]; Nuttall I, 2013, SCIENCE, V339, P1287, DOI 10.1126/science.1236434; Perrin A, 2003, TIME, V161, P3; Twu SJ, 2003, EMERG INFECT DIS, V9, P718; Wang KY, 2004, WATER AIR SOIL POLL, V156, P29, DOI 10.1023/B:WATE.0000036788.41409.5b; Wayne RP, 1993, CHEM ATMOSPHERE; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Zhou GF, 2003, EMERG INFECT DIS, V9, P1608	28	42	42	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89405	10.1371/journal.pone.0089405	http://dx.doi.org/10.1371/journal.pone.0089405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647278	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500005
J	Dominguez, LG; Radhu, N; Farzan, F; Daskalakis, ZJ				Dominguez, Luis Garcia; Radhu, Natasha; Farzan, Faranak; Daskalakis, Zafiris J.			Characterizing Long Interval Cortical Inhibition over the Time-Frequency Domain	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EEG; STIMULATION; MECHANISMS; DEFICITS; GABA	Objective: Long-interval cortical inhibition (LICI) can be recorded from motor and non-motor regions of the cortex through combined transcranial magnetic stimulation (TMS) with electroencephalography (EEG). This study aimed to evaluate additional dimensions of LICI characteristics over an extended time-frequency and spatial domain. This was done by introducing two alternative measures of LICI signal amplitude: the Discrete Fourier Transform (DFT) and the Hilbert transform (HT). Both approaches estimate signal amplitude not taking into account the phase. In both cases LICI was measured as the difference between the unconditioned and conditioned activity evoked by the test pulse. Finally, we evaluated whether the topographical patterns of single and paired responses differed beyond the expected variations in amplitude. Materials and Methods: LICI was delivered as single and paired pulses to the motor cortex (MC) and dorsolateral prefrontal cortex (DLPFC) in 33 healthy subjects with TMS-EEG. Results: Significant differences (p < 0.0001) between the unconditioned and conditioned evoked activity were found for both the DLPFC and MC using both methods (i.e., DFT and HT) after correcting for multiple comparisons in the time-frequency domain. The influence of inhibition was found to be significantly larger in space and time than previously considered. Single and paired conditions differ in intensity, but also in their topographic pattern (i.e., the specific spatiotemporal configuration of active sources). Conclusion: Similar results were found by both DFT and HT. The effect of inhibition across the cortex was also found to be complex and extended. In particular, it was found that LICI may be measured with high sensitivity in areas that were relatively distant from the stimulation site, which may have important practical applications. The analysis presented in this study overcomes some limitations of previous studies and could serve as a key reference for future studies examining TMS-indices of inhibition/excitation in healthy and diseased states.	[Dominguez, Luis Garcia; Radhu, Natasha; Farzan, Faranak; Daskalakis, Zafiris J.] Univ Toronto, Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Dominguez, LG (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada.	luisgarcia.dominguez@camh.ca		Farzan, Faranak/0000-0001-9249-2994	Temerty family foundation	Temerty family foundation	Funders: The Temerty family foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLAUS D, 1992, J NEUROL SCI, V111, P180, DOI 10.1016/0022-510X(92)90066-T; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Daskalakis ZJ, 2012, BIOL PSYCHIAT, V72, P714, DOI 10.1016/j.biopsych.2012.08.010; Daskalakis ZJ, 2012, BRAIN RES, V1463, P93, DOI 10.1016/j.brainres.2012.04.045; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Farzan F, 2010, J NEUROPHYSIOL, V104, P1339, DOI 10.1152/jn.00279.2010; Farzan F, 2010, BRAIN, V133, P1505, DOI 10.1093/brain/awq046; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; Fitzgerald PB, 2009, CLIN NEUROPHYSIOL, V120, P1706, DOI 10.1016/j.clinph.2009.06.019; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Hoppenbrouwers SS, 2013, CORTEX, V49, P1377, DOI 10.1016/j.cortex.2012.06.003; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCCORMICK DA, 1989, J NEUROPHYSIOL, V62, P1018, DOI 10.1152/jn.1989.62.5.1018; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Rogasch NC, 2013, J NEUROPHYSIOL, V109, P89, DOI 10.1152/jn.00762.2012; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; VALLSSOLE J, 1992, ELECTROEN CLIN NEURO, V85, P355, DOI 10.1016/0168-5597(92)90048-G; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	24	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92354	10.1371/journal.pone.0092354	http://dx.doi.org/10.1371/journal.pone.0092354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642981	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900123
J	Wu, YW; Tseng, PH; Lee, YC; Wang, SY; Chiu, HM; Tu, CH; Wang, HP; Lin, JT; Wu, MS; Yang, WS				Wu, Yen-Wen; Tseng, Ping-Huei; Lee, Yi-Chia; Wang, Shan-Ying; Chiu, Han-Mo; Tu, Chia-Hung; Wang, Hsiu-Po; Lin, Jaw-Town; Wu, Ming-Shiang; Yang, Wei-Shiung			Association of Esophageal Inflammation, Obesity and Gastroesophageal Reflux Disease: From FDG PET/CT Perspective	PLOS ONE			English	Article							EROSIVE ESOPHAGITIS; BARRETTS-ESOPHAGUS; ADIPOSE-TISSUE; ARTERIAL INFLAMMATION; ENDOSCOPIC DIAGNOSIS; NONEROSIVE REFLUX; F-18-FDG UPTAKE; RISK-FACTORS; ADENOCARCINOMA; BENIGN	Objective: Gastroesophageal reflux disease (GERD) is associated with bothersome symptoms and neoplastic progression into Barrett's esophagus and esophageal adenocarcinoma. We aim to determine the correlation between GERD, esophageal inflammation and obesity with F-18-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). Methods: We studied 458 subjects who underwent a comprehensive health check-up, which included an upper gastrointestinal endoscopy, FDG PET/CT and complete anthropometric measures. GERD symptoms were evaluated with Reflux Disease Questionnaire. Endoscopically erosive esophagitis was scored using the Los Angeles classification system. Inflammatory activity, represented by standardized uptake values (SUVmax) of FDG at pre-determined locations of esophagus, stomach and duodenum, were compared. Association between erosive esophagitis, FDG activity and anthropometric evaluation, including body mass index (BMI), waist circumference, visceral and subcutaneous adipose tissue volumes were analyzed. Results: Subjects with erosive esophagitis (n = 178, 38.9%) had significantly higher SUVmax at middle esophagus (2.69 +/- 0.74 vs. 2.41 +/- 0.57, P<.001) and esophagogastric junction (3.10 +/- 0.89 vs. 2.38 +/-.57, P<001), marginally higher at upper esophageal sphincter (2.29 +/- 0.42 vs. 2.21 +/- 0.48, P=.062), but not in stomach or duodenum. The severity of erosive esophagitis correlated with SUVmax and subjects with Barrett's esophagus had the highest SUVmax at middle esophagus and esophagogastric junction. Heartburn positively correlated with higher SUVmax at middle oesophagus (r=.262, P=.003). Using multivariate regression analyses, age (P=.027), total cholesterol level (P=.003), alcohol drinking (P=.03), subcutaneous adipose tissue (P<001), BMI (P<.001) and waist circumference (P<.001) were independently associated with higher SUVmax at respective esophageal locations. Conclusions: Esophageal inflammation demonstrated by FDG PET/CT correlates with endoscopic findings and symptomatology of GERD. Obesity markers, both visceral and general, are independent determinants of esophageal inflammation.	[Wu, Yen-Wen; Tseng, Ping-Huei; Lee, Yi-Chia; Chiu, Han-Mo; Tu, Chia-Hung; Wang, Hsiu-Po; Wu, Ming-Shiang; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen; Wang, Shan-Ying] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen; Wang, Shan-Ying] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Tseng, Ping-Huei; Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lee, Yi-Chia] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Lin, Jaw-Town] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; Fu Jen Catholic University; E-Da Hospital	Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	wsyang@ntu.edu.tw	Tseng, Ping-Huei/GZA-8772-2022; Chiu, Han-Mo/AAY-6809-2020	YANG, WEI-SHIUNG/0000-0001-5087-373X; WU, YEN-WEN/0000-0003-1520-1166; LEE, YI-CHIA/0000-0002-8160-1216; CHIU, HAN-MO/0000-0003-2786-8056; TSENG, PING-HUEI/0000-0002-7483-7538; Wu, Ming-Shiang/0000-0002-1940-6428	National Taiwan University Hospital [NTUH.100-M1707, NTUH.101-M1991]; National Science Council of Taiwan [NSC 102-2314-B-002-037]	National Taiwan University Hospital(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants funded by National Taiwan University Hospital (NTUH.100-M1707, NTUH.101-M1991) and National Science Council of Taiwan (NSC 102-2314-B-002-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Andres E, 2010, EUR J RADIOL, V75, P122, DOI 10.1016/j.ejrad.2009.04.067; Bakheet SM, 1999, CLIN NUCL MED, V24, P995, DOI 10.1097/00003072-199912000-00026; Bhargava P, 2003, CLIN NUCL MED, V28, P849, DOI 10.1097/01.rlu.0000090936.30974.e2; Busing KA, 2013, NUCL MED BIOL, V40, P206, DOI 10.1016/j.nucmedbio.2012.10.014; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; El-Serag HB, 2008, GUT, V57, DOI 10.1136/gut.2007.127878; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Erichsen R, 2012, CLIN GASTROENTEROL H, V10, P475, DOI 10.1016/j.cgh.2011.12.038; Fass R, 2007, J CLIN GASTROENTEROL, V41, P131, DOI 10.1097/01.mcg.0000225631.07039.6d; Fock KM, 2009, CLIN GASTROENTEROL H, V7, P54, DOI 10.1016/j.cgh.2008.08.030; Friedenberg FK, 2008, AM J GASTROENTEROL, V103, P2111, DOI 10.1111/j.1572-0241.2008.01946.x; Imperiale A, 2010, CLIN NUCL MED, V35, P86, DOI 10.1097/RLU.0b013e3181c7be8d; Isomoto H, 2007, J CLIN BIOCHEM NUTR, V41, P84, DOI 10.3164/jcbn.2007012; Kamimura K, 2007, EUR J NUCL MED MOL I, V34, P1815, DOI 10.1007/s00259-007-0477-3; Kandulski A, 2012, NAT REV GASTRO HEPAT, V9, P15, DOI 10.1038/nrgastro.2011.210; Lee HL, 2009, J CLIN GASTROENTEROL, V43, P240, DOI 10.1097/MCG.0b013e318167b88a; Lee YC, 2010, ENDOSCOPY, V42, P699, DOI 10.1055/s-0030-1255629; Lee YC, 2009, GUT, V58, P174, DOI 10.1136/gut.2008.162305; Lee YC, 2007, GASTROINTEST ENDOSC, V66, P230, DOI 10.1016/j.gie.2006.10.056; Li Y, 2008, CANCER INVEST, V26, P278, DOI 10.1080/07357900701708401; Lu CL, 2012, J NEUROGASTROENTEROL, V18, P236, DOI 10.5056/jnm.2012.18.3.236; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metser U, 2007, SEMIN NUCL MED, V37, P206, DOI 10.1053/j.semnuclmed.2007.01.001; Mine S, 2008, J GASTROEN HEPATOL, V23, P303, DOI 10.1111/j.1440-1746.2007.05113.x; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; Nelsen EM, 2012, CLIN GASTROENTEROL H, V10, P728, DOI 10.1016/j.cgh.2012.03.007; Ott K, 2006, DIS ESOPHAGUS, V19, P433, DOI 10.1111/j.1442-2050.2006.00617.x; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Roedl JB, 2008, AM J ROENTGENOL, V191, P515, DOI 10.2214/AJR.07.3320; Salaun PY, 2005, J NUCL MED, V46, P48; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Sharma P, 2007, GASTROENTEROLOGY, V133, P454, DOI 10.1053/j.gastro.2007.06.006; Shaw M, 2004, GUT, V53, P25, DOI 10.1136/gut.2003.034280; Spier BJ, 2010, MOL IMAGING BIOL, V12, P85, DOI 10.1007/s11307-009-0232-1; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Tilg H, 2010, GASTROENTEROLOGY, V139, P1823, DOI 10.1053/j.gastro.2010.10.038; Tsai MK, 2012, SCI WORLD J, DOI 10.1100/2012/702803; Tseng PH, 2008, J CLIN GASTROENTEROL, V42, P1074, DOI 10.1097/MCG.0b013e31809e7126; Tseng PH, 2011, J CLIN GASTROENTEROL, V45, P501, DOI 10.1097/MCG.0b013e3181eeb115; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wu YW, 2012, EUR J NUCL MED MOL I, V39, P399, DOI 10.1007/s00259-011-1994-7; Yeung Henry W.D., 1999, Clin Positron Imaging, V2, P255, DOI 10.1016/S1095-0397(99)00035-7	44	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92001	10.1371/journal.pone.0092001	http://dx.doi.org/10.1371/journal.pone.0092001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642729	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900057
J	Keller, KK; Thomsen, JS; Stengaard-Pedersen, K; Hauge, EM				Keller, Kresten Krarup; Thomsen, Jesper Skovhus; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe			Systemic but No Local Effects of Combined Zoledronate and Parathyroid Hormone Treatment in Experimental Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MICRO-COMPUTED-TOMOGRAPHY; FACTOR-MEDIATED ARTHRITIS; BONE-MINERAL DENSITY; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; NECROSIS-FACTOR; POSTMENOPAUSAL OSTEOPOROSIS; BISPHOSPHONATE THERAPY; STRUCTURAL DAMAGE	Introduction: Local bone erosions and osteoporosis in rheumatoid arthritis (RA) are the result of a more pronounced bone resorption than bone formation. Present treatment strategies for RA inhibit inflammation, but do not directly target bone erosions. The aim of the study was in experimental arthritis to investigate the juxtaarticular and systemic effects of simultaneous osteoclast inhibition with zoledronate (ZLN) and osteoblast stimulation with parathyroid hormone (PTH). Methods: Arthritis was induced in 36 SKG mice. The mice were randomized to three treatment groups and an untreated group: ZLN, PTH, PTH+ZLN, and untreated. Arthritis score and ankle width measurements were performed. Histological sections were cut from the right hind paw, and design-based stereological estimators were used to quantify histological variables of bone volume and bone formation and resorption. The femora were DXA-and mu CT-scanned, and the bone strength was determined at the femoral neck and mid-diaphysis. Results: Locally, we found no differences in arthritis score or ankle width throughout the study. Similarly, none of the treatments inhibited bone erosions or stimulated bone formation in the paw. Systemically, all treatments improved bone mineral density, strength of the femoral neck and mid-diaphysis, and mu CT parameters of both cortical and trabecular bone. In addition, there was an additive effect of combination treatment compared with single treatments for most trabecular parameters including bone mineral density and bone volume fraction. Conclusions: No local effect on bone was found by the combined action of inhibiting bone resorption and stimulating bone formation. However, a clear systemic effect of the combination treatment was demonstrated.	[Keller, Kresten Krarup; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Thomsen, Jesper Skovhus] Aarhus Univ, Dept Biomed Anat, Aarhus, Denmark	Aarhus University; Aarhus University	Keller, KK (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark.	kresten@ana.au.dk	Keller, Kresten Krarup/S-2067-2019	Keller, Kresten Krarup/0000-0003-2474-3389; Thomsen, Jesper Skovhus/0000-0001-9386-6679	Danish Rheumatism Association; A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Horslev Foundation; Clinical Institute Aarhus University; Peter Ryholts Grant; Hede Nielsens Family Foundation	Danish Rheumatism Association; A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Horslev Foundation; Clinical Institute Aarhus University; Peter Ryholts Grant; Hede Nielsens Family Foundation	This work was supported by the Danish Rheumatism Association, The A.P. Moller Foundation for the Advancement of Medical Science, Aase and Ejnar Danielsens Foundation, the Horslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant and the Hede Nielsens Family Foundation. The mu CT scanner was donated by the Velux Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Breuil V, 2006, JOINT BONE SPINE, V73, P349, DOI 10.1016/j.jbspin.2005.10.019; Caetano-Lopes J, 2009, CLIN EXP RHEUMATOL, V27, P475; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Cosman F, 2009, J CLIN ENDOCR METAB, V94, P3772, DOI 10.1210/jc.2008-2719; Cosman F, 2008, CURR OPIN ENDOCRINOL, V15, P495, DOI 10.1097/MED.0b013e32831a46d6; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Fukata S, 2004, ARTHRITIS RHEUM-US, V50, P4060, DOI 10.1002/art.20728; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Gravallese EM, 1998, AM J PATHOL, V152, P943; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hardy R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4065; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hauge E, 1999, BONE, V25, P389, DOI 10.1016/S8756-3282(99)00194-5; Herrak P, 2004, ARTHRITIS RHEUM-US, V50, P2327, DOI 10.1002/art.20384; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Jarrett SJ, 2006, ARTHRITIS RHEUM-US, V54, P1410, DOI 10.1002/art.21824; Keller KK, 2011, CLIN EXP RHEUMATOL, V29, P536; Keller KK, 2013, RHEUMATOL INT, V33, P1127, DOI 10.1007/s00296-012-2500-7; Keller KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053034; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Kobayashi K, 2006, INFLAMM RES, V55, P335, DOI 10.1007/s00011-006-5208-x; Le Goff B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2877; Mosekilde L, 1999, BONE, V24, P71, DOI 10.1016/S8756-3282(98)00169-0; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Rau R, 2006, CLIN EXP RHEUMAT S43, V24, pS; Recknor C, 2011, EXPERT OPIN PHARMACO, V12, P807, DOI 10.1517/14656566.2011.562201; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Romas E, 2005, BEST PRACT RES CL RH, V19, P1065, DOI 10.1016/j.berh.2005.06.008; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schafer AL, 2012, J CLIN ENDOCR METAB, V97, P3522, DOI 10.1210/jc.2012-1844; Schett G, 2005, ARTHRITIS RHEUM-US, V52, P1604, DOI 10.1002/art.21021; Sims NA, 2004, ARTHRITIS RHEUM-US, V50, P2338, DOI 10.1002/art.20382; Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x; Valleala H, 2012, CLIN EXP RHEUMATOL, V30, P114; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]	46	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92359	10.1371/journal.pone.0092359	http://dx.doi.org/10.1371/journal.pone.0092359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637846	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100146
J	Kosciolek, T; Jones, DT				Kosciolek, Tomasz; Jones, David T.			De Novo Structure Prediction of Globular Proteins Aided by Sequence Variation-Derived Contacts	PLOS ONE			English	Article							RESIDUE CONTACTS; CORRELATED MUTATIONS; FOLDS; FAMILIES; GENOMICS	The advent of high accuracy residue-residue intra-protein contact prediction methods enabled a significant boost in the quality of de novo structure predictions. Here, we investigate the potential benefits of combining a well-established fragment-based folding algorithm - FRAGFOLD, with PSICOV, a contact prediction method which uses sparse inverse covariance estimation to identify co-varying sites in multiple sequence alignments. Using a comprehensive set of 150 diverse globular target proteins, up to 266 amino acids in length, we are able to address the effectiveness and some limitations of such approaches to globular proteins in practice. Overall we find that using fragment assembly with both statistical potentials and predicted contacts is significantly better than either statistical potentials or contacts alone. Results show up to nearly 80% of correct predictions (TM-score >= 0.5) within analysed dataset and a mean TM-score of 0.54. Unsuccessful modelling cases emerged either from conformational sampling problems, or insufficient contact prediction accuracy. Nevertheless, a strong dependency of the quality of final models on the fraction of satisfied predicted long-range contacts was observed. This not only highlights the importance of these contacts on determining the protein fold, but also (combined with other ensemble-derived qualities) provides a powerful guide as to the choice of correct models and the global quality of the selected model. A proposed quality assessment scoring function achieves 0.93 precision and 0.77 recall for the discrimination of correct folds on our dataset of decoys. These findings suggest the approach is well-suited for blind predictions on a variety of globular proteins of unknown 3D structure, provided that enough homologous sequences are available to construct a large and accurate multiple sequence alignment for the initial contact prediction step.	[Kosciolek, Tomasz; Jones, David T.] UCL, Dept Comp Sci, Bioinformat Grp, London, England; [Kosciolek, Tomasz; Jones, David T.] UCL, Inst Struct & Mol Biol, London, England	University of London; University College London; University of London; Birkbeck University London; University College London	Jones, DT (corresponding author), UCL, Dept Comp Sci, Bioinformat Grp, London, England.	d.t.jones@ucl.ac.uk	Kosciolek, Tomasz/Y-2805-2019	Kosciolek, Tomasz/0000-0002-9915-7387	Wellcome Trust [096624/Z/11/Z]; Biotechnology and Biological Sciences Research Council [BB/E023533/1] Funding Source: researchfish; BBSRC [BB/E023533/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TK is supported by the Wellcome Trust PhD studentship (096624/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Hamilton N, 2004, PROTEINS, V56, P679, DOI 10.1002/prot.20160; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 2005, PROTEINS, V61, P143, DOI 10.1002/prot.20731; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; Jones DT, 2001, PROTEINS, P127; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones DT, 1997, PROTEINS, P185; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kolinski A, 2004, ACTA BIOCHIM POL, V51, P349; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; Liwo A, 1997, J COMPUT CHEM, V18, P849, DOI 10.1002/(SICI)1096-987X(199705)18:7<849::AID-JCC1>3.0.CO;2-R; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Punta M, 2005, BIOINFORMATICS, V21, P2960, DOI 10.1093/bioinformatics/bti454; Simons KT, 1999, PROTEINS, P171; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	43	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92197	10.1371/journal.pone.0092197	http://dx.doi.org/10.1371/journal.pone.0092197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637808	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100126
J	Labeyrie, V; Deu, M; Barnaud, A; Calatayud, C; Buiron, M; Wambugu, P; Manel, S; Glaszmann, JC; Leclerc, C				Labeyrie, Vanesse; Deu, Monique; Barnaud, Adeline; Calatayud, Caroline; Buiron, Marylene; Wambugu, Peterson; Manel, Stephanie; Glaszmann, Jean-Christophe; Leclerc, Christian			Influence of Ethnolinguistic Diversity on the Sorghum Genetic Patterns in Subsistence Farming Systems in Eastern Kenya	PLOS ONE			English	Article							POPULATION-STRUCTURE; FARMERS; MAIZE; VARIETIES; SEED; DIFFERENTIATION; INFORMATION; LANDRACES; DYNAMICS; EXCHANGE	Understanding the effects of actions undertaken by human societies on crop evolution processes is a major challenge for the conservation of genetic resources. This study investigated the mechanisms whereby social boundaries associated with patterns of ethnolinguistic diversity have influenced the on-farm distribution of sorghum diversity. Social boundaries limit the diffusion of planting material, practices and knowledge, thus shaping crop diversity in situ. To assess the effect of social boundaries, this study was conducted in the contact zone between the Chuka, Mbeere and Tharaka ethnolinguistic groups in eastern Kenya. Sorghum varieties were inventoried and samples collected in 130 households. In all, 297 individual plants derived from seeds collected under sixteen variety names were characterized using a set of 18 SSR molecular markers and 15 morphological descriptors. The genetic structure was investigated using both a Bayesian assignment method and distance-based clustering. Principal Coordinates Analysis was used to describe the structure of the morphological diversity of the panicles. The distribution of the varieties and the main genetic clusters across ethnolinguistic groups was described using a non-parametric MANOVA and pairwise Fisher tests. The spatial distribution of landrace names and the overall genetic spatial patterns were significantly correlated with ethnolinguistic partition. However, the genetic structure inferred from molecular makers did not discriminate the short-cycle landraces despite their morphological distinctness. The cases of two improved varieties highlighted possible fates of improved materials. The most recent one was often given the name of local landraces. The second one, that was introduced a dozen years ago, displays traces of admixture with local landraces with differential intensity among ethnic groups. The patterns of congruence or discordance between the nomenclature of farmers' varieties and the structure of both genetic and morphological diversity highlight the effects of the social organization of communities on the diffusion of seed, practices, and variety nomenclature.	[Labeyrie, Vanesse; Deu, Monique; Calatayud, Caroline; Buiron, Marylene; Glaszmann, Jean-Christophe; Leclerc, Christian] UMR AGAP, CIRAD, Montpellier, France; [Wambugu, Peterson] Natl Genebank Kenya, KARI, Nairobi, Kenya; [Barnaud, Adeline] UMR DIADE, IRD, Montpellier, France; [Manel, Stephanie] Univ Aix Marseille, IRD, UMR LPED, Marseille, France; [Manel, Stephanie] UMR AMAP, CIRAD, Montpellier, France	CIRAD; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Labeyrie, V (corresponding author), UMR AGAP, CIRAD, Montpellier, France.	vanesse.labeyrie@gmail.com	Labeyrie, Vanesse/AAF-7767-2021	Wambugu, Peterson/0000-0003-4957-9386; barnaud, adeline/0000-0001-9896-1210	Agropolis Fondation [0900-001]; CIRAD	Agropolis Fondation; CIRAD	This study was supported by Agropolis Fondation in the framework of the ARCAD project No.0900-001. V. Labeyrie was supported by Agropolis Fondation through a Ph.D. grant and received financial support from CIRAD for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler C, 1988, KENYAN COMMUNITIES A, P123; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2000, GENES FIELD ON FARM; Baco MN, 2008, CAH AGRIC, V17, P172; Badstue LB, 2007, WORLD DEV, V35, P1579, DOI 10.1016/j.worlddev.2006.05.023; Bandiera O, 2006, ECON J, V116, P869, DOI 10.1111/j.1468-0297.2006.01115.x; Barnaud A, 2007, THEOR APPL GENET, V114, P237, DOI 10.1007/s00122-006-0426-8; Barth F, 1969, ETHNIC GROUPS BOUND; Belkhir K, 2004, GENETIX SOFTWARE WIN; Bellon MR, 2004, WORLD DEV, V32, P159, DOI 10.1016/j.worlddev.2003.04.007; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthouly C, 2009, MOL ECOL, V18, P3980, DOI 10.1111/j.1365-294X.2009.04342.x; Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Billot C, 2012, AM J BOT, V99, pE245, DOI 10.3732/ajb.1100548; BOSTER JS, 1986, AM ANTHROPOL, V88, P428, DOI 10.1525/aa.1986.88.2.02a00100; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Camberlin P, 2012, INT J CLIMATOL, DOI DOI 10.1002/J0C.3427/FULL.ACCESSED; Cavalli-Sforza Luigi L., 1981, CULTURAL TRANSMISSIO; Chesaina C, 1997, ORAL LIT EMBU MBEERE, P3; David S., 1999, Agriculture and Human Values, V16, P381, DOI 10.1023/A:1007603902380; Deu M, 2008, THEOR APPL GENET, V116, P903, DOI 10.1007/s00122-008-0721-7; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI 10.1111/j.1558-5646.1967.tb03434.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fadiman Jeffrey A., 1993, WE BEGAN THERE WERE; Gibson RW, 2009, ECON BOT, V63, P242, DOI 10.1007/s12231-009-9086-3; Glazier J, 1970, RITUAL SOCIAL CONFLI; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harlan Jack R., 1976, ORIGINS AFRICAN PLAN, P3, DOI DOI 10.1515/9783110806373.465; Herbich I., 2008, CULTURAL TRANSMISSIO, P223; International Fund for Agricultural Development (IFAD), 2001, RUR POV REP 2001 CHA; IPGRI, 1993, DESCR SORGH; Jaetzold R, 2007, FARM MANAGEMENT HD C, VII; Labeyrie V, 2013, AGR HUMAN V IN PRESS; Leclerc C., 2011, DIVERSITY, V4, P1, DOI [DOI 10.3390/D4010001, 10.3390/d4010001]; Lewis M., 2013, ETHNOLOGUE LANGUAGES, V17th; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; McGuire SJ, 2008, HUM ECOL, V36, P217, DOI 10.1007/s10745-007-9143-4; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Middleton J, 1953, CENTRAL TRIBES N E B; Moehlig WJG, 1980, DIALECTOLOGIE COMP A, P27; Nakazawa M, 2013, FMSB FUNCTIONS MED S; Nei M, 1987, MOL EVOLUTIONARY GEN; Nuijten E, 2008, ECON BOT, V62, P148, DOI 10.1007/s12231-008-9012-0; Oksanen J., 2017, R PACKAGE VERSION 26; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Perrier X., 2006, DARWIN SOFTWARE; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Plucknett D. L., 1970, Advances in Agronomy, V22, P285, DOI 10.1016/S0065-2113(08)60271-0; Pressoir G, 2004, HEREDITY, V92, P95, DOI 10.1038/sj.hdy.6800388; Pritchard JK, 2000, GENETICS, V155, P945; Rabbi IY, 2010, PLANT GENET RESOUR-C, V8, P116, DOI 10.1017/S147926211000002X; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes-Garcia V, 2009, EVOL HUM BEHAV, V30, P274, DOI 10.1016/j.evolhumbehav.2009.02.001; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sardos J, 2012, GENET RESOUR CROP EV, V59, P805, DOI 10.1007/s10722-011-9720-7; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Soler C, 2013, PLANT GENET RESOUR-C, V11, P36, DOI 10.1017/S1479262112000342; Van den Broeck K, 2011, J DEV STUD, V47, P231, DOI 10.1080/00220381003599360; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	66	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92178	10.1371/journal.pone.0092178	http://dx.doi.org/10.1371/journal.pone.0092178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637745	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100124
J	Puga-Gonzalez, I; Butovskaya, M; Thierry, B; Hemelrijk, CK				Puga-Gonzalez, Ivan; Butovskaya, Marina; Thierry, Bernard; Hemelrijk, Charlotte Korinna			Empathy versus Parsimony in Understanding Post-Conflict Affiliation in Monkeys: Model and Empirical Data	PLOS ONE			English	Article							POSTCONFLICT 3RD-PARTY AFFILIATION; MACAQUE MACACA-MULATTA; CAPTIVE CHIMPANZEES; BARBARY MACAQUES; RHESUS; RECONCILIATION; CONSOLATION; DOMINANCE; RECIPROCITY; MECHANISMS	Post-conflict affiliation between former opponents and bystanders occurs in several species of non-human primates. It is classified in four categories of which affiliation received by the former victim, 'consolation', has received most attention. The hypotheses of cognitive constraint and social constraint are inadequate to explain its occurrence. The cognitive constraint hypothesis is contradicted by recent evidence of 'consolation' in monkeys and the social constraint hypothesis lacks information why 'consolation' actually happens. Here, we combine a computational model and an empirical study to investigate the minimum cognitive requirements for post-conflict affiliation. In the individual-based model, individuals are steered by cognitively simple behavioural rules. Individuals group and when nearby each other they fight if they are likely to win, otherwise, they may groom, especially when anxious. We parameterize the model after empirical data of a tolerant species, the Tonkean macaque (Macaca tonkeana). We find evidence for the four categories of post-conflict affiliation in the model and in the empirical data. We explain how in the model these patterns emerge from the combination of a weak hierarchy, social facilitation, risk-sensitive aggression, interactions with partners close-by and grooming as tension-reduction mechanism. We indicate how this may function as a new explanation for empirical data.	[Puga-Gonzalez, Ivan; Hemelrijk, Charlotte Korinna] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Butovskaya, Marina] Russian Acad Sci, Inst Ethnol & Anthropol, Moscow, Russia; [Thierry, Bernard] Univ Strasbourg, Dept Ecol Physiol & Ethol, Inst Interdisciplinaire Hubert Curien, Ctr Natl Rech Sci, Strasbourg, France	University of Groningen; Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	c.k.hemelrijk@rug.nl	Butovskaya, Marina/E-2368-2016; Hemelrijk, Charlotte/E-4828-2013	Butovskaya, Marina/0000-0002-5528-0519; Hemelrijk, Charlotte/0000-0001-6160-077X; Puga-Gonzalez, Ivan/0000-0003-2510-6760	NWO; University of Groningen	NWO(Netherlands Organization for Scientific Research (NWO)); University of Groningen	A NWO visitor grant was awarded to Prof. Dr. Marina Butovskaya for the realization of this project. The University of Groningen provided financial support to Ivan Puga-Gonzalez during his Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barchas P. R., 1984, SOCIAL HIERARCHIES E, P81; Butovskaya M. L., 2004, MACAQUE SOC MODEL ST, P182; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cozzi A, 2010, BEHAV PROCESS, V85, P185, DOI 10.1016/j.beproc.2010.07.007; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; DAS M, 2000, NATURAL CONFLICT RES; De Marco A, 2011, AM J PHYS ANTHROPOL, V146, P457, DOI 10.1002/ajpa.21606; De Marco A, 2010, ANIM BEHAV, V80, P197, DOI 10.1016/j.anbehav.2010.04.016; De Waal Frans B. M., 1996, P80; Demaria C, 2001, BEHAVIOUR, V138, P397, DOI 10.1163/15685390152032514; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Evers E, 2012, BEHAV ECOL SOCIOBIOL, V66, P931, DOI 10.1007/s00265-012-1342-3; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Graves FC, 2002, BEHAV NEUROSCI, V116, P489, DOI 10.1037//0735-7044.116.3.489; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002678; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hogeweg P, 1988, ARTIFICIAL LIFE SFI, P297; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; McFarland R, 2012, ANIM BEHAV, V84, P583, DOI 10.1016/j.anbehav.2012.06.010; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P105, DOI 10.1002/ajpa.20242; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; Romero T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022173; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2008, INT J PRIMATOL, V29, P1591, DOI 10.1007/s10764-008-9315-0; Romero T, 2009, AM J PRIMATOL, V71, P60, DOI 10.1002/ajp.20619; SCHINO G, 1992, BRAIN RES, V576, P125, DOI 10.1016/0006-8993(92)90617-I; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Setchell JM, 2008, HORM BEHAV, V54, P365, DOI 10.1016/j.yhbeh.2008.05.004; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; THIERRY B, 1989, FOLIA PRIMATOL, V52, P178, DOI 10.1159/000156396; THIERRY B, 1990, J THEOR BIOL, V145, P511, DOI 10.1016/S0022-5193(05)80485-0; THIERRY B, 1985, AGGRESSIVE BEHAV, V11, P223, DOI 10.1002/1098-2337(1985)11:3<223::AID-AB2480110305>3.0.CO;2-A; Thierry B., 2006, P29; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3	57	22	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91262	10.1371/journal.pone.0091262	http://dx.doi.org/10.1371/journal.pone.0091262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637720	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100024
J	Tang, YC; Xu, XJ; Guo, SX; Zhang, CB; Tang, Y; Tian, Y; Ni, B; Lu, BF; Wang, HZ				Tang, Yichen; Xu, Xuejun; Guo, Shixiang; Zhang, Chaobin; Tang, Yan; Tian, Yi; Ni, Bing; Lu, Binfeng; Wang, Huaizhi			An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; PERIPHERAL-BLOOD; IMMUNE-RESPONSE; HEPATOCELLULAR-CARCINOMA; ANTITUMOR IMMUNITY; MICROENVIRONMENT; RECRUITMENT; SURVIVAL; IMMUNOTHERAPY; LYMPHOCYTES	CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4(+) T cells and CD8(+) T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8(+) T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4(+)CD25(+)Foxp3(+) Tregs and CD8(+) T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3(+) T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3(+) T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8(+) T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.	[Tang, Yichen; Xu, Xuejun; Guo, Shixiang; Zhang, Chaobin; Wang, Huaizhi] Third Mil Med Univ, Southwest Hosp, Inst Hepatopancreatobiliary Surg, Chongqing, Peoples R China; [Tang, Yan; Tian, Yi; Ni, Bing] Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China; [Lu, Binfeng] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA USA	Army Medical University; Army Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ni, B (corresponding author), Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China.	nibingxi@yahoo.com; lumobile@hotmail.com; whuaizhi@gmail.com		Ni, Bing/0000-0002-4297-5346	National Natural Science Foundation of China [81072439, 81372242]; Logistics Research Projects of PLA [CWS11J051]; National High Technology Research and Development Program of China (863 Program) [2012AA021105]; Special Research Fund for Public Welfare for the Health Industry [201202007]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Logistics Research Projects of PLA; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Special Research Fund for Public Welfare for the Health Industry; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the National Natural Science Foundation of China (No. 81072439, 81372242), the Logistics Research Projects of PLA (No. CWS11J051), the National High Technology Research and Development Program of China (863 Program) (No. 2012AA021105), and the Special Research Fund for Public Welfare for the Health Industry (No. 201202007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Betts G, 2012, GUT, V61, P1163, DOI 10.1136/gutjnl-2011-300970; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clark RA, 2008, J EXP MED, V205, P2221, DOI 10.1084/jem.20071190; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Rezende LCD, 2010, ARCH IMMUNOL THER EX, V58, P179, DOI 10.1007/s00005-010-0075-0; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hiraoka N, 2010, INT J CLIN ONCOL, V15, P544, DOI 10.1007/s10147-010-0130-1; Huang Xin, 2009, V506, P115, DOI 10.1007/978-1-59745-409-4_9; Huang Y, 2012, DIGESTION, V86, P329, DOI 10.1159/000342801; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Kelsen DP, 1997, SURGERY, V122, P53, DOI 10.1016/S0039-6060(97)90264-6; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Labidi-Galy SI, 2011, CANCER RES, V71, P5423, DOI 10.1158/0008-5472.CAN-11-0367; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Litzinger MT, 2007, BLOOD, V110, P3192, DOI 10.1182/blood-2007-06-094615; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Loddenkemper C, 2009, CANCER SCI, V100, P1112, DOI 10.1111/j.1349-7006.2009.01153.x; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Okita R, 2005, ONCOL REP, V14, P1269; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Pedroza-Gonzalez A, 2013, HEPATOLOGY, V57, P183, DOI 10.1002/hep.26013; Preston CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080063; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Siddiqui SA, 2007, CLIN CANCER RES, V13, P2075, DOI 10.1158/1078-0432.CCR-06-2139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; van Steenwijk PJD, 2013, INT J CANCER, V133, P2884, DOI 10.1002/ijc.28309; Vizio B, 2012, EXP THER MED, V4, P70, DOI 10.3892/etm.2012.553; Yamamoto T, 2012, PANCREAS, V41, P409, DOI 10.1097/MPA.0b013e3182373a66; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	47	105	108	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91551	10.1371/journal.pone.0091551	http://dx.doi.org/10.1371/journal.pone.0091551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637664	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000333254100042
J	Tatsuke, T; Zhu, L; Li, ZQ; Mitsunobu, H; Yoshimura, K; Mon, H; Lee, JM; Kusakabe, T				Tatsuke, Tsuneyuki; Zhu, Li; Li, Zhiqing; Mitsunobu, Hitoshi; Yoshimura, Kaito; Mon, Hiroaki; Lee, Jae Man; Kusakabe, Takahiro			Roles of Piwi Proteins in Transcriptional Regulation Mediated by HP1s in Cultured Silkworm Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; BOMBYX-MORI; DROSOPHILA; HETEROCHROMATIN; GENE; TRANSPOSONS; LOCALIZATION; BIOGENESIS; MECHANISMS; MACHINERY	Piwi proteins are part of a superfamily of Argonaute proteins, which are one of the core components of the RNA silencing pathway in many eukaryotes. Piwi proteins are thought to repress the transposon expression both transcriptionally and post-transcriptionally. Recently, Drosophila melanogaster Piwi was recently reported to associate with chromatin and to interact directly with the Heterochromatin Protein 1 (HP1a). However, similar interactions have not been reported in other higher eukaryotes. Here we show that silkworm Piwi proteins interact with HP1s in the nucleus. The silkworm, Bombyx mori, has two Piwi proteins, Ago3 and Siwi, and two typical HP1 proteins, HP1a and HP1b. We found that HP1a plays an important role in the interaction between Ago3/Siwi and HP1b in the ovary-derived BmN4 cell line. We also found that Ago3/Siwi regulates the transcription in an HP1-dependent manner. These results suggest that silkworm Piwi proteins function as a chromatin regulator in collaboration with HP1a and HP1b.	[Tatsuke, Tsuneyuki; Zhu, Li; Li, Zhiqing; Yoshimura, Kaito; Mon, Hiroaki; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan; [Mitsunobu, Hitoshi] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Kyushu University; Harvard University; Harvard Medical School	Kusakabe, T (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan.	kusakabe@agr.kyushu-u.ac.jp	Tatsuke, Tsuneyuki/I-3714-2019; Zhu, Li/S-7517-2018	Tatsuke, Tsuneyuki/0000-0003-2322-4528; Zhu, Li/0000-0002-4919-1894	Japan Society for the Promotion of Science [22248004, 23580077]; Grants-in-Aid for Scientific Research [22248004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) no. 22248004 and 23580077 from the Japan Society for the Promotion of Science to TK and JML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034330; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Maeda Takuji, 2005, Journal of Insect Biotechnology and Sericology, V74, P21; Mitsunobu H, 2012, INSECT MOL BIOL, V21, P9, DOI 10.1111/j.1365-2583.2011.01115.x; Mitsunobu Hitoshi, 2006, Journal of Insect Biotechnology and Sericology, V75, P141; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Mon H, 2009, ANAL BIOCHEM, V392, P180, DOI 10.1016/j.ab.2009.05.033; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92313	10.1371/journal.pone.0092313	http://dx.doi.org/10.1371/journal.pone.0092313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637637	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100140
J	Vatanavicharn, T; Prapavorarat, A; Jaree, P; Somboonwiwat, K; Tassanakajon, A				Vatanavicharn, Tipachai; Prapavorarat, Adisak; Jaree, Phattarunda; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee			PmVRP15, a Novel Viral Responsive Protein from the Black Tiger Shrimp, Penaeus monodon, Promoted White Spot Syndrome Virus Replication	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; CDNA MICROARRAY; RT-PCR; BACULOVIRUS; WSSV; INFECTION; IDENTIFICATION; HEMOCYTES; DISCOVERY; JAPONICUS	Suppression subtractive hybridization of Penaeus monodon hemocytes challenged with white spot syndrome virus (WSSV) has identified the viral responsive gene, PmVRP15, as the highest up-regulated gene ever reported in shrimps. Expression analysis by quantitative real time RT-PCR revealed 9410-fold up-regulated level at 48 h post WSSV injection. Tissue distribution analysis showed that PmVRP15 transcript was mainly expressed in the hemocytes of shrimp. The full-length cDNA of PmVRP15 transcript was obtained and showed no significant similarity to any known gene in the GenBank database. The predicted open reading frame of PmVRP15 encodes for a deduced 137 amino acid protein containing a putative transmembrane helix. Immunofluorescent localization of the PmVRP15 protein revealed it accumulated around the nuclear membrane in all three types of shrimp hemocytes and that the protein was highly up-regulated in WSSV-infected shrimps. Double-stranded RNA interference-mediated gene silencing of PmVRP15 in P. monodon significantly decreased WSSV propagation compared to the control shrimps (injected with GFP dsRNA). The significant decrease in cumulative mortality rate of WSSV-infected shrimp following PmVRP15 knockdown was observed. These results suggest that PmVRP15 is likely to be a nuclear membrane protein and that it acts as a part of WSSV propagation pathway.	[Vatanavicharn, Tipachai] King Mongkuts Inst Technol Ladkrabang, Dept Chem, Appl Analyt Chem Res Unit, Fac Sci, Bangkok, Thailand; [Prapavorarat, Adisak; Jaree, Phattarunda; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee] Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Bangkok, Thailand	King Mongkuts Institute of Technology Ladkrabang; Chulalongkorn University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Bangkok, Thailand.	anchalee.k@chula.ac.th			Thailand Research Fund (TRF) [RTA5580008]; Chulalongkorn University [RSA5580024]; International Foundation for Science (IFS), Stockholm, Sweden; project "Development of Aquaculture Technology for Food Security and Food Safety in the Next Generation'' under JST-JICA joint program "Science and Technology Research Partnership for Sustainable Development, SATREPS; Royal Golden Jubilee Ph.D. Program, Thailand Research Fund; Chulalongkorn University under the Ratchadaphisek Somphot Endowment	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); International Foundation for Science (IFS), Stockholm, Sweden(International Foundation for Science); project "Development of Aquaculture Technology for Food Security and Food Safety in the Next Generation'' under JST-JICA joint program "Science and Technology Research Partnership for Sustainable Development, SATREPS; Royal Golden Jubilee Ph.D. Program, Thailand Research Fund; Chulalongkorn University under the Ratchadaphisek Somphot Endowment	This work was supported by research grants from the Thailand Research Fund (TRF Senior Scholar number RTA5580008), TRF and Chulalongkorn University (TRF Research Career Development Grant number RSA5580024). This research was also partially support by International Foundation for Science (IFS), Stockholm, Sweden, through a grant to KS and from project "Development of Aquaculture Technology for Food Security and Food Safety in the Next Generation'' under JST-JICA joint program "Science and Technology Research Partnership for Sustainable Development, SATREPS. A Ph.D. student fellowship granted to PJ by the Royal Golden Jubilee Ph.D. Program, Thailand Research Fund is greatly appreciated. The authors also thank Chulalongkorn University for the support under the Ratchadaphisek Somphot Endowment to the Center of Excellence for Molecular Biology and Genomics of Shrimp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2011, MAR BIOTECHNOL, V13, P629, DOI 10.1007/s10126-010-9291-1; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chai YM, 2012, FISH SHELLFISH IMMUN, V32, P307, DOI 10.1016/j.fsi.2011.11.020; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Du HH, 2007, AQUACULTURE, V262, P532, DOI 10.1016/j.aquaculture.2006.11.002; Durand S, 1997, DIS AQUAT ORGAN, V29, P205, DOI 10.3354/dao029205; Flegel TW, 1997, WORLD J MICROB BIOT, V13, P433, DOI 10.1023/A:1018580301578; He F, 2006, J VIROL, V80, P3884, DOI 10.1128/JVI.80.8.3884-3892.2006; Hutchinson EC, 2012, VACCINE, V30, P7353, DOI 10.1016/j.vaccine.2012.04.085; INOUYE K, 1994, FISH PATHOL, V29, P149, DOI 10.3147/jsfp.29.149; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Karunasagar I, 1997, AQUACULTURE, V153, P9, DOI 10.1016/S0044-8486(97)00011-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Lei KY, 2008, DEV COMP IMMUNOL, V32, P808, DOI 10.1016/j.dci.2007.11.010; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Lightner DV, 1996, REV SCI TECH OIE, V15, P579, DOI 10.20506/rst.15.2.944; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Mekata T, 2011, MOL CELL PROBE, V25, P94, DOI 10.1016/j.mcp.2011.02.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Sung HH, 1999, FISH SHELLFISH IMMUN, V9, P167, DOI 10.1006/fsim.1998.0185; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang HC, 2007, DIS AQUAT ORGAN, V74, P179, DOI 10.3354/dao074179; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Wongpanya Ratree, 2007, ScienceAsia, V33, P165, DOI 10.2306/scienceasia1513-1874.2007.33.165; WONGTEERASUPAYA C, 1995, DIS AQUAT ORGAN, V21, P69, DOI 10.3354/dao021069; Woramongkolchai N, 2011, DEV COMP IMMUNOL, V35, P530, DOI 10.1016/j.dci.2010.12.016; Zhan WB, 1998, J AQUAT ANIM HEALTH, V10, P405, DOI 10.1577/1548-8667(1998)010&lt;0405:WSSVIO&gt;2.0.CO;2	43	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91930	10.1371/journal.pone.0091930	http://dx.doi.org/10.1371/journal.pone.0091930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637711	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100083
J	Fahrenbach, JP; Stoller, D; Kim, G; Aggarwal, N; Yerokun, B; Earley, JU; Hadhazy, M; Shi, NQ; Makielski, JC; McNally, EM				Fahrenbach, John P.; Stoller, Douglas; Kim, Gene; Aggarwal, Nitin; Yerokun, Babatunde; Earley, Judy U.; Hadhazy, Michele; Shi, Nian-Qing; Makielski, Jonathan C.; McNally, Elizabeth M.			Abcc9 is required for the transition to oxidative metabolism in the newborn heart	FASEB JOURNAL			English	Article						cardiomyopathy; neonatal heart failure; sulfonylurea receptor; mitochondria	K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; FATTY-ACID; CANTU-SYNDROME; DISRUPTION; MUTATIONS; CARDIOMYOPATHY; ACTIVATION; INHIBITION; DIAZOXIDE	The newborn heart adapts to postnatal life by shifting from a fetal glycolytic metabolism to a mitochondrial oxidative metabolism. Abcc9, an ATP-binding cassette family member, increases expression concomitant with this metabolic shift. Abcc9 encodes a membrane-associated receptor that partners with a potassium channel to become the major potassium-sensitive ATP channel in the heart. Abcc9 also encodes a smaller protein enriched in the mitochondria. We now deleted exon 5 of Abcc9 to ablate expression of both plasma membrane and mitochondria-associated Abcc9-encoded proteins, and found that the myocardium failed to acquire normal mature metabolism, resulting in neonatal cardiomyopathy. Unlike wild-type neonatal cardiomyocytes, mitochondria from Ex5 cardiomyocytes were unresponsive to the K-ATP agonist diazoxide, consistent with loss of K-ATP activity. When exposed to hydrogen peroxide to induce cell stress, Ex5 neonatal cardiomyocytes displayed a rapid collapse of mitochondria membrane potential, distinct from wild-type cardiomyocytes. Ex5 cardiomyocytes had reduced fatty acid oxidation, reduced oxygen consumption and reserve. Morphologically, Ex5 cardiac mitochondria exhibited an immature pattern with reduced cross-sectional area and intermitochondrial contacts. In the absence of Abcc9, the newborn heart fails to transition normally from fetal to mature myocardial metabolism.	[Fahrenbach, John P.; Stoller, Douglas; Kim, Gene; Yerokun, Babatunde; Earley, Judy U.; Hadhazy, Michele; McNally, Elizabeth M.] Univ Chicago, Dept Med, Div Cardiovasc Med, Chicago, IL USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL USA; [Aggarwal, Nitin; Shi, Nian-Qing; Makielski, Jonathan C.] Univ Wisconsin, Dept Med, Div Cardiol, Madison, WI USA	University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	McNally, EM (corresponding author), Univ Chicago, 5841 S Maryland,MC6088, Chicago, IL 60637 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019	Kim, Gene/0000-0001-6461-1992; McNally, Elizabeth/0000-0002-1221-719X; fahrenbach, john/0000-0001-6785-9707; Stoller, Douglas/0000-0002-4064-4324	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [R01-HL078926, R01-HL57414, R21-HL93626, K08-HL098565, F32-HL097587, U54 AR052646]; American Heart Association National Center [11GRNT7600070, 0630268N]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098565, R21HL093626, F32HL097587, R01HL057414, R01HL078926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association National Center(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by U.S. National Institutes of Health/National Heart, Lung, and Blood Institute grants R01-HL078926 (E. M. M), R01-HL57414 (J.C.M.), R21-HL93626 (N.-Q.S.), K08-HL098565, (G. K.), F32-HL097587 (J.P.F.), and U54 AR052646. N.-Q.S. is also supported by American Heart Association National Center grants 11GRNT7600070 and 0630268N. The authors thank Stephen Archer and Glenn Marsboom for helpful conversations.	Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; BROOK WH, 1983, J ANAT, V137, P729; Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Crawford RM, 2001, FASEB J, V15, P102, DOI 10.1096/fj.01-0446fje; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Elrod JW, 2008, CIRCULATION, V117, P1405, DOI 10.1161/CIRCULATIONAHA.107.745539; Finck BN, 2002, COLD SPRING HARB SYM, V67, P371, DOI 10.1101/sqb.2002.67.371; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Garlid KD, 1997, CIRC RES, V81, P1072; Grange DK, 2006, AM J MED GENET A, V140A, P1673, DOI 10.1002/ajmg.a.31348; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Kakkar R, 2006, CIRC RES, V98, P682, DOI 10.1161/01.RES.0000207498.40005.e7; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lascano EC, 2002, MOL CELL BIOCHEM, V236, P53, DOI 10.1023/A:1016198011919; Leu M, 2001, ANAT EMBRYOL, V204, P217, DOI 10.1007/s004290100206; LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172; Makinde AO, 1998, MOL CELL BIOCHEM, V188, P49, DOI 10.1023/A:1006860104840; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Piquereau J, 2010, J PHYSIOL-LONDON, V588, P2443, DOI 10.1113/jphysiol.2010.189670; Pu JL, 2008, J MOL CELL CARDIOL, V44, P188, DOI 10.1016/j.yjmcc.2007.09.010; Rodrigo GC, 2004, CARDIOVASC RES, V61, P570, DOI 10.1016/j.cardiores.2003.10.004; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Stoller D, 2007, J MOL CELL CARDIOL, V43, P445, DOI 10.1016/j.yjmcc.2007.07.058; Stoller D, 2009, AM J PHYSIOL-REG I, V297, pR1144, DOI 10.1152/ajpregu.00081.2009; Stoller DA, 2010, AM J PHYSIOL-HEART C, V299, pH1100, DOI 10.1152/ajpheart.00084.2010; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; WARSHAW JB, 1972, DEV BIOL, V28, P537, DOI 10.1016/0012-1606(72)90001-2; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Ye B, 2009, CIRC RES, V105, P1083, DOI 10.1161/CIRCRESAHA.109.195040; Zhang HX, 2010, J MOL CELL CARDIOL, V48, P71, DOI 10.1016/j.yjmcc.2009.07.002; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	44	13	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2804	2815		10.1096/fj.13-244459	http://dx.doi.org/10.1096/fj.13-244459			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24648545	Green Published			2022-12-25	WOS:000337949400007
J	Chen, HF; Choi, JH; Bailey, S				Chen, Hongfan; Choi, Jihoon; Bailey, Scott			Cut Site Selection by the Two Nuclease Domains of the Cas9 RNA-guided Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA-binding Protein; DNA Transformation; RNA; RNA-binding Protein; CRISPR; Cas9; Genome Editing; Nuclease	CRISPR RNA; IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; ESCHERICHIA-COLI; TARGETED MUTAGENESIS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; SEED SEQUENCE; PLASMID DNA; COMPLEX	Background: The Cas9 RNA-guided endonuclease has been adapted for genome manipulation and regulation. Results: We have characterized target recognition and cleavage by Streptococcus thermophilus LMG18311 Cas9. Conclusion: The two nuclease domains of Cas9 select their cleavage sites by different mechanisms. Significance: These findings contribute to the molecular basis of Cas9-mediated DNA cleavage. Cas9, the RNA-guided DNA endonuclease from the CRISPR-Cas (clustered regularly interspaced short palindromic repeat-CRISPR-associated) system, has been adapted for genome editing and gene regulation in multiple model organisms. Here we characterize a Cas9 ortholog from Streptococcus thermophilus LMG18311 (LMG18311 Cas9). In vitro reconstitution of this system confirms that LMG18311 Cas9 together with a trans-activating RNA (tracrRNA) and a CRISPR RNA (crRNA) cleaves double-stranded DNA with a specificity dictated by the sequence of the crRNA. Cleavage requires not only complementarity between crRNA and target but also the presence of a short motif called the PAM. Here we determine the sequence requirements of the PAM for LMG18311 Cas9. We also show that both the efficiency of DNA target cleavage and the location of the cleavage sites vary based on the position of the PAM sequence.	[Chen, Hongfan; Choi, Jihoon; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Dept Biochem & Mol Biol, 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [GM097330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097330 (to S. B.).	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Panyutin IV, 2001, RADIAT RES, V156, P158, DOI 10.1667/0033-7587(2001)156[0158:SBIWPD]2.0.CO;2; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	46	57	79	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13284	13294		10.1074/jbc.M113.539726	http://dx.doi.org/10.1074/jbc.M113.539726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24634220	hybrid, Green Published			2022-12-25	WOS:000335522800028
J	Delgoshaie, N; Tang, XJ; Kanshin, ED; Williams, EC; Rudner, AD; Thibault, P; Tyers, M; Verreault, A				Delgoshaie, Neda; Tang, Xiaojing; Kanshin, Evgeny D.; Williams, Elizabeth C.; Rudner, Adam D.; Thibault, Pierre; Tyers, Mike; Verreault, Alain			Regulation of the Histone Deacetylase Hst3 by Cyclindependent Kinases and the Ubiquitin Ligase SCFCdc4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Chromatin Histone Modification; E3 Ubiquitin Ligase; Histone Deacetylase; Histones; Ubiquitination	SISTER-CHROMATID COHESION; H3 LYSINE-56 ACETYLATION; DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; MULTISITE PHOSPHORYLATION; GENOME INTEGRITY; YEAST; REPLICATION	Background: A genome-wide wave of histone H3 acetylation and deacetylation occurs during the fungal cell cycle. Results: Cyclin-dependent kinases and the ubiquitin ligase SCFCdc4 promote timely degradation of Hst3, a sirtuin involved in genome-wide histone H3 deacetylation. Conclusion: Mutations that interfere with cell cycle-regulated degradation of the Hst3 histone deacetylase reduce cell fitness. Significance: Similar regulatory mechanisms may exist in pathogenic fungi. In Saccharomyces cerevisiae, histone H3 lysine 56 acetylation (H3K56ac) is a modification of new H3 molecules deposited throughout the genome during S-phase. H3K56ac is removed by the sirtuins Hst3 and Hst4 at later stages of the cell cycle. Previous studies indicated that regulated degradation of Hst3 plays an important role in the genome-wide waves of H3K56 acetylation and deacetylation that occur during each cell cycle. However, little is known regarding the mechanism of cell cycle-regulated Hst3 degradation. Here, we demonstrate that Hst3 instability in vivo is dependent upon the ubiquitin ligase SCFCdc4 and that Hst3 is phosphorylated at two Cdk1 sites, threonine 380 and threonine 384. This creates a diphosphorylated degron that is necessary for Hst3 polyubiquitylation by SCFCdc4. Mutation of the Hst3 diphospho-degron does not completely stabilize Hst3 in vivo, but it nonetheless results in a significant fitness defect that is particularly severe in mutant cells treated with the alkylating agent methyl methanesulfonate. Unexpectedly, we show that Hst3 can be degraded between G(2) and anaphase, a window of the cell cycle where Hst3 normally mediates genome-wide deacetylation of H3K56. Our results suggest an intricate coordination between Hst3 synthesis, genome-wide H3K56 deacetylation by Hst3, and cell cycle-regulated degradation of Hst3 by cyclin-dependent kinases and SCFCdc4.	[Delgoshaie, Neda; Kanshin, Evgeny D.; Thibault, Pierre; Tyers, Mike; Verreault, Alain] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Tang, Xiaojing] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Williams, Elizabeth C.; Rudner, Adam D.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Williams, Elizabeth C.; Rudner, Adam D.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Tyers, Mike] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Verreault, Alain] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Ottawa; University of Ottawa; Universite de Montreal; Universite de Montreal; Universite de Montreal	Verreault, A (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	alain.verreault@umontreal.ca	Kanshin, Evgeny/GXM-7047-2022; Tyers, Michael/ABE-3194-2021	Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes for Health Research [MOP 89928, 123780]; Natural Sciences and Engineering Research Council of Canada/Canadian Institutes for Health Research [MOP CPG104289, MOP 177774, MOP 126129]; Cole Foundation; Canadian Institutes for Health Research; "Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie du Quebec" through Genome Quebec; Canada Research Chair in Systems and Synthetic Biology	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada/Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cole Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); "Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie du Quebec" through Genome Quebec; Canada Research Chair in Systems and Synthetic Biology	This work was supported in part by Canadian Institutes for Health Research Grants MOP 89928 and 123780 (to A. V.), Natural Sciences and Engineering Research Council of Canada/Canadian Institutes for Health Research Grants MOP CPG104289 (to A. V. and P. T.), MOP 177774 (to A. D. R.), and MOP 126129 (M. T.). The Institute for Research in Immunology and Cancer receives infrastructure support from the Centre of Excellence for Commercialization and Research, the Canadian Foundation for Innovation, and the Fonds de Recherche Quebecois en Sante.; Recipient of a Ph.D. award from the Cole Foundation.; Supported by a graduate fellowship from the Canadian Institutes for Health Research.; Supported by the "Ministere de l'Enseignement Superieur, de la Recherche, de la Science et de la Technologie du Quebec" through Genome Quebec, and a Canada Research Chair in Systems and Synthetic Biology.	Bao MZ, 2010, EUKARYOT CELL, V9, P31, DOI 10.1128/EC.00250-09; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ge ZQ, 2013, MOL CELL BIOL, V33, P3286, DOI 10.1128/MCB.00460-13; Gharib M, 2009, MOL CELL PROTEOMICS, V8, P506, DOI 10.1074/mcp.M800327-MCP200; Goh PY, 1999, MOL CELL BIOL, V19, P5512; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hachinohe M, 2011, GENES CELLS, V16, P467, DOI 10.1111/j.1365-2443.2011.01493.x; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Ikui AE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003099; Kanshin E, 2013, J PROTEOME RES, V12, P2905, DOI 10.1021/pr400198e; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	52	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13186	13196		10.1074/jbc.M113.523530	http://dx.doi.org/10.1074/jbc.M113.523530			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648511	Green Published, hybrid			2022-12-25	WOS:000335522800020
J	Kumar, A; Singh, PK; Parihar, R; Dwivedi, V; Lakhotia, SC; Ganesh, S				Kumar, Amit; Singh, Pankaj Kumar; Parihar, Rashmi; Dwivedi, Vibha; Lakhotia, Subhash C.; Ganesh, Subramaniam			Decreased O-Linked GlcNAcylation Protects from Cytotoxicity Mediated by Huntingtin Exon1 Protein Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Neurodegenerative Diseases; O-GlcNAcylation; Post-translational Modification; Protein Aggregation	UBIQUITIN-PROTEASOME SYSTEM; AGGREGATE-PRONE PROTEINS; N-ACETYLGLUCOSAMINE; CELLULAR TOXICITY; MUTANT HUNTINGTIN; GLCNAC MODIFICATION; AUTOPHAGY; DISEASE; DROSOPHILA; MODELS	Background: Earlier reports indicate that O-GlcNAcylation might be protective in neurodegenerative disorders. Results: Suppressing O-GlcNAcylation modulates autophagy to enhance the viability of neuronal cells expressing cytotoxic mutant huntingtin exon 1 protein (mHtt). Conclusion:O-GlcNAcylation regulates the clearance of mHtt by modulating the fusion of autophagosomes with lysosomes. Significance: This regulatory mechanism emerges as a novel therapeutic strategy for Huntington disease. O-GlcNAcylation is an important post-translational modification of proteins and is known to regulate a number of pathways involved in cellular homeostasis. This involves dynamic and reversible modification of serine/threonine residues of different cellular proteins catalyzed by O-linked N-acetylglucosaminyltransferase and O-linked N-acetylglucosaminidase in an antagonistic manner. We report here that decreasing O-GlcNAcylation enhances the viability of neuronal cells expressing polyglutamine-expanded huntingtin exon 1 protein fragment (mHtt). We further show that O-GlcNAcylation regulates the basal autophagic process and that suppression of O-GlcNAcylation significantly increases autophagic flux by enhancing the fusion of autophagosome with lysosome. This regulation considerably reduces toxic mHtt aggregates in eye imaginal discs and partially restores rhabdomere morphology and vision in a fly model for Huntington disease. This study is significant in unraveling O-GlcNAcylation-dependent regulation of an autophagic process in mediating mHtt toxicity. Therefore, targeting the autophagic process through the suppression of O-GlcNAcylation may prove to be an important therapeutic approach in Huntington disease.	[Kumar, Amit; Singh, Pankaj Kumar; Parihar, Rashmi; Ganesh, Subramaniam] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Dwivedi, Vibha; Lakhotia, Subhash C.] Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Banaras Hindu University (BHU)	Ganesh, S (corresponding author), Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India.	sganesh@iitk.ac.in	Singh, Pankaj K/AAG-7486-2021; Lakhotia, Subhash C/D-2058-2011; Parihar, Rashmi/AAA-7857-2020; Kumar, Amit/L-7132-2017	Singh, Pankaj K/0000-0001-9626-5182; Lakhotia, Subhash C/0000-0003-1842-8411; Parihar, Rashmi/0000-0002-3904-2262; Kumar, Amit/0000-0001-5017-9887	Department of Atomic Energy, Government of India; Department of Biotechnology, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a research grant from the Department of Atomic Energy, Government of India (to S. G.).; Recipient of a post-doctoral fellowship from the Department of Biotechnology, Government of India. Present address: Burke Medical Research Institute, New York, NY 10605.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chatham JC, 2010, CURR SIGNAL TRANSD T, V5, P49, DOI 10.2174/157436210790226492; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037113; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jadhav S, 2013, MOL NEUROBIOL, V48, P516, DOI 10.1007/s12035-013-8440-8; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Love D. C., 2005, SCI STKE, V2005, pre13; Mallik M, 2010, J GENET, V89, P497, DOI 10.1007/s12041-010-0072-4; Mallik M, 2009, RNA BIOL, V6, P464, DOI 10.4161/rna.6.4.9268; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mittal S, 2010, NEUROSCI RES, V68, P159, DOI 10.1016/j.neures.2010.08.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Puri R, 2011, FEBS J, V278, P3688, DOI 10.1111/j.1742-4658.2011.08287.x; Rajapakse AG, 2009, AM J PHYSIOL-HEART C, V296, pH815, DOI 10.1152/ajpheart.00756.2008; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Ravikumar Brinda, 2008, V445, P195, DOI 10.1007/978-1-59745-157-4_13; Rozas JL, 2011, J NEUROSCI, V31, P1106, DOI 10.1523/JNEUROSCI.2011-10.2011; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2	53	45	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13543	13553		10.1074/jbc.M114.553321	http://dx.doi.org/10.1074/jbc.M114.553321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648514	Green Published, hybrid			2022-12-25	WOS:000335522800049
J	Yu, SL; Levi, L; Casadesus, G; Kunos, G; Noy, N				Yu, Shuiliang; Levi, Liraz; Casadesus, Gemma; Kunos, George; Noy, Noa			Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor beta/delta(PPAR beta/delta) in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Endocannabinoids; Lipids; Lipid-binding Protein; Peroxisome Proliferator-activated Receptor (PPAR)	RETINOIC ACID; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; HIPPOCAMPAL NEUROGENESIS; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; MEMORY; ALPHA; MICE; CB1	Background: FABP5 shuttles ligands to the nuclear receptor PPAR/ and enhances degradation of the endocannabinoid anandamide. Results: Brain level of anandamide is high and PPAR/ activation is low in FABP5-null mice. These mice display impaired learning and memory. Conclusion: FABP5 regulates learning and memory by two distinct mechanisms. Significance: The data suggest that FABP5 may be a novel target for therapy of cognitive dysfunction. Endocannabinoids modulate multiple behaviors, including learning and memory. We show that the endocannabinoid anandamide (AEA) can alter neuronal cell function both through its established role in activation of the G-protein-coupled receptor CB1, and by serving as a precursor for a potent agonist of the nuclear receptor PPAR/, in turn up-regulating multiple cognition-associated genes. We show further that the fatty acid-binding protein FABP5 controls both of these functions in vivo. FABP5 both promotes the hydrolysis of AEA into arachidonic acid and thus reduces brain endocannabinoid levels, and directly shuttles arachidonic acid to the nucleus where it delivers it to PPAR/, enabling its activation. In accordance, ablation of FABP5 in mice results in excess accumulation of AEA, abolishes PPAR/ activation in the brain, and markedly impairs hippocampus-based learning and memory. The data indicate that, by controlling anandamide disposition and activities, FABP5 plays a key role in regulating hippocampal cognitive function.	[Yu, Shuiliang; Levi, Liraz; Noy, Noa] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Casadesus, Gemma] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Kunos, George] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Noy, N (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave W333, Cleveland, OH 44106 USA.	noa.noy@case.edu		Levi, Liraz/0000-0001-7462-2396; Casadesus, Gemma/0000-0002-5206-5637	National Institutes of Health [R01 DK060684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK060684 (to N. N.).	Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Basavarajappa BS, 2009, MINI-REV MED CHEM, V9, P448, DOI 10.2174/138955709787847921; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Castellano C, 1997, BEHAV PHARMACOL, V8, P707, DOI 10.1097/00008877-199712000-00005; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Goonawardena AV, 2011, NEUROPHARMACOLOGY, V61, P1016, DOI 10.1016/j.neuropharm.2011.07.003; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kobilo T, 2011, LEARN MEMORY, V18, P103, DOI 10.1101/lm.2001611; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Liu J, 2013, P NATL ACAD SCI USA, V110, P18832, DOI 10.1073/pnas.1309469110; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Mallet PE, 1996, BEHAV PHARMACOL, V7, P276; Manor D, 2003, CANCER RES, V63, P4426; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Maurelli S, 1995, FEBS LETT, V377, P82, DOI 10.1016/0014-5793(95)01311-3; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Mochizuki K, 2006, LIFE SCI, V80, P140, DOI 10.1016/j.lfs.2006.08.029; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Munguba H, 2011, NEUROBIOL LEARN MEM, V95, P527, DOI 10.1016/j.nlm.2011.03.006; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Norris AW, 1998, METH MOL B, V89, P123; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Paylor R, 1996, BEHAV NEUROSCI, V110, P1415, DOI 10.1037/0735-7044.110.6.1415; Pedroza-Llinas R, 2013, BEHAV BRAIN RES, V237, P141, DOI 10.1016/j.bbr.2012.09.032; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Trazzi S, 2010, J BIOL CHEM, V285, P10098, DOI 10.1074/jbc.M109.043711; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057; Zhou ZK, 2009, NEUROPHARMACOLOGY, V56, P81, DOI 10.1016/j.neuropharm.2008.07.031	54	58	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12748	12758		10.1074/jbc.M114.559062	http://dx.doi.org/10.1074/jbc.M114.559062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644281	Green Published, hybrid			2022-12-25	WOS:000335581400045
J	Zhang, Y; Lei, CQ; Hu, YH; Xia, T; Li, M; Zhong, B; Shu, HB				Zhang, Yu; Lei, Cao-Qi; Hu, Yun-Hong; Xia, Tian; Li, Mi; Zhong, Bo; Shu, Hong-Bing			Kruppel-like Factor 6 Is a Co-activator of NF- kappa B That Mediates p65-dependent Transcription of Selected Downstream Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Interleukin; Kruppel-like factor (KLF); NF-B (NF-B); Signal Transduction; Transcription; Tumor Necrosis Factor (TNF)	CELLULAR ANTIVIRAL RESPONSE; TNF-ALPHA; ACTIVATION; PROTEINS; EXPRESSION; PATHWAYS; IRF3; DNA	Background: Transcription factor NF-B is involved in various biological processes and regulated at multiple levels. Results: KLF6 modulates NF-B-mediated transcription by promoting binding of p65 to promoters of downstream genes. Conclusion: KLF6 is a co-activator of NF-B-mediated transcription of selected downstream genes. Significance: Our study reveals a new regulatory mechanism for NF-B-mediated transcriptional activation in the nucleus. The transcription factor NF-B plays a pivotal role in a broad range of physiological and pathological processes, including development, inflammation, and immunity. How NF-B integrates activating signals to expression of specific sets of target genes is of great interest. Here, we identified Kruppel-like factor 6 (KLF6) as a co-activator of NF-B after TNF and IL-1 stimulation. Overexpression of KLF6 enhanced TNF- and IL-1-induced activation of NF-B and transcription of a subset of downstream genes, whereas knockdown of KLF6 had opposite effects. KLF6 interacted with p65 in the nucleus and bound to the promoters of target genes. Upon IL-1 stimulation, KLF6 was recruited to promoters of a subset of NF-B target genes in a p65-dependent manner, which was in turn required for the optimal binding of p65 to the target gene promoters. Our findings thus identified KLF6 as a previously unknown but essential co-activator of NF-B and provided new insight into the molecular regulation of p65-dependent gene expression.	[Zhang, Yu; Lei, Cao-Qi; Hu, Yun-Hong; Xia, Tian; Li, Mi; Zhong, Bo; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn			Ministry of Science and Technology of China [2012CB910201, 2010CB911800, 2014CB542600]; National Natural Science Foundation of China [31221061, 31130020, 31371427, 91029302]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Ministry of Science and Technology of China (2012CB910201, 2010CB911800, 2014CB542600), and the National Natural Science Foundation of China (31221061, 31130020, 31371427, and 91029302).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; Lei CQ, 2013, J BIOL CHEM, V288, P12596, DOI 10.1074/jbc.M112.444794; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Liu LJ, 2012, CELL RES, V22, P603, DOI 10.1038/cr.2011.199; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Rodriguez E., 2010, PLOS ONE, V5; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang X, 2012, J CELL SCI, V125, P4058, DOI 10.1242/jcs.103531; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	25	44	46	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12876	12885		10.1074/jbc.M113.535831	http://dx.doi.org/10.1074/jbc.M113.535831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634218	Green Published, hybrid			2022-12-25	WOS:000335581400056
J	Chen, HJ; Wang, Y; Zhu, XQ; Li, PC; Teng, GJ				Chen, Hua-Jun; Wang, Yu; Zhu, Xi-Qi; Li, Pei-Cheng; Teng, Gao-Jun			Classification of Cirrhotic Patients with or without Minimal Hepatic Encephalopathy and Healthy Subjects Using Resting-State Attention-Related Network Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; INHIBITORY CONTROL TEST; FUNCTIONAL MRI; ALZHEIMERS-DISEASE; HUMAN BRAIN; IMPAIRMENT; DIAGNOSIS; ABNORMALITIES; DYSFUNCTION	Background: Attention deficit is an early and key characteristic of minimal hepatic encephalopathy (MHE) and has been used as indicator for MHE detection. The aim of this study is to classify the cirrhotic patients with or without MHE (NMHE) and healthy controls (HC) using the resting-state attention-related brain network analysis. Methods and Findings: Resting-state fMRI was administrated to 20 MHE patients, 21 NMHE patients, and 17 HCs. Three attention-related networks, including dorsal attention network (DAN), ventral attention network (VAN), and default mode network (DMN), were obtained by independent component analysis. One-way analysis of covariance was performed to determine the regions of interest (ROIs) showing significant functional connectivity (FC) change. With FC strength of ROIs as indicators, Linear Discriminant Analysis (LDA) was conducted to differentiate MHE from HC or NMHE. Across three groups, significant FC differences were found within DAN (left superior/inferior parietal lobule and right inferior parietal lobule), VAN (right superior parietal lobule), and DMN (bilateral posterior cingulate gyrus and precuneus, and left inferior parietal lobule). With FC strength of ROIs from three networks as indicators, LDA yielded 94.6% classification accuracy between MHE and HC (100% sensitivity and 88.2% specificity) and 85.4% classification accuracy between MHE and NMHE (90.0% sensitivity and 81.0% specificity). Conclusions: Our results suggest that the resting-state attention-related brain network analysis can be useful in classification of subjects with MHE, NMHE, and HC and may provide a new insight into MHE detection.	[Chen, Hua-Jun; Wang, Yu; Zhu, Xi-Qi; Li, Pei-Cheng; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China; [Zhu, Xi-Qi] Southeast Univ, Dept Radiol, Hosp Nanjing 2, Sch Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.	gjteng@vip.sina.com	xiqi, zhu/GLU-8790-2022		National Basic Research Program of China (973 Program) [2013CB733800, 2013CB733803]; National Natural Science Foundation of China [30910103905]; Scientific Research Foundation of Graduate School of Southeast University [YBJJ1243]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Southeast University	This work was supported by grants from the National Basic Research Program of China (973 Program: No. 2013CB733800, No. 2013CB733803), National Natural Science Foundation of China (No. 30910103905), and Scientific Research Foundation of Graduate School of Southeast University (No. YBJJ1243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P754, DOI 10.1111/j.1572-0241.2007.01048.x; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2012, HEPATOLOGY, V55, P1164, DOI 10.1002/hep.25507; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bao ZJ, 2007, WORLD J GASTROENTERO, V13, P3003, DOI 10.3748/wjg.v13.i21.3003; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Chen HJ, 2013, RADIOLOGY, V266, P261, DOI 10.1148/radiol.12120026; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Li YY, 2004, WORLD J GASTROENTERO, V10, P2397; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036986; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Romero-Gomez M, 2004, HEPATOLOGY, V39, P939, DOI 10.1002/hep.20152; Schomerus H, 2001, METAB BRAIN DIS, V16, P37, DOI 10.1023/A:1011610427843; Sharma P, 2007, J HEPATOL, V47, P67, DOI 10.1016/j.jhep.2007.02.022; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2005, METAB BRAIN DIS, V20, P359, DOI 10.1007/s11011-005-7919-z; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong B, 2001, Zhonghua Nei Ke Za Zhi, V40, P13; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	46	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89684	10.1371/journal.pone.0089684	http://dx.doi.org/10.1371/journal.pone.0089684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647353	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500007
J	Chester, ET; Matthews, TG; Howson, TJ; Johnston, K; Mackie, JK; Strachan, SR; Robson, BJ				Chester, Edwin T.; Matthews, Ty G.; Howson, Travis J.; Johnston, Kerrylyn; Mackie, Jonathon K.; Strachan, Scott R.; Robson, Belinda J.			Constraints upon the Response of Fish and Crayfish to Environmental Flow Releases in a Regulated Headwater Stream Network	PLOS ONE			English	Article							MACULATUS JENYNS 1842; FRESH-WATER FISH; GALAXIAS-MACULATUS; PROCAMBARUS-CLARKII; INVASIVE CRAYFISH; CLIMATE-CHANGE; LIFE-HISTORY; DROUGHT; RIVER; RECOLONIZATION	In dry climate zones, headwater streams are often regulated for water extraction causing intermittency in perennial streams and prolonged drying in intermittent streams. Regulation thereby reduces aquatic habitat downstream of weirs that also form barriers to migration by stream fauna. Environmental flow releases may restore streamflow in rivers, but are rarely applied to headwaters. We sampled fish and crayfish in four regulated headwater streams before and after the release of summer-autumn environmental flows, and in four nearby unregulated streams, to determine whether their abundances increased in response to flow releases. Historical data of fish and crayfish occurrence spanning a 30 year period was compared with contemporary data (electrofishing surveys, Victoria Range, Australia; summer 2008 to summer 2010) to assess the longer-term effects of regulation and drought. Although fish were recorded in regulated streams before 1996, they were not recorded in the present study upstream or downstream of weirs despite recent flow releases. Crayfish (Geocharax sp. nov. 1) remained in the regulated streams throughout the study, but did not become more abundant in response to flow releases. In contrast, native fish (Gadopsis marmoratus, Galaxias oliros, Galaxias maculatus) and crayfish remained present in unregulated streams, despite prolonged drought conditions during 2006-2010, and the assemblages of each of these streams remained essentially unchanged over the 30 year period. Flow release volumes may have been too small or have operated for an insufficient time to allow fish to recolonise regulated streams. Barriers to dispersal may also be preventing recolonisation. Indefinite continuation of annual flow releases, that prevent the unnatural cessation of flow caused by weirs, may eventually facilitate upstream movement of fish and crayfish in regulated channels; but other human-made dispersal barriers downstream need to be identified and ameliorated, to allow native fish to fulfil their life cycles in these headwater streams.	[Chester, Edwin T.; Strachan, Scott R.; Robson, Belinda J.] Murdoch Univ, Perth, WA, Australia; [Matthews, Ty G.; Howson, Travis J.; Mackie, Jonathon K.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Johnston, Kerrylyn] Murdoch Univ, Marine & Freshwater Res Lab, Perth, WA, Australia	Murdoch University; Deakin University; Murdoch University	Robson, BJ (corresponding author), Murdoch Univ, Perth, WA, Australia.	b.robson@murdoch.edu.au	Matthews, Ty/G-1677-2013	Robson, Belinda/0000-0002-9215-3666	Glenelg-Hopkins Catchment Management Authority; Wannon Water	Glenelg-Hopkins Catchment Management Authority; Wannon Water	This research was funded by the Glenelg-Hopkins Catchment Management Authority (www.ghcma.vic.gov.au) and Wannon Water (www.wannonwater.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Barbee NC, 2011, MAR FRESHWATER RES, V62, P790, DOI 10.1071/MF10284; Barriga JP, 2007, J APPL ICHTHYOL, V23, P128, DOI 10.1111/j.1439-0426.2006.00820.x; Beatty S., 2013, NOVEL METHODS MANAGI; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Bond N, 2010, FRESHWATER BIOL, V55, P1997, DOI 10.1111/j.1365-2427.2010.02421.x; Chapman A, 2006, ENVIRON BIOL FISH, V77, P21, DOI 10.1007/s10641-006-9051-2; Chessman BC, 2010, FRESHWATER BIOL, V55, P1780, DOI 10.1111/j.1365-2427.2010.02403.x; Chester ET, 2011, FRESHWATER BIOL, V56, P2094, DOI 10.1111/j.1365-2427.2011.02644.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coleman RA, 2010, CONSERV GENET, V11, P1911, DOI 10.1007/s10592-010-0082-z; Creed RP, 2004, J N AM BENTHOL SOC, V23, P224, DOI 10.1899/0887-3593(2004)023&lt;0224:EEBCIA&gt;2.0.CO;2; Dexter T, 2013, AUSTRAL ECO IN PRESS; Doehring K, 2011, MAR FRESHWATER RES, V62, P38, DOI 10.1071/MF10101; Dorn NJ, 2008, HYDROBIOLOGIA, V605, P209, DOI 10.1007/s10750-008-9355-7; Englund G, 1999, OIKOS, V87, P48, DOI 10.2307/3546995; Feurich R, 2012, ECOL ENG, V47, P1, DOI 10.1016/j.ecoleng.2012.06.013; Finn DS, 2011, J N AM BENTHOL SOC, V30, P963, DOI 10.1899/11-012.1; Flinders CA, 2003, AM MIDL NAT, V149, P134, DOI 10.1674/0003-0031(2003)149[0134:EOSPOC]2.0.CO;2; GARVEY JE, 1994, ECOLOGY, V75, P532, DOI 10.2307/1939556; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gherardi F, 2000, ARCH HYDROBIOL, V150, P153; Harris JH, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P223; Hitt NP, 2012, OIKOS, V121, P127, DOI 10.1111/j.1600-0706.2011.19482.x; Howson TJ, 2012, ECOL ENG, V40, P144, DOI 10.1016/j.ecoleng.2011.12.007; JACKSON P D, 1983, Proceedings of the Royal Society of Victoria, V95, P39; JACKSON PD, 1978, AUST J MAR FRESH RES, V29, P293; JACKSON PD, 1978, AUST J MAR FRESH RES, V29, P725, DOI 10.1071/MF9780725; Johnston K., 2010, Freshwater Crayfish, V17, P245; Johnston K, 2011, AUSTRAL ECOL, V36, P269, DOI 10.1111/j.1442-9993.2010.02147.x; Kerby JL, 2005, BIOL CONSERV, V126, P402, DOI 10.1016/j.biocon.2005.06.020; King AJ, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P159; Koster WM, 2008, ECOL FRESHW FISH, V17, P146, DOI 10.1111/j.1600-0633.2007.00269.x; Lassalle G, 2009, FRESHWATER BIOL, V54, P587, DOI 10.1111/j.1365-2427.2008.02135.x; Laurenson LJB, 2012, J FISH BIOL, V81, P1085, DOI 10.1111/j.1095-8649.2012.03383.x; Lind PR, 2007, RIVER RES APPL, V23, P933, DOI 10.1002/rra.1016; Mackie JK, 2013, ECOL ENG, V53, P100, DOI 10.1016/j.ecoleng.2012.12.018; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; McMaster D, 2008, MAR FRESHWATER RES, V59, P177, DOI 10.1071/MF07140; Miller Adam D., 2004, Memoirs of Museum Victoria, V61, P121; Morrongiello JR, 2011, MAR FRESHWATER RES, V62, P1082, DOI 10.1071/MF10308; Murchie KJ, 2008, RIVER RES APPL, V24, P197, DOI 10.1002/rra.1058; Raadik TA, 2011, SYSTEMATIC REVISION; Raadik TA, 1996, AQUATIC FAUNA SURVEY; Robson BJ, 2010, MAR FRESHWATER RES, V61, P778, DOI 10.1071/MF09073; Robson BJ, 2013, HYDROBIOLOGIA, V719, P77, DOI 10.1007/s10750-012-1371-y; Robson BJ, 2011, ECOL ENG, V37, P1379, DOI 10.1016/j.ecoleng.2011.03.015; Robson BJ, 2008, FRESHWATER BIOL, V53, P2385, DOI 10.1111/j.1365-2427.2008.02061.x; Schultz MB, 2007, INVERTEBR SYST, V21, P569, DOI 10.1071/IS07019; STEIN RA, 1977, ECOLOGY, V58, P1237, DOI 10.2307/1935078; Urbina MA, 2011, PHYSIOL BEHAV, V103, P240, DOI 10.1016/j.physbeh.2011.02.009	52	16	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91925	10.1371/journal.pone.0091925	http://dx.doi.org/10.1371/journal.pone.0091925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647407	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500061
J	Dobrowolska, JA; Kasten, T; Huang, YF; Benzinger, TLS; Sigurdson, W; Ovod, V; Morris, JC; Bateman, RJ				Dobrowolska, Justyna A.; Kasten, Tom; Huang, Yafei; Benzinger, Tammie L. S.; Sigurdson, Wendy; Ovod, Vitaliy; Morris, John C.; Bateman, Randall J.			Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BETA-SECRETASE; CEREBROSPINAL-FLUID; ALPHA-SECRETASE; ALZHEIMERS-DISEASE; DEMENTIA; DYNAMICS; CLEAVAGE; BRAIN; REDUCTION	The amyloid-beta (A beta) protein is diurnally regulated in both the cerebrospinal fluid and blood in healthy adults; circadian amplitudes decrease with aging and the presence of cerebral A beta deposits. The cause of the A beta diurnal pattern is poorly understood. One hypothesis is that the Amyloid Precursor Protein (APP) is diurnally regulated, leading to APP product diurnal patterns. APP in the central nervous system is processed either via the beta-pathway (amyloidogenic), generating soluble APP-beta (sAPP beta) and A beta, or the alpha-pathway (non-amyloidogenic), releasing soluble APP-alpha (sAPP alpha). To elucidate the potential contributions of APP to the A beta diurnal pattern and the balance of the alpha- and beta- pathways in APP processing, we measured APP proteolytic products over 36 hours in human cerebrospinal fluid from cognitively normal and Alzheimer's disease participants. We found diurnal patterns in sAPP alpha, sAPP beta, A beta(40), and A beta(42), which diminish with increased age, that support the hypothesis that APP is diurnally regulated in the human central nervous system and thus results in A beta diurnal patterns. We also found that the four APP metabolites were positively correlated in all participants without cerebral A beta deposits. This positive correlation suggests that the a-and b-APP pathways are non-competitive under normal physiologic conditions where APP availability may be the limiting factor that determines sAPP alpha and sAPP beta production. However, in participants with cerebral A beta deposits, there was no correlation of A beta to sAPP metabolites, suggesting that normal physiologic regulation of cerebrospinal fluid A beta is impaired in the presence of amyloidosis. Lastly, we found that the ratio of sAPP beta to sAPP alpha was significantly higher in participants with cerebral A beta deposits versus those without deposits. Therefore, the sAPP beta to sAPP alpha ratio may be a useful biomarker for cerebral amyloidosis.	[Dobrowolska, Justyna A.; Kasten, Tom; Huang, Yafei; Ovod, Vitaliy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Sigurdson, Wendy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Bateman, Randall J.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu	Benzinger, Tammie/L-6104-2013; Zakaria, Justyna Dobrowolska/L-7283-2019	Benzinger, Tammie/0000-0002-8114-0552; Zakaria, Justyna Dobrowolska/0000-0003-1718-147X; Bateman, Randall/0000-0002-7729-1702	US National Institutes of Health [K08 AG027091-01, K23 03094601, R-01-NS065667, P50 AG5681-22, P01 AG03991-22]; Washington University Clinical & Translational Science Award [UL1 RR024992]; Betty and Steve Schmid; Knight Initiative for Alzheimer Research; James and Elizabeth McDonnell Fund for Alzheimer Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG042791, P01AG003991, P50AG005681, U19AG032438, K08AG027091, U01AG032438, UF1AG032438, P01AG026276] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Clinical & Translational Science Award; Betty and Steve Schmid; Knight Initiative for Alzheimer Research; James and Elizabeth McDonnell Fund for Alzheimer Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US National Institutes of Health (K08 AG027091-01, K23 03094601, R-01-NS065667, P50 AG5681-22, and P01 AG03991-22), Washington University Clinical & Translational Science Award UL1 RR024992, grants from an anonymous foundation, a gift from Betty and Steve Schmid, The Knight Initiative for Alzheimer Research, The James and Elizabeth McDonnell Fund for Alzheimer Research, and a research grant from Eli Lilly for the purchase of antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The donors have no competing interests in relation to this work. The authors are not aware of any competing interests. The identity of the donors is not relevant to the editors' or reviewers' assessment of the validity of the manuscript. There was no involvement of any tobacco company in this research, neither through funding of the research costs, nor by funding of the authors' salaries.	Alexopoulos P, 2012, ALZHEIMERS DEMENT, V8, P304, DOI 10.1016/j.jalz.2011.04.009; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Brinkmalm G, 2013, BRAIN RES, V1513, P117, DOI 10.1016/j.brainres.2013.03.019; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gabelle A, 2010, BRAIN RES, V1357, P175, DOI 10.1016/j.brainres.2010.08.022; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GANDY SE, 1992, NEUROBIOL AGING, V13, P601, DOI 10.1016/0197-4580(92)90063-4; Haimov I, 1997, SLEEP, V20, P294, DOI 10.1093/sleep/20.4.294; Holtzman DM, 2011, SCI TRANSL MED, V3; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P1591, DOI 10.1001/archneurol.2012.18107; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Savage MJ, 1998, J NEUROSCI, V18, P1743; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	36	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89998	10.1371/journal.pone.0089998	http://dx.doi.org/10.1371/journal.pone.0089998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646516	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500012
J	Lodha, A; Sauve, R; Bhandari, V; Tang, S; Christianson, H; Bhandari, A; Amin, H; Singhal, N				Lodha, Abhay; Sauve, Reg; Bhandari, Vineet; Tang, Selphee; Christianson, Heather; Bhandari, Anita; Amin, Harish; Singhal, Nalini			Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXTREMELY PRETERM INFANTS; CHRONIC LUNG-DISEASE; LANGUAGE OUTCOMES; THERAPY; CHILDREN; DEFINITION; HEALTH; GROWTH; DESATURATION	Objectives: To determine if chronic oxygen dependency (discharge home on supplemental oxygen) in children with bronchopulmonary dysplasia (BPD; defined as requirement for supplemental O-2 at 36 weeks postmenstrual age) predicts neurodevelopmental disability rates and growth outcomes at 36 months corrected age (CA). Study Design: Longitudinal cohort study. Setting: Southern Alberta regional center located at high altitude. Participants: Preterm infants weighing <= 1250 grams with no BPD, BPD, and BPD with chronic oxygen dependency. Main outcome measures: Neurodevelopmental and growth outcomes. Results: Of 1563 preterm infants admitted from 1995-2007, 1212 survived. Complete follow-up data were available for 1030 (85%) children. Children in BPD and BPD with chronic oxygen dependency groups had significantly lower birth weights, gestational ages, prolonged mechanical ventilation and oxygen supplementation and received more postnatal steroids, compared to those without BPD. Children with BPD and BPD with chronic oxygen dependency were more likely to be below the 5th centile in weight and height compared to those without BPD but there was little difference between the BPD and BPD with chronic oxygen dependency groups. After controlling for confounding variables, children who had BPD and BPD with chronic oxygen dependency had higher odds of neurodevelopmental disability compared to those without BPD [OR (odds ratio) 1.9 (95% CI 1.1 to 3.5) and OR 1.8 (1.1 to 2.9), respectively], with no significant difference between BPD and BPD with chronic oxygen dependency [OR 0.9 (95% CI 0.6 to 1.5)]. Conclusions: BPD and BPD with chronic oxygen dependency in children predicts abnormal neurodevelopmental outcomes at 36 months CA. However, the neurodevelopmental disability rates were not significantly higher in BPD with chronic oxygen dependency children compared to children with BPD only. Compared to those without BPD, growth is impaired in children with BPD and BPD with chronic oxygen dependency, but no difference between the latter two groups.	[Lodha, Abhay; Sauve, Reg; Amin, Harish; Singhal, Nalini] Alberta Childrens Prov Gen Hosp, Peter Lougheed Ctr, Foothills Med Ctr, Dept Pediat, Calgary, AB, Canada; [Lodha, Abhay; Sauve, Reg; Christianson, Heather] Univ Calgary, Calgary, AB, Canada; [Lodha, Abhay; Sauve, Reg; Tang, Selphee; Christianson, Heather; Amin, Harish; Singhal, Nalini] Alberta Hlth Serv, Calgary, AB, Canada; [Lodha, Abhay; Sauve, Reg; Singhal, Nalini] Alberta Childrens Prov Gen Hosp, Inst Child & Maternal Hlth, Calgary, AB, Canada; [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Bhandari, Anita] Connecticut Childrens Med Ctr, Dept Pediat Pulmonol, Hartford, CT USA	Alberta Childrens Hospital; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Childrens Hospital; University of Calgary; Yale University; Connecticut Children's Medical Center	Lodha, A (corresponding author), Alberta Childrens Prov Gen Hosp, Peter Lougheed Ctr, Foothills Med Ctr, Dept Pediat, Calgary, AB, Canada.	aklodha@ucalgary.ca	Bhandari, Vineet/AAS-3365-2020		University of Calgary and Department of Pediatrics	University of Calgary and Department of Pediatrics	This work was supported by the University of Calgary and Department of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2006, SEMIN PERINATOL, V30, P227, DOI 10.1053/j.semperi.2006.05.010; [Anonymous], 2001, PAEDIAT CHILD HLTH, V6, P39; Bancalari E, 2005, EARLY HUM DEV, V81, P171, DOI 10.1016/j.earlhumdev.2004.12.005; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bhandari V, 2013, SEMIN PERINATOL, V37, P108, DOI 10.1053/j.semperi.2013.01.007; Bhandari V, 2010, SEMIN FETAL NEONAT M, V15, P223, DOI 10.1016/j.siny.2010.03.009; Bhandari V, 2009, PEDIATRICS, V124, P517, DOI 10.1542/peds.2008-1302; Bizzarro MJ, 2013, J PERINATOL; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Botet F, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-63; Britton JR, 2012, J PERINATOL, V32, P880, DOI 10.1038/jp.2012.6; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Fitzgerald DA, 2008, MED J AUSTRALIA, V189, P578, DOI 10.5694/j.1326-5377.2008.tb02186.x; Hennessy EM, 2008, ARCH DIS CHILD, V93, P1037, DOI 10.1136/adc.2008.140830; Jeng SF, 2008, DEV MED CHILD NEUROL, V50, P51, DOI 10.1111/j.1469-8749.2007.02011.x; Karagianni P, 2011, PEDIATR NEUROL, V44, P40, DOI 10.1016/j.pediatrneurol.2010.07.008; Kuczmarski RJ, 2000, ADV DATA, V8, P1; Lagatta JM, 2013, J PEDIAT; Lagatta J, 2012, J PEDIATR-US, V160, P232, DOI 10.1016/j.jpeds.2011.08.033; Laughon M, 2009, PEDIATRICS, V124, P637, DOI 10.1542/peds.2008-2874; Lee SK, 2012, AM J PERINATOL; Lewis BA, 2002, J COMMUN DISORD, V35, P393, DOI 10.1016/S0021-9924(02)00085-0; Lodha A, 2011, POSTGRAD MED J, V87, P175, DOI 10.1136/pgmj.2010.107532; LUCHI JM, 1991, AM J DIS CHILD, V145, P813; Madden J, 2010, J PERINATOL, V30, P103, DOI 10.1038/jp.2009.142; Majnemer A, 2000, DEV MED CHILD NEUROL, V42, P53; Moon NM, 2007, EARLY HUM DEV, V83, P209, DOI 10.1016/j.earlhumdev.2006.05.015; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; Nesterenko TH, 2008, AM J PERINAT, V25, P251, DOI 10.1055/s-2008-1075038; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Russman B S, 1989, Curr Probl Pediatr, V19, P65; SAUVE RS, 1989, CLIN PEDIATR, V28, P113, DOI 10.1177/000992288902800301; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Sedowofia K, 2008, NEONATOLOGY, V94, P113, DOI 10.1159/000119721; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Shepherd EG, 2012, J PERINATOL, V32, P33, DOI 10.1038/jp.2011.45; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Short EJ, 2007, ARCH PEDIAT ADOL MED, V161, P1082, DOI 10.1001/archpedi.161.11.1082; SINGER L, 1992, PEDIATRICS, V90, P380; Singer LT, 2001, J DEV BEHAV PEDIATR, V22, P19, DOI 10.1097/00004703-200102000-00003; Sola A, 2007, ACTA PAEDIATR, V96, P801, DOI 10.1111/j.1651-2227.2007.00287.x; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Trittmann JK, 2013, EUR J PEDIATR, V172, P1173, DOI 10.1007/s00431-013-2016-5; Trittmann JK, 2013, EUR J PEDIAT; Van Marter LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF20, DOI 10.1136/adc.2010.183012; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; Vohr BR, 2004, PEDIATRICS, V113, P781, DOI 10.1542/peds.113.4.781; Wang LY, 2010, PEDIATR PULM, V45, P165, DOI 10.1002/ppul.21171; WHITEHEAD J, 1993, STAT MED, V12, P2257, DOI 10.1002/sim.4780122404; Zanardo V, 2001, EARLY HUM DEV, V65, P39, DOI 10.1016/S0378-3782(01)00190-6	56	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90843	10.1371/journal.pone.0090843	http://dx.doi.org/10.1371/journal.pone.0090843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646665	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500018
J	Norberg, P; Bergstrom, M; Hermansson, M				Norberg, Peter; Bergstrom, Maria; Hermansson, Malte			Complete Nucleotide Sequence and Analysis of Two Conjugative Broad Host Range Plasmids from a Marine Microbial Biofilm	PLOS ONE			English	Article							RESISTANCE INCP-1 PLASMID; COMPLETE GENOME SEQUENCE; HORIZONTAL GENE-TRANSFER; ANTIMICROBIAL RESISTANCE; BACTERIAL COMMUNITIES; SEDIMENT BACTERIA; ESCHERICHIA-COLI; TRANSPOSONS; RECOMBINATION; DIVERSITY	The complete nucleotide sequence of plasmids pMCBF1 and pMCBF6 was determined and analyzed. pMCBF1 and pMCBF6 form a novel clade within the IncP-1 plasmid family designated IncP-1 sigma. The plasmids were exogenously isolated earlier from a marine biofilm. pMCBF1 (62 689 base pairs; bp) and pMCBF6 (66 729 bp) have identical backbones, but differ in their mercury resistance transposons. pMCBF1 carries Tn5053 and pMCBF6 carries Tn5058. Both are flanked by 5 bp direct repeats, typical of replicative transposition. Both insertions are in the vicinity of a resolvase gene in the backbone, supporting the idea that both transposons are "res-site hunters'' that preferably insert close to and use external resolvase functions. The similarity of the backbones indicates recent insertion of the two transposons and the ongoing dynamics of plasmid evolution in marine biofilms. Both plasmids also carry the insertion sequence ISPst1, albeit without flanking repeats. ISPs1is located in an unusual site within the control region of the plasmid. In contrast to most known IncP-1 plasmids the pMCBF1/pMCBF6 backbone has no insert between the replication initiation gene (trfA) and the vegetative replication origin (oriV). One pMCBF1/pMCBF6 block of about 2.5 kilo bases (kb) has no similarity with known sequences in the databases. Furthermore, insertion of three genes with similarity to the multidrug efflux pump operon mexEF and a gene from the NodT family of the tripartite multi-drug resistance-nodulation-division (RND) system in Pseudomonas aeruginosa was found. They do not seem to confer antibiotic resistance to the hosts of pMCBF1/pMCBF6, but the presence of RND on promiscuous plasmids may have serious implications for the spread of antibiotic multi-resistance.	[Norberg, Peter] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Bergstrom, Maria; Hermansson, Malte] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hermansson, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	malte.hermansson@cmb.gu.se			Swedish Research Council [2002-214]; University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg	Financial support for this study was provided by The Swedish Research Council (contract no. 2002-214), to M. H. and by the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl MI, 2007, PLASMID, V58, P31, DOI 10.1016/j.plasmid.2006.11.007; BAYA AM, 1986, APPL ENVIRON MICROB, V51, P1285, DOI 10.1128/AEM.51.6.1285-1292.1986; Bolognese F, 1999, APPL ENVIRON MICROB, V65, P1876; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Cook MA, 2001, MICROBIOL-SGM, V147, P2089, DOI 10.1099/00221287-147-8-2089; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; Dahlberg C, 1997, APPL ENVIRON MICROB, V63, P4692, DOI 10.1128/AEM.63.12.4692-4697.1997; Dahlberg C, 1998, APPL ENVIRON MICROB, V64, P2670; Dahlberg C, 1998, MOL BIOL EVOL, V15, P385, DOI 10.1093/oxfordjournals.molbev.a025935; del Castillo CS, 2013, INT J ANTIMICROB AG, V42, P10, DOI 10.1016/j.ijantimicag.2013.02.027; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; HERMANSSON M, 1987, APPL ENVIRON MICROB, V53, P2338, DOI 10.1128/AEM.53.10.2338-2342.1987; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Holmes EC, 1999, EVOLUTION OF HIV, P177; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kholodii G, 2002, MICROBIOL-SGM, V148, P3569, DOI 10.1099/00221287-148-11-3569; KHOLODII GY, 1995, MOL MICROBIOL, V17, P1189, DOI 10.1111/j.1365-2958.1995.mmi_17061189.x; KHOLODII GY, 1993, J MOL BIOL, V230, P1103, DOI 10.1006/jmbi.1993.1228; Kirzhner V, 2007, J MOL EVOL, V64, P448, DOI 10.1007/s00239-006-0178-8; KOBAYASHI N, 1994, MICROBIOL-SGM, V140, P289, DOI 10.1099/13500872-140-2-289; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lopez-Perez M, 2013, GENOME BIOL EVOL, V5, P1220, DOI 10.1093/gbe/evt089; Ma Y, 2011, ENVIRON MICROBIOL, V14, P453; Maniatis T., 1982, MOL CLONING LAB MANU; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; MCCLURE NC, 1989, APPL ENVIRON MICROB, V55, P2627, DOI 10.1128/AEM.55.10.2627-2634.1989; Minakhina S, 1999, MOL MICROBIOL, V33, P1059, DOI 10.1046/j.1365-2958.1999.01548.x; Mindlin S, 2005, RES MICROBIOL, V156, P994, DOI 10.1016/j.resmic.2005.05.011; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Norberg P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1267; Oliveira CS, 2012, PLASMID, V67, P252, DOI 10.1016/j.plasmid.2011.11.002; Oliveira CS, 2013, PLASMID, V70, P412, DOI 10.1016/j.plasmid.2013.06.002; Oosterkamp MJ, 2011, J BACTERIOL, V193, P5028, DOI 10.1128/JB.00365-11; Osborn AM, 2000, FEMS MICROBIOL LETT, V186, P203, DOI 10.1111/j.1574-6968.2000.tb09105.x; Palenik B, 2009, ENVIRON MICROBIOL, V11, P349, DOI 10.1111/j.1462-2920.2008.01772.x; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Petersen J, 2013, APPL MICROBIOL BIOT, V97, P2805, DOI 10.1007/s00253-013-4746-8; Phelan RW, 2011, APPL ENVIRON MICROB, V77, P327, DOI 10.1128/AEM.01239-10; Pinyon JL, 2011, MICROB DRUG RESIST, V17, P339, DOI 10.1089/mdr.2010.0196; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Pradella S, 2010, ARCH MICROBIOL, V192, P115, DOI 10.1007/s00203-009-0535-2; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Schierup MH, 2000, GENETICS, V156, P879; Schierup MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/oxfordjournals.molbev.a026256; SINGER M, 1989, MICROBIOL REV, V53, P1; SIZEMORE RK, 1977, ANTIMICROB AGENTS CH, V12, P373, DOI 10.1128/AAC.12.3.373; SLATKIN M, 1991, GENETICS, V129, P555; Smalla K, 2002, FEMS MICROBIOL ECOL, V42, P165, DOI 10.1111/j.1574-6941.2002.tb01006.x; SMITH CA, 1993, J GEN MICROBIOL, V139, P1761, DOI 10.1099/00221287-139-8-1761; Sobecky PA, 1997, APPL ENVIRON MICROB, V63, P888, DOI 10.1128/AEM.63.3.888-895.1997; Sobecky PA, 1998, APPL ENVIRON MICROB, V64, P2822; Sobecky Patricia A., 2009, V532, P435, DOI 10.1007/978-1-60327-853-9_25; Tauch A, 2003, MOL GENET GENOMICS, V268, P570, DOI 10.1007/s00438-002-0785-z; Thomas CM, 2000, HORIZONTAL GENE POOL; Thorsted PA, 1998, J MOL BIOL, V282, P969, DOI 10.1006/jmbi.1998.2060; Tralau T, 2001, APPL ENVIRON MICROB, V67, P1508, DOI 10.1128/AEM.67.4.1508-1516.2001; van Elsas JD, 1998, APPL ENVIRON MICROB, V64, P880; Vedler E, 2004, J BACTERIOL, V186, P7161, DOI 10.1128/JB.186.21.7161-7174.2004; Villeneuve C, 2012, J BACTERIOL, V194, P4126, DOI 10.1128/JB.00726-12; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Yang J, 2013, MICROB ECOL, V65, P975, DOI 10.1007/s00248-013-0187-2; Zhong ZP, 2003, PLASMID, V49, P233, DOI 10.1016/S0147-619X(03)00014-3; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001	64	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92321	10.1371/journal.pone.0092321	http://dx.doi.org/10.1371/journal.pone.0092321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647540	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500116
J	Pirastu, N; Kooyman, M; Traglia, M; Robino, A; Willems, SM; Pistis, G; d'Adamo, P; Amin, N; d'Eustacchio, A; Navarini, L; Sala, C; Karssen, LC; van Duijn, C; Toniolo, D; Gasparini, P				Pirastu, Nicola; Kooyman, Maarten; Traglia, Michela; Robino, Antonietta; Willems, Sara M.; Pistis, Giorgio; d'Adamo, Pio; Amin, Najaf; d'Eustacchio, Angela; Navarini, Luciano; Sala, Cinzia; Karssen, Lennart C.; van Duijn, Cornelia; Toniolo, Daniela; Gasparini, Paolo			Association Analysis of Bitter Receptor Genes in Five Isolated Populations Identifies a Significant Correlation between TAS2R43 Variants and Coffee Liking	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES-MELLITUS; TASTE RECEPTORS; CAFFEINE; RISK; CONSUMPTION; FOOD; DISEASE; TWINS; SENSITIVITY	Coffee, one of the most popular beverages in the world, contains many different physiologically active compounds with a potential impact on people's health. Despite the recent attention given to the genetic basis of its consumption, very little has been done in understanding genes influencing coffee preference among different individuals. Given its markedly bitter taste, we decided to verify if bitter receptor genes (TAS2Rs) variants affect coffee liking. In this light, 4066 people from different parts of Europe and Central Asia filled in a field questionnaire on coffee liking. They have been consequently recruited and included in the study. Eighty-eight SNPs covering the 25 TAS2R genes were selected from the available imputed ones and used to run association analysis for coffee liking. A significant association was detected with three SNP: one synonymous and two functional variants (W35S and H212R) on the TAS2R43 gene. Both variants have been shown to greatly reduce in vitro protein activity. Surprisingly the wild type allele, which corresponds to the functional form of the protein, is associated to higher liking of coffee. Since the hTAS2R43 receptor is sensible to caffeine, we verified if the detected variants produced differences in caffeine bitter perception on a subsample of people coming from the FVG cohort. We found a significant association between differences in caffeine perception and the H212R variant but not with the W35S, which suggests that the effect of the TAS2R43 gene on coffee liking is mediated by caffeine and in particular by the H212R variant. No other significant association was found with other TAS2R genes. In conclusion, the present study opens new perspectives in the understanding of coffee liking. Further studies are needed to clarify the role of the TAS2R43 gene in coffee hedonics and to identify which other genes and pathways are involved in its genetics.	[Pirastu, Nicola; Robino, Antonietta; d'Adamo, Pio; d'Eustacchio, Angela; Gasparini, Paolo] Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Pirastu, Nicola; Robino, Antonietta; d'Adamo, Pio; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Kooyman, Maarten; Willems, Sara M.; Amin, Najaf; Karssen, Lennart C.; van Duijn, Cornelia] Erasmus MC, Genet Epidemiol Unit, Dept Epidemiol, Rotterdam, Netherlands; [Navarini, Luciano] Illycaffe Spa, Trieste, Italy; [van Duijn, Cornelia] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Leiden, Netherlands; [Traglia, Michela; Pistis, Giorgio; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	IRCCS Burlo Garofolo; University of Trieste; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pirastu, N (corresponding author), Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	nicola.pirastu@burlo.trieste.it	d'Adamo, Adamo Pio/G-4064-2011; Sala, Cinzia Felicita/AAN-1900-2020; Pirastu, Nicola/AHB-6226-2022; Toniolo, Daniela/AAE-2969-2019; Gasparini, Paolo/B-6173-2014; Traglia, Michela/AAX-5816-2020; Robino, Antonietta/K-9398-2016	d'Adamo, Adamo Pio/0000-0001-9367-4909; Toniolo, Daniela/0000-0001-9545-6032; Pirastu, Nicola/0000-0002-5363-3886; Kooyman, Maarten/0000-0002-9023-5617; s, hema/0000-0002-3440-9475; Van Duijn, Cornelia/0000-0002-2374-9204; Amin, Najaf/0000-0002-8944-1771; Karssen, Lennart C./0000-0002-1959-342X; Robino, Antonietta/0000-0003-2152-2353; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Gasparini, Paolo/0000-0002-0859-0856	Region Friuli Venezia Giulia [35\09]; Italian Ministry of health; POR-FESR Regione Autonoma Friuli Venezia Giulia, Italy; European Commission [018947 (LSHG-CT-2006-01947)]; European Community by the European Commission [HEALTH-F4-2007-201413, QLG2-CT-2002-01254]; Netherlands Organisation for Scientific Research; Russian Foundation for Basic Research [NWO-RFBR 047.017.043]; Netherlands Scientific Organization [NWO 480-05-003]; BBMRI-NL, a Research Infrastructure; Dutch Government [NWO 184.021.007]	Region Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Italian Ministry of health(Ministry of Health, Italy); POR-FESR Regione Autonoma Friuli Venezia Giulia, Italy; European Commission(European CommissionEuropean Commission Joint Research Centre); European Community by the European Commission; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Netherlands Scientific Organization; BBMRI-NL, a Research Infrastructure; Dutch Government	The SR study has been funded by the Region Friuli Venezia Giulia grant number 35\09 Linea 2 "Sulle tracce di Marco Polo: geni, gusto e loro implicazioni sulla salute lungo la Via della Seta". The INGI-FVG study was funded through the Italian Ministry of health. This work is part of a joint project with illycaffe' s.p.a. within the framework of the "Nutrigenomica e consumo di caffe' : effetti fisiologici, genetica del gusto e genetica della pianta" project partially supported by the POR-FESR 2007-2013 Regione Autonoma Friuli Venezia Giulia, Italy. The VB study was founded trough Fondazione Compagnia di San Paolo, Torino, Fondazione Cariplo, Milano and Health Ministry (Progetto Finalizzato and Italian Centre for Disease Prevention and Control). The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no. QLG2-CT-2002-01254). High-throughput analysis of the ERF data was supported by joint grant from Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). Statistical analyses were partly carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003 PI: Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. This research was financially supported by BBMRI-NL, a Research Infrastructure financed by the Dutch Government (NWO 184.021.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Coetzee H, 1996, FOOD QUAL PREFER, V7, P81, DOI 10.1016/0950-3293(95)00039-9; CONTERIO F, 1962, HEREDITY, V17, P347, DOI 10.1038/hdy.1962.36; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dorea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370; Dragana V, 2013, HEAR BALANC IN PRESS; Drewnowski A, 1998, ANN NY ACAD SCI, V855, P797, DOI 10.1111/j.1749-6632.1998.tb10661.x; Duffy VB, 2007, J AM DIET ASSOC, V107, P237, DOI 10.1016/j.jada.2006.11.005; Duffy VB, 2009, ANN NY ACAD SCI, V1170, P558, DOI 10.1111/j.1749-6632.2009.04593.x; Farah A, 2012, COFFEE EMERGING HLTH, P1; Genick UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027745; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; GOLDSTEIN A, 1965, J PHARMACOL EXP THER, V149, P156; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727; Grigg D., 2002, GeoJournal, V57, P283, DOI 10.1023/B:GEJO.0000007249.91153.c3; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Heath A C, 1998, Twin Res, V1, P176, DOI 10.1375/twin.1.4.176; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lanier SA, 2005, PHYSIOL BEHAV, V83, P821, DOI 10.1016/j.physbeh.2004.10.004; Ledda M, 2013, HUM MOL GENET; Lim J-W, 2012, EMERGING HLTH EFFECT, P111, DOI [10.1002/9781119949893.ch6, DOI 10.1002/9781119949893.CH6]; Lindsay J, 2012, EMERGING HLTH EFFECT, P97, DOI [10.1002/9781119949893.ch5, DOI 10.1002/9781119949893.CH5]; Luciano M, 2005, ADDICTION, V100, P1510, DOI 10.1111/j.1360-0443.2005.01223.x; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Nkondjock A., 2012, Coffee: emerging health effects and disease prevention, P197; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; ROBERTSON D, 1984, AM J MED, V77, P54, DOI 10.1016/0002-9343(84)90435-2; Roudnitzky N, 2011, HUM MOL GENET, V20, P3437, DOI 10.1093/hmg/ddr252; Sacerdote C, 2007, AM J EPIDEMIOL, V166, P576, DOI 10.1093/aje/kwm113; SCHIFFMAN SS, 1985, PHARMACOL BIOCHEM BE, V22, P195, DOI 10.1016/0091-3057(85)90377-6; Thurstone L., 1955, J FOOD SCI, V20, P512, DOI DOI 10.1111/J.1365-2621.1955.TB16862.X; Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213; Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Vink JM, 2009, TWIN RES HUM GENET, V12, P127, DOI 10.1375/twin.12.2.127; Yeomans MR, 2007, PHYSIOL BEHAV, V92, P831, DOI 10.1016/j.physbeh.2007.06.006; Yeomans MR, 2012, PHYSIOL BEHAV, V106, P345, DOI 10.1016/j.physbeh.2012.03.013	50	29	32	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92065	10.1371/journal.pone.0092065	http://dx.doi.org/10.1371/journal.pone.0092065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647340	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500078
J	Pucci, F; Dhanani, M; Dehouck, Y; Rooman, M				Pucci, Fabrizio; Dhanani, Malik; Dehouck, Yves; Rooman, Marianne			Protein Thermostability Prediction within Homologous Families Using Temperature-Dependent Statistical Potentials	PLOS ONE			English	Article							THERMAL-STABILITY; STRUCTURAL ENTROPY; SALT BRIDGES; EVOLUTION; ENZYMES	The ability to rationally modify targeted physical and biological features of a protein of interest holds promise in numerous academic and industrial applications and paves the way towards de novo protein design. In particular, bioprocesses that utilize the remarkable properties of enzymes would often benefit from mutants that remain active at temperatures that are either higher or lower than the physiological temperature, while maintaining the biological activity. Many in silico methods have been developed in recent years for predicting the thermodynamic stability of mutant proteins, but very few have focused on thermostability. To bridge this gap, we developed an algorithm for predicting the best descriptor of thermostability, namely the melting temperature T-m, from the protein's sequence and structure. Our method is applicable when the T-m of proteins homologous to the target protein are known. It is based on the design of several temperature-dependent statistical potentials, derived from datasets consisting of either mesostable or thermostable proteins. Linear combinations of these potentials have been shown to yield an estimation of the protein folding free energies at low and high temperatures, and the difference of these energies, a prediction of the melting temperature. This particular construction, that distinguishes between the interactions that contribute more than others to the stability at high temperatures and those that are more stabilizing at low T, gives better performances compared to the standard approach based on T-independent potentials which predict the thermal resistance from the thermodynamic stability. Our method has been tested on 45 proteins of known T-m that belong to 11 homologous families. The standard deviation between experimental and predicted T-m's is equal to 13.6 degrees C in cross validation, and decreases to 8.3 degrees C if the 6 worst predicted proteins are excluded. Possible extensions of our approach are discussed.	[Pucci, Fabrizio; Dhanani, Malik; Dehouck, Yves; Rooman, Marianne] Univ Libre Bruxelles, Dept BioModeling BioInformat & BioProc, Brussels, Belgium	Universite Libre de Bruxelles	Pucci, F (corresponding author), Univ Libre Bruxelles, Dept BioModeling BioInformat & BioProc, Brussels, Belgium.	fapucci@ulb.ac.be; mrooman@ulb.ac.be		Dehouck, Yves/0000-0002-7401-104X	FRFC project of the Belgian fund for scientific research (FNRS)	FRFC project of the Belgian fund for scientific research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by FRFC project of the Belgian fund for scientific research (FNRS). FP is Postdoctoral Fellow, YD Postdoctoral Researcher, and MR Research Director at the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2006.04.002; Bae E, 2008, P NATL ACAD SCI USA, V105, P9594, DOI 10.1073/pnas.0800938105; Berezovsky IN, 2007, PLOS COMPUT BIOL, V3, P498, DOI 10.1371/journal.pcbi.0030052; Berezovsky IN, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035002; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Dehouck Y, 2006, BIOPHYS J, V90, P4010, DOI 10.1529/biophysj.105.079434; Dehouck Y, 2008, PROTEIN ENG DES SEL, V21, P275, DOI 10.1093/protein/gzn001; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Folch B, 2008, J CHEM INF MODEL, V48, P119, DOI 10.1021/ci700237g; Folch B, 2010, BIOPHYS J, V98, P667, DOI 10.1016/j.bpj.2009.10.050; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Gromiha MM, 2001, BIOPHYS CHEM, V91, P71, DOI 10.1016/S0301-4622(01)00154-5; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Ku TH, 2009, COMPUT BIOL CHEM, V33, P445, DOI 10.1016/j.compbiolchem.2009.10.002; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Li YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047247; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Mora M, 2010, J MOL MED, V88, P143, DOI 10.1007/s00109-009-0574-9; NOJIMA H, 1978, J MOL BIOL, V122, P33, DOI 10.1016/0022-2836(78)90106-7; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; ROOMAN MJ, 1991, J MOL BIOL, V221, P961, DOI 10.1016/0022-2836(91)80186-X; Seeliger D, 2010, BIOPHYS J, V98, P2309, DOI 10.1016/j.bpj.2010.01.051; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wijma HJ, 2013, CURRENT OPINION STRU, V23, P17	45	34	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91659	10.1371/journal.pone.0091659	http://dx.doi.org/10.1371/journal.pone.0091659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646884	Green Submitted, gold, Green Published			2022-12-25	WOS:000333348500044
J	Stadnicka-Michalak, J; Tanneberger, K; Schirmer, K; Ashauer, R				Stadnicka-Michalak, Julita; Tanneberger, Katrin; Schirmer, Kristin; Ashauer, Roman			Measured and Modeled Toxicokinetics in Cultured Fish Cells and Application to In Vitro - In Vivo Toxicity Extrapolation	PLOS ONE			English	Article							3 WATERBORNE CHLOROETHANES; ORGANIC-CHEMICALS; RAINBOW-TROUT; ECOTOXICOLOGY; QSARS; LINE	Effect concentrations in the toxicity assessment of chemicals with fish and fish cells are generally based on external exposure concentrations. External concentrations as dose metrics, may, however, hamper interpretation and extrapolation of toxicological effects because it is the internal concentration that gives rise to the biological effective dose. Thus, we need to understand the relationship between the external and internal concentrations of chemicals. The objectives of this study were to: (i) elucidate the time-course of the concentration of chemicals with a wide range of physicochemical properties in the compartments of an in vitro test system, (ii) derive a predictive model for toxicokinetics in the in vitro test system, (iii) test the hypothesis that internal effect concentrations in fish (in vivo) and fish cell lines (in vitro) correlate, and (iv) develop a quantitative in vitro to in vivo toxicity extrapolation method for fish acute toxicity. To achieve these goals, time-dependent amounts of organic chemicals were measured in medium, cells (RTgill-W1) and the plastic of exposure wells. Then, the relation between uptake, elimination rate constants, and log K-OW was investigated for cells in order to develop a toxicokinetic model. This model was used to predict internal effect concentrations in cells, which were compared with internal effect concentrations in fish gills predicted by a Physiologically Based Toxicokinetic model. Our model could predict concentrations of non-volatile organic chemicals with log K-OW between 0.5 and 7 in cells. The correlation of the log ratio of internal effect concentrations in fish gills and the fish gill cell line with the log K-OW was significant (r>0.85, p = 0.0008, F-test). This ratio can be predicted from the log K-OW of the chemical (77% of variance explained), comprising a promising model to predict lethal effects on fish based on in vitro data.	[Stadnicka-Michalak, Julita; Tanneberger, Katrin; Schirmer, Kristin; Ashauer, Roman] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Stadnicka-Michalak, Julita; Schirmer, Kristin] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Stadnicka-Michalak, Julita; Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, Lausanne, Switzerland; [Tanneberger, Katrin] Ecosens AG, Wallisellen, Switzerland; [Ashauer, Roman] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of York - UK	Stadnicka-Michalak, J (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.	julita.stadnicka@gmail.com	SCHIRMER, KRISTIN/AAG-2332-2019; morantes, silvana/S-3841-2018; Ashauer, Roman/E-6640-2010	morantes, silvana/0000-0001-6628-4526; Ashauer, Roman/0000-0002-9579-8793	European Union [PITN-GA-2009-238148]	European Union(European Commission)	This research is financially supported by the European Union under the 7th Framework Programme ( project acronym CREAM, contract number PITN-GA-2009-238148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MULTIMEDIA ENV MODEL, DOI DOI 10.1201/9781420032543; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI [10.1139/A06-005, 10.1139/a06-005]; Ashauer R, 2010, J ENVIRON MONITOR, V12, P2056, DOI 10.1039/c0em00234h; Bernhard MJ, 2005, ENVIRON TOXICOL CHEM, V24, P1738, DOI 10.1897/04-234R.1; Bertelsen SL, 1998, EVALUATION LOG KOW T; Bols NC, 2005, BIOCH MOLEC, V6, P43; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Cowan-Ellsberry CE, 2008, CHEMOSPHERE, V70, P1804, DOI 10.1016/j.chemosphere.2007.08.030; Debruyn AMH, 2007, ENVIRON TOXICOL CHEM, V26, P1803, DOI 10.1897/07-016R.1; Endo S, 2013, ENV SCI TECHNOLOGY; Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100; Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h; FOCUS, 2006, SANCO100582005 FOCUS, P434; Gulden M, 2005, AQUAT TOXICOL, V72, P327, DOI 10.1016/j.aquatox.2005.02.002; Gulden M, 2001, TOXICOL IN VITRO, V15, P233, DOI 10.1016/S0887-2333(01)00008-X; Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316; Hoffman D, 2005, PHARM STAT, V4, P15, DOI 10.1002/pst.147; Jager T, 2009, ECOTOXICOLOGY, V18, P187, DOI 10.1007/s10646-008-0271-4; Johnson I, 2009, PROPOSED EQS WATER F, P60; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k; Kramer NI, 2010, CHEM RES TOXICOL, V23, P1806, DOI 10.1021/tx1002595; Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029; Li ZH, 2010, COMP BIOCHEM PHYS C, V152, P392, DOI 10.1016/j.cbpc.2010.06.006; MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719, DOI 10.1021/es00046a001; Meador JP, 2008, J ENVIRON MONITOR, V10, P1486, DOI 10.1039/b814041n; Nichols JW, 2007, ENVIRON TOXICOL CHEM, V26, P1304, DOI 10.1897/06-259R.1; NICHOLS JW, 1993, AQUAT TOXICOL, V27, P83, DOI 10.1016/0166-445X(93)90049-7; NICHOLS JW, 1991, TOXICOL APPL PHARM, V110, P374, DOI 10.1016/0041-008X(91)90040-L; NICHOLS JW, 1990, TOXICOL APPL PHARM, V106, P433, DOI 10.1016/0041-008X(90)90338-U; OECD, 2019, FISH AC TOX TEST OEC, V2, DOI [10.1787/9789264069961-en, DOI 10.1787/9789264069961-EN]; Ramos EU, 1997, ENVIRON SCI POLLUT R, V4, P83, DOI 10.1007/BF02986285; Rubach Mascha N., 2011, Integrated Environmental Assessment and Management, V7, P172, DOI 10.1002/ieam.105; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7; Schirmer K, 2006, TOXICOLOGY, V224, P163, DOI 10.1016/j.tox.2006.04.042; Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005; Schreiber R, 2008, ENVIRON TOXICOL CHEM, V27, P1676, DOI 10.1897/07-504; Smith KEC, 2010, AQUAT TOXICOL, V98, P15, DOI 10.1016/j.aquatox.2010.01.007; Stadnicka J, 2012, ENVIRON SCI TECHNOL, V46, P3273, DOI 10.1021/es2043728; Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z; Tanneberger K, 2010, ENVIRON SCI TECHNOL, V44, P4775, DOI 10.1021/es100045y; Van Leeuwen C.J., 2007, RISK ASSESSMENT CHEM, P686	43	54	54	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92303	10.1371/journal.pone.0092303	http://dx.doi.org/10.1371/journal.pone.0092303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647349	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500111
J	van der Plas, MJA; Andersen, AS; Nazir, S; van Tilburg, NH; Oestergaard, PR; Krogfelt, KA; van Dissel, JT; Hensbergen, PJ; Bertina, RM; Nibbering, PH				van der Plas, Mariena J. A.; Andersen, Anders S.; Nazir, Sheresma; van Tilburg, Nico H.; Oestergaard, Peter R.; Krogfelt, Karen A.; van Dissel, Jaap T.; Hensbergen, Paul J.; Bertina, Rogier M.; Nibbering, Peter H.			A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis	PLOS ONE			English	Article							PRO-INFLAMMATORY RESPONSES; LUCILIA-SERICATA; IN-VITRO; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; DENATURED PROTEINS; DERMAL FIBROBLASTS; SURGICAL MAGGOTS; CHRONIC WOUNDS; LEG ULCERS	Maggots of the blowfly Lucilia sericata are used for the treatment of chronic wounds. As haemostatic processes play an important role in wound healing, this study focused on the effects of maggot secretions on coagulation and fibrinolysis. The results showed that maggot secretions enhance plasminogen activator-induced formation of plasmin and fibrinolysis in a dose-and time-dependent manner. By contrast, coagulation was not affected by secretions. Biochemical studies indicated that a novel serine protease within secretions, designated Sericase, cleaved plasminogen to several fragments. Recombinant Sericase degraded plasminogen leading amongst others to the formation of the mini-plasminogen like fragment Val454-plasminogen. In addition, the presence of a non-proteolytic cofactor in secretions was discovered, which plays a role in the enhancement of plasminogen activator-induced fibrinolysis by Sericase. We conclude from our in vitro studies that the novel serine protease Sericase, with the aid of a non-proteolytic cofactor, enhances plasminogen activator-induced fibrinolysis.	[van der Plas, Mariena J. A.; Nazir, Sheresma; van Dissel, Jaap T.; Nibbering, Peter H.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [van der Plas, Mariena J. A.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [Andersen, Anders S.; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Andersen, Anders S.; Oestergaard, Peter R.] Novozymes AS, Bagsvaerd, Denmark; [Andersen, Anders S.] Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark; [van Tilburg, Nico H.; Bertina, Rogier M.] Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands; [Hensbergen, Paul J.] Leiden Univ, Ctr Prote & Metabol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Statens Serum Institut; Novozymes; University of Copenhagen; Bispebjerg Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Plas, MJA (corresponding author), Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	mjavanderplas@gmail.com	van der Plas, Mariena/GYV-3702-2022; Krogfelt, Karen Angeliki/P-2430-2018; Bertina, Rogier/AGQ-5246-2022; Krogfelt, Karen Angeliki A/O-8145-2016	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; van der Plas, Mariena/0000-0002-3233-2881; Hensbergen, Paul/0000-0002-3193-5445	University of Copenhagen, Faculty of Health Sciences; Danish Research Council for Technology and Production [274-05-0435]	University of Copenhagen, Faculty of Health Sciences; Danish Research Council for Technology and Production	Anders Schou Andersen was supported by a clinical PhD scholarship from the University of Copenhagen, Faculty of Health Sciences. The TAST project was financed by a material grant from The Danish Research Council for Technology and Production 274-05-0435 to Professor Karen A. Krogfelt, Statens Serum Institute, Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirbasli M, 2005, INT J CLIN PRACT, V59, P102, DOI 10.1111/j.1742-1241.2005.00379.x; Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394; Andersen A, 2008, 18 EUR TISS REP SOC; Andersen AS, 2010, J ANTIMICROB CHEMOTH, V65, P1646, DOI 10.1093/jac/dkq165; Andersen AS, 2009, MICROBIOLOGY, V156, P400; Becker F, 2004, J MICROBIOL METH, V57, P123, DOI 10.1016/j.mimet.2003.12.002; Brown A, 2012, MED VET ENTOMOL, V26, P432, DOI 10.1111/j.1365-2915.2012.01029.x; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Chambers L, 2003, BRIT J DERMATOL, V148, P14, DOI 10.1046/j.1365-2133.2003.04935.x; Chen WYJ, 2007, WOUND REPAIR REGEN, V15, P434, DOI 10.1111/j.1524-475X.2007.00250.x; CHRISTENSEN U, 1979, BIOCHIM BIOPHYS ACTA, V567, P472, DOI 10.1016/0005-2744(79)90133-5; Church John C T, 2005, Int J Low Extrem Wounds, V4, P59, DOI 10.1177/153473460500400110; Clark RAF, 2001, ANN NY ACAD SCI, V936, P355; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Fine A, 1934, J BONE JOINT SURG, V16, P572; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Greiling D, 1997, J CELL SCI, V110, P861; Horobin AJ, 2006, J INVEST DERMATOL, V126, P1410, DOI 10.1038/sj.jid.5700256; Horobin AJ, 2005, WOUND REPAIR REGEN, V13, P422, DOI 10.1111/j.1067-1927.2005.130410.x; Jukema GN, 2002, CLIN INFECT DIS, V35, P1566, DOI 10.1086/344904; Kastl SP, 2006, J THROMB HAEMOST, V4, P1790, DOI 10.1111/j.1538-7836.2006.02046.x; Kim PY, 2012, J BIOL CHEM, V287, P4652, DOI 10.1074/jbc.M111.317719; Lasne D, 2006, CAN J ANAESTH, V53, pS2, DOI 10.1007/BF03022247; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lerant I, 2000, BBA-PROTEIN STRUCT M, V1480, P311, DOI 10.1016/S0167-4838(00)00083-2; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; MACHOVICH R, 1989, BIOCHEMISTRY-US, V28, P4517, DOI 10.1021/bi00436a059; Machovich R, 1997, ARCH BIOCHEM BIOPHYS, V344, P343, DOI 10.1006/abbi.1997.0221; MOROZ LA, 1981, BLOOD, V58, P97; Mumcuoglu KY, 1998, DIABETES CARE, V21, P2030, DOI 10.2337/diacare.21.11.2030; Namias N, 2000, J BURN CARE REHABIL, V21, P254, DOI 10.1097/00004630-200021030-00012; RADCLIFFE R, 1981, ARCH BIOCHEM BIOPHYS, V211, P750, DOI 10.1016/0003-9861(81)90512-9; Robinson W, 1933, J BONE JOINT SURG, V15, P409; Schmidtchen A, 2003, ACTA DERM-VENEREOL, V83, P310, DOI 10.1080/00015550310016689; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SHERMAN RA, 1988, MED VET ENTOMOL, V2, P225, DOI 10.1111/j.1365-2915.1988.tb00188.x; Skurk T, 2004, INT J OBESITY, V28, P1357, DOI 10.1038/sj.ijo.0802778; Steen Hanno, 2002, Sci STKE, V2002, ppl16, DOI 10.1126/stke.2002.154.pl16; Steenvoorde P, 2005, Int J Low Extrem Wounds, V4, P57, DOI 10.1177/153473460500400109; Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201; Subramaniam K, 2008, INT WOUND J, V5, P79, DOI 10.1111/j.1742-481X.2007.00336.x; Telford G, 2012, MED VET ENTOMOL, V26, P291, DOI 10.1111/j.1365-2915.2011.01000.x; Telford G, 2010, BRIT J DERMATOL, V163, P523, DOI 10.1111/j.1365-2133.2010.09854.x; van der Plas MJA, 2009, DIABETOLOGIA, V52, P1962, DOI 10.1007/s00125-009-1432-6; van der Plas MJA, 2008, J ANTIMICROB CHEMOTH, V61, P117, DOI 10.1093/jac/dkm407; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; van der Plas MJA, 2010, J ANTIMICROB CHEMOTH, V65, P917, DOI 10.1093/jac/dkq042; van der Plas MJA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008071; VISTNES LM, 1981, SURGERY, V90, P835; Walter MC, 2009, NUCLEIC ACIDS RES, V37, pD408, DOI 10.1093/nar/gkn749; Weil Grover C., 1933, AM J SURG, V19, P36; Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002; Woeldike HF, 1989, PRODUCTION PROTEINS; Wysocki AB, 1999, WOUND REPAIR REGEN, V7, P154, DOI 10.1046/j.1524-475X.1999.00154.x; Zollner TM, 1997, BRIT J DERMATOL, V136, P341, DOI 10.1046/j.1365-2133.1997.5601515.x	56	12	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92096	10.1371/journal.pone.0092096	http://dx.doi.org/10.1371/journal.pone.0092096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647546	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500084
J	Akrawinthawong, K; Park, JW; Piknova, B; Sibmooh, N; Fucharoen, S; Schechter, AN				Akrawinthawong, Krittapoom; Park, Ji Won; Piknova, Barbora; Sibmooh, Nathawut; Fucharoen, Suthat; Schechter, Alan N.			A Flow Cytometric Analysis of the Inhibition of Platelet Reactivity Due to Nitrite Reduction by Deoxygenated Erythrocytes	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; HYPOXIC CONDITIONS; DIETARY NITRATE; RELAXING FACTOR; OXIDE; ENDOTHELIUM; AGGREGATION; ACTIVATION; ASPIRIN; HUMANS	Nitric oxide (NO), a small gas molecule, has long been known to be a potent inhibitor of platelet function but the physiological and pathological implications of platelet inhibition by NO have not been well clarified. We recently showed that the addition of nitrite to platelet-rich plasma in the presence of erythrocytes could inhibit platelet aggregation and this inhibitory effect of nitrite + erythrocytes was enhanced by deoxygenation of erythrocytes as measured by P-selectin expression and cGMP production. In order to study the nitrite effect on platelets at different oxygen levels, we used the flow cytometric assays to detect platelet membrane surface markers upon activation. The P-selectin and activated gpIIb/IIIa expression on platelet membranes in response to ADP, collagen and thrombin stimulation was measured at various hematocrit and oxygen levels. Nitrite (0.1 to 1.0 mu M) significantly decreased the percentage of these surface markers on the platelet membrane at the hematocrit values above 23% and oxygen levels lower than 49 mmHg. The inhibitory effect of nitrite was augmented by increasing hematocrit values and decreasing oxygen saturation. C-PTIO (an NO scavenger) prevented the platelet inhibition by nitrite + erythrocytes whereas the inhibitors of NO synthase and xanthine oxidoreductase had no effect. These results support the proposal that circulating nitrite decreases platelet reactivity in the presence of partially deoxygenated erythrocytes through its reduction to NO, which may also explain certain differences between arterial and venous thrombosis and support directly the role of deoxyhemoglobin in this process. We believe that our flow cytometric assays offer a possibility to identify the individual molecular process involved in these effects.	[Akrawinthawong, Krittapoom; Park, Ji Won; Piknova, Barbora; Schechter, Alan N.] Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Sibmooh, Nathawut] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Akrawinthawong, Krittapoom] Mahidol Univ, Dept Biochem, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Fucharoen, Suthat] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhon Pathom, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Mahidol University; Mahidol University; Mahidol University	Schechter, AN (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	alans@intra.niddk.nih.gov		Schechter, Alan N/0000-0002-5235-9408	intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025104] Funding Source: NIH RePORTER	intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID U, 1987, THROMB RES, V47, P561, DOI 10.1016/0049-3848(87)90361-6; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Becker RC, 2012, NEW ENGL J MED, V366, P2028, DOI 10.1056/NEJMe1201911; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; BULT H, 1988, BRIT J PHARMACOL, V95, P1308, DOI 10.1111/j.1476-5381.1988.tb11769.x; Carlsson S, 2001, NITRIC OXIDE-BIOL CH, V5, P580, DOI 10.1006/niox.2001.0371; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; LAUSTIOLA KE, 1991, PHARMACOL TOXICOL, V68, P60, DOI 10.1111/j.1600-0773.1991.tb01209.x; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Machha A, 2011, EUR J NUTR, V50, P293, DOI 10.1007/s00394-011-0192-5; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Naseem KM, 2011, PLATELETS, V22, P148, DOI 10.3109/09537104.2010.522629; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Richardson G, 2002, NITRIC OXIDE-BIOL CH, V7, P24, DOI 10.1016/S1089-8603(02)00010-1; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Sibmooh N, 2008, BIOCHEMISTRY-US, V47, P2989, DOI 10.1021/bi702158d; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Velmurugan S, 2013, FREE RADIC BIOL MED, DOI [10.1016/j.freeradbiomed.2013.06.031, DOI 10.1016/J.FREERADBI0MED.2013.06.031.[]; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Zhang Zhi, 1997, Biochemical Society Transactions, V25, p524S	32	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92435	10.1371/journal.pone.0092435	http://dx.doi.org/10.1371/journal.pone.0092435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642865	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900139
J	Broca, C; Varin, E; Armanet, M; Tourrel-Cuzin, C; Bosco, D; Dalle, S; Wojtusciszyn, A				Broca, Christophe; Varin, Elodie; Armanet, Mathieu; Tourrel-Cuzin, Cecile; Bosco, Domenico; Dalle, Stephane; Wojtusciszyn, Anne			Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN PANCREATIC-ISLETS; INSULIN-SECRETION; OXIDATIVE STRESS; AMYLOID POLYPEPTIDE; ER STRESS; RAT MODEL; UBIQUITIN; PROTEIN; SYSTEM	The ubiquitin/proteasome system (UPS), a major cellular protein degradation machinery, plays key roles in the regulation of many cell functions. Glucotoxicity mediated by chronic hyperglycaemia is detrimental to the function and survival of pancreatic beta cells. The aim of our study was to determine whether proteasome dysfunction could be involved in beta cell apoptosis in glucotoxic conditions, and to evaluate whether such a dysfunction might be pharmacologically corrected. Therefore, UPS activity was measured in GK rats islets, INS-1E beta cells or human islets after high glucose and/or UPS inhibitor exposure. Immunoblotting was used to quantify polyubiquitinated proteins, endoplasmic reticulum (ER) stress through CHOP expression, and apoptosis through the cleavage of PARP and caspase-3, whereas total cell death was detected through histone-associated DNA fragments measurement. In vitro, we found that chronic exposure of INS-1E cells to high glucose concentrations significantly decreases the three proteasome activities by 20% and leads to caspase-3-dependent apoptosis. We showed that pharmacological blockade of UPS activity by 20% leads to apoptosis in a same way. Indeed, ER stress was involved in both conditions. These results were confirmed in human islets, and proteasome activities were also decreased in hyperglycemic GK rats islets. Moreover, we observed that a high glucose treatment hypersensitized beta cells to the apoptotic effect of proteasome inhibitors. Noteworthily, the decreased proteasome activity can be corrected with Exendin-4, which also protected against glucotoxicity-induced apoptosis. Taken together, our findings reveal an important role of proteasome activity in high glucose-induced beta cell apoptosis, potentially linking ER stress and glucotoxicity. These proteasome dysfunctions can be reversed by a GLP-1 analog. Thus, UPS may be a potent target to treat deleterious metabolic conditions leading to type 2 diabetes.	[Broca, Christophe; Varin, Elodie; Dalle, Stephane; Wojtusciszyn, Anne] CNRS, INSERM, UMR 5203, U661, Montpellier, France; [Broca, Christophe; Varin, Elodie; Dalle, Stephane; Wojtusciszyn, Anne] Montpellier 1&2 Univ, Inst Funct Genom, Montpellier, France; [Broca, Christophe; Varin, Elodie; Armanet, Mathieu; Dalle, Stephane; Wojtusciszyn, Anne] Univ Hosp St Eloi, Inst Res Biotherapy, Lab Diabet Cell Therapy, Montpellier, France; [Tourrel-Cuzin, Cecile] Univ Paris Diderot, CNRS, EAC4413, B2PE Lab Biol & Pathol Endocrine Pancreas,BFA Uni, Paris, France; [Bosco, Domenico] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Bosco, Domenico] Univ Geneva, Geneva, Switzerland; [Wojtusciszyn, Anne] Univ Hosp Lapeyronie, Dept Endocrinol Diabet Nutr, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Montpellier	Wojtusciszyn, A (corresponding author), CNRS, INSERM, UMR 5203, U661, Montpellier, France.	a-wojtusciszyn@chu-montpellier.fr		Wojtusciszyn, Anne/0000-0002-9410-9909; Tourrel-Cuzin, Cecile/0000-0002-5368-4018; Broca, Christophe/0000-0002-7715-8231; Bosco, Domenico/0000-0003-3453-9613	Societe Francophone du Diabete (SFD) bourse ALFEDIAM-Industrie; Agence de Biomedecine bourse AOR Recherche et Greffe; Institut National de la Sante et de la Recherche Medicale (INSERM, Paris, France); Region Languedoc-Roussillon, France	Societe Francophone du Diabete (SFD) bourse ALFEDIAM-Industrie; Agence de Biomedecine bourse AOR Recherche et Greffe; Institut National de la Sante et de la Recherche Medicale (INSERM, Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Languedoc-Roussillon, France(Region Occitanie)	This work was supported by grants obtained from the following: the Societe Francophone du Diabete (SFD) bourse ALFEDIAM-Industrie; the Agence de Biomedecine bourse AOR Recherche et Greffe; the Institut National de la Sante et de la Recherche Medicale (INSERM, Paris, France); and the Region Languedoc-Roussillon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Chang TL, 2009, METABOLISM, V58, P1643, DOI 10.1016/j.metabol.2009.05.020; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Costes S, 2009, DIABETES, V58, P1105, DOI 10.2337/db08-0926; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Kalbe L, 2005, BRIT J NUTR, V93, P309, DOI 10.1079/BJN20041313; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kitagawa H, 1999, FEBS LETT, V443, P181, DOI 10.1016/S0014-5793(98)01709-8; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miralles F, 2001, DIABETES, V50, pS84, DOI 10.2337/diabetes.50.2007.S84; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Portha B, 2005, METHOD MOL BIOL, V933, P125; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Roccaro AM, 2008, BLOOD, V111, P4752, DOI 10.1182/blood-2007-11-120972; Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890; Schmidt N, 2012, TRANSPLANTATION, V94, P352, DOI 10.1097/TP.0b013e318257acf6; Storling J, 2005, ENDOCRINOLOGY, V146, P1718, DOI 10.1210/en.2004-0963; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tourrel C, 2002, DIABETES, V51, P1443, DOI 10.2337/diabetes.51.5.1443; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL33, DOI 10.1152/ajplung.00001.2013; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wojcik C, 1999, CELL MOL LIFE SCI, V56, P908, DOI 10.1007/s000180050483; Wu LW, 1999, BLOOD CELL MOL DIS, V25, P20, DOI 10.1006/bcmd.1999.0223; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200	49	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92066	10.1371/journal.pone.0092066	http://dx.doi.org/10.1371/journal.pone.0092066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642635	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900074
J	Deramaudt, TB; Dujardin, D; Noulet, F; Martin, S; Vauchelles, R; Takeda, K; Ronde, P				Deramaudt, Therese B.; Dujardin, Denis; Noulet, Fanny; Martin, Sophie; Vauchelles, Romain; Takeda, Ken; Ronde, Philippe			Altering FAK-Paxillin Interactions Reduces Adhesion, Migration and Invasion Processes	PLOS ONE			English	Article							C-TERMINAL DOMAIN; TYROSINE PHOSPHORYLATION; CELL MOTILITY; FOCAL ADHESIONS; BINDING-SITE; CALCIUM OSCILLATIONS; P130CAS LOCALIZATION; ASTROCYTOMA-CELLS; KINASE INHIBITOR; IN-VIVO	Focal adhesion kinase (FAK) plays an important role in signal transduction pathways initiated at sites of integrin-mediated cell adhesion to the extracellular matrix. Thus, FAK is involved in many aspects of the metastatic process including adhesion, migration and invasion. Recently, several small molecule inhibitors which target FAK catalytic activity have been developed by pharmaceutical companies. The current study was aimed at addressing whether inhibiting FAK targeting to focal adhesions (FA) represents an efficient alternative strategy to inhibit FAK downstream pathways. Using a mutagenesis approach to alter the targeting domain of FAK, we constructed a FAK mutant that fails to bind paxillin. Inhibiting FAK-paxillin interactions led to a complete loss of FAK localization at FAs together with reduced phosphorylation of FAK and FAK targets such as paxillin and p130Cas. This in turn resulted in altered FA dynamics and inhibition of cell adhesion, migration and invasion. Moreover, the migration properties of cells expressing the FAK mutant were reduced as compared to FAK(-/-) cells. This was correlated with a decrease in both phospho-Src and phospho-p130Cas levels at FAs. We conclude that targeting FAK-paxillin interactions is an efficient strategy to reduce FAK signalling and thus may represent a target for the development of new FAK inhibitors.	[Deramaudt, Therese B.; Dujardin, Denis; Noulet, Fanny; Martin, Sophie; Vauchelles, Romain; Takeda, Ken; Ronde, Philippe] CNRS, UMR 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Deramaudt, Therese B.; Dujardin, Denis; Noulet, Fanny; Martin, Sophie; Vauchelles, Romain; Takeda, Ken; Ronde, Philippe] Univ Strasbourg, Fac Pharm, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ronde, P (corresponding author), CNRS, UMR 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France.	philippe.ronde@unistra.fr	Dujardin, Denis/GYA-0463-2022; martin, sophie/AAP-3498-2021	Dujardin, Denis/0000-0001-6372-5293	Ligue contre le cancer (Comites du Bas-Rhin et Haut-Rhin); ARC; CNRS; Universite de Strasbourg	Ligue contre le cancer (Comites du Bas-Rhin et Haut-Rhin); ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg	Ligue contre le cancer (Comites du Bas-Rhin et Haut-Rhin); ARC; CNRS; Universite de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Giannone G, 2002, J BIOL CHEM, V277, P26364, DOI 10.1074/jbc.M203952200; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang YT, 2005, ANTICANCER RES, V25, P2017; ILLC D, 1995, NATURE, V377, P539; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Kolli-Bouhafs K, 2012, INVEST NEW DRUG, V30, P2121, DOI 10.1007/s10637-011-9777-3; Kurenova EV, 2009, J MED CHEM, V52, P4716, DOI 10.1021/jm900159g; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mortier E, 2001, CELL SIGNAL, V13, P901, DOI 10.1016/S0898-6568(01)00226-1; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; Sieg DJ, 1999, J CELL SCI, V112, P2677; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05	51	75	83	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92059	10.1371/journal.pone.0092059	http://dx.doi.org/10.1371/journal.pone.0092059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642576	Green Published, gold			2022-12-25	WOS:000333259900073
J	Iadevaia, S; Nakhleh, LK; Azencott, R; Ram, PT				Iadevaia, Sergio; Nakhleh, Luay K.; Azencott, Robert; Ram, Prahlad T.			Mapping Network Motif Tunability and Robustness in the Design of Synthetic Signaling Circuits	PLOS ONE			English	Article							FEEDBACK LOOPS; BIOLOGY; SYSTEMS	Cellular networks are highly dynamic in their function, yet evolutionarily conserved in their core network motifs or topologies. Understanding functional tunability and robustness of network motifs to small perturbations in function and structure is vital to our ability to synthesize controllable circuits. In establishing core sets of network motifs, we selected topologies that are overrepresented in mammalian networks, including the linear, feedback, feed-forward, and bifan circuits. Static and dynamic tunability of network motifs were defined as the motif ability to respectively attain steady-state or transient outputs in response to pre-defined input stimuli. Detailed computational analysis suggested that static tunability is insensitive to the circuit topology, since all of the motifs displayed similar ability to attain predefined steady-state outputs in response to constant inputs. Dynamic tunability, in contrast, was tightly dependent on circuit topology, with some motifs performing superiorly in achieving observed time-course outputs. Finally, we mapped dynamic tunability onto motif topologies to determine robustness of motif structures to changes in topology and identify design principles for the rational assembly of robust synthetic networks.	[Iadevaia, Sergio; Ram, Prahlad T.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Nakhleh, Luay K.] Rice Univ, Dept Comp Sci, Houston, TX USA; [Azencott, Robert] Univ Houston, Dept Math, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Houston System; University of Houston	Iadevaia, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	siadevai@mdanderson.org; pram@mdanderson.org		Ram, Prahlad/0000-0003-4739-3166	NIH [R01CA125109, U54 CA112970]; NATIONAL CANCER INSTITUTE [U54CA112970, R01CA125109] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIH R01CA125109 and U54 CA112970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A., 2006, SWARM INTELLIGENT SY; Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arpino JAJ, 2013, MICROBIOL-SGM, V159, P1236, DOI 10.1099/mic.0.067975-0; Barnes CP, 2011, INTERFACE FOCUS, V1, P895, DOI 10.1098/rsfs.2011.0056; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Kim D, 2008, BIOESSAYS, V30, P1204, DOI 10.1002/bies.20839; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MacDonald JT, 2011, INTEGR BIOL-UK, V3, P97, DOI 10.1039/c0ib00077a; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Nicklas D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083531; Oyarzun DA, 2012, J R SOC INTERFACE; Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006	26	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91743	10.1371/journal.pone.0091743	http://dx.doi.org/10.1371/journal.pone.0091743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642504	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900033
J	Kalajzic, AC; Vidacek, NS; Huzak, M; Ivankovic, M; Rubelj, I				Kalajzic, Andrea Cukusic; Vidacek, Nikolina Skrobot; Huzak, Miljenko; Ivankovic, Milena; Rubelj, Ivica			Telomere Q-PNA-FISH - Reliable Results from Stochastic Signals	PLOS ONE			English	Article							NORMAL HUMAN FIBROBLASTS; HUMAN-CELLS; LENGTH; SENESCENCE; LIFE; ACCUMULATION; HUMANS; CHROMOSOMES; STRESS	Structural and functional analysis of telomeres is very important for understanding basic biological functions such as genome stability, cell growth control, senescence and aging. Recently, serious concerns have been raised regarding the reliability of current telomere measurement methods such as Southern blot and quantitative polymerase chain reaction. Since telomere length is associated with age related pathologies, including cardiovascular disease and cancer, both at the individual and population level, accurate interpretation of measured results is a necessity. The telomere Q-PNA-FISH technique has been widely used in these studies as well as in commercial analysis for the general population. A hallmark of telomere Q-PNA-FISH is the wide variation among telomere signals which has a major impact on obtained results. In the present study we introduce a specific mathematical and statistical analysis of sister telomere signals during cell culture senescence which enabled us to identify high regularity in their variations. This phenomenon explains the reproducibility of results observed in numerous telomere studies when the Q-PNA-FISH technique is used. In addition, we discuss the molecular mechanisms which probably underlie the observed telomere behavior.	[Kalajzic, Andrea Cukusic; Vidacek, Nikolina Skrobot; Ivankovic, Milena; Rubelj, Ivica] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Huzak, Miljenko] Univ Zagreb, Dept Math, Zagreb 41000, Croatia	Rudjer Boskovic Institute; University of Zagreb	Rubelj, I (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	rubelj@irb.hr	Cukusic Kalajzic, Andrea/D-6223-2017	Cukusic Kalajzic, Andrea/0000-0002-3085-3181	Croatian Ministry of Sciences, Education and Sports [098-0982913-2768, 037-0372790-2800]	Croatian Ministry of Sciences, Education and Sports	Croatian Ministry of Sciences, Education and Sports [098-0982913-2768 to I. R., 037-0372790-2800 to M. H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bekaert S, 2002, CYTOMETRY, V48, P34, DOI 10.1002/cyto.10105; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gilson E, 2007, CELL CYCLE, V6, P2486, DOI 10.4161/cc.6.20.4798; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Graakjaer J, 2006, ANN NY ACAD SCI, V1067, P311, DOI 10.1196/annals.1354.042; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Harley CB, 2011, REJUV RES, V14, P45, DOI 10.1089/rej.2010.1085; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Krejci K, 1998, CHROMOSOMA, V107, P198, DOI 10.1007/s004120050297; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Londono-Vallejo JA, 2001, NUCLEIC ACIDS RES, V29, P3164, DOI 10.1093/nar/29.15.3164; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Rubelj I, 2000, MECH AGEING DEV, V112, P233, DOI 10.1016/S0047-6374(99)00090-1; Steenstrup T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt370; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462; Vidacek NS, 2010, EXP GERONTOL, V45, P235, DOI 10.1016/j.exger.2010.01.009; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200	33	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92559	10.1371/journal.pone.0092559	http://dx.doi.org/10.1371/journal.pone.0092559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643066	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900146
J	Kotkamp, K; Kur, E; Wendik, B; Polok, BK; Ben-Dor, S; Onichtchouk, D; Driever, W				Kotkamp, Kay; Kur, Esther; Wendik, Bjoern; Polok, Bozena K.; Ben-Dor, Shifra; Onichtchouk, Daria; Driever, Wolfgang			Pou5f1/Oct4 Promotes Cell Survival via Direct Activation of mych Expression during Zebrafish Gastrulation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; C-MYC; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL EXPRESSION; ONCOGENE EXPRESSION; OCT4 PROMOTES; DNA-BINDING; APOPTOSIS; MOUSE; GENES	Myc proteins control cell proliferation, cell cycle progression, and apoptosis, and play important roles in cancer as well in establishment of pluripotency. Here we investigated the control of myc gene expression by the Pou5f1/Oct4 pluripotency factor in the early zebrafish embryo. We analyzed the expression of all known zebrafish Myc family members, myca, mycb, mych, mycl1a, mycl1b, and mycn, by whole mount in situ hybridization during blastula and gastrula stages in wildtype and maternal plus zygotic pou5f1 mutant (MZspg) embryos, as well as by quantitative PCR and in time series microarray data. We found that the broad blastula and gastrula stage mych expression, as well as late gastrula stage mycl1b expression, both depend on Pou5f1 activity. We analyzed ChIP-Seq data and found that both Pou5f1 and Sox2 bind to mych and mycl1b control regions. The regulation of mych by Pou5f1 appears to be direct transcriptional activation, as overexpression of a Pou5f1 activator fusion protein in MZspg embryos induced strong mych expression even when translation of zygotically expressed mRNAs was suppressed. We further showed that MZspg embryos develop enhanced apoptosis already during early gastrula stages, when apoptosis was not be detected in wildtype embryos. However, Mych knockdown alone did not induce early apoptosis, suggesting potentially redundant action of several early expressed myc genes, or combination of several pathways affected in MZspg. Experimental mych overexpression in MZspg embryos did significantly, but not completely suppress the apoptosis phenotype. Similarly, p53 knockdown only partially suppressed apoptosis in MZspg gastrula embryos. However, combined knockdown of p53 and overexpression of Mych completely rescued the MZspg apoptosis phenotype. These results reveal that Mych has anti-apoptotic activity in the early zebrafish embryo, and that p53-dependent and Myc pathways are likely to act in parallel to control apoptosis at these stages.	[Kotkamp, Kay; Kur, Esther; Wendik, Bjoern; Polok, Bozena K.; Onichtchouk, Daria; Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Fac Biol, Freiburg, Germany; [Ben-Dor, Shifra] Weizmann Inst Sci, Biol Serv, IL-76100 Rehovot, Israel; [Onichtchouk, Daria; Driever, Wolfgang] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; Weizmann Institute of Science	Driever, W (corresponding author), Univ Freiburg, Inst Biol 1, Fac Biol, Albertstr 21A, Freiburg, Germany.	driever@biologie.uni-freiburg.de	Onichtchouk, Daria/E-1741-2012; BEN-DOR, SHIFRA/M-6718-2019	Onichtchouk, Daria/0000-0001-6497-1445; BEN-DOR, SHIFRA/0000-0001-9604-1939; Driever, Wolfgang/0000-0002-9551-9141	BMBF FORSYS center FRISYS; Excellence Initiative of the German Federal Government (BIOSS Centre for Biological Signalling Studies) [EXC 294]; Excellence Initiative of the German State Government (BIOSS Centre for Biological Signalling Studies) [EXC 294]; German Research Foundation [DFG-SFB592-A3, SFB850-A1]	BMBF FORSYS center FRISYS(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal Government (BIOSS Centre for Biological Signalling Studies); Excellence Initiative of the German State Government (BIOSS Centre for Biological Signalling Studies); German Research Foundation(German Research Foundation (DFG))	This work was supported by BMBF FORSYS center FRISYS, the Excellence Initiative of the German Federal and State Governments (BIOSS Centre for Biological Signalling Studies EXC 294), and German Research Foundation (DFG-SFB592-A3 & SFB850-A1, WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Belting HG, 2001, DEVELOPMENT, V128, P4165; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Domashenko AD, 1997, MOL REPROD DEV, V47, P57, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;57::AID-MRD8&gt;3.0.CO;2-P; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hauptmann G, 2000, METH MOL B, V137, P139; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002029; HOURDRY J, 1988, DEVELOPMENT, V104, P631; Inohara N, 2000, CELL DEATH DIFFER, V7, P509, DOI 10.1038/sj.cdd.4400679; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kotkamp K, 2013, POU5F1 OCT4 DEPENDEN, DOI DOI 10.1016/J.YDBI0.2013.10.025I; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Krumschnabel G, 2009, APOPTOSIS, V14, P1, DOI 10.1007/s10495-008-0281-y; Lachnit M, 2008, DEV BIOL, V315, P1, DOI 10.1016/j.ydbio.2007.10.008; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; SCHREIBERAGUS N, 1993, MOL CELL BIOL, V13, P2765, DOI 10.1128/MCB.13.5.2765; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Song SM, 2013, DEV CELL, V24, P486, DOI 10.1016/j.devcel.2013.01.016; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Swartling FJ, 2012, UPSALA J MED SCI, V117, P122, DOI 10.3109/03009734.2012.658975; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thisse B, 2004, ZFIN DIRECT DATA SUB; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; VIZE PD, 1990, DEVELOPMENT, V110, P885; Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	74	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92356	10.1371/journal.pone.0092356	http://dx.doi.org/10.1371/journal.pone.0092356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643012	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900124
J	Kwak, Y; Lee, HE; Kim, WH; Kim, DW; Kang, SB; Lee, HS				Kwak, Yoonjin; Lee, Hee Eun; Kim, Woo Ho; Kim, Duck-Woo; Kang, Sung-Bum; Lee, Hye Seung			The Clinical Implication of Cancer-Associated Microvasculature and Fibroblast in Advanced Colorectal Cancer Patients with Synchronous or Metachronous Metastases	PLOS ONE			English	Article							LYMPHATIC VESSEL DENSITY; MICROVESSEL DENSITY; TUMOR-GROWTH; CARCINOMA; HETEROGENEITY; EXPRESSION; PTEN; KRAS; ANGIOGENESIS; METAANALYSIS	Background: We aimed to evaluate the clinical significance of microvessel density (MVD), lymphatic vessel density (LVD), and cancer-associated fibroblasts (CAFs) in relation to tumor location in advanced colorectal cancer (CRC). Methods: Using immunohistochemistry, we examined 181 advanced CRC patients for CD31 and D2-40 to measure MVD and LVD, respectively, a-smooth muscle actin (SMA) and desmin to identify CAFs, and PTEN to examine genetic changes of CAFs. To evaluate the regional heterogeneity of these properties, we examined tissue from four sites (the center and periphery of the primary cancer, a distant metastasis, and a lymph node metastasis) in each patient. Results: MVD, LVD, and CAFs showed significant heterogeneity with respect to the tumor location. LVD was the greatest in the center of the primary cancers and the amount of CAFs was the lowest in distant metastases. In distant metastases, those from the lung had higher LVD and MVD, but fewer CAFs than those from the liver, peritoneum, or ovary. Patients with low MVD and LVD in the center of the primary cancer had worse outcomes and patients with few CAFs in distant metastases and in the primary tumor had a lower survival rate. PTEN expression in CAFs in distant metastases was lost in 11 of 181 CRC patients (6.1%), which was associated with a worse prognosis. Conclusions: The microenvironment, including cancer-associated microvasculature and fibroblasts, is heterogeneous with respect to the tumor location in CRC patients. Therefore, heterogeneity of microenvironments should be taken into account when managing CRC patients.	[Kwak, Yoonjin; Lee, Hee Eun; Kim, Woo Ho] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Kwak, Yoonjin; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, Gyeonggi Do, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi Do, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	Seoul National University Bundang Hospital Research Fund [03-2011-012]	Seoul National University Bundang Hospital Research Fund	This study was supported by grant number 03-2011-012 from the Seoul National University Bundang Hospital Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Barresi V, 2010, VIRCHOWS ARCH, V457, P11, DOI 10.1007/s00428-010-0933-5; BARSKY SH, 1987, CANCER RES, V47, P1663; Bosman FT, 2010, WHO CLASSIFICATION T, V4th; Campbell I, 2011, J PATHOL, V223, P450, DOI 10.1002/path.2842; Chen Y, 2013, LYMPHOLOGY, V46, P42; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; Duff SE, 2007, COLORECTAL DIS, V9, P793, DOI 10.1111/j.1463-1318.2006.01199.x; Edge S B, 2010, AJCC CANC STAGING MA; Gombos Z, 2005, CLIN CANCER RES, V11, P8364, DOI 10.1158/1078-0432.CCR-05-1238; Jain RK, 2002, J NATL CANCER I, V94, P417; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-347; Kitadai Y, 2005, INT J CANCER, V115, P388, DOI 10.1002/ijc.20859; Knijn N, 2010, DISCOV MED, V9, P328; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lee Hye Seung, 2006, Cancer Res Treat, V38, P1, DOI 10.4143/crt.2006.38.1.1; Lindmark G, 1996, J CLIN ONCOL, V14, P461, DOI 10.1200/JCO.1996.14.2.461; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Matsumoto N, 2003, BRIT J CANCER, V89, P707, DOI 10.1038/sj.bjc.6601141; Mekenkamp LJM, 2010, BRIT J CANCER, V103, P159, DOI 10.1038/sj.bjc.6605737; Moreira LR, 2011, TUMOR BIOL, V32, P527, DOI 10.1007/s13277-010-0147-0; Muller-Hubenthal B, 2009, ANTICANCER RES, V29, P4795; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PAGET S, 1989, CANCER METAST REV, V8, P98; Park JH, 2011, CANCER CHEMOTH PHARM, V68, P1045, DOI 10.1007/s00280-011-1586-z; Prall F, 2003, HISTOPATHOLOGY, V42, P482, DOI 10.1046/j.1365-2559.2003.01610.x; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Ryu HS, 2012, HUM PATHOL, V43, P520, DOI 10.1016/j.humpath.2011.07.003; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Van Cutsem E, 2007, CLIN COLORECTAL CANC, V6, pS60, DOI 10.3816/CCC.2007.s.004; VERMEULEN PB, 1995, BRIT J CANCER, V71, P340, DOI 10.1038/bjc.1995.68; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91811	10.1371/journal.pone.0091811	http://dx.doi.org/10.1371/journal.pone.0091811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642707	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900038
J	Opena, JL; Chauhan, BS; Baltazar, AM				Opena, Jhoana L.; Chauhan, Bhagirath S.; Baltazar, Aurora M.			Seed Germination Ecology of Echinochloa glabrescens and Its Implication for Management in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; WEED MANAGEMENT; LOWLAND RICE; GROWTH; WATER; PHILIPPINES; EMERGENCE; LIGHT	Echinochloa glabrescens is a C-4 grass weed that is very competitive with rice when left uncontrolled. The competitive ability of weeds is intensified in direct-seeded rice production systems. A better understanding is needed of factors affecting weed seed germination, which can be used as a component of integrated weed management in direct-seeded rice. This study was conducted to determine the effects of temperature, light, salt and osmotic stress, burial depth, crop residue, time and depth of flooding, and herbicide application on the emergence, survival, and growth of two populations [Nueva Ecija (NE) and Los Banos (IR)] of E. glabrescens. Seeds from both populations germinated at all temperatures. The NE population had a higher germination rate (88%) from light stimulation than did the IR population (34%). The salt concentration and osmotic potential required to inhibit 50% of germination were 313 mM and -0.24 MPa, respectively, for the NE population and 254 mM and -0.33 MPa, respectively, for the IR population. Emergence in the NE population was totally inhibited at 4-cm burial depth in the soil, whereas that of the IR population was inhibited at 8 cm. Compared with zero residue, the addition of 5 t ha(-1) of rice residue reduced emergence in the NE and IR populations by 38% and 9%, respectively. Early flooding (within 2 days after sowing) at 2-cm depth reduced shoot growth by 50% compared with non-flooded conditions. Pretilachlor applied at 0.075 kg ai ha(-1) followed by shallow flooding (2-cm depth) reduced seedling emergence by 94-96% compared with the nontreated flooded treatment. Application of postemergence herbicides at 4-leaf stage provided 85-100% control in both populations. Results suggest that integration of different strategies may enable sustainable management of this weed and of weeds with similar germination responses.	[Opena, Jhoana L.; Chauhan, Bhagirath S.] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Baltazar, Aurora M.] Univ Philippines, Los Banos, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Chauhan, BS (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines.	b.chauhan@irri.org	Chauhan, Bhagirath/G-8892-2014; Opena, Jhoana/AFD-9723-2022; Opena, Jhoana/AAE-9487-2022	Chauhan, Bhagirath/0000-0003-1540-4668; Opena, Jhoana/0000-0002-6043-3663; Opena, Jhoana/0000-0002-6043-3663				Abilay WP, 1984, IRRI RES PAPER SERIE, V100; [Anonymous], 1991, WORLDS WORST WEEDS D; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BENVENUTI S, 1995, WEED RES, V35, P343, DOI 10.1111/j.1365-3180.1995.tb01629.x; Bolfrey-Arku GEK, 2011, WEED SCI, V59, P182, DOI 10.1614/WS-D-10-00095.1; Boyd N, 2004, WEED SCI, V52, P589, DOI 10.1614/WS-03-15R2; Bureau of Agricultural Statistics, 2011, MONTHL AGR SIT REP 2; Chauhan B. S., 2012, The Scientific World Journal, V2012, P123071; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Chauhan BS, 2010, WEED RES, V50, P553, DOI 10.1111/j.1365-3180.2010.00807.x; Chauhan BS, 2009, CROP PROT, V28, P887, DOI 10.1016/j.cropro.2009.05.005; Chauhan BS, 2008, WEED SCI, V56, P699, DOI 10.1614/WS-08-048.1; Chauhan BS, 2008, WEED SCI, V56, P383, DOI 10.1614/WS-07-154.1; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Chauhan BS, 2012, WEED SCI, V60, P199, DOI 10.1614/WS-D-11-00137.1; Chauhan BS, 2009, SOIL TILL RES, V106, P15, DOI 10.1016/j.still.2009.10.004; Chauhan BS, 2014, ADV AGRON, V123, P65; CRUTCHFIELD DA, 1986, WEED SCI, V34, P110, DOI 10.1017/S0043174500026564; DIOP AM, 1984, PHIL J WEED SCI, V11, P65; Dorji S., 2013, CAN J PLANT PROT, V1, P43; EGLEY G H, 1986, Reviews of Weed Science, V2, P67; Erguiza A., 1990, IRRI RES PAPER SERIE; Eslami SV, 2011, WEED SCI, V59, P90, DOI 10.1614/WS-D-10-00059.1; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Gadde B, 2009, ENVIRON POLLUT, V157, P1554, DOI 10.1016/j.envpol.2009.01.004; Kent RJ, 2001, CROP PROT, V20, P691, DOI 10.1016/S0261-2194(01)00034-5; Lee J, 2011, WEED SCI, V59, P495, DOI 10.1614/WS-D-11-00002.1; Mandac AM, 1982, IRRI RES PAPER SERIE, V80; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Pablico PP, 1993, PHILIPPINE J WEED SC, V20, P56; PONS TL, 1982, WEED RES, V22, P155, DOI 10.1111/j.1365-3180.1982.tb00159.x; Rao A. N, 1987, INT RICE RES NEWSL, V12, P51; RAO AN, 1992, TROP PEST MANAGE, V38, P25; Schutz W, 2002, ANN BOT-LONDON, V90, P707, DOI 10.1093/aob/mcf250; Singh S, 2004, WEED TECHNOL, V18, P1031, DOI 10.1614/WT-03-209R2; SMITH RJ, 1973, WEED SCI, V21, P61, DOI 10.1017/S0043174500031702; Sushil Pandey, 2005, Rice is life: scientific perspectives for the 21st century. Proceedings of the World Rice Research Conference held in Tsukuba, Japan, 4-7 November 2004, P178; Tuong TP, 2005, PLANT PROD SCI, V8, P231, DOI 10.1626/pps.8.231	41	26	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92261	10.1371/journal.pone.0092261	http://dx.doi.org/10.1371/journal.pone.0092261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642568	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900112
J	Paredes, JL; Orabi, AI; Ahmad, T; Benbourenane, I; Tobita, K; Tadros, S; Bae, KT; Husain, SZ				Paredes, Jose L.; Orabi, Abrahim I.; Ahmad, Taimur; Benbourenane, Iman; Tobita, Kimimasa; Tadros, Sameh; Bae, Kyongtae T.; Husain, Sohail Z.			A Non-Invasive Method of Quantifying Pancreatic Volume in Mice Using Micro-MRI	PLOS ONE			English	Article							ORTHOTOPIC MODEL; ENDOCRINE; CELLS; REGENERATION; EXOCRINE	In experimental models of pancreatic growth and recovery, changes in pancreatic size are assessed by euthanizing a large cohort of animals at varying time points and measuring organ mass. However, to ascertain this information in clinical practice, patients with pancreatic disorders routinely undergo non-invasive cross-sectional imaging of the pancreas using magnetic resonance imaging (MRI) or computed tomography (CT). The aim of the current study was to develop a thin-sliced, optimized sequence protocol using a high field MRI to accurately calculate pancreatic volumes in the most common experimental animal, the mouse. Using a 7 Telsa Bruker micro-MRI system, we performed abdominal imaging in whole-fixed mice in three standard planes: axial, sagittal, and coronal. The contour of the pancreas was traced using Vitrea software and then transformed into a 3-dimensional (3D) reconstruction, from which volumetric measurements were calculated. Images were optimized using heart perfusion-fixation, T1 sequence analysis, and 0.2 to 0.4 mm thick slices. As proof of principle, increases in pancreatic volume among mice of different ages correlated tightly with increasing body weight. In summary, this is the first study to measure pancreatic volumes in mice, using a high field 7 Tesla micro-MRI and a thin-sliced, optimized sequence protocol. We anticipate that micro-MRI will improve the ability to non-invasively quantify changes in pancreatic size and will dramatically reduce the number of animals required to serially assess pancreatic growth and recovery.	[Paredes, Jose L.; Orabi, Abrahim I.; Ahmad, Taimur; Benbourenane, Iman; Husain, Sohail Z.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15219 USA; [Paredes, Jose L.; Orabi, Abrahim I.; Ahmad, Taimur; Benbourenane, Iman; Tobita, Kimimasa; Tadros, Sameh; Bae, Kyongtae T.; Husain, Sohail Z.] Univ Pittsburgh, Pittsburgh, PA USA; [Tobita, Kimimasa] UPMC, Childrens Hosp Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Tadros, Sameh; Bae, Kyongtae T.] UPMC, Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15219 USA.	sohail.husain@chp.edu		Tobita, Kimimasa/0000-0001-5435-8436; Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [R01 DK083327, DK093491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, T32DK007017, R01DK093491, R01DK103002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health Grant R01 DK083327, and DK093491 (to SZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili AK, 2010, INT J CARDIOVAS IMAG, V26, P27, DOI 10.1007/s10554-009-9571-x; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Flurkey K., 2007, MOUSE BIOMEDICAL RES; Foster JR, 2013, TOXICOL PATHOL; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Geraghty EM, 2004, ABDOM IMAGING, V29, P482, DOI 10.1007/s00261-003-0139-2; Grimm J, 2003, INT J CANCER, V106, P806, DOI 10.1002/ijc.11281; Grippo PJ, 2011, AM J PATHOL, V179, P610, DOI 10.1016/j.ajpath.2011.04.007; Gurda GT, 2010, GASTROENTEROLOGY, V139, P609, DOI 10.1053/j.gastro.2010.04.050; He ZQ, 2000, PANCREAS, V21, P69, DOI 10.1097/00006676-200007000-00054; HEUCK A, 1987, GASTROINTEST RADIOL, V12, P18, DOI 10.1007/BF01885094; Kaufman MH, 1995, ATLAS MOUSE DEV; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Low MJ, 2012, GASTROENTEROLOGY, V143, P1410, DOI 10.1053/j.gastro.2012.10.011; Moore A, 2004, DIABETES, V53, P1459, DOI 10.2337/diabetes.53.6.1459; Nakamura Y, 2005, PANCREATOLOGY, V5, P422, DOI 10.1159/000086543; Orabi AI, 2013, JOVE-J VIS EXP, DOI 10.3791/50391; Prodhomme O, 2012, ARCH DIS CHILD-FETAL, V97, pF434, DOI 10.1136/fetalneonatal-2011-301309; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Saluja AK, 2013, GASTROENTEROLOGY, V144, P1194, DOI 10.1053/j.gastro.2013.01.070; Sequeiros IM, 2010, BRIT J RADIOL, V83, P921, DOI 10.1259/bjr/24009651; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Suetens P., 2009, FUNDAMENTALS MED IMA, V2nd, DOI DOI 10.1017/CBO9780511596803; Szczepaniak EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055991; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Williams AJK, 2007, DIABETIC MED, V24, P35, DOI 10.1111/j.1464-5491.2007.02027.x; Williams JA, 2010, CURR OPIN GASTROEN, V26, P478, DOI 10.1097/MOG.0b013e32833d11c6	29	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92263	10.1371/journal.pone.0092263	http://dx.doi.org/10.1371/journal.pone.0092263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642611	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333259900113
J	Stefan, N; Sun, Q; Fritsche, A; Machann, J; Schick, F; Gerst, F; Jeppesen, C; Joost, HG; Hu, FB; Boeing, H; Ullrich, S; Haring, HU; Schulze, MB				Stefan, Norbert; Sun, Qi; Fritsche, Andreas; Machann, Juergen; Schick, Fritz; Gerst, Felicia; Jeppesen, Charlotte; Joost, Hans-Georg; Hu, Frank B.; Boeing, Heiner; Ullrich, Susanne; Haering, Hans-Ulrich; Schulze, Matthias B.			Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; METABOLICALLY BENIGN; RISK; EXPRESSION; PATHOPHYSIOLOGY; POLYMORPHISMS; ASSOCIATION; MECHANISMS	Background: Among adipokines and hepatokines, adiponectin and fetuin-A were consistently found to predict the incidence of type 2 diabetes, both by regulating insulin sensitivity. Objective: To determine to what extent circulating adiponectin and fetuin-A are independently associated with incident type 2 diabetes in humans, and the major mechanisms involved. Methods: Relationships with incident diabetes were tested in two cohort studies: within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study (628 cases) and the Nurses' Health Study (NHS; 470 cases). Relationships with body fat compartments, insulin sensitivity and insulin secretion were studied in the Tubingen Lifestyle Intervention Program (TULIP; N = 358). Results: Circulating adiponectin and fetuin-A, independently of several confounders and of each other, associated with risk of diabetes in EPIC-Potsdam (RR for 1 SD: adiponectin: 0.45 [95% CI 0.37-0.54], fetuin-A: 1.18 [1.05-1.32]) and the NHS (0.51 [0.42-0.62], 1.35 [1.16-1.58]). Obesity measures considerably attenuated the association of adiponectin, but not of fetuin-A. Subjects with low adiponectin and concomitantly high fetuin-A had the highest risk. Whereas both proteins were independently (both p < 1.8x10(-7)) associated with insulin sensitivity, circulating fetuin-A (r = -0.37, p = 0.0004), but not adiponectin, associated with insulin secretion in subjects with impaired glucose tolerance. Conclusions: We provide novel information that adiponectin and fetuin-A independently of each other associate with the diabetes risk. Furthermore, we suggest that they are involved in the development of type 2 diabetes via different mechanisms, possibly by mediating effects of their source tissues, expanded adipose tissue and nonalcoholic fatty liver.	[Stefan, Norbert; Fritsche, Andreas; Gerst, Felicia; Ullrich, Susanne; Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med 4, Tubingen, Germany; [Stefan, Norbert; Fritsche, Andreas; Gerst, Felicia; Ullrich, Susanne; Haering, Hans-Ulrich] Inst Diabet Res & Metab Dis, Tubingen, Germany; [Stefan, Norbert; Fritsche, Andreas; Machann, Juergen; Gerst, Felicia; Jeppesen, Charlotte; Joost, Hans-Georg; Ullrich, Susanne; Haering, Hans-Ulrich; Schulze, Matthias B.] DZD, Munich, Germany; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sun, Qi; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA; [Machann, Juergen; Schick, Fritz] Univ Tubingen Hosp, Sect Expt Radiol, Tubingen, Germany; [Jeppesen, Charlotte; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Joost, Hans-Georg] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Harvard University; Harvard T.H. Chan School of Public Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Stefan, N (corresponding author), Univ Tubingen Hosp, Dept Internal Med 4, Tubingen, Germany.	norbert.stefan@med.uni-tuebingen.de	Schulze, Matthias B/AAH-6906-2021; Joost, Hans-Georg/J-4462-2013	Schulze, Matthias B/0000-0002-0830-5277; Joost, Hans-Georg/0000-0002-5860-606X; Schick, Fritz/0000-0002-4231-3406; Stefan, Norbert/0000-0002-2186-9595	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05F02]; National Institutes of Health [CA87969, CA4449, DK58845, DK58785, P30 DK46200]; National Heart, Lung, and Blood Institute [K99HL098459]; Pilot and Feasibility program; Boston Obesity Nutrition Research Center [DK46200]; German Research Foundation (DFG) [KFO 114, STE 1096/3-1]; German Federal Ministry of Education and Research; Diabetes Stiftung [270-07-10]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058785, P30DK046200, R56DK058785, R01DK058845] Funding Source: NIH RePORTER	Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pilot and Feasibility program; Boston Obesity Nutrition Research Center; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Diabetes Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam Study was supported by the German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02). The NHS was supported by research grants (CA87969, CA4449, DK58845, DK58785, and P30 DK46200) from the National Institutes of Health. Q.S. was supported by a career development award K99HL098459 from the National Heart, Lung, and Blood Institute and a Pilot and Feasibility program sponsored by the Boston Obesity Nutrition Research Center (DK46200). The TULIP was supported by grants from the German Research Foundation (DFG; KFO 114, and a Heisenberg-Professorship to NS: STE 1096/3-1). The study was also supported by the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD eV) and a grant from the Diabetes Stiftung (270-07-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fisher E, 2009, CIRC-CARDIOVASC GENE, V2, P607, DOI 10.1161/CIRCGENETICS.109.870410; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haukeland JW, 2012, EUR J ENDOCRINOL, V166, P503, DOI 10.1530/EJE-11-0864; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Ix JH, 2012, CIRCULATION, V125, P2316, DOI 10.1161/CIRCULATIONAHA.111.072751; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Ou HY, 2012, ENDOCRINOLOGY, V153, P2974, DOI 10.1210/en.2011-2043; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Perseghin G, 2011, DIABETES CARE, V34, pS367, DOI 10.2337/dc11-s249; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rees DA, 2012, DIABETIC MED, V22, P359; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2013, NAT MED, V19, P394, DOI 10.1038/nm.3116; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Sun Q, 2013, DIABETES, V62, P49, DOI 10.2337/db12-0372; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418	38	57	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92238	10.1371/journal.pone.0092238	http://dx.doi.org/10.1371/journal.pone.0092238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643166	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900109
J	Zhao, X; Wang, JX; Feng, YF; Wu, ZX; Zhang, Y; Shi, L; Tan, QC; Yan, YB; Lei, W				Zhao, Xiong; Wang, Jia-xing; Feng, Ya-fei; Wu, Zi-xiang; Zhang, Yang; Shi, Lei; Tan, Quan-chang; Yan, Ya-bo; Lei, Wei			Systemic Treatment with Telmisartan Improves Femur Fracture Healing in Mice	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME; BONE; RISK; CALCIFICATION; OSTEOPOROSIS; RECEPTOR; CELLS; HYPERTENSION; INHIBITORS	Recent clinical studies indicated that angiotensin receptor blockers (ARBs) would decrease the risk of bone fractures in the elderly populations. There is little known about the role of the ARBs in the process of fracture healing. The purpose of the present study was to verify the hypothesis that systemic treatment with telmisartan has the ability to promote fracture healing. In this study, femur fractures were produced in 96 mature male BALB/c mice. Animals were treated with the ARBs telmisartan or vehicle. Fracture healing was analysed after 2, 5 and 10 weeks postoperatively using X-ray, biomechanical testing, histomorphometry, immunohistochemistry and micro-computed tomography (micro-CT). Radiological analysis showed the diameter of the callus in the telmisartan treated animals was significantly increased when compared with that of vehicle treated controls after two weeks of fracture healing. The radiologically observed promotion of callus formation was confirmed by histomorphometric analyses, which revealed a significantly increased amount of bone formation when compared with vehicle-treated controls. Biomechanical testing further showed a significantly greater peak torque at failure, and a higher torsional stiffness in telmisartan-treated animals compared with controls. There was an increased fraction of PCNA-positive cells and VEGF-positive cells in telmisartan-treated group compared with vehicle-treated controls. From the three-dimensional reconstruction of the bony callus, telmisartan-treated group significantly increased the values of BV/TV by 21.7% and CsAr by 26.0% compared to the vehicle-treated controls at 5 weeks post-fracture. In summary, we demonstrate in the current study that telmisartan could promote fracture healing in a mice model via increasing mechanical strength and improving microstructure. The most mechanism is probably by an increase of cell proliferation and neovascularization associated with a decreased VEGF expression in hypertrophic chondrocytes.	[Zhao, Xiong; Feng, Ya-fei; Wu, Zi-xiang; Zhang, Yang; Shi, Lei; Tan, Quan-chang; Yan, Ya-bo; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopead, Xian 710032, Peoples R China; [Wang, Jia-xing] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Wang, Jia-xing] PLA, Hosp 309, ICU, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Yan, YB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopead, Xian 710032, Peoples R China.	yaboyan@fmmu.edu.cn; wlspine@163.com		Lei, Wei/0000-0002-7346-6915	National Natural Science Foundation of China [81300710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 81300710). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI 10.1359/JBMR.081006; Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Danilevicius CF, 2007, BRAZ J MED BIOL RES, V40, P435, DOI 10.1590/S0100-879X2007000400001; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Fu LJ, 2009, BONE, V44, P893, DOI 10.1016/j.bone.2009.01.378; Garcia P, 2008, J BIOMECH, V41, P1689, DOI 10.1016/j.jbiomech.2008.03.010; Garcia P, 2010, BRIT J PHARMACOL, V159, P1672, DOI 10.1111/j.1476-5381.2010.00651.x; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Hagiwara H, 1998, J ENDOCRINOL, V156, P543, DOI 10.1677/joe.0.1560543; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Hayashi Y, 1998, PSYCHIAT CLIN NEUROS, V52, P621; Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914; Holstein JH, 2007, J BIOMECH, V40, P215, DOI 10.1016/j.jbiomech.2005.10.034; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Muller R, 1997, ST HEAL T, V40, P61; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Sakai K, 2007, J CLIN INVEST, V117, P1088, DOI 10.1172/JCI31242; Sanada M, 2004, ATHEROSCLEROSIS, V176, P387, DOI 10.1016/j.atherosclerosis.2004.05.021; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Schurman SJ, 2004, PEDIATR NEPHROL, V19, P33, DOI 10.1007/s00467-003-1361-4; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Solomon DH, 2011, J BONE MINER RES, V26, P1561, DOI 10.1002/jbmr.356; Song HJ, 2012, BONE, V51, P1008, DOI 10.1016/j.bone.2012.08.126; Stojanovic OL, 2011, ARCH MED SCI, V7, P179, DOI 10.5114/aoms.2011.22066; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006	35	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92085	10.1371/journal.pone.0092085	http://dx.doi.org/10.1371/journal.pone.0092085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642982	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900081
J	Ebner, OA; Selbach, M				Ebner, Olivia A.; Selbach, Matthias			Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; TRANSLATIONAL REPRESSION; GROWTH-INHIBITION; DOWN-REGULATION; P53 TARGET; MICRORNA; EXPRESSION; FAMILY; APOPTOSIS	microRNAs (miRNAs) repress target genes by destabilizing mRNAs and/or by inhibiting translation. The best known factor for target recognition is the so called seed - a short continuous region of Watson-Crick base pairing between nucleotides 2-7 of the miRNA and complementary sequences in 3' untranslated regions of target mRNAs. The miR-34 family consists of three conserved members with important tumor suppressor functions linked to the p53 pathway. The family members share the same seed, raising the question if they also have the same targets. Here, we analyse the effect of miR-34a and miR-34c on protein synthesis by pSILAC. Despite significant overlap, we observe that the impact of both family members on protein synthesis differs. The ability to identify specific targets of a family member is complicated by the occurrence of * strand mediated repression. Transfection of miR-34 chimeras indicates that the 3' end of the miRNA might be responsible for differential regulation in case of targets without a perfect seed site. Pathway analysis of regulated proteins indicates overlapping functions related to cell cycle and the p53 pathway and preferential targeting of several anti-apoptotic proteins by miR-34a. We used luciferase assays to confirm that Vcl and Fkbp8, an important anti-apoptotic protein, are specifically repressed by miR-34a. In summary, we find that miR-34a and miR-34c down-regulate distinct subsets of targets which might mediate different cellular outcomes. Our data provides a rich resource of miR-34 targets that might be relevant for clinical trials that want to implement the miR-34 family in cancer therapy.	[Ebner, Olivia A.; Selbach, Matthias] Max Delbrueck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ebner, OA (corresponding author), Max Delbrueck Ctr Mol Med, Berlin, Germany.	oliviaaebner@gmail.com			Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba M, 2012, ANTICANCER AGENTS ME; [Anonymous], 2006, ENCY STAT SCI; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartonicek N, 2010, BIOINFORMATICS, V26, P2900, DOI 10.1093/bioinformatics/btq545; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Choi BH, 2011, CURR OPIN PHARMACOL, V11, P354, DOI 10.1016/j.coph.2011.04.013; CIARDIELLO F, 1993, INT J CANCER, V53, P438, DOI 10.1002/ijc.2910530315; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Jain AK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002859; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim SN, 2000, J CELL PHYSIOL, V182, P421, DOI 10.1002/(SICI)1097-4652(200003)182:3<421::AID-JCP13>3.0.CO;2-2; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Preall JB, 2005, CELL, V123, P543, DOI 10.1016/j.cell.2005.11.006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; WEISS J, 1992, BIOCHIM BIOPHYS ACTA, V1136, P208, DOI 10.1016/0167-4889(92)90259-E; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wong MY, 2010, INT J ONCOL, V38, P1189; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	70	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92166	10.1371/journal.pone.0092166	http://dx.doi.org/10.1371/journal.pone.0092166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637697	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000333254100122
J	Gustafson, DJ; Major, C; Jones, D; Synovec, J; Baer, SG; Gibson, DJ				Gustafson, Danny J.; Major, Charles; Jones, Dewitt; Synovec, John; Baer, Sara G.; Gibson, David J.			Genetic Sorting of Subordinate Species in Grassland Modulated by Intraspecific Variation in Dominant Species	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; BIG BLUESTEM; COMMUNITY STRUCTURE; ECOSYSTEM GENETICS; ECOTYPIC VARIATION; LOCAL ADAPTATION; PLANT; POPULATIONS; EVOLUTION; DIFFERENTIATION	Genetic variation in a single species can have predictable and heritable effects on associated communities and ecosystem processes, however little is known about how genetic variation of a dominant species affects plant community assembly. We characterized the genetic structure of a dominant grass (Sorghastrum nutans) and two subordinate species (Chamaecrista fasciculata, Silphium integrifolium), during the third growing season in grassland communities established with genetically distinct (cultivated varieties or local ecotypes) seed sources of the dominant grasses. There were genetic differences between subordinate species growing in the cultivar versus local ecotype communities, indicating that intraspecific genetic variation in the dominant grasses affected the genetic composition of subordinate species during community assembly. A positive association between genetic diversity of S. nutans, C. fasciculata, and S. integrifolium and species diversity established the role of an intraspecific biotic filter during community assembly. Our results show that intraspecific variation in dominant species can significantly modulate the genetic composition of subordinate species.	[Gustafson, Danny J.; Major, Charles; Jones, Dewitt; Synovec, John] The Citadel, Dept Biol, Charleston, SC 29409 USA; [Baer, Sara G.; Gibson, David J.] Southern Illinois Univ Carbondale, Dept Plant Biol, Carbondale, IL USA; [Baer, Sara G.; Gibson, David J.] Southern Illinois Univ Carbondale, Ctr Ecol, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Gustafson, DJ (corresponding author), The Citadel, Dept Biol, Charleston, SC 29409 USA.	danny.gustafson@citadel.edu	Gustafson, Danny J./H-7075-2019	Synovec, John/0000-0003-4003-5681; Gibson, David/0000-0002-0308-7506	National Science Foundation (NSF) [DEB 0516429]; National Science Foundation supplemental Research Opportunity Award (NSF ROA) [DEB 0516429]; The Citadel Foundation (TCF)	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation supplemental Research Opportunity Award (NSF ROA)(National Science Foundation (NSF)); The Citadel Foundation (TCF)	This research has been made possible by funding from National Science Foundation (NSF (DEB 0516429), www.nsf.gov) to S. G. Baer and D. J. Gibson, National Science Foundation supplemental Research Opportunity Award (NSF ROA through DEB 0516429, http://www.nsf.gov/bio/deb/suppopp.jsp) to D. J. Gustafson and The Citadel Foundation (TCF, http://foundation.citadel.edu/) to D. J. Gustafson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; Avolio ML, 2013, OECOLOGIA, V171, P571, DOI 10.1007/s00442-012-2427-4; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bangert RK, 2008, HEREDITY, V100, P121, DOI 10.1038/sj.hdy.6800914; Bangert RK, 2007, EVOL ECOL, V21, P549, DOI 10.1007/s10682-006-9135-7; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Carter DL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00223.1; CLAUSEN J, 1947, AM NAT, V81, P114, DOI 10.1086/281507; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Crawford KM, 2012, J ECOL, V100, P1512, DOI 10.1111/j.1365-2745.2012.02016.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Fehr W.R., 1987, PRINCIPLES CULTIVAR, V2; Genung MA, 2012, ECOL LETT, V15, P65, DOI 10.1111/j.1461-0248.2011.01710.x; Genung MA, 2011, FUNCT ECOL, V25, P408, DOI 10.1111/j.1365-2435.2010.01797.x; Gibson DJ, 2013, J VEG SCI, V24, P429, DOI 10.1111/j.1654-1103.2012.01475.x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; GIBSON DJ, 1987, VEGETATIO, V72, P175; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Gustafson DJ, 2004, J APPL ECOL, V41, P389, DOI 10.1111/j.0021-8901.2004.00904.x; Gustafson DJ, 1999, MOL ECOL, V8, P1693, DOI 10.1046/j.1365-294x.1999.00756.x; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Gustafson DJ., 2001, P 17 N AM PRAIRIE C, P118; Gustafson DJ, 2014, DRYAD DIGITAL REPOSI, DOI DOI 10.5061/DRYAD.CQ8BH; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Huff DR, 1998, MOL ECOL, V7, P1591, DOI 10.1046/j.1365-294x.1998.00473.x; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert AM, 2011, RESTOR ECOL, V19, P43, DOI 10.1111/j.1526-100X.2010.00673.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MCMILLAN C, 1959, ECOL MONOGR, V29, P285, DOI 10.2307/1942132; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Price DL, 2012, CROP SCI, V52, P189, DOI 10.2135/cropsci2011.05.0280; Rouse MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017641; Schroder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071066; Seliskar DM, 2002, J ECOL, V90, P1, DOI 10.1046/j.0022-0477.2001.00632.x; SNAYDON RW, 1982, EVOLUTION, V36, P289, DOI [10.2307/2408047, 10.1111/j.1558-5646.1982.tb05044.x]; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Turesson G, 1925, HEREDITAS, V6, P147; United States Department of Agriculture (USDA), 1995, GRASS VAR US; *USDA NRCS, 2002, PLANTS DAT VER 3 5; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x; Whitlock R, 2010, ECOLOGY, V91, P1344, DOI 10.1890/08-2098.1; Wolfe AD, 1998, P NATL ACAD SCI USA, V95, P5112, DOI 10.1073/pnas.95.9.5112	56	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91511	10.1371/journal.pone.0091511	http://dx.doi.org/10.1371/journal.pone.0091511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637462	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100038
J	Hervy, M; Weber, JL; Pecheul, M; Dolley-Sonneville, P; Henry, D; Zhou, Y; Melkoumian, Z				Hervy, Martial; Weber, Jennifer L.; Pecheul, Marylene; Dolley-Sonneville, Paula; Henry, David; Zhou, Yue; Melkoumian, Zara			Long Term Expansion of Bone Marrow-Derived hMSCs on Novel Synthetic Microcarriers in Xeno-Free, Defined Conditions	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SIGNALING PATHWAYS; CULTURE	Human mesenchymal stem cells (hMSCs) present an attractive target for cell therapy given their wide availability, immunomodulatory properties, and multipotent nature for differentiation into chondrocytes, osteocytes, and adipocytes. With the progression of hMSC clinical studies, there is an increasing demand for development of technologies that enable efficient cell scale-up into clinically relevant quantities. Commercial scale manufacturing of hMSCs will require a large surface area which is not cost effective with available two-dimensional culture vessels. Recent studies showed that microcarriers provide a three-dimensional culture environment suitable for hMSC expansion. Traditionally, biological coatings and/or serum-containing medium are required to facilitate hMSC attachment and expansion in dynamic conditions. These limitations may hinder the use of microcarriers as a scale-up technology for hMSC therapeutics, where cell products, and therefore patient safety, are more controlled with the use of xeno-free, defined culture conditions. Here we report the long term culture of hMSCs on novel synthetic Synthemax II microcarriers in two different xeno-free media. Cells were maintained over 40 days on sterile, ready-to-use microcarriers in spinner flasks with programmed agitation. hMSC expansion was obtained by addition of fresh beads without the need for enzymatic dissociation. We achieved a cumulative cell expansion of >10,000 fold, and cells retained normal hMSC phenotype, karyotype, and tri-lineage differentiation potential. To our knowledge, this report is the first example of long term culture of hMSCs on synthetic microcarriers in xeno-free, defined conditions.	[Weber, Jennifer L.; Dolley-Sonneville, Paula; Zhou, Yue; Melkoumian, Zara] Corning Inc, Corning Life Sci Dev, Corning, NY 14831 USA; [Hervy, Martial; Pecheul, Marylene; Henry, David] Corning Inc, Corning European Technol Ctr, Avon, France	Corning Inc; State University of New York (SUNY) System; SUNY Community College; Corning Inc	Hervy, M (corresponding author), Corning Inc, Corning European Technol Ctr, Avon, France.	hervym@corning.com			Corning Incorporated	Corning Incorporated	This work was supported by Corning Incorporated. The funder played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bulj Z, 2013, INT J ONCOL, V42, P118, DOI 10.3892/ijo.2012.1700; Chase LG, 2012, STEM CELL TRANSL MED, V1, P750, DOI 10.5966/sctm.2012-0072; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; Dander E, 2012, LEUKEMIA, V26, P1681, DOI 10.1038/leu.2011.384; Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12; Dolley-Sonneville PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070263; dos Santos DCM, 2012, LIVER INT, V32, P147, DOI 10.1111/j.1478-3231.2011.02654.x; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Ferrari C, 2012, BIOTECHNOL PROGR, V28, P780, DOI 10.1002/btpr.1527; Hewitt CJ, 2011, BIOTECHNOL LETT, V33, P2325, DOI 10.1007/s10529-011-0695-4; Jung S, 2012, J TISSUE ENG REGEN M, V6, P391, DOI 10.1002/term.441; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Matthay MA, 2010, CRIT CARE MED, V38, pS569, DOI 10.1097/CCM.0b013e3181f1ff1d; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Sart S, 2009, J BIOTECHNOL, V139, P291, DOI 10.1016/j.jbiotec.2008.12.011; Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Wang YS, 1999, CYTOTECHNOLOGY, V31, P221, DOI 10.1023/A:1008079013375; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Yang ZJ, 2010, CARDIOVASC THER, V28, P380, DOI 10.1111/j.1755-5922.2009.00116.x; Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007; Yuan Y, 2012, J TISSUE ENG REGEN M; Zheng LS, 2012, J BIOMECH, V45, P2368, DOI 10.1016/j.jbiomech.2012.07.013	27	55	58	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92120	10.1371/journal.pone.0092120	http://dx.doi.org/10.1371/journal.pone.0092120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638103	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100116
J	Kong, XZ; Yin, RH; Ning, HM; Zheng, WW; Dong, XM; Yang, Y; Xu, FF; Li, JJ; Zhan, YQ; Yu, M; Ge, CH; Zhang, JH; Chen, H; Li, CY; Yang, XM				Kong, Xiang-Zhen; Yin, Rong-Hua; Ning, Hong-Mei; Zheng, Wei-Wei; Dong, Xiao-Ming; Yang, Yang; Xu, Fei-Fei; Li, Jian-Jie; Zhan, Yi-Qun; Yu, Miao; Ge, Chang-Hui; Zhang, Jian-Hong; Chen, Hui; Li, Chang-Yan; Yang, Xiao-Ming			Effects of THAP11 on Erythroid Differentiation and Megakaryocytic Differentiation of K562 Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-2; EMBRYONIC STEM-CELLS; C-MYC; HEMATOPOIETIC-CELLS; ZINC-FINGER; GENE-EXPRESSION; DOWN-REGULATION; PROLIFERATION; TESCALCIN; ELEMENT	Hematopoiesis is a complex process regulated by sets of transcription factors in a stage-specific and context-dependent manner. THAP11 is a transcription factor involved in cell growth, ES cell pluripotency, and embryogenesis. Here we showed that THAP11 was down-regulated during erythroid differentiation but up-regulated during megakaryocytic differentiation of cord blood CD34(+) cells. Overexpression of THAP11 in K562 cells inhibited the erythroid differentiation induced by hemin with decreased numbers of benzidine-positive cells and decreased mRNA levels of alpha-globin (HBA) and glycophorin A (GPA), and knockdown of THAP11 enhanced the erythroid differentiation. Conversely, THAP11 overexpression accelerated the megakaryocytic differentiation induced by phorbol myristate acetate (PMA) with increased percentage of CD41(+) cells, increased numbers of 4N cells, and elevated CD61 mRNA levels, and THAP11 knockdown attenuated the megakaryocytic differentiation. The expression levels of transcription factors such as c-Myc, c-Myb, GATA-2, and Fli1 were changed by THAP11 overexpression. In this way, our results suggested that THAP11 reversibly regulated erythroid and megakaryocytic differentiation.	[Kong, Xiang-Zhen; Dong, Xiao-Ming; Yang, Xiao-Ming] Tianjin Univ, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China; [Kong, Xiang-Zhen; Yin, Rong-Hua; Zheng, Wei-Wei; Xu, Fei-Fei; Zhan, Yi-Qun; Yu, Miao; Ge, Chang-Hui; Zhang, Jian-Hong; Chen, Hui; Li, Chang-Yan; Yang, Xiao-Ming] Beijing Inst Radiat Med, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Yin, Rong-Hua; Li, Chang-Yan; Yang, Xiao-Ming] State Key Lab Prote, Beijing, Peoples R China; [Ning, Hong-Mei] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China; [Yang, Yang] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Li, Jian-Jie] Acad Mil Med Sci, Affiliated Hosp, Dept Pulm Neoplasms Internal Med, Beijing, Peoples R China	Tianjin University; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Academy of Military Medical Sciences - China	Li, CY (corresponding author), Beijing Inst Radiat Med, Dept Biochem & Mol Biol, Beijing, Peoples R China.	fmmli@163.com; xiaomingyang@sina.com		Dong, xiao-ming/0000-0003-2413-8541	Chinese National Natural Science Foundation [81222005, 81070435]; Major State Basic Research of China [2012AA020206, 2013CB910800]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research of China	This study is partly supported by Chinese National Natural Science Foundation Projects (81222005, 81070435); and Major State Basic Research of China (2012AA020206, 2013CB910800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou M, 2000, LEUKEMIA, V14, P439, DOI 10.1038/sj.leu.2401689; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Brewer G, 2000, J BIOL CHEM, V275, P33336, DOI 10.1074/jbc.M006145200; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Ikonomi P, 2000, EXP HEMATOL, V28, P1423, DOI 10.1016/S0301-472X(00)00553-1; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parker JB, 2012, MOL CELL BIOL, V32, P1654, DOI 10.1128/MCB.06033-11; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Rubin CI, 2003, EXP HEMATOL, V31, P389, DOI 10.1016/S0301-472X(03)00043-2; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Ukarapong S, 2012, EXP CELL RES, V318, P662, DOI 10.1016/j.yexcr.2012.01.009; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160	30	6	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91557	10.1371/journal.pone.0091557	http://dx.doi.org/10.1371/journal.pone.0091557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637716	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100043
J	Koorem, K; Gazol, A; Opik, M; Moora, M; Saks, U; Uibopuu, A; Sober, V; Zobel, M				Koorem, Kadri; Gazol, Antonio; Oepik, Maarja; Moora, Mari; Saks, Uelle; Uibopuu, Annika; Sober, Virve; Zobel, Martin			Soil Nutrient Content Influences the Abundance of Soil Microbes but Not Plant Biomass at the Small-Scale	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY COMPOSITION; SPECIES RICHNESS; FATTY-ACIDS; ECTOMYCORRHIZAL MYCELIA; SAPROTROPHIC FUNGI; CARBON ALLOCATION; SPATIAL-PATTERN; GROWTH; BACTERIA	Small-scale heterogeneity of abiotic and biotic factors is expected to play a crucial role in species coexistence. It is known that plants are able to concentrate their root biomass into areas with high nutrient content and also acquire nutrients via symbiotic microorganisms such as arbuscular mycorrhizal (AM) fungi. At the same time, little is known about the small-scale distribution of soil nutrients, microbes and plant biomass occurring in the same area. We examined small-scale temporal and spatial variation as well as covariation of soil nutrients, microbial biomass (using soil fatty acid biomarker content) and above-and belowground biomass of herbaceous plants in a natural herb-rich boreonemoral spruce forest. The abundance of AM fungi and bacteria decreased during the plant growing season while soil nutrient content rather increased. The abundance of all microbes studied also varied in space and was affected by soil nutrient content. In particular, the abundance of AM fungi was negatively related to soil phosphorus and positively influenced by soil nitrogen content. Neither shoot nor root biomass of herbaceous plants showed any significant relationship with variation in soil nutrient content or the abundance of soil microbes. Our study suggests that plants can compensate for low soil phosphorus concentration via interactions with soil microbes, most probably due to a more efficient symbiosis with AM fungi. This compensation results in relatively constant plant biomass despite variation in soil phosphorous content and in the abundance of AM fungi. Hence, it is crucial to consider both soil nutrient content and the abundance of soil microbes when exploring the mechanisms driving vegetation patterns.	[Koorem, Kadri; Gazol, Antonio; Oepik, Maarja; Moora, Mari; Saks, Uelle; Uibopuu, Annika; Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Sober, Virve] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Koorem, K (corresponding author), NIOO KNAW, Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	kadri.koorem@ut.ee	Zobel, Martin/H-1336-2015; Öpik, Maarja/A-1765-2008; Moora, Mari/D-1961-2009; Gazol, Antonio/B-7322-2015; KNAW, NIOO-KNAW/A-4320-2012	Zobel, Martin/0000-0001-7957-6704; Öpik, Maarja/0000-0001-8025-7460; Moora, Mari/0000-0002-4819-7506; Gazol, Antonio/0000-0001-5902-9543; Koorem, Kadri/0000-0002-3376-9372; KNAW, NIOO-KNAW/0000-0002-3835-159X	Estonian Science Foundation [9050, 9157]; European Union [GA-2010-267243-PLANT FELLOWS]; ERMOS programme grant [14]; Marie Curie Actions; European Regional Development Fund (Centre of Excellence FIBIR);  [IUT 20-28]	Estonian Science Foundation; European Union(European Commission); ERMOS programme grant; Marie Curie Actions(European Commission); European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); 	This research was funded by grants from the Estonian Science Foundation (9050, 9157), targeted financing (IUT 20-28), European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no GA-2010-267243-PLANT FELLOWS, ERMOS programme grant 14 (co-funded by Marie Curie Actions), and the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atul-Nayyar, 2008, APPL SOIL ECOL, V40, P30, DOI 10.1016/j.apsoil.2008.03.004; Baldrian P, 2012, APPL ENVIRON MICROB, V78, P3473, DOI 10.1128/AEM.07953-11; Baldrian P, 2010, BIOL FERT SOILS, V46, P717, DOI 10.1007/s00374-010-0478-4; Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Bjornstad O. N, 2012, NCF SPATIAL NONPARAM; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Calvaruso C, 2006, APPL ENVIRON MICROB, V72, P1258, DOI 10.1128/AEM.72.2.1258-1266.2006; Campbell CD, 2008, SOIL BIOL BIOCHEM, V40, P2246, DOI 10.1016/j.soilbio.2008.04.020; Chagnon PL, 2013, FUNGAL ECOL, V6, P557, DOI 10.1016/j.funeco.2013.09.005; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Day KJ, 2003, J ECOL, V91, P541, DOI 10.1046/j.1365-2745.2003.00799.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Franklin RB, 2009, SOIL BIOL BIOCHEM, V41, P1833, DOI 10.1016/j.soilbio.2009.06.003; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Gazol A, 2013, OECOLOGIA, V173, P545, DOI 10.1007/s00442-013-2623-x; GRAHAM JH, 1995, APPL ENVIRON MICROB, V61, P58, DOI 10.1128/AEM.61.1.58-64.1995; Groffman PM, 2011, SOIL BIOL BIOCHEM, V43, P2441, DOI 10.1016/j.soilbio.2011.08.011; Hamel C, 2006, SOIL BIOL BIOCHEM, V38, P2104, DOI 10.1016/j.soilbio.2006.01.011; Hinojosa MB, 2005, J ENVIRON QUAL, V34, P1789, DOI 10.2134/jeq2004.0470; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hoffland E, 2003, ECOSYSTEMS, V6, P739, DOI 10.1007/s10021-003-0191-3; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kabir Z, 1998, AGR ECOSYST ENVIRON, V68, P151, DOI 10.1016/S0167-8809(97)00155-2; Kaiser C, 2010, NEW PHYTOL, V187, P843, DOI 10.1111/j.1469-8137.2010.03321.x; Kikuchi K, 2007, MYCORRHIZA, V17, P563, DOI 10.1007/s00572-007-0131-8; Klironomos JN, 1999, APPL SOIL ECOL, V12, P227, DOI 10.1016/S0929-1393(99)00014-1; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; Koorem K, 2010, FOREST ECOL MANAG, V260, P1407, DOI 10.1016/j.foreco.2010.07.043; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leigh J, 2011, FEMS MICROBIOL ECOL, V76, P428, DOI 10.1111/j.1574-6941.2011.01066.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; MCNAUGHTON SJ, 1990, OIKOS, V59, P92, DOI 10.2307/3545127; Moora M, 2007, FOREST ECOL MANAG, V250, P64, DOI 10.1016/j.foreco.2007.03.010; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; NICHOLS P, 1986, ARCH MICROBIOL, V146, P1, DOI 10.1007/BF00690149; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Olsson PA, 1996, FEMS MICROBIOL ECOL, V21, P77, DOI 10.1111/j.1574-6941.1996.tb00335.x; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Olsson PA, 1997, APPL ENVIRON MICROB, V63, P3531, DOI 10.1128/AEM.63.9.3531-3538.1997; Olsson PA, 1998, PLANT SOIL, V201, P9, DOI 10.1023/A:1004379404220; Osorio F., 2012, R PACKAGE VERSION 02, V3, P4; Paul E. A., 1989, Soil microbiology and biochemistry.; Pausas JG, 2003, J VEG SCI, V14, P661, DOI 10.1111/j.1654-1103.2003.tb02198.x; Pereira E, 2012, MYCORRHIZA, V22, P41, DOI 10.1007/s00572-011-0379-x; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Potila H, 2009, PLANT SOIL, V316, P139, DOI 10.1007/s11104-008-9766-2; R Core Team, 2016, R FDN STAT COMP; Ranneklev SB, 2003, APPL ENVIRON MICROB, V69, P3532, DOI 10.1128/AEM.69.6.3532-3539.2003; Roesti D, 2005, APPL ENVIRON MICROB, V71, P6673, DOI 10.1128/AEM.71.11.6673-6679.2005; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Schnoor TK, 2011, OECOLOGIA, V167, P809, DOI 10.1007/s00442-011-2020-2; Schutter ME, 2000, SOIL SCI SOC AM J, V64, P1659, DOI 10.2136/sssaj2000.6451659x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Staddon PL, 2003, GLOBAL CHANGE BIOL, V9, P186, DOI 10.1046/j.1365-2486.2003.00593.x; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Tran T.S., 1993, SOIL SAMPL METHODS A, V43, P49; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Walder F, 2013, SOIL BIOL BIOCHEM, V58, P341, DOI 10.1016/j.soilbio.2012.12.008; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zobel M, 2007, FOREST ECOL MANAG, V250, P71, DOI 10.1016/j.foreco.2007.03.011; Zuur Alain F., 2009, P1	76	49	50	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91998	10.1371/journal.pone.0091998	http://dx.doi.org/10.1371/journal.pone.0091998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637633	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100100
J	Laass, S; Kleist, S; Bill, N; Druppel, K; Kossmehl, S; Wohlbrand, L; Rabus, R; Klein, J; Rohde, M; Bartsch, A; Wittmann, C; Schmidt-Hohagen, K; Tielen, P; Jahn, D; Schomburg, D				Laass, Sebastian; Kleist, Sarah; Bill, Nelli; Drueppel, Katharina; Kossmehl, Sebastian; Woehlbrand, Lars; Rabus, Ralf; Klein, Johannes; Rohde, Manfred; Bartsch, Annekathrin; Wittmann, Christoph; Schmidt-Hohagen, Kerstin; Tielen, Petra; Jahn, Dieter; Schomburg, Dietmar			Gene Regulatory and Metabolic Adaptation Processes of Dinoroseobacter shibae DFL12T during Oxygen Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Metabolism; Metabolomics; Proteomics; Respiration; Systems Biology; Transcriptomics; Roseobacter; Polyhydroxybutanoate	INHIBENS DSM 17395; PHAEOBACTER-GALLAECIENSIS; ROSEOBACTER CLADE; PROTEIN; EXPRESSION; BACTERIA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DEHYDROGENASE; PURIFICATION; BIOLOGY	Background: The bacterium Dinoroseobacter shibae was exposed to environmental anoxia. Results: Systems biology analyses showed the time-resolved cellular adaptation processes of D. shibae during oxygen depletion. Conclusion: Oxygen depletion led to a metabolic crisis due to the missing regeneration of ATP and reduction equivalents, until denitrification was established. Significance: Here we have elucidated the adaptation processes of marine bacteria to anoxic respiration. Metabolic flexibility is the key to the ecological success of the marine Roseobacter clade bacteria. We investigated the metabolic adaptation and the underlying changes in gene expression of Dinoroseobacter shibae DFL12(T) to anoxic life by a combination of metabolome, proteome, and transcriptome analyses. Time-resolved studies during continuous oxygen depletion were performed in a chemostat using nitrate as the terminal electron acceptor. Formation of the denitrification machinery was found enhanced on the transcriptional and proteome level, indicating that D. shibae DFL12(T) established nitrate respiration to compensate for the depletion of the electron acceptor oxygen. In parallel, arginine fermentation was induced. During the transition state, growth and ATP concentration were found to be reduced, as reflected by a decrease of A(578) values and viable cell counts. In parallel, the central metabolism, including gluconeogenesis, protein biosynthesis, and purine/pyrimidine synthesis was found transiently reduced in agreement with the decreased demand for cellular building blocks. Surprisingly, an accumulation of poly-3-hydroxybutanoate was observed during prolonged incubation under anoxic conditions. One possible explanation is the storage of accumulated metabolites and the regeneration of NADP(+) from NADPH during poly-3-hydroxybutanoate synthesis (NADPH sink). Although D. shibae DFL12(T) was cultivated in the dark, biosynthesis of bacteriochlorophyll was increased, possibly to prepare for additional energy generation via aerobic anoxygenic photophosphorylation. Overall, oxygen depletion led to a metabolic crisis with partly blocked pathways and the accumulation of metabolites. In response, major energy-consuming processes were reduced until the alternative respiratory denitrification machinery was operative.	[Laass, Sebastian; Tielen, Petra; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Kleist, Sarah; Bill, Nelli; Klein, Johannes; Schmidt-Hohagen, Kerstin; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Drueppel, Katharina; Kossmehl, Sebastian; Woehlbrand, Lars; Rabus, Ralf] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm Gen & Mol Microb, D-26111 Oldenburg, Germany; [Bartsch, Annekathrin; Wittmann, Christoph] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res HZI, Dept Med Microbiol, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Carl von Ossietzky Universitat Oldenburg; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Langer Kamp 19 B, D-38106 Braunschweig, Germany.	d.schomburg@tu-bs.de		Schomburg, Dietmar/0000-0002-3354-822X; Wittmann, Christoph/0000-0002-7952-985X; Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [Transregio SFB TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Transregio SFB TRR 51.	Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Borner J, 2007, ANAL BIOCHEM, V367, P143, DOI 10.1016/j.ab.2007.04.036; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buddruhs N, 2013, INT J SYST EVOL MICR, V63, P4340, DOI 10.1099/ijs.0.053900-0; DELDON C, 1994, AQUAT SCI, V56, P1; Druppel K, 2014, ENVIRON MICROBIOL, V16, P218, DOI 10.1111/1462-2920.12276; Ebert M, 2013, J BACTERIOL, V195, P4769, DOI 10.1128/JB.00860-13; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Furch T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-209; Gade D, 2003, J MOL MICROB BIOTECH, V5, P240, DOI 10.1159/000071076; Gonzalez B, 2000, YEAST, V16, P483, DOI 10.1002/(SICI)1097-0061(200004)16:6<483::AID-YEA542>3.0.CO;2-E; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; GRAY CT, 1966, BIOCHIM BIOPHYS ACTA, V117, P22, DOI 10.1016/0304-4165(66)90148-6; Hansen T, 2002, FEMS MICROBIOL LETT, V216, P249, DOI 10.1016/S0378-1097(02)01021-2; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Lebedeva NV, 2002, MICROBIOLOGY+, V71, P657, DOI 10.1023/A:1021471621183; LESSMANN D, 1975, EUR J BIOCHEM, V59, P545, DOI 10.1111/j.1432-1033.1975.tb02481.x; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Nam TW, 2005, NUCLEIC ACIDS RES, V33, P6712, DOI 10.1093/nar/gki978; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Pardo MA, 1999, BBA-PROTEIN STRUCT M, V1431, P87, DOI 10.1016/S0167-4838(99)00052-7; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Reusch RN, 2013, INT J MOL SCI, V14, P10727, DOI 10.3390/ijms140610727; Rex R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003224; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHAEFFER F, 1978, ARCH MICROBIOL, V116, P9, DOI 10.1007/BF00408728; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; SENIOR PJ, 1971, BIOCHEM J, V125, P55, DOI 10.1042/bj1250055; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Trautwein K, 2008, APPL ENVIRON MICROB, V74, P2267, DOI 10.1128/AEM.02381-07; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Xiao N, 2011, APPL ENVIRON MICROB, V77, P7445, DOI 10.1128/AEM.05955-11; Zech H, 2013, PROTEOMICS, V13, P2869, DOI 10.1002/pmic.201200560; Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513; Zech H, 2011, PROTEOMICS, V11, P3380, DOI 10.1002/pmic.201100071; Zech H, 2009, PROTEOMICS, V9, P3677, DOI 10.1002/pmic.200900120; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	46	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13219	13231		10.1074/jbc.M113.545004	http://dx.doi.org/10.1074/jbc.M113.545004			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648520	Green Published, hybrid			2022-12-25	WOS:000335522800023
J	Wilhelmsen, K; Khakpour, S; Tran, A; Sheehan, K; Schumacher, M; Xu, FY; Hellman, J				Wilhelmsen, Kevin; Khakpour, Samira; Tran, Alphonso; Sheehan, Kayla; Schumacher, Mark; Xu, Fengyun; Hellman, Judith			The Endocannabinoid/Endovanilloid N-Arachidonoyl Dopamine ( NADA) and Synthetic Cannabinoid WIN55,212-2 Abate the Inflammatory Activation of Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cannabinoid Receptors; Cannabinoids; Endocannabinoids; Endothelial Cell; Endothelial Dysfunction; Endothelium; Sepsis; Toll-like Receptors (TLR); TRP Channels	ANANDAMIDE MEMBRANE TRANSPORTER; RECEPTOR MESSENGER-RNA; GENE-EXPRESSION DATA; TNF-ALPHA; VANILLOID RECEPTOR; CB2 RECEPTOR; IN-VITRO; SIGNAL-TRANSDUCTION; CAPSAICIN RECEPTOR; CALCIUM-CHANNELS	Background: The endothelium is centrally involved in acute inflammatory disorders. Results: WIN55,212-2 and the endocannabinoid N-arachidonoyl dopamine (NADA), but not anandamide nor 2-arachidonoylglycerol, reduce endothelial activation by bacterial Toll-like receptor agonists and TNF. Conclusion: NADA is a newly identified endogenous regulator of endothelial inflammation. Significance: The endothelial endocannabinoid system represents a novel immune regulatory system that could be exploited therapeutically. Although cannabinoids, such as (9)-tetrahydrocannabinol, have been studied extensively for their psychoactive effects, it has become apparent that certain cannabinoids possess immunomodulatory activity. Endothelial cells (ECs) are centrally involved in the pathogenesis of organ injury in acute inflammatory disorders, such as sepsis, because they express cytokines and chemokines, which facilitate the trafficking of leukocytes to organs, and they modulate vascular barrier function. In this study, we find that primary human ECs from multiple organs express the cannabinoid receptors CB1R, GPR18, and GPR55, as well as the ion channel transient receptor potential cation channel vanilloid type 1. In contrast to leukocytes, CB2R is only minimally expressed in some EC populations. Furthermore, we show that ECs express all of the known endocannabinoid (eCB) metabolic enzymes. Examining a panel of cannabinoids, we demonstrate that the synthetic cannabinoid WIN55,212-2 and the eCB N-arachidonoyl dopamine (NADA), but neither anandamide nor 2-arachidonoylglycerol, reduce EC inflammatory responses induced by bacterial lipopeptide, LPS, and TNF. We find that endothelial CB1R/CB2R are necessary for the effects of NADA, but not those of WIN55,212-2. Furthermore, transient receptor potential cation channel vanilloid type 1 appears to counter the anti-inflammatory properties of WIN55,212-2 and NADA, but conversely, in the absence of these cannabinoids, its inhibition exacerbates the inflammatory response in ECs activated with LPS. These data indicate that the eCB system can modulate inflammatory activation of the endothelium and may have important implications for a variety of acute inflammatory disorders that are characterized by EC activation.	[Wilhelmsen, Kevin; Tran, Alphonso; Sheehan, Kayla; Schumacher, Mark; Xu, Fengyun; Hellman, Judith] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Khakpour, Samira] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Hellman, Judith] Univ Calif San Francisco, Div Crit Care Med, San Francisco, CA 94143 USA; [Hellman, Judith] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wilhelmsen, K (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	wilhelmsenk@anesthesia.ucsf.edu			Department of Anesthesia and Perioperative Care; University of California at San Francisco; National Science Foundation [1144247]; University of California at San Francisco Research Evaluation and Allocation Committee Program (Huntington Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	Department of Anesthesia and Perioperative Care; University of California at San Francisco(University of California System); National Science Foundation(National Science Foundation (NSF)); University of California at San Francisco Research Evaluation and Allocation Committee Program (Huntington Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Anesthesia and Perioperative Care, University of California at San Francisco, National Science Foundation Graduate Research Fellowship Program Grant 1144247, and the University of California at San Francisco Research Evaluation and Allocation Committee Program (Huntington Fund).	Agro A, 1996, J RHEUMATOL, V23, P862; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Akimov MG, 2007, RUSS J BIOORG CHEM+, V33, P602, DOI 10.1134/S1068162007060118; Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P295, DOI 10.1016/j.drudis.2013.07.009; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; Bezuglov V, 2001, BIOORG MED CHEM LETT, V11, P447, DOI 10.1016/S0960-894X(00)00689-2; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bjorklund E, 2010, BRIT J PHARMACOL, V161, P1512, DOI 10.1111/j.1476-5381.2010.00974.x; Bobrov MY, 2008, NEUROSCI LETT, V431, P6, DOI 10.1016/j.neulet.2007.11.010; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Caldwell MD, 2013, BRIT J PHARMACOL, V169, P834, DOI 10.1111/bph.12136; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang WC, 2006, ACTA PHARMACOL SIN, V27, P813, DOI 10.1111/j.1745-7254.2006.00395.x; Chang YH, 2001, J CELL BIOCHEM, V81, P715, DOI 10.1002/jcb.1103; Chu CJ, 2003, J BIOL CHEM, V278, P13633, DOI 10.1074/jbc.M211231200; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Croxford JL, 2005, CELL MICROBIOL, V7, P1592, DOI 10.1111/j.1462-5822.2005.00577.x; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; DAMBRA TE, 1992, J MED CHEM, V35, P124, DOI 10.1021/jm00079a016; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Petrocellis L, 2001, J BIOL CHEM, V276, P12856, DOI 10.1074/jbc.M008555200; De Petrocellis L, 2007, EXP CELL RES, V313, P1911, DOI 10.1016/j.yexcr.2007.01.008; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; De Petrocellis L, 2009, CELL CALCIUM, V45, P611, DOI 10.1016/j.ceca.2009.03.003; Eilers H, 2007, NEUROREPORT, V18, P969, DOI 10.1097/WNR.0b013e328165d1a2; Elphick MR, 2012, PHILOS T R SOC B, V367, P3201, DOI 10.1098/rstb.2011.0394; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Gokoh M, 2005, FEBS LETT, V579, P6473, DOI 10.1016/j.febslet.2005.10.030; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Goyal RK, 2013, AUTON NEUROSCI-BASIC, V176, P11, DOI 10.1016/j.autneu.2013.02.012; Graham ES, 2010, INT J IMMUNOPATH PH, V23, P25, DOI 10.1177/039463201002300103; Griffith DA, 2009, J MED CHEM, V52, P234, DOI 10.1021/jm8012932; Gui H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/741303; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Hao MX, 2010, J LIPID RES, V51, P2181, DOI 10.1194/jlr.M001511; Harrison S, 2003, EUR J PHARMACOL, V475, P107, DOI 10.1016/S0014-2999(03)02114-9; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; HOLLADAY CS, 1993, PROSTAG LEUKOTR ESS, V49, P915, DOI 10.1016/0952-3278(93)90176-W; Hu SSJ, 2009, PROSTAG LEUKOTR ESS, V81, P291, DOI 10.1016/j.plefa.2009.05.026; Huang NL, 2010, ACTA PHARMACOL SIN, V31, P1447, DOI 10.1038/aps.2010.126; Huang SM, 2006, J NEUROPHYSIOL, V95, P1207, DOI 10.1152/jn.00395.2005; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; JEANNIN P, 1994, BLOOD, V84, P2229; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kasten Kevin Richard, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P224; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Lee SF, 2001, EUR J PHARMACOL, V423, P235, DOI 10.1016/S0014-2999(01)01122-0; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; Li SW, 2002, TRENDS PHARMACOL SCI, V23, P63, DOI 10.1016/S0165-6147(00)01897-6; Li YY, 2013, LAB INVEST, V93, P322, DOI 10.1038/labinvest.2012.177; LITTLE PJ, 1988, J PHARMACOL EXP THER, V247, P1046; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu WL, 2011, CURR OPIN INFECT DIS, V24, P254, DOI 10.1097/QCO.0b013e3283463e5b; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TS, 2008, J IMMUNOL, V181, P6406, DOI 10.4049/jimmunol.181.9.6406; Lu VB, 2013, MOL PHARMACOL, V83, P267, DOI 10.1124/mol.112.081182; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Marinelli S, 2007, NEUROPSYCHOPHARMACOL, V32, P298, DOI 10.1038/sj.npp.1301118; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mestre L, 2009, MOL CELL NEUROSCI, V40, P258, DOI 10.1016/j.mcn.2008.10.015; Millns PJ, 2006, EUR J NEUROSCI, V24, P3489, DOI 10.1111/j.1460-9568.2006.05236.x; Mormina ME, 2006, EUR J PHARMACOL, V540, P183, DOI 10.1016/j.ejphar.2006.04.015; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Navarrete CM, 2010, BIOCHEM PHARMACOL, V79, P1805, DOI 10.1016/j.bcp.2010.02.014; Navarrete CM, 2009, J NEUROCHEM, V109, P452, DOI 10.1111/j.1471-4159.2009.05966.x; O'Sullivan SE, 2009, PPAR RES, V2009, DOI 10.1155/2009/425289; O'Sullivan SE, 2004, BRIT J PHARMACOL, V141, P803, DOI 10.1038/sj.bjp.0705643; Okuno T, 2011, J BIOCHEM, V149, P495, DOI 10.1093/jb/mvr022; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Opitz CA, 2007, FEBS LETT, V581, P4927, DOI 10.1016/j.febslet.2007.09.032; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; Piomelli D, 2014, NEUROPHARMACOLOGY, V76, P228, DOI 10.1016/j.neuropharm.2013.07.026; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; Premkumar LS, 2004, J NEUROPHYSIOL, V91, P1442, DOI 10.1152/jn.00745.2003; Price TJ, 2005, NEUROPHARMACOLOGY, V49, P25, DOI 10.1016/j.neuropharm.2005.01.031; Price TJ, 2004, BRIT J PHARMACOL, V141, P1118, DOI 10.1038/sj.bjp.0705711; Prusakiewicz JJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P260, DOI 10.1016/j.abb.2007.04.007; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rajesh M, 2010, BRIT J PHARMACOL, V160, P688, DOI 10.1111/j.1476-5381.2010.00712.x; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; Rom S, 2013, J NEUROIMMUNE PHARM, V8, P608, DOI 10.1007/s11481-013-9445-9; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ross HR, 2009, BRIT J PHARMACOL, V156, P740, DOI 10.1111/j.1476-5381.2008.00072.x; Russo EB, 2005, NEUROCHEM RES, V30, P1037, DOI 10.1007/s11064-005-6978-1; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sagar DR, 2004, EUR J NEUROSCI, V20, P175, DOI 10.1111/j.1460-9568.2004.03481.x; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Sancho R, 2005, J IMMUNOL, V175, P3990, DOI 10.4049/jimmunol.175.6.3990; Sancho R, 2004, J IMMUNOL, V172, P2341, DOI 10.4049/jimmunol.172.4.2341; Sasaki Makoto, 2005, BMC Physiol, V5, P3, DOI 10.1186/1472-6793-5-3; Schaefer U, 1998, INFLAMM RES, V47, P256, DOI 10.1007/s000110050327; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Southall MD, 2003, J PHARMACOL EXP THER, V304, P217, DOI 10.1124/jpet.102.040675; Sugiura T, 2004, J PHARMACOL SCI, V96, P367, DOI 10.1254/jphs.FMJ04003X3; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; Sugiura T, 2009, BIOFACTORS, V35, P88, DOI 10.1002/biof.18; Sun Y, 2006, BIOCHEM SOC T, V34, P1095, DOI 10.1042/BST0341095; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tschop J, 2009, J IMMUNOL, V183, P499, DOI 10.4049/jimmunol.0900203; TSENG CF, 1992, CHEM PHARM BULL, V40, P396, DOI 10.1248/cpb.40.396; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wilhelmsen K, 2013, JOVE-J VIS EXP, DOI 10.3791/50677; Wilhelmsen K, 2012, J BIOL CHEM, V287, P26478, DOI 10.1074/jbc.M112.359489; Wilhelmsen K, 2012, INNATE IMMUN-LONDON, V18, P602, DOI 10.1177/1753425911429336; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wojtalla A, 2012, AM J PHYSIOL-GASTR L, V302, pG873, DOI 10.1152/ajpgi.00241.2011; Yoo JM, 2013, LIPIDS, V48, P383, DOI 10.1007/s11745-013-3758-6; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zavala K, 2014, NEUROSCI LETT, V578, P211, DOI 10.1016/j.neulet.2014.01.021	157	36	36	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13079	13100		10.1074/jbc.M113.536953	http://dx.doi.org/10.1074/jbc.M113.536953			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24644287	hybrid, Green Published			2022-12-25	WOS:000335522800011
J	Mazhab-Jafari, MT; Marshall, CB; Ho, J; Ishiyama, N; Stambolic, V; Ikura, M				Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Ho, Jason; Ishiyama, Noboru; Stambolic, Vuk; Ikura, Mitsuhiko			Structure-guided Mutation of the Conserved G3-box Glycine in Rheb Generates a Constitutively Activated Regulator of Mammalian Target of Rapamycin ( mTOR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Catalysis; mTOR Complex (mTORC); Protein Engineering; Small GTPases; Constitutively Active; G3-box; Rheb; TSC2GAP	CELL-GROWTH; GTPASE; GAP; RAS; HYDROLYSIS; SYSTEM; TCTP	Background: GTPases regulate cellular signaling by cycling between GDP-(inactive) and GTP-(active) bound states. Results: Rheb GTPase cycling was manipulated by structure-guided mutagenesis of an ultraconserved residue. Conclusion: Constitutively activated or inactive Rheb mutants were generated by substitutions that displace the hydrolytic water or -phosphate, respectively. Significance: These mutants offer new research tools, and the approach may be extended to other GTPases. Constitutively activated variants of small GTPases, which provide valuable functional probes of their role in cellular signaling pathways, can often be generated by mutating the canonical catalytic residue (e.g. Ras Q61L) to impair GTP hydrolysis. However, this general approach is ineffective for a substantial fraction of the small GTPase family in which this residue is not conserved (e.g. Rap) or not catalytic (e.g. Rheb). Using a novel engineering approach, we have manipulated nucleotide binding through structure-guided substitutions of an ultraconserved glycine residue in the G3-box motif (DXXG). Substitution of Rheb Gly-63 with alanine impaired both intrinsic and TSC2 GTPase-activating protein (GAP)-mediated GTP hydrolysis by displacing the hydrolytic water molecule, whereas introduction of a bulkier valine side chain selectively blocked GTP binding by steric occlusion of the -phosphate. Rheb G63A stimulated phosphorylation of the mTORC1 substrate p70S6 kinase more strongly than wild-type, thus offering a new tool for mammalian target of rapamycin (mTOR) signaling.	[Mazhab-Jafari, Mohammad T.; Marshall, Christopher B.; Ho, Jason; Ishiyama, Noboru; Stambolic, Vuk; Ikura, Mitsuhiko] Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr & Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Ikura, Mitsuhiko] Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Ikura, M (corresponding author), Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.	mikura@uhnres.utoronto.ca	Marshall, Christopher/K-8943-2019	Marshall, Christopher/0000-0002-7571-5700; Stambolic, Vuk/0000-0001-8853-3239; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877; Ikura, Mitsuhiko/0000-0002-9524-1303	Canada Foundation for Innovation	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank Aiping Dong from the Structural Genomics Consortium and Doug Kuntz for x-ray data collection. NMR spectrometers were funded by the Canada Foundation for Innovation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Goddard T. D., 2008, SPARKY 3; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jiang H, 2008, ONCOGENE, V27, P5729, DOI 10.1038/onc.2008.180; JOHN J, 1993, J BIOL CHEM, V268, P923; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lee MN, 2013, CELL SIGNAL, V25, P539, DOI 10.1016/j.cellsig.2012.11.006; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Marshall CB, 2012, METHODS, V57, P473, DOI 10.1016/j.ymeth.2012.06.014; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mazhab-Jafari MT, 2012, STRUCTURE, V20, P1528, DOI 10.1016/j.str.2012.06.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Sung YJ, 1996, J BIOL CHEM, V271, P30537, DOI 10.1074/jbc.271.48.30537; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	31	10	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12195	12201		10.1074/jbc.C113.543736	http://dx.doi.org/10.1074/jbc.C113.543736			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648513	Green Published, hybrid			2022-12-25	WOS:000335581400002
J	Hill, J; Kayentao, K; Toure, M; Diarwara, S; Bruce, J; Smedley, J; Doumbo, OK; ter Kuile, FO; Webster, J				Hill, Jenny; Kayentao, Kassoum; Toure, Mahamoudou; Diarwara, Sory; Bruce, Jane; Smedley, James; Doumbo, Ogobara K.; ter Kuile, Feiko O.; Webster, Jayne			Effectiveness of Antenatal Clinics to Deliver Intermittent Preventive Treatment and Insecticide Treated Nets for the Control of Malaria in Pregnancy in Mali: A Household Survey	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PRESUMPTIVE TREATMENT; WOMEN; METAANALYSIS; TANZANIA; COVERAGE; THERAPY; AFRICA	Background: WHO recommends intermittent-preventive-treatment (IPTp) with sulphadoxine-pyrimethamine (SP) and insecticide-treated-nets (ITNs) to prevent malaria in pregnancy in sub-Saharan Africa, however uptake remains unacceptably low. We evaluated the effectiveness of antenatal clinics (ANC) to deliver two doses of IPTp and ITNs to pregnant women in Segou district, Mali. Methods: We used household data to assess the systems effectiveness of ANC to deliver IPTp and ITNs to pregnant women and used logistic regression to identify predictors of ANC attendance, receipt of IPTp and ITN use during pregnancy, and the impact on community effectiveness. Results: Of 81% of recently pregnant women who made at least one ANC visit, 59% of these attended during the eligible gestational age for IPTp. Of these, 82% reported receiving one dose of SP and 91% attended ANC again, of whom 66% received a second dose, resulting in a cumulative effectiveness for 2-dose IPTp of 29%, most of whom used an ITN (90%). Cumulative effectiveness of 2-dose SP by directly observed therapy (DOT) was very low (6%). ITN use was 92%, and ANC was the main source (81%). Reported and ANC-card data showed some doses of SP are given to women in their first trimester. Women were less likely to receive two doses by DOT if they were married (OR 0.10; CI 0.03, 0.40), or lived <5 km from the health facility (OR 0.34; CI 0.14, 0.83). A high household person-LLIN ratio predicted low ITN use in pregnant women (OR 0.16; CI 0.04, 0.55). Conclusion: Our findings suggest poor adherence by health workers to provision of IPTp by eligible gestational age and DOT, contributing to low effectiveness of this strategy in this setting. ITN delivery and use among women was substantially higher. Efforts to improve health worker adherence to IPTp guidelines are needed to improve service delivery of IPTp.	[Hill, Jenny; Kayentao, Kassoum; Smedley, James; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Kayentao, Kassoum; Toure, Mahamoudou; Diarwara, Sory; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Bruce, Jane; Webster, Jayne] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Science & Technology of Bamako; University of London; London School of Hygiene & Tropical Medicine	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	j.hill@liv.ac.uk	Kuile, Feiko ter/ABD-6681-2020; Hill, Jenny/C-3839-2017	Kuile, Feiko ter/0000-0003-3663-5617; Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1991, NEPHRON, V59, P522, DOI 10.1159/000186630; [Anonymous], 2011, ROLL BACK MALARIA PA; [Anonymous], 2004, STRATEGIC FRAMEWORK; Baiden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028944; Cellule de Planification et de Statistique Ministere de la Sante Direction Nationale de la Statistique et de I'Informatique Ministere de I'Economie dlledC Bamako Mali, 2007, ENQ DEM SANT MAL 200; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Chico RM, 2011, TROP MED INT HLTH; Countdown to 2015, 2010, TRACK PROGR MAT NEWB; Diala C, 2012, BARRIERS UPTAKE MALA; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Gross K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-140; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064913; Iliyasu Z, 2012, PATHOG GLOB HEALTH, V106, P323, DOI 10.1179/2047773212Y.0000000037; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035; Programme National de Lutte Contre le Paludisme MInistere de al Sante Organisation Mondiale de la Sante, 2006, POL NAT LUTT PAL MAL; Ridde V, 2004, Sante Publique, V16, P37; Roll Back Malaria MEASURE Evaluation USAID UNICEF World Health Organization, 2009, RBMWG2009TP1 USAID U; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webster J, 2011, THESIS LONDON SCH HY; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067520; Webster J, 2010, AM J TROP MED HYG, V82, P672, DOI 10.4269/ajtmh.2010.09-0473; World Health Organisation, 2006, MAL PREGN GUID MEAS; World Health Organization, 2012, UPD WHO POL REC OCT; Worrall E, 2007, LANCET INFECT DIS, V7, P156, DOI 10.1016/S1473-3099(07)70027-0	40	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92102	10.1371/journal.pone.0092102	http://dx.doi.org/10.1371/journal.pone.0092102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651078	Green Accepted, gold, Green Published			2022-12-25	WOS:000333352800070
J	Balestrino, F; Puggioli, A; Gilles, JRL; Bellini, R				Balestrino, Fabrizio; Puggioli, Arianna; Gilles, Jeremie R. L.; Bellini, Romeo			Validation of a New Larval Rearing Unit for Aedes albopictus (Diptera: Culicidae) Mass Rearing	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; ANOPHELES-ARABIENSIS; BORNE DISEASES; MOSQUITOS; SEPARATION; COMPETITION; AEGYPTI; PUPAE; DEVICE; REPLACEMENT	The mosquito larval rearing unit developed at the Insect Pest Control Laboratory (IPCL) of the FAO/IAEA Joint Division was evaluated for its potential use for Aedes albopictus (Skuse, 1895) mass rearing in support of the development of a sterile insect technique (SIT) package for this species. The use of the mass rearing trays and rack did not adversely affect larval development, pupation and survival rates and allowed the management of large larval rearing colonies with reduced space requirements in comparison with classical individual trays. The effects of larval density, water temperature and diet composition on pupal production and size differentiation for sex separation efficacy were analyzed for individual mass rearing trays as well as multiple trays stacked within the dedicated rack unit. Best results were obtained using eighteen thousand larvae per tray at a density of 3 larvae per ml of deionized water at a temperature of 28 degrees C on a diet consisting of 50% tuna meal, 36% bovine liver powder, 14% brewer's yeast and, as an additive, 0.2 gr of Vitamin Mix per 100 ml of diet solution. Pupae were harvested on the sixth day from larval introduction at L-1 stage and males were separated out by the use of a 1400 mu m sieve with 99.0% accuracy with a recovery rate of ca. 25% of the total available males. With the use of this larval rearing unit, an average production of 100,000 male pupae per week can be achieved in just 2 square meter of laboratory space. Compared to previous laboratory rearing method, the same pupal production and sex separation efficacy could only be achieved by use of ca. 200 plastic trays which required the space of two 5 square meter climatic-controlled rooms.	[Balestrino, Fabrizio; Gilles, Jeremie R. L.] IAEA, Div Nucl Tech Food & Agr, Int Atom Energy Agcy FAO IAEA, Insect Pest Control Lab,Joint Food & Agr Org, A-1400 Vienna, Austria; [Puggioli, Arianna; Bellini, Romeo] Ctr Agr Ambiente CAA G Nicoli, Med & Vet Entomol Dept, Crevalcore, Italy	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Balestrino, F (corresponding author), IAEA, Div Nucl Tech Food & Agr, Int Atom Energy Agcy FAO IAEA, Insect Pest Control Lab,Joint Food & Agr Org, A-1400 Vienna, Austria.	fabriziobalestrino@hotmail.com			Emilia-Romagna Regional Bureau - Public Health Department; FP7 Infrastructure project "INFRAVEC'' Research capacity for the implementation of genetic control of mosquitoes [228421]	Emilia-Romagna Regional Bureau - Public Health Department(Regione Emilia Romagna); FP7 Infrastructure project "INFRAVEC'' Research capacity for the implementation of genetic control of mosquitoes	This work was supported by grants from the Emilia-Romagna Regional Bureau - Public Health Department and from the FP7 Infrastructure project "INFRAVEC'' Research capacity for the implementation of genetic control of mosquitoes, grant 228421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; ANSARI MA, 1977, INDIAN J MED RES, V65, P91; Balestrino F, 2012, J MED ENTOMOL, V49, P595, DOI 10.1603/ME11188; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Balestrino F, 2013, J MED ENTOM IN PRESS, V51; Balestrino F, 2011, J AM MOSQUITO CONTR, V27, P227, DOI 10.2987/10-6085.1; BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Bellini R., 2005, THESIS U BOLOGNA ITA; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Briegel H, 2003, J VECTOR ECOL, V28, P1; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; FOLGER HT, 1946, PHYSIOL ZOOL, V19, P190, DOI 10.1086/physzool.19.2.30151892; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Ikeshoji T., 1981, Japanese Journal of Sanitary Zoology, V32, P7; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; LOWE RE, 1981, MOSQ NEWS, V41, P634; MCCRAY EM, 1961, J ECON ENTOMOL, V54, P819, DOI 10.1093/jee/54.4.819; Medici A, 2011, J ECON ENTOMOL, V104, P266, DOI 10.1603/EC10108; Mellanby K., 1958, Entomologia Experimentalis et Applicata, V1, P153, DOI 10.1007/BF00291058; MOORE CG, 1972, ANN ENTOMOL SOC AM, V65, P915, DOI 10.1093/aesa/65.4.915; MORI A, 1979, Tropical Medicine, V21, P85; OMARDEEN T. A., 1957, BULL ENT RES, V48, P349, DOI 10.1017/S0007485300047180; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; SHARMA VP, 1972, B WORLD HEALTH ORGAN, V47, P429; SHUEY JA, 1987, J AM MOSQUITO CONTR, V3, P65; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; THOMAS IM, 1950, AUST J SCI RES SER B, V3, P113, DOI 10.1071/BI9500113; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; WHO/TDR, 2010, PLANN M 1 TECHN CONS; Wilke AB, 2009, ASIA PACIFIC J MOL B, V17, P65; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x; Yamada H, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-197	45	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91914	10.1371/journal.pone.0091914	http://dx.doi.org/10.1371/journal.pone.0091914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647347	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500059
J	Bartels, DJP; van Laarhoven, AIM; Haverkamp, EA; Wilder-Smith, OH; Donders, ART; van Middendorp, H; van de Kerkhof, PCM; Evers, AWM				Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Haverkamp, Elise A.; Wilder-Smith, Oliver H.; Donders, A. Rogier T.; van Middendorp, Henriet; van de Kerkhof, Peter C. M.; Evers, Andrea W. M.			Role of Conditioning and Verbal Suggestion in Placebo and Nocebo Effects on Itch	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MOTION SICKNESS; DAILY STRESSORS; ANALGESIA; PAIN; EXPECTATIONS; PERSONALITY; VALIDATION; EXPECTANCY; PSORIASIS	Placebo and nocebo effects are known to play a key role in treatment effects in a wide variety of conditions. These effects have frequently been investigated with regard to pain and also in other physical sensations, but have hardly been investigated with regard to itch. In addition, neither in pain nor in any other physical sensation, the single and combined contribution of the expectancy mechanisms of conditioning and verbal suggestion have ever been investigated in both placebo and nocebo effects within one design. For the first time, the role of verbal suggestion and conditioning in placebo and nocebo effects on itch was experimentally investigated. Expectations about itch stimuli were induced in healthy subjects by verbal suggestion, conditioning, or a combination of both procedures, and compared with a control group without expectation induction. Itch was induced electrically by means of quantitative sensory testing. Significant placebo and nocebo effects were induced in the group in which combined procedures of conditioning and verbal suggestion were applied in comparison with the control group. The conditioning and verbal suggestion procedures applied individually did not induce significant placebo and nocebo effects when compared with the control group. The results of this study extend existing evidence on different physical sensations, like pain, by showing that also for itch, the combination of conditioning and verbal suggestion is most promising in inducing both placebo and nocebo effects. More research on placebo and nocebo effects at a perceptive and neurobiological level is warranted to further elucidate the common and specific mechanisms underlying placebo and nocebo effects on itch and other physical sensations.	[Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Inst Psychol, Unit Hlth Med & Neuropsychol, Leiden, Netherlands; [Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Haverkamp, Elise A.; van Middendorp, Henriet; Evers, Andrea W. M.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Wilder-Smith, Oliver H.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [Donders, A. Rogier T.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [van de Kerkhof, Peter C. M.] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bartels, DJP (corresponding author), Leiden Univ, Inst Psychol, Unit Hlth Med & Neuropsychol, Leiden, Netherlands.	D.Bartels@fsw.leidenuniv.nl	Evers, Andrea/GWV-9705-2022; van Middendorp, Henriet/B-8300-2013; Evers, Andrea/U-8983-2019; Wilder-Smith, Oliver H.G./E-7541-2012; van de Kerkhof, P.C.M./H-8059-2014; Evers, A.W.M./L-4299-2015; Donders, A.R.T./L-4277-2015	Evers, Andrea/0000-0002-0090-5091; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; Donders, A.R.T./0000-0002-0484-1419; van Laarhoven, Antoinette/0000-0001-6932-9283; van Middendorp, Henriet/0000-0003-4575-0895	Netherlands Organization for Scientific Research (NOW)	Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO))	This work is financed by the Netherlands Organization for Scientific Research (NOW, http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Brouwer D, 2008, PSYCHOL ASSESSMENT, V20, P310, DOI 10.1037/1040-3590.20.3.310; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2013, PAIN, V154, P511, DOI 10.1016/j.pain.2013.02.002; Colloca L, 2011, PSYCHOSOM MED, V73, P598, DOI 10.1097/PSY.0b013e3182294a50; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Eysenck HJ, 1975, EPQ EYSENCK PERSONAL; Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011; Geers AL, 2007, J PSYCHOSOM RES, V62, P563, DOI 10.1016/j.jpsychores.2006.12.005; Holle H, 2012, P NATL ACAD SCI USA, V109, P19816, DOI 10.1073/pnas.1216160109; Horing B, 2013, PSYCHOSOM MED, V75, P497, DOI 10.1097/PSY.0b013e3182915ee7; Ikoma A, 2005, PAIN, V113, P148, DOI 10.1016/j.pain.2004.10.003; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Klinger R, 2007, PAIN, V128, P31, DOI 10.1016/j.pain.2006.08.025; Klosterhalfen S, 2000, PSYCHOSOM MED, V62, P671, DOI 10.1097/00006842-200009000-00011; Lee HF, 2012, PAIN, V153, P1301, DOI 10.1016/j.pain.2012.03.018; Martin-Pichora Andrea L, 2011, J Pain Res, V4, P67, DOI 10.2147/JPR.S15966; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Morton DL, 2009, PAIN, V146, P194, DOI 10.1016/j.pain.2009.07.026; Musial F, 2007, WORLD J GASTROENTERO, V13, P3425, DOI 10.3748/wjg.v13.i25.3425; Niemeier V., 2000, DERMATOL PSYCHOSOM, V1, P15, DOI [10.1159/000057993, DOI 10.1159/000057993]; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Pecina M, 2013, NEUROPSYCHOPHARMACOL, V38, P639, DOI 10.1038/npp.2012.227; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schneider G, 2006, CLIN EXP DERMATOL, V31, P762, DOI 10.1111/j.1365-2230.2006.02211.x; Scholz O, 1994, Z KLIN PSYCHOL-FORSC, V23, P127; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; van Laarhoven AIM, 2012, BRIT J DERMATOL, V167, P262, DOI 10.1111/j.1365-2133.2012.10933.x; van Laarhoven AIM, 2011, PAIN, V152, P1486, DOI 10.1016/j.pain.2011.01.043; Verhoeven EWM, 2009, BRIT J DERMATOL, V161, P295, DOI 10.1111/j.1365-2133.2009.09194.x; Verhoeven EWM, 2008, ACTA DERM-VENEREOL, V88, P211, DOI 10.2340/00015555-0452; Verhoeven EWM, 2009, J INVEST DERMATOL, V129, P2075, DOI 10.1038/jid.2008.460; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	86	87	2	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91727	10.1371/journal.pone.0091727	http://dx.doi.org/10.1371/journal.pone.0091727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646924	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500049
J	Liao, YX; Shen, WF; Kong, GM; Lv, HN; Tao, WH; Bo, P				Liao, Yuexia; Shen, Weigan; Kong, Guimei; Lv, Houning; Tao, Wenhua; Bo, Ping			Apigenin Induces the Apoptosis and Regulates MAPK Signaling Pathways in Mouse Macrophage ANA-1 Cells	PLOS ONE			English	Article							INFLAMMATION; FLAVONOIDS; KINASE; P38	Apigenin is a naturally occurring plant flavonoid that possesses antioxidant, anti-cancer and anti-inflammatory properties. However, there are few reports has been done on the ability of apigenin to induce apoptosis in macrophages. In this study, mouse macrophage ANA-1 cells were incubated with different concentrations of apigenin. The cell viability was determined by an MTT assay. The cell apoptosis were analyzed by flow cytometric analysis. Apoptosis were also analyzed using a TUNEL assay and a DNA ladder. The level of intracellular ROS was detected using a dichlorofluorescein -diacetate probe. The expression levels of apoptosis-related proteins were detected by western blot analysis. The results showed that apigenin decreased the viability of ANA-1 cells and induced apoptosis in a dose-and time-dependent manner. Apigenin increased the level of intracellular ROS, downregulated the expression of Bcl-2 and upregulated the expression of caspase-3 and caspase-8 in ANA-1 cells. Furthermore, apigenin downregulated the expression of phospho-ERK and phospho-JNK, upregulated the expression of phospho-p38 and had no significant effect on the expression of Bax, ERK, JNK and p38. The results suggested that apigenin induced cell apoptosis in mouse macrophage ANA-1 cells may via increasing intracellular ROS, regulating the MAPK pathway, and then inhibiting Bcl-2 expression.	[Liao, Yuexia; Kong, Guimei; Tao, Wenhua; Bo, Ping] Yangzhou Univ, Sch Med, Dept Chinese Med Integrated Western Med, Yangzhou, Peoples R China; [Shen, Weigan] Yangzhou Univ, Sch Med, Dept Cell Biol, Yangzhou, Peoples R China; [Lv, Houning] Yangzhou Univ, Sch Med, Dept Med, Yangzhou, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Bo, P (corresponding author), Yangzhou Univ, Sch Med, Dept Chinese Med Integrated Western Med, Yangzhou, Peoples R China.	yangzboping@163.com			National Natural Science Foundation of China [30873343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30873343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Blanchette J, 2009, IMMUNOLOGY, V127, P123, DOI 10.1111/j.1365-2567.2008.02929.x; Bolego C, 2013, ARTERIOSCL THROM VAS, V33, P1127, DOI 10.1161/ATVBAHA.113.301328; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Chakrabarti M, 2013, J MOL NEUROSCI; Cohen-Saidon C, 2006, BLOOD, V107, P1413, DOI 10.1182/blood-2005-07-2648; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Grey ADNJ, 2006, FREE RADICAL RES, V40, P1244, DOI 10.1080/10715760600913176; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Han JY, 2012, BIOL PHARM BULL, V35, P1440, DOI 10.1248/bpb.b110686; Hristodorov D, 2012, TOXINS, V4, P676, DOI 10.3390/toxins4090676; Kang OH, 2011, IMMUNOPHARM IMMUNOT, V33, P473, DOI 10.3109/08923973.2010.538851; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kim SH, 2013, MOL CELL ENDOCRINOL, V369, P130, DOI 10.1016/j.mce.2013.01.012; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Lordan S, 2008, BRIT J NUTR, V100, P287, DOI 10.1017/S0007114507898643; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Milisav I, 2012, INT J MOL SCI, V13, P10771, DOI 10.3390/ijms130910771; Mounho BJ, 1999, TOXICOL APPL PHARM, V159, P125, DOI 10.1006/taap.1999.8740; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Park WH, 2013, ONCOL LETT, V5, P1633, DOI 10.3892/ol.2013.1216; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sagaert X, 2012, VIRCHOWS ARCH, V460, P555, DOI 10.1007/s00428-012-1244-9; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Tang X, 2012, IMMUNOLOGY; Taylor CA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-35; Tong X, 2013, ANTICANCER AGENTS ME; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Wang J, 2012, INFLAMMATION, V35, P1466, DOI 10.1007/s10753-012-9460-7; Wang LL, 2012, TOXICOL LETT, V209, P193, DOI 10.1016/j.toxlet.2011.12.014; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Yoon O, 2012, ONCOL LETT, V4, P1033, DOI 10.3892/ol.2012.834	39	27	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92007	10.1371/journal.pone.0092007	http://dx.doi.org/10.1371/journal.pone.0092007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646936	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500070
J	Lim, R; Morwood, CJ; Barker, G; Lappas, M				Lim, Ratana; Morwood, Carrington J.; Barker, Gillian; Lappas, Martha			Effect of Silibinin in Reducing Inflammatory Pathways in In Vitro and In Vivo Models of Infection-Induced Preterm Birth	PLOS ONE			English	Article							FACTOR-KAPPA-B; HUMAN FETAL MEMBRANES; PROLABOR MEDIATORS; MILK THISTLE; PROINFLAMMATORY CYTOKINES; PREMATURE RUPTURE; HUMAN PLACENTA; MYELOID CELLS; HUMAN LABOR; EXPRESSION	Infection-induced preterm birth is the largest cause of infant death and of neurological disabilities in survivors. Silibinin, from milk thistle, exerts potent anti-inflammatory activities in non-gestational tissues. The aims of this study were to determine the effect of silibinin on pro-inflammatory mediators in (i) human fetal membranes and myometrium treated with bacterial endotoxin lipopolysaccharide (LPS) or the pro-inflammatory cytokine IL-1 beta, and (ii) in preterm fetal membranes with active infection. The effect of silibinin on infection induced inflammation and brain injury in pregnant mice was also assessed. Fetal membranes and myometrium (tissue explants and primary cells) were treated with 200 mu M silibinin in the presence or absence of 10 mu g/ml LPS or 1 ng/ml IL-1 beta. C57BL/6 mice were injected with 70 mg/kg silibinin with or without 50 mu g LPS on embryonic day 16. Fetal brains were collected after 6 h. In human fetal membranes, silibinin significantly decreased LPS-stimulated expression of IL-6 and IL-8, COX-2, and prostaglandins PGE(2) and PGF(2 alpha). In primary amnion and myometrial cells, silibinin also decreased IL-1 beta-induced MMP-9 expression. Preterm fetal membranes with active infection treated with silibinin showed a decrease in IL-6, IL-8 and MMP-9 expression. Fetal brains from mice treated with silibinin showed a significant decrease in LPS-induced IL-8 and ninjurin, a marker of brain injury. Our study demonstrates that silibinin can reduce infection and inflammation-induced pro-labour mediators in human fetal membranes and myometrium. Excitingly, the in vivo results indicate a protective effect of silibinin on infection-induced brain injury in a mouse model of preterm birth.	[Lim, Ratana; Morwood, Carrington J.; Barker, Gillian; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia; [Lim, Ratana; Morwood, Carrington J.; Barker, Gillian; Lappas, Martha] Univ Melbourne, Obstet Nutr & Endocrinol Grp, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia	University of Melbourne	Lappas, M (corresponding author), Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au			National Health and Medical Research Council (NHMRC) [1047025]; University of Melbourne; Austin Hospital Medical Research Foundation (AMRF); Medical Research Foundation for Women and Babies; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Austin Hospital Medical Research Foundation (AMRF); Medical Research Foundation for Women and Babies; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation	Associate Professor Martha Lappas was in recipient of a National Health and Medical Research Council (NHMRC) Career Development Award (grant no. 1047025). Dr. Ratana Lim was, in part, supported by an early career researcher grant from the University of Melbourne. This work was supported by the Austin Hospital Medical Research Foundation (AMRF), Medical Research Foundation for Women and Babies, and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici A, 2012, OBSTET GYN CLIN N AM, V39, P77, DOI 10.1016/j.ogc.2011.12.003; Agarwal R, 2006, ANTICANCER RES, V26, P4457; Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Alfirevic Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6531; Au AY, 2011, J VET PHARMACOL THER, V34, P120, DOI 10.1111/j.1365-2885.2010.01200.x; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BENNETT PR, 1987, AM J OBSTET GYNECOL, V156, P649, DOI 10.1016/0002-9378(87)90070-6; Bhupathiraju SN, 2013, AM J CLIN NUTR; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Chawanpaiboon Saifon, 2012, Journal of the Medical Association of Thailand, V95, P636; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Choi YH, 2012, BIOCHEM BIOPH RES CO, V427, P450, DOI 10.1016/j.bbrc.2012.07.112; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; Deep G, 2007, INTEGR CANCER THER, V6, P130, DOI 10.1177/1534735407301441; Denison FC, 1998, HUM REPROD, V13, P3560, DOI 10.1093/humrep/13.12.3560; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Galinsky R, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/412831; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gross G, 2000, AM J PHYSIOL-REG I, V278, pR1415, DOI 10.1152/ajpregu.2000.278.6.R1415; Hackett ES, 2013, J VET INTERN MED, V27, P10, DOI 10.1111/jvim.12002; Helmer H, 2002, J SOC GYNECOL INVEST, V9, P15, DOI 10.1016/S1071-5576(01)00142-3; Hoh C, 2006, CLIN CANCER RES, V12, P2944, DOI 10.1158/1078-0432.CCR-05-2724; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Giorgi VSI, 2012, J REPROD IMMUNOL, V95, P67, DOI 10.1016/j.jri.2012.06.004; Kaga N, 1996, AM J OBSTET GYNECOL, V174, P754, DOI 10.1016/S0002-9378(96)70460-X; Kang JS, 2004, BIOCHEM PHARMACOL, V67, P175, DOI 10.1016/j.bcp.2003.08.032; Kaukola T, 2006, PEDIATR RES, V59, P478, DOI 10.1203/01.pdr.0000182596.66175.ee; Kaur M, 2009, MOL CANCER THER, V8, P2366, DOI 10.1158/1535-7163.MCT-09-0304; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim BR, 2013, INFLAMM RES; Kovacevic Z, 2011, CURR TOP MED CHEM, V11, P483, DOI 10.2174/156802611794785190; Ladas EJ, 2003, J ALTERN COMPLEM MED, V9, P411, DOI 10.1089/107555303765551633; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P2365, DOI 10.1210/jc.2003-031385; Lappas M, 2011, PLACENTA, V32, P1016, DOI 10.1016/j.placenta.2011.09.011; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lappas M, 2013, J REPROD IMMUNOL, V99, P24, DOI 10.1016/j.jri.2013.04.005; Lappas M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110056; Lee PR, 2003, AM J OBSTET GYNECOL, V189, P261, DOI 10.1067/mob.2003.485; Lee Y, 2003, MOL HUM REPROD, V9, P213, DOI 10.1093/molehr/gag026; Li JF, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-18; Lim R, 2013, REPROD SCI, V20, P957, DOI 10.1177/1933719112472741; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108126; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105163; Liu WW, 2013, FEBS J, V280, P4572, DOI 10.1111/febs.12426; Lu P, 2009, BRIT J PHARMACOL, V157, P1270, DOI 10.1111/j.1476-5381.2009.00295.x; Mateen S, 2010, MOL CARCINOGEN, V49, P247, DOI 10.1002/mc.20595; McClure J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041832; MEISS R, 1982, AGENTS ACTIONS, V12, P254; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Myhre R, 2013, J NUTR, V143, P1100, DOI 10.3945/jn.112.173229; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Park SW, 2010, J PHARMACOL EXP THER, V333, P736, DOI 10.1124/jpet.110.166884; Parrish MR, 2013, J PERINATOL, V33, P593, DOI 10.1038/jp.2013.18; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Pedersen L, 2011, J PHYSIOL-LONDON, V589, P1409, DOI 10.1113/jphysiol.2010.200733; Raina K, 2013, MOL CARCINOGEN, V52, P195, DOI 10.1002/mc.21843; Rauk PN, 2000, AM J REPROD IMMUNOL, V43, P152, DOI 10.1111/j.8755-8920.2000.430304.x; Redline RW, 2007, PEDIATR DEVEL PATHOL, V10, P282, DOI 10.2350/06-12-0203.1; Roos C, 2013, JAMA-J AM MED ASSOC, V309, P41, DOI 10.1001/jama.2012.153817; Salim R, 2012, OBSTET GYNECOL, V120, P1323, DOI [10.1097/AOG.0b013e3182755dff, http://10.1097/AOG.0b013e3182755dff]; Sebastian BM, 2011, J BIOL CHEM, V286, P35989, DOI 10.1074/jbc.M111.254201; Sennstrom MB, 2000, MOL HUM REPROD, V6, P375, DOI 10.1093/molehr/6.4.375; Singh RP, 2002, CANCER RES, V62, P3063; Sparey C, 1999, J CLIN ENDOCR METAB, V84, P1705, DOI 10.1210/jc.84.5.1705; Suppiej A, 2009, EARLY HUM DEV, V85, P187, DOI 10.1016/j.earlhumdev.2008.09.410; Tamayo C, 2007, INTEGR CANCER THER, V6, P146, DOI 10.1177/1534735407301942; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; Wall C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/485201; Wang Q, 2012, J ASIAN NAT PROD RES, V14, P688, DOI 10.1080/10286020.2012.685725; Wang QO, 2011, PHARMACOL BIOCHEM BE, V98, P140, DOI 10.1016/j.pbb.2010.12.006; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445	83	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92505	10.1371/journal.pone.0092505	http://dx.doi.org/10.1371/journal.pone.0092505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647589	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500139
J	Sanner, H; Schwartz, T; Flato, B; Vistnes, M; Christensen, G; Sjaastad, I				Sanner, Helga; Schwartz, Thomas; Flato, Berit; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar			Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; PROGNOSTIC-FACTORS; CHEMOKINES; CHILDREN; CHEMOATTRACTANT; INTERLEUKIN-18; ANTAGONIST; CYTOKINES; ARTHRITIS; FIBROSIS	Objective: To compare cytokine profiles in patients with juvenile dermatomyositis (JDM) after medium to long-term follow-up with matched controls, and to examine associations between cytokine levels and disease activity, disease duration and organ damage. Methods: Fifty-four JDM patients were examined median 16.8 years (2-38) after disease onset (follow-up) and compared with 54 sex- and age-matched controls. Cytokine concentrations in serum were quantified by Luminex technology. In patients, disease activity score (DAS), myositis damage index (MDI) and other disease parameters were collected by chart review (early parameters) and clinical examination (follow-up). Results: Serum levels of eotaxin, monocyte chemoattractant protein-1 (MCP-1) and interferon-inducible protein 10 (IP-10) were elevated in JDM patients compared to controls (31.5%, 37.2% and 43.2% respectively, all p<0.05). Patients with active (n = 28), but not inactive disease (n = 26) had a higher level of MCP-1 than their respective controls. Levels of eotaxin and MCP-1 correlated with disease duration (r = 0.47 and r = 0.64, both p<0.001) and age in patients, but not with age in controls. At follow-up, MDI was associated with MCP-1(standardized beta = 0.43, p = 0.002) after adjusting for disease duration and gender. High MDI 1 year post-diagnosis predicted high levels of eotaxin and MCP-1 at follow-up (standardized beta = 0.24 and 0.29, both p<0.05) after adjusting for disease duration and gender. Conclusion: Patients with JDM had higher eotaxin, MCP-1 and IP-10 than controls. High eotaxin and MCP-1 at follow-up was predicted by early disease parameters, and MCP-1 was associated with organ damage at follow-up, highlighting a role of these chemokines in JDM.	[Sanner, Helga; Flato, Berit] Univ Oslo, Rikshosp, Oslo Univ Hosp, Rheumatol Sect, N-0027 Oslo, Norway; [Sanner, Helga] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian Competence Ctr Pediat & Adolescent Rheu, N-0027 Oslo, Norway; [Schwartz, Thomas; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar] Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway; [Schwartz, Thomas; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Schwartz, Thomas; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Schwartz, Thomas; Flato, Berit] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sjaastad, Ivar] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Schwartz, T (corresponding author), Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway.	thomas.schwartz@medisin.uio.no		Vistnes, Maria/0000-0002-6243-0626				Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Bilgic H, 2009, ARTHRITIS RHEUM-US, V60, P3436, DOI 10.1002/art.24936; Bode RK, 2003, ARTHRIT RHEUM-ARTHR, V49, P7, DOI 10.1002/art.10924; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; FELDMAN BM, 1995, J RHEUMATOL, V22, P326; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Fujii H, 2011, ARTHRITIS RHEUM-US, V63, P96, DOI 10.1002/art.30106; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gono T, 2010, RHEUMATOLOGY, V49, P1878, DOI 10.1093/rheumatology/keq196; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; Isenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Lazarevic D, 2013, ANN RHEUM DIS, V72, P686, DOI 10.1136/annrheumdis-2012-201483; Martinelli R, 2001, J BIOL CHEM, V276, P42957, DOI 10.1074/jbc.M103933200; Mathiesen PR, 2010, CLIN EXP RHEUMATOL, V28, P782; McCann LJ, 2006, RHEUMATOLOGY, V45, P1255, DOI 10.1093/rheumatology/kel099; Mielnik P, 2012, RHEUMATOL INT, V32, P639, DOI 10.1007/s00296-010-1692-y; Morokata T, 2006, J PHARMACOL EXP THER, V317, P244, DOI 10.1124/jpet.105.097048; Niewold TB, 2009, ARTHRITIS RHEUM, V60, P1815, DOI 10.1002/art.24555; OPPENHEIM JJ, 2001, CYTOKINE REFERENCE, P3; Pachman LM, 2006, J PEDIATR-US, V148, P247, DOI 10.1016/j.jpeds.2005.10.032; Ravelli A, 2010, ARTHRIT CARE RES, V62, P63, DOI 10.1002/acr.20015; Sanner H, 2014, RHEUMATOLOG IN PRESS; Sanner H, 2011, ANN RHEUM DIS, V70, P86, DOI 10.1136/ard.2010.131433; Sanner H, 2010, ARTHRIT CARE RES, V62, P1103, DOI 10.1002/acr.20203; Sanner H, 2009, RHEUMATOLOGY, V48, P1541, DOI 10.1093/rheumatology/kep302; Schwartz T, 2013, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-, DOI 10.1136/ANNRHEUMDIS-2013-]; Schwartz T, 2011, ANN RHEUM DIS, V70, P766, DOI 10.1136/ard.2010.137968; Sultan SM, 2002, RHEUMATOLOGY, V41, P22, DOI 10.1093/rheumatology/41.1.22; Szodoray P, 2010, RHEUMATOLOGY, V49, P1867, DOI 10.1093/rheumatology/keq151; Tacke F, 2007, J GASTROEN HEPATOL, V22, P1256, DOI 10.1111/j.1440-1746.2006.04621.x; Tucci M, 2006, CLIN EXP IMMUNOL, V146, P21, DOI 10.1111/j.1365-2249.2006.03180.x; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; Vistnes M, 2010, J APPL PHYSIOL, V108, P1357, DOI 10.1152/japplphysiol.01084.2009; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39; Zweifel M, 2010, TRANSPL P, V42, P2763, DOI 10.1016/j.transproceed.2010.05.152	39	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92171	10.1371/journal.pone.0092171	http://dx.doi.org/10.1371/journal.pone.0092171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647150	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500094
J	Xu, W; Chen, H; He, CL; Wang, Q				Xu, Wen; Chen, Hui; He, Chen-Liu; Wang, Qiang			Deep Sequencing-Based Identification of Small Regulatory RNAs in Synechocystis sp PCC 6803	PLOS ONE			English	Article							SMALL NONCODING RNAS; PLASMID COPY NUMBER; ANTISENSE-RNA; 6S RNA; GENE-EXPRESSION; PHOTOSYSTEM-I; P RNA; STRAIN; LIGHT; PREDICTION	Synechocystis sp. PCC 6803 is a genetically tractable model organism for photosynthesis research. The genome of Synechocystis sp. PCC 6803 consists of a circular chromosome and seven plasmids. The importance of small regulatory RNAs (sRNAs) as mediators of a number of cellular processes in bacteria has begun to be recognized. However, little is known regarding sRNAs in Synechocystis sp. PCC 6803. To provide a comprehensive overview of sRNAs in this model organism, the sRNAs of Synechocystis sp. PCC 6803 were analyzed using deep sequencing, and 7,951,189 reads were obtained. High quality mapping reads (6,127,890) were mapped onto the genome and assembled into 16,192 transcribed regions (clusters) based on read overlap. A total number of 5211 putative sRNAs were revealed from the genome and the 4 megaplasmids, and 27 of these molecules, including four from plasmids, were confirmed by RT-PCR. In addition, possible target genes regulated by all of the putative sRNAs identified in this study were predicted by IntaRNA and analyzed for functional categorization and biological pathways, which provided evidence that sRNAs are indeed involved in many different metabolic pathways, including basic metabolic pathways, such as glycolysis/gluconeogenesis, the citrate cycle, fatty acid metabolism and adaptations to environmentally stress-induced changes. The information from this study provides a valuable reservoir for understanding the sRNA-mediated regulation of the complex physiology and metabolic processes of cyanobacteria.	[Xu, Wen; Chen, Hui; He, Chen-Liu; Wang, Qiang] Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China; [Xu, Wen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China.	wangqiang@ihb.ac.cn	Chen, Hui/T-4383-2019; Wang, Qiang/P-7806-2016	Wang, Qiang/0000-0002-7388-4703	National Program on Key Basic Research Project [2011CB200902]; National Natural Science Foundation of China [31270094]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported jointly by the National Program on Key Basic Research Project (2011CB200902) and the National Natural Science Foundation of China (31270094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Axmann IM, 2007, GENE, V406, P69, DOI 10.1016/j.gene.2007.06.011; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Coornaert A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003156; CSISZAR K, 1987, GENE, V60, P29, DOI 10.1016/0378-1119(87)90210-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Eisenhut M, 2012, J BIOL CHEM, V287, P33153, DOI 10.1074/jbc.M112.391755; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Fujimori T, 2005, J BIOL CHEM, V280, P22191, DOI 10.1074/jbc.M500369200; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Hernandez JA, 2010, J PLANT PHYSIOL, V167, P430, DOI 10.1016/j.jplph.2009.10.009; Hess WR, 1998, FEBS LETT, V431, P138, DOI 10.1016/S0014-5793(98)00729-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Ikeuchi M, 1996, Tanpakushitsu Kakusan Koso, V41, P2579; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P1809, DOI 10.1093/pcp/pch207; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; Kurpiel PM, 2012, J ANTIMICROB CHEMOTH, V67, P339, DOI 10.1093/jac/dkr479; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Okibe N, 2010, MICROBIOL-SGM, V156, P3609, DOI 10.1099/mic.0.043745-0; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Sakurai I, 2012, PLANT PHYSIOL, V160, P1000, DOI 10.1104/pp.112.202127; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; Schon A, 2002, INT J SYST EVOL MICR, V52, P1383, DOI 10.1099/ijs.0.01983-0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Tous C, 2001, J BIOL CHEM, V276, P29059, DOI 10.1074/jbc.M103418200; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; VIOQUE A, 1992, NUCLEIC ACIDS RES, V20, P6331, DOI 10.1093/nar/20.23.6331; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Voss B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-375; Voss B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060224; Voss B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-123; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Watanabe T, 1997, FEBS LETT, V416, P302, DOI 10.1016/S0014-5793(97)01237-4; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weaver KE, 2007, CURR OPIN MICROBIOL, V10, P110, DOI 10.1016/j.mib.2007.03.002; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x	67	17	18	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92711	10.1371/journal.pone.0092711	http://dx.doi.org/10.1371/journal.pone.0092711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647397	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500152
J	Ekert, JE; Johnson, K; Strake, B; Pardinas, J; Jarantow, S; Perkinson, R; Colter, DC				Ekert, Jason E.; Johnson, Kjell; Strake, Brandy; Pardinas, Jose; Jarantow, Stephen; Perkinson, Robert; Colter, David C.			Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro - Implication for Drug Development	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; C-MET ANTIBODY; CANCER-CELLS; MULTICELLULAR SPHEROIDS; ERLOTINIB RESISTANCE; KINASE INHIBITORS; ANTICANCER DRUGS; PROSTATE-CANCER; CARCINOMA-CELLS; CROSS-TALK	Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular models that better mimic physiologic tissues. Spheroids are one such 3D model where clusters of cells will undergo self-assembly to form viable, 3D tumor-like structures. However, to date little is known about how spheroid biology compares to that of the more traditional and widely utilized 2D monolayer cultures. Therefore, the goal of this study was to characterize the phenotypic and functional differences between lung tumor cells grown as 2D monolayer cultures, versus cells grown as 3D spheroids. Eight lung tumor cell lines, displaying varying levels of epidermal growth factor receptor (EGFR) and cMET protein expression, were used to develop a 3D spheroid cell culture model using low attachment U-bottom plates. The 3D spheroids were compared with cells grown in monolayer for 1) EGFR and cMET receptor expression, as determined by flow cytometry, 2) EGFR and cMET phosphorylation by MSD assay, and 3) cell proliferation in response to epidermal growth factor (EGF) and hepatocyte growth factor (HGF). In addition, drug responsiveness to EGFR and cMET inhibitors (Erlotinib, Crizotinib, Cetuximab [Erbitux] and Onartuzumab [MetMab]) was evaluated by measuring the extent of cell proliferation and migration. Data showed that EGFR and cMET expression is reduced at day four of untreated spheroid culture compared to monolayer. Basal phosphorylation of EGFR and cMET was higher in spheroids compared to monolayer cultures. Spheroids showed reduced EGFR and cMET phosphorylation when stimulated with ligand compared to 2D cultures. Spheroids showed an altered cell proliferation response to HGF, as well as to EGFR and cMET inhibitors, compared to monolayer cultures. Finally, spheroid cultures showed exceptional utility in a cell migration assay. Overall, the 3D spheroid culture changed the cellular response to drugs and growth factors and may more accurately mimic the natural tumor microenvironment.	[Ekert, Jason E.; Pardinas, Jose; Jarantow, Stephen; Perkinson, Robert; Colter, David C.] Janssen R&D LLC, Biotechnol Ctr Excellence, Biol Res, Spring House, PA USA; [Johnson, Kjell] Arbor Analyt LLC, Ann Arbor, MI USA	Johnson & Johnson; Janssen Pharmaceuticals	Ekert, JE (corresponding author), Janssen R&D LLC, Biotechnol Ctr Excellence, Biol Res, Spring House, PA USA.	jekert@its.jnj.com			Janssen RD	Janssen RD	This research was supported by Janssen R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; Arrondeau J, 2010, DISCOV MED, V10, P355; BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Burga LN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2850; Castoldi R, 2013, ONCOGENE; Catros S, 2012, TISSUE ENG PART C-ME, V18, P62, DOI [10.1089/ten.tec.2011.0382, 10.1089/ten.TEC.2011.0382]; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; David L, 2008, ACTA BIOMATER, V4, P256, DOI 10.1016/j.actbio.2007.08.012; de Castro DG, 2013, CLIN PHARMACOL THER, V93, P252, DOI 10.1038/clpt.2012.237; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Graveel CR, 2013, COLD SPRING HARB PER, V5; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WJ, 2010, CANCER SCI, V101, P2637, DOI 10.1111/j.1349-7006.2010.01723.x; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kim SH, 2009, ARCH PHARM RES, V32, P915, DOI 10.1007/s12272-009-1614-2; Kiss DL, 2013, CYTOKINE, V64, P122, DOI 10.1016/j.cyto.2013.07.012; Kola I, 2008, CLIN PHARMACOL THER, V83, P227, DOI 10.1038/sj.clpt.6100479; Kurtze I, 2011, ONCOL REP, V25, P1021, DOI 10.3892/or.2011.1160; Lama R, 2013, BIOORGAN MED CHEM, V21, P922, DOI 10.1016/j.bmc.2012.12.007; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Liu TF, 2003, CANCER RES, V63, P1834; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; Moritz W, 2011, EFFECTIVE DETERMINAT; Nakagawa T, 2012, MOL CANCER THER, V11, P2149, DOI 10.1158/1535-7163.MCT-12-0195; Nedergaard MK, 2012, BIODRUGS, V26, P83, DOI 10.2165/11599760-000000000-00000; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Phung YT, 2011, J CANCER, V2, P507, DOI 10.7150/jca.2.507; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Puri Neelu, 2008, J Carcinog, V7, P9; Schulte A, 2013, NEUROONCOL; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Sun R, 2012, ONCOL LETT, V3, P1124, DOI 10.3892/ol.2012.613; Sundstrom L, 2012, EXPERT OPIN DRUG DIS, V7, P525, DOI 10.1517/17460441.2012.686488; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Takata M, 2012, CANCER BIOL THER, V13, P369, DOI 10.4161/cbt.19238; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Vinci Maria, 2013, Methods Mol Biol, V986, P253, DOI 10.1007/978-1-62703-311-4_16; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013; Workman P, 2011, CANCER CELL, V19, P437, DOI 10.1016/j.ccr.2011.03.020; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Yamada T, 2012, J THORAC ONCOL, V7, P272, DOI 10.1097/JTO.0b013e3182398e69; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	70	104	105	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92248	10.1371/journal.pone.0092248	http://dx.doi.org/10.1371/journal.pone.0092248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638075	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100133
J	Gramer, BM; Martinez, PD; Chin, AS; Sylvestre, MP; Larrivee, S; Stevens, LM; Noiseux, N; Soulez, G; Rummeny, EJ; Chartrand-Lefebvre, C				Gramer, Bettina M.; Martinez, Patricia Diez; Chin, Anne S.; Sylvestre, Marie-Pierre; Larrivee, Sandra; Stevens, Louis-Mathieu; Noiseux, Nicolas; Soulez, Gilles; Rummeny, Ernst J.; Chartrand-Lefebvre, Carl			256-Slice CT Angiographic Evaluation of Coronary Artery Bypass Grafts: Effect of Heart Rate, Heart Rate Variability and Z-Axis Location on Image Quality	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; DIAGNOSTIC-ACCURACY; NONINVASIVE ASSESSMENT; MAGNETIC-RESONANCE; AMERICAN-COLLEGE; TASK-FORCE; PERFORMANCE; PATENCY; SURGERY; INTERVENTIONS	Purpose: The objective of this study is to assess the effect of heart rate, heart rate variability and z-axis location on coronary artery bypass graft (CABG) image quality using a 256-slice computed tomography (CT) scanner. Methods: A total of 78 patients with 254 CABG (762 graft segments) were recruited to undergo CABG assessment with 256-slice CT and prospective ECG-gating. Two observers rated graft segments for image quality on a 5-point scale. Quantitative measurements were also made. Logistic and cumulative link mixed models were used to assess the predictors of graft image quality. Results: Graft image quality was judged as diagnostic (scores 5 (excellent), 4 (good) and 3 (moderate)) in 96.6% of the 762 segments. Interobserver agreement was excellent (kappa >= 0.90). Graft image quality was not affected by heart rate level. However, high heart rate variability was associated with an important and significant image quality deterioration (odds ratio 4.31; p = 0.036). Distal graft segments had significantly lower image quality scores than proximal segments (p <= 0.02). Significantly higher noise was noted at the origin of the mammary grafts (p = 0.001), owing to streak artifacts from the shoulders. Conclusion: CABG imaging with 270-msec rotation 256-slice CT and prospective ECG-gating showed an adequate image quality in 96.6% of graft segments, and an excellent interobserver agreement. Graft image quality was not influenced by heart rate level. Image quality scores were however significantly decreased in patients with high heart rate variability, as well as in distal graft segments, which are closer to the heart.	[Gramer, Bettina M.; Martinez, Patricia Diez; Chin, Anne S.; Soulez, Gilles; Chartrand-Lefebvre, Carl] Univ Montreal Med Ctr CHUM, Montreal, PQ, Canada; [Gramer, Bettina M.; Sylvestre, Marie-Pierre; Larrivee, Sandra; Stevens, Louis-Mathieu; Noiseux, Nicolas; Soulez, Gilles; Chartrand-Lefebvre, Carl] Univ Montreal Med Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada; [Gramer, Bettina M.; Rummeny, Ernst J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany; [Sylvestre, Marie-Pierre] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Stevens, Louis-Mathieu; Noiseux, Nicolas] Univ Montreal, CHUM, Montreal, PQ, Canada; [Stevens, Louis-Mathieu; Noiseux, Nicolas] CRCHUM, Montreal, PQ, Canada	Universite de Montreal; Technical University of Munich; Universite de Montreal; Universite de Montreal; Universite de Montreal	Chartrand-Lefebvre, C (corresponding author), Univ Montreal Med Ctr CHUM, Montreal, PQ, Canada.	chartrandlef@videotron.ca	Stevens, Louis-Mathieu/E-6453-2016; Chartrand-Lefebvre, Carl/G-1260-2015; Soulez, Gilles/F-2834-2013; Sylvestre, Marie-Pierre/CAF-5219-2022	Stevens, Louis-Mathieu/0000-0003-3372-3419; Chartrand-Lefebvre, Carl/0000-0002-2299-7855; Sylvestre, Marie-Pierre/0000-0001-5803-4615; soulez, gilles/0000-0002-5566-3552	state of Bavaria, Germany; University of Montreal, Department of Radiology	state of Bavaria, Germany; University of Montreal, Department of Radiology	This work was supported by an academic grant from the state of Bavaria, Germany, and a grant from the University of Montreal, Department of Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders K, 2006, EUR J RADIOL, V57, P336, DOI 10.1016/j.ejrad.2005.12.018; BOURASSA MG, 1985, CIRCULATION, V72, P71; Brodoefel H, 2008, RADIOLOGY, V247, P346, DOI 10.1148/radiol.2472070906; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; de Graaf FR, 2011, EUR RADIOL, V21, P2285, DOI 10.1007/s00330-011-2192-5; Dewey M, 2006, ANN INTERN MED, V145, P407, DOI 10.7326/0003-4819-145-6-200609190-00004; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Feuchtner GM, 2007, AM J ROENTGENOL, V189, P574, DOI 10.2214/AJR.07.2174; Goetti R, 2010, INVEST RADIOL, V45, P324, DOI 10.1097/RLI.0b013e3181dfa47e; Hamon M, 2008, RADIOLOGY, V247, P679, DOI 10.1148/radiol.2473071132; Lee JH, 2011, INT J CARDIOVAS IMAG, V27, P657, DOI 10.1007/s10554-011-9904-4; Lee YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049212; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; Leschka S, 2006, RADIOLOGY, V241, P378, DOI 10.1148/radiol.2412051384; Marano R, 2004, EUR RADIOL, V14, P1353, DOI 10.1007/s00330-004-2323-3; Meyer TS, 2007, J AM COLL CARDIOL, V49, P946, DOI 10.1016/j.jacc.2006.10.066; Moller CH, 2010, SCAND CARDIOVASC J, V44, P161, DOI 10.3109/14017430903556286; Muenzel D, 2011, EUR RADIOL, V21, P2277, DOI 10.1007/s00330-011-2185-4; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; R Development Core Team, 2012, R LANG ENV STAT COMP; Ropers D, 2006, CIRCULATION, V114, P2334, DOI 10.1161/CIRCULATIONAHA.106.631051; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Schlosser T, 2004, J AM COLL CARDIOL, V44, P1224, DOI 10.1016/j.jacc.2003.09.075; Schonenberger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000246; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Tremblay JA, 2013, EUR J CARDIO-THORAC, V44, pE302, DOI 10.1093/ejcts/ezt388; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Viera AJ, 2005, FAM MED, V37, P360; Weustink AC, 2009, JACC-CARDIOVASC IMAG, V2, P816, DOI 10.1016/j.jcmg.2009.02.010; Willmann JK, 2004, RADIOLOGY, V232, P568, DOI 10.1148/radiol.2322030788; Wintersperger BJ, 2006, INVEST RADIOL, V41, P436, DOI 10.1097/01.rli.0000202639.99949.c6; Yee TW, 2010, J STAT SOFTW, V32, P1	32	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91861	10.1371/journal.pone.0091861	http://dx.doi.org/10.1371/journal.pone.0091861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637891	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100071
J	Kotilainen, H; Lokki, ML; Paakkanen, R; Seppanen, M; Tukiainen, P; Meri, S; Poussa, T; Eskola, J; Valtonen, V; Jarvinen, A				Kotilainen, Hannele; Lokki, Marja-Liisa; Paakkanen, Riitta; Seppanen, Mikko; Tukiainen, Pentti; Meri, Seppo; Poussa, Tuija; Eskola, Jussi; Valtonen, Ville; Jarvinen, Asko			Complement C4 Deficiency - A Plausible Risk Factor for Non-Tuberculous Mycobacteria (NTM) Infection in Apparently Immunocompetent Patients	PLOS ONE			English	Article							PULMONARY-DISEASE; INTERFERON-GAMMA; AVIUM-COMPLEX; SUSCEPTIBILITY; IMMUNITY; DEFECTS; BODY	Background: Non-tuberculous mycobacteria (NTM) are ubiquitous in the environment and they infect mainly persons with underlying pulmonary diseases but also previously healthy elderly women. Defects in host resistance that lead to pulmonary infections by NTM are relatively unknown. A few genetic defects have been associated with both pulmonary and disseminated mycobacterial infections. Rare disseminated NTM infections have been associated with genetic defects in T-cell mediated immunity and in cytokine signaling in families. We investigated whether there was an association between NTM infections and deficiencies of complement components C4A or C4B that are encoded by major histocompatibility complex (MHC). Methods: 50 adult patients with a positive NTM culture with symptoms and findings of a NTM disease were recruited. Patients' clinical history was collected and symptoms and clinical findings were categorized according to 2007 diagnostic criteria of The American Thoracic Society (ATS). To investigate the deficiencies of complement, C4A and C4B gene copy numbers and phenotype frequencies of the C4 allotypes were analyzed. Unselected, healthy, 149 Finnish adults were used as controls. Results: NTM patients had more often C4 deficiencies (C4A or C4B) than controls (36/50 [72%] vs 83/149 [56%], OR = 2.05, 95%CI = 1.019-4.105, p = 0.042). C4 deficiencies for female NTM patients were more common than for controls (29/36 [81%] vs 55/100 [55%], OR = 3.39, 95% CI = 1.358-8.460, p = 0.007). C4 deficiences seemed not to be related to any specific underlying disease or C4 phenotype. Conclusions: C4 deficiency may be a risk factor for NTM infection in especially elderly female patients.	[Kotilainen, Hannele; Seppanen, Mikko; Valtonen, Ville; Jarvinen, Asko] Univ Helsinki, Cent Hosp, Div Infect Dis, Dept Med, Helsinki, Finland; [Lokki, Marja-Liisa; Paakkanen, Riitta] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Paakkanen, Riitta] Univ Helsinki, Cent Hosp, Div Cardiol, Dept Med, Helsinki, Finland; [Tukiainen, Pentti] Univ Helsinki, Cent Hosp, Div Lung Dis, Dept Med, Helsinki, Finland; [Meri, Seppo] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Eskola, Jussi] Univ Helsinki, Cent Hosp Lab, Mycobacteriol Unit, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kotilainen, H (corresponding author), Univ Helsinki, Cent Hosp, Div Infect Dis, Dept Med, Helsinki, Finland.	hannele.kotilainen@hus.fi		Seppanen, Mikko/0000-0001-9733-3650; Meri, Seppo/0000-0001-9142-501X	Finnish Lung Health Association (FILHA)	Finnish Lung Health Association (FILHA)	This study was financially supported by a research grant from the Finnish Lung Health Association (FILHA), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Colombo RE, 2010, CHEST, V137, P629, DOI 10.1378/chest.09-1173; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x; Field SK, 2004, CHEST, V126, P566, DOI 10.1378/chest.126.2.566; Fowler CJ, 2013, AM J RESP CRIT CARE, V187, P1374, DOI 10.1164/rccm.201212-2197OC; Guide SV, 2002, INFECT DIS CLIN N AM, V16, P163, DOI 10.1016/S0891-5520(03)00051-5; Haverkamp MH, 2006, MICROBES INFECT, V8, P1157, DOI 10.1016/j.micinf.2005.10.029; Holland SM, 2001, AM J MED SCI, V321, P49, DOI 10.1097/00000441-200101000-00008; ISEMAN MD, 1991, AM REV RESPIR DIS, V144, P914, DOI 10.1164/ajrccm/144.4.914; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Kartalija M, 2013, AM J RESP CRIT CARE, V187, P197, DOI 10.1164/rccm.201206-1035OC; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Koh WJ, 2005, CHEST, V128, P94, DOI 10.1378/chest.128.1.94; Kotilainen H, 2011, SCAND J INFECT DIS, V43, P188, DOI 10.3109/00365548.2010.535558; Maliwan N, 2005, POSTGRAD MED J, V81, P530, DOI 10.1136/pgmj.2004.026229; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Senbagavalli P, 2011, HUM IMMUNOL, V72, P173, DOI 10.1016/j.humimm.2010.11.002; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Yuliwulandari R, 2010, HUM IMMUNOL, V71, P697, DOI 10.1016/j.humimm.2010.04.005	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91450	10.1371/journal.pone.0091450	http://dx.doi.org/10.1371/journal.pone.0091450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638111	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100035
J	Lo, YL; Liu, Y				Lo, Yu-Li; Liu, Yu			Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides	PLOS ONE			English	Article							INDUCED APOPTOSIS; P-GLYCOPROTEIN; DRUG-DELIVERY; IN-VITRO; CANCER; EXPRESSION; CELLS; BCL-2; EPIRUBICIN; INDUCTION	Multidrug resistance (MDR) is a major impediment to chemotherapy. In the present study, we designed antisense oligonucleotides (ASOs) against MDR1, MDR-associated protein (MRP)1, MRP2, and/or BCL-2/BCL-xL to reverse MDR transporters and induce apoptosis, respectively. The cationic liposomes (100 nm) composed of N-[1-(2,3-dioleyloxy) propyl]-n, n, n-trimethylammonium chloride and dioleoyl phosphotidylethanolamine core surrounded by a polyethylene glycol (PEG) shell were prepared to carry ASOs and/or epirubicin, an antineoplastic agent. We aimed to simultaneously suppress efflux pumps, provoke apoptosis, and enhance the chemosensitivity of human colon adenocarcinoma Caco-2 cells to epirubicin. We evaluated encapsulation efficiency, particle size, cytotoxicity, intracellular accumulation, mRNA levels, cell cycle distribution, and caspase activity of these formulations. We found that PEGylated liposomal ASOs significantly reduced Caco-2 cell viability and thus intensified epirubicin-mediated apoptosis. These formulations also decreased the MDR1 promoter activity levels and enhanced the intracellular retention of epirubicin in Caco-2 cells. Epirubicin and ASOs in PEGylated liposomes remarkably decreased mRNA expression levels of human MDR1, MRP1, MRP2, and BCL-2. The combined treatments all significantly increased the mRNA expressions of p53 and BAX, and activity levels of caspase-3, -8, and -9. The formulation of epirubicin and ASOs targeting both pump resistance of MDR1, MRP1, and MRP2 and nonpump resistance of BCL-2/BCL-xL demonstrated more superior effect to all the other formulations used in this study. Our results provide a novel insight into the mechanisms by which PEGylated liposomal ASOs against both resistance types act as activators to epirubicin-induced apoptosis through suppressing MDR1, MRP1, and MRP2, as well as triggering intrinsic mitochondrial and extrinsic death receptor pathways. The complicated regulation of MDR highlights the necessity for a multifunctional approach using an effective delivery system, such as PEGylated liposomes, to carry epirubicin and ASOs as a potent nanomedicine for improving the clinical efficacy of chemotherapy.	[Lo, Yu-Li; Liu, Yu] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan	National University Tainan	Lo, YL (corresponding author), Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan.	yulilo@mail.nutn.edu.tw		Lo, Yu-Li/0000-0002-6548-3280	National Science Council of Taiwan [NSC 96-2320-B-024-002, NSC 102-2320-B-024-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The National Science Council of Taiwan (Grant No. NSC 96-2320-B-024-002 and NSC 102-2320-B-024-002) is gratefully acknowledged for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altundag K, 2004, MED HYPOTHESES, V63, P823, DOI 10.1016/j.mehy.2004.03.026; Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Campone M, 2001, LEUKEMIA, V15, P1377, DOI 10.1038/sj.leu.2402222; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Dean NM, 2003, ONCOGENE, V22, P9087, DOI 10.1038/sj.onc.1207231; Falkson G., 1984, ADV ANTHRACYCLINE CH, P105; Haley B, 2008, UROL ONCOL-SEMIN ORI, V26, P57, DOI 10.1016/j.urolonc.2007.03.015; Harada T, 2003, CANCER SCI, V94, P394, DOI 10.1111/j.1349-7006.2003.tb01453.x; He T, 2013, COLORECTAL DIS, V15, P12, DOI 10.1111/j.1463-1318.2012.02919.x; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Liu D, 1995, BBA-BIOMEMBRANES, V1240, P277, DOI 10.1016/0005-2736(95)00184-0; Lo YL, 2008, EUR J PHARM SCI, V35, P52, DOI 10.1016/j.ejps.2008.06.003; Lo YI, 2003, J CONTROL RELEASE, V90, P37, DOI 10.1016/S0168-3659(03)00163-9; Lo YL, 2013, BIOMED PHARMACOTHER, V67, P261, DOI 10.1016/j.biopha.2012.12.002; Lo YL, 2013, INT J MOL SCI, V14, P158, DOI 10.3390/ijms14010158; Lo YL, 2012, TOXICOLOGY, V302, P221, DOI 10.1016/j.tox.2012.08.003; Makhey VD, 1998, PHARMACEUT RES, V15, P1160, DOI 10.1023/A:1011971303880; Marbeuf-Gueye C, 2000, EUR J PHARMACOL, V391, P207, DOI 10.1016/S0014-2999(00)00047-9; Marwick C, 1998, JAMA-J AM MED ASSOC, V280, P871, DOI 10.1001/jama.280.10.871; Men Y, 2011, INT J NANOMED, V6, P3125, DOI 10.2147/IJN.S24847; Miao ZH, 2003, INT J CANCER, V106, P108, DOI 10.1002/ijc.11174; Minko T, 2005, J CONTROL RELEASE, V105, P269, DOI 10.1016/j.jconrel.2005.03.019; Minko T, 2004, CURR DRUG TARGETS, V5, P389, DOI 10.2174/1389450043345443; Nakagawa O, 2010, J AM CHEM SOC, V132, P8848, DOI 10.1021/ja102635c; Pakunlu RI, 2006, J CONTROL RELEASE, V114, P153, DOI 10.1016/j.jconrel.2006.06.010; Perouzel E, 2003, BIOCONJUGATE CHEM, V14, P884, DOI 10.1021/bc034068q; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Ray RM, 2011, APOPTOSIS, V16, P35, DOI 10.1007/s10495-010-0538-0; Rayburn Elizabeth Rose, 2006, Expert Opin Emerg Drugs, V11, P337, DOI 10.1517/14728214.11.2.337; Ruefli A, 2002, CELL DEATH DIFFER, V9, P1266, DOI 10.1038/sj.cdd.4401081; Shabbits JA, 2003, MOL CANCER THER, V2, P805; Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; Takane H, 2004, J PHARMACOL EXP THER, V311, P1179, DOI 10.1124/jpet.104.069724; Wang XF, 2007, LEUKEMIA RES, V31, P989, DOI 10.1016/j.leukres.2006.09.001; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; Yamanaka K, 2005, MOL CANCER THER, V4, P1689, DOI 10.1158/1535-7163.MCT-05-0064; Yamanaka K, 2006, BJU INT, V97, P1300, DOI 10.1111/j.1464-410X.2006.06147.x; Zhang W, 2011, BIOMATERIALS, V32, P5934, DOI 10.1016/j.biomaterials.2011.04.075; Zhou L, 2011, SURGERY, V150, P25, DOI 10.1016/j.surg.2010.12.010	43	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90180	10.1371/journal.pone.0090180	http://dx.doi.org/10.1371/journal.pone.0090180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637737	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100004
J	Morita, K; Shiraishi, S; Motoyama, N; Kitayama, T; Kanematsu, T; Uezono, Y; Dohi, T				Morita, Katsuya; Shiraishi, Seiji; Motoyama, Naoyo; Kitayama, Tomoya; Kanematsu, Takashi; Uezono, Yasuhito; Dohi, Toshihiro			Palliation of Bone Cancer Pain by Antagonists of Platelet-Activating Factor Receptors	PLOS ONE			English	Article							NEUROPATHIC PAIN; FACTOR PAF; SPINAL-CORD; TACTILE ALLODYNIA; MICE; METASTASIS; MORPHINE; OXYCODONE; GROWTH; CELLS	Bone cancer pain is the most severe among cancer pain and is often resistant to current analgesics. Thus, the development of novel analgesics effective at treating bone cancer pain are desired. Platelet-activating factor (PAF) receptor antagonists were recently demonstrated to have effective pain relieving effects on neuropathic pain in several animal models. The present study examined the pain relieving effect of PAF receptor antagonists on bone cancer pain using the femur bone cancer (FBC) model in mice. Animals were injected with osteolytic NCTC2472 cells into the tibia, and subsequently the effects of PAF receptor antagonists on pain behaviors were evaluated. Chemical structurally different type of antagonists, TCV-309, BN 50739 and WEB 2086 ameliorated the allodynia and improved pain behaviors such as guarding behavior and limb-use abnormalities in FBC model mice. The pain relieving effects of these antagonists were achieved with low doses and were long lasting. Blockade of spinal PAF receptors by intrathecal injection of TCV-309 and WEB 2086 or knockdown of the expression of spinal PAF receptor protein by intrathecal transfer of PAF receptor siRNA also produced a pain relieving effect. The amount of an inducible PAF synthesis enzyme, lysophosphatidylcholine acyltransferase 2 (LPCAT2) protein significantly increased in the spinal cord after transplantation of NCTC 2472 tumor cells into mouse tibia. The combination of morphine with PAF receptor antagonists develops marked enhancement of the analgesic effect against bone cancer pain without affecting morphine-induced constipation. Repeated administration of TCV-309 suppressed the appearance of pain behaviors and prolonged survival of FBC mice. The present results suggest that PAF receptor antagonists in combination with, or without, opioids may represent a new strategy for the treatment of persistent bone cancer pain and improve the quality of life of patients.	[Morita, Katsuya] Hiroshima Bunka Gakuen Univ, Fac Nursing, Dept Pharmacol, Hiroshima, Japan; [Morita, Katsuya; Shiraishi, Seiji; Motoyama, Naoyo; Uezono, Yasuhito] Div Natl Canc Ctr Res Inst, Tokyo, Japan; [Motoyama, Naoyo] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Integrated Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Morita, Katsuya; Kitayama, Tomoya; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cell & Mol Pharmacol, Div Basic Life Sci, Hiroshima, Japan; [Dohi, Toshihiro] Nihon Pharmaceut Univ, Dept Pharmacotherapy, Saitama, Japan	Hiroshima University; Hiroshima University	Dohi, T (corresponding author), Nihon Pharmaceut Univ, Dept Pharmacotherapy, Saitama, Japan.	t-dohi@nichiyaku.ac.jp	Shiraishi, Seiji/GPX-5566-2022		Japanese Society for Promotion of Sciences [22390349, 21592421, 24592798]; National Cancer Center Research and Development Fund [23-A-30]; Grants-in-Aid for Scientific Research [26670809] Funding Source: KAKEN	Japanese Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in Aid for Scientific Research (B) 22390349, (C) 21592421 and (C) 24592798 from the Japanese Society for Promotion of Sciences and by the National Cancer Center Research and Development Fund (23-A-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil H, 1998, DRUG ALCOHOL DEPEN, V51, P127, DOI 10.1016/S0376-8716(98)00071-4; Becker R, 2000, STEREOT FUNCT NEUROS, V75, P16, DOI 10.1159/000048379; Biancone L, 1999, AM J PATHOL, V155, P1731, DOI 10.1016/S0002-9440(10)65488-0; Bussolati B, 2002, INT J CANCER, V100, P654, DOI 10.1002/ijc.10545; Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; BUSSOLINO F, 1995, J CLIN INVEST, V96, P940, DOI 10.1172/JCI118142; de Oliveira SI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-200; de Wit R, 2001, PAIN, V91, P339, DOI 10.1016/S0304-3959(00)00455-3; Dohi T, 2009, PHARMACOL THERAPEUT, V123, P54, DOI 10.1016/j.pharmthera.2009.03.018; Fallani A, 2002, PROSTAG OTH LIPID M, V70, P209, DOI 10.1016/S0090-6980(02)00109-0; Hasegawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010467; Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164; Honore P, 2000, PAIN MED, V1, P303, DOI 10.1046/j.1526-4637.2000.00047.x; Im SY, 1996, CANCER RES, V56, P2662; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Li X, 2013, J PHYSIOL SCI, DOI [10.1007/s12576-D12-0244-5, DOI 10.1007/S12576-D12-0244-5]; LILLEMOE KD, 1993, ANN SURG, V217, P447, DOI 10.1097/00000658-199305010-00004; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; MAGGI M, 1994, CANCER RES, V54, P4777; Melnikova V, 2007, CANCER METAST REV, V26, P359, DOI 10.1007/s10555-007-9092-9; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; MINAMI T, 1995, PAIN, V61, P285, DOI 10.1016/0304-3959(94)00183-F; Morita K, 2004, PAIN, V111, P351, DOI 10.1016/j.pain.2004.07.016; Morita K, 2008, PAIN, V138, P525, DOI 10.1016/j.pain.2008.01.030; Motoyama N, 2013, EUR J PAIN, V17, P1156, DOI 10.1002/j.1532-2149.2013.00289.x; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakamura A, 2013, BRIT J PHARMACOL, V168, P375, DOI 10.1111/j.1476-5381.2012.02139.x; Narita M, 2008, NEUROPSYCHOPHARMACOL, V33, P1097, DOI 10.1038/sj.npp.1301471; Okubo M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-8; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 1999, LANCET, V353, P1695, DOI 10.1016/S0140-6736(99)01310-0; TERASHITA ZI, 1992, J PHARMACOL EXP THER, V260, P748; Tsoupras A. B., 2009, Infectious Disorders - Drug Targets, V9, P390; Yanagisawa Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-38; Yuan C-S, 2005, HDB OPIOID BOWEL SYN; Yuan CS, 2000, REGION ANESTH PAIN M, V25, P639, DOI 10.1053/rapm.2000.8658	36	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91746	10.1371/journal.pone.0091746	http://dx.doi.org/10.1371/journal.pone.0091746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637403	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100057
J	van Wouwe, JP; van Gameren-Oosterom, HBM; Verkerk, PH; van Dommelen, P; Fekkes, M				van Wouwe, Jacobus P.; van Gameren-Oosterom, Helma B. M.; Verkerk, Paul H.; van Dommelen, Paula; Fekkes, Minne			Mainstream and Special School Attendance among a Dutch Cohort of Children with Down Syndrome	PLOS ONE			English	Article							SKILLS	Object: To determine the level of mainstream education in a nationwide cohort of adolescents with Down Syndrome (DS), and to find characteristics related to mainstream or special school attendance. Method: Dutch children with DS born in 1992, 1993 or 1994, were assessed when 16-19 years old. Parents scored school enrolment between the age of 4-18 years, general characteristics and the levels of intellectual disability using the Dutch Social Competence Rating Scale. Associations between disability and years in mainstream school were assessed by ordinal logistic regression, adjusting for sex and parental education. Results: We collected data from 170 boys and 152 girls (response 63%); mean age 18.3 years (ranges 16.8-19.9). Intellectual disability was mostly moderate (43%). Most children (74%) entered mainstream education between 4 and 6 years of age. At 13 years 17% was in mainstream school and 7% stayed in up to 16 years. From the age of 8 years onwards the majority was in special education, while 6% never attended school. Girls were more often in mainstream school and stayed in longer. Level of disability was significantly associated with number of years in mainstream education. Conclusion: Three out of four Dutch children with DS entered mainstream primary education, however late entry and high dropout are common.	[van Wouwe, Jacobus P.; van Gameren-Oosterom, Helma B. M.; Verkerk, Paul H.; Fekkes, Minne] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [van Dommelen, Paula] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research	van Wouwe, JP (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	ko.vanwouwe@tno.nl	Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258	Nederlandse Stichting voor het Gehandicapte Kind (NSGK, Dutch Foundation for Disabled Children)	Nederlandse Stichting voor het Gehandicapte Kind (NSGK, Dutch Foundation for Disabled Children)	This study is financed by the Nederlandse Stichting voor het Gehandicapte Kind (NSGK, Dutch Foundation for Disabled Children). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley S, 2006, DOWN SYNDROME RES PR, V89, P54; Coppus AMW, 2008, NEUROBIOL AGING, V29, P828, DOI 10.1016/j.neurobiolaging.2006.12.013; Crombie MP, 1994, THESIS U QUEENSLAND; Cuckle P, 1999, Downs Syndr Res Pract, V6, P95, DOI 10.3104/reviews.100; De Bildt A., 2004, SOCIAL INDEPENDENCE; de Graaf G, 2013, J INTELL DISABIL RES, V57, P21, DOI 10.1111/j.1365-2788.2011.01512.x; De Graaf G, 2013, J INTELL DISABIL RES, DOI [10.1111/jir.12060, DOI 10.1111/JIR.12060.ACCESSED]; Dolva AS, 2007, AM J OCCUP THER, V61, P414, DOI 10.5014/ajot.61.4.414; Lightfoota L, 2013, EDUC PSYCHOL PRACT, V29, P163, DOI 10.1080/02667363.2013.800024; Turner S, 2008, J INTELL DISABIL RES, V52, P380, DOI 10.1111/j.1365-2788.2007.01038.x; van Gameren-Oosterom HBM, 2013, J PEDIATR-US, V163, P1396, DOI 10.1016/j.jpeds.2013.06.054; van Gameren-Oosterom HBM, 2012, PRENATAL DIAG, V32, P1035, DOI 10.1002/pd.3951; Van Gamereri-Oosterom HBM, 2013, RES DEV DISABIL, V34, P4599, DOI 10.1016/j.ridd.2013.09.041; Weijerman ME, 2010, EUR J PEDIATR, V169, P1445, DOI 10.1007/s00431-010-1253-0	14	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91737	10.1371/journal.pone.0091737	http://dx.doi.org/10.1371/journal.pone.0091737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638156	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100056
J	Laker, RC; Xu, P; Ryall, KA; Sujkowski, A; Kenwood, BM; Chain, KH; Zhang, M; Royal, MA; Hoehn, KL; Driscoll, M; Adler, PN; Wessells, RJ; Saucerman, JJ; Yan, Z				Laker, Rhianna C.; Xu, Peng; Ryall, Karen A.; Sujkowski, Alyson; Kenwood, Brandon M.; Chain, Kristopher H.; Zhang, Mei; Royal, Mary A.; Hoehn, Kyle L.; Driscoll, Monica; Adler, Paul N.; Wessells, Robert J.; Saucerman, Jeffrey J.; Yan, Zhen			A Novel MitoTimer Reporter Gene for Mitochondrial Content, Structure, Stress, and Damage in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Exercise; Mitochondria; Oxidative Stress; Skeletal Muscle; High-fat Diet; Reporter Gene	FLUORESCENT PROTEINS; OXIDATIVE STRESS; SKELETAL-MUSCLE; DYSFUNCTION; DISEASE; EXERCISE; RESTRICTION; RESPIRATION; EXPRESSION; REDUCTION	Background: Mitochondrial health is difficult to assess in vivo. Results: We have generated a reporter gene, MitoTimer, which targets mitochondria, and fluoresces green and shifts to red when oxidized, for assessment of mitochondrial content, structure, stress, and damage under physiological and pathological conditions. Conclusion:MitoTimer is useful for assessment of mitochondrial health in vivo. Significance:MitoTimer could advance mitochondrial research in multiple disciplines. Mitochondrial dysfunction plays important roles in many diseases, but there is no satisfactory method to assess mitochondrial health in vivo. Here, we engineered a MitoTimer reporter gene from the existing Timer reporter gene. MitoTimer encodes a mitochondria-targeted green fluorescent protein when newly synthesized, which shifts irreversibly to red fluorescence when oxidized. Confocal microscopy confirmed targeting of the MitoTimer protein to mitochondria in cultured cells, Caenorhabditis elegans touch receptor neurons, Drosophila melanogaster heart and indirect flight muscle, and mouse skeletal muscle. A ratiometric algorithm revealed that conditions that cause mitochondrial stress led to a significant shift toward red fluorescence as well as accumulation of pure red fluorescent puncta of damaged mitochondria targeted for mitophagy. Long term voluntary exercise resulted in a significant fluorescence shift toward green, in mice and D. melanogaster, as well as significantly improved structure and increased content in mouse FDB muscle. In contrast, high-fat feeding in mice resulted in a significant shift toward red fluorescence and accumulation of pure red puncta in skeletal muscle, which were completely ameliorated by voluntary wheel running. Hence, MitoTimer allows for robust analysis of multiple parameters of mitochondrial health under both physiological and pathological conditions and will be highly useful for future research of mitochondrial health in multiple disciplines in vivo.	[Laker, Rhianna C.; Xu, Peng; Zhang, Mei; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Kenwood, Brandon M.; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Chain, Kristopher H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Adler, Paul N.] Univ Virginia, Dept Biol, Charlottesville, VA 22908 USA; [Ryall, Karen A.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Laker, Rhianna C.; Xu, Peng; Chain, Kristopher H.; Zhang, Mei; Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, Charlottesville, VA 22908 USA; [Royal, Mary A.; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Sujkowski, Alyson; Wessells, Robert J.] Univ Michigan, Dept Geriatr Med, Sch Med, Ann Arbor, MI 48109 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Rutgers State University New Brunswick; University of Michigan System; University of Michigan	Yan, Z (corresponding author), 409 Lane Rd,MR4-6041A, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu	Wessells, Robert/AAG-3406-2020	Sujkowski, Alyson/0000-0002-9909-9279; Wessells, Robert/0000-0002-4516-3183; Yan, Zhen/0000-0002-4826-9813; Hoehn, Kyle/0000-0002-0214-3238	National Institutes of Health [AR050429]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047101, R01AG046358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AR050429 (to Z. Y.).	Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Broderick TL, 2002, MOL CELL BIOCHEM, V233, P119, DOI 10.1023/A:1015506327849; CHANG L, 1995, DEMENTIA, V6, P1, DOI 10.1159/000106915; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; DiFranco Marino, 2009, J Vis Exp, DOI 10.3791/1520; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Ferree AW, 2013, AUTOPHAGY, V9, P1887, DOI 10.4161/auto.26503; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Liu ZH, 2012, NEUROBIOL DIS, V45, P362, DOI 10.1016/j.nbd.2011.08.022; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MILLER SE, 1988, J ELECTRON MICR TECH, V8, P41, DOI 10.1002/jemt.1060080105; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Ponsot E, 2006, J APPL PHYSIOL, V100, P1249, DOI 10.1152/japplphysiol.00361.2005; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Ravid R, 2012, FEBS J, V279, P1167, DOI 10.1111/j.1742-4658.2012.08518.x; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Roma LP, 2012, BIOCHEM J, V441, P971, DOI 10.1042/BJ20111770; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tinkerhess MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3786; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wolf Alexander M., 2008, Journal of Nippon Medical School, V75, P66, DOI 10.1272/jnms.75.66; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	43	155	156	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12005	12015		10.1074/jbc.M113.530527	http://dx.doi.org/10.1074/jbc.M113.530527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24644293	Green Published, hybrid			2022-12-25	WOS:000335010600039
J	Cao, HH; Zhang, M; Zhao, H; Zhang, Y; Wang, XX; Guo, SS; Zhang, ZF; Liu, TX				Cao, He-He; Zhang, Meng; Zhao, Hui; Zhang, Yi; Wang, Xing-Xing; Guo, Shan-Shan; Zhang, Zhan-Feng; Liu, Tong-Xian			Deciphering the Mechanism of beta-Aminobutyric Acid-Induced Resistance in Wheat to the Grain Aphid, Sitobion avenae	PLOS ONE			English	Article							PLANT DEFENSE; ARABIDOPSIS; GROWTH; ACCUMULATION; POTENTIATION; TOLERANCE; BEHAVIOR; TOMATO	The non-protein amino acid beta-aminobutyric acid (BABA) can induce plant resistance to a broad spectrum of biotic and abiotic stresses. However, BABA-induced plant resistance to insects is less well-studied, especially its underlying mechanism. In this research, we applied BABA to wheat seedlings and tested its effects on Sitobion avenae (F.). When applied as a soil drench, BABA significantly reduced weights of S. avenae, whereas foliar spray and seed treatment had no such effects. BABA-mediated suppression of S. avenae growth was dose dependent and lasted at least for 7 days. The aminobutyric acid concentration in phloem sap of BABA-treated plants was higher and increased with BABA concentrations applied. Moreover, after 10 days of treatment, the aminobutyric acid content in BABA-treated plants was still higher than that in control treatment. Sitobion avenae could not discriminate artificial diet containing BABA from standard diet, indicating that BABA itself is not a deterrent to this aphid. Also S. avenae did not show preference for control plants or BABA-treated plants. Consistent with choice test results, S. avenae had similar feeding activities on control and BABA-treated plants, suggesting that BABA did not induce antifeedants in wheat seedlings. In addition, aminobutyric acid concentration in S. avenae feeding on BABA-treated plants was significantly higher than those feeding on control plants. Sitobion avenae growth rate was reduced on the artificial diet containing BABA, indicating that BABA had direct toxic effects on this aphid species. These results suggest that BABA application reduced S. avenae performance on wheat seedlings and the mechanism is possibly due to direct toxicity of high BABA contents in plant phloem.	[Cao, He-He; Zhang, Meng; Zhao, Hui; Zhang, Yi; Wang, Xing-Xing; Guo, Shan-Shan; Zhang, Zhan-Feng; Liu, Tong-Xian] Northwest A&F Univ, Minist Agr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cao, He-He; Zhang, Meng; Zhao, Hui; Zhang, Yi; Wang, Xing-Xing; Guo, Shan-Shan; Zhang, Zhan-Feng; Liu, Tong-Xian] Northwest A&F Univ, Minist Agr, Key Lab Crop Pest Management Losses Plateau, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Liu, TX (corresponding author), Northwest A&F Univ, Minist Agr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, TX (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Crop Pest Management Losses Plateau, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn			National Basic Research Program of China (973 Projects) [2012CB114105]; Special Fund for Agro-Scientific Research in the Public Interest [201103022]; China Agriculture Research System [CARS-25-B-06]	National Basic Research Program of China (973 Projects)(National Basic Research Program of China); Special Fund for Agro-Scientific Research in the Public Interest; China Agriculture Research System	Funding of this research was partially supported by each of the following grants: the National Basic Research Program of China (973 Projects No. 2012CB114105), Special Fund for Agro-Scientific Research in the Public Interest (201103022), China Agriculture Research System (CARS-25-B-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUCLAIR JACQUES L., 1965, ANN ENTOMOL SOC AMER, V58, P855, DOI 10.1093/aesa/58.6.855; Cao HH, 2014, INSECT SCI, V21, P47, DOI 10.1111/1744-7917.12023; COHEN Y, 1994, PHYSIOL MOL PLANT P, V45, P441, DOI 10.1016/S0885-5765(05)80041-4; Du YL, 2012, J EXP BOT, V63, P4849, DOI 10.1093/jxb/ers164; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hodge S, 2006, ANN APPL BIOL, V148, P223, DOI 10.1111/j.1744-7348.2006.00061.x; Hodge S, 2005, B ENTOMOL RES, V95, P449, DOI 10.1079/BER2005375; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hubner CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00177; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Justyna PG, 2013, ACTA PHYSIOL PLANT, V35, P1735, DOI 10.1007/s11738-013-1215-z; Liu XM, 2010, PLANT PHYSIOL, V152, P985, DOI 10.1104/pp.109.150656; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Oka Y, 1999, PHYTOPATHOLOGY, V89, P1138, DOI 10.1094/PHYTO.1999.89.12.1138; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Ramputh AL, 1996, PLANT PHYSIOL, V111, P1349, DOI 10.1104/pp.111.4.1349; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Sasek V, 2012, EUR J PLANT PATHOL, V133, P279, DOI 10.1007/s10658-011-9897-9; SCHMIEDEN V, 1995, MOL PHARMACOL, V48, P919; Siegrist J, 2000, PHYSIOL MOL PLANT P, V56, P95, DOI 10.1006/pmpp.1999.0255; Singh P, 2010, PLANT SIGNAL BEHAV, V5, P878, DOI 10.4161/psb.5.7.11903; Tiwari S, 2013, B ENTOMOL RES, V103, P592, DOI 10.1017/S0007485313000229; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; URQUHART AA, 1981, PLANT PHYSIOL, V68, P750, DOI 10.1104/pp.68.3.750; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Wu CC, 2010, J EXP BOT, V61, P995, DOI 10.1093/jxb/erp363; Zhang HT, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P181, DOI 10.1007/978-0-387-85498-4_8; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897; Zimmerli L, 2008, PLANT J, V53, P144, DOI 10.1111/j.1365-313X.2007.03343.x	36	24	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91768	10.1371/journal.pone.0091768	http://dx.doi.org/10.1371/journal.pone.0091768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651046	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800049
J	Cortopassi, WA; Penna-Coutinho, J; Aguiar, ACC; Pimentel, AS; Buarque, CD; Costa, PRR; Alves, BRM; Franca, TCC; Krettli, AU				Cortopassi, Wilian A.; Penna-Coutinho, Julia; Aguiar, Anna C. C.; Pimentel, Andre S.; Buarque, Camilla D.; Costa, Paulo R. R.; Alves, Bruna R. M.; Franca, Tanos C. C.; Krettli, Antoniana U.			Theoretical and Experimental Studies of New Modified Isoflavonoids as Potential Inhibitors of Topoisomerase I from Plasmodium falciparum	PLOS ONE			English	Article							MALIGNANT CELL-LINES; ANTINEOPLASIC ACTIVITY; ANTIMALARIAL ACTIVITY; MALARIA; PTEROCARPANQUINONE; RESISTANCE; DOCKING; VITRO; CAMPTOTHECIN; SENSITIVITY	DNA topoisomerase I from Plasmodium falciparum (PfTopoI), a potential selective target for chemotherapy and drug development against malaria, is used here, together with human Topo I (HssTopoI), for docking, molecular dynamics (MD) studies and experimental assays. Six synthetic isoflavonoid derivatives and the known PfTopoI inhibitors camptothecin and topotecan were evaluated in parallel. Theoretical results suggest that these compounds dock in the binding site of camptothecin and topotecan inside both enzymes and that LQB223 binds selectively in PfTopoI. In vitro tests against P. falciparum blood parasites corroborated the theoretical findings. The selectivity index (SI) of LQB223 >= 98 suggests that this molecule is the most promising in the group of compounds tested. In vivo experiments in mice infected with P. berghei showed that LQB223 has an antimalarial activity similar to that of chloroquine.	[Cortopassi, Wilian A.; Pimentel, Andre S.; Buarque, Camilla D.; Alves, Bruna R. M.] Pontificia Univ Catolica Rio de Janeiro, Dept Quim, Rio De Janeiro, Brazil; [Cortopassi, Wilian A.; Franca, Tanos C. C.] Inst Mil Engn, Lab Modelagem Aplicada Def Quim & Biol, Rio De Janeiro, Brazil; [Penna-Coutinho, Julia; Aguiar, Anna C. C.; Krettli, Antoniana U.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [Penna-Coutinho, Julia; Aguiar, Anna C. C.; Krettli, Antoniana U.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Costa, Paulo R. R.] Nucleo Pesquisas Prod Nat, Lab Quim Bioorgan, Rio De Janeiro, Brazil	Pontificia Universidade Catolica do Rio de Janeiro; Instituto Militar de Engenharia (IME); Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Krettli, AU (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	akrettli@cpqrr.fiocruz.br	Pimentel, Andre/B-1278-2010; Aguiar, Anna Caroline/J-6970-2015; BUARQUE, CAMILLA DJENNE/AAZ-1268-2020; Costa, Paulo Roberto Ribeiro/F-1153-2013; Costa, Paulo Roberto Ribeiro/AAH-4777-2021; Cortopassi, Wilian/P-3136-2014; França, Tanos Celmar Costa/I-9519-2012	Pimentel, Andre/0000-0002-1301-0561; Aguiar, Anna Caroline/0000-0003-0139-8279; BUARQUE, CAMILLA DJENNE/0000-0002-2639-2220; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Cortopassi, Wilian/0000-0001-8038-7847; França, Tanos Celmar Costa/0000-0002-6048-8103	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304557/2012-9]; Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) [E-26/102.993/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-304557/2012-9 and Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)-E-26/102.993/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar ACC, 2012, MEM I OSWALDO CRUZ, V107, P831, DOI 10.1590/S0074-02762012000700001; Bacelar TD, 2013, ANTI-CANCER DRUG, V24, P73, DOI 10.1097/CAD.0b013e3283592da8; Barbara A, 2013, PLOS ONE, V8; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458; Bodley AL, 1998, BIOCHEM PHARMACOL, V55, P709, DOI 10.1016/S0006-2952(97)00556-X; Buarque CD, 2011, BIOORGAN MED CHEM, V19, P6885, DOI 10.1016/j.bmc.2011.09.025; CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113; Cortopassi WA, 2012, MOL SIMULAT, V38, P1132, DOI 10.1080/08927022.2012.696113; Costa P.R.R., 2010, Patent, Patent No. [WO2010054452-A1, 2010054452]; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drwal MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025150; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hess B, 2009, ABSTR PAP AM CHEM S, V237; Kasam V, 2007, J CHEM INF MODEL, V47, P1818, DOI 10.1021/ci600451t; Kontoyianni M, 2004, J MED CHEM, V47, P558, DOI 10.1021/jm0302997; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Netto CD, 2010, BIOORGAN MED CHEM, V18, P1610, DOI 10.1016/j.bmc.2009.12.073; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; ODUOLA AMJ, 1988, EXP PARASITOL, V67, P354, DOI 10.1016/0014-4894(88)90082-3; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Portes JD, 2012, VET PARASITOL, V186, P261, DOI 10.1016/j.vetpar.2011.11.008; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Reguera RM, 2006, BBA-GENE STRUCT EXPR, V1759, P117, DOI 10.1016/j.bbaexp.2006.03.006; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; RIECKMANN KH, 1978, LANCET, V1, P22; Roy A, 2011, MOL BIOL INT, V2011; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Webb MR, 2004, BIOCHEM J, V384, P527, DOI 10.1042/BJ20040474; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1	47	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91191	10.1371/journal.pone.0091191	http://dx.doi.org/10.1371/journal.pone.0091191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651068	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800032
J	Dusek, RJ; Hallgrimsson, GT; Ip, HS; Jonsson, JE; Sreevatsan, S; Nashold, SW; TeSlaa, JL; Enomoto, S; Halpin, RA; Lin, XD; Fedorova, N; Stockwell, TB; Dugan, VG; Wentworth, DE; Hall, JS				Dusek, Robert J.; Hallgrimsson, Gunnar T.; Ip, Hon S.; Jonsson, Jon E.; Sreevatsan, Srinand; Nashold, Sean W.; TeSlaa, Joshua L.; Enomoto, Shinichiro; Halpin, Rebecca A.; Lin, Xudong; Fedorova, Nadia; Stockwell, Timothy B.; Dugan, Vivien G.; Wentworth, David E.; Hall, Jeffrey S.			North Atlantic Migratory Bird Flyways Provide Routes for Intercontinental Movement of Avian Influenza Viruses	PLOS ONE			English	Article							A VIRUS; SPRING MIGRATION; WILD WATERFOWL; LINEAGE; EVOLUTION; GENES; GULLS; PERFORMANCE; OUTBREAK; SEQUENCE	Avian influenza virus (AIV) in wild birds has been of increasing interest over the last decade due to the emergence of AIVs that cause significant disease and mortality in both poultry and humans. While research clearly demonstrates that AIVs can move across the Pacific or Atlantic Ocean, there has been no data to support the mechanism of how this occurs. In spring and autumn of 2010 and autumn of 2011 we obtained cloacal swab samples from 1078 waterfowl, gulls, and shorebirds of various species in southwest and west Iceland and tested them for AIV. From these, we isolated and fully sequenced the genomes of 29 AIVs from wild caught gulls (Charadriiformes) and waterfowl (Anseriformes) in Iceland. We detected viruses that were entirely (8 of 8 genomic segments) of American lineage, viruses that were entirely of Eurasian lineage, and viruses with mixed American-Eurasian lineage. Prior to this work only 2 AIVs had been reported from wild birds in Iceland and only the sequence from one segment was available in GenBank. This is the first report of finding AIVs of entirely American lineage and Eurasian lineage, as well as reassortant viruses, together in the same geographic location. Our study demonstrates the importance of the North Atlantic as a corridor for the movement of AIVs between Europe and North America.	[Dusek, Robert J.; Ip, Hon S.; Nashold, Sean W.; TeSlaa, Joshua L.; Hall, Jeffrey S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Hallgrimsson, Gunnar T.] Southwest Iceland Nat Res Inst, Sandgeroi, Iceland; [Jonsson, Jon E.] Univ Iceland, Snaefellsnes Res Ctr, Stykkisholmur, Iceland; [Sreevatsan, Srinand; Enomoto, Shinichiro] Univ Minnesota, Coll Vet Med, Vet & Biomed Sci Dept, St Paul, MN 55108 USA; [Halpin, Rebecca A.; Lin, Xudong; Fedorova, Nadia; Stockwell, Timothy B.; Dugan, Vivien G.; Wentworth, David E.] J Craig Venter Inst, Rockville, MD USA	United States Department of the Interior; United States Geological Survey; University of Iceland; University of Minnesota System; University of Minnesota Twin Cities; J. Craig Venter Institute	Dusek, RJ (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	rdusek@usgs.gov	Jónsson, Jón Einar/K-7482-2015; Hallgrimsson, Gunnar Thor/M-3105-2015; Sreevatsan, Srinand/V-6808-2019	Jónsson, Jón Einar/0000-0003-1198-786X; Hallgrimsson, Gunnar Thor/0000-0002-3697-9148; Sreevatsan, Srinand/0000-0002-5162-2403; Stockwell, Timothy/0000-0002-3595-4539; TeSlaa, Joshua/0000-0001-7802-3454; Dusek, Robert/0000-0001-6177-7479; Ip, Hon/0000-0003-4844-7533; Hall, Jeffrey/0000-0001-5599-2826; Wentworth, David/0000-0002-5190-980X; Nashold, Sean/0000-0002-8869-6633	United States Geological Service; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN266200700007C, HHSN272200900007C]	United States Geological Service; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded by the United States Geological Service and with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services under Contract Nos. HHSN266200700007C and HHSN272200900007C. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Boere CG, 2006, WATERBIRDS WORLD, P40; Buscaglia C, 2012, AVIAN DIS, V56, P1017, DOI 10.1637/10147-040712-Reg.1; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Docherty D.E., 1988, Journal of Tissue Culture Methods, V11, P165, DOI 10.1007/BF01404270; Dohna HZ, 2009, EMERG INFECT DIS, V15, P1040, DOI 10.3201/eid1507.090245; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Escorcia M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-57; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; GUDMUNDSSON GA, 1992, ARDEA, V80, P315; GUDMUNDSSON GA, 1995, P ROY SOC B-BIOL SCI, V261, P73, DOI 10.1098/rspb.1995.0119; GUDMUNDSSON GA, 1993, IBIS, V135, P166, DOI 10.1111/j.1474-919X.1993.tb02828.x; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hallgrimsson GT, 2012, J ORNITHOL, V153, P603, DOI 10.1007/s10336-012-0816-4; Hallgrimsson Gunnar Thor, 2011, Marine Ornithology, V39, P137; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LATORREMARGALEF N, 2008, P ROY SOC LOND B BIO, V276, P1029; Lebarbenchon C, 2009, J MOL GENET MED, V3, P121, DOI DOI 10.4172/1747-0862.1000023; LUDWIG S, 1991, VIROLOGY, V183, P566, DOI 10.1016/0042-6822(91)90985-K; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen K.M., 2003, GULLS EUROPE ASIA N; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Ratanakorn P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049939; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2007, J VIROL, V81, P11612, DOI 10.1128/JVI.01368-07; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Vijaykrishna D, 2013, J VIROL, V87, P10182, DOI 10.1128/JVI.03437-12; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Zhou Bin, 2012, Methods Mol Biol, V865, P175, DOI 10.1007/978-1-61779-621-0_11; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zohari S, 2009, VIROL J, V5, DOI 10.1186/1743-422X-5-147	51	58	58	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92075	10.1371/journal.pone.0092075	http://dx.doi.org/10.1371/journal.pone.0092075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647410	Green Submitted, gold, Green Published			2022-12-25	WOS:000333348500080
J	Kosinska, MK; Liebisch, G; Lochnit, G; Wilhelm, J; Klein, H; Kaesser, U; Lasczkowski, G; Rickert, M; Schmitz, G; Steinmeyer, J				Kosinska, Marta Krystyna; Liebisch, Gerhard; Lochnit, Guenter; Wilhelm, Jochen; Klein, Heiko; Kaesser, Ulrich; Lasczkowski, Gabriele; Rickert, Markus; Schmitz, Gerd; Steinmeyer, Juergen			Sphingolipids in Human Synovial Fluid - A Lipidomic Study	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; RABBIT ARTICULAR-CARTILAGE; NECROSIS-FACTOR-ALPHA; LYSOPHOSPHATIDIC ACID; RHEUMATOID-ARTHRITIS; MATRIX-METALLOPROTEINASE; HUMAN PLASMA; CERAMIDE; APOPTOSIS; CARDIOLIPIN	Articular synovial fluid (SF) is a complex mixture of components that regulate nutrition, communication, shock absorption, and lubrication. Alterations in its composition can be pathogenic. This lipidomic investigation aims to quantify the composition of sphingolipids (sphingomyelins, ceramides, and hexosyl- and dihexosylceramides) and minor glycerophospholipid species, including (lyso)phosphatidic acid, (lyso)phosphatidylglycerol, and bis(monoacylglycero)phosphate species, in the SF of knee joints from unaffected controls and from patients with early (eOA) and late (lOA) stages of osteoarthritis (OA), and rheumatoid arthritis (RA). SF without cells and cellular debris from 9 postmortem donors (control), 18 RA, 17 eOA, and 13 lOA patients were extracted to measure lipid species using electrospray ionization tandem mass spectrometry - directly or coupled with hydrophilic interaction liquid chromatography. We provide a novel, detailed overview of sphingolipid and minor glycerophospholipid species in human SF. A total of 41, 48, and 50 lipid species were significantly increased in eOA, lOA, and RA SF, respectively when compared with normal SF. The level of 21 lipid species differed in eOA SF versus SF from lOA, an observation that can be used to develop biomarkers. Sphingolipids can alter synovial inflammation and the repair responses of damaged joints. Thus, our lipidomic study provides the foundation for studying the biosynthesis and function of lipid species in health and most prevalent joint diseases.	[Kosinska, Marta Krystyna; Klein, Heiko; Rickert, Markus; Steinmeyer, Juergen] Univ Giessen, Dept Orthoped, D-35390 Giessen, Germany; [Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp Regensburg, Dept Clin Chem & Lab Med, Regensburg, Germany; [Lochnit, Guenter] Univ Giessen, Dept Biochem, D-35390 Giessen, Germany; [Wilhelm, Jochen] Univ Giessen, Med Clin 2 4, D-35390 Giessen, Germany; [Kaesser, Ulrich] Krankenhaus Balser Stiftung, Internist Praxiszentrum, Giessen, Germany; [Lasczkowski, Gabriele] Univ Giessen, Inst Forens Med, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Regensburg; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Steinmeyer, J (corresponding author), Univ Giessen, Dept Orthoped, D-35390 Giessen, Germany.	juergen.steinmeyer@ortho.med.uni-giessen.de	Liebisch, Gerhard/G-6130-2010; Wilhelm, Jochen/AAX-4302-2021; Rickert, Markus/D-8731-2017	Liebisch, Gerhard/0000-0003-4886-0811; Wilhelm, Jochen/0000-0001-5544-9647; Rickert, Markus/0000-0001-7681-9918; Steinmeyer, Juergen/0000-0002-4053-503X	DRB foundation; "LipidomicNet'' project; European Union [202272]	DRB foundation; "LipidomicNet'' project; European Union(European Commission)	This work was supported in part by a grant of the DRB foundation and by the "LipidomicNet'' project, funded within the Seventh Framework Programme of the European Union (Grant agreement number 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Berckmans RJ, 2005, ARTHRITIS RES THER, V7, pR536, DOI 10.1186/ar1706; Colosimo M, 2000, BONE MARROW TRANSPL, V25, P549, DOI 10.1038/sj.bmt.1702166; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Gerritsen ME, 1998, AM J PATHOL, V152, P505; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Hullin-Matsuda F, 2009, PROSTAG LEUKOTR ESS, V81, P313, DOI 10.1016/j.plefa.2009.09.006; Hurst-Kennedy J, 2009, BBA-MOL CELL RES, V1793, P836, DOI 10.1016/j.bbamcr.2009.01.020; Ichinose Y, 1998, J LAB CLIN MED, V131, P410, DOI 10.1016/S0022-2143(98)90141-X; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kim MK, 2005, BIOCHEM PHARMACOL, V70, P1764, DOI 10.1016/j.bcp.2005.09.015; Kosinska MK, 2013, ARTHRITIS RHEUM-US, V65, P2323, DOI 10.1002/art.38053; Kraus VB, 2002, ARTHRITIS RHEUM-US, V46, P420, DOI 10.1002/art.10124; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lee JY, 2011, ANAL BIOANAL CHEM, V400, P2953, DOI 10.1007/s00216-011-4958-7; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Masuda I, 2013, OSTEOARTHR CARTILAGE, V21, pS296, DOI 10.1016/j.joca.2013.02.622; Meikle PJ, 2008, BIOCHEM J, V411, P71, DOI 10.1042/BJ20071043; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mizushima N, 1998, ANN RHEUM DIS, V57, P495, DOI 10.1136/ard.57.8.495; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Orosa B, 2012, ARTHRITIS RHEUM-US, V64, P2460, DOI 10.1002/art.34443; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Sabatini M, 2001, BIOCHEM BIOPH RES CO, V283, P1105, DOI 10.1006/bbrc.2001.4920; Sabatini M, 2000, BIOCHEM BIOPH RES CO, V267, P438, DOI 10.1006/bbrc.1999.1983; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Song HY, 2010, BBA-MOL CELL BIOL L, V1801, P23, DOI 10.1016/j.bbalip.2009.08.011; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tokumura A, 2002, BBA-MOL CELL BIOL L, V1582, P18, DOI 10.1016/S1388-1981(02)00133-6; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Yin HY, 2012, FREE RADICAL RES, V46, P959, DOI 10.3109/10715762.2012.676642	49	62	62	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91769	10.1371/journal.pone.0091769	http://dx.doi.org/10.1371/journal.pone.0091769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646942	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500051
J	Paulander, W; Wang, Y; Folkesson, A; Charbon, G; Lobner-Olesen, A; Ingmer, H				Paulander, Wilhelm; Wang, Ying; Folkesson, Anders; Charbon, Godefroid; Lobner-Olesen, Anders; Ingmer, Hanne			Bactericidal Antibiotics Increase Hydroxyphenyl Fluorescein Signal by Altering Cell Morphology	PLOS ONE			English	Article							DEATH; RESISTANCE; DIVISION; CLUSTER	It was recently proposed that for bactericidal antibiotics a common killing mechanism contributes to lethality involving indirect stimulation of hydroxyl radical (OH center dot) formation. Flow cytometric detection of OH center dot by hydroxyphenyl fluorescein (HPF) probe oxidation was used to support this hypothesis. Here we show that increased HPF signals in antibiotics-exposed bacterial cells are explained by fluorescence associated with increased cell size, and do not reflect reactive oxygen species (ROS) concentration. Independently of antibiotics, increased fluorescence was seen for elongated cells expressing the oxidative insensitive green fluorescent protein (GFP). Although our data question the role of ROS in lethality of antibiotics other research approaches point to important interplays between basic bacterial metabolism and antibiotic susceptibility. To underpin such relationships, methods for detecting bacterial metabolites at a cellular level are needed.	[Paulander, Wilhelm; Wang, Ying; Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Folkesson, Anders] Tech Univ Denmark, Dept Microbial Ecol & Anim Hlth, Frederiksberg C, Denmark; [Charbon, Godefroid; Lobner-Olesen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Paulander, W (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark.	wp@sund.ku.dk	charbon, godefroid/D-3040-2011; Løbner-Olesen, Anders/K-4344-2014	charbon, godefroid/0000-0003-4792-1889; Løbner-Olesen, Anders/0000-0002-0344-6417; Ingmer, Hanne/0000-0002-8350-5631; Folkesson, Anders/0000-0002-2175-830X	Danish Research Council of Independent Research [274-08-0531, 09-069656]; Ung Elitforskarpris [09-076146]; Lundbeck Foundation; Danish Council for Strategic Research; Novo Nordisk Foundation; Lundbeck Foundation [R100-2011-9542] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0001802] Funding Source: researchfish	Danish Research Council of Independent Research; Ung Elitforskarpris; Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	HI is supported by grants from the Danish Research Council of Independent Research (274-08-0531); WP is supported by grants from the Danish Research Council of Independent Research (09-069656) and Ung Elitforskarpris (09-076146); GC and ALO are supported by the Lundbeck Foundation; and ALO is supported by the Danish Research Council of Independent Research, the Danish Council for Strategic Research and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chittezham Thomas V, 2013, MBIO, V20, P4; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; FLETCHER G, 1978, J BACTERIOL, V133, P91, DOI 10.1128/JB.133.1.91-100.1978; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gottfredsson M, 1998, ANTIMICROB AGENTS CH, V42, P1005, DOI 10.1128/AAC.42.5.1005; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; MASON DJ, 1995, ANTIMICROB AGENTS CH, V39, P2752, DOI 10.1128/AAC.39.12.2752; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999	19	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92231	10.1371/journal.pone.0092231	http://dx.doi.org/10.1371/journal.pone.0092231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647480	Green Published, gold			2022-12-25	WOS:000333348500101
J	Cheng, XR; Schafer, G; Riddell, PM				Cheng, Xiaorong; Schafer, Graham; Riddell, Patricia M.			Immediate Auditory Repetition of Words and Nonwords: An ERP Study of Lexical and Sublexical Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SHORT-TERM-MEMORY; NEIGHBORHOOD ACTIVATION; PHONOTACTIC PROBABILITY; SERIAL-RECALL; SPOKEN WORDS; TIME-COURSE; TREE MODEL; RECOGNITION; DECISION	ERPs were elicited to (1) words, (2) pseudowords derived from these words, and (3) nonwords with no lexical neighbors, in a task involving listening to immediately repeated auditory stimuli. There was a significant early (P200) effect of phonotactic probability in the first auditory presentation, which discriminated words and pseudowords from nonwords; and a significant somewhat later (N400) effect of lexicality, which discriminated words from pseudowords and nonwords. There was no reliable effect of lexicality in the ERPs to the second auditory presentation. We conclude that early sublexical phonological processing differed according to phonotactic probability of the stimuli, and that lexically-based redintegration occurred for words but did not occur for pseudowords or nonwords. Thus, in online word recognition and immediate retrieval, phonological and/or sublexical processing plays a more important role than lexical level redintegration.	[Cheng, Xiaorong] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [Cheng, Xiaorong] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Cheng, Xiaorong; Schafer, Graham; Riddell, Patricia M.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	Central China Normal University; University of Reading	Schafer, G (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	g.w.schafer@reading.ac.uk	Schafer, Graham/ABB-4360-2020; Riddell, Patricia/S-3724-2019	Riddell, Patricia/0000-0002-4916-2057	University of Reading; SRF for ROCS, SEM; China Postdoctoral Science Foundation [20110491179]; Humanities and Social Sciences Foundation of the Ministry of Education of China [11YJC190006]; National Natural Science Foundation of China [31170979]; Economic and Social Research Council [RES-474-25-0014] Funding Source: researchfish	University of Reading; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Humanities and Social Sciences Foundation of the Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was conducted at the University of Reading, UK, by the first author with the support of an Overseas PhD Studentship from the University of Reading. Additional data analyses and writing up were funded by SRF for ROCS, SEM, the China Postdoctoral Science Foundation (Grant No. 20110491179), the Humanities and Social Sciences Foundation of the Ministry of Education of China (Grant No. 11YJC190006) and the National Natural Science Foundation of China (Grant No. 31170979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev YG, 1998, NEUROIMAGE, V7, P1, DOI 10.1006/nimg.1997.0309; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; BENTIN S, 1993, PSYCHOPHYSIOLOGY, V30, P161, DOI 10.1111/j.1469-8986.1993.tb01729.x; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BENTIN S, 1994, J EXP PSYCHOL LEARN, V20, P130, DOI 10.1037/0278-7393.20.1.130; Bonte ML, 2007, NEUROPSYCHOLOGIA, V45, P1427, DOI 10.1016/j.neuropsychologia.2006.11.009; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Carreiras M, 2005, J COGNITIVE NEUROSCI, V17, P1803, DOI 10.1162/089892905774589217; Chauncey K, 2008, LANG COGNITIVE PROC, V23, P183, DOI 10.1080/01690960701579839; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; DANNENBRING GL, 1982, CAN J PSYCHOL, V36, P435, DOI 10.1037/h0080650; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; Deacon D, 2004, PSYCHOPHYSIOLOGY, V41, P60, DOI 10.1111/1469-8986.00120; Dhond RP, 2005, NEUROIMAGE, V28, P293, DOI 10.1016/j.neuroimage.2005.06.027; Dienes Z., 2008, UNDERSTANDING PSYCHO; Donchin E, 1984, COGNITIVE PSYCHOPHYS; Doyle MC, 1996, PSYCHOPHYSIOLOGY, V33, P132, DOI 10.1111/j.1469-8986.1996.tb02117.x; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Embick D, 2001, COGNITIVE BRAIN RES, V10, P345, DOI 10.1016/S0926-6410(00)00053-7; Gathercole SE, 1999, J EXP PSYCHOL LEARN, V25, P84, DOI 10.1037/0278-7393.25.1.84; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; GERKEN L, 1995, PERCEPT PSYCHOPHYS, V57, P475, DOI 10.3758/BF03213073; Gupta P, 2009, J MEM LANG, V61, P481, DOI 10.1016/j.jml.2009.08.001; Herzmann G, 2007, PSYCHOPHYSIOLOGY, V44, P262, DOI 10.1111/j.1469-8986.2007.00505.x; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; Holcomb PJ, 2009, J NEUROLINGUIST, V22, P301, DOI 10.1016/j.jneuroling.2008.06.004; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Huber DE, 2008, J EXP PSYCHOL HUMAN, V34, P1389, DOI 10.1037/a0013625; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Hutzler F, 2004, NEUROSCI LETT, V372, P179, DOI 10.1016/j.neulet.2004.07.050; Jefferies E, 2006, J MEM LANG, V54, P81, DOI 10.1016/j.jml.2005.08.001; Jones G, 2011, MEM COGNITION, V39, P588, DOI 10.3758/s13421-010-0045-0; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; KARAYANIDIS F, 1991, PSYCHOPHYSIOLOGY, V28, P307, DOI 10.1111/j.1469-8986.1991.tb02200.x; Kim MS, 2008, BRAIN RES, V1240, P132, DOI 10.1016/j.brainres.2008.08.061; Kucera H., 1967, COMPUTATIONAL ANAL P; Leech G, 2001, WORD FREQUENCIES WRI; Lewandowsky S, 2000, PSYCHOL RES-PSYCH FO, V63, P163, DOI 10.1007/PL00008175; MacGregor LJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1715; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; MICHAS IC, 1994, BRIT J DEV PSYCHOL, V12, P147, DOI 10.1111/j.2044-835X.1994.tb00625.x; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Munson B, 2001, J SPEECH LANG HEAR R, V44, P778, DOI 10.1044/1092-4388(2001/061); Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; Page M. P., 2008, INTERACTIONS SHORT T, P136; PAPAGNO C, 1992, Q J EXP PSYCHOL-A, V44, P47, DOI 10.1080/14640749208401283; Pickering S., 2001, WORKING MEMORY TEST; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Roodenrys S, 2002, J EXP PSYCHOL LEARN, V28, P29, DOI 10.1037//0278-7393.28.1.29; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rossi S, 2010, J COGNITIVE IN PRESS; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Ruchkin DS, 1999, J MEM LANG, V41, P345, DOI 10.1006/jmla.1999.2644; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; RUGG MD, 1995, J COGNITIVE NEUROSCI, V7, P209, DOI 10.1162/jocn.1995.7.2.209; RUGG MD, 1995, NEUROPSYCHOLOGIA, V33, P471, DOI 10.1016/0028-3932(94)00132-9; RUGG MD, 1987, MEM COGNITION, V15, P473, DOI 10.3758/BF03198381; Rugg MD., 1994, COGNITIVE ELECTROPHY, P124, DOI [10.1007/978-1-4612-0283-7%5F5, DOI 10.1007/978-1-4612-0283-7_5]; Samuel AG, 2011, ANNU REV PSYCHOL, V62, P49, DOI 10.1146/annurev.psych.121208.131643; SCHWEICKERT R, 1993, MEM COGNITION, V21, P168, DOI 10.3758/BF03202729; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Stark CEL, 2000, J EXP PSYCHOL LEARN, V26, P945, DOI 10.1037//0278-7393.26.4.945; Steinberg J, 2010, J COGNITIVE NEUROSCI, V22, P2174, DOI 10.1162/jocn.2009.21408; Swick D, 1997, J EXP PSYCHOL LEARN, V23, P123, DOI 10.1037/0278-7393.23.1.123; Thorn ASC, 2005, COGNITIVE PSYCHOL, V50, P133, DOI 10.1016/j.cogpsych.2004.07.001; Vitevitch MS, 1999, J MEM LANG, V40, P374, DOI 10.1006/jmla.1998.2618; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Vitevitch MS, 1999, BRAIN LANG, V68, P306, DOI 10.1006/brln.1999.2116; Wagenmakers EJM, 2004, Q J EXP PSYCHOL-A, V57, P1191, DOI 10.1080/02724980343000729; Zangl R, 2005, J COGN DEV, V6, P179, DOI 10.1207/s15327647jcd0602_2; Zeelenberg R, 2004, J EXP PSYCHOL LEARN, V30, P270, DOI 10.1037/0278-7393.30.1.270	78	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91988	10.1371/journal.pone.0091988	http://dx.doi.org/10.1371/journal.pone.0091988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642662	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900055
J	Mazurier, N; Parain, K; Parlier, D; Pretto, S; Hamdache, J; Vernier, P; Locker, M; Bellefroid, E; Perron, M				Mazurier, Nicolas; Parain, Karine; Parlier, Damien; Pretto, Silvia; Hamdache, Johanna; Vernier, Philippe; Locker, Morgane; Bellefroid, Eric; Perron, Muriel			Ascl1 as a Novel Player in the Ptf1a Transcriptional Network for GABAergic Cell Specification in the Retina	PLOS ONE			English	Article							GLYCINERGIC AMACRINE CELLS; DEVELOPING NERVOUS-SYSTEM; PRONEURAL GENES; FATE SPECIFICATION; XENOPUS-EMBRYOS; ACHAETE-SCUTE; VERTEBRATE RETINA; BHLH GENES; NEURONAL DIFFERENTIATION; SEROTONERGIC NEURONS	In contrast with the wealth of data involving bHLH and homeodomain transcription factors in retinal cell type determination, the molecular bases underlying neurotransmitter subtype specification is far less understood. Using both gain and loss of function analyses in Xenopus, we investigated the putative implication of the bHLH factor Ascl1 in this process. We found that in addition to its previously characterized proneural function, Ascl1 also contributes to the specification of the GABAergic phenotype. We showed that it is necessary for retinal GABAergic cell genesis and sufficient in overexpression experiments to bias a subset of retinal precursor cells towards a GABAergic fate. We also analysed the relationships between Ascl1 and a set of other bHLH factors using an in vivo ectopic neurogenic assay. We demonstrated that Ascl1 has unique features as a GABAergic inducer and is epistatic over factors endowed with glutamatergic potentialities such as Neurog2, NeuroD1 or Atoh7. This functional specificity is conferred by the basic DNA binding domain of Ascl1 and involves a specific genetic network, distinct from that underlying its previously demonstrated effects on catecholaminergic differentiation. Our data show that GABAergic inducing activity of Ascl1 requires the direct transcriptional regulation of Ptf1a, providing therefore a new piece of the network governing neurotransmitter subtype specification during retinogenesis.	[Mazurier, Nicolas; Parain, Karine; Pretto, Silvia; Hamdache, Johanna; Locker, Morgane; Perron, Muriel] Univ Paris 11, UPR Ctr Natl Rech Sci Neurobiol & Dev 3294, Orsay, France; [Parlier, Damien; Bellefroid, Eric] ULB IBMM, Lab Embryol Mol, Gosselies, Belgium; [Vernier, Philippe] Inst Alfred Fessard, UPR Ctr Natl Rech Sci Neurobiol & Dev 3294, Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; Universite Libre de Bruxelles	Perron, M (corresponding author), Univ Paris 11, UPR Ctr Natl Rech Sci Neurobiol & Dev 3294, Orsay, France.	muriel.perron@u-psud.fr	Perron, Muriel/F-6795-2019	Perron, Muriel/0000-0002-1558-8236	Agence Nationale de la Recherche [056054]; Centre national de la recherche scientifique, University Paris-Sud, Retina France; ARC [1108]; Belgian Fonds de la Recherche Scientifique [FRFC 3.4635.06]; Belgian Queen Elisabeth Medical Foundation; Federation Wallonie-Bruxelles;  [IFR144]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre national de la recherche scientifique, University Paris-Sud, Retina France; ARC(Australian Research Council); Belgian Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Queen Elisabeth Medical Foundation; Federation Wallonie-Bruxelles; 	NM is a Neuropole de Recherche Francilien fellow; DP is a Belgian Fonds pour la formation A A la Recherche dans l'Industrie et dans l'Agriculture fellow. This research was supported by grants to MP from the Agence Nationale de la Recherche (056054), Centre national de la recherche scientifique, University Paris-Sud, Retina France, ARC (1108), IFR144 and to EB from the Belgian Fonds de la Recherche Scientifique (FRFC 3.4635.06), the Belgian Queen Elisabeth Medical Foundation, the Federation Wallonie-Bruxelles (Action de Recherche Concertee) and the Walloon Region Excellence Programme ("CIBLES"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2008, BRAIN RES, V1192, P134, DOI 10.1016/j.brainres.2007.03.044; Afelik S, 2006, GENE DEV, V20, P1441, DOI 10.1101/gad.378706; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Amato MA, 2005, J COMP NEUROL, V481, P331, DOI 10.1002/cne.20387; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Casarosa S, 1999, DEVELOPMENT, V126, P525; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chitnis A, 1996, DEVELOPMENT, V122, P2295; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; Duquette PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013232; Farah MH, 2006, BRAIN RES REV, V52, P264, DOI 10.1016/j.brainresrev.2006.04.002; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; FERREIRO B, 1993, MECH DEVELOP, V40, P25, DOI 10.1016/0925-4773(93)90085-C; Fode C, 2000, GENE DEV, V14, P67; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Gammill LS, 1997, DEVELOPMENT, V124, P471; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Henke RM, 2009, DEV BIOL, V328, P529, DOI 10.1016/j.ydbio.2009.01.007; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Jacob J, 2013, DIS MODEL MECH; Jasoni CL, 1996, J COMP NEUROL, V369, P319; JASONI CL, 1994, DEVELOPMENT, V120, P769; Jiang HS, 2009, J NEUROSCI, V29, P10449, DOI 10.1523/JNEUROSCI.3048-09.2009; Jo AY, 2007, EXP CELL RES, V313, P4066, DOI 10.1016/j.yexcr.2007.08.026; Jusuf PR, 2011, J NEUROSCI, V31, P2549, DOI 10.1523/JNEUROSCI.4713-10.2011; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Lang B, 2010, NEUROPHARMACOLOGY, V58, P215, DOI 10.1016/j.neuropharm.2009.07.003; Lea Robert, 2012, Methods Mol Biol, V917, P431, DOI 10.1007/978-1-61779-992-1_24; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lelievre EC, 2011, DEV BIOL, V358, P296, DOI 10.1016/j.ydbio.2011.07.033; Li M, 2006, J COMP NEUROL, V495, P645, DOI 10.1002/cne.20900; Lo LC, 1998, DEVELOPMENT, V125, P609; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mao WM, 2009, DEV NEUROBIOL, V69, P88, DOI 10.1002/dneu.20693; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Meredith DM, 2009, J NEUROSCI, V29, P11139, DOI 10.1523/JNEUROSCI.2303-09.2009; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Morikawa Y, 2007, DEV BIOL, V307, P114, DOI 10.1016/j.ydbio.2007.04.027; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nieuwkoop P D, 1967, Acta Biotheor, V17, P178, DOI 10.1007/BF01601987; Ohnuma S, 2002, METHODS, V28, P411, DOI 10.1016/S1046-2023(02)00260-8; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Osorio J, 2010, J COMP NEUROL, V518, P851, DOI 10.1002/cne.22247; Parain K, 2012, DEV NEUROBIOL, V72, P491, DOI 10.1002/dneu.20973; Park CH, 2006, J CELL SCI, V119, P2310, DOI 10.1242/jcs.02955; Parlier D, 2008, DEV DYNAM, V237, P2147, DOI 10.1002/dvdy.21621; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Peltopuro P, 2010, DEV BIOL, V343, P63, DOI 10.1016/j.ydbio.2010.04.015; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Souopgui J, 2007, INT J DEV BIOL, V51, P339, DOI 10.1387/ijdb.062235js; Suga A, 2009, DEV BIOL, V330, P318, DOI 10.1016/j.ydbio.2009.04.002; Taelman V, 2004, DEV BIOL, V276, P47, DOI 10.1016/j.ydbio.2004.08.019; Talikka M, 2002, DEV BIOL, V247, P137, DOI 10.1006/dbio.2002.0677; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang JCC, 2005, DEV BIOL, V285, P101, DOI 10.1016/j.ydbio.2005.05.041; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zaghloul NA, 2007, MOL VIS, V13, P86; Zordan P, 2008, DEV DYNAM, V237, P1726, DOI 10.1002/dvdy.21571	82	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92113	10.1371/journal.pone.0092113	http://dx.doi.org/10.1371/journal.pone.0092113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643195	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900089
J	Hatazawa, Y; Tadaishi, M; Nagaike, Y; Morita, A; Ogawa, Y; Ezaki, O; Takai-Igarashi, T; Kitaura, Y; Shimomura, Y; Kamei, Y; Miura, S				Hatazawa, Yukino; Tadaishi, Miki; Nagaike, Yuta; Morita, Akihito; Ogawa, Yoshihiro; Ezaki, Osamu; Takai-Igarashi, Takako; Kitaura, Yasuyuki; Shimomura, Yoshiharu; Kamei, Yasutomi; Miura, Shinji			PGC-1 alpha-Mediated Branched-Chain Amino Acid Metabolism in the Skeletal Muscle	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MESSENGER-RNA; DEHYDROGENASE COMPLEX; EXERCISE; RECEPTOR; EXPRESSION; OVEREXPRESSION; CATABOLISM; ANGIOGENESIS; INCREASES	Peroxisome proliferator-activated receptor (PPAR) c coactivator 1 alpha (PGC-1 alpha) is a coactivator of various nuclear receptors and other transcription factors, which is involved in the regulation of energy metabolism, thermogenesis, and other biological processes that control phenotypic characteristics of various organ systems including skeletal muscle. PGC-1 alpha in skeletal muscle is considered to be involved in contractile protein function, mitochondrial function, metabolic regulation, intracellular signaling, and transcriptional responses. Branched-chain amino acid (BCAA) metabolism mainly occurs in skeletal muscle mitochondria, and enzymes related to BCAA metabolism are increased by exercise. Using murine skeletal muscle overexpressing PGC-1 alpha and cultured cells, we investigated whether PGC-1 alpha stimulates BCAA metabolism by increasing the expression of enzymes involved in BCAA metabolism. Transgenic mice overexpressing PGC-1 alpha specifically in the skeletal muscle had increased the expression of branched-chain aminotransferase (BCAT) 2, branched-chain a-keto acid dehydrogenase (BCKDH), which catabolize BCAA. The expression of BCKDH kinase (BCKDK), which phosphorylates BCKDH and suppresses its enzymatic activity, was unchanged. The amount of BCAA in the skeletal muscle was significantly decreased in the transgenic mice compared with that in the wild-type mice. The amount of glutamic acid, a metabolite of BCAA catabolism, was increased in the transgenic mice, suggesting the activation of muscle BCAA metabolism by PGC-1 alpha. In C2C12 cells, the overexpression of PGC-1 alpha significantly increased the expression of BCAT2 and BCKDH but not BCKDK. Thus, PGC-1 alpha in the skeletal muscle is considered to significantly contribute to BCAA metabolism.	[Hatazawa, Yukino; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Grad Sch Med & Dent Sci, Tokyo, Japan; [Hatazawa, Yukino; Kamei, Yasutomi] Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Kyoto 606, Japan; [Tadaishi, Miki] Natl Inst Hlth & Nutr, Dept Food Funct & Labeling, Tokyo 162, Japan; [Nagaike, Yuta; Morita, Akihito; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka 4228526, Japan; [Ezaki, Osamu] Showa Womens Univ, Dept Human Hlth & Design, Tokyo, Japan; [Takai-Igarashi, Takako] Tohoku Univ, Dept Hlth Record Informat, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kitaura, Yasuyuki; Shimomura, Yoshiharu] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan	Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; National Institute of Health & Nutrition - Japan; University of Shizuoka; Tohoku University; Nagoya University	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Kyoto 606, Japan.	kamei@kpu.ac.jp; miura@u-shizuoka-ken.ac.jp	Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; Ogawa, Yoshihiro/0000-0002-0834-2836; xing zhi, shi zhi/0000-0003-3289-5681	Fuji Foundation for Protein Research; Sapporo Bioscience Foundation; Kieikai Research Foundation; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Sapporo Bioscience Foundation; Kieikai Research Foundation(Kieikai Research Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Fuji Foundation for Protein Research, Sapporo Bioscience Foundation, The Kieikai Research Foundation, The Uehara Memorial Foundation, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kobayashi R, 2000, ARCH BIOCHEM BIOPHYS, V375, P55, DOI 10.1006/abbi.1999.1635; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Misawa K, 2000, P NATL ACAD SCI USA, V97, P3062, DOI 10.1073/pnas.060489597; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; Shimomura Y, 2006, J NUTR, V136, p250S, DOI 10.1093/jn/136.1.250S; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Takahashi M, 2013, BIOCHEM BIOPH RES CO, V434, P873, DOI 10.1016/j.bbrc.2013.04.041; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3	32	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91006	10.1371/journal.pone.0091006	http://dx.doi.org/10.1371/journal.pone.0091006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638054	Green Published, gold			2022-12-25	WOS:000333254100015
J	Jaligot, E; Hooi, WY; Debladis, E; Richaud, F; Beule, T; Collin, M; Agbessi, MDT; Sabot, F; Garsmeur, O; D'Hont, A; Alwee, SSRS; Rival, A				Jaligot, Estelle; Hooi, Wei Yeng; Debladis, Emilie; Richaud, Frederique; Beule, Thierry; Collin, Myriam; Agbessi, Mawusse D. T.; Sabot, Francois; Garsmeur, Olivier; D'Hont, Angelique; Alwee, Sharifah Shahrul Rabiah Syed; Rival, Alain			DNA Methylation and Expression of the EgDEF1 Gene and Neighboring Retrotransposons in mantled Somaclonal Variants of Oil Palm	PLOS ONE			English	Article							ELAEIS-GUINEENSIS JACQ.; MADS BOX GENES; TRANSPOSABLE ELEMENTS; EPIGENETIC CONTROL; FLOWER STRUCTURE; TISSUE-CULTURE; ARABIDOPSIS; PLANTS; EVOLUTION; APETALA3	The mantled floral phenotype of oil palm (Elaeis guineensis) affects somatic embryogenesis-derived individuals and is morphologically similar to mutants defective in the B-class MADS-box genes. This somaclonal variation has been previously demonstrated to be associated to a significant deficit in genome-wide DNA methylation. In order to elucidate the possible role of DNA methylation in the transcriptional regulation of EgDEF1, the APETALA3 ortholog of oil palm, we studied this epigenetic mark within the gene in parallel with transcript accumulation in both normal and mantled developing inflorescences. We also examined the methylation and expression of two neighboring retrotransposons that might interfere with EgDEF1 regulation. We show that the EgDEF1 gene is essentially unmethylated and that its methylation pattern does not change with the floral phenotype whereas expression is dramatically different, ruling out a direct implication of DNA methylation in the regulation of this gene. Also, we find that both the gypsy element inserted within an intron of the EgDEF1 gene and the copia element located upstream from the promoter are heavily methylated and show little or no expression. Interestingly, we identify a shorter, alternative transcript produced by EgDEF1 and characterize its accumulation with respect to its full-length counterpart. We demonstrate that, depending on the floral phenotype, the respective proportions of these two transcripts change differently during inflorescence development. We discuss the possible phenotypical consequences of this alternative splicing and the new questions it raises in the search for the molecular mechanisms underlying the mantled phenotype in the oil palm.	[Jaligot, Estelle; Hooi, Wei Yeng; Debladis, Emilie; Richaud, Frederique; Beule, Thierry; Agbessi, Mawusse D. T.; Rival, Alain] CIRAD, UMR DIADE, Montpellier, France; [Collin, Myriam; Sabot, Francois] IRD, UMR DIADE, Montpellier, France; [Garsmeur, Olivier; D'Hont, Angelique] CIRAD, UMR AGAP, Montpellier, France; [Hooi, Wei Yeng; Alwee, Sharifah Shahrul Rabiah Syed] FASSB, FELDA Biotechnol Ctr, Bandar Enstek, Malaysia	CIRAD; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Universite de Montpellier	Jaligot, E (corresponding author), CIRAD, UMR DIADE, Montpellier, France.	estelle.jaligot@cirad.fr	Sabot, Francois/B-7820-2010; RIVAL, Alain/A-9064-2011; DHONT, Angélique/AAL-8074-2021	Sabot, Francois/0000-0002-8522-7583; Debladis, Emilie/0000-0003-4734-7426; Jaligot, Estelle/0000-0002-9252-5271	PalmElit SAS; CIRAD (Centre de cooperation internationale en recherche agronomique pour le developpement); CIRAD; FELDA/FASSB (Federal Land Development Authority/Agricultural Services Sdn Bdh); Genoscope [AAP2007/8]; AIRD (Agence inter-etablissements de recherche pour le developpement)	PalmElit SAS; CIRAD (Centre de cooperation internationale en recherche agronomique pour le developpement); CIRAD; FELDA/FASSB (Federal Land Development Authority/Agricultural Services Sdn Bdh); Genoscope; AIRD (Agence inter-etablissements de recherche pour le developpement)	This work was partly funded through the RnaPalm (between PalmElit SAS and CIRAD (Centre de cooperation internationale en recherche agronomique pour le developpement) and FloriPalm projects (between CIRAD and FELDA/FASSB (Federal Land Development Authority/Agricultural Services Sdn Bdh). BAC sequencing was funded by Genoscope (AAP2007/8). WYH is the recipient of a PhD grant from CIRAD and AIRD (Agence inter-etablissements de recherche pour le developpement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H, 2006, J MOL EVOL, V62, P15, DOI 10.1007/s00239-005-0333-7; Adam H, 2005, AM J BOT, V92, P1836, DOI 10.3732/ajb.92.11.1836; Adam H, 2007, ANN BOT-LONDON, V100, P1, DOI 10.1093/aob/mcm027; Adam H, 2007, J EXP BOT, V58, P1245, DOI 10.1093/jxb/erl263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausin I, 2012, EPIGENETICS-US, V7, P29, DOI 10.4161/epi.7.1.18782; Cegan R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-180; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Galimba KD, 2012, P NATL ACAD SCI USA, V109, pE2267, DOI 10.1073/pnas.1203686109; Grafi G, 2011, PLANTA, V233, P433, DOI 10.1007/s00425-011-1366-3; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Hands P, 2011, ANN BOT-LONDON, V107, P1557, DOI 10.1093/aob/mcr045; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Jaligot E, 2002, THEOR APPL GENET, V104, P1263, DOI 10.1007/s00122-002-0906-4; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Jaligot E, 2011, ANN BOT, V108, P1463; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; KAEPPLER SM, 1993, IN VITRO CELL DEV-PL, V29P, P125, DOI 10.1007/BF02632283; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li-Byarlay H, 2013, P NATL ACAD SCI USA, V110, P12750, DOI 10.1073/pnas.1310735110; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Liu ZX, 2013, PLANT CELL REP, V32, P227, DOI 10.1007/s00299-012-1357-2; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P2723, DOI 10.1093/nar/gkp129; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Morcillo F, 2006, TREE PHYSIOL, V26, P585, DOI 10.1093/treephys/26.5.585; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; PANNETIER C, 1981, OLEAGINEUX, V36, P119; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pelissier T, 2012, TOPICS CURRENT GENET, P125; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piffanelli P, 2002, PLANT AN MICR GEN 10; Piwarzyk E, 2007, PLANT PHYSIOL, V145, P1495, DOI 10.1104/pp.107.105346; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Rival A, 2008, J EXP BOT, V59, P3271, DOI 10.1093/jxb/ern178; Salemme M, 2013, MOL BIOL REP, P1; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Schor IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048084; Seo PJ, 2012, PLANT J, V72, P162, DOI 10.1111/j.1365-313X.2012.05069.x; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Shearman JR, 2013, GENOMICS, V101, P306, DOI 10.1016/j.ygeno.2013.02.012; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Tregear JW, 2002, J EXP BOT, V53, P1387, DOI 10.1093/jexbot/53.373.1387; Tsaftaris AS, 2005, BIOL PLANTARUM, V49, P499, DOI 10.1007/s10535-005-0041-6; Tsuchiya T, 2013, P NATL ACAD SCI USA, V110, pE3535, DOI 10.1073/pnas.1312545110; Wang XG, 2013, P NATL ACAD SCI USA, V110, P15467, DOI 10.1073/pnas.1315399110; Weil C, 2008, CURR OPIN GENET DEV, V18, P188, DOI 10.1016/j.gde.2008.01.015; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zhang CJ, 2013, EMBO J, V32, P1128, DOI 10.1038/emboj.2013.49; Zhang JQ, 2011, GENE, V473, P82, DOI 10.1016/j.gene.2010.11.005; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	66	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91896	10.1371/journal.pone.0091896	http://dx.doi.org/10.1371/journal.pone.0091896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638102	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100076
J	Niu, JW; Vysochan, A; Luo, WQ				Niu, Jingwen; Vysochan, Anna; Luo, Wenqin			Dual Innervation of Neonatal Merkel Cells in Mouse Touch Domes	PLOS ONE			English	Article							SENSORY NEURONS; CUTANEOUS MECHANORECEPTORS; DIFFERENTIAL DEPENDENCY; TRK RECEPTORS; OVEREXPRESSION; NEUROTROPHINS; SPECIFICATION; CORPUSCLE; SUBTYPES; RAT	Merkel cell-neurite complexes are specialized mechanosensory end organs that mediate discriminative touch sensation. It is well established that type I slowly adapting (SAI) mechanoreceptors, which express neural filament heavy chain (NFH), innervate Merkel cells. It was previously shown that neurotrophic factor NT3 and its receptor TrkC play crucial roles in controlling touch dome Merkel cell innervation of NFH+ fibers. In addition, nerve fibers expressing another neurotrophic tyrosine receptor kinase (NTRK), Ret, innervate touch dome Merkel cells as well. However, the relationship between afferents responsive to NT3/TrkC signaling and those expressing Ret is unclear. It is also controversial if these Ret(+) fibers belong to the early or late Ret(+) DRG neurons, which are defined based on the co-expression and developmental dependence of TrkA. To address these questions, we genetically traced Ret(+) and TrkC(+) fibers and analyzed their developmental dependence on TrkA. We found that Merkel cells in neonatal mouse touch domes receive innervation of two types of fibers: one group is Ret(+), while the other subset expresses TrkC and NFH. In addition, Ret(+) fibers depend on TrkA for their survival and normal innervation whereas NFH+ Merkel cell innervating fibers are almost unaltered in TrkA mutant mice, supporting that Ret(+) and NFH+/TrkC(+) afferents are two distinct groups. Ret signaling, on the other hand, plays a minor role for the innervation of neonatal touch domes. In contrast, Merkel cells in the glabrous skin are mainly contacted by NFH+/TrkC(+) afferents. Taken together, our results suggest that neonatal Merkel cells around hair follicles receive dual innervation while Merkel cells in the glabrous skin are mainly innervated by only SAI mechanoreceptors. In addition, our results suggest that neonatal Ret(+) Merkel cell innervating fibers most likely belong to the late but not early Ret(+) DRG neurons.	[Niu, Jingwen; Vysochan, Anna; Luo, Wenqin] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Luo, WQ (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	luow@mail.med.upenn.edu		Niu, Jingwen/0000-0001-5456-1485	National Institutes of Health (NIH) [R00NS069799, 1R01NS083702]; Basil O'Connor Starter Scholar Research Award; Thomas B. McCabe and Jeanette E. Laws McCabe Pilot Award; Institute of Regenerative Medicine Pilot Grant from UPenn; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS069799, R01NS083702] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor Starter Scholar Research Award(March of Dimes); Thomas B. McCabe and Jeanette E. Laws McCabe Pilot Award; Institute of Regenerative Medicine Pilot Grant from UPenn; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health (NIH, R00NS069799 and 1R01NS083702), Basil O'Connor Starter Scholar Research Award, Thomas B. McCabe and Jeanette E. Laws McCabe Pilot Award, and the Institute of Regenerative Medicine Pilot Grant from UPenn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo H, 2011, EUR J NEUROSCI, V34, P1529, DOI 10.1111/j.1460-9568.2011.07883.x; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cronk KM, 2002, DEVELOPMENT, V129, P3739; Fleming Michael S, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1271-1; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359; Gong SC, 2010, NAT PROTOC, V5, P1678, DOI 10.1038/nprot.2010.131; Halata Z, 2005, ANAT EMBRYOL, V209, P335, DOI 10.1007/s00429-005-0455-0; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Krimm RF, 2004, J COMP NEUROL, V471, P352, DOI 10.1002/cne.20041; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045551; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Niu JW, 2013, J NEUROSCI, V33, P17691, DOI 10.1523/JNEUROSCI.3429-13.2013; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Rice FL, 2008, SENSES COMPREHENSIVE, P1, DOI 10.1016/B978-0-12-805408-6.00340-7; Senzaki K, 2010, MOL CELL NEUROSCI, V43, P296, DOI 10.1016/j.mcn.2009.12.003; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Zelena J, 1994, NERVES MECHANORECEPT	35	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92027	10.1371/journal.pone.0092027	http://dx.doi.org/10.1371/journal.pone.0092027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637732	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100103
J	Ohlsson, C; Engdahl, C; Fak, F; Andersson, A; Windahl, SH; Farman, HH; Moverare-Skrtic, S; Islander, U; Sjogren, K				Ohlsson, Claes; Engdahl, Cecilia; Fak, Frida; Andersson, Annica; Windahl, Sara H.; Farman, Helen H.; Moverare-Skrtic, Sofia; Islander, Ulrika; Sjogren, Klara			Probiotics Protect Mice from Ovariectomy-Induced Cortical Bone Loss	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; C-REACTIVE PROTEIN; T-CELLS; MINERAL DENSITY; TRABECULAR BONE; GUT MICROBIOTA; IMMUNE-SYSTEM; TNF-ALPHA; OSTEOPROTEGERIN; WOMEN	The gut microbiota (GM) modulates the hosts metabolism and immune system. Probiotic bacteria are defined as live microorganisms which when administered in adequate amounts confer a health benefit on the host and can alter the composition of the GM. Germ-free mice have increased bone mass associated with reduced bone resorption indicating that the GM also regulates bone mass. Ovariectomy (ovx) results in bone loss associated with altered immune status. The purpose of this study was to determine if probiotic treatment protects mice from ovx-induced bone loss. Mice were treated with either a single Lactobacillus (L) strain, L. paracasei DSM13434 (L. para) or a mixture of three strains, L. paracasei DSM13434, L. plantarum DSM 15312 and DSM 15313 (L. mix) given in the drinking water during 6 weeks, starting two weeks before ovx. Both the L. para and the L. mix treatment protected mice from ovx-induced cortical bone loss and bone resorption. Cortical bone mineral content was higher in both L. para and L. mix treated ovx mice compared to vehicle (veh) treated ovx mice. Serum levels of the resorption marker C-terminal telopeptides and the urinary fractional excretion of calcium were increased by ovx in the veh treated but not in the L. para or the L. mix treated mice. Probiotic treatment reduced the expression of the two inflammatory cytokines, TNF alpha and IL-1 beta, and increased the expression of OPG, a potent inhibitor of osteoclastogenesis, in cortical bone of ovx mice. In addition, ovx decreased the frequency of regulatory T cells in bone marrow of veh treated but not probiotic treated mice. In conclusion, treatment with L. para or the L. mix prevents ovxinduced cortical bone loss. Our findings indicate that these probiotic treatments alter the immune status in bone resulting in attenuated bone resorption in ovx mice.	[Ohlsson, Claes; Engdahl, Cecilia; Andersson, Annica; Windahl, Sara H.; Farman, Helen H.; Moverare-Skrtic, Sofia; Islander, Ulrika; Sjogren, Klara] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Engdahl, Cecilia; Andersson, Annica; Islander, Ulrika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Fak, Frida] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden	University of Gothenburg; University of Gothenburg; Lund University	Sjogren, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.	Klara.Sjogren@medic.gu.se	Skrtic, Sofia/AAQ-1585-2020; Islander, Ulrika/S-4824-2019; Ohlsson, Claes/AGP-3544-2022; Andersson, Annica/B-4424-2015	Islander, Ulrika/0000-0002-8493-1739; Ohlsson, Claes/0000-0002-9633-2805; Andersson, Annica/0000-0002-3333-8687; Engdahl, Cecilia/0000-0002-8914-0178; Windahl, Sara/0000-0002-6611-6001; Sjogren, Klara/0000-0001-5776-7278	Swedish Research Council; Swedish Foundation for Strategic Research; COMBINE; Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Inga-Britt and Arne Lundberg Foundation; Novo Nordisk Fonden [NNF13OC0005785, NNF14OC0010513] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); COMBINE; Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Magnus Bergvall Foundation; Ake Wiberg Foundation; Inga-Britt and Arne Lundberg Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, COMBINE, Avtal om Lakarutbildning och Forskning/Lakarutbildningsavtalet research grant in Gothenburg, Lundberg Foundation, Torsten and Ragnar Soderberg Foundation, Novo Nordisk Foundation, Magnus Bergvall Foundation and Ake Wiberg Foundation. The BD FACS Canto II was bought thanks to generous support from the Inga-Britt and Arne Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal N, 2013, J CLIN ENDOCRINOL ME; Bouladoux N, 2012, MUCOSAL IMMUNOL, V5, P623, DOI 10.1038/mi.2012.36; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Buchwald ZS, 2013, BONE, V56, P163, DOI 10.1016/j.bone.2013.05.024; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; Eriksson AL, 2013, J BONE MINER RES; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Kim YG, 2007, BIOCHEM BIOPH RES CO, V357, P1046, DOI 10.1016/j.bbrc.2007.04.042; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Luo CY, 2011, CELL MOL IMMUNOL, V8, P50, DOI 10.1038/cmi.2010.54; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; MCKANE WR, 1995, J CLIN ENDOCR METAB, V80, P3458, DOI 10.1210/jc.80.12.3458; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Pasco JA, 2006, JAMA-J AM MED ASSOC, V296, P1353, DOI 10.1001/jama.296.11.1353; Pytlik M, 2004, CALCIFIED TISSUE INT, V75, P225, DOI 10.1007/s00223-004-0097-x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schett G, 2006, ARCH INTERN MED, V166, P2495, DOI 10.1001/archinte.166.22.2495; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Williams S, 1996, BONE, V19, P637, DOI 10.1016/S8756-3282(96)00302-X; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	43	184	205	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92368	10.1371/journal.pone.0092368	http://dx.doi.org/10.1371/journal.pone.0092368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637895	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100148
J	Samuelson, EM; Laird, RM; Papillion, AM; Tatum, AH; Princiotta, MF; Hayes, SM				Samuelson, Elizabeth M.; Laird, Renee M.; Papillion, Amber M.; Tatum, Arthur H.; Princiotta, Michael F.; Hayes, Sandra M.			Reduced B Lymphoid Kinase (Blk) Expression Enhances Proinflammatory Cytokine Production and Induces Nephrosis in C57BL/6-lpr/lpr Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; FOLLICULAR HELPER-CELL; TUMOR-NECROSIS-FACTOR; T-CELLS; INDUCIBLE COSTIMULATOR; SUSCEPTIBILITY LOCI; RHEUMATOID-ARTHRITIS; IL-21 RECEPTOR; SERUM-LEVELS	BLK, which encodes B lymphoid kinase, was recently identified in genome wide association studies as a susceptibility gene for systemic lupus erythematosus (SLE), and risk alleles mapping to the BLK locus result in reduced gene expression. To determine whether BLK is indeed a bona fide susceptibility gene, we developed an experimental mouse model, namely the Blk(+/-). lpr/lpr (Blk(+/-). lpr) mouse, in which Blk expression levels are reduced to levels comparable to those in individuals carrying a risk allele. Here, we report that Blk is expressed not only in B cells, but also in IL-17-producing gamma delta and DN alpha beta T cells and in plasmacytoid dendritic cells (pDCs). Moreover, we found that solely reducing Blk expression in C57BL/6-lpr/lpr mice enhanced proinflammatory cytokine production and accelerated the onset of lymphoproliferation, proteinuria, and kidney disease. Together, these findings suggest that BLK risk alleles confer susceptibility to SLE through the dysregulation of a proinflammatory cytokine network.	[Samuelson, Elizabeth M.; Laird, Renee M.; Papillion, Amber M.; Princiotta, Michael F.; Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Tatum, Arthur H.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Hayes, SM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	HayesSa@upstate.edu			National Institutes of Health [R21 AI097694, R56 AI091908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097694, R56AI091908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R21 AI097694 and R56 AI091908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Bae YJ, 2012, ALLERGY ASTHMA IMMUN, pe125; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Brennan F, 2007, CURR OPIN RHEUMATOL, V19, P296, DOI 10.1097/BOR.0b013e32805e87f1; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Calvani N, 2005, AUTOIMMUN REV, V4, P542, DOI 10.1016/j.autrev.2005.04.009; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cash H, 2010, J RHEUMATOL, V37, P60, DOI 10.3899/jrheum.090194; Cay HF, 2012, CLIN EXP RHEUMATOL, V30, P843; Chan OTM, 1999, IMMUNOL REV, V169, P107, DOI 10.1111/j.1600-065X.1999.tb01310.x; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Delgado-Vega AM, 2012, ANN RHEUM DIS, V71, P1219, DOI 10.1136/annrheumdis-2011-200987; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; ESPERSEN GT, 1991, CLIN RHEUMATOL, V10, P374, DOI 10.1007/BF02206655; Fairhurst AM, 2006, ADV IMMUNOL, V92, P1, DOI 10.1016/S0065-2776(06)92001-X; Fina Daniele, 2007, Inflammation & Allergy Drug Targets, V6, P63, DOI 10.2174/187152807780077246; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Gourh P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2821; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gutierrez S, 2012, NEFROLOGIA, V32, P245, DOI 10.3265/Nefrologia.pre2011.Nov.11138; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hu HB, 2011, P NATL ACAD SCI USA, V108, P12827, DOI 10.1073/pnas.1105774108; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; ISLAM KB, 1995, J IMMUNOL, V154, P1265; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; IZUI S, 1984, J IMMUNOL, V133, P227; Jacob N, 2010, AUTOIMMUNITY, V43, P84, DOI 10.3109/08916930903374600; Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263; Jia S, 2010, CLIN EXP IMMUNOL, V162, P131, DOI 10.1111/j.1365-2249.2010.04236.x; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kang KY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3504; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Koca SS, 2008, RHEUMATOLOGY, V47, P172, DOI 10.1093/rheumatology/kem344; Koga M, 2011, J HUM GENET, V56, P503, DOI 10.1038/jhg.2011.49; Korn T, 2012, ANN NY ACAD SCI, V1247, P34, DOI 10.1111/j.1749-6632.2011.06355.x; Kraft SW, 2005, J AM SOC NEPHROL, V16, P175, DOI 10.1681/ASN.2004050350; Krishnan S, 2006, SEMIN IMMUNOL, V18, P230, DOI 10.1016/j.smim.2006.03.011; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Laird RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063178; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Li H, 2001, IMMUNITY; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Lopes-Carvalho Thiago, 2005, V8, P91; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Ma CY, 2012, RHEUMATOL INT, V32, P395, DOI 10.1007/s00296-010-1636-6; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; METSARINNE KP, 1992, RHEUMATOL INT, V12, P93, DOI 10.1007/BF00290261; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Navarro JF, 1999, AM J KIDNEY DIS, V33, P458, DOI 10.1016/S0272-6386(99)70182-4; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Quiroga MF, 2006, J IMMUNOL, V176, P5965, DOI 10.4049/jimmunol.176.10.5965; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Rankin AL, 2012, J IMMUNOL, V188, P1656, DOI 10.4049/jimmunol.1003871; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Samuelson EM, 2012, IMMUNOL CELL BIOL, V90, P620, DOI 10.1038/icb.2011.76; Sanchez E, 2011, ARTHRITIS RHEUM-US, V63, P3493, DOI 10.1002/art.30563; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Segal R, 2001, LUPUS, V10, P23, DOI 10.1191/096120301675275538; Seshan SV, 2009, ARCH PATHOL LAB MED, V133, P233, DOI 10.1043/1543-2165-133.2.233; Sille FCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029632; Simons DM, 2013, J IMMUNOL, V190, P3134, DOI 10.4049/jimmunol.1203212; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698; Tai GP, 2013, BIOL OPEN, V2, P416, DOI 10.1242/bio.20133780; Texido G, 2000, MOL CELL BIOL, V20, P1227, DOI 10.1128/MCB.20.4.1227-1233.2000; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Watanabe M, 2008, J IMMUNOL, V180, P5222, DOI 10.4049/jimmunol.180.8.5222; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhang Z, 2010, J IMMUNOL, V183, P3160; Zhang Z, 2010, ARCH DERMATOL RES, V302, P619, DOI 10.1007/s00403-010-1029-4	102	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92054	10.1371/journal.pone.0092054	http://dx.doi.org/10.1371/journal.pone.0092054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637841	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100108
J	Ma, L; Gong, HY; Zhu, HY; Ji, Q; Su, P; Liu, P; Cao, SN; Yao, JF; Jiang, LL; Han, MZ; Ma, XT; Xiong, DS; Luo, HBR; Wang, F; Zhou, JX; Xu, YF				Ma, Li; Gong, Haiyan; Zhu, Haiyan; Ji, Qing; Su, Pei; Liu, Peng; Cao, Shannan; Yao, Jianfeng; Jiang, Linlin; Han, Mingzhe; Ma, Xiaotong; Xiong, Dongsheng; Luo, Hongbo R.; Wang, Fei; Zhou, Jiaxi; Xu, Yuanfu			A Novel Small-molecule Tumor Necrosis Factor alpha Inhibitor Attenuates Inflammation in a Hepatitis Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Signaling; Inflammation; Small Molecules; Tumor Necrosis Factor (TNF); Computer Modeling; Surface Plasmon Resonance (SPR)	TNF-ALPHA; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; CELL-DEATH; RECEPTOR SUPERFAMILY; THERAPEUTIC TARGET; JNK ACTIVATION; BINDING; PEPTIDOMIMETICS; GALACTOSAMINE	Background: Most commercial TNF inhibitors are biomacromolecules. Results: A lead compound named C87 was identified using computer-aided drug design and could attenuate murine acute hepatitis. Conclusion: C87 was one of the first effective small-molecule inhibitors of TNF identified to date. Significance: The study highlights the effectiveness of combining virtual screening with functional assays for developing novel small-molecule TNF inhibitors. Overexpression of tumor necrosis factor (TNF) is a hallmark of many inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and septic shock and hepatitis, making it a potential therapeutic target for clinical interventions. To explore chemical inhibitors against TNF activity, we applied computer-aided drug design combined with in vitro and cell-based assays and identified a lead chemical compound, (E)-4-(2-(4-chloro-3-nitrophenyl) (named as C87 thereafter), which directly binds to TNF, potently inhibits TNF-induced cytotoxicity (IC50 = 8.73 m) and effectively blocks TNF-triggered signaling activities. Furthermore, by using a murine acute hepatitis model, we showed that C87 attenuates TNF-induced inflammation, thereby markedly reducing injuries to the liver and improving animal survival. Thus, our results lead to a novel and highly specific small-molecule TNF inhibitor, which can be potentially used to treat TNF-mediated inflammatory diseases.	[Ma, Li; Gong, Haiyan; Zhu, Haiyan; Ji, Qing; Su, Pei; Liu, Peng; Cao, Shannan; Yao, Jianfeng; Jiang, Linlin; Han, Mingzhe; Ma, Xiaotong; Xiong, Dongsheng; Zhou, Jiaxi; Xu, Yuanfu] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Ma, Li; Gong, Haiyan; Zhu, Haiyan; Ji, Qing; Su, Pei; Liu, Peng; Cao, Shannan; Yao, Jianfeng; Jiang, Linlin; Han, Mingzhe; Ma, Xiaotong; Xiong, Dongsheng; Zhou, Jiaxi; Xu, Yuanfu] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Luo, Hongbo R.] Harvard Univ, Sch Med, Joint Program Transfus Med, Dept Pathol, Boston, MA 02115 USA; [Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Lab Med, Boston, MA 02115 USA; [Luo, Hongbo R.] Childrens Hosp, Boston, MA 02115 USA; [Wang, Fei] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Wang, Fei] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhou, JX (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, 288 Nanjing Rd, Tianjin 300020, Peoples R China.	zhoujx@ihcams.ac.cn; xuyf@ihcams.ac.cn	zhu, xueqiong/U-1320-2019; Xu, Yuanfu/Z-1135-2019		National Basic Research Program of China [2012CB966403]; Chinese National Natural Science Foundation [31271484, 31171431, 30400405]; Tianjin Natural Science Foundation [12JCZDJC24600, 11JCYBJC27300]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin)	This work was supported by National Basic Research Program of China Grant 2012CB966403, Chinese National Natural Science Foundation Grants 31271484, 31171431, and 30400405, and Tianjin Natural Science Foundation Grants 12JCZDJC24600 and 11JCYBJC27300.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Berezov A, 2002, J BIOL CHEM, V277, P28330, DOI 10.1074/jbc.M202880200; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Davis JM, 2013, FUTURE MED CHEM, V5, P69, DOI 10.4155/fmc.12.192; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Endo Y, 1999, BRIT J PHARMACOL, V128, P5, DOI 10.1038/sj.bjp.0702747; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Hasegawa Akihiro, 2001, Mini-Reviews in Medicinal Chemistry, V1, P5, DOI 10.2174/1389557013407214; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karlsson R, 2004, J MOL RECOGNIT, V17, P151, DOI 10.1002/jmr.660; Kubinyi H, 1999, J RECEPT SIGNAL TR R, V19, P15, DOI 10.3109/10799899909036635; Liedtke C, 2012, EUR J CELL BIOL, V91, P582, DOI 10.1016/j.ejcb.2011.10.001; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Nam J, 2010, MOD RHEUMATOL, V20, P325, DOI 10.1007/s10165-010-0277-7; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Saito H, 2007, ARTHRITIS RHEUM-US, V56, P1164, DOI 10.1002/art.22495; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Simsek I, 2010, BULL HOSP JT DIS, V68, P204; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Thurmond RL, 2001, EUR J BIOCHEM, V268, P5747, DOI 10.1046/j.0014-2956.2001.02512.x; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vinay DS, 2011, CLIN EXP IMMUNOL, V164, P145, DOI 10.1111/j.1365-2249.2011.04375.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	40	44	53	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12457	12466		10.1074/jbc.M113.521708	http://dx.doi.org/10.1074/jbc.M113.521708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634219	hybrid, Green Published			2022-12-25	WOS:000335581400022
J	Jiang, Q; Wang, F; Li, MY; Ma, J; Tan, GF; Xiong, AS				Jiang, Qian; Wang, Feng; Li, Meng-Yao; Ma, Jing; Tan, Guo-Fei; Xiong, Ai-Sheng			Selection of Suitable Reference Genes for qPCR Normalization under Abiotic Stresses in Oenanthe javanica (BI.) DC	PLOS ONE			English	Article							EXPRESSION ANALYSIS; HEAT-STRESS; IDENTIFICATION; TOLERANT; MODEL; SALT; VALIDATION; PERSICARIN; MANNITOL; PATHWAY	Accurate normalization of gene expression data is an absolute prerequisite to obtain reliable results in qPCR analysis. Oenanthe javanica, an aquatic perennial herb, belongs to the Oenanthe genus in Apiaceae family, with known medicinal properties. In the current study, O. javanica was subjected to hormone stimuli (gibberellin, salicylic acid, methyl jasmonate, and abscisic acid) and abiotic stresses (heat, cold, salt, and drought), and the expression of nine candidate reference genes (eIF-4 alpha, ACT7, TIP41, GAPDH, SAND, EF-1 alpha, PP2A, TBP, and TUB) was evaluated. Stability of the genes was assessed using geNorm, NormFinder and BestKeeper. All the genes presented distinct expression profiles under the experimental conditions analyzed. Under abiotic stress conditions, ACT7 and PP2A genes displayed the maximum stability; PP2A and SAND were the most stable genes under hormone stimuli. Even though PP2A gene was most stable across all the samples, individual analysis revealed changes in expression profile. To further validate the suitability of the reference genes identified in this study, the expression level of M6PR gene under salt treatment was studied. Based on our data, we propose that it is essential to normalize the target gene expression with specific reference genes under different experimental conditions for most accurate results. To our knowledge, this is the first systematic analysis for reference genes under abiotic stress and hormone stimuli conditions in O. javanica. This will be beneficial for future studies on O. javanica and other plants in Apiaceae family at molecular level.	[Jiang, Qian; Wang, Feng; Li, Meng-Yao; Ma, Jing; Tan, Guo-Fei; Xiong, Ai-Sheng] Nanjing Agr Univ, Key Lab Biol & Germplasm Enhancement Hort Crops E, State Key Lab Crop Genet & Germplasm Enhancement, Minist Agr,Coll Hort, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Key Lab Biol & Germplasm Enhancement Hort Crops E, State Key Lab Crop Genet & Germplasm Enhancement, Minist Agr,Coll Hort, Nanjing, Jiangsu, Peoples R China.	Xiongaisheng@njau.edu.cn		Xiong, Ai-Sheng/0000-0002-7900-5001; Jiang, Qian/0000-0002-2877-1179	National Natural Science Foundation of China [31272175]; New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; Graduate Educated Innovation Project of Jiangsu Province [CXZZ13_0297]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Shuangchuang Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Graduate Educated Innovation Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Shuangchuang Project	The research was supported by the National Natural Science Foundation of China (31272175); New Century Excellent Talents in University (NCET-11-0670); Jiangsu Natural Science Foundation (BK20130027); Graduate Educated Innovation Project of Jiangsu Province (CXZZ13_0297); Priority Academic Program Development of Jiangsu Higher Education Institutions and Jiangsu Shuangchuang Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attala MN, 2013, PLANT MOL BIOL; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Chan ZL, 2011, J EXP BOT, V62, P4787, DOI 10.1093/jxb/err130; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Carvalho K, 2013, MOL BIOTECHNOL, V53, P315, DOI 10.1007/s12033-012-9529-4; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Galli V, 2013, PLANT CELL REP, V32, P1869, DOI 10.1007/s00299-013-1499-x; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Han YQ, 2008, J ETHNOPHARMACOL, V118, P148, DOI 10.1016/j.jep.2008.03.024; Humbeck K, 2003, J EXP BOT, V54, P375, DOI [10.1093/jxb/54.381.375, 10.1093/jxb/erg012]; Ji G, 1990, Zhongguo Zhong Yao Za Zhi, V15, P429; Kim JY, 2009, BMB REP, V42, P482, DOI 10.5483/BMBRep.2009.42.8.482; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Kozera B, 2013, J APPL GENET; Ku SK, 2013, THROMB RES, V132, pE58, DOI 10.1016/j.thromres.2013.05.004; Ku SK, 2013, FOOD CHEM TOXICOL, V53, P197, DOI 10.1016/j.fct.2012.11.040; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Ma CJ, 2010, PHYTOTHER RES, V24, P913, DOI 10.1002/ptr.3065; Ma G, 2007, CHEM-BIOL INTERACT, V167, P153, DOI 10.1016/j.cbi.2007.02.006; Manickavelu A, 2010, DNA RES, V17, P211, DOI 10.1093/dnares/dsq009; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park HJ, 2013, INT J MOL SCI, V14, P11871, DOI 10.3390/ijms140611871; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; REN X, 2010, PLANT J; Staneloni RJ, 2008, MOL PLANT, V1, P75, DOI 10.1093/mp/ssm007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Yang XB, 2000, ACTA PHARMACOL SIN, V21, P239; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	43	41	51	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92262	10.1371/journal.pone.0092262	http://dx.doi.org/10.1371/journal.pone.0092262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651080	Green Submitted, Green Published, gold			2022-12-25	WOS:000333352800089
J	Shao, ML; Lu, XM; Cong, WT; Xing, X; Tan, Y; Li, YQ; Li, XK; Jin, LT; Wang, XJ; Dong, JC; Jin, SZ; Zhang, C; Cai, L				Shao, Minglong; Lu, Xuemian; Cong, Weitao; Xing, Xiao; Tan, Yi; Li, Yunqian; Li, Xiaokun; Jin, Litai; Wang, Xiaojie; Dong, Juancong; Jin, Shunzi; Zhang, Chi; Cai, Lu			Multiple Low-Dose Radiation Prevents Type 2 Diabetes-Induced Renal Damage through Attenuation of Dyslipidemia and Insulin Resistance and Subsequent Renal Inflammation and Oxidative Stress	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; BREAST-CANCER PATIENTS; APOPTOTIC CELL-DEATH; AKT ACTIVATION; KIDNEY-DISEASE; POTENTIAL ROLE; NEPHROPATHY; OBESITY; PROLIFERATION; LIPOTOXICITY	Background: Dyslipidemia and lipotoxicity-induced insulin resistance, inflammation and oxidative stress are the key pathogeneses of renal damage in type 2 diabetes. Increasing evidence shows that whole-body low dose radiation (LDR) plays a critical role in attenuating insulin resistance, inflammation and oxidative stress. Objective: The aims of the present study were to investigate whether LDR can prevent type 2 diabetes-induced renal damage and the underlying mechanisms. Methods: Mice were fed with a high-fat diet (HFD, 40% of calories from fat) for 12 weeks to induce obesity followed by a single intraperitoneal injection of streptozotocin (STZ, 50 mg/kg) to develop a type 2 diabetic mouse model. The mice were exposed to LDR at different doses (25, 50 and 75 mGy) for 4 or 8 weeks along with HFD treatment. At each time-point, the kidney weight, renal function, blood glucose level and insulin resistance were examined. The pathological changes, renal lipid profiles, inflammation, oxidative stress and fibrosis were also measured. Results: HFD/STZ-induced type 2 diabetic mice exhibited severe pathological changes in the kidney and renal dysfunction. Exposure of the mice to LDR for 4 weeks, especially at 50 and 75 mGy, significantly improved lipid profiles, insulin sensitivity and protein kinase B activation, meanwhile, attenuated inflammation and oxidative stress in the diabetic kidney. The LDR-induced anti-oxidative effect was associated with up-regulation of renal nuclear factor E2-related factor-2 (Nrf-2) expression and function. However, the above beneficial effects were weakened once LDR treatment was extended to 8 weeks. Conclusion: These results suggest that LDR exposure significantly prevented type 2 diabetes-induced kidney injury characterized by renal dysfunction and pathological changes. The protective mechanisms of LDR are complicated but may be mainly attributed to the attenuation of dyslipidemia and the subsequent lipotoxicity-induced insulin resistance, inflammation and oxidative stress.	[Shao, Minglong; Xing, Xiao; Dong, Juancong; Jin, Shunzi] Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China; [Shao, Minglong; Cong, Weitao; Tan, Yi; Li, Xiaokun; Jin, Litai; Zhang, Chi; Cai, Lu] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Peoples R China; [Shao, Minglong; Lu, Xuemian; Zhang, Chi] Wenzhou Med Univ, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Peoples R China; [Cong, Weitao; Li, Xiaokun; Jin, Litai; Wang, Xiaojie] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Xing, Xiao] Changchun Inst Food & Drug Control, Changchun, Peoples R China; [Tan, Yi; Cai, Lu] Univ Louisville, Dept Pediat, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA; [Li, Yunqian] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China	Jilin University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University of Louisville; Jilin University	Jin, SZ (corresponding author), Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China.	jinsz@jlu.edu.cn; zhangchi515@126.com	DONG, JUANCONG/GRS-2303-2022; Cai, Lu/AAG-9920-2019		National Science Foundation of China [81000294, 81370917]; Wenzhou Medical University [QTJ13005]; National Institutes of Health [1 R01 DK091338-01A1]; Wenzhou Medical University; Zhejiang Provincial Natural Science Foundation [LQ12H07002, LQ13H020005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091338] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenzhou Medical University; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by a Young Scientist Award from the National Science Foundation of China (81000294, to CZ); the National Science Foundation of China (81370917, to CZ); the Research Development Fund of Wenzhou Medical University (QTJ13005, to CZ); the National Institutes of Health (1 R01 DK091338-01A1, to LC); a Start-up Fund for the Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University (to XL and LC); and the Zhejiang Provincial Natural Science Foundation (LQ12H07002, to WTC; LQ13H020005, to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2008, PHYSIOL BEHAV, V94, P8, DOI 10.1016/j.physbeh.2007.11.016; Athyros VG, 2010, EXPERT OPIN PHARMACO, V11, P723, DOI 10.1517/14656560903575654; Aunapuu M, 2004, ANN ANAT, V186, P277, DOI 10.1016/S0940-9602(04)80017-7; Bagby SP, 2007, KIDNEY INT, V71, P1199, DOI 10.1038/sj.ki.5002286; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bonnet F, 2000, DIABETES METAB, V26, P254; Burrows NR, 2008, ADV CHRONIC KIDNEY D, V15, P147, DOI 10.1053/j.ackd.2008.01.002; Cai L, 1999, HUM EXP TOXICOL, V18, P419, DOI 10.1191/096032799678840291; Calabrese EJ, 2013, BIOGERONTOLOGY, V14, P365, DOI 10.1007/s10522-013-9436-5; Cui WP, 2013, AM J PHYSIOL-ENDOC M, V304, pE87, DOI 10.1152/ajpendo.00430.2012; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Franceschini N, 2012, KIDNEY INT, V82, P220, DOI 10.1038/ki.2012.107; Gaipl US, 2009, AUTOIMMUNITY, V42, P340, DOI 10.1080/08916930902831233; Gilbert ER, 2011, EXP DIABETES RES, DOI 10.1155/2011/416254; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Harjai KJ, 1999, ANN INTERN MED, V131, P376, DOI 10.7326/0003-4819-131-5-199909070-00009; Heerspink Hiddo J Lambers, 2011, Rev Diabet Stud, V8, P392, DOI 10.1900/RDS.2011.8.392; Hellman B, 2005, EXP ONCOL, V27, P102; Hirano T, 1999, KIDNEY INT, V56, pS22; Iseki K, 2008, INTERNAL MED, V47, P681, DOI 10.2169/internalmedicine.47.0906; Ji H, 2005, AM J PHYSIOL-HEART C, V288, pH43, DOI 10.1152/ajpheart.00630.2004; Jisieike-Onuigbo NN, 2011, NIGER J CLIN PRACT, V14, P171, DOI 10.4103/1119-3077.84009; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Kim CS, 2007, MOL CELLS, V24, P424; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Lee S, 2009, AM J PHYSIOL-HEART C, V297, pH569, DOI 10.1152/ajpheart.00293.2009; Li B, 2012, EXP DIABETES RES, DOI 10.1155/2012/216512; Lin JL, 2008, DIABETES CARE, V31, P2338, DOI 10.2337/dc08-0277; Liu GW, 2007, CRIT REV TOXICOL, V37, P587, DOI 10.1080/10408440701493061; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Mantovani Giovanni, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P17, DOI 10.1615/JEnvPathToxOncol.v22.i1.20; Marney AM, 2007, CLIN SCI, V113, P267, DOI 10.1042/CS20070123; Matheny RW, 2010, CELL DEATH DIFFER, V17, P677, DOI 10.1038/cdd.2009.150; McKay GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058472; Meguro S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/687867; Miller AW, 2001, AM J PHYSIOL-HEART C, V281, pH1524, DOI 10.1152/ajpheart.2001.281.4.H1524; Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Palyvoda O, 2002, ANTICANCER RES, V22, P1721; Pathak CM, 2007, J RADIAT RES, V48, P113, DOI 10.1269/jrr.06063; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pinar B, 2007, RADIAT RES, V168, P415, DOI 10.1667/RR0746.1; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Popanda O, 2003, INT J RADIAT ONCOL, V55, P1216, DOI 10.1016/S0360-3016(02)04415-2; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Rivero A, 2009, CLIN SCI, V116, P479, DOI 10.1042/CS20080394; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; San Miguel Symone M, 2011, Compend Contin Educ Dent, V32, pE10; Skrha J, 2003, ACTA DIABETOL, V40, pS324, DOI 10.1007/s00592-003-0113-z; Soetikno V, 2011, MOL NUTR FOOD RES, V55, P1655, DOI 10.1002/mnfr.201100080; Song Y, 2004, EXP MOL PATHOL, V76, P66, DOI 10.1016/j.yexmp.2003.08.002; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; van Kleef EM, 2000, INT J RADIAT BIOL, V76, P641, DOI 10.1080/095530000138303; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Xing X, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/291087; Yang RL, 2008, J CLIN BIOCHEM NUTR, V43, P154, DOI 10.3164/jcbn.2008044; Zhang C, 2009, AM J PHYSIOL-ENDOC M, V297, pE1366, DOI 10.1152/ajpendo.00478.2009; Zhao HG, 2010, TOXICOL LETT, V192, P356, DOI 10.1016/j.toxlet.2009.11.011; Zhao WY, 2006, AM J PHYSIOL-HEART C, V291, pH336, DOI 10.1152/ajpheart.01307.2005; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001	67	51	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92574	10.1371/journal.pone.0092574	http://dx.doi.org/10.1371/journal.pone.0092574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651118	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800129
J	Gross, KM; Schote, AB; Schneider, KK; Schulz, A; Meyer, J				Gross, Katharina M.; Schote, Andrea B.; Schneider, Katja Kerstin; Schulz, Andre; Meyer, Jobst			Elevated Social Stress Levels and Depressive Symptoms in Primary Hyperhidrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; PALMAR HYPERHIDROSIS; FOCAL HYPERHIDROSIS; HORMONE; ANXIETY; TIME	Primary hyperhidrosis is defined as excessive sweating of certain body areas without physiological reasons. Hyperhidrotic individuals report a high psychological strain and an impairment of their quality of life. Thus, the aim of the study is to investigate the relation between hyperhidrosis and different psychological as well as physiological aspects of chronic stress as a co-factor for the etiology of depression. In this study, forty hyperhidrotic subjects were compared to forty age-and sex-matched healthy control subjects. The Trier Inventory of Chronic Stress ('Trierer Inventar zum chronischen Stress': TICS), the Beck Depression Inventory (BDI-II) and the Screening for Somatoform Disorders (SOMS-2) were used to examine the correlation between primary hyperhidrosis and stress as well as accompanying depressive and somatic symptoms. The cortisol awakening response of each subject was analyzed as a physiological stress correlate. In hyperhidrotics, we found a significant lack of social recognition as well as significantly more depressive symptoms compared to the control subjects. A subgroup of patients with axillary hyperhidrosis had the highest impact on these increased issues of chronic stress, pointing to a higher embarrassment in these subjects. Especially in social situations, hyperhidrotics showed higher stress levels, whereby a vicious circle of stress and sweating is triggered. However, the cortisol awakening response did not significantly differ between hyperhidrotics and controls. Moreover, affected persons suffer from more depressive symptoms, which may be caused by feelings of shame and a lack of self-confidence. This initial study provides an impetus for further investigation to reveal a causative relationship between hyperhidrosis and its psychological concomitants.	[Gross, Katharina M.; Schote, Andrea B.; Meyer, Jobst] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany; [Schneider, Katja Kerstin] Univ Trier, Dept Psychol, Trier, Germany; [Schulz, Andre] Univ Luxembourg, Res Unit INSIDE, Walferdange, Luxembourg; [Schulz, Andre] Univ Trier, Inst Psychobiol, Dept Clin Psychophysiol, Trier, Germany	Universitat Trier; Universitat Trier; University of Luxembourg; Universitat Trier	Meyer, J (corresponding author), Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany.	meyerjo@uni-trier.de	Schulz, André/AAC-5576-2021	Schulz, André/0000-0002-9381-2651	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [GRK 1389]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	JM and ABS were supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), grant GRK 1389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR R, 1977, ANN SURG, V186, P34, DOI 10.1097/00000658-197707000-00006; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Beck A.T., 1996, MANUAL BECK DEPRESSI; Becker P., 2004, TRIERER INVENTAR ZUM; Benson RA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6800; BYRNE J, 1990, BRIT J SURG, V77, P1046, DOI 10.1002/bjs.1800770931; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; DRUMMOND PD, 1987, BRAIN, V110, P793, DOI 10.1093/brain/110.3.793; Eisenach JH, 2005, MAYO CLIN PROC, V80, P657, DOI 10.4065/80.5.657; Erikson E., 1968, IDENTITY YOUTH CRISI; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Genazzani AR, 2007, CLIMACTERIC, V10, P11, DOI 10.1080/13697130601114891; Hamm H, 2006, DERMATOLOGY, V212, P343, DOI 10.1159/000092285; Hautzinger M., 2009, BDI 2 BECK DEPRESSIO; HELLHAMMER DH, 1993, PSYCHOTHER PSYCHOSOM, V60, P8, DOI 10.1159/000288675; Higashimoto I, 2006, AM J MED GENET A, V140A, P567, DOI 10.1002/ajmg.a.31127; Iwase S, 1997, J AUTONOM NERV SYST, V64, P65, DOI 10.1016/S0165-1838(97)00014-3; Kaufmann H, 2003, CLIN AUTON RES, V13, P96, DOI 10.1007/s10286-003-0082-x; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kopelman D, 1996, J VASC SURG, V24, P194, DOI 10.1016/S0741-5214(96)70093-9; Lee HH, 2012, KOREAN J PAIN, V25, P28, DOI 10.3344/kjp.2012.25.1.28; OGAWA T, 1975, JPN J PHYSIOL, V25, P525; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; REINAUER S, 1993, BRIT J DERMATOL, V129, P166, DOI 10.1111/j.1365-2133.1993.tb03521.x; Rief W., 2008, SOMS SCREENING SOMAT; Ro KM, 2002, J VASC SURG, V35, P382, DOI 10.1067/mva.2002.119507; Ruchinskas RA, 2002, BRIT J DERMATOL, V147, P733, DOI 10.1046/j.1365-2133.2002.04857.x; Ruchinskas R, 2007, DERMATOLOGY, V214, P195, DOI 10.1159/000099581; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; SHIH CJ, 1983, J AUTONOM NERV SYST, V8, P33, DOI 10.1016/0165-1838(83)90021-8; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Sonntag M, 2004, ZFA Z F R ALLGEMEINM, V80, P289, DOI [10.1055/s-2004-822835, DOI 10.1055/S-2004-822835]; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040; Weber A, 2005, BRIT J DERMATOL, V152, P342, DOI 10.1111/J.1365-2133.2004.06334.X; Wilke K., 2007, International Journal of Cosmetic Science, V29, P169, DOI 10.1111/j.1467-2494.2007.00387.x; Wolosker N, 2012, J VASC SURG, V55, P154, DOI 10.1016/j.jvs.2011.07.097	42	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92412	10.1371/journal.pone.0092412	http://dx.doi.org/10.1371/journal.pone.0092412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647796	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500127
J	Hansel, A; Steinbach, D; Greinke, C; Schmitz, M; Eiselt, J; Scheungraber, C; Gajda, M; Hoyer, H; Runnebaum, IB; Durst, M				Hansel, Alfred; Steinbach, Daniel; Greinke, Christiane; Schmitz, Martina; Eiselt, Juliane; Scheungraber, Cornelia; Gajda, Mieczyslaw; Hoyer, Heike; Runnebaum, Ingo B.; Duerst, Matthias			A Promising DNA Methylation Signature for the Triage of High-Risk Human Papillomavirus DNA-Positive Women	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; SIGNALING PATHWAY; CANCER CELLS; FOLLOW-UP; PCR; HYPERMETHYLATION; POPULATION; COLPOSCOPY; CARCINOMAS; BIOMARKERS	High-risk human papillomavirus (hrHPV)-DNA testing is frequently performed parallel to cytology for the detection of high-grade dysplasia and cervical cancer particularly in women above 30 years of age. Although highly sensitive, hrHPV testing cannot distinguish between HPV-positive women with or without clinically relevant lesions. However, in principle discrimination is possible on the basis of DNA methylation markers. In order to identify novel DNA regions which allow an effective triage of hrHPV-positive cases, hypermethylated DNA enriched from cervical cancers was compared with that from cervical scrapes of HPV16-positive cases with no evidence for disease by CpG island microarray hybridization. The most promising marker regions were validated by quantitative methylation-specific PCR (qMSP) using DNA from archived cervical tissues and cervical scrapes. The performance of these markers was then determined in an independent set of 217 hrHPV-positive cervical scrapes from outpatients with histopathological verification. A methylation signature comprising the 59 regions of the genes DLX1, ITGA4, RXFP3, SOX17 and ZNF671 specific for CIN3 and cervical cancer (termed CIN3+) was identified and validated. A high detection rate of CIN3+ was obtained if at least 2 of the 5 markers were methylated. In the subsequent cross-sectional study all cervical carcinomas (n = 19) and 56% (13/23) of CIN3 were identified by this algorithm. Only 10% (11/105) of hrHPV-positive women without histological evidence of cervical disease were scored positive by the methylation assay. Of note is that the detection rate of CIN3 differed between age groups. Eight of nine CIN3 were detected among women >= 30 years of age but only five of fourteen among,30 year old group (p = 0.03). The specificity for CIN3+ in the older age group was 76.6% (95% CI 65.6-85.5%). Clinical validation studies are required to determine the usefulness of these novel markers for triage after primary hrHPV testing in a cervical cancer screening setting.	[Hansel, Alfred; Steinbach, Daniel; Greinke, Christiane; Schmitz, Martina; Eiselt, Juliane; Scheungraber, Cornelia; Runnebaum, Ingo B.; Duerst, Matthias] Jena Univ Hosp, Dept Gynaecol, Jena, Germany; [Hoyer, Heike] Jena Univ Hosp, IMSID, Jena, Germany; [Gajda, Mieczyslaw] Jena Univ Hosp, Inst Pathol, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Durst, M (corresponding author), Jena Univ Hosp, Dept Gynaecol, Jena, Germany.	matthias.duerst@med.uni-jena.de		Steinbach, Daniel/0000-0002-0276-3701	European Commission [LSHC-CT-2005-018704]; Bundesministerium fur Wirtschaft und Technologie [03 EFT 5T06]	European Commission(European CommissionEuropean Commission Joint Research Centre); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi))	This work was supported in part by a grant to MD from the European Commission (LSHC-CT-2005-018704) and a grant to AH from the Bundesministerium fur Wirtschaft und Technologie (03 EFT 5T06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bierkens M, 2013, INT J CANCER, V133, P1293, DOI 10.1002/ijc.28138; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Bulkmans NWJ, LANCET, V370, P1764; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Cuzick J, 2010, CANCER PREV RES, V3, P689, DOI 10.1158/1940-6207.CAPR-10-0096; Eijsink JJH, 2012, INT J CANCER, V130, P1861, DOI 10.1002/ijc.26326; GLOBOCAN, 2012, GLOBOCAN 2012 EST CA; Hafner N, 2011, GYNECOL ONCOL, V121, P224, DOI 10.1016/j.ygyno.2010.11.018; Hesselink AT, 2011, CLIN CANCER RES, V17, P2459, DOI 10.1158/1078-0432.CCR-10-2548; Huang YW, 2010, GYNECOL ONCOL, V117, P239, DOI 10.1016/j.ygyno.2010.02.006; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Jia Y, 2012, J MOL DIAGN, V14, P577, DOI 10.1016/j.jmoldx.2012.06.004; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Lechner M, 2010, ADV GENET, V70, P247, DOI [10.1016/S0065-2660(10)70009-2, 10.1016/B978-0-12-380866-0.60009-5]; Lendvai A, 2012, EPIGENETICS-US, V7, P1268, DOI 10.4161/epi.22301; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mirabello L, 2012, JNCI-J NATL CANCER I, V104, P556, DOI 10.1093/jnci/djs135; Overmeer RM, 2011, INT J CANCER, V129, P2218, DOI 10.1002/ijc.25890; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Park J, 2004, ONCOGENE, V23, P3474, DOI 10.1038/sj.onc.1207470; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Wentzensen N, 2012, JNCI-J NATL CANCER I, V104, P1738, DOI 10.1093/jnci/djs425; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631	36	48	53	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91905	10.1371/journal.pone.0091905	http://dx.doi.org/10.1371/journal.pone.0091905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647315	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500058
J	Yuan, ZB; Chen, J; Chen, DW; Xu, G; Xia, MJ; Xu, Y; Gao, YQ				Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Xia, Minjie; Xu, Yong; Gao, Yuqi			Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CLASS-II TRANSACTIVATOR; ARTERIAL-HYPERTENSION; COL1A2 TRANSCRIPTION; NITRIC-OXIDE; TGF-BETA; ACTIVATION; EXPRESSION; INDUCTION; GENE	Hypoxia induced pulmonary hypertension (HPH) represents a complex pathology that involves active vascular remodeling, loss of vascular tone, enhanced pulmonary inflammation, and increased deposition of extracellular matrix proteins. Megakaryocytic leukemia 1 (MKL1) is a transcriptional regulator known to influence cellular response to stress signals in the vasculature. We report here that in response to chronic hypobaric hypoxia, MKL1 expression was up-regulated in the lungs in rats. Short hairpin RNA (shRNA) mediated depletion of MKL1 significantly ameliorated the elevation of pulmonary arterial pressure in vivo with a marked alleviation of vascular remodeling. MKL1 silencing also restored the expression of NO, a key vasoactive molecule necessary for the maintenance of vascular tone. In addition, hypoxia induced pulmonary inflammation was dampened in the absence of MKL1 as evidenced by normalized levels of pro-inflammatory cytokines and chemokines as well as reduced infiltration of pro-inflammatory immune cells in the lungs. Of note, MKL1 knockdown attenuated fibrogenesis in the lungs as indicated by picrosirius red staining. Finally, we demonstrate that MKL1 mediated transcriptional activation of type I collagen genes in smooth muscle cells under hypoxic conditions. In conclusion, we data highlight a previously unidentified role for MKL1 in the pathogenesis of HPH and as such lay down groundwork for future investigation and drug development.	[Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Gao, Yuqi] Third Mil Med Univ, Coll High Altitude Mil Med, Dept Pathophysiol & High Altitude Physiol, Chongqing, Peoples R China; [Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Gao, Yuqi] Third Mil Med Univ, Key Lab High Altitude Med, Minist Educ, Chongqing, Peoples R China; [Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Gao, Yuqi] Third Mil Med Univ, PLA, Key Lab High Altitude Med, Chongqing, Peoples R China; [Xia, Minjie; Xu, Yong] Nanjing Med Univ, Dept Pathophysiol, Key Lab Cardiovasc Dis, Nanjing, Jiangsu, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Med Univ, Dept Pathophysiol, Key Lab Cardiovasc Dis, Nanjing, Jiangsu, Peoples R China.	yxu2005@gmail.com; gyq@mail.tmmu.edu.cn		chen, jian/0000-0003-0258-9878	National Basic Science Research "973" Program of China [2012CB518201, 2012CB517503]; Program for New Century Excellent Talents in University of China [NCET-11-0991]; Natural Science Foundation of China [81100041, 31270805]; Natural Science Foundation of Jiangsu Province [BK2012043]; Ministry of Education [212059]; Postdoctoral Research Grant of China [20100471771]	National Basic Science Research "973" Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ministry of Education; Postdoctoral Research Grant of China	This study was supported, in part, by the National Basic Science Research "973" Program of China (2012CB518201, 2012CB517503), the Program for New Century Excellent Talents in University of China (NCET-11-0991), Natural Science Foundation of China (81100041, 31270805), Natural Science Foundation of Jiangsu Province (BK2012043), the Ministry of Education (212059), and the Postdoctoral Research Grant of China (20100471771). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Berkenbosch JW, 2000, AM J PHYSIOL-LUNG C, V278, pL276, DOI 10.1152/ajplung.2000.278.2.L276; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; CHANG SW, 1994, J APPL PHYSIOL, V77, P2817, DOI 10.1152/jappl.1994.77.6.2817; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; CROUCH EC, 1989, AM REV RESPIR DIS, V140, P1045, DOI 10.1164/ajrccm/140.4.1045; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; DURMOWICZ AG, 1994, AM J PATHOL, V145, P1411; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Fang MM, 2009, NUCLEIC ACIDS RES, V37, P4393, DOI 10.1093/nar/gkp398; Hanaoka M, 1998, CIRCULATION, V97, P1124, DOI 10.1161/01.CIR.97.12.1124; Jeong JK, 2012, BIOCHEM BIOPH RES CO, V429, P93, DOI 10.1016/j.bbrc.2012.10.086; Ko Eun A, 2010, Drug Discov Today Dis Models, V7, P123; Koizume S, 2012, NUCLEIC ACIDS RES, V40, P5389, DOI 10.1093/nar/gks201; Kong XC, 2009, J MOL CELL CARDIOL, V46, P748, DOI 10.1016/j.yjmcc.2009.01.011; Kong XC, 2009, J MOL CELL CARDIOL, V46, P292, DOI 10.1016/j.yjmcc.2008.10.023; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Li J, 2012, DEVELOPMENT, V139, P3531, DOI 10.1242/dev.082222; Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479; Luchsinger LL, 2011, J BIOL CHEM; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; POIANI GJ, 1992, CIRC RES, V70, P912, DOI 10.1161/01.RES.70.5.912; Prie S, 1997, J PHARMACOL EXP THER, V282, P1312; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Raiesdana A, 2006, ANN MED, V38, P95, DOI 10.1080/07853890600622143; Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stenmark KR, 2005, J APPL PHYSIOL, V98, P715, DOI 10.1152/japplphysiol.00840.2004; STENMARK KR, 1991, AM J PHYSIOL, V261, P97, DOI 10.1152/ajplung.1991.261.4.L97; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tian W, 2012, HEPATOLOGY; Tsai BM, 2004, AM J PHYSIOL-LUNG C, V287, pL1215, DOI 10.1152/ajplung.00179.2004; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Xia J, 2012, BIOCHEM BIOPH RES CO, V428, P264, DOI 10.1016/j.bbrc.2012.10.043; Xu Y, 2011, AM J RESP CELL MOL, V44, P898, DOI 10.1165/rcmb.2009-0416OC; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	44	8	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e83895	10.1371/journal.pone.0083895	http://dx.doi.org/10.1371/journal.pone.0083895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647044	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500001
J	Hewitt, SK; Donaldson, IJ; Lovell, SC; Delneri, D				Hewitt, Sarah K.; Donaldson, Ian J.; Lovell, Simon C.; Delneri, Daniela			Sequencing and Characterisation of Rearrangements in Three S. pastorianus Strains Reveals the Presence of Chimeric Genes and Gives Evidence of Breakpoint Reuse	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ADAPTIVE EVOLUTION; NATURAL HYBRIDS; YEAST; GENOME; RECOMBINATION; DIVERGENCE; ALLELES; ORIGINS; REGIONS	Gross chromosomal rearrangements have the potential to be evolutionarily advantageous to an adapting organism. The generation of a hybrid species increases opportunity for recombination by bringing together two homologous genomes. We sought to define the location of genomic rearrangements in three strains of Saccharomyces pastorianus, a natural lager-brewing yeast hybrid of Saccharomyces cerevisiae and Saccharomyces eubayanus, using whole genome shotgun sequencing. Each strain of S. pastorianus has lost species-specific portions of its genome and has undergone extensive recombination, producing chimeric chromosomes. We predicted 30 breakpoints that we confirmed at the single nucleotide level by designing species-specific primers that flank each breakpoint, and then sequencing the PCR product. These rearrangements are the result of recombination between areas of homology between the two subgenomes, rather than repetitive elements such as transposons or tRNAs. Interestingly, 28/30 S. cerevisiae- S. eubayanus recombination breakpoints are located within genic regions, generating chimeric genes. Furthermore we show evidence for the reuse of two breakpoints, located in HSP82 and KEM1, in strains of proposed independent origin.	[Hewitt, Sarah K.; Donaldson, Ian J.; Lovell, Simon C.; Delneri, Daniela] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Delneri, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	d.delneri@manchester.ac.uk		Delneri, Daniela/0000-0001-8070-411X; Lovell, Simon/0000-0002-4092-8458; Hewitt, Sarah/0000-0002-7220-9300; Donaldson, Ian/0000-0002-0032-0931	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F007620/1]; BBSRC [BB/D009901/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007620/1, BB/D009901/1] Funding Source: researchfish; Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SKH was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship. This work was also supported by a BBSRC grant to SCL and DD (BB/F007620/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Bond U, 2004, CURR GENET, V45, P360, DOI 10.1007/s00294-004-0504-x; Bond U, 2009, GENOMES LAGER YEASTS, P159; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; HANSEN J, 1994, GENE, V140, P33, DOI 10.1016/0378-1119(94)90727-7; Hao Weilong, 2011, Mob Genet Elements, V1, P256; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; Infante JJ, 2003, GENETICS, V165, P1745; James TC, 2008, CURR GENET, V53, P139, DOI 10.1007/s00294-007-0172-8; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Libkind D, 2011, P NATL ACAD SCI; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; MARTINI AV, 1987, A VAN LEEUW J MICROB, V53, P77, DOI 10.1007/BF00419503; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Rainieri S, 2008, FEMS YEAST RES, V8, P586, DOI 10.1111/j.1567-1364.2008.00363.x; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sato M, 2002, J BIOSCI BIOENG, V93, P395, DOI 10.1263/jbb.93.395; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Usher J, 2009, APPL ENVIRON MICROB, V75, P4573, DOI 10.1128/AEM.00351-09; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000	46	53	52	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92203	10.1371/journal.pone.0092203	http://dx.doi.org/10.1371/journal.pone.0092203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643015	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900103
J	Ho, ECY; Eubanks, JH; Zhang, L; Skinner, FK				Ho, Ernest C. Y.; Eubanks, James H.; Zhang, Liang; Skinner, Frances K.			Network Models Predict that Reduced Excitatory Fluctuations Can Give Rise to Hippocampal Network Hyper-Excitability in MeCP2-Null Mice	PLOS ONE			English	Article							SYNAPTIC CIRCUIT ABNORMALITIES; 2/3 PYRAMIDAL NEURONS; MOUSE MODEL; RETT-SYNDROME; BRAIN; CONDUCTANCES; DYSFUNCTION; INHIBITION; INITIATION; THRESHOLD	Rett syndrome is a severe pediatric neurological disorder caused by loss of function mutations within the gene encoding methyl CpG-binding protein 2 (MeCP2). Although MeCP2 is expressed near ubiquitously, the primary pathophysiology of Rett syndrome stems from impairments of nervous system function. One alteration within different regions of the MeCP2-deficient brain is the presence of hyper-excitable network responses. In the hippocampus, such responses exist despite there being an overall decrease in spontaneous excitatory drive within the network. In this study, we generated and used mathematical, neuronal network models to resolve this apparent paradox. We did this by taking advantage of previous mathematical modelling insights that indicated that decreased excitatory fluctuations, but not mean excitatory drive, more critically explain observed changes in hippocampal network oscillations from MeCP2-null mouse slices. Importantly, reduced excitatory fluctuations could also bring about hyper-excitable responses in our network models. Therefore, these results indicate that diminished excitatory fluctuations may be responsible for the hyper-excitable state of MeCP2-deficient hippocampal circuitry.	[Ho, Ernest C. Y.; Eubanks, James H.; Zhang, Liang; Skinner, Frances K.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Ho, Ernest C. Y.; Skinner, Frances K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Eubanks, James H.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; [Zhang, Liang; Skinner, Frances K.] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Skinner, FK (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	frances.skinner@utoronto.ca		Skinner, Frances/0000-0001-7819-4202; Zhang, Liang/0000-0002-7888-5043; Eubanks, James/0000-0001-8595-2024	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; Canadian Institutes of Health Research (CIHR) [MOP-106481]; Ontario Brain Institute; Canada Foundation for Innovation under the auspices of Compute Canada; Government of Ontario; Ontario Research Fund - Research Excellence; University of Toronto	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute; Canada Foundation for Innovation under the auspices of Compute Canada; Government of Ontario; Ontario Research Fund - Research Excellence; University of Toronto(University of Toronto)	Funders: Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (FKS, LZ); Canadian Institutes of Health Research (CIHR) MOP-106481 (JHE, LZ), and Ontario Brain Institute (LZ). Computations were performed on the GPC supercomputer at the SciNet HPC Consortium. SciNet is funded by: the Canada Foundation for Innovation under the auspices of Compute Canada; the Government of Ontario; Ontario Research Fund - Research Excellence; and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2010, P NATL ACAD SCI USA, V107, P18208, DOI 10.1073/pnas.1012104107; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/976164; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Dur-e-Ahmad M, 2012, J COMPUT NEUROSCI, V33, P21, DOI 10.1007/s10827-011-0372-6; Glaze DG, 2005, J CHILD NEUROL, V20, P740; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho ECY, 2011, THESIS U TORONTO; Ho ECY, 2012, J NEUROSCI, V32, P9931, DOI 10.1523/JNEUROSCI.5446-11.2012; Ho ECY, 2009, HIPPOCAMPUS, V19, P152, DOI 10.1002/hipo.20493; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnston MV, 2003, J CHILD NEUROL, V18, P688, DOI 10.1177/08830738030180100501; Jugloff DGM, 2006, J NEUROSCI METH, V154, P89, DOI 10.1016/j.jneumeth.2005.12.002; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Lane JB, 2011, NEUROLOGY, V77, P1812, DOI 10.1212/WNL.0b013e3182377dd2; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; McLeod F, 2013, NEUROSCIENCE, V231, P195, DOI 10.1016/j.neuroscience.2012.11.058; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Moser SJ, 2007, PEDIATR NEUROL, V36, P95, DOI 10.1016/j.pediatrneurol.2006.10.003; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Nomura Y, 2005, J CHILD NEUROL, V20, P764, DOI 10.1177/08830738050200091201; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; Stauder JEA, 2006, BRAIN DEV-JPN, V28, P487, DOI 10.1016/j.braindev.2006.02.011; Stettner GM, 2007, J PHYSIOL-LONDON, V579, P863, DOI 10.1113/jphysiol.2006.119966; Takano H, 2012, J NEUROSCI, V32, P4743, DOI 10.1523/JNEUROSCI.4277-11.2012; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Wood L, 2010, NEUROBIOL DIS, V38, P281, DOI 10.1016/j.nbd.2010.01.018; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Wu CP, 2005, J NEUROPHYSIOL, V94, P741, DOI 10.1152/jn.00086.2005; Wu CP, 2005, J NEUROPHYSIOL, V93, P2302, DOI 10.1152/jn.00806.2004; Wu CP, 2002, J PHYSIOL-LONDON, V540, P509, DOI 10.1113/jphysiol.2001.013441; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91148	10.1371/journal.pone.0091148	http://dx.doi.org/10.1371/journal.pone.0091148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642514	Green Published, gold			2022-12-25	WOS:000333259900013
J	Naveau, E; Pinson, A; Gerard, A; Nguyen, L; Charlier, C; Thome, JP; Zoeller, RT; Bourguignon, JP; Parent, AS				Naveau, Elise; Pinson, Anneline; Gerard, Arlette; Nguyen, Laurent; Charlier, Corinne; Thome, Jean-Pierre; Zoeller, R. Thomas; Bourguignon, Jean-Pierre; Parent, Anne-Simone			Alteration of Rat Fetal Cerebral Cortex Development after Prenatal Exposure to Polychlorinated Biphenyls	PLOS ONE			English	Article							THYROID-HORMONE RECEPTORS; CELL-PROLIFERATION; PURKINJE-CELL; PCB EXPOSURE; BRAIN; EXPRESSION; DIFFERENTIATION; MIGRATION; HYPOTHALAMUS; AROCLOR-1254	Polychlorinated biphenyls (PCBs) are environmental contaminants that persist in environment and human tissues. Perinatal exposure to these endocrine disruptors causes cognitive deficits and learning disabilities in children. These effects may involve their ability to interfere with thyroid hormone (TH) action. We tested the hypothesis that developmental exposure to PCBs can concomitantly alter TH levels and TH-regulated events during cerebral cortex development: progenitor proliferation, cell cycle exit and neuron migration. Pregnant rats exposed to the commercial PCB mixture Aroclor 1254 ended gestation with reduced total and free serum thyroxine levels. Exposure to Aroclor 1254 increased cell cycle exit of the neuronal progenitors and delayed radial neuronal migration in the fetal cortex. Progenitor cell proliferation, cell death and differentiation rate were not altered by prenatal exposure to PCBs. Given that PCBs remain ubiquitous, though diminishing, contaminants in human systems, it is important that we further understand their deleterious effects in the brain.	[Naveau, Elise; Pinson, Anneline; Gerard, Arlette; Bourguignon, Jean-Pierre; Parent, Anne-Simone] Univ Liege, CHU, GIGA Neurosci, Dev Neuroendocrinol Unit, Liege, Belgium; [Nguyen, Laurent] Univ Liege, CHU, GIGA Neurosci, Dev Neurobiol Unit, Liege, Belgium; [Charlier, Corinne] Univ Liege, CHU, Lab Clin Forens & Environm Toxicol, Liege, Belgium; [Thome, Jean-Pierre] Univ Liege, Lab Anim Ecol & Ecotoxicol LEAE CART, Liege, Belgium; [Zoeller, R. Thomas] Univ Massachusetts, Dept Biol, Morrill Sci Ctr, Amherst, MA 01003 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Massachusetts System; University of Massachusetts Amherst	Parent, AS (corresponding author), Univ Liege, CHU, GIGA Neurosci, Dev Neuroendocrinol Unit, Liege, Belgium.	asparent@ulg.ac.be	Nguyen, Laurent/E-9882-2016; Parent, Anne-Simone/ABC-1458-2021	Nguyen, Laurent/0000-0002-8560-3008	Fonds National de la Recherche Scientifique (FNRS, National Foundation for Research) [3.4567.09]; Belgian Study Group for Pediatric Endocrinology	Fonds National de la Recherche Scientifique (FNRS, National Foundation for Research)(Fonds de la Recherche Scientifique - FNRS); Belgian Study Group for Pediatric Endocrinology	This work was supported by the Fonds National de la Recherche Scientifique (FNRS, National Foundation for Research) grant 3.4567.09 and the Belgian Study Group for Pediatric Endocrinology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2009, ENVIRON RES, V109, P620, DOI 10.1016/j.envres.2009.03.009; Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; [Anonymous], 1999, ORTHO SIDE PCBS OCCU; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Bansal R, 2005, DEV BRAIN RES, V156, P13, DOI 10.1016/j.devbrainres.2005.01.007; Bansal R, 2008, ENDOCRINOLOGY, V149, P4001, DOI 10.1210/en.2007-1774; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Boucher O, 2009, ENVIRON HEALTH PERSP, V117, P7, DOI 10.1289/ehp.11294; BYRNE JJ, 1987, ENDOCRINOLOGY, V121, P520, DOI 10.1210/endo-121-2-520; Charlier C, 2003, J ANAL TOXICOL, V27, P74, DOI 10.1093/jat/27.2.74; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Colciago A, 2009, TOXICOL APPL PHARM; Cuevas E, 2005, EUR J NEUROSCI, V22, P541, DOI 10.1111/j.1460-9568.2005.04243.x; de Nijs L, 2009, NAT NEUROSCI, V12, P1266, DOI 10.1038/nn.2390; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Dugas JC, 2012, MOL CELL NEUROSCI, V50, P45, DOI 10.1016/j.mcn.2012.03.007; Erickson M.D., 2001, PCBS RECENT ADV ENV, P11; Farwell AP, 2005, DEV BRAIN RES, V154, P121, DOI 10.1016/j.devbrainres.2004.07.016; Farwell AP, 1999, ENDOCRINOLOGY, V140, P5014, DOI 10.1210/en.140.11.5014; Fritsche E, 2005, ENVIRON HEALTH PERSP, V113, P871, DOI 10.1289/ehp.7793; Gauger KJ, 2004, ENVIRON HEALTH PERSP, V112, P516, DOI 10.1289/ehp.6672; Giera S, 2011, ENDOCRINOLOGY, V152, P2909, DOI 10.1210/en.2010-1490; Gilbert ME, 2012, NEUROTOXICOLOGY, V33, P842, DOI 10.1016/j.neuro.2011.11.005; Gilbert ME, 2011, NEUROTOXICOLOGY; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Iskaros J, 2000, J CLIN ENDOCR METAB, V85, P2620, DOI 10.1210/jc.85.7.2620; Kimura-Kuroda J, 2005, DEV BRAIN RES, V154, P259, DOI 10.1016/j.devbrainres.2004.11.004; Kimura-Kuroda J, 2002, DEV BRAIN RES, V137, P55, DOI 10.1016/S0165-3806(02)00408-X; Kobayashi K, 2009, BRAIN RES, V1264, P24, DOI 10.1016/j.brainres.2008.12.029; KOOPMANESSEBOOM C, 1994, PEDIATR RES, V36, P468, DOI 10.1203/00006450-199410000-00009; Lackmann GM, 2004, SCI TOTAL ENVIRON, V329, P289, DOI 10.1016/j.scitotenv.2004.03.014; Lanting CI, 1998, PEDIATR RES, V44, P222, DOI 10.1203/00006450-199808000-00014; Lein PJ, 2007, ENVIRON HEALTH PERSP, V115, P556, DOI 10.1289/ehp.9773; Morse DC, 1996, TOXICOL APPL PHARM, V136, P269, DOI 10.1006/taap.1996.0034; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Parent AS, 2011, J TOXICOL ENV HEAL B, V14, P328, DOI 10.1080/10937404.2011.578556; Pravettoni A, 2005, REPROD TOXICOL, V20, P521, DOI 10.1016/j.reprotox.2005.03.008; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Roegge CS, 2006, NEUROTOXICOL TERATOL, V28, P74, DOI 10.1016/j.ntt.2005.10.001; Sanchez-Alonso JA, 2004, TOXICOL LETT, V153, P311, DOI 10.1016/j.toxlet.2004.05.012; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schnitzler JG, 2008, MAR POLLUT BULL, V56, P1755, DOI 10.1016/j.marpolbul.2008.06.011; Sessa A, 2010, GENE DEV, V24, P1816, DOI 10.1101/gad.575410; Sharlin DS, 2006, ENDOCRINOLOGY, V147, P846, DOI 10.1210/en.2005-0778; Stewart PW, 2008, ENVIRON HEALTH PERSP, V116, P1416, DOI 10.1289/ehp.11058; Thompson CC, 2000, CEREB CORTEX, V10, P939, DOI 10.1093/cercor/10.10.939; Uchida K, 2005, NEUROREPORT, V16, P103, DOI 10.1097/00001756-200502080-00005; Yang D, 2009, ENVIRON HEALTH PERSP, V117, P426, DOI 10.1289/ehp.11771; Zhang LQ, 2009, NEUROBIOL DIS, V34, P366, DOI 10.1016/j.nbd.2009.02.006; Zoeller R. Thomas, 2001, P265; Zoeller RT, 2000, ENDOCRINOLOGY, V141, P181, DOI 10.1210/en.141.1.181; Zoeller RT, 2002, ENVIRON HEALTH PERSP, V110, P355, DOI 10.1289/ehp.02110s3355	52	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91903	10.1371/journal.pone.0091903	http://dx.doi.org/10.1371/journal.pone.0091903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642964	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900043
J	O'Malley, G; Asrat, L; Sharma, A; Hamunime, N; Stephanus, Y; Brandt, L; Ali, D; Kaindjee-Tjituka, F; Natanael, S; Gweshe, J; Feldacker, C; Shihepo, E				O'Malley, Gabrielle; Asrat, Lily; Sharma, Anjali; Hamunime, Ndapewa; Stephanus, Yvonne; Brandt, Laura; Ali, Deqa; Kaindjee-Tjituka, Francina; Natanael, Salomo; Gweshe, Justice; Feldacker, Caryl; Shihepo, Ella			Nurse Task Shifting for Antiretroviral Treatment Services in Namibia: Implementation Research to Move Evidence into Action	PLOS ONE			English	Article							OPERATIONAL-RESEARCH; SOUTH-AFRICA; SCALE-UP; CARE; THERAPY; OUTCOMES; TRIAL; MODEL; INFECTION; STRETCH	Background: Evidence from several sub-Saharan countries support nurse-initiated antiretroviral treatment as a feasible alternative to doctor-led models characteristic of early responses to the HIV epidemic. However, service delivery models shown to be effective in one country may not be readily adopted in another. This study used an implementation research approach to assist policy makers and other stakeholders to assess the acceptability and feasibility of task shifting in the Namibian context. Methods: The Namibian Ministry of Health and Social Services implemented a Task Shifting Demonstration Project (TSDP) at 9 sites at different levels of the health system. Six months after implementation, a mixed methods evaluation was conducted. Seventy semi-structured interviews were conducted with patients, managers, doctors and nurses directly involved with the TSDP. Physician-evaluators observed and compared health service provision between doctors and nurses for 40 patients (80 observations), documenting performance in agreement with the national guidelines on 13 clinical care indicators. Results: Doctors, nurses, and patients interviewed believed task shifting would improve access to and quality of HIV services. Doctors and nurses both reported an increase in nurses' skills as a result of the project. Observation data showed doctors and nurses were in considerable agreement (>80%) with each other on all dimensions of HIV care and >= 90% on eight dimensions. To ensure success of national scale-up of the task shifting model, challenges involving infrastructure, ongoing mentoring, and nursing scope of practice should be anticipated and addressed. Conclusion: In combination with findings from other studies in the region, data from the TSDP provided critical and timely information to the Namibian Ministry of Health and Social Services, thus helping to move evidence into action. Small-scale implementation research projects enable stakeholders to learn by doing, and provide an opportunity to test and modify the intervention before expansion.	[O'Malley, Gabrielle; Sharma, Anjali; Feldacker, Caryl] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Asrat, Lily; Stephanus, Yvonne; Brandt, Laura; Ali, Deqa] Univ Washington, Int Training & Educ Ctr Hlth, Windhoek, Namibia; [Hamunime, Ndapewa; Kaindjee-Tjituka, Francina; Natanael, Salomo; Gweshe, Justice; Shihepo, Ella] Namibia Minist Hlth & Social Serv, Windhoek, Namibia	University of Washington; University of Washington Seattle	O'Malley, G (corresponding author), Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA.	gomalley@uw.edu		O&apos;Malley, Gabrielle/0000-0002-7514-8240; Feldacker, Caryl/0000-0002-8152-6754	US Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]	US Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This study and the activities detailed were developed and conducted by the Namibian Ministry of Health and Social Services and the University of Washington International Training and Education Center for Health (I-TECH) with funding from Cooperative Agreement U91HA06801 from the US Department of Health and Human Services, Health Resources and Services Administration (HRSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2008, INDIAN J PEDIATR, V75, P1115, DOI [10.1007/s12098-008-0185-4, 10.1007/S12098-008-0185-4]; ASSEFA Y, 2011, J HLTH SERVICES RES; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Boyer S, 2011, CURR OPIN HIV AIDS, V6, P239, DOI 10.1097/COH.0b013e3283478757; Brentlinger PE, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-23; Chang Larry William, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P130, DOI 10.1177/1545109708318525; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Curran GM, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-17; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Davidoff F, 2008, ANN INTERN MED, V149, P670, DOI 10.7326/0003-4819-149-9-200811040-00009; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; GIMBELSHERR K, 2008, 17 ANN INT AIDS C ME; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; HULELA E, 2008, 17 ANN INT AIDS C ME; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; KAMWI R, 2012, 19 ANN INT AIDS C WA; Katzenstein D, 2010, AIDS, V24, pS1, DOI 10.1097/01.aids.0000366077.37827.0a; KOSGEI R, 2008, 17 ANN INT AIDS C ME; Leeman J, 2007, J ADV NURS, V58, P191, DOI 10.1111/j.1365-2648.2006.04207.x; MCGUIRE M, 2008, 17 ANN INT AIDS C ME; MCGUIRE M, 2013, 6 INT AIDS SOC C HIV; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; *MIN HLTH SOC SERV, WINDH DIR SPEC PROGR; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; *NAM HLTH FAC CENS, 2009, KEY FIND HIV AIDS TB; *NAM MIN HLTH SOC, 2010, REP 2010 NAT HIV SEN; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Remme JHF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001000; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; Vasan A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-75; *WHO, GLOB ATL WORLDS WORK; *WHO PEPFAR UNAIDS, 2008, TREAT TRAIN RET TASK; World Health Organization, 2008, TASK SHIFT RAT RED T; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92014	10.1371/journal.pone.0092014	http://dx.doi.org/10.1371/journal.pone.0092014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642894	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900061
J	Fan, SH; Hu, YA; Li, C; Liu, YR				Fan, Sanhong; Hu, Yanan; Li, Chen; Liu, Yanrong			Optimization of Preparation of Antioxidative Peptides from Pumpkin Seeds Using Response Surface Method	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; PROTEIN; HYDROLYSIS; OIL	Protein isolates of pumpkin (Cucurbita pepo L) seeds were hydrolyzed by acid protease to prepare antioxidative peptides. The hydrolysis conditions were optimized through Box-Behnken experimental design combined with response surface method (RSM). The second-order model, developed for the DPPH radical scavenging activity of pumpkin seed hydrolysates, showed good fit with the experiment data with a high value of coefficient of determination (0.9918). The optimal hydrolysis conditions were determined as follows: hydrolyzing temperature 50 degrees C, pH 2.5, enzyme amount 6000 U/g, substrate concentration 0.05 g/ml and hydrolyzing time 5 h. Under the above conditions, the scavenging activity of DPPH radical was as high as 92.82%.	[Fan, Sanhong; Hu, Yanan; Li, Chen; Liu, Yanrong] Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China	Shanxi University	Fan, SH (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China.	fsh729@sxu.edu.cn			Natural Science Foundation of Shanxi [2012011031-4]	Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province)	This work was supported by the Natural Science Foundation of Shanxi (2012011031-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1995, OFFICIAL METHODS ANA, V16th; Chalamaiah M, 2010, FOOD CHEM, V120, P652, DOI 10.1016/j.foodchem.2009.10.057; Chen HM, 1998, J AGR FOOD CHEM, V46, P49, DOI 10.1021/jf970649w; Cumby N, 2008, FOOD CHEM, V109, P144, DOI 10.1016/j.foodchem.2007.12.039; Darmawan R, 2010, PLANT FOOD HUM NUTR, V65, P233, DOI 10.1007/s11130-010-0185-1; El-Adawy TA, 2001, FOOD CHEM, V74, P47, DOI 10.1016/S0308-8146(00)00337-X; El-Soukkary FAH, 2001, PLANT FOOD HUM NUTR, V56, P365, DOI 10.1023/A:1011802014770; Fu CL, 2006, PLANT FOOD HUM NUTR, V61, P73, DOI 10.1007/s11130-006-0016-6; Gao DD, 2010, J SCI FOOD AGR, V90, P1855, DOI 10.1002/jsfa.4024; Giami SY, 2004, J SCI FOOD AGR, V84, P1901, DOI 10.1002/jsfa.1881; Girish TK, 2012, FOOD CHEM TOXICOL, V50, P1690, DOI 10.1016/j.fct.2012.01.043; Hwang JY, 2010, LWT-FOOD SCI TECHNOL, V43, P285, DOI 10.1016/j.lwt.2009.08.020; Jamdar SN, 2010, FOOD CHEM, V121, P178, DOI 10.1016/j.foodchem.2009.12.027; Jao CL, 2002, FISHERIES SCI, V68, P430, DOI 10.1046/j.1444-2906.2002.00442.x; Kong BH, 2012, FOOD CHEM, V135, P540, DOI 10.1016/j.foodchem.2012.04.122; Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067; Liu Y, 2013, IND CROP PROD, V49, P837, DOI 10.1016/j.indcrop.2013.07.023; Rao P.S., 2011, FREE RADICALS ANTIOX, V1, P2, DOI [10.5530/ax.2011.4.2, DOI 10.5530/AX.2011.4.2]; Rezig L, 2012, IND CROP PROD, V37, P82, DOI 10.1016/j.indcrop.2011.12.004; SATHE SK, 1984, CRC CR REV FOOD SCI, V20, P1; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Suetsuna K, 2002, FOOD SCI TECHNOL RES, V8, P227, DOI 10.3136/fstr.8.227; Triveni R, 2001, PROCESS BIOCHEM, V36, P787, DOI 10.1016/S0032-9592(00)00279-X; Vastag Z, 2010, FOOD BIOPROD PROCESS, V88, P277, DOI 10.1016/j.fbp.2009.12.003; Zielinski H, 2012, FOOD CHEM, V135, P2965, DOI 10.1016/j.foodchem.2012.07.009	25	10	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92335	10.1371/journal.pone.0092335	http://dx.doi.org/10.1371/journal.pone.0092335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637721	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100142
J	Farag, IF; Davis, JP; Youssef, NH; Elshahed, MS				Farag, Ibrahim F.; Davis, James P.; Youssef, Noha H.; Elshahed, Mostafa S.			Global Patterns of Abundance, Diversity and Community Structure of the Aminicenantes (Candidate Phylum OP8)	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; MICROBIAL DIVERSITY; MOLECULAR ANALYSIS; SOIL; GENOME; RARE; SEDIMENTS; INSIGHTS; VERRUCOMICROBIA; METAGENOMICS	We investigated the global patterns of abundance, diversity, and community structure of members of the Aminicenantes (candidate phylum OP8). Our aim was to identify the putative ecological role(s) played by members of this poorly characterized bacterial lineages in various ecosystems. Analysis of near full-length 16S rRNA genes identified four classes and eight orders within the Aminicenantes. Within 3,134 datasets comprising similar to 1.8 billion high throughput-generated partial 16S rRNA genes, 47,351 Aminicenantes-affiliated sequences were identified in 913 datasets. The Aminicenantes exhibited the highest relative abundance in hydrocarbon-impacted environments, followed by marine habitats (especially hydrothermal vents and coral-associated microbiome samples), and aquatic, non-marine habitats (especially in terrestrial springs and groundwater samples). While the overall abundance of the Aminicenantes was higher in low oxygen tension as well as non-saline and low salinity habitats, it was encountered in a wide range of oxygen tension, salinities, and temperatures. Analysis of the community structure of the Aminicenantes showed distinct patterns across various datasets that appear to be, mostly, driven by habitat variations rather than prevalent environmental parameters. We argue that the detection of the Aminicenantes across environmental extremes and the observed distinct community structure patterns reflect a high level of intraphylum metabolic diversity and adaptive capabilities that enable its survival and growth in a wide range of habitats and environmental conditions.	[Farag, Ibrahim F.; Davis, James P.; Youssef, Noha H.; Elshahed, Mostafa S.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Elshahed, MS (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Mostafa@okstate.edu	Youssef, Noha H./T-5198-2019	Youssef, Noha H./0000-0001-9159-3785; Farag, Ibrahim/0000-0002-5732-4108	National Science Foundation Microbial Observatories Program [EF0801858]; Emerging Frontiers [0801858] Funding Source: National Science Foundation	National Science Foundation Microbial Observatories Program(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation Microbial Observatories Program (grant EF0801858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Benson DA, 2008, NUCLEIC ACIDS RES, V36, pD25, DOI 10.1093/nar/gkm929; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Buckley DH, 2006, APPL ENVIRON MICROB, V72, P4522, DOI 10.1128/AEM.00149-06; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Dalevi D, 2001, INT J SYST EVOL MICR, V51, P385, DOI 10.1099/00207713-51-2-385; Davis JP, 2012, MICROB ECOL, V64, P942, DOI 10.1007/s00248-012-0073-3; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Elshahed MS, 2005, APPL ENVIRON MICROB, V71, P7598, DOI 10.1128/AEM.71.11.7598-7602.2005; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hugenholtz P, 2002, GENOME BIOL, V3; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Joynt J, 2006, MICROB ECOL, V51, P209, DOI 10.1007/s00248-005-0205-0; Kielak AM, 2010, APPL ENVIRON MICROB, V76, P6769, DOI 10.1128/AEM.00343-10; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legg TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00082; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McLean JS, 2013, P NATL ACAD SCI USA, V110, pE2390, DOI 10.1073/pnas.1219809110; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Saidi-Mehrabad A, 2013, ISME J, V7, P908, DOI 10.1038/ismej.2012.163; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stevenson BS, 2011, ENVIRON MICROBIOL, V13, P1078, DOI 10.1111/j.1462-2920.2010.02413.x; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R. D. C, 2011, R LANG ENV STAT COMP; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Youssef N, 2012, APPL ENVIRON MICROB, V78, P2677, DOI 10.1128/AEM.00002-12; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	64	66	71	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92139	10.1371/journal.pone.0092139	http://dx.doi.org/10.1371/journal.pone.0092139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637619	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100120
J	Gao, WN; Fu, YC; Yu, C; Wang, SK; Zhang, YC; Zong, C; Xu, TF; Liu, Y; Li, X; Wang, XD				Gao, Weina; Fu, Yuchang; Yu, Cong; Wang, Shunke; Zhang, Yuchao; Zong, Chen; Xu, Tongfu; Liu, Yong; Li, Xia; Wang, Xiangdong			Elevation of NR4A3 Expression and Its Possible Role in Modulating Insulin Expression in the Pancreatic Beta Cell	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NUCLEAR RECEPTOR NOR-1; ORPHAN RECEPTOR; ENDOPLASMIC-RETICULUM; TRANSCRIPTIONAL ACTIVITY; METABOLIC DISEASE; INDUCED APOPTOSIS; GENE-EXPRESSION; ER STRESS; NGFI-B	Background: NR4A3/NOR-1 is a member of the NR4A orphan nuclear receptor subfamily, which contains early response genes that sense and respond to a variety of stimuli in the cellular environment. The role of NR4A3 in insulin expression in pancreatic beta cells remains unknown. Methods: Dynamic changes in NR4A3 were examined in a pancreatic beta-cell line, MIN6, treated with thapsigargin (TG), palmitate (PA), tunicamycin (TM), and dithiothreitol (DTT), chemicals that produce cell stress and even apoptosis. We exploited virus infection techniques to induce expression of NR4A3 or three deletion mutants, and determined expression of insulin and insulin regulatory genes in MIN6 cells. Results: TG and PA, two endoplasmic reticulum (ER) stress inducers, were able to induce unfolded protein response (UPR) activation and elevation of NR4A3 expression in MIN6 cells, whereas TM and DTT, two other ER stress inducers, were able to induce UPR activation but not NR4A3 elevation. MIN6 cells over-expressing NR4A3 protein after adenoviral infection exhibited reduced transcription of the insulin genes Ins1 and Ins2, and reduced insulin protein secretion, which were negatively correlated with NR4A3 expression levels. Functional analysis of different deletion mutants of NR4A3 showed that deleting the activation domain AF1 or the DNA-binding domain abolished the down-regulation of insulin transcription by NR4A3 in MIN6 cells, indicating that this down-regulative role was closely related to the NR4A3 trans-activation activity. Over-expression of NR4A3 in MIN6 cells resulted in reduced mRNA transcription of the insulin positive-regulation genes, Pdx1 and NeuroD1. Conclusion: Some ER stress inducers, such as TG or PA, are able to elevate NR4A3 expression in MIN6 cells, while others, such as TM or DTT, are not. Over-expression of NR4A3 in MIN6 cells results in down-regulation of insulin gene transcription and insulin secretion. NR4A3 reduces insulin gene expression by modulating the expression of Pdx1 and NeuroD1.	[Gao, Weina; Yu, Cong; Wang, Shunke; Zhang, Yuchao; Zong, Chen; Xu, Tongfu; Li, Xia; Wang, Xiangdong] Shandong Univ, Dept Cell Biol, Sch Med, Jinan 250100, Peoples R China; [Gao, Weina] Henan Univ Sci & Technol, Sch Med Technol & Engn, Luoyang, Peoples R China; [Fu, Yuchang] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Liu, Yong] Chinese Acad Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Xiangdong] Shandong Univ, Key Lab Prot Sci Chron Degenerat Dis, Jinan 250100, Peoples R China	Shandong University; Henan University of Science & Technology; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Shandong University	Li, X (corresponding author), Shandong Univ, Dept Cell Biol, Sch Med, Jinan 250100, Peoples R China.	lixia1666@sdu.edu.cn; xdongw@sdu.edu.cn			National Natural Science Foundation of China (NSFC) [81170814, 81370881]; Education Ministry of China for PhD program [20100131110037]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Education Ministry of China for PhD program	This work was supported by National Natural Science Foundation of China (NSFC, funding numbers are 81170814, 81370881) and the Education Ministry of China for PhD program (funding number is 20100131110037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx J, 1999, CELL, V97, P161; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Bandoh S, 1995, MOL CELL ENDOCRINOL, V115, P227, DOI 10.1016/0303-7207(95)03685-7; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chen HZ, 2013, INT J BIOCHEM CELL B, V45, P1600, DOI 10.1016/j.biocel.2013.04.026; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Crespo J, 2005, CARDIOVASC RES, V67, P333, DOI 10.1016/j.cardiores.2005.03.016; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Evans R, 2004, NAT MED, V10, P1022, DOI 10.1038/nm1004-1022; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Guo QS, 2012, EXP DIABETES RES, DOI 10.1155/2012/672013; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hummasti S, 2008, MOL ENDOCRINOL, V22, P1743, DOI 10.1210/me.2007-0566; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Ordelheide AM, 2013, MOL METAB, V2, P243, DOI 10.1016/j.molmet.2013.06.003; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Weyrich P, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-77; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	46	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91462	10.1371/journal.pone.0091462	http://dx.doi.org/10.1371/journal.pone.0091462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638142	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100036
J	Paoloni, M; Webb, C; Mazcko, C; Cherba, D; Hendricks, W; Lana, S; Ehrhart, EJ; Charles, B; Fehling, H; Kumar, L; Vail, D; Henson, M; Childress, M; Kitchell, B; Kingsley, C; Kim, S; Neff, M; Davis, B; Chand, K; Trent, J				Paoloni, Melissa; Webb, Craig; Mazcko, Christina; Cherba, David; Hendricks, William; Lana, Susan; Ehrhart, E. J.; Charles, Brad; Fehling, Heather; Kumar, Leena; Vail, David; Henson, Michael; Childress, Michael; Kitchell, Barbara; Kingsley, Christopher; Kim, Seungchan; Neff, Mark; Davis, Barbara; Khanna, Chand; Trent, Jeffrey			Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials	PLOS ONE			English	Article							GENOME; CHEMOSENSITIVITY; ONCOLOGY; TARGETS; TUMORS; GENES	Background: Molecularly-guided trials (i.e. PMed) now seek to aid clinical decision-making by matching cancer targets with therapeutic options. Progress has been hampered by the lack of cancer models that account for individual-to-individual heterogeneity within and across cancer types. Naturally occurring cancers in pet animals are heterogeneous and thus provide an opportunity to answer questions about these PMed strategies and optimize translation to human patients. In order to realize this opportunity, it is now necessary to demonstrate the feasibility of conducting molecularly-guided analysis of tumors from dogs with naturally occurring cancer in a clinically relevant setting. Methodology: A proof-of-concept study was conducted by the Comparative Oncology Trials Consortium (COTC) to determine if tumor collection, prospective molecular profiling, and PMed report generation within 1 week was feasible in dogs. Thirty-one dogs with cancers of varying histologies were enrolled. Twenty-four of 31 samples (77%) successfully met all predefined QA/QC criteria and were analyzed via Affymetrix gene expression profiling. A subsequent bioinformatics workflow transformed genomic data into a personalized drug report. Average turnaround from biopsy to report generation was 116 hours (4.8 days). Unsupervised clustering of canine tumor expression data clustered by cancer type, but supervised clustering of tumors based on the personalized drug report clustered by drug class rather than cancer type. Conclusions: Collection and turnaround of high quality canine tumor samples, centralized pathology, analyte generation, array hybridization, and bioinformatic analyses matching gene expression to therapeutic options is achievable in a practical clinical window (<1 week). Clustering data show robust signatures by cancer type but also showed patient-to-patient heterogeneity in drug predictions. This lends further support to the inclusion of a heterogeneous population of dogs with cancer into the preclinical modeling of personalized medicine. Future comparative oncology studies optimizing the delivery of PMed strategies may aid cancer drug development.	[Paoloni, Melissa; Mazcko, Christina; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Webb, Craig; Cherba, David; Neff, Mark; Trent, Jeffrey] Van Andel Res Inst, Grand Rapids, MI USA; [Hendricks, William; Kingsley, Christopher; Kim, Seungchan; Davis, Barbara; Trent, Jeffrey] Translat Genom Res Inst TGen, Phoenix, AZ USA; [Lana, Susan; Ehrhart, E. J.; Charles, Brad] Colorado State Univ, Coll Vet Med, Ft Collins, CO 80523 USA; [Fehling, Heather; Kumar, Leena] Clin Reference Lab, Lenexa, KS USA; [Vail, David] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Henson, Michael] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Childress, Michael] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA; [Kitchell, Barbara] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Van Andel Institute; Translational Genomics Research Institute; Colorado State University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Michigan State University	Chand, K (corresponding author), NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA.	khannac@mail.nih.gov; jtrent@tgen.org		, William/0000-0001-7192-8699; Childress, Michael/0000-0001-6127-4679; Kim, Seungchan/0000-0003-4183-4338	National Institutes of Health [UC2 CA148149]; NATIONAL CANCER INSTITUTE [ZIGBC010569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: National Institutes of Health UC2 CA148149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2010, J MOL MED, V88, P1095, DOI 10.1007/s00109-010-0644-z; Beijnen JH, 2010, CURR CLIN PHARMACOL, V5, P141, DOI 10.2174/157488410791498789; Briggs JW, 2011, TLS-TIMES LIT SUPPL, P6; Collisson EA, 2012, NAT REV CLIN ONCOL; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gheeya JS, 2009, CANCER BIOL THER, V8, P2386, DOI 10.4161/cbt.8.24.10184; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; Monks NR, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-158; NCI, 2002, NCI BIOINF OR 2002 F; Normanno N, 2012, J CELL BIOCH; Ofiara LM, 2012, CURR ONCOL, V19, pS16, DOI 10.3747/co.19.1062; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Paoloni MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011013; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Ramsey SD, 2011, HEALTH AFFAIR, V30, P2259, DOI 10.1377/hlthaff.2010.0637; Richards KL, 2013, CANC RES; Roukos DH, 2012, ANN SURG ONCOL, V19, P3646, DOI 10.1245/s10434-012-2542-9; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Sholler G., 2012, J CANC THER, V3, P602, DOI [DOI 10.4236/JCT.2012.35077, 10.4236/jct.2012.35077]; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stricker T, 2011, SEMIN ONCOL, V38, P173, DOI 10.1053/j.seminoncol.2011.01.013; Tian Q, 2012, J INTERN MED, V271, P111, DOI 10.1111/j.1365-2796.2011.02498.x; Tsimberidou AM, 2012, CLIN CANC RES; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Veterinary cooperative oncology group D common terminology criteria for adverse events (VCOG-CTCAE), 2011, VET COMP ONCOL, DOI [10.1111/j.1476-5829.2011.00283.x, DOI 10.1111/J.1476-5829.2011.00283.X]; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Xian W, 2011, GENOME MED, V3, DOI 10.1186/gm236; Zhang L, 2011, CURR DRUG METAB, V12, P455, DOI 10.2174/138920011795495303	38	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90028	10.1371/journal.pone.0090028	http://dx.doi.org/10.1371/journal.pone.0090028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637659	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100002
J	Rivera, MF; Chukkapalli, SS; Velsko, IM; Lee, JY; Bhattacharyya, I; Dolce, C; Toro, EJ; Holliday, LS; Kesavalu, L				Rivera, Mercedes F.; Chukkapalli, Sasanka S.; Velsko, Irina M.; Lee, Ju-Youn; Bhattacharyya, Indraneel; Dolce, Calogero; Toro, Edgardo J.; Holliday, L. Shannon; Kesavalu, Lakshmyya			Bis-Enoxacin Blocks Rat Alveolar Bone Resorption from Experimental Periodontitis	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; OSTEOCLAST FORMATION; ALZHEIMERS-DISEASE; ALENDRONATE; IDENTIFICATION; INFLAMMATION; PHOSPHATASE; INHIBITOR; PATHOGENS; VIRULENCE	Periodontal diseases are multifactorial, caused by polymicrobial subgingival pathogens, including Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Chronic periodontal infection results in inflammation, destruction of connective tissues, periodontal ligament, and alveolar bone resorption, and ultimately tooth loss. Enoxacin and a bisphosphonate derivative of enoxacin (bis-enoxacin) inhibit osteoclast formation and bone resorption and also contain antibiotic properties. Our study proposes that enoxacin and/or bis-enoxacin may be useful in reducing alveolar bone resorption and possibly bacterial colonization. Rats were infected with 10(9) cells of polymicrobial inoculum consisting of P. gingivalis, T. denticola, and T. forsythia, as an oral lavage every other week for twelve weeks. Daily subcutaneous injections of enoxacin (5 mg/kg/day), bis-enoxacin (5, 25 mg/kg/day), alendronate (1, 10 mg/kg/day), or doxycycline (5 mg/day) were administered after 6 weeks of polymicrobial infection. Periodontal disease parameters, including bacterial colonization/infection, immune response, inflammation, alveolar bone resorption, and systemic spread, were assessed post-euthanasia. All three periodontal pathogens colonized the rat oral cavity during polymicrobial infection. Polymicrobial infection induced an increase in total alveolar bone resorption, intrabony defects, and gingival inflammation. Treatment with bis-enoxacin significantly decreased alveolar bone resorption more effectively than either alendronate or doxycycline. Histologic examination revealed that treatment with bis-enoxacin and enoxacin reduced gingival inflammation and decreased apical migration of junctional epithelium. These data support the hypothesis that bis-enoxacin and enoxacin may be useful for the treatment of periodontal disease.	[Rivera, Mercedes F.; Chukkapalli, Sasanka S.; Velsko, Irina M.; Lee, Ju-Youn; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Bhattacharyya, Indraneel] Univ Florida, Coll Dent, Dept Oral Diagnost Sci, Gainesville, FL USA; [Dolce, Calogero; Toro, Edgardo J.; Holliday, L. Shannon] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL USA; [Holliday, L. Shannon] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kesavalu, L (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu	Holliday, Lexie/GYQ-4972-2022; Bhattacharyya, Indraneel/U-7752-2019	Holliday, Lexie/0000-0002-0844-1965	USPHS from National Institute of Dental and Craniofacial Research, NIH [R21 DE019862]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019862] Funding Source: NIH RePORTER	USPHS from National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by USPHS research grant R21 DE019862 (LSH) from National Institute of Dental and Craniofacial Research, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2010, ORAL DIS, V16, P674, DOI 10.1111/j.1601-0825.2010.01677.x; [Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Herczegh P, 2002, J MED CHEM, V45, P2338, DOI 10.1021/jm0105326; Herrera BS, 2013, J PERIODONTOL, V84; Hoff AO, 2011, ANN NY ACAD SCI, V1218, P47, DOI 10.1111/j.1749-6632.2010.05771.x; Inoue K, 2004, J PERIODONTAL RES, V39, P50, DOI 10.1111/j.1600-0765.2004.00704.x; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Karimbux NY, 1998, J PERIODONTOL, V69, P34, DOI 10.1902/jop.1998.69.1.34; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee JJ, 2013, HEAD NECK-J SCI SPEC, V35, P1787, DOI 10.1002/hed.23235; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Nahid MA, 2011, INFECT IMMUN, V79, P1597, DOI 10.1128/IAI.01062-10; Ostrov DA, 2009, J MED CHEM, V52, P5144, DOI 10.1021/jm900277z; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Scannapieco Frank A, 2003, Ann Periodontol, V8, P70, DOI 10.1902/annals.2003.8.1.70; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sousa EJ, 2013, EPIGENETICS-US, V8, P548, DOI 10.4161/epi.24519; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Toro EJ, 2013, J DENT RES, V92, P925, DOI 10.1177/0022034513501876; Toro EJ, 2012, J BIOL CHEM, V287, P17894, DOI 10.1074/jbc.M111.280511; Toro EJ, 2012, CURR PROTEIN PEPT SC, V13, P180; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIPLINARY PE, V2010, P1; WOLFSON JS, 1991, AM J MED, V91, pS153, DOI 10.1016/0002-9343(91)90330-Z; Zubery Y, 1998, INFECT IMMUN, V66, P4158; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	41	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92119	10.1371/journal.pone.0092119	http://dx.doi.org/10.1371/journal.pone.0092119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638087	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100115
J	Wang, JH; Lin, RY; Zhang, WB; Li, L; Gottstein, B; Blagosklonov, O; Lu, GD; Zhang, CS; Lu, XM; Vuitton, DA; Wen, H				Wang, Junhua; Lin, Renyong; Zhang, Wenbao; Li, Liang; Gottstein, Bruno; Blagosklonov, Oleg; Lu, Guodong; Zhang, Chuangshan; Lu, Xiaomei; Vuitton, Dominique A.; Wen, Hao			Transcriptional Profiles of Cytokine/Chemokine Factors of Immune Cell-Homing to the Parasitic Lesions: A Comprehensive One-Year Course Study in the Liver of E. multilocularis-Infected Mice	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; IN-VIVO TREATMENT; ECHINOCOCCUS-MULTILOCULARIS; SCHISTOSOMA-MANSONI; IFN-GAMMA; PERIPARASITIC GRANULOMA; ALVEOLAR ECHINOCOCCOSIS; HELMINTH INFECTION; CHEMOKINE RELEASE; CYTOKINE	Pathogenesis of chronically developing alveolar echinococcosis (AE) is characterized by a continuous, granulomatous, periparasitic infiltration of immune cells surrounding the metacestode of Echinococcus multilocularis (E. multilocularis) in the affected liver. A detailed cytokine and chemokine profile analysis of the periparasitic infiltrate in the liver has, however, not yet been carried out in a comprehensive way all along the whole course of infection in E. multilocularis intermediate hosts. We thus assessed the hepatic gene expression profiles of 18 selected cytokine and chemokine genes using qRT-PCR in the periparasitic immune reaction and the subsequent adjacent, not directly affected, liver tissue of mice from day 2 to day 360 post intra-hepatic injection of metacestode. DNA microarray analysis was also used to get a more complete picture of the transcriptional changes occurring in the liver surrounding the parasitic lesions. Profiles of mRNA expression levels in the hepatic parasitic lesions showed that a mixed Th1/Th2 immune response, characterized by the concomitant presence of IL-12 alpha, IFN-gamma and IL-4, was established very early in the development of E. multilocularis. Subsequently, the profile extended to a combined tolerogenic profile associating IL-5, IL-10 and TGF-beta. IL-17 was permanently expressed in the liver, mostly in the periparasitic infiltrate; this was confirmed by the increased mRNA expression of both IL-17A and IL-17F from a very early stage, with a subsequent decrease of IL-17A after this first initial rise. All measured chemokines were significantly expressed at a given stage of infection; their expression paralleled that of the corresponding Th1, Th2 or Th17 cytokines. In addition to giving a comprehensive insight in the time course of cytokines and chemokines in E. multilocularis lesion, this study contributes to identify new targets for possible immune therapy to minimize E. multilocularis-related pathology and to complement the only parasitostatic effect of benzimidazoles in AE.	[Wang, Junhua; Lin, Renyong; Zhang, Wenbao; Li, Liang; Lu, Guodong; Zhang, Chuangshan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Xinjiang Major Dis Res, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua; Lin, Renyong; Zhang, Wenbao; Li, Liang; Lu, Guodong; Zhang, Chuangshan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua] Univ Franche Comte, Dept Nucl Med, F-25030 Besancon, Franche Comte, France; [Wang, Junhua] Jean Minjoz Univ Hosp, Besancon, Franche Comte, France; [Wang, Junhua; Gottstein, Bruno; Blagosklonov, Oleg] Univ Bern, Inst Parasitol, Bern, Switzerland; [Vuitton, Dominique A.] Univ Franche Comte, WHO Collaborating Ctr Prevent & Treatment Human E, F-25030 Besancon, Franche Comte, France; [Vuitton, Dominique A.] Univ Hosp, Besancon, Franche Comte, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; University of Bern; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Vuitton, DA (corresponding author), Univ Franche Comte, WHO Collaborating Ctr Prevent & Treatment Human E, F-25030 Besancon, Franche Comte, France.	dvuitton@univ-fcomte.fr; Dr.wenhao@163.com	Wang, Junhua/ABB-6324-2021	Wang, Junhua/0000-0002-6110-3711	NSFC [81260452, 81260252]; Swiss National Science Foundation [31003A_141039/1]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1181]; Xinjiang Key-Lab Projects [SKLIB-XJMDR-2012-Y1]	NSFC(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Xinjiang Key-Lab Projects	This work was supported by NSFC Grant Projects (81260452, 81260252), the Swiss National Science Foundation (31003A_141039/1), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1181), and Xinjiang Key-Lab Projects (SKLIB-XJMDR-2012-Y1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot F, 1999, PARASITE IMMUNOL, V21, P475, DOI 10.1046/j.1365-3024.1999.00245.x; Amri M, 2009, EUR CYTOKINE NETW, V20, P63, DOI 10.1684/ecn.2009.0154; Aumuller E, 2004, PARASITE IMMUNOL, V26, P387, DOI 10.1111/j.0141-9838.2004.00724.x; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; Brunet LR, 1999, J PARASITOL, V85, P734, DOI 10.2307/3285752; Caoduro C, 2013, J NUCL MED, V54, P358, DOI 10.2967/jnumed.112.109942; Correa-Oliveira R, 1998, BRAZ J MED BIOL RES, V31, P171, DOI 10.1590/S0100-879X1998000100024; Dai WJ, 1999, IMMUNOLOGY, V97, P107, DOI 10.1046/j.1365-2567.1999.00723.x; Dai WJ, 2004, IMMUNOLOGY, V112, P481, DOI 10.1111/j.1365-2567.2004.01885.x; Dreweck CM, 1999, PARASITE IMMUNOL, V21, P433, DOI 10.1046/j.1365-3024.1999.00243.x; Eger A, 2003, PARASITE IMMUNOL, V25, P103, DOI 10.1046/j.1365-3024.2003.00601.x; Emery I, 1998, PARASITE IMMUNOL, V20, P81, DOI 10.1046/j.1365-3024.1998.00131.x; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Godot V, 2003, GASTROENTEROLOGY, V124, P1441, DOI 10.1016/S0016-5085(03)00273-7; Godot V, 2000, CLIN EXP IMMUNOL, V121, P484, DOI 10.1046/j.1365-2249.2000.01308.x; Gottstein B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009779; Harraga S, 2003, ACTA TROP, V85, P231, DOI 10.1016/S0001-706X(02)00218-8; Hicks DJ, 2013, J COMP PATHOL; Hubner MP, 2006, CLIN EXP IMMUNOL, V145, P243, DOI 10.1111/j.1365-2249.2006.03142.x; Jenne L, 1997, CLIN EXP IMMUNOL, V109, P90, DOI 10.1046/j.1365-2249.1997.4031299.x; Kocherscheidt L, 2008, EXP PARASITOL, V119, P467, DOI 10.1016/j.exppara.2008.04.006; Lechner CJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/735342; Liance M, 1998, PARASITE, V5, P231, DOI 10.1051/parasite/1998053231; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Manfras BJ, 2004, INT IMMUNOL, V16, P43, DOI 10.1093/intimm/dxh005; Manfras BJ, 2002, INFECT IMMUN, V70, P1168, DOI 10.1128/IAI.70.3.1168-1174.2002; Mejri N, 2010, PARASITOLOGY, V137, P557, DOI 10.1017/S0031182009991533; Mejri N, 2011, PARASITOL INT, V60, P45, DOI 10.1016/j.parint.2010.10.002; Mourglia-Ettlin G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001293; Mutapi F, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-139; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; Rigano R, 2001, INFECT IMMUN, V69, P288, DOI 10.1128/IAI.69.1.288-296.2001; Rigano R, 1996, CLIN EXP IMMUNOL, V105, P456, DOI 10.1046/j.1365-2249.1996.d01-796.x; Rutitzky LI, 2005, J IMMUNOL, V175, P3920, DOI 10.4049/jimmunol.175.6.3920; SABIN EA, 1995, J IMMUNOL, V155, P4844; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Shi DZ, 2004, WORLD J GASTROENTERO, V10, P3674, DOI 10.3748/wjg.v10.i24.3674; Vuitton DA, 2006, PARASITOL INT, V55, pS51, DOI 10.1016/j.parint.2005.11.007; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1989, CLIN EXP IMMUNOL, V78, P67; Wang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055379; Zhang CS, 2012, PLOS ONE, V7, P436, DOI 10.1371/journal.pone.0030127; ZHAO H, 2012, LAS DIAGN OPT MEAS, P1	44	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91638	10.1371/journal.pone.0091638	http://dx.doi.org/10.1371/journal.pone.0091638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637903	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100050
J	Wei, L; Zhu, SS; She, RP; Hu, FJ; Wang, J; Yan, X; Zhang, CY; Liu, SH; Quan, R; Li, ZX; Du, F; Wei, T; Liu, J				Wei, Li; Zhu, Shanshan; She, Ruiping; Hu, Fengjiao; Wang, Jing; Yan, Xu; Zhang, Chunyan; Liu, Shuhang; Quan, Rong; Li, Zixuan; Du, Fang; Wei, Ting; Liu, Jue			Viral Replication and Lung Lesions in BALB/c Mice Experimentally Inoculated with Avian Metapneumovirus Subgroup C Isolated from Chickens	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AIRWAY-OBSTRUCTION; IMMUNE-RESPONSE; INFECTION; PNEUMOVIRUS; HYPERRESPONSIVENESS; PATHOGENESIS; SEQUENCE; PROTEIN; HMPV	Avian metapneumovirus (aMPV) emerged as an important respiratory pathogen causing acute respiratory tract infection in avian species. Here we used a chicken aMPV subgroup C (aMPV/C) isolate to inoculate experimentally BALB/c mice and found that the aMPV/C can efficiently replicate and persist in the lungs of mice for at least 21 days with a peak viral load at day 6 postinoculation. Lung pathological changes were characterized by increased inflammatory cells. Immunochemical assay showed the presence of viral antigens in the lungs and significant upregulation of pulmonary inflammatory cytokines and chemokines including MCP-1, MIP-1 alpha, RANTES, IL-1 beta, IFN-gamma, and TNF-alpha were detected following inoculation. These results indicate for the first time that chicken aMPV/C may replicate in the lung of mice. Whether aMPV/C has potential as zoonotic pathogen, further investigation will be required.	[Wei, Li; Zhu, Shanshan; Wang, Jing; Yan, Xu; Zhang, Chunyan; Liu, Shuhang; Quan, Rong; Li, Zixuan; Liu, Jue] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China; [She, Ruiping; Hu, Fengjiao; Du, Fang] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Wei, Ting] QIMR Berghofer Med Res Inst, Mol Virol Lab, Brisbane, Qld, Australia	Beijing Academy of Agriculture & Forestry; China Agricultural University; QIMR Berghofer Medical Research Institute	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China.	liujue23@yahoo.com			China Agriculture Research System [CARS-42]	China Agriculture Research System	This work was supported by a grant from China Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Alvarez R, 2004, J VIROL, V78, P14003, DOI 10.1128/JVI.78.24.14003-14011.2004; Alvarez R, 2004, CLIN DIAGN LAB IMMUN, V11, P245, DOI 10.1128/CDLI.11.2.245-249.2004; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Buys S.B., 1980, TURKEYS, P36; Cha RM, 2011, VET IMMUNOL IMMUNOP, V140, P30, DOI 10.1016/j.vetimm.2010.11.006; Chakraborty K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037173; Cook JKA, 1999, AVIAN PATHOL, V28, P607, DOI 10.1080/03079459994407; Darniot M, 2005, VACCINE, V23, P4473, DOI 10.1016/j.vaccine.2005.04.027; Darniot M, 2009, J VIROL, V83, P3323, DOI 10.1128/JVI.02198-08; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Jirjis FF, 2002, VET PATHOL, V39, P300, DOI 10.1354/vp.39-3-300; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Kukavica-Ibrulj I, 2009, J VIROL, V83, P1341, DOI 10.1128/JVI.01123-08; Lee EH, 2007, VIRUS RES, V128, P18, DOI 10.1016/j.virusres.2007.03.029; MacPhail M, 2004, J GEN VIROL, V85, P1655, DOI 10.1099/vir.0.79805-0; MCDOUGALL JS, 1986, VET REC, V118, P206, DOI 10.1136/vr.118.8.206; Njenga MK, 2003, VIRUS RES, V91, P163, DOI 10.1016/S0168-1702(02)00256-3; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Skiadopoulos MH, 2004, J VIROL, V78, P6927, DOI 10.1128/JVI.78.13.6927-6937.2004; Toquin D, 2006, VIRUS GENES, V32, P97, DOI 10.1007/s11262-005-5850-3; Turpin EA, 2008, AVIAN PATHOL, V37, P343, DOI 10.1080/03079450802068566; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; Velayudhan BT, 2006, EMERG INFECT DIS, V12, P1853; Wei L, 2013, EMERG INFECT DIS, V19, P1092, DOI 10.3201/eid1907.121126; World Organization for Animal Health, 2011, TERR AN HLTH COD; Yunus AS, 2003, VIRUS RES, V93, P91, DOI 10.1016/S0168-1702(03)00074-1	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92136	10.1371/journal.pone.0092136	http://dx.doi.org/10.1371/journal.pone.0092136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637582	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100119
J	Zhang, R; Gong, H; Zhu, D; Gao, JZ; Fang, J; Fan, YB				Zhang, Rui; Gong, He; Zhu, Dong; Gao, Jiazi; Fang, Juan; Fan, Yubo			Seven Day Insertion Rest in Whole Body Vibration Improves Multi-Level Bone Quality in Tail Suspension Rats	PLOS ONE			English	Article							LOW-MAGNITUDE; HIGH-FREQUENCY; TRABECULAR BONE; MECHANICAL-PROPERTIES; RESISTANCE EXERCISE; MINERAL DENSITY; DAILY EXPOSURE; FEMORAL BONE; SINGLE; HETEROGENEITY	Objective: This study aimed to investigate the effects of low-magnitude, high-frequency vibration with rest days on bone quality at multiple levels. Methods: Forty-nine three-month-old male Wistar rats were randomly divided into seven groups, namely, vibrational loading for X day followed by X day rest (VLXR, X= 1, 3, 5, 7), vibrational loading every day (VLNR), tail suspension (SPD), and baseline control (BCL). One week after tail suspension, rats were loaded by vibrational loading (35 Hz, 0.25 g, 15 min/day) except SPD and BCL. Fluorescence markers were used in all rats. Eight weeks later, femora were harvested to investigate macromechanical properties, and micro-computed tomography scanning and fluorescence test were used to evaluate microarchitecture and bone growth rate. Atomic force microscopy analyses and nanoindentation test were used to analyze the nanostructure and mechanical properties of bone material, respectively. Inductively coupled plasma optical emission spectroscopy was used for quantitative chemical analyses. Results: Microarchitecture, mineral apposition rate and bone formation rate and macromechanical properties were improved in VL7R. Grain size and roughness were significantly different among all groups. No statistical difference was found for the mechanical properties of the bone material, and the chemical composition of all groups was almost similar. Conclusions: Low-magnitude, high-frequency vibration with rest days altered bone microarchitecture and macrobiomechanical properties, and VL7R was more efficacious in improving bone loss caused by mechanical disuse, which provided theoretical basis and explored the mechanisms of vibration for improving bone quality in clinics.	[Zhang, Rui; Gong, He; Gao, Jiazi; Fang, Juan] Jilin Univ, Dept Engn Mech, Changchun 130023, Jilin, Peoples R China; [Zhu, Dong] Jilin Univ, Hosp 1, Dept Orthoped Surg, Changchun 130023, Jilin, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China	Jilin University; Jilin University; Beihang University	Gong, H (corresponding author), Jilin Univ, Dept Engn Mech, Changchun 130023, Jilin, Peoples R China.	gonghe1976@yahoo.com; swyxgc@126.com			National Natural Science Foundation of China [11322223, 11272134]; 973 Program [2012CB821202]; Program for New Century Excellent Talents in University [NCET-12-0024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work is supported by the National Natural Science Foundation of China (Nos. 11322223 and 11272134), the 973 Program (No. 2012CB821202), and the Program for New Century Excellent Talents in University (NCET-12-0024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCENZI A, 1990, J BIOMECH, V23, P763, DOI 10.1016/0021-9290(90)90023-V; BOSKEY AL, 2001, BONE MECH HDB; Brisceno CE, 2009, AM J ORTHOD DENTOFAC, V135, P292, DOI 10.1016/j.ajodo.2008.06.023; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Chen PY, 2011, CALCIFIED TISSUE INT, V88, P351, DOI 10.1007/s00223-011-9462-8; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Fan ZF, 2007, COMPOS PART B-ENG, V38, P411, DOI 10.1016/j.compositesb.2006.08.006; FAULKNER KG, 1995, CALCIFIED TISSUE INT, V56, P26, DOI 10.1007/BF00298740; Feng LA, 2011, J BIOMECH, V44, P313, DOI 10.1016/j.jbiomech.2010.10.011; Flieger J, 1998, CALCIFIED TISSUE INT, V63, P510, DOI 10.1007/s002239900566; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Gong H, 2006, J BONE MINER METAB, V24, P386, DOI 10.1007/s00774-006-0698-8; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Hassenkam T, 2005, MICRON, V36, P681, DOI 10.1016/j.micron.2005.06.007; Hassenkam T, 2006, ANAT REC PART A, V288A, P1087, DOI 10.1002/ar.a.20376; Hembree M, 2009, AM J ORTHOD DENTOFAC, V135, DOI 10.1016/j.ajodo.2008.06.022; Hoffler CE, 2000, J ORTHOPAED RES, V18, P432, DOI 10.1002/jor.1100180315; Hoffler CE, 2000, BONE, V26, P603, DOI 10.1016/S8756-3282(00)00268-4; Lafage V, 2002, Stud Health Technol Inform, V91, P428; Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; LeBlanc A, 1998, BONE, V22, p113S, DOI 10.1016/S8756-3282(98)00013-1; LI XJ, 1990, ANAT RECORD, V227, P12, DOI 10.1002/ar.1092270103; Li ZL, 2012, EUR J APPL PHYSIOL, V112, P3743, DOI 10.1007/s00421-012-2355-3; LOTZ JC, 1991, J BIOMECH, V24, P317, DOI 10.1016/0021-9290(91)90350-V; Luu YK, 2010, INT J OBESITY, V34, P401, DOI 10.1038/ijo.2009.240; Ma RS, 2012, HIP INT, V22, P218, DOI 10.5301/HIP.2012.9033; Manske SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036486; Matsuda J, 2009, IFMBE PROC, V23, P1766; Milovanovic P, 2011, ACTA BIOMATER, V7, P3446, DOI 10.1016/j.actbio.2011.05.028; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634; Rahmani P, 2009, CAN MED ASSOC J, V181, P815, DOI 10.1503/cmaj.080709; Rankovic D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/33/335202; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Robling AG, 2002, MED SCI SPORT EXER, V34, P196, DOI 10.1097/00005768-200202000-00003; Rubin C, 2002, J BONE MINER RES, V17, P349, DOI 10.1359/jbmr.2002.17.2.349; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Rubin CT, 2001, DRUG DISCOV TODAY, V6, P848, DOI 10.1016/S1359-6446(01)01872-4; Ruff C, 1999, 1 BIENN SPAC BIOM IN, V1, P86; Ruimerman R, 2001, COMPUT METHOD BIOMEC, V4, P433; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Sun LW, 2009, ACTA BIOMATER, V5, P3506, DOI 10.1016/j.actbio.2009.04.042; Tezval M, 2011, CALCIFIED TISSUE INT, V88, P33, DOI 10.1007/s00223-010-9423-7; Thurner J., 2007, MODERN RES ED TOPICS, P37; Thurner P. J., 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5746, P515, DOI 10.1117/12.595799; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; Yamauchi H, 2003, JPN J PHYS FIT SPORT, V52, P119, DOI 10.7600/jspfsm1949.52.1_119; Yang P, 2009, AVIAT SPACE ENVIR MD, V80, P88, DOI 10.3357/ASEM.2368.2009	58	26	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92312	10.1371/journal.pone.0092312	http://dx.doi.org/10.1371/journal.pone.0092312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637608	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100139
J	Kampf, C; Mardinoglu, A; Fagerberg, L; Hallstrom, BM; Edlund, K; Lundberg, E; Ponten, F; Nielsen, J; Uhlen, M				Kampf, Caroline; Mardinoglu, Adil; Fagerberg, Linn; Hallstrom, Bjorn M.; Edlund, Karolina; Lundberg, Emma; Ponten, Fredrik; Nielsen, Jens; Uhlen, Mathias			The human liver-specific proteome defined by transcriptomics and antibody-based profiling	FASEB JOURNAL			English	Article						immunohistochemistry; RNA sequencing; metabolism	GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; RNA-SEQ; METABOLISM; SERUM; INTEGRATION; DISEASES; DRUGS	Human liver physiology and the genetic etiology of the liver diseases can potentially be elucidated through the identification of proteins with enriched expression in the liver. Here, we combined data from RNA sequencing (RNA-Seq) and antibody-based immunohistochemistry across all major human tissues to explore the human liver proteome with enriched expression, as well as the cell type-enriched expression in hepatocyte and bile duct cells. We identified in total 477 protein-coding genes with elevated expression in the liver: 179 genes have higher expression as compared to all the other analyzed tissues; 164 genes have elevated transcript levels in the liver shared with at least one other tissue type; and an additional 134 genes have a mild level of increased expression in the liver. We identified the precise localization of these proteins through antibody-based protein profiling and the subcellular localization of these proteins through immunofluorescent-based profiling. We also identified the biological processes and metabolic functions associated with these proteins, investigated their contribution in the occurrence of liver diseases, and identified potential targets for their treatment. Our study demonstrates the use of RNA-Seq and antibody-based immunohistochemistry for characterizing the human liver proteome, as well as the use of tissue-specific proteins in identification of novel drug targets and discovery of biomarkers.	[Kampf, Caroline; Edlund, Karolina; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Mardinoglu, Adil; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Fagerberg, Linn; Hallstrom, Bjorn M.; Lundberg, Emma; Nielsen, Jens] Royal Inst Technol KTH, Sci Life Lab, SE-17121 Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol KTH, Dept Prote, Sch Biotechnol, SE-17121 Stockholm, Sweden	Uppsala University; Chalmers University of Technology; Royal Institute of Technology; Royal Institute of Technology	Uhlen, M (corresponding author), Royal Inst Technol KTH, AlbaNova Univ Ctr, SE-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021; Mardinoglu, Adil/AAS-6360-2021; Lundberg, Emma S K/F-3891-2010; Nielsen, Jens/Q-1347-2017	Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137; Nielsen, Jens/0000-0002-9955-6003; Kaller Lundberg, Emma/0000-0001-7034-0850	Knut and Alice Wallenberg Foundation; Chalmers Foundation; European Directorate [HEALTH-F4-2008-201648/PROSPECTS]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation; European Directorate	Funding was provided by the Knut and Alice Wallenberg Foundation, Chalmers Foundation and PROSPECTS, a 7th Framework grant by the European Directorate (grant agreement HEALTH-F4-2008-201648/PROSPECTS). Pathologists and staff at the Department of Clinical Pathology, Uppsala University Hospital, are greatly acknowledged for providing the tissues used in the study; in particular, the authors thank Simin Tahmasebpoor for excellent help with preparing frozen tissues for RNA extraction. The authors also thank the staff of the Human Protein Atlas project in both Sweden and India for their efforts generating the Human Protein Atlas. The authors declare no conflicts of interest. Author contributions: M. U. conceived the study; J.N. supervised the data analysis; C. K. performed the protein analysis; A. M. performed the statistical analysis of metabolic genes; E. L. contributed to the subcellular analysis; L. F. and B. M. H. performed analysis of the RNA-Seq data and statistical analysis; F. P. provided the biopsies and material for RNA-Seq; K. E. prepared the RNA samples; A. M., C. K., J.N., and M. U. wrote the manuscript. Ancillary Data pertaining to this study (8 Microsoft Excel spreadsheets) can be accessed at the authors' website (http://www.metabolicatlas.org/livertissue).	Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bell LN, 2010, HEPATOLOGY, V51, P111, DOI 10.1002/hep.23271; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fagerberg L, 2013, J PROTEOME RES, V12, P2439, DOI 10.1021/pr300924j; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; HABER B, 1995, HEPATOLOGY, V22, P906, DOI 10.1016/0270-9139(95)90314-3; HAUSSINGER D, 1985, J HEPATOL, V1, P3, DOI 10.1016/S0168-8278(85)80063-5; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang QC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026168; KABADI UM, 1985, GASTROENTEROLOGY, V88, P750, DOI 10.1016/0016-5085(85)90146-5; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kampf C., 2004, CLIN PROTEOM, V1, P285, DOI DOI 10.1385/CP:1:3-4:285; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Lake AD, 2011, DRUG METAB DISPOS, V39, P1954, DOI 10.1124/dmd.111.040592; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Lundberg E, 2010, PROTEOMICS, V10, P3984, DOI 10.1002/pmic.201000125; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Mardinoglu A, 2013, BIOTECHNOL J, V8, P985, DOI 10.1002/biot.201200275; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Prie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066182; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Sekine S, 2011, CANCER SCI, V102, P1742, DOI 10.1111/j.1349-7006.2011.01990.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Teng SL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S10; Tortora G, 2012, PRINCIPLES ANATOMY P, V13th; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tung EKK, 2011, LIVER INT, V31, P1494, DOI 10.1111/j.1478-3231.2011.02597.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Yang XQ, 2011, PHYSIOL GENOMICS, V43, P457, DOI 10.1152/physiolgenomics.00178.2010; Yilmaz Y, 2010, ANN CLIN BIOCHEM, V47, P549, DOI 10.1258/acb.2010.010169; Zekri ARN, 2012, ASIAN PAC J CANCER P, V13, P5433, DOI 10.7314/APJCP.2012.13.11.5433	51	57	59	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2901	2914		10.1096/fj.14-250555	http://dx.doi.org/10.1096/fj.14-250555			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24648543				2022-12-25	WOS:000337949400015
J	Cragle, C; MacNicol, AM				Cragle, Chad; MacNicol, Angus M.			Musashi Protein-directed Translational Activation of Target mRNAs Is Mediated by the Poly( A) Polymerase, Germ Line Development Defective-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Oocyte; Polyadenylation; RNA-binding Protein; Translation Control; Xenopus	XENOPUS OOCYTE MATURATION; CYTOPLASMIC POLYADENYLATION ELEMENTS; FATE DETERMINANT MUSASHI; BINDING-PROTEIN; CELL-CYCLE; MEIOTIC MATURATION; C-MOS; CAENORHABDITIS-ELEGANS; MYELOID-LEUKEMIA; TEMPORAL CONTROL	Background: Although Musashi mediates target mRNA polyadenylation, the underlying molecular mechanism has not been elucidated. Results: Germ line development defective-2, a poly(A) polymerase, associates with Musashi and is necessary and sufficient for Musashi-directed polyadenylation. Conclusion: Germ line development defective-2 mediates Musashi-dependent mRNA translation. Significance: Germ line development defective-2 couples Musashi to polyadenylation and translational activation of target mRNAs. The mRNA-binding protein, Musashi, has been shown to regulate translation of select mRNAs and to control cellular identity in both stem cells and cancer cells. Within the mammalian cells, Musashi has traditionally been characterized as a repressor of translation. However, we have demonstrated that Musashi is an activator of translation in progesterone-stimulated oocytes of the frog Xenopus laevis, and recent evidence has revealed Musashi's capability to function as an activator of translation in mammalian systems. The molecular mechanism by which Musashi directs activation of target mRNAs has not been elucidated. Here, we report a specific association of Musashi with the noncanonical poly(A) polymerase germ line development defective-2 (GLD2) and map the association domain to 31 amino acids within the C-terminal domain of Musashi. We show that loss of GLD2 interaction through deletion of the binding domain or treatment with antisense oligonucleotides compromises Musashi function. Additionally, we demonstrate that overexpression of both Musashi and GLD2 significantly enhances Musashi function. Finally, we report a similar co-association also occurs between murine Musashi and GLD2 orthologs, suggesting that coupling of Musashi to the polyadenylation apparatus is a conserved mechanism to promote target mRNA translation.	[Cragle, Chad] Univ Arkansas Med Sci, Little Rock, AR USA; [Cragle, Chad; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Genet, Little Rock, AR USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	MacNicol, AM (corresponding author), Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 W Markham, Little Rock, AR 72205 USA.	Angus@UAMS.edu			National Institutes of Health [RO1 HD35688]; NCRR [UL1TR000039, KL2TR000063]; Arkansas Breast Cancer Research Program; Sturgis Charitable Trust; University of Arkansas for Medical Sciences College of Medicine Research Council; University of Arkansas for Medical Sciences Translational Research Institute; Arkansas BioSciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000063, UL1TR000039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Arkansas Breast Cancer Research Program; Sturgis Charitable Trust; University of Arkansas for Medical Sciences College of Medicine Research Council; University of Arkansas for Medical Sciences Translational Research Institute; Arkansas BioSciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HD35688 and Grants UL1TR000039 and KL2TR000063 from NCRR. This work was also supported by the Arkansas Breast Cancer Research Program, the Sturgis Charitable Trust, intramural funding support from the University of Arkansas for Medical Sciences College of Medicine Research Council, the University of Arkansas for Medical Sciences Translational Research Institute and the Arkansas BioSciences Institute.	Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2012, J BIOL CHEM, V287, P10639, DOI 10.1074/jbc.M111.300681; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Charlesworth A, 2013, WIRES RNA, V4, P437, DOI 10.1002/wrna.1171; Cosson B, 2002, BIOL CELL, V94, P217, DOI 10.1016/S0248-4900(02)01195-4; Cragle C. E., 2014, XENOPUS DEV; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; DWORKIN MB, 1985, P NATL ACAD SCI USA, V82, P7636, DOI 10.1073/pnas.82.22.7636; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; FREEMAN RS, 1991, MOL CELL BIOL, V11, P1713, DOI 10.1128/MCB.11.3.1713; GOOD PJ, 1993, NUCLEIC ACIDS RES, V21, P999, DOI 10.1093/nar/21.4.999; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Howard EL, 1999, MOL CELL BIOL, V19, P1990; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; MacNicol MC, 1997, GENE, V196, P25, DOI 10.1016/S0378-1119(97)00171-6; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Murakami MS, 1998, DEVELOPMENT, V125, P237; Nakajo N, 2000, GENE DEV, V14, P328; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; ROSENTHAL ET, 1983, J MOL BIOL, V166, P309, DOI 10.1016/S0022-2836(83)80087-4; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SHEETS MD, 1995, NATURE, V374, P511, DOI 10.1038/374511a0; Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103; Szostak E, 2013, BRIEF FUNCT GENOMICS, V12, P58, DOI 10.1093/bfgp/els056; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Voeltz GK, 2001, GENE DEV, V15, P774, DOI 10.1101/gad.872201; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039	56	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14239	14251		10.1074/jbc.M114.548271	http://dx.doi.org/10.1074/jbc.M114.548271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24644291	hybrid, Green Published			2022-12-25	WOS:000335984600049
J	Chyu, KY; Lio, WM; Dimayuga, PC; Zhou, JC; Zhao, XN; Yano, J; Trinidad, P; Honjo, T; Cercek, B; Shah, PK				Chyu, Kuang-Yuh; Lio, Wai Man; Dimayuga, Paul C.; Zhou, Jianchang; Zhao, Xiaoning; Yano, Juliana; Trinidad, Portia; Honjo, Tomoyuki; Cercek, Bojan; Shah, Prediman K.			Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro	PLOS ONE			English	Article							INCREASES COLLAGEN CONTENT; LOW-DENSITY LIPOPROTEINS; HYPERCHOLESTEROLEMIA LEADS; ATHEROSCLEROTIC LESIONS; PROLIFERATION; RESPONSES; DIET; STATINS; PLAQUES; LDL	Background: The lipid milleu exacerbates the inflammatory response in atherosclerosis but its effect on T cell mediated immune response has not been fully elucidated. We hypothesized that lipid lowering would modulate T cell mediated immune function. Methods and Results: T cells isolated from human PBMC or splenic T cells from apoE-/- mouse had higher proliferative response to T cell receptor (TCR) ligation in medium supplemented with 10% fetal bovine serum (FBS) compared to medium with 10% delipidated FBS. The differences in proliferation were associated with changes in lipid rafts, cellular cholesterol content, IL-10 secretion and subsequent activation of signaling molecule activated by TCR ligation. Immune biomarkers were also assessed in vivo using male apoE-/- mice fed atherogenic diet (AD) starting at 7 weeks of age. At 25 weeks of age, a sub-group was switched to normal diet (ND) whereas the rest remained on AD until euthanasia at 29 weeks of age. Dietary change resulted in a lower circulating level of cholesterol, reduced plaque size and inflammatory phenotype of plaques. These changes were associated with reduced intracellular IL-10 and IL-12 expression in CD4(+) and CD8(+) T cells. Conclusion: Our results show that lipid lowering reduces T cell proliferation and function, supporting the notion that lipid lowering modulates T cell function in vivo and in vitro.	[Chyu, Kuang-Yuh; Lio, Wai Man; Dimayuga, Paul C.; Zhou, Jianchang; Zhao, Xiaoning; Yano, Juliana; Trinidad, Portia; Honjo, Tomoyuki; Cercek, Bojan; Shah, Prediman K.] Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Chyu, KY (corresponding author), Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Chyuk@cshs.org			Heart Foundation; Spielberg Cardiovascular Research Fund; Skirball Foundation	Heart Foundation; Spielberg Cardiovascular Research Fund; Skirball Foundation	This study is supported by the Heart Foundation, the Spielberg Cardiovascular Research Fund and the Skirball Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 1998, CIRC RES, V83, P1015, DOI 10.1161/01.RES.83.10.1015; Aikawa M, 1999, CIRCULATION, V100, P1215, DOI 10.1161/01.CIR.100.11.1215; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; CARUZZO C, 1995, ANGIOLOGY, V46, P269, DOI 10.1177/000331979504600401; Chyu KY, 2004, ATHEROSCLEROSIS, V176, P27, DOI 10.1016/j.atherosclerosis.2004.04.016; Cipollone F, 2003, CIRCULATION, V107, P1479, DOI 10.1161/01.CIR.0000056530.03783.81; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; CUTHBERT JA, 1984, P NATL ACAD SCI-BIOL, V81, P4539, DOI 10.1073/pnas.81.14.4539; CUTHBERT JA, 1986, J BIOL CHEM, V261, P3620; CUTHBERT JA, 1987, J BIOL CHEM, V262, P7808; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3; Gotto AM, 2001, CURR OPIN LIPIDOL, V12, P391, DOI 10.1097/00041433-200108000-00004; Graham LS, 2010, J BONE MINER RES, V25, P2460, DOI 10.1002/jbmr.148; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Mays ME, 2008, CURR ATHEROSCLER REP, V10, P45, DOI 10.1007/s11883-008-0008-0; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Pasterkamp G, 2010, EXPERT REV CARDIOVAS, V8, P1235, DOI 10.1586/ERC.10.107; Robertson AKL, 2004, SCAND J IMMUNOL, V59, P285, DOI 10.1111/j.0300-9475.2004.01403.x; Surls J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038733; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Zhao XQ, 2001, ARTERIOSCL THROM VAS, V21, P1623, DOI 10.1161/hq1001.098463; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 2009, ATHEROSCLEROSIS, V204, P381, DOI 10.1016/j.atherosclerosis.2008.10.017	30	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92095	10.1371/journal.pone.0092095	http://dx.doi.org/10.1371/journal.pone.0092095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647529	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500083
J	Grimaldi-Bensouda, L; Begaud, B; Rossignol, M; Avouac, B; Lert, F; Rouillon, F; Benichou, J; Massol, J; Duru, G; Magnier, AM; Abenhaim, L; Guillemot, D				Grimaldi-Bensouda, Lamiae; Begaud, Bernard; Rossignol, Michel; Avouac, Bernard; Lert, France; Rouillon, Frederic; Benichou, Jacques; Massol, Jacques; Duru, Gerard; Magnier, Anne-Marie; Abenhaim, Lucien; Guillemot, Didier			Management of Upper Respiratory Tract Infections by Different Medical Practices, Including Homeopathy, and Consumption of Antibiotics in Primary Care: The EPI3 Cohort Study in France 2007-2008	PLOS ONE			English	Article							CONSULTATION RATES	Background: Prescribing of antibiotics for upper respiratory tract infections (URTI) varies substantially in primary care. Objectives: To describe and compare antibiotic and antipyretic/anti-inflammatory drugs use, URTI symptoms' resolution and occurrence of potentially-associated infections in patients seeking care from general practitioners (GPs) who exclusively prescribe conventional medications (GP-CM), regularly prescribe homeopathy within a mixed practice (GP-Mx), or are certified homeopathic GPs (GP-Ho). Method: The EPI3 survey was a nationwide population-based study of a representative sample of 825 GPs and their patients in France (2007-2008). GP recruitment was stratified by self-declared homeopathic prescribing preferences. Adults and children with confirmed URTI were asked to participate in a standardized telephone interview at inclusion, one-, three- and twelve-month follow up. Study outcomes included medication consumption, URTI symptoms' resolution and potentially-associated infections (sinusitis or otitis media/externa) as reported by patients. Analyses included calibration to account for non-respondents and groups were compared using multivate analyses adjusting for baseline differences with a propensity score. Results: 518 adults and children with URTI (79.3% rhinopharyngitis) were included (36.9% response rate comparable between groups). As opposed to GP-CM patients, patients in the GP-Ho group showed significantly lower consumption of antibiotics (Odds ratio (OR) = 0.43, 95% confidence interval (CI): 0.27-0.68) and antipyretic/anti-inflammatory drugs (OR = 0.54, 95% CI: 0.38-0.76) with similar evolution in related symptoms (OR = 1.16, 95% CI: 0.64-2.10). An excess of potentially-associated infections (OR = 1.70, 95% CI: 0.90-3.20) was observed in the GP-Ho group (not statistically significant). No difference was found between GP-CM and GP-Mx patients. Conclusion: Patients who chose to consult GPs certified in homeopathy used less antibiotics and antipyretic/antiinflammatory drugs for URTI than those seen by GPs prescribing conventional medications. No difference was observed in patients consulting GPs within mixed-practice. A non-statistically significant excess was estimated through modelling for associated infections in the GP-Ho group and needs to be further studied.	[Grimaldi-Bensouda, Lamiae; Avouac, Bernard] LA SER, Paris, France; [Grimaldi-Bensouda, Lamiae] Inst Pasteur, Pharmacoepidemiol & Infect Dis Res Grp, Paris, France; [Begaud, Bernard] Univ Bordeaux Segalen, INSERM, U657, Bordeaux, France; [Rossignol, Michel] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Rossignol, Michel] LA SER Ctr Risk Res, Montreal, PQ, Canada; [Lert, France] INSERM, Ctr Epidemiol & Populat Hlth, U1018, Villejuif, France; [Rouillon, Frederic] Univ Paris 05, St Anne Hosp, Paris, France; [Benichou, Jacques] Univ Bordeaux 2, Dept Pharmacol, INSERM, Tondu Hosp Case 41,U657, F-33076 Bordeaux, France; [Benichou, Jacques] Univ Hosp Rouen, Dept Biostat, Rouen, France; [Massol, Jacques] Univ Franche Comte, Fac Med, F-25030 Besancon, France; [Duru, Gerard] Cyklad Grp, Rillieux La Pape, France; [Magnier, Anne-Marie] Univ Paris 06, Fac Med, Paris, France; [Abenhaim, Lucien] Univ London London Sch Hyg & Trop Med, Dept Epidemiol, London WC1E 7HT, England; [Abenhaim, Lucien] LA SER Europe Ltd, London, England; [Guillemot, Didier] Inst Pasteur, Paris, France; [Guillemot, Didier] Univ Paris Ile France Ouest, Fac Med, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU de Rouen; Universite de Franche-Comte; CHU Besancon; UDICE-French Research Universities; Sorbonne Universite; University of London; London School of Hygiene & Tropical Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Grimaldi-Bensouda, L (corresponding author), LA SER, Paris, France.	Lamiae.grimaldi@la-ser.com	Guillemot, Didier/AAN-3051-2020	Guillemot, Didier/0000-0002-8497-1765; Grimaldi-Bensouda, Lamiae/0000-0003-1952-5467	Laboratoires Boiron, France	Laboratoires Boiron, France	This study was funded by Laboratoires Boiron, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunc U, 2007, MAYO CLIN PROC, V82, P69; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Chahwakilian P, 2011, J ANTIMICROB CHEMOTH, V66, P2872, DOI 10.1093/jac/dkr387; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Davey Peter, 2010, Expert Rev Clin Pharmacol, V3, P667, DOI 10.1586/ecp.10.46; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; DEVILLE JC, 1992, J AM STAT ASSOC, V87, P376, DOI 10.2307/2290268; Dommergues MA, 2012, SCAND J INFECT DIS, V44, P495, DOI 10.3109/00365548.2012.669840; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P423, DOI 10.1093/jac/dkl183; Filipetto Frank A, 2008, Patient Prefer Adherence, V2, P35; Grimaldi-Bensouda L, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000215; Grimaldi-Bensouda L, 2012, PHARMACOEPIDEM DR S, V21, P753, DOI 10.1002/pds.3194; Haidvogl Max, 2007, BMC Complement Altern Med, V7, P7, DOI 10.1186/1472-6882-7-7; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Jain Asha, 2003, Homeopathy, V92, P71, DOI 10.1016/S1475-4916(03)00004-3; Kirkby R, 2010, HOMEOPATHY, V99, P69, DOI 10.1016/j.homp.2009.09.001; Kooreman P, 2012, EUR J HEALTH ECON, V13, P769, DOI 10.1007/s10198-011-0330-2; Labarthe G., 2004, DREES ETUDES RESULTA, V315, P1; Lamiae GB, 2010, PHARMACOEPIDEM DR S, V19, P591, DOI 10.1002/pds.1952; Pulcini C, 2013, EUR J PUBLIC HEALTH, V23, P262, DOI 10.1093/eurpub/cks100; Rossi E, 2009, HOMEOPATHY, V98, P2, DOI 10.1016/j.homp.2008.11.005; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4; Trichard M, 2005, Homeopathy, V94, P3, DOI 10.1016/j.homp.2004.11.021; Vincent S, 2013, J ALTERN COMPLEM MED, V19, P146, DOI 10.1089/acm.2011.0706; Welschen I, 2004, FAM PRACT, V21, P234, DOI 10.1093/fampra/cmh303; Williams-Piehota PA, 2011, ALTERN THER HEALTH M, V17, P22; World Health Organization, 1977, STAT CLASS DIS CAUS	27	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89990	10.1371/journal.pone.0089990	http://dx.doi.org/10.1371/journal.pone.0089990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646513	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500011
J	de Oliveira, MPA; Ferreira, RL				Alves de Oliveira, Marcus Paulo; Ferreira, Rodrigo Lopes			Aspects of the Behavior and Activity Rhythms of Rowlandius potiguar (Schizomida: Hubbardiidae)	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; ARACHNIDA; PATTERNS	Although organisms of the order Schizomida are not widely distributed in caves throughout the world, they can, eventually, be abundant in certain regions, becoming a major faunal element in some caves. The majority of works on this order includes species descriptions, with rare references to behavioral aspects. As such, the present study describes the behavioral repertoire, and the activity and feeding periods of Rowlandius potiguar (Schizomida: Hubbardiidae) in the laboratory. The specimens were maintained in a terrarium, in an aphotic room, with temperature and humidity levels similar to the cave of origin. We used the focal-animal and ad libitum methods to describe behavior with qualitative and quantitative evaluations of behavioral acts. We witnessed nineteen behavioral acts, which is considered representative for observations in captivity. Two activity periods were observed: between 10 a. m. and 4 p. m. and between 10 p. m. and 4 a. m., characterizing an ultradian rhythm. In adaptive terms, this condition may be important for population maintenance in oligotrophic environments such as caverns. Necrophagy and cannibalism were also registered and could have been selected in the subterranean environment due to oligotrophy. The observation of rare and unprecedented behavior in this group, as well as the presence of rhythmicity in activity patterns, contribute to a better understanding of the ecological aspects of the species of this still little known Order.	[Alves de Oliveira, Marcus Paulo; Ferreira, Rodrigo Lopes] Univ Fed Lavras, Dept Biol Setor Zool, Lab Ecol Subterranea, Lavras, Brazil	Universidade Federal de Lavras	de Oliveira, MPA (corresponding author), Univ Fed Lavras, Dept Biol Setor Zool, Lab Ecol Subterranea, Lavras, Brazil.	marcuspbr@gmail.com	Ferreira, RL/L-8419-2014	Ferreira, RL/0000-0003-3288-4405	Conselho Nacional de Pesquisa (CNPq) [477712/2006-1]	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Conselho Nacional de Pesquisa (CNPq), process No. 477712/2006-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adis J, 1999, J ARACHNOL, V27, P205; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Armas LF, 2004, ESPECIAL MONOGRAFICO, V2, P3; Ayres M., 2007, BIOESTAT 5 0 APL EST; BECK L, 1968, Amazoniana, V1, P247; Bonaldo A, 2007, REV BRAS ZOOL, V24, P323, DOI 10.1590/S0101-81752007000200009; Cokendolpher JC, 2000, AMAZONIANA, V16, P187; Culver DC, 1982, CAVE LIFE EVOLUTION; EICKSTEDT VRD, 1994, VENENOS ANIMAIS VISA, P151; Elpino-Campos Abner, 2001, Bulletin of the British Arachnological Society, V12, P144; Ferreira R.L., 2010, REV BRASILEIRA ESPEL, V1, P25; Gerkema M, 1985, EXP BRAIN RES S, V12, P321, DOI DOI 10.1007/978-3-642-70483-3; HAMILTON WD, 1978, DIVERSITY INSECT FAU, P154; Harvey MS, 2007, ZOOTAXA, P363; Hoenen S, 2005, EUR J ENTOMOL, V102, P663, DOI 10.14411/eje.2005.094; Hoenen S, 1999, J ARACHNOL, V27, P159; HUMPHREYS WF, 1989, J ZOOL, V217, P177, DOI 10.1111/j.1469-7998.1989.tb02481.x; Idema - Instituto de Desenvolvimento Sustentavel e Meio Ambiente do Rio Grande do Norte, 2008, PERF MUN FELIP GUERR; KRAUS O, 1967, Senckenbergiana Biologica, V48, P401; LAMPRECHT G, 1986, NSS B, V47, P147; Lehner PN, 1996, HDB ETHOLOGICAL METH; Marques N, 1997, CRONOBIOLOGIA; Martin P., 2007, MEASURING BEHAV INTR, V3; Medeiros WE, 2001, RELATORIO TECNICO; Mineo Marina Farcic, 2003, Revista Brasileira de Zoociencias, V5, P23; ORTEGA J, 1992, J INTERDISCIPL CYCLE, V23, P295, DOI 10.1080/09291019209360188; PAGE TL, 1980, PHYSIOL ENTOMOL, V5, P271, DOI 10.1111/j.1365-3032.1980.tb00235.x; Page TL, 1985, COMPREHENSIVE INSECT, P577; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; R Development Core Team, 2012, R LANG ENV STAT COMP; Reddell J.R., 2002, P387; Reddell James R., 1995, Texas Memorial Museum Speleological Monograph, V4, P1; ROWLAND J M, 1972, Entomological News, V83, P69; Sandidge JS, 2003, NATURE, V426, P30, DOI 10.1038/426030a; Santoro AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065813, 10.1371/journal.pone.0066932]; Santos AJ, 2008, ZOOTAXA, P53; Saunders DS, 1982, INSECT CLOCKS; STURM H, 1973, Zeitschrift fuer Tierpsychologie, V33, P113; Tizo-Pedroso E, 2011, ETHOLOGY, V117, P498, DOI 10.1111/j.1439-0310.2011.01906.x; Tourinho Ana Lucia M., 1999, Boletim do Museu Nacional Rio de Janeiro Zoologia, V405, P1; TRAJANO E, 1995, BIOL RHYTHM RES, V26, P341, DOI 10.1080/09291019509360347	41	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91913	10.1371/journal.pone.0091913	http://dx.doi.org/10.1371/journal.pone.0091913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643024	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900045
J	Bishi, DK; Mathapati, S; Cherian, KM; Guhathakurta, S; Verma, RS				Bishi, Dillip Kumar; Mathapati, Santosh; Cherian, Kotturathu Mammen; Guhathakurta, Soma; Verma, Rama Shanker			In Vitro Hepatic Trans-Differentiation of Human Mesenchymal Stem Cells Using Sera from Congestive/Ischemic Liver during Cardiac Failure	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BONE-MARROW; HEART-FAILURE; CULTURE-SYSTEM; TRANSPLANTATION; PROLIFERATION; DYSFUNCTION; EXPRESSION; CHALLENGES; BILIRUBIN	Cellular therapy for end-stage liver failures using human mesenchymal stem cells (hMSCs)-derived hepatocytes is a potential alternative to liver transplantation. Hepatic trans-differentiation of hMSCs is routinely accomplished by induction with commercially available recombinant growth factors, which is of limited clinical applications. In the present study, we have evaluated the potential of sera from cardiac-failure-associated congestive/ischemic liver patients for hepatic trans-differentiation of hMSCs. Results from such experiments were confirmed through morphological changes and expression of hepatocyte-specific markers at molecular and cellular level. Furthermore, the process of mesenchymal-to-epithelial transition during hepatic trans-differentiation of hMSCs was confirmed by elevated expression of E-Cadherin and downregulation of Snail. The functionality of hMSCs-derived hepatocytes was validated by various liver function tests such as albumin synthesis, urea release, glycogen accumulation and presence of a drug inducible cytochrome P450 system. Based on these findings, we conclude that sera from congestive/ischemic liver during cardiac failure support a liver specific microenvironment for effective hepatic trans-differentiation of hMSCs in vitro.	[Bishi, Dillip Kumar; Mathapati, Santosh; Verma, Rama Shanker] Indian Inst Technol, Dept Biotechnol, Stem Cells & Mol Biol Lab, Madras 600036, Tamil Nadu, India; [Bishi, Dillip Kumar; Mathapati, Santosh; Cherian, Kotturathu Mammen] Frontier Lifeline, Stem Cells & Tissue Engn Lab, Int Ctr Cardiothorac & Vasc Dis, Madras, Tamil Nadu, India; [Guhathakurta, Soma] Indian Inst Technol, Dept Engn Design, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Guhathakurta, S (corresponding author), Indian Inst Technol, Dept Engn Design, Madras 600036, Tamil Nadu, India.	husun1971@gmail.com; vermars@iitm.ac.in	Mathapati, Santosh/O-9151-2017; BISHI, DILLIP KUMAR/N-9758-2014	Mathapati, Santosh/0000-0001-9448-6889; BISHI, DILLIP KUMAR/0000-0003-4025-979X; Verma, Rama/0000-0001-7287-7803				Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Asgari S, 2010, J HEPATOL, V53, P738, DOI 10.1016/j.jhep.2010.05.009; Avital L, 2001, BIOCHEM BIOPH RES CO, V288, P156; Cai YF, 2004, WORLD J GASTROENTERO, V10, P3308, DOI 10.3748/wjg.v10.i22.3308; Chang CY, 2007, ALIMENT PHARM THER, V25, P1135, DOI 10.1111/j.1365-2036.2007.03307.x; Czyz J, 2003, BIOL CHEM, V384, P1391, DOI 10.1515/BC.2003.155; Dalgetty DM, 2009, AM J PHYSIOL-GASTR L, V297, pG241, DOI 10.1152/ajpgi.00138.2009; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Gallegos-Orozco JF, 2009, MED CLIN N AM, V93, P931, DOI 10.1016/j.mcna.2009.03.010; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; JANES CH, 1995, J CLIN INVEST, V95, P2581, DOI 10.1172/JCI117959; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Lamblin N, 2005, AM HEART J, V150, P137, DOI 10.1016/j.ahj.2005.03.047; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li ZD, 2007, AM J PHYSIOL-GASTR L, V292, pG639, DOI 10.1152/ajpgi.00292.2006; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Maleki M, 2011, HEART ASIA, V3, P143, DOI 10.1136/heartasia-2011-010023; Matsumori A, 1996, BIOCHEM BIOPH RES CO, V221, P391, DOI 10.1006/bbrc.1996.0606; Min J, 2007, ACTA PHARMACOL SIN, V28, P1931, DOI 10.1111/j.1745-7254.2007.00715.x; Mohamadnejad M, 2007, ARCH IRAN MED, V10, P459; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura Y, 1996, HYPERTENSION, V28, P409, DOI 10.1161/01.HYP.28.3.409; Ochiya T, 2010, DIFFERENTIATION, V79, P65, DOI 10.1016/j.diff.2009.10.002; Ong SY, 2006, TISSUE ENG, V12, P3477, DOI 10.1089/ten.2006.12.3477; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Poelzl G, 2012, EUR J CLIN INVEST, V42, P153, DOI 10.1111/j.1365-2362.2011.02573.x; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rius C, 1998, BLOOD, V92, P4677; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Rychli K, 2011, HEART, V97, P1158, DOI 10.1136/hrt.2010.220228; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; SHERLOCK S, 1951, BRIT HEART J, V13, P273; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1002/hep.1840210119; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sivasubramaniyan K, 2008, REGEN MED, V3, P23, DOI 10.2217/17460751.3.1.23; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Snykers S, 2011, METHODS MOL BIOL, V698, P305, DOI 10.1007/978-1-60761-999-4_23; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; Szygula-Jurkiewicz Bozena, 2007, Pol Arch Med Wewn, V117, P227; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Ueno S, 2001, J CARD FAIL, V7, P329, DOI 10.1054/jcaf.2001.27686; Ueno S, 1997, INT HEPATOL COMMUN, V6, P294, DOI 10.1016/S0928-4346(97)00359-9; Van Deursen VM, 2010, J CARD FAIL, V16, P84, DOI 10.1016/j.cardfail.2009.08.002; Wang PP, 2004, BIOCHEM BIOPH RES CO, V320, P712, DOI 10.1016/j.bbrc.2004.05.213; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xu J, 2008, STEM CELLS DEV, V17, P143, DOI 10.1089/scd.2007.0094; Yamagamim H, 2002, CANCER, V95, P824, DOI 10.1002/cncr.10732; Yamazaki S, 2003, J HEPATOL, V39, P17, DOI 10.1016/S0168-8278(03)00150-8; Yang Y, 2009, J SURG RES, V155, P18, DOI 10.1016/j.jss.2009.01.006; Zhao QJ, 2009, BIOL CELL, V101, P557, DOI 10.1042/BC20080105; Zhao YS, 2010, TISSUE ENG PART C-ME, V16, P653, DOI 10.1089/ten.TEC.2009.0053; Zhu Y, 2000, HEART, V83, P450, DOI 10.1136/heart.83.4.450	57	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92397	10.1371/journal.pone.0092397	http://dx.doi.org/10.1371/journal.pone.0092397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642599	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900132
J	Cordero, JG; Juarez, ML; Gonzalez-Y-Merchand, JA; Barron, LC; Castaneda, BG				Garcia Cordero, Julio; Leon Juarez, Moises; Gonzalez-Y-Merchand, Jorge A.; Cedillo Barron, Leticia; Gutierrez Castaneda, Benito			Caveolin-1 in Lipid Rafts Interacts with Dengue Virus NS3 during Polyprotein Processing and Replication in HMEC-1 Cells	PLOS ONE			English	Article							RICH MEMBRANE MICRODOMAINS; NF-KAPPA-B; RNA REPLICATION; PROTEIN INTERACTIONS; MONOCLONAL-ANTIBODY; ANCHORED PROTEINS; IMMUNE-RESPONSE; CHOLESTEROL; ENTRY; FLAVIVIRUS	Lipid rafts are ordered microdomains within cellular membranes that are rich in cholesterol and sphingolipids. Caveolin (Cav-1) and flotillin (Flt-1) are markers of lipid rafts, which serve as an organizing center for biological phenomena and cellular signaling. Lipid rafts involvement in dengue virus (DENV) processing, replication, and assembly remains poorly characterized. Here, we investigated the role of lipid rafts after DENV endocytosis in human microvascular endothelial cells (HMEC-1). The non-structural viral proteins NS3 and NS2B, but not NS5, were associated with detergent-resistant membranes. In sucrose gradients, both NS3 and NS2B proteins appeared in Cav-1 and Flt-1 rich fractions. Additionally, double immunofluorescence staining of DENV-infected HMEC-1 cells showed that NS3 and NS2B, but not NS5, colocalized with Cav-1 and Flt-1. Furthermore, in HMEC-1cells transfected with NS3 protease, shown a strong overlap between NS3 and Cav-1, similar to that in DENV-infected cells. In contrast, double-stranded viral RNA (dsRNA) overlapped weakly with Cav-1 and Flt-1. Given these results, we investigated whether Cav-1 directly interacted with NS3. Cav-1 and NS3 co-immunoprecipitated, indicating that they resided within the same complex. Furthermore, when cellular cholesterol was depleted by methyl-beta cyclodextrin treatment after DENV entrance, lipid rafts were disrupted, NS3 protein level was reduced, besides Cav-1 and NS3 were displaced to fractions 9 and 10 in sucrose gradient analysis, and we observed a dramatically reduction of DENV particles release. These data demonstrate the essential role of caveolar cholesterol-rich lipid raft microdomains in DENV polyprotein processing and replication during the late stages of the DENV life cycle.	[Garcia Cordero, Julio; Leon Juarez, Moises; Cedillo Barron, Leticia] IPN, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City 07738, DF, Mexico; [Garcia Cordero, Julio; Gonzalez-Y-Merchand, Jorge A.] IPN, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City 07738, DF, Mexico; [Gutierrez Castaneda, Benito] Univ Autonoma Mexico, Fac Estudios Super, Lab Inmunol, Tlalnepantla Estado Mexi, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Barron, LC (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City 07738, DF, Mexico.	lcedillo@civestav.mx; benitogc@yahoo.com.mx	Juarez, Moises Leon/AAI-1958-2019	Leon Juarez, Moises/0000-0002-5726-5953	National Council for Science and Technology (CONACyT) [CB-2010-01/0154270]	National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council for Science and Technology (CONACyT) Grant CB-2010-01/0154270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; Garcia-Cordero J, 2005, HYBRIDOMA, V24, P160, DOI 10.1089/hyb.2005.24.160; Garcia-Cordero J, 2014, IMMUNOL INVEST, V43, P28, DOI 10.3109/08820139.2013.833622; Gayen S, 2012, BIOCHEM BIOPH RES CO, V423, P799, DOI 10.1016/j.bbrc.2012.06.043; Hailstones D, 1998, J LIPID RES, V39, P369; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Huang JH, 2007, J BIOL CHEM, V282, P6143, DOI 10.1074/jbc.M607701200; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lin SS, 2010, J VIROL, V84, P9487, DOI 10.1128/JVI.00763-10; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Metzner C, 2008, VIROLOGY, V382, P125, DOI 10.1016/j.virol.2008.09.014; Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0; Radyukhin V, 2008, ARCH VIROL, V153, P1977, DOI 10.1007/s00705-008-0214-7; Ravid D, 2010, J VIROL, V84, P9749, DOI 10.1128/JVI.01079-10; Reeves VL, 2012, ADV EXP MED BIOL, V729, P3, DOI 10.1007/978-1-4614-1222-9_1; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Simmons GE, 2012, VIROLOGY, V432, P110, DOI 10.1016/j.virol.2012.05.016; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7; Wang XM, 2011, J VIROL, V85, P5483, DOI 10.1128/JVI.00254-11; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007	45	29	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90704	10.1371/journal.pone.0090704	http://dx.doi.org/10.1371/journal.pone.0090704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643062	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900007
J	Juhasz, T; Matta, C; Katona, E; Somogyi, C; Takacs, R; Gergely, P; Csernoch, L; Panyi, G; Toth, G; Reglodi, D; Tamas, A; Zakany, R				Juhasz, Tamas; Matta, Csaba; Katona, Eva; Somogyi, Csilla; Takacs, Roland; Gergely, Pal; Csernoch, Laszlo; Panyi, Gyorgy; Toth, Gabor; Regloedi, Dora; Tamas, Andrea; Zakany, Roza			Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signalling Exerts Chondrogenesis Promoting and Protecting Effects: Implication of Calcineurin as a Downstream Target	PLOS ONE			English	Article							STRESS-INDUCED APOPTOSIS; INDUCED CELL-DEATH; HYDROGEN-PEROXIDE; CYCLIC-AMP; IN-VITRO; CARTILAGE DIFFERENTIATION; EXTRACELLULAR DOMAIN; CHICKEN PINEALOCYTES; CORTICAL-NEURONS; PROGENITOR CELLS	Pituitary adenylate cyclase activating polypeptide (PACAP) is an important neurotrophic factor influencing differentiation of neuronal elements and exerting protecting role during traumatic injuries or inflammatory processes of the central nervous system. Although increasing evidence is available on its presence and protecting function in various peripheral tissues, little is known about the role of PACAP in formation of skeletal components. To this end, we aimed to map elements of PACAP signalling in developing cartilage under physiological conditions and during oxidative stress. mRNAs of PACAP and its receptors (PAC1, VPAC1, VPAC2) were detectable during differentiation of chicken limb bud-derived chondrogenic cells in micromass cell cultures. Expression of PAC1 protein showed a peak on days of final commitment of chondrogenic cells. Administration of either the PAC1 receptor agonist PACAP 1-38, or PACAP 6-38 that is generally used as a PAC1 antagonist, augmented cartilage formation, stimulated cell proliferation and enhanced PAC1 and Sox9 protein expression. Both variants of PACAP elevated the protein expression and activity of the Ca-calmodulin dependent Ser/Thr protein phosphatase calcineurin. Application of PACAPs failed to rescue cartilage formation when the activity of calcineurin was pharmacologically inhibited with cyclosporine A. Moreover, exogenous PACAPs prevented diminishing of cartilage formation and decrease of calcineurin activity during oxidative stress. As an unexpected phenomenon, PACAP 6-38 elicited similar effects to those of PACAP 1-38, although to a different extent. On the basis of the above results, we propose calcineurin as a downstream target of PACAP signalling in differentiating chondrocytes either in normal or pathophysiological conditions. Our observations imply the therapeutical perspective that PACAP can be applied as a natural agent that may have protecting effect during joint inflammation and/or may promote cartilage regeneration during degenerative diseases of articular cartilage.	[Juhasz, Tamas; Matta, Csaba; Katona, Eva; Somogyi, Csilla; Takacs, Roland; Zakany, Roza] Univ Debrecen, Fac Med, Dept Anat Histol & Embryol, H-4012 Debrecen, Hungary; [Gergely, Pal] Univ Debrecen, Cell Biol & Signalling Res Grp, Hungarian Acad Sci, Dept Med Chem,Res Ctr Mol Med,Fac Med, H-4012 Debrecen, Hungary; [Csernoch, Laszlo] Univ Debrecen, Dept Physiol, Fac Med, H-4012 Debrecen, Hungary; [Panyi, Gyorgy] Univ Debrecen, Dept Biophys & Cell Biol, Fac Med, H-4012 Debrecen, Hungary; [Toth, Gabor] Univ Szeged, Fac Med, Dept Med Chem, Szeged, Hungary; [Regloedi, Dora; Tamas, Andrea] Univ Pecs, Sch Med, Dept Anat PTE MTA Lendulet PACAP Res Team, Pecs, Hungary	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; University of Debrecen; Szeged University; University of Pecs	Zakany, R (corresponding author), Univ Debrecen, Fac Med, Dept Anat Histol & Embryol, H-4012 Debrecen, Hungary.	roza@anat.med.unideb.hu	Panyi, Gyorgy/H-4406-2013; Matta, Csaba/C-7066-2017; Juhasz, Tamas/M-6878-2019; Gergely, Pál/A-5547-2008	Matta, Csaba/0000-0002-9678-7420; Juhasz, Tamas/0000-0003-0489-5676; Katona, Eva/0000-0002-8166-1438; Csernoch, Laszlo/0000-0002-2446-1456; Panyi, Gyorgy/0000-0001-6227-3301; Takacs, Roland Adam/0000-0002-1598-3922	Akira Arimura Foundation Research Grant; Hungarian Science Research Fund [OTKA CNK80709]; Bolyai Scholarship; Hungarian Ministry of Education [TAMOP 4.2.1.B-10/2/KONV-2010-002]; New Szechenyi Plan [TAMOP-4.2.2.A-11/1/KONV-2012-0025]; European Union; European Social Fund; Medical and Health Science Center, University of Debrecen, Hungary [DEOEC Mec-9/2011]; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]	Akira Arimura Foundation Research Grant; Hungarian Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Scholarship(Hungarian Academy of Sciences); Hungarian Ministry of Education; New Szechenyi Plan; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Medical and Health Science Center, University of Debrecen, Hungary; European Social Fund(European Social Fund (ESF))	This work was supported by grants from Akira Arimura Foundation Research Grant, the Hungarian Science Research Fund (OTKA CNK80709), Bolyai Scholarship and the Hungarian Ministry of Education (TAMOP 4.2.1.B-10/2/KONV-2010-002, PTE-MTA "Lendulet'') and from the New Szechenyi Plan (TAMOP-4.2.2.A-11/1/KONV-2012-0025; The project is co-financed by the European Union and the European Social Fund). C. M. is supported by a Mecenatura grant (DEOEC Mec-9/2011) from the Medical and Health Science Center, University of Debrecen, Hungary. Research activity of T.J. was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Bergstrom AL, 2003, EUR J NEUROSCI, V18, P2552, DOI 10.1046/j.1460-9568.2003.03000.x; Borzsei R, 2009, EUR J ENDOCRINOL, V160, P561, DOI 10.1530/EJE-08-0911; Brandl A, 2011, J ORTHOP RES, V29, P1114, DOI 10.1002/jor.21348; Cochaud S, 2010, NEUROPEPTIDES, V44, P373, DOI 10.1016/j.npep.2010.06.003; Cohen JR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-676; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Di Michele M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.007625; Fodor J, 2009, CELL CALCIUM, V45, P421, DOI 10.1016/j.ceca.2009.02.004; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Gourlet P, 1997, PEPTIDES, V18, P1539, DOI 10.1016/S0196-9781(97)00228-3; HADHAZY C, 1982, ACTA MORPHOL HUNG, V30, P65; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Holighaus Y, 2011, PEPTIDES, V32, P1647, DOI 10.1016/j.peptides.2011.06.004; Horvath G, 2011, J MOL NEUROSCI, V43, P67, DOI 10.1007/s12031-010-9428-8; Horvath G, 2010, NEUROSCI LETT, V484, P148, DOI 10.1016/j.neulet.2010.08.039; Horvath G, 2010, NEUROSCI LETT, V469, P70, DOI 10.1016/j.neulet.2009.11.046; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Jolivel V, 2009, NEUROSCIENCE, V160, P434, DOI 10.1016/j.neuroscience.2009.02.028; Jovanovic DV, 2002, J RHEUMATOL, V29, P2165; Juhasz T, 2010, CENT EUR J BIOL, V5, P572, DOI 10.2478/s11535-010-0053-x; Kano M, 2011, ANN ANAT, V193, P494, DOI 10.1016/j.aanat.2011.08.005; Khan AM, 2011, J INVEST MED, V59, P793, DOI 10.2310/JIM.0b013e31821452a2; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Kovacs CS, 1996, J ENDOCRINOL, V149, P287, DOI 10.1677/joe.0.1490287; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lacombe A, 2006, P NATL ACAD SCI USA, V103, P3793, DOI 10.1073/pnas.0505827103; Lam SY, 2012, ADV EXP MED BIOL, V758, P301, DOI 10.1007/978-94-007-4584-1_41; Lee VA, 2007, MOL CELLS, V24, P9; Masmoudi-Kouki O, 2011, J NEUROCHEM, V117, P403, DOI 10.1111/j.1471-4159.2011.07185.x; Matta C, 2008, CELL CALCIUM, V44, P310, DOI 10.1016/j.ceca.2007.12.010; Matta C, 2011, BIOCHIMIE, V93, P149, DOI 10.1016/j.biochi.2010.09.005; McIlvain HB, 2006, BRAIN RES, V1077, P16, DOI 10.1016/j.brainres.2005.12.130; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Moody TW, 2012, J MOL NEUROSCI, V46, P68, DOI 10.1007/s12031-011-9639-7; Nagata A, 2009, J CELL PHYSIOL, V221, P75, DOI 10.1002/jcp.21831; Nakamachi T, 2012, J MOL NEUROSCI, V48, P518, DOI 10.1007/s12031-012-9819-0; Nakamachi T, 2011, CURR PHARM DESIGN, V17, P973, DOI 10.2174/138161211795589346; Njaine B, 2010, EUR J NEUROSCI, V32, P311, DOI 10.1111/j.1460-9568.2010.07286.x; Payet MD, 2003, J BIOL CHEM, V278, P1663, DOI 10.1074/jbc.M206470200; Persson E, 2011, J CELL BIOCHEM, V112, P3732, DOI 10.1002/jcb.23304; Pirone A, 2011, ACTA HISTOCHEM, V113, P477, DOI 10.1016/j.acthis.2010.04.008; Racz B, 2007, GEN COMP ENDOCR, V153, P115, DOI 10.1016/j.ygcen.2006.12.006; Racz B, 2008, J MOL NEUROSCI, V36, P220, DOI 10.1007/s12031-008-9112-4; Reglodi D, 2010, J ENDOCRINOL INVEST, V33, P443, DOI 10.1007/BF03346621; Reglodi D, 2008, J MOL NEUROSCI, V36, P270, DOI 10.1007/s12031-008-9089-z; Reglodi D, 2012, NEUROPEPTIDES, V46, P61, DOI 10.1016/j.npep.2011.05.001; Reinhold MI, 2004, J BIOL CHEM, V279, P38209, DOI 10.1074/jbc.M404855200; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sanchez A, 2009, REGUL PEPTIDES, V152, P33, DOI 10.1016/j.regpep.2008.07.004; Sanchez A, 2008, NEUROSCI LETT, V448, P52, DOI 10.1016/j.neulet.2008.10.021; Sherwood NM, 2007, PEPTIDES, V28, P1680, DOI 10.1016/j.peptides.2007.03.008; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Shpakov A O, 2011, Zh Evol Biokhim Fiziol, V47, P40; St Hilaire RC, 2010, PEPTIDES, V31, P1517, DOI 10.1016/j.peptides.2010.04.024; StrangeVognsen HH, 1997, NEUROPEPTIDES, V31, P137, DOI 10.1016/S0143-4179(97)90082-2; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; TIKU ML, 1990, J IMMUNOL, V145, P690; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; Tomita M, 2002, J BIOL CHEM, V277, P42214, DOI 10.1074/jbc.C200504200; Tsuji G, 2006, FREE RADICAL BIO MED, V40, P1721, DOI 10.1016/j.freeradbiomed.2006.01.006; Ushiyama M, 2007, MOL PHARMACOL, V72, P103, DOI 10.1124/mol.107.035477; VANDERMEERS A, 1992, EUR J BIOCHEM, V208, P815, DOI 10.1111/j.1432-1033.1992.tb17252.x; Varga Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027957; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vincze A, 2011, INT J DEV NEUROSCI, V29, P923, DOI 10.1016/j.ijdevneu.2011.06.008; Walker CS, 2014, BRIT J PHARMACOL, V171, P1521, DOI 10.1111/bph.12541; Zakany R, 2005, EXP CELL RES, V305, P190, DOI 10.1016/j.yexcr.2004.12.016; Zakany R, 2002, EXP CELL RES, V275, P1, DOI 10.1006/excr.2002.5487; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5	75	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91541	10.1371/journal.pone.0091541	http://dx.doi.org/10.1371/journal.pone.0091541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643018	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900025
J	Kranz, K; Warnecke, A; Lenarz, T; Durisin, M; Scheper, V				Kranz, Katharina; Warnecke, Athanasia; Lenarz, Thomas; Durisin, Martin; Scheper, Verena			Phosphodiesterase Type 4 Inhibitor Rolipram Improves Survival of Spiral Ganglion Neurons In Vitro	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; INNER HAIR-CELLS; NEUROTROPHIC FACTOR; AXONAL REGENERATION; FUNCTIONAL RECOVERY; INDUCED APOPTOSIS; AUDITORY NEURONS; OPTIC-NERVE; CAMP; GROWTH	Sensorineural deafness is caused by damage of hair cells followed by degeneration of the spiral ganglion neurons and can be moderated by cochlear implants. However, the benefit of the cochlear implant depends on the excitability of the spiral ganglion neurons. Therefore, current research focuses on the identification of agents that will preserve their degeneration. In this project we investigated the neuroprotective effect of Rolipram as a promising agent to improve the viability of the auditory neurons. It is a pharmaceutical agent that acts by selective inhibition of the phosphodiesterase 4 leading to an increase in cyclic AMP. Different studies reported a neuroprotective effect of Rolipram. However, its significance for the survival of SGN has not been reported so far. Thus, we isolated spiral ganglion cells of neonatal rats for cultivation with different Rolipram concentrations and determined the neuronal survival rate. Furthermore, we examined immunocytologically distinct proteins that might be involved in the neuroprotective signalling pathway of Rolipram and determined endogenous BDNF by ELISA. When applied at a concentration of 0.1 nM, Rolipram improved the survival of SGN in vitro. According to previous studies, our immunocytological data showed that Rolipram application induces the phosphorylation and thereby activation of the transcription factor CREB. This activation can be mediated by the cAMP-PKA-signalling pathway as well as via ERK as a part of the MAP-kinase pathway. However, only in cultures pre-treated with BDNF, an endogenous increase of BDNF was detected. We conclude that Rolipram has the potential to improve the vitality of neonatal auditory nerve cells in vitro. Further investigations are necessary to prove the effect of Rolipram in vivo in the adult organism after lesion of the hair cells and insertion of cochlear implants.	[Kranz, Katharina; Warnecke, Athanasia; Lenarz, Thomas; Durisin, Martin; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793	cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all"; EC project	cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all"(German Research Foundation (DFG)); EC project	Work was supported by the cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all" and by the EC project NeuEar: Neurotrophic Cochlear Implant for Severe Hearing Loss. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletsee C, 2003, LARYNGOSCOPE, V113, P791, DOI 10.1097/00005537-200305000-00005; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bok J, 2003, J NEUROSCI, V23, P777; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Carreno FR, 2013, INT J NEUROPSYCHOPH, V8, P1; Costa LM, 2013, BEHAV BRAIN RES, V243, P66, DOI 10.1016/j.bbr.2012.12.056; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Drescher MJ, 2002, MOL BRAIN RES, V98, P1, DOI 10.1016/S0169-328X(01)00289-3; Flora G, 2012, CELL TRANSPLANT, V8, P8; Garcia-Hernandez S, 2013, BRAIN RES, V1529, P39, DOI 10.1016/j.brainres.2013.07.030; Gillespie LN, 2004, NEUROREPORT, V15, P1121, DOI 10.1097/00001756-200405190-00008; Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Gudasheva TA, 2013, DOKL BIOCHEM BIOPHYS, V451, P212, DOI 10.1134/S1607672913040121; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Hu ZQ, 2013, REGEN MED, V8, P309, DOI [10.2217/RME.13.32, 10.2217/rme.13.32]; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Incesulu A, 1998, ANN OTO RHINOL LARYN, V107, P906, DOI 10.1177/000348949810701102; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Kajana S, 2009, J SPINAL CORD MED, V32, P175, DOI 10.1080/10790268.2009.11760769; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189; Kraft P, 2013, EXP NEUROL, V247, P80, DOI 10.1016/j.expneurol.2013.03.026; Lee HT, 2004, ANN NEUROL, V56, P611, DOI 10.1002/ana.20259; Lin CH, 2005, EXP NEUROL, V194, P384, DOI 10.1016/j.expneurol.2005.02.016; Linthicum FH, 2009, OTOL NEUROTOL, V30, P418, DOI 10.1097/MAO.0b013e31819a8827; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Meyer H, 2012, INT J NANOMED, V7, P2449, DOI 10.2147/IJN.S29712; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Park JW, 2013, EUR J PHARMACOL, V706, P76, DOI 10.1016/j.ejphar.2013.02.049; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Reddy CS, 2005, HUM EXP TOXICOL, V24, P235, DOI 10.1191/0960327105ht514oa; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Song BN, 2009, ACTA OTO-LARYNGOL, V129, P142, DOI 10.1080/00016480802043949; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Sun XJ, 2012, EXP NEUROL, V237, P304, DOI 10.1016/j.expneurol.2012.07.011; Teixeira MM, 1997, TRENDS PHARMACOL SCI, V18, P164, DOI 10.1016/S0165-6147(97)90613-1; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Udina E, 2010, EXP NEUROL, V223, P143, DOI 10.1016/j.expneurol.2009.08.026; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Warnecke A, 2010, NEUROREPORT, V21, P517, DOI 10.1097/WNR.0b013e328339045b; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wirtz-Brugger F, 2000, NEUROSCIENCE, V99, P737, DOI 10.1016/S0306-4522(00)00243-8; Xu HX, 2012, ACTA OTO-LARYNGOL, V132, P482, DOI 10.3109/00016489.2011.647361; Xu NY, 2012, HEARING RES, V283, P33, DOI 10.1016/j.heares.2011.11.010; Yan Y, 2013, DEV NEUROBIOL, V73, P559, DOI 10.1002/dneu.22080; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010; Yao H, 2009, CELL DEATH DIFFER, V16, P1681, DOI 10.1038/cdd.2009.108; Yin Y, 2013, NEUROCHEM INT, V62, P903, DOI 10.1016/j.neuint.2013.03.005; Yossifoff M, 2008, EUR J NEUROSCI, V28, P2267, DOI 10.1111/j.1460-9568.2008.06532.x; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2; Zhai SQ, 2004, ACTA OTO-LARYNGOL, V124, P124, DOI 10.1080/00016480310015939; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	75	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92157	10.1371/journal.pone.0092157	http://dx.doi.org/10.1371/journal.pone.0092157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642701	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900096
J	Ogawa, N; Kawai, H; Terashima, T; Kojima, H; Oka, K; Chan, L; Maegawa, H				Ogawa, Nobuhiro; Kawai, Hiromichi; Terashima, Tomoya; Kojima, Hideto; Oka, Kazuhiro; Chan, Lawrence; Maegawa, Hiroshi			Gene Therapy for Neuropathic Pain by Silencing of TNF-alpha Expression with Lentiviral Vectors Targeting the Dorsal Root Ganglion in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SPINAL NERVE LIGATION; NEUTRALIZING ANTIBODIES; MECHANICAL HYPERALGESIA; DIABETIC-NEUROPATHY; SODIUM-CHANNELS; SENSORY NEURONS; IMMUNE-SYSTEM; UP-REGULATION; RAT	Neuropathic pain can be a debilitating condition. Many types of drugs that have been used to treat neuropathic pain have only limited efficacy. Recent studies indicate that pro-inflammatory mediators including tumor necrosis factor alpha (TNF-alpha) are involved in the pathogenesis of neuropathic pain. In the present study, we engineered a gene therapy strategy to relieve neuropathic pain by silencing TNF-alpha expression in the dorsal root ganglion (DRG) using lentiviral vectors expressing TNF short hairpin RNA1-4 (LV-TNF-shRNA1-4) in mice. First, based on its efficacy in silencing TNF-alpha in vitro, we selected shRNA3 to construct LV-TNF-shRNA3 for in vivo study. We used L5 spinal nerve transection (SNT) mice as a neuropathic pain model. These animals were found to display up-regulated mRNA expression of activating transcription factor 3 (ATF3) and neuropeptide Y (NPY), injury markers, and interleukin (IL)-6, an inflammatory cytokine in the ipsilateral L5 DRG. Injection of LV-TNF-shRNA3 onto the proximal transected site suppressed significantly the mRNA levels of ATF3, NPY and IL-6, reduced mechanical allodynia and neuronal cell death of DRG neurons. These results suggest that lentiviral-mediated silencing of TNF-alpha in DRG relieves neuropathic pain and reduces neuronal cell death, and may constitute a novel therapeutic option for neuropathic pain.	[Ogawa, Nobuhiro; Kawai, Hiromichi; Terashima, Tomoya; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Kojima, Hideto] Shiga Univ Med Sci, Dept Mol Genet Med, Otsu, Shiga 52021, Japan; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Shiga University of Medical Science; Shiga University of Medical Science; Baylor College of Medicine; Baylor College of Medicine	Terashima, T (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan.	tom@belle.shiga-med.ac.jp		Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science and Technology, Japan [23590378]; US National Institutes of Health [R01-HL051586]; Shiga University of Medical Science [1515503L, 1515503F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shiga University of Medical Science(Shiga University of Medical Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Grant-in-Aid (#23590378 to H. Kojima) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grants from the US National Institutes of Health (R01-HL051586 (to L. Chan), and the President's Discretionary Fund from Shiga University of Medical Science (no. 1515503L and no. 1515503F to H. Kojima). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade P, 2011, NEUROL SCI, V32, P757, DOI 10.1007/s10072-011-0599-z; Andre N, 2002, FEBS LETT, V532, P256, DOI 10.1016/S0014-5793(02)03691-8; Arruda JL, 1998, MOL BRAIN RES, V62, P228, DOI 10.1016/S0169-328X(98)00257-5; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blomer U, 1997, J VIROL, V71, P6641; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Camussi G, 1998, DRUGS, V55, P613, DOI 10.2165/00003495-199855050-00001; Caroyer JM, 2002, NEUROLOGY, V59, P1113, DOI 10.1212/WNL.59.7.1113; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Desmaris N, 2001, MOL THER, V4, P149, DOI 10.1006/mthe.2001.0431; Drory VE, 1998, J NEUROL SCI, V158, P1, DOI 10.1016/S0022-510X(98)00098-7; El Maarouf A, 2005, P NATL ACAD SCI USA, V102, P11516, DOI 10.1073/pnas.0504718102; Empl M, 2001, NEUROLOGY, V56, P1371, DOI 10.1212/WNL.56.10.1371; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016/S0304-3959(98)00111-0; Fukuoka T, 2012, PAIN, V153, P68, DOI 10.1016/j.pain.2011.09.009; Ghosh AK, 1999, BIOCHEM BIOPH RES CO, V264, P601, DOI 10.1006/bbrc.1999.1568; Glatzel W, 2000, P NATL ACAD SCI USA, V97, P442, DOI 10.1073/pnas.97.1.442; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; HANSSON PT, 2001, NEUROPATHIC PAIN PAT; Hao S, 2007, GENE THER, V14, P1010, DOI 10.1038/sj.gt.3302950; Homma Y, 2002, PAIN, V95, P239, DOI 10.1016/S0304-3959(01)00404-3; Hotta Y, 2003, DEV BRAIN RES, V143, P1, DOI 10.1016/S0165-3806(03)00035-X; Huang Y, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/968218; Jaggi AS, 2011, FUND CLIN PHARMACOL, V25, P1, DOI 10.1111/j.1472-8206.2009.00801.x; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Karppinen J, 2003, SPINE, V28, P750, DOI 10.1097/00007632-200304150-00004; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kuntzer T, 2004, MUSCLE NERVE, V30, P255, DOI 10.1002/mus.20100; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Latha M, 2013, J MOL NEUROSCI, V46, P497; Lee KM, 2009, EUR J PAIN, V13, P794, DOI 10.1016/j.ejpain.2008.09.009; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; Lindenlaub T, 2000, BRAIN RES, V866, P15, DOI 10.1016/S0006-8993(00)02190-9; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; Merskey HE, 1994, TASK FORCE TAXONOMY, P209; Miao PH, 2008, NEUROL RES, V30, P623, DOI 10.1179/174313208X289606; Mitchell S. Weir, 1872, INJURIES NERVES THEI; Murata Y, 2006, SPINE, V31, P530, DOI 10.1097/01.brs.0000201260.10082.23; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Ossipov MH, 2002, J NEUROSCI, V22, P9858; Puljak L, 2009, ANESTH ANALG, V108, P1021, DOI 10.1213/ane.0b013e318193873e; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Schafers M, 2003, J NEUROSCI, V23, P2517; Sommer C, 2001, BRAIN RES, V913, P86, DOI 10.1016/S0006-8993(01)02743-3; Sommer C, 2001, J PERIPHER NERV SYST, V6, P67, DOI 10.1046/j.1529-8027.2001.01010.x; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Sorkin LS, 2000, J PERIPHER NERV SYST, V5, P96, DOI 10.1046/j.1529-8027.2000.00012.x; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Terashima T, 2009, J CLIN INVEST, V119, P2100, DOI 10.1172/JCI39038; Tonini G, 2002, J BIOL REG HOMEOS AG, V16, P105; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Wei XH, 2013, EXP NEUROL, V241, P159, DOI 10.1016/j.expneurol.2012.12.007; WELLS MR, 1992, J NEUROIMMUNOL, V39, P261, DOI 10.1016/0165-5728(92)90260-R; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Xu JT, 2006, PAIN, V123, P306, DOI 10.1016/j.pain.2006.03.011; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; Yamakawa I, 2011, AM J PHYSIOL-ENDOC M, V301, pE844, DOI 10.1152/ajpendo.00029.2011; Yang P, 2012, J MOL NEUROSCI, V47, P173, DOI 10.1007/s12031-012-9710-z; Yu HW, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-63; Zhang JM, 2002, J NEUROPHYSIOL, V88, P1387, DOI 10.1152/jn.2002.88.3.1387; Zhang YH, 2002, J PHYSIOL-LONDON, V544, P385, DOI 10.1113/jphysiol.2002.024265	71	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92073	10.1371/journal.pone.0092073	http://dx.doi.org/10.1371/journal.pone.0092073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642694	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900076
J	Zhang, J; Ren, RM; Luo, XF; Fan, P; Liu, XH; Liang, SS; Ma, L; Yu, P; Bai, H				Zhang, Juan; Ren, Rongmei; Luo, Xuefeng; Fan, Ping; Liu, Xinghui; Liang, Shanshan; Ma, Lei; Yu, Ping; Bai, Huai			A Small Physiological Electric Field Mediated Responses of Extravillous Trophoblasts Derived from HTR8/SVneo Cells: Involvement of Activation of Focal Adhesion Kinase Signaling	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; MIGRATION; MOTILITY; STIMULATION; OVEREXPRESSION; KERATINOCYTES; PREECLAMPSIA; FIBRONECTIN; ORIENTATION	Moderate invasion of trophoblast cells into endometrium is essential for the placental development and normal pregnancy. Electric field (EF)-induced effects on cellular behaviors have been observed in many cell types. This study was to investigate the effect of physiological direct current EF (dc EF) on cellular responses such as elongation, orientation and motility of trophoblast cells. Immortalized first trimester extravillous trophoblast cells (HTR-8/SVneo) were exposed to the dc EF at physiological magnitude. Cell images were recorded and analyzed by image analyzer. Cell lysates were used to detect protein expression by Western blot. Cultured in the dc EFs the cells showed elongation, orientation and enhanced migration rate compared with non-EF stimulated cells at field strengths of 100 mV/mm to 200 mV/mm. EF exposure increased focal adhesion kinase (FAK) phosphorylation in a time-dependent manner and increased expression levels of MMP-2. Pharmacological inhibition of FAK impaired the EF-induced responses including motility and abrogated the elevation of MMP-2 expression. However, the expression levels of integrins like integrin alpha 1, alpha 5, alpha V and beta 1 were not affected by EF stimulation. Our results demonstrate the importance of FAK activation in migration/motility of trophobalst cells driven by EFs. In addition, it raises the feasibility of using applied EFs to promote placentation through effects on trophoblast cells.	[Zhang, Juan; Ren, Rongmei; Luo, Xuefeng; Fan, Ping; Liang, Shanshan; Ma, Lei; Bai, Huai] Sichuan Univ, Lab Genet Dis & Perinatal Med, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Juan; Ren, Rongmei; Luo, Xuefeng; Fan, Ping; Liang, Shanshan; Ma, Lei; Bai, Huai] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, West China Univ Hosp 2, Minist Educ, Chengdu 610064, Sichuan, Peoples R China; [Liu, Xinghui] Sichuan Univ, Dept Obstet & Gynecol, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Yu, Ping] Sichuan Univ, Lab Cell & Gene Therapy, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Bai, H (corresponding author), Sichuan Univ, Lab Genet Dis & Perinatal Med, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China.	baihuai60@aliyun.com	LUO, XUEFENG/AAX-3762-2021		National Natural Science Foundation of China [30872774, 81271733]; Sichuan Province Science and Research foundation of China [2012SZ0011]; National Basic Research Program of China (973 program) [2007CB948101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0935]; West China Second University Hospital of Sichuan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Research foundation of China; National Basic Research Program of China (973 program)(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); West China Second University Hospital of Sichuan University	This work was supported by grants from the National Natural Science Foundation of China 30872774 (HB) and 81271733 (HB), Sichuan Province Science and Research foundation of China 2012SZ0011 (HB), National Basic Research Program of China (973 program, No. 2007CB948101), Program for Changjiang Scholars and Innovative Research Team in University IRT0935, and Research Seed Fund from West China Second University Hospital of Sichuan University (HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Androulidaki A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-30; Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; Bai H, 2011, CYTOKINE, V55, P110, DOI 10.1016/j.cyto.2011.03.003; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Cary LA, 1996, J CELL SCI, V109, P1787; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Chang MM, 2011, BIOCHEM MOL BIOL EDU, V39, P291, DOI 10.1002/bmb.20501; Chao PHG, 2000, J BIOMECH ENG-T ASME, V122, P261, DOI 10.1115/1.429661; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; FERRIER J, 1986, J CELL PHYSIOL, V129, P283, DOI 10.1002/jcp.1041290303; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; GATES RE, 1994, CELL GROWTH DIFFER, V5, P891; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Huppertz B, 1998, CELL TISSUE RES, V291, P133; ILLC D, 1995, NATURE, V377, P539; Johnsen GM, 2011, PLACENTA, V32, P626, DOI 10.1016/j.placenta.2011.06.009; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishimura KY, 1996, J CELL SCI, V109, P199; OWENS LV, 1995, CANCER RES, V55, P2752; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; ROBINSON KR, 1996, NERVE GROWTH GUIDANC, P131; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868	51	11	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92252	10.1371/journal.pone.0092252	http://dx.doi.org/10.1371/journal.pone.0092252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643246	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900111
J	Alzoghaibi, MA; Pandi-Perumal, SR; Sharif, MM; BaHammam, AS				Alzoghaibi, Mohammed A.; Pandi-Perumal, Seithikurippu R.; Sharif, Munir M.; BaHammam, Ahmed S.			Diurnal Intermittent Fasting during Ramadan: The Effects on Leptin and Ghrelin Levels	PLOS ONE			English	Article							EPWORTH SLEEPINESS SCALE; PLASMA LEPTIN; HEALTHY-SUBJECTS; FOOD-INTAKE; INSULIN; OBESE; HUMANS; ADIPOSITY; SECRETION; RESPONSES	We aimed to assess the effect of Islamic intermittent fasting, during and outside of Ramadan, on plasma levels of leptin and ghrelin while controlling for several potential confounding variables. Eight healthy male volunteers with a mean age of 26.6 +/- 4.9 years reported to the sleep disorders center (SDC) at King Saud University on four occasions: 1) adaptation; 2) 4 weeks before Ramadan while performing Islamic fasting for 1 week (baseline fasting) (BLF); 3) 1 week before Ramadan (non-fasting baseline) (BL); and 4) during the second week of Ramadan while fasting. Plasma leptin and ghrelin levels were measured using enzyme- linked immunoassays at 22: 00, 02: 00, 04: 00, 06: 00, and 11: 00. During BLF, there were significant reductions in plasma leptin concentrations at 22: 00 and 02: 00 compared with the baseline concentrations (at 22: 00: 194.2 +/- 177.2 vs. 146.7 +/- 174.5; at 02: 00: 203.8 +/- 189.5 vs. 168.1 +/- 178.1; p<0.05). During Ramadan, there was a significant reduction in plasma leptin levels at 22: 00 (194.2 +/- 177.2 vs. 132.6 +/- 130.4, p<0.05). No significant difference in plasma ghrelin concentrations was detected during the BL, BLF, or Ramadan periods. Cosinor analyses of leptin and ghrelin plasma levels revealed no significant changes in the acrophases of the hormones during the three periods. The nocturnal reduction in plasma leptin levels during fasting may be the result of the changes in meal times during fasting.	[Alzoghaibi, Mohammed A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh 11461, Saudi Arabia; [Pandi-Perumal, Seithikurippu R.] NYU, Clin & Translat Res Inst, Ctr Healthful Behav Change,Langone Med Ctr, Div Hlth & Behav,Dept Populat Hlth, New York, NY USA; [Pandi-Perumal, Seithikurippu R.] Somnogen Canada Inc, Toronto, ON, Canada; [Sharif, Munir M.; BaHammam, Ahmed S.] King Saud Univ, Coll Med, Dept Med, Univ Sleep Disorders Ctr, Riyadh 11461, Saudi Arabia; [Alzoghaibi, Mohammed A.; Sharif, Munir M.; BaHammam, Ahmed S.] King Saud Univ, Riyadh, Saudi Arabia	King Saud University; New York University; NYU Langone Medical Center; King Saud University; King Saud University	BaHammam, AS (corresponding author), King Saud Univ, Coll Med, Dept Med, Univ Sleep Disorders Ctr, Riyadh 11461, Saudi Arabia.	ashammam2@gmail.com	BaHammam, Ahmed Salem/B-9037-2008; Pandi-Perumal, Seithikurippu R./Q-8281-2016; Pandi-Perumal, Seithikurippu R/HDM-2070-2022; BaHammam, Ahmed S/D-7521-2011	BaHammam, Ahmed Salem/0000-0002-1706-6167; Pandi-Perumal, Seithikurippu R./0000-0002-8686-7259; BaHammam, Ahmed S/0000-0002-1706-6167	National Plan for Science and Technology, King Saud University; King Abdulaziz City for Science and Technology, Saudi Arabia	National Plan for Science and Technology, King Saud University(King Saud University); King Abdulaziz City for Science and Technology, Saudi Arabia	This study was supported by a grant from the National Plan for Science and Technology, King Saud University, and King Abdulaziz City for Science and Technology, Saudi Arabia (http://npst.ksu.edu.sa/index.php?page_id=101). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid Alfonso, 2012, Indian J Endocrinol Metab, V16, pS617, DOI 10.4103/2230-8210.105580; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Al-Abri Mohammed, 2013, Oman Med J, V28, P454, DOI 10.5001/omj.2013.126; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Azizi F, 2002, ANN SAUDI MED, V22, P186, DOI 10.5144/0256-4947.2002.186; Bahammam A, 2006, INT J CLIN PRACT, V60, P1631, DOI 10.1111/j.1742-1241.2005.00811.x; BaHammam A, 2010, APPETITE, V54, P426, DOI 10.1016/j.appet.2010.01.011; Bahammam AS, 2013, J SLEEP RES; Bogdan A, 2005, BRIT J NUTR, V93, P515, DOI 10.1079/BJN20041380; Caixas A, 2002, J CLIN ENDOCR METAB, V87, P1902, DOI 10.1210/jc.87.4.1902; Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Chan JL, 2004, J CLIN ENDOCR METAB, V89, P335, DOI 10.1210/jc.2003-031412; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dorwny CA, 2008, MED SCI SPORT EXER, V40, P699, DOI 10.1249/MSS.0b013e318161ea8f; Elimam A, 2002, EUR J ENDOCRINOL, V147, P181, DOI 10.1530/eje.0.1470181; Figueiro MG, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/530726; Flanagan DE, 2003, AM J PHYSIOL-ENDOC M, V284, pE313, DOI 10.1152/ajpendo.00569.2001; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kolaczynski JW, 1996, DIABETES, V45, P1511, DOI 10.2337/diabetes.45.11.1511; Malavolti M, 2007, NUTR METAB CARDIOVAS, V17, P338, DOI 10.1016/j.numecd.2005.12.009; Mantzoros CS, 1998, CLIN ENDOCRINOL, V49, P551, DOI 10.1046/j.1365-2265.1998.00571.x; Mignault D, 2005, DIABETES CARE, V28, P225, DOI 10.2337/diacare.28.1.225-a; Morris CJ, 2010, CHRONOBIOL INT, V27, P590, DOI 10.3109/07420521003663819; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Natalucci G, 2005, EUR J ENDOCRINOL, V152, P845, DOI 10.1530/eje.1.01919; Nedvidkova J, 2003, J CLIN ENDOCR METAB, V88, P1678, DOI 10.1210/jc.2002-021669; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nicklas BJ, 1997, OBES RES, V5, P62, DOI 10.1002/j.1550-8528.1997.tb00284.x; Radic R, 2003, COLLEGIUM ANTROPOL, V27, P555; Roky R, 2001, J SLEEP RES, V10, P319, DOI 10.1046/j.1365-2869.2001.00269.x; Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Sadiya A, 2011, DIABETES METAB SYNDR, V4, P409, DOI 10.2147/DMSO.S24221; Schaller G, 2003, DIABETES, V52, P16, DOI 10.2337/diabetes.52.1.16; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ueno H, 2005, REGUL PEPTIDES, V126, P11, DOI 10.1016/j.regpep.2004.08.007; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	43	34	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92214	10.1371/journal.pone.0092214	http://dx.doi.org/10.1371/journal.pone.0092214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637892	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100129
J	Austdal, M; Skrastad, RB; Gundersen, AS; Austgulen, R; Iversen, AC; Bathen, TF				Austdal, Marie; Skrastad, Ragnhild Bergene; Gundersen, Astrid Solberg; Austgulen, Rigmor; Iversen, Ann-Charlotte; Bathen, Tone Frost			Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia	PLOS ONE			English	Article							NMR-SPECTROSCOPY; PLASMA; METABONOMICS; PREGNANCY; LIPIDS	Objective: To explore the potential of magnetic resonance (MR) metabolomics for study of preeclampsia, for improved phenotyping and elucidating potential clues to etiology and pathogenesis. Methods: Urine and serum samples from pregnant women with preeclampsia (n = 10), normal pregnancies (n = 10) and non-pregnant women (n = 10) matched by age and gestational age were analyzed with MR spectroscopy and subjected to multivariate analysis. Metabolites were then quantified and compared between groups. Results: Urine and serum samples revealed clear differences between women with preeclampsia and both control groups (normal pregnant and non-pregnant women). Nine urine metabolites were significantly different between preeclampsia and the normal pregnant group. Urine samples from women with early onset preeclampsia clustered together in the multivariate analysis. The preeclampsia serum spectra showed higher levels of low and very-low density lipoproteins and lower levels of high-density lipoproteins when compared to both non-pregnant and normal pregnant women. Conclusion: The MR determined metabolic profiles in urine and serum from women with preeclampsia are clearly different from normal pregnant women. The observed differences represent a potential to examine mechanisms underlying different preeclampsia phenotypes in urine and serum samples in larger studies. In addition, similarities between preeclampsia and cardiovascular disease in metabolomics are demonstrated.	[Austdal, Marie; Bathen, Tone Frost] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Fac Med, Trondheim, Norway; [Austdal, Marie] Liaison Comm Cent Norway Reg Hlth Author RHA & No, Trondheim, Norway; [Austdal, Marie; Bathen, Tone Frost] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Skrastad, Ragnhild Bergene] Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Fac Med, Trondheim, Norway; [Skrastad, Ragnhild Bergene] St Olavs Hosp, Natl Ctr Fetal Med, Trondheim, Norway; [Gundersen, Astrid Solberg; Austgulen, Rigmor; Iversen, Ann-Charlotte] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, Trondheim, Norway; [Austgulen, Rigmor; Iversen, Ann-Charlotte] NTNU, Ctr Mol Inflammat Res CEMIR, Fac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Austdal, M (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Fac Med, Trondheim, Norway.	marie.austdal@ntnu.no	Iversen, Ann-Charlotte/C-6920-2011	Iversen, Ann-Charlotte/0000-0001-7726-7684; Skrastad, Ragnhild Bergene/0000-0003-3810-0413	Central Norway Regional Health Authority (RHA) [46052200]; Norwegian University of Science and Technology (NTNU), Trondheim, Norway [46052200]	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU), Trondheim, Norway	The work is funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and Norwegian University of Science and Technology (NTNU), Trondheim, Norway, project number 46052200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahado-Sing RO, 2012, J MATERN FETAL NEO M; Bahado-Singh RO, 2012, AM J OBSTET GYNECOL, V208, pe10; Bathen TF, 2000, NMR BIOMED, V13, P271, DOI 10.1002/1099-1492(200008)13:5<271::AID-NBM646>3.0.CO;2-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergsjo P, 2001, PREEKLAMPSI EKLAMPSI; Bolin M, 2011, AM J HYPERTENS, V24, P496, DOI 10.1038/ajh.2010.264; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Braekke K, 2007, PEDIATR RES, V62, P319, DOI 10.1203/PDR.0b013e318123fba2; Craici Iasmina, 2008, Ther Adv Cardiovasc Dis, V2, P249, DOI 10.1177/1753944708094227; Demirci O, 2011, J OBSTET GYNAECOL RE, V37, P1427, DOI 10.1111/j.1447-0756.2011.01562.x; Diaz SO, 2013, J PROTEOME RES, V12, P969, DOI 10.1021/pr301022e; Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m; Dreier L, 2006, MAGN RESON CHEM, V44, pS206, DOI 10.1002/mrc.1838; Friesen RW, 2007, J NUTR, V137, P2641; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Lorentzen B, 2008, HYPERTENSIVE SVANGER; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schott Susanne, 2012, Int J Biomed Sci, V8, P258; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Turner E, 2008, HYPERTENS PREGNANCY, V27, P225, DOI 10.1080/10641950801955725; Turner E, 2007, HYPERTENS PREGNANCY, V26, P329, DOI 10.1080/10641950701436073; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Watanabe H, 2013, KIDNEY INT; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	28	48	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91923	10.1371/journal.pone.0091923	http://dx.doi.org/10.1371/journal.pone.0091923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637620	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100081
J	Jaschinski, K; Babski, J; Lehr, M; Burmester, A; Benz, J; Heyer, R; Dorr, M; Marchfelder, A; Soppa, J				Jaschinski, Katharina; Babski, Julia; Lehr, Matthias; Burmester, Anna; Benz, Juliane; Heyer, Ruth; Doerr, Marcella; Marchfelder, Anita; Soppa, Joerg			Generation and Phenotyping of a Collection of sRNA Gene Deletion Mutants of the Haloarchaeon Haloferax volcanii	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; SMALL NONCODING RNAS; MESSENGER-RNAS; ARCHAEA; IDENTIFICATION; TRANSCRIPTOME; AVAILABILITY; CONSTRUCTION; EXPRESSION; MICRORNAS	The haloarchaeon Haloferax volcanii was shown to contain 145 intergenic and 45 antisense sRNAs. In a comprehensive approach to unravel various biological roles of haloarchaeal sRNAs in vivo, 27 sRNA genes were selected and deletion mutants were generated. The phenotypes of these mutants were compared to that of the parent strain under ten different conditions, i.e. growth on four different carbon sources, growth at three different salt concentrations, and application of four different stress conditions. In addition, cell morphologies in exponential and stationary phase were observed. Furthermore, swarming of 17 mutants was analyzed. 24 of the 27 mutants exhibited a difference from the parent strain under at least one condition, revealing that haloarchaeal sRNAs are involved in metabolic regulation, growth under extreme conditions, regulation of morphology and behavior, and stress adaptation. Notably, 7 deletion mutants showed a gain of function phenotype, which has not yet been described for any other prokaryotic sRNA gene deletion mutant. Comparison of the transcriptomes of one sRNA gene deletion mutant and the parent strain led to the identification of differentially expressed genes. Genes for flagellins and chemotaxis were up-regulated in the mutant, in accordance with its gain of function swarming phenotype. While the deletion mutant analysis underscored that haloarchaeal sRNAs are involved in many biological functions, the degree of conservation is extremely low. Only 3 of the 27 genes are conserved in more than 10 haloarchaeal species. 22 of the 27 genes are confined to H. volcanii, indicating a fast evolution of haloarchaeal sRNA genes.	[Jaschinski, Katharina; Babski, Julia; Lehr, Matthias; Burmester, Anna; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany; [Benz, Juliane; Heyer, Ruth; Doerr, Marcella; Marchfelder, Anita] Univ Ulm, D-89069 Ulm, Germany	Goethe University Frankfurt; Ulm University	Soppa, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany.	soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840; Marchfelder, Anita/0000-0002-1382-1794	German Research Council (Deutsche Forschungsgemeinschaft) [SPP1258, DFG Ma1238/11-2, So264/14-2]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was funded by the German Research Council (Deutsche Forschungsgemeinschaft) through the Priority Program SPP1258 "Sensory and regulatory RNAs in prokaryotes" (grants DFG Ma1238/11-2 and So264/14-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Babski J, 2011, RNA BIOL, V8, P806, DOI 10.4161/rna.8.5.16039; Baumann A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-21; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2011, TRENDS CARDIOVAS MED, V21, P172, DOI 10.1016/j.tcm.2012.05.005; Brantl S, 2012, FUTURE MICROBIOL, V7, P853, DOI [10.2217/FMB.12.59, 10.2217/fmb.12.59]; Dennis PP, 2005, CURR OPIN MICROBIOL, V8, P685, DOI 10.1016/j.mib.2005.10.013; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Ehlers C, 2011, ARCHAEA, V2011, DOI 10.1155/2011/439608; Fischer S, 2010, J BIOL CHEM, V285, P34429, DOI 10.1074/jbc.M110.118950; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Gottesman S, 2011, COLD SPRING HARB PER, V3, DOI 10.1101; Hammelmann M, 2008, J MICROBIOL METH, V75, P201, DOI 10.1016/j.mimet.2008.05.029; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Heyer R, 2012, RNA BIOL, V9, P1011, DOI 10.4161/rna.20826; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Huang Y, 2013, BIOCHEMISTRY-MOSCOW+, V78, P221, DOI 10.1134/S0006297913030024; Jager D, 2012, NUCLEIC ACIDS RES, V40, P10964, DOI 10.1093/nar/gks847; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Jantzer K, 2011, FEMS MICROBIOL LETT, V322, P123, DOI 10.1111/j.1574-6968.2011.02341.x; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Prasse D, 2013, BIOCHEM SOC T, V41, P344, DOI 10.1042/BST20120280; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Sambrook J, 2001, MOL CLONING LAB MANU; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Soppa J, 2009, BIOCHEM SOC T, V37, P133, DOI 10.1042/BST0370133; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Straub J, 2009, RNA BIOL, V6, P281, DOI 10.4161/rna.6.3.8357; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wanner C, 2002, J BACTERIOL, V184, P3114, DOI 10.1128/JB.184.11.3114-3121.2002; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90763	10.1371/journal.pone.0090763	http://dx.doi.org/10.1371/journal.pone.0090763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637842	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100009
J	Zhao, Q; Xiao, JZ; He, J; Zhang, XL; Hong, J; Kong, XM; Mills, KT; Weng, JP; Jia, WP; Yang, WY				Zhao, Qi; Xiao, Jianzhong; He, Jiang; Zhang, Xuelian; Hong, Jing; Kong, Xiaomu; Mills, Katherine T.; Weng, Jianping; Jia, Weiping; Yang, Wenying			Cross-Sectional and Longitudinal Replication Analyses of Genome-Wide Association Loci of Type 2 Diabetes in Han Chinese	PLOS ONE			English	Article							COMMON VARIANTS; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; RISK LOCI; GLUCOSE; TCF7L2; CDKAL1; GENES; METAANALYSIS; POPULATIONS	This study aimed to examine genomic loci of type 2 diabetes (T2D) initially identified by genome-wide association studies in populations of European ancestry for their associations with T2D and quantitative glycemic traits, as well as their effects on longitudinal change in fasting plasma glucose (FPG) and T2D development, in the Chinese population. Single nucleotide polymorphisms (SNP) from 25 loci were genotyped in a large case-control sample of 10,001 subjects (5,338 T2D cases and 4,663 controls) and a prospective cohort of 1,881 Chinese. In the case-control sample, 8 SNPs in or near WFS1, CDKAL1, CDKN2A/2B, CDC123, HHEX, TCF7L2, KCNQ1, and MTNR1B were significantly associated with T2D (P<0.05). Thirteen SNPs were associated with quantitative glycemic traits. For example, the most significant SNP, rs10811661 near CDKN2A/2B (P = 1.11x10(-8) for T2D), was also associated with 2-h glucose level of an oral glucose tolerance test (P = 9.11x10(-3)) and insulinogenic index (P = 2.71x10(-2)). In the cohort study, individuals carrying more risk alleles of the replicated SNPs had greater FPG increase and T2D incidence in a 7.5-year follow-up period, with each quartile increase in the number of risk alleles being associated with a 0.06 mmol/l greater increase in FPG (P = 0.03) and 19% higher odds of developing T2D (P = 0.058). Our study identified the associations of several established T2D-loci in Europeans with T2D and quantitative glycemic traits in the Chinese population. The prospective data also suggest their potential role in the risk prediction of T2D in the Chinese population.	[Zhao, Qi; He, Jiang; Mills, Katherine T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Xiao, Jianzhong; Zhang, Xuelian; Hong, Jing; Kong, Xiaomu; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Weng, Jianping] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China	Tulane University; China-Japan Friendship Hospital; Tulane University; Sun Yat Sen University; Shanghai Jiao Tong University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Zhao, Qi/Y-9866-2019; He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Kong, Xiaomu/0000-0002-5920-4759; Weng, Jianping/0000-0002-7889-1697	Chinese Medical Association Foundation; sanofi (China) Investment Co., Ltd.; National 973 Program [2011CB504001]; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. [R01HL087263]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087263] Funding Source: NIH RePORTER	Chinese Medical Association Foundation; sanofi (China) Investment Co., Ltd.; National 973 Program(National Basic Research Program of China); National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The DMS study was supported by grants from the Chinese Medical Association Foundation, sanofi (China) Investment Co., Ltd. and the National 973 Program (2011CB504001). The GenSalt study is supported by the research grant (R01HL087263) from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Dr. Qi Zhao was supported by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang YC, 2012, CLIN ENDOCRINOL, V76, P365, DOI 10.1111/j.1365-2265.2011.04175.x; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Das Swapan Kumar, 2006, Cellscience, V2, P100; Gloyn AL, 2009, DIABETES, V58, P800, DOI 10.2337/db09-0099; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kota SK, 2012, DIABETES METAB SYND, V6, P54, DOI 10.1016/j.dsx.2012.05.014; Liu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021464; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Savic D, 2013, DIABETOLOGIA, V56, P121, DOI 10.1007/s00125-012-2730-y; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031093; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xi B, 2011, OBESITY, V19, P236, DOI 10.1038/oby.2010.139; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	37	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91790	10.1371/journal.pone.0091790	http://dx.doi.org/10.1371/journal.pone.0091790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637646	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100062
J	Lu, T; Huang, J; Zeng, FG				Lu, Thomas; Huang, Juan; Zeng, Fan-Gang			Accurate Guitar Tuning by Cochlear Implant Musicians	PLOS ONE			English	Article							MODULATION TRANSFER-FUNCTIONS; EVOKED-POTENTIALS; PERCEPTION; PITCH; RECOGNITION; REFLECTS; CHILDREN; HEARING; LIMITS	Modern cochlear implant (CI) users understand speech but find difficulty in music appreciation due to poor pitch perception. Still, some deaf musicians continue to perform with their CI. Here we show unexpected results that CI musicians can reliably tune a guitar by CI alone and, under controlled conditions, match simultaneously presented tones to <0.5 Hz. One subject had normal contralateral hearing and produced more accurate tuning with CI than his normal ear. To understand these counterintuitive findings, we presented tones sequentially and found that tuning error was larger at similar to 30 Hz for both subjects. A third subject, a non-musician CI user with normal contralateral hearing, showed similar trends in performance between CI and normal hearing ears but with less precision. This difference, along with electric analysis, showed that accurate tuning was achieved by listening to beats rather than discriminating pitch, effectively turning a spectral task into a temporal discrimination task.	[Lu, Thomas; Zeng, Fan-Gang] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92697 USA; [Huang, Juan] Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD USA	University of California System; University of California Irvine; Johns Hopkins University	Lu, T (corresponding author), Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92697 USA.	telu@uci.edu			NIH [2RO1 DC008858, P30 DC008369]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008858, P30DC008369] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was carried out at University of California, Irvine with support from NIH Grants 2RO1 DC008858 and P30 DC008369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON SP, 1985, AUDIOLOGY, V24, P117; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; Chen JKC, 2010, PEDIATRICS, V125, pE793, DOI 10.1542/peds.2008-3620; Fu QJ, 2008, HEARING RES, V242, P198, DOI 10.1016/j.heares.2007.11.010; GFELLER K, 1991, J SPEECH HEAR RES, V34, P916, DOI 10.1044/jshr.3404.916; Gfeller Kate, 2002, Cochlear Implants Int, V3, P29, DOI 10.1179/cim.2002.3.1.29; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HINOJOSA R, 1980, ARCH OTOLARYNGOL, V106, P193; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Mitani C, 2007, EAR HEARING, V28, p29S, DOI 10.1097/AUD.0b013e318031547a; Olszewski Carol, 2005, Cochlear Implants Int, V6, P123, DOI 10.1179/cim.2005.6.3.123; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Pijl S, 1997, EAR HEARING, V18, P364, DOI 10.1097/00003446-199710000-00002; Sandmann P, 2010, CLIN NEUROPHYSIOL; Sandmann P, 2009, BRAIN, V132, P1967, DOI 10.1093/brain/awp034; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SHANNON RV, 1992, J ACOUST SOC AM, V91, P2156, DOI 10.1121/1.403807; SHANNON RV, 1983, HEARING RES, V12, P1, DOI 10.1016/0378-5955(83)90115-6; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; Zeng FG, 2002, HEARING RES, V174, P101, DOI 10.1016/S0378-5955(02)00644-5	31	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92454	10.1371/journal.pone.0092454	http://dx.doi.org/10.1371/journal.pone.0092454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651081	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800109
J	Carrolo, M; Pinto, FR; Melo-Cristino, J; Ramirez, M				Carrolo, Margarida; Pinto, Francisco Rodrigues; Melo-Cristino, Jose; Ramirez, Mario			Pherotype Influences Biofilm Growth and Recombination in Streptococcus pneumoniae	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; NATURAL COMPETENCE; FRATRICIDE; DNA; IDENTIFICATION; PHEROMONE; MECHANISM; PNEUMOCOCCUS; INDUCTION; CHILDREN	In Streptococcus pneumoniae the competence-stimulating peptide (CSP), encoded by the comC gene, controls competence development and influences biofilm growth. We explored the influence of pherotype, defined by the two major comC allelic variants (comC1 and comC2), on biofilm development and recombination efficiency. Among isolates recovered from human infections those presenting comC1 show a higher capacity to form in vitro biofilms. The influence of pherotype on biofilm growth was confirmed by experiments with isogenic strains differing in their comC alleles. Biofilm architecture evaluated by confocal laser scanning microscopy showed that strains carrying comC1 form biofilms that are denser and thicker than those carrying the comC2 allele. Isogenic strains carrying the comC1 allele yielded more transformants than those carrying the comC2 allele in both planktonic and biofilm growth. Transformation assays with comC knockout strains show that ComD1 needs lower doses of the signaling peptide to reach the same biological outcomes. In contrast to mixed planktonic growth, within mixed biofilms inter-pherotype genetic exchange is less frequent than that occurring between bacteria of the same pherotype. Since biofilms are a major bacterial lifestyle, these observations may explain the genetic differentiation between populations with different pherotypes reported previously. Considering that biofilms have been associated with colonization our results suggest that strains carrying the comC1 allele may be more transmissible and more efficient at persisting in carriage. Both effects may help explain the higher prevalence of the comC1 allele in the pneumococcal population.	[Carrolo, Margarida; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Inst Microbiol, Fac Med, P-1699 Lisbon, Portugal; [Carrolo, Margarida; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Pinto, Francisco Rodrigues] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Inst Microbiol, Fac Med, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Ramirez, Mario/B-4993-2008; Carrolo, Margarida/AAM-2938-2020; Pinto, Francisco/A-7443-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Pinto, Francisco/0000-0002-4217-0054; Melo-Cristino, Jose A G/0000-0001-8643-1722; Carrolo, Margarida/0000-0002-6866-9515	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BPD/79310/2011, PTDC/SAU-ESA/64888/2006, PTDC/BIA-MIC/119709/2010, PTDC/EBB-EBI/113824/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Margarida Carrolo is supported research grants from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/35854/2007 and SFRH/BPD/79310/2011). This work was partially supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-ESA/64888/2006, PTDC/BIA-MIC/119709/2010 and PTDC/EBB-EBI/113824/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Berg KH, 2012, APPL ENVIRON MICROB, V78, P3515, DOI 10.1128/AEM.00098-12; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Carrolo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015678; Carrolo M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-191; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Cornejo OE, 2010, MOL BIOL EVOL, V27, P694, DOI 10.1093/molbev/msp287; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Evans BA, 2013, ISME J, V7, P791, DOI 10.1038/ismej.2012.170; Feil EJ, 2000, GENETICS, V154, P1439; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Iannelli F, 2005, FEMS MICROBIOL LETT, V252, P321, DOI 10.1016/j.femsle.2005.09.008; Johnsborg O, 2008, MOL MICROBIOL, V69, P245, DOI 10.1111/j.1365-2958.2008.06288.x; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Marks LR, 2012, MBIO, V3, DOI [10.1128/mBio.00200-12, DOI 10.1128/MBI0.00200-12]; MORRISON DA, 1983, J BACTERIOL, V156, P281, DOI 10.1128/JB.156.1.281-290.1983; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Neil RB, 2009, MICROBES INFECT, V11, P281, DOI 10.1016/j.micinf.2008.12.001; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Piotrowski A, 2009, J BACTERIOL, V191, P3359, DOI 10.1128/JB.01750-08; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Ramirez M, 1997, MICROB DRUG RESIST, V3, P39, DOI 10.1089/mdr.1997.3.39; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suntharalingam P, 2005, TRENDS MICROBIOL, V13, P3, DOI 10.1016/j.tim.2004.11.009; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Tikhomirova A, 2013, PATHOG DIS, V69, P114, DOI 10.1111/2049-632X.12073; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Tortosa P, 1999, CURR OPIN MICROBIOL, V2, P588, DOI 10.1016/S1369-5274(99)00026-0; Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11; Valente C, 2012, MICROB DRUG RESIST, V18, P550, DOI 10.1089/mdr.2011.0228; Vestrheim DF, 2011, INFECT GENET EVOL, V11, P1703, DOI 10.1016/j.meegid.2011.07.003; Wei H, 2012, APPL ENVIRON MICROB, V78, P5897, DOI 10.1128/AEM.01343-12	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92138	10.1371/journal.pone.0092138	http://dx.doi.org/10.1371/journal.pone.0092138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646937	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500089
J	Dalla Costa, E; Minero, M; Lebelt, D; Stucke, D; Canali, E; Leach, MC				Dalla Costa, Emanuela; Minero, Michela; Lebelt, Dirk; Stucke, Diana; Canali, Elisabetta; Leach, Matthew C.			Development of the Horse Grimace Scale (HGS) as a Pain Assessment Tool in Horses Undergoing Routine Castration	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EQUINE CASTRATION; YOUNG HORSES; POSTOPERATIVE PAIN; ANALGESIA; PHENYLBUTAZONE; BUTORPHANOL; RELIABILITY; RESPONSES; SURGERY	Background: The assessment of pain is critical for the welfare of horses, in particular when pain is induced by common management procedures such as castration. Existing pain assessment methods have several limitations, which reduce the applicability in everyday life. Assessment of facial expression changes, as a novel means of pain scoring, may offer numerous advantages and overcome some of these limitations. The objective of this study was to develop and validate a standardised pain scale based on facial expressions in horses (Horse Grimace Scale [HGS]). Methodology/Principal Findings: Forty stallions were assigned to one of two treatments and all animals underwent routine surgical castration under general anaesthesia. Group A (n = 19) received a single injection of Flunixin immediately before anaesthesia. Group B (n = 21) received Flunixin immediately before anaesthesia and then again, as an oral administration, six hours after the surgery. In addition, six horses were used as anaesthesia controls (C). These animals underwent non-invasive, indolent procedures, received the same treatment as group A, but did not undergo surgical procedures that could be accompanied with surgical pain. Changes in behaviour, composite pain scale (CPS) scores and horse grimace scale (HGS) scores were assessed before and 8-hours post-procedure. Only horses undergoing castration (Groups A and B) showed significantly greater HGS and CPS scores at 8-hours post compared to pre operatively. Further, maintenance behaviours such as explorative behaviour and alertness were also reduced. No difference was observed between the two analgesic treatment groups. Conclusions: The Horse Grimace Scale potentially offers an effective and reliable method of assessing pain following routine castration in horses. However, auxiliary studies are required to evaluate different painful conditions and analgesic schedules.	[Dalla Costa, Emanuela; Minero, Michela; Canali, Elisabetta] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy; [Lebelt, Dirk; Stucke, Diana] Havelland Equine Hosp, Pferdeklin Havelland, Beetzsee Brielow, Germany; [Leach, Matthew C.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Milan; Newcastle University - UK	Dalla Costa, E (corresponding author), Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy.	emanuela.dallacosta@unimi.it	Costa, Emanuela Dalla/G-9746-2017; Lebelt, Dirk/ABC-4048-2020; Minero, Michela/G-9001-2017; canali, elisabetta/G-8897-2017	Costa, Emanuela Dalla/0000-0002-5037-3759; Minero, Michela/0000-0001-8285-5501; canali, elisabetta/0000-0002-4962-5955	EU	EU(European Commission)	The authors would like to thank the EU VII Framework program (FP7-KBBE-2010-4) for financing the Animal Welfare Indicators (AWIN) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Ashraf AB, 2009, IMAGE VISION COMPUT, V27, P1788, DOI 10.1016/j.imavis.2009.05.007; Bidwell LA, 2007, VET ANAESTH ANALG, V34, P23, DOI 10.1111/j.1467-2995.2005.00283.x; Bussieres G, 2008, RES VET SCI, V85, P294, DOI 10.1016/j.rvsc.2007.10.011; Canadian Veterinary Medical Association, 2006, CASTR HORS DONK MUL; Capner C, 2001, VET REC, V149, P252; Dalla Costa E, 2010, P 46 C INT SOC APPL, P235; di Perrotolo Maud Scotto, 2010, STAL, V36, P49; Eager R, 2002, PRELIMINARY INVESTIG; Ekman P, 1978, FACIAL ACTION CODING; England GCW, 1996, BRIT VET J, V152, P641, DOI 10.1016/S0007-1935(96)80118-7; Erber R, 2012, VET J, V191, P171, DOI 10.1016/j.tvjl.2011.08.008; European Horse Network, 2010, KEY FIG; Figueiredo J. P., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P249; Flecknell P, 2001, VET REC, V149, P252; Graubner C, 2011, VET J, V188, P178, DOI 10.1016/j.tvjl.2010.04.029; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; Hall CW, 1983, VET ANESTHESIA; Heleski MC, 2012, CODE PRACTICE CARE H; JOHNSON CB, 1993, VET REC, V133, P336, DOI 10.1136/vr.133.14.336; Jones R, 2001, VET REC, V149, P252; Jordan A, 2011, INT J GERIATR PSYCH, V26, P118, DOI 10.1002/gps.2489; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Love EJ, 2009, EQUINE VET EDUC, V21, P46, DOI 10.2746/095777309X390290; Love EJ, 2009, EQUINE VET J, V41, P552, DOI 10.2746/042516409X391024; Maassen E, 2009, PFERDEHEILKUNDE, V25, P451, DOI 10.21836/PEM20090502; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mcdonnell SM, 2003, EQUID ETHOGRAM; McGreevy P, 2004, EQUINE BEHAV; Molony V, 1997, J ANIM SCI, V75, P266; Moya SL, 2008, APPL ANIM BEHAV SCI, V111, P133, DOI 10.1016/j.applanim.2007.05.019; MUIR WW, 1982, AM J VET RES, V43, P1756; National Equine Welfare Council (NEWC), 2009, EQ IND WELF GUID COM; Price J, 2005, RES VET SCI, V78, P277, DOI 10.1016/j.rvsc.2004.09.009; Price J, 2003, VET ANAESTH ANALG, V30, P124, DOI 10.1046/j.1467-2995.2003.00139.x; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Sanz MG, 2009, JAVMA-J AM VET MED A, V235, P1194, DOI 10.2460/javma.235.10.1194; Searle D, 1999, AUST VET J, V77, P428, DOI 10.1111/j.1751-0813.1999.tb12083.x; Sondergaard E, 2003, APPL ANIM BEHAV SCI, V84, P265, DOI 10.1016/j.applanim.2003.08.011; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Taylor PM, 2002, VET CLIN N AM-EQUINE, V18, P1, DOI 10.1016/S0749-0739(02)00009-3; van Loon JPAM, 2010, J EQUINE VET SCI, V30, P641, DOI 10.1016/j.jevs.2010.09.011; Vinuela-Fernandez I, 2011, VET J, V188, P171, DOI 10.1016/j.tvjl.2010.05.011; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	47	273	274	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92281	10.1371/journal.pone.0092281	http://dx.doi.org/10.1371/journal.pone.0092281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647606	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500106
J	Dierselhuis, MP; Jankowska-Gan, E; Blokland, E; Pool, J; Burlingham, WJ; van Halteren, AGS; Goulmy, E				Dierselhuis, Miranda P.; Jankowska-Gan, Ewa; Blokland, Els; Pool, Jos; Burlingham, William J.; van Halteren, Astrid G. S.; Goulmy, Els			HY Immune Tolerance Is Common in Women without Male Offspring	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLOGRAFT ACCEPTANCE; PREGNANCY; MICROCHIMERISM; LONG; SEX; LYMPHOCYTES; RECIPIENTS; CHIMERISM; BLOOD	Background: Sex difference is an established risk factor for hematopoietic stem cell transplantation (HSCT)-related complications like graft versus host disease (GVHD). CD8(pos) cytotoxic T cells specific for Y chromosome-encoded minor Histocompatibility antigens (HY) play an important role therein. Prior to HSC donation, female donors may encounter HY antigens through fetomaternal or transmaternal cell flow, potentially leading to the induction of HY-specific cytotoxic or regulatory immune responses. Whether HY priming occurs independent of parity, and whether HY priming is dependent on the presence of male microchimerism, is as yet unknown. Methods: We investigated the presence of HY-specific regulatory T cells (Treg) and male microchimerism in 45 healthy women with a fully documented pregnancy and family history. HY peptide-induced linked suppression, a commonly reported functional feature of CD4(pos) and CD8(pos) Treg, was measured by trans vivo Delayed Type Hypersensitivity testing. As source of HY antigens, male microchimerism was analyzed by real-time PCR and defined by the presence of male DNA in at least one purified leukocyte cell type. Results: HLA class I or class II restricted HY-specific Treg were detected in 26/42 (62%) women eligible for analysis. The prevalence of HY-specific Treg was significantly higher in women who had never given birth to sons than in women with male offspring (p = 0.004). Male microchimerism could be detected in 24 out of 45 (53%) women but did not correlate with the presence of HY specific Treg. Conclusions: HY-specific Treg in women with male offspring have been described previously. Here we show for the first time that, in fact, HY specific Treg are more common in nulliparous women and in parous women with female offspring. Their presence is independent of the presence of male microchimerism. Whether HY-specific Treg presence in female stem cell grafts might decrease the GVHD incidence in male HSCT recipients needs to be investigated.	[Dierselhuis, Miranda P.; Blokland, Els; Pool, Jos; Goulmy, Els] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Jankowska-Gan, Ewa; Burlingham, William J.] Univ Wisconsin, Dept Surg, Madison, WI USA; [van Halteren, Astrid G. S.] Leiden Univ, Med Ctr, Immunol Lab, Dept Pediat WAKZ, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Wisconsin System; University of Wisconsin Madison; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Halteren, AGS (corresponding author), Leiden Univ, Med Ctr, Immunol Lab, Dept Pediat WAKZ, Leiden, Netherlands.	a.g.s.van_Halteren@lumc.nl			Netherlands Organization for Scientific Research (NWO Spinoza award); Macropa Foundation; National Blood Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO Spinoza award)(Netherlands Organization for Scientific Research (NWO)); Macropa Foundation; National Blood Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by the Netherlands Organization for Scientific Research (NWO Spinoza award; http://www.nwo.nl/onderzoek-enresultaten/programmas/spinozapremie), the Macropa Foundation (www.macropa.com) and the National Blood Foundation (www.sanquin.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bucher C, 2007, BLOOD, V110, P468, DOI 10.1182/blood-2007-02-076257; Burlingham WJ, 2007, AM J TRANSPLANT, V7, P466, DOI 10.1111/j.1600-6143.2006.01627.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai JC, 2004, J EXP MED, V199, P1017, DOI 10.1084/jem.20031012; de Bellefon Laurent Meric, 2010, Chimerism, V1, P56, DOI 10.4161/chim.1.2.14294; Dierselhuis MP, 2012, BLOOD, V120, P505, DOI 10.1182/blood-2012-02-410571; Drabbels JJM, 2011, BLOOD, V118, pE149, DOI 10.1182/blood-2011-06-362053; Dutta Partha, 2010, Chimerism, V1, P2, DOI 10.4161/chim.1.1.12667; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Fehse B, 2001, J HEMATOTH STEM CELL, V10, P419, DOI 10.1089/152581601750289028; Gammill HS, 2010, INT J DEV BIOL, V54, P531, DOI 10.1387/ijdb.082767hg; Jankowska-Gan E, 2002, HUM IMMUNOL, V63, P862, DOI 10.1016/S0198-8859(02)00450-0; Jankowska-Gan E, 2013, JOVE-J VIS EXP, DOI 10.3791/4454; Kim YH, 2012, BIOL BLOOD MARROW TR, V18, P381, DOI 10.1016/j.bbmt.2011.10.038; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Lissauer D, 2012, J IMMUNOL, V189, P1072, DOI 10.4049/jimmunol.1200544; Loren AW, 2006, BIOL BLOOD MARROW TR, V12, P758, DOI 10.1016/j.bbmt.2006.03.015; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Olson BM, 2012, J IMMUNOL, V189, P5590, DOI 10.4049/jimmunol.1201744; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Spierings Eric, 2012, Methods Mol Biol, V882, P509, DOI 10.1007/978-1-61779-842-9_29; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; VanBuskirk AM, 1998, TRANSPLANTATION, V65, P1115, DOI 10.1097/00007890-199804270-00017; VanBuskirk AM, 2000, J CLIN INVEST, V106, P145, DOI 10.1172/JCI9171; Verdijk RM, 2004, BLOOD, V103, P1961, DOI 10.1182/blood-2003-05-1625; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	31	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91274	10.1371/journal.pone.0091274	http://dx.doi.org/10.1371/journal.pone.0091274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646895	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500026
J	Ng, K; Higurashi, M; Uemiya, N; Qian, Y				Keith Ng; Higurashi, Masakazu; Uemiya, Nahoko; Qian, Yi			Secondary Histomorphological Changes in Cerebral Arteries of Normotensive and Hypertensive Rats following a Carotid-Jugular Fistula Induction	PLOS ONE			English	Article							BLOOD-FLOW; ARTERIOVENOUS-MALFORMATIONS; MECHANICAL-PROPERTIES; AGE; RUPTURE; MODELS; YOUNG; SIZE	Haemodynamic changes in cerebral circulation are associated with the natural ageing process and associated pathology, leading to the development of incapacitating neurological and neurovascular diseases. Due to inherent biological limitations, current literatures mostly aimed at studying the correlation descriptively or quantifying the relationship in vitro or using computational models. In this paper, a model of a carotid-jugular fistula in the rat was used to create a haemodynamic insult to the intracranial arterial circulation and subsequent venous drainage. An arterial-venous (AV) fistula was created in 12 rats, 6 of which are normotensive Wistar-Kyoto strain (WKY) and the rest spontaneously hypertensive strain (SHR) with an additional 6 in each strains designed as controls without previous surgery. After 4 weeks of convalescence, all 24 rats were euthanised and their cerebral circulation was examined histomorphologically. We confirmed an intrinsic morphological difference between normotensive WKY and hypertensive SHR and found a modest but significant arterial shrinkage in both strains induced with AV fistula. We also reported that alterations in blood flow are also associated with marked extracellular matrix changes. We concluded that the model was suitable for studying the relative contributions of altering haemodynamic patterns and venous drainage on cerebrovascular changes. We also found that hypertension modulated cerebral vascular changes in addition to disrupted blood flow.	[Keith Ng; Qian, Yi] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Higurashi, Masakazu] Yokohama Minami Kyousai Hosp, Dept Neurosurg, Yokohama, Kanagawa, Japan; [Uemiya, Nahoko] Saitama Med Univ, Dept Endovasc Neurosurg, Saitama, Japan	Macquarie University; Saitama Medical University	Qian, Y (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	yi.qian@mq.edu.au			Australian Research Council [DP110102985]; Macquarie University	Australian Research Council(Australian Research Council); Macquarie University	This work was supported by research grants from the Australian Research Council DP110102985. Dr Ng is supported by the Macquarie University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; BAUMBACH GL, 1991, CIRC RES, V68, P338, DOI 10.1161/01.RES.68.2.338; BAUMBACH GL, 1993, HYPERTENSION, V21, P816, DOI 10.1161/01.HYP.21.6.816; Chen J, 2012, CHINESE MED J-PEKING, V125, P1303, DOI 10.3760/cma.j.issn.0366-6999.2012.07.021; COX RH, 1977, AM J PHYSIOL, V233, pH256, DOI 10.1152/ajpheart.1977.233.2.H256; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; de la Torre JC, 1999, ACTA NEUROPATHOL, V98, P1, DOI 10.1007/s004010051044; Eldawoody H, 2009, BRAIN RES, V1300, P159, DOI 10.1016/j.brainres.2009.08.099; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Hainsworth AH, 2012, J NEUROL SCI, V322, P237, DOI 10.1016/j.jns.2012.05.046; HAJDU MA, 1990, CIRC RES, V66, P1747, DOI 10.1161/01.RES.66.6.1747; HAJDU MA, 1991, HYPERTENSION, V18, P15; HAJDU MA, 1994, AM J PHYSIOL, V266, pH1027, DOI 10.1152/ajpheart.1994.266.3.H1027; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Illies T, 2012, STROKE, V43, P2910, DOI 10.1161/STROKEAHA.112.669945; INGEBRIGTSEN R, 1965, Acta Chir Scand, V129, P156; Jimenez-Altayo F, 2007, AM J PHYSIOL-HEART C, V293, pH628, DOI 10.1152/ajpheart.00165.2007; JOHANSSON BB, 1985, J CARDIOVASC PHARM, V7, pS90, DOI 10.1097/00005344-198507002-00017; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Laurant P, 2004, CAN J PHYSIOL PHARM, V82, P269, DOI 10.1139/Y04-026; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; LINVILLE DG, 1991, NEUROBIOL AGING, V12, P503, DOI 10.1016/0197-4580(91)90080-4; Lv XL, 2011, WORLD NEUROSURG, V76, P455, DOI 10.1016/j.wneu.2011.04.015; Moftakhar P, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS09317; MORGAN MK, 1989, BRAIN RES, V496, P241, DOI 10.1016/0006-8993(89)91071-8; Prosenz P, 1971, STROKE, V2, P279, DOI 10.1161/01.STR.2.3.279; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Raymond J, 2013, AM J NEURORADIOL, V34, P346, DOI 10.3174/ajnr.A3407; Sammons V, 2011, J CLIN NEUROSCI, V18, P165, DOI 10.1016/j.jocn.2010.04.045; Schultz SK, 1999, NEUROREPORT, V10, P2493, DOI 10.1097/00001756-199908200-00011; STEHBENS WE, 1963, ARCH NEUROL-CHICAGO, V8, P272, DOI 10.1001/archneur.1963.00460030056005; TACHIBANA H, 1984, AM J ROENTGENOL, V142, P1027, DOI 10.2214/ajr.142.5.1027; WARSHAW DM, 1979, CIRC RES, V45, P250, DOI 10.1161/01.RES.45.2.250	37	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92433	10.1371/journal.pone.0092433	http://dx.doi.org/10.1371/journal.pone.0092433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647348	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500131
J	Zhang, L; Wang, H; Zou, JW; Rogers, WE; Siemann, E				Zhang, Ling; Wang, Hong; Zou, Jianwen; Rogers, William E.; Siemann, Evan			Non-Native Plant Litter Enhances Soil Carbon Dioxide Emissions in an Invaded Annual Grassland	PLOS ONE			English	Article							LEAF-LITTER; DECOMPOSITION DYNAMICS; NITROGEN; RESPIRATION; AVAILABILITY; INVASIONS; ECOSYSTEM; RELEASE; BALANCE; PURE	Litter decomposition is a fundamental ecosystem process in which breakdown and decay of plant detritus releases carbon and nutrients. Invasive exotic plants may produce litter that differs from native plant litter in quality and quantity. Such differences may impact litter decomposition and soil respiration in ways that depend on whether exotic and native plant litters decompose in mixtures. However, few field experiments have examined how exotic plants affect soil respiration via litter decomposition. Here, we conducted an in situ study of litter decomposition of an annual native grass (Eragrostis pilosa), a perennial exotic forb (Alternanthera philoxeroides), and their mixtures in an annual grassland in China to examine potential invasion effects on soil respiration. Alternanthera litter decomposed faster than Eragrostis litter when each was incubated separately. Mass loss in litter mixes was more rapid than predicted from rates in single species bags (only 35% of predicted mass remained at 8 months) showing synergistic effects. Notably, exotic plant litter decomposition rate was unchanged but native plant litter decomposition rate was accelerated in mixtures (decay constant k = 0.20 month(-1)) compared to in isolation (k = 0.10 month(-1)). On average, every litter type increased soil respiration compared to bare soil from which litter was removed. However, the increases were larger for mixed litter (1.82 times) than for Alternanthera litter (1.58 times) or Eragrostis litter (1.30 times). Carbon released as CO2 relative to litter carbon input was also higher for mixed litter (3.34) than for Alternathera litter (2.29) or Eragrostis litter (1.19). Our results indicated that exotic Alternanthera produces rapidly decomposing litter which also accelerates the decomposition of native plant litter in litter mixtures and enhances soil respiration rates. Thus, this exotic invasive plant species will likely accelerate carbon cycling and increase soil respiration even at intermediate stages of invasion in these annual grasslands.	[Zhang, Ling; Wang, Hong; Zou, Jianwen; Siemann, Evan] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Ling; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Zou, Jianwen] Cornell Univ, Dept Hort, Ithaca, NY USA; [Rogers, William E.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX USA	Nanjing Agricultural University; Rice University; Cornell University; Texas A&M University System; Texas A&M University College Station	Zou, JW (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	jwzou21@njau.edu.cn; siemann@rice.edu	huang, yao/GWR-5388-2022; ZOU, JIANWEN/B-3059-2012	ZOU, JIANWEN/0000-0003-4689-9237	NSFC [41225003]; Ministry of Education 111 project [B12009]; US-NSF [DEB 0820560]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Scholarship Council; Direct For Biological Sciences [0820560] Funding Source: National Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education 111 project(Ministry of Education, China - 111 Project); US-NSF(National Science Foundation (NSF)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Scholarship Council(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the NSFC (41225003), the Ministry of Education 111 project (B12009), US-NSF (DEB 0820560), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the China Scholarship Council (for providing funding support to LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Ashton IW, 2005, ECOL APPL, V15, P1263, DOI 10.1890/04-0741; Barlocher Felix, 2005, P37, DOI 10.1007/1-4020-3466-0_6; Bassett IE, 2010, NEW ZEAL J ECOL, V34, P324; Berger TW, 2010, SOIL BIOL BIOCHEM, V42, P986, DOI 10.1016/j.soilbio.2010.02.020; Berglund SL, 2012, OIKOS, V121, P1112, DOI 10.1111/j.1600-0706.2011.19787.x; Briones MJI, 1996, SOIL BIOL BIOCHEM, V28, P1381, DOI 10.1016/S0038-0717(96)00158-7; CHAPMAN K, 1988, AGR ECOSYST ENVIRON, V24, P33, DOI 10.1016/0167-8809(88)90054-0; Chapman SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062671; Chen BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066289; CROSSLEY DA, 1962, ECOLOGY, V43, P571, DOI 10.2307/1933396; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Feng YL, 2007, OECOLOGIA, V153, P501, DOI 10.1007/s00442-007-0759-2; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Frey SD, 2003, SOIL BIOL BIOCHEM, V35, P1001, DOI 10.1016/S0038-0717(03)00155-X; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hickman JE, 2013, OECOLOGIA, V173, P319, DOI 10.1007/s00442-013-2607-x; Holdredge C, 2011, BIOL INVASIONS, V13, P423, DOI 10.1007/s10530-010-9836-2; HORNER JD, 1988, AM NAT, V132, P869, DOI 10.1086/284894; Kainulainen P, 2002, SOIL BIOL BIOCHEM, V34, P37, DOI 10.1016/S0038-0717(01)00147-X; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; McLaren JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023702; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Meisner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031596; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rodgers VL, 2008, OECOLOGIA, V157, P459, DOI 10.1007/s00442-008-1089-8; Rubino M, 2010, SOIL BIOL BIOCHEM, V42, P1009, DOI 10.1016/j.soilbio.2010.02.018; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Siemann E, 2003, J ECOL, V91, P923, DOI 10.1046/j.1365-2745.2003.00822.x; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; WIEDER RK, 1982, ECOLOGY, V63, P1636, DOI 10.2307/1940104; Zeid M, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P135, DOI 10.1007/978-3-642-14255-0_8; Zou JW, 2004, CHINESE SCI BULL, V49, P381, DOI 10.1360/03wd0270; Zuo SP, 2012, WEED BIOL MANAG, V12, P123, DOI 10.1111/j.1445-6664.2012.00443.x	46	29	30	11	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92301	10.1371/journal.pone.0092301	http://dx.doi.org/10.1371/journal.pone.0092301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647312	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500110
J	Feasey, NA; Houston, A; Mukaka, M; Komrower, D; Mwalukomo, T; Tenthani, L; Jahn, A; Moore, M; Peters, RPH; Gordon, MA; Everett, DB; French, N; van Oosterhout, JJ; Allain, TJ; Heyderman, RS				Feasey, Nicholas A.; Houston, Angela; Mukaka, Mavuto; Komrower, Dan; Mwalukomo, Thandie; Tenthani, Lyson; Jahn, Andreas; Moore, Mike; Peters, Remco P. H.; Gordon, Melita A.; Everett, Dean B.; French, Neil; van Oosterhout, Joep J.; Allain, Theresa J.; Heyderman, Robert S.			A Reduction in Adult Blood Stream Infection and Case Fatality at a Large African Hospital following Antiretroviral Therapy Roll-Out	PLOS ONE			English	Article							COTRIMOXAZOLE PROPHYLAXIS; SALMONELLA BACTEREMIA; HIV; MALAWI; MORTALITY; RESISTANCE; TUBERCULOSIS; PREVALENCE; CHILDREN; PROGRAM	Introduction: Blood-stream infection (BSI) is one of the principle determinants of the morbidity and mortality associated with advanced HIV infection, especially in sub-Saharan Africa. Over the last 10 years, there has been rapid roll-out of antiretroviral therapy (ART) and cotrimoxazole prophylactic therapy (CPT) in many high HIV prevalence African countries. Methods: A prospective cohort of adults with suspected BSI presenting to Queen's Hospital, Malawi was recruited between 2009 and 2010 to describe causes of and outcomes from BSI. Comparison was made with a cohort pre-dating ART roll-out to investigate whether and how ART and CPT have affected BSI. Malawian census and Ministry of Health ART data were used to estimate minimum incidence of BSI in Blantyre district. Results: 2,007 patients were recruited, 90% were HIV infected. Since 1997/8, culture-confirmed BSI has fallen from 16% of suspected cases to 10% (p < 0.001) and case fatality rate from confirmed BSI has fallen from 40% to 14% (p < 0.001). Minimum incidence of BSI was estimated at 0.03/1000 years in HIV uninfected vs. 2.16/1000 years in HIV infected adults. Compared to HIV seronegative patients, the estimated incidence rate-ratio for BSI was 80 (95% CI: 46-139) in HIV-infected/untreated adults, 568 (95% CI: 302-1069) during the first 3 months of ART and 30 (95% CI: 16-59) after 3 months of ART. Conclusions: Following ART roll-out, the incidence of BSI has fallen and clinical outcomes have improved markedly. Nonetheless, BSI incidence remains high in the first 3 months of ART despite CPT. Further interventions to reduce BSI-associated mortality in the first 3 months of ART require urgent evaluation.	[Feasey, Nicholas A.; Mukaka, Mavuto; Mwalukomo, Thandie; Moore, Mike; Everett, Dean B.; van Oosterhout, Joep J.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Feasey, Nicholas A.; Houston, Angela; Komrower, Dan; Mwalukomo, Thandie; Allain, Theresa J.; Heyderman, Robert S.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Feasey, Nicholas A.; Moore, Mike; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Tenthani, Lyson; Jahn, Andreas] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Tenthani, Lyson] I TECH Lilongwe, Lilongwe, Malawi; [Jahn, Andreas] Univ Washington, Dept Global Hlth, I TECH, Seattle, WA 98195 USA; [Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Peters, Remco P. H.] Anova Hlth Inst, Tzaneen, South Africa; [Gordon, Melita A.; Everett, Dean B.; French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [van Oosterhout, Joep J.] Dignitas Int, Blantyre, Malawi	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Washington; University of Washington Seattle; University of Liverpool	Feasey, NA (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	nfeasey@liverpool.ac.uk	Jahn, Andreas/ABB-7796-2020; Gordon, Melita/F-5563-2012	Jahn, Andreas/0000-0003-4645-1600; Heyderman, Robert/0000-0003-4573-449X; Peters, Remco Petrus Hendricus/0000-0003-2124-7275; French, Neil/0000-0003-4814-8293; Everett, Dean/0000-0002-8458-6779; Feasey, Nicholas/0000-0003-4041-1405; Gordon, Melita/0000-0002-0629-0884	Wellcome Trust [WT092152MA, 084679/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust: Nicholas Feasey is supported by Wellcome Trust Research Fellowship WT092152MA and MLW is supported by Wellcome Trust Core Award 084679/Z/08/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wellcome Trust URL: www.wellcome.ac.uk	[Anonymous], 2011, MAL DHS 2010 PREL RE; Arthur G, 2001, CLIN INFECT DIS, V33, P248, DOI 10.1086/321820; Barrow GI, 1993, COWAN STEELES MANUAL; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; BSAC, 2009, METH ANT SUSC TEST V; Chihana M, 2012, TROP MED INT HEALTH, V17, pe74, DOI 10.1111/j.1365-3156.2012.02929.x; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Feasey NA, 2013, J CLIN MICROBIOL, V51, P2311, DOI 10.1128/JCM.00330-13; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Hung CC, 2007, CLIN INFECT DIS, V45, pE60, DOI 10.1086/520681; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Malawi MoHo, 2010, Q HIV PROGRAMME REPO; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Monique van Lettow AA, 2012, PLOS1 IN PRESS; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; PETIT PLC, 1995, E AFR MED J, V72, P116; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Roca-Feltrer A, 2012, EMERG INFECT DIS, V18, P272, DOI 10.3201/eid1802.111008; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; UNAIDS, 2010, MAL HIV AIDS MON EV; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS362, DOI 10.1093/cid/cir987; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; WHO, 2011, WHONMHMNM111	33	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92226	10.1371/journal.pone.0092226	http://dx.doi.org/10.1371/journal.pone.0092226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643091	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000333259900108
J	Garcia-Alvarez, A; Egan, B; de Klein, S; Dima, L; Maggi, FM; Isoniemi, M; Ribas-Barba, L; Raats, MM; Meissner, EM; Badea, M; Bruno, F; Salmenhaara, M; Mila-Villarroel, R; Knaze, V; Hodgkins, C; Marculescu, A; Uusitalo, L; Restani, P; Serra-Majem, L				Garcia-Alvarez, Alicia; Egan, Bernadette; de Klein, Simone; Dima, Lorena; Maggi, Franco M.; Isoniemi, Merja; Ribas-Barba, Lourdes; Raats, Monique M.; Meissner, Eva Melanie; Badea, Mihaela; Bruno, Flavia; Salmenhaara, Maija; Mila-Villarroel, Raimon; Knaze, Viktoria; Hodgkins, Charo; Marculescu, Angela; Uusitalo, Liisa; Restani, Patrizia; Serra-Majem, Lluis			Usage of Plant Food Supplements across Six European Countries: Findings from the PlantLIBRA Consumer Survey	PLOS ONE			English	Article							NATIONAL-HEALTH; ALTERNATIVE MEDICINE; DIETARY-SUPPLEMENTS; UNITED-STATES; HERBAL SUPPLEMENTS; ADULT-POPULATION; US ADULTS; COMPLEMENTARY; PATTERNS; PREVALENCE	Background: The popularity of botanical products is on the rise in Europe, with consumers using them to complement their diets or to maintain health, and products are taken in many different forms (e. g. teas, juices, herbal medicinal products, plant food supplements (PFS)). However there is a scarcity of data on the usage of such products at European level. Objective: To provide an overview of the characteristics and usage patterns of PFS consumers in six European countries. Design: Data on PFS usage were collected in a cross-sectional, retrospective survey of PFS consumers using a bespoke frequency of PFS usage questionnaire. Subjects/setting: A total sample of 2359 adult PFS consumers from Finland, Germany, Italy, Romania, Spain and the United Kingdom. Data analyses: Descriptive analyses were conducted, with all data stratified by gender, age, and country. Absolute frequencies, percentages and 95% confidence intervals are reported. Results: Overall, an estimated 18.8% of screened survey respondents used at least one PFS. Characteristics of PFS consumers included being older, well-educated, never having smoked and self-reporting health status as "good or very good". Across countries, 491 different botanicals were identified in the PFS products used, with Ginkgo biloba (Ginkgo), Oenothera biennis (Evening primrose) and Cynara scolymus (Artichoke) being most frequently reported; the most popular dose forms were capsules and pills/tablets. Most consumers used one product and half of all users took single-botanical products. Some results varied across countries. Conclusions: The PlantLIBRA consumer survey is unique in reporting on usage patterns of PFS consumers in six European countries. The survey highlights the complexity of measuring the intake of such products, particularly at pan-European level. Incorporating measures of the intake of botanicals in national dietary surveys would provide much-needed data for comprehensive risk and benefit assessments at the European level.	[Garcia-Alvarez, Alicia; Ribas-Barba, Lourdes; Mila-Villarroel, Raimon; Knaze, Viktoria; Serra-Majem, Lluis] Univ Barcelona, Fdn Invest Nutr, Barcelona, Spain; [Egan, Bernadette; Raats, Monique M.; Hodgkins, Charo] Univ Surrey, Food Consumer Behav & Hlth Res Ctr, Guildford GU2 5XH, Surrey, England; [de Klein, Simone; Meissner, Eva Melanie] PhytoLab GmbH & Co KG, Vestenbergsgreuth, Germany; [Dima, Lorena; Badea, Mihaela; Marculescu, Angela] Transilvania Univ Brasov, Brasov, Romania; [Maggi, Franco M.; Bruno, Flavia; Restani, Patrizia] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Isoniemi, Merja; Salmenhaara, Maija; Uusitalo, Liisa] Finnish Food Safety Author Evira, Helsinki, Finland; [Ribas-Barba, Lourdes; Serra-Majem, Lluis] Inst Salud Carlos III, Ciber Obn Fisiopatol Obesidad & Nutr, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Inst Biomed & Hlth Res Las Palmas, Las Palmas Gran Canaria, Spain	University of Barcelona; University of Surrey; Transylvania University of Brasov; University of Milan; Finnish Food Authority; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria	Serra-Majem, L (corresponding author), Univ Barcelona, Fdn Invest Nutr, Barcelona Sci Pk, Barcelona, Spain.	lserra@dcc.ulpgc.es	Badea, Mihaela/B-8240-2012; Garcia-Alvarez, Alicia/AAV-9762-2020; Badea, Mihaela/Z-1490-2018; Milà Villarroel, Raimon/AGR-2823-2022; Raats, Monique/G-5348-2012; Serra-Majem, Lluis/I-6708-2019	Badea, Mihaela/0000-0003-4824-2175; Raats, Monique/0000-0002-8057-2783; Serra-Majem, Lluis/0000-0002-9658-9061; Egan, Bernadette/0000-0002-5767-0457; Hodgkins, Charo/0000-0003-4775-0338; Dima, Lorena/0000-0002-4406-9304	European Community [245199]; European Commission	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245199. It has been carried out within the PlantLIBRA project (www.plantlibra.eu). This report does not necessarily reflect the Commission's views or its future policy on this area. The European Commission had no direct say in the project methods or outcome beyond providing funding for materials and personnel, and did not directly contribute to the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, BIRTH-ISS PERINAT C, V36, P237, DOI 10.1111/j.1523-536X.2009.00328.x; [Anonymous], 2002, OFF J EUR COMMUNIT L, VL183, P51; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Bardia A, 2007, MAYO CLIN PROC, V82, P561, DOI 10.4065/82.5.561; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Bundesinstitut fur Risikobewertung, 2013, TARG GROUP OR RISK C; Centro de Investigacion sobre Fitoterapia, 2007, EST INFITO CONS PLAN; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dwyer J, 2013, AM J CLIN NUTR, V97, P1331, DOI 10.3945/ajcn.112.052373; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.225r; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; European Advisory Service (EAS), 2007, US SUBST NUTR PHYS E; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2663; Federal Office of Consumer Protection and Food Safety (BVL), 2010, SUBST LIST DRAFT LIS; Finger JD, 2013, BUNDESGESUNDHEITSBLA, V56, P607; Foote JA, 2003, AM J EPIDEMIOL, V157, P888, DOI 10.1093/aje/kwg072; Harrison RA, 2004, INT J VITAM NUTR RES, V74, P183, DOI 10.1024/0300-9831.74.3.183; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kelly JP, 2005, ARCH INTERN MED, V165, P281, DOI 10.1001/archinte.165.3.281; Larranaga-Guetaria A, 2012, AGRO FOOD IND HI TEC, V23, P20; Max Rubner Institut, 2008, GERM NAT NUTR SURV N; Menniti-Ippolito F, 2002, EUR J CLIN PHARMACOL, V58, P61, DOI 10.1007/s00228-002-0435-8; Messerer M, 2001, J INTERN MED, V250, P160, DOI 10.1046/j.1365-2796.2001.00872.x; National Center for Health Statistics, 2009, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2003, 2002 NAT HLTH INT SU; Nielsen MW, 2005, ANN PHARMACOTHER, V39, P1534, DOI 10.1345/aph.1G119; Nilsson M, 2001, J INTERN MED, V250, P225, DOI 10.1046/j.1365-2796.2001.00882.x; Picciano MF, 2007, ARCH PEDIAT ADOL MED, V161, P978, DOI 10.1001/archpedi.161.10.978; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Rovira MA, 2013, J NUTR EDUC BEHAV, V45, P386, DOI 10.1016/j.jneb.2012.03.007; Schaffer DM, 2003, J AM DIET ASSOC, V103, P1500, DOI 10.1016/j.jada.2003.08.026; Silano V, 2011, FOOD FUNCT, V2, P710, DOI 10.1039/c1fo10105f; Skeie G, 2009, EUR J CLIN NUTR, V63, pS226, DOI 10.1038/ejcn.2009.83; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Touvier M, 2009, EUR J CLIN NUTR, V63, P39, DOI 10.1038/sj.ejcn.1602907; Vargas-Murga L, 2011, FOOD FUNCT, V2, P731, DOI 10.1039/c1fo10075k; World Health Organization (WHO), 2013, BMI CLASS; Wu CH, 2011, CLIN THER, V33, P1749, DOI 10.1016/j.clinthera.2011.09.024	42	81	81	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92265	10.1371/journal.pone.0092265	http://dx.doi.org/10.1371/journal.pone.0092265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642692	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900115
J	Jia, X; Miao, ZQ; Li, W; Zhang, LC; Feng, CC; He, YH; Bi, XM; Wang, LQ; Du, YW; Hou, M; Hao, DP; Xiao, Y; Chen, LN; Li, KN				Jia, Xu; Miao, Zhengqiang; Li, Wan; Zhang, Liangcai; Feng, Chenchen; He, Yuehan; Bi, Xiaoman; Wang, Liqiang; Du, Youwen; Hou, Min; Hao, Dapeng; Xiao, Yun; Chen, Lina; Li, Kongning			Cancer-Risk Module Identification and Module-Based Disease Risk Evaluation: A Case Study on Lung Cancer	PLOS ONE			English	Article							GENE COEXPRESSION NETWORK; QUALITY-OF-LIFE; DIFFERENTIAL COEXPRESSION; BIOLOGICAL PROCESSES; MULTIPLE GENES; EXPRESSION; INFORMATION; ACTIVATION; MICROARRAY; GROWTH	Gene expression profiles have drawn broad attention in deciphering the pathogenesis of human cancers. Cancer-related gene modules could be identified in co-expression networks and be applied to facilitate cancer research and clinical diagnosis. In this paper, a new method was proposed to identify lung cancer-risk modules and evaluate the module-based disease risks of samples. The results showed that thirty one cancer-risk modules were closely related to the lung cancer genes at the functional level and interactional level, indicating that these modules and genes might synergistically lead to the occurrence of lung cancer. Our method was proved to have good robustness by evaluating the disease risk of samples in eight cancer expression profiles (four for lung cancer and four for other cancers), and had better performance than the WGCNA method. This method could provide assistance to the diagnosis and treatment of cancers and a new clue for explaining cancer mechanisms.	[Jia, Xu; Miao, Zhengqiang; Li, Wan; Zhang, Liangcai; Feng, Chenchen; He, Yuehan; Bi, Xiaoman; Wang, Liqiang; Du, Youwen; Hou, Min; Hao, Dapeng; Xiao, Yun; Chen, Lina; Li, Kongning] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Hei Longjiang P, Peoples R China	Harbin Medical University	Chen, LN (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Hei Longjiang P, Peoples R China.	chenlina@ems.hrbmu.edu.cn; kongningli@hotmail.com	Bi, Xiaoman/AAA-6462-2022; Xiao, Yun/A-8359-2013; Zhang, Liang/GWM-6088-2022; Zhang, Liangcai/AAD-4415-2020	Chen, Lina/0000-0002-4576-6814; Bi, Xiaoman/0000-0003-4464-5014; Li, Wan/0000-0002-9797-0315	National Natural Science Foundation of China [61272388, 31301040]; Oversea Scholars Project; Education Department of Heilongjiang Province [1155H012]; Master Innovation Funds of Heilongjiang Province [YJSCX2012-209HLJ, YJSCX2012-224HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oversea Scholars Project; Education Department of Heilongjiang Province; Master Innovation Funds of Heilongjiang Province	Funding provided by the National Natural Science Foundation of China (No. 61272388 and No. 31301040); Oversea Scholars Project funded by Education Department of Heilongjiang Province (NO. 1155H012); and the Master Innovation Funds of Heilongjiang Province (No. YJSCX2012-209HLJ and YJSCX2012-224HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Cho SB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-109; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Dong LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004895; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fang G, 2010, BIOCOMPUT-PAC SYM, P145; Hollen PJ, 1996, SEMIN ONCOL, V23, P31; Hong Shengjun, 2011, International Journal of Computational Biology and Drug Design, V4, P147, DOI 10.1504/IJCBDD.2011.041008; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kona FR, 2012, BREAST CANCER RES TR, V135, P495, DOI 10.1007/s10549-012-2107-4; Kreiman G, 2004, NUCLEIC ACIDS RES, V32, P2889, DOI 10.1093/nar/gkh614; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lattimore BS, 2005, COMPUT BIOL CHEM, V29, P354, DOI 10.1016/j.compbiolchem.2005.07.002; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; MARCHANDISE FXP, 1989, EUR RESPIR J, V2, P623; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Okabe H, 2001, CANCER RES, V61, P2129; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purmann A, 2007, GENOMICS, V89, P580, DOI 10.1016/j.ygeno.2007.01.010; Reimand J, 2008, NUCLEIC ACIDS RES, V36, pW452, DOI 10.1093/nar/gkn230; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Rusiniak ME, 2012, ONCOGENE, V31, P4034, DOI 10.1038/onc.2011.566; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shakhnovich Boris E, 2004, Genome Inform, V15, P221; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Taniwaki M, 2007, CLIN CANCER RES, V13, P6624, DOI 10.1158/1078-0432.CCR-07-1328; Teschendorff AE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-604; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang Guiping, 2010, Zhongguo Fei Ai Za Zhi, V13, P282, DOI 10.3779/j.issn.1009-3419.2010.04.02; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; West M, 2006, GENOME RES, V16, P559, DOI 10.1101/gr.3851306; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang LC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-38; Zhang YQ, 2012, INT J CANCER, V131, P83, DOI 10.1002/ijc.26346; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	66	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92395	10.1371/journal.pone.0092395	http://dx.doi.org/10.1371/journal.pone.0092395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643254	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900131
J	Li, XY; Tao, H; Xie, KW; Ni, ZH; Yan, YC; Wei, K; Chuang, PY; He, JC; Gu, LY				Li, Xiaoying; Tao, Hua; Xie, Kewei; Ni, Zhaohui; Yan, Yucheng; Wei, Kai; Chuang, Peter Y.; He, John Cijiang; Gu, Leyi			cAMP Signaling Prevents Podocyte Apoptosis via Activation of Protein Kinase A and Mitochondrial Fusion	PLOS ONE			English	Article							GLOMERULAR PODOCYTES; EPITHELIAL-CELLS; MOUSE MODEL; IN-VITRO; PATHWAY; EXPRESSION; RECEPTOR; NEPHROPATHY; DAMAGE; STRESS	Our previous in vitro studies suggested that cyclic AMP (cAMP) signaling prevents adriamycin (ADR) and puromycin aminonucleoside (PAN)-induced apoptosis in podocytes. As cAMP is an important second messenger and plays a key role in cell proliferation, differentiation and cytoskeleton formation via protein kinase A (PKA) or exchange protein directly activated by cAMP (Epac) pathways, we sought to determine the role of PKA or Epac signaling in cAMP-mediated protection of podocytes. In the ADR nephrosis model, we found that forskolin, a selective activator of adenylate cyclase, attenuated albuminuria and improved the expression of podocyte marker WT-1. When podocytes were treated with pCPT-cAMP (a selective cAMP/PKA activator), PKA activation was increased in a time-dependent manner and prevented PAN-induced podocyte loss and caspase 3 activation, as well as a reduction in mitochondrial membrane potential. We found that PAN and ADR resulted in a decrease in Mfn1 expression and mitochondrial fission in podocytes. pCPT-cAMP restored Mfn1 expression in puromycin or ADR-treated podocytes and induced Drp1 phosphorylation, as well as mitochondrial fusion. Treating podocytes with arachidonic acid resulted in mitochondrial fission, podocyte loss and cleaved caspase 3 production. Arachidonic acid abolished the protective effects of pCPT-cAMP on PAN-treated podocytes. Mdivi, a mitochondrial division inhibitor, prevented PAN-induced cleaved caspase 3 production in podocytes. We conclude that activation of cAMP alleviated murine podocyte caused by ADR. PKA signaling resulted in mitochondrial fusion in podocytes, which at least partially mediated the effects of cAMP.	[Li, Xiaoying; Tao, Hua; Xie, Kewei; Ni, Zhaohui; Yan, Yucheng; Wei, Kai; Gu, Leyi] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China; [Li, Xiaoying; Tao, Hua; Xie, Kewei; Ni, Zhaohui; Yan, Yucheng; Wei, Kai; Gu, Leyi] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Mol Cell Lab Kidney Dis, Shanghai 200030, Peoples R China; [Chuang, Peter Y.; He, John Cijiang] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY USA; [He, John Cijiang] James J Peter Vet Affairs Med Ctr, Renal Sect, Bronx, NY USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gu, LY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China.	guleyi@aliyun.com			National Nature Science Foundation Grant of China [30971363, 81270781]; Nature Science Foundation Grant of Shanghai [08ZR1413200]; National Basic Research Program of China 973 Program [2012CB517602]; Nature Science Foundation of Shanghai [10JC1410200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078897] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000345] Funding Source: NIH RePORTER	National Nature Science Foundation Grant of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation Grant of Shanghai; National Basic Research Program of China 973 Program(National Basic Research Program of China); Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Nature Science Foundation Grant of China (30971363 and 81270781, http://www.nsfc.gov.cn) and Nature Science Foundation Grant of Shanghai (08ZR1413200, http://www.stcsm.gov.cn) to Dr Gu. National Basic Research Program of China 973 Program (2012CB517602,http://program.most.gov.cn) to Dr Ni as well as by a grant (10JC1410200,http://www.stcsm.gov.cn) from the Nature Science Foundation of Shanghai to Dr Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparaton of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bek M, 1999, NEPHROL DIAL TRANSPL, V14, P581, DOI 10.1093/ndt/14.3.581; Bridgewater DJ, 2005, KIDNEY INT, V67, P1308, DOI 10.1111/j.1523-1755.2005.00208.x; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Cowell RM, 2008, NEUROSCI LETT, V439, P269, DOI 10.1016/j.neulet.2008.04.104; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Endlich N, 2002, MICROSC RES TECHNIQ, V57, P228, DOI 10.1002/jemt.10079; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Gao SY, 2007, CELL TISSUE RES, V328, P391, DOI 10.1007/s00441-006-0365-3; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gu LY, 2013, AIDS, V27, P1091, DOI 10.1097/QAD.0b013e32835f1ea1; Gu LY, 2012, KIDNEY INT, V81, P458, DOI 10.1038/ki.2011.406; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Huber TB, 1998, J AM SOC NEPHROL, V9, P335; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Keravis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028899; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Li Y, 2008, AM J PHYSIOL-RENAL, V295, pF525, DOI 10.1152/ajprenal.00448.2007; Marshall CB, 2006, KIDNEY INT, V70, P1962, DOI 10.1038/sj.ki.5001965; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Oba S, 2008, NEPHROL DIAL TRANSPL, V23, P510, DOI 10.1093/ndt/gfm600; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Qin Y, 2012, BRIT J PHARMACOL, V165, P1137, DOI 10.1111/j.1476-5381.2011.01594.x; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Ruster C, 2011, AM J NEPHROL, V34, P309, DOI 10.1159/000329321; Saito Y, 2010, AM J PHYSIOL-RENAL, V298, pF1436, DOI 10.1152/ajprenal.00512.2009; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Stokman G, 2011, J AM SOC NEPHROL, V22, P859, DOI 10.1681/ASN.2010040423; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Wada T, 2005, KIDNEY INT, V68, P1618, DOI 10.1111/j.1523-1755.2005.00574.x; Xiao HQ, 2009, AM J NEPHROL, V30, P34, DOI 10.1159/000200769; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhong YF, 2012, KIDNEY INT, V81, P856, DOI 10.1038/ki.2011.467; Zhu CH, 2011, AM J PATHOL, V178, P2020, DOI 10.1016/j.ajpath.2011.01.029	43	23	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92003	10.1371/journal.pone.0092003	http://dx.doi.org/10.1371/journal.pone.0092003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642777	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900058
J	Li, YL; Zheng, J; Li, QS				Li Yunlan; Zheng Juan; Li Qingshan			Antitumor Activity of Di-n-Butyl-(2,6-Difluorobenzohydroxamato) Tin(IV) against Human Gastric Carcinoma SGC-7901 Cells via G2/M Cell Cycle Arrest and Cell Apoptosis	PLOS ONE			English	Article							ACTIVATION; PHOSPHORYLATION; CHECKPOINTS; MECHANISMS; PATHWAY; PHASE; P53	Di-n-butyl-(2,6-difluorobenzohydroxamato) Tin(IV) (DBDFT), a potential antitumor agent against malignancies, exhibited high activities both in vitro and in vivo. Flow cytometric analysis showed that treatment with DBDFT against Human Gastric Carcinoma (SGC-7901) cells induced a concentration and time-dependent cell accumulation in the G2/M phase of the cell cycle with a parallel depletion of the percentage of cells in G0/G1, the cell apoptosis was observed by characteristic morphological changes and AnnexinV/PI dual-immunofluorescence staining. Fluorescence quantitative FQ-PCR and western blot results showed that G2/M-phase arrest was correlated with up-regulation of cyclin dependent kinase inhibitor p21, Chk2 and CyclinB1, whereas the expressions of other G2/M regulatory check-point protein, Cdc2, and feedback loop protein Cdc25C were obviously down-regulated in a p53-independent manner after the SGC-7901 cells were treated with DBDFT (2.5, 5.0, 7.5 mu mol.L-1) compared with the control. Furthermore, the up-regulation of Bax and down-regulation of Bcl-2 as well as the activation of caspase-3 were observed, which indicated that DBDFT treatment triggered the mitochondrial apoptotic pathway with an increase of Bax/Bcl-2 ratios, resulting in mitochondrial membrane potential loss and caspase-9 activation in DBDFT treated SGC-7901 cells. In summary, the results illustrated the involvement of multiple signaling pathways targeted by DBDFT in mediating G2/M cell cycle arrest and apoptosis in SGC-7901 cells, which suggested that DBDFT might have therapeutic potential against gastric carcinoma as an effective compound.	[Li Yunlan; Zheng Juan; Li Qingshan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Peoples R China	Shanxi Medical University	Li, YL (corresponding author), Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Peoples R China.	liyunlanrr@163.com; qingshanl@yahoo.com			National Natural Science Foundation of China [30973603]; State Key Science and Technology of China [2009ZX09103-104]; Shanxi Foundation for overseas returned [2010-54]; science and technology activities [201368]; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Shanxi Province Foundation Science for Youths; Foundation for the Younth Doctor from Shanxi Medical University; Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Science and Technology of China; Shanxi Foundation for overseas returned; science and technology activities; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Shanxi Province Foundation Science for Youths; Foundation for the Younth Doctor from Shanxi Medical University; Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi province	This research was supported by the National Natural Science Foundation of China (No. 30973603), the "Innovative Drug Development'' State Key Science and Technology of China (No. 2009ZX09103-104), the Shanxi Foundation for overseas returned (No. 2010-54) and preferred project supported by the science and technology activities (No. 201368), the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province and by Shanxi Province Foundation Science for Youths, the Foundation for the Younth Doctor from Shanxi Medical University in 2008 and Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi province(2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Baul TSB, 2008, J INORG BIOCHEM, V102, P1719, DOI 10.1016/j.jinorgbio.2008.05.001; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen YL, 2006, BIOCHEM PHARMACOL, V72, P308, DOI 10.1016/j.bcp.2006.04.031; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Gielen M, 2003, J BRAZIL CHEM SOC, V14, P870, DOI 10.1590/S0103-50532003000600003; Gielen M, 1997, Met Based Drugs, V4, P193, DOI 10.1155/MBD.1997.193; Grivicich I, 2005, ONCOL RES, V15, P385, DOI 10.3727/096504005776449680; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho John W., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P131, DOI 10.2174/1568011053174819; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Li QS, 2004, CHEM-EUR J, V10, P1456, DOI 10.1002/chem.200305266; Li YL, 2010, MOL CARCINOGEN, V49, P566, DOI 10.1002/mc.20623; Lian FR, 1998, NUTR CANCER, V31, P184, DOI 10.1080/01635589809514701; LIEBERMANN DA, 1995, ONCOGENE, V11, P199; McShea A, 2000, J BIOL CHEM, V275, P23181, DOI 10.1074/jbc.M001772200; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Tabassum S, 2006, J ORGANOMET CHEM, V691, P1761, DOI 10.1016/j.jorganchem.2005.12.033; Tang L, 2012, TOXICOL LETT, V213, P167, DOI 10.1016/j.toxlet.2012.06.008; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; WANG XW, 2001, NUCLEIC ACIDS RES, V29, P2020; Yin H, 1999, CHEM RES, V4, P54; Yu J, 2007, CARCINOGENESIS, V28, P632, DOI 10.1093/carcin/bgl168; Yunlan L, 1997, J INORGANIC BIOCH, V102, P1731; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; 尚先梅, 2008, [中国科学. B辑, 化学, Science in China. Series B, Chemistry], V38, P429	36	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90793	10.1371/journal.pone.0090793	http://dx.doi.org/10.1371/journal.pone.0090793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643073	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900008
J	Poormasjedi-Meibod, MS; Hartwell, R; Kilani, RT; Ghahary, A				Poormasjedi-Meibod, Malihe-Sadat; Hartwell, Ryan; Kilani, Ruhangiz Taghi; Ghahary, Aziz			Anti-Scarring Properties of Different Tryptophan Derivatives	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HYPERTROPHIC SCAR; INDOLEAMINE 2,3-DIOXYGENASE; SKIN SUBSTITUTE; MATRIX METALLOPROTEINASES; ONCOFETAL FIBRONECTIN; EXTRACELLULAR-MATRIX; LOCAL EXPRESSION	Hypertrophic scars are associated with prolonged extracellular matrix (ECM) production, aberrant ECM degradation and high tissue cellularity. Routinely used antifibrotic strategies aim to reduce ECM deposition and enhance matrix remodeling. Our previous study investigating the antifibrotic effects of indoleamine2, 3 dioxygenase (IDO) led to the identification of kynurenine (Kyn) as an antiscarring agent. A topical antifibrogenic therapy using Kyn is very attractive; however, it is well established that Kyn passes the blood brain barrier (BBB) which causes complications including excitatory neuronal death. Here we investigated the antiscarring properties of kynurenic acid (KynA), a downstream end product of Kyn that is unlikely to pass the BBB, as an effective and safe replacement for Kyn. Our results indicated that while not having any adverse effect on dermal cell viability, KynA significantly increases the expression of matrix metalloproteinases (MMP1 and MMP3) and suppresses the production of type-I collagen and fibronectin by fibroblasts. Topical application of cream containing KynA in fibrotic rabbit ear significantly decreased scar elevation index (1.13 +/- 0.13 vs. 1.61 +/- 0.12) and tissue cellularity (221.38 +/- 21.7 vs. 314.5 +/- 68.66 cells/hpf) in KynA treated wounds compared to controls. KynA treated wounds exhibited lower levels of collagen deposition which is accompanied with a significant decrease in type-I collagen and fibronectin expression, as well as an increase in MMP1 expression compared to untreated wounds or wounds treated with cream only. The results of this study provided evidence for the first time that KynA is promising candidate antifibrogenic agent to improve healing outcome in patients at risk of hypertrophic scarring.	[Poormasjedi-Meibod, Malihe-Sadat; Hartwell, Ryan; Kilani, Ruhangiz Taghi; Ghahary, Aziz] Univ British Columbia, Dept Surg, Div Plast Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Ghahary, A (corresponding author), Univ British Columbia, Dept Surg, Div Plast Surg, Vancouver, BC V6T 1W5, Canada.	aghahary@mail.ubc.ca			Collaborative Health Research Projects (CHRP); Vanier Canada Graduate Scholarship (Vanier CGS), Transplantation Scholarship Training awards; CIHR Skin Research Training Centre	Collaborative Health Research Projects (CHRP)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship (Vanier CGS), Transplantation Scholarship Training awards; CIHR Skin Research Training Centre(Canadian Institutes of Health Research (CIHR))	This study was supported by the Collaborative Health Research Projects (CHRP). M. P. was supported by Vanier Canada Graduate Scholarship (Vanier CGS), Transplantation Scholarship Training awards and CIHR Skin Research Training Centre awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Montilla N, 2013, BLOOD, V121, pE108, DOI 10.1182/blood-2012-07-445106; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; BALDWIN D, 1995, INT CLIN PSYCHOPHARM, V9, P41, DOI 10.1097/00004850-199501004-00006; Baumann P, 2002, EUR NEUROPSYCHOPHARM, V12, P433, DOI 10.1016/S0924-977X(02)00051-2; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BENDER DA, 1982, BIOCHIM BIOPHYS ACTA, V717, P56, DOI 10.1016/0304-4165(82)90379-8; BORDEN JH, 1976, SCIENCE, V192, P894, DOI 10.1126/science.1273573; Chavez-Munoz C, 2012, J INVEST DERMATOL, V132, P1501, DOI 10.1038/jid.2011.467; COOPER SM, 1979, ARTHRITIS RHEUM, V22, P983, DOI 10.1002/art.1780220906; Dasu MRK, 2004, J PATHOL, V202, P476, DOI 10.1002/path.1539; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Ding Y, 2012, FEBS LETT, V586, P1813, DOI 10.1016/j.febslet.2012.05.020; Forouzandeh F, 2010, WOUND REPAIR REGEN, V18, P614, DOI 10.1111/j.1524-475X.2010.00635.x; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Ghahary A, 1996, J INVEST DERMATOL, V106, P476, DOI 10.1111/1523-1747.ep12343658; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Ghahary Aziz, 1993, Wound Repair and Regeneration, V1, P166, DOI 10.1046/j.1524-475X.1993.10306.x; Hayashi S, 2012, J DERMATOL SCI, V67, P20, DOI 10.1016/j.jdermsci.2012.02.013; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Huang JS, 2002, FASEB J, V16, P1269, DOI 10.1096/fj.02-0103fje; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Ishida M, 2010, CARCINOGENESIS, V31, P287, DOI 10.1093/carcin/bgp222; KISCHER CW, 1983, CELL TISSUE RES, V231, P29; KISCHER CW, 1989, CONNECT TISSUE RES, V23, P279, DOI 10.3109/03008208909005627; Kohan M, 2010, FASEB J, V24, P4503, DOI 10.1096/fj.10-154435; Kung T, 2009, BIOCHEM PHARMACOL, V77, P536, DOI 10.1016/j.bcp.2008.09.031; Li M, 2009, MOL CELL BIOCHEM, V332, P1, DOI 10.1007/s11010-009-0167-5; Li Y, 2013, J INVEST DERMATOL; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; McDonald GA, 2003, AM J PHYSIOL-RENAL, V285, pF59, DOI 10.1152/ajprenal.00157.2002; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; Murphy KA, 2004, J BIOL CHEM, V279, P25284, DOI 10.1074/jbc.M402168200; Nakagami Y, 1996, JPN J PHARMACOL, V71, P183, DOI 10.1254/jjp.71.183; Okuda S, 1998, J NEUROCHEM, V70, P299; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; RAFFA RB, 1993, J PHARMACOL EXP THER, V267, P331; Rahmani-Neishaboor E, 2010, WOUND REPAIR REGEN, V18, P401, DOI 10.1111/j.1524-475X.2010.00598.x; RENNARD SI, 1981, P NATL ACAD SCI-BIOL, V78, P7147, DOI 10.1073/pnas.78.11.7147; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; Singer AJ, 2009, J BURN CARE RES, V30, P329, DOI 10.1097/BCR.0b013e31819a6369; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Tredget EE, 1999, ANN NY ACAD SCI, V888, P165, DOI 10.1111/j.1749-6632.1999.tb07955.x; Tuan TL, 1998, MOL MED TODAY, V4, P19, DOI 10.1016/S1357-4310(97)80541-2; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; WELCH MP, 1990, J CELL BIOL, V110, P133, DOI 10.1083/jcb.110.1.133; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005	58	31	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91955	10.1371/journal.pone.0091955	http://dx.doi.org/10.1371/journal.pone.0091955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637853	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100089
J	Zhai, R; Liu, XT; Feng, WT; Chen, SS; Xu, LF; Wang, ZG; Zhang, JL; Li, PM; Ma, FW				Zhai, Rui; Liu, Xiao-Ting; Feng, Wen-Ting; Chen, Sha-Sha; Xu, Ling-Fei; Wang, Zhi-Gang; Zhang, Jiang-Li; Li, Peng-Min; Ma, Feng-Wang			Different Biosynthesis Patterns among Flavonoid 3-glycosides with Distinct Effects on Accumulation of Other Flavonoid Metabolites in Pears (Pyrus bretschneideri Rehd.)	PLOS ONE			English	Article							PYRIFOLIA NAKAI; ANTHOCYANIN ACCUMULATION; PHENOLIC-COMPOUNDS; GENE-EXPRESSION; RED; LIGHT; SKIN	Flavonoid biosynthesis profile was clarified by fruit bagging and re-exposure treatments in the green Chinese pear 'Zaosu' (Pyrus bretschneideri Rehd.) and its red mutant 'Red Zaosu'. Two distinct biosynthesis patterns of flavonoid 3-glycosides were found in 'Zaosu' pear. By comparison with 'Red Zaosu', the biosynthesis of flavonoid 3-galactosides and flavonoid 3-arabinosides were inhibited by bagging and these compounds only re-accumulated to a small degree in the fruit peel of 'Zaosu' after the bags were removed. In contrast, the biosynthesis of flavonoid 3-gluctosides and flavonoid 3-rutinosides was reduced by bagging and then increased when the fruits were re-exposed to sunlight. A combination of correlation, multicollinearity test and partial-correlation analyses among major flavonoid metabolites indicated that biosynthesis of each phenolic compound was independent in 'Zaosu' pear, except for the positive correlation between flavonoid 3-rutincosides and flavanols. In contrast with the green pear cultivar, almost all phenolic compounds in the red mutant had similar biosynthesis patterns except for arbutin. However, only the biosynthesis of flavonoid 3-galactosides was relatively independent and strongly affected the synthesis of the other phenolic compounds. Therefore, we propose a hypothesis that the strong accumulation of flavonoid 3-galactosides stimulated the biosynthesis of other flavonoid compounds in the red mutant and, therefore, caused systemic variation of flavonoid biosynthesis profiles between 'Zaosu' and its red mutant. This hypothesis had been further demonstrated by the enzyme activity of UFGT, and transcript levels of flavonoid biosynthetic genes and been well tested by a stepwise linear regression forecasting model. The gene that encodes flavonoid 3-galacosyltransferase was also identified and isolated from the pear genome.	[Zhai, Rui; Liu, Xiao-Ting; Feng, Wen-Ting; Chen, Sha-Sha; Xu, Ling-Fei; Wang, Zhi-Gang; Zhang, Jiang-Li; Li, Peng-Min; Ma, Feng-Wang] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Xu, LF (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	lingfxu2013@sina.com		Li, Pengmin/0000-0003-3514-0153	National Natural Science Foundation of China [31171925]; Fundamental Research Funds for the Central Universities [ZD201300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 31171925)326 and the Fundamental Research Funds for the Central Universities (No. ZD201300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MA, 2001, SCI HORTIC-AMSTERDAM, V90, P69, DOI 10.1016/S0304-4238(00)00255-7; Chen CS, 2012, SCI HORTIC-AMSTERDAM, V142, P68, DOI 10.1016/j.scienta.2012.05.001; Feng ShouQian, 2008, Agricultural Sciences in China, V7, P1318, DOI 10.1016/S1671-2927(08)60180-7; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Fonseca S, 2004, PLANT SCI, V167, P457, DOI 10.1016/j.plantsci.2004.03.033; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Huang CH, 2009, SCI HORTIC-AMSTERDAM, V121, P149, DOI 10.1016/j.scienta.2009.01.031; Jakopic J, 2009, SCI HORTIC-AMSTERDAM, V123, P234, DOI 10.1016/j.scienta.2009.09.004; JU ZG, 1995, SCI HORTIC-AMSTERDAM, V61, P215, DOI 10.1016/0304-4238(94)00739-3; Ju ZG, 1998, SCI HORTIC-AMSTERDAM, V77, P155, DOI 10.1016/S0304-4238(98)00161-7; Kim SH, 2003, PLANT SCI, V165, P403, DOI 10.1016/S0168-9452(03)00201-2; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Li PM, 2008, PHYSIOL PLANTARUM, V134, P486, DOI 10.1111/j.1399-3054.2008.01155.x; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu YJ, 2012, NEW ZEAL J CROP HORT, V40, P87, DOI 10.1080/01140671.2011.610325; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; Neill SO, 2003, FUNCT PLANT BIOL, V30, P865, DOI 10.1071/FP03118; Qian MJ, 2013, SCI HORTIC-AMSTERDAM, V151, P75, DOI 10.1016/j.scienta.2012.12.020; RITENOUR M, 1997, HORTSCIENCE, V32, P272; Ryan KG, 2001, Z NATURFORSCH C, V56, P745; Szankowski I, 2009, PLANTA, V229, P681, DOI 10.1007/s00425-008-0864-4; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Wang ZG, 2013, PLANT PHYSIOL, V162, P885, DOI 10.1104/pp.113.214700; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yang YN, 2013, TREE GENET GENOMES, V9, P75; Yu B, 2012, SCI HORTIC-AMSTERDAM, V136, P29, DOI 10.1016/j.scienta.2011.12.026; Zhang D, 2012, SCI HORTIC-AMSTERDAM, V134, P53, DOI 10.1016/j.scienta.2011.10.025; Zhang YZ, 2010, FOOD CHEM, V123, P1013, DOI 10.1016/j.foodchem.2010.05.053	30	16	16	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91945	10.1371/journal.pone.0091945	http://dx.doi.org/10.1371/journal.pone.0091945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637788	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100087
J	Zhu, HD; Zhou, JM; Ni, YX; Yu, ZY; Mao, AH; Hu, YY; Wang, W; Zhang, XH; Wen, LB; Li, B; Wang, XM; Yu, Y; Lv, LX; Guo, RL; Lu, CP; He, KW				Zhu, Haodan; Zhou, Junming; Ni, Yanxiu; Yu, Zhengyu; Mao, Aihua; Hu, Yiyi; Wang, Wei; Zhang, Xuehan; Wen, Libin; Li, Bin; Wang, Xiaomin; Yu, Yang; Lv, Lixin; Guo, Rongli; Lu, Chengping; He, Kongwang			Contribution of Eukaryotic-Type Serine/Threonine Kinase to Stress Response and Virulence of Streptococcus suis	PLOS ONE			English	Article							PROTEIN-KINASE; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; FULL VIRULENCE; SER/THR KINASE; IDENTIFICATION; SEROTYPE-2; PATHOGENESIS; PHOSPHATASE	Streptococcus suis serotype 2 (SS2) is an important swine and human pathogen responsible for septicemia and meningitis. The bacterial homologues of eukaryotic-type serine/threonine kinases (ESTKs) have been reported to play critical roles in various cellular processes. To investigate the role of STK in SS2, an isogenic stk mutant strain (Dstk) and a complemented strain (CDstk) were constructed. The Dstk showed a significant decrease in adherence to HEp-2 cells, compared with the wild-type strain, and a reduced survival ratio in whole blood. In addition, the Dstk exhibited a notable reduced tolerance of environmental stresses including high temperature, acidic pH, oxidative stress, and high osmolarity. More importantly, the Dstk was attenuated in both the CD1 mouse and piglet models of infection. The results of quantitative reverse transcription-PCR (qRT-PCR) analysis indicated that the expressions of a few genes involving in adherence, stress response and virulence were clearly decreased in the Dstk mutant strain. Our data suggest that SsSTK is required for virulence and stress response in SS2.	[Zhu, Haodan; Zhou, Junming; Ni, Yanxiu; Yu, Zhengyu; Mao, Aihua; Hu, Yiyi; Wang, Wei; Zhang, Xuehan; Wen, Libin; Li, Bin; Wang, Xiaomin; Yu, Yang; Lv, Lixin; Guo, Rongli; He, Kongwang] Natl Ctr Engn Res Vet Bioprod, Jiangsu Acad Agr Sci, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China; [Zhu, Haodan; Zhou, Junming; Ni, Yanxiu; Yu, Zhengyu; Mao, Aihua; Hu, Yiyi; Wang, Wei; Zhang, Xuehan; Wen, Libin; Li, Bin; Wang, Xiaomin; Yu, Yang; Lv, Lixin; Guo, Rongli; He, Kongwang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China; [Lu, Chengping] Nanjing Agr Univ, Key Lab Anim Bacteriol, Minist Agr, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	He, KW (corresponding author), Natl Ctr Engn Res Vet Bioprod, Jiangsu Acad Agr Sci, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China.	kwh2003@263.net			National Natural Science Foundation of China [31302114, 31072155]; China Postdoctoral Science Foundation [2012M521026]; Innovation of Agricultural Sciences in Jiangsu province [CX(11)2060]; Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture [201303041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation of Agricultural Sciences in Jiangsu province; Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture	This work was supported by National Natural Science Foundation of China (31302114 and 31072155), China Postdoctoral Science Foundation Grant (2012M521026), Innovation of Agricultural Sciences in Jiangsu province (CX(11)2060), and Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (201303041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Banu LD, 2010, INFECT IMMUN, V78, P2209, DOI 10.1128/IAI.01167-09; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Bonifait L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-42; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Bugrysheva J, 2011, INFECT IMMUN, V79, P4201, DOI 10.1128/IAI.05360-11; Burnside K, 2011, FUTURE MICROBIOL, V6, P747, DOI [10.2217/FMB.11.62, 10.2217/fmb.11.62]; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jang J, 2010, MICROBIOL-SGM, V156, P1619, DOI 10.1099/mic.0.038133-0; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Lapointe L, 2002, CAN J VET RES, V66, P8; Li J, VET MICROBIOL, V148, P99; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Misra SK, 2011, PROTEOMICS, V11, P4155, DOI 10.1002/pmic.201100259; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tang YL, 2012, VET MICROBIOL, V158, P360, DOI 10.1016/j.vetmic.2012.02.028; Tran LSP, 1999, APPL MICROBIOL BIOT, V52, P845, DOI 10.1007/s002530051602; Vanier G, 2004, INFECT IMMUN, V72, P1441, DOI 10.1128/IAI.72.3.1441-1449.2004; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Wu T, 2011, MICROB PATHOGENESIS, V51, P69, DOI 10.1016/j.micpath.2010.10.001; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zhang XH, 2009, MICROB PATHOGENESIS, V47, P267, DOI 10.1016/j.micpath.2009.09.001; Zhu HD, 2011, MICROB PATHOGENESIS, V51, P442, DOI 10.1016/j.micpath.2011.08.002	59	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91971	10.1371/journal.pone.0091971	http://dx.doi.org/10.1371/journal.pone.0091971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637959	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100092
J	Oh, YT; Park, Y; Yoon, MY; Bari, W; Go, J; Min, KB; Raskin, DM; Lee, KM; Yoon, SS				Oh, Young Taek; Park, Yongjin; Yoon, Mi Young; Bari, Wasimul; Go, Junhyeok; Min, Kyung Bae; Raskin, David M.; Lee, Kang-Mu; Yoon, Sang Sun			Cholera Toxin Production during Anaerobic Trimethylamine N-Oxide Respiration Is Mediated by Stringent Response in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Cholera Toxin; Respiration; Stress Response; Virulence Factors; Anaerobic Respiration; Stringent Response; Vibrio cholerae	VIRULENCE GENE-EXPRESSION; OUTER-MEMBRANE PROTEINS; RIBOSOMAL-RNA PROMOTERS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; OMEGA-SUBUNIT; EL-TOR; MYCOBACTERIUM-TUBERCULOSIS; BIOFILM FORMATION; STRESS SURVIVAL	Background: Cholera toxin (CT) production is induced during anaerobic respiration with trimethylamine N-oxide (TMAO) in Vibrio cholerae. Results: A bacterial stringent response to nutrient starvation was activated during anaerobic TMAO respiration and influenced CT production. Conclusion: CT production during anaerobic TMAO respiration is mediated by stringent response in V. cholerae.Significance: A mechanism of TMAO-stimulated CT production is uncovered. As a facultative anaerobe, Vibrio cholerae can grow by anaerobic respiration. Production of cholera toxin (CT), a major virulence factor of V. cholerae, is highly promoted during anaerobic growth using trimethylamine N-oxide (TMAO) as an alternative electron acceptor. Here, we investigated the molecular mechanisms of TMAO-stimulated CT production and uncovered the crucial involvement of stringent response in this process. V. cholerae 7th pandemic strain N16961 produced a significantly elevated level of ppGpp, the bacterial stringent response alarmone, during anaerobic TMAO respiration. Bacterial viability was impaired, and DNA replication was also affected under the same growth condition, further suggesting that stringent response is induced. A relA spoT ppGpp overproducer strain produced an enhanced level of CT, whereas anaerobic growth via TMAO respiration was severely inhibited. In contrast, a ppGpp-null strain (relA spoT relV) grew substantially better, but produced no CT, suggesting that CT production and bacterial growth are inversely regulated in response to ppGpp accumulation. Bacterial capability to produce CT was completely lost when the dksA gene, which encodes a protein that works cooperatively with ppGpp, was deleted. In the dksA mutant, stringent response growth inhibition was alleviated, further supporting the inverse regulation of CT production and anaerobic growth. In vivo virulence of relA spoT relV or dksA mutants was significantly attenuated. The relA spoT mutant maintained virulence when infected with exogenous TMAO despite its defective growth. Together, our results reveal that stringent response is activated under TMAO-stimulated anaerobic growth, and it regulates CT production in a growth-dependent manner in V. cholerae.	[Oh, Young Taek; Park, Yongjin; Yoon, Mi Young; Bari, Wasimul; Go, Junhyeok; Min, Kyung Bae; Lee, Kang-Mu; Yoon, Sang Sun] Yonsei Univ, Dept Microbiol & Immunol, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul 120752, South Korea; [Raskin, David M.] Marian Univ, Coll Osteopath Med, Indianapolis, IN 46222 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, KM (corresponding author), Yonsei Univ, Dept Microbiol & Immunol, Coll Med, 250 Seongsanno, Seoul 120752, South Korea.	kmlee@yuhs.ac; sangsun_yoon@yuhs.ac	Raskin, David/AAZ-5973-2021; Yoon, Mi Young/ACQ-1374-2022	Raskin, David/0000-0001-7421-7809; LEE, Kang-Mu/0000-0001-7414-5921; Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea - Korean Government (MEST) [2011-0016210]; NRF of Korea - Ministry of Education [2013R1A6A3A01064850]	National Research Foundation (NRF) of Korea - Korean Government (MEST); NRF of Korea - Ministry of Education	This work was supported by National Research Foundation (NRF) of Korea Grant 2011-0016210, funded by the Korean Government (MEST). This work was also supported by Basic Science Research Program Grant 2013R1A6A3A01064850, through the NRF of Korea, funded by the Ministry of Education.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Balzer GJ, 2002, CAN J MICROBIOL, V48, P675, DOI 10.1139/W02-060; Bari W, 2012, J MICROBIOL, V50, P631, DOI 10.1007/s12275-012-2116-3; Bernardo LMD, 2009, J BIOL CHEM, V284, P828, DOI 10.1074/jbc.M807707200; Boes N, 2008, J BACTERIOL, V190, P7189, DOI 10.1128/JB.00600-08; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Ferullo DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000300; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; GENTRY DR, 1989, J BACTERIOL, V171, P1271, DOI 10.1128/jb.171.3.1271-1277.1989; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; He HJ, 2012, J BACTERIOL, V194, P2962, DOI 10.1128/JB.00014-12; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jain V, 2006, J MICROBIOL, V44, P1; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Klose KE, 2001, INT J MED MICROBIOL, V291, P81, DOI 10.1078/1438-4221-00104; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Krishnan HH, 2004, INFECT IMMUN, V72, P3961, DOI 10.1128/IAI.72.7.3961-3967.2004; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mallik P, 2006, J BACTERIOL, V188, P5775, DOI 10.1128/JB.00276-06; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Na HS, 2006, VACCINE, V24, P2027, DOI 10.1016/j.vaccine.2005.11.031; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Pal RR, 2011, INDIAN J MED RES, V133, P212; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	65	18	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13232	13242		10.1074/jbc.M113.540088	http://dx.doi.org/10.1074/jbc.M113.540088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648517	Green Published, hybrid			2022-12-25	WOS:000335522800024
J	Li, W; Sharma, M; Kaur, P				Li, Wen; Sharma, Madhu; Kaur, Parjit			The DrrAB Efflux System of Streptomyces peucetius Is a Multidrug Transporter of Broad Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Anticancer Drug; Drug Resistance; Multidrug Transporters; Protein Drug Interactions; Competitive Inhibition; Drug Binding Sites; Inside-out Membrane Vesicles; Non-competitive Inhibition; Single-drug Transporters	NUCLEOTIDE-BINDING DOMAINS; P-GLYCOPROTEIN; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; ATPASE ACTIVITY; CRYSTAL-STRUCTURE; LIPID-BILAYER; DRUG-BINDING; RESISTANCE; MECHANISM	Background: DrrAB is dedicated to export of doxorubicin in Streptomyces peucetius, an organism that produces this anticancer drug. Whether this prototype system can export other drugs has not been investigated. Results: DrrAB exports multiple drugs efficiently. Conclusion: Substrate specificity of DrrAB overlaps with known bacterial and human multidrug resistance proteins. Significance: This study suggests common mechanisms and origin for DrrAB and other MDR proteins. The soil bacterium Streptomyces peucetius produces two widely used anticancer antibiotics, doxorubicin and daunorubicin. Present within the biosynthesis gene cluster in S. peucetius is the drrAB operon, which codes for a dedicated ABC (ATP binding cassette)-type transporter for the export of these two closely related antibiotics. Because of its dedicated nature, the DrrAB system is believed to belong to the category of single-drug transporters. However, whether it also contains specificity for other known substrates of multidrug transporters has never been tested. In this study we demonstrate under both in vivo and in vitro conditions that the DrrAB system can transport not only doxorubicin but is also able to export two most commonly studied MDR substrates, Hoechst 33342 and ethidium bromide. Moreover, we demonstrate that many other substrates (including verapamil, vinblastine, and rifampicin) of the well studied multidrug transporters inhibit DrrAB-mediated Dox transport with high efficiency, indicating that they are also substrates of the DrrAB pump. Kinetic studies show that inhibition of doxorubicin transport by Hoechst 33342 and rifampicin occurs by a competitive mechanism, whereas verapamil inhibits transport by a non-competitive mechanism, thus suggesting the possibility of more than one drug binding site in the DrrAB system. This is the first in-depth study of a drug resistance system from a producer organism, and it shows that a dedicated efflux system like DrrAB contains specificity for multiple drugs. The significance of these findings in evolution of poly-specificity in drug resistance systems is discussed.	[Li, Wen; Sharma, Madhu; Kaur, Parjit] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), Georgia State Univ, Dept Biol, 161 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	pkaur@gsu.edu			National Institutes of Health [GM51981-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051981, R29GM051981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51981-09 (to P. K.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANGOV E, 1988, J BACTERIOL, V170, P459, DOI 10.1128/jb.170.1.459-462.1988; AWASTHI S, 1994, J CLIN INVEST, V93, P958, DOI 10.1172/JCI117102; Ayesh S, 1996, BBA-MOL BASIS DIS, V1316, P8, DOI 10.1016/0925-4439(96)00008-7; BLANC V, 1995, MOL MICROBIOL, V17, P989, DOI 10.1111/j.1365-2958.1995.mmi_17050989.x; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Chambon MH, 1998, ANAL BIOCHEM, V263, P198, DOI 10.1006/abio.1998.2790; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Ernst R, 2006, J BIOL CHEM, V281, P27471, DOI 10.1074/jbc.M601131200; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gandlur SM, 2004, J BIOL CHEM, V279, P27799, DOI 10.1074/jbc.M402898200; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Holland I.B., 2003, ABC PROTEINS BACTERI, P3; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kaur P, 1998, J BIOL CHEM, V273, P17933, DOI 10.1074/jbc.273.28.17933; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Li W, 2013, J BIOL CHEM, V288, P11854, DOI 10.1074/jbc.M112.441915; Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Mazurkiewicz P, 2004, BBA-BIOENERGETICS, V1658, P252, DOI 10.1016/j.bbabio.2004.06.004; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Parveen Z, 2011, MOL PHARMACOL, V79, P443, DOI 10.1124/mol.110.067611; PAWAGI AB, 1994, J MOL BIOL, V235, P554, DOI 10.1006/jmbi.1994.1013; Poelarends GJ, 2002, BBA-BIOENERGETICS, V1555, P1, DOI 10.1016/S0005-2728(02)00246-3; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Rao DK, 2008, BIOCHEMISTRY-US, V47, P3038, DOI 10.1021/bi701699a; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SAFA AR, 1987, J BIOL CHEM, V262, P7884; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P115, DOI 10.1111/j.1432-1033.1997.00115.x; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Sharom F.J., 2007, DRUG TRANSPORTERS MO, P223; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang H, 2010, J BIOL CHEM, V285, P38324, DOI 10.1074/jbc.M110.131540	71	30	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12633	12646		10.1074/jbc.M113.536136	http://dx.doi.org/10.1074/jbc.M113.536136			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634217	hybrid, Green Published			2022-12-25	WOS:000335581400035
J	Muller, PA; Dhamne, SC; Vahabzadeh-Hagh, AM; Pascual-Leone, A; Jensen, FE; Rotenberg, A				Muller, Paul A.; Dhamne, Sameer C.; Vahabzadeh-Hagh, Andrew M.; Pascual-Leone, Alvaro; Jensen, Frances E.; Rotenberg, Alexander			Suppression of Motor Cortical Excitability in Anesthetized Rats by Low Frequency Repetitive Transcranial Magnetic Stimulation	PLOS ONE			English	Article							LONG-TERM DEPRESSION; VALERIC ACID APV; CORTICOSPINAL EXCITABILITY; CORTEX EXCITABILITY; STATUS EPILEPTICUS; NMDA RECEPTORS; ELECTRIC-FIELD; MODULATION; INHIBITION; RTMS	Repetitive transcranial magnetic stimulation (rTMS) is a widely-used method for modulating cortical excitability in humans, by mechanisms thought to involve use-dependent synaptic plasticity. For example, when low frequency rTMS (LF rTMS) is applied over the motor cortex, in humans, it predictably leads to a suppression of the motor evoked potential (MEP), presumably reflecting long-term depression (LTD) - like mechanisms. Yet how closely such rTMS effects actually match LTD is unknown. We therefore sought to (1) reproduce cortico-spinal depression by LF rTMS in rats, (2) establish a reliable animal model for rTMS effects that may enable mechanistic studies, and (3) test whether LTD-like properties are evident in the rat LF rTMS setup. Lateralized MEPs were obtained from anesthetized Long-Evans rats. To test frequency-dependence of LF rTMS, rats underwent rTMS at one of three frequencies, 0.25, 0.5, or 1 Hz. We next tested the dependence of rTMS effects on N-methyl-D-aspartate glutamate receptor (NMDAR), by application of two NMDAR antagonists. We find that 1 Hz rTMS preferentially depresses unilateral MEP in rats, and that this LTD-like effect is blocked by NMDAR antagonists. These are the first electrophysiological data showing depression of cortical excitability following LF rTMS in rats, and the first to demonstrate dependence of this form of cortical plasticity on the NMDAR. We also note that our report is the first to show that the capacity for LTD-type cortical suppression by rTMS is present under barbiturate anesthesia, suggesting that future neuromodulatory rTMS applications under anesthesia may be considered.	[Muller, Paul A.; Dhamne, Sameer C.; Vahabzadeh-Hagh, Andrew M.; Rotenberg, Alexander] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Vahabzadeh-Hagh, Andrew M.; Pascual-Leone, Alvaro; Rotenberg, Alexander] Harvard Univ, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Univ Neurorehabilitacio Guttmann, Badalona, Spain; [Jensen, Frances E.] Univ Penn Hlth Syst, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona; University of Pennsylvania; Pennsylvania Medicine	Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA.	alexander.rotenberg@childrens.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Muller, Paul/0000-0002-1957-4763	Boston Children's Hospital Translational Research Program; NIH [K08 NS055895, 5R01NS031718]; IDDRC [P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055895, R01NS031718] Funding Source: NIH RePORTER	Boston Children's Hospital Translational Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Boston Children's Hospital Translational Research Program (AR), NIH K08 NS055895 (AR), NIH 5R01NS031718 (FEJ), IDDRC P30-HD18655 (AR, FEJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Bouras R, 2003, HIPPOCAMPUS, V13, P780, DOI 10.1002/hipo.10124; Brasil-Neto JP, 2004, ARQ NEURO-PSIQUIAT, V62, P21, DOI 10.1590/S0004-282X2004000100004; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cincotta M, 2003, CLIN NEUROPHYSIOL, V114, P1827, DOI 10.1016/S1388-2457(03)00181-0; de Olmos S, 2009, NEUROSCIENCE, V164, P1347, DOI 10.1016/j.neuroscience.2009.09.022; Dragasevic N, 2002, MOVEMENT DISORD, V17, P528, DOI 10.1002/mds.10109; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fitzgerald PB, 2005, NEUROREPORT, V16, P1525, DOI 10.1097/01.wnr.0000177005.14108.f1; Fregni Felipe, 2005, Curr Psychiatry Rep, V7, P381, DOI 10.1007/s11920-005-0041-4; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Ghiglieri V, 2012, EXP NEUROL, V236, P395, DOI 10.1016/j.expneurol.2012.04.020; Guerrini L, 1997, J NEUROSCI, V17, P6057; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Kent S, 1996, DEV BRAIN RES, V94, P1, DOI 10.1016/0165-3806(96)00023-5; Khedr EM, 2007, CLIN NEUROPHYSIOL, V118, P140, DOI 10.1016/j.clinph.2006.09.006; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kobayashi M, 2010, RESTOR NEUROL NEUROS, V28, P437, DOI 10.3233/RNN-2010-0562; Kourrich S., 2008, NEURAL PLAST, V2008; Lai MC, 2009, PEDIATR RES, V66, P441, DOI 10.1203/PDR.0b013e3181b337d2; Lee SL, 2008, OTOLARYNG HEAD NECK, V138, P398, DOI 10.1016/j.otohns.2007.11.035; Liu AL, 2013, SEIZURE-EUR J EPILEP, V22, P893, DOI 10.1016/j.seizure.2013.06.014; LOEB C, 1990, EPILEPSY RES, V6, P249, DOI 10.1016/0920-1211(90)90080-F; Loeb C, 1993, Seizure, V2, P309, DOI 10.1016/S1059-1311(05)80146-3; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; McGuire M, 2008, J APPL PHYSIOL, V105, P942, DOI 10.1152/japplphysiol.01274.2006; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Muller PA, 2012, BRAIN STIMUL, V5, P320, DOI 10.1016/j.brs.2011.05.003; Nakano M, 2004, EUR J NEUROSCI, V19, P2881, DOI 10.1111/j.0953-816X.2004.03390.x; Padberg F, 2009, EXP NEUROL, V219, P2, DOI 10.1016/j.expneurol.2009.04.020; Patrizi F, 2006, THESCIENTIFICWORLDJO, V6, P472, DOI 10.1100/tsw.2006.98; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rosen AC, 2009, CURR PAIN HEADACHE R, V13, P12, DOI 10.1007/s11916-009-0004-2; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; Rotenberg A, 2010, BRAIN TOPOGR, V22, P257, DOI 10.1007/s10548-009-0116-3; Rotenberg A, 2009, EPILEPSY BEHAV, V14, P253, DOI 10.1016/j.yebeh.2008.09.007; Rotenberg A, 2008, CLIN NEUROPHYSIOL, V119, P2697, DOI 10.1016/j.clinph.2008.09.003; Siegelbaum S A, 1991, Curr Opin Neurobiol, V1, P113, DOI 10.1016/0959-4388(91)90018-3; Sokhadze EM, 2009, J AUTISM DEV DISORD, V39, P619, DOI 10.1007/s10803-008-0662-7; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Sun W, 2012, EPILEPSIA, V53, P1782, DOI 10.1111/j.1528-1167.2012.03626.x; Thordstein M, 2012, EPILEPSY BEHAV, V25, P468, DOI 10.1016/j.yebeh.2012.07.026; Ting JT, 2013, BEHAV BRAIN RES, V255, P3, DOI 10.1016/j.bbr.2013.02.037; TOFTS PS, 1991, ELECTROEN CLIN NEURO, V81, P238, DOI 10.1016/0168-5597(91)90077-B; Tostes JG, 2013, NEUROSCIENCE, V255, P212, DOI 10.1016/j.neuroscience.2013.09.064; Vahabzadeh-Hagh AM, 2012, NEUROMODULATION, V15, P296, DOI 10.1111/j.1525-1403.2012.00482.x; Vahabzadeh-Hagh AM, 2011, J NEUROPHYSIOL, V105, P615, DOI 10.1152/jn.00660.2010; Wang F, 2010, J MOL NEUROSCI, V41, P145, DOI 10.1007/s12031-009-9311-7; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Watanabe K, 2007, BRAIN RES, V1166, P20, DOI 10.1016/j.brainres.2007.06.049; WHISHAW IQ, 1977, PHYSIOL BEHAV, V19, P719, DOI 10.1016/0031-9384(77)90304-3; Wohrl R, 2007, EUR J NEUROSCI, V25, P251, DOI 10.1111/j.1460-9568.2006.05274.x; Zheng JB, 2005, P ANN INT IEEE EMBS, P1529	63	48	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91065	10.1371/journal.pone.0091065	http://dx.doi.org/10.1371/journal.pone.0091065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646791	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500021
J	Richards, M; Phoon, CW; Goh, GTW; Seng, EK; Guo, XM; Tan, CMF; Chan, WK; Lee, JMK				Richards, Mark; Phoon, Chee Wee; Goh, Gwendoline Tze Wei; Seng, Eng Khuan; Guo, Xu Ming; Tan, Cherine Mei Fong; Chan, Woon-Khiong; Lee, Joel Mun Kin			A New Class of Pluripotent Stem Cell Cytotoxic Small Molecules	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; REGENERATIVE MEDICINE; TERATOMA FORMATION; SUICIDE GENE; TUMORIGENICITY; ANTIBODY; STRESS	A major concern in Pluripotent Stem Cell (PSC)-derived cell replacement therapy is the risk of teratoma formation from contaminating undifferentiated cells. Removal of undifferentiated cells from differentiated cultures is an essential step before PSC-based cell therapies can be safely deployed in a clinical setting. We report a group of novel small molecules that are cytotoxic to PSCs. Our data indicates that these molecules are specific and potent in their activity allowing rapid eradication of undifferentiated cells. Experiments utilizing mixed PSC and primary human neuronal and cardiomyocyte cultures demonstrate that up to a 6-fold enrichment for specialized cells can be obtained without adversely affecting cell viability and function. Several structural variants were synthesized to identify key functional groups and to improve specificity and efficacy. Comparative microarray analysis and ensuing RNA knockdown studies revealed involvement of the PERK/ATF4/DDIT3 ER stress pathway. Surprisingly, cell death following ER stress induction was associated with a concomitant decrease in endogenous ROS levels in PSCs. Undifferentiated cells treated with these molecules preceding transplantation fail to form teratomas in SCID mice. Furthermore, these molecules remain non-toxic and non-teratogenic to zebrafish embryos suggesting that they may be safely used in vivo.	[Richards, Mark; Phoon, Chee Wee; Seng, Eng Khuan; Guo, Xu Ming; Tan, Cherine Mei Fong; Lee, Joel Mun Kin] Nanyang Polytech, Sch Chem & Life Sci, Singapore, Singapore; [Goh, Gwendoline Tze Wei] Singapore Eye Res Inst, Singapore, Singapore; [Chan, Woon-Khiong] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Lee, Joel Mun Kin] Newcastle Univ, Food & Human Nutr Programme Singapore, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Nanyang Polytechnic; National University of Singapore; Singapore National Eye Center; National University of Singapore; Newcastle University - UK	Richards, M (corresponding author), Nanyang Polytech, Sch Chem & Life Sci, Singapore, Singapore.	mark_richards@nyp.gov.sg; dbscwk@nus.edu.sg	Khiong, Chan Woon/A-8064-2008	Khiong, Chan Woon/0000-0001-7395-7506; Seng, Eng Khuan/0000-0001-9980-6431	Singapore Ministry of Education Innovation Fund [MOE IF-2008-1-043]	Singapore Ministry of Education Innovation Fund(Ministry of Education, Singapore)	This research was supported by the Singapore Ministry of Education Innovation Fund grant MOE IF-2008-1-043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Fu X, 2011, REGEN MED, V6, P327, DOI [10.2217/RME.11.18, 10.2217/rme.11.18]; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Geens M, 2007, HUM REPROD, V22, P733, DOI 10.1093/humrep/del418; Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Scadden David, 2012, Cell Stem Cell, V10, P149, DOI 10.1016/j.stem.2012.01.010; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497	26	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e85039	10.1371/journal.pone.0085039	http://dx.doi.org/10.1371/journal.pone.0085039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647085	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500002
J	Tougard, C; Folly, J; Berrebi, P				Tougard, Christelle; Folly, Joy; Berrebi, Patrick			New Light on the Evolutionary History of the Common Goby (Pomatoschistus microps) with an Emphasis on Colonization Processes in the Mediterranean Sea	PLOS ONE			English	Article							POPULATION-GROWTH; DIFFERENTIAL DISTRIBUTION; HOLOCENE EVOLUTION; DNA-SEQUENCES; P-MARMORATUS; GENE FLOW; PHYLOGEOGRAPHY; TELEOSTEI; LAGOON; REGION	Through the study of the phylogeographic structure and demographic history of the common goby, Pomatoschistus microps, the influence of Quaternary climatic changes on the evolutionary history of coastal and marine fishes is investigated. Because of its sedentary life cycle in Mediterranean lagoons, it is also a good model to study more specifically if the formation of lagoons during the Holocene had an impact on population structure and demography. Mitochondrial sequences of Northeastern Atlantic and Western Mediterranean specimens were used for phylogenetic reconstructions as well as divergence time estimates, demographic history and population structure analyses. Pomatoschistus microps was a highly supported monophyletic clade including four lineages. It may have appeared 77,000 yr ago, and the divergence of its lineages likely occured shortly thereafter (between 61,000 and 54,000 yr). Most lineages had polytomic topologies, low nucleotide diversity and demographic analyses providing evidence of population expansion. Each lineage was characterized by a large number of private haplotypes. Most haplotypes found in Mediterranean localities were endemic, and one was dominant. Complex reticulated relationships connecting North European, Atlantic and Mediterranean haplotypes were observed. Moderate to high population structure was underlined. Contrary to previous published studies, no significant differentiation was observed between Atlantic and Mediterranean populations, indicating that the Gibraltar Strait is not a phylogeographic break for P. microps. Indeed, molecular dating combined with the tree topologies, phylogeographic and demographic analyses as well as high haplotype diversity underline a recent and rapid population divergence during the last glacial. However, population structure indicates that differentiation is an ongoing process. From an ancestral population trapped in the Atlantic, this goby colonized first northern Europe and later the Mediterranean Sea. Shared haplotypes could have dispersed in the western Mediterranean basin before the lagoon formation, while most private haplotypes, evidencing a recent isolation, probably diverged in lagoons after their closure.	[Tougard, Christelle; Folly, Joy; Berrebi, Patrick] CNRS, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Tougard, C (corresponding author), CNRS, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France.	Christelle.Tougard@univ-montp2.fr			French Government (CNRS); French Government (UM2)	French Government (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Government (UM2)	This work was funded by the French Government (CNRS and UM2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKHIPOV SA, 1995, BOREAS, V24, P196; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bargelloni L, 2005, MOL PHYLOGENET EVOL, V36, P523, DOI 10.1016/j.ympev.2005.04.017; Bargelloni L, 2003, J EVOLUTION BIOL, V16, P1149, DOI 10.1046/j.1420-9101.2003.00620.x; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Berrebi P, 2005, ESTUAR COAST SHELF S, V65, P708, DOI 10.1016/j.ecss.2005.07.008; Berrebi P, 2009, FOLIA ZOOL, V58, P123; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Boissin E, 2011, BIOL J LINN SOC, V102, P175, DOI 10.1111/j.1095-8312.2010.01565.x; Bouchereau JL, 1998, OCEANOL ACTA, V21, P503, DOI 10.1016/S0399-1784(98)80034-0; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Cavazza W, 2003, EPISODES, V26, P160, DOI 10.18814/epiiugs/2003/v26i3/002; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Demboski JR, 2001, MOL ECOL, V10, P1227, DOI 10.1046/j.1365-294X.2001.01260.x; Durand JD, 2012, MOL PHYLOGENET EVOL, V64, P73, DOI 10.1016/j.ympev.2012.03.006; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P259, DOI 10.1016/S0031-0182(00)00053-5; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Garcia CF, 2012, J COASTAL RES, V28, P1617, DOI 10.2112/JCOASTRES-D-11-00007.1; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Frigola J, 2008, QUATERN INT, V181, P88, DOI 10.1016/j.quaint.2007.06.016; Fu YX, 1997, GENETICS, V147, P915; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gysels ES, 2004, BIOL J LINN SOC, V83, P561, DOI 10.1111/j.1095-8312.2004.00411.x; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HEALEY MC, 1972, J NAT HIST, V6, P133, DOI 10.1080/00222937200770121; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; Huyse T, 2004, MOL PHYLOGENET EVOL, V32, P324, DOI 10.1016/j.ympev.2003.11.007; JONES D., 1966, HYDROBIOLOGIA, V27, P515, DOI 10.1007/BF00042710; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Krijgsman W, 2002, EARTH PLANET SC LETT, V205, P1, DOI 10.1016/S0012-821X(02)01008-7; Lambeck K, 2000, EARTH PLANET SC LETT, V175, P203, DOI 10.1016/S0012-821X(99)00289-7; Landini W, 2005, QUATERN INT, V140, P64, DOI 10.1016/j.quaint.2005.05.019; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucchi MR, 2006, SEDIMENT GEOL, V183, P1, DOI 10.1016/j.sedgeo.2005.09.003; Mazzini I, 1999, MAR MICROPALEONTOL, V37, P289, DOI 10.1016/S0377-8398(99)00023-7; Mejri R, 2011, MOL PHYLOGENET EVOL, V58, P395, DOI 10.1016/j.ympev.2010.12.001; Mejri R, 2009, MOL PHYLOGENET EVOL, V53, P596, DOI 10.1016/j.ympev.2009.04.018; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Miller P.J., 1986, P1019; Nelson JS, 1984, FISHES WORLD; Nylander J, 2004, MR MODELTEST V2 PROG; Pampoulie C, 1999, THESIS U MONTPELLIER; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulos SE, 2009, Z GEOMORPHOL, V53, P151, DOI 10.1127/0372-8854/2009/0053S1-0151; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raynal O, 2010, B SOC GEOL FR, V181, P211, DOI 10.2113/gssgfbull.181.2.211; Rigal F, 2008, SCI MAR, V72, P469; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Sabatier P, 2010, B SOC GEOL FR, V181, P27, DOI 10.2113/gssgfbull.181.1.27; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simonovic PD, 1999, J FISH BIOL, V54, P533; SLATKIN M, 1991, GENETICS, V129, P555; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; Vanhove MPM, 2012, BIOL J LINN SOC, V105, P73, DOI 10.1111/j.1095-8312.2011.01781.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILSON RCL, 2000, GREAT ICE AGE CLIMAT; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	79	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91576	10.1371/journal.pone.0091576	http://dx.doi.org/10.1371/journal.pone.0091576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646724	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500040
J	Ward, BK; Tan, GXJ; Roberts, DC; Della Santina, CC; Zee, DS; Carey, JP				Ward, Bryan K.; Tan, Grace X-J; Roberts, Dale C.; Della Santina, Charles C.; Zee, David S.; Carey, John P.			Strong Static Magnetic Fields Elicit Swimming Behaviors Consistent with Direct Vestibular Stimulation in Adult Zebrafish	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; LATERAL-LINE; VERTEBRATE MAGNETORECEPTOR; VELOCITY STORAGE; INNER-EAR; FISH; GENTAMICIN; QUANTIFICATION; NEUROBIOLOGY; CHINCHILLA	Zebrafish (Danio rerio) offer advantages as model animals for studies of inner ear development, genetics and ototoxicity. However, traditional assessment of vestibular function in this species using the vestibulo-ocular reflex requires agar-immobilization of individual fish and specialized video, which are difficult and labor-intensive. We report that using a static magnetic field to directly stimulate the zebrafish labyrinth results in an efficient, quantitative behavioral assay in free-swimming fish. We recently observed that humans have sustained nystagmus in high strength magnetic fields, and we attributed this observation to magnetohydrodynamic forces acting on the labyrinths. Here, fish were individually introduced into the center of a vertical 11.7T magnetic field bore for 2-minute intervals, and their movements were tracked. To assess for heading preference relative to a magnetic field, fish were also placed in a horizontally oriented 4.7T magnet in infrared (IR) light. A sub-population was tested again in the magnet after gentamicin bath to ablate lateral line hair cell function. Free-swimming adult zebrafish exhibited markedly altered swimming behavior while in strong static magnetic fields, independent of vision or lateral line function. Two-thirds of fish showed increased swimming velocity or consistent looping/rolling behavior throughout exposure to a strong, vertically oriented magnetic field. Fish also demonstrated altered swimming behavior in a strong horizontally oriented field, demonstrating in most cases preferred swimming direction with respect to the field. These findings could be adapted for 'high-throughput' investigations of the effects of environmental manipulations as well as for changes that occur during development on vestibular function in zebrafish.	[Ward, Bryan K.; Della Santina, Charles C.; Zee, David S.; Carey, John P.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Roberts, Dale C.; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tan, Grace X-J] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Della Santina, Charles C.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ward, BK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	bward15@jhmi.edu	Ward, Bryan/AAM-7721-2020; Ward, Bryan/M-2306-2018	Ward, Bryan/0000-0001-5201-6117; Tan, Grace/0000-0002-7606-193X	NIDCD [T32DC0000027]; Zebrafish International Resource Center (ZIRC); NIH-NCRR [P40 RR012546]; Johns Hopkins Center for Hearing and Balance histology core [P30 DC005211];  [R21DC011919]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R21DC011919, T32DC000027] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Zebrafish International Resource Center (ZIRC); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Johns Hopkins Center for Hearing and Balance histology core; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was made possible by R21DC011919 and salary support for BW from NIDCD T32DC0000027. The authors would like to especially thank contributors to the Vestibular NeuroEngineering Lab Research Fund, the Lloyd B. Minor Vestibular Research Fund, and the Cinquegrana Fund. Additional support was provided by the Zebrafish International Resource Center (ZIRC), which is supported by the NIH-NCRR P40 RR012546 and the Johns Hopkins Center for Hearing and Balance histology core P30 DC005211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anken RH, 1998, ADV SPACE RES-SERIES, V22, P277, DOI 10.1016/S0273-1177(98)80020-3; BARLOW HB, 1947, AM J PHYSIOL, V148, P372, DOI 10.1152/ajplegacy.1947.148.2.372; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Bianco IH, 2012, CURR BIOL, V22, P1285, DOI 10.1016/j.cub.2012.05.026; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chen CC, 2013, J PHYSL; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; EMRAN F, 2008, J VIS EXP; Faucher K, 2008, HEARING RES, V240, P12, DOI 10.1016/j.heares.2008.03.007; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Hirvonen TP, 2005, J NEUROPHYSIOL, V93, P643, DOI 10.1152/jn.00160.2004; Houpt TA, 2013, AM J PHYSL REGUL INT; Houpt TA, 2012, PHYSIOL BEHAV, V105, P388, DOI 10.1016/j.physbeh.2011.08.030; Ijiri K, 2000, ADV SPACE RES-SERIES, V25, P1997, DOI 10.1016/S0273-1177(99)01005-4; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; KATZ E, 1991, EXP BRAIN RES, V87, P505, DOI 10.1007/BF00227076; Lopez I, 1997, INT J DEV NEUROSCI, V15, P447, DOI 10.1016/S0736-5748(96)00103-7; Mo W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-110; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Moore A, 2009, J FISH BIOL, V74, P1629, DOI 10.1111/j.1095-8649.2009.02197.x; MOORE A, 1990, PHILOS T ROY SOC B, V329, P11, DOI 10.1098/rstb.1990.0145; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; PASTOR AM, 1992, J NEUROPHYSIOL, V68, P2003, DOI 10.1152/jn.1992.68.6.2003; Rahmann H, 2000, ADV SPACE RES-SERIES, V25, P1985, DOI 10.1016/S0273-1177(99)01007-8; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; Roberts DC, 2011, CURR BIOL; ROBINSON DA, 1977, EXP BRAIN RES, V30, P447; Schonleber J, 2004, ADV SPACE RES-SERIES, V33, P1416, DOI 10.1016/j.asr.2003.12.006; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Takebe A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00727; Van Trump WJ, 2010, HEARING RES, V261, P42, DOI 10.1016/j.heares.2010.01.001; von Baumgarten R J, 1979, Life Sci Space Res, V17, P161; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058	38	20	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92109	10.1371/journal.pone.0092109	http://dx.doi.org/10.1371/journal.pone.0092109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647586	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500086
J	Wen, B; Combes, V; Bonhoure, A; Weksler, BB; Couraud, PO; Grau, GER				Wen, Beryl; Combes, Valery; Bonhoure, Amandine; Weksler, Babette B.; Couraud, Pierre-Olivier; Grau, Georges E. R.			Endotoxin-Induced Monocytic Microparticles Have Contrasting Effects on Endothelial Inflammatory Responses	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; PROCOAGULANT ACTIVITY; VASCULAR HOMEOSTASIS; ADHESION MOLECULES; SEPTIC SHOCK; VE-CADHERIN; SEPSIS; CELLS; PERMEABILITY; CYTOKINES	Septic shock is a severe disease state characterised by the body's life threatening response to infection. Complex interactions between endothelial cells and circulating monocytes are responsible for microvasculature dysfunction contributing to the pathogenesis of this syndrome. Here, we intended to determine whether microparticles derived from activated monocytes contribute towards inflammatory processes and notably vascular permeability. We found that endotoxin stimulation of human monocytes enhances the release of microparticles of varying phenotypes and mRNA contents. Elevated numbers of LPS-induced monocytic microparticles (mMP) expressed CD54 and contained higher levels of transcripts for pro-inflammatory cytokines such as TNF, IL-6 and IL-8. Using a prothrombin time assay, a greater reduction in plasma coagulation time was observed with LPS-induced mMP than with non-stimulated mMP. Co-incubation of mMP with the human brain endothelial cell line hCMEC/D3 triggered their time-dependent uptake and significantly enhanced endothelial microparticle release. Unexpectedly, mMP also modified signalling pathways by diminishing pSrc (tyr416) expression and promoted endothelial monolayer tightness, as demonstrated by endothelial impedance and permeability assays. Altogether, these data strongly suggest that LPS-induced mMP have contrasting effects on the intercellular communication network and display a dual potential: enhanced pro-inflammatory and procoagulant properties, together with protective function of the endothelium.	[Wen, Beryl; Combes, Valery; Bonhoure, Amandine; Grau, Georges E. R.] Univ Sydney, Sydney Med Sch, Vasc Immunol Unit, Camperdown, NSW, Australia; [Wen, Beryl; Combes, Valery; Bonhoure, Amandine; Grau, Georges E. R.] Univ Sydney, Bosch Inst, Camperdown, NSW, Australia; [Weksler, Babette B.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Couraud, Pierre-Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR 8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France	University of Sydney; University of Sydney; Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wen, B (corresponding author), Univ Sydney, Sydney Med Sch, Vasc Immunol Unit, Camperdown, NSW, Australia.	beryl.wen@sydney.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	National Health Medical Research Council [570771, 571014, 1009914, 1028241]; Rebecca L. Cooper Medical Research Foundation; University of Sydney; Al Kerr Bequest, Sydney Medical School	National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation; University of Sydney(University of Sydney); Al Kerr Bequest, Sydney Medical School	This work was supported by grants from the National Health Medical Research Council # 570771, 571014, 1009914, 1028241 and the Rebecca L. Cooper Medical Research Foundation. The support of the University of Sydney Bridging Support Grant and funding from the Al Kerr Bequest, Sydney Medical School is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Bernimoulin M, 2009, J THROMB HAEMOST, V7, P1019, DOI 10.1111/j.1538-7836.2009.03434.x; Borrelli E, 1996, CRIT CARE MED, V24, P392, DOI 10.1097/00003246-199603000-00006; Bozza FA, 2010, J CEREBR BLOOD F MET, V30, P440, DOI 10.1038/jcbfm.2009.215; Brown GT, 2011, J IMMUNOLOGY; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Connor DE, 2009, BLOOD COAGUL FIBRIN, V20, P558, DOI 10.1097/MBC.0b013e32832ee915; Dean WL, 2009, THROMB HAEMOSTASIS, V102, P711, DOI 10.1160/TH09-04-243; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Densmore JC, 2006, SHOCK, V26, P464, DOI 10.1097/01.shk.0000228791.10550.36; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Dwyer J, 2011, ONCOGENE, V30, P190, DOI 10.1038/onc.2010.411; Essayagh S, 2007, THROMB HAEMOSTASIS, V98, P831, DOI 10.1160/TH07-02-0082; FINGERLE G, 1993, BLOOD, V82, P3170; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gorbunova EE, 2011, J VIROL, V85, P2296, DOI 10.1128/JVI.02319-10; Habersberger J, 2012, CARDIOVASC RES, V96, P64, DOI 10.1093/cvr/cvs237; Hillenbrand A, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-26; Hollenberg SM, 2007, CRIT CARE, V11, DOI 10.1186/cc6190; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; Jaiswal R, 2011, FASEB J; Jaiswal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061515; Jimenez JJ, 2005, MULT SCLER J, V11, P310, DOI 10.1191/1352458505ms1184oa; Kanazawa S, 2003, LUNG CANCER-J IASLC, V39, P145, DOI 10.1016/S0169-5002(02)00441-5; Lou J, 1996, EUR J IMMUNOL, V26, P3107, DOI 10.1002/eji.1830261242; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marceau F, 2010, INT IMMUNOPHARMACOL, V10, P1344, DOI 10.1016/j.intimp.2010.08.016; Mastronardi ML, 2010, FUNDAMENTAL CLIN PHA; Mfonkeu JBP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013415; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Morel O, 2009, HAEMATOL-HEMATOL J, V94, P313, DOI 10.3324/haematol.2009.003657; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Oehmcke S, 2011, CELLULAR MICROBIOLOG; Ogata N, 2006, DIABETES RES CLIN PR, V73, P241, DOI 10.1016/j.diabres.2006.01.014; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; PINE RW, 1983, ARCH SURG-CHICAGO, V118, P242; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; SATTA N, 1994, J IMMUNOL, V153, P3245; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; Trappenburg MC, 2011, NEPHROLOGY DIALYSIS; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Wassmer SC, 2011, CELL MICROBIOL, V13, P198, DOI 10.1111/j.1462-5822.2010.01528.x; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weksler BB, 2005, FASEB J; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; YOUNG GB, 1990, CLIN INVEST MED, V13, P297; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	61	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91597	10.1371/journal.pone.0091597	http://dx.doi.org/10.1371/journal.pone.0091597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646764	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500041
J	Christidis, L; Goodman, SM; Naughton, K; Appleton, B				Christidis, Les; Goodman, Steven M.; Naughton, Kate; Appleton, Belinda			Insights into the Evolution of a Cryptic Radiation of Bats: Dispersal and Ecological Radiation of Malagasy Miniopterus (Chiroptera: Miniopteridae)	PLOS ONE			English	Article							LONG-FINGERED BATS; ADAPTIVE RADIATION; MITOCHONDRIAL-DNA; MOLECULAR SYSTEMATICS; MADAGASCAR; COMORO; SCHREIBERSII; BIOGEOGRAPHY; PHYLOGENY; ALGORITHM	The past decade has seen a proliferation of new species of Miniopterus bats (family Miniopteridae) recognized from Madagascar and the neighboring Comoros archipelago. The interspecific relationships of these taxa, their colonization history, and the evolution of this presumed adaptive radiation have not been sufficiently explored. Using the mitochondrial cytochrome-b gene, we present a phylogeny of the Malagasy members of this widespread Old World genus, based on 218 sequences, of which 82 are new and 136 derived from previous studies. Phylogenetic analyses recovered 18 clades, which divide into five primary lineages: (1) M. griveaudi; (2) M. mahafaliensis, M. sororculus and X3; (3) M. majori, M. gleni and M. griffithsi; (4) M. brachytragos; M. aelleniA, and M. aelleniB; and (5) M. manavi and M. petersoni recovered as sister species, which were in turn linked to a group comprising M. egeri and five genetically distinct populations referred to herein as P3, P4, P5, P6 and P7. Beast analysis indicated that the initial divergence within the Malagasy Miniopterus radiation took place 4.5 Myr; most species diverged between 4 and 2.5 Myr, and a secondary period was between 1.25 and 1 Myr. DNA K2P-distances between recognized taxa ranged from 12.9% to 2.5% and intraspecific variation was less than 1.8%. Of the 18 identified clades, Latin binomials are only associated with 11, which indicates much greater differentiation than currently recognized for Malagasy Miniopterus. These data are placed in a context of the dispersal history of this genus on the island and patterns of ecological diversity.	[Christidis, Les] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Christidis, Les; Naughton, Kate; Appleton, Belinda] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar; [Appleton, Belinda] Deakin Univ, Geelong, Vic 3217, Australia	Southern Cross University; University of Melbourne; Field Museum of Natural History (Chicago); Deakin University	Christidis, L (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	les.christidis@gmail.com			CABS of Conservation International; John D. and Catherine T. MacArthur Foundation; Volkswagen Foundation	CABS of Conservation International; John D. and Catherine T. MacArthur Foundation; Volkswagen Foundation(Volkswagen)	Financial support for the fieldwork associated with this project was graciously given by CABS of Conservation International, The John D. and Catherine T. MacArthur Foundation and Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Appleton BR, 2004, MOL PHYLOGENET EVOL, V31, P431, DOI 10.1016/j.ympev.2003.08.017; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BERMINGHAM E, 1993, P NATL ACAD SCI USA, V90, P2734, DOI 10.1073/pnas.90.7.2734; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Burney David A., 1999, P145; Cardinal BR, 2000, AUST J ZOOL, V48, P1, DOI 10.1071/ZO99067; Carleton Michael D., 1998, Fieldiana Zoology, V90, P163; Cibois A, 2001, EVOLUTION, V55, P1198; Cibois A, 2010, ZOOTAXA, P65, DOI 10.11646/zootaxa.2554.1.6; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eagles G, 2008, GEOPHYS J INT, V173, P703, DOI [10.1111/j.1365-246X.2008.03753.x, 10.1111/J.1365-246X.2008.03753.X]; Gaffney ES, 2003, AM MUS NOVIT, P1; Goodman SM, 2007, J MAMMAL, V88, P1216, DOI 10.1644/06-MAMM-A-285R1.1; Goodman SM, 2010, J ZOOL SYST EVOL RES, V48, P75, DOI 10.1111/j.1439-0469.2009.00524.x; Goodman S. M., WINDOWS EXT IN PRESS; Goodman S. M., 2011, CHAUVES SOURIS MADAG; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2008, MAMM BIOL, V73, P199, DOI 10.1016/j.mambio.2007.12.003; Goodman SM, 2011, ZOOTAXA, P1; Goodman SM, 2012, J MAMMAL, V93, P1440, DOI 10.1644/11-MAMM-A-271.1; Goodman SM, 2009, AM MUS NOVIT, P1, DOI 10.1206/652.1; Goodman SM, 2010, ACTA CHIROPTEROL, V12, P117, DOI 10.3161/150811010X504635; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jonsson KA, 2008, MOL PHYLOGENET EVOL, V47, P221, DOI 10.1016/j.ympev.2008.01.017; Jonsson KA, 2012, P NATL ACAD SCI USA, V109, P6620, DOI 10.1073/pnas.1115835109; Juste J, 2007, ACTA CHIROPTEROL, V9, P27, DOI 10.3161/1733-5329(2007)9[27:TOLBBM]2.0.CO;2; KERTH G, 2006, FUNCTIONAL EVOLUTION, P199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kundu S, 2012, MOL PHYLOGENET EVOL, V62, P296, DOI 10.1016/j.ympev.2011.09.025; MARCK C, 1990, DNA STRIDER A C PROG; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Miller-Butterworth CM, 2005, J MAMMAL, V86, P1121, DOI 10.1644/05-MAMM-A-021R1.1; Monadjem A, ZOOTAXA IN PRESS; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Peterson R., 1995, FAUNE MADAGASCAR, V84; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; Rambaut A., 2007, TRACER V1 5; Raxworthy Christopher J., 1997, P124; Reddy S, 2012, P ROY SOC B-BIOL SCI, V279, P2062, DOI 10.1098/rspb.2011.2380; Redondo RAF, 2008, MOL PHYLOGENET EVOL, V49, P44, DOI 10.1016/j.ympev.2008.07.001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell AL, 2008, J MAMMAL, V89, P209, DOI 10.1644/07-MAMM-A-044.1; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Weyeneth N, 2011, J EVOLUTION BIOL, V24, P1298, DOI 10.1111/j.1420-9101.2011.02262.x; Weyeneth N, 2008, MOL ECOL, V17, P5205, DOI 10.1111/j.1365-294X.2008.03994.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303	63	20	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92440	10.1371/journal.pone.0092440	http://dx.doi.org/10.1371/journal.pone.0092440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642892	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900140
J	Exline, MC; Justiniano, S; Hollyfield, JL; Berhe, F; Besecker, BY; Das, S; Wewers, MD; Sarkar, A				Exline, Matthew C.; Justiniano, Steven; Hollyfield, Jennifer L.; Berhe, Freweine; Besecker, Beth Y.; Das, Srabani; Wewers, Mark D.; Sarkar, Anasuya			Microvesicular Caspase-1 Mediates Lymphocyte Apoptosis in Sepsis	PLOS ONE			English	Article							CELL-DEATH; IL-1-BETA-CONVERTING ENZYME; MEMBRANE MICROPARTICLES; IMPROVES SURVIVAL; MICE DEFICIENT; UNITED-STATES; ACTIVATION; INTERLEUKIN-1-BETA; INFLAMMASOME; IL-1-BETA	Objective: Immune dysregulation during sepsis is poorly understood, however, lymphocyte apoptosis has been shown to correlate with poor outcomes in septic patients. The inflammasome, a molecular complex which includes caspase-1, is essential to the innate immune response to infection and also important in sepsis induced apoptosis. Our group has recently demonstrated that endotoxin-stimulated monocytes release microvesicles (MVs) containing caspase-1 that are capable of inducing apoptosis. We sought to determine if MVs containing caspase-1 are being released into the blood during human sepsis and induce apoptosis.. Design: Single-center cohort study Measurements: 50 critically ill patients were screened within 24 hours of admission to the intensive care unit and classified as either a septic or a critically ill control. Circulatory MVs were isolated and analyzed for the presence of caspase-1 and the ability to induce lymphocyte apoptosis. Patients remaining in the ICU for 48 hours had repeated measurement of caspase-1 activity on ICU day 3. Main Results: Septic patients had higher microvesicular caspase-1 activity 0.05 (0.04, 0.07) AFU versus 0.0 AFU (0, 0.02) (p < 0.001) on day 1 and this persisted on day 3, 0.12 (0.1, 0.2) versus 0.02 (0, 0.1) (p < 0.001). MVs isolated from septic patients on day 1 were able to induce apoptosis in healthy donor lymphocytes compared with critically ill control patients (17.8 +/- 9.2% versus 4.3 +/- 2.6% apoptotic cells, p < 0.001) and depletion of MVs greatly diminished this apoptotic signal. Inhibition of caspase-1 or the disruption of MV integrity abolished the ability to induce apoptosis. Conclusion: These findings suggest that microvesicular caspase-1 is important in the host response to sepsis, at least in part, via its ability to induce lymphocyte apoptosis. The ability of microvesicles to induce apoptosis requires active caspase-1 and intact microvesicles.	[Exline, Matthew C.; Justiniano, Steven; Hollyfield, Jennifer L.; Berhe, Freweine; Besecker, Beth Y.; Das, Srabani; Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Davis Heart & Lung Res Inst, Pulm Allergy Crit Care & Sleep Med Div, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sarkar, A (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Pulm Allergy Crit Care & Sleep Med Div, Wexner Med Ctr, Columbus, OH 43210 USA.	anasuya.sarkar@osumc.edu	Wewers, Mark/AAB-6202-2021		NHLBI NIH HHS [R01 HL124325] Funding Source: Medline; NIGMS NIH HHS [K23 GM107624] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM107624] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Brabant D, 2011, BIOCHEM BIOPH RES CO, V412, P260, DOI 10.1016/j.bbrc.2011.07.080; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Grobmyer SR, 1999, MOL MED, V5, P585, DOI 10.1007/BF03402071; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948; Kumar A, 2005, J BIOL CHEM, V280, P42619, DOI 10.1074/jbc.M508416200; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, J CELL BIOCHEM, V64, P27, DOI 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2006, CELL DEATH DIFFER; McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Monick MM, 2003, ANNU REV PHYSIOL, V65, P643, DOI 10.1146/annurev.physiol.65.092101.142440; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Scott AM, 2006, CELL DEATH DIFFER; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vaki I, J LEUKOC BIOL, V89, P343; Vaki I, 2011, J LEUKOCYTE BIOL, V89, P343, DOI 10.1189/jlb.0410232; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Wang W, 2005, AM J PHYSIOL-RENAL, V288, pF997, DOI 10.1152/ajprenal.00130.2004; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	61	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90968	10.1371/journal.pone.0090968	http://dx.doi.org/10.1371/journal.pone.0090968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643116	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900009
J	Gurushidze, M; Hensel, G; Hiekel, S; Schedel, S; Valkov, V; Kumlehn, J				Gurushidze, Maia; Hensel, Goetz; Hiekel, Stefan; Schedel, Sindy; Valkov, Vladimir; Kumlehn, Jochen			True-Breeding Targeted Gene Knock-Out in Barley Using Designer TALE-Nuclease in Haploid Cells	PLOS ONE			English	Article							HORDEUM-VULGARE L.; DNA-BINDING SPECIFICITY; GENOME; TRANSFORMATION; VECTORS; MARKER	Transcription activator-like effector nucleases (TALENs) are customizable fusion proteins able to cleave virtually any genomic DNA sequence of choice, and thereby to generate site-directed genetic modifications in a wide range of cells and organisms. In the present study, we expressed TALENs in pollen-derived, regenerable cells to establish the generation of instantly true-breeding mutant plants. A gfp-specific TALEN pair was expressed via Agrobacterium-mediated transformation in embryogenic pollen of transgenic barley harboring a functional copy of gfp. Thanks to the haploid nature of the target cells, knock-out mutations were readily detected, and homozygous primary mutant plants obtained following genome duplication. In all, 22% of the TALEN transgenics proved knocked out with respect to gfp, and the loss of function could be ascribed to the deletions of between four and 36 nucleotides in length. The altered gfp alleles were transmitted normally through meiosis, and the knock-out phenotype was consistently shown by the offspring of two independent mutants. Thus, here we describe the efficient production of TALEN-mediated gene knock-outs in barley that are instantaneously homozygous and non-chimeric in regard to the site-directed mutations induced. This TALEN approach has broad applicability for both elucidating gene function and tailoring the phenotype of barley and other crop species.	[Gurushidze, Maia; Hensel, Goetz; Hiekel, Stefan; Schedel, Sindy; Valkov, Vladimir; Kumlehn, Jochen] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Valkov, Vladimir] Inst Genet & Biophys, Naples, Italy	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Gurushidze, M (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	maiko@ipk-gatersleben.de	Hensel, Goetz/ABA-8238-2020; Kumlehn, Jochen/AAF-8241-2020; Hensel, G./F-9957-2010; Valkov, Vladimir Totev/M-4753-2017	Hensel, Goetz/0000-0002-5539-3097; Kumlehn, Jochen/0000-0001-7080-7983; Hensel, G./0000-0002-5539-3097; Valkov, Vladimir Totev/0000-0002-3811-0913; Chamas (nee Schedel), Sindy/0000-0003-2765-0719; Hiekel, Stefan/0000-0001-7649-3989	German Federal Ministry of Education and Research [FKZ 0315965]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was made financially possible through a grant number FKZ 0315965 from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Fang YD, 2002, J PLANT PHYSIOL, V159, P1131, DOI 10.1078/0176-1617-00707; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gonzalez-Melendi P, 2005, PLANTA, V222, P47, DOI 10.1007/s00425-005-1515-7; Hensel Goetz, 2009, Int J Plant Genomics, V2009, P835608, DOI 10.1155/2009/835608; Kasha KJ, 2001, J EXP BOT, V52, P1227, DOI 10.1093/jexbot/52.359.1227; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Kumlehn J, 2006, PLANT BIOTECHNOL J, V4, P251, DOI 10.1111/j.1467-7652.2005.00178.x; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Maluszynski M., 2003, DOUBLED HAPLOID PROD; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Puchta H, 2013, PLANT J, DOI 101111/tpj12338; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THIEBAUT J, 1978, CAN J GENET CYTOL, V20, P513, DOI 10.1139/g78-060; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	35	68	76	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92046	10.1371/journal.pone.0092046	http://dx.doi.org/10.1371/journal.pone.0092046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643227	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900071
J	Herberg, M; Kalkan, T; Glauche, I; Smith, A; Roeder, I				Herberg, Maria; Kalkan, Tuezer; Glauche, Ingmar; Smith, Austin; Roeder, Ingo			nA Model-Based Analysis of Culture-Dependent Phenotypes of mESCs	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MOUSE ES CELLS; GROUND-STATE PLURIPOTENCY; NANOG GENE-EXPRESSION; SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; OCT4; SOX2; ESRRB	Mouse embryonic stem cells (mESCs) can be maintained in a proliferative and undifferentiated state over many passages (self-renewal) while retaining the potential to give rise to every cell type of the organism (pluripotency). Autocrine FGF4/Erk signalling has been identified as a major stimulus for fate decisions and lineage commitment in these cells. Recent findings on serum-free culture conditions with specific inhibitors (known as 2i) demonstrate that the inhibition of this pathway reduces transcription factor heterogeneity and is vital to maintain ground state pluripotency of mESCs. We suggest a novel mathematical model to explicitly integrate FGF4/Erk signalling into an interaction network of key pluripotency factors (namely Oct4, Sox2, Nanog and Rex1). The envisaged model allows to explore whether and how proposed mechanisms and feedback regulations can account for different expression patterns in mESC cultures. We demonstrate that an FGF4/Erk-mediated negative feedback is sufficient to induce molecular heterogeneity with respect to Nanog and Rex1 expression and thus critically regulates the propensity for differentiation and the loss of pluripotency. Furthermore, we compare simulation results on the transcription factor dynamics in different self-renewing states and during differentiation with experimental data on a Rex1GFPd2 reporter cell line using flow cytometry and qRT-PCR measurements. Concluding from our results we argue that interaction between FGF4/Erk signalling and Nanog expression qualifies as a key mechanism to manipulate mESC pluripotency. In particular, we infer that ground state pluripotency under 2i is achieved by shifting stable expression pattern of Nanog from a bistable into a monostable regulation impeding stochastic state transitions. Furthermore, we derive testable predictions on altering the degree of Nanog heterogeneity and on the frequency of state transitions in LIF/serum conditions to challenge our model assumptions.	[Herberg, Maria; Glauche, Ingmar; Roeder, Ingo] Tech Univ Dresden, Inst Med Informat & Biometry, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany; [Kalkan, Tuezer; Smith, Austin] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge, England	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cambridge	Herberg, M (corresponding author), Tech Univ Dresden, Inst Med Informat & Biometry, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany.	maria.herberg@tu-dresden.de		Smith, Austin/0000-0002-3029-4682	European Commission project EuroSyStem [200270]; DFG Priority Program: SPP 1356 Pluripotency and Cellular Reprogramming [RO35002-1]; German Research Foundation; Open Access Publication Funds of the TU Dresden; Medical Research Council [G1100526, MC_PC_12009] Funding Source: researchfish	European Commission project EuroSyStem; DFG Priority Program: SPP 1356 Pluripotency and Cellular Reprogramming; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the European Commission project EuroSyStem (200270) and the DFG Priority Program: SPP 1356 Pluripotency and Cellular Reprogramming (RO35002-1). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-98; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo Y, 2012, J ROYAL SOC INTERFAC; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	60	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92496	10.1371/journal.pone.0092496	http://dx.doi.org/10.1371/journal.pone.0092496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643025	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900144
J	Wientzek, A; Vigl, M; Steindorf, K; Bruhmann, B; Bergmann, MM; Harttig, U; Katzke, V; Kaaks, R; Boeing, H				Wientzek, Angelika; Vigl, Matthaeus; Steindorf, Karen; Bruehmann, Boris; Bergmann, Manuela M.; Harttig, Ulrich; Katzke, Verena; Kaaks, Rudolf; Boeing, Heiner			The Improved Physical Activity Index for Measuring Physical Activity in EPIC Germany	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; HEART-RATE; VALIDITY; RELIABILITY; REPEATABILITY; ACCELEROMETERS; NUTRITION; CANCER; ADULTS; RISK	In the European Investigation into Cancer and Nutrition study (EPIC), physical activity (PA) has been indexed as a cross-tabulation between PA at work and recreational activity. As the proportion of non-working participants increases, other categorization strategies are needed. Therefore, our aim was to develop a valid PA index for this population, which will also be able to express PA continuously. In the German EPIC centers Potsdam and Heidelberg, a clustered sample of 3,766 participants was re-invited to the study center. 1,615 participants agreed to participate and 1,344 participants were finally included in this study. PA was measured by questionnaires on defined activities and a 7-day combined heart rate and acceleration sensor. In a training sample of 433 participants, the Improved Physical Activity Index (IPAI) was developed. Its performance was evaluated in a validation sample of 911 participants and compared with the Cambridge Index and the Total PA Index. The IPAI consists of items covering five areas including PA at work, sport, cycling, television viewing, and computer use. The correlations of the IPAI with accelerometer counts in the training and validation sample ranged r = 0.40-0.43 and with physical activity energy expenditure (PAEE) r = 0.33-0.40 and were higher than for the Cambridge Index and the Total PA Index previously applied in EPIC. In non-working participants the IPAI showed higher correlations than the Cambridge Index and the Total PA Index, with r = 0.34 for accelerometer counts and r = 0.29 for PAEE. In conclusion, we developed a valid physical activity index which is able to express PA continuously as well as to categorize participants according to their PA level. In populations with increasing rates of non-working people the performance of the IPAI is better than the established indices used in EPIC.	[Wientzek, Angelika; Vigl, Matthaeus; Bergmann, Manuela M.; Harttig, Ulrich; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Steindorf, Karen; Bruehmann, Boris] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Div Prevent Oncol G110, Heidelberg, Germany; [Katzke, Verena; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol C020, Heidelberg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Wientzek, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	angelika.wientzek@dife.de	Wientzek, Angelika/F-4851-2013	Wientzek, Angelika/0000-0002-9068-3022	German Federal Ministry of Education and Research [BMBF FKZ: 01ER0808]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant from the German Federal Ministry of Education and Research (BMBF FKZ: 01ER0808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Dorner TE, 2013, WIEN KLIN WOCHENSCHR; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; Spittaels H, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-48; Straker LM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-54; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Tooze JA, 2013, AM J EPIDEMIOL, V177, P1199, DOI 10.1093/aje/kws379; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875	23	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92005	10.1371/journal.pone.0092005	http://dx.doi.org/10.1371/journal.pone.0092005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642812	gold, Green Submitted, Green Published			2022-12-25	WOS:000333259900059
J	Gonzalez-Tokman, D; Ruch, J; Pulpitel, T; Ponton, F				Gonzalez-Tokman, Daniel; Ruch, Jasmin; Pulpitel, Tamara; Ponton, Fleur			Cuticular Antifungals in Spiders: Density- and Condition Dependence	PLOS ONE			English	Article							DISEASE RESISTANCE; TRADE-OFFS; GROUP-SIZE; ANTIPREDATOR BENEFITS; PREDATION RISK; INSECT; DEFENSES; RECOGNITION; RELATEDNESS; PROPHYLAXIS	Animals living in groups face a high risk of disease contagion. In many arthropod species, cuticular antimicrobials constitute the first protective barrier that prevents infections. Here we report that group-living spiders produce cuticular chemicals which inhibit fungal growth. Given that cuticular antifungals may be costly to produce, we explored whether they can be modulated according to the risk of contagion (i.e. under high densities). For this purpose, we quantified cuticular antifungal activity in the subsocial crab spider Diaea ergandros in both natural nests and experimentally manipulated nests of varying density. We quantified the body-condition of spiders to test whether antifungal activity is condition dependent, as well as the effect of spider density on body-condition. We predicted cuticular antifungal activity to increase and body-condition to decrease with high spider densities, and that antifungal activity would be inversely related to body-condition. Contrary to our predictions, antifungal activity was neither density-nor condition-dependent. However, body-condition decreased with density in natural nests, but increased in experimental nests. We suggest that pathogen pressure is so important in nature that it maintains high levels of cuticular antifungal activity in spiders, impacting negatively on individual energetic condition. Future studies should identify the chemical structure of the isolated antifungal compounds in order to understand the physiological basis of a trade-off between disease prevention and energetic condition caused by group living, and its consequences in the evolution of sociality in spiders.	[Gonzalez-Tokman, Daniel] Univ Nacl Autonoma Mexico, Inst Fis, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Ruch, Jasmin] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Ruch, Jasmin] Univ Hamburg, Zool Museum, Hamburg, Germany; [Ruch, Jasmin] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Pulpitel, Tamara; Ponton, Fleur] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ponton, Fleur] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	Universidad Nacional Autonoma de Mexico; University of Hamburg; University of Hamburg; Macquarie University; University of Sydney; University of Sydney	Gonzalez-Tokman, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	danigt@gmail.com	Gonzalez-Tokman, Daniel/Q-6833-2018	Gonzalez-Tokman, Daniel/0000-0001-7251-5773; Ponton, Fleur/0000-0001-7156-3896	Consejo Nacional de Ciencia y Tecnologia (Beca Mixta); Posgrado en Ciencias Biologicas (Programa de Apoyo a Estudiantes de Posgrado); University of Sydney; Macquarie University	Consejo Nacional de Ciencia y Tecnologia (Beca Mixta); Posgrado en Ciencias Biologicas (Programa de Apoyo a Estudiantes de Posgrado); University of Sydney(University of Sydney); Macquarie University	Daniel Gonzalez-Tokman was supported by the Consejo Nacional de Ciencia y Tecnologia (Beca Mixta) and by the Posgrado en Ciencias Biologicas (Programa de Apoyo a Estudiantes de Posgrado). Fleur Ponton was supported by the University of Sydney. The study was funded by a scholarship of Jasmin Ruch from Macquarie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2010, ANIM BEHAV, V79, P3, DOI 10.1016/j.anbehav.2009.10.012; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Aviles Leticia, 1997, P476; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Bilde T, 2001, J EVOLUTION BIOL, V14, P959, DOI 10.1046/j.1420-9101.2001.00346.x; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Crawley MJ., 2007, R BOOK; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; ERWIN RM, 1978, CONDOR, V80, P211, DOI 10.2307/1367920; Evans TA, 1998, P ROY SOC B-BIOL SCI, V265, P129, DOI 10.1098/rspb.1998.0273; Evans TA, 2002, MOL ECOL, V11, P2307, DOI 10.1046/j.1365-294X.2002.01623.x; Evans Theodore A., 1995, Records of the Western Australian Museum Supplement, V52, P151; FREELAND WJ, 1983, AM NAT, V121, P223, DOI 10.1086/284052; Fritz H, 1996, J ANIM ECOL, V65, P736, DOI 10.2307/5672; Godfrey SS, 2006, PARASITOL RES, V99, P223, DOI 10.1007/s00436-005-0120-9; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gross J, 1998, J INVERTEBR PATHOL, V72, P296, DOI 10.1006/jipa.1998.4781; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hass CC, 2002, BEHAV ECOL SOCIOBIOL, V51, P570, DOI 10.1007/s00265-002-0463-5; JAKOB EM, 1991, ANIM BEHAV, V41, P711, DOI 10.1016/S0003-3472(05)80908-X; James RR, 2003, J INVERTEBR PATHOL, V84, P67, DOI 10.1016/j.jip.2003.08.006; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; KOIDSUMI K, 1957, J INSECT PHYSIOL, V1, P40, DOI 10.1016/0022-1910(57)90022-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Machado G, 2002, INSECT SOC, V49, P388, DOI 10.1007/PL00012663; Ortiz-Urquiza Almudena, 2013, Insects, V4, P357, DOI 10.3390/insects4030357; POIANI A, 1992, OECOLOGIA, V92, P429, DOI 10.1007/BF00317470; R Development Core Team, 2009, R FDN STAT COMP; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Rifkin JL, 2012, AM NAT, V180, P70, DOI 10.1086/666081; Ruch J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-257; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P., 1998, Parasites in social insects.; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHYKOFF JA, 1991, P ROY SOC B-BIOL SCI, V243, P55, DOI 10.1098/rspb.1991.0009; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; Stow A, 2008, BRAIN BEHAV IMMUN, V22, P1009, DOI 10.1016/j.bbi.2008.03.008; Stow A, 2007, BIOL LETTERS, V3, P422, DOI 10.1098/rsbl.2007.0178; Uetz GW, 2002, ANIM BEHAV, V63, P445, DOI 10.1006/anbe.2001.1918; Unglaub B, 2013, BEHAV ECOL SOCIOBIOL, V67, P785, DOI 10.1007/s00265-013-1502-0; Whitehouse MEA, 2005, BIOL REV, V80, P347, DOI 10.1017/S1464793104006694; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Wise DH, 2006, ANNU REV ENTOMOL, V51, P441, DOI 10.1146/annurev.ento.51.110104.150947; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	52	5	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91785	10.1371/journal.pone.0091785	http://dx.doi.org/10.1371/journal.pone.0091785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637563	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100060
J	Jiao, SP; Wu, MQ; Ye, F; Tang, HL; Xie, XH; Xie, XM				Jiao, Shiping; Wu, Minqing; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming			BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer	PLOS ONE			English	Article							NONINVASIVE IMAGING MODELS; MALIGNANT-TRANSFORMATION; TARGETED EXPRESSION; DRUG-RESISTANCE; POOR-PROGNOSIS; CELL-DEATH; BCL-2; APOPTOSIS; PROMOTES; PATHWAY	Our previous studies showed that BikDD, a constitutively active mutant form of Bik, exhibited powerful antitumor effects in preclinical pancreatic, lung and breast cancer models. Howerver, the antitumor activity of BikDD in triple-negative breast cancer (TNBC) is unknown. Here we show that aberrant expression of p-ERK1/2 was a meaningful molecular phenotype in TNBC patients, and can be an obstacle for treatment because of the converse correlation with Bik. A novel mutant, BikDDA, in which Ser(124) was changed to Alanine to block BikDD phosphorylation by p-ERK1/2 prevented subsequent ubiquitin-proteasome degradation. BikDDA showed a prolonged half-life and enhanced pro-apoptotic ability in TNBC cells compared with BikDD. Moreover, aberrant expression of p-ERK1/2 was associated with 5-fluorouracil resistance in breast cancer patients and BikDDA enhanced the therapeutic effects of 5-fluorouracil in vitro.	[Jiao, Shiping; Wu, Minqing; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Jiao, Shiping; Ye, Feng; Tang, Hailin; Xie, Xinhua; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Minqing] Sun Yat Sen Univ, Ctr Canc, Dept Canc Prevent Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Jiao, Shiping] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn		Jiao, Shiping/0000-0001-6546-9369	National Natural Science Foundation of China [81272514, 31100935, 81302318, 31030061]; China Postdoctoral Science Foundation [2012M520075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from the National Natural Science Foundation of China (81272514, 31100935, 81302318), the Key Programme of the National Natural Science Foundation of China (31030061), and the China Postdoctoral Science Foundation (2012M520075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2011, CELL, V144, P638, DOI 10.1016/j.cell.2011.02.030; Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; Eralp Y, 2008, ANN ONCOL, V19, P669, DOI 10.1093/annonc/mdm522; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065138; Hamilton A, 2000, ANN ONCOL, V11, P647, DOI 10.1023/A:1008390429428; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li YM, 2003, CANCER RES, V63, P7630; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mebratu YA, 2008, J CELL BIOL, V183, P429, DOI 10.1083/jcb.200801186; Sher YP, 2011, MOL CANCER THER, V10, P637, DOI 10.1158/1535-7163.MCT-10-0827; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Xie XM, 2007, CANCER CELL, V12, P52, DOI 10.1016/j.ccr.2007.05.009; Xie XH, 2012, MOL CANCER THER, V11, P1915, DOI 10.1158/1535-7163.MCT-12-0191; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130; Zou YY, 2002, CANCER RES, V62, P8	30	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92172	10.1371/journal.pone.0092172	http://dx.doi.org/10.1371/journal.pone.0092172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637719	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100123
J	Su, YF; Wu, TF; Ko, JL; Tsai, HT; Tee, YT; Chien, MH; Chou, CH; Lin, WL; Low, HY; Chou, MY; Yang, SF; Wang, PH				Su, Ying-Fang; Wu, Tzu-Fan; Ko, Jiunn-Liang; Tsai, Hsiu-Ting; Tee, Yi-Torng; Chien, Ming-Hsien; Chou, Chi-Hung; Lin, Wea-Lung; Low, Hui-Ying; Chou, Ming-Yung; Yang, Shun-Fa; Wang, Po-Hui			The Expression of Ribonucleotide Reductase M2 in the Carcinogenesis of Uterine Cervix and Its Relationship with Clinicopathological Characteristics and Prognosis of Cancer Patients	PLOS ONE			English	Article							DNA-DAMAGE; CELL-PROLIFERATION; EARLY-STAGE; SUBUNIT M2; IN-VITRO; REPAIR; RRM2; R2; INHIBITORS; CARCINOMA	Background: To investigate the implication of ribonucleotide reductase M2 (RRM2) in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients. Methodology and Principal Findings: The impact of RRM2 on cell viability was investigated in SiHa cervical cancer cells after RRM2 knockdown and the addition of cisplatin, which induces inter-and intra-strand DNA crosslinks. RRM2 immunoreactivity was evaluated by semi-quantitative H score among 29 normal, 30 low-grade dysplasia, 30 high-grade dysplasia and 103 invasive cancer tissue specimens of the uterine cervix, using tissue microarrays. RRM2 was then correlated with the clinicopathological variables of cervical cancer and patient survival. A greater toxic effect on cell viability using cisplatin was reflected by the greater reduction in RRM2 protein expression in SiHa cells. The RRM2 expression in cancer tissues was higher than that in high-grade dysplasia, low-grade dysplasia or normal cervical tissues. RRM2 upregulation was correlated with deep stromal invasion, large tumors and parametrial invasion and predicted poor survival. Conclusions: RRM2 is a new molecular marker for the diagnosis and clinical outcomes of cervical cancer. It is involved in cervical carcinogenesis and predicts poor survival, and may be a potential therapeutic target including in cisplatin treatment.	[Su, Ying-Fang; Wu, Tzu-Fan; Ko, Jiunn-Liang; Tee, Yi-Torng; Chou, Chi-Hung; Yang, Shun-Fa; Wang, Po-Hui] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Su, Ying-Fang; Chou, Ming-Yung] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Su, Ying-Fang] Chung Shan Med Univ Hosp, Dept Stomatol, Taichung, Taiwan; [Tsai, Hsiu-Ting] Chung Shan Med Univ, Sch Nursing, Taichung, Taiwan; [Tsai, Hsiu-Ting] Chung Shan Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Tee, Yi-Torng; Lin, Wea-Lung; Wang, Po-Hui] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Tee, Yi-Torng; Low, Hui-Ying; Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan; [Chou, Chi-Hung] Yuan Sheng Hosp, Dept Internal Med, Div Cardiol, Yuanlin, Taiwan; [Chou, Chi-Hung] Changhua Christian Hosp, Yuanlin Branch, Yuanlin, Taiwan; [Lin, Wea-Lung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Wang, PH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ginhow84921344@yahoo.com.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Ko, Jiunn-Liang/0000-0001-6855-9239; Tsai, Hsiu Ting/0000-0003-1137-9274	Chung Shan Medical University Hospital [CSH-2013-D-001]; Taiwan National Science Council [NSC 102-2314-B-040-014-MY3]	Chung Shan Medical University Hospital; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from Chung Shan Medical University Hospital, (CSH-2013-D-001) and Taiwan National Science Council (NSC 102-2314-B-040-014-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2013, PROG MOL BIOL TRANSL, V117, P389, DOI 10.1016/B978-0-12-386931-9.00014-3; Altaha R, 2004, INT J MOL MED, V14, P959; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Burton TR, 2003, INT J ONCOL, V22, P21; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; DELGADO G, 1990, GYNECOL ONCOL, V38, P352, DOI 10.1016/0090-8258(90)90072-S; Duxbury MS, 2007, BIOCHEM BIOPH RES CO, V354, P190, DOI 10.1016/j.bbrc.2006.12.177; Fan HZ, 1998, CANCER RES, V58, P1650; FULLER AF, 1989, GYNECOL ONCOL, V33, P34, DOI 10.1016/0090-8258(89)90598-2; Grisaru DA, 2003, CANCER, V97, P1904, DOI 10.1002/cncr.11269; Heidel JD, 2007, CLIN CANCER RES, V13, P2207, DOI 10.1158/1078-0432.CCR-06-2218; Kristensen GB, 1999, GYNECOL ONCOL, V74, P245, DOI 10.1006/gyno.1999.5420; Kurman RJ, 2008, AM J OBSTET GYNECOL, V198, P351, DOI 10.1016/j.ajog.2008.01.005; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Lien E J, 1987, Prog Drug Res, V31, P101; Lin ZP, 2011, MOL PHARMACOL, V80, P1000, DOI 10.1124/mol.111.074708; Liu XY, 2007, CLIN COLORECTAL CANC, V6, P374, DOI 10.3816/CCC.2007.n.007; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Sapp H, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.028; SEVIN BU, 1995, CANCER-AM CANCER SOC, V76, P1978, DOI 10.1002/1097-0142(19951115)76:10+<1978::AID-CNCR2820761313>3.0.CO;2-K; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Wang LM, 2012, CHINESE MED J-PEKING, V125, P2151, DOI 10.3760/cma.j.issn.0366-6999.2012.12.013; Wang PH, 2011, INT J CANCER, V129, P2380, DOI 10.1002/ijc.25936; Yen Y, 2003, CLIN CANCER RES, V9, P4304; Zhang KQ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-11; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	40	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91644	10.1371/journal.pone.0091644	http://dx.doi.org/10.1371/journal.pone.0091644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637958	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100051
J	Yu, H; Waddell, JN; Kuang, SH; Bidwell, CA				Yu, Hui; Waddell, Jolena N.; Kuang, Shihuan; Bidwell, Christopher A.			Park7 Expression Influences Myotube Size and Myosin Expression in Muscle	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; SKELETAL-MUSCLE; GENE-EXPRESSION; CALLIPYGE GENE; PHENOTYPIC CHARACTERIZATION; PARKINSONS-DISEASE; FIBER-TYPE; DJ-1; GROWTH; HYPERTROPHY	Callipyge sheep exhibit postnatal muscle hypertrophy due to the up-regulation of DLK1 and/or RTL1. The up-regulation of PARK7 was identified in hypertrophied muscles by microarray analysis and further validated by quantitative PCR. The expression of PARK7 in hypertrophied muscle of callipyge lambs was confirmed to be up-regulated at the protein level. PARK7 was previously identified to positively regulate PI3K/AKT pathway by suppressing the phosphatase activity of PTEN in mouse fibroblasts. The purpose of this study was to investigate the effects of PARK7 in muscle growth and protein accretion in response to IGF1. Primary myoblasts isolated from Park7 (+/+) and Park7 (-/-) mice were used to examine the effect of differential expression of Park7. The Park7 (+/+) myotubes had significantly larger diameters and more total sarcomeric myosin expression than Park7 (-/-) myotubes. IGF1 treatment increased the mRNA abundance of Myh4, Myh7 and Myh8 between 20-40% in Park7 (+/+) myotubes relative to Park7 (-/-). The level of AKT phosphorylation was increased in Park7 (+/+) myotubes at all levels of IGF1 supplementation. After removal of IGF1, the Park7 (+/+) myotubes maintained higher AKT phosphorylation through 3 hours. PARK7 positively regulates the PI3K/AKT pathway by inhibition of PTEN phosphatase activity in skeletal muscle. The increased PARK7 expression can increase protein synthesis and result in myotube hypertrophy. These results support the hypothesis that elevated expression of PARK7 in callipyge muscle would increase levels of AKT activity to cause hypertrophy in response to the normal IGF1 signaling in rapidly growing lambs. Increasing expression of PARK7 could be a novel mechanism to increase protein accretion and muscle growth in livestock or help improve muscle mass with disease or aging.	[Yu, Hui; Waddell, Jolena N.; Kuang, Shihuan; Bidwell, Christopher A.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bidwell, CA (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	cbidwell@purdue.edu	Yu, Hui/AAR-3692-2021; yu, hui/K-3222-2017	Kuang, Shihuan/0000-0001-9180-3180	Chinese Scholarship Council; Purdue University Department of Animal Sciences; Purdue University Agricultural Research Programs; Purdue University Department of Animal Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Chinese Scholarship Council(China Scholarship Council); Purdue University Department of Animal Sciences; Purdue University Agricultural Research Programs; Purdue University Department of Animal Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	HY was partially supported by the Chinese Scholarship Council and the Purdue University Department of Animal Sciences. The work was supported by the Purdue University Agricultural Research Programs and gift funds through the Purdue University Department of Animal Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Carpenter CE, 2000, CAN J ANIM SCI, V80, P511, DOI 10.4141/A00-009; Carpenter E, 1996, J ANIM SCI, V74, P388; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Chelh I, 2011, ANIMAL, V5, P278, DOI 10.1017/S1751731110001862; Chelh I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-196; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Duckett SK, 2000, J ANIM SCI, V78, P2836; Eltoweissy M, 2011, MOL BIOSYST, V7, P1277, DOI 10.1039/c0mb00116c; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; He XY, 2011, J DIGEST DIS, V12, P131, DOI 10.1111/j.1751-2980.2011.00488.x; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jackson SP, 1997, J ANIM SCI, V75, P125; Jackson SP, 1997, J ANIM SCI, V75, P133; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Liu H, 2008, BIOCHEM BIOPH RES CO, V375, P477, DOI 10.1016/j.bbrc.2008.08.046; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Miyajima Y, 2010, ANTICANCER RES, V30, P265; Murphy SK, 2006, GENOME RES, V16, P340, DOI 10.1101/gr.4389306; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Pucci-Minafra I, 2008, J PROTEOME RES, V7, P1412, DOI 10.1021/pr700748m; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sandirasegarane L, 2001, BIOCHEM BIOPH RES CO, V283, P158, DOI 10.1006/bbrc.2001.4739; Shinbo YM, 2005, INT J ONCOL, V26, P641; Smit M, 2003, GENETICS, V163, P453; STAVAUX D, 1994, J VET MED A, V41, P229, DOI 10.1111/j.1439-0442.1994.tb00089.x; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	58	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92030	10.1371/journal.pone.0092030	http://dx.doi.org/10.1371/journal.pone.0092030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637782	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100105
J	Liu, SQ; Jiang, S; Li, CR; Zhang, BJ; Li, QJ				Liu, Si-Qi; Jiang, Shan; Li, Chaoran; Zhang, Baojun; Li, Qi-Jing			miR-17-92 Cluster Targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to Promote TH17-mediated Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Cell Differentiation; Inflammation; MicroRNA; Pten; T Cell; IKZF4; Th17; miR-17-92	REGULATORY T-CELLS; ROR-GAMMA; MIR-17-SIMILAR-TO-92 FAMILY; IMMUNE FUNCTION; HELPER-CELLS; TH17 CELLS; DIFFERENTIATION; EXPRESSION; MICRORNA; LYMPHOCYTES	Background: miRNA is a key component of post-transcriptional network governing the fate of T cells. Results: By targeting PTEN and IKZF4, miR-17-92 cluster promotes T(H)17 differentiation and T(H)17-related inflammation. Conclusion: miR-19b and miR-17 within the cluster additively promote T(H)17 responses through distinct regulatory networks. Significance: Our study provides novel regulatory mechanisms and potential therapeutic candidates against autoimmunity. The miR-17-92 cluster regulates a broad spectrum of biological processes of T cell immunity. This cluster was found to facilitate T cell proliferation, enhance antitumor activities and promote T cell-dependent antibody responses. However, little is known about the role of this miRNA cluster in the development of autoimmune diseases. Multiple sclerosis is a neuro-destructive autoimmune disease caused by the pathogenicity of T(H)17 cells, whose differentiation is tightly controlled by a variety of transcriptional and post-transcriptional regulators. Our study unveils the critical role of miR-17-92 in T(H)17 differentiation: T cell-specific miR-17-92 deficiency reduced T(H)17 differentiation and ameliorated experimental autoimmune encephalomyelitis (EAE) symptoms. We demonstrated that miR-17 and miR-19b are the two miRNAs in this cluster responsible for promoting T(H)17 responses. MiR-19b represses the expression of Phosphatase and Tensin Homology (PTEN), thereby augmenting the PI3K-AKT-mTOR axis essential for proper T(H)17 differentiation. Meanwhile, miR-17 enhances T(H)17 polarization by inhibiting a novel target, Ikaros Family Zinc Finger 4 (IKZF4). By establishing the miR-17-92 cluster as a key driver of T(H)17 responses, our data identify this miRNA cluster as a potential therapeutic target for the clinical intervention of multiple sclerosis.	[Liu, Si-Qi; Jiang, Shan; Li, Chaoran; Zhang, Baojun; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, 207 Res Dr, Durham, NC 27710 USA.	Qi-Jing.Li@Duke.edu	ZHANG, BAOJUN/N-3863-2014; Liu, Siqi/AAL-6891-2020; Zhang, Baojun/AAN-8246-2020	ZHANG, BAOJUN/0000-0002-7786-4304; Liu, Siqi/0000-0001-9727-9498; 	NIAID, National Institutes of Health [RAI091878A, RAI091878B]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091878, R56AI091878] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Grants RAI091878A and RAI091878B from the NIAID, National Institutes of Health.	Alkhatib A, 2012, J EXP MED, V209, P395, DOI 10.1084/jem.20110216; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hoechst B, 2011, BLOOD, V117, P6532, DOI 10.1182/blood-2010-11-317321; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lindberg RLP, 2010, EUR J IMMUNOL, V40, P888, DOI 10.1002/eji.200940032; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Lykken EA, 2011, IMMUNOL RES, V49, P87, DOI 10.1007/s12026-010-8196-4; Nagai S, 2013, ANN NY ACAD SCI, V1280, P30, DOI 10.1111/nyas.12059; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rottiers V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006840; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	49	115	119	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12446	12456		10.1074/jbc.M114.550723	http://dx.doi.org/10.1074/jbc.M114.550723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644282	Green Published, hybrid			2022-12-25	WOS:000335581400021
J	Ikeda, S; Tainaka, K; Matsumoto, K; Shinohara, Y; Ode, KL; Susaki, EA; Ueda, HR				Ikeda, Shuji; Tainaka, Kazuki; Matsumoto, Katsuhiko; Shinohara, Yuta; Ode, Koji L.; Susaki, Etsuo A.; Ueda, Hiroki R.			Non-Enzymatic DNA Cleavage Reaction Induced by 5-Ethynyluracil in Methylamine Aqueous Solution and Application to DNA Concatenation	PLOS ONE			English	Article							STRAND CLEAVAGE; RESTRICTION	DNA can be concatenated by hybridization of DNA fragments with protruding single-stranded termini. DNA cleavage occurring at a nucleotide containing a DNA base analogue is a useful method to obtain DNA with designed protruding termini. Here, we report a novel non-enzymatic DNA cleavage reaction for DNA concatenation. We found that DNA is cleaved at a nucleotide containing 5-ethynyluracil in a methylamine aqueous solution to generate 59-phosphorylated DNA fragment as a cleavage product. We demonstrated that the reaction can be applied to DNA concatenation of PCR-amplified DNA fragments. This novel non-enzymatic DNA cleavage reaction is a simple practical approach for DNA concatenation.	[Ikeda, Shuji; Matsumoto, Katsuhiko; Ueda, Hiroki R.] RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo, Japan; [Ueda, Hiroki R.] RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo, Japan; [Tainaka, Kazuki; Ode, Koji L.; Susaki, Etsuo A.; Ueda, Hiroki R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, Tokyo, Japan; [Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan; [Shinohara, Yuta; Ueda, Hiroki R.] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; RIKEN; University of Tokyo; Osaka University; Osaka University	Ueda, HR (corresponding author), RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014	Ueda, Hiroki R/0000-0001-8342-9176; Susaki, Etsuo/0000-0001-5621-7311; Tainaka, Kazuki/0000-0002-5943-8723; Matsumoto, Katsuhiko/0000-0002-9680-8711	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25221004]; MEXT/Japan Society for the Promotion of Science (JSPS) [23115006]; RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST); Japan Foundation for Applied Enzymology;  [A2559890]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Foundation for Applied Enzymology; 	This work was supported by the Program for Innovative Cell Biology by Innovative Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to HRU), a Grant-in-Aid for Scientific Research (S) (Grant No. 25221004) (to HRU), a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 23115006) from MEXT/Japan Society for the Promotion of Science (JSPS) (to HRU), a grant for the strategic programs for R&D (President's discretionary fund) of RIKEN (to HRU), an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center (to HRU), a grant from Core Research for Evolutional Science and Technology (CREST) (to HRU), the RIKEN Special Postdoctoral Research Program (to EAS), a Grant-in-Aid from Japan Foundation for Applied Enzymology (to EAS), and a Grant-in-Aid for JSPS Fellows A2559890 (to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOMBS MM, 1969, BIOCHIM BIOPHYS ACTA, V174, P161, DOI 10.1016/0005-2787(69)90239-1; Ding P, 2010, CHEM-EUR J, V16, P14385, DOI 10.1002/chem.201001572; Dumas A, 2010, J AM CHEM SOC, V132, P18004, DOI 10.1021/ja1079578; FROEHLER BC, 1983, NUCLEIC ACIDS RES, V11, P8031, DOI 10.1093/nar/11.22.8031; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Graham D, 1998, J CHEM SOC PERK T 1, P1131, DOI 10.1039/a707031d; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; HORN T, 1986, TETRAHEDRON LETT, V27, P4705, DOI 10.1016/S0040-4039(00)85043-1; Hudson HER, 2006, SYNLETT, V18, P2997; Irwin C. R., 2012, METHOD MOL BIOL, V890, P23, DOI DOI 10.1007/978-1-61779-876-4_; Kuzuya A, 2009, BIOCONJUGATE CHEM, V20, P3; Loakes D, 2003, HELV CHIM ACTA, V86, P1193, DOI 10.1002/hlca.200390103; Meyer C, 2003, CHEMBIOCHEM, V4, P610, DOI 10.1002/cbic.200300587; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Nichols N.M, 2009, CURR PROTOC MOL BIOL, P3; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Rai D, 2005, J MED CHEM, V48, P7012, DOI 10.1021/jm058167w; Rospigliosi A, 2007, LANGMUIR, V23, P8264, DOI 10.1021/la063704g; Saito I, 2011, Japan patent, Patent No. [JP2011-037796A, 2011037796]; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Stein V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp589; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; Tanaka K, 2008, CHEMBIOCHEM, V9, P2120, DOI 10.1002/cbic.200800285; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; Western EC, 2003, J ORG CHEM, V68, P6767, DOI 10.1021/jo034289p	27	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92369	10.1371/journal.pone.0092369	http://dx.doi.org/10.1371/journal.pone.0092369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647759	Green Submitted, gold, Green Published			2022-12-25	WOS:000333348500123
J	Schmitt, V; Schloegl, C; Fischer, J				Schmitt, Vanessa; Schloegl, Christian; Fischer, Julia			Seeing the Experimenter Influences the Response to Pointing Cues in Long-Tailed Macaques	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; DOGS CANIS-FAMILIARIS; OBJECT-CHOICE TASKS; GAZE DIRECTION; PONGO-PYGMAEUS; SOCIAL CUES; GIVEN CUES; COMPREHENSION; GESTURES; DOMESTICATION	Methodological variations in experimental conditions can strongly influence animals' performances in cognitive tests. Specifically, the procedure of the so-called object-choice task has been controversially discussed; here, a human experimenter indicates the location of hidden food by pointing or gazing at one of two or more containers. Whereas dogs usually succeed, results for nonhuman primates are ambiguous. In the standard version of the task the majority of subjects do not respond appropriately to human pointing. However, modifying the task setup, such as placing the containers further apart, seems to improve subjects' performances, suggesting that cue salience may be an important variable. Here we investigated whether the visibility of the experimenter inhibits long-tailed macaques' (Macaca fascicularis) usage of the pointing cue. In our baseline condition, with the experimenter fully visible, the monkeys chose the correct container in 61% of the trials. The performance increased significantly, however, when the experimenter was hidden behind a curtain and only the arm of the experimenter, a doll's arm, or a stick was visible. Furthermore, the monkeys performed significantly better when the tip of the pointing finger or device was close to the target compared to the more distant condition. Intriguingly, after these experiments the monkeys' performance was also significantly improved in the baseline condition (70%). Apparently, the monkeys were first distracted by the presence of the experimenter, but then learned to use the cue. These findings highlight the importance of the test conditions, and question some of the assumptions about species-specific differences in the object-choice task.	[Schmitt, Vanessa] Univ Cologne, Social Cognit Cologne, D-50931 Cologne, Germany; [Schmitt, Vanessa; Schloegl, Christian; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Schmitt, Vanessa; Schloegl, Christian; Fischer, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, D-37073 Gottingen, Germany	University of Cologne; Deutsches Primatenzentrum (DPZ); University of Gottingen	Schmitt, V (corresponding author), Univ Cologne, Social Cognit Cologne, D-50931 Cologne, Germany.	vschmitt@dpz.eu	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074	German Initiative of Excellence; Leibniz Graduate School for Primate Neurobiology (Neuroprimm); Leibniz Graduate School "Foundations of Primate Social Behaviour"	German Initiative of Excellence; Leibniz Graduate School for Primate Neurobiology (Neuroprimm); Leibniz Graduate School "Foundations of Primate Social Behaviour"	This study was funded by the German Initiative of Excellence and the Leibniz Graduate School for Primate Neurobiology (Neuroprimm). CS was supported by the Leibniz Graduate School "Foundations of Primate Social Behaviour" (http://www.dpz.eu/en/career/leibniz-graduate-schools.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1996, BEHAV PROCESS, V37, P47, DOI 10.1016/0376-6357(95)00074-7; Barrera G, 2012, BEHAV PROCESS, V89, P44, DOI 10.1016/j.beproc.2011.10.013; Barth J, 2005, ANIM COGN, V8, P84, DOI 10.1007/s10071-004-0235-x; Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Elgier AM, 2012, ANIM COGN, V15, P1111, DOI 10.1007/s10071-012-0534-6; Elgier AM, 2009, BEHAV PROCESS, V81, P402, DOI 10.1016/j.beproc.2009.03.017; Emery NJ, 2009, ANNU REV PSYCHOL, V60, P87, DOI 10.1146/annurev.psych.60.110707.163526; Emery NJ, 2000, EYES HAVE IT NEUROET; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2006, COGNITION, V101, P495, DOI 10.1016/j.cognition.2005.01.011; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Hauser MD, 2007, P ROY SOC B-BIOL SCI, V274, P1913, DOI 10.1098/rspb.2007.0586; Hauser MD, 2011, P ROY SOC B-BIOL SCI, V278, P158, DOI 10.1098/rspb.2010.1441; Herman LM, 1999, J COMP PSYCHOL, V113, P347, DOI 10.1037/0735-7036.113.4.347; Herrmann E, 2006, DEVELOPMENTAL SCI, V9, P518, DOI 10.1111/j.1467-7687.2006.00519.x; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Itakura S, 1999, DEVELOPMENTAL SCI, V2, P448, DOI 10.1111/1467-7687.00089; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Lakatos G, 2012, ANIM COGN, V15, P201, DOI 10.1007/s10071-011-0446-x; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lyn H., 2010, J EVOLUTIONARY PSYCH, V8, P333, DOI DOI 10.1556/JEP.8.2010.4.3; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; MORISSETTE P, 1995, BRIT J DEV PSYCHOL, V13, P163, DOI 10.1111/j.2044-835X.1995.tb00671.x; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Mulcahy NJ, 2011, J COMP PSYCHOL, V125, P112, DOI 10.1037/a0020905; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; POVINELLI DJ, 1992, ANIM BEHAV, V43, P633, DOI 10.1016/0003-3472(92)90085-N; Povinelli DJ, 1999, BRIT J DEV PSYCHOL, V17, P37, DOI 10.1348/026151099165140; POVINELLI DJ, 1990, J COMP PSYCHOL, V104, P203, DOI 10.1037/0735-7036.104.3.203; Povinelli DJ, 1997, COGNITIVE DEV, V12, P327, DOI 10.1016/S0885-2014(97)90017-4; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Russell JL, 2011, DEVELOPMENTAL SCI, V14, P1459, DOI 10.1111/j.1467-7687.2011.01090.x; Sandel AA, 2011, ANIM BEHAV, V81, P925, DOI 10.1016/j.anbehav.2011.01.020; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Schmitt V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032024; Schmitt V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1262; Tomasello M, 2008, JEAN NICOD LECT, P1; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Udell MAR, 2010, ANIM BEHAV, V79, pE9, DOI 10.1016/j.anbehav.2009.11.033; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y	48	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91348	10.1371/journal.pone.0091348	http://dx.doi.org/10.1371/journal.pone.0091348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646501	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500029
J	Winkler, PA; Gornik, KR; Ramsey, DT; Dubielzig, RR; Venta, PJ; Petersen-Jones, SM; Bartoe, JT				Winkler, Paige A.; Gornik, Kara R.; Ramsey, David T.; Dubielzig, Richard R.; Venta, Patrick J.; Petersen-Jones, Simon M.; Bartoe, Joshua T.			A Partial Gene Deletion of SLC45A2 Causes Oculocutaneous Albinism in Doberman Pinscher Dogs	PLOS ONE			English	Article							CONGENITAL SENSORINEURAL DEAFNESS; MESSENGER-RNA DECAY; CREAM COAT COLOR; STRIA VASCULARIS; MALIGNANT-MELANOMA; INNER-EAR; MATP GENE; MUTATIONS; MELANOCYTES; POLYMORPHISMS	The first white Doberman pinscher (WDP) dog was registered by the American Kennel Club in 1976. The novelty of the white coat color resulted in extensive line breeding of this dog and her offspring. The WDP phenotype closely resembles human oculocutaneous albinism (OCA) and clinicians noticed a seemingly high prevalence of pigmented masses on these dogs. This study had three specific aims: (1) produce a detailed description of the ocular phenotype of WDPs, (2) objectively determine if an increased prevalence of ocular and cutaneous melanocytic tumors was present in WDPs, and (3) determine if a genetic mutation in any of the genes known to cause human OCA is causal for the WDP phenotype. WDPs have a consistent ocular phenotype of photophobia, hypopigmented adnexal structures, blue irides with a tan periphery and hypopigmented retinal pigment epithelium and choroid. WDPs have a higher prevalence of cutaneous melanocytic neoplasms compared with control standard color Doberman pinschers (SDPs); cutaneous tumors were noted in 12/20 WDP (<5 years of age: 4/12; >5 years of age: 8/8) and 1/20 SDPs (p<0.00001). Using exclusion analysis, four OCA causative genes were investigated for their association with WDP phenotype; TYR, OCA2, TYRP1 and SLC45A2. SLC45A2 was found to be linked to the phenotype and gene sequencing revealed a 4,081 base pair deletion resulting in loss of the terminus of exon seven of SLC45A2 (chr4: 77,062,968-77,067,051). This mutation is highly likely to be the cause of the WDP phenotype and is supported by a lack of detectable SLC45A2 transcript levels by reverse transcriptase PCR. The WDP provides a valuable model for studying OCA4 visual disturbances and melanocytic neoplasms in a large animal model.	[Winkler, Paige A.; Venta, Patrick J.; Petersen-Jones, Simon M.; Bartoe, Joshua T.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Winkler, Paige A.; Venta, Patrick J.; Petersen-Jones, Simon M.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Gornik, Kara R.] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Ramsey, David T.] Anim Ophthalmol Ctr, Williamston, MI USA; [Dubielzig, Richard R.] Univ Wisconsin, Sch Vet Med, Comparat Ocular Pathol Lab Wisconsin, Madison, WI 53706 USA	Michigan State University; Michigan State University; Tufts University; University of Wisconsin System; University of Wisconsin Madison	Bartoe, JT (corresponding author), Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	bartoejo@cvm.msu.edu	Petersen-Jones, Simon/B-3822-2018	Petersen-Jones, Simon/0000-0002-7410-2304; Gornik, Kara/0000-0002-5523-7991	MSU Faculty Development Funds; Myers-Dunlap Endowment for Canine Health; Animal Ophthalmology Center Research Fund	MSU Faculty Development Funds; Myers-Dunlap Endowment for Canine Health; Animal Ophthalmology Center Research Fund	Funding support for this project included: MSU Faculty Development Funds, Myers-Dunlap Endowment for Canine Health, and The Animal Ophthalmology Center Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; CABLE J, 1992, HEARING RES, V64, P6, DOI 10.1016/0378-5955(92)90164-I; Chong GT, 2009, ARCH OPHTHALMOL-CHIC, V127, P37, DOI 10.1001/archophthalmol.2008.550; Christophers AJ, 1998, MUTAT RES-FUND MOL M, V422, P113, DOI 10.1016/S0027-5107(98)00182-1; Clark LA, 2011, GENOMICS, V97, P244, DOI 10.1016/j.ygeno.2011.01.003; Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graf J, 2007, HUM MUTAT, V28, P710, DOI 10.1002/humu.20504; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Inagaki K, 2004, AM J HUM GENET, V74, P466, DOI 10.1086/382195; Jin Z, 2007, CELL TISSUE RES, V328, P257, DOI 10.1007/s00441-006-0369-z; Juzeniene A, 2013, SUNLIGHT VITAMIN D S, P1; King RA, 1997, EMERY RIMOINS PRINCI, P1171; Kumar A, 2011, INVEST OPHTH VIS SCI, V52, P2306, DOI 10.1167/iovs.10-5685; LOOKINGBILL DP, 1995, J AM ACAD DERMATOL, V32, P653, DOI 10.1016/0190-9622(95)90352-6; Mabula JB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-5; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Montoliu L, 2013, PIGMENT CELL MELANOM; Neilan BA, 1997, NUCLEIC ACIDS RES, V25, P2938, DOI 10.1093/nar/25.14.2938; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Opara KO, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-73; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Prado-Martinez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-363; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Rooryck C, 2008, PIGM CELL MELANOMA R, V21, P583, DOI 10.1111/j.1755-148X.2008.00496.x; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; RUSSELLEGGITT I, 1990, BRIT J OPHTHALMOL, V74, P136, DOI 10.1136/bjo.74.3.136; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2007, J HERED, V98, P544, DOI 10.1093/jhered/esm018; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; STEEL KP, 1989, DEVELOPMENT, V107, P453; Strain GM, 2009, J VET INTERN MED, V23, P282, DOI 10.1111/j.1939-1676.2008.0257.x; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; Vitavska O, 2013, MOL ASPECTS MED, V34, P655, DOI 10.1016/j.mam.2012.05.014; Winkler PA, 2013, J NEGAT RESULTS BIOM, V12, DOI 10.1186/1477-5751-12-6; Winkler PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072229; Wolf AB, 2005, J AAPOS, V9, P363, DOI 10.1016/j.jaapos.2005.03.003; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054	47	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92127	10.1371/journal.pone.0092127	http://dx.doi.org/10.1371/journal.pone.0092127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647637	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500088
J	Beaudry, JL; Dunford, EC; Teich, T; Zaharieva, D; Hunt, H; Belanoff, JK; Riddell, MC				Beaudry, Jacqueline L.; Dunford, Emily C.; Teich, Trevor; Zaharieva, Dessi; Hunt, Hazel; Belanoff, Joseph K.; Riddell, Michael C.			Effects of Selective and Non-Selective Glucocorticoid Receptor II Antagonists on Rapid-Onset Diabetes in Young Rats	PLOS ONE			English	Article							INSULIN SENSITIVITY; MIFEPRISTONE RU-486; FASTING GLUCOSE; WEIGHT-GAIN; RU 486; FAT; MECHANISMS; OLANZAPINE; STRESS; RESISTANCE	The blockade of glucocorticoid (GC) action through antagonism of the glucocorticoid receptor II (GRII) has been used to minimize the undesirable effects of chronically elevated GC levels. Mifepristone (RU486) is known to competitively block GRII action, but not exclusively, as it antagonizes the progesterone receptor. A number of new selective GRII antagonists have been developed, but limited testing has been completed in animal models of overt type 2 diabetes mellitus. Therefore, two selective GRII antagonists (C113176 and C108297) were tested to determine their effects in our model of GC-induced rapid-onset diabetes (ROD). Male Sprague-Dawley rats (similar to six weeks of age) were placed on a high-fat diet (60%), surgically implanted with pellets containing corticosterone (CORT) or wax (control) and divided into five treatment groups. Each group was treated with either a GRII antagonist or vehicle for 14 days after surgery: CORT pellets (400 mg/rat) + antagonists (80 mg/kg/day); CORT pellets + drug vehicle; and wax pellets (control) + drug vehicle. After 10 days of CORT treatment, body mass gain was increased with RU486 (by similar to 20% from baseline) and maintained with C113176 administration, whereas rats given C108297 had similar body mass loss (similar to 15%) to ROD animals. Fasting glycemia was elevated in the ROD animals (> 20 mM), normalized completely in animals treated with RU486 (6.2 +/- 0.1 mM, p < 0.05) and improved in animals treated with C108297 and C113176 (14.0 +/- 1.6 and 8.8 +/- 1.6 mM, p < 0.05 respectively). Glucose intolerance was normalized with RU486 treatment, whereas acute insulin response was improved with RU486 and C113176 treatment. Also, peripheral insulin resistance was attenuated with C113176 treatment along with improved levels of beta-cell function while C108297 antagonism only provided modest improvements. In summary, C113176 is an effective agent that minimized some GC-induced detrimental metabolic effects and may provide an alternative to the effective, but non-selective, GRII antagonist RU486.	[Beaudry, Jacqueline L.; Dunford, Emily C.; Teich, Trevor; Zaharieva, Dessi; Riddell, Michael C.] York Univ, Sch Kinesiol & Hlth Sci, Fac Hlth, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Beaudry, Jacqueline L.; Dunford, Emily C.; Teich, Trevor; Zaharieva, Dessi; Riddell, Michael C.] York Univ, Phys Act & Chron Dis Unit, Toronto, ON M3J 2R7, Canada; [Hunt, Hazel; Belanoff, Joseph K.] Corcept Therapeut, Menlo Pk, CA USA	York University - Canada; York University - Canada	Riddell, MC (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Fac Hlth, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada.	mriddell@yorku.ca		Zaharieva, Dessi/0000-0002-9374-8469	Corcept Therapuetics; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC-Canadian Graduate Scholarship Doctoral Award	Corcept Therapuetics; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-Canadian Graduate Scholarship Doctoral Award	This study was funded by Corcept Therapuetics and the Natural Sciences and Engineering Research Council of Canada (NSERC) grant to MCR. JLB is a recipient of an NSERC-Canadian Graduate Scholarship Doctoral Award. The funders had no role in data collection or analysis. The funders did help to prepare the manuscript for submission.	Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; [Anonymous], 2012, MED LETT DRUGS THER, V54, P46; Asagami T, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/235389; Beaudry JL, 2013, ENDOCRINOLOGY, V154, P3197, DOI 10.1210/en.2012-2114; Beebe KL, 2006, BEHAV BRAIN RES, V171, P225, DOI 10.1016/j.bbr.2006.03.039; Belanoff JK, 2010, DIABETES OBES METAB, V12, P545, DOI 10.1111/j.1463-1326.2009.01185.x; Belanoff JK, 2011, EUR J PHARMACOL, V655, P117, DOI 10.1016/j.ejphar.2011.01.019; Belavic Jennifer M, 2013, Nurse Pract, V38, P24, DOI 10.1097/01.NPR.0000425824.44694.e8; BOURGEOIS S, 1984, EMBO J, V3, P751, DOI 10.1002/j.1460-2075.1984.tb01879.x; Bujalska IJ, 2005, J MOL ENDOCRINOL, V34, P675, DOI 10.1677/jme.1.01718; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Chan O, 2003, Minerva Endocrinol, V28, P87; Chrousos GP, 2004, P NATL ACAD SCI USA, V101, P6329, DOI 10.1073/pnas.0401671101; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Dallman MF, 2003, TRENDS ENDOCRIN MET, V14, P394, DOI 10.1016/j.tem.2003.09.005; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Debono M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060984; deSchoolmeester J, 2013, DIABETES OBES METAB, V15, P1056, DOI 10.1111/dom.12137; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; FRIEDMAN JE, 1993, J BIOL CHEM, V268, P12952; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Goldberg JR, 1998, ARCH FAM MED, V7, P219, DOI 10.1001/archfami.7.3.219; Gross C, 2009, ADV THER, V26, P959, DOI 10.1007/s12325-009-0070-1; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; HEIKINHEIMO O, 1987, J STEROID BIOCHEM, V26, P279; Hoes JN, 2011, ANN RHEUM DIS, V70, P1887, DOI 10.1136/ard.2011.151464; Hoffman RP, 2008, PEDIATR DIABETES, V9, P57, DOI 10.1111/j.1399-5448.2007.00350.x; Holness MJ, 2005, DIABETOLOGIA, V48, P2062, DOI 10.1007/s00125-005-1894-0; Johanssen S, 2007, EUR J ENDOCRINOL, V157, P561, DOI 10.1530/EJE-07-0458; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Koizumi M, 2008, J ENDOCRINOL, V197, P221, DOI 10.1677/JOE-07-0462; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; LANGLEY SC, 1990, AM J PHYSIOL, V259, pR539, DOI 10.1152/ajpregu.1990.259.3.R539; Lansang MC, 2011, CLEV CLIN J MED, V78, P748, DOI 10.3949/ccjm.78a.10180; Linssen MML, 2011, CELL SIGNAL, V23, P1708, DOI 10.1016/j.cellsig.2011.06.002; Matthews LC, 2011, DIABETOLOGIA, V54, P223, DOI 10.1007/s00125-010-1963-x; MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105; Mohler ML, 2007, EXPERT OPIN THER PAT, V17, P59, DOI 10.1517/13543776.17.1.59; Nielsen MF, 2004, AM J PHYSIOL-ENDOC M, V286, pE102, DOI 10.1152/ajpendo.00566.2002; OKADA S, 1992, AM J PHYSIOL, V262, pR1106, DOI 10.1152/ajpregu.1992.262.6.R1106; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; ROY RR, 1983, ARCH ORAL BIOL, V28, P639, DOI 10.1016/0003-9969(83)90012-2; Sartor O, 1996, CLIN OBSTET GYNECOL, V39, P506, DOI 10.1097/00003081-199606000-00024; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Shibli-Rahhal A, 2006, CLIN DERMATOL, V24, P260, DOI 10.1016/j.clindermatol.2006.04.012; Shpilberg Y, 2012, DIS MODEL MECH, V5, P671, DOI 10.1242/dmm.008912; Simmons LR, 2012, ISRN ENDOCRINOL, V2012, DOI DOI 10.5402/2012/910905.PMID:22830041; Spiga F, 2007, J NEUROENDOCRINOL, V19, P891, DOI 10.1111/j.1365-2826.2007.01605.x; Stewart PM, 1996, CLIN ENDOCRINOL, V44, P493, DOI 10.1046/j.1365-2265.1996.716535.x; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Taylor AI, 2009, HORM METAB RES, V41, P899, DOI 10.1055/s-0029-1234071; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang Y, 2011, DIABETOLOGIA, V54, P440, DOI 10.1007/s00125-010-1956-9; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	61	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91248	10.1371/journal.pone.0091248	http://dx.doi.org/10.1371/journal.pone.0091248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642683	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900016
J	Ivanisenko, NV; Mishchenko, EL; Akberdin, IR; Demenkov, PS; Likhoshvai, VA; Kozlov, KN; Todorov, DI; Gursky, VV; Samsonova, MG; Samsonov, AM; Clausznitzer, D; Kaderali, L; Kolchanov, NA; Ivanisenko, VA				Ivanisenko, Nikita V.; Mishchenko, Elena L.; Akberdin, Ilya R.; Demenkov, Pavel S.; Likhoshvai, Vitaly A.; Kozlov, Konstantin N.; Todorov, Dmitry I.; Gursky, Vitaly V.; Samsonova, Maria G.; Samsonov, Alexander M.; Clausznitzer, Diana; Kaderali, Lars; Kolchanov, Nikolay A.; Ivanisenko, Vladimir A.			A New Stochastic Model for Subgenomic Hepatitis C Virus Replication Considers Drug Resistant Mutants	PLOS ONE			English	Article							HCV PROTEASE INHIBITOR; IN-VITRO RESISTANCE; RNA REPLICATION; ANTIVIRAL ACTIVITY; NS3 PROTEASE; CYCLOPHILIN INHIBITOR; POLYMERASE INHIBITORS; VIROLOGICAL RESPONSE; REPLICON VARIANTS; CROSS-RESISTANCE	As an RNA virus, hepatitis C virus (HCV) is able to rapidly acquire drug resistance, and for this reason the design of effective anti-HCV drugs is a real challenge. The HCV subgenomic replicon-containing cells are widely used for experimental studies of the HCV genome replication mechanisms, for drug testing in vitro and in studies of HCV drug resistance. The NS3/4A protease is essential for virus replication and, therefore, it is one of the most attractive targets for developing specific antiviral agents against HCV. We have developed a stochastic model of subgenomic HCV replicon replication, in which the emergence and selection of drug resistant mutant viral RNAs in replicon cells is taken into account. Incorporation into the model of key NS3 protease mutations leading to resistance to BILN-2061 (A156T, D168V, R155Q), VX-950 (A156S, A156T, T54A) and SCH 503034 (A156T, A156S, T54A) inhibitors allows us to describe the long term dynamics of the viral RNA suppression for various inhibitor concentrations. We theoretically showed that the observable difference between the viral RNA kinetics for different inhibitor concentrations can be explained by differences in the replication rate and inhibitor sensitivity of the mutant RNAs. The pre-existing mutants of the NS3 protease contribute more significantly to appearance of new resistant mutants during treatment with inhibitors than wild-type replicon. The model can be used to interpret the results of anti-HCV drug testing on replicon systems, as well as to estimate the efficacy of potential drugs and predict optimal schemes of their usage.	[Ivanisenko, Nikita V.; Mishchenko, Elena L.; Akberdin, Ilya R.; Demenkov, Pavel S.; Likhoshvai, Vitaly A.; Kolchanov, Nikolay A.; Ivanisenko, Vladimir A.] Inst Cytol & Genet SB RAS, Dept Syst Biol, Novosibirsk, Russia; [Kozlov, Konstantin N.; Todorov, Dmitry I.; Gursky, Vitaly V.; Samsonova, Maria G.; Samsonov, Alexander M.] St Petersburg State Polytech Univ, Dept Computat Biol, St Petersburg, Russia; [Clausznitzer, Diana; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Ivanisenko, Vladimir A.] PB Soft Llc, Novosibirsk, Russia; [Todorov, Dmitry I.] St Petersburg State Univ, Chebyshev Lab, St Petersburg 199034, Russia; [Gursky, Vitaly V.; Samsonov, Alexander M.] Russian Acad Sci, Ioffe Phys Tech Inst, Dept Theoret, St Petersburg 196140, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Peter the Great St. Petersburg Polytechnic University; Technische Universitat Dresden; Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute	Ivanisenko, VA (corresponding author), Inst Cytol & Genet SB RAS, Dept Syst Biol, Novosibirsk, Russia.	salix@bionet.nsc.ru	Akberdin, Ilya R/J-3172-2018; Todorov, Dmitry I/H-1856-2013; Kolchanov, Nikolay/A-9916-2014; Ivanisenko, Nikita/AAO-1621-2020; Gursky, Vitaly V/A-9187-2014; Ivanisenko, Vladimir/J-7832-2018; Kozlov, Konstantin/N-6748-2013; Demenkov, Pavel/AAC-8708-2020	Akberdin, Ilya R/0000-0003-0010-8620; Todorov, Dmitry I/0000-0002-6155-5865; Gursky, Vitaly V/0000-0003-4094-1983; Kozlov, Konstantin/0000-0001-6765-236X; Demenkov, Pavel/0000-0001-9433-8341; Ivanisenko, Vladimir/0000-0002-1859-4631; Kaderali, Lars/0000-0002-2359-2294; Kolchanov, Nikolay/0000-0001-6800-8787	EU [260429]	EU(European Commission)	This work is supported by the FP7 EU grant SysPatho No260429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiwijaya BS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000745; Ali S, 2008, ANTIMICROB AGENTS CH, V52, P4356, DOI 10.1128/AAC.00444-08; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartenschlager R, 2003, ANTIVIR RES, V60, P91, DOI 10.1016/j.antiviral.2003.08.016; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Berenguer M, 2011, VIRUS ADAPTATION TRE, V3, P7; Berger Kristi L, 2009, Commun Integr Biol, V2, P471; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; de Bruijne J, 2012, ANTIMICROB AGENTS CH, V56, P4525, DOI 10.1128/AAC.00451-12; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Flores MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1441, DOI 10.1016/j.bbapap.2009.06.004; Forestier N, 2011, J HEPATOL, V54, P1130, DOI 10.1016/j.jhep.2010.11.001; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Habersetzer F, 2012, PHARMACOGEN PERS MED, V5, P125, DOI 10.2147/PGPM.S24259; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Herrmann E, 2006, ANTIVIR THER, V11, P371; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Hotho DM, 2013, J VIRAL HEPATITIS, V20, pe78, DOI 10.1111/jvh.12012; Hotho DM, 2012, ANTIVIR THER, V17, P365, DOI 10.3851/IMP1989; Johnson CL, 2007, J BIOL CHEM, V282, P10792, DOI 10.1074/jbc.M610361200; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Kozlov K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002635; Kozlov K, 2011, J SUPERCOMPUT, V57, P172, DOI 10.1007/s11227-010-0390-6; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lam AM, 2011, ANTIMICROB AGENTS CH, V55, P2566, DOI 10.1128/AAC.00032-11; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Liang YQ, 2008, GASTROENTEROLOGY, V135, P1710, DOI 10.1053/j.gastro.2008.07.023; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lu LJ, 2007, ANTIMICROB AGENTS CH, V51, P1889, DOI 10.1128/AAC.01004-06; Lu LJ, 2004, ANTIMICROB AGENTS CH, V48, P2260, DOI 10.1128/AAC.48.6.2260-2266.2004; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2012, LIVER INT, V32, P27, DOI 10.1111/j.1478-3231.2011.02725.x; Mathy JE, 2008, ANTIMICROB AGENTS CH, V52, P3267, DOI 10.1128/AAC.00498-08; Matthews SJ, 2012, CLIN THER, V34, P1857, DOI 10.1016/j.clinthera.2012.07.011; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McLean AK, 2010, J THEOR BIOL, V267, P565, DOI 10.1016/j.jtbi.2010.09.031; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mishchenko EL, 2007, J BIOINF COMPUT BIOL, V5, P593, DOI 10.1142/S0219720007002849; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nag A, 2012, J VIROL, V86, P12616, DOI 10.1128/JVI.01351-12; Nakabayashi J, 2012, J THEOR BIOL, V300, P110, DOI 10.1016/j.jtbi.2012.01.023; O'Leary Jacqueline G, 2010, Therap Adv Gastroenterol, V3, P43, DOI 10.1177/1756283X09353353; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rajagopalan R, 2009, BIOCHEMISTRY-US, V48, P2559, DOI 10.1021/bi900038p; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Reiser M, 2005, HEPATOLOGY, V41, P832, DOI 10.1002/hep.20612; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Robinson M, 2011, P NATL ACAD SCI USA, V108, P10290, DOI 10.1073/pnas.1101515108; Rong LB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002959; Rong LB, 2012, B MATH BIOL, V74, P1789, DOI 10.1007/s11538-012-9736-y; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Soriano V, 2008, J ANTIMICROB CHEMOTH, V62, P1, DOI 10.1093/jac/dkn175; Svarovskaia ES, 2012, J CLIN MICROBIOL, V50, P3267, DOI 10.1128/JCM.00838-12; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Tong X, 2010, ANTIMICROB AGENTS CH, V54, P2365, DOI 10.1128/AAC.00135-10; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Upadhyay A, 2013, MOL CELL PROTEOMICS, V12, P1539, DOI 10.1074/mcp.M112.017020; Verbinnen T, 2012, J ANTIMICROB CHEMOTH, V67, P2327, DOI 10.1093/jac/dks234; Verbinnen T, 2010, J VIROL, V84, P11124, DOI 10.1128/JVI.01217-10; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	89	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91502	10.1371/journal.pone.0091502	http://dx.doi.org/10.1371/journal.pone.0091502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643004	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900024
J	Oksanen, KM; Waldum, ER; McDaniel, MA; Braver, TS				Oksanen, Kevin M.; Waldum, Emily R.; McDaniel, Mark A.; Braver, Todd S.			Neural Mechanisms of Time-Based Prospective Memory: Evidence for Transient Monitoring	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; MULTIPLE PROCESSES; RETRIEVAL; EVENT; AGE; COSTS; PERFORMANCE; ATTENTION; AREA-10; REVEAL	In daily life, we often need to remember to perform an action after, or at, a specific period of time (e. g., take pizza out of oven in 15 minutes). Surprisingly, little is known about the neural mechanisms that support this form of memory, termed time-based prospective memory (PM). Here we pioneer an fMRI paradigm that enables examination of both sustained and transient processes engaged during time-based PM. Participants were scanned while performing a demanding on-going task (n-back working memory), with and without an additional time-based PM demand. During the PM condition participants could access a hidden clock with a specific button-press response, while in the control condition, pseudo-clocks randomly appeared and were removed via the same response. Analyses tested for sustained activation associated with the PM condition, and also transient activation associated with clock-checks and the PM target response. Contrary to prior findings with event-based PM (i.e., remembering to perform a future action when a specific event occurs), no sustained PM-related activity was observed in anterior prefrontal cortex (aPFC) or elsewhere in the brain; instead, transient clock-related activity was observed in this region. Critically, the activation was anticipatory, increasing before clock-check responses. Anticipatory activity prior to the PM target response was weaker in aPFC, but strong in pre-Supplementary Motor Area (pre-SMA; relative to clock-check responses), suggesting a functional double dissociation related to volitional decision-making. Together, the results suggest that aPFC-activity dynamics during time-based PM reflect a distinct transient monitoring process, enabling integration of the PM intention with current temporal information to facilitate scheduling of upcoming PM-related actions.	[Oksanen, Kevin M.; Waldum, Emily R.; McDaniel, Mark A.; Braver, Todd S.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Oksanen, KM (corresponding author), Washington Univ, St Louis, MO 63130 USA.	kevinoksanen@gmail.com		Braver, Todd/0000-0002-2631-3393	National Institutes of Health (NIH) [1RC1AG036258]; Aging Training grant [5T32AG000030-37]; Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the NIH [UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036258, T32AG000030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aging Training grant; Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by National Institutes of Health (NIH) grants 1RC1AG036258-Neural Mechanisms of Age Related Changes in Prospective Memory, and The Aging Training grant 5T32AG000030-37. Additionally support was provided by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Brewer GA, 2010, MEM COGNITION, V38, P304, DOI 10.3758/MC.38.3.304; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cona G, 2012, NEUROPSYCHOLOGIA, V50, P2692, DOI 10.1016/j.neuropsychologia.2012.07.033; Cona G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031659; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craik FIM, 1996, BRAIN COGNITION, V49, P402; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HARRIS JE, 1982, HUM LEARN, V1, P123; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Katai S, 2003, J NEUROL NEUROSUR PS, V74, P704, DOI 10.1136/jnnp.74.6.704; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Marsh RL, 2006, MEM COGNITION, V34, P1037, DOI 10.3758/BF03193250; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; McDaniel MA, 2013, PSYCHOL SCI, V24, P1791, DOI 10.1177/0956797613481233; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; Miller GA, 1960, PLANS STRUCTURE BEHA; Momennejad I, 2012, NEUROIMAGE, V61, P139, DOI 10.1016/j.neuroimage.2012.02.079; Moscovitch Morris, 1994, P269; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Waldum ER, 2013, J EXP PSYCHOL GEN, V142, P809, DOI 10.1037/a0030113; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yarkoni T, 2010, SPRINGER SER HUM EXC, P87, DOI 10.1007/978-1-4419-1210-7_6	47	33	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92123	10.1371/journal.pone.0092123	http://dx.doi.org/10.1371/journal.pone.0092123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643226	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900090
J	Rao, K; Erb-Downward, JR; Walk, ST; Micic, D; Falkowski, N; Santhosh, K; Mogle, JA; Ring, C; Young, VB; Huffnagle, GB; Aronoff, DM				Rao, Krishna; Erb-Downward, John R.; Walk, Seth T.; Micic, Dejan; Falkowski, Nicole; Santhosh, Kavitha; Mogle, Jill A.; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.			The Systemic Inflammatory Response to Clostridium difficile Infection	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TOXIN-B; INTERLEUKIN-8; AMERICA; RANTES; MODEL	Background: The systemic inflammatory response to Clostridium difficile infection (CDI) is incompletely defined, particularly for patients with severe disease. Methods: Analysis of 315 blood samples from 78 inpatients with CDI (cases), 100 inpatients with diarrhea without CDI (inpatient controls), and 137 asymptomatic outpatient controls without CDI was performed. Serum or plasma was obtained from subjects at the time of CDI testing or shortly thereafter. Severe cases had intensive care unit admission, colectomy, or death due to CDI within 30 days after diagnosis. Thirty different circulating inflammatory mediators were quantified using an antibody-linked bead array. Principal component analysis (PCA), multivariate analysis of variance (MANOVA), and logistic regression were used for analysis. Results: Based on MANOVA, cases had a significantly different inflammatory profile from outpatient controls but not from inpatient controls. In logistic regression, only chemokine (C-C motif) ligand 5 (CCL5) levels were associated with cases vs. inpatient controls. Several mediators were associated with cases vs. outpatient controls, especially hepatocyte growth factor, CCL5, and epithelial growth factor (inversely associated). Eight cases were severe and associated with elevations in IL8, IL-6, and eotaxin. Conclusions: A broad systemic inflammatory response occurs during CDI and severe cases appear to differ from non-severe infections.	[Rao, Krishna; Walk, Seth T.; Santhosh, Kavitha; Mogle, Jill A.; Ring, Cathrin; Young, Vincent B.] Univ Michigan, Sch Med, Div Infect Dis, Ann Arbor, MI USA; [Erb-Downward, John R.; Falkowski, Nicole; Huffnagle, Gary B.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Rao, Krishna; Erb-Downward, John R.; Walk, Seth T.; Micic, Dejan; Falkowski, Nicole; Santhosh, Kavitha; Mogle, Jill A.; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Young, Vincent B.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Walk, Seth T.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Rao, Krishna] Vet Affairs Ann Arbor Healthcare Syst, Div Infect Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Montana State University System; Montana State University Bozeman; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Aronoff, DM (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA.	daronoff@umich.edu	Huffnagle, Gary B./ABF-1323-2020; Rao, Krishna/R-3726-2019; Young, Vincent B/B-3179-2009; Young, Vincent Bensan/M-9916-2019	Rao, Krishna/0000-0002-9213-7850; Young, Vincent B/0000-0003-3687-2364; Young, Vincent Bensan/0000-0003-3687-2364; Aronoff, David/0000-0003-4587-6121	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [U19-AI090871, K01-AI097281]; Claude D. Pepper Older Americans Independence Center [AG-024824]; Michigan Institute for Clinical and Health Research [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI097281, U19AI090871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Claude D. Pepper Older Americans Independence Center; Michigan Institute for Clinical and Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [grant numbers U19-AI090871 and K01-AI097281], the Claude D. Pepper Older Americans Independence Center [grant number AG-024824], and the Michigan Institute for Clinical and Health Research [grant number 2UL1TR000433]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akha AS, 2012, J IMMUNOL, V188; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Brown NA, 2011, INFECT DIS REP, V3, P15, DOI 10.4081/idr.2011.e5; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; El Feghaly RE, 2013, CLIN INFECT DIS; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Jiang ZD, 2007, CLIN GASTROENTEROL H, V5, P964, DOI 10.1016/j.cgh.2007.04.018; Klapproth JMA, 2010, INFLAMM BOWEL DIS, V16, P2173, DOI 10.1002/ibd.21332; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lawrence JP, 1997, J PEDIATR SURG, V32, P430, DOI 10.1016/S0022-3468(97)90598-4; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; MEURER R, 1993, J EXP MED, V178, P1913, DOI 10.1084/jem.178.6.1913; Morteau O, 2002, GASTROENTEROLOGY, V122, P725, DOI 10.1053/gast.2002.31873; Neal MD, 2011, ANN SURG, V254, P423, DOI 10.1097/SLA.0b013e31822ade48; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; PRICE AB, 1977, J CLIN PATHOL, V30, P1, DOI 10.1136/jcp.30.1.1; Rao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058265; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Riegler M, 1997, AM J PHYSIOL-GASTR L, V273, pG1014, DOI 10.1152/ajpgi.1997.273.5.G1014; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Steiner TS, 1997, CLIN DIAGN LAB IMMUN, V4, P719, DOI 10.1128/CDLI.4.6.719-722.1997; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	37	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92578	10.1371/journal.pone.0092578	http://dx.doi.org/10.1371/journal.pone.0092578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643077	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900147
J	Wilson, TJ; Garner, LI; Metcalfe, C; King, E; Margraf, S; Brown, MH				Wilson, Timothy J.; Garner, Lee I.; Metcalfe, Clive; King, Elliott; Margraf, Stefanie; Brown, Marion H.			Fine Specificity and Molecular Competition in SLAM Family Receptor Signalling	PLOS ONE			English	Article							PHOSPHOLIPASE C-GAMMA; PROTEIN-TYROSINE-PHOSPHATASE; NK CELL ACTIVATION; GENE-PRODUCT SAP; SH2 DOMAIN; T-CELLS; CUTTING EDGE; B-CELLS; EAT-2; 2B4	SLAM family receptors regulate activation and inhibition in immunity through recruitment of activating and inhibitory SH2 domain containing proteins to immunoreceptor tyrosine based switch motifs (ITSMs). Binding of the adaptors, SAP and EAT2 to ITSMs in the cytoplasmic regions of SLAM family receptors is important for activation. We analysed the fine specificity of SLAM family receptor phosphorylated ITSMs and the conserved tyrosine motif in EAT-2 for SH2 domain containing signalling proteins. Consistent with the literature describing dependence of CRACC (SLAMF7) on EAT-2, CRACC bound EAT-2 (K-D = 0.003 mu M) with approximately 2 orders of magnitude greater affinity than SAP (K-D = 0.44 mu M). RNA interference in cytotoxicity assays in NK92 cells showed dependence of CRACC on SAP in addition to EAT-2, indicating selectivity of SAP and EAT-2 may depend on the relative concentrations of the two adaptors. The concentration of SAP was four fold higher than EAT-2 in NK92 cells. Compared with SAP, the significance of EAT-2 recruitment and its downstream effectors are not well characterised. We identified PLC gamma 1 and PLC gamma 2 as principal binding partners for the EAT-2 tail. Both PLC gamma 1 and PLC gamma 2 are functionally important for cytotoxicity in NK92 cells through CD244 (SLAMF4), NTB-A (SLAMF6) and CRACC. Comparison of the specificity of SH2 domains from activating and inhibitory signalling mediators revealed a hierarchy of affinities for CD244 (SLAMF4) ITSMs. While binding of phosphatase SH2 domains to individual ITSMs of CD244 was weak compared with SAP or EAT-2, binding of tandem SH2 domains of SHP-2 to longer peptides containing tandem phosphorylated ITSMs in human CD244 increased the affinity ten fold. The concentration of the tyrosine phosphatase, SHP-2 was in the order of a magnitude higher than the adaptors, SAP and EAT-2. These data demonstrate a mechanism for direct recruitment of phosphatases in inhibitory signalling by ITSMs, while explaining competitive dominance of SAP and EAT-2.	[Wilson, Timothy J.; Garner, Lee I.; Metcalfe, Clive; King, Elliott; Margraf, Stefanie; Brown, Marion H.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, MH (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	Marion.Brown@path.ox.ac.uk		Wilson, Timothy/0000-0001-8403-9401; Metcalfe, Clive/0000-0002-7856-8574	European Commission [PIIF-GA-2009-235224]; Medical Research Council, UK [G0400808]; Cancer Research UK [C29938/A13236]; Cancer Research UK [13236] Funding Source: researchfish; Medical Research Council [G0400808] Funding Source: researchfish; MRC [G0400808] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Marie Curie International Incoming Fellowship, European Commission 7th Framework Programme (PIIF-GA-2009-235224) awarded to TJW, the Medical Research Council, UK (G0400808) and Cancer Research UK (C29938/A13236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOV S, 1986, CELL IMMUNOL, V100, P1, DOI 10.1016/0008-8749(86)90001-8; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Bida AT, 2011, MOL IMMUNOL, V48, P1149, DOI 10.1016/j.molimm.2011.02.008; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Calpe S, 2006, IMMUNOGENETICS, V58, P15, DOI 10.1007/s00251-005-0056-3; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Clarkson NG, 2007, J BIOL CHEM, V282, P25385, DOI 10.1074/jbc.M704483200; Clarkson NG, 2009, J BIOL CHEM, V284, P24725, DOI 10.1074/jbc.M109.028209; Coxon CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049543; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Dushek O, 2012, IMMUNOL REV, V250, P258, DOI 10.1111/imr.12008; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; HARADA S, 1982, INT J CANCER, V30, P739, DOI 10.1002/ijc.2910300610; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Klem J, 2002, J IMMUNOL, V169, P55, DOI 10.4049/jimmunol.169.1.55; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Lewis J, 2001, CLIN IMMUNOL, V100, P15, DOI 10.1006/clim.2001.5035; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li CJ, 2003, J BIOL CHEM, V278, P3852, DOI 10.1074/jbc.M206649200; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Norman PJ, 2009, GENOME RES, V19, P757, DOI 10.1101/gr.085738.108; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Sharifi R, 2004, BLOOD, V103, P3821, DOI 10.1182/blood-2003-09-3359; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Thompson AD, 1996, ONCOGENE, V13, P2649; Tovar V, 2002, IMMUNOGENETICS, V54, P394, DOI 10.1007/s00251-002-0483-3; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	56	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92184	10.1371/journal.pone.0092184	http://dx.doi.org/10.1371/journal.pone.0092184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642916	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900100
J	Wuren, T; Simonson, TS; Qin, G; Xing, JC; Huff, CD; Witherspoon, DJ; Jorde, LB; Ge, RL				Wuren, Tana; Simonson, Tatum S.; Qin, Ga; Xing, Jinchuan; Huff, Chad D.; Witherspoon, David J.; Jorde, Lynn B.; Ge, Ri-Li			Shared and Unique Signals of High-Altitude Adaptation in Geographically Distinct Tibetan Populations	PLOS ONE			English	Article							POSITIVE SELECTION; BLOOD-PRESSURE; GENETIC-EVIDENCE; PLATEAU; HYPERTENSION; ASSOCIATION; EGLN1; LOCI	Recent studies have used a variety of analytical methods to identify genes targeted by selection in high-altitude populations located throughout the Tibetan Plateau. Despite differences in analytic strategies and sample location, hypoxia-related genes, including EPAS1 and EGLN1, were identified in multiple studies. By applying the same analytic methods to genome-wide SNP information used in our previous study of a Tibetan population (n = 31) from the township of Maduo, located in the northeastern corner of the Qinghai-Tibetan Plateau (4200 m), we have identified common targets of natural selection in a second geographically and linguistically distinct Tibetan population (n = 46) in the Tuo Tuo River township (4500 m). Our analyses provide evidence for natural selection based on iHS and XP-EHH signals in both populations at the p < 0.02 significance level for EPAS1, EGLN1, HMOX2, and CYP17A1 and for PKLR, HFE, and HBB and HBG2, which have also been reported in other studies. We highlight differences (i.e., stratification and admixture) in the two distinct Tibetan groups examined here and report selection candidate genes common to both groups. These findings should be considered in the prioritization of selection candidate genes in future genetic studies in Tibet.	[Wuren, Tana; Qin, Ga; Ge, Ri-Li] Qinghai Univ, Sch Med, Res Ctr High Altitude Med, Xining, Qinghai, Peoples R China; [Simonson, Tatum S.] Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92093 USA; [Simonson, Tatum S.; Xing, Jinchuan; Huff, Chad D.; Witherspoon, David J.; Jorde, Lynn B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Qinghai University; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah	Ge, RL (corresponding author), Qinghai Univ, Sch Med, Res Ctr High Altitude Med, Xining, Qinghai, Peoples R China.	geriligao@hotmail.com			National Basic Research Program of China [2012CB518200]; Program of International S&T Cooperation of China [0S2012GR0195]; National Natural Science Foundation of China [30393133]; National Institutes of Health [NIH GM-59290]; National Institute of Health [NIH T32 GM-007464]; National Human Genome Research Institute, National Institute of Health [K99HG005846]	National Basic Research Program of China(National Basic Research Program of China); Program of International S&T Cooperation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by The National Basic Research Program of China (No. 2012CB518200, L-RG), Program of International S&T Cooperation of China (No: 0S2012GR0195, L-RG) and National Natural Science Foundation of China (No. 30393133, L-RG), and the National Institutes of Health (NIH GM-59290). T. S. S. was supported by the National Institute of Health (NIH T32 GM-007464). J.X. is supported by the National Human Genome Research Institute, National Institute of Health (K99HG005846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Beall CM, 2011, HIGH ALT MED BIOL, V12, P101, DOI 10.1089/ham.2011.1007; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham Abigail W., 2009, Human Genomics, V4, P79; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; Hong KW, 2010, J HUM GENET, V55, P336, DOI 10.1038/jhg.2010.31; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lorenzo F, 2011, TIBETAN PHD2 POLYMOR; MacInnis MJ, 2011, HIGH ALT MED BIOL, V12, P133, DOI 10.1089/ham.2010.1090; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Qingying C, 1990, TIBETAN TRIBE CHINA; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	37	33	35	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e88252	10.1371/journal.pone.0088252	http://dx.doi.org/10.1371/journal.pone.0088252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642866	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900001
J	Zhang, QB; Matzke, M; Schepmoes, AA; Moore, RJ; Webb-Robertson, BJ; Hu, ZP; Monroe, ME; Qian, WJ; Smith, RD; Morgan, WF				Zhang, Qibin; Matzke, Melissa; Schepmoes, Athena A.; Moore, Ronald J.; Webb-Robertson, Bobbie-Jo; Hu, Zeping; Monroe, Matthew E.; Qian, Wei-Jun; Smith, Richard D.; Morgan, William F.			High and Low Doses of Ionizing Radiation Induce Different Secretome Profiles in a Human Skin Model	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; SOFTWARE PACKAGE; GENE-EXPRESSION; GAMMA-RADIATION; PROTEOMICS DATA; MS; IDENTIFICATION; BIOMARKERS; PROTEINS; TISSUE	It is postulated that secreted soluble factors are important contributors of bystander effect and adaptive responses observed in low dose ionizing radiation. Using multidimensional liquid chromatography-mass spectrometry based proteomics, we quantified the changes of skin tissue secretome - the proteins secreted from a full thickness, reconstituted 3-dimensional skin tissue model 48 hr after exposure to 3, 10 and 200 cGy of X-rays. Overall, 135 proteins showed statistical significant difference between the sham (0 cGy) and any of the irradiated groups (3, 10 or 200 cGy) on the basis of Dunnett adjusted t-test; among these, 97 proteins showed a trend of downregulation and 9 proteins showed a trend of upregulation with increasing radiation dose. In addition, there were 21 and 8 proteins observed to have irregular trends with the 10 cGy irradiated group either having the highest or the lowest level among all three radiated doses. Moreover, two proteins, carboxypeptidase E and ubiquitin carboxyl-terminal hydrolase isozyme L1 were sensitive to ionizing radiation, but relatively independent of radiation dose. Conversely, proteasome activator complex subunit 2 protein appeared to be sensitive to the dose of radiation, as rapid upregulation of this protein was observed when radiation doses were increased from 3, to 10 or 200 cGy. These results suggest that different mechanisms of action exist at the secretome level for low and high doses of ionizing radiation.	[Zhang, Qibin; Schepmoes, Athena A.; Moore, Ronald J.; Hu, Zeping; Monroe, Matthew E.; Qian, Wei-Jun; Smith, Richard D.; Morgan, William F.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Matzke, Melissa; Webb-Robertson, Bobbie-Jo] Pacific NW Natl Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Zhang, QB (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	qibin.zhang@pnnl.gov	Webb-Robertson, Bobbie-Jo/K-8230-2019; Monroe, Matthew/L-1157-2019; Smith, Richard D/J-3664-2012; QIAN, Wei-Jun/AAC-1907-2021; Hu, Zeping/F-6205-2010; Qian, Wei-Jun/C-6167-2011; Zhang, Qibin/L-6283-2017	Smith, Richard D/0000-0002-2381-2349; QIAN, Wei-Jun/0000-0002-5393-2827; Hu, Zeping/0000-0003-4146-7750; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397; Zhang, Qibin/0000-0002-6135-8706	Office of Science, U.S. Department of Energy, under the Low Dose Radiation Science Focus Area Program; NIH [5P41RR018522-10]; National Institute of General Medical Sciences [8P41 GM103493-10]; DOE by Battelle [DE-AC05-76RLO-1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	Office of Science, U.S. Department of Energy, under the Low Dose Radiation Science Focus Area Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE by Battelle(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Office of Science, U.S. Department of Energy, under the Low Dose Radiation Science Focus Area Program. This work used instrumentation and capabilities developed with support from the NIH grant 5P41RR018522-10, the National Institute of General Medical Sciences grant 8P41 GM103493-10, and the U.S. Department of Energy Office of Biological and Environmental Research (DOE/BER). Significant portions of this work were performed in the Environmental Molecular Science Laboratory, a DOE/BER national scientific user facility at Pacific Northwest National Laboratory (PNNL) in Richland, Washington. PNNL is operated for the DOE by Battelle under contract DE-AC05-76RLO-1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 2012, RADIAT RES, V177, P69, DOI 10.1667/RR2524.1; Amundson S A, 2001, Expert Rev Mol Diagn, V1, P211, DOI 10.1586/14737159.1.2.211; Barjaktarovic Z, 2013, RADIAT ENVIRON BIOPH, V52, P87, DOI 10.1007/s00411-012-0439-4; BIER V, 2006, PHASE 2 HLTH RISKS E; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Chaker S, 2013, PROTEOMICS, V13, P771, DOI 10.1002/pmic.201200356; Chaudhry MA, 2012, MOL BIOL REP, V39, P7549, DOI 10.1007/s11033-012-1589-9; Datta K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-205; Dauer LT, 2010, RADIAT PROT DOSIM, V140, P103, DOI 10.1093/rpd/ncq141; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Hu ZP, 2012, MOL BIOSYST, V8, P1979, DOI 10.1039/c2mb25061f; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Knops K, 2012, RADIAT RES, V178, P304, DOI 10.1667/RR2913.1; Laiakis EC, 2012, RADIAT RES, V177, P187, DOI 10.1667/RR2771.1; Liu Y, 2004, J PROTEOME RES, V3, P728, DOI 10.1021/pr034127+; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Matzke MM, 2011, BIOINFORMATICS; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2012, INT J RADIAT BIOL, V88, P763, DOI 10.3109/09553002.2012.715795; Nanashima N, 2012, INT J MOL MED, V30, P579, DOI 10.3892/ijmm.2012.1018; Petritis K, 2006, ANAL CHEM, V78, P5026, DOI 10.1021/ac060143p; Piehowski PD, 2013, J PROTEOME RES, V12, P2128, DOI 10.1021/pr301146m; Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9; Royal HD, 2008, SEMIN NUCL MED, V38, P392, DOI 10.1053/j.semnuclmed.2008.05.006; Shi TJ, 2012, METHODS, V56, P246, DOI 10.1016/j.ymeth.2011.09.001; Snijders AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045394; Varnum SM, 2012, RADIAT RES, V178, P591, DOI 10.1667/RR2976.1; Wang FL, 2013, J RADIAT RES, V54, P649, DOI 10.1093/jrr/rrt010; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247; Yang F, 2012, EXP DERMATOL, V21, P352, DOI 10.1111/j.1600-0625.2012.01470.x; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	38	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92332	10.1371/journal.pone.0092332	http://dx.doi.org/10.1371/journal.pone.0092332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642900	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900121
J	Awad, WA; Hess, C; Khayal, B; Aschenbach, JR; Hess, M				Awad, Wageha A.; Hess, Claudia; Khayal, Basel; Aschenbach, Joerg R.; Hess, Michael			In Vitro Exposure to Escherichia coli Decreases Ion Conductance in the Jejunal Epithelium of Broiler Chickens	PLOS ONE			English	Article							BARRIER FUNCTION; SECRETION; TRANSPORT; CHLORIDE; EXPRESSION; PATHOGEN; DIARRHEA; PROTEIN; PERMEABILITY; MONOLAYERS	Escherichia coli (E. coli) infections are very widespread in poultry. However, little is known about the interaction between the intestinal epithelium and E. coli in chickens. Therefore, the effects of avian non-pathogenic and avian pathogenic Escherichia coli (APEC) on the intestinal function of broiler chickens were investigated by measuring the electrogenic ion transport across the isolated jejunal mucosa. In addition, the intestinal epithelial responses to cholera toxin, histamine and carbamoylcholine (carbachol) were evaluated following an E. coli exposure. Jejunal tissues from 5-week-old broilers were exposed to 6 x 10(8) CFU/mL of either avian non-pathogenic E. coli IMT11322 (Ont:H16) or avian pathogenic E. coli IMT4529 (O24:H4) in Ussing chambers and electrophysiological variables were monitored for 1 h. After incubation with E. coli for 1 h, either cholera toxin (1 mg/L), histamine (100 mu M) or carbachol (100 mu M) were added to the incubation medium. Both strains of avian E. coli (non-pathogenic and pathogenic) reduced epithelial ion conductance (G(t)) and short-circuit current (I-sc). The decrease in ion conductance after exposure to avian pathogenic E. coli was, at least, partly reversed by the histamine or carbachol treatment. Serosal histamine application produced no significant changes in the I-sc in any tissues. Only the uninfected control tissues responded significantly to carbachol with an increase of I-sc, while the response to carbachol was blunted to non-significant values in infected tissues. Together, these data may explain why chickens rarely respond to intestinal infections with overt secretory diarrhea. Instead, the immediate response to intestinal E. coli infections appears to be a tightening of the epithelial barrier.	[Awad, Wageha A.; Hess, Claudia; Khayal, Basel; Hess, Michael] Univ Vet Med, Clin Poultry & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Fac Vet Med, Berlin, Germany	University of Veterinary Medicine Vienna; Free University of Berlin	Awad, WA (corresponding author), Univ Vet Med, Clin Poultry & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	wageha.awad@vetmeduni.ac.at	Aschenbach, Joerg R/R-7572-2016; Awad, Wageha/R-1705-2016	Aschenbach, Joerg R/0000-0001-5080-1007; Awad, Wageha/0000-0003-0843-2089; Hess, Claudia/0000-0002-3535-5157; Hess, Michael/0000-0002-6991-0120				Ahrens F, 2003, INFLAMM RES, V52, P79; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Awad WA, 2007, J ANIM PHYSIOL AN N, V91, P175, DOI 10.1111/j.1439-0396.2007.00689.x; Awad WA, 2012, POULTRY SCI, V91, P2949, DOI 10.3382/ps.2012-02448; Awad WA, 2015, INNATE IMMUN-LONDON, V21, P151, DOI 10.1177/1753425914521648; Barnes H.J., 2008, DIS POULTRY, P691; Borenshtein D, 2009, INFECT IMMUN, V77, P3639, DOI 10.1128/IAI.00225-09; Caldwell DJ, 2004, POULTRY SCI, V83, P591, DOI 10.1093/ps/83.4.591; Caldwell DJ, 2001, DEV COMP IMMUNOL, V25, P169, DOI 10.1016/S0145-305X(00)00055-0; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Chausse AM, 2011, INFECT IMMUN, V79, P3445, DOI 10.1128/IAI.00025-11; Collington GK, 1998, GUT, V42, P200, DOI 10.1136/gut.42.2.200; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Dho-Moulin M, 1999, VET RES, V30, P299; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Fraser SA, 2003, INFECT IMMUN, V71, P1527, DOI 10.1128/IAI.71.3.1527-1537.2003; Ginns CA, 1998, AVIAN PATHOL, V27, P505, DOI 10.1080/03079459808419375; GRUBB BR, 1987, J COMP PHYSIOL B, V157, P181, DOI 10.1007/BF00692362; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Guttman JA, 2008, TRENDS MICROBIOL, V16, P535, DOI 10.1016/j.tim.2008.08.004; Hanson PJ, 2011, INNATE IMMUN-LONDON, V17, P269, DOI 10.1177/1753425910367813; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; Hering NA, 2014, MUCOSAL IMMUNOL, V7, P369, DOI 10.1038/mi.2013.55; HOLMGREN J, 1973, INFECT IMMUN, V8, P851, DOI 10.1128/IAI.8.6.851-859.1973; Huff GR, 2013, POULTRY SCI, V92, P655, DOI 10.3382/ps.2012-02787; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Kock J, 2007, LIVEST SCI, V109, P42, DOI 10.1016/j.livsci.2007.01.044; Kuldeep Dhama, 2013, Research Opinions in Animal and Veterinary Sciences, V3, P179; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lucas ML, 2008, J PHYSIOL BIOCHEM, V64, P69, DOI 10.1007/BF03168236; Matsuzawa T, 2005, INFECT IMMUN, V73, P6283, DOI 10.1128/IAI.73.10.6283-6289.2005; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; McPeake SJM, 2005, VET MICROBIOL, V110, P245, DOI 10.1016/j.vetmic.2005.08.001; Murek M, 2010, EXP PHYSIOL, V95, P471, DOI 10.1113/expphysiol.2009.049445; PAL SC, 1968, INDIAN J MED RES, V56, P1482; PARRY SH, 1977, IMMUNOLOGY, V32, P731; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Roxas JL, 2010, LAB INVEST, V90, P1152, DOI 10.1038/labinvest.2010.91; Ruhnke I, 2013, ARCH ANIM NUTR, V67, P161, DOI 10.1080/1745039X.2013.776328; Sanni Saka, 2005, Veterinarski Arhiv, V75, P423; Schultheiss G, 2006, EUR J PHARMACOL, V546, P161, DOI 10.1016/j.ejphar.2006.07.047; Schwarz A, 2011, DEV COMP IMMUNOL, V35, P774, DOI 10.1016/j.dci.2011.02.012; Singh SD, 2011, POULTRY WORLD    OCT, P14; Sklan D, 2003, BRIT J NUTR, V89, P747, DOI 10.1079/BJN2003853; SPITZ J, 1995, AM J PHYSIOL-GASTR L, V268, pG374, DOI 10.1152/ajpgi.1995.268.2.G374; Stordeur P, 2002, VET MICROBIOL, V84, P231, DOI 10.1016/S0378-1135(01)00464-3; Vandekerchove D, 2005, VET MICROBIOL, V108, P75, DOI 10.1016/j.vetmic.2005.02.009; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; Wilking H, 2009, THESIS U BERLIN BERL; Yunus AW, 2010, POULTRY SCI, V89, P1372, DOI 10.3382/ps.2009-00617; Zareie M, 2005, CELL MICROBIOL, V7, P1782, DOI 10.1111/j.1462-5822.2005.00595.x; Zhu HL, 2013, INNATE IMMUN-LONDON, V19, P242, DOI 10.1177/1753425912456223	57	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92156	10.1371/journal.pone.0092156	http://dx.doi.org/10.1371/journal.pone.0092156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637645	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100121
J	Gras, B; Jacqueroud, L; Wierinckx, A; Lamblot, C; Fauvet, F; Lachuer, J; Puisieux, A; Ansieau, S				Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane			Snail Family Members Unequally Trigger EMT and Thereby Differ in Their Ability to Promote the Neoplastic Transformation of Mammary Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; TO-MESENCHYMAL TRANSITION; E-CADHERIN; BREAST-CARCINOMA; ANOIKIS RESISTANCE; GENE-EXPRESSION; POOR-PROGNOSIS; SLUG; CANCER; TWIST	By fostering cell commitment to the epithelial-to-mesenchymal transition (EMT), SNAIL proteins endow cells with motility, thereby favoring the metastatic spread of tumor cells. Whether the phenotypic change additionally facilitates tumor initiation has never been addressed. Here we demonstrate that when a SNAIL protein is ectopically produced in non-transformed mammary epithelial cells, the cells are protected from anoikis and proliferate under low-adherence conditions: a hallmark of cancer cells. The three SNAIL proteins show unequal oncogenic potential, strictly correlating with their ability to promote EMT. SNAIL3 especially behaves as a poor EMT-inducer comforting the concept that the transcription factor functionally diverges from its two related proteins.	[Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Ctr Rech Cancerol Lyon, INSERM, UMR S1052, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] LabEx DEVweCAN, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] UNIV, UMR1052, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Univ Lyon, Lyon, France; [Gras, Baptiste; Jacqueroud, Laurent; Wierinckx, Anne; Lamblot, Christelle; Fauvet, Frederique; Lachuer, Joel; Puisieux, Alain; Ansieau, Stephane] Ctr Leon Berard, F-69373 Lyon, France; [Wierinckx, Anne; Lachuer, Joel] ProfileXpert, Bron, France; [Puisieux, Alain] Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Institut Universitaire de France	Puisieux, A (corresponding author), Ctr Rech Cancerol Lyon, INSERM, UMR S1052, Lyon, France.	alain.puisieux@lyon.unicancer.fr; stephane.ansieau@lyon.unicancer.fr	Ansieau, Stephane/I-6195-2016; Wierinckx, Anne/AAF-5233-2021	Wierinckx, Anne/0000-0002-0186-6645; ANSIEAU, Stephane/0000-0003-0989-2108; PUISIEUX, Alain/0000-0002-9938-3798; lachuer, joel/0000-0002-5209-5094	Association pour la Recherche contre le Cancer; French National Agency (ANR) [ANR-10-LABX-0061, ANR-11-IDEX 0007]; Ministere de la Recherche and the Fondation des Treilles; Ligue Nationale Contre le Cancer	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); French National Agency (ANR)(French National Research Agency (ANR)); Ministere de la Recherche and the Fondation des Treilles; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was financially supported by the Association pour la Recherche contre le Cancer and was performed within the framework of the LABEX DEVweCAN (ANR-10-LABX-0061 of Lyon University, within the program "Investissements d'Avenir (ANR-11-IDEX 0007) operated by the French National Agency (ANR). BG received support from the Ministere de la Recherche and the Fondation des Treilles. LJ is a recipient of fellowships from the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; ALBERGA A, 1991, DEVELOPMENT, V111, P983; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Ansieau S, 2008, CELL CYCLE, V7, P3659, DOI 10.4161/cc.7.23.7049; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bradley CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065344; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Dahlem T, 2012, EUR J IMMUNOL, V42, P1038, DOI 10.1002/eji.201142193; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Geradts J, 2011, HUM PATHOL, V42, P1125, DOI 10.1016/j.humpath.2010.11.004; HAMMERSCHMIDT M, 1993, DEVELOPMENT, V119, P1107; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Kataoka H, 2000, NUCLEIC ACIDS RES, V28, P626, DOI 10.1093/nar/28.2.626; Katoh M, 2003, INT J MOL MED, V11, P383; Kobayashi M, 2013, ANN THORAC SURG, V95, P1181, DOI 10.1016/j.athoracsur.2013.01.012; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mayor R, 2000, MECH DEVELOP, V97, P47, DOI 10.1016/S0925-4773(00)00412-3; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Natsugoe S, 2007, ONCOL REP, V17, P517; NIETO MA, 1992, DEVELOPMENT, V116, P227; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pioli PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069216; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; SMITH DE, 1992, DEVELOPMENT, V116, P1033; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Wada S, 1999, DEV GROWTH DIFFER, V41, P9; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhuge X, 2005, INT J MOL MED, V15, P945	52	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92254	10.1371/journal.pone.0092254	http://dx.doi.org/10.1371/journal.pone.0092254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638100	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100134
J	Kjaergaard, AG; Rodgaard-Hansen, S; Dige, A; Krog, J; Moller, HJ; Tonnesen, E				Kjaergaard, Anders G.; Rodgaard-Hansen, Sidsel; Dige, Anders; Krog, Jan; Moller, Holger J.; Tonnesen, Else			Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients	PLOS ONE			English	Article							SERUM MARKERS; ORGAN FAILURE; CD163; SEPSIS; BACTEREMIA; RESPONSES; PROTEIN; DISEASE	Background: The diagnosis of sepsis is challenging and there is an unmet need for sensitive and specific diagnostic and prognostic biomarkers. Following activation of macrophages and monocytes, the haptoglobin-haemoglobin receptor (CD163) and the mannose receptor (MR) are shed into the circulation (sCD163 and sMR). Objective: We investigated monocyte expression of CD163 and MR, and levels of sCD163 and sMR in septic and non-septic patients, and in healthy controls. We hypothesised that these receptors are elevated during sepsis and can be used diagnostic and prognostic. Methods: Twenty-one patients with severe sepsis or septic shock and 15 critically ill non-septic patients were included in this prospective observational study at three ICUs at Aarhus University Hospital and Randers Regional Hospital, Denmark. Fifteen age-and gender-matched healthy volunteers served as controls. Levels of sCD163 and sMR were measured using a sandwich ELISA and monocyte expression of CD163 and MR was evaluated by flow cytometry during the first four days of ICU stay. The diagnostic and prognostic values of the receptors were assessed using AUROC curves. Results: At ICU admission and during the observation period, monocyte expression of CD163 and levels of sCD163 and sMR were significantly higher in septic patients compared with non-septic patients and healthy controls (p<0.01 for all comparisons). Monocytes did not express MR. The diagnostic values estimated by AUROC were 1.00 for sMR, 0.95 for sCD163, 0.87 for CRP, and 0.75 for monocyte-bound CD163. Among the septic patients, monocyte expression of CD163 was higher in non-survivors compared with survivors at ICU admission (p = 0.02) and during the observation period (p = 0.006). The prognostic value of monocyte-bound CD163 estimated by AUROC at ICU admission was 0.82. Conclusion: The macrophage-specific markers CD163, sCD163, and sMR are increased in septic patients. Particularly sMR is a promising new biomarker of sepsis.	[Kjaergaard, Anders G.; Krog, Jan; Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care, DK-8000 Aarhus C, Denmark; [Kjaergaard, Anders G.; Krog, Jan] Randers Reg Hosp, Dept Anaesthesiol & Intens Care, Randers, Denmark; [Dige, Anders] Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, GIRL, DK-8000 Aarhus C, Denmark; [Rodgaard-Hansen, Sidsel; Moller, Holger J.] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Kjaergaard, AG (corresponding author), Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care, DK-8000 Aarhus C, Denmark.	ajk@dadlnet.dk	Krog, Jan/ABD-2700-2021	Moller, Holger Jon/0000-0001-7687-5995	A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Danish Society of Anaesthesiology and Intensive Care Medicines Foundation; Danish council for strategic research [TRAIN 10-092797]	A.P. Moller Foundation for the Advancement of Medical Science; Aase and Ejnar Danielsens Foundation; Danish Society of Anaesthesiology and Intensive Care Medicines Foundation; Danish council for strategic research(Danske Strategiske Forskningsrad (DSF))	The A.P. Moller Foundation for the Advancement of Medical Science, The Aase and Ejnar Danielsens Foundation, The Danish Society of Anaesthesiology and Intensive Care Medicines Foundation and the Danish council for strategic research for funding (TRAIN 10-092797, HJM) supported the study. University of Aarhus holds patent applications for the use of sCD163 and sMR as biomarkers. HJM has received royalties from IQ-Products, NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9; Brunialti MK, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0037393; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Holland-Fischer P, 2011, GUT, V60, P1389, DOI 10.1136/gut.2010.234542; Ingels C, 2012, J CLIN IMMUNOL; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Rodgaard-Hansen S, 2013, CLIN CHEM LAB MED, P1; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Smeekens SP, 2011, EUR J IMMUNOL, V41, P2915, DOI 10.1002/eji.201141418; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weiss M, 2006, CRIT CARE MED, V34, P2682, DOI 10.1097/01.CCM.0000240242.10583.86; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3	24	36	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92331	10.1371/journal.pone.0092331	http://dx.doi.org/10.1371/journal.pone.0092331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637679	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100141
J	Pazos, M; Casanova, M; Palacios, P; Margolin, W; Natale, P; Vicente, M				Pazos, Manuel; Casanova, Mercedes; Palacios, Pilar; Margolin, William; Natale, Paolo; Vicente, Miguel			FtsZ Placement in Nucleoid-Free Bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIVISION; RING FORMATION; MIN PROTEINS; LOCALIZATION; SYSTEM; SITE; TOPOREGULATION; OSCILLATION; REQUIRES	We describe the placement of the cytoplasmic FtsZ protein, an essential component of the division septum, in nucleoid-free Escherichia coli maxicells. The absence of the nucleoid is accompanied in maxicells by degradation of the SlmA protein. This protein, together with the nucleoid, prevents the placement of the septum in the regions occupied by the chromosome by a mechanism called nucleoid occlusion (NO). A second septum placement mechanism, the MinCDE system (Min) involving a pole-to-pole oscillation of three proteins, nonetheless remains active in maxicells. Both Min and NO act on the polymerization of FtsZ, preventing its assembly into an FtsZ-ring except at midcell. Our results show that even in the total absence of NO, Min oscillations can direct placement of FtsZ in maxicells. Deletion of the FtsZ carboxyl terminal domain (FtsZ*), a central hub that receives signals from a variety of proteins including MinC, FtsA and ZipA, produces a Min-insensitive form of FtsZ unable to interact with the membrane-anchoring FtsA and ZipA proteins. This protein produces a totally disorganized pattern of FtsZ localization inside the maxicell cytoplasm. In contrast, FtsZ*-VM, an artificially cytoplasmic membrane-anchored variant of FtsZ*, forms helical or repetitive ring structures distributed along the entire length of maxicells even in the absence of NO. These results show that membrane anchoring is needed to organize FtsZ into rings and underscore the role of the C-terminal hub of FtsZ for their correct placement.	[Pazos, Manuel; Casanova, Mercedes; Palacios, Pilar; Natale, Paolo; Vicente, Miguel] CSIC, CNB, Madrid, Spain; [Margolin, William] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Texas System; University of Texas Health Science Center Houston	Vicente, M (corresponding author), CSIC, CNB, Madrid, Spain.	mvicente@cnb.csic.es	Pazos, Manuel/AAH-7922-2019; Natale, Paolo/E-9326-2012	Pazos, Manuel/0000-0002-8774-4453; Natale, Paolo/0000-0002-4759-0816	European Commission [HEALTH-F3-2009-223431]; Ministerio de Ciencia e Innovacion [BIO2011-28941-C03-01]; Human Frontier Science Program [RGP0050/2010]; Programa Juan de la Cierva Ministerio de Educacion y Ciencia; Programa de Formacion de Personal Investigador Ministerio de Educacion y Ciencia	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Human Frontier Science Program(Human Frontier Science Program); Programa Juan de la Cierva Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); Programa de Formacion de Personal Investigador Ministerio de Educacion y Ciencia	This work was supported through grants from European Commission HEALTH-F3-2009-223431 (DIVINOCELL) (http://ec.europa.eu/research/index.cfm) to MV, Ministerio de Ciencia e Innovacion BIO2011-28941-C03-01 (http://www.idi.mineco.gob.es/) to MV, and Human Frontier Science Program RGP0050/2010 (http://www.hfsp.org/) to MV and WM. PN acknowledges a fellowship from Programa Juan de la Cierva Ministerio de Educacion y Ciencia. MP acknowledges a fellowship from Programa de Formacion de Personal Investigador Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Cambridge J, 2013, J BACTERIOL; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cho H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003304; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; JAFFE A, 1990, J BACTERIOL, V172, P3500, DOI 10.1128/jb.172.6.3500-3502.1990; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Osawa M, 2005, MICROBIOL-SGM, V151, P4033, DOI 10.1099/mic.0.28219-0; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; PLA J, 1993, FEMS SYMP, P363; Potluri LP, 2012, MOL MICROBIOL, V84, P203, DOI 10.1111/j.1365-2958.2012.08023.x; Rasband W., 2006, IMAGEJ; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; Sambrook J, 2001, MOL CLONING LAB MANU; SANCAR A, 1979, J BACTERIOL, V137, P692, DOI 10.1128/JB.137.1.692-693.1979; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Sun Q, 2004, J BACTERIOL, V186, P3951, DOI 10.1128/JB.186.12.3951-3959.2004; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vischer N, NONDESTRUCTIVE MARKI; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; WOLDRINGH CL, 1991, RES MICROBIOL, V142, P309, DOI 10.1016/0923-2508(91)90046-D; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	49	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91984	10.1371/journal.pone.0091984	http://dx.doi.org/10.1371/journal.pone.0091984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638110	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100096
J	Saye, M; Miranda, MR; di Girolamo, F; Camara, MD; Pereira, CA				Saye, Melisa; Miranda, Mariana R.; di Girolamo, Fabio; de los Milagros Camara, Maria; Pereira, Claudio A.			Proline Modulates the Trypanosoma cruzi Resistance to Reactive Oxygen Species and Drugs through a Novel D, L-Proline Transporter	PLOS ONE			English	Article							OXIDATIVE STRESS; LEISHMANIA-DONOVANI; ARGININE UPTAKE; EXPRESSION; PERMEASE; RACEMASES; INFECTION; FAMILY	Trypanosoma cruzi, the etiological agent of Chagas' disease, has a metabolism largely based on the consumption of glucose and proline. This amino acid is essential for host cells infection and intracellular differentiation. In this work we identified a proline transporter (TcAAAP069) by yeasts complementation assays and overexpression in Trypanosoma cruzi epimastigotes. TcAAAP069 is mono-specific for proline but presents an unusual feature; the lack of stereospecificity, because it is competitively inhibited by the D-enantiomer. Parasites overexpressing TcAAAP069 have an increased intracellular proline concentration, 2.6-fold higher than controls, as a consequence of a higher proline transport rate. Furthermore, augmented proline concentration correlates with an improved resistance to trypanocidal drugs and also to reactive oxygen species including hydrogen peroxide and nitric oxide, emulating natural physiological situations. The IC(50)s for nifurtimox, benznidazole, H2O2 and NO. were 125%, 68%, 44% and 112% higher than controls, respectively. Finally, proline metabolism generates a higher concentration (48%) of ATP in TcAAAP069 parasites. Since proline participates on essential energy pathways, stress and drug resistance responses, these results provide a novel target for the development of new drugs for the treatments for Chagas' disease.	[Pereira, Claudio A.] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pereira, CA (corresponding author), Univ Buenos Aires, Inst Invest Med Alfredo Lanari, LBMTC, Buenos Aires, DF, Argentina.	cpereira@retina.ar	Pereira, Claudio A/F-5382-2012	Pereira, Claudio A/0000-0001-7874-1894; SAYE, MELISA/0000-0003-0246-1356; Miranda, Mariana/0000-0002-0692-5675	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2010-0685, 2011-0263]; Agencia Nacional de Promocion Cientifica y Tecnologica [FONCYT PICT 2008-1209, 2010-0289, 2012-0559]; Fundacion Bunge y Born [2012]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Bunge y Born	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2010-0685 and 2011-0263), Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT 2008-1209, 2010-0289 and 2012-0559), and Fundacion Bunge y Born (grant 2012). CAP and MRM are members of the career of scientific investigator and MdMC and MS are research fellows from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman M, 2004, BIOCHEM BIOPH RES CO, V325, P353, DOI 10.1016/j.bbrc.2004.09.212; Bouvier LA, 2004, BIOCHEM BIOPH RES CO, V321, P547, DOI 10.1016/j.bbrc.2004.07.002; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carrillo C, 2010, FEMS MICROBIOL LETT, V306, P97, DOI 10.1111/j.1574-6968.2010.01936.x; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Coatnoan N, 2009, MEM I OSWALDO CRUZ, V104, P295, DOI 10.1590/S0074-02762009000900039; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; Inbar E, 2012, AMINO ACIDS, V42, P347, DOI 10.1007/s00726-010-0812-z; Kaul S, 2008, AMINO ACIDS, V34, P315, DOI 10.1007/s00726-006-0407-x; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Miranda MR, 2006, EXP PARASITOL, V114, P341, DOI 10.1016/j.exppara.2006.04.004; Miranda MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032760; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Saeftel M, 2001, INFECT IMMUN, V69, P2252, DOI 10.1128/IAI.69.4.2252-2259.2001; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Shao HB, 2008, CR BIOL, V331, P433, DOI 10.1016/j.crvi.2008.03.011; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; TROLL W, 1955, J BIOL CHEM, V215, P655; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; VISSERS S, 1989, EUR J BIOCHEM, V181, P357, DOI 10.1111/j.1432-1033.1989.tb14732.x; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5	42	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92028	10.1371/journal.pone.0092028	http://dx.doi.org/10.1371/journal.pone.0092028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637744	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100104
J	Thomson, V; Aplin, KP; Cooper, A; Hisheh, S; Suzuki, H; Maryanto, I; Yap, G; Donnellan, SC				Thomson, Vicki; Aplin, Ken P.; Cooper, Alan; Hisheh, Susan; Suzuki, Hitoshi; Maryanto, Ibnu; Yap, Grace; Donnellan, Stephen C.			Molecular Genetic Evidence for the Place of Origin of the Pacific Rat, Rattus exulans	PLOS ONE			English	Article							PHYLOGENIES; NETWORKS; MTDNA	Commensal plants and animals have long been used to track human migrations, with Rattus exulans (the Pacific rat) a common organism for reconstructing Polynesian dispersal in the Pacific. However, with no knowledge of the homeland of R. exulans, the place of origin of this human-commensal relationship is unknown. We conducted a mitochondrial DNA phylogeographic survey of R. exulans diversity across the potential natural range in mainland and Island Southeast Asia in order to establish the origin of this human-commensal dyad. We also conducted allozyme electrophoresis on samples from ISEA to obtain a perspective on patterns of genetic diversity in this critical region. Finally, we compared molecular genetic evidence with knowledge of prehistoric rodent faunas in mainland and ISEA. We find that ISEA populations of R. exulans contain the highest mtDNA lineage diversity including significant haplotype diversity not represented elsewhere in the species range. Within ISEA, the island of Flores in the Lesser Sunda group contains the highest diversity in ISEA (across all loci) and also has a deep fossil record of small mammals that appears to include R. exulans. Therefore, in addition to Flores harboring unusual diversity in the form of Homo floresiensis, dwarfed stegodons and giant rats, this island appears to be the homeland of R. exulans.	[Thomson, Vicki; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Aplin, Ken P.] Smithsonian Inst, Div Mammals, US Natl Museum, Washington, DC 20560 USA; [Aplin, Ken P.] Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT, Australia; [Hisheh, Susan] Univ Melbourne, Austin Acad Ctr, Melbourne, Vic, Australia; [Suzuki, Hitoshi] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Maryanto, Ibnu] Indonesian Inst Sci, Biol Res Ctr, Div Zool, Bogor, Indonesia; [Yap, Grace] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Donnellan, Stephen C.] S Australian Museum, Adelaide, SA 5000, Australia; [Donnellan, Stephen C.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia	University of Adelaide; Smithsonian Institution; Smithsonian National Museum of Natural History; Australian National University; University of Melbourne; Hokkaido University; Indonesian Institute of Sciences; University of Adelaide	Thomson, V (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia.	vicki.thomson@adelaide.edu.au	Suzuki, Hitoshi/F-8539-2012; Thomson, Vicki A./B-9971-2014; Donnellan, Stephen/F-2442-2013	Suzuki, Hitoshi/0000-0003-4426-385X; Thomson, Vicki A./0000-0001-8368-9664; Donnellan, Stephen/0000-0002-5448-3226; Cooper, Alan/0000-0002-7738-7851	National Geographic Society Exploration Grant; Australian Centre for International Agricultural Research; AUSAid; Australian Research Council [DP0988863]; Australian post-graduate award	National Geographic Society Exploration Grant(National Geographic Society); Australian Centre for International Agricultural Research; AUSAid(Australian Aid (AusAID)); Australian Research Council(Australian Research Council); Australian post-graduate award(Australian Government)	A National Geographic Society Exploration Grant provided funding for the vertebrate fauna survey in eastern Indonesia, and the Australian Centre for International Agricultural Research and AUSAid provided funding for fieldwork in the agricultural landscapes of Southeast Asia. The study was partially funded from Australian Research Council grant DP0988863 to SCD and KPA. VT was supported by an Australian post-graduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin K, 2008, QUATERNARY MURID R 1, P160; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chaimanee Y, 1998, PLIO PLEISTOCENE ROD; Chasen F N, 1940, B RAFFLES MUSEUM, V15; Cooper A, 2000, SCIENCE, V289, P1139; Drummond A., 2011, GENEIOUS V5 5; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrison JL, 1966, INTRO MAMMALS SINGAP; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kitchener D. J., 1991, RECORDS W AUSTR MUSE, V15, P611; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Matisoo-Smith E, 1994, AM J PHYS ANTHROPOL, V0, P141; Murphy Robert W., 1996, P51; Musser G.G., 1984, Modern Quaternary Research in Southeast Asia, V8, P61; MUSSER GG, 1983, B AM MUS NAT HIST, V174, P327; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RICHARDSON BJ, 1986, ALLOZYME ELECTROPHOR; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; SCHWARZ E., 1967, AN ESC NAC CIENC BIOL MEX, V14, P79; TATE G. H. H., 1935, BULL ARNER MUS NAT HIST, V68, P145; van den Bergh GD, 2009, J HUM EVOL, V57, P527, DOI 10.1016/j.jhevol.2008.08.015; van der Meulen A.J., 1999, Deinsea, V7, P361; Waite E, 1897, P ZOOLOGICAL SOC, V1897, P857; Yom-Tov Y, 1999, J BIOGEOGR, V26, P947, DOI 10.1046/j.1365-2699.1999.00338.x; Zhang RZ., 1997, DISTRIBUTION MAMMALI	30	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91356	10.1371/journal.pone.0091356	http://dx.doi.org/10.1371/journal.pone.0091356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637896	Green Published, gold			2022-12-25	WOS:000333254100030
J	Cheah, FC; Peskin, AV; Wong, FL; Ithnin, A; Othman, A; Winterbourn, CC				Cheah, Fook-Choe; Peskin, Alexander V.; Wong, Fei-Liang; Ithnin, Azlin; Othman, Ainoon; Winterbourn, Christine C.			Increased basal oxidation of peroxiredoxin 2 and limited peroxiredoxin recycling in glucose-6-phosphate dehydrogenase-deficient erythrocytes from newborn infants	FASEB JOURNAL			English	Article						antioxidant defense; hydrogen peroxide; hemolytic anemia	HYDROGEN-PEROXIDE; ACID; H2O2	Erythrocytes require glucose-6-phosphate dehydrogenase (G6PD) to generate NADPH and protect themselves against hemolytic anemia induced by oxidative stress. Peroxiredoxin 2 (Prx2) is a major antioxidant enzyme that requires NADPH to recycle its oxidized (disulfide-bonded) form. Our aims were to determine whether Prx2 is more highly oxidized in G6PD-deficient erythrocytes and whether these cells are able to recycle oxidized Prx2 after oxidant challenge. Blood was obtained from 61 Malaysian neonates with G6PD deficiency (average 33% normal activity) and 86 controls. Prx2 redox state was analyzed by Western blotting under nonreducing conditions. Prx2 in freshly isolated blood was predominantly reduced in both groups, but the median level of oxidation was significantly higher (8 vs 3%) and the range greater for the G6PD-deficient population. When treated with reagent H2O2, the G6PD-deficient erythrocytes were severely compromised in their ability to recycle oxidized Prx2, with only 27 or 4% reduction after 1 h treatment with 0.1 or 1 mM H2O2 respectively, compared with > 97% reduction in control erythrocytes. The accumulation of oxidized Prx2 in oxidatively stressed erythrocytes with common G6PD variants suggests that impaired antioxidant activity of Prx2 could contribute to the hemolysis and other complications associated with the condition.	[Cheah, Fook-Choe; Wong, Fei-Liang] Univ Kebangsaan Malaysia, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia; [Ithnin, Azlin] Univ Kebangsaan Malaysia, Med Ctr, Dept Pathol, Kuala Lumpur, Malaysia; [Peskin, Alexander V.; Winterbourn, Christine C.] Univ Otago Christchurch, Dept Pathol, Ctr Free Rad Res, Christchurch, New Zealand; [Winterbourn, Christine C.] Univ Otago Christchurch, Gravida Natl Ctr Growth & Dev, Christchurch, New Zealand; [Othman, Ainoon] Univ Sains Islam Malaysia, Dept Pathol, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; University of Otago; University of Otago; Universiti Sains Islam Malaysia	Winterbourn, CC (corresponding author), Univ Otago Christchurch, Dept Pathol, Ctr Free Rad Res, POB 4345, Christchurch, New Zealand.	christine.winterbourn@otago.ac.nz	Peskin, alexander/R-6457-2019; Cheah, Fook-Choe/AAC-9465-2021	Cheah, Fook-Choe/0000-0002-1137-6295; peskin, alexander/0000-0001-9890-6043	Ministry of Higher Education of Malaysia [UKM-FF-03-FRGS0038-2010]; Health Research Council of New Zealand	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Fundamental Research Grant Scheme (UKM-FF-03-FRGS0038-2010) from the Ministry of Higher Education of Malaysia and the Health Research Council of New Zealand. The authors thank Ms. Angeline Loh Mee-Ling, Dr. Chow Soon-Ken, and the nurses, doctors, and staff in the postnatal wards, neonatal intensive care unit, and molecular hematology laboratory of Universiti Kebangsaan Malaysia Medical Centre for their technical assistance.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Azma RZ, 2010, SE ASIAN J TROP MED, V41, P982; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; HOCHSTEIN P, 1988, FREE RADICAL BIO MED, V5, P387, DOI 10.1016/0891-5849(88)90112-8; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Johnson RM, 2010, FREE RADICAL BIO MED, V48, P519, DOI 10.1016/j.freeradbiomed.2009.11.021; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Maisels MJ, 2004, PEDIATRICS, V114, P297; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; MOORE RB, 1991, J BIOL CHEM, V266, P18964; Nagababu E, 2013, FREE RADICAL RES, V47, P164, DOI 10.3109/10715762.2012.756138; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; SEIDMAN DS, 1995, J PEDIATR-US, V127, P804, DOI 10.1016/S0022-3476(95)70177-X; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; WINTERBOURN CC, 1987, J CLIN INVEST, V80, P1486, DOI 10.1172/JCI113230; WINTERBOURN CC, 1985, ENVIRON HEALTH PERSP, V64, P321, DOI 10.2307/3430020	27	13	14	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3205	3210		10.1096/fj.14-250050	http://dx.doi.org/10.1096/fj.14-250050			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24636884				2022-12-25	WOS:000337949400040
J	Fukumoto, Y; Morii, M; Miura, T; Kubota, S; Ishibashi, K; Honda, T; Okamoto, A; Yamaguchi, N; Iwama, A; Nakayama, Y; Yamaguchi, N				Fukumoto, Yasunori; Morii, Mariko; Miura, Takahito; Kubota, Sho; Ishibashi, Kenichi; Honda, Takuya; Okamoto, Aya; Yamaguchi, Noritaka; Iwama, Atsushi; Nakayama, Yuji; Yamaguchi, Naoto			Src Family Kinases Promote Silencing of ATR-Chk1 Signaling in Termination of DNA Damage Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Checkpoint Control; DNA Damage; DNA Damage Response; Src; Checkpoint Recovery	DOUBLE-STRAND BREAKS; LYN TYROSINE KINASE; POLO-LIKE KINASE-1; CELL-CYCLE CHECKPOINTS; IONIZING-RADIATION; GENOTOXIC STRESS; PROTEIN-KINASE; REPLICATION STRESS; MEDIATED PHOSPHORYLATION; NUCLEAR-LOCALIZATION	Background: Once DNA repair is completed, the DNA damage checkpoint is terminated, and the cell cycle is resumed. Results: Src inhibition induced a delay in G(2) checkpoint recovery and persistent ATR-Chk1 activation. Conclusion: Src inhibits ATR signaling to promote recovery from G(2) checkpoint arrest. Significance: Src sends a termination signal between the completion of DNA repair and the initiation of checkpoint termination. The DNA damage checkpoint arrests cell cycle progression to allow time for repair. Once DNA repair is completed, checkpoint signaling is terminated. Currently little is known about the mechanism by which checkpoint signaling is terminated, and the disappearance of DNA lesions is considered to induce the end of checkpoint signaling; however, here we show that the termination of checkpoint signaling is an active process promoted by Src family tyrosine kinases. Inhibition of Src activity delays recovery from the G(2) phase DNA damage checkpoint following DNA repair. Src activity is required for the termination of checkpoint signaling, and inhibition of Src activity induces persistent activation of ataxia telangiectasia mutated (ATM)- and Rad3-related (ATR) and Chk1 kinases. Src-dependent nuclear protein tyrosine phosphorylation and v-Src expression suppress the ATR-mediated Chk1 and Rad17 phosphorylation induced by DNA double strand breaks or DNA replication stress. Thus, Src family kinases promote checkpoint recovery through termination of ATR- and Chk1-dependent G(2) DNA damage checkpoint. These results suggest a model according to which Src family kinases send a termination signal between the completion of DNA repair and the initiation of checkpoint termination.	[Fukumoto, Yasunori; Morii, Mariko; Miura, Takahito; Kubota, Sho; Ishibashi, Kenichi; Honda, Takuya; Okamoto, Aya; Yamaguchi, Noritaka; Nakayama, Yuji; Yamaguchi, Naoto] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan	Chiba University; Chiba University	Fukumoto, Y (corresponding author), Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	fukumoto@faculty.chiba-u.jp		Honda, Takuya/0000-0002-7141-0088; Kubota, Sho/0000-0001-6119-1259; Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nanohana Competition Award of Chiba University; Futaba Electronics Memorial Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nanohana Competition Award of Chiba University; Futaba Electronics Memorial Foundation	This work was supported in part by grants-in-aid for scientific research, the Global Centers of Excellence (COE) Program (Global Center for Education and Research in Immune Regulation and Treatment), and Special Funds for Education and Research (Development of single photon emission computed tomography (SPECT) Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and a research grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research.; Recipient of a research grant from the Nanohana Competition 2011 Award of Chiba University and the Futaba Electronics Memorial Foundation. To whom correspondence should be addressed: Dept. of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675, Japan. Tel. and Fax: 81-43-226-2869; E-mail: fukumoto@faculty.chiba-u.jp.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Calonge TM, 2008, DNA REPAIR, V7, P136, DOI 10.1016/j.dnarep.2007.07.017; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Fukumoto Y, 2008, MOL CELL BIOL, V28, P6746, DOI 10.1128/MCB.00757-08; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; He ZW, 2005, J BIOL CHEM, V280, P2446, DOI 10.1074/jbc.M402053200; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; KHARBANDA S, 1994, J BIOL CHEM, V269, P20739; Kharbanda S, 1996, CANCER RES, V56, P3617; Kikuchi I, 2010, CELL BIOL INT, V34, P645, DOI 10.1042/CBI20090398; Kohn EA, 2003, CANCER RES, V63, P31; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lovly CM, 2008, MOL CELL BIOL, V28, P5874, DOI 10.1128/MCB.00821-08; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Madoz-Gurpide J, 2007, MOL CELL PROTEOMICS, V6, P2150, DOI 10.1074/mcp.M700006-MCP200; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Maruo A, 1999, INT IMMUNOL, V11, P1371, DOI 10.1093/intimm/11.9.1371; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MOHN H, 1995, BIOCHEM J, V309, P657; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Paliwal P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-45; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Qin SF, 1997, J BIOL CHEM, V272, P17994, DOI 10.1074/jbc.272.29.17994; Radha V, 1996, EUR J BIOCHEM, V236, P352, DOI 10.1111/j.1432-1033.1996.00352.x; Riffell JL, 2009, CELL CYCLE, V8, P3025; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Shangary S, 2003, EXP CELL RES, V289, P67, DOI 10.1016/S0014-4827(03)00234-9; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vavrova J, 2013, RADIAT ENVIRON BIOPH, V52, P471, DOI 10.1007/s00411-013-0486-5; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	95	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12313	12329		10.1074/jbc.M113.533752	http://dx.doi.org/10.1074/jbc.M113.533752			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634213	Green Published, hybrid			2022-12-25	WOS:000335581400011
J	Grove, LM; Southern, BD; Jin, TH; White, KE; Paruchuri, S; Harel, E; Wei, Y; Rahaman, SO; Gladson, CL; Ding, Q; Craik, CS; Chapman, HA; Olman, MA				Grove, Lisa M.; Southern, Brian D.; Jin, Tong H.; White, Kimberly E.; Paruchuri, Sailaja; Harel, Efrat; Wei, Ying; Rahaman, Shaik O.; Gladson, Candece L.; Ding, Qiang; Craik, Charles S.; Chapman, Harold A.; Olman, Mitchell A.			Urokinase-type Plasminogen Activator Receptor ( uPAR) Ligation Induces a Raft-localized Integrin Signaling Switch That Mediates the Hypermotile Phenotype of Fibrotic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast; Fibrosis; Integrin; Lipid Raft; Urokinase Receptor	IDIOPATHIC PULMONARY-FIBROSIS; LIPID RAFTS; CELL-ADHESION; LUNG FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; GLIOBLASTOMA CELLS; DOWN-REGULATION; MIGRATION; KINASE; GROWTH	Background: Fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) overexpress the urokinase-type plasminogen activator receptor (uPAR) and are hypermotile. Results: uPAR ligation increases fibroblast motility by localizing 51 integrin-Fyn signaling complexes to lipid rafts. Conclusion: The hypermotile phenotype of IPF fibroblasts is due to lipid raft-localized uPAR-integrin-Fyn signaling complexes. Significance: These unique lipid raft signals may be therapeutic targets for IPF. The urokinase-type plasminogen activator receptor (uPAR) is a glycosylphosphatidylinositol-linked membrane protein with no cytosolic domain that localizes to lipid raft microdomains. Our laboratory and others have documented that lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) exhibit a hypermotile phenotype. This study was undertaken to elucidate the molecular mechanism whereby uPAR ligation with its cognate ligand, urokinase, induces a motile phenotype in human lung fibroblasts. We found that uPAR ligation with the urokinase receptor binding domain (amino-terminal fragment) leads to enhanced migration of fibroblasts on fibronectin in a protease-independent, lipid raft-dependent manner. Ligation of uPAR with the amino-terminal fragment recruited 51 integrin and the acylated form of the Src family kinase, Fyn, to lipid rafts. The biological consequences of this translocation were an increase in fibroblast motility and a switch of the integrin-initiated signal pathway for migration away from the lipid raft-independent focal adhesion kinase pathway and toward a lipid raft-dependent caveolin-Fyn-Shc pathway. Furthermore, an integrin homologous peptide as well as an antibody that competes with 1 for uPAR binding have the ability to block this effect. In addition, its relative insensitivity to cholesterol depletion suggests that the interactions of 51 integrin and uPAR drive the translocation of 51 integrin-acylated Fyn signaling complexes into lipid rafts upon uPAR ligation through protein-protein interactions. This signal switch is a novel pathway leading to the hypermotile phenotype of IPF patient-derived fibroblasts, seen with uPAR ligation. This uPAR dependent, fibrotic matrix-selective, and profibrotic fibroblast phenotype may be amenable to targeted therapeutics designed to ameliorate IPF.	[Grove, Lisa M.; Southern, Brian D.; Paruchuri, Sailaja; Rahaman, Shaik O.; Olman, Mitchell A.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Gladson, Candece L.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Jin, Tong H.; White, Kimberly E.; Ding, Qiang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Wei, Ying; Chapman, Harold A.] Univ Calif San Francisco, Pulm & Crit Care Div, San Francisco, CA 94143 USA; [Wei, Ying; Chapman, Harold A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Harel, Efrat; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Olman, MA (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave NC-22, Cleveland, OH 44195 USA.	Olmanm@ccf.org		Southern, Brian/0000-0003-2983-5741	National Institutes of Health (NIH) [HL-58655, HL-103553, HL-085324, HL-44712]; NIH, NCI [R01 CA152883, CA127620]; Veterans Administration MERIT Review; Department of Defense Idea Development Award [PC 111318]; NATIONAL CANCER INSTITUTE [R01CA152883, R01CA127620, R01CA175120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655, R01HL119792, R01HL103553, R01HL044712, R01HL085324] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration MERIT Review(US Department of Veterans Affairs); Department of Defense Idea Development Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants HL-58655 and HL-103553 (to M. A. O.), HL-085324 (to Q. D. and M. A. O.), and HL-44712 (to H. A. C.) and NIH, NCI, Grants R01 CA152883 and CA127620 (to C. L. G.). This work was also supported by grants from the Veterans Administration MERIT Review (to M. A. O.) and Department of Defense Idea Development Award PC 111318 (to C. S. C.).	Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Chapman HA, 1999, THROMB HAEMOSTASIS, V82, P291; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Donadello K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-2; DUNN TL, 1988, AM J MED, V85, P221; Duriseti S, 2010, J BIOL CHEM, V285, P26878, DOI 10.1074/jbc.M109.077677; Fell CD, 2007, CHEST, V131, P641, DOI 10.1378/chest.07-0057; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Goel HL, 2013, J CELL PHYSIOL, V228, P1601, DOI 10.1002/jcp.24323; Gunther A, 2003, AM J RESP CRIT CARE, V168, P1358, DOI 10.1164/rccm.2201082; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Lagares D, 2012, ARTHRITIS RHEUM-US, V64, P1653, DOI 10.1002/art.33482; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-41; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Madsen CD, 2008, EUR J CELL BIOL, V87, P617, DOI 10.1016/j.ejcb.2008.02.003; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Monaghan-Benson E, 2006, J BIOL CHEM, V281, P9450, DOI 10.1074/jbc.M501901200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Olman MA, 1996, AM J PHYSIOL-LUNG C, V271, pL519, DOI 10.1152/ajplung.1996.271.4.L519; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; PORN MI, 1995, BIOCHEM J, V308, P269; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P444, DOI 10.1164/ajrccm.149.2.8306043; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sisson TH, 2002, AM J PHYSIOL-LUNG C, V283, pL1023, DOI 10.1152/ajplung.00049.2002; Sisson TH, 1999, HUM GENE THER, V10, P2315, DOI 10.1089/10430349950016960; SUGANUMA H, 1995, THORAX, V50, P984, DOI 10.1136/thx.50.9.984; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; Veeravalli KK, 2012, CELL ADHES MIGR, V6, P509, DOI 10.4161/cam.21673; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; Zhou Y, 2010, J BIOL CHEM, V285, P22382, DOI 10.1074/jbc.M110.126227; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	75	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12791	12804		10.1074/jbc.M113.498576	http://dx.doi.org/10.1074/jbc.M113.498576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644284	Green Published, hybrid			2022-12-25	WOS:000335581400048
J	Aufauvre, J; Misme-Aucouturier, B; Vigues, B; Texier, C; Delbac, F; Blot, N				Aufauvre, Julie; Misme-Aucouturier, Barbara; Vigues, Bernard; Texier, Catherine; Delbac, Frederic; Blot, Nicolas			Transcriptome Analyses of the Honeybee Response to Nosema ceranae and Insecticides	PLOS ONE			English	Article							BEE APIS-MELLIFERA; PESTICIDE-RESIDUES; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; NATURAL INFECTION; TOXICITY; PATHOGEN; DETOXIFICATION; MICROSPORIDIA; METABOLISM	Honeybees (Apis mellifera) are constantly exposed to a wide variety of environmental stressors such as parasites and pesticides. Among them, Nosema ceranae and neurotoxic insecticides might act in combination and lead to a higher honeybee mortality. We investigated the molecular response of honeybees exposed to N. ceranae, to insecticides (fipronil or imidacloprid), and to a combination of both stressors. Midgut transcriptional changes induced by these stressors were measured in two independent experiments combining a global RNA-Seq transcriptomic approach with the screening of the expression of selected genes by quantitative RT-PCR. Although N. ceranae-insecticide combinations induced a significant increase in honeybee mortality, we observed that they did not lead to a synergistic effect. According to gene expression profiles, chronic exposure to insecticides had no significant impact on detoxifying genes but repressed the expression of immunity-related genes. Honeybees treated with N. ceranae, alone or in combination with an insecticide, showed a strong alteration of midgut immunity together with modifications affecting cuticle coatings and trehalose metabolism. An increasing impact of treatments on gene expression profiles with time was identified suggesting an absence of stress recovery which could be linked to the higher mortality rates observed.	[Aufauvre, Julie; Misme-Aucouturier, Barbara; Vigues, Bernard; Texier, Catherine; Delbac, Frederic; Blot, Nicolas] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Aufauvre, Julie; Misme-Aucouturier, Barbara; Vigues, Bernard; Texier, Catherine; Delbac, Frederic; Blot, Nicolas] CNRS, LMGE, UMR 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Blot, N (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, BP 10448, Clermont Ferrand, France.	Nicolas.Blot@univ-bpclermont.fr	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; TOTTEY, Julie/0000-0001-6500-1117	French Centre National de la Recherche Scientifique APEGE program (ParaTox-Synergie project); French Agence Nationale de la Recherche (BEELOSS program) [ANR-12-BSV3-0020]	French Centre National de la Recherche Scientifique APEGE program (ParaTox-Synergie project); French Agence Nationale de la Recherche (BEELOSS program)(French National Research Agency (ANR))	This work was supported by the French Centre National de la Recherche Scientifique APEGE program (ParaTox-Synergie project) and the French Agence Nationale de la Recherche (BEELOSS program, grant no. ANR-12-BSV3-0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aliferis KA, 2012, J INSECT PHYSIOL, V58, P1349, DOI 10.1016/j.jinsphys.2012.07.010; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Barraza A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24778; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bernadou A, 2009, J INSECT PHYSIOL, V55, P1099, DOI 10.1016/j.jinsphys.2009.08.019; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Botias C, 2012, RES VET SCI, V93, P150, DOI 10.1016/j.rvsc.2011.08.002; Broderick NA, 2009, RECOGNITION RESPONSE, P272; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2009, HAZ PEST BEES 10 INT; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Dussaubat C, 2013, VET MICROBIOL, V162, P670, DOI 10.1016/j.vetmic.2012.09.012; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Garcia-Palencia P, 2010, J APICULT RES, V49, P278, DOI 10.3896/IBRA.1.49.3.08; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Junell A, 2010, MOL CELL BIOL, V30, P3672, DOI 10.1128/MCB.00223-10; Kanost MR, 2005, PROTEASES COMPREHENS, V4, P247; Kievits J., 2007, ABEILLES CIE, V118, P12; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lovallo N, 1999, J INSECT PHYSIOL, V45, P1037, DOI 10.1016/S0022-1910(99)00086-4; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Garrido PM, 2013, J INSECT PHYSIOL, V59, P113, DOI 10.1016/j.jinsphys.2012.10.019; Min-Oo G, 2010, EXP PARASITOL, V125, P315, DOI 10.1016/j.exppara.2010.02.009; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pareja L, 2011, INT J ENV RES PUB HE, V8, P3844, DOI 10.3390/ijerph8103844; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pick L, 2012, ANN NY ACAD SCI, V1256, P15, DOI 10.1111/j.1749-6632.2011.06385.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Sun W, 2012, INSECT BIOCHEM MOLEC, V42, P935, DOI 10.1016/j.ibmb.2012.09.006; Terra WR, 2001, ARCH INSECT BIOCHEM, V47, P47, DOI 10.1002/arch.1036; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550	75	147	153	7	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91686	10.1371/journal.pone.0091686	http://dx.doi.org/10.1371/journal.pone.0091686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646894	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500045
J	Bocchetta, S; Maillard, P; Yamamoto, M; Gondeau, C; Douam, F; Lebreton, S; Lagaye, S; Pol, S; Helle, F; Plengpanich, W; Guerin, M; Bourgine, M; Michel, ML; Lavillette, D; Roingeard, P; le Goff, W; Budkowska, A				Bocchetta, Simone; Maillard, Patrick; Yamamoto, Mami; Gondeau, Claire; Douam, Florian; Lebreton, Stephanie; Lagaye, Sylvie; Pol, Stanislas; Helle, Francois; Plengpanich, Wanee; Guerin, Maryse; Bourgine, Maryline; Michel, Marie Louise; Lavillette, Dimitri; Roingeard, Philippe; le Goff, Wilfried; Budkowska, Agata			Up-Regulation of the ATP-Binding Cassette Transporter A1 Inhibits Hepatitis C Virus Infection	PLOS ONE			English	Article							LIVER X RECEPTOR; CHOLESTEROL EXPORTER ABCA1; GPI-ANCHORED PROTEINS; NASCENT HDL FORMATION; LOW-DENSITY; LIPID-METABOLISM; PLASMA-MEMBRANE; REPLICATION; ENTRY; PATHWAY	Hepatitis C virus (HCV) establishes infection using host lipid metabolism pathways that are thus considered potential targets for indirect anti-HCV strategies. HCV enters the cell via clathrin-dependent endocytosis, interacting with several receptors, and virus-cell fusion, which depends on acidic pH and the integrity of cholesterol-rich domains of the hepatocyte membrane. The ATP-binding Cassette Transporter A1 (ABCA1) mediates cholesterol efflux from hepatocytes to extracellular Apolipoprotein A1 and moves cholesterol within cell membranes. Furthermore, it generates high-density lipoprotein (HDL) particles. HDL protects against arteriosclerosis and cardiovascular disease. We show that the up-regulation of ABCA1 gene expression and its cholesterol efflux function in Huh7.5 hepatoma cells, using the liver X receptor (LXR) agonist GW3965, impairs HCV infection and decreases levels of virus produced. ABCA1-stimulation inhibited HCV cell entry, acting on virus-host cell fusion, but had no impact on virus attachment, replication, or assembly/secretion. It did not affect infectivity or properties of virus particles produced. Silencing of the ABCA1 gene and reduction of the specific cholesterol efflux function counteracted the inhibitory effect of the GW3965 on HCV infection, providing evidence for a key role of ABCA1 in this process. Impaired virus-cell entry correlated with the reorganisation of cholesterol-rich membrane microdomains (lipid rafts). The inhibitory effect could be reversed by an exogenous cholesterol supply, indicating that restriction of HCV infection was induced by changes of cholesterol content/distribution in membrane regions essential for virus-cell fusion. Stimulation of ABCA1 expression by GW3965 inhibited HCV infection of both human primary hepatocytes and isolated human liver slices. This study reveals that pharmacological stimulation of the ABCA1-dependent cholesterol efflux pathway disrupts membrane cholesterol homeostasis, leading to the inhibition of virus-cell fusion and thus HCV cell entry. Therefore besides other beneficial roles, ABCA1 might represent a potential target for HCV therapy.	[Bocchetta, Simone; Maillard, Patrick; Yamamoto, Mami; Budkowska, Agata] CNRS, Unite Hepacivirus & Immunite Innee, UMR3569, Paris, France; [Bocchetta, Simone] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Med Translaz, Novara, Italy; [Yamamoto, Mami] Nihon Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Gondeau, Claire] Hop St Eloi, Inst Rech Biotherapie, INSERM, U1040, Montpellier, France; [Douam, Florian; Lavillette, Dimitri] CNRS, Gup Rech Dynam Microbienne & Transmiss Virale, UMR 5557, Villeurbanne, France; [Lebreton, Stephanie] Inst Pasteur, Unite Traf Membranaire & Pathogenese, Paris, France; [Lagaye, Sylvie; Pol, Stanislas] Grp Hosp Cochin Hotel Dieu, AP HP, Unite Hepatol, Paris, France; [Pol, Stanislas] CNRS, INSERM, Equipe Cycle Cellulaire Regenerat & Hepatopathies, Inst Cochin,U1016,UMR8104, Paris, France; [Helle, Francois] CHU Sud Amiens, Lab Virol, Ctr Biol Humaine, Amiens, France; [Plengpanich, Wanee; Guerin, Maryse; le Goff, Wilfried] INSERM, UMRS939, Paris, France; [Plengpanich, Wanee] Chulalongkorn Univ, Dept Med, Endocrinol & Metab Unit, Bangkok, Thailand; [Plengpanich, Wanee] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand; [Bourgine, Maryline; Michel, Marie Louise] Inst Pasteur, INSERM, U845, F-75724 Paris, France; [Roingeard, Philippe] Univ Tours, INSERM, U966, Tours, France; [Roingeard, Philippe] CHRU Tours, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Eastern Piedmont Amedeo Avogadro; Nihon University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Budkowska, A (corresponding author), CNRS, Unite Hepacivirus & Immunite Innee, UMR3569, Paris, France.	agata.budkowska@pasteur.fr	BOURGINE, Maryline/G-3940-2017; Michel, Marie-Louise/N-4384-2017; Le Goff, Wilfried/N-6326-2017; Le Goff, Wilfried/N-7593-2019; HELLE, Francois/G-7427-2011; Guerin, Maryse/N-5794-2017	BOURGINE, Maryline/0000-0002-8850-8073; Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; HELLE, Francois/0000-0001-6884-2456; GUERIN, Maryse/0000-0003-0150-1360; Lebreton, Stephanie/0000-0002-9879-0404; Lavillette, Dimitri/0000-0002-4706-1519	Italian Ministry of Science and Education; French Embassy in Japan	Italian Ministry of Science and Education; French Embassy in Japan	SB was supported by the Doctoral Fellowship from the Italian Ministry of Science and Education and MY by the Postdoctoral Fellowship from the French Embassy in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Asselah T, 2012, LIVER INT, V32, P88, DOI 10.1111/j.1478-3231.2011.02699.x; Bartenschlager R, 2010, J HEPATOL, V53, P583, DOI 10.1016/j.jhep.2010.04.015; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bassendine MF, 2013, SEMIN IMMUNOPATHOL, V35, P87, DOI 10.1007/s00281-012-0356-2; Bassendine MF, 2011, J HEPATOL, V55, P1428, DOI 10.1016/j.jhep.2011.06.004; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Chamoun-Emanuelli AM, 2013, ANTIMICROB AGENTS CH, V57, P2571, DOI 10.1128/AAC.02593-12; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Di DM, 2012, BIOCHEM BIOPH RES CO, V421, P152, DOI 10.1016/j.bbrc.2012.04.022; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gondeau C, 2013, GUT, DOI 10.1136; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; Ji AL, 2012, J LIPID RES, V53, P446, DOI 10.1194/jlr.M017079; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lagaye S, 2012, HEPATOLOGY, V56, P861, DOI 10.1002/hep.25738; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Lebreton S, 2008, J BIOL CHEM, V283, P29545, DOI 10.1074/jbc.M803819200; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Maillard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026637; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Milosavljevic D, 2003, BBA-MOL CELL BIOL L, V1631, P51, DOI 10.1016/S1388-1981(02)00355-4; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morrow MP, 2010, MOL PHARMACOL, V78, P215, DOI 10.1124/mol.110.065029; Nagao K, 2011, FEBS J, V278, P3190, DOI 10.1111/j.1742-4658.2011.08170.x; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oosterveer MH, 2010, PROG LIPID RES, V49, P343, DOI 10.1016/j.plipres.2010.03.002; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Peng DC, 2011, BRIT J PHARMACOL, V162, P1792, DOI 10.1111/j.1476-5381.2011.01202.x; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ramcharran D, 2011, J VIRAL HEPATITIS, V18, pe144, DOI 10.1111/j.1365-2893.2010.01394.x; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Smith B, 2012, CELL REP, V2, P580, DOI 10.1016/j.celrep.2012.08.011; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Thi VLD, 2012, J BIOL CHEM, V287, P31242, DOI 10.1074/jbc.M112.365924; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	78	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92140	10.1371/journal.pone.0092140	http://dx.doi.org/10.1371/journal.pone.0092140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646941	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500090
J	Dodge, KL; Galuardi, B; Miller, TJ; Lutcavage, ME				Dodge, Kara L.; Galuardi, Benjamin; Miller, Timothy J.; Lutcavage, Molly E.			Leatherback Turtle Movements, Dive Behavior, and Habitat Characteristics in Ecoregions of the Northwest Atlantic Ocean	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; DERMOCHELYS-CORIACEA; SEA-TURTLES; FORAGING BEHAVIOR; SATELLITE TELEMETRY; CARETTA-CARETTA; SCALE MOVEMENTS; GPS TRACKING; MIGRATION; WATERS	Leatherback sea turtles, Dermochelys coriacea, are highly migratory predators that feed exclusively on gelatinous zooplankton, thus playing a unique role in coastal and pelagic food webs. From 2007 to 2010, we used satellite telemetry to monitor the movements and dive behavior of nine adult and eleven subadult leatherbacks captured on the Northeast USA shelf and tracked throughout the Northwest Atlantic. Leatherback movements and environmental associations varied by oceanographic region, with slow, sinuous, area-restricted search behavior and shorter, shallower dives occurring in cool (median sea surface temperature: 18.4 degrees C), productive (median chlorophyll a: 0.80 mg m(-3)), shallow (median bathymetry: 57 m) shelf habitat with strong sea surface temperature gradients (median SST gradient: 0.23 degrees C km(-1)) at temperate latitudes. Leatherbacks were highly aggregated in temperate shelf and slope waters during summer, early fall, and late spring and more widely dispersed in subtropical and tropical oceanic and neritic habitat during late fall, winter and early spring. We investigated the relationship of ecoregion, satellite-derived surface chlorophyll, satellite-derived sea surface temperature, SST gradient, chlorophyll gradient and bathymetry with leatherback search behavior using generalized linear mixed-effects models. The most well supported model showed that differences in leatherback search behavior were best explained by ecoregion and regional differences in bathymetry and SST. Within the Northwest Atlantic Shelves region, leatherbacks increased path sinuosity (i.e., looping movements) with increasing SST, but this relationship reversed within the Gulf Stream region. Leatherbacks increased path sinuosity with decreasing water depth in temperate and tropical shelf habitats. This relationship is consistent with increasing epipelagic gelatinous zooplankton biomass with decreasing water depth, and bathymetry may be a key feature in identifying leatherback foraging habitat in neritic regions. High-use habitat for leatherbacks in our study occurred in coastal waters of the North American eastern seaboard and eastern Caribbean, putting turtles at heightened risk from land- and ocean-based human activity.	[Dodge, Kara L.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Dodge, Kara L.; Galuardi, Benjamin; Lutcavage, Molly E.] Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA; [Miller, Timothy J.] Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Woods Hole, MA 02543 USA	University System Of New Hampshire; University of New Hampshire; University of Massachusetts System; University of Massachusetts Amherst; National Oceanic Atmospheric Admin (NOAA) - USA	Dodge, KL (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	kara.dodge@post.harvard.edu		Miller, Timothy/0000-0003-1411-1206	University of New Hampshire; National Oceanic and Atmospheric Administration [NA04NMF4550391]; National Fish and Wildlife Foundation [2008-0076-000]; Cape Cod Commercial Fishermen's Alliance; Massachusetts Division of Marine Fisheries through National Oceanic and Atmospheric Administration [NA07NMF4720052]	University of New Hampshire; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Fish and Wildlife Foundation; Cape Cod Commercial Fishermen's Alliance; Massachusetts Division of Marine Fisheries through National Oceanic and Atmospheric Administration	KD was supported by a University of New Hampshire Marine Program Fellowship administered by the Large Pelagics Research Center. This study was funded by a National Oceanic and Atmospheric Administration Grant #NA04NMF4550391 (www.noaa.gov) and National Fish and Wildlife Foundation Grant #2008-0076-000 (www.nfwf.org) to ML. Additional funding was provided by the Cape Cod Commercial Fishermen's Alliance (www.capecodfishermen.org). Turtle disentanglement was supported by the Massachusetts Division of Marine Fisheries through National Oceanic and Atmospheric Administration Grant #NA07NMF4720052. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alfaro-Shigueto J, 2007, CHELONIAN CONSERV BI, V6, P129, DOI 10.2744/1071-8443(2007)6[129:IBLTAP]2.0.CO;2; Alfaro-Shigueto J, 2010, FISH RES, V106, P8, DOI 10.1016/j.fishres.2010.06.004; ASPER ED, 1975, J FISH RES BOARD CAN, V32, P1191, DOI 10.1139/f75-138; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Batschelet E, 1981, CIRCULAR STAT BIOL; Belkin IM, 2009, J MARINE SYST, V78, P319, DOI 10.1016/j.jmarsys.2008.11.018; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benson SR, 2007, FISH B-NOAA, V105, P337; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; BLEAKNEY J. SHERMAN, 1965, CAN FIELD NATUR, V79, P120; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Brudenall DK, 2008, VET OPHTHALMOL, V11, P99, DOI 10.1111/j.1463-5224.2008.00607.x; Bryant E., 2007, 2D LOCATION ACCURACY; Burnham K. P., 1998, MODEL SELECTION INFE; Carr AF, 1959, AM MUS NOVIT, P1835; Casey J, 2010, J EXP BIOL, V213, P3961, DOI 10.1242/jeb.048611; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; CHI EM, 1989, J AM STAT ASSOC, V84, P452, DOI 10.2307/2289929; Deibel D, 2009, J PLANKTON RES, V31, P1571, DOI 10.1093/plankt/fbp091; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dodge KL, 2011, MAR BIOL, V158, P2813, DOI 10.1007/s00227-011-1780-x; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; ECKERT SA, 1989, CAN J ZOOL, V67, P2834, DOI 10.1139/z89-399; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Faes C, 2009, AM STAT, V63, P389, DOI 10.1198/tast.2009.08196; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fossette S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013908; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; FRAIR W, 1972, SCIENCE, V177, P791, DOI 10.1126/science.177.4051.791; Fratantoni DM, 2006, J PHYS OCEANOGR, V36, P1241, DOI 10.1175/JPO2907.1; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hays GC, 2004, ANIM BEHAV, V67, P733, DOI 10.1016/j.anbehav.2003.08.011; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Hughes GR, 1998, J EXP MAR BIOL ECOL, V229, P209, DOI 10.1016/S0022-0981(98)00052-5; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2007, MAR ECOL PROG SER, V337, P245, DOI 10.3354/meps337245; James MC, 2006, BIOL CONSERV, V133, P347, DOI 10.1016/j.biocon.2006.06.012; JOHNS WE, 1990, J GEOPHYS RES-OCEANS, V95, P22103, DOI 10.1029/JC095iC12p22103; Jones TT, 2011, NMFSSWFSC480 NOAA; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kuhn Carey E., 2010, Endangered Species Research, V12, P125, DOI 10.3354/esr00297; Larson RJ, 1976, 397 NOAA NMFS; LAZELL JD, 1980, COPEIA, P290, DOI 10.2307/1444006; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Lopez-Mendilaharsu M, 2009, J EXP MAR BIOL ECOL, V378, P31, DOI 10.1016/j.jembe.2009.07.010; Lum Lori Lee, 2006, Applied Herpetology, V3, P357, DOI 10.1163/157075406778905081; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Lutcavage M., 2001, MAR TURT NEWSL, V95, P9; Lutcavage ME, 1996, P 15 ANN WORKSH SEA, P355; Madin LP, 2006, DEEP-SEA RES PT I, V53, P804, DOI 10.1016/j.dsr.2005.12.018; Mann KH, 2006, DYNAMICS MARINE ECOS; McCarthy AL, 2010, PROG OCEANOGR, V86, P224, DOI 10.1016/j.pocean.2010.04.009; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Morreale SJ, 1996, NATURE, V384, P319, DOI 10.1038/384319a0; Musick John A., 1997, P137; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plot V, 2013, PHYSIOL BIOCHEM ZOOL, V86, P385, DOI 10.1086/671127; Plotkin P., 2002, BIOL SEA TURTLES, V2, P225; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Potter IF, 2011, MAR BIOL, V158, P531, DOI 10.1007/s00227-010-1578-2; Purcell J.E., 2001, JELLYFISH BLOOMS ECO; R Core Team, 2021, R LANG ENV STAT COMP; Rakow KC, 2006, LIMNOL OCEANOGR, V51, P1097, DOI 10.4319/lo.2006.51.2.1097; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Royer F, 2008, J EXP MAR BIOL ECOL, V359, P1, DOI 10.1016/j.jembe.2008.01.026; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saba VS, 2013, CRC MAR BIOL SER, P163; Schick RS, 2004, FISH OCEANOGR, V13, P225, DOI 10.1111/j.1365-2419.2004.00290.x; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; SHENKER JM, 1984, ESTUAR COAST SHELF S, V19, P619, DOI 10.1016/0272-7714(84)90019-2; Sherman K, 2002, LAR MAR ECOSYST, P195; Shillinger GL, 2011, MAR ECOL PROG SER, V422, P275, DOI 10.3354/meps08884; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; SHOOP CR, 1992, HERPETOL MONOGR, V6, P43; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; TEWG (Turtle Expert Working Group), 2007, NMFSSEFSC555 TEWG NO; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Whitehead H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060901; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467; Zuur Alain F., 2009, P1	118	46	49	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91726	10.1371/journal.pone.0091726	http://dx.doi.org/10.1371/journal.pone.0091726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646920	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500048
J	Martinelli, VC; Kyle, WB; Kojic, S; Vitulo, N; Li, ZH; Belgrano, A; Maiuri, P; Banks, L; Vatta, M; Valle, G; Faulkner, G				Martinelli, Valentina C.; Kyle, W. Buck; Kojic, Snezana; Vitulo, Nicola; Li, Zhaohui; Belgrano, Anna; Maiuri, Paolo; Banks, Lawrence; Vatta, Matteo; Valle, Giorgio; Faulkner, Georgine			ZASP Interacts with the Mechanosensing Protein Ankrd2 and p53 in the Signalling Network of Striated Muscle	PLOS ONE			English	Article							SARCOMERIC Z-DISC; SKELETAL-MUSCLE; LIM-DOMAIN; DILATED CARDIOMYOPATHY; TRANSCRIPTIONAL REPRESSION; MYOGENIC DIFFERENTIATION; ALPHA-ACTININ; SEVERE FORM; PDZ; BINDING	ZASP is a cytoskeletal PDZ-LIM protein predominantly expressed in striated muscle. It forms multiprotein complexes and plays a pivotal role in the structural integrity of sarcomeres. Mutations in the ZASP protein are associated with myofibrillar myopathy, left ventricular non-compaction and dilated cardiomyopathy. The ablation of its murine homologue Cypher results in neonatal lethality. ZASP has several alternatively spliced isoforms, in this paper we clarify the nomenclature of its human isoforms as well as their dynamics and expression pattern in striated muscle. Interaction is demonstrated between ZASP and two new binding partners both of which have roles in signalling, regulation of gene expression and muscle differentiation; the mechanosensing protein Ankrd2 and the tumour suppressor protein p53. These proteins and ZASP form a triple complex that appears to facilitate poly-SUMOylation of p53. We also show the importance of two of its functional domains, the ZM-motif and the PDZ domain. The PDZ domain can bind directly to both Ankrd2 and p53 indicating that there is no competition between it and p53 for the same binding site on Ankrd2. However there is competition for this binding site between p53 and a region of the ZASP protein lacking the PDZ domain, but containing the ZM-motif. ZASP is negative regulator of p53 in transactivation experiments with the p53-responsive promoters, MDM2 and BAX. Mutations in the ZASP ZM-motif induce modification in protein turnover. In fact, two mutants, A165V and A171T, were not able to bind Ankrd2 and bound only poorly to alpha-actinin2. This is important since the A165V mutation is responsible for zaspopathy, a well characterized autosomal dominant distal myopathy. Although the mechanism by which this mutant causes disease is still unknown, this is the first indication of how a ZASP disease associated mutant protein differs from that of the wild type ZASP protein.	[Martinelli, Valentina C.; Belgrano, Anna; Maiuri, Paolo; Banks, Lawrence; Faulkner, Georgine] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Kyle, W. Buck; Li, Zhaohui; Vatta, Matteo] Baylor Coll Med, Dept Paediat Cardiol, Houston, TX 77030 USA; [Kojic, Snezana] Univ Belgrade, Inst Mol Genet & Genet Engn, Mol Biol Lab, Belgrade, Serbia; [Vitulo, Nicola; Valle, Giorgio; Faulkner, Georgine] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Padua, Italy; [Maiuri, Paolo] Inst Curie, Syst Cell Biol Cell Polar & Cell Div, Paris, France; [Vatta, Matteo] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA	International Center for Genetic Engineering & Biotechnology (ICGEB); Baylor College of Medicine; University of Belgrade; University of Padua; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Indiana University System; Indiana University-Purdue University Indianapolis	Faulkner, G (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	georgine.faulkner@cribi.unipd.it	Vitulo, Nicola/GVT-2319-2022; Kojic, Snezana/AAF-4873-2019	VALLE, GIORGIO/0000-0003-4377-5685; Kojic, Snezana/0000-0001-5090-1278; Maiuri, Paolo/0000-0001-5079-445X; Vitulo, Nicola/0000-0002-9571-0747	Fondazione Cariparo, Italy; Italian Ministry of Research [PRIN 20108XYHJS]; Collaborative Research Programme, ICGEB, Italy [CRP/YUG-05-01]; Ministry of Education and Science of Serbia [173008]; NIH [R21-HL07887]; Indiana University Health - Indiana University School of Medicine Strategic Research Initiative	Fondazione Cariparo, Italy(Fondazione Cariparo); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Collaborative Research Programme, ICGEB, Italy; Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Health - Indiana University School of Medicine Strategic Research Initiative	This study was supported by grants from the Fondazione Cariparo, Italy (Progetto Eccellenza 2010 CHROMUS to GV and GF), the Italian Ministry of Research (PRIN 20108XYHJS to GV) as well as the Collaborative Research Programme, ICGEB, Italy (grant CRP/YUG-05-01 to SK) and the Ministry of Education and Science of Serbia (Project No. 173008). This work was also supported in part by NIH R21-HL07887 (MV) and by the Indiana University Health - Indiana University School of Medicine Strategic Research Initiative (MV.)(http://www.fondazionecariparo.it, http://www.mpn.gov.rs/, http://medicine.iu.edu/research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; Belgrano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025519; Benna C, 2009, CELL TISSUE RES, V337, P463, DOI 10.1007/s00441-009-0813-y; Birks EJ, 2008, CARDIOVASC RES, V79, P472, DOI 10.1093/cvr/cvn083; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Cai HY, 2012, J NEUROL, V259, P1913, DOI 10.1007/s00415-012-6439-0; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Carrero G, 2004, B MATH BIOL, V66, P1515, DOI 10.1016/j.bulm.2004.02.005; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Conte M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081064, 10.1371/journal.pone.0073709]; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Ehrnhoefer DE, 2014, HUM MOL GENET, V23, P717, DOI 10.1093/hmg/ddt458; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frank D, 2007, FUTUR CARDIOL, V3, P611, DOI 10.2217/14796678.3.6.611; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Griggs R, 2007, BRAIN, V130, P1477, DOI 10.1093/brain/awm006; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Holmes WB, 2008, CELL MOTIL CYTOSKEL, V65, P130, DOI 10.1002/cm.20249; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Hudson AM, 2008, DEV BIOL, V314, P329, DOI 10.1016/j.ydbio.2007.11.029; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Isogai T, 2007, HOMOSAPIENS CDNA FLJ; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Katzemich A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003342; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Knoll R, 2013, CELL BIOCHEM BIOPHYS, V66, P65, DOI 10.1007/s12013-012-9430-6; Knoll R, 2011, CIRC RES, V109, P758, DOI 10.1161/CIRCRESAHA.111.245787; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Leung MC, 2013, J BIOL CHEM, V288, P4891, DOI 10.1074/jbc.M112.410316; Lin CS, 2013, J BIOL CHEM, V288, P29403, DOI 10.1074/jbc.M113.470708; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mohamed JS, 2013, J BIOL CHEM, V288, P24560, DOI 10.1074/jbc.M112.434423; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131; Passier R, 2000, MECH DEVELOP, V92, P277, DOI 10.1016/S0925-4773(99)00330-5; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salem IH, 2012, MOL BIOL REP, V39, P7479, DOI 10.1007/s11033-012-1581-4; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Selcen D, 2005, GENEREVIEW, P1993; Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Stindt Maren H, 2011, Cell Cycle, V10, P3176; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Vatta M, 2013, ZASP8 IS NOVEL ISOFO; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xi YT, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1017, DOI 10.1161/CIRCEP.111.969220; Yanku Y, 2012, REGULATION PROTEIN P; Yoshida N, 1998, J CELL SCI, V111, P769; Zeng G, 2000, Z BAND ALTERNATIVELY; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	93	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92259	10.1371/journal.pone.0092259	http://dx.doi.org/10.1371/journal.pone.0092259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647531	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500103
J	Villegas-Patraca, R; Cabrera-Cruz, SA; Herrera-Alsina, L				Villegas-Patraca, Rafael; Cabrera-Cruz, Sergio A.; Herrera-Alsina, Leonel			Soaring Migratory Birds Avoid Wind Farm in the Isthmus of Tehuantepec, Southern Mexico	PLOS ONE			English	Article							COLLISION RISK; RADAR; MORTALITY; BEHAVIOR; TURBINES; IMPACT; RATES	The number of wind farms operating in the Isthmus of Tehuantepec, southern Mexico, has rapidly increased in recent years; yet, this region serves as a major migration route for various soaring birds, including Turkey Vultures (Cathartes aura) and Swainson's Hawks (Buteo swainsoni). We analyzed the flight trajectories of soaring migrant birds passing the La Venta II wind farm during the two migratory seasons of 2011, to determine whether an avoidance pattern existed or not. We recorded three polar coordinates for the flight path of migrating soaring birds that were detected using marine radar, plotted the flight trajectories and estimated the number of trajectories that intersected the polygon defined by the wind turbines of La Venta II. Finally, we estimated the actual number of intersections per kilometer and compared this value with the null distributions obtained by running 10,000 simulations of our datasets. The observed number of intersections per kilometer fell within or beyond the lower end of the null distributions in the five models proposed for the fall season and in three of the four models proposed for the spring season. Flight trajectories had a non-random distribution around La Venta II, suggesting a strong avoidance pattern during fall and a possible avoidance pattern during spring. We suggest that a nearby ridgeline plays an important role in this pattern, an issue that may be incorporated into strategies to minimize the potential negative impacts of future wind farms on soaring birds. Studies evaluating these issues in the Isthmus of Tehuantepec have not been previously published; hence this work contributes important baseline information about the movement patterns of soaring birds and its relationship to wind farms in the region.	[Villegas-Patraca, Rafael; Cabrera-Cruz, Sergio A.] Inst Ecol AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Herrera-Alsina, Leonel] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Cabrera-Cruz, SA (corresponding author), Inst Ecol AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.	sergio.cabrera@inecol.mx	Colorado, Rafael/E-8091-2010; Villegas-Patraca, Rafael/T-2682-2018; Cabrera-Cruz, Sergio A./E-6424-2011	Colorado, Rafael/0000-0003-2078-8467; Villegas-Patraca, Rafael/0000-0003-4403-2613; Cabrera-Cruz, Sergio A./0000-0001-8742-4719; Herrera-Alsina, Leonel/0000-0003-0474-3592	World Bank; CFE	World Bank(The World Bank India); CFE	This research was made possible with funding from the World Bank to the Comision Federal de Electricidad (CFE) for monitoring the environmental impacts of the wind farm. The funders of this study were the CFE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMDEE, 2012, PROYECT EOL OP MEX; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bildstein KL, 2004, ORNITOL NEOTROP, V15, P83; Binford L.C, 1989, ORNITHOLOGICAL MONOG, V43, P1; COOPER BA, 1991, J FIELD ORNITHOL, V62, P367; De Lucas M, 2004, BIODIVERS CONSERV, V13, P395, DOI 10.1023/B:BIOC.0000006507.22024.93; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Devereux CL, 2008, J APPL ECOL, V45, P1689, DOI 10.1111/j.1365-2664.2008.01560.x; Diehl RH, 2013, TRENDS ECOL EVOL, V28, P377, DOI 10.1016/j.tree.2013.02.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Elliott Dennis, 2003, WIND ENERGY RESOURCE; Fuller MR, 1998, J AVIAN BIOL, V29, P433, DOI 10.2307/3677162; Gallo-Gomez CA, 2009, IMPLICACIONES FISIOG; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Harmata AR, 1999, WILDLIFE SOC B, V27, P44; Hau E., 2006, WIND TURBINES FUNDAM, Vsecond, DOI [10.1007/3-540-29284-5, DOI 10.1007/3-540-29284-5]; Huppop O, 2006, IBIS, V148, P90, DOI 10.1111/j.1474-919X.2006.00536.x; Hull CL, 2013, WILDLIFE SOC B, V37, P49, DOI 10.1002/wsb.254; Instituto de Ecologia AC, 2003, MAN IMP AMB MOD PART; Jaramillo OA, 2004, RENEW ENERG, V29, P1613, DOI 10.1016/j.renene.2004.02.001; Kerlinger P, 1995, BIRDS MIGRATE; Kovach W.L., 2012, ORIANA CIRCULAR STAT; Larsen JK, 2007, J APPL ECOL, V44, P516, DOI 10.1111/j.1365-2664.2007.01303.x; LEDEC GC, 2011, GREENING WIND ENV SO; Leung DYC, 2012, RENEW SUST ENERG REV, V16, P1031, DOI 10.1016/j.rser.2011.09.024; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; National Research Council, 2007, ENV IMP WIND EN PROJ; Plonczkier P, 2012, J APPL ECOL, V49, P1187, DOI 10.1111/j.1365-2664.2012.02181.x; Portador-Garcia TJ, 2009, CLAROSCUROS FUTURO E; R Development Core Team, 2012, R LANG ENV STAT COMP; Secretaria de Energia, 2012, ESTR NAC EN 2012 202; Winker K, 1995, AUK, V112, P690; World Wind Energy Association, 2013, 2013 HALF YEAR REP; Zalles J.I., 2000, BIRDL CONSERV SER	36	24	25	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92462	10.1371/journal.pone.0092462	http://dx.doi.org/10.1371/journal.pone.0092462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647442	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500134
J	Badaoui, B; Rutigliano, T; Anselmo, A; Vanhee, M; Nauwynck, H; Giuffra, E; Botti, S				Badaoui, Bouabid; Rutigliano, Teresa; Anselmo, Anna; Vanhee, Merijn; Nauwynck, Hans; Giuffra, Elisabetta; Botti, Sara			RNA-Sequence Analysis of Primary Alveolar Macrophages after In Vitro Infection with Porcine Reproductive and Respiratory Syndrome Virus Strains of Differing Virulence	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; SIGNALING PATHWAYS; IMMUNE-RESPONSES; TYROSINE KINASE; ACTIVATION; CELLS; DISEASE; GENOME; SWINE	Porcine reproductive and respiratory syndrome virus (PRRSV) mainly infects porcine alveolar macrophages (PAMs), resulting in porcine reproductive and respiratory syndrome (PRRS) in pigs. Most of the transcriptomic studies on PAMs infected with PRRSV conducted thus far have made use of microarray technology. Here, we investigated the transcriptome of PAMs in vitro at 12 h post-infection with two European PRRSV strains characterized by low (Lelystad, LV) and high (Lena) virulence through RNA-Seq. The expression levels of genes, isoforms, alternative transcription start sites (TSS) and differential promoter usage revealed a complex pattern of transcriptional and post-transcriptional gene regulation upon infection with the two strains. Gene ontology analysis confirmed that infection of PAMs with both the Lena and LV strains affected signaling pathways directly linked to the innate immune response, including interferon regulatory factors (IRF), RIG1-like receptors, TLRs and PKR pathways. The results confirmed that interferon signaling is crucial for transcriptional regulation during PAM infection. IFN-beta 1 and IFN-alpha omega, but not IFN-alpha, were up-regulated following infection with either the LV or Lena strain. The down-regulation of canonical pathways, such as the interplay between the innate and adaptive immune responses, cell death and TLR3/TLR7 signaling, was observed for both strains, but Lena triggered a stronger down-regulation than LV. This analysis contributes to a better understanding of the interactions between PRRSV and PAMs and outlines the differences in the responses of PAMs to strains with different levels of virulence, which may lead to the development of new PRRSV control strategies.	[Badaoui, Bouabid; Rutigliano, Teresa; Anselmo, Anna; Giuffra, Elisabetta; Botti, Sara] Parco Tecnol Padano, Lodi, Italy; [Vanhee, Merijn; Nauwynck, Hans] Univ Ghent, Fac Vet Med, Virol Lab, B-9000 Ghent, Belgium	Ghent University	Badaoui, B (corresponding author), Parco Tecnol Padano, Via Einstein, Lodi, Italy.	bouabid.badaoui@tecnoparco.org	Giuffra, Elisabetta/J-8080-2014; Badaoui, Bouabid/AAV-8968-2021	Nauwynck, Hans/0000-0001-5470-0713; Giuffra, Elisabetta/0000-0001-9568-2056; Anselmo, Anna/0000-0002-5279-8670	EC project FP7-PoRRSCon [245141]; "Progetto AGER" Cariplo Foundation, Italy [2011-0279]	EC project FP7-PoRRSCon; "Progetto AGER" Cariplo Foundation, Italy	This project was funded by EC project FP7-PoRRSCon (grant no. 245141) and "Progetto AGER" (grant no. 2011-0279) Cariplo Foundation, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060; Ait-Ali T, 2008, DEV BIOLOGICALS, V132, P239, DOI 10.1159/000317166; Badaoui B, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-58; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; BLOMSTROM DC, 1986, J BIOL CHEM, V261, P8811; Carter-Su C, 2000, PEDIATR NEPHROL, V14, P550, DOI 10.1007/s004670000366; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Eskildsen S, 2003, NUCLEIC ACIDS RES, V31, P3166, DOI 10.1093/nar/gkg427; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; Fortin CF, 2007, INT IMMUNOL, V19, P41, DOI 10.1093/intimm/dxl119; Frydas IS, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-73; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gimeno M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-9; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; HALLER O, 1980, NATURE, V283, P660, DOI 10.1038/283660a0; Hou J, 2012, VIRUS RES, V167, P106, DOI 10.1016/j.virusres.2012.03.017; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Johnson W, 2004, VET IMMUNOL IMMUNOP, V102, P233, DOI 10.1016/j.vetimm.2004.09.010; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kim TS, 2002, VIRUS RES, V85, P133, DOI 10.1016/S0168-1702(02)00029-1; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CH, 2004, VET IMMUNOL IMMUNOP, V102, P189, DOI 10.1016/j.vetimm.2004.09.020; Lee SM, 2004, VET IMMUNOL IMMUNOP, V102, P217, DOI 10.1016/j.vetimm.2004.09.009; Liu CH, 2009, VET MICROBIOL, V136, P266, DOI 10.1016/j.vetmic.2008.11.016; Loving CL, 2008, VIRAL IMMUNOL, V21, P315, DOI 10.1089/vim.2008.0038; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; MARDASSI H, 1994, J CLIN MICROBIOL, V32, P2197, DOI 10.1128/JCM.32.9.2197-2203.1994; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Miller LC, 2004, VET IMMUNOL IMMUNOP, V102, P131, DOI 10.1016/j.vetimm.2004.09.004; Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nieuwenhuis N, 2012, VET REC, V170, P225, DOI 10.1136/vr.100101; Onomoto K, 2007, CURR TOP MICROBIOL, V316, P193; Pitkin A, 2009, VET MICROBIOL, V136, P1, DOI 10.1016/j.vetmic.2008.10.013; Prieto C, 2009, VET J, V180, P363, DOI 10.1016/j.tvjl.2008.01.005; Reiner G, 2009, APPL ANIM BEHAV SCI, V118, P217, DOI 10.1016/j.applanim.2009.02.011; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schmit F, 2009, FEBS J, V276, P5703, DOI 10.1111/j.1742-4658.2009.07261.x; Schwickart M, 2004, SWML APCL3 EVOLUTION; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun Y, 2012, VIRUSES-BASEL, V4, P424, DOI 10.3390/v4040424; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tessarz AS, 2007, J IMMUNOL, V178, P1991, DOI 10.4049/jimmunol.178.4.1991; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhang XX, 1999, VIROLOGY, V262, P152, DOI 10.1006/viro.1999.9914; Zhou A, 2012, CELL SIGNAL, V24, P973, DOI 10.1016/j.cellsig.2012.01.004; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	72	33	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91918	10.1371/journal.pone.0091918	http://dx.doi.org/10.1371/journal.pone.0091918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643046	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900046
J	Gocek, E; Marchwicka, A; Bujko, K; Marcinkowska, E				Gocek, Elzbieta; Marchwicka, Aleksandra; Bujko, Kamila; Marcinkowska, Ewa			NADPH-Cytochrome P450 Reductase Is Regulated by All-Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D-3 in Human Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							OXIDOREDUCTASE DEFICIENCY; DIFFERENTIATION; VASCULOGENESIS; PROLIFERATION; HOMEOSTASIS; MEMBRANE; PROMOTER; RESCUE; SYSTEM; CYP26	Acute myeloid leukemia (AML) cell lines can be driven to differentiate to monocyte-like cells by 1,25-dihydroxyvitamin D-3 (1,25D) and to granulocyte-like cells by all-trans-retinoic acid (ATRA). Both compounds activate their specific intracellular receptors, vitamin D receptor (VDR) and retinoic acid receptors (RARs) respectively. Inside the cells 1,25D is degraded to calcitrioic acid by a mitochondrial enzyme CYP24A1, while ATRA is degraded to several polar metabolites by CYP26. NADPH-cytochrome P450 oxidoreductase (POR) is a membrane-bound enzyme required for electron transfer to cytochrome P450 (CYP), vital in the processes of the metabolism of drugs and steroid production in humans. In this paper we report that POR in AML cells, from both cell lines and patients, is upregulated by ATRA and by 1,25D at the level of mRNA and protein. Partial silencing of POR in HL60 cells resulted in augmented differentiation response to 1,25D.	[Gocek, Elzbieta; Marchwicka, Aleksandra; Bujko, Kamila; Marcinkowska, Ewa] Univ Wroclaw, Dept Biotechnol, PL-50138 Wroclaw, Poland	University of Wroclaw	Marcinkowska, E (corresponding author), Univ Wroclaw, Dept Biotechnol, PL-50138 Wroclaw, Poland.	ema@cs.uni.wroc.pl	Bujko, Kamila/ABE-3627-2020; Marcinkowska, Ewa/AAE-1272-2019; Marcinkowska, Ewa/F-5979-2014	Bujko, Kamila/0000-0002-2205-1154; Marcinkowska, Ewa/0000-0002-6808-5464; Marcinkowska, Ewa/0000-0002-6808-5464; Marchwicka, Aleksandra/0000-0003-3707-4997; Gocek, Elzbieta/0000-0002-1941-0275	National Science Centre [0351/B/P01/2011/40]; Wroclaw Research Center EIT+ within the Project "Biotechnologies and advanced medical Technologies-BioMed" [POIG 01.01.02-02-003/08-00]; European Regional Development Fund (Operational Program Innovative Economy) [1.1.2]	National Science Centre(National Science Centre, Poland); Wroclaw Research Center EIT+ within the Project "Biotechnologies and advanced medical Technologies-BioMed"; European Regional Development Fund (Operational Program Innovative Economy)	The research was financed by the National Science Centre grant No. 0351/B/P01/2011/40 and by the Wroclaw Research Center EIT+ within the Project "Biotechnologies and advanced medical Technologies-BioMed" (POIG 01.01.02-02-003/08-00) financed by the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baurska H, 2011, J STEROID BIOCHEM, V126, P46, DOI 10.1016/j.jsbmb.2011.04.006; BRACKMAN D, 1995, LEUKEMIA RES, V19, P57, DOI 10.1016/0145-2126(94)00061-E; Eichelbaum M, 2004, ENCY REFERENCE MOL P, P705; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Gocek E, 2012, LEUK RES TREATMENT, V2012; Gocek E, 2012, J STEROID BIOCHEM, V132, P220, DOI 10.1016/j.jsbmb.2012.07.001; Gocek E, 2010, LEUKEMIA RES, V34, P649, DOI 10.1016/j.leukres.2009.10.004; LANOTTE M, 1991, BLOOD, V77, P1080; LOEPER J, 1993, GASTROENTEROLOGY, V104, P203, DOI 10.1016/0016-5085(93)90853-5; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; Merla G, 2006, AM J HUM GENET; MUNKER R, 1986, J CLIN INVEST, V78, P424, DOI 10.1172/JCI112593; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Pike W, 2011, VITAMIN D, P97; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; Robin MA, 2000, J PHARMACOL EXP THER, V294, P1063; Ross AC, 2003, J NUTR, V133, p291S, DOI 10.1093/jn/133.1.291S; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; SIMMONS DL, 1989, BLOOD, V73, P284; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91752	10.1371/journal.pone.0091752	http://dx.doi.org/10.1371/journal.pone.0091752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642534	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900034
J	Lauer, SA; Iyer, S; Sanchez, T; Forst, CV; Bowden, B; Carlson, K; Sriranganathan, N; Boyle, SM				Lauer, Sabine A.; Iyer, Srinivas; Sanchez, Timothy; Forst, Christian V.; Bowden, Brent; Carlson, Kay; Sriranganathan, Nammalwar; Boyle, Stephen M.			Proteomic Analysis of Detergent Resistant Membrane Domains during Early Interaction of Macrophages with Rough and Smooth Brucella melitensis	PLOS ONE			English	Article							IV SECRETION SYSTEM; ENDOPLASMIC-RETICULUM; LIPID RAFTS; CELL-DEATH; INTRACELLULAR SURVIVAL; GENE-EXPRESSION; ABORTUS; VIRB; IDENTIFICATION; SUIS	The plasma membrane contains discrete nanometer-sized domains that are resistant to non-ionic detergents, and which are called detergent resistant membrane domains (DRMDs) or lipid rafts. Exposure of host cells to pathogenic bacteria has been shown to induce the re-distribution of specific host proteins between DRMDs and detergent soluble membranes, which leads to the initiation of cell signaling that enable pathogens to access host cells. DRMDs have been shown to play a role in the invasion of Brucella into host macrophages and the formation of replicative phagosomes called Brucella-containing vacuoles (BCVs). In this study we sought to characterize changes to the protein expression profiles in DRMDs and to respective cellular pathways and networks of Mono Mac 6 cells in response to the adherence of rough VTRM1 and smooth 16 M B. melitensis strains. DRMDs were extracted from Mono Mac 6 cells exposed for 2 minutes at 4 degrees C to Brucella (no infection occurs) and from unexposed control cells. Protein expression was determined using the non-gel based quantitative iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) mass spectrometry technique. Using the identified iTRAQ proteins we performed enrichment analyses and probed constructed human biochemical networks for interactions and metabolic reactions. We identified 149 proteins, which either became enriched, depleted or whose amounts did not change in DRMDs upon Brucella exposure. Several of these proteins were distinctly enriched or depleted in DRMDs upon exposure to rough and smooth B. melitensis strains which results in the differential engagement of cellular pathways and networks immediately upon Brucella encounter. For some of the proteins such as myosin 9, small G protein signaling modulator 3, lysine-specific demethylase 5D, erlin-2, and voltage-dependent anion-selective channel protein 2, we observed extreme differential depletion or enrichment in DRMDs. The identified proteins and pathways could provide the basis for novel ways of treating or diagnosing Brucellosis.	[Lauer, Sabine A.; Iyer, Srinivas; Sanchez, Timothy] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Forst, Christian V.] Univ Texas Dallas, SW Med Ctr, Dept Clin Sci, Dallas, TX USA; [Bowden, Brent; Carlson, Kay; Sriranganathan, Nammalwar; Boyle, Stephen M.] Virginia Polytech & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Bowden, Brent; Carlson, Kay; Sriranganathan, Nammalwar; Boyle, Stephen M.] Ctr Mol Med & Infect Dis, Blacksburg, VA USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Virginia Polytechnic Institute & State University	Lauer, SA (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	zellarhoen@gmail.com		Sanchez, Timothy/0000-0001-8952-4414; Forst, Christian/0000-0003-0229-9459	Chem-Bio Diagnostics program from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA) [IACRO B0844741]	Chem-Bio Diagnostics program from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA)	This work was supported by the Chem-Bio Diagnostics program contract IACRO B0844741 from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA). [http://www.dtra.mil/missions/ChemicalbiologicalDefense/ChemicalBiologicalDefenseHome.aspx] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Arocena GM, 2010, J BACTERIOL, V192, P3434, DOI 10.1128/JB.00232-10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Bronner DN, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00083; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Cabusora L, 2005, BIOINFORMATICS, V21, P2898, DOI 10.1093/bioinformatics/bti440; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Cloeckaert A, 2002, VACCINE, V20, P1820, DOI 10.1016/S0264-410X(02)00035-X; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Comerci DJ, 1998, INFECT IMMUN, V66, P3862, DOI 10.1128/IAI.66.8.3862-3866.1998; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Corbel MJ, 1997, J MED MICROBIOL, V46, P101, DOI 10.1099/00222615-46-2-101; Crockford D, 2010, ANN NY ACAD SCI, V1194, P179, DOI 10.1111/j.1749-6632.2010.05492.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2001, CELL MICROBIOL, V3, P487, DOI 10.1046/j.1462-5822.2001.00131.x; Eppstein D, 1998, SIAM J COMPUT, V28, P652, DOI 10.1137/S0097539795290477; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FREEMAN BA, 1961, J INFECT DIS, V108, P333, DOI 10.1093/infdis/108.3.333; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; Guzman-Verri C, 2001, J BIOL CHEM, V276, P44435, DOI 10.1074/jbc.M105606200; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Hershbereger J, 2003, FINDING K SHORTEST S; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kim S, 2002, MICROB PATHOGENESIS, V33, P225, DOI 10.1006/mpat.2002.0531; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Kusumawati A, 2000, MICROB PATHOGENESIS, V28, P343, DOI 10.1006/mpat.2000.0354; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Li N, 2000, BIOCHEM BIOPH RES CO, V279, P487, DOI 10.1006/bbrc.2000.3935; Li XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043512; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Pei JW, 2008, MICROBES INFECT, V10, P582, DOI 10.1016/j.micinf.2008.01.005; Pei JW, 2006, INFECT IMMUN, V74, P2667, DOI 10.1128/IAI.74.5.2667-2675.2006; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Raulin J, 2002, PROG LIPID RES, V41, P27, DOI 10.1016/S0163-7827(01)00019-4; Reynaud EG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-21; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Ruppen I, 2010, MOL CELL PROTEOMICS, V9, P2276, DOI 10.1074/mcp.M900255-MCP200; Seleem M, 2007, APPL MICROBIOL BIOT, V75, P1385, DOI 10.1007/s00253-007-0970-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Solera J, 2010, INT J ANTIMICROB AG, V36, pS18, DOI 10.1016/j.ijantimicag.2010.06.015; Spera JM, 2013, J BIOL CHEM, V288, P20208, DOI 10.1074/jbc.M113.453282; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tolomeo M, 2003, CLIN INFECT DIS, V36, P1533, DOI 10.1086/375223; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Valderas MW, 2008, J ANTIMICROB CHEMOTH, V61, P128, DOI 10.1093/jac/dkm433; Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	92	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91706	10.1371/journal.pone.0091706	http://dx.doi.org/10.1371/journal.pone.0091706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643124	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900030
J	Shahid, MA; Markham, PF; Marenda, MS; Agnew-Crumpton, R; Noormohammadi, AH				Shahid, Muhammad A.; Markham, Philip F.; Marenda, Marc S.; Agnew-Crumpton, Rebecca; Noormohammadi, Amir H.			High-Resolution Melting-Curve Analysis of obg Gene to Differentiate the Temperature-Sensitive Mycoplasma synoviae Vaccine Strain MS-H from Non-Temperature-Sensitive Strains	PLOS ONE			English	Article							REAL-TIME PCR; SINGLE-NUCLEOTIDE POLYMORPHISMS; EGGSHELL APEX ABNORMALITIES; INFECTIOUS SYNOVITIS; BACILLUS-ANTHRACIS; LIVE VACCINE; FIELD; HEMAGGLUTININ; VLHA; IDENTIFICATION	Temperature-sensitive (ts(+)) vaccine strain MS-H is the only live attenuated M. synoviae vaccine commercially available for use in poultry. With increasing use of this vaccine to control M. synoviae infections, differentiation of MS-H from field M. synoviae strains and from rarely occurring non-temperature-sensitive (ts(-)) MS-H revertants has become important, especially in countries where local strains are indistinguishable from MS-H by sequence analysis of variable lipoprotein haemagglutinin (vlhA) gene. Single nucleotide polymorphisms (SNPs) in the obg of MS-H have been found to associate with ts phenotype. In this study, four PCRs followed by high-resolution melting (HRM)-curve analysis of the regions encompassing these SNPs were developed and evaluated for their potential to differentiate MS-H from 36 M. synoviae strains/isolates. The nested-obg PCR-HRM differentiated ts(+) MS-H vaccine not only from field M. synoviae strains/isolates but also from ts(-) MS-H revertants. The mean genotype confidence percentages, 96.9 +/- 3.4 and 8.8 +/- 11.2 for ts(+) and ts(-) strains, respectively, demonstrated high differentiating power of the nested-obg PCR-HRM. Using a combination of nested-obg and obg-F3R3 PCR-HRM, 97% of the isolates/strains were typed according to their ts phenotype with all MS-H isolates typed as MS-H. A set of respiratory swabs from MS-H vaccinated specific pathogen free chickens and M. synoviae infected commercial chicken flocks were tested using obg PCR-HRM system and results were consistent with those of vlhA genotyping. The PCR-HRM system developed in this study, proved to be a rapid and reliable tool using pure M. synoviae cultures as well as direct clinical specimens.	[Shahid, Muhammad A.; Marenda, Marc S.; Agnew-Crumpton, Rebecca; Noormohammadi, Amir H.] Univ Melbourne, Fac Vet Sci, Werribee, Vic, Australia; [Markham, Philip F.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Shahid, MA (corresponding author), Univ Melbourne, Fac Vet Sci, Werribee, Vic, Australia.	m.shahid@student.unimelb.edu.au	Shahid, Muhammad Akbar/M-7608-2019	Shahid, Muhammad Akbar/0000-0003-2554-5990; MARENDA, MARC/0000-0001-6778-1110; NOORMOHAMMADI, AMIR/0000-0003-3459-2692	University of Melbourne; Higher Education Commission of Pakistan	University of Melbourne(University of Melbourne); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Financial support to conduct this study was provided jointly by the University of Melbourne and the Higher Education Commission of Pakistan. The senior author was supported by the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; Bencina D, 2001, FEMS MICROBIOL LETT, V203, P115, DOI 10.1111/j.1574-6968.2001.tb10829.x; BRUNNER H, 1973, ANN NY ACAD SCI, V225, P436, DOI 10.1111/j.1749-6632.1973.tb45668.x; Buim MR, 2010, COMP IMMUNOL MICROB, V33, P15, DOI 10.1016/j.cimid.2008.07.005; Easterday WR, 2005, J CLIN MICROBIOL, V43, P1995, DOI 10.1128/JCM.43.4.1995-1997.2005; Edenberg HJ, 2009, COLD SPRING HARB PRO, V2009, P1; Feberwee A, 2010, AVIAN PATHOL, V39, P133, DOI 10.1080/03079451003657637; Feberwee A, 2009, AVIAN PATHOL, V38, P77, DOI 10.1080/03079450802662772; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; GREENBERG H, 1974, P NATL ACAD SCI USA, V71, P4015, DOI 10.1073/pnas.71.10.4015; Hammond PP, 2009, VET MICROBIOL, V136, P61, DOI 10.1016/j.vetmic.2008.10.011; Harada K, 2009, AVIAN DIS, V53, P538, DOI 10.1637/8934-052309-Reg.1; Hong Y, 2004, AVIAN DIS, V48, P606, DOI 10.1637/7156-011504R; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; KLEVEN SH, 2008, DIS POULTRY, P845; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Lopes VC, 2002, AVIAN DIS, V46, P162, DOI 10.1637/0005-2086(2002)046[0162:DCAPEO]2.0.CO;2; Markham JF, 1998, AVIAN DIS, V42, P682, DOI 10.2307/1592703; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; MORROW CJ, 1990, AUST VET J, V67, P121, DOI 10.1111/j.1751-0813.1990.tb07726.x; Noormohammadi AH, 1997, INFECT IMMUN, V65, P2542, DOI 10.1128/IAI.65.7.2542-2547.1997; Noormohammadi AH, 2003, AVIAN DIS, V47, P355, DOI 10.1637/0005-2086(2003)047[0355:EOTNFC]2.0.CO;2; Ogino S, 2011, AVIAN DIS, V55, P187, DOI 10.1637/9461-071310-Reg.1; OLSON NO, 1956, AM J VET RES, V17, P747; Ramirez AS, 2011, AVIAN PATHOL, V40, P79, DOI 10.1080/03079457.2010.537305; Raviv Z, 2009, AVIAN DIS, V53, P103, DOI 10.1637/8469-091508-Reg.1; Shahid MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073954; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Twyman R., 2005, ENCY DIAGNOSTIC GENO, V6, P1202; U'Ren JM, 2005, J CLIN MICROBIOL, V43, P5771, DOI 10.1128/JCM.43.11.5771-5774.2005; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Wetzel AN, 2010, AVIAN DIS, V54, P1292, DOI 10.1637/9349-033010-ResNote.1; Whithear K., 1993, AUSTR STANDARD DIAGN, P1; WHITHEAR KG, 1990, AUST VET J, V67, P159, DOI 10.1111/j.1751-0813.1990.tb07745.x	37	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92215	10.1371/journal.pone.0092215	http://dx.doi.org/10.1371/journal.pone.0092215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643035	gold, Green Published			2022-12-25	WOS:000333259900104
J	Shetty, A; Hickey, WJ				Shetty, Ameesha; Hickey, William J.			Effects of Outer Membrane Vesicle Formation, Surface-Layer Production and Nanopod Development on the Metabolism of Phenanthrene by Delftia acidovorans Cs1-4	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; LIPOPOLYSACCHARIDE; VIRULENCE; BACTERIA; RELEASE; PROTEIN; ARCHAEA; PQS	Nanopods are extracellular structures arising from the convergence of two widely distributed bacterial characteristics: production of outer membrane vesicles (OMV) and formation of surface layers (S-layers). Nanopod production is driven by OMV formation, and in Delftia acidovorans Cs1-4 growth on phenanthrene induces OMV/nanopod formation. While OMV production has been associated with many functions, particularly with pathogens, linkage to biodegradation has been limited to a membrane stress response to lipophilic compounds. The objectives of this study were to determine: 1.) Whether induction of nanopod formation was linked to phenanthrene metabolism or a non-specific membrane stress response, and 2.) The relative importance of OMV/nanopod formation vs. formation of the S-layer alone to phenanthrene utilization. Membrane stress response was investigated by quantifying nanopod formation following exposure to compounds that exceeded phenanthrene in membrane stress-inducing potential. Naphthalene did not induce nanopod formation, and toluene was a weak inducer compared to phenanthrene (two-vs. six-fold increase, respectively). Induction of nanopod formation by growth on phenanthrene was therefore linked to phenanthrene metabolism and not a membrane stress response. Impacts on phenanthrene biodegradation of OMV/nanopod production vs. S-layer formation were assessed with D. acidovorans Cs1-4 mutants deficient in S-layer formation or OMV/nanopod production. Both mutants had impaired growth on phenanthrene, but the loss of OMV/nanopod production was more significant than loss of the S-layer. The Slayer of D. acidovorans Cs1-4 did not affect phenanthrene uptake, and its primary role in phenanthrene biodegradation process appeared to be enabling nanopod development. Nanopods appeared to benefit phenanthrene biodegradation by enhancing cellular retention of metabolites. Collectively, these studies established that nanopod/OMV formation was an essential characteristic of the D. acidovorans Cs1-4 phenanthrene degradation process. This report thus established a new dimension in the area of biodegradation, namely, the involvement of extracellular structures as elements supporting metabolic processes underlying biodegradation.	[Shetty, Ameesha; Hickey, William J.] Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Hickey, WJ (corresponding author), Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA.	wjhickey@wisc.edu	Hickey, William/HGC-5490-2022		National Science Foundation [NSF MCB0920664]; O. N. Allen Professorship endowment	National Science Foundation(National Science Foundation (NSF)); O. N. Allen Professorship endowment	This study was funded by National Science Foundation grant NSF MCB0920664 (WJH) and by the O. N. Allen Professorship endowment (WJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasnezhad H, 2011, APPL MICROBIOL BIOT, V92, P653, DOI 10.1007/s00253-011-3589-4; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Baumgarten T, 2012, APPL ENVIRON MICROB, V78, P6217, DOI 10.1128/AEM.01525-12; Berleman J, 2013, ENVIRON MICROBIOL, V15, P347, DOI 10.1111/1462-2920.12048; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; Chen SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00187; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; HICKEY WJ, 1990, APPL ENVIRON MICROB, V56, P3842, DOI 10.1128/AEM.56.12.3842-3850.1990; KAY WW, 1981, J BACTERIOL, V147, P1077, DOI 10.1128/JB.147.3.1077-1084.1981; KAY WW, 1985, J BACTERIOL, V164, P1332, DOI 10.1128/JB.164.3.1332-1336.1985; Marguet E, 2013, BIOCHEM SOC T, V41, P436, DOI 10.1042/BST20120293; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Rengstl B, 2013, PLANTA, V237, P471, DOI 10.1007/s00425-012-1720-0; Rengstl B, 2011, J BIOL CHEM, V286, P21944, DOI 10.1074/jbc.M111.237867; Schwechheimer C, 2013, BIOCHEMISTRY-US, V52, P3031, DOI 10.1021/bi400164t; Shetty A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020725; Tashiro Y, 2012, ENVIRON MICROBIOL, V14, P1349, DOI 10.1111/j.1462-2920.2011.02632.x; Toyofuku M, 2013, ENVIRON MICROBIOL; Yokota S, 2007, COMP IMMUNOL MICROB, V30, P97, DOI 10.1016/j.cimid.2006.11.002; Yuroff AS, 2003, APPL ENVIRON MICROB, V69, P7401, DOI 10.1128/AEM.69.12.7401-7408.2003	27	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92143	10.1371/journal.pone.0092143	http://dx.doi.org/10.1371/journal.pone.0092143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642639	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900094
J	Spira, B; Ferreira, GM; de Almeida, LG				Spira, Beny; Ferreira, Gerson Moura; de Almeida, Luiz Gustavo			relA Enhances the Adherence of Enteropathogenic Escherichia coli	PLOS ONE			English	Article							BUNDLE-FORMING PILUS; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; PROTEIN-SYNTHESIS; EPITHELIAL-CELLS; GENE-EXPRESSION; PPGPP SYNTHESIS; IN-VIVO; VIRULENCE; (P)PPGPP	Enteropathogenic Escherichia coli (EPEC) is a known causative agent of diarrhea in children. In the process of colonization of the small intestine, EPEC synthesizes two types of adhesins, the bundle-forming pilus (BFP) and intimin. The BFP pilus is an adhesin associated with the initial stages of adherence of EPEC to epithelial cells, while the outer membrane protein intimin carries out the intimate adherence that takes place at the third stage of infection. BFP is encoded by the bfp operon located in plasmid EAF, present only in typical EPEC isolates, while eae, the gene that encodes intimin is situated in the LEE, a chromosomal pathogenicity island. Transcription of bfp and eae is regulated by the products of the perABC operon, also present in plasmid EAF. Here we show that deletion of relA, that encodes a guanosine penta and tetraphosphate synthetase impairs EPEC adherence to epithelial cells in vitro. In the absence of relA, the transcription of the regulatory operon perABC is reduced, resulting in lower levels of BFP and intimin. Bacterial adherence, BFP and intimin synthesis and perABC expression are restored upon complementation with the wild-type relA allele.	[Spira, Beny; Ferreira, Gerson Moura; de Almeida, Luiz Gustavo] Univ Sao Paulo, Dept Microbiol, Inst Ceincias Biomed, Sao Paulo, Brazil	Universidade de Sao Paulo	Spira, B (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Ceincias Biomed, Sao Paulo, Brazil.	benys@usp.br	Spira, Beny/D-6928-2012; Spira, Beny/GSD-2097-2022; Ferreira, Gerson Moura/B-4698-2017; Spira, Beny/AAR-2287-2020	Spira, Beny/0000-0001-5394-9074; Spira, Beny/0000-0001-5394-9074; Ferreira, Gerson Moura/0000-0002-3467-2580; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAPESP scholarship; CNPq; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). GMF was supported by a FAPESP scholarship. LGA was supported by CNPq and CAPES scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2006, MOL MICROBIOL, V60, P1520, DOI 10.1111/j.1365-2958.2006.05191.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; CASHEL M, 1969, J BIOL CHEM, V244, P3133; CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong P, 2007, APPL ENVIRON MICROB, V73, P508, DOI 10.1128/AEM.01299-06; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Dutta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056068; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; ECHOLS H, 1961, J MOL BIOL, V3, P425, DOI 10.1016/S0022-2836(61)80055-7; EDLIN G, 1971, J BIOL CHEM, V246, P4371; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Faron M, 2013, INFECT IMMUN, V81, P2800, DOI 10.1128/IAI.00073-13; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Ferreira GM, 2008, MICROBIOL-SGM, V154, P2025, DOI 10.1099/mic.0.2008/016634-0; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GOLDMAN E, 1990, MOL MICROBIOL, V4, P2035, DOI 10.1111/j.1365-2958.1990.tb00563.x; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Gummesson B, 2013, J BIOL CHEM; HERNANDEZ VJ, 1995, J MOL BIOL, V252, P536; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Murphy KC, 2000, GENE, V246, P321, DOI 10.1016/S0378-1119(00)00071-8; Murray KD, 1996, J MOL BIOL, V259, P41; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Moreno ACR, 2010, DIAGN MICR INFEC DIS, V66, P50, DOI 10.1016/j.diagmicrobio.2008.03.017; RUDD KE, 1985, J BACTERIOL, V163, P534, DOI 10.1128/JB.163.2.534-542.1985; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Spira B, 1998, MOL GEN GENET, V257, P469, DOI 10.1007/s004380050671; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Sun W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006720; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Tobe T, 2001, CELL MICROBIOL, V3, P579, DOI 10.1046/j.1462-5822.2001.00136.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002	56	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91703	10.1371/journal.pone.0091703	http://dx.doi.org/10.1371/journal.pone.0091703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643076	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900029
J	Barresi, S; Tomaselli, S; Athanasiadis, A; Galeano, F; Locatelli, F; Bertini, E; Zanni, G; Gallo, A				Barresi, Sabina; Tomaselli, Sara; Athanasiadis, Alekos; Galeano, Federica; Locatelli, Franco; Bertini, Enrico; Zanni, Ginevra; Gallo, Angela			Oligophrenin-1 (OPHN1), a Gene Involved in X-Linked Intellectual Disability, Undergoes RNA Editing and Alternative Splicing during Human Brain Development	PLOS ONE			English	Article							MENTAL-RETARDATION; MESSENGER-RNA; VENTRICULAR ENLARGEMENT; CEREBELLAR HYPOPLASIA; BAR DOMAIN; RECEPTOR; PROTEIN; INOSINE; DROSOPHILA; MUTATIONS	Oligophrenin-1 (OPHN1) encodes for a Rho-GTPase-activating protein, important for dendritic morphogenesis and synaptic function. Mutations in this gene have been identified in patients with X-linked intellectual disability associated with cerebellar hypoplasia. ADAR enzymes are responsible for A-to-I RNA editing, an essential post-transcriptional RNA modification contributing to transcriptome and proteome diversification. Specifically, ADAR2 activity is essential for brain development and function. Herein, we show that the OPHN1 transcript undergoes post-transcriptional modifications such as A-to-I RNA editing and alternative splicing in human brain and other tissues. We found that OPHN1 editing is detectable already at the 18th week of gestation in human brain with a boost of editing at weeks 20 to 33, concomitantly with OPHN1 expression increase and the appearance of a novel OPHN1 splicing isoform. Our results demonstrate that multiple post-transcriptional events occur on OPHN1, a gene playing an important role in brain function and development.	[Barresi, Sabina; Bertini, Enrico; Zanni, Ginevra] Bambino Gesu Childrens Hosp IRCCS, Mol Med Lab, Dept Neurosci, Rome, Italy; [Tomaselli, Sara; Galeano, Federica; Locatelli, Franco; Gallo, Angela] Bambino Gesu Childrens Hosp IRCCS, Oncohaematol Dept, RNA Editing Lab, Rome, Italy; [Athanasiadis, Alekos] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; Instituto Gulbenkian de Ciencia; University of Pavia	Zanni, G (corresponding author), Bambino Gesu Childrens Hosp IRCCS, Mol Med Lab, Dept Neurosci, Rome, Italy.	ginevra.zanni@opbg.net; angela.gallo@opbg.net	Gallo, Angela/E-7837-2011; Gallo, Angela/AAA-5003-2020; Athanasiadis, Alekos/F-2038-2011; Zanni, Ginevra/L-2869-2015; Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014	Gallo, Angela/0000-0003-0297-1807; Gallo, Angela/0000-0003-0297-1807; Athanasiadis, Alekos/0000-0003-1526-0000; Zanni, Ginevra/0000-0002-6367-1843; Bertini, Enrico/0000-0001-9276-4590; BARRESI, SABINA/0000-0002-7307-388X	IG grant from AIRC (Associazione Italiana Ricerca sul cancro) [13202]; special project 5x1000 AIRC	IG grant from AIRC (Associazione Italiana Ricerca sul cancro)(Fondazione AIRC per la ricerca sul cancro); special project 5x1000 AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by an IG grant (n. 13202) to A. G. from AIRC (Associazione Italiana Ricerca sul cancro) and by the special project 5x1000 AIRC to F. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Owain M, 2011, CLIN GENET, V79, P363, DOI 10.1111/j.1399-0004.2010.01462.x; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Ba W, 2013, EXP CELL RES, V319, P2368, DOI 10.1016/j.yexcr.2013.05.033; Bedeschi MF, 2008, AM J MED GENET A, V146A, P1718, DOI 10.1002/ajmg.a.32365; Beghini A, 2000, HUM MOL GENET, V9, P2297, DOI 10.1093/oxfordjournals.hmg.a018921; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Gallo A, 2011, BIOL REV CAMB PHILOS, V87, P95, DOI DOI 10.1111/J.1469-185X.2011.00186.X; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Greenberger S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-608; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Ljubimova JY, 2001, INT J ONCOL, V18, P287; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mallela A, 2012, CRIT REV BIOCHEM MOL, V47, P493, DOI 10.3109/10409238.2012.714350; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Pirozzi F, 2011, HUM MUTAT, V32, pE2294, DOI 10.1002/humu.21567; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rocas D, 2013, EUR J MED GENET, V56, P270, DOI 10.1016/j.ejmg.2013.01.014; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI 10.1038/nchembio.434; Santos-Reboucas CB, 2014, EUR J HUM GENET, V22, P644, DOI 10.1038/ejhg.2013.216; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tojo K, 2006, MOVEMENT DISORD, V21, P1510, DOI 10.1002/mds.21011; Valnegri P, 2011, NAT NEUROSCI, V14, P1293, DOI 10.1038/nn.2911; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang QQ, 2005, CURR BIOL, V15, P384, DOI 10.1016/j.cub.2005.01.046; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Yang L, 2010, FASEB J; Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91351	10.1371/journal.pone.0091351	http://dx.doi.org/10.1371/journal.pone.0091351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637888	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100029
J	Huang, Y; Caputo, CR; Noordmans, GA; Yazdani, S; Monteiro, LH; van den Born, J; van Goor, H; Heeringa, P; Korstanje, R; Hillebrands, JL				Huang, Yuan; Caputo, Christina R.; Noordmans, Gerda A.; Yazdani, Saleh; Monteiro, Luiz Henrique; van den Born, Jaap; van Goor, Harry; Heeringa, Peter; Korstanje, Ron; Hillebrands, Jan-Luuk			Identification of Novel Genes Associated with Renal Tertiary Lymphoid Organ Formation in Aging Mice	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CHRONIC REJECTION; IMMUNE-RESPONSE; HUMAN KIDNEY; NEOGENESIS; DISEASE; EXPRESSION; CD30; FAMILY; TISSUE	A hallmark of aging-related organ deterioration is a dysregulated immune response characterized by pathologic leukocyte infiltration of affected tissues. Mechanisms and genes involved are as yet unknown. To identify genes associated with aging-related renal infiltration, we analyzed kidneys from aged mice (>= 20 strains) for infiltrating leukocytes followed by Haplotype Association Mapping (HAM) analysis. Immunohistochemistry revealed CD45(+) cell clusters (predominantly T and B cells) in perivascular areas coinciding with PNAd(+) high endothelial venules and podoplanin(+) lymph vessels indicative of tertiary lymphoid organs. Cumulative cluster size increased with age (analyzed at 6, 12 and 20 months). Based on the presence or absence of clusters in male and female mice at 20 months, HAM analysis revealed significant associations with loci on Chr1, Chr2, Chr8 and Chr14 in male mice, and with loci on Chr4, Chr7, Chr13 and Chr14 in female mice. Wisp2 (Chr2) showed the strongest association (P = 5.00x10(-137)) in male mice; Ctnnbip1 (P = 6.42x10(-267)) and Tnfrsf8 (P = 5.42x10(-245)) (both on Chr4) showed the strongest association in female mice. Both Wisp2 and Ctnnbip1 are part of the Wnt-signaling pathway and the encoded proteins were expressed within the tertiary lymphoid organs. In conclusion, this study revealed differential lymphocytic infiltration and tertiary lymphoid organ formation in aged mouse kidneys across different inbred mouse strains. HAM analysis identified candidate genes involved in the Wnt-signaling pathway that may be causally linked to tertiary lymphoid organ formation.	[Huang, Yuan; Noordmans, Gerda A.; Monteiro, Luiz Henrique; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Pathol, Groningen, Netherlands; [Huang, Yuan] Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai 200433, Peoples R China; [Caputo, Christina R.; Korstanje, Ron] Jackson Lab, Bar Harbor, ME 04609 USA; [Yazdani, Saleh; van den Born, Jaap] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Med Biol, Groningen, Netherlands	University of Groningen; Fudan University; Jackson Laboratory; University of Groningen; University of Groningen	Hillebrands, JL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Pathol, Groningen, Netherlands.	j.l.hillebrands@umcg.nl	Yazdani, Saleh/K-9640-2015; van+Goor, Harry/AAS-7712-2020; Heeringa, Peter/A-6008-2009	Yazdani, Saleh/0000-0002-5162-9904; Heeringa, Peter/0000-0001-8684-763X; Hillebrands, Jan-Luuk/0000-0003-3135-3274; van Goor, Harry/0000-0002-6670-1577	University of Groningen Graduate School of Medical Sciences; NIGMS [GM076468]; NIA [AG038070]; National Cancer Institute Cancer Core grant [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038070] Funding Source: NIH RePORTER	University of Groningen Graduate School of Medical Sciences; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute Cancer Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the University of Groningen Graduate School of Medical Sciences (YH [Bernoulli Bursary], GAN and SY), GM076468 from the NIGMS (RK), AG038070 from NIA (RK), and the National Cancer Institute Cancer Core grant (CA034196) to The Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bowen MA, 1996, J IMMUNOL, V156, P442; Brink TC, 2009, BIOGERONTOLOGY, V10, P721, DOI 10.1007/s10522-009-9219-1; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Gaspal FM, 2011, J EXP MED, V208, P1579, DOI 10.1084/jem.20101484; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; Hoang K, 2003, KIDNEY INT, V64, P1417, DOI 10.1046/j.1523-1755.2003.00207.x; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kelly FM, 2009, AM J PHYSIOL-RENAL, V296, pF512, DOI 10.1152/ajprenal.90629.2008; Lee AS, 2013, KIDNEY INT, V83, P50, DOI 10.1038/ki.2012.312; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027496; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Matsui K, 2003, J AM SOC NEPHROL, V14, P1981, DOI 10.1097/01.ASN.0000076078.50889.43; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Nasr IW, 2007, AM J TRANSPLANT, V7, P1071, DOI 10.1111/j.1600-6143.2007.01756.x; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Pabst R, 2007, IMMUNOL LETT, V112, P1, DOI 10.1016/j.imlet.2007.06.009; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; Segerer S, 2008, KIDNEY INT, V73, P533, DOI 10.1038/sj.ki.5002734; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Tago K, 2000, GENE DEV, V14, P1741; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Thaunat O, 2010, J IMMUNOL, V185, P717, DOI 10.4049/jimmunol.0903589; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; Tsaih SW, 2009, METHODS MOL BIOL, V573, P213, DOI 10.1007/978-1-60761-247-6_12; Tullius SG, 2011, NEW ENGL J MED, V364, P1369, DOI 10.1056/NEJMc1103007; van Goor H, 2009, KIDNEY INT, V75, P767, DOI 10.1038/ki.2009.45; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; WATANABE Y, 1991, NEPHRON, V58, P210, DOI 10.1159/000186417; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	41	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91850	10.1371/journal.pone.0091850	http://dx.doi.org/10.1371/journal.pone.0091850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637805	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100068
J	Machado, VS; Bicalho, MLD; Junior, EBDM; Rossi, R; Ribeiro, BL; Lima, S; Santos, T; Kussler, A; Foditsch, C; Ganda, EK; Oikonomou, G; Cheong, SH; Gilbert, RO; Bicalho, RC				Machado, Vinicius Silva; Bicalho, Marcela Luccas de Souza; Junior, Enoch Brandao de Souza Meira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Lima, Svetlana; Santos, Thiago; Kussler, Arieli; Foditsch, Carla; Ganda, Erika Korzune; Oikonomou, Georgios; Cheong, Soon Hon; Gilbert, Robert Owen; Bicalho, Rodrigo Carvalho			Subcutaneous Immunization with Inactivated Bacterial Components and Purified Protein of Escherichia coli, Fusobacterium necrophorum and Trueperella pyogenes Prevents Puerperal Metritis in Holstein Dairy Cows	PLOS ONE			English	Article							POSTPARTUM UTERINE DISEASE; ARCANOBACTERIUM-PYOGENES; FIMH-ADHESIN; NEUTROPHIL FUNCTION; REPRODUCTIVE-TRACT; RETAINED PLACENTA; PERIPARTUM PERIOD; LIVER-ABSCESSES; FEEDLOT CATTLE; CLINICAL-TRIAL	In this study we evaluate the efficacy of five vaccine formulations containing different combinations of proteins (FimH; leukotoxin, LKT; and pyolysin, PLO) and/or inactivated whole cells (Escherichia coli, Fusobacterium necrophorum, and Trueperella pyogenes) in preventing postpartum uterine diseases. Inactivated whole cells were produced using two genetically distinct strains of each bacterial species (E. coli, F. necrophorum, and T. pyogenes). FimH and PLO subunits were produced using recombinant protein expression, and LKT was recovered from culturing a wild F. necrophorum strain. Three subcutaneous vaccines were formulated: Vaccine 1 was composed of inactivated bacterial whole cells and proteins; Vaccine 2 was composed of proteins only; and Vaccine 3 was composed of inactivated bacterial whole cells only. Two intravaginal vaccines were formulated: Vaccine 4 was composed of inactivated bacterial whole cells and proteins; and Vaccine 5 was composed of PLO and LKT. To evaluate vaccine efficacy, a randomized clinical trial was conducted at a commercial dairy farm; 371 spring heifers were allocated randomly into one of six different treatments groups: control, Vaccine 1, Vaccine 2, Vaccine 3, Vaccine 4 and Vaccine 5. Late pregnant heifers assigned to one of the vaccine groups were each vaccinated twice: at 230 and 260 days of pregnancy. When vaccines were evaluated grouped as subcutaneous and intravaginal, the subcutaneous ones were found to significantly reduce the incidence of puerperal metritis. Additionally, subcutaneous vaccination significantly reduced rectal temperature at 661 days in milk. Reproduction was improved for cows that received subcutaneous vaccines. In general, vaccination induced a significant increase in serum IgG titers against all antigens, with subcutaneous vaccination again being more effective. In conclusion, subcutaneous vaccination with inactivated bacterial components and/or protein subunits of E. coli, F. necrophorum and T. pyogenes can prevent puerperal metritis during the first lactation of dairy cows, leading to improved reproduction.	[Machado, Vinicius Silva; Bicalho, Marcela Luccas de Souza; Junior, Enoch Brandao de Souza Meira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Lima, Svetlana; Santos, Thiago; Kussler, Arieli; Foditsch, Carla; Ganda, Erika Korzune; Oikonomou, Georgios; Cheong, Soon Hon; Gilbert, Robert Owen; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Ganda, Erika/AAD-6286-2020; Ribeiro, Bruno Leonardo Mendonça/W-2138-2019; Gilbert, Robert/J-9107-2012	Ganda, Erika/0000-0002-8735-0753; Ribeiro, Bruno Leonardo Mendonça/0000-0002-4303-0504; Gilbert, Robert/0000-0002-1528-243X; Monteiro Araujo dos Santos, Thiago/0000-0002-0648-6078; Cheong, Soon Hon/0000-0001-9002-7589; Rossi, Rodolfo/0000-0002-4776-1232	Merck Animal Health	Merck Animal Health(Merck & Company)	This study was funded by a grant from Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Bannerman DD, 2003, J DAIRY SCI, V86, P3128, DOI 10.3168/jds.S0022-0302(03)73914-9; Bicalho MLS, 2012, VET MICROBIOL, V157, P125, DOI 10.1016/j.vetmic.2011.11.034; Bicalho RC, 2010, J DAIRY SCI, V93, P5818, DOI 10.3168/jds.2010-3550; Billington SJ, 1997, J BACTERIOL, V179, P6100, DOI 10.1128/jb.179.19.6100-6106.1997; Bondurant RH, 1999, J ANIM SCI, V77, P101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTT BM, 1993, INFECT IMMUN, V61, P2558, DOI 10.1128/IAI.61.6.2558-2562.1993; CAI TQ, 1994, AM J VET RES, V55, P934; Cheong SH, 2012, THERIOGENOLOGY, V77, P858, DOI 10.1016/j.theriogenology.2011.09.009; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CORBEIL LB, 1974, INFECT IMMUN, V10, P422, DOI 10.1128/IAI.10.3.422-429.1974; Dohmen MJW, 2000, THERIOGENOLOGY, V54, P1019, DOI 10.1016/S0093-691X(00)00410-6; Dolejska M, 2011, VET MICROBIOL, V149, P513, DOI 10.1016/j.vetmic.2010.11.032; Dubuc J, 2010, J DAIRY SCI, V93, P5764, DOI 10.3168/jds.2010-3429; Dubuc J, 2010, J DAIRY SCI, V93, P5225, DOI 10.3168/jds.2010-3428; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Fricke PM, 2003, J DAIRY SCI, V86, P3941, DOI 10.3168/jds.S0022-0302(03)74003-X; Galvao KN, 2010, J DAIRY SCI, V93, P2926, DOI 10.3168/jds.2009-2551; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Jones G, 2004, BOVINE PR, V38, P36; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kelton DF, 1998, J DAIRY SCI, V81, P2502, DOI 10.3168/jds.S0022-0302(98)70142-0; Kim IH, 2005, J REPROD DEVELOP, V51, P757, DOI 10.1262/jrd.17036; Kimura K, 2002, J DAIRY SCI, V85, P544, DOI 10.3168/jds.S0022-0302(02)74107-6; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; LeBlanc SJ, 2008, VET J, V176, P102, DOI 10.1016/j.tvjl.2007.12.019; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; Machado VS, 2012, J DAIRY SCI, V95, P3100, DOI 10.3168/jds.2011-5063; Machado VS, 2012, J DAIRY SCI, V95, P1349, DOI 10.3168/jds.2011-4867; Miller ANA, 2007, THERIOGENOLOGY, V68, P972, DOI 10.1016/j.theriogenology.2007.07.013; MOOI FR, 1985, CURR TOP MICROBIOL, V118, P119; Moreira F, 2001, J DAIRY SCI, V84, P1646, DOI 10.3168/jds.S0022-0302(01)74600-0; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P351, DOI 10.1016/j.cvfa.2007.05.002; Narayanan S, 2002, INFECT IMMUN, V70, P4609, DOI 10.1128/IAI.70.8.4609-4620.2002; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Overton M., 2008, DAIRY CATTLE REPROD, P39; PURSLEY JR, 1995, THERIOGENOLOGY, V44, P915, DOI 10.1016/0093-691X(95)00279-H; Sannmann I, 2013, J DAIRY SCI, V96, P5773, DOI 10.3168/jds.2013-6813; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Santos TMA, 2010, VET MICROBIOL, V145, P84, DOI 10.1016/j.vetmic.2010.03.001; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Singh J, 2008, VET J, V175, P301, DOI 10.1016/j.tvjl.2007.02.003; TAN ZL, 1994, AM J VET RES, V55, P515; TAN ZL, 1992, VET MICROBIOL, V32, P15, DOI 10.1016/0378-1135(92)90003-C; TAN ZL, 1994, VET MICROBIOL, V42, P121, DOI 10.1016/0378-1135(94)90012-4; UEHLING DT, 1994, J UROLOGY, V152, P2308, DOI 10.1016/S0022-5347(17)31664-6; Uehling DT, 2003, J UROLOGY, V170, P867, DOI 10.1097/01.ju.0000075094.54767.6e; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017	54	59	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91734	10.1371/journal.pone.0091734	http://dx.doi.org/10.1371/journal.pone.0091734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638139	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100055
J	Yoo, SH; Lee, BH; Moon, Y; Spalding, MH; Jane, JL				Yoo, Sang-Ho; Lee, Byung-Hoo; Moon, Youyoun; Spalding, Martin H.; Jane, Jay-Lin			Glycogen Synthase Isoforms in Synechocystis sp PCC6803: Identification of Different Roles to Produce Glycogen by Targeted Mutagenesis	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; SP PCC 6803; STARCH SYNTHASE; BACTERIAL GLYCOGEN; AMYLOPECTIN; ENZYME; POTATO; CYANOBACTERIA; BIOSYNTHESIS; BIOGENESIS	Synechocystis sp. PCC6803 belongs to cyanobacteria which carry out photosynthesis and has recently become of interest due to the evolutionary link between bacteria and plant species. Similar to other bacteria, the primary carbohydrate storage source of Synechocystis sp. PCC6803 is glycogen. While most bacteria are not known to have any isoforms of glycogen synthase, analysis of the genomic DNA sequence of Synechocystis sp. PCC6803 predicts that this strain encodes two isoforms of glycogen synthase (GS) for synthesizing glycogen structure. To examine the functions of the putative GS genes, each gene (sll1393 or sll0945) was disrupted by double cross-over homologous recombination. Zymogram analysis of the two GS disruption mutants allowed the identification of a protein band corresponding to each GS isoform. Results showed that two GS isoforms (GSI and GSII) are present in Synechocystis sp. PCC6803, and both are involved in glycogen biosynthesis with different elongation properties: GSI is processive and GSII is distributive. Total GS activities in the mutant strains were not affected and were compensated by the remaining isoform. Analysis of the branch-structure of glycogen revealed that the sll1393 2 mutant (GSI 2) produced glycogen containing more intermediate-length chains (DP 8-18) at the expense of shorter and longer chains compared with the wild-type strain. The sll0945 2 mutant (GSII 2) produced glycogen similar to the wildtype, with only a slightly higher proportion of short chains (DP 4-11). The current study suggests that GS isoforms in Synechocystis sp. PCC6803 have different elongation specificities in the biosynthesis of glycogen, combined with ADPglucose pyrophosphorylase and glycogen branching enzyme.	[Yoo, Sang-Ho] Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea; [Yoo, Sang-Ho] Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea; [Lee, Byung-Hoo] Purdue Univ, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Lee, Byung-Hoo] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Moon, Youyoun; Spalding, Martin H.] Iowa State Univ, Dept Bot, Ames, IA USA; [Jane, Jay-Lin] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA USA	Sejong University; Sejong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; Iowa State University	Yoo, SH (corresponding author), Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea.	shyoo@sejong.ac.kr	Yoo, Sang-Ho/AAI-4446-2020		National Research Foundation of Korea (NRF); Korea government (MEST) [2012R1A2A2A01047497]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A2A2A01047497, http://www.nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GJW, 1996, PLANT J, V10, P981, DOI 10.1046/j.1365-313X.1996.10060981.x; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BOYER CD, 1981, PLANT PHYSIOL, V67, P1141, DOI 10.1104/pp.67.6.1141; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; CHAO L, 1971, J BACTERIOL, V105, P331, DOI 10.1128/JB.105.1.331-338.1971; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Craig J, 1998, PLANT CELL, V10, P413, DOI 10.1105/tpc.10.3.413; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EDWARDS A, 1995, PLANT J, V8, P283, DOI 10.1046/j.1365-313X.1995.08020283.x; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Edwards A, 1999, EUR J BIOCHEM, V266, P724, DOI 10.1046/j.1432-1327.1999.00861.x; Ermakova-Gerdes S, 1999, J BIOL CHEM, V274, P30540, DOI 10.1074/jbc.274.43.30540; FARKAS I, 1991, J BIOL CHEM, V266, P15602; FONTAINE T, 1993, J BIOL CHEM, V268, P16223; Fujimori K, 1995, FISHERIES SCI, V61, P951, DOI 10.2331/fishsci.61.951; Gao M, 1998, PLANT CELL, V10, P399, DOI 10.1105/tpc.10.3.399; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; GUAN HP, 1995, P NATL ACAD SCI USA, V92, P964, DOI 10.1073/pnas.92.4.964; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; Iglesias AA, 2006, PLANT CELL PHYSIOL, V47, P523, DOI 10.1093/pcp/pcj021; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Kaneko T, 1996, DNA Res, V3, P109; Kossmann J, 2000, CRIT REV BIOCHEM MOL, V35, P141; Li L, 2006, THESIS IOWA STATE U; MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Miao XL, 2003, FEMS MICROBIOL LETT, V218, P71, DOI 10.1111/j.1574-6968.2003.tb11500.x; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Sivak MN, 1998, STARCH BASIC SCI BIO; STEINER KE, 1977, J BACTERIOL, V129, P246, DOI 10.1128/JB.129.1.246-253.1977; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; TYYNELA J, 1993, PHYSIOL PLANTARUM, V89, P835, DOI [10.1111/j.1399-3054.1993.tb05293.x, 10.1034/j.1399-3054.1993.890422.x]; Vasanthan T, 2001, CURRENT PROTOCOLS FO; Wang CX, 2007, MICROBIOL-SGM, V153, P388, DOI 10.1099/mic.0.29214-0; WANG YJ, 1993, CEREAL CHEM, V70, P171; Wong KS, 1997, J LIQ CHROMATOGR R T, V20, P297, DOI 10.1080/10826079708010654; Yoo SH, 2007, INT J BIOL MACROMOL, V40, P498, DOI 10.1016/j.ijbiomac.2006.11.009	44	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91524	10.1371/journal.pone.0091524	http://dx.doi.org/10.1371/journal.pone.0091524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637565	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100040
J	Qin, Y; Fu, MY; Takahashi, M; Iwanami, A; Kuga, D; Rao, RG; Sudhakar, D; Huang, T; Kiyohara, M; Torres, K; Dillard, C; Inagaki, A; Kasahara, N; Goodglick, L; Braun, J; Mischel, PS; Gordon, LK; Wadehra, M				Qin, Yu; Fu, Maoyong; Takahashi, Masamichi; Iwanami, Akio; Kuga, Daisuke; Rao, Rajiv G.; Sudhakar, Deepthi; Huang, Tiffany; Kiyohara, Meagan; Torres, Kathleen; Dillard, Christen; Inagaki, Akihito; Kasahara, Noriyuki; Goodglick, Lee; Braun, Jonathan; Mischel, Paul S.; Gordon, Lynn K.; Wadehra, Madhuri			Epithelial Membrane Protein-2 ( EMP2) Activates Src Protein and Is a Novel Therapeutic Target for Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Glioblastoma; Immunotherapy; Tetraspanins; Tumor Marker; EMP2	ALPHA-V-BETA-3 INTEGRIN; MOLECULAR DETERMINANTS; IN-VITRO; CANCER; EXPRESSION; GROWTH; CELLS; ANTIBODY; ANGIOGENESIS; VITRONECTIN	Background: EMP2 is a tetraspan protein linked with aggressive disease. Results: EMP2 correlates with activated Src in patients with GBM. Using intracranial mouse models, EMP2 promotes tumor cell invasiveness. Antibodies to EMP2 reduce GBM tumor load. Conclusion: EMP2 is a novel therapeutic target in GBM. Significance: The clinical outcome for patients with GBM remains poor, and thus new targeted therapies are needed. Despite recent advances in molecular classification, surgery, radiotherapy, and targeted therapies, the clinical outcome of patients with malignant brain tumors remains extremely poor. In this study, we have identified the tetraspan protein epithelial membrane protein-2 (EMP2) as a potential target for glioblastoma (GBM) killing. EMP2 had low or undetectable expression in normal brain but was highly expressed in GBM as 95% of patients showed some expression of the protein. In GBM cells, EMP2 enhanced tumor growth in vivo in part by up-regulating v3 integrin surface expression, activating focal adhesion kinase and Src kinases, and promoting cell migration and invasion. Consistent with these findings, EMP2 expression significantly correlated with activated Src kinase in patient samples and promoted tumor cell invasion using intracranial mouse models. As a proof of principle to determine whether EMP2 could serve as a target for therapy, cells were treated using specific anti-EMP2 antibody reagents. These reagents were effective in killing GBM cells in vitro and in reducing tumor load in subcutaneous mouse models. These results support the role of EMP2 in the pathogenesis of GBM and suggest that anti-EMP2 treatment may be a novel therapeutic treatment.	[Qin, Yu; Gordon, Lynn K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Fu, Maoyong; Iwanami, Akio; Kuga, Daisuke; Rao, Rajiv G.; Sudhakar, Deepthi; Huang, Tiffany; Kiyohara, Meagan; Torres, Kathleen; Dillard, Christen; Goodglick, Lee; Braun, Jonathan; Wadehra, Madhuri] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Goodglick, Lee; Braun, Jonathan; Wadehra, Madhuri] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Takahashi, Masamichi; Inagaki, Akihito; Kasahara, Noriyuki] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Mischel, Paul S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Wadehra, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Box 951732,675 Charles Young Dr South, Los Angeles, CA 90095 USA.	mwadehra@mednet.ucla.edu	Takahashi, Masamichi/GRJ-2866-2022	Kasahara, Noriyuki/0000-0002-6069-9082; Braun, Jonathan/0000-0003-1646-2974; Takahashi, Masamichi/0000-0001-8792-1993	National Institutes of Health from NCI Early Detection Research Network [CA-86366, R01 CA163971, CA 143931CDU/UCLA, P30 CA016042]; CFAR [5P30 AI028697]; Stein Oppenheimer seed grant; NATIONAL CANCER INSTITUTE [U54CA143931, P30CA016042, U24CA086366, R01CA163971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health from NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; Stein Oppenheimer seed grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-86366 from NCI Early Detection Research Network (to L. G.), R01 CA163971 (to M. W.), CA 143931CDU/UCLA Cancer Center Partnership U54 (to M. W.), Grant P30 CA016042 to Jonsson Comprehensive Cancer Center, and Grant 5P30 AI028697 from CFAR. This work was also supported by a Stein Oppenheimer seed grant (to L. G.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Agus DB, 1999, CANCER RES, V59, P4761; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Buonerba C, 2011, CRIT REV ONCOL HEMAT, V80, P54, DOI 10.1016/j.critrevonc.2010.09.001; Chang MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037935; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; de Groot J, 2009, J NEURO-ONCOL, V95, P151, DOI 10.1007/s11060-009-9916-2; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Frank RT, 2011, BBA-REV CANCER, V1816, P191, DOI 10.1016/j.bbcan.2011.07.002; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fu M, 2014, MOL CANCER THER, V13, P902, DOI 10.1158/1535-7163.MCT-13-0199; Fu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019945; Fu MY, 2010, CLIN CANCER RES, V16, P3954, DOI 10.1158/1078-0432.CCR-10-0368; Fukai J, 2008, CANCER SCI, V99, P2062, DOI 10.1111/j.1349-7006.2008.00945.x; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Gordon LK, 2013, ONCOGENE, V32, P5369, DOI 10.1038/onc.2012.622; Habeeb O, 2010, CANCER-AM CANCER SOC, V116, P4718, DOI 10.1002/cncr.25259; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang TT, 2013, CANCER GENE THER, V20, P544, DOI 10.1038/cgt.2013.51; JIAO Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0041591; Kanamori M, 2006, J BIOL CHEM, V281, P37256, DOI 10.1074/jbc.M605344200; Kawaguchi T, 2006, CANCER RES, V66, P11331, DOI 10.1158/0008-5472.CAN-06-1540; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerr JS, 2000, EXPERT OPIN INV DRUG, V9, P1271, DOI 10.1517/13543784.9.6.1271; Kim K, 2008, MOL CANCER RES, V6, P426, DOI 10.1158/1541-7786.MCR-07-0313; Lorger M., 2012, INTEGRIN SIGNALING A, P311; McEarchern JA, 2007, BLOOD, V109, P1185, DOI 10.1182/blood-2006-07-034017; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morales SA, 2009, INVEST OPHTH VIS SCI, V50, P462, DOI 10.1167/iovs.07-1598; Petras Miklos, 2009, Magy Onkol, V53, P253, DOI 10.1556/MOnkol.53.2009.3.3; Rolle CE, 2010, NEUROSURG CLIN N AM, V21, P201, DOI 10.1016/j.nec.2009.08.002; Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9; Shimazaki K, 2008, CLIN CANCER RES, V14, P7367, DOI 10.1158/1078-0432.CCR-08-1016; Teodorczyk M, 2010, J CELL PHYSIOL, V222, P1, DOI 10.1002/jcp.21901; Wadehra M, 2006, DEV BIOL, V292, P430, DOI 10.1016/j.ydbio.2006.01.015; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wadehra M, 2003, EXP MOL PATHOL, V74, P106, DOI 10.1016/S0014-4800(03)00009-1; Wadehra M, 2002, J BIOL CHEM, V277, P41094, DOI 10.1074/jbc.M206868200; Wadehra M, 2006, CANCER-AM CANCER SOC, V107, P90, DOI 10.1002/cncr.21957; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Wang WJ, 2005, J NEUROSURG, V103, P1058, DOI 10.3171/jns.2005.103.6.1058; Wang YL, 2004, ONCOGENE, V23, P1283, DOI 10.1038/sj.onc.1207244; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482	51	20	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13974	13985		10.1074/jbc.M113.543728	http://dx.doi.org/10.1074/jbc.M113.543728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24644285	hybrid, Green Published			2022-12-25	WOS:000335984600028
J	Rappe, U; Schlechter, T; Aschoff, M; Hotz-Wagenblatt, A; Hofmann, I				Rappe, Ulrike; Schlechter, Tanja; Aschoff, Moritz; Hotz-Wagenblatt, Agnes; Hofmann, Ilse			Nuclear ARVCF Protein Binds Splicing Factors and Contributes to the Regulation of Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adherens Junction; Alternative Splicing; Catenin; Cell Junctions; Molecular Cell Biology; Ribonuclear Protein (RNP); Post-transcriptional Gene Expression Regulation; Arm Repeat Protein	EXPANDED CUG REPEATS; CELL-CELL ADHESION; MESSENGER-RNA; PLAQUE PROTEIN; CYTOPLASMIC PARTICLES; EPITHELIAL-CELLS; LIGHT-CHAINS; CATENIN; EXPRESSION; GENE	Background: ARVCF occurs both at adherens junctions and in the nucleus, but little is known about its nuclear function. Results: ARVCF interacts with RNA-binding proteins involved in splicing and contributes to alternative splicing of specific transcripts. Conclusion: ARVCF influences splicing of specific pre-mRNAs. Significance: We propose a new role of nuclear ARVCF in post-transcriptional regulation of gene expression. The armadillo repeat protein ARVCF is a component of adherens junctions. Similar to related proteins, such as p120-catenin and -catenin, with known signaling functions, localization studies indicate a cytoplasmic and a nuclear pool of ARVCF. We find that ARVCF interacts with different proteins involved in mRNA-processing: the splicing factor SRSF1 (SF2/ASF), the RNA helicase p68 (DDX5), and the heterogeneous nuclear ribonucleoprotein hnRNP H2. All three proteins bind to ARVCF in an RNA-independent manner. Furthermore, ARVCF occurs in large RNA-containing complexes that contain both spliced and unspliced mRNAs of housekeeping genes. By domain analysis, we show that interactions occur via the ARVCF C terminus. Overexpression of ARVCF, p68, SRSF1, and hnRNP H2 induces a significant increase in splicing activity of a reporter mRNA. Upon depletion of ARVCF followed by RNA sequence analysis, several alternatively spliced transcripts are significantly changed. Therefore, we conclude that nuclear ARVCF influences splicing of pre-mRNAs. We hypothesize that ARVCF is involved in alternative splicing, generating proteomic diversity, and its deregulation may contribute to diseased states, such as cancer and neurological disorders.	[Rappe, Ulrike; Schlechter, Tanja; Hofmann, Ilse] DKFZ ZMBH Alliance, German Canc Res Ctr, Div Vasc Oncol & Metastasis, D-69120 Heidelberg, Germany; [Rappe, Ulrike; Schlechter, Tanja; Hofmann, Ilse] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Aschoff, Moritz; Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Genom Prote Core Facil, Bioinformat HUSAR, D-69120 Heidelberg, Germany; [Aschoff, Moritz] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hofmann, I (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr, Div Vasc Oncol & Metastasis, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	i.hofmann@dkfz.de			German Cancer Aid [108978]	German Cancer Aid(Deutsche Krebshilfe)	This work was supported by Grant 108978 from the German Cancer Aid (to I. H.).	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Cho K, 2010, J CELL SCI, V123, P4128, DOI 10.1242/jcs.072041; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hofmann I, 2002, MOL BIOL CELL, V13, P1665, DOI 10.1091/mbc.01-12-0567; Hofmann I, 2008, CELL TISSUE RES, V334, P381, DOI 10.1007/s00441-008-0725-2; HONORE B, 1995, J BIOL CHEM, V270, P28780; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Kaufmann U, 2000, J CELL SCI, V113, P4121; Kausalya PJ, 2004, MOL BIOL CELL, V15, P5503, DOI 10.1091/mbc.E04-04-0350; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Laurent FX, 2012, NUCLEIC ACIDS RES, V40, P3159, DOI 10.1093/nar/gkr1228; LENZ S, 1989, J BIOL CHEM, V264, P9009; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; LIEW CC, 1989, FEBS LETT, V248, P101, DOI 10.1016/0014-5793(89)80440-5; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Mariner DJ, 2000, J CELL SCI, V113, P1481; Mas S, 2010, AM J MED GENET B, V153B, P1052, DOI 10.1002/ajmg.b.31073; Mas S, 2009, PROG NEURO-PSYCHOPH, V33, P1064, DOI 10.1016/j.pnpbp.2009.06.001; Maynard TM, 2003, P NATL ACAD SCI USA, V100, P14433, DOI 10.1073/pnas.2235651100; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mohr K, 2012, METHODS MOL BIOL, V812, P89, DOI 10.1007/978-1-61779-455-1_5; Morikawa T, 2010, NEUROCHEM INT, V57, P691, DOI 10.1016/j.neuint.2010.08.012; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; Paul S, 2011, J BIOL CHEM, V286, P38427, DOI 10.1074/jbc.M111.255224; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P1669, DOI 10.2741/4012; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rajan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029088; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Sirotkin H, 1997, GENOMICS, V41, P75, DOI 10.1006/geno.1997.4627; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Stenzel N, 2009, J CELL SCI, V122, P3374, DOI 10.1242/jcs.046854; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Waibler Z, 2001, J CELL SCI, V114, P3873; Walter B, 2008, HISTOCHEM CELL BIOL, V130, P943, DOI 10.1007/s00418-008-0456-1; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2013, NAT STRUCT MOL BIOL, V20, P36, DOI 10.1038/nsmb.2459; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; Yang C, 2013, VIRCHOWS ARCH, V463, P379, DOI 10.1007/s00428-013-1452-y; Zhang PX, 2011, INT J ONCOL, V38, P1625, DOI 10.3892/ijo.2011.995	72	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12421	12434		10.1074/jbc.M113.530717	http://dx.doi.org/10.1074/jbc.M113.530717			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644279	Green Published, hybrid			2022-12-25	WOS:000335581400019
J	VanderLaan, DP; Blanchard, R; Wood, H; Zucker, KJ				VanderLaan, Doug P.; Blanchard, Ray; Wood, Hayley; Zucker, Kenneth J.			Birth Order and Sibling Sex Ratio of Children and Adolescents Referred to a Gender Identity Service	PLOS ONE			English	Article							OLDER BROTHERS; ORIENTATION; HOMOSEXUALITY; MEN; PREGNANCY; DNA; MICROCHIMERISM; PROPORTION; WEIGHT; PLASMA	In adult male samples, homosexuality is associated with a preponderance of older brothers (i.e., the fraternal birth order effect). In several studies comparing gender dysphoric youth, who are likely to be homosexual in adulthood, to clinical or non-clinical control groups, the findings have been consistent with the fraternal birth order effect in males; however, less is known about unique sibship characteristics of gender dysphoric females. The current study investigated birth order and sibling sex ratio in a large sample of children and adolescents referred to the same Gender Identity Service (N = 768). Probands were classified as heterosexual males, homosexual males, or homosexual females based on clinical diagnostic information. Groups differed significantly in age and sibship size, and homosexual females were significantly more likely to be only children. Subsequent analyses controlled for age and for sibship size. Compared to heterosexual males, homosexual males had a significant preponderance of older brothers and homosexual females had a significant preponderance of older sisters. Similarly, the older sibling sex ratio of homosexual males showed a significant excess of brothers whereas that of homosexual females showed a significant excess of sisters. Like previous studies of gender dysphoric youth and adults, these findings were consistent with the fraternal birth order effect. In addition, the greater frequency of only children and elevated numbers of older sisters among the homosexual female group adds to a small literature on sibship characteristics of potential relevance to the development of gender identity and sexual orientation in females.	[VanderLaan, Doug P.; Wood, Hayley; Zucker, Kenneth J.] Ctr Addict & Mental Hlth, Gender Ident Serv, Toronto, ON, Canada; [Blanchard, Ray; Zucker, Kenneth J.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Zucker, KJ (corresponding author), Ctr Addict & Mental Hlth, Gender Ident Serv, Toronto, ON, Canada.	ken.zucker@camh.ca			Canadian Institutes of Health Research Postdoctoral Fellowship	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR))	The first author was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Bearman PS, 2002, AM J SOCIOL, V107, P1179, DOI 10.1086/341906; Bianchi DW, 2001, ANN NY ACAD SCI, V945, P119; Blanchard R, 1996, ARCH SEX BEHAV, V25, P495, DOI 10.1007/BF02437544; BLANCHARD R, 1995, DEV PSYCHOL, V31, P22, DOI 10.1037/0012-1649.31.1.22; BLANCHARD R, 1992, J NERV MENT DIS, V180, P40, DOI 10.1097/00005053-199201000-00009; Blanchard R, 2004, AM J HUM BIOL, V16, P151, DOI 10.1002/ajhb.20006; Blanchard R, 1997, Annu Rev Sex Res, V8, P27; Blanchard R, 1996, AM J PSYCHIAT, V153, P27; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Blanchard R, 1997, J THEOR BIOL, V185, P373, DOI 10.1006/jtbi.1996.0315; Blanchard R, 2002, HORM BEHAV, V41, P321, DOI 10.1006/hbeh.2002.1765; Blanchard R, 2001, J BIOSOC SCI, V33, P451, DOI 10.1017/S0021932001004515; Blanchard R, 2008, ARCH SEX BEHAV, V37, P970, DOI 10.1007/s10508-006-9107-6; Blanchard R, 2008, LATERALITY, V13, P51, DOI 10.1080/13576500701710432; Blanchard R, 2014, ARCH SEX BEHAV, V43, P845, DOI 10.1007/s10508-013-0245-3; Blanchard R, 2012, ARCH SEX BEHAV, V41, P1507, DOI 10.1007/s10508-011-9896-0; Bogaert AF, 1997, BEHAV NEUROSCI, V111, P1395, DOI 10.1037/0735-7044.111.6.1395; Bogaert AF, 2003, J PERS SOC PSYCHOL, V84, P644, DOI 10.1037/0022-3514.84.3.644; Bogaert AF, 2006, P NATL ACAD SCI USA, V103, P10771, DOI 10.1073/pnas.0511152103; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; Drummond KD, 2008, DEV PSYCHOL, V44, P34, DOI 10.1037/0012-1649.44.1.34; Ellis L, 2001, PERS INDIV DIFFER, V30, P543, DOI 10.1016/S0191-8869(00)00051-9; Francis AM, 2008, J SEX RES, V45, P371, DOI 10.1080/00224490802398357; Gomez-Gil E, 2011, ARCH SEX BEHAV, V40, P505, DOI 10.1007/s10508-010-9614-3; Green R, 2000, PSYCHOL MED, V30, P789, DOI 10.1017/S0033291799001932; Green R, 1987, SISSY BOY SYNDROME D; JAMES WH, 1987, HUM BIOL, V59, P721; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Lambert NC, 2001, ANN NY ACAD SCI, V945, P164; LANG T, 1960, Acta Genet Med Gemellol (Roma), V9, P370; Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9; Pertl B, 2001, OBSTET GYNECOL, V98, P483, DOI 10.1016/S0029-7844(01)01195-4; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Poasa KH, 2004, J SEX MARITAL THER, V30, P13, DOI 10.1080/00926230490247110; Schagen SEE, 2012, ARCH SEX BEHAV, V41, P541, DOI 10.1007/s10508-011-9777-6; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; Singh D, 2012, FOLLOW UP STUDY BOYS; Steensma T. D., 2013, THESIS VRIJE U AMSTE; TSOI WF, 1977, BRIT J PSYCHIAT, V131, P405, DOI 10.1192/bjp.131.4.405; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Wallien MSC, 2008, J AM ACAD CHILD PSY, V47, P1413, DOI 10.1097/CHI.0b013e31818956b9; Wood H, 2013, J SEX MARITAL THER, V39, P1, DOI 10.1080/0092623X.2012.675022; Zucker KJ, 2007, PSYCHIAT CLIN NEUROS, V61, P529, DOI 10.1111/j.1440-1819.2007.01703.x; Zucker KJ, 2012, J SEX MARITAL THER, V38, P151, DOI 10.1080/0092623X.2011.611219; Zucker KJ, 2003, J SEX MARITAL THER, V29, P251, DOI 10.1080/00926230390195489; Zucker KJ, 1998, EUR CHILD ADOLES PSY, V7, P30, DOI 10.1007/s007870050042; Zucker KJ, 1997, J CHILD PSYCHOL PSYC, V38, P543, DOI 10.1111/j.1469-7610.1997.tb01541.x	52	25	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90257	10.1371/journal.pone.0090257	http://dx.doi.org/10.1371/journal.pone.0090257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651045	gold, Green Published, Green Submitted			2022-12-25	WOS:000333352800013
J	Beltran-Garcia, MJ; Prado, FM; Oliveira, MS; Ortiz-Mendoza, D; Scalfo, AC; Pessoa, A; Medeiros, MHG; White, JF; Di Mascio, P				Beltran-Garcia, Miguel J.; Prado, Fernanda M.; Oliveira, Marilene S.; Ortiz-Mendoza, David; Scalfo, Alexsandra C.; Pessoa, Adalberto, Jr.; Medeiros, Marisa H. G.; White, James F.; Di Mascio, Paolo			Singlet Molecular Oxygen Generation by Light-Activated DHN-Melanin of the Fungal Pathogen Mycosphaerella fijiensis in Black Sigatoka Disease of Bananas	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CELLULAR-DNA; MELANIZATION; BIOSYNTHESIS; APPRESSORIA; MECHANISMS; EUMELANIN; OXIDATION; RADICALS; SHUTTLE	In pathogenic fungi, melanin contributes to virulence, allowing tissue invasion and inactivation of the plant defence system, but has never been implicated as a factor for host cell death, or as a light-activated phytotoxin. Our research shows that melanin synthesized by the fungal banana pathogen Mycosphaerella fijiensis acts as a virulence factor through the photogeneration of singlet molecular oxygen O-2 ((1)Delta(g)). Using analytical tools, including elemental analysis, ultraviolet/infrared absorption spectrophometry and MALDI-TOF mass spectrometry analysis, we characterized both pigment content in mycelia and secreted to the culture media as 1,8-dihydroxynaphthalene (DHN)-melanin type compound. This is sole melanin-type in M. fijiensis. Isolated melanins irradiated with a Nd:YAG laser at 532 nm produced monomol light emission at 1270 nm, confirming generation of O-2 ((1)Delta(g)), a highly reactive oxygen specie (ROS) that causes cellular death by reacting with all cellular macromolecules. Intermediary polyketides accumulated in culture media by using tricyclazole and pyroquilon (two inhibitors of DHN-melanin synthesis) were identified by ESI-HPLC-MS/MS. Additionally, irradiation at 532 nm of that mixture of compounds and whole melanized mycelium also generated O-2 ((1)Delta(g)). A pigmented-strain generated more O-2 ((1)Delta(g)) than a strain with low melanin content. Banana leaves of cultivar Cavendish, naturally infected with different stages of black Sigatoka disease, were collected from field. Direct staining of the naturally infected leaf tissues showed the presence of melanin that was positively correlated to the disease stage. We also found hydrogen peroxide (H2O2) but we cannot distinguish the source. Our results suggest that O-2 ((1)Delta(g)) photogenerated by DHN-melanin may be involved in the destructive effects of Mycosphaerella fijiensis on banana leaf tissues. Further studies are needed to fully evaluate contributions of melanin-mediated ROS to microbial pathogenesis.	[Beltran-Garcia, Miguel J.] Univ Autonoma Guadalajara, Dept Quim ICET, Zapopan, Jalisco, Mexico; [Beltran-Garcia, Miguel J.; Prado, Fernanda M.; Oliveira, Marilene S.; Scalfo, Alexsandra C.; Medeiros, Marisa H. G.; Di Mascio, Paolo] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Ortiz-Mendoza, David] Univ Autonoma Baja California, Inst Ingn, Mexicali 21100, Baja California, Mexico; [Pessoa, Adalberto, Jr.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil; [White, James F.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Universidad Autonoma de Guadalajara; Universidade de Sao Paulo; Universidad Autonoma de Baja California; Universidade de Sao Paulo; Rutgers State University New Brunswick	Beltran-Garcia, MJ (corresponding author), Univ Autonoma Guadalajara, Dept Quim ICET, Zapopan, Jalisco, Mexico.	jbeltran@uag.mx; pdmascio@iq.usp.br	Beltran, Miguel/GPX-3786-2022; Pessoa, Adalberto/B-7963-2012; Medeiros, Marisa Helena Gennari de/A-5212-2008	White, James/0000-0002-6780-7066; Pessoa, Adalberto/0000-0002-5268-8690; Medeiros, Marisa Helena Gennari de/0000-0002-5438-1174	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Proc. 2006/56530-4, Pr. 2012/12663-1]; CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); PRONEX/FINEP (Programa de Apoio aos Nucleos de Excelencia); PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo); Instituto do Milenio-Redoxoma [Proc. 420011/2005-6]; INCT Redoxoma (FAPESP/CNPq/CAPES) [Proc. 573530/2008-4]; NAP Redoxoma (PRPUSP) [Proc. 2011.1.9352.1.8]; CEPID Redoxoma (FAPESP) [Proc. 2013/07937-8]; John Simon Guggenheim Memorial Foundation; CONACYT [SEP-CB-79626, 217649]; National Council of Science and Technology (CONACYT) of Mexico [186241]; Program of Estancias Sabaticas y Posdoctorales al Extranjero para la Consolidacion de Grupos de Investigacion [186241]; John E. and Christina C. Craighead Foundation; United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [W3147]; New Jersey Agricultural Experiment Station	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX/FINEP (Programa de Apoio aos Nucleos de Excelencia); PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo); Instituto do Milenio-Redoxoma; INCT Redoxoma (FAPESP/CNPq/CAPES); NAP Redoxoma (PRPUSP); CEPID Redoxoma (FAPESP); John Simon Guggenheim Memorial Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Science and Technology (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Program of Estancias Sabaticas y Posdoctorales al Extranjero para la Consolidacion de Grupos de Investigacion; John E. and Christina C. Craighead Foundation; United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); New Jersey Agricultural Experiment Station	The authors acknowledge the Brazilian research funding institutions FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Proc. 2006/56530-4 and Pr. 2012/12663-1), CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), PRONEX/FINEP (Programa de Apoio aos Nucleos de Excelencia), PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo), Instituto do Milenio-Redoxoma (Proc. 420011/2005-6), INCT Redoxoma (FAPESP/CNPq/CAPES; Proc. 573530/2008-4), NAP Redoxoma (PRPUSP; Proc. 2011.1.9352.1.8), CEPID Redoxoma (FAPESP; Proc. 2013/07937-8) and John Simon Guggenheim Memorial Foundation (PDM Fellowship). MJB-G thanks CONACYT for Grant SEP-CB-79626 and National Council of Science and Technology (CONACYT) of Mexico and the Program of Estancias Sabaticas y Posdoctorales al Extranjero para la Consolidacion de Grupos de Investigacion awarded with the Fellowship number 186241. DO-M thanks CONACYT fellowship # 217649 for his PhD studies. JFW thanks funding support from the John E. and Christina C. Craighead Foundation, United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Multistate Project W3147, and the New Jersey Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Loayza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016386; Arzanlou M, 2007, PHYTOPATHOLOGY, V97, P1112, DOI 10.1094/PHYTO-97-9-1112; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Beltran-Garcia MJ, 2009, CAN J MICROBIOL, V55, P887, DOI [10.1139/w09-023, 10.1139/W09-023]; Busogoro JP, 2004, BANANA IMPROVEMENT: CELLULAR, MOLECULAR BIOLOGY, AND INDUCED MUTATIONS, P161; Butler MJ, 2005, MYCOLOGIA, V97, P312, DOI 10.3852/mycologia.97.2.312; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; Chiarelli-Neto O, 2011, FREE RADICAL BIO MED, V51, P1195, DOI 10.1016/j.freeradbiomed.2011.06.013; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Daub ME, 2000, ANNU REV PHYTOPATHOL, V38, P461, DOI 10.1146/annurev.phyto.38.1.461; de Lucas NC, 2012, PHOTOCH PHOTOBIO SCI, V11, P1201, DOI 10.1039/c2pp05412d; DI MASCIO P, 1990, PHOTOCHEM PHOTOBIOL, V51, P293; Donzelli BGG, 2007, PHYTOPATHOLOGY, V97, P916, DOI 10.1094/PHYTO-97-8-0916; Edens WA, 1999, APPL ENVIRON MICROB, V65, P3071; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; El Hadrami A, 2005, EUR J PLANT PATHOL, V113, P241, DOI 10.1007/s10658-005-8675-y; Foure E., 1987, ACIAR Proceedings Series, Australian Centre for International Agricultural Research, P110; Frederick BA, 1999, MYCOL RES, V103, P99, DOI 10.1017/S0953756298006959; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Gomez-Gutierrez A., 2012, THESIS U AUTONOMA GU; Gomez-Marin AM, 2010, J NON-CRYST SOLIDS, V356, P1576, DOI 10.1016/j.jnoncrysol.2010.05.054; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; Gutierrez I, 1997, CAN J CHEM, V75, P423, DOI 10.1139/v97-048; Henson JM, 1999, ANNU REV PHYTOPATHOL, V37, P447, DOI 10.1146/annurev.phyto.37.1.447; Hoss R, 2000, J PHYTOPATHOL, V148, P387, DOI 10.1046/j.1439-0434.2000.00530.x; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Kogej T, 2004, FEMS MICROBIOL LETT, V232, P203, DOI 10.1016/S0378-1097(04)00073-4; KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x; Krol ES, 1998, CHEM RES TOXICOL, V11, P1434, DOI 10.1021/tx980114c; KUBO Y, 1991, MOL PLANT MICROBE IN, V4, P440, DOI 10.1094/MPMI-4-440; Kunwar A, 2012, TOXICOL APPL PHARM, V264, P202, DOI 10.1016/j.taap.2012.08.002; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Llorente C, 2012, MYCOPATHOLOGIA, V174, P397, DOI 10.1007/s11046-012-9558-3; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Netto-Ferreira JC, 2008, PHYS CHEM CHEM PHYS, V10, P6645, DOI 10.1039/b810413a; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosfinger JB, 2002, BIOPOLYMERS, V67, P302; PAIM S, 1990, BIOL FERT SOILS, V10, P72; Ravanat JL, 2004, BIOL CHEM, V385, P17, DOI 10.1515/BC.2004.003; Rizner TL, 2003, CAN J MICROBIOL, V49, P110, DOI [10.1139/W03-016, 10.1139/w03-016]; Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g; Seagle BLL, 2005, J AM CHEM SOC, V127, P11220, DOI 10.1021/ja052773z; SENESI N, 1987, BIOL FERT SOILS, V5, P120, DOI 10.1007/BF00257646; Steiner U, 2007, PHYTOPATHOLOGY, V97, P1222, DOI 10.1094/PHYTO-97-10-1222; STIERLE AA, 1991, EXPERIENTIA, V47, P853, DOI 10.1007/BF01922472; Suzukawa AA, 2012, FREE RADICAL BIO MED, V52, P1945, DOI 10.1016/j.freeradbiomed.2012.02.039; Tada M, 2010, J CLIN BIOCHEM NUTR, V46, P224, DOI 10.3164/jcbn.09-84; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Turick CE, 2002, APPL ENVIRON MICROB, V68, P2436, DOI 10.1128/AEM.68.5.2436-2444.2002; Turick CE, 2009, FEMS MICROBIOL ECOL, V68, P223, DOI 10.1111/j.1574-6941.2009.00670.x; Wang A, 2008, PHOTOCHEM PHOTOBIOL, V84, P679, DOI 10.1111/j.1751-1097.2008.00353.x; Ye M, 2011, ADV MATER RES-SWITZ, V284-286, P1742, DOI 10.4028/www.scientific.net/AMR.284-286.1742	59	49	52	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91616	10.1371/journal.pone.0091616	http://dx.doi.org/10.1371/journal.pone.0091616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646830	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500042
J	Frontzek, K; Fluri, F; Siemerkus, J; Muller, B; Gass, A; Christ-Crain, M; Katan, M				Frontzek, Karl; Fluri, Felix; Siemerkus, Jakob; Mueller, Beat; Gass, Achim; Christ-Crain, Mirjam; Katan, Mira			Isolated Insular Strokes and Plasma MR-proANP Levels Are Associated with Newly Diagnosed Atrial Fibrillation: A Pilot Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PROATRIAL NATRIURETIC PEPTIDE; INVOLVEMENT; PREVENTION; PREDICTOR; CORTEX; VOLUME; RISK	Introduction: In this study, we assessed the relationship of insular strokes and plasma MR-proANP levels with newly diagnosed atrial fibrillation (NDAF). Methods: This study is based on a prospective acute stroke cohort (http://www.clinicaltrials.gov, NCT00390962). Patient eligibility was dependent on the diagnosis of acute ischemic stroke, absence of previous stroke based on past medical history and MRI, no history of AF and congestive heart failure (cohort A) and, additionally, no stroke lesion size >= 20 mL (sub-cohort A*). AF, the primary endpoint, was detected on 24-hour electrocardiography and/or echocardiography. Involvement of the insula was assessed by two experienced readers on MRI blinded to clinical data. MR-proANP levels were obtained through a novel sandwich immunoassay. Logistic-regression-models were fitted to estimate odds ratios for the association of insular strokes and MR-proANP with NDAF. The discriminatory accuracy of insular strokes and MR-proANP was assessed by a model-wise comparison of the area under the receiver-operating-characteristics-curve (AUC) with known predictors of AF. Results: 104 (cohort A) and 83 (cohort A*) patients fulfilled above-mentioned criteria. Patients with isolated insular strokes had a 10.7-fold higher odds of NDAF than patients with a small ischemic stroke at any other location. The AUC of multivariate logistic regression models for the prediction of NDAF improved significantly when adding stroke location and MR-proANP levels. Moreover, MR-proANP levels remained significantly elevated throughout the acute hospitalization period in patients with NDAF compared to those without. Conclusions: Isolated insular strokes and plasma MR-proANP levels on admission are independent predictors of NDAF and significantly improve the prediction accuracy of identifying patients with NDAF compared to known predictors including age, the NIHSS and lesion size. To accelerate accurate diagnosis and enhance secondary prevention in acute stroke, higher levels of MR-proANP and insular strokes may represent easily accessible indicators of AF if confirmed in an independent validation cohort.	[Frontzek, Karl] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Frontzek, Karl; Fluri, Felix] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Fluri, Felix; Katan, Mira] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Siemerkus, Jakob] Univ Hosp Psychiat, Zurich, Switzerland; [Mueller, Beat] Cantonal Hosp Aarau, Med Univ Clin, Aarau, Switzerland; [Gass, Achim] Univ Hosp Mannheim, Dept Neurol, Mannheim, Germany; [Christ-Crain, Mirjam] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); Ruprecht Karls University Heidelberg; University of Basel	Katan, M (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	mira.katan@usz.ch	Mueller, Beat/G-2662-2012	Katan, Mira/0000-0002-9265-8066; Frontzek, Karl/0000-0002-0945-8857; Christ-Crain, Mirjam/0000-0002-6336-0965	Swiss National Science Foundation [PBZHP3-130982]; Fondation Leducq	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Leducq(Leducq Foundation)	This work was supported by the Swiss National Science Foundation (PBZHP3-130982 [M.Katan]) as well as the Fondation Leducq (M.Katan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ala-Kopsala M, 2004, CLIN CHEM, V50, P1576, DOI 10.1373/clinchem.2004.032490; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Butti C, 2010, BRAIN STRUCT FUNCT, V214, P477, DOI 10.1007/s00429-010-0264-y; Christensen H, 2005, J NEUROL NEUROSUR PS, V76, P269, DOI 10.1136/jnnp.2004.037531; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Cotter PE, 2013, NEUROLOGY, V80, P1546, DOI 10.1212/WNL.0b013e31828f1828; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Katan M, 2010, J AM COLL CARDIOL, V56, P1045, DOI 10.1016/j.jacc.2010.02.071; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kennedy DN, 2012, NEUROINFORMATICS, V10, P129, DOI 10.1007/s12021-011-9130-1; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Longstreth WT, 2013, STROKE, V44, P714, DOI 10.1161/STROKEAHA.112.675942; Menezes AR, 2013, MAYO CLIN PROC, V88, P394, DOI 10.1016/j.mayocp.2013.01.022; Meune C, 2011, CLIN BIOCHEM, V44, P1315, DOI 10.1016/j.clinbiochem.2011.08.906; Meyer S, 2004, NEUROREPORT, V15, P357, DOI 10.1097/00001756-200402090-00029; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Rossi A, 2000, J AM COLL CARDIOL, V35, P1256, DOI 10.1016/S0735-1097(00)00515-5; Shibazaki K, 2012, AM J CARDIOL, V109, P1303, DOI 10.1016/j.amjcard.2011.12.022; Taggart P, 2011, HEART, V97, P698, DOI 10.1136/hrt.2010.209304; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13	25	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92421	10.1371/journal.pone.0092421	http://dx.doi.org/10.1371/journal.pone.0092421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647802	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500128
J	Carey, AL; Vorlander, C; Reddy-Luthmoodoo, M; Natoli, AK; Formosa, MF; Bertovic, DA; Anderson, MJ; Duffy, SJ; Kingwell, BA				Carey, Andrew L.; Vorlander, Camilla; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; Formosa, Melissa F.; Bertovic, David A.; Anderson, Mitchell J.; Duffy, Stephen J.; Kingwell, Bronwyn A.			Reduced UCP-1 Content in In Vitro Differentiated Beige/Brite Adipocytes Derived from Preadipocytes of Human Subcutaneous White Adipose Tissues in Obesity	PLOS ONE			English	Article							BROWN FAT; ADULT HUMANS; MESSENGER-RNA; COLD-EXPOSURE; EXPRESSION; THERMOGENESIS; ADIPOGENESIS; METABOLISM; ACTIVATION; INCREASES	Introduction: Brown adipose tissue (BAT) is a potential therapeutic target to reverse obesity. The purpose of this study was to determine whether primary precursor cells isolated from human adult subcutaneous white adipose tissue (WAT) can be induced to differentiate in-vitro into adipocytes that express key markers of brown or beige adipose, and whether the expression level of such markers differs between lean and obese young adult males. Methods: Adipogenic precursor cells were isolated from lean and obese individuals from subcutaneous abdominal WAT biopsies. Cells were grown to confluence, differentiated for 2.5 weeks then harvested for measurement of gene expression and UCP1 protein. Results: There was no difference between groups with respect to differentiation into adipocytes, as indicated by oil red-O staining, rates of lipolysis, and expression of adipogenic genes (FABP4, PPARG). WAT genes (HOXC9, RB1) were expressed equally in the two groups. Post differentiation, the beige adipose specific genes CITED1 and CD137 were significantly increased in both groups, but classic BAT markers ZIC1 and LHX8 decreased significantly. Cell lines from both groups also equally increased post-differentiation expression of the thermogenic-responsive gene PPARGC1A (PGC-1 alpha). UCP1 gene expression was undetectable prior to differentiation, however after differentiation both gene expression and protein content were increased in both groups and were significantly greater in cultures from lean compared with obese individuals (p < 0.05). Conclusion: Human subcutaneous WAT cells can be induced to attain BAT characteristics, but this capacity is reduced in WAT cells from obese individuals.	[Carey, Andrew L.; Vorlander, Camilla; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; Formosa, Melissa F.; Bertovic, David A.; Anderson, Mitchell J.; Duffy, Stephen J.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [Duffy, Stephen J.; Kingwell, Bronwyn A.] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health	Carey, AL (corresponding author), Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia.	andrew.carey@bakeridi.edu.au	Kingwell, Bronwyn A/B-1183-2009	Formosa, Melissa Frances/0000-0002-9837-7476; Carey, Andrew/0000-0003-3452-1501; Anderson, Mitchell/0000-0003-1458-1689	National Health and Medical Research Council of Australia; Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	This study was supported by the National Health and Medical Research Council of Australia and the Operational Infrastructure Support (OIS) Scheme of the Victorian State Government. BAK is a Senior Research Fellow of the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondin DP, 2014, J CLIN ENDOCR METAB; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Camera DM, 2010, EUR J APPL PHYSIOL, V109, P307, DOI 10.1007/s00421-010-1356-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Carey AL, 2013, PHARMACOL THERAPEUT, V140, P26, DOI 10.1016/j.pharmthera.2013.05.009; Cinti S, 2009, AM J PHYSL ENDOCRINO; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Esposito F, 2009, J BIOL CHEM, V284, P25993, DOI 10.1074/jbc.M109.034280; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Frontini A, 2013, BIOCH BIOPHYS ACTA; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; HIMMSHAGEN J, 1979, CAN MED ASSOC J, V121, P1361; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jo SJ, 2011, LIPIDS, V46, P487, DOI 10.1007/s11745-011-3525-5; Kozak L. P., 2011, PROG MOL BIOL TRANSL, V94, P75; KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191; Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Oberkofler H, 1997, J LIPID RES, V38, P2125; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Orava J, 2013, OBESITY SILVER SPRIN; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Silva FJ, 2014, STEM CELLS, V32, P572, DOI 10.1002/stem.1595; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	50	57	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91997	10.1371/journal.pone.0091997	http://dx.doi.org/10.1371/journal.pone.0091997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642703	Green Published, gold			2022-12-25	WOS:000333259900056
J	Schule, SA; Clowes, P; Kroidl, I; Kowuor, DO; Nsojo, A; Mangu, C; Riess, H; Geldmacher, C; Laubender, RP; Mhina, S; Maboko, L; Loscher, T; Hoelscher, M; Saathoff, E				Schuele, Steffen Andreas; Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Nsojo, Anthony; Mangu, Chacha; Riess, Helene; Geldmacher, Christof; Laubender, Ruediger Paul; Mhina, Seif; Maboko, Leonard; Loescher, Thomas; Hoelscher, Michael; Saathoff, Elmar			Ascaris lumbricoides Infection and Its Relation to Environmental Factors in the Mbeya Region of Tanzania, a Cross-Sectional, Population-Based Study	PLOS ONE			English	Article							GEOGRAPHICAL INFORMATION-SYSTEMS; TRANSMITTED HELMINTH INFECTIONS; FRACTIONAL POLYNOMIALS; RISK-FACTORS; EPIDEMIOLOGY; TRICHURIS; VARIABLES; CHILDREN; MOISTURE; PROGRAM	Background: With one quarter of the world population infected, the intestinal nematode Ascaris lumbricoides is one of the most common infectious agents, especially in the tropics and sub-tropics. Infection is caused by oral intake of eggs and can cause respiratory and gastrointestinal problems. To identify high risk areas for intervention, it is necessary to understand the effects of climatic, environmental and socio-demographic conditions on A. lumbricoides infection. Methodology: Cross-sectional survey data of 6,366 study participants in the Mbeya region of South-Western Tanzania were used to analyze associations between remotely sensed environmental data and A. lumbricoides infection. Non-linear associations were accounted for by using fractional polynomial regression, and socio-demographic and sanitary data were included as potential confounders. Principal Findings: The overall prevalence of A. lumbricoides infection was 6.8%. Our final multivariable model revealed a significant non-linear association between rainfall and A. lumbricoides infection with peak prevalences at 1740 mm of mean annual rainfall. Mean annual land surface temperature during the day was linearly modeled and negatively associated with A. lumbricoides infection (odds ratio (OR) = 0.87, 95% confidence interval (CI) = 0.78-0.97). Furthermore, age, which also showed a significant non-linear association (infection maximum at 7.7 years), socio-economic status (OR = 0.82, CI = 0.68-0.97), and latrine coverage around the house (OR = 0.80, CI = 0.67-0.96) remained in the final model. Conclusions: A. lumbricoides infection was associated with environmental, socio-demographic and sanitary factors both in uni-and multivariable analysis. Non-linear analysis with fractional polynomials can improve model fit, resulting in a better understanding of the relationship between environmental conditions and helminth infection, and more precise predictions of high prevalence areas. However, socio-demographic determinants and sanitary conditions should also be considered, especially when planning public health interventions on a smaller scale, such as the community level.	[Schuele, Steffen Andreas; Kroidl, Inge; Riess, Helene; Geldmacher, Christof; Loescher, Thomas; Hoelscher, Michael; Saathoff, Elmar] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Schuele, Steffen Andreas; Riess, Helene; Laubender, Ruediger Paul] Univ Munich, Inst Med Bioinformat Biometry & Epidemiol, Munich, Germany; [Schuele, Steffen Andreas] Univ Bremen, Inst Publ Hlth & Nursing Res, Dept Social Epidemiol, D-28359 Bremen, Germany; [Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Nsojo, Anthony; Mangu, Chacha; Maboko, Leonard; Hoelscher, Michael] NIMR Mbeya Med Res Ctr MMRC, Mbeya, Tanzania; [Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] German Ctr Infect Res DZIF, Munich, Germany; [Mhina, Seif] Mbeya Reg Med Off, Mbeya, Tanzania	University of Munich; University of Munich; University of Bremen; German Center for Infection Research	Schule, SA (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.	steffenschuele@t-online.de	Löscher, Thomas/AAA-8399-2020; Hoelscher, Michael/D-3436-2012		European Commission [SANTE/2004/078-545/130, SANTE/2006/129-931]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The EMINI study was funded by the European Commission (SANTE/2004/078-545/130 & SANTE/2006/129-931). Helminth data collection was supported by the German Science foundation DFG (SA 1878/1-1) and the German Federal Ministry of Education and Research BMBF (01 KA 0904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin SAN, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P67; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083; Anderson RM, 1982, POPULATION DYNAMICS, P68; BEAVER PC, 1975, HEALTH LAB SCI, V12, P116; BEAVER PC, 1952, J PARASITOL, V38, P445, DOI 10.2307/3273923; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; Brooker S, 2004, EPIDEMIOL INFECT, V132, P1065, DOI 10.1017/S0950268804003024; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2002, PHOTOGRAMM ENG REM S, V68, P175; Brooker S., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P24; Brooker S, 2002, B WORLD HEALTH ORGAN, V80, P783; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Carneiro FF, 2002, B WORLD HEALTH ORGAN, V80, P40; Crompton D.W.T., 1985, P9; Crompton DWT, 2001, ADV PARASIT, V48, P285, DOI 10.1016/S0065-308X(01)48008-0; Crompton DWT, 2007, HDB HELMINTHIASISI P; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; deSilva NR, 1997, TROP MED INT HEALTH, V2, P189, DOI 10.1046/j.1365-3156.1997.d01-241.x; deSilva NR, 1997, TROP MED INT HEALTH, V2, P519; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Drake LJ., 2000, SEMIN PEDIAT INFECT, V11, P245, DOI [10.1053/spid.2000.9638, DOI 10.1053/SPID.2000.9638]; ELKINS DB, 1986, T ROY SOC TROP MED H, V80, P774, DOI 10.1016/0035-9203(86)90384-6; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FORRESTER JE, 1988, T ROY SOC TROP MED H, V82, P282, DOI 10.1016/0035-9203(88)90448-8; Gunawardena GSA, 2004, J HELMINTHOL, V78, P305, DOI 10.1079/JOH2004252; Harrell FE, 2001, REGRESSION MODELING, pxxii; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kan S. P., 1985, Ascariasis and its public health significance, P69; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Menard SW, 2002, APPL LOGISTIC REGRES, pviii; Montresor A., 1998, WORLD HLTH ORG; NASA Land Processes Distributed Active Archive Center (LP DAAC), 2001, 11A2 LA DAAC MODIS; NASA Land Processes Distributed Active Archive Center (LP DAAC), 2001, 13Q1 MODIS; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; Otto GF, 1929, AM J HYG, V10, P0497, DOI 10.1093/oxfordjournals.aje.a112765; Pisati M., 2001, STATA TECHNICAL B, V60, P21; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; Riess H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002408; Rogers WH, 1993, STATA TECHN B, V13, P19; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Royston P, 1997, J ROY STAT SOC D-STA, V46, P411; Royston P, 2008, MULTIVARIABLE MODEL, pxvii; Saathoff E, 2005, TROP MED INT HEALTH, V10, P412, DOI 10.1111/j.1365-3156.2005.01406.x; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott ME., 2008, ANN NESTLE, V66, P7, DOI DOI 10.1159/000113305; Spindler LA, 1929, AM J HYG, V10, P0476, DOI 10.1093/oxfordjournals.aje.a112764; Stephenson L. S., 1985, Ascariasis and its public health significance, P113; STOREY GW, 1985, PARASITOLOGY, V91, P585, DOI 10.1017/S003118200006282X; Tarafder MR, 2010, INT J PARASITOL, V40, P399, DOI 10.1016/j.ijpara.2009.09.003; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; TSHIKUKA JG, 1995, ANN TROP MED PARASIT, V89, P505, DOI 10.1080/00034983.1995.11812983; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001047; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; World Health Organization, 1991, BAS LAB METH MED PAR	67	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92032	10.1371/journal.pone.0092032	http://dx.doi.org/10.1371/journal.pone.0092032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643023	gold, Green Submitted, Green Published			2022-12-25	WOS:000333259900065
J	Wang, Y; Wang, LF; Zhang, JW; Wang, GX; Chen, WB; Chen, L; Zhang, XL				Wang, Ying; Wang, Lifang; Zhang, Jianwei; Wang, Guangxi; Chen, Wenbi; Chen, Lin; Zhang, Xilin			Preparation of Colloidal Gold Immunochromatographic Strip for Detection of Paragonimiasis skrjabini	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; ASSAY; CHINA; NANOPARTICLES; PERFORMANCE; WESTERMANI; PROTEINS; FEATURES; CAMEROON; SIZE	Background: Paragonimiasis is a food-borne trematodiasis, a serious public health issue and a neglected tropical disease. Paragonimus skrjabini is a unique species found in China. Unlike paragonimiasis westermani, it is nearly impossible to make a definitive diagnosis for paragonimiasis skrjabini by finding eggs in sputum or feces. Immunodiagnosis is the best choice to detect paragonimiasis skrjabini. There is an urgent need to develop a novel, rapid and simple immunoassay for large-scale screening patients in endemic areas. Methodology/Principal Findings: To develop a rapid, simple immunodiagnostic assay for paragonimiasis, rabbit antihuman IgG was conjugated to colloidal gold particles and used to detect antibodies in the sera of paragonimiasis patients. The synthesis and identification of colloidal gold particles and antibody-colloidal gold conjugates were performed. The size of colloidal gold particles was examined using a transmission electron microscope (TEM). The average diameter of colloidal gold particles was 17.46 nm with a range of 14.32-21.80 nm according to the TEM images. The formation of antibody-colloidal gold conjugates was monitored by UV/Vis spectroscopy. Excretory-secretory (ES) antigen of Paragonimus skrjabini was coated on nitrocellulose membrane as the capture line. Recombinant Staphylococcus protein A was used to prepare the control line. This rapid gold immunochromatographic strip was assembled in regular sequence through different accessories sticked on PVC board. The relative sensitivity and specificity of the strip was 94.4% (51/54) and 94.1% (32/34) respectively using ELISA as the standard method. Its stability and reproducibility were quite excellent after storage of the strip at 4 degrees C for 6 months. Conclusions/Significance: Immunochromatographic strip prepared in this study can be used in a rapid one-step immunochromatographic assay, which is instantaneous and convenient.	[Wang, Ying; Zhang, Xilin] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Wang, Lifang; Wang, Guangxi; Chen, Wenbi] Luzhou Med Coll, Dept Pathogen Biol, Luzhou, Sichuan, Peoples R China; [Zhang, Jianwei] Chengdu Med Coll, Dept Phys, Chengdu, Sichuan, Peoples R China; [Chen, Lin; Zhang, Xilin] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China	Army Medical University; Southwest Medical University; Chengdu Medical College; Army Medical University	Zhang, XL (corresponding author), Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China.	zhxljsc120@163.com		Wang, Ying/0000-0003-1368-6497	Natural Science Foundation of Chongqing (CSTC) [2007BB5055]; Military Pre-research Fund [2009XYY01]; Education Sciences Foundation of Sichuan [2005A067]; National Natural Science Foundation of China [30872366, 30371261]	Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Military Pre-research Fund; Education Sciences Foundation of Sichuan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of Chongqing (CSTC, 2007BB5055), the Military Pre-research Fund (No. 2009XYY01) and the Education Sciences Foundation of Sichuan (No. 2005A067). The author's laboratory was supported in part by grants from the National Natural Science Foundation of China (No. 30872366 and No. 30371261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzazy HME, 2009, CLIN CHIM ACTA, V403, P1, DOI 10.1016/j.cca.2009.01.016; Chai Jong-Yil, 2013, Handb Clin Neurol, V114, P283, DOI 10.1016/B978-0-444-53490-3.00023-6; Devi KR, 2007, T ROY SOC TROP MED H, V101, P786, DOI 10.1016/j.trstmh.2007.02.028; Doanh PN, 2009, PARASITOL RES, V104, P1149, DOI 10.1007/s00436-008-1302-z; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Jurgens L, 1999, CYTOMETRY, V37, P87; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kim YJ, 2010, J CLIN MICROBIOL, V48, P2365, DOI 10.1128/JCM.02506-09; Liu Q, 2008, TRENDS PARASITOL, V24, P318, DOI 10.1016/j.pt.2008.03.014; Lou S, 2012, ANALYST, V137, P1174, DOI 10.1039/c2an15844b; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Nkouawa A, 2011, SE ASIAN J TROP MED, V42, P1365; Nkouawa A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000732; Odermatt P, 2007, ACTA TROP, V103, P108, DOI 10.1016/j.actatropica.2007.05.015; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Perfetti M, 2013, SMALL; Philip D, 2008, SPECTROCHIM ACTA A, V71, P80, DOI 10.1016/j.saa.2007.11.012; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Rouf M A, 2009, Mymensingh Med J, V18, pS1; Sheele JM, 2013, TROP MED INT HEALTH, V18, P477, DOI 10.1111/tmi.12063; Sheng XZ, 2012, J APPL MICROBIOL, V113, P737, DOI 10.1111/j.1365-2672.2012.05389.x; Thobhani S, 2010, J IMMUNOL METHODS, V356, P60, DOI 10.1016/j.jim.2010.02.007; Yan J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-73; Yang SH, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.87; Zhang GP, 2006, VET PARASITOL, V137, P286, DOI 10.1016/j.vetpar.2006.01.026; Zhang XL, 2012, PARASITOL INT, V61, P645, DOI 10.1016/j.parint.2012.06.007; Zhang ZH, 2005, DIS NATURAL FOCUS, P1085; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	30	16	23	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92034	10.1371/journal.pone.0092034	http://dx.doi.org/10.1371/journal.pone.0092034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643068	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900067
J	Antonsson, A; Cornford, M; Perry, S; Davis, M; Dunne, MP; Whiteman, DC				Antonsson, Annika; Cornford, Michelle; Perry, Susan; Davis, Marcia; Dunne, Michael P.; Whiteman, David C.			Prevalence and Risk Factors for Oral HPV Infection in Young Australians	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL CARCINOMA; GAMMAPAPILLOMAVIRUS GENERA; OROPHARYNGEAL CANCER; NUCLEOTIDE-SEQUENCE; UNITED-STATES; NECK CANCERS; SWEDEN; HEAD; MEN	The prevalence of human papillomavirus (HPV)-associated head and neck cancers is increasing, but the prevalence of oral HPV infection in the wider community remains unknown. We sought to determine the prevalence of, and identify risk factors for, oral HPV infection in a sample of young, healthy Australians. For this study, we recruited 307 Australian university students (18-35 years). Participants reported anonymously about basic characteristics, sexual behaviour, and alcohol, tobacco and illicit drugs use. We collected oral rinse samples from all participants for HPV testing and typing. Seven of 307 (2.3%) students tested positive for oral HPV infection (3 HPV-18, one each of HPV-16, -67, -69, -90), and six of them were males (p = 0.008). Compared to HPV negative students, those with oral HPV infection were more likely to have received oral sex from more partners in their lifetime (p = 0.0004) and in the last year (p = 0.008). We found no statistically significant associations with alcohol consumption, smoking or numbers of partners for passionate kissing or sexual intercourse. In conclusion, oral HPV infection was associated with male gender and receiving oral sex in our sample of young Australians.	[Antonsson, Annika; Perry, Susan; Davis, Marcia; Whiteman, David C.] QIMR Berghofer Med Res Inst, Dept Populat Hlth, Brisbane, Qld, Australia; [Cornford, Michelle; Dunne, Michael P.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia	QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT)	Antonsson, A (corresponding author), QIMR Berghofer Med Res Inst, Dept Populat Hlth, Brisbane, Qld, Australia.	Annika.Antonsson@qimrberghofer.edu.au	Antonsson, Annika/A-2725-2015; Whiteman, David C/P-2728-2014	Antonsson, Annika/0000-0002-7383-8416; Whiteman, David C/0000-0003-2563-9559; Dunne, Michael/0000-0001-9041-4802	NHMRC [552429]; Garnett Passe and Rodney Williams Memorial Foundation; Australian Research Council [FT0990987]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Garnett Passe and Rodney Williams Memorial Foundation; Australian Research Council(Australian Research Council)	This project was funded by NHMRC program grant 552429. Annika Antonsson is funded by a Research Fellowship from the Garnett Passe and Rodney Williams Memorial Foundation. David C. Whiteman is funded by a Future Fellowship (FT0990987) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding bodies.	Attner P, 2012, INT J CANCER, V131, P1124, DOI 10.1002/ijc.26490; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; De Roda Husman A. M., 1995, Journal of Medical Virology, V46, P97, DOI 10.1002/jmv.1890460203; De Roda Husman Ana-Maria, 1995, Journal of General Virology, V76, P1057, DOI 10.1099/0022-1317-76-4-1057; Du J, 2012, EMERG INFECT DIS, V18, P1468, DOI 10.3201/eid1809.111731; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Kino N, 2000, CLIN DIAGN LAB IMMUN, V7, P91, DOI 10.1128/CDLI.7.1.91-95.2000; Kirii Y, 1998, VIRUS GENES, V17, P117, DOI 10.1023/A:1008002905588; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kurose K, 2004, ORAL SURG ORAL MED O, V98, P91, DOI 10.1016/j.tripleo.2003.12.029; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nordfors C, 2013, SCAND J INFECT DIS; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Terai M, 2002, J INFECT DIS, V185, P1794, DOI 10.1086/340824	26	64	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91761	10.1371/journal.pone.0091761	http://dx.doi.org/10.1371/journal.pone.0091761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637512	Green Published, gold			2022-12-25	WOS:000333254100059
J	Cox, GN; Chlipala, EA; Smith, DJ; Carlson, SJ; Bell, SJ; Doherty, DH				Cox, George N.; Chlipala, Elizabeth A.; Smith, Darin J.; Carlson, Sharon J.; Bell, Stacie J.; Doherty, Daniel H.			Hematopoietic Properties of Granulocyte Colony-Stimulating Factor/Immunoglobulin (G-CSF/IgG-Fc) Fusion Proteins in Normal and Neutropenic Rodents	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; POLYETHYLENE-GLYCOL; GROWTH-FACTORS; CSF; GENE; FILGRASTIM; ANTIBODIES; DURATION; RATS; MICE	Previously we showed that granulocyte colony-stimulating factor (G-CSF) in vitro bioactivity is preserved when the protein is joined via a flexible 7 amino acid linker to an immunoglobulin-1 (IgG1)-Fc domain and that the G-CSF/IgG1-Fc fusion protein possessed a longer circulating half-life and improved hematopoietic properties compared to G-CSF in normal rats. We have extended this analysis by comparing the relative hematopoietic potencies of G-CSF/IgG1-Fc to G-CSF in normal mice and to G-CSF and polyethylene glycol (PEG) - modified G-CSF in neutropenic rats. Mice were treated for 5 days using different doses and dosing regimens of G-CSF/IgG1-Fc or G-CSF and circulating neutrophil levels in the animals measured on Day 6. G-CSF/IgG1-Fc stimulated greater increases in blood neutrophils than comparable doses of G-CSF when administered using daily, every other day or every third day dosing regimens. In rats made neutropenic with cyclophosphamide, G-CSF/IgG1-Fc accelerated recovery of blood neutrophils to normal levels (from Day 9 to Day 5) when administered as 5 daily injections or as a single injection on Day 1. By contrast, G-CSF accelerated neutrophil recovery when administered as 5 daily injections, but not when administered as a single injection. G-CSF/IgG1-Fc was as effective as PEG-G-CSF at accelerating neutrophil recovery following a single injection in neutropenic rats. G-CSF/IgG1-Fc and G-CSF/IgG4-Fc fusion proteins in which the 7 amino acid linker was deleted also were effective at accelerating neutrophil recovery following a single injection in neutropenic rats. These studies confirm the enhanced in vivo hematopoietic properties of G-CSF/IgG-Fc fusion proteins.	[Cox, George N.; Smith, Darin J.; Carlson, Sharon J.; Bell, Stacie J.; Doherty, Daniel H.] Bolder BioTechnol Inc, Boulder, CO USA; [Chlipala, Elizabeth A.] Univ Colorado, BolderPATH Inc, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Cox, GN (corresponding author), Bolder BioTechnol Inc, Boulder, CO USA.	jcox@bolderbio.com			National Institutes of Diabetes, Digestive, and Kidney Diseases of The National Institutes of Health [1 R43 DK054561, 2R44 DK054561]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK054561, R43DK054561] Funding Source: NIH RePORTER	National Institutes of Diabetes, Digestive, and Kidney Diseases of The National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants 1 R43 DK054561 and 2R44 DK054561 to G. C. from the National Institutes of Diabetes, Digestive, and Kidney Diseases of The National Institutes of Health. The publication contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; Bowen S, 1999, EXP HEMATOL, V27, P425, DOI 10.1016/S0301-472X(98)00051-4; Cox GN, 2004, EXP HEMATOL, V32, P441, DOI 10.1016/j.exphem.2004.01.012; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; ELLISON J, 1981, DNA-J MOLEC CELL BIO, V1, P11, DOI 10.1089/dna.1.1981.1.11; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; Gaertner HF, 1996, BIOCONJUGATE CHEM, V7, P38, DOI 10.1021/bc950074d; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Kinstler OB, 1996, PHARMACEUT RES, V13, P996, DOI 10.1023/A:1016042220817; KUBOTA N, 1990, J BIOCHEM, V107, P486, DOI 10.1093/oxfordjournals.jbchem.a123072; KUGA T, 1989, BIOCHEM BIOPH RES CO, V159, P103, DOI 10.1016/0006-291X(89)92410-8; LAYTON JE, 1991, J BIOL CHEM, V266, P23815; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Molineux G, 1999, EXP HEMATOL, V27, P1724, DOI 10.1016/S0301-472X(99)00112-5; MOTT HR, 1995, CURR OPIN STRUC BIOL, V5, P114, DOI 10.1016/0959-440X(95)80016-T; NAGATA S, 1986, EMBO J, V5, P575, DOI 10.1002/j.1460-2075.1986.tb04249.x; Nohynek GJ, 1997, CANCER CHEMOTH PHARM, V39, P259; Paige AG, 1995, PHARMACEUT RES, V12, P1883, DOI 10.1023/A:1016227519561; Rosendahl Mary S, 2005, Bioprocess Int, V3, P52; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; TANAKA H, 1991, CANCER RES, V51, P3710; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Young DC, 1997, PROTEIN SCI, V6, P1228, DOI 10.1002/pro.5560060611	26	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91990	10.1371/journal.pone.0091990	http://dx.doi.org/10.1371/journal.pone.0091990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637521	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100098
J	Jonason, D; Franzen, M; Ranius, T				Jonason, Dennis; Franzen, Markus; Ranius, Thomas			Surveying Moths Using Light Traps: Effects of Weather and Time of Year	PLOS ONE			English	Article							ABUNDANCE; DIVERSITY; RICHNESS; CONSERVATION; BIODIVERSITY; LEPIDOPTERA; TEMPERATURE; BUTTERFLIES; MANAGEMENT; MOONLIGHT	Light trapping is an ideal method for surveying nocturnal moths, but in the absence of standardised survey methods effects of confounding factors may impede interpretation of the acquired data. We explored the influence of weather, time of year, and light source on nightly catches of macro moths in light traps, and compared four strategies for sampling by estimating observed species richness using rarefaction. We operated two traps with different light sources for 225 consecutive nights from mid-March to the end of October in eastern Germany in 2011. In total, 49 472 individuals of 372 species were recorded. Species richness and abundance per night were mainly influenced by night temperature, humidity and lamp type. With a limited sample size (<10 nights) it was slightly better to concentrate sampling on the warmest summer nights, but with more sampling nights it was slightly better to sample during the warmest nights in each month (March to October). By exploiting the higher moth activity during warm nights and an understanding of the species' phenology, it is possible to increase the number of species caught and reduce effects of confounding abiotic factors.	[Jonason, Dennis] Linkoping Univ, IFM Biol, Div Ecol, Linkoping, Sweden; [Jonason, Dennis; Ranius, Thomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Franzen, Markus] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany	Linkoping University; Swedish University of Agricultural Sciences; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Jonason, D (corresponding author), Linkoping Univ, IFM Biol, Div Ecol, Linkoping, Sweden.	dennis.jonason@liu.se			Marie-Claire Cronstedts Stiftelse; Stiftelsen Langmanska kulturfonden	Marie-Claire Cronstedts Stiftelse; Stiftelsen Langmanska kulturfonden	This work was supported by Marie-Claire Cronstedts Stiftelse and Stiftelsen Langmanska kulturfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RR, 1978, NATURE, V276, P818, DOI 10.1038/276818a0; Barton K., 2012, MUMIN MULTIMODEL INF; Bates AJ, 2013, ENTOMOL EXP APPL, V146, P386, DOI 10.1111/eea.12038; Bates D, 2012, LME4 LINEAR MIXED EF; Butler L, 1999, ENVIRON ENTOMOL, V28, P795, DOI 10.1093/ee/28.5.795; EASAC, 2004, US GUID BIOD IND; Ehnstrom B, 2011, SALG LIVETS VIKTIGAS; Elmquist H., 2011, SVERIGES FJARILAR FA; Fayle Tom M., 2007, British Journal of Entomology and Natural History, V20, P221; Fowler J., 2013, PRACTICAL STAT FIELD; Fox R, 2013, STATE BRITAINS LARGE, DOI [10.23637/rotham-sted.898z8, DOI 10.23637/ROTHAM-STED.898Z8]; Franzen M, 2007, J INSECT CONSERV, V11, P367, DOI 10.1007/s10841-006-9053-6; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Fuentes-Montemayor E, 2012, BIOL CONSERV, V153, P265, DOI 10.1016/j.biocon.2012.04.019; Fuentes-Montemayor E, 2011, J APPL ECOL, V48, P532, DOI 10.1111/j.1365-2664.2010.01927.x; GELMAN A., 2013, PACKAGE ARM; Grant BS, 1998, J HERED, V89, P465, DOI 10.1093/jhered/89.5.465; Groenendijk D, 2011, J INSECT CONSERV, V15, P95, DOI 10.1007/s10841-010-9326-y; Groombridge B., 1992, GLOBAL BIODIVERSITY; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Holyoak M, 1997, ENTOMOL EXP APPL, V83, P329, DOI 10.1023/A:1003015401648; Intachat J, 1999, B ENTOMOL RES, V89, P153, DOI 10.1017/S0007485399000243; Jonason D, 2013, BASIC APPL ECOL, V14, P515, DOI [10.1016/j.baae.2013.07.002, 10.1016/j.baae.2013.07.003]; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Leinonen R, 1998, ENTOMOL FENNICA, V9, P37, DOI 10.33338/ef.83965; Leraut P, 2009, MOTHS EUROPE GEOMETR; Littlewood NA, 2008, INSECT CONSERV DIVER, V1, P151, DOI 10.1111/j.1752-4598.2008.00021.x; MANLEY C, 2008, BRIT MOTHS BUTTERFLI; MCGEACHIE WJ, 1989, B ENTOMOL RES, V79, P185, DOI 10.1017/S0007485300018162; Mellanby K, 1939, PROC R SOC SER B-BIO, V127, P473, DOI 10.1098/rspb.1939.0035; Merckx T, 2009, AGR ECOSYST ENVIRON, V129, P302, DOI 10.1016/j.agee.2008.10.004; Merckx T, 2014, INSECT CONSERV DIVER, V7, P453, DOI 10.1111/icad.12068; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; New TR, 2004, J INSECT CONSERV, V8, P79, DOI 10.1023/B:JICO.0000045807.04047.bd; Nowacki J., 1998, NOCTUIDS LEPIDOPTERA; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Rakosy L, 2011, ECOL INDIC, V11, P1040, DOI 10.1016/j.ecolind.2010.10.010; Schowalter TD, 2011, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 3RD EDITION, P1; Shapiro A.M., 1975, P181; Skinner B., 2009, COLOUR IDENTIFICATIO, V3rd; Skou, 1991, NORDENS UGLER HANDBO; Skou P., 1984, NORDENS MALERE HANDB; Slade EM, 2013, ECOLOGY, V94, P1519, DOI 10.1890/12-1366.1; Somers-Yeates R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0376; Summerville KS, 2004, BIOL CONSERV, V116, P9, DOI 10.1016/S0006-3207(03)00168-X; Summerville KS, 2003, OIKOS, V100, P134, DOI 10.1034/j.1600-0706.2003.11992.x; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Truxa C, 2012, INSECT CONSERV DIVER, V5, P389, DOI 10.1111/j.1752-4598.2011.00177.x; van Langevelde F, 2011, BIOL CONSERV, V144, P2274, DOI 10.1016/j.biocon.2011.06.004; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283	55	47	49	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92453	10.1371/journal.pone.0092453	http://dx.doi.org/10.1371/journal.pone.0092453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637926	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000333254100149
J	Popovic, J; Stanisavljevic, D; Schwirtlich, M; Klajn, A; Marjanovic, J; Stevanovic, M				Popovic, Jelena; Stanisavljevic, Danijela; Schwirtlich, Marija; Klajn, Andrijana; Marjanovic, Jelena; Stevanovic, Milena			Expression Analysis of SOX14 during Retinoic Acid Induced Neural Differentiation of Embryonal Carcinoma Cells and Assessment of the Effect of Its Ectopic Expression on SOXB Members in HeLa Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; STEM-CELLS; VERTEBRATE NEUROGENESIS; GENOMIC ORGANIZATION; CERVICAL-CANCER; GLIAL-CELLS; TRANSCRIPTION; NEURONS; MOUSE	SOX14 is a member of the SOXB2 subgroup of transcription factors implicated in neural development. Although the first SOX14 gene in vertebrates was cloned and characterized more than a decade ago and its expression profile during development was revealed in various animal model systems, the role of this gene during neural development is largely unknown. In the present study we analyzed the expression of SOX14 in human NT2/D1 and mouse P19 pluripotent embryonal carcinoma cells. We demonstrated that it is expressed in both cell lines and upregulated during retinoic acid induced neural differentiation. We showed that SOX14 was expressed in both neuronal and non-neuronal differentiated derivatives, as revealed by immunocytochemistry. Since it was previously proposed that increased SOXB2 proteins level interfere with the activity of SOXB1 counteracting partners, we compared expression patterns of SOXB members during retinoic acid induction of embryonal carcinoma cells. We revealed that upregulation of SOX14 expression is accompanied by alterations in the expression patterns of SOXB1 members. In order to analyze the potential cross-talk between them, we generated SOX14 expression construct. The ectopic expression of SOX14 was demonstrated at the mRNA level in NT2/D1, P19 and HeLa cells, while an increased level of SOX14 protein was detected in HeLa cells only. By transient transfection experiments in HeLa cells we showed for the first time that ectopic expression of SOX14 repressed SOX1 expression, whereas no significant effect on SOX2, SOX3 and SOX21 was observed. Data presented here provide an insight into SOX14 expression during in vitro neural differentiation of embryonal carcinoma cells and demonstrate the effect of its ectopic expression on protein levels of SOXB members in HeLa cells. Obtained results contribute to better understanding the role of one of the most conserved SOX proteins.	[Popovic, Jelena; Stanisavljevic, Danijela; Schwirtlich, Marija; Klajn, Andrijana; Marjanovic, Jelena; Stevanovic, Milena] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Human Mol Genet, Belgrade, Serbia	University of Belgrade	Popovic, J (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Human Mol Genet, Belgrade, Serbia.	jpopovic@imgge.bg.ac.rs	Popovic, Jelena/S-6304-2017	Popovic, Jelena/0000-0001-8565-1555; Lazic, Andrijana/0000-0003-4433-7695; Stevanovic, Milena/0000-0003-4286-7334; Stanisavljevic Ninkovic, Danijela/0000-0003-0481-4004; Schwirtlich, Marija/0000-0002-2183-0164	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Arsic N, 1998, CYTOGENET CELL GENET, V83, P139, DOI 10.1159/000015149; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Buescher M, 2002, DEVELOPMENT, V129, P4193; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cnaani A, 2007, SEX DEV, V1, P207, DOI 10.1159/000102109; Collignon J, 1996, DEVELOPMENT, V122, P509; Cunningham DD, 2008, INT J DEV BIOL, V52, P999, DOI 10.1387/ijdb.082586dc; Delogu A, 2012, NEURON, V75, P648, DOI 10.1016/j.neuron.2012.06.013; Djurovic J, 2004, BBA-GENE STRUCT EXPR, V1680, P53, DOI 10.1016/j.bbaexp.2004.08.011; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guillemain I, 2000, J COMP NEUROL, V422, P380, DOI 10.1002/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C; Hargrave M, 2000, HUM GENET, V106, P432, DOI 10.1007/s004390000266; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kirby PJ, 2002, CYTOGENET GENOME RES, V98, P96, DOI 10.1159/000068539; Kishi M, 2000, DEVELOPMENT, V127, P791; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lin YW, 2013, GYNECOL ONCOL, V131, P174, DOI 10.1016/j.ygyno.2013.07.111; Malas S, 1999, MAMM GENOME, V10, P934, DOI 10.1007/s003359901118; MATUS A, 1981, P NATL ACAD SCI-BIOL, V78, P3010, DOI 10.1073/pnas.78.5.3010; Mazzuchelli J, 2011, CHROMOSOME RES, V19, P657, DOI 10.1007/s10577-011-9225-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McKimmie C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-26; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Popovic J, 2010, BBA-GENE REGUL MECH, V1799, P411, DOI 10.1016/j.bbagrm.2010.01.002; Popovic J, 2009, J GENET, V88, P15, DOI 10.1007/s12041-009-0003-4; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; RUDNICKI MA, 1988, MOL CELL BIOL, V8, P406, DOI 10.1128/MCB.8.1.406; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STAINES WA, 1994, NEUROSCIENCE, V58, P735, DOI 10.1016/0306-4522(94)90451-0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2011, DEV GROWTH DIFFER, V53, P761, DOI 10.1111/j.1440-169X.2011.01286.x; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1	58	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91852	10.1371/journal.pone.0091852	http://dx.doi.org/10.1371/journal.pone.0091852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637840	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100069
J	Radlowski, EC; Conrad, MS; Lezmi, S; Dilger, RN; Sutton, B; Larsen, R; Johnson, RW				Radlowski, Emily C.; Conrad, Matthew S.; Lezmi, Stephane; Dilger, Ryan N.; Sutton, Brad; Larsen, Ryan; Johnson, Rodney W.			A Neonatal Piglet Model for Investigating Brain and Cognitive Development in Small for Gestational Age Human Infants	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INTRAUTERINE GROWTH-RETARDATION; MAGNETIC-RESONANCE SPECTROSCOPY; ADULTS BORN PRETERM; N-ACETYL-ASPARTATE; CATCH-UP GROWTH; T-MAZE TASK; DEVELOPING-COUNTRIES; IN-VIVO; CHILDREN	The piglet was investigated as a potential model for studying brain and cognitive deficits associated with being born small for gestational age (SGA). Naturally farrowed SGA (0.7-1.0 kg BW) and average for gestational age (AGA, 1.3-1.6 kg BW) piglets were obtained on postnatal day (PD) 2, placed in individual cages, and provided a nutritionally adequate milk replacer diet (285 ml/kg/d). Beginning at PD14, performance in a spatial T-maze task was assessed. At PD28, piglets were anesthetized for magnetic resonance (MR) imaging to assess brain structure (voxel-based morphometry), connectivity (diffusion-tensor imaging) and metabolites in the hippocampus and corpus callosum (proton MR spectroscopy). Piglets born SGA showed compensatory growth such that BW of SGA and AGA piglets was similar (P>0.05), by PD15. Birth weight lffected maze performance, with SGA piglets taking longer to reach criterion than AGA piglets (p<0.01). Total brain volume of SGA and AGA piglets was similar (P<0.05), but overall, SGA piglets had less gray matter than AGA piglets (p<0.01) and tended to have a smaller internal capsule (p = 0.07). Group comparisons between SGA and AGA piglets defined 9 areas (>= 20 clusters) where SGA piglets had less white matter (p<0.01); 2 areas where SGA piglets had more white matter (p<0.01); and 3 areas where SGA piglets had more gray matter (p<0.01). The impact of being born SGA on white matter was supported by a lower (p<0.04) fractional anisotropy value for SGA piglets, suggesting reduced white matter development and connectivity. None of the metabolites measured were different between groups. Collectively, the results show that SGA piglets have spatial learning deficits and abnormal development of white matter. As learning deficits and abnormalities in white matter are common in SGA human infants, the piglet is a tractable translational model that can be used to investigate SGA-associated cognitive deficits and potential interventions.	[Radlowski, Emily C.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Radlowski, Emily C.; Dilger, Ryan N.; Johnson, Rodney W.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Conrad, Matthew S.; Dilger, Ryan N.; Sutton, Brad; Johnson, Rodney W.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Lezmi, Stephane] Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61801 USA; [Sutton, Brad] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Larsen, Ryan] Univ Illinois, Beckman Inst, Biomed Imaging Ctr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RW (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	rwjohn@illinois.edu	Sutton, Bradley P./A-4801-2008	Sutton, Bradley P./0000-0002-8443-0408; Johnson, Rodney/0000-0002-2376-1852; /0000-0003-0661-4321; Dilger, Ryan/0000-0003-2538-2845; Lezmi, Stephane/0000-0002-3412-4058	University of Illinois Center for Nutrition, Learning, and Memory; National Institutes of Health [R01 HD069899]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069899] Funding Source: NIH RePORTER	University of Illinois Center for Nutrition, Learning, and Memory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the University of Illinois Center for Nutrition, Learning, and Memory, and the National Institutes of Health (R01 HD069899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Abernethy LJ, 2002, ARCH DIS CHILD, V87, P279, DOI 10.1136/adc.87.4.279; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baker-Henningham H, 2009, J NUTR, V139, P1765, DOI 10.3945/jn.109.106294; Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bhakoo KK, 2000, J NEUROCHEM, V74, P254, DOI 10.1046/j.1471-4159.2000.0740254.x; Bluml S., 2013, MR SPECTROSCOPY PEDI; braham H, 2010, INT J DEV NEUROSCI, V28, P401; BUEKENS P, 1984, J EPIDEMIOL COMMUN H, V38, P79, DOI 10.1136/jech.38.1.79; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; COOPER J E, 1975, Laboratory Animals (London), V9, P329, DOI 10.1258/002367775780957188; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Easton A, 2000, AMYGDALA FUNCTIONAL, P569; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Elmore MRP, 2012, ANIM COGN, V15, P667, DOI 10.1007/s10071-012-0495-9; Fang MR, 2005, NEUROSIGNALS, V14, P222, DOI 10.1159/000088638; Fields RD, 2008, SCI AM, V298, P54; Fitz NF, 2008, BRAIN RES BULL, V77, P356, DOI 10.1016/j.brainresbull.2008.08.016; Ghetti S, 2012, DEV COGN NEUROS-NETH, V2, P381, DOI 10.1016/j.dcn.2012.05.002; Gieling ET, 2011, PEDIAT RES; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gutbrod T, 2000, ARCH DIS CHILD-FETAL, V82, pF208, DOI 10.1136/fn.82.3.F208; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Ishizu K, 2000, SYNAPSE, V38, P87, DOI 10.1002/1098-2396(200010)38:1<87::AID-SYN10>3.0.CO;2-C; Jakobsen S, 2006, J NUCL MED, V47, P2008; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P4498, DOI 10.1210/jc.2012-1716; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lepomaki V, 2013, PEDIATR RADIOL, V43, P80, DOI 10.1007/s00247-012-2509-9; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Martin E, 2001, ANN NEUROL, V49, P518, DOI 10.1002/ana.102; Mathews T J, 2010, Natl Vital Stat Rep, V58, P1; MATTHEWS PM, 1991, NEUROLOGY, V41, P1251, DOI 10.1212/WNL.41.8.1251; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; Mirandola C, 2011, LEARN INDIVID DIFFER, V21, P206, DOI 10.1016/j.lindif.2010.12.001; Nakagawa H, 1998, AM J NEURORADIOL, V19, P1129; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Provencher SW, 2011, LCMODEL LCMGUI USERS; Roelants-Van Rijn AM, 2004, PEDIATR RES, V56, P285, DOI 10.1203/01.PDR.0000132751.09067.3F; Rosen Y, 2007, NEUROTHERAPEUTICS, V4, P330, DOI 10.1016/j.nurt.2007.04.009; Rosenberg Melanie, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P338, DOI 10.1016/j.cppeds.2007.07.003; SANDSON J, 1984, NEUROPSYCHOLOGIA, V22, P715, DOI 10.1016/0028-3932(84)90098-8; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Sommerfelt K, 2000, ARCH DIS CHILD, V83, P25, DOI 10.1136/adc.83.1.25; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Stringer KG, 2005, BEHAV NEUROSCI, V119, P946, DOI 10.1037/0735-7044.119.4.946; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Widdowson E, 1971, NEONATOLOGY, V19, P329; Winter JD, 2007, MAGN RESON IMAGING, V25, P1283, DOI 10.1016/j.mri.2007.03.010; Woodcock R. W., 1989, WJ R TESTS ACHIEVEME; WOOTTON R, 1983, J REPROD FERTIL, V69, P659, DOI 10.1530/jrf.0.0690659; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yang PC, 2010, PSYCHIAT RES-NEUROIM, V181, P199, DOI 10.1016/j.pscychresns.2009.10.001	75	60	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91951	10.1371/journal.pone.0091951	http://dx.doi.org/10.1371/journal.pone.0091951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637829	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100088
J	Sivaji, M; Sadasivam, V; Narayanasamy, J; Samuel, S; Fan, CZ				Sivaji, Manigandan; Sadasivam, Vinoth; Narayanasamy, Jayabalan; Samuel, Selvaraj; Fan, Chuanzhu			Detection, Characterization and Evolution of Internal Repeats in Chitinases of Known 3-D Structure	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TANDEM REPEATS; PROTEINS; TOOL	Chitinase proteins have evolved and diversified almost in all organisms ranging from prokaryotes to eukaryotes. During evolution, internal repeats may appear in amino acid sequences of proteins which alter the structural and functional features. Here we deciphered the internal repeats from Chitinase and characterized the structural similarities between them. Out of 24 diverse Chitinase sequences selected, six sequences (2CJL, 2DSK, 2XVP, 2Z37, 3EBV and 3HBE) did not contain any internal repeats of amino acid sequences. Ten sequences contained repeats of length,50, and the remaining 8 sequences contained repeat length between 50 and 100 residues. Two Chitinase sequences, 1ITX and 3SIM, were found to be structurally similar when analyzed using secondary structure of Chitinase from secondary and 3-Dimensional structure database of Protein Data Bank. Internal repeats of 3N17 and 1O6I were also involved in the ligand-binding site of those Chitinase proteins, respectively. Our analyses enhance our understanding towards the identification of structural characteristics of internal repeats in Chitinase proteins.	[Sivaji, Manigandan; Sadasivam, Vinoth; Narayanasamy, Jayabalan] Bharathidasan Univ, Dept Plant Sci, Tiruchirappalli, Tamil Nadu, India; [Narayanasamy, Jayabalan; Fan, Chuanzhu] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Samuel, Selvaraj] Bharathidasan Univ, Dept Bioinformat, Tiruchirappalli, Tamil Nadu, India	Bharathidasan University; Wayne State University; Bharathidasan University	Samuel, S (corresponding author), Bharathidasan Univ, Dept Bioinformat, Tiruchirappalli, Tamil Nadu, India.	selvarajsamuel@gmail.com; cfan@wayne.edu	Samuel, Selvaraj/AAU-2166-2021; Narayanasamy, Jayabalan/J-3133-2016	Narayanasamy, Jayabalan/0000-0001-6358-5470	Wayne State University; Bharathidasan University	Wayne State University; Bharathidasan University	C.F. was supported by start-up fund from Wayne State University. J.N. and S. S. were supported by fund from Bharathidasan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AL, 2008, BIOINFORMATICS, V24, P1536, DOI 10.1093/bioinformatics/btn234; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Fukamizo T, 2003, FOODS FOOD INGREDIEN, V208, P6; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Heringa J, 1998, CURR OPIN STRUC BIOL, V8, P338, DOI 10.1016/S0959-440X(98)80068-7; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; MCLACHLAN AD, 1983, J MOL BIOL, V169, P15, DOI 10.1016/S0022-2836(83)80173-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91915	10.1371/journal.pone.0091915	http://dx.doi.org/10.1371/journal.pone.0091915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637574	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100080
J	Trane, AE; Pavlov, D; Sharma, A; Saqib, U; Lau, K; van Petegem, F; Minshall, RD; Roman, LJ; Bernatchez, PN				Trane, Andy E.; Pavlov, Dmitri; Sharma, Arpeeta; Saqib, Uzma; Lau, Kelvin; van Petegem, Filip; Minshall, Richard D.; Roman, Linda J.; Bernatchez, Pascal N.			Deciphering the Binding of Caveolin-1 to Client Protein Endothelial Nitric-oxide Synthase ( eNOS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caveolae; Caveolin; Endothelium; Nitric Oxide; Nitric-oxide Synthase	MICROVASCULAR PERMEABILITY; SCAFFOLDING DOMAIN; PULMONARY DEFECTS; KNOCKOUT MICE; NULL MICE; IN-VIVO; ATHEROSCLEROSIS; DYSFUNCTION; HYPERTENSION; ACTIVATION	Background: One of the most significant client proteins of Cav-1 is the endothelial nitric-oxide synthase (eNOS), but their specific binding site is unknown. Results: We describe how Cav-1 binds to eNOS and how biologically active NO can be increased. Conclusion: We provide the most detailed characterization of eNOS binding to Cav-1. Significance: Our data provide a deeper understanding of Cav-1 signaling and NO generation in physiological processes. Caveolin-1 (Cav-1) gene inactivation interferes with caveolae formation and causes a range of cardiovascular and pulmonary complications in vivo. Recent evidence suggests that blunted Cav-1/endothelial nitric-oxide synthase (eNOS) interaction, which occurs specifically in vascular endothelial cells, is responsible for the multiple phenotypes observed in Cav-1-null animals. Under basal conditions, Cav-1 binds eNOS and inhibits nitric oxide (NO) production via the Cav-1 scaffolding domain (CAV; amino acids 82-101). Although we have recently shown that CAV residue Phe-92 is responsible for eNOS inhibition, the inactive F92A Cav-1 mutant unexpectedly retains its eNOS binding ability and can increase NO release, indicating the presence of a distinct eNOS binding domain within CAV. Herein, we identified and characterized a small 10-amino acid CAV subsequence (90-99) that accounted for the majority of eNOS association with Cav-1 (K-d = 49 nm), and computer modeling of CAV(90-99) docking to eNOS provides a rationale for the mechanism of eNOS inhibition by Phe-92. Finally, using gene silencing and reconstituted cell systems, we show that intracellular delivery of a F92A CAV(90-99) peptide can promote NO bioavailability in eNOS- and Cav-1-dependent fashions. To our knowledge, these data provide the first detailed analysis of Cav-1 binding to one of its most significant client proteins, eNOS.	[Trane, Andy E.; Pavlov, Dmitri; Sharma, Arpeeta; Bernatchez, Pascal N.] Univ British Columbia, St Pauls Hosp, Ctr Heart & Lung Innovat, Vancouver, BC V6T 1Z3, Canada; [Trane, Andy E.; Pavlov, Dmitri; Sharma, Arpeeta; Bernatchez, Pascal N.] Univ British Columbia, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Lau, Kelvin; van Petegem, Filip] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Roman, Linda J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Saqib, Uzma; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Minshall, Richard D.] Univ Illinois, Dept Anaesthesiol, Chicago, IL 60612 USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of British Columbia; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bernatchez, PN (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, St Pauls Hosp, Ctr Heart & Lung Innovat, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	pascal.bernatchez@ubc.ca	Lau, Kelvin/M-2639-2019; Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; Lau, Kelvin/0000-0002-9040-7597	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [GM052419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of British Columbia; Heart and Stroke Foundation of Yukon; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, British Columbia, and Yukon (to A. E. T. and P. N. B.), the Canada Foundation for Innovation, British Columbia Knowledge Development Fund, Natural Sciences and Engineering Research Council of Canada (to A. S.).; Supported by National Institutes of Health Grant GM052419.	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Babak R., 2002, PHARMACOL REV, V54, P431; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; BUSCONI L, 1995, MOL PHARMACOL, V47, P655; Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; GRIFFITH TM, 1984, NATURE, V308, P645, DOI 10.1038/308645a0; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kaplanek R, 2012, J MED CHEM, V55, P9541, DOI 10.1021/jm300805x; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Maniatis NA, 2008, AM J PHYSIOL-LUNG C, V294, pL865, DOI 10.1152/ajplung.00079.2007; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nadar S, 2004, CURR PHARM DESIGN, V10, P3591, DOI 10.2174/1381612043382765; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Razani B, 2001, J BIOL CHEM, V276, P38121; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Sharma A, 2011, EUR J PHARMACOL, V659, P206, DOI 10.1016/j.ejphar.2011.03.028; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Taddei S, 2000, Curr Hypertens Rep, V2, P64, DOI 10.1007/s11906-000-0061-8; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Yamamoto M, 1999, EXP CELL RES, V247, P380, DOI 10.1006/excr.1998.4379; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	56	48	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13273	13283		10.1074/jbc.M113.528695	http://dx.doi.org/10.1074/jbc.M113.528695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648521	hybrid, Green Published			2022-12-25	WOS:000335522800027
J	Argyri, L; Dafnis, I; Theodossiou, TA; Gantz, D; Stratikos, E; Chroni, A				Argyri, Letta; Dafnis, Ioannis; Theodossiou, Theodossis A.; Gantz, Donald; Stratikos, Efstratios; Chroni, Angeliki			Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; ApoE; Apolipoproteins; Biophysics; Lipoprotein; Reactive Oxygen Species (ROS); Amyloid Peptide; Mutation; Thermodynamic Stability; Toxicity	E CONCENTRATION DECREASES; AMYLOID-BETA; SECONDARY STRUCTURE; OXIDATIVE STRESS; AQUEOUS-SOLUTION; LIPID-BINDING; A-I; E3; ASSOCIATION; STABILITY	Background: The apoE4 mutant apoE4[L28P] is associated with an increased risk for Alzheimer disease (AD) in addition to the known effect of apoE4. Results: ApoE4[L28P] displays folding defects and aberrant functions associated with AD pathogenesis. Conclusion: The structural integrity of apoE4 is an important component of its role in AD pathogenesis. Significance: We provide insights into the molecular basis for the added risk for AD in apoE4[L28P] carriers. The apolipoprotein (apo) E4 isoform has consistently emerged as a susceptibility factor for late-onset Alzheimer disease (AD), although the exact mechanism is not clear. A rare apoE4 mutant, apoE4[L28P] Pittsburgh, burdens carriers with an added risk for late-onset AD and may be a useful tool for gaining insights into the role of apoE4 in disease pathogenesis. Toward this end, we evaluated the effect of the L28P mutation on the structural and functional properties of apoE4. ApoE4[L28P] was found to have significantly perturbed thermodynamic properties, to have reduced helical content, and to expose a larger portion of the hydrophobic surface to the solvent. Furthermore, this mutant is thermodynamically destabilized and more prone to proteolysis. When interacting with lipids, apoE4[L28P] formed populations of lipoprotein particles with structural defects. The structural perturbations brought about by the mutation were accompanied by aberrant functions associated with the pathogenesis of AD. Specifically, apoE4[L28P] promoted the cellular uptake of extracellular amyloid peptide 42 (A42) by human neuroblastoma SK-N-SH cells as well as by primary mouse neuronal cells and led to increased formation of intracellular reactive oxygen species that persisted for at least 24 h. Furthermore, lipoprotein particles containing apoE4[L28P] induced intracellular reactive oxygen species formation and reduced SK-N-SH cell viability. Overall, our findings suggest that the L28P mutation leads to significant structural and conformational perturbations in apoE4 and can induce functional defects associated with neuronal A42 accumulation and oxidative stress. We propose that these structural and functional changes underlie the observed added risk for AD development in carriers of apoE4[L28P].	[Argyri, Letta; Dafnis, Ioannis; Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece; [Theodossiou, Theodossis A.] Natl Ctr Sci Res Demokritos, Inst Adv Mat Physicochem Proc Nanotechnol & Micro, Phys Chem Sect, Athens 15310, Greece; [Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Prot Chem Lab, Inst Nucl & Radiol Sci & Technol Energy & Safety, Athens 15310, Greece; [Gantz, Donald] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA	National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; National Centre of Scientific Research "Demokritos"; Boston University	Stratikos, E (corresponding author), Natl Ctr Sci Res Demokritos, Prot Chem Lab, Inst Nucl & Radiol Sci & Technol Energy & Safety, Aghia Paraskevi 15310, Greece.	stratos@rrp.demokritos.gr; achroni@bio.demokritos.gr	Stratikos, Efstratios/N-2969-2014; Theodossiou, Theodossis/AAC-2075-2022	Stratikos, Efstratios/0000-0002-3566-2309; Theodossiou, Theodossis/0000-0002-1982-8372; Chroni, Angeliki/0000-0003-3107-1189	ARISTEIA II program [4839]; European Social Fund; European Union; Greek National Resources	ARISTEIA II program; European Social Fund(European Social Fund (ESF)); European Union(European Commission); Greek National Resources(Greek Ministry of Development-GSRT)	This work was supported by the ARISTEIA II program (project code 4839), which is cofunded by the European Social Fund, European Union and Greek National Resources, under the Operational Program "Education and Lifelong Learning."	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Argyri L, 2011, PROTEIN EXPRES PURIF, V79, P251, DOI 10.1016/j.pep.2011.06.011; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bayer TA, 2008, GENES BRAIN BEHAV, V7, P6, DOI 10.1111/j.1601-183X.2007.00372.x; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Chou CY, 2005, BIOPHYS J, V88, P455, DOI 10.1529/biophysj.104.046813; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Clement-Collin V, 2006, BIOPHYS CHEM, V119, P170, DOI 10.1016/j.bpc.2005.07.009; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Dafnis I, 2012, NEUROSCIENCE, V210, P21, DOI 10.1016/j.neuroscience.2012.03.013; Dafnis I, 2010, J NEUROCHEM, V115, P873, DOI 10.1111/j.1471-4159.2010.06756.x; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Dubochet J, 1982, ADV OPTICAL ELECT MI, P107; Georgiadou D, 2013, J LIPID RES, V54, P164, DOI 10.1194/jlr.M030965; Georgiadou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027037; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; Gorshkova IN, 2008, BIOCHEMISTRY-US, V47, P12644, DOI 10.1021/bi8015857; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Harris Jonathan Gil, 1994, ELECT MICROSCOPY BIO, P203; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Huber G, 2000, NEUROSCIENCE, V101, P211, DOI 10.1016/S0306-4522(00)00341-9; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kamboh MI, 1999, NEUROSCI LETT, V263, P129, DOI 10.1016/S0304-3940(99)00129-9; Kay AD, 2003, J NEUROTRAUM, V20, P243, DOI 10.1089/089771503321532824; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; Scacchi R, 2003, NEUROBIOL AGING, V24, P339, DOI 10.1016/S0197-4580(02)00089-1; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P4240, DOI 10.1021/bi060023b; Wang L, 2010, SEIZURE-EUR J EPILEP, V19, P79, DOI 10.1016/j.seizure.2009.12.001; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Zannis V. I., 2004, MOL MECH ATHEROSCLER, P111; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028; Zhao W., 2013, HUM MOL GENET	62	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12931	12945		10.1074/jbc.M113.538124	http://dx.doi.org/10.1074/jbc.M113.538124			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644280	Green Published, hybrid			2022-12-25	WOS:000335581400061
J	Guo, JN; Turek, ME; Price, DH				Guo, Jiannan; Turek, Michael E.; Price, David H.			Regulation of RNA Polymerase II Termination by Phosphorylation of Gdown1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitosis; Phosphorylation; RNA Polymerase II; Transcription Elongation Factors; Transcription Termination; Gdown1; TFIIF; TTF2	TRANSCRIPTION ELONGATION; P-TEFB; PRODUCTIVE ELONGATION; INITIATION-COMPLEXES; MEDIATOR COMPLEX; IN-VITRO; DSIF; ORGANIZATION; TRANSITION; MITOSIS	Background: Gdown1 is a substoichiometric subunit of RNA polymerase II that blocks termination by TTF2 and the function of TFIIF during initiation and elongation. Results: Domains of Gdown1 responsible for inhibiting TTF2 and TFIIF as well as a controlling phosphorylation site are identified. Conclusion: Gdown1 can be regulated by phosphorylation of Ser-270. Significance: Our results reveal a mechanism that allows termination of all polymerases during mitosis. Gdown1 is a substoichiometric subunit of RNA polymerase II (Pol II) that has been recently demonstrated to be involved in stabilizing promoter-proximal paused Pol II. It was shown to inhibit termination of Pol II by transcription termination factor 2 (TTF2) as well as block elongation stimulation by transcription factor IIF (TFIIF). Here, using in vitro transcription assays, we identified two functional domains in Gdown1. Although both are required to maintain a tight association with Pol II, the N- and C-terminal domains are responsible for blocking TTF2 and TFIIF, respectively. A highly conserved LPDKG motif found in the N-terminal domain of Gdown1 is also highly conserved in TTF2. Deletion of this motif eliminated the TTF2 inhibitory activity of Gdown1. We identified a phosphorylated form of Gdown1 with altered mobility in SDS-PAGE that appears during mitosis. A kinase in HeLa nuclear extract that caused the shift was partially purified. In vitro, Gdown1 phosphorylated by this kinase demonstrated reduced activity in blocking both TTF2 and TFIIF because of its reduced affinity for Pol II. Mass spectrometry identified Ser-270 as the site of this phosphorylation. An S270A mutation was not phosphorylated by the partially purified kinase, and an S270E mutation partially mimicked the properties of phospho-Gdown1. Gdown1 Ser-270 phosphorylation occurs predominately during mitosis, and we suggest that this would enable TTF2 to terminate all Pol II even if it is associated with Gdown1.	[Guo, Jiannan; Turek, Michael E.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	david-price@uiowa.edu		Price, David/0000-0002-5597-385X	National Institutes of Health [GM35500]; American Heart Association [12POST12040106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM35500 (to D. H. P.). This work was also supported by American Heart Association Postdoctoral Fellowship 12POST12040106 (to J. G.).	Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Jishage M, 2012, MOL CELL, V45, P51, DOI 10.1016/j.molcel.2011.12.014; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Liang XQ, 2007, J AM SOC MASS SPECTR, V18, P1932, DOI 10.1016/j.jasms.2007.08.001; Luse DS, 2012, TRANSCR-AUSTIN, V3, P156, DOI 10.4161/trns.20725; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Peng J, 1998, COLD SPRING HARB SYM, V63, P365, DOI 10.1101/sqb.1998.63.365; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu YM, 2012, EMBO J, V31, P3575, DOI 10.1038/emboj.2012.205; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	40	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12657	12665		10.1074/jbc.M113.537662	http://dx.doi.org/10.1074/jbc.M113.537662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24634214	Green Published, hybrid			2022-12-25	WOS:000335581400037
J	Hewit, KD; Fraser, A; Nibbs, RJB; Graham, GJ				Hewit, Kay D.; Fraser, Alasdair; Nibbs, Robert J. B.; Graham, Gerard J.			The N-terminal Region of the Atypical Chemokine Receptor ACKR2 Is a Key Determinant of Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Chemokines; Flow Cytometry; Inflammation; Mutagenesis	HIV-1 ENVELOPE GLYCOPROTEIN; DECOY RECEPTOR; TYROSINE SULFATION; AMINO-TERMINUS; D6; INFLAMMATION; IMMUNE; EXPRESSION; PEPTIDES; SYSTEM	Background: ACKR2 is an atypical chemokine receptor that is biologically distinct from conventional chemokine receptors. Results: An N-terminal sulfated tyrosine motif is essential for ligand binding by ACKR2. Conclusion: The structure/function basis for ligand binding by ACKR2 is similar to that of conventional chemokine receptors. Significance: ACKR2 N-terminal peptides may be therapeutically useful as pan-chemokine blockers in inflammatory pathologies. The atypical chemokine receptor, ACKR2 is a pivotal regulator of chemokine-driven inflammatory responses and works by binding, internalizing, and degrading inflammatory CC-chemokines. ACKR2 displays promiscuity of ligand binding and is capable of interacting with up to 14 different inflammatory CC-chemokines. Despite its prominent biological role, little is known about the structure/function relationship within ACKR2, which regulates ligand binding. Here we demonstrate that a conserved tyrosine motif at the N terminus of ACKR2 is essential for ligand binding, internalization, and scavenging. In addition we demonstrate that sulfation of this motif contributes to ligand internalization. Furthermore, a peptide derived from this region is capable of binding inflammatory chemokines and inhibits their interaction with their cognate signaling receptors. Importantly, the peptide is only active in the sulfated form, further confirming the importance of the sulfated tyrosines for function. Finally, we demonstrate that the bacterial protease, staphopain A, can cleave the N terminus of ACKR2 and suppress its ligand internalization activity. Overall, these results shed new light on the nature of the structural motifs in ACKR2 that are responsible for ligand binding. The study also highlights ACKR2-derived N-terminal peptides as being of potential therapeutic significance.	[Hewit, Kay D.; Fraser, Alasdair; Nibbs, Robert J. B.; Graham, Gerard J.] Univ Glasgow, Chemokine Res Grp, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Graham, GJ (corresponding author), Univ Glasgow, Chemokine Res Grp, Glasgow Biomed Res Ctr, Rm B3-27, Glasgow G12 8TA, Lanark, Scotland.	gerard.graham@glasgow.ac.uk		Graham, Gerard/0000-0002-7801-204X; Nibbs, Robert/0000-0002-8150-0044; Hewit, Kay/0000-0003-1671-6604	Medical Research Council Programme Grant; MRC [G0901113] Funding Source: UKRI; Medical Research Council [G0901113] Funding Source: researchfish; Versus Arthritis [19656] Funding Source: researchfish	Medical Research Council Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was funded by a Medical Research Council Programme Grant (to G. J. G. and R. J. B. N.).	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Borroni EM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003627; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Codullo V, 2011, ANN RHEUM DIS, V70, P1115, DOI 10.1136/ard.2010.137349; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Graham GJ, 2013, J PATHOL, V229, P168, DOI 10.1002/path.4123; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Hansell CAH, 2011, BLOOD, V117, P5413, DOI 10.1182/blood-2010-11-317115; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kwong JA, 2011, J VIROL, V85, P7563, DOI 10.1128/JVI.00630-11; Laarman AJ, 2012, EMBO J, V31, P3607, DOI 10.1038/emboj.2012.212; Lee KM, 2013, TRENDS IMMUNOL, V34, P7, DOI 10.1016/j.it.2012.08.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Madigan J, 2010, J IMMUNOL, V184, P3202, DOI 10.4049/jimmunol.0902118; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; McKimmie CS, 2008, J IMMUNOL, V181, P3353, DOI 10.4049/jimmunol.181.5.3353; McKimmie CS, 2013, BLOOD, V121, P3768, DOI 10.1182/blood-2012-04-425314; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2013, J IMMUNOL, V190, P6450, DOI 10.4049/jimmunol.1201429; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Singh MD, 2012, AM J PATHOL, V181, P1158, DOI 10.1016/j.ajpath.2012.06.042; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Webb LMC, 2005, MINI-REV MED CHEM, V5, P833, DOI 10.2174/1389557054867110; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	53	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12330	12342		10.1074/jbc.M113.534545	http://dx.doi.org/10.1074/jbc.M113.534545			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644289	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000335581400012
J	Takahashi, K; Furuya, F; Shimura, H; Kaneshige, M; Kobayashi, T				Takahashi, Kazuya; Furuya, Fumihiko; Shimura, Hiroki; Kaneshige, Masahiro; Kobayashi, Tetsuro			Impaired Oxidative Endoplasmic Reticulum Stress Response Caused by Deficiency of Thyroid Hormone Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Endoplasmic Reticulum Stress; Islet; Thyroid; Thyroid Hormone	UNFOLDED PROTEIN RESPONSE; BETA-CELL; INSULIN-SECRETION; REPLACEMENT THERAPY; GLUCOSE; HYPOTHYROIDISM; SENSITIVITY; METABOLISM; EXPRESSION; APOPTOSIS	Background: Endoplasmic reticulum (ER) stress is involved in -cell failure and apoptotic death. Results: Upon endogenous TR knockdown, ER stress significantly enhanced apoptosis in pancreatic -cells. Conclusion: TR facilitates reduced apoptosis in pancreatic -cells under ER stress. Significance: TR is coupled to stress response modulation and improved survival of pancreatic -cells. Thyroid hormone receptor (TR) is critical to postnatal pancreatic -cell maintenance. To investigate the association between TR and the survival of pancreatic -cells under endoplasmic reticulum (ER) stress, the expression of endogenous TR was inhibited by infection with an adenovirus expressing double-stranded short hairpin RNA against TR (AdshTR). In control adenovirus-infected pancreatic -cells, palmitate enhanced the expression of activating transcription factor 4 (ATF4) and heme oxygenase 1, which facilitates adaptation to oxidative ER stress. However, in AdshTR-infected pancreatic -cells, palmitate did not induce ATF4-mediated integrated stress response, and oxidative stress-associated apoptotic cell death was significantly enhanced. TR-deficient mice or wild-type mice (WT) were fed a high fat diet (HFD) for 30 weeks, and the effect of oxidative ER stress on pancreatic -cells was analyzed. HFD-treated TR-deficient mice had high blood glucose levels and low plasma insulin levels. In HFD-treated TR-deficient mice, ATF4 was not induced, and apoptosis was enhanced compared with HFD-treated WT mice. Furthermore, the expression level of 8-hydroxydeoxyguanosine, an oxidative stress marker, was enhanced in the -cells of HFD-treated TR-deficient mice. These results indicate that endogenous TR plays an important role for the expression of ATF4 and facilitates reduced apoptosis in pancreatic -cells under ER stress.	[Takahashi, Kazuya; Furuya, Fumihiko; Kaneshige, Masahiro; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo, Yamanashi 4093898, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima 9601247, Japan	University of Yamanashi; Fukushima Medical University	Furuya, F (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	ffuruya@yamanashi.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24591359]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 24591359.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; Furuya F, 2013, J BIOL CHEM, V288, P16155, DOI 10.1074/jbc.M112.438192; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Handisurya A, 2008, CLIN ENDOCRINOL, V69, P963, DOI 10.1111/j.1365-2265.2008.03280.x; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hassani Z., 2007, NUCLEIC ACIDS RES, V35, pe65; Hill JO, 2000, J NUTR, V130, p284S, DOI 10.1093/jn/130.2.284S; LENZEN S, 1984, ENDOCR REV, V5, P411, DOI 10.1210/edrv-5-3-411; LENZEN S, 1976, ENDOCRINOLOGY, V99, P125, DOI 10.1210/endo-99-1-125; LENZEN S, 1978, METABOLISM, V27, P81, DOI 10.1016/0026-0495(78)90126-9; Lin KH, 1997, BIOCHEM BIOPH RES CO, V238, P280, DOI 10.1006/bbrc.1997.7285; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; Macchia PE, 2001, P NATL ACAD SCI USA, V98, P349, DOI 10.1073/pnas.011306998; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stanicka S, 2005, CLIN CHEM LAB MED, V43, P715, DOI 10.1515/CCLM.2005.121; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Woods SC, 2004, PHYSIOL BEHAV, V82, P187, DOI 10.1016/j.physbeh.2004.04.050; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06	34	11	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12485	12493		10.1074/jbc.M113.544122	http://dx.doi.org/10.1074/jbc.M113.544122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644288	hybrid, Green Published			2022-12-25	WOS:000335581400024
J	Abeles, IY; Gomez-Ramirez, M				Abeles, Ilana Y.; Gomez-Ramirez, Manuel			Impairments in Background and Event-Related Alpha-Band Oscillatory Activity in Patients with Schizophrenia	PLOS ONE			English	Article							VISUAL EVOKED-RESPONSE; VISUOSPATIAL ATTENTION; WORKING-MEMORY; NEURONAL OSCILLATIONS; PHASE SYNCHRONIZATION; SELECTIVE ATTENTION; PROCESSING DEFICITS; SPATIAL ATTENTION; QUANTITATIVE EEG; OCCIPITAL CORTEX	Studies show that patients with schizophrenia exhibit impaired responses to sensory stimuli, especially at the early stages of neural processing. In particular, patients' alpha-band (8-14 Hz) event-related desynchronization (ERD) and visual P1 event-related potential (ERP) component tend to be significantly reduced, with P1 ERP deficits greater for visual stimuli biased towards the magnocellular system. In healthy controls, studies show that pre-stimulus alpha (background alpha) plays a pivotal role in sensory processing and behavior, largely by shaping the neural responses to incoming stimuli. Here, we address whether patients' ERD and P1 deficits stem from impairments in pre-stimulus alpha mechanisms. To address this question we recorded electrophysiological activity in patients with schizophrenia and healthy controls while they engaged in a visual discrimination task with low, medium, and high contrast stimuli. The results revealed a significant decrease in patients' ERDs, which was largely driven by reductions in pre-stimulus alpha. These reductions were most prominent in right-hemispheric areas. We also observed a systematic relationship between pre-stimulus alpha and the P1 component across different contrast levels. However, this relationship was only observed in healthy controls. Taken together, these findings highlight a substantial anomaly in patients' amplitude-based alpha background activity over visual areas. The results provide further support that pre-stimulus alpha activity plays an active role in perception by modulating the neural responses to incoming sensory inputs, a mechanism that seems to be compromised in schizophrenia.	[Abeles, Ilana Y.; Gomez-Ramirez, Manuel] CUNY City Coll, Dept Psychol, Program Cognit Neurosci, New York, NY 10031 USA; [Abeles, Ilana Y.] Nathan S Kline Inst Psychiat Res, Program Cognit Neurosci & Schizophrenia, Orangeburg, NY 10962 USA; [Gomez-Ramirez, Manuel] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD USA	City University of New York (CUNY) System; City College of New York (CUNY); Nathan Kline Institute for Psychiatric Research; Johns Hopkins University	Gomez-Ramirez, M (corresponding author), CUNY City Coll, Dept Psychol, Program Cognit Neurosci, New York, NY 10031 USA.	gomezramirezm@jhu.edu		gomez-ramirez, manuel/0000-0002-1017-5256	National Institute of Mental Health; Johns Hopkins University Libraries;  [RO1 MH84848]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084848] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johns Hopkins University Libraries(Johns Hopkins University); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The funders, National Institute of Mental Health, had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript. Funding source: RO1 MH84848 awarded to Dr. Pamela D. Butler. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries.	Bachman P, 2008, SCHIZOPHR RES, V103, P293, DOI 10.1016/j.schres.2008.04.006; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P2593, DOI 10.1016/j.clinph.2004.06.004; BASAR E, 1984, INT J NEUROSCI, V24, P1, DOI 10.3109/00207458409079530; Basar-Eroglu C, 2008, BRAIN RES, V1235, P143, DOI 10.1016/j.brainres.2008.06.114; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; BRANDT ME, 1991, INT J NEUROSCI, V61, P261, DOI 10.3109/00207459108990744; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Butler PD, 2001, AM J PSYCHIAT, V158, P1126, DOI 10.1176/appi.ajp.158.7.1126; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Ciulla C, 1999, BRAIN TOPOGR, V11, P211, DOI 10.1023/A:1022233828999; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Collins HR, 2012, J COGNITIVE NEUROSCI, V24, P2428, DOI 10.1162/jocn_a_00273; Dias EC, 2011, ARCH GEN PSYCHIAT, V68, P654, DOI 10.1001/archgenpsychiatry.2011.17; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Dockree PM, 2005, NEUROIMAGE, V27, P587, DOI 10.1016/j.neuroimage.2005.05.044; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doniger GM, 2002, ARCH GEN PSYCHIAT, V59, P1011, DOI 10.1001/archpsyc.59.11.1011; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; EKMAN P, 1974, WESTERN J MED, V120, P310; Fellinger R, 2011, BRAIN RES BULL, V85, P417, DOI 10.1016/j.brainresbull.2011.03.025; Ford JM, 2008, BRAIN RES, V1235, P133, DOI 10.1016/j.brainres.2008.06.048; Foxe JJ, 2001, NEUROREPORT, V12, P3815, DOI 10.1097/00001756-200112040-00043; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Gaspar PA, 2011, SCHIZOPHR RES, V131, P268, DOI 10.1016/j.schres.2011.06.010; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Gomez-Ramirez M, 2009, BRAIN TOPOGR, V22, P44, DOI 10.1007/s10548-008-0068-z; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Higashima M, 2007, INT J PSYCHOPHYSIOL, V65, P95, DOI 10.1016/j.ijpsycho.2007.03.008; Holz EM, 2008, BRAIN TOPOGR, V21, P93, DOI 10.1007/s10548-008-0066-1; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; ITIL TM, 1972, BIOL PSYCHIAT, V5, P1; ITIL TM, 1977, SCHIZOPHRENIA BULL, V3, P61, DOI 10.1093/schbul/3.1.61; JANSEN BH, 1991, ELECTROEN CLIN NEURO, V80, P241, DOI 10.1016/0168-5597(91)90107-9; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kelly SP, 2009, EUR J NEUROSCI, V30, P2224, DOI 10.1111/j.1460-9568.2009.06980.x; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Knott V, 2001, SCHIZOPHR RES, V50, P41, DOI 10.1016/S0920-9964(00)00165-1; Koh Y, 2011, SCHIZOPHR RES, V126, P36, DOI 10.1016/j.schres.2010.10.001; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2013, J NEUROSCI, V33, P11692, DOI 10.1523/JNEUROSCI.0010-13.2013; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; McCourt ME, 2008, SCHIZOPHR RES, V102, P189, DOI 10.1016/j.schres.2008.03.021; Mishra J, 2012, NEUROIMAGE, V59, P1968, DOI 10.1016/j.neuroimage.2011.09.028; Mizuno M, 1997, J NERV MENT DIS, V185, P427, DOI 10.1097/00005053-199707000-00002; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; OMORI M, 1995, BIOL PSYCHIAT, V38, P303, DOI 10.1016/0006-3223(95)00300-6; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Popov T, 2011, NEUROIMAGE, V56, P307, DOI 10.1016/j.neuroimage.2011.02.016; Praamstra P, 2007, J NEUROPHYSIOL, V98, P2848, DOI 10.1152/jn.00224.2007; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schechter I, 2005, CLIN NEUROPHYSIOL, V116, P2204, DOI 10.1016/j.clinph.2005.06.013; SCHIMKE H, 1990, EEG-EMG-Z ELEK ELEKT, V21, P219; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SPONHEIM SR, 1994, PSYCHOPHYSIOLOGY, V31, P37, DOI 10.1111/j.1469-8986.1994.tb01023.x; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Vanni S, 1997, J NEUROSCI, V17, P7141; White TP, 2010, CLIN NEUROPHYSIOL, V121, P1427, DOI 10.1016/j.clinph.2010.03.024; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Witham CL, 2012, J NEUROPHYSIOL, V108, P3342, DOI 10.1152/jn.00462.2012; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Worden MS, 2000, J NEUROSCI, V20	79	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91720	10.1371/journal.pone.0091720	http://dx.doi.org/10.1371/journal.pone.0091720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646909	Green Published, gold			2022-12-25	WOS:000333348500047
J	Goltz, D; Hittetiya, K; Yadegari, H; Driesen, J; Kirfel, J; Neuhaus, T; Steiner, S; Esch, C; Bedorf, J; Hertfelder, HJ; Fischer, HP				Goltz, Diane; Hittetiya, Kanishka; Yadegari, Hamideh; Driesen, Julia; Kirfel, Jutta; Neuhaus, Thomas; Steiner, Susanne; Esch, Christiane; Bedorf, Joerg; Hertfelder, Hans-Joerg; Fischer, Hans-Peter			ATZ11 Recognizes Not Only Z-alpha(1)-Antitrypsin-Polymers and Complexed Forms of Non-Z-alpha(1)-Antitrypsin but Also the von Willebrand Factor	PLOS ONE			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; ALPHA-1-ANTITRYPSIN; IDENTIFICATION; POLYMERS; INSIGHTS; ALLELE; MUTANT; TISSUE; ELISA	Aims: The ATZ11 antibody has been well established for the identification of alpha(1)-anti-trypsin (AAT) molecule type PiZ (Z-AAT) in blood samples and liver tissue. In this study, we systematically analyzed the antibody for additional binding sites in human tissue. Methods and Results: Ultrastructural ATZ11 binding was investigated immunoelectron microscopically in human umbilical vein endothelial cells (HUVECs) and in platelets of a healthy individual. Human embryonic kidney (HEK293) cells were transiently transfected with Von Willebrand factor (VWF) and analyzed immunocytochemically using confocal microscopy and SDS-PAGE electrophoresis followed by western blotting (WB). Platelets and serum samples of VWF-competent and VWF-deficient patients were investigated using native PAGE and SDS-PAGE electrophoresis followed by WB. The specificity of the ATZ11 reaction was tested immunohistochemically by extensive antibody-mediated blocking of AAT- and VWF-antigens. ATZ11-positive epitopes could be detected in Weibel-Palade bodies (WPBs) of HUVECs and alpha-granules of platelets. ATZ11 stains pseudo-WBP containing recombinant wild-type VWF (rVWF-WT) in HEK293 cells. In SDS-PAGE electrophoresis followed by WB, anti-VWF and ATZ11 both identified rVWF-WT. However, neither rVWF-WT-multimers, human VWF-multimers, nor serum proteins of VWF-deficient patients were detected using ATZ11 by WB, whereas anti-VWF antibody (anti-VWF) detected rVWF-WT-multimers as well as human VWF-multimers. In human tissue specimens, AAT-antigen blockade using anti-AAT antibody abolished ATZ11 staining of Z-AAT in a heterozygous AAT- deficient patient, whereas VWF-antigen blockade using anti-VWF abolished ATZ11 staining of endothelial cells and megakaryocytes. Conclusions: ATZ11 reacts with cellular bound and denatured rVWF-WT and human VWF as shown using immunocytochemistry and subsequent confocal imaging, immunoelectron microscopy, SDS-PAGE and WB, and immunohistology. These immunoreactions are independent of the binding of Z-AAT-molecules and non-Z-AAT complexes.	[Goltz, Diane; Hittetiya, Kanishka; Kirfel, Jutta; Steiner, Susanne; Esch, Christiane; Bedorf, Joerg; Fischer, Hans-Peter] Univ Bonn, Dept Pathol, Bonn, Germany; [Yadegari, Hamideh; Driesen, Julia; Hertfelder, Hans-Joerg] Univ Bonn, Inst Expt Hematol, Bonn, Germany; [Neuhaus, Thomas] St Vincenz Hosp, Med Clin, Limburg, Germany	University of Bonn; University of Bonn	Fischer, HP (corresponding author), Univ Bonn, Dept Pathol, Bonn, Germany.	hans-peter.fischer@ukb.uni-bonn.de	Yadegari, Hamideh/AAA-8749-2019					Aldonyte R, 2004, HISTOPATHOLOGY, V45, P587, DOI 10.1111/j.1365-2559.2004.02021.x; Baslund B, 1996, EUR J CLIN INVEST, V26, P786, DOI 10.1046/j.1365-2362.1996.2070553.x; Blano I, 2008, PAIN REASEARCH PORGR, P113; BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312; CALLEA F, 1991, J HEPATOL, V12, P372, DOI 10.1016/0168-8278(91)90842-Y; Fischer HP, 2000, J HEPATOL, V33, P883, DOI 10.1016/S0168-8278(00)80119-1; GEE B, 1991, J HISTOCHEM CYTOCHEM, V39, P863, DOI 10.1177/39.6.1709659; Gershagen S, 2004, CLIN CHEM, V50, P2407, DOI 10.1373/clinchem.2004.042424; Janciauskiene S, 2004, HEPATOLOGY, V40, P1203, DOI 10.1002/hep.20451; Janciauskiene S, 1996, SCAND J CLIN LAB INV, V56, P597, DOI 10.3109/00365519609090594; Janciauskiene S, 2002, J BIOL CHEM, V277, P26540, DOI 10.1074/jbc.M203832200; Kiskin NI, 2010, J CELL SCI, V123, P2964, DOI 10.1242/jcs.073593; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Mahr AD, 2010, ARTHRITIS RHEUM-US, V62, P3760, DOI 10.1002/art.27742; Mazodier P, 1996, QJM-INT J MED, V89, P599; Morris H, 2011, ANN RHEUM DIS, V70, P1851, DOI 10.1136/ard.2011.153569; Pannerden HVT, 2010, BLOOD, V116, P1147, DOI 10.1182/blood-2010-02-268680; ROTH J, 1989, HISTOCHEMISTRY, V92, P47, DOI 10.1007/BF00495015; SAVIGE JA, 1995, CLIN EXP IMMUNOL, V100, P194; Theuerkauf I, 2001, VIRCHOWS ARCH, V438, P498, DOI 10.1007/s004280000364; WALLMARK A, 1984, P NATL ACAD SCI-BIOL, V81, P5690, DOI 10.1073/pnas.81.18.5690; Yadegari H, 2013, HAEMATOLOGICA, V98, P1315, DOI 10.3324/haematol.2013.084111; Zelvyte I, 2003, EUR J CANCER PREV, V12, P117, DOI 10.1097/00008469-200304000-00005	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91538	10.1371/journal.pone.0091538	http://dx.doi.org/10.1371/journal.pone.0091538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646657	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500038
J	Lee, WH; Hsu, PC; Chu, CY; Su, HM; Lee, CS; Yen, HW; Lin, TH; Voon, WC; Lai, WT; Sheu, SH				Lee, Wen-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Su, Ho-Ming; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Cardiovascular Events in Patients with Atherothrombotic Disease: A Population-Based Longitudinal Study in Taiwan	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ASIA-PACIFIC REGION; PERIPHERAL ARTERY-DISEASE; ANKLE-BRACHIAL INDEX; ISCHEMIC-STROKE; RISK-FACTORS; REACH REGISTRY; ETHNIC-DIFFERENCES; CAROTID PLAQUE; BLOOD-PRESSURE	Background: Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disease (CAD), and peripheral arterial disease (PAD), contribute to the major causes of death in the world. Although several studies showed the association between polyvascular disease and poor cardiovascular (CV) outcomes in Asian population, there was no large-scale study to validate this relationship in this population. Methods and Results: This retrospective cohort study included patients with a diagnosis of CVD, CAD, or PAD from the database contained in the Taiwan National Health Insurance Bureau during 2001-2004. A total of 19954 patients were enrolled in this study. The atherothrombotic disease score was defined according to the number of atherothrombotic disease. The study endpoints included acute coronary syndrome (ACS), all strokes, vascular procedures, in hospital mortality, and so on. The event rate of ischemic stroke (18.2%) was higher than that of acute myocardial infarction (5.7%) in our patients (P = 0.0006). In the multivariate Cox regression analyses, the adjusted hazard ratios (HRs) of each increment of atherothrombotic disease score in predicting ACS, all strokes, vascular procedures, and in hospital mortality were 1.41, 1.66, 1.30, and 1.14, respectively (P <= 0.0169). Conclusions: This large population-based longitudinal study in patients with atherothrombotic disease demonstrated the risk of subsequent ischemic stroke was higher than that of subsequent AMI. In addition, the subsequent adverse CV events including ACS, all stroke, vascular procedures, and in hospital mortality were progressively increased as the increase of atherothrombotic disease score.	[Lee, Wen-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Su, Ho-Ming; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Wen-Hsien; Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan.	cobeshm@seed.net.tw	蘇, 河名/AAE-9843-2019	Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X; Lin, Tsung-Hsien/0000-0002-7226-8730				ASSAF AR, 1993, NEW ENGL J MED, V329, P931, DOI 10.1056/NEJM199309233291307; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Blanco M, 2010, ATHEROSCLEROSIS, V208, P587, DOI 10.1016/j.atherosclerosis.2009.07.041; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Brilakis ES, 2009, CIRCULATION, V120, P560, DOI 10.1161/CIRCULATIONAHA.109.877092; Chang KC, 2003, STROKE, V34, pE219, DOI 10.1161/01.STR.0000095565.12945.18; Chang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053207; Chen CL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-118; Chen JJ, 2011, ANGIOLOGY, V62, P306, DOI 10.1177/0003319710382771; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003435; Directorate-general of budget accounting and statistics executive yuan republic of china, 2010, HEALTH, V114; Huang HL, 2013, J FORMOS MED ASSOC, P1, DOI DOI 10.1007/S10878-013-9633-9; Ji RJ, 2013, JAMA NEUROL, V70, P51, DOI 10.1001/jamaneurol.2013.575; Klein LW, 2003, J AM COLL CARDIOL, V41, P529, DOI 10.1016/S0735-1097(02)02861-9; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lee WH, 2013, THROMB RES, V132, P190, DOI 10.1016/j.thromres.2013.01.036; Lee WH, 2013, CIRC J, V77, P1046, DOI 10.1253/circj.CJ-12-1122; Li CY, 2012, ACTA CARDIOL SIN, V28, P17; Lin MS, 2008, CIRC-CARDIOVASC INTE, V1, P119, DOI 10.1161/CIRCINTERVENTIONS.108.772350; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; Mukherjee D, 2007, AM J CARDIOL, V100, P1, DOI 10.1016/j.amjcard.2007.02.046; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakano T, 2004, CEREBROVASC DIS, V17, P212, DOI 10.1159/000075793; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Suarez C, 2010, VASC MED, V15, P259, DOI 10.1177/1358863X10373299; Uchiyama S, 2009, J NEUROL SCI, V287, P45, DOI 10.1016/j.jns.2009.09.011; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wang TD, 2010, METABOLISM, V59, P400, DOI 10.1016/j.metabol.2009.08.009; Wen HC, 2006, ANN THORAC SURG, V81, P835, DOI 10.1016/j.athoracsur.2005.09.031; Woodward M, 2003, DIABETES CARE, V26, P360; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92577	10.1371/journal.pone.0092577	http://dx.doi.org/10.1371/journal.pone.0092577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647769	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500146
J	Tang, J; Liu, H; Gao, C; Mu, LX; Yang, SL; Rong, MQ; Zhang, ZY; Liu, J; Ding, Q; Lai, R				Tang, Jing; Liu, Han; Gao, Chen; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Ding, Qiang; Lai, Ren			A Small Peptide with Potential Ability to Promote Wound Healing	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SKIN; MYOFIBROBLASTS; MIGRATION; SMAD2	Wound-healing represents a major health burden, such as diabetes-induced skin ulcers and burning. Many works are being tried to find ideal clinical wound-healing biomaterials. Especially, small molecules with low cost and function to promote production of endogenous wound healing agents (i.e. transforming growth factor beta, TGF-beta) are excellent candidates. In this study, a small peptide (tiger17, c[WCKPKPKPRCH-NH2]) containing only 11 amino acid residues was designed and proved to be a potent wound healer. It showed strong wound healing-promoting activity in a murine model of full thickness dermal wound. Tiger17 exerted significant effects on three stages of wound healing progresses including (1) the induction of macrophages recruitment to wound site at inflammatory reaction stage; (2) the promotion of the migration and proliferation both keratinocytes and fibroblasts, leading to reepithelialization and granulation tissue formation; and (3) tissue remodeling phase, by promoting the release of transforming TGF-beta 1 and interleukin 6 (IL-6) in murine macrophages and activating mitogen-activated protein kinases (MAPK) signaling pathways. Considering its easy production, store and transfer and function to promote production of endogenous wound healing agents (TGF-beta), tiger17 might be an exciting biomaterial or template for the development of novel wound-healing agents.	[Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Gao, Chen] Jiangsu Anim Husb & Vet Coll, Coll Vet Med, Taizhou, Jiangsu, Peoples R China; [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Zhang, Zhiye; Liu, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ding, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	dqnj2000@aliyun.com; rlai@mail.kiz.ac.cn		Liu, Jie/0000-0002-1069-2384	Ministry of Science and Technology [2010CB529800, 2013CB911300]; National Natural Science Foundation [30830021, 31070701, 31000960, 31025025, U1132601, 31200590]; Yunnan Province [2011CI139, 2012BC009]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported by Ministry of Science and Technology (2010CB529800, 2013CB911300), National Natural Science Foundation (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590), and Yunnan Province (2011CI139, 2012BC009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Block ER, 2010, MOL BIOL CELL, V21, P2172, DOI 10.1091/mbc.E09-12-1026; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Brem H, 2000, ARCH SURG-CHICAGO, V135, P627, DOI 10.1001/archsurg.135.6.627; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; DARBY I, 1990, LAB INVEST, V63, P21; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; GABBIANI G, 1972, PATHOL BIOL, V20, P6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haroon ZA, 2000, ANN SURG, V231, P137, DOI 10.1097/00000658-200001000-00020; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Katherine MM, 1998, J IMMUNOL, V160, P1001; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Luckett-Chastain LR, 2009, BRIT J DERMATOL, V161, P237, DOI 10.1111/j.1365-2133.2009.09215.x; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nwomeh BC, 1998, CLIN PLAST SURG, V25, P341; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Raja, 2007, Front Biosci, V12, P2849; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Song YZ, 2009, PEPTIDES, V30, P1228, DOI 10.1016/j.peptides.2009.03.020; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072923	39	55	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92082	10.1371/journal.pone.0092082	http://dx.doi.org/10.1371/journal.pone.0092082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647450	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500081
J	Vollmer, AL; Muhlig, M; Steil, JJ; Pitsch, K; Fritsch, J; Rohlfing, KJ; Wrede, B				Vollmer, Anna-Lisa; Muehlig, Manuel; Steil, Jochen J.; Pitsch, Karola; Fritsch, Jannik; Rohlfing, Katharina J.; Wrede, Britta			Robots Show Us How to Teach Them: Feedback from Robots Shapes Tutoring Behavior during Action Learning	PLOS ONE			English	Article							KNOWLEDGE; TASK	Robot learning by imitation requires the detection of a tutor's action demonstration and its relevant parts. Current approaches implicitly assume a unidirectional transfer of knowledge from tutor to learner. The presented work challenges this predominant assumption based on an extensive user study with an autonomously interacting robot. We show that by providing feedback, a robot learner influences the human tutor's movement demonstrations in the process of action learning. We argue that the robot's feedback strongly shapes how tutors signal what is relevant to an action and thus advocate a paradigm shift in robot action learning research toward truly interactive systems learning in and benefiting from interaction.	[Vollmer, Anna-Lisa] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Muehlig, Manuel; Fritsch, Jannik] Honda Res Inst Europe, Offenbach, Germany; [Steil, Jochen J.; Pitsch, Karola; Rohlfing, Katharina J.; Wrede, Britta] Univ Bielefeld, Fac Technol, Res Inst Cognit & Robot, D-33615 Bielefeld, Germany	University of Plymouth; Honda Motor Company; University of Bielefeld	Vollmer, AL (corresponding author), Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Portland Sq, Plymouth PL4 8AA, Devon, England.	anna-lisa.vollmer@plymouth.ac.uk		Vollmer, Anna-Lisa/0000-0002-9378-7249; Pitsch, Karola/0000-0002-6458-7264	Honda Research Institute Europe	Honda Research Institute Europe	The authors gratefully acknowledge the financial support from Honda Research Institute Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJCSY R, 1988, P IEEE, V76, P996, DOI 10.1109/5.5968; Calinon S, 2008, P WORKSH SOC INT INT, P27; Calinon S, 2007, IEEE T SYST MAN CY B, V37, P286, DOI 10.1109/TSMCB.2006.886952; Call J, 2002, FROM ANIM ANIMAT, P211; Chao C, 2010, ACMIEEE INT CONF HUM, P317, DOI 10.1109/HRI.2010.5453178; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Fischer K, 2011, INTERACT STUD, V12, P134, DOI 10.1075/is.12.1.06fis; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Gergely G, 2006, WENNER GREN INT S SE, P229; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; KUNIYOSHI Y, 1994, IEEE T ROBOTIC AUTOM, V10, P799, DOI 10.1109/70.338535; Mirnig N., 2011, 2011 RO-MAN: The 20th IEEE International Symposium on Robot and Human Interactive Communication, P343, DOI 10.1109/ROMAN.2011.6005260; Muhlig M, 2012, AUTON ROBOT, V32, P97, DOI 10.1007/s10514-011-9261-0; Nagai Y, 2009, IEEE T AUTON MENT DE, V1, P44, DOI 10.1109/TAMD.2009.2021090; Pitsch K, 2009, P INT C GEST SPEECH; Pitsch K, 2013, INTERACT STUD, V14, P268, DOI 10.1075/is.14.2.06pit; Rohlfing KJ, 2006, ADV ROBOTICS, V20, P1183, DOI 10.1163/156855306778522532; Rosenthal Stephanie, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P1137, DOI 10.1109/ROMAN.2009.5326291; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Strauss S, 2002, COGNITIVE DEV, V17, P1473, DOI 10.1016/S0885-2014(02)00128-4; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Thibault PJ, 2011, ECOL PSYCHOL, V23, P210, DOI 10.1080/10407413.2011.591274; Thomaz A. L., 2009, 2009 4th ACM/IEEE International Conference on Human-Robot Interaction (HRI), P15; Thomaz AL, 2006, P IEEE 5 INT C DEV L; Vollmer Anna-Lisa, 2010, 2010 IEEE 9th International Conference on Development and Learning (ICDL 2010), P76, DOI 10.1109/DEVLRN.2010.5578863; Vollmer A-L, 2009, P IEEE 8 INT C DEV L; Vollmer A-L, 2013, P 17 WORKSH SEM PRAG; Weiss A, 2011, ADV INTERACT STUD, V2, P89	28	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91349	10.1371/journal.pone.0091349	http://dx.doi.org/10.1371/journal.pone.0091349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646510	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500030
J	Wan, SB; Mak, MW; Kung, SY				Wan, Shibiao; Mak, Man-Wai; Kung, Sun-Yuan			HybridGO-Loc: Mining Hybrid Features on Gene Ontology for Predicting Subcellular Localization of Multi-Location Proteins	PLOS ONE			English	Article							SEMANTIC SIMILARITY MEASURES; FUNCTIONAL SIMILARITY; GO; EXPRESSION; TAXONOMY; CLASSIFIER; LOCATION; ATTRIBUTES; MECHANISMS; SEQUENCE	Protein subcellular localization prediction, as an essential step to elucidate the functions in vivo of proteins and identify drugs targets, has been extensively studied in previous decades. Instead of only determining subcellular localization of single-label proteins, recent studies have focused on predicting both single-and multi-location proteins. Computational methods based on Gene Ontology (GO) have been demonstrated to be superior to methods based on other features. However, existing GO-based methods focus on the occurrences of GO terms and disregard their relationships. This paper proposes a multi-label subcellular-localization predictor, namely HybridGO-Loc, that leverages not only the GO term occurrences but also the inter-term relationships. This is achieved by hybridizing the GO frequencies of occurrences and the semantic similarity between GO terms. Given a protein, a set of GO terms are retrieved by searching against the gene ontology database, using the accession numbers of homologous proteins obtained via BLAST search as the keys. The frequency of GO occurrences and semantic similarity (SS) between GO terms are used to formulate frequency vectors and semantic similarity vectors, respectively, which are subsequently hybridized to construct fusion vectors. An adaptive-decision based multi-label support vector machine (SVM) classifier is proposed to classify the fusion vectors. Experimental results based on recent benchmark datasets and a new dataset containing novel proteins show that the proposed hybrid-feature predictor significantly outperforms predictors based on individual GO features as well as other state-of-the-art predictors. For readers' convenience, the HybridGO-Loc server, which is for predicting virus or plant proteins, is available online at http://bioinfo.eie.polyu.edu.hk/HybridGoServer/.	[Wan, Shibiao; Mak, Man-Wai] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China; [Kung, Sun-Yuan] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Hong Kong Polytechnic University; Princeton University	Mak, MW (corresponding author), Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China.	enmwmak@polyu.edu.hk	Mak, Manwai/C-3750-2014; Wan, Shibiao/P-1667-2014	Mak, Manwai/0000-0001-8854-3760; Wan, Shibiao/0000-0003-0661-2684	HKPolyU [G-YJ86, G-YL78]	HKPolyU	This work was in part supported by HKPolyU Grant Nos. G-YJ86 and G-YL78. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P655; Adelfio A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-502; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bodenreider O, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P91; Brady Scott, 2008, Pac Symp Biocomput, P604; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chabalier J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-235; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Chi SM, 2012, BIOINFORMATICS, V28, P1028, DOI 10.1093/bioinformatics/bts062; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; del Pozo A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-50; Dembczynski K, 2012, MACH LEARN, V88, P5, DOI 10.1007/s10994-012-5285-8; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Faria D., 2007, PROTEINON WEB TOOL P; Fyshe A, 2008, BIOINFORMATICS, V24, P2512, DOI 10.1093/bioinformatics/btn463; Gao W, 2013, ARTIF INTELL, V199, P22, DOI 10.1016/j.artint.2013.03.001; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hastie T., 2001, ELEMENT STAT LEARNIN; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; He J, 2011, PLOS ONE, V7; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Jiang J.J., 1997, P INT C RES COMP LIN, P19; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; KRUTOVSKIKH V, 1994, INT J CANCER, V56, P87; Kung S.Y., 2011, 2011 IEEE INT WORKSH, P1; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Li LQ, 2012, PROTEIN PEPTIDE LETT, V19, P375, DOI 10.2174/092986612799789369; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075826; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Mak MW, 2008, IEEE ACM T COMPUT BI, V5, P416, DOI 10.1109/TCBB.2007.70256; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Mueller JC, 2004, MITOCHONDRION, V3, P315, DOI 10.1016/j.mito.2004.02.002; Nair R, 2008, METHODS MOL BIOL, V484, P435, DOI 10.1007/978-1-59745-398-1_27; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Odell J., 1998, ADV OBJECT ORIENTED, P139; Pesquita C, 2009, JB2009 CHALLENGES BI, V157; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Riensche Roderick M., 2007, 2007 IEEE Congress on Services, P99, DOI 10.1109/SERVICES.2007.73; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Tao Y, 2007, BIOINFORMATICS, V23, pI529, DOI 10.1093/bioinformatics/btm195; Wan S, 2013, ENGINEERING, V5, P68; Wan SB, 2013, INT CONF ACOUST SPEE, P3547, DOI 10.1109/ICASSP.2013.6638318; Wan SB, 2013, J THEOR BIOL, V323, P40, DOI 10.1016/j.jtbi.2013.01.012; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036317; WINSTON ME, 1987, COGNITIVE SCI, V11, P417, DOI 10.1207/s15516709cog1104_2; Wu HW, 2005, NUCLEIC ACIDS RES, V33, P2822, DOI 10.1093/nar/gki573; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xu T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-472; Yang D, 2008, BIOINFORMATICS, V24, P265, DOI 10.1093/bioinformatics/btm558; Yang Y, 2010, INT J NEURAL SYST, V20, P13, DOI 10.1142/S0129065710002206; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu H, 2005, GENE, V352, P75, DOI 10.1016/j.gene.2005.03.033; Zhu MZ, 2007, GENE, V391, P113, DOI 10.1016/j.gene.2006.12.008	83	65	67	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89545	10.1371/journal.pone.0089545	http://dx.doi.org/10.1371/journal.pone.0089545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647341	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500006
J	Rao, RP; Scheffer, L; Srideshikan, SM; Parthibane, V; Kosakowska-Cholody, T; Masood, MA; Nagashima, K; Gudla, P; Lockett, S; Acharya, U; Acharya, JK				Rao, Raghavendra Pralhada; Scheffer, Luana; Srideshikan, Sargur M.; Parthibane, Velayoudame; Kosakowska-Cholody, Teresa; Masood, M. Athar; Nagashima, Kunio; Gudla, Prabhakar; Lockett, Stephen; Acharya, Usha; Acharya, Jairaj K.			Ceramide Transfer Protein Deficiency Compromises Organelle Function and Leads to Senescence in Primary Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; RAT-LIVER; LIFE-SPAN; GOLGI; TRAFFICKING; CERT; GLUCOSYLCERAMIDE; APOPTOSIS; TRANSPORT	Ceramide transfer protein (CERT) transfers ceramide from the endoplasmic reticulum (ER) to the Golgi complex. Its deficiency in mouse leads to embryonic death at E11.5. CERT deficient embryos die from cardiac failure due to defective organogenesis, but not due to ceramide induced apoptotic or necrotic cell death. In the current study we examined the effect of CERT deficiency in a primary cell line, namely, mouse embryonic fibroblasts (MEFs). We show that in MEFs, unlike in mutant embryos, lack of CERT does not lead to increased ceramide but causes an accumulation of hexosylceramides. Nevertheless, the defects due to defective sphingolipid metabolism that ensue, when ceramide fails to be trafficked from ER to the Golgi complex, compromise the viability of the cell. Therefore, MEFs display an incipient ER stress. While we observe that ceramide trafficking from ER to the Golgi complex is compromised, the forward transport of VSVG-GFP protein is unhindered from ER to Golgi complex to the plasma membrane. However, retrograde trafficking of the plasma membrane-associated cholera toxin B to the Golgi complex is reduced. The dysregulated sphingolipid metabolism also leads to increased mitochondrial hexosylceramide. The mitochondrial functions are also compromised in mutant MEFs since they have reduced ATP levels, have increased reactive oxygen species, and show increased glutathione reductase activity. Live-cell imaging shows that the mutant mitochondria exhibit reduced fission and fusion events. The mitochondrial dysfunction leads to an increased mitophagy in the CERT mutant MEFs. The compromised organelle function compromise cell viability and results in premature senescence of these MEFs.	[Rao, Raghavendra Pralhada; Scheffer, Luana; Srideshikan, Sargur M.; Parthibane, Velayoudame; Kosakowska-Cholody, Teresa; Acharya, Jairaj K.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA; [Masood, M. Athar] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Frederick, MD USA; [Nagashima, Kunio] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Frederick, MD USA; [Gudla, Prabhakar; Lockett, Stephen] Frederick Natl Lab Canc Res, Opt Microscopy & Anal Lab, Frederick, MD USA; [Acharya, Usha] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester	Acharya, JK (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA.	acharyaj@mail.nih.gov	Madabushi, Srideshikan Sargur/AAG-1208-2020	Madabushi, Srideshikan Sargur/0000-0002-1087-6044; Acharya, Jairaj/0000-0001-7366-4228	intramural division of the National Cancer Institute, National Institutes of Health, Department of Health and Human Resources; NATIONAL CANCER INSTITUTE [ZIABC011187] Funding Source: NIH RePORTER	intramural division of the National Cancer Institute, National Institutes of Health, Department of Health and Human Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole by the intramural division of the National Cancer Institute, National Institutes of Health, Department of Health and Human Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Fisher R, 2010, HIPR2 ADAPTIVE THRES; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Obeid LM, 2003, SCI AGING KNOWLEDGE, V2003, pPE27; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1989, METHOD CELL BIOL, V29, P75; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140; SIXMA TK, 1993, BIOCHEMISTRY-US, V32, P191, DOI 10.1021/bi00052a025; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309	36	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92142	10.1371/journal.pone.0092142	http://dx.doi.org/10.1371/journal.pone.0092142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642596	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900093
J	Sousa, MC; Varandas, R; Santos, RC; Santos-Rosa, M; Alves, V; Salvador, JAR				Sousa, Maria C.; Varandas, Raquel; Santos, Rita C.; Santos-Rosa, Manuel; Alves, Vera; Salvador, Jorge A. R.			Antileishmanial Activity of Semisynthetic Lupane Triterpenoids Betulin and Betulinic Acid Derivatives: Synergistic Effects with Miltefosine	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; LEISHMANIA-DONOVANI; IN-VITRO; CHEMOTHERAPY; APOPTOSIS; AGENTS; DRUGS; ASSAY	Leishmaniasis is a neglected tropical disease (NTDs), endemic in 88 countries, affecting more than 12 million people. The treatment consists in pentavalent antimony compounds, amphotericin B, pentamidine and miltefosine, among others. However, these current drugs are limited due to their toxicity, development of biological resistance, length of treatment and high cost. Thus, it is important to continue the search for new effective and less toxic treatments. The anti-Leishmania activity of sixteen semisynthetic lupane triterpenoids derivatives of betulin (BT01 to BT09) and betulinic acid (AB10 to AB16) were evaluated. Drug interactions between the active compounds and one current antileishmanial drug, miltefosine, were assessed using the fixed ratio isobologram method. In addition, effects on the cell cycle, apoptosis/necrosis events, morphology and DNA integrity were studied. The derivatives BT06 (3 beta-Hydroxy-(20R)-lupan-29-oxo-28-yl-1H-imidazole-1-carboxylate) and AB13 (28-(1H-imidazole-1-yl)-3,28-dioxo-lup-1,20(29)-dien-2-yl-1H-imidazole-1-carboxylate) were found to be the most active, with IC50 values of 50.8 mu M and 25.8 mu M, respectively. Interactions between these two compounds and miltefosine were classified as synergistic, with the most effective association being between AB13 and miltefosine, where decreases of IC50 values to 6 mM were observed, similar to the miltefosine activity alone. AB13 induced significant morphological changes, while both derivatives produced anti-proliferative activity through cell cycle arrest at the G0/G1 phase. Neither of these derivatives induced significant apoptosis/necrosis, as indicated by phosphatidylserine externalization and DNA fragmentation assays. In addition, neither of the derivatives induced death in macrophage cell lines. Thus, they do not present any potential risk of toxicity for the host cells. This study has identified the betulin derivative BT06 and the betulinic acid derivative AB13 as promising molecules in the development of new alternative therapies for leishmaniasis, including those involving combined-therapy with miltefosine.	[Sousa, Maria C.; Varandas, Raquel; Santos, Rita C.; Salvador, Jorge A. R.] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Sousa, Maria C.] Univ Coimbra CEF FFUC, Fac Pharm, Ctr Pharmaceut Studies, Coimbra, Portugal; [Salvador, Jorge A. R.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Santos-Rosa, Manuel; Alves, Vera] Univ Coimbra, Fac Med, Inst Immunol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Sousa, MC (corresponding author), Univ Coimbra, Fac Pharm, Coimbra, Portugal.	mcsousa@ci.uc.pt; salvador@ci.uc.pt	Sousa, Maria/HCI-9642-2022; Sousa, Maria do Céu/AGQ-8739-2022; Alves, Vera/AAX-8195-2020; SALVADOR, JORGE A. R./N-7174-2017	Alves, Vera/0000-0002-2625-1671; SALVADOR, JORGE A. R./0000-0003-0779-6083; Varandas, Raquel/0000-0002-5985-2019; SOUSA, Maria do Ceu Rodrigues/0000-0003-4957-7831	"(POCI)/FEDER'' da Fundacao para a Ciencia e Tecnologia (FCT)	"(POCI)/FEDER'' da Fundacao para a Ciencia e Tecnologia (FCT)	This work was supported by "(POCI)/FEDER'' da Fundacao para a Ciencia e Tecnologia (FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Alakurtti S, 2010, BIOORGAN MED CHEM, V18, P1573, DOI 10.1016/j.bmc.2010.01.003; Baglin I, 2003, MINI-REV MED CHEM, V3, P525, DOI 10.2174/1389557033487917; Carvalho L, 2011, ANTIMICROB AGENTS CH, V55, P4204, DOI 10.1128/AAC.00520-11; Chowdhury AR, 2003, MOL MED, V9, P26; Chowdhury S, 2011, MOL PHARMACOL, V80, P694, DOI 10.1124/mol.111.072785; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; da Silva AA, 2009, FITOTERAPIA, V80, P478, DOI 10.1016/j.fitote.2009.06.007; Darzynkiewicz Z, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0804s01; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dominguez-Carmona DB, 2010, PHYTOMEDICINE, V17, P379, DOI 10.1016/j.phymed.2009.08.002; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Fuertes MA, 2008, CURR MED CHEM, V15, P433; Gazanion E, 2011, PARASITOL INT, V60, P19, DOI 10.1016/j.parint.2010.09.005; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Kappagoda S, 2011, MAYO CLIN PROC, V86, P561, DOI 10.4065/mcp.2011.0203; Lakshmi V, 2007, PHYTOMEDICINE, V14, P36, DOI 10.1016/j.phymed.2005.10.002; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Moreira W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.83; Mukherjee Rama, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P271, DOI 10.2174/187152006776930846; Nakayama H, 2007, BIOMED PHARMACOTHER, V61, P186, DOI 10.1016/j.biopha.2007.02.001; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Prada CF, 2013, BIOCHEM PHARMACOL, V85, P1433, DOI 10.1016/j.bcp.2013.02.024; RajuGautam S, 2009, MED RES REV, V29, P767; Ryu SY, 2000, PLANTA MED, V66, P358, DOI 10.1055/s-2000-8531; Santin MR, 2009, PARASITOL RES, V105, P1489, DOI 10.1007/s00436-009-1578-7; Santos RC, 2011, BIOCHIMIE, V93, P1065, DOI 10.1016/j.biochi.2011.02.014; Santos RC, 2010, BIOORGAN MED CHEM, V18, P4385, DOI 10.1016/j.bmc.2010.04.085; Santos RC, 2009, BIOORGAN MED CHEM, V17, P6241, DOI 10.1016/j.bmc.2009.07.050; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; van Zandbergen G, 2010, TRENDS PARASITOL, V26, P477, DOI 10.1016/j.pt.2010.06.008; Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wagenpfeil S, 2006, ARTIF INTELL MED, V37, P65, DOI 10.1016/j.artmed.2005.01.011; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; Xiong JA, 2010, BIOORGAN MED CHEM, V18, P6451, DOI 10.1016/j.bmc.2010.06.092; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214	43	45	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e89939	10.1371/journal.pone.0089939	http://dx.doi.org/10.1371/journal.pone.0089939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643019	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900005
J	Khonmee, J; Brown, JL; Rojanasthien, S; Aunsusin, A; Thumasanukul, D; Kongphoemphun, A; Siriaroonrat, B; Tipkantha, W; Punyapornwithaya, V; Thitaram, C				Khonmee, Jaruwan; Brown, Janine L.; Rojanasthien, Suvichai; Aunsusin, Anurut; Thumasanukul, Dissakul; Kongphoemphun, Adisorn; Siriaroonrat, Boripat; Tipkantha, Wanlaya; Punyapornwithaya, Veerasak; Thitaram, Chatchote			Gender, Season and Management Affect Fecal Glucocorticoid Metabolite Concentrations in Captive Goral (Naemorhedus griseus) in Thailand	PLOS ONE			English	Article							BLACK-FOOTED FERRET; ADRENAL ACTIVITY; ENVIRONMENTAL ENRICHMENT; CORTISOL METABOLITES; SEX-DIFFERENCES; ADRENOCORTICAL ACTIVITY; DOMESTIC LIVESTOCK; ZOO VISITORS; STRESS; BEHAVIOR	Chinese goral (Naemorhedus griseus) are a threatened species in Thailand and the focus of captive breeding for possible reintroduction. However, little is known of their biology or what factors in the captive environment affect welfare. Our objective was to determine the impact of gender, season, and management on goral adrenal activity. We hypothesized that differences in fecal glucocorticoid concentrations would be related to animal density. Fecal samples were collected 3 days/week for 1 year from 63 individuals (n = 32 males, 31 females) at two facilities that house the majority of goral in Thailand: Omkoi Wildlife Sanctuary (Omkoi), an off-exhibit breeding center that houses goral in individual pens (16 pens; n = 8 males, 8 females) and in small family groups (8 pens; n = 8 males, 8 females); and the Chiang Mai Night Safari (NS), a zoo that maintains 31 goral (n = 17 males, 14 females) in one large pen. Glucocorticoid metabolite concentrations were higher in male than female goral at Omkoi throughout the year, and there was a seasonal effect on adrenal activity (p<0.05). Goral at Omkoi and NS were used to test the effect of animal density on fecal glucocorticoid excretion of goral housed in similar-sized enclosures. Overall, the highest levels were found at NS (n = 31 adults/pen; 27 m(2) per animal) compared to Omkoi (n = 2 adults/pen; 400 m(2) per animal) (p<0.05). Overall findings support our hypothesis that animal density and aspects of the captive environment impact adrenal steroid activity in captive goral. In addition, gender and season also had significant effects on glucocorticoid metabolite production. Potential stressors pertaining to the welfare of this species were identified, which will guide future efforts to improve management and create self-sustaining and healthy populations of this threatened species.	[Khonmee, Jaruwan; Rojanasthien, Suvichai; Punyapornwithaya, Veerasak; Thitaram, Chatchote] Chiang Mai Univ, Fac Vet Med, Chiang Mai 50000, Thailand; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Aunsusin, Anurut] Chiang Mai Night Safari, Chiang Mai, Thailand; [Thumasanukul, Dissakul; Kongphoemphun, Adisorn] Omkoi Wildlife Sanctuary, Dept Natl Pk Wildlife & Plant Conservat, Chiang Mai, Thailand; [Siriaroonrat, Boripat; Tipkantha, Wanlaya] Zool Pk Org, Conservat Res & Educ Div, Bangkok, Thailand	Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Chiang Mai 50000, Thailand.	jaruwan.khonmee@cmu.ac.th; chatchote.thitaram@cmu.ac.th	Punyapornwithaya, Veerasak/ABE-5119-2020; Punyapornwithaya, Verasak/V-9323-2019; Thitaram, Chatchote/AHD-1584-2022	Punyapornwithaya, Verasak/0000-0001-9870-7773; 	National Research Council of Thailand (NRCT)	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This study was funded by National Research Council of Thailand (NRCT). All laboratory analyses and additional lab support was provided by Faculty of Veterinary Medicine, Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Brown JL, 2001, ZOO BIOL, V20, P463, DOI 10.1002/zoo.10028; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Bubenik GA, 1998, COMP BIOCHEM PHYS C, V120, P307, DOI 10.1016/S0742-8413(98)10010-5; BUIRSKI P, 1978, ANIM BEHAV, V26, P123, DOI 10.1016/0003-3472(78)90011-8; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Chaiyarat Rattanawat, 1999, Natural History Bulletin of the Siam Society, V47, P191; CHRISTISON GI, 1972, J ANIM SCI, V35, P1005; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Cyr NE, 2008, GEN COMP ENDOCR, V158, P20, DOI 10.1016/j.ygcen.2008.05.001; Davis N, 2005, APPL ANIM BEHAV SCI, V90, P131, DOI 10.1016/j.applanim.2004.08.020; DOBSON H, 1995, J REPROD FERTIL, P451; Duckworth J.W., 2008, NAEMORHEDUS GRISEUS, DOI [10.2305/IUCN.UK.2008.RLTS.T14303A4430834.en, DOI 10.2305/IUCN.UK.2008.RLTS.T14303A4430834.EN]; ERIKSSON H, 1970, EUR J BIOCHEM, V15, P132, DOI 10.1111/j.1432-1033.1970.tb00987.x; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Harper JM, 2001, GEN COMP ENDOCR, V123, P337, DOI 10.1006/gcen.2001.7682; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; HORTON GMJ, 1991, APPL ANIM BEHAV SCI, V32, P197, DOI 10.1016/S0168-1591(05)80043-7; Hosey GR, 2005, APPL ANIM BEHAV SCI, V90, P107, DOI 10.1016/j.applanim.2004.08.015; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; LIPTRAP RM, 1993, ANN NY ACAD SCI, V697, P275, DOI 10.1111/j.1749-6632.1993.tb49941.x; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Moreira N, 2007, ZOO BIOL, V26, P441, DOI 10.1002/zoo.20139; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Morrow CJ, 2002, GEN COMP ENDOCR, V126, P229, DOI 10.1006/gcen.2002.7797; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MULLER CJC, 1994, S AFR J ANIM SCI, V24, P56; OTTENWELLER JE, 1979, ACTA ENDOCRINOL-COP, V91, P150, DOI 10.1530/acta.0.0910150; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Palme R, 1997, Z SAUGETIERKD, V62, P192; Patton ML, 2000, J ZOO WILDLIFE MED, V31, P228, DOI 10.1638/1042-7260(2000)031[0228:SCIAHO]2.0.CO;2; PERKINS LA, 1992, ZOO BIOL, V11, P177, DOI 10.1002/zoo.1430110306; Pinheiro J., 2019, NLME LINEAR NONLINEA; Poessel SA, 2011, GEN COMP ENDOCR, V172, P526, DOI 10.1016/j.ygcen.2011.04.018; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabinowitz A, 1998, ORYX, V32, P201, DOI 10.1046/j.1365-3008.1998.d01-37.x; Rajagopal T, 2011, J APPL ANIM WELF SCI, V14, P18, DOI 10.1080/10888705.2011.527598; Raminelli JLF, 2001, BIOL RHYTHM RES, V32, P159; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Saito TR, 1996, CONTEMP TOP LAB ANIM, V35, P80; Scarlata CD, 2013, ANIM WELFARE, V22, P357, DOI 10.7120/09627286.22.3.357; Schatz S, 2001, VET RES COMMUN, V25, P271, DOI 10.1023/A:1010626608498; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Shepherdson DJ, 2004, ANIM WELFARE, V13, pS105; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; Strier KB, 1999, HORM BEHAV, V35, P125, DOI 10.1006/hbeh.1998.1505; Tan HM, 2013, RES VET SCI, V94, P228, DOI 10.1016/j.rvsc.2012.09.024; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Teskey-Gerstl A, 2000, J COMP PHYSIOL B, V170, P163, DOI 10.1007/s003600050271; Thai Meteorological Department, 2013, THAI MET DEP CHIANG; Thitaram C, 2008, THERIOGENOLOGY, V69, P237, DOI 10.1016/j.theriogenology.2007.09.018; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; van Lier E, 2003, ANIM REPROD SCI, V79, P81, DOI 10.1016/S0378-4320(03)00083-6; VANDENHEEDE M, 1993, APPL ANIM BEHAV SCI, V37, P39, DOI 10.1016/0168-1591(93)90069-2; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; WOODWARD CJH, 1991, BRIT J NUTR, V66, P117, DOI 10.1079/BJN19910015; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Young KM, 2001, ZOO BIOL, V20, P517, DOI 10.1002/zoo.10001	66	14	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91633	10.1371/journal.pone.0091633	http://dx.doi.org/10.1371/journal.pone.0091633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637886	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100049
J	Tuteja, A; Siddiqui, AB; Madan, K; Goyal, R; Shalimar; Sreenivas, V; Kaur, N; Panda, SK; Narayanasamy, K; Subodh, S; Acharya, SK				Tuteja, Amit; Siddiqui, Abu Baker; Madan, Kaushal; Goyal, Rohit; Shalimar; Sreenivas, Vishnubhatla; Kaur, Navkiran; Panda, Subrat K.; Narayanasamy, Krishnamoorthy; Subodh, Swati; Acharya, Subrat K.			Mutation Profiling of the Hepatitis B Virus Strains Circulating in North Indian Population	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; BASAL CORE PROMOTER; HEPATOCELLULAR-CARCINOMA; HBV GENOTYPES; VIROLOGICAL CHARACTERISTICS; SURFACE-ANTIGEN; EASTERN INDIA; PHYLOGENETIC RELATEDNESS; SEQUENTIAL ACCUMULATION; MOLECULAR EPIDEMIOLOGY	Aims: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B virus strains causing infection in the Indian population. Further, we wanted to analyze the biological significance of these mutations in HBV mediated disease. Methods: 222 HBsAg positive patients were enrolled in the study. The genotype and mutation profile was determined for the infecting HBV isolate by sequencing overlapping fragments. These sequences were analyzed by using different tools and compared with previously available HBV sequence information. Mutation Frequency Index (MFI) for the Genes and Diagnosis group was also calculated. Results: HBV Genotype D was found in 55% (n = 121) of the patient group and genotype A was found in 30% (n = 66) of samples. The majority (52%) of the HBV-infected individuals in the present study were HBeAg-negative in all the age groups studied. Spontaneous drug associated mutations implicated in resistance to antiviral therapy were also identified in about quarter of our patients, which is of therapeutic concern. The MFI approach used in the study indicated that Core peptide was the most conserved region in both genotypes and Surface peptide had highest mutation frequency. Few mutations in X gene (T36A and G50R) showed high frequency of association with HCC. A rare recombinant strain of HBV genotype A and D was also identified in the patient group. Conclusions: HBV genotype D was found out to be most prevalent. More than half of the patients studied had HBeAg negative disease. Core region was found to be most conserved. Drug Associated mutations were detected in 22% of the patient group and T36A and G50R mutations in X gene were found to be associated with HCC.	[Tuteja, Amit; Siddiqui, Abu Baker; Narayanasamy, Krishnamoorthy; Subodh, Swati] Inst Mol Med, New Delhi, India; [Tuteja, Amit; Kaur, Navkiran] Amity Univ, Amity Inst Biotechnol, Noida, India; [Subodh, Swati] CSIR, Open Source Drug Discovery Unit, New Delhi, India; [Madan, Kaushal; Goyal, Rohit; Shalimar; Acharya, Subrat K.] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Panda, Subrat K.] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Stat, New Delhi, India	Amity University Noida; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Subodh, S (corresponding author), Inst Mol Med, New Delhi, India.	swatisubodh@yahoo.com; subratacharya@hotmail.com	kaur, Navkiran/AAR-2942-2021; , .Shalimar/J-5686-2016	, .Shalimar/0000-0003-1247-437X; Kaur, Navkiran/0000-0003-2522-7044	Rapid Grant for Young Investigator (RGYI) Scheme of Department of Biotechnology, Government of India [BT/PR8942/GBD/27/44/2006]	Rapid Grant for Young Investigator (RGYI) Scheme of Department of Biotechnology, Government of India	The work was funded under the Rapid Grant for Young Investigator (RGYI) Scheme of Department of Biotechnology, Government of India (Websitehttp://dbtindia.nic.in) awarded to Dr. Swati Subodh (Grant number - BT/PR8942/GBD/27/44/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, J CLIN MICROBIOL, V37, P2899, DOI 10.1128/JCM.37.9.2899-2903.1999; Acharya SK, 2006, NATL MED J INDIA, V19, P203; Alam MM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-115; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; BLUM HE, 1991, J VIROL, V65, P1836, DOI 10.1128/JVI.65.4.1836-1842.1991; BLUM HE, 1995, DIGESTION, V56, P85, DOI 10.1159/000201226; Borkakoty BJ, 2008, INDIAN J MED RES, V127, P65; Borroto-Esoda K, 2007, J HEPATOL, V47, P492, DOI 10.1016/j.jhep.2007.06.011; Bozkaya H, 1997, J HEPATOL, V26, P508, DOI 10.1016/S0168-8278(97)80415-1; Brunetto MR, 2003, J HEPATOL, V39, pS164, DOI 10.1016/S0168-8278(03)00329-5; Chattopadhyay S, 2006, WORLD J GASTROENTERO, V12, P6702, DOI 10.3748/wjg.v12.i41.6702; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Choi CS, 2009, J MED VIROL, V81, P1721, DOI 10.1002/jmv.21591; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P6410, DOI 10.3748/wjg.v11.i41.6410; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Gandhe SS, 2003, J MED VIROL, V69, P324, DOI 10.1002/jmv.10292; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; HAWKINS AE, 1994, J MED VIROL, V43, P5, DOI 10.1002/jmv.1890430103; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Ijaz S, 2003, J GEN VIROL, V84, P269, DOI 10.1099/vir.0.18667-0; Jeantet D, 2002, HEPATOLOGY, V35, P1215, DOI 10.1053/jhep.2002.32710; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kajiya Y, 2001, DIGEST DIS SCI, V46, P509, DOI 10.1023/A:1005582812466; Karayiannis P, 1995, HEPATOLOGY, V22, P1628, DOI 10.1016/0270-9139(95)90183-3; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; KIDDLJUNGGREN K, 1995, J GEN VIROL, V76, P2119, DOI 10.1099/0022-1317-76-9-2119; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Kuang SY, 2004, P NATL ACAD SCI USA, V101, P3575, DOI 10.1073/pnas.0308232100; Kumar Ashish, 2005, Indian J Gastroenterol, V24, P19; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Lin X, 2005, WORLD J GASTROENTERO, V11, P4703, DOI 10.3748/wjg.v11.i30.4703; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Liu WC, 2007, VIRUS RES, V129, P212, DOI 10.1016/j.virusres.2007.07.016; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; Madan K, 2009, HEPATOL RES, V39, P157, DOI 10.1111/j.1872-034X.2008.00417.x; Mizokami M, 1999, INTERVIROLOGY, V42, P159, DOI 10.1159/000024975; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Pastor R, 2009, WORLD J GASTROENTERO, V15, P753, DOI 10.3748/wjg.15.753; Sarin SK, 2001, J GASTROEN HEPATOL, V16, P666, DOI 10.1046/j.1440-1746.2001.02476.x; Scheiblauer H, 2010, VOX SANG, V98, P403, DOI 10.1111/j.1423-0410.2009.01272.x; Sen U, 2002, INT J CANCER, V100, P86, DOI 10.1002/ijc.10446; Shin YC, 2011, FEBS LETT, V585, P3964, DOI 10.1016/j.febslet.2011.11.003; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Simon B, 2013, J CLIN MICROBIOL, V51, P163, DOI 10.1128/JCM.01630-12; Song BC, 2006, INTERVIROLOGY, V49, P266, DOI 10.1159/000093456; Sugauchi F, 2004, J GEN VIROL, V85, P811, DOI 10.1099/vir.0.79811-0; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Suwannakarn K, 2005, J GEN VIROL, V86, P3027, DOI 10.1099/vir.0.81241-0; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thakur V, 2002, J GASTROEN HEPATOL, V17, P165, DOI 10.1046/j.1440-1746.2002.02605.x; Tong Shuping, 2005, Int J Med Sci, V2, P2; Utsumi T, 2009, J CLIN MICROBIOL, V47, P1842, DOI 10.1128/JCM.02328-08; Villet S, 2007, J HEPATOL, V46, P531, DOI 10.1016/j.jhep.2006.11.016; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; Warner N, 2007, ANTIMICROB AGENTS CH, V51, P2285, DOI 10.1128/AAC.01499-06; Zekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-74; Zhang DK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-271	76	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91150	10.1371/journal.pone.0091150	http://dx.doi.org/10.1371/journal.pone.0091150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637457	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100018
J	Zhou, R; Sun, YX; Yang, WJ; Yang, F				Zhou, Rong; Sun, Yu-Xia; Yang, Wei-Jun; Yang, Fan			Identification and Characterization of a Ste20-Like Kinase in Artemia and Its Role in the Developmental Regulation and Resistance to Environmental Stress	PLOS ONE			English	Article							SHOCK/ALPHA-CRYSTALLIN PROTEIN; MITOGEN-ACTIVATED PROTEIN; RIBOSOMAL S6 KINASE; CHAPERONE ACTIVITY; MOLECULAR CHARACTERIZATION; ENCYSTED EMBRYOS; BRINE SHRIMP; FRANCISCANA; SLK; P26	Background: To adapt to extreme environments, the crustacean Artemia has evolved two alternative reproductive pathways. During ovoviviparous (direct) development, nauplius larvae are produced. In contrast, Artemia females release encysted diapause embryos (cysts) via the oviparous pathway. To date, the cellular mechanisms that regulate stress resistance of Artemia remain largely unknown. Ste20-like kinase (SLK) participates in multiple biological processes, including stress responses, apoptosis, and cell cycle progression. Principal Finding: We isolated and characterized a member of the SLK superfamily termed ArSLK from Artemia parthenogenetica. The ArSLK gene is transcribed throughout both ovoviviparous and oviparous development; however, the protein is located mainly in the nuclei of stress-resistant diapause cysts, unlike the nauplii and nauplius-destined embryos where it is cytoplasmic. Interestingly, exposure of nauplii to heat shock, acidic pH, and UV irradiation induced the translocation of ArSLK from cytoplasm to nucleus. This translocation was reversed following stress removal. Moreover, under physiologically-stressful conditions, the nauplius larvae produced by adults after gene knockdown of endogenous ArSLK by RNAi, lost the ability of free-swimming much earlier than those of control larvae from females injected with GFP dsRNA. Conclusions/Significance: Taken together, this study demonstrated that trafficking of ArSLK between the cytoplasm and the nucleus participates in regulating the stress resistance of Artemia. Our findings may provide significant insight into the functions of members of the SLK superfamily.	[Yang, Fan] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, F (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	fan_yang@zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830	National Natural Science Foundation of China [31270424 1/4 CE31370394]; National Basic Research Program of China (863 Program) [2012AA092205]; Scientific Research Fund of Zhejiang Provincial Education Department [N20080103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (863 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); Scientific Research Fund of Zhejiang Provincial Education Department	This work was supported by the National Natural Science Foundation of China (31270424 1/4 CE31370394), National Basic Research Program of China (863 Program, 2012AA092205) and the Scientific Research Fund of Zhejiang Provincial Education Department (N20080103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; Alves PS, 2006, EXP CELL RES, V312, P308, DOI 10.1016/j.yexcr.2005.10.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browne RA, 1990, ARTEMIA BIOL; Chen T, 2003, EUR J BIOCHEM, V270, P137, DOI 10.1046/j.1432-1033.2003.03373.x; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clegg JS, 1999, AM ZOOL, V39, P836; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; CLEGG JS, 1974, T AM MICROSC SOC, V93, P481, DOI 10.2307/3225153; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Delarosa S, 2011, AM J PHYSIOL-RENAL, V301, pF554, DOI 10.1152/ajprenal.00062.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; Manzerra P, 1996, EXP CELL RES, V229, P35, DOI 10.1006/excr.1996.0341; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; Willsie JK, 2001, J EXP BIOL, V204, P2339; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	37	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92234	10.1371/journal.pone.0092234	http://dx.doi.org/10.1371/journal.pone.0092234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637947	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100131
J	Wang, Y; Li, GL; Mao, FB; Li, XF; Liu, Q; Chen, L; Lv, L; Wang, X; Wu, JY; Dai, W; Wang, G; Zhao, EF; Tang, KF; Sun, ZS				Wang, Yan; Li, Guiling; Mao, Fengbiao; Li, Xianfeng; Liu, Qi; Chen, Lin; Lv, Lu; Wang, Xin; Wu, Jinyu; Dai, Wei; Wang, Guan; Zhao, Enfeng; Tang, Kai-Fu; Sun, Zhong Sheng			Ras-induced Epigenetic Inactivation of the RRAD ( Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Metabolism; Ovarian Cancer; Ras; Tumor Suppressor Gene; Oncogenic Transformation; RRAD	MEDIATED ONCOGENIC TRANSFORMATION; DNA METHYLATION; MICROARRAY ANALYSIS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GTPASE GENE; CELLS; EXPRESSION; CARCINOMA; MUTATIONS	Background: Increased glucose uptake is essential for carcinogenesis. Results: Ras(V12)-induced epigenetic inactivation of RRAD promotes glucose uptake and tumor formation. Conclusion: RRAD might act as a functional tumor suppressor by inhibiting glucose uptake. Significance: Down-regulation of RRAD in tumor tissues might be associated with the Warburg effect. RRAD (Ras-related associated with diabetes) is a small Ras-related GTPase that is frequently inactivated by DNA methylation of the CpG island in its promoter region in cancer tissues. However, the role of the methylation-induced RRAD inactivation in tumorigenesis remains unclear. In this study, the Ras-regulated transcriptome and epigenome were profiled by comparing T29H (a Ras(V12)-transformed human ovarian epithelial cell line) with T29 (an immortalized but non-transformed cell line) through reduced representation bisulfite sequencing and digital gene expression. We found that Ras(V12)-mediated oncogenic transformation was accompanied by RRAD promoter hypermethylation and a concomitant loss of RRAD expression. In addition, we found that the RRAD promoter was hypermethylated, and its transcription was reduced in ovarian cancer versus normal ovarian tissues. Treatment with the DNA methyltransferase inhibitor 5-aza-2-deoxycytidine resulted in demethylation in the RRAD promoter and restored RRAD expression in T29H cells. Additionally, treatment with farnesyltransferase inhibitor FTI277 resulted in restored RRAD expression and inhibited DNA methytransferase expression and activity in T29H cells. By employing knockdown and overexpression techniques in T29 and T29H, respectively, we found that RRAD inhibited glucose uptake and lactate production by repressing the expression of glucose transporters. Finally, RRAD overexpression in T29H cells inhibited tumor formation in nude mice, suggesting that RRAD is a tumor suppressor gene. Our results indicate that Ras(V12)-mediated oncogenic transformation induces RRAD epigenetic inactivation, which in turn promotes glucose uptake and may contribute to ovarian cancer tumorigenesis.	[Wang, Yan; Dai, Wei] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Wang, Yan; Mao, Fengbiao] Univ Chinese Acad Sci, Beijing 100080, Peoples R China; [Li, Guiling; Liu, Qi; Lv, Lu; Wang, Xin; Wu, Jinyu; Tang, Kai-Fu; Sun, Zhong Sheng] Wenzhou Med Univ, Inst Genom Med, Wenzhou 325000, Zhejiang, Peoples R China; [Mao, Fengbiao; Chen, Lin; Sun, Zhong Sheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100101, Peoples R China; [Li, Xianfeng] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Wang, Guan; Zhao, Enfeng] Chinese Peoples Liberat Army, Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wenzhou Medical University; Chinese Academy of Sciences; Central South University; Chinese People's Liberation Army General Hospital	Tang, KF (corresponding author), Wenzhou Med Univ, Inst Genom Med, 268 West Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China.	tangkaifu@hotmail.com; zhongshengsun@yeah.net	Sun, Zhongsheng/AAS-4883-2020; li, xianfeng/GYD-5825-2022; fengbiao, mao/AAB-5632-2019; Wang, Xin/AAD-2149-2019; Mao, Feng/B-8280-2019	Sun, Zhongsheng/0000-0002-7640-5026; fengbiao, mao/0000-0003-0852-4266; Wang, Xin/0000-0001-8866-5223; Tang, Kai-Fu/0000-0002-2657-4163; Tang, Kai-Fu/0000-0002-6892-1207	Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant [81161120541]; National High-tech RD Program Grant [2012AA02A202]; NSFC [31171236/C060503, 31200976]; Zhejiang Provincial Natural Science Foundation of China [Z2110521]; Innovation Center China of AstraZeneca	Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant; National High-tech RD Program Grant; NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Innovation Center China of AstraZeneca	This work was supported by Natural Science Foundation of China (NSFC)-Canadian Institutes of Health Research Collaborative Research Project Grant 81161120541, National High-tech R&D Program Grant 2012AA02A202, NSFC Grants 31171236/C060503 and 31200976, Zhejiang Provincial Natural Science Foundation of China Grant Z2110521, and the Innovation Center China of AstraZeneca.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BOS JL, 1989, CANCER RES, V49, P4682; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cormont M, 2001, MOL MEMBR BIOL, V18, P213; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Gao F, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r100; Ghezzi C, 2012, AM J PHYSIOL-CELL PH, V303, pC348, DOI 10.1152/ajpcell.00115.2012; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirabayashi S, 2013, CELL, V154, P664, DOI 10.1016/j.cell.2013.06.030; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsiao BY, 2011, J MOL MED, V89, P481, DOI 10.1007/s00109-010-0717-z; Huang RL, 2013, EPIGENETICS-US, V8, P624, DOI 10.4161/epi.24816; Ilany J, 2006, P NATL ACAD SCI USA, V103, P4481, DOI 10.1073/pnas.0511246103; Kalamanathan S, 2011, ANTICANCER RES, V31, P2661; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laville M, 1996, J CLIN INVEST, V98, P43, DOI 10.1172/JCI118775; Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; MARBACH EP, 1967, CLIN CHEM, V13, P314; Mei FC, 2005, FASEB J, V19, P497, DOI 10.1096/fj.05-4586fje; Mo YX, 2012, CANCER LETT, V323, P147, DOI 10.1016/j.canlet.2012.03.042; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Moyers JS, 1998, BIOCHEM J, V333, P609, DOI 10.1042/bj3330609; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ojuka EO, 2012, AM J PHYSIOL-ENDOC M, V303, pE322, DOI 10.1152/ajpendo.00091.2012; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Pyla R, 2013, AM J PHYSIOL-CELL PH, V304, pC574, DOI 10.1152/ajpcell.00275.2012; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Rusconi P, 2012, CURR MED CHEM, V19, P1164; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Suzuki M, 2007, ANN SURG ONCOL, V14, P1397, DOI 10.1245/s10434-006-9089-6; Suzuki M, 2006, CANCER LETT, V242, P222, DOI 10.1016/j.canlet.2005.11.002; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Tseng YH, 2001, CANCER RES, V61, P2071; Varras MN, 1999, ONCOLOGY-BASEL, V56, P89, DOI 10.1159/000011946; Wang T, 2013, HUM MUTAT, V34, P1606, DOI 10.1002/humu.22444; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Weisenberger DJ, 2014, J CLIN INVEST, V124, P17, DOI 10.1172/JCI69740; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Young T, 2005, ONCOGENE, V24, P6174, DOI 10.1038/sj.onc.1208753; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222; Zeimet AG, 2011, GYNECOL ONCOL, V121, P24, DOI 10.1016/j.ygyno.2010.12.332; ZHU JH, 1995, J BIOL CHEM, V270, P4805, DOI 10.1074/jbc.270.9.4805	55	23	25	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14225	14238		10.1074/jbc.M113.527671	http://dx.doi.org/10.1074/jbc.M113.527671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24648519	hybrid, Green Published			2022-12-25	WOS:000335984600048
J	Rayala, S; Francis, VG; Sivagnanam, U; Gummadi, SN				Rayala, Sarika; Francis, Vincent G.; Sivagnanam, Ulaganathan; Gummadi, Sathyanarayana N.			N-terminal Proline-rich Domain Is Required for Scrambling Activity of Human Phospholipid Scramblases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Proteins; Fluorescence; Membrane Biophysics; Membrane Proteins; Membrane Reconstitution; Protein Aggregation; Human Phospholipid Scramblase; Proline-rich Domain	NUCLEAR-LOCALIZATION SIGNAL; PLASMA-MEMBRANE; BINDING-SITE; SUBCELLULAR-LOCALIZATION; TRANSBILAYER MOVEMENT; PROTEIN; CELLS; IDENTIFICATION; APOPTOSIS; REGION	Background: The role of PRD in scrambling of phospholipids by hPLSCR1 is not known. Results: The addition of PRD of hPLSCR1 to hPLSCR2 restored its PL scrambling activity, which in turn leads to aggregation of the protein. Conclusion: PRD is crucial for PL scrambling activity and could probably mediate its function by metal ion-dependent oligomerization. Significance: The results provide an insight in understanding the mechanism of scramblases. Human phospholipid scramblase 1 (hPLSCR1), a type II integral class membrane protein, is known to mediate bidirectional scrambling of phospholipids in a Ca2+-dependent manner. hPLSCR2, a homolog of hPLSCR1 that lacks N-terminal proline-rich domain (PRD), did not show scramblase activity. We attribute this absence of scramblase activity of hPLSCR2 to the lack of N-terminal PRD. Hence to investigate the above hypothesis, we added the PRD of hPLSCR1 to hPLSCR2 (PRD-hPLSCR2) and checked whether scramblase activity was restored. Functional assays showed that the addition of PRD to hPLSCR2 restored scrambling activity, and deletion of PRD in hPLSCR1 (PRD-hPLSCR1) resulted in a lack of activity. These results suggest that PRD is crucial for the function of the protein. The effects of the PRD deletion in hPLSCR1 and the addition of PRD to hPLSCR2 were characterized using various spectroscopic techniques. Our results clearly showed that hPLSCR1 and PRD-hPLSCR2 showed Ca2+-dependent aggregation and scrambling activity, whereas hPLSCR2 and PRD-hPLSCR1 did not show aggregation and activity. Thus we conclude that scramblases exhibit Ca2+-dependent scrambling activity by aggregation of protein. Our results provide a possible mechanism for phospholipid scrambling mediated by PLSCRs and the importance of PRD in its function and cellular localization.	[Rayala, Sarika; Francis, Vincent G.; Sivagnanam, Ulaganathan; Gummadi, Sathyanarayana N.] Indian Inst Technol, Appl & Ind Microbiol Lab, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gummadi, SN (corresponding author), Indian Inst Technol, Appl & Ind Microbiol Lab, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.	gummadi@iitm.ac.in	Gummadi, Sathyanarayana Naidu/K-2303-2019; Gummadi, Sathyanarayana/W-5354-2019	Gummadi, Sathyanarayana Naidu/0000-0003-0707-5710; Sivagnanam, Ulaganathan/0000-0003-1351-2518	Department of Science and Technology	Department of Science and Technology(Department of Science & Technology (India))	We thank the Department of Science and Technology for financial support for CD spectroscopy. We also thank Dr. Suresh Kumar Rayala, IIT Madras for providing anti-GFP monoclonal antibody.	Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Damer CK, 1996, J NEUROCHEM, V67, P1661; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Edwards SJ, 2003, ONCOGENE, V22, P4517, DOI 10.1038/sj.onc.1206726; Fan CW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-254; Francis VG, 2013, FEBS J, V280, P2855, DOI 10.1111/febs.12289; Francis VG, 2012, BIOL CHEM, V393, P1173, DOI 10.1515/hsz-2012-0129; Francis VG, 2012, J IND MICROBIOL BIOT, V39, P1041, DOI 10.1007/s10295-012-1105-1; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; Li YJ, 2006, MOL CELL BIOL, V26, P3401, DOI 10.1128/MCB.26.9.3401-3413.2006; Liu JH, 2003, MOL CANCER RES, V1, P892; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sanyal S., 2009, CHEM BIOL, V4, P895; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Stout JG, 1997, J CLIN INVEST, V99, P2232, DOI 10.1172/JCI119397; Stout JG, 1998, BIOCHEMISTRY-US, V37, P14860, DOI 10.1021/bi9812930; Sudo T, 1999, FEBS LETT, V444, P11, DOI 10.1016/S0014-5793(99)00014-9; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Yu A, 2003, J BIOL CHEM, V278, P9706, DOI 10.1074/jbc.M204614200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zamparelli C, 1997, FEBS LETT, V409, P1, DOI 10.1016/S0014-5793(97)00464-X; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	44	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13206	13218		10.1074/jbc.M113.522953	http://dx.doi.org/10.1074/jbc.M113.522953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648509	hybrid, Green Published			2022-12-25	WOS:000335522800022
J	Koshy, S; Huq, R; Tanner, MR; Atik, MA; Porter, PC; Khan, FS; Pennington, MW; Hanania, NA; Corry, DB; Beeton, C				Koshy, Shyny; Huq, Redwan; Tanner, Mark R.; Atik, Mustafa A.; Porter, Paul C.; Khan, Fatima S.; Pennington, Michael W.; Hanania, Nicola A.; Corry, David B.; Beeton, Christine			Blocking K(V)1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Animal Models; Asthma; Cellular Immune Response; Potassium Channels; KCNA3; K(V)1; 3; T Lymphocyte; Airway Inflammation; Therapy	MEMORY T-CELLS; GATED K+ CHANNELS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; POTASSIUM CHANNEL; KV1.3 CHANNEL; SHK TOXIN; PHARMACOLOGICAL RESPONSES; AIRWAY INFLAMMATION; MULTIPLE-SCLEROSIS; UP-REGULATION	Background: CCR7(-) effector memory T lymphocytes are major players in lung inflammation that characterizes allergic asthma. Results: Blocking K(V)1.3 channels reduced the severity of an ovalbumin-induced model of asthma in rats. Conclusion: K(V)1.3 channels are attractive targets for immunomodulation and the treatment of allergic asthma. Significance: Selective K(V)1.3 channel blockers may prove beneficial in the treatment of asthma. Allergic asthma is a chronic inflammatory disease of the airways. Of the different lower airway-infiltrating immune cells that participate in asthma, T lymphocytes that produce Th2 cytokines play important roles in pathogenesis. These T cells are mainly fully differentiated CCR7(-) effector memory T (T-EM) cells. Targeting T-EM cells without affecting CCR7(+) naive and central memory (T-CM) cells has the potential of treating T-EM-mediated diseases, such as asthma, without inducing generalized immunosuppression. The voltage-gated K(V)1.3 potassium channel is a target for preferential inhibition of T-EM cells. Here, we investigated the effects of ShK-186, a selective K(V)1.3 channel blocker, for the treatment of asthma. A significant proportion of T lymphocytes in the lower airways of subjects with asthma expressed high levels of K(V)1.3 channels. ShK-186 inhibited the allergen-induced activation of peripheral blood T cells from those subjects. Immunization of F344 rats against ovalbumin followed by intranasal challenges with ovalbumin induced airway hyper-reactivity, which was reduced by the administration of ShK-186. ShK-186 also reduced total immune infiltrates in the bronchoalveolar lavage and number of infiltrating lymphocytes, eosinophils, and neutrophils assessed by differential counts. Rats with the ovalbumin-induced model of asthma had elevated levels of the Th2 cytokines IL-4, IL-5, and IL-13 measured by ELISA in their bronchoalveolar lavage fluids. ShK-186 administration reduced levels of IL-4 and IL-5 and induced an increase in the production of IL-10. Finally, ShK-186 inhibited the proliferation of lung-infiltrating ovalbumin-specific T cells. Our results suggest that K(V)1.3 channels represent effective targets for the treatment of allergic asthma.	[Koshy, Shyny; Huq, Redwan; Tanner, Mark R.; Khan, Fatima S.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Huq, Redwan] Baylor Coll Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Tanner, Mark R.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Atik, Mustafa A.; Hanania, Nicola A.] Baylor Coll Med, Asthma Clin Res Ctr, Houston, TX 77030 USA; [Atik, Mustafa A.; Porter, Paul C.; Hanania, Nicola A.; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Pennington, Michael W.] Peptides Int, Louisville, KY 40299 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Beeton, C (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Mail Stop BCM335, Houston, TX 77030 USA.	beeton@bcm.edu	Hanania, Nicola A/C-5875-2016	Hanania, Nicola A/0000-0003-3087-9530; pennington, michael/0000-0001-5446-3447; Tanner, Mark/0000-0002-6516-0166	National Institutes of Health [RR024574, AI036211, CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI053831, R56AI084981, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The Cytometry and Cell Sorting Core at Baylor College of Medicine is supported in part by National Institutes of Health Grants RR024574, AI036211, and CA125123.	Agbetile J, 2012, CLIN EXP ALLERGY, V42, P782, DOI 10.1111/j.1365-2222.2012.03987.x; Baiz N, 2012, CLIN CHEST MED, V33, P419, DOI 10.1016/j.ccm.2012.06.001; Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Bunce C, 1997, J EXP MED, V185, P767, DOI 10.1084/jem.185.4.767; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chang SC, 2012, TOXICON, V60, P840, DOI 10.1016/j.toxicon.2012.05.017; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Chung F, 2001, MEDIAT INFLAMM, V10, P51, DOI 10.1080/09629350120054518; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; de Pater-Huijsen FL, 2000, HISTOCHEM J, V32, P3, DOI 10.1023/A:1003967726621; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Fadool DA, 1998, J NEUROSCI, V18, P6126; Femling JK, 2006, J GEN PHYSIOL, V127, P659, DOI 10.1085/jgp.200609504; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Follenweider LM, 2013, NURS CLIN N AM, V48, P1, DOI 10.1016/j.cnur.2012.12.008; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gilhar A, 2011, J INVEST DERMATOL, V131, P118, DOI 10.1038/jid.2010.245; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Koshy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076740; Krampera M, 1999, ANN ALLERG ASTHMA IM, V83, P144, DOI 10.1016/S1081-1206(10)62626-9; Kruschinski C, 2005, CLIN EXP IMMUNOL, V139, P17, DOI 10.1111/j.1365-2249.2005.02666.x; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Machura E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/606139; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Norton R. S., 2013, VENOMS DRUG IN PRESS; Ohtsuka R, 2005, EXP TOXICOL PATHOL, V56, P361, DOI 10.1016/j.etp.2005.02.002; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pizzichini MMM, 1996, AM J RESP CRIT CARE, V154, P866, DOI 10.1164/ajrccm.154.4.8887576; Polikepahad S., 2010, J VIS EXP, V38, P1720; Porter P, 2011, MED MYCOL, V49, pS158, DOI 10.3109/13693786.2010.509743; Porter PC, 2011, INFECT IMMUN, V79, P4459, DOI 10.1128/IAI.05209-11; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schuijs MJ, 2013, CURR OPIN PHARMACOL, V13, P351, DOI 10.1016/j.coph.2013.03.013; Schwingshackl A, 2002, J LEUKOCYTE BIOL, V71, P807; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Syed F, 1999, QJM-MON J ASSOC PHYS, V92, P463, DOI 10.1093/qjmed/92.8.463; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Van Woerden H. C., 2013, BMC INFECT DIS, V13; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921	53	50	53	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12623	12632		10.1074/jbc.M113.517037	http://dx.doi.org/10.1074/jbc.M113.517037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644290	Green Published, hybrid			2022-12-25	WOS:000335581400034
J	Stockdreher, Y; Sturm, M; Josten, M; Sahl, HG; Dobler, N; Zigann, R; Dahl, C				Stockdreher, Yvonne; Sturm, Marga; Josten, Michaele; Sahl, Hans-Georg; Dobler, Nadine; Zigann, Renate; Dahl, Christiane			New Proteins Involved in Sulfur Trafficking in the Cytoplasm of Allochromatium vinosum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Intracellular Trafficking; Microbiology; Sulfur; Thiol; Allochromatium vinosum; Purple Sulfur Bacteria; Sulfur Oxidation; Sulfur Relay System; TusA	INVITRO INSERTIONAL MUTAGENESIS; ESCHERICHIA-COLI; SULFITE REDUCTASE; NMR STRUCTURE; OXIDATION; BACTERIUM; INSIGHTS; GROWTH; IRON; YHHP	Background: Sulfur carrier proteins Rhd_2599, TusA, and DsrE2 occur in many sulfur oxidizing prokaryotes. Results: Rhd_2599, TusA, and possibly DsrE2 are involved in cytoplasmic sulfur trafficking during dissimilatory sulfur oxidation. Conclusion: Sulfur transfer from persulfide intermediates to dissimilatory sulfite reductase involves Rhd_2599, TusA, and possibly DsrE2. Significance: Proteins involved in dissimilatory sulfur oxidation have been identified. The formation of periplasmic sulfur globules is an intermediate step during the oxidation of reduced sulfur compounds in various sulfur-oxidizing microorganisms. The mechanism of how this sulfur is activated and crosses the cytoplasmic membrane for further oxidation to sulfite by the dissimilatory reductase DsrAB is incompletely understood, but it has been well documented that the pathway involves sulfur trafficking mediated by sulfur-carrying proteins. So far sulfur transfer from DsrEFH to DsrC has been established. Persulfurated DsrC very probably serves as a direct substrate for DsrAB. Here, we introduce further important players in oxidative sulfur metabolism; the proteins Rhd_2599, TusA, and DsrE2 are strictly conserved in the Chromatiaceae, Chlorobiaceae, and Acidithiobacillaceae families of sulfur-oxidizing bacteria and are linked to genes encoding complexes involved in sulfur oxidation (Dsr or Hdr) in the latter two. Here we show via relative quantitative real-time PCR and microarray analysis an increase of mRNA levels under sulfur-oxidizing conditions for rhd_2599, tusA, and dsrE2 in Allochromatium vinosum. Transcriptomic patterns for the three genes match those of major genes for the sulfur-oxidizing machinery rather than those involved in biosynthesis of sulfur-containing biomolecules. TusA appears to be one of the major proteins in A. vinosum. A rhd_2599-tusA-dsrE2-deficient mutant strain, although not viable in liquid culture, was clearly sulfur oxidation negative upon growth on solid media containing sulfide. Rhd_2599, TusA, and DsrE2 bind sulfur atoms via conserved cysteine residues, and experimental evidence is provided for the transfer of sulfur between these proteins as well as to DsrEFH and DsrC.	[Stockdreher, Yvonne; Sturm, Marga; Dobler, Nadine; Zigann, Renate; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Abt Pharmazeut Mikrobiol, Inst Med Mikrobiol Immunol & Parasitol, D-53115 Bonn, Germany	University of Bonn; University of Bonn	Dahl, C (corresponding author), Univ Bonn, Inst Mikrobiol & Biotechnol, Meckenheimer Allee 168, D-53115 Bonn, Germany.	ChDahl@uni-bonn.de	Dahl, Christiane/H-4786-2019	Dahl, Christiane/0000-0001-8288-7546	Deutsche Forschungsgemeinschaft [Da 351/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Da 351/6-1 (to C. D.).	Cort JR, 2008, J MOL BIOL, V382, P692, DOI 10.1016/j.jmb.2008.07.022; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl Christiane, 2008, V27, P289; Dahl C, 2007, ACTA CRYSTALLOGR F, V63, P890, DOI 10.1107/S1744309107041188; Dahl C, 2013, MICROBIOL-SGM, V159, P2626, DOI 10.1099/mic.0.071019-0; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dahl JU, 2013, J BIOL CHEM, V288, P5426, DOI 10.1074/jbc.M112.431569; EVERETT SA, 1994, FREE RADICAL RES, V20, P387, DOI 10.3109/10715769409145638; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Frigaard Niels-Ulrik, 2008, V27, P337; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Grein F, 2010, J BACTERIOL, V192, P6369, DOI 10.1128/JB.00849-10; Grimm F, 2010, J BACTERIOL, V192, P1652, DOI 10.1128/JB.01269-09; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heising S, 1999, ARCH MICROBIOL, V172, P116, DOI 10.1007/s002030050748; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Kelly DP, 2008, POL J MICROBIOL, V57, P275; KELLY DP, 1969, ANAL CHEM, V41, P898, DOI 10.1021/ac60276a029; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubbe YJ, 2006, FEMS MICROBIOL LETT, V261, P194, DOI 10.1111/j.1574-6968.2006.00343.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Numata T, 2006, STRUCTURE, V14, P357, DOI 10.1016/j.str.2005.11.009; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; OVERMANN J, 1992, ARCH MICROBIOL, V157, P329, DOI 10.1007/BF00248677; PATTARAGULWANIT K, 1995, ARCH MICROBIOL, V164, P217, DOI 10.1007/BF02529974; Pfennig N., 1992, PROKARYOTES, P3200; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Rethmeier J, 1997, J CHROMATOGR A, V760, P295, DOI 10.1016/S0021-9673(96)00809-6; Riederer BM, 2009, CURR PROTEOMICS, V6, P51, DOI 10.2174/157016409787847448; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solovyev V., 2010, METAGENOMICS ITS APP, P71; SORBO B, 1987, METHOD ENZYMOL, V143, P3; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Tajc SG, 2004, J AM CHEM SOC, V126, P10508, DOI 10.1021/ja047929u; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Venceslau SS, 2014, BBA-BIOENERGETICS, V1837, P1148, DOI 10.1016/j.bbabio.2014.03.007; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Weissgerber T, 2014, APPL ENVIRON MICROB, V80, P2279, DOI 10.1128/AEM.04182-13; Weissgerber T, 2013, J BACTERIOL, V195, P4231, DOI 10.1128/JB.00154-13; Yamashino T, 1998, J BACTERIOL, V180, P2257, DOI 10.1128/JB.180.8.2257-2261.1998; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	54	23	26	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12390	12403		10.1074/jbc.M113.536425	http://dx.doi.org/10.1074/jbc.M113.536425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648525	Green Published, hybrid			2022-12-25	WOS:000335581400017
J	Himsworth, CG; Jardine, CM; Parsons, KL; Feng, AYT; Patrick, DM				Himsworth, Chelsea G.; Jardine, Claire M.; Parsons, Kirbee L.; Feng, Alice Y. T.; Patrick, David M.			The Characteristics of Wild Rat (Rattus spp.) Populations from an Inner-City Neighborhood with a Focus on Factors Critical to the Understanding of Rat-Associated Zoonoses	PLOS ONE			English	Article							LEPTOSPIRA-INTERROGANS; NORWAY RATS; HANTAVIRUS INFECTION; NORVEGICUS BERK.; BUENOS-AIRES; ECOLOGY; RODENTS; PREVALENCE; BALTIMORE; PATHOGENS	Norway and black rats (Rattus norvegicus and Rattus rattus) are among the most ubiquitous urban wildlife species and are the source of a number of zoonotic diseases responsible for significant human morbidity and mortality in cities around the world. Rodent ecology is a primary determinant of the dynamics of zoonotic pathogens in rodent populations and the risk of pathogen transmission to people, yet many studies of rat-associated zoonoses do not account for the ecological characteristics of urban rat populations. This hinders the development of an in-depth understanding of the ecology of rat-associated zoonoses, limits comparability among studies, and can lead to erroneous conclusions. We conducted a year-long trapping-removal study to describe the ecological characteristics of urban rat populations in an inner-city neighborhood of Vancouver, Canada. The study focused on factors that might influence the ecology of zoonotic pathogens in these populations and/or our understanding of that ecology. We found that rat population density varied remarkably over short geographical distances, which could explain observed spatial distributions of rat-associated zoonoses and have implications for sampling and data analysis during research and surveillance. Season appeared to influence rat population composition even within the urban environment, which could cause temporal variation in pathogen prevalence. Body mass and bite wounds, which are often used in epidemiologic analyses as simple proxies for age and aggression, were shown to be more complex than previously thought. Finally, we found that factors associated with trapping can determine the size and composition of sampled rat population, and thus influence inferences made about the source population. These findings may help guide future studies of rats and rat-associated zoonoses.	[Himsworth, Chelsea G.; Parsons, Kirbee L.; Feng, Alice Y. T.; Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Himsworth, Chelsea G.] British Columbia Minist Agr, Ctr Anim Hlth, Abbotsford, BC, Canada; [Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of British Columbia; University of Guelph	Himsworth, CG (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	Chelsea.Himsworth@gov.bc.ca			Canadian Institutes of Health Research [MOP -119530, CGV -104833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) MOP -119530 and CGV -104833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz KF, 2011, VECTOR-BORNE ZOONOT, V11, P979, DOI 10.1089/vbz.2010.0117; Agudelo-Florez P, 2009, AM J TROP MED HYG, V81, P906, DOI 10.4269/ajtmh.2009.09-0195; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Antoniou M, 2010, VECTOR-BORNE ZOONOT, V10, P867, DOI 10.1089/vbz.2009.0123; Aplin K., 2003, RATS MICE PEOPLE ROD, P487; Aplin KP, 2003, FIELD METHODS RODENT; Aviat F, 2009, COMP IMMUNOL MICROB, V32, P463, DOI 10.1016/j.cimid.2008.05.004; BABINSKA J, 1969, Acta Theriologica, V14, P267; Barnett S. A., 1963, RAT STUDY BEHAV; BARNETT SA, 1951, BEHAVIOUR, V3, P229; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; Billeter SA, 2011, APPL ENVIRON MICROB, V77, P7850, DOI 10.1128/AEM.06012-11; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Clapperton B. K., 2006, REV CURRENT KNOWLEDG; CLINTON JM, 1969, PUBLIC HEALTH REP, V84, P1, DOI 10.2307/4593484; Cueto GR, 2008, TROP MED INT HEALTH, V13, P46, DOI 10.1111/j.1365-3156.2007.01968.x; DAVIS DE, 1951, ECOLOGY, V32, P469, DOI 10.2307/1931724; DAVIS DE, 1949, J MAMMAL, V30, P125, DOI 10.2307/1375259; DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Dohoo I, 2007, VET EPIDEMIOLOGIC RE; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; EMLEN JT, 1949, ECOLOGY, V30, P430, DOI 10.2307/1932446; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x; GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418; GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350; Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; GURNELL J, 1980, ACTA THERIOL, V25, P255, DOI 10.4098/AT.arch.80-20; Harrell FE, 2001, REGRESSION MODELING; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Himsworth CG, 2014, APPL ENVIRON MICROB, V80, P1299, DOI 10.1128/AEM.03609-13; Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Himsworth CG, 2013, URBAN ECOSYST, V16, P341, DOI 10.1007/s11252-012-0261-4; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; Koizumi N, 2009, J MED MICROBIOL, V58, P1227, DOI 10.1099/jmm.0.011528-0; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Krebs Charles J., 1999, ACIAR Monograph Series, V59, P33; Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; MARGULIS HL, 1977, GEOGR REV, V67, P221, DOI 10.2307/214022; Meyer A., 2003, RATS MICE PEOPLE ROD, P446; Migliani R, 2006, TROP MED INT HEALTH, V11, P1228, DOI 10.1111/j.1365-3156.2006.01677.x; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Nagorsen D.W, 2002, IDENTIFICATION MANUA; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; Palma RE, 2012, J WILDLIFE DIS, V48, P267, DOI 10.7589/0090-3558-48.2.267; Psaroulaki A, 2010, T ROY SOC TROP MED H, V104, P733, DOI 10.1016/j.trstmh.2010.08.005; Reeves WK, 2008, J VECTOR ECOL, V33, P205, DOI 10.3376/1081-1710(2008)33[205:SEOTGR]2.0.CO;2; Scialfa E, 2010, REV ARGENT MICROBIOL, V42, P126, DOI 10.1590/S0325-75412010000200012; Smith H. A., 2000, WORLDS COLLIDE SOCIA; Tagliapietra V, 2009, EMERG INFECT DIS, V15, P1019, DOI 10.3201/eid1507.081524; TAYLOR KD, 1974, J APPL ECOL, V11, P453, DOI 10.2307/2402199; Taylor PJ, 2008, INTEGR ZOOL, V3, P38, DOI 10.1111/j.1749-4877.2008.00072.x; Traweger D, 2005, J PEST SCI, V78, P17, DOI 10.1007/s10340-004-0062-5; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; United Nations, 2012, WORLD URB PROSP 2011; Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2; Vadell MV, 2010, INT J PEST MANAGE, V56, P327, DOI 10.1080/09670874.2010.499479; Villanueva SYAM, 2010, AM J TROP MED HYG, V82, P889, DOI 10.4269/ajtmh.2010.09-0711; WORTH CB, 1950, J MAMMAL, V31, P293, DOI 10.2307/1375298	69	63	66	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91654	10.1371/journal.pone.0091654	http://dx.doi.org/10.1371/journal.pone.0091654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646877	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500043
J	Kimble, SJA; Rhodes, OE; Williams, RN				Kimble, Steven J. A.; Rhodes, O. E., Jr.; Williams, Rod N.			Unexpectedly Low Rangewide Population Genetic Structure of the Imperiled Eastern Box Turtle Terrapene c. carolina	PLOS ONE			English	Article							FLOW; MIGRATION; DIVERSITY; CONSERVATION; INFERENCE; SOFTWARE; DIFFERENTIATION; INDIVIDUALS; BOTTLENECK; DISTANCE	Rangewide studies of genetic parameters can elucidate patterns and processes that operate only over large geographic scales. Herein, we present a rangewide population genetic assessment of the eastern box turtle Terrapene c. carolina, a species that is in steep decline across its range. To inform conservation planning for this species, we address the hypothesis that disruptions to demographic and movement parameters associated with the decline of the eastern box turtle has resulted in distinctive genetic signatures in the form of low genetic diversity, high population structuring, and decreased gene flow. We used microsatellite genotype data from (n = 799) individuals from across the species range to perform two Bayesian population assignment approaches, two methods for comparing historical and contemporary migration among populations, an evaluation of isolation by distance, and a method for detecting barriers to gene flow. Both Bayesian methods of population assignment indicated that there are two populations rangewide, both of which have maintained high levels of genetic diversity (H-O = 0.756). Evidence of isolation by distance was detected in this species at a spatial scale of 300 - 500 km, and the Appalachian Mountains were identified as the primary barrier to gene flow across the species range. We also found evidence for historical but not contemporary migration between populations. Our prediction of many, highly structured populations across the range was not supported. This may point to cryptic contemporary gene flow, which might in turn be explained by the presence of rare transients in populations. However these data may be influenced by historical signatures of genetic connectivity because individuals of this species can be long-lived.	[Kimble, Steven J. A.; Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Rhodes, O. E., Jr.] Savannah River Ecol Lab, Aiken, SC USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Kimble, SJA (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	sjkimble@gmail.com			Indiana Department of Natural Resources, Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement [E2-08-WDS15]; Indiana Division of Forestry [E-9-6-A558]; Department of Forestry and Natural Resources, Purdue University	Indiana Department of Natural Resources, Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement; Indiana Division of Forestry; Department of Forestry and Natural Resources, Purdue University	Support for this project was provided by the Indiana Department of Natural Resources, Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement Grant E2-08-WDS15; Indiana Division of Forestry Grant E-9-6-A558; and the Department of Forestry and Natural Resources, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresco MJ, 2005, J WILDLIFE MANAGE, V69, P549, DOI 10.2193/0022-541X(2005)069[0549:MMTRHM]2.0.CO;2; AVISE JC, 1988, MOL BIOL EVOL, V5, P331; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; Burke RL, 2011, CHELONIAN CONSERV BI, V10, P256, DOI 10.2744/CCB-0855.1; Butler JM, 2011, BIOL J LINN SOC, V102, P889, DOI 10.1111/j.1095-8312.2011.01625.x; Cook RP, 2010, NPSNCBNNRTR2010380 U; Currylow AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040473; Dharmarajan G, 2013, J WILDLIFE MANAGE, V77, P226, DOI 10.1002/jwmg.458; Dharmarajan G, 2009, CAN J ZOOL, V87, P814, DOI 10.1139/Z09-072; DODD CK, 2001, N AM BOX TURTLES NAT; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ERNST C H, 1974, Transactions of the Kentucky Academy of Science, V35, P27; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2002, INTRO CONSERVATION G; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hagood S, 2009, THESIS U MARYLAND; Hall RJ, 1999, BIOL CONSERV, V88, P165; Hartl D., 2007, PRINCIPLES POPULATIO; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KIESTER AR, 1982, EVOLUTION, V36, P617, DOI 10.1111/j.1558-5646.1982.tb05086.x; Kimble SJA, 2011, CONSERV GENET RESOUR, V3, P65, DOI 10.1007/s12686-010-9291-5; Kimble SJA, 2012, J WILDLIFE DIS, V48, P799, DOI 10.7589/0090-3558-48.3.799; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Lemer S, 2011, J HERED, V102, P243, DOI 10.1093/jhered/esq123; Lerner HRL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007336; Lesica P, 1999, RESTOR ECOL, V7, P42, DOI 10.1046/j.1526-100X.1999.07105.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MADDEN R. C., 1975, THESIS CITY U NEW YO; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Marsack K, 2009, COPEIA, P647, DOI 10.1643/CE-08-233; McKay JK, 2005, RESTOR ECOL, V13, P432, DOI 10.1111/j.1526-100X.2005.00058.x; METCALF E, 1970, Transactions of the Kansas Academy of Science, V73, P96, DOI 10.2307/3627283; MILLER BK, 1993, HOOSIER FARMLAND WIL, V1, P2; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2009, R FDN STAT COMP; Rambaut A, 2007, TRACER V 5; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richtsmeier RJ, 2008, CHELONIAN CONSERV BI, V7, P3, DOI 10.2744/CCB-0653.1; Rousset F, 1997, GENETICS, V145, P1219; Sambrook J, 2001, MOL CLONING LAB MANU; Schwartz CW, 1974, 3 TOED BOX TURTLE 1; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; SOKAL RR, 1983, GENETICS, V105, P219; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; Steyaert LT, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008277; STICKEL LF, 1978, COPEIA, P221; Tsai YHE, 2010, P NATL ACAD SCI USA, V107, P17035, DOI 10.1073/pnas.1006225107; Turtle Conservation Genetics Working Group, 2007, Chelonian Research Monographs, V4, P107; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Victory ER, 2006, AM J BOT, V93, P118, DOI 10.3732/ajb.93.1.118; Waples RS, 1995, AM FISH S S, V17, P8; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WILLIAMS EC, 1987, HERPETOLOGICA, V43, P328; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114	71	13	13	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92274	10.1371/journal.pone.0092274	http://dx.doi.org/10.1371/journal.pone.0092274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647580	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500105
J	Liu, XL; Ward, BD; Binder, JR; Li, SJ; Hudetz, AG				Liu, Xiaolin; Ward, B. Douglas; Binder, Jeffrey R.; Li, Shi-Jiang; Hudetz, Anthony G.			Scale-Free Functional Connectivity of the Brain Is Maintained in Anesthetized Healthy Participants but Not in Patients with Unresponsive Wakefulness Syndrome	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; PERSISTENT VEGETATIVE STATE; SMALL-WORLD; THALAMOCORTICAL CONNECTIVITY; ADAPTIVE-RECONFIGURATION; INDUCED UNCONSCIOUSNESS; NEURONAL AVALANCHES; CEREBRAL METABOLISM; GENERAL-ANESTHESIA; FREE ORGANIZATION	Loss of consciousness in anesthetized healthy participants and in patients with unresponsive wakefulness syndrome (UWS) is associated with substantial alterations of functional connectivity across large-scale brain networks. Yet, a prominent distinction between the two cases is that after anesthesia, brain connectivity and consciousness are spontaneously restored, whereas in patients with UWS this restoration fails to occur, but why? A possible explanation is that the self-organizing capability of the brain is compromised in patients with UWS but not in healthy participants undergoing anesthesia. According to the theory of self-organized criticality, many natural complex systems, including the brain, evolve spontaneously to a critical state wherein system behaviors display spatial and/or temporal scale-invariant characteristics. Here we tested the hypothesis that the scale-free property of brain network organization is in fact fundamentally different between anesthetized healthy participants and UWS patients. We introduced a novel, computationally efficient approach to determine anatomical-functional parcellation of the whole-brain network at increasingly finer spatial scales. We found that in healthy participants, scale-free distributions of node size and node degree were present across wakefulness, propofol sedation, and recovery, despite significant propofol-induced functional connectivity changes. In patients with UWS, the scale-free distribution of node degree was absent, reflecting a fundamental difference between the two groups in adaptive reconfiguration of functional interaction between network components. The maintenance of scale-invariance across propofol sedation in healthy participants suggests the presence of persistent, on-going self-organizing processes to a critical state - a capacity that is compromised in patients with UWS.	[Liu, Xiaolin; Ward, B. Douglas; Li, Shi-Jiang] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Binder, Jeffrey R.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Hudetz, Anthony G.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Hudetz, AG (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	ahudetz@mcw.edu	Li, Shi-Jiang/M-2534-2017; Binder, Jeff/CAJ-3303-2022	Binder, Jeffrey/0000-0002-2233-5640	National Institute of General Medical Sciences of the National Institutes of Health [R01-GM103894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103894] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01-GM103894. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Agnati LF, 2004, LECT NOTES COMPUT SC, V3146, P24; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Boonstra TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00079; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fiset P, 1999, J NEUROSCI, V19, P5506; Fraiman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00307; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Hudetz AG, 2012, BRAIN CONNECT, V2, P291, DOI 10.1089/brain.2012.0107; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; Kaiser M, 2007, PHILOS T R SOC A, V365, P3033, DOI 10.1098/rsta.2007.0007; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lee H, 2013, ANESTHESIOLOGY, V119, P1347, DOI 10.1097/ALN.0b013e3182a8ec8c; Lee U, 2010, ANESTHESIOLOGY, V113, P1081, DOI 10.1097/ALN.0b013e3181f229b5; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liu XL, 2013, ANESTHESIOLOGY, V118, P59, DOI 10.1097/ALN.0b013e318277a801; Liu XL, 2012, HUM BRAIN MAPP, V33, P2487, DOI 10.1002/hbm.21385; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Perlin K, 2002, ACM T GRAPHIC, V21, P681, DOI 10.1145/566570.566636; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schroter MS, 2012, J NEUROSCI, V32, P12832, DOI 10.1523/JNEUROSCI.6046-11.2012; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; SteynRoss DA, 2010, SPR SER COMPUT NEURO, V4, P1; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Werner G, 2007, J PHYSIOL-PARIS, V101, P273, DOI 10.1016/j.jphysparis.2007.12.001; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Werner G, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00015; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0; Zhou JS, 2011, CONSCIOUS COGN, V20, P257, DOI 10.1016/j.concog.2010.08.003	68	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92182	10.1371/journal.pone.0092182	http://dx.doi.org/10.1371/journal.pone.0092182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647227	gold, Green Published			2022-12-25	WOS:000333348500095
J	Nugraha, C; Bora, M; Venkatraman, SS				Nugraha, Chandra; Bora, Meghali; Venkatraman, Subbu S.			Release Retardation of Model Protein on Polyelectrolyte-Coated PLGA Nano- and Microparticles	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; POLYMERIC MICROSPHERES; MULTILAYERED LIPOSOMES; ORAL DELIVERY; NANOPARTICLES; NANOCAPSULES; CELLS; FILMS; FUNCTIONALIZATION; PARTICLES	PEM capsules have been proposed for vehicles of drug microencapsulation, with the release triggered by pH, salt, magnetic field, or light. When built on another carrier encapsulating drugs, such as nanoparticles, it could provide additional release barrier to the releasing drug, providing further control to drug release. Although liposomes have received considerable attention with PEM coating for sustained drug release, similar results employing PEM built on poly(lactic-co-lycolic acid) (PLGA) particles is scant. In this work, we demonstrate that the build-up pH and polyelectrolyte pairs of PEM affect the release retardation of BSA from PLGA particles. PAH/PSS pair, the most commonly used polyelectrolyte pair, was used in comparison with PLL/DES. In addition, we also demonstrate that the release retardation effect of PEM-coated PLGA particles diminishes as the particle size increases. We attribute this to the diminishing relative thickness of the PEM coating with respect to the size of the particle as the particle size increases, reducing the diffusional resistance of the PEM.	[Nugraha, Chandra; Bora, Meghali; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	assubbu@ntu.edu.sg	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070; Bora, Meghali/0000-0002-8676-6810	National Research Foundation	National Research Foundation	This study was supported by the grant from National Research Foundation (http://www.nrf.gov.sg/) under the Competitive Research Programme Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AO, 2008, J PHARM SCI-US, V97, P2448, DOI 10.1002/jps.21215; Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; Anandhakumar S, 2010, COLLOID SURFACE B, V78, P266, DOI 10.1016/j.colsurfb.2010.03.016; Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+; Antipov AA, 2004, ADV COLLOID INTERFAC, V111, P49, DOI 10.1016/j.cis.2004.07.006; Ball V, 2002, J PHYS CHEM B, V106, P2357, DOI 10.1021/jp012522m; Bordi F, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/203102; Crouzier T, 2009, BIOMACROMOLECULES, V10, P433, DOI 10.1021/bm8012378; Cuomo F, 2012, SOFT MATTER, V8, P4415, DOI 10.1039/c2sm07388a; De Geest BG, 2007, CHEM SOC REV, V36, P636, DOI 10.1039/b600460c; Dejeu J, 2006, COLLOID SURFACE A, V288, P26, DOI 10.1016/j.colsurfa.2006.03.050; Fischer S, 2006, J CONTROL RELEASE, V111, P135, DOI 10.1016/j.jconrel.2005.11.015; Fischer S, 2007, BIOMATERIALS, V28, P994, DOI 10.1016/j.biomaterials.2006.10.034; Fujimoto K, 2007, MACROMOLECULES, V40, P5122, DOI 10.1021/ma070477w; Gebhart B., 1993, HEAT CONDUCTION MASS; Gillies G, 2007, J PHYS CHEM B, V111, P8626, DOI 10.1021/jp069009z; Girod S, 2004, CARBOHYD POLYM, V55, P37, DOI 10.1016/j.carbpol.2003.07.006; Gupta GK, 2011, AAPS PHARMSCITECH, V12, P344, DOI 10.1208/s12249-011-9593-2; Haidar ZS, 2008, BIOMATERIALS, V29, P1207, DOI 10.1016/j.biomaterials.2007.11.012; Huang XB, 2013, CARBOHYD POLYM, V92, P1064, DOI 10.1016/j.carbpol.2012.10.063; Jain P, 2009, MOL PHARMACEUT, V6, P593, DOI 10.1021/mp8002539; Jain S, 2012, MOL PHARMACEUT, V9, P2626, DOI 10.1021/mp300202c; Jain S, 2012, BIOMATERIALS, V33, P6758, DOI 10.1016/j.biomaterials.2012.05.026; Kakade S, 2009, INT J PHARMACEUT, V365, P44, DOI 10.1016/j.ijpharm.2008.08.019; Kato N, 2002, MACROMOLECULES, V35, P9780, DOI 10.1021/ma0209388; Keren K, 2002, PHYS REV LETT, V89, P4; Kittitheeranun P, 2010, LANGMUIR, V26, P6869, DOI 10.1021/la1003676; Luo RC, 2012, SMALL, V8, P2585, DOI 10.1002/smll.201200398; Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]; Na K, 2007, J AM CHEM SOC, V129, P5788, DOI 10.1021/ja067707r; Palama IE, 2013, BIOTECHNOL BIOENG, V110, P586, DOI 10.1002/bit.24626; Pechenkin MA, 2012, SOFT MATTER, V8, P8659, DOI 10.1039/c2sm25971k; SACCO D, 1986, FEBS LETT, V199, P254, DOI 10.1016/0014-5793(86)80490-2; Salis A, 2011, LANGMUIR, V27, P11597, DOI 10.1021/la2024605; Sato K, 2012, POLYM BULL, V68, P891, DOI 10.1007/s00289-011-0670-1; Sennato S, 2009, COLLOID SURFACE A, V343, P34, DOI 10.1016/j.colsurfa.2009.01.026; Shu SJ, 2010, BIOMATERIALS, V31, P6039, DOI 10.1016/j.biomaterials.2010.04.016; Shu SJ, 2010, ACTA BIOMATER, V6, P210, DOI 10.1016/j.actbio.2009.06.020; Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1; Tripathy J, 2013, COLLOID SURFACE B, V101, P487, DOI 10.1016/j.colsurfb.2012.07.025; van der Walle CF, 2009, EXPERT OPIN DRUG DEL, V6, P177, DOI [10.1517/17425240802680169, 10.1517/17425240802680169 ]; Volodkin D, 2007, J CONTROL RELEASE, V117, P111, DOI 10.1016/j.jconrel.2006.10.021; Wang ZJ, 2009, COLLOID SURFACE A, V348, P137, DOI 10.1016/j.colsurfa.2009.07.008; Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015; Yang YY, 2001, BIOMATERIALS, V22, P231, DOI 10.1016/S0142-9612(00)00178-2; Zhang JX, 2004, J MICROENCAPSUL, V21, P775, DOI 10.1080/02652040400008465; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004; Zhou J, 2010, J COLLOID INTERF SCI, V345, P241, DOI 10.1016/j.jcis.2010.02.004; Zhou J, 2009, MACROMOL BIOSCI, V9, P326, DOI 10.1002/mabi.200800188	49	6	6	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92393	10.1371/journal.pone.0092393	http://dx.doi.org/10.1371/journal.pone.0092393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647768	Green Published, gold			2022-12-25	WOS:000333348500125
J	Porolak, G; Dabek, L; Krockenberger, AK				Porolak, Gabriel; Dabek, Lisa; Krockenberger, Andrew K.			Spatial Requirements of Free-Ranging Huon Tree Kangaroos, Dendrolagus matschiei (Macropodidae), in Upper Montane Forest	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HOME-RANGE; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; BODY-SIZE; SPACE USE; FOOD; MAMMALS; ORGANIZATION; POPULATIONS	Tree kangaroos (Macropodidae, Dendrolagus) are some of Australasia's least known mammals. However, there is sufficient evidence of population decline and local extinctions that all New Guinea tree kangaroos are considered threatened. Understanding spatial requirements is important in conservation and management. Expectations from studies of Australian tree kangaroos and other rainforest macropodids suggest that tree kangaroos should have small discrete home ranges with the potential for high population densities, but there are no published estimates of spatial requirements of any New Guinea tree kangaroo species. Home ranges of 15 Huon tree kangaroos, Dendrolagus matschiei, were measured in upper montane forest on the Huon Peninsula, Papua New Guinea. The home range area was an average of 139.6 +/- 26.5 ha (100% MCP; n = 15) or 81.8 +/- 28.3 ha (90% harmonic mean; n = 15), and did not differ between males and females. Home ranges of D. matschiei were 40-100 times larger than those of Australian tree kangaroos or other rainforest macropods, possibly due to the impact of hunting reducing density, or low productivity of their high altitude habitat. Huon tree kangaroos had cores of activity within their range at 45% (20.9 +/- 4.1 ha) and 70% (36.6 +/- 7.5 ha) harmonic mean isopleths, with little overlap (4.8 +/- 2.9%; n = 15 pairs) between neighbouring females at the 45% isopleth, but, unlike the Australian species, extensive overlap between females (20.8 +/- 5.5%; n = 15 pairs) at the complete range (90% harmonic mean). Males overlapped each other and females to a greater extent than did pairs of females. From core areas and overlap, the density of female D. matschiei was one per 19.4 ha. Understanding the cause of this low density is crucial in gaining greater understanding of variations in density of tree kangaroos across the landscape. We consider the potential role of habitat fragmentation, productivity and hunting pressure in limiting tree kangaroo density in New Guinea rainforests.	[Porolak, Gabriel; Krockenberger, Andrew K.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Cairns, Australia; [Porolak, Gabriel; Krockenberger, Andrew K.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Australia; [Porolak, Gabriel; Dabek, Lisa] Woodland Pk Zoo, Dept Field Conservat, Seattle, WA USA	James Cook University; James Cook University	Porolak, G (corresponding author), James Cook Univ, Ctr Trop Biodivers & Climate Change, Cairns, Australia.	gabriel.porolak@my.jcu.edu.au		Krockenberger, Andrew/0000-0003-2872-9939	National Geographic Society; Conservation International; Woodland Park Zoo; Roger Williams Park Zoo; American Zoo and Aquarium Association's (AZA) Tree Kangaroo Species Survival Plan	National Geographic Society(National Geographic Society); Conservation International; Woodland Park Zoo; Roger Williams Park Zoo; American Zoo and Aquarium Association's (AZA) Tree Kangaroo Species Survival Plan	The authors would like to acknowledge in-kind and financial support from the following institutions, the National Geographic Society (Grant of $19,900-Determining Activity Patterns, Home Range Size, and Habitat Use by the Matschie's Tree Kangaroo (Dendrolagus matschiei) on the Huon Peninsula, Papua New Guinea through Radiotelemetry), Conservation International, Woodland Park Zoo, Roger Williams Park Zoo, and the American Zoo and Aquarium Association's (AZA) Tree Kangaroo Species Survival Plan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett E., 2002, Conservation in Practice, V3, P28; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; BERGER J, 1990, CONSERV BIOL, V4, P91, DOI 10.1111/j.1523-1739.1990.tb00271.x; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; CLUTTONBROCK TH, 1989, NATURE, V337, P70, DOI 10.1038/337070a0; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Coombes KE, 2005, THESIS J COOK U; Davies NB, 1991, BEHAV ECOLOGY EVOLUT; DIFFENDORFER JE, 1995, ECOLOGY, V76, P827, DOI 10.2307/1939348; DWYER PD, 1991, HUM ECOL, V19, P187, DOI 10.1007/BF00888745; DWYER PD, 1985, MAN, V20, P243, DOI 10.2307/2802383; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Evans M, 1996, WILDLIFE RES, V23, P547, DOI 10.1071/WR9960547; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Fisher DO, 2000, J ANIM ECOL, V69, P1083, DOI 10.1046/j.1365-2656.2000.00450.x; Flannery TF, 1996, TREE KANGAROOS CURIO, P84; FLEHARTY E D, 1973, Southwestern Naturalist, V18, P21, DOI 10.2307/3669907; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fowler J., 1998, PRACTICAL STAT FIELD, P130; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; IMS RA, 1987, J ANIM ECOL, V56, P585, DOI 10.2307/5070; IMS RA, 1995, MOSAIC LANDSCAPES EC; IUCN, 2013, RED LIST THREAT SPEC; Jensen R, 2005, GEN COLLECTION FLORA; JOHNSON CN, 1986, BEHAV ECOL SOCIOBIOL, V19, P143, DOI 10.1007/BF00299949; Jonsson P, 2002, EVOL ECOL, V16, P455, DOI 10.1023/A:1020854525220; Kenward R., 1996, RANGES 5 ANAL SYSTEM; Kenward RE., 2000, MANUAL WILDLIFE RADI; Leary T, 2009, IUCN RED LIST THREAT; Lieth H, 1975, PRIMARY PRODUCTIVITY; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Mack LA, 2005, 61 RES MAN AS PAC, P1; MARES MA, 1976, OECOLOGIA, V25, P1, DOI 10.1007/BF00345029; Martin R., 1992, Australian Natural History, V24, P22; Martin R, 2005, AUSTRAL NAT HIST SER, P1; Martin RW, 1996, TREE KANGAROOS CURIO, P36; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; METZGAR LH, 1979, J MAMMAL, V60, P129, DOI 10.2307/1379764; Newell GR, 1999, BIOL CONSERV, V91, P181, DOI 10.1016/S0006-3207(99)00083-X; Newell GR, 1999, WILDLIFE RES, V26, P129, DOI 10.1071/WR98016; Pellissier L, 2012, ECOL EVOL, V2, P1818, DOI 10.1002/ece3.296; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Procter-Gray E., 1984, P129; Rapp JM, 2012, ECOLOGY, V93, P2061, DOI 10.1890/11-1725.1; Robinson EJ, 2000, HUNTING SUSTAINABILI; ROLSTAD J, 1991, BIOL J LINN SOC, V42, P149, DOI 10.1111/j.1095-8312.1991.tb00557.x; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; SCOTT JM, 1993, WILDLIFE MONOGR, P1; SLOBODCHIKOFF CN, 1984, NEW ECOLOGY NOVEL AP; Steadman DW, 2002, HUM ECOL, V30, P339, DOI 10.1023/A:1016520602698; TAITT MJ, 1981, J ANIM ECOL, V50, P125, DOI 10.2307/4036; Terborgh J, 1980, CONSERVATION BIOL EC; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; van der Ree R, 2003, J ZOOL, V259, P327, DOI 10.1017/S0952836902003229; van der Ree R, 2001, WILDLIFE RES, V28, P517, DOI 10.1071/WR00051; White G.C., 1990, ANAL WILDLIFE RADIO; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wittenberger JF, 1981, ANIMAL SOCIAL BEHA; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Yahner RH, 1997, CONSERV BIOL, V11, P569, DOI 10.1046/j.1523-1739.1997.96322.x	63	4	4	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91870	10.1371/journal.pone.0091870	http://dx.doi.org/10.1371/journal.pone.0091870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642914	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000333259900042
J	Sartorius, T; Peter, A; Schulz, N; Drescher, A; Bergheim, I; Machann, J; Schick, F; Siegel-Axel, D; Schurmann, A; Weigert, C; Haring, HU; Hennige, AM				Sartorius, Tina; Peter, Andreas; Schulz, Nadja; Drescher, Andrea; Bergheim, Ina; Machann, Juergen; Schick, Fritz; Siegel-Axel, Dorothea; Schuermann, Annette; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.			Cinnamon Extract Improves Insulin Sensitivity in the Brain and Lowers Liver Fat in Mouse Models of Obesity	PLOS ONE			English	Article							FASTING BLOOD-GLUCOSE; IN-VITRO; ANTIOXIDANT ACTIVITY; ESSENTIAL OILS; GLYCOGEN; EUGENOL; CINNAMALDEHYDE; INFLAMMATION; INHIBITION; OVERWEIGHT	Objectives: Treatment of diabetic subjects with cinnamon demonstrated an improvement in blood glucose concentrations and insulin sensitivity but the underlying mechanisms remained unclear. This work intends to elucidate the impact of cinnamon effects on the brain by using isolated astrocytes, and an obese and diabetic mouse model. Methods: Cinnamon components (eugenol, cinnamaldehyde) were added to astrocytes and liver cells to measure insulin signaling and glycogen synthesis. Ob/ob mice were supplemented with extract from cinnamomum zeylanicum for 6 weeks and cortical brain activity, locomotion and energy expenditure were evaluated. Insulin action was determined in brain and liver tissues. Results: Treatment of primary astrocytes with eugenol promoted glycogen synthesis, whereas the effect of cinnamaldehyde was attenuated. In terms of brain function in vivo, cinnamon extract improved insulin sensitivity and brain activity in ob/ob mice, and the insulin-stimulated locomotor activity was improved. In addition, fasting blood glucose levels and glucose tolerance were greatly improved in ob/ob mice due to cinnamon extracts, while insulin secretion was unaltered. This corresponded with lower triglyceride and increased liver glycogen content and improved insulin action in liver tissues. In vitro, Fao cells exposed to cinnamon exhibited no change in insulin action. Conclusions: Together, cinnamon extract improved insulin action in the brain as well as brain activity and locomotion. This specific effect may represent an important central feature of cinnamon in improving insulin action in the brain, and mediates metabolic alterations in the periphery to decrease liver fat and improve glucose homeostasis.	[Sartorius, Tina; Peter, Andreas; Drescher, Andrea; Siegel-Axel, Dorothea; Weigert, Cora; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Sartorius, Tina; Schulz, Nadja; Machann, Juergen; Schuermann, Annette; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.] German Ctr Diabet Res DZD, Tubingen, Germany; [Sartorius, Tina; Machann, Juergen; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.] Univ Tuebingen IDM, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany; [Schulz, Nadja; Schuermann, Annette] German Inst Human Nutr, Dept Expt Diabetol, Potsdam, Germany; [Bergheim, Ina] Univ Jena, Dept Nutr Sci, SD Model Syst Mol Nutr, Jena, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sartorius, T (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany.	tina.sartorius@med.uni-tuebingen.de		Schick, Fritz/0000-0002-4231-3406; Schurmann, Annette/0000-0002-4113-4377	German Federal Ministry of Education and Research (BMBF) [01GI0925]; University of Tuebingen	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Tuebingen	The project was supported in part by grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.; 01GI0925). Additional parts of the funding are internal department funds of the University of Tuebingen (employment of people at the University of Tuebingen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler JA, 2007, DIABETES CARE, V30, P813, DOI 10.2337/dc06-1871; Anand P, 2010, CHEM-BIOL INTERACT, V186, P72, DOI 10.1016/j.cbi.2010.03.044; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Chericoni S, 2005, J AGR FOOD CHEM, V53, P4762, DOI 10.1021/jf050183e; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Couturier K, 2011, METABOLISM, V60, P1590, DOI 10.1016/j.metabol.2011.03.016; Davis PA, 2011, J MED FOOD, V14, P884, DOI 10.1089/jmf.2010.0180; Deepa B, 2013, TOXICOL MECH METHOD, V23, P223, DOI 10.3109/15376516.2012.743638; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Gruenwald J, 2010, CRIT REV FOOD SCI, V50, P822, DOI 10.1080/10408390902773052; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Hennige AM, 2006, DIABETOLOGIA, V49, P1274, DOI 10.1007/s00125-006-0192-9; Hennige AM, 2005, DIABETES, V54, P361, DOI 10.2337/diabetes.54.2.361; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Ho YS, 2010, AGEING RES REV, V9, P354, DOI 10.1016/j.arr.2009.10.001; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Kleinridders A, 2009, CURR OPIN PHARMACOL, V9, P794, DOI 10.1016/j.coph.2009.10.006; Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003; Lungarini S, 2008, FOOD ADDIT CONTAM A, V25, P1297, DOI 10.1080/02652030802105274; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Nagababu E, 2010, METHODS MOL BIOL, V610, P165, DOI 10.1007/978-1-60327-029-8_10; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Rafehi H, 2012, DIABETES OBES METAB, V14, P493, DOI 10.1111/j.1463-1326.2011.01538.x; Ranasinghe P, 2012, DIABETIC MED, V29, P1480, DOI 10.1111/j.1464-5491.2012.03718.x; Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756; Sartorius T, 2012, CELL PHYSIOL BIOCHEM, V30, P238, DOI 10.1159/000339060; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Sartorius T, 2012, FASEB J, V26, P1799, DOI 10.1096/fj.11-191023; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Sebai H, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-189; Shimada Y, 2000, PHYTOTHER RES, V14, P466, DOI 10.1002/1099-1573(200009)14:6&lt;466::AID-PTR614&gt;3.0.CO;2-Z; Simic A, 2004, PHYTOTHER RES, V18, P713, DOI 10.1002/ptr.1516; Singh G, 2007, FOOD CHEM TOXICOL, V45, P1650, DOI 10.1016/j.fct.2007.02.031; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Suppapitiporn Suchat, 2006, J Med Assoc Thai, V89 Suppl 3, pS200; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Tschritter O, 2009, J CLIN ENDOCR METAB, V94, P4600, DOI 10.1210/jc.2009-0469; Tsou RC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00192; Usta J, 2003, HUM EXP TOXICOL, V22, P355, DOI 10.1191/0960327103ht379oa; Usta J, 2002, FOOD CHEM TOXICOL, V40, P935, DOI 10.1016/S0278-6915(02)00071-6; Vuksan V, 2005, NUTR METAB CARDIOVAS, V15, P149, DOI 10.1016/j.numecd.2005.05.001; Wickenbere J, 2012, BRIT J NUTR, V107, P1845, DOI 10.1017/S0007114511005113; Wie MB, 1997, NEUROSCI LETT, V225, P93, DOI 10.1016/S0304-3940(97)00195-X; Yu IC, 2013, DIABETES, V62, P411, DOI 10.2337/db12-0135; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	61	64	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92358	10.1371/journal.pone.0092358	http://dx.doi.org/10.1371/journal.pone.0092358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643026	Green Published, gold			2022-12-25	WOS:000333259900125
J	Lehmann, A; Kliewer, A; Martens, JC; Nagel, F; Schulz, S				Lehmann, Andreas; Kliewer, Andrea; Maertens, Jan Carlo; Nagel, Falko; Schulz, Stefan			Carboxyl-Terminal Receptor Domains Control the Differential Dephosphorylation of Somatostatin Receptors by Protein Phosphatase 1 Isoforms	PLOS ONE			English	Article							ARRESTIN BINDING; CUSHINGS-DISEASE; INTERNALIZATION; PHOSPHORYLATION	We have recently identified protein phosphatase 1 beta (PP1 beta) as G protein-coupled receptor (GPCR) phosphatase for the sst(2) somatostatin receptor using siRNA knockdown screening. By contrast, for the sst(5) somatostatin receptor we identified protein phosphatase 1 gamma (PP1 gamma) as GPCR phosphatase using the same approach. We have also shown that sst(2) and sst(5) receptors differ substantially in the temporal dynamics of their dephosphorylation and trafficking patterns. Whereas dephosphorylation and recycling of the sst(2) receptor requires extended time periods of similar to 30 min, dephosphorylation and recycling of the sst(5) receptor is completed in less than 10 min. Here, we examined which receptor domains determine the selection of phosphatases for receptor dephosphorylation. We found that generation of tail-swap mutants between sst(2) and sst(5) was required and sufficient to reverse the patterns of dephosphorylation and trafficking of these two receptors. In fact, siRNA knockdown confirmed that the sst(5) receptor carrying the sst(2) tail is predominantly dephosphorylated by PP1 beta, whereas the sst(2) receptor carrying the sst(5) tail is predominantly dephosphorylated by PP1 gamma. Thus, the GPCR phosphatase responsible for dephosphorylation of individual somatostatin receptor subtypes is primarily determined by their different carboxyl-terminal receptor domains. This phosphatase specificity has in turn profound consequences for the dephosphorylation dynamics and trafficking patterns of GPCRs.	[Lehmann, Andreas; Kliewer, Andrea; Maertens, Jan Carlo; Nagel, Falko; Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Schulz, S (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, Lobderstr 1, D-07743 Jena, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885	Deutsche Forschungsgemeinschaft [SCHU924/10-3]; Deutsche Krebshilfe grant [109952]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe grant(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft grant SCHU924/10-3 and the Deutsche Krebshilfe grant 109952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choy MS, 2012, BIOCHEM SOC T, V40, P969, DOI 10.1042/BST20120094; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Doll C, 2012, BRIT J PHARMACOL, V167, P1259, DOI 10.1111/j.1476-5381.2012.02080.x; Donangelo I, 2005, ENDOCRINE, V28, P131, DOI 10.1385/ENDO:28:2:131; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Gatto F, 2013, J CLIN ENDOCR METAB, V98, pE66, DOI 10.1210/jc.2012-2609; Gehret AU, 2013, ACS CHEM BIOL, V8, P588, DOI 10.1021/cb3004513; Krueger KM, 1997, J BIOL CHEM, V272, P5; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Petrich A, 2013, MOL ENDOCRINOL, V24, P436; Peverelli E, 2008, MOL ENDOCRINOL, V22, P676, DOI 10.1210/me.2007-0068; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Poll F, 2011, J BIOL CHEM, V286, P32931, DOI 10.1074/jbc.M111.224899; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200	15	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91526	10.1371/journal.pone.0091526	http://dx.doi.org/10.1371/journal.pone.0091526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637622	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100041
J	Mussolin, C; Nys, J; Content, A; Leybaert, J				Mussolin, Christophe; Nys, Julie; Content, Alain; Leybaert, Jacqueline			Symbolic Number Abilities Predict Later Approximate Number System Acuity in Preschool Children	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SENSE; REPRESENTATIONS; DISCRIMINATION; DISABILITIES; ACHIEVEMENT; SUBTRACTION; JUDGMENTS; KNOWLEDGE	An ongoing debate in research on numerical cognition concerns the extent to which the approximate number system and symbolic number knowledge influence each other during development. The current study aims at establishing the direction of the developmental association between these two kinds of abilities at an early age. Fifty-seven children of 3-4 years performed two assessments at 7 months interval. In each assessment, children's precision in discriminating numerosities as well as their capacity to manipulate number words and Arabic digits was measured. By comparing relationships between pairs of measures across the two time points, we were able to assess the predictive direction of the link. Our data indicate that both cardinality proficiency and symbolic number knowledge predict later accuracy in numerosity comparison whereas the reverse links are not significant. The present findings are the first to provide longitudinal evidence that the early acquisition of symbolic numbers is an important precursor in the developmental refinement of the approximate number representation system.	[Mussolin, Christophe; Nys, Julie; Content, Alain; Leybaert, Jacqueline] Univ Libre Bruxelles, Ctr Res Cognit & Neurosci, Lab Cognit Language Dev, Brussels, Belgium	Universite Libre de Bruxelles	Mussolin, C (corresponding author), Univ Libre Bruxelles, Ctr Res Cognit & Neurosci, Lab Cognit Language Dev, Brussels, Belgium.	christophe.mussolin@ulb.ac.be		Content, Alain/0000-0003-4170-463X	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The first author is supported by a grant from the National Fund for Scientific Research (Belgium). The authors declare no conflict of interest that might be interpreted as influencing the research, and APA ethical standards were followed in the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Brannon EM, 2002, COGNITION, V83, P223, DOI 10.1016/S0010-0277(02)00005-7; Brannon EM, 2001, COGNITIVE PSYCHOL, V43, P53, DOI 10.1006/cogp.2001.0756; Briars D.J., 1988, CHILDRENS COUNTING C, P63; Brunswick N, 2012, J EXP CHILD PSYCHOL, V111, P268, DOI 10.1016/j.jecp.2011.08.001; Carey S, 2001, MIND LANG, V16, P37, DOI 10.1111/1468-0017.00155; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Carey Susan, 2009, OXFORD SERIES COGNIT; Chevrie-Muller C., 2001, NOUVELLES EPREUVES E; Coquet F, 2007, REEDUCATION ORTHOPHO, V231, P203; Corsi PM, 1972, THESIS MONTREAL; CRANO WD, 1978, J EDUC PSYCHOL, V70, P39, DOI 10.1037/0022-0663.70.1.39; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; Dehaene S, 1997, NUMBER SENSE MIND CR; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; ELLIS N, 1988, APPL COGNITIVE PSYCH, V2, P47, DOI 10.1002/acp.2350020106; Elzhov TV, 2012, R INTERFACE LEVENBER; Gallistel C. R., 2005, CAMBRIDGE HDB THINKI, P559, DOI [DOI 10.1037/002775, 10.1037/002775]; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Gelman R., 1978, CHILDS UNDERSTANDING; Gilmore CK, 2007, NATURE, V447, P589, DOI 10.1038/nature05850; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Huntley-Fenner G, 2000, PSYCHOL SCI, V11, P147, DOI 10.1111/1467-9280.00230; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lindskog M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00510; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; Luo YLL, 2011, LEARN INDIVID DIFFER, V21, P710, DOI 10.1016/j.lindif.2011.09.001; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2009, 5 LOOKS 6 DEFICIT NU; Mussolin C, 2012, TRENDS NEUROSCI EDUC, V1, P21, DOI 10.1016/j.tine.2012.09.003; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Noel MP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00165; Nys J, 2013, TRENDS NEUROSCI EDUC, V2, P13, DOI 10.1016/j.tine.2013.01.001; Ostad SA, 1997, BRIT J EDUC PSYCHOL, V67, P345, DOI 10.1111/j.2044-8279.1997.tb01249.x; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Quartana PJ, 2010, PAIN, V149, P325, DOI 10.1016/j.pain.2010.02.029; Raven J.C., 1977, RAVENS COLOURED PROG; ROGOSA D, 1980, PSYCHOL BULL, V88, P245, DOI 10.1037/0033-2909.88.2.245; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Schneider W., 2002, E PRIME VERSION 20 C; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; Shalev R. S., 2007, WHY IS MATH SO HARD, P49; Sikora P, 2008, WORK STRESS, V22, P51, DOI 10.1080/02678370801999651; Slaughter V, 2006, DEVELOPMENTAL SCI, V9, P33, DOI 10.1111/j.1467-7687.2005.00460.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Van Nieuwenhoven C., 2001, TEST DIAGNOSTIQUE CO; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; von Aster M., 2006, ZAREKI R BATTERIE EV; Wagner JB, 2011, COGNITION, V119, P10, DOI 10.1016/j.cognition.2010.11.014; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	74	58	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91839	10.1371/journal.pone.0091839	http://dx.doi.org/10.1371/journal.pone.0091839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637785	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100066
J	Dasgupta, T; Croll, DH; Owen, JA; Vander Heiden, MG; Locasale, JW; Alon, U; Cantley, LC; Gunawardena, J				Dasgupta, Tathagata; Croll, David H.; Owen, Jeremy A.; Vander Heiden, Matthew G.; Locasale, Jason W.; Alon, Uri; Cantley, Lewis C.; Gunawardena, Jeremy			A Fundamental Trade-off in Covalent Switching and Its Circumvention by Enzyme Bifunctionality in Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Covalent Regulation; Glucose Metabolism; Mathematical Modeling; Multifunctional Enzymes; Phosphorylation; 6-Phosphofructo-2-kinase; Fructose-2; 6-bisphosphatase; Goldbeter-Koshland Loop; Covalent Modification Cycle; Linear Framework	SIGNAL-TRANSDUCTION CASCADES; MULTISITE PHOSPHORYLATION; ISOCITRATE DEHYDROGENASE; PROTEIN-PHOSPHORYLATION; REGULATORY SYSTEM; ROBUST-CONTROL; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; SENSITIVITY; ULTRASENSITIVITY; METABOLISM	Background: Covalent modification cycles are widely used as regulatory switches. Results: Mathematical analysis reveals, under very general assumptions, an unavoidable trade-off between switching efficiency and cell-to-cell coherence. Conclusion: Enzyme bifunctionality offers a way to circumvent this trade-off. Significance: This may explain the bifunctionality of PFK-2/FBPase-2 in controlling the switch between glycolysis and gluconeogenesis in the mammalian liver. Covalent modification provides a mechanism for modulating molecular state and regulating physiology. A cycle of competing enzymes that add and remove a single modification can act as a molecular switch between on and off and has been widely studied as a core motif in systems biology. Here, we exploit the recently developed linear framework for time scale separation to determine the general principles of such switches. These methods are not limited to Michaelis-Menten assumptions, and our conclusions hold for enzymes whose mechanisms may be arbitrarily complicated. We show that switching efficiency improves with increasing irreversibility of the enzymes and that the on/off transition occurs when the ratio of enzyme levels reaches a value that depends only on the rate constants. Fluctuations in enzyme levels, which habitually occur due to cellular heterogeneity, can cause flipping back and forth between on and off, leading to incoherent mosaic behavior in tissues, that worsens as switching becomes sharper. This trade-off can be circumvented if enzyme levels are correlated. In particular, if the competing catalytic domains are on the same protein but do not influence each other, the resulting bifunctional enzyme can switch sharply while remaining coherent. In the mammalian liver, the switch between glycolysis and gluconeogenesis is regulated by the bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2). We suggest that bifunctionality of PFK-2/FBPase-2 complements the metabolic zonation of the liver by ensuring coherent switching in response to insulin and glucagon.	[Dasgupta, Tathagata; Owen, Jeremy A.; Cantley, Lewis C.; Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Croll, David H.] Regis Coll, Dept Chem & Phys, Weston, MA 02493 USA; [Vander Heiden, Matthew G.] MIT, Koch Inst Canc Res, Cambridge, MA 02139 USA; [Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14850 USA; [Alon, Uri] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Regis University; Massachusetts Institute of Technology (MIT); Cornell University; Weizmann Institute of Science; Harvard University; Beth Israel Deaconess Medical Center	Gunawardena, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	jeremy@hms.harvard.edu	Cantley, Lewis C/D-1800-2014; Locasale, Jason W/ABE-6505-2020	Cantley, Lewis C/0000-0002-1298-7653; Locasale, Jason W/0000-0002-7766-3502	National Institutes of Health from NCRR [1S10RR028832-01]; NATIONAL CANCER INSTITUTE [R00CA168997] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Raafat El-Maghrabi for helpful information on PFK-2/FBPase-2; Jeremy Muhlich for assistance with cluster computing, support for which was partially provided by National Institutes of Health Grant 1S10RR028832-01 from NCRR; Joseph Dexter for helpful discussions, and Rebecca Ward for generous assistance with Tex to Word conversion.	Anderson Karen S., 2003, P19; Atsumi T, 2002, CANCER RES, V62, P5881; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Beard D., 2008, CAMB TEXT BIOMED ENG; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; Dexter JP, 2013, J BIOL CHEM, V288, P5770, DOI 10.1074/jbc.M112.339226; El-Maghrabi MR, 2001, CURR OPIN CLIN NUTR, V4, P411, DOI 10.1097/00075197-200109000-00012; ELMAGHRABI MR, 1984, BIOCHEM BIOPH RES CO, V123, P749; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fersht A., 1985, ENZYME STRUCTURE MEC; Gibson D., 2002, METABOLIC REGULATION; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldstein BN, 2002, FEBS LETT, V532, P295, DOI 10.1016/S0014-5793(02)03639-6; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Gunawardena J, 2014, FEBS J, V281, P473, DOI 10.1111/febs.12532; Gunawardena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036321; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hart Y, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-171; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; JUNGERMANN K, 1992, ENZYME, V46, P33, DOI 10.1159/000468777; Karp RL, 2012, J THEOR BIOL, V311, P130, DOI 10.1016/j.jtbi.2012.07.004; Kurland IJ, 2000, BIOCHEM J, V347, P459, DOI 10.1042/0264-6021:3470459; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Michaelis L, 1913, BIOCHEM Z, V49, P333; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Mirzaev I, 2013, B MATH BIOL, V75, P2118, DOI 10.1007/s11538-013-9884-8; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Ortega F, 2002, P NATL ACAD SCI USA, V99, P1170, DOI 10.1073/pnas.022267399; Pilkis S. J., 1987, ENZYMES, VXVIII, P4; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Saier M. H, 1987, ENZYMES METABOLIC PA; SHACTERNOIMAN E, 1983, PHILOS T ROY SOC B, V302, P157, DOI 10.1098/rstb.1983.0049; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Straube R, 2013, BIOPHYS J, V105, P1925, DOI 10.1016/j.bpj.2013.09.010; Thomson M, 2009, J THEOR BIOL, V261, P626, DOI 10.1016/j.jtbi.2009.09.003; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Torre C, 2010, PROG MOL BIOL TRANSL, V97, P127, DOI 10.1016/B978-0-12-385233-5.00005-2; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195; Xu YQ, 2012, J THEOR BIOL, V311, P139, DOI 10.1016/j.jtbi.2012.07.012	57	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13010	13025		10.1074/jbc.M113.546515	http://dx.doi.org/10.1074/jbc.M113.546515			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24634222	hybrid, Green Published			2022-12-25	WOS:000335522800006
J	Hiemer, SE; Szymaniak, AD; Varelas, X				Hiemer, Samantha E.; Szymaniak, Aleksander D.; Varelas, Xaralabos			The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor beta-induced Tumorigenic Phenotypes in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Migration; Cell Signaling; Coregulator Transcription; Signal Transduction; Transforming Growth Factor (TGF); Hippo Pathway; Signaling Cross-talk; YAP; TAZ	EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO SIGNALING PATHWAY; YES-ASSOCIATED PROTEIN; TGF-BETA; IN-VITRO; PROLIFERATION; COACTIVATOR; INHIBITION; INDUCTION; CARCINOMA	Background: The TGF and Hippo pathways are dysregulated in metastatic breast cancers. Results: TGF-induced cues and nuclear TAZ/YAP converge at the transcriptional level to control gene expression important for tumorigenesis. Conclusion: TAZ/YAP are required to promote TGF-induced tumorigenic phenotypes in breast cancer cells. Significance: Our study reveals novel cross-talk between the TGF pathway and TAZ/YAP in late-stage breast cancers. Uncontrolled transforming growth factor- (TGF) signaling promotes aggressive metastatic properties in late-stage breast cancers. However, how TGF-mediated cues are directed to induce tumorigenic events is poorly understood, particularly given that TGF has clear tumor suppressing activity in other contexts. Here, we demonstrate that the transcriptional regulators TAZ and YAP (TAZ/YAP), key effectors of the Hippo pathway, are necessary to promote and maintain TGF-induced tumorigenic phenotypes in breast cancer cells. Interactions between TAZ/YAP, TGF-activated SMAD2/3, and TEAD transcription factors reveal convergent roles for these factors in the nucleus. Genome-wide expression analyses indicate that TAZ/YAP, TEADs, and TGF-induced signals coordinate a specific pro-tumorigenic transcriptional program. Importantly, genes cooperatively regulated by TAZ/YAP, TEAD, and TGF, such as the novel targets NEGR1 and UCA1, are necessary for maintaining tumorigenic activity in metastatic breast cancer cells. Nuclear TAZ/YAP also cooperate with TGF signaling to promote phenotypic and transcriptional changes in nontumorigenic cells to overcome TGF-repressive effects. Our work thus identifies cross-talk between nuclear TAZ/YAP and TGF signaling in breast cancer cells, revealing novel insight into late-stage disease-driving mechanisms.	[Hiemer, Samantha E.; Szymaniak, Aleksander D.; Varelas, Xaralabos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Varelas, X (corresponding author), Boston Univ, Sch Med, Dept Biochem, Rm K225, Boston, MA 02118 USA.	xvarelas@bu.edu	Varelas, Xaralabos/ABB-9141-2020	/0000-0003-1913-0465; Varelas, Xaralabos/0000-0002-2882-4541	Boston University Clinical and Translational Science Institute (CTSA Grant) [UL1-TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER	Boston University Clinical and Translational Science Institute (CTSA Grant); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the Boston University Clinical and Translational Science Institute for funds to perform the microarray analysis (CTSA Grant UL1-TR000157) and Adam Gower and the Boston University Microarray Core for help with microarray data analysis. We thank Alicia Viloria-Petit (University of Guelph, Canada) for the LM2-4 cells; Kathrin Kirsch (Boston University) for the BT20, HS578T, MCF7, and SKBR3 cells; and David Sherr (Boston University) for the SUM149 cells.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bakin AV, 2002, J CELL SCI, V115, P3193; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bayarmagnai B, 2012, CELL CYCLE, V11, P4191, DOI 10.4161/cc.22486; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bouquet F, 2011, CLIN CANCER RES, V17, P6754, DOI 10.1158/1078-0432.CCR-11-0544; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Choki I, 1998, ANTICANCER RES, V18, P4213; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hashimoto T, 2009, CELL BIOCHEM FUNCT, V27, P496, DOI 10.1002/cbf.1600; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Iavarone A, 1997, NATURE, V387, P417; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Spaltmann F, 1996, J NEUROSCI, V16, P1770; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vlug EJ, 2013, CELL ONCOL, V36, P375, DOI 10.1007/s13402-013-0143-7; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang XD, 2012, EUR J CANCER, V48, P1227, DOI 10.1016/j.ejca.2011.10.001; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wu JH, 2011, MOL CANCER RES, V9, P1562, DOI 10.1158/1541-7786.MCR-11-0340; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie D, 2001, CANCER RES, V61, P8917; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	73	164	170	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13461	13474		10.1074/jbc.M113.529115	http://dx.doi.org/10.1074/jbc.M113.529115			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648515	hybrid, Green Published			2022-12-25	WOS:000335522800043
J	Chiang, CH; Huang, PH; Chiu, CC; Hsu, CY; Leu, HB; Huang, CC; Chen, JW; Lin, SJ				Chiang, Chia-Hung; Huang, Po-Hsun; Chiu, Chun-Chih; Hsu, Chien-Yi; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong			Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ACUTE-RENAL-FAILURE; NITRIC-OXIDE; ISCHEMIA; PROLIFERATION; MOBILIZATION; DYSFUNCTION	Objectives: Reduced number and impaired function of circulating endothelial progenitor cells (EPCs) in patients with chronic kidney disease have been reported. However, there is little data about the association between circulating EPC levels and risk of contrast-induced nephropathy (CIN). The aim of this study was to investigate the relationship between circulating EPCs and CIN in patients after angiography. Methods and Results: A total of 77 consecutive patients undergoing elective percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) were enrolled. Flow cytometry with quantification of EPC markers (defined as CD34(+), CD34(+)KDR(+), and CD34(+)KDR(+)CD133(+)) in peripheral blood samples was used to assess EPC number before the procedure. CIN was defined as an absolute increase >= 0.5 mg/dl or a relative increase >= 25% in the serum creatinine level at 48 hours after the procedure. Eighteen (24%) of the study subjects developed CIN. Circulating EPC levels were significantly lower in patients who developed CIN than in those without CIN (CD34(+)KDR(+), 4.11 +/- 2.59 vs. 9.25 +/- 6.30 cells/10(5) events, P<0.001). The incidence of CIN was significantly greater in patients in the lowest EPC tertile (CD34(+)KDR(+); from lowest to highest, 52%, 15%, and 4%, P<0.001). Using univariate logistic regression, circulating EPC number (CD34(+)KDR(+)) was a significant negative predictor for development of CIN (odds ratio 0.69, 95% CI 0.54-0.87, P = 0.002). Over a two-year follow-up, patients with CIN had a higher incidence of major adverse cardiovascular events including myocardial infarction, stroke, revascularization of treated vessels, and death (66.7% vs. 25.4%, P = 0.004) than did patients without CIN. Conclusions: Decreased EPC level is associated with a greater risk of CIN, which may explain part of the pathophysiology of CIN and the poor prognosis in CIN patients.	[Chiang, Chia-Hung] Taipei Vet Gen Hosp, Hsinchu Branch, Dept Med, Div Cardiol, Hsinchu, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Chiu, Chun-Chih; Hsu, Chien-Yi; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Chiu, Chun-Chih; Hsu, Chien-Yi; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, PH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw		Hsu, Chien-Yi/0000-0002-9493-7325	UST-UCSD International Center of Excellence in Advanced Bio-engineering from National Science Council [NSC-99-2911-I-009-101]; Taipei Veterans General Hospital [VGH-V98B1-003, VGH-V100E2-002]; Ministry of Education "Aim for the Top University" Plan;  [NSC 97-2314-B-075-039];  [NSC 98-2314-B-075-035]	UST-UCSD International Center of Excellence in Advanced Bio-engineering from National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education "Aim for the Top University" Plan(Ministry of Education, Taiwan); ; 	This study was supported in part by research grants from the NSC 97-2314-B-075-039, NSC 98-2314-B-075-035, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101 from the National Science Council; VGH-V98B1-003 and VGH-V100E2-002 from Taipei Veterans General Hospital, and also a grant from the Ministry of Education "Aim for the Top University" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; Chu K, 2008, STROKE, V39, P1441, DOI 10.1161/STROKEAHA.107.499236; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McCullough Peter A, 2003, Rev Cardiovasc Med, V4 Suppl 5, pS3; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Ozuyaman B, 2005, THROMB HAEMOSTASIS, V94, P770, DOI 10.1160/TH05-01-0038; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Perticone F, 2010, CIRCULATION, V122, P379, DOI 10.1161/CIRCULATIONAHA.110.940932; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ribeiro L, 2004, KIDNEY INT, V65, P589, DOI 10.1111/j.1523-1755.2004.00408.x; Ricardo SD, 2005, NEPHROLOGY, V10, P276, DOI 10.1111/j.1440-1797.2005.00373.x; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; SCHWARTZ D, 1994, AM J PHYSIOL, V267, pF374, DOI 10.1152/ajprenal.1994.267.3.F374; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; Vallance P, 2001, HEART, V85, P342, DOI 10.1136/heart.85.3.342; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wong PCY, 2012, INT J CARDIOL, V158, P186, DOI 10.1016/j.ijcard.2011.06.115; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	28	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89942	10.1371/journal.pone.0089942	http://dx.doi.org/10.1371/journal.pone.0089942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646509	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500010
J	Fonjungo, PN; Kalish, ML; Schaefer, A; Rayfield, M; Mika, J; Rose, LE; Heslop, O; Soudre, R; Pieniazek, D				Fonjungo, Peter N.; Kalish, Marcia L.; Schaefer, Amanda; Rayfield, Mark; Mika, Jennifer; Rose, Laura E.; Heslop, Orville; Soudre, Robert; Pieniazek, Danuta			Recombinant Viruses Initiated the Early HIV-1 Epidemic in Burkina Faso	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; WEST CENTRAL-AFRICA; GROUP-N; HIGHLY DIVERGENT; GROUP-O; GENETIC DIVERSITY; TYPE-1 SUBTYPE; GUINEA-BISSAU; GENOME SEQUENCES; ANTIBODY-BINDING	We analyzed genetic diversity and phylogenetic relationships among 124 HIV-1 and 19 HIV-2 strains in sera collected in 1986 from patients of the state hospital in Ouagadougou, Burkina Faso. Phylogenetic analysis of the HIV-1 env gp41 region of 65 sequences characterized 37 (56.9%) as CRF06_cpx strains, 25 (38.5%) as CRF02_AG, 2 (3.1%) as CRF09_cpx, and 1 (1.5%) as subtype A. Similarly, phylogenetic analysis of the protease (PR) gene region of 73 sequences identified 52 (71.2%) as CRF06_cpx, 15 (20.5%) as CRF02_AG, 5 (6.8%) as subtype A, and 1 (1.4%) was a unique strain that clustered along the B/D lineage but basal to the node connecting the two lineages. HIV-2 PR or integrase (INT) groups A (n = 17 [89.5%]) and B (n = 2 [10.5%]) were found in both monotypic (n = 11) and heterotypic HIV-1/HIV-2 (n = 8) infections, with few HIV-2 group B infections. Based on limited available sampling, evidence suggests two recombinant viruses, CRF06_cpx and CRF02_AG, appear to have driven the beginning of the mid-1980s HIV-1 epidemic in Burkina Faso.	[Fonjungo, Peter N.; Kalish, Marcia L.; Schaefer, Amanda; Rayfield, Mark; Mika, Jennifer; Rose, Laura E.; Heslop, Orville; Pieniazek, Danuta] Ctr Dis Control, Natl Ctr Infect Dis, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA; [Fonjungo, Peter N.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Soudre, Robert] Univ Ouagadougou, Unite Format & Rech Sci Sante UFR SDS, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fonjungo, PN (corresponding author), Ctr Dis Control, Natl Ctr Infect Dis, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA.	Pfonjungo@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work was funded by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LOS ALAMOS DATABASE; Ayouba A, 2000, AIDS, V14, P2623, DOI 10.1097/00002030-200011100-00033; Ayouba A, 2001, EMERG INFECT DIS, V7, P466, DOI 10.3201/eid0703.017321; Barin F, 1996, AIDS RES HUM RETROV, V12, P1279, DOI 10.1089/aid.1996.12.1279; Barin F, 2007, AIDS, V21, P2351, DOI 10.1097/QAD.0b013e3282f15637; BARNETT SW, 1993, J VIROL, V67, P1006, DOI 10.1128/JVI.67.2.1006-1014.1993; Brennan CA, 1997, AIDS RES HUM RETROV, V13, P401, DOI 10.1089/aid.1997.13.401; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; CHARNEAU P, 1994, VIROLOGY, V205, P247, DOI 10.1006/viro.1994.1640; CHEINGSONGPOPOV R, 1994, AIDS RES HUM RETROV, V10, P1379, DOI 10.1089/aid.1994.10.1379; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; DELEYS R, 1990, J VIROL, V64, P1207, DOI 10.1128/JVI.64.3.1207-1216.1990; DIETRICH U, 1989, NATURE, V342, P948, DOI 10.1038/342948a0; EsuWilliams E, 1997, J ACQ IMMUN DEF SYND, V16, P204, DOI 10.1097/00042560-199711010-00010; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fonjungo PN, 2000, AIDS RES HUM RETROV, V16, P1319, DOI 10.1089/08892220050117087; Fonjungo PN, 2002, J CLIN MICROBIOL, V40, P837, DOI 10.1128/JCM.40.3.837-845.2002; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Imamichi H, 2009, AIDS RES HUM RETROV, V25, P45, DOI 10.1089/aid.2008.0111; Ishikawa K, 2001, AIDS RES HUM RETROV, V17, P1661, DOI 10.1089/088922201753342077; Janini LM, 1996, VIRUS GENES, V13, P69, DOI 10.1007/BF00576981; Kalish ML, 2004, EMERG INFECT DIS, V10, P1227; KANKI PJ, 1987, SCIENCE, V236, P827, DOI 10.1126/science.3033826; KIRCHHOFF F, 1990, AIDS, V4, P847, DOI 10.1097/00002030-199009000-00003; KONG LI, 1988, SCIENCE, V240, P1525, DOI 10.1126/science.3375832; Lankoande S, 1998, INT J STD AIDS, V9, P146, DOI 10.1258/0956462981921909; Machuca A, 1999, INTERVIROLOGY, V42, P37, DOI 10.1159/000024958; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Masciotra S, 2000, AIDS RES HUM RETROV, V16, P1007, DOI 10.1089/08892220050058425; Masciotra S, 2002, J CLIN MICROBIOL, V40, P3167, DOI 10.1128/JCM.40.9.3167-3171.2002; McCutchan FE, 1999, VIROLOGY, V254, P226, DOI 10.1006/viro.1998.9505; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; MIURA T, 1990, AIDS, V4, P1257, DOI 10.1097/00002030-199012000-00012; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Montavon C, 2000, J ACQ IMMUN DEF SYND, V23, P363; Montavon C, 1999, AIDS RES HUM RETROV, V15, P1707, DOI 10.1089/088922299309757; Montavon C, 2002, J ACQ IMMUN DEF SYND, V29, P522, DOI 10.1097/00126334-200204150-00014; NAUCLER A, 1991, AIDS, V5, P301, DOI 10.1097/00002030-199103000-00009; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Nkengasong JN, 2000, J ACQ IMMUN DEF SYND, V23, P430; Oelrichs RB, 1998, AIDS RES HUM RETROV, V14, P1495, DOI 10.1089/aid.1998.14.1495; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Ouedraogo-Traore R, 2003, AIDS, V17, P441, DOI 10.1097/00002030-200302140-00019; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Peeters M, 1999, J VIROL, V73, P7368, DOI 10.1128/JVI.73.9.7368-7375.1999; Piedade J, 2000, ACTA TROP, V76, P119, DOI 10.1016/S0001-706X(00)00096-6; Pieniazek D, 1999, AIDS RES HUM RETROV, V15, P603, DOI 10.1089/088922299311132; PIENIAZEK D, 1991, AIDS, V5, P1293, DOI 10.1097/00002030-199111000-00002; Plantier JC, 1999, J ACQ IMMUN DEF SYND, V20, P432, DOI 10.1097/00042560-199904150-00004; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; POULSEN AG, 1993, J ACQ IMMUN DEF SYND, V6, P941; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Roques P, 2004, AIDS, V18, P1371, DOI 10.1097/01.aids.0000125990.86904.28; Ruelle J, 2007, AIDS RES HUM RETROV, V23, P955, DOI 10.1089/aid.2007.0034; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; SMITH TF, 1981, J MOL EVOL, V18, P38, DOI 10.1007/BF01733210; Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W; Tapia N, 2003, J GEN VIROL, V84, P607, DOI 10.1099/vir.0.18754-0; Tebit DM, 2008, JAIDS-J ACQ IMM DEF, V49, P17, DOI 10.1097/QAI.0b013e318182d2bc; Tebit DM, 2006, JAIDS-J ACQ IMM DEF, V43, P144, DOI 10.1097/01.qai.0000228148.40539.d3; Tebit DM, 2009, J MED VIROL, V81, P1691, DOI 10.1002/jmv.21600; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178; van der Loeff MFS, 1999, AIDS, V13, pS69; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Wiktor SZ, 1999, AIDS, V13, P695, DOI 10.1097/00002030-199904160-00010; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P83, DOI 10.1089/aid.2006.22.83; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P453, DOI 10.1089/aid.2006.22.453; Yang CF, 2000, J INFECT DIS, V181, P1791, DOI 10.1086/315439; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	82	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92423	10.1371/journal.pone.0092423	http://dx.doi.org/10.1371/journal.pone.0092423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647246	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500129
J	Harter, PN; Zinke, J; Scholz, A; Tichy, J; Zachskorn, C; Kvasnicka, HM; Goeppert, B; Delloye-Bourgeois, C; Hattingen, E; Senft, C; Steinbach, JP; Plate, KH; Mehlen, P; Schulte, D; Mittelbronn, M				Harter, Patrick N.; Zinke, Jenny; Scholz, Alexander; Tichy, Julia; Zachskorn, Cornelia; Kvasnicka, Hans M.; Goeppert, Benjamin; Delloye-Bourgeois, Celine; Hattingen, Elke; Senft, Christian; Steinbach, Joachim P.; Plate, Karl H.; Mehlen, Patrick; Schulte, Dorothea; Mittelbronn, Michel			Netrin-1 Expression Is an Independent Prognostic Factor for Poor Patient Survival in Brain Metastases	PLOS ONE			English	Article							CELL LUNG-CANCER; COLORECTAL-CANCER; RECEPTOR; CARCINOMA; NUCLEAR; DCC; ANGIOGENESIS; APOPTOSIS; UNC5C; OVEREXPRESSION	The multifunctional molecule netrin-1 is upregulated in various malignancies and has recently been presented as a major general player in tumorigenesis leading to tumor progression and maintenance in various animal models. However, there is still a lack of clinico-epidemiological data related to netrin-1 expression. Therefore, the aim of our study was to elucidate the association of netrin-1 expression and patient survival in brain metastases since those constitute one of the most limiting factors for patient prognosis. We investigated 104 brain metastases cases for netrin-1 expression using in-situ hybridization and immunohistochemistry with regard to clinical parameters such as patient survival and MRI data. Our data show that netrin-1 is strongly upregulated in most cancer subtypes. Univariate analyses revealed netrin-1 expression as a significant factor associated with poor patient survival in the total cohort of brain metastasis patients and in sub-entities such as non-small cell lung carcinomas. Interestingly, many cancer samples showed a strong nuclear netrin-1 signal which was recently linked to a truncated netrin-1 variant that enhances tumor growth. Nuclear netrin-1 expression was associated with poor patient survival in univariate as well as in multivariate analyses. Our data indicate both total and nuclear netrin-1 expression as prognostic factors in brain metastases patients in contrast to other prognostic markers in oncology such as patient age, number of brain metastases or Ki67 proliferation index. Therefore, nuclear netrin-1 expression constitutes one of the first reported molecular biomarkers for patient survival in brain metastases. Furthermore, netrin-1 may constitute a promising target for future anti-cancer treatment approaches in brain metastases.	[Harter, Patrick N.; Zinke, Jenny; Scholz, Alexander; Zachskorn, Cornelia; Plate, Karl H.; Schulte, Dorothea; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Harter, Patrick N.; Zachskorn, Cornelia; Kvasnicka, Hans M.; Goeppert, Benjamin; Steinbach, Joachim P.; Plate, Karl H.; Mittelbronn, Michel] German Canc Consortium DKTK, Heidelberg, Germany; [Harter, Patrick N.; Zachskorn, Cornelia; Kvasnicka, Hans M.; Goeppert, Benjamin; Steinbach, Joachim P.; Plate, Karl H.; Mittelbronn, Michel] German Canc Res Ctr, Heidelberg, Germany; [Tichy, Julia; Steinbach, Joachim P.] Goethe Univ Frankfurt, Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany; [Kvasnicka, Hans M.] Goethe Univ Frankfurt, Senckenberg Inst Pathol, D-60054 Frankfurt, Germany; [Goeppert, Benjamin] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Delloye-Bourgeois, Celine; Mehlen, Patrick] Univ Lyon, Apoptosis Canc & Dev Lab,,Ctr Leon Berard, Equipe Labellisee La Ligue,CNRS,UMR5286, LabEx DEVweCAN,Ctr Cancerol Lyon,INSERM,U1052, Lyon, France; [Hattingen, Elke] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany; [Senft, Christian] Goethe Univ Frankfurt, Dept Neurosurg, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Goethe University Frankfurt; Goethe University Frankfurt	Mittelbronn, M (corresponding author), Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany.	michel.mittelbronn@kgu.de	Kvasnicka, Hans Michael/E-7993-2011; Delloye-Bourgeois, Céline/G-8988-2017; Goeppert, Benjamin/AAC-2303-2022; Hattingen, Elke/D-7880-2015; Senft, Christian/F-4252-2010	Kvasnicka, Hans Michael/0000-0002-3081-1395; Delloye-Bourgeois, Céline/0000-0002-7162-0034; Senft, Christian/0000-0003-1288-6913; Goeppert, Benjamin/0000-0002-4135-9250; Mittelbronn, Michel/0000-0002-2998-052X; Schulte, Dorothea/0000-0002-7243-6319; Hattingen, Elke/0000-0002-8392-9004; Harter, Patrick N./0000-0001-5530-6910	Goethe University Frankfurt am Main, Germany	Goethe University Frankfurt am Main, Germany	The present study was financially supported by the Goethe University Frankfurt am Main, Germany (UCT-Trx program 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; Barnholtz-Sloan JS, 2012, NEURO-ONCOLOGY, V14, P910, DOI 10.1093/neuonc/nos087; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; CAO H, 1995, ENDOCRINOLOGY, V136, P3163, DOI 10.1210/en.136.7.3163; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Coissieux MM, 2011, GASTROENTEROLOGY, V141, P2039, DOI 10.1053/j.gastro.2011.08.041; Delloye-Bourgeois C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002456; Delloye-Bourgeois C, 2009, JNCI-J NATL CANCER I, V101, P237, DOI 10.1093/jnci/djn491; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P1543, DOI 10.1038/jcbfm.2008.39; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Flannery TW, 2008, INT J RADIAT ONCOL, V72, P19, DOI 10.1016/j.ijrobp.2007.12.031; GALICICH JH, 1980, J NEUROSURG, V53, P63, DOI 10.3171/jns.1980.53.1.0063; Hammoud MA, 1996, ANN SURG ONCOL, V3, P453, DOI 10.1007/BF02305763; Harter PN, 2010, NEUROPATH APPL NEURO, V36, P623, DOI 10.1111/j.1365-2990.2010.01100.x; Hibi K, 2010, ANTICANCER RES, V30, P107; Hibi K, 2009, WORLD J SURG, V33, P1053, DOI 10.1007/s00268-008-9909-x; Kefeli U, 2012, BIOMARKERS, V17, P663, DOI 10.3109/1354750X.2012.709882; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Link BC, 2007, ANN SURG ONCOL, V14, P2591, DOI 10.1245/s10434-007-9469-6; Lo H-W, 2005, CANCER RES, V65, P338; Lv D, 2011, EUR J CANCER, V47, P2068, DOI 10.1016/j.ejca.2011.04.021; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Papanastasiou AD, 2011, ONCOTARGET, V2, P363; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Ramesh G, 2011, BIOMARKERS, V16, P172, DOI 10.3109/1354750X.2010.541564; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Shuch B, 2008, CANCER-AM CANCER SOC, V113, P1641, DOI 10.1002/cncr.23769; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012	39	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92311	10.1371/journal.pone.0092311	http://dx.doi.org/10.1371/journal.pone.0092311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647424	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500113
J	Herzog, E; Falke, KC; Presterl, T; Scheuermann, D; Ouzunova, M; Frisch, M				Herzog, Eva; Falke, Karen Christin; Presterl, Thomas; Scheuermann, Daniela; Ouzunova, Milena; Frisch, Matthias			Selection Strategies for the Development of Maize Introgression Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; CHROMOSOME SEGMENTS; LINES; QTL; RESISTANCE; CONSTRUCTION; LIBRARIES; BLIGHT; WHEAT	Introgression libraries are valuable resources for QTL detection and breeding, but their development is costly and time-consuming. Selection strategies for the development of introgression populations with a limited number of individuals and high-throughput (HT) marker assays are required. The objectives of our simulation study were to design and compare selection strategies for the development of maize introgression populations of 100 lines with population sizes of 360-720 individuals per generation for different DH and S-2 crossing schemes. Pre-selection for complete donor chromosomes or donor chromosome halves reduced the number of simultaneous backcross programs. The investigated crossing and selection schemes differed considerably with respect to their suitability to create introgression populations with clearly separated, evenly distributed target donor chromosome segments. DH crossing schemes were superior to S-2 crossing schemes, mainly due to complete homozygosity, which greatly reduced the total number of disjunct genome segments in the introgression populations. The S-2 crossing schemes were more flexible with respect to selection and provided economic alternatives to DH crossing schemes. For the DH crossing schemes, increasing population sizes gradually over backcross generations was advantageous as it reduced the total number of required HT assays compared to constant population sizes. For the S-2 crossing schemes, large population sizes in the final backcross generation facilitated selection for the target segments in the final backcross generation and reduced fixation of large donor chromosome segments. The suggested crossing and selection schemes can help to make the genetic diversity of exotic germplasm available for enhancing the genetic variation of narrow-based breeding populations of crops.	[Herzog, Eva; Frisch, Matthias] Univ Giessen, Inst Agron & Plant Breeding 2, D-35390 Giessen, Germany; [Falke, Karen Christin] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Presterl, Thomas; Scheuermann, Daniela; Ouzunova, Milena] KWS Saat AG, Einbeck, Germany	Justus Liebig University Giessen; University of Munster; KWS Saat AG	Frisch, M (corresponding author), Univ Giessen, Inst Agron & Plant Breeding 2, D-35390 Giessen, Germany.	matthias.frisch@uni-giessen.de	Frisch, Matthias/R-1564-2019	Frisch, Matthias/0000-0003-4234-8972	German Federal Ministry of Education and Research (BMBF) [0315951]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Funding from the German Federal Ministry of Education and Research (BMBF Grant 0315951) is gratefully acknowledged. [http://www.bmbf.de/en/index.php] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher AR, 2012, THEOR APPL GENET, V124, P433, DOI 10.1007/s00122-011-1718-1; Cheema KK, 2008, EUPHYTICA, V160, P401, DOI 10.1007/s10681-007-9560-x; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Falke KC, 2008, THEOR APPL GENET, V117, P641, DOI 10.1007/s00122-008-0808-1; Falke KC, 2011, HEREDITY, V106, P576, DOI 10.1038/hdy.2010.87; Falke KC, 2009, THEOR APPL GENET, V119, P595, DOI 10.1007/s00122-009-1069-3; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Lin SY, 1998, THEOR APPL GENET, V96, P997, DOI 10.1007/s001220050831; Liu SB, 2006, THEOR APPL GENET, V112, P1360, DOI 10.1007/s00122-006-0238-x; Lubberstedt T, 2012, PLANT BREEDING, V131, P449, DOI 10.1111/j.1439-0523.2011.01948.x; Mahone GS, 2012, CROP SCI, V52, P2198, DOI 10.2135/cropsci2011.06.0341; Mano Y, 2013, ANN BOT-LONDON, V112, P1125, DOI 10.1093/aob/mct160; Matus I, 2003, GENOME, V46, P1010, DOI 10.1139/G03-080; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; Pumphrey MO, 2007, CROP SCI, V47, P200, DOI 10.2135/cropsci2006.03.0206; R Core Team, 2021, R LANG ENV STAT COMP; Ribaut JM, 2007, J EXP BOT, V58, P351, DOI 10.1093/jxb/erl214; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; STAM P, 1979, GENETICS, V92, P573; Syed NH, 2004, MOL BREEDING, V13, P59, DOI 10.1023/B:MOLB.0000012845.37366.b5; Szalma SJ, 2007, THEOR APPL GENET, V114, P1211, DOI 10.1007/s00122-007-0512-6; Torjek O, 2008, J HERED, V99, P396, DOI 10.1093/jhered/esn014; Welcker C, 2011, PLANT PHYSIOL, V157, P718, DOI 10.1104/pp.111.176479; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	24	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92429	10.1371/journal.pone.0092429	http://dx.doi.org/10.1371/journal.pone.0092429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647313	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500130
J	Leblond, F; Poirier, S; Yu, C; Duquette, N; Mayer, G; Thorin, E				Leblond, Francois; Poirier, Steve; Yu, Carol; Duquette, Natacha; Mayer, Gaetan; Thorin, Eric			The Anti-Hypercholesterolemic Effect of Low p53 Expression Protects Vascular Endothelial Function in Mice	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; BILE-ACID HOMEOSTASIS; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; DEPENDENT CONTRACTIONS; ATHEROSCLEROTIC PATIENTS; CARDIOVASCULAR-DISEASE; CELLULAR SENESCENCE; POSSIBLE MECHANISM; NUCLEAR RECEPTOR	Aims: To demonstrate that p53 modulates endothelial function and the stress response to a high-fat western diet (WD). Methods and Results: Three-month old p53(+/+) wild type (WT) and p53(+/-) male mice were fed a regular or WD for 3 months. Plasma levels of total cholesterol (TC) and LDL-cholesterol were significantly elevated (p < 0.05) in WD-fed WT (from 2.1 +/- 0.2 mmol/L to 3.1 +/- 0.2, and from 0.64 +/- 0.09 mmol/L to 1.25 +/- 0.11, respectively) but not in p53(+/-) mice. The lack of cholesterol accumulation in WD-fed p53(+/-) mice was ass-ociated with high bile acid plasma concentrations (p53(+/-) = 4.7 +/- 0.9 vs. WT = 3.3 +/- 0.2 mu mol/L, p < 0.05) concomitant with an increased hepatic 7-alpha-hydroxylase mRNA expression. While the WD did not affect aortic endothelial relaxant function in p53(+/-) mice (WD = 8365 and RD = 82 +/- 4% relaxation), it increased the maximal response to acetylcholine in WT mice (WD = 8762 vs. RD = 62 +/- 5% relaxation, p < 0.05) to levels of p53(+/-). In WT mice, the rise in TC associated with higher (p < 0.05) plasma levels of pro-inflammatory keratinocyte-derived chemokine, and an over-activation (p < 0.05) of the relaxant non-nitric oxide/non-prostacyclin endothelial pathway. It is likely that in WT mice, activations of these pathways are adaptive and contributed to maintain endothelial function, while the WD neither promoted inflammation nor affected endothelial function in p53(+/-) mice. Conclusions: Our data demonstrate that low endogenous p53 expression prevents the rise in circulating levels of cholesterol when fed a WD. Consequently, the endothelial stress of hypercholesterolemia is absent in young p53(+/-) mice as evidenced by the absence of endothelial adaptive pathway over-activation to minimize stress-related damage.	[Leblond, Francois; Poirier, Steve; Yu, Carol; Mayer, Gaetan; Thorin, Eric] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Thorin, Eric] Univ Montreal, Dept Surg, Montreal, PQ H3C 3J7, Canada; [Leblond, Francois; Poirier, Steve; Yu, Carol; Mayer, Gaetan; Thorin, Eric] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Leblond, Francois; Poirier, Steve; Yu, Carol; Duquette, Natacha; Mayer, Gaetan; Thorin, Eric] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Thorin, E (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	eric.thorin@umontreal.ca	Thorin, Eric/K-3978-2013	Thorin, Eric/0000-0001-5827-8935	Canadian Institutes of Health Research [MOP 14496]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (MOP 14496 to E. T.). F. Leblond is supported by a Banting and Best PhD scholarship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Bailey-Downs LC, 2013, J GERONTOL A-BIOL, V68, P780, DOI 10.1093/gerona/gls238; Benkhoff S, 2012, ARTERIOSCL THROM VAS, V32, P1605, DOI 10.1161/ATVBAHA.112.251140; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Cheng HM, 2007, EUR J CLIN INVEST, V37, P197, DOI 10.1111/j.1365-2362.2007.01772.x; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chumakov PM, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1399, DOI 10.1134/S0006297907130019; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Drouin A, 2011, PFLUG ARCH EUR J PHY, V462, P371, DOI 10.1007/s00424-011-0973-y; Drouin A, 2011, AM J PHYSIOL-HEART C, V300, pH1032, DOI 10.1152/ajpheart.00410.2010; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Gendron ME, 2007, AM J PHYSIOL-HEART C, V293, pH2508, DOI 10.1152/ajpheart.00352.2007; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Grigore L, 2013, EUR J CLIN PHARMACOL, V69, P341, DOI 10.1007/s00228-012-1345-z; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kim CS, 2008, CIRC RES, V103, P1441, DOI 10.1161/CIRCRESAHA.108.181644; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2011, P NATL ACAD SCI USA, V108, P12266, DOI 10.1073/pnas.1019678108; Krummen S, 2005, BRIT J PHARMACOL, V145, P264, DOI 10.1038/sj.bjp.0706194; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; Mercer J, 2006, CELL CYCLE, V5, P1907, DOI 10.4161/cc.5.17.3166; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; NISHINA PM, 1993, J LIPID RES, V34, P1413; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sansbury BE, 2012, CIRC RES, V111, P1176, DOI [10.1161/circresaha.112.266395, 10.1161/CIRCRESAHA.112.266395]; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Shi Y, 2008, ACTA PHARMACOL SIN, V29, P185, DOI 10.1111/j.1745-7254.2008.00749.x; Thorin E, 2000, CIRCULATION, V101, P1430, DOI 10.1161/01.CIR.101.12.1430; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Voghel G, 2008, MECH AGEING DEV, V129, P261, DOI 10.1016/j.mad.2008.01.004; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Webster NJG, 1996, CANCER RES, V56, P2781; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92394	10.1371/journal.pone.0092394	http://dx.doi.org/10.1371/journal.pone.0092394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647794	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500126
J	Nakajima, M; Toyoizumi, H; Abe, K; Nakai, H; Taguchi, H; Kitaoka, M				Nakajima, Masahiro; Toyoizumi, Hiroyuki; Abe, Koichi; Nakai, Hiroyuki; Taguchi, Hayao; Kitaoka, Motomitsu			1,2-beta-Oligoglucan Phosphorylase from Listeria innocua	PLOS ONE			English	Article							CYCLIC-BETA-GLUCANS; N-BIOSE-I; CELLOBIOSE PHOSPHORYLASE; CELLODEXTRIN PHOSPHORYLASE; CLOSTRIDIUM-THERMOCELLUM; PRACTICAL PREPARATION; VIRULENCE FACTOR; RHIZOBIUM; IDENTIFICATION; AGROBACTERIUM	We characterized recombinant Lin1839 protein (Lin1839r) belonging to glycoside hydrolase family 94 from Listeria innocua. Lin1839r catalyzed the synthesis of a series of 1,2-beta-oligoglucans (Sop(n): n denotes degree of polymerization) using sophorose (Sop(2)) as the acceptor and alpha-D-glucose 1-phosphate (Glc1P) as the donor. Lin1839r recognized glucose as a very weak acceptor substrate to form polymeric 1,2-beta-glucan. The degree of polymerization of the 1,2-beta-glucan gradually decreased with long-term incubation to generate a series of Sop(n)s. Kinetic analysis of the phosphorolytic reaction towards sophorotriose revealed that Lin1839r followed a sequential Bi Bi mechanism. The kinetic parameters of the phosphorolysis of sophorotetraose and sophoropentaose were similar to those of sophorotriose, although the enzyme did not exhibit significant phosphorolytic activity on Sop(2). These results indicate that the Lin1839 protein is a novel inverting phosphorylase that catalyzes reversible phosphorolysis of 1,2-beta-glucan with a degree of polymerization of >= 3. We propose 1,2-beta-oligoglucan: phosphate a-glucosyltransferase as the systematic name and 1,2-beta-oligoglucan phosphorylase as the short name for this Lin1839 protein.	[Nakajima, Masahiro; Toyoizumi, Hiroyuki; Abe, Koichi; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Nakajima, Masahiro; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Nakai, Hiroyuki] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan	Tokyo University of Science; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Niigata University	Kitaoka, M (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	mkitaoka@affrc.go.jp	Nakajima, Masahiro/J-3566-2019; Kitaoka, Motomitsu/R-1536-2019	Nakajima, Masahiro/0000-0002-3182-0859; Kitaoka, Motomitsu/0000-0002-0083-1838; Taguchi, Hayao/0000-0001-5270-581X	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; NARO; Tokyo University of Science	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; NARO; Tokyo University of Science	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Internal Research Fund of NARO, and Research Fund of Tokyo University of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bianchetti CM, 2011, ACTA CRYSTALLOGR F, V67, P1345, DOI 10.1107/S1744309111032660; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castro OA, 1996, J BACTERIOL, V178, P6043, DOI 10.1128/jb.178.20.6043-6048.1996; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; COHEN JL, 1991, J BACTERIOL, V173, P4271, DOI 10.1128/JB.173.14.4271-4276.1991; De Iannino NI, 1998, J BACTERIOL, V180, P4392; DOUGLAS CJ, 1982, J BACTERIOL, V152, P1265; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; GEREMIA RA, 1987, J BACTERIOL, V169, P880, DOI 10.1128/jb.169.2.880-884.1987; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; HIGASHIURA T, 1985, AGR BIOL CHEM TOKYO, V49, P1865, DOI 10.1080/00021369.1985.10866991; Hiraishi M, 2009, CARBOHYD RES, V344, P2468, DOI 10.1016/j.carres.2009.10.002; Kim YK, 2002, J BIOCHEM, V132, P197, DOI 10.1093/oxfordjournals.jbchem.a003210; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; KOIZUMI K, 1983, J CHROMATOGR, V265, P89, DOI 10.1016/S0021-9673(01)96701-9; Krishnareddy M., 2002, J APPL GLYCOSCI, V49, P1, DOI [DOI 10.5458/jag.49.1, DOI 10.5458/JAG.49.1]; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; Michal G., 1984, METHODS ENZYMATIC AN, P185; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2010, BIOSCI BIOTECH BIOCH, V74, P1652, DOI 10.1271/bbb.100263; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Ohdan K, 2007, J BIOTECHNOL, V127, P496, DOI 10.1016/j.jbiotec.2006.07.023; Ohdan K, 2006, BIOCATAL BIOTRANSFOR, V24, P77, DOI 10.1080/10242420600598152; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rajashekhara E, 2002, BIOSCI BIOTECH BIOCH, V66, P2578, DOI 10.1271/bbb.66.2578; Reichenbecher M, 1997, EUR J BIOCHEM, V247, P262, DOI 10.1111/j.1432-1033.1997.00262.x; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Roset MS, 2006, J BACTERIOL, V188, P5003, DOI 10.1128/JB.00086-06; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TSUMURAYA Y, 1990, ARCH BIOCHEM BIOPHYS, V281, P58, DOI 10.1016/0003-9861(90)90412-R; Van Hoorebeke A, 2010, ACTA CRYSTALLOGR F, V66, P346, DOI 10.1107/S1744309110002642	48	27	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92353	10.1371/journal.pone.0092353	http://dx.doi.org/10.1371/journal.pone.0092353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647662	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500121
J	Richards, MH; Seaton, MS; Wallace, J; Al-Harthi, L				Richards, Maureen H.; Seaton, Melanie S.; Wallace, Jennilee; Al-Harthi, Lena			Porcupine Is Not Required for the Production of the Majority of Wnts from Primary Human Astrocytes and CD8+T Cells	PLOS ONE			English	Article							SEGMENT POLARITY GENES; BETA-CATENIN; N-GLYCOSYLATION; DROSOPHILA; SECRETION; WINGLESS; PROTEIN; REPLICATION; LIPIDATION; HOMOLOG	Wnts are small secreted glycoproteins that are highly conserved among species. To date, 19 Wnts have been described, which initiate a signal transduction cascade that is either beta-catenin dependent or independent, culminating in the regulation of hundreds of target genes. Extracellular release of Wnts is dependent on lipidation of Wnts by porcupine, a membrane-bound-O-acyltransferase protein in the endoplasmic reticulum. Studies demonstrating the requirement of porcupine for Wnts production are based on cell line and non-human primary cells. We evaluated the requirement for porcupine for Wnts production in human primary astrocytes and CD8+ T cells. Using IWP-2, an inhibitor of porcupine, or siRNA targeting porcupine, we demonstrate that porcupine is not required for the release of Wnt 1, 3, 5b, 6,7a, 10b, and 16a. While IWP had no effect on Wnt 2b release, knockdown of porcupine by siRNA reduced Wnt 2b release by 60%. These data indicate that porcupine-mediated production of Wnts is context dependent and is not required for all Wnts production, suggesting that alternative mechanisms exist for Wnts production.	[Richards, Maureen H.; Seaton, Melanie S.; Wallace, Jennilee; Al-Harthi, Lena] Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA	Rush University	Al-Harthi, L (corresponding author), Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA.	Lena_Al-Harthi@rush.edu			National Institute of Mental Health [R01 NIMH100628]; National Institute of Neurologic Diseases and Stroke [R01 NS060632, 1F32NS080657-01A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080657, R01NS060632] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding came from the National Institute of Mental Health R01 NIMH100628 to LA, the National Institute of Neurologic Diseases and Stroke R01 NS060632 to LA and 1F32NS080657-01A to MHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P725, DOI 10.1007/s11481-012-9412-x; Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P731, DOI 10.1007/s11481-012-9411-y; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.10.1436817, 10.1358/dnp.2009.22.10.1443391]; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Dawson K, 2013, J PHYSIOL-LONDON, V591, P1409, DOI 10.1113/jphysiol.2012.235382; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hadian K, 2009, J BIOL CHEM, V284, P33384, DOI 10.1074/jbc.M109.021659; Herr P, 2012, TRENDS MOL MED, V18, P483, DOI 10.1016/j.molmed.2012.06.008; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Lamba S, 2009, GLIA, V57, P971, DOI 10.1002/glia.20821; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; NOORDERMEER J, 1995, MECH DEVELOP, V51, P145, DOI 10.1016/0925-4773(95)00348-7; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; PERRIMON N, 1989, GENETICS, V121, P333; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Tsukiyama T, 2012, NEUROSCI LETT, V512, P48, DOI 10.1016/j.neulet.2012.01.062; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wang XL, 2013, J MED CHEM, V56, P2700, DOI 10.1021/jm400159c; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	41	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92159	10.1371/journal.pone.0092159	http://dx.doi.org/10.1371/journal.pone.0092159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647048	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500092
J	Son, M; Bang, WY; Park, C; Lee, Y; Kwon, SG; Kim, SW; Kim, CW; Lee, KW				Son, Minky; Bang, Woo Young; Park, Chanin; Lee, Yuno; Kwon, Seul Gi; Kim, Sam Woong; Kim, Chul Wook; Lee, Keun Woo			Functional Mechanism of C-Terminal Tail in the Enzymatic Role of Porcine Testicular Carbonyl Reductase: A Combined Experiment and Molecular Dynamics Simulation Study of the C-Terminal Tail in the Enzymatic Role of PTCR	PLOS ONE			English	Article							GENERAL FORCE-FIELD; NEONATAL PIG TESTIS; SHORT-CHAIN DEHYDROGENASES/REDUCTASES; BETA-HYDROXYSTEROID DEHYDROGENASE; PARTICLE MESH EWALD; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; TERNARY COMPLEX	Porcine testicular carbonyl reductase, PTCR which is one of the short chain dehydrogenases/reductases (SDR) superfamily catalyzes the NADPH-dependent reduction of carbonyl compounds including steroids and prostaglandins. Previously we reported C-terminal tail of PTCR was deleted due to a nonsynonymous single nucleotide variation (nsSNV). Here we identified from kinetic studies that the enzymatic properties for 5 alpha-dihydrotestosterone (5 alpha-DHT) were different between wild-type and C-terminal-deleted PTCRs. Compared to wild-type PTCR, C-terminal-deleted PTCR has much higher reduction rate. To investigate structural difference between wild-type and C-terminal-deleted PTCRs upon 5a-DHT binding, we performed molecular dynamics simulations for two complexes. Using trajectories, molecular interactions including hydrogen bonding patterns, distance between 5a-DHT and catalytic Tyr193, and interaction energies are analyzed and compared. During the MD simulation time, the dynamic behavior of C-terminal tail in wild-type PTCR is also examined using essential dynamics analysis. The results of our simulations reveal that the binding conformation of 5 alpha-DHT in C-terminal-deleted PTCR is more favorable for reduction reaction in PTCR, which shows strong agreement with kinetic data. These structural findings provide valuable information to understand substrate specificity of PTCR and further kinetic properties of enzymes belonging to the SDR superfamily.	[Son, Minky; Park, Chanin; Lee, Yuno; Lee, Keun Woo] GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, Jinju, South Korea; [Bang, Woo Young] Gyeongnam Natl Univ Sci & Technol, Ind Acad Cooperat Fdn, Jinju, South Korea; [Kwon, Seul Gi; Kim, Sam Woong; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology	Lee, KW (corresponding author), GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, 501 Jinju Daero, Jinju, South Korea.	kwlee@gnu.ac.kr			Management of Climate Change Program [2010-0029084]; Basic Science Research Program [2011-0024925]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) [2011-0022965]; Ministry of Education of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	Management of Climate Change Program; Basic Science Research Program; Priority Research Centers Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education of Republic of Korea(Ministry of Education (MOE), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This research was supported by Management of Climate Change Program (2010-0029084), Basic Science Research Program (2011-0024925), and Priority Research Centers Program (2011-0022965) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Benach J, 1998, J MOL BIOL, V282, P383, DOI 10.1006/jmbi.1998.2015; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brigo A, 2005, BIOPHYS J, V88, P3072, DOI 10.1529/biophysj.104.050286; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, CHEM-BIOL INTERACT, V130, P637, DOI 10.1016/S0009-2797(00)00255-6; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Joernvall H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI DOI 10.1021/BI00018A001; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; Kobayashi K, 1996, J STEROID BIOCHEM, V59, P485, DOI 10.1016/S0960-0760(96)00137-9; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nakajin S, 1997, BIOL PHARM BULL, V20, P1215; Nakajin S, 2001, BBA-PROTEIN STRUCT M, V1550, P175, DOI 10.1016/S0167-4838(01)00285-0; NAKAJIN S, 1987, CHEM PHARM BULL, V35, P2490; NAKAJIN S, 1988, J BIOCHEM-TOKYO, V104, P565, DOI 10.1093/oxfordjournals.jbchem.a122511; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; OHNO S, 1991, J STEROID BIOCHEM, V38, P787, DOI 10.1016/0960-0760(91)90093-K; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VARUGHESE KI, 1992, P NATL ACAD SCI USA, V89, P6080, DOI 10.1073/pnas.89.13.6080; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	39	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90712	10.1371/journal.pone.0090712	http://dx.doi.org/10.1371/journal.pone.0090712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646606	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500016
J	Chou, AK; Yang, MC; Tsai, HP; Chai, CY; Tai, MH; Kwan, AL; Hong, YR				Chou, An-Kuo; Yang, Ming-Chang; Tsai, Hung-Pei; Chai, Chee-Yin; Tai, Ming-Hong; Kwan, Aij-Li; Hong, Yi-Ren			Adenoviral-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Has a Protective Effect on Sciatic Nerve Following Constriction-Induced Spinal Cord Injury	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AMYOTROPHIC-LATERAL-SCLEROSIS; ROOT GANGLION APOPTOSIS; SUPERFICIAL DORSAL HORN; NEUROPATHIC PAIN; ADENOASSOCIATED VIRUS; MECHANICAL ALLODYNIA; INDUCED HYPERALGESIA; RECEPTOR COMPONENTS; TISSUE-INJURY	Neuropathic pain due to peripheral nerve injury may be associated with abnormal central nerve activity. Glial cell-line-derived neurotrophic factor (GDNF) can help attenuate neuropathic pain in different animal models of nerve injury. However, whether GDNF can ameliorate neuropathic pain in the spinal cord dorsal horn (SCDH) in constriction-induced peripheral nerve injury remains unknown. We investigated the therapeutic effects of adenoviral-mediated GDNF on neuropathic pain behaviors, microglial activation, pro-inflammatory cytokine expression and programmed cell death in a chronic constriction injury (CCI) nerve injury animal model. In this study, neuropathic pain was produced by CCI on the ipsilateral SCDH. Mechanical allodynia was examined with von Frey filaments and thermal sensitivity was tested using a plantar test apparatus post-operatively. Target proteins GDNF-1, GDNFRa-1, MMP2, MMP9, p38, phospho-p38, ED1, IL6, IL1 beta, AIF, caspase-9, cleaved caspase-9, caspase-3, cleaved caspase-3, PARP, cleaved PARP, SPECTRIN, cleaved SPECTRIN, Beclin-1, PKC sigma, PKC gamma, iNOS, eNOS and nNOS were detected. Microglial activity was measured by observing changes in immunoreactivity with OX-42. NeuN and TUNEL staining were used to reveal whether apoptosis was attenuated by GDNF. Results showed that administrating GDNF began to attenuate both allodynia and thermal hyperalgesia at day 7. CCI-rats were found to have lower GDNF and GDNFRa-1 expression compared to controls, and GDNF re-activated their expression. Also, GDNF significantly down-regulated CCI-induced protein expression except for MMP2, eNOS and nNOS, indicating that the protective action of GDNF might be associated with anti-inflammation and prohibition of microglia activation. Immunocytochemistry staining showed that GDNF reduced CCI-induced neuronal apoptosis. In sum, GDNF enhanced the neurotrophic effect by inhibiting microglia activation and cytokine production via p38 and PKC signaling. GDNF could be a good therapeutic tool to attenuate programmed cell death, including apoptosis and autophagy, consequent to CCI-induced peripheral nerve injury.	[Chou, An-Kuo] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Chou, An-Kuo] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yang, Ming-Chang; Hong, Yi-Ren] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Yang, Ming-Chang; Hong, Yi-Ren] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Yang, Ming-Chang] Kaohsiung Armed Forces Gen Hosp, Lab Med Res, Kaohsiung, Taiwan; [Tsai, Hung-Pei; Kwan, Aij-Li; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Kwan, Aij-Li] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kwan, AL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.	aijliekwan@yahoo.com.tw; m835016@cc.kmu.edu.tw		Yang, Ming-Chang/0000-0001-8657-8708; Chai, Chee-Yin/0000-0003-0486-9742; Hong, Yi-Ren/0000-0001-5470-6090	National Science Council [96-2314-B-182A-018-MY2, 95-2314-B-182A-151]; Chang Gung Memorial Hospital [CMRP83031]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was sponsored by National Science Council-96-2314-B-182A-018-MY2, National Science Council-95-2314-B-182A-151, and Chang Gung Memorial Hospital grant CMRP83031 to AKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; Calvo M, 2011, GLIA; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Eslamboli A, 2005, REV NEUROSCIENCE, V16, P303; George A, 2004, NEUROSCI LETT, V372, P215, DOI 10.1016/j.neulet.2004.09.075; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; GIRAUD C, 1995, J VIROL, V69, P6917, DOI 10.1128/JVI.69.11.6917-6924.1995; Hao SL, 2003, MOL THER, V8, P367, DOI 10.1016/S1525-0016(03)00185-0; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Ji RR, 2009, TRENDS PHARMACOL SCI, V30, P336, DOI 10.1016/j.tips.2009.04.002; Jin SX, 2003, J NEUROSCI, V23, P4017; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Lekan HA, 1996, NEUROSCI LETT, V208, P147, DOI 10.1016/0304-3940(96)12566-0; Maione S, 2002, NEUROREPORT, V13, P101, DOI 10.1097/00001756-200201210-00024; Manabe Y, 2002, APOPTOSIS, V7, P329, DOI 10.1023/A:1016123413038; MAO JR, 1995, NEUROSCI LETT, V198, P75, DOI 10.1016/0304-3940(95)11975-3; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Schaeffer V, 2010, GLIA, V58, P169, DOI 10.1002/glia.20910; Sekiguchi M, 2008, SPINE, V33, P1163, DOI 10.1097/BRS.0b013e31817144fc; Shortland P, 1999, BRAIN RES, V815, P206, DOI 10.1016/S0006-8993(98)01152-4; Sung CS, 2005, J NEUROCHEM, V94, P742, DOI 10.1111/j.1471-4159.2005.03226.x; Svensson CI, 2005, J NEUROCHEM, V92, P1508, DOI 10.1111/j.1471-4159.2004.02996.x; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Svensson CI, 2005, NEUROSCI LETT, V379, P209, DOI 10.1016/j.neulet.2004.12.064; Tai MH, 2003, EXP NEUROL, V183, P508, DOI 10.1016/S0014-4886(03)00130-4; Tang QB, 2007, EUR J NEUROSCI, V25, P2964, DOI 10.1111/j.1460-9568.2007.05576.x; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Wang LJ, 2002, J NEUROSCI, V22, P6920; Wen YR, 2011, J FORMOS MED ASSOC, V110, P487, DOI 10.1016/S0929-6646(11)60074-0; Whiteside GT, 2001, J NEUROSCI RES, V64, P168, DOI 10.1002/jnr.1062; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; YAMAZAKI K, 1988, P SOC EXP BIOL MED, V187, P209; Zhang E, 2013, BRAIN RES, V1519, P31, DOI 10.1016/j.brainres.2013.04.055; Zhang W, 2013, PHARMACOL BIOCHEM BE, V111, P64, DOI 10.1016/j.pbb.2013.07.017; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	48	17	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92264	10.1371/journal.pone.0092264	http://dx.doi.org/10.1371/journal.pone.0092264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642655	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900114
J	de Sousa, JT; Milan, M; Bargelloni, L; Pauletto, M; Matias, D; Joaquim, S; Matias, AM; Quillien, V; Leitao, A; Huvet, A				de Sousa, Joana Teixeira; Milan, Massimo; Bargelloni, Luca; Pauletto, Marianna; Matias, Domitilia; Joaquim, Sandra; Matias, Ana Margarete; Quillien, Virgile; Leitao, Alexandra; Huvet, Arnaud			A Microarray-Based Analysis of Gametogenesis in Two Portuguese Populations of the European Clam Ruditapes decussatus	PLOS ONE			English	Article							VASA-LIKE GENE; CARPET SHELL CLAM; CRASSOSTREA-GIGAS; GONADAL DEVELOPMENT; REPRODUCTIVE-CYCLE; MATURATION; OYSTER; EXPRESSION; GERMLINE; MOLLUSK	The European clam, Ruditapes decussatus is a species with a high commercial importance in Portugal and other Southern European countries. Its production is almost exclusively based on natural recruitment, which is subject to high annual fluctuations. Increased knowledge of the natural reproductive cycle of R. decussatus and its molecular mechanisms would be particularly important in providing new highly valuable genomic information for better understanding the regulation of reproduction in this economically important aquaculture species. In this study, the transcriptomic bases of R. decussatus reproduction have been analysed using a custom oligonucleotide microarray representing 51,678 assembled contigs. Microarray analyses were performed in four gonadal maturation stages from two different Portuguese wild populations, characterized by different responses to spawning induction when used as progenitors in hatchery. A comparison between the two populations elucidated a specific pathway involved in the recognition signals and binding between the oocyte and components of the sperm plasma membrane. We suggest that this pathway can explain part of the differences in terms of spawning induction success between the two populations. In addition, sexes and reproductive stages were compared and a correlation between mRNA levels and gonadal area was investigated. The lists of differentially expressed genes revealed that sex explains most of the variance in gonadal gene expression. Additionally, genes like Foxl2, vitellogenin, condensing 2, mitotic apparatus protein p62, Cep57, sperm associated antigens 6, 16 and 17, motile sperm domain containing protein 2, sperm surface protein Sp17, sperm flagellar proteins 1 and 2 and dpy-30, were identified as being correlated with the gonad area and therefore supposedly with the number and/or the size of the gametes produced.	[de Sousa, Joana Teixeira; Quillien, Virgile; Huvet, Arnaud] UMR CNRS 6539, IFREMER, Lab Sci Environm Marin, Plouzane, France; [de Sousa, Joana Teixeira; Matias, Domitilia; Joaquim, Sandra; Matias, Ana Margarete; Leitao, Alexandra] IPMA, Olhao, Portugal; [Milan, Massimo; Bargelloni, Luca; Pauletto, Marianna] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Instituto Portugues do Mar e da Atmosfera; University of Padua	Huvet, A (corresponding author), UMR CNRS 6539, IFREMER, Lab Sci Environm Marin, Plouzane, France.	ahuvet@ifremer.fr	Pauletto, Marianna/K-5518-2019; MILAN, MASSIMO/ABE-6936-2021; Milan, Massimo/H-7428-2019	Pauletto, Marianna/0000-0002-2424-7484; MILAN, MASSIMO/0000-0003-0246-9008; Matias, Domitilia/0000-0002-2191-7497; Joaquim, Sandra/0000-0002-6324-5908; Huvet, Arnaud/0000-0001-6912-881X; Leitao-BenHamadou, Alexandra/0000-0001-8903-3797	European program REPROSEED EU [245119]	European program REPROSEED EU	This study was supported by the European program REPROSEED EU Grant No. 245119 (http://www.reproseed.eu/). The first author is a Ph.D. student financially supported by the same program. The authors are grateful to the REPROSEED partners JL Nicolas, R Robert and P Boudry for their support during the course as well as P Sourdaine, P Favrel and C Lelong for helpful discussion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Aji L.P., 2011, JURNAL PENELITIAN SA, V14, P33; Bobe J, 2003, MOL REPROD DEV, V66, P46, DOI 10.1002/mrd.10334; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Caskey JL, 2009, INVERTEBR REPROD DEV, V53, P93, DOI 10.1080/07924259.2009.9652295; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Deguchi R, 2003, J CELL SCI, V116, P367, DOI 10.1242/jcs.00221; Delgado M, 2005, SCI MAR, V69, P87; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; Di Patrizi L, 2001, GLYCOCONJUGATE J, V18, P511, DOI 10.1023/A:1019617728660; Ernande B, 2004, J EVOLUTION BIOL, V17, P342, DOI 10.1046/j.1420-9101.2003.00674.x; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Evens JP, 2001, BIOESSAYS, V23, P628; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fard Jahromi S.S., 2013, ISRN BIOINFORMATICS, V2013, P1; Fleury E, 2008, GENE, V410, P187, DOI 10.1016/j.gene.2007.12.017; GOBET I, 1994, DEV BIOL, V164, P540, DOI 10.1006/dbio.1994.1222; Goto M, 2010, HUM REPROD, V25, P1884, DOI 10.1093/humrep/deq138; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hidaka H, 1985, CALMODULIN ANTAGONIS; HSU DR, 1994, GENETICS, V137, P999; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Leite RB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-741; Li MWM, 2009, TRENDS MOL MED, V15, P159, DOI 10.1016/j.molmed.2009.02.002; Llera-Herrera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073176; Martoja R, 1967, INITIATION TECHNIQUE; Matias D, 2013, AQUACULTURE, V406, P52, DOI 10.1016/j.aquaculture.2013.04.030; Matias D, 2009, AQUACULT INT, V17, P257, DOI 10.1007/s10499-008-9197-3; Moreira R, 2012, DEV COMP IMMUNOL, V36, P140, DOI 10.1016/j.dci.2011.06.012; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Royer J, 2008, AQUACULTURE, V277, P313, DOI 10.1016/j.aquaculture.2008.02.033; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Serdar S, 2010, FRESEN ENVIRON BULL, V19, P1055; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Venditti JJ, 2010, BIOL REPROD, V82, P572, DOI 10.1095/biolreprod.109.076695; Vilela H., 1950, Archivos do Museu Bocage, VNo, 21, P1; Wada T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks765; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	47	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92202	10.1371/journal.pone.0092202	http://dx.doi.org/10.1371/journal.pone.0092202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643002	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900102
J	He, T; Sa, J; Zhong, PS; Cui, YH				He, Tao; Sa, Jian; Zhong, Ping-Shou; Cui, Yuehua			Statistical Dissection of Cyto-Nuclear Epistasis Subject to Genomic Imprinting in Line Crosses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COMPREHENSIVE GENETIC-MAP; MITOCHONDRIAL EPISTASIS; ENDOSPERM TRAITS; LINKAGE MAP; CYTOPLASM; FITNESS; MODEL; DROSOPHILA; FRAMEWORK	Cytoplasm contains important metabolism reaction organelles such as mitochondria and chloroplast (in plant). In particular, mitochondria contains special DNA information which can be passed to offsprings through maternal gametes, and has been confirmed to play a pivotal role in nuclear activities. Experimental evidences have documented the importance of cyto-nuclear interactions in affecting important biological traits. While studies have also pointed out the role of interaction between imprinting nuclear DNA and cytoplasm, no statistical method has been developed to efficiently model such effect and further quantify its effect size. In this work, we developed an efficient statistical model for genome-wide estimating and testing the cytoplasmic effect, nuclear DNA imprinting effect as well as the interaction between them under reciprocal backcross and F-2 designs derived from inbred lines. Parameters are estimated under maximum likelihood framework implemented with the EM algorithm. Extensive simulations show good performance in a variety of scenarios. The utility of the method is demonstrated by analyzing a published data set in an F-2 family derived from C3H/HeJBir and C57BL/6 J mouse strains. Important cyto-nuclear interactions were identified. Our approach provides a quantitative framework for identifying and estimating cyto-nuclear interactions subject to genomic imprinting involved in the genetic control of complex traits.	[He, Tao; Sa, Jian; Zhong, Ping-Shou; Cui, Yuehua] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Sa, Jian; Cui, Yuehua] Shanxi Med Univ, Sch Publ Hlth, Div Med Stat, Taiyuan, Shanxi, Peoples R China	Michigan State University; Shanxi Medical University	Cui, YH (corresponding author), Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA.	cui@stt.msu.edu	Cui, Yuehua/A-3529-2008; Cui, Yuehua/E-8004-2010	Cui, Yuehua/0000-0001-8099-1753; Cui, Yuehua/0000-0001-8099-1753	NSF [DMS-1209112, IOS-1237969, MCB-1121650]; National Natural Science Foundation of China [31371336]; Division Of Mathematical Sciences [1209112] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by NSF grants DMS-1209112, IOS-1237969, and MCB-1121650, and by National Natural Science Foundation of China grant 31371336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess KS, 2004, AM J BOT, V91, P1802, DOI 10.3732/ajb.91.11.1802; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6; CHURCHILL GA, 1994, GENETICS, V138, P963; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; Cui YH, 2006, GENOMICS, V87, P543, DOI 10.1016/j.ygeno.2005.11.021; Cui YH, 2007, GENETICA, V130, P227, DOI 10.1007/s10709-006-9101-x; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; de Koning DJ, 2002, GENETICS, V161, P931; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Farmer MA, 2001, P NATL ACAD SCI USA, V98, P13820, DOI 10.1073/pnas.241258698; HAGA N, 1995, J CELL SCI, V108, P3671; HALDANE JBS, 1922, AM NAT, V67, P5; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Huxley JS, 1928, J GENET, V20, P145, DOI 10.1007/BF02983136; Isles AR, 2005, EARLY HUM DEV, V81, P73, DOI 10.1016/j.earlhumdev.2004.10.006; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; LANDER ES, 1989, GENETICS, V121, P185; Levin DA, 2003, SYST BOT, V28, P5; Li GX, 2010, ANN APPL STAT, V4, P1214, DOI 10.1214/09-AOAS323; Li SY, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1474; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Manichaikul A, 2006, GENETICS, V174; Marklund L, 1996, ANIM GENET, V27, P255, DOI 10.1111/j.1365-2052.1996.tb00487.x; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NANNEY DL, 1953, BIOL BULL, V105, P133, DOI 10.2307/1538562; Neff MW, 1999, GENETICS, V151, P803; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Tang ZX, 2007, GENETICS, V177, P669, DOI 10.1534/genetics.107.074302; Tao DY, 2004, EUPHYTICA, V135, P129, DOI 10.1023/B:EUPH.0000009548.81467.73; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Wu RL, 2002, GENETICS, V162, P875; Zeng Z, 1994, GENETICS, V136, P228; Zeyl C, 2005, EVOLUTION, V59, P910	44	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91702	10.1371/journal.pone.0091702	http://dx.doi.org/10.1371/journal.pone.0091702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643065	gold, Green Submitted, Green Published			2022-12-25	WOS:000333259900028
J	Heller, KG; Hemp, C				Heller, Klaus-Gerhard; Hemp, Claudia			Fiddler on the Tree - A Bush-Cricket Species with Unusual Stridulatory Organs and Song	PLOS ONE			English	Article							SOUND PRODUCTION; KATYDIDS ORTHOPTERA; MOLE CRICKETS; TETTIGONIIDAE; CONSTRAINTS; MECHANICS	Insects of the order Orthoptera are well-known for their acoustic communication. The structures used for this purpose show a high diversity which obviously relates to differences in song parameters and to the physics of sound production. Here we describe song and morphology of the sound producing organs of a tropical bush-cricket, Ectomoptera nepicauda, from East Africa. It has a very unusual calling song consisting of frequency-modulated, pure-tone sounds in the high ultrasonic range of 80 to 120 kHz and produced by extremely fast wing movements. Concerning morphology, it represents the most extreme state in the degree of left-right fore-wing differentiation found among Orthoptera: the acoustic parts of the left fore-wing consist exclusively of the stridulatory file, comparable in function to the bow of a violin, while the right wing carries only the plectrum (= string) and mirror (= soundbox).	[Heller, Klaus-Gerhard] Humboldt Univ, Dept Biol, Berlin, Germany; [Hemp, Claudia] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	Humboldt University of Berlin; University of Wurzburg	Heller, KG (corresponding author), Humboldt Univ, Dept Biol, Berlin, Germany.	heller.volleth@t-online.de	Hemp, Claudia/AAL-3227-2020	Hemp, Claudia/0000-0001-9170-7113	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge grants by the Deutsche Forschungsgemeinschaft (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY WJ, 1970, J EXP BIOL, V52, P495; Belwood J.J., 1990, P8; Bennet-Clark H.C., 1989, P227; Bennet-Clark HC, 2003, J EXP BIOL, V206, P1479, DOI 10.1242/jeb.00281; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; BENNETCLARK HC, 1970, J EXP BIOL, V52, P619; Bethoux O, 2012, ARTHROPOD SYST PHYLO, V70, P43; Chivers B, 2014, BIOACOUSTICS, V23, P67, DOI 10.1080/09524622.2013.816639; Eades DC, ORTHOPTERA SPECIES F; ELLIOTT CJH, 1983, ANIM BEHAV, V31, P887, DOI 10.1016/S0003-3472(83)80244-9; FORREST TG, 1987, FLA ENTOMOL, V70, P284, DOI 10.2307/3495161; Harz K, 1969, ORTHOPTEREN EUROPAS, V5; Heller K.-G., 1988, BIOAKUSTIK EUROPAISC; Heller KG, 1997, ZOOL-ANAL COMPLEX SY, V100, P110; Hemp C, 2013, ORG DIVERS EVOL, V13, P373, DOI 10.1007/s13127-012-0123-1; Henry G. M., 1940, Proceedings of the Royal Entomological Society of London, V9, P97; Karsch F., 1891, BERL ENTOMOL ZEIT, V36, P210, DOI [10.1002/mmnd.18910360119, DOI 10.1002/MMND.18910360119]; LEROY Y, 1969, ANN SOC ENTOMOL FR, V5, P775; Montealegre-Z F, 2005, J EXP BIOL, V208, P1219, DOI 10.1242/jeb.01526; Montealegre-Z F, 2004, SYST ENTOMOL, V29, P21, DOI 10.1111/j.1365-3113.2004.00223.x; Montealegre-Z F, 2009, J EVOLUTION BIOL, V22, P355, DOI 10.1111/j.1420-9101.2008.01652.x; Montealegre-Z F, 2006, J EXP BIOL, V209, P4923, DOI 10.1242/jeb.02608; Montealegre-Z F, 2012, J INSECT PHYSIOL, V58, P116, DOI 10.1016/j.jinsphys.2011.10.006; Montealegre ZF, 2009, J EXP BIOL, V212, P257, DOI 10.1242/jeb.022731; MORRIS G K, 1978, Psyche (Cambridge), V85, P147, DOI 10.1155/1978/84389; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; Ragge D.R., 1980, Bulletin of the British Museum (Natural History) Entomology, V40, P67; Ragge D. R., 1969, Bulletin of the British Museum (Natural History) Entomology, V23, P167; Regen J, 1903, ARBEITEN WIENER ZOOL, V14, P38; SPOONER JD, 1973, ANN ENTOMOL SOC AM, V66, P4, DOI 10.1093/aesa/66.1.4; Spooner John D., 1995, Journal of Orthoptera Research, V4, P127; WALKER TJ, 1972, SCIENCE, V178, P174, DOI 10.1126/science.178.4057.174	33	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92366	10.1371/journal.pone.0092366	http://dx.doi.org/10.1371/journal.pone.0092366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643071	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900127
J	Liu, Y; Yang, L; Chen, KL; Zhou, B; Yan, H; Zhou, ZG; Li, Y				Liu, Yong; Yang, Lie; Chen, Ke-Ling; Zhou, Bin; Yan, Hui; Zhou, Zong-Guang; Li, Yuan			Knockdown of GRP78 Promotes Apoptosis in Pancreatic Acinar Cells and Attenuates the Severity of Cerulein and LPS Induced Pancreatic Inflammation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; ER CHAPERONE GRP78; REGULATOR GRP78/BIP; CASPASE ACTIVATION; DEATH PROGRAM; CANCER CELLS; AR42J CELLS; CROSS-TALK; PROTEIN	Acute pancreatitis (AP) is a potentially lethal disease characterized by inflammation and parenchymal cell death; also, the severity of AP correlates directly with necrosis and inversely with apoptosis. However, mechanisms of regulating cell death in AP remain unclear. The endoplasmic reticulum (ER) chaperone protein GRP78 has anti-apoptotic properties, in addition to modulating ER stress responses. This study used RNA interference (RNAi) approach to investigate the potential role of GRP78 in regulating apoptosis during AP. In vitro models of AP were successfully developed by treating AR42J cells with cerulein or cerulein plus lipoplysaccharide (LPS). There was more pancreatic inflammation and less apoptosis with the cerulein plus LPS treatment. Furthermore, knockdown of GRP78 expression markedly promoted apoptosis and reduced necrosis in pancreatic acinar cells. This was accomplished by enhancing the activation of caspases and inhibiting the activity of X-linked inhibitor of apoptosis protein (XIAP), as well as a receptor interacting protein kinase-1(RIPK1), which is a key mediator of necrosis. This attenuated the severity of pancreatic inflammation, especially after cerulein plus LPS treatment. In conclusion, these findings indicate that GRP78 plays an anti-apoptotic role in regulating the cell death response during AP. Therefore, GRP78 is a potential therapeutic target for AP.	[Liu, Yong; Yang, Lie; Yan, Hui; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Surg Gastroenterol, Chengdu 610064, Sichuan, Peoples R China; [Chen, Ke-Ling; Zhou, Bin; Zhou, Zong-Guang; Li, Yuan] Sichuan Univ, Inst Digest Surg, Chengdu 610064, Sichuan, Peoples R China; [Chen, Ke-Ling; Zhou, Bin; Zhou, Zong-Guang; Li, Yuan] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, Y (corresponding author), Sichuan Univ, Inst Digest Surg, Chengdu 610064, Sichuan, Peoples R China.	liyuanletters@163.com		, Zongguang/0000-0002-7616-1199	National Natural Science Fund of China (NSFC) [30830100, 30972924, 81170439]; SRF for ROCS, SEM [20101174-4-2]; Research Fund for the Doctoral Program of Higher Education, SEM [200806100058]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Research Fund for the Doctoral Program of Higher Education, SEM	This work was supported by grants from the National Natural Science Fund of China (NSFC key project No. 30830100; project No. 30972924; project No. 81170439) and The Project-sponsored by SRF for ROCS, SEM (No. 20101174-4-2); The Research Fund for the Doctoral Program of Higher Education, SEM (No. 200806100058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; BUJA LM, 1993, ARCH PATHOL LAB MED, V117, P1208; Chao KC, 2006, BRIT J SURG, V93, P332, DOI 10.1002/bjs.5251; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gukovskaya AS, 2004, PANCREATOLOGY, V4, P567, DOI 10.1159/000082182; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W; Liu Y, 2012, HEPATO-GASTROENTEROL, V59, P1670, DOI 10.5754/hge12281; Lomberk G, 2009, PANCREATOLOGY, V9, P6, DOI 10.1159/000178860; Malka D, 2000, GASTROENTEROLOGY, V119, P816, DOI 10.1053/gast.2000.16491; Malleo G, 2007, SHOCK, V28, P130, DOI 10.1097/shk.0b013e3180487ba1; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Mayer J, 2000, GUT, V47, P546, DOI 10.1136/gut.47.4.546; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Naidoo N, 2009, SLEEP MED REV, V13, P195, DOI 10.1016/j.smrv.2009.01.001; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Norman JG, 1997, DIGEST DIS SCI, V42, P1783, DOI 10.1023/A:1018886120711; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Qian YC, 2007, AM J PHYSIOL-CELL PH, V293, pC897, DOI 10.1152/ajpcell.00059.2007; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P503, DOI 10.1016/j.biocel.2007.09.001; Zhang XP, 2007, DIGEST DIS SCI, V52, P1199, DOI 10.1007/s10620-006-9388-6; Zhao M, 2007, WORLD J GASTROENTERO, V13, P5612, DOI 10.3748/wjg.v13.i42.5612	50	16	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92389	10.1371/journal.pone.0092389	http://dx.doi.org/10.1371/journal.pone.0092389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643222	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900130
J	Wang, Z; Yu, GH; Shi, BB; Wang, XM; Qiang, HP; Gao, HW				Wang, Zan; Yu, Guohui; Shi, Binbin; Wang, Xuemin; Qiang, Haiping; Gao, Hongwen			Development and Characterization of Simple Sequence Repeat (SSR) Markers Based on RNA-Sequencing of Medicago sativa and In silico Mapping onto the M. truncatula Genome	PLOS ONE			English	Article							GENIC MICROSATELLITE MARKERS; EST-DERIVED SSR; GENETIC DIVERSITY; ALFALFA; TRANSFERABILITY; IDENTIFICATION; MAP; L.; VALIDATION; PROGRAM	Sufficient codominant genetic markers are needed for various genetic investigations in alfalfa since the species is an outcrossing autotetraploid. With the newly developed next generation sequencing technology, a large amount of transcribed sequences of alfalfa have been generated and are available for identifying SSR markers by data mining. A total of 54,278 alfalfa non-redundant unigenes were assembled through the Illumina HiSeqTM 2000 sequencing technology. Based on 3,903 unigene sequences, 4,493 SSRs were identified. Tri-nucleotide repeats (56.71%) were the most abundant motif class while AG/CT (21.7%), AGG/CCT (19.8%), AAC/GTT (10.3%), ATC/ATG (8.8%), and ACC/GGT (6.3%) were the subsequent top five nucleotide repeat motifs. Eight hundred and thirty-seven EST-SSR primer pairs were successfully designed. Of these, 527 (63%) primer pairs yielded clear and scored PCR products and 372 (70.6%) exhibited polymorphisms. High transferability was observed for ssp falcata at 99.2% (523) and 71.7% (378) in M. truncatula. In addition, 313 of 527 SSR marker sequences were in silico mapped onto the eight M. truncatula chromosomes. Thirty-six polymorphic SSR primer pairs were used in the genetic relatedness analysis of 30 Chinese alfalfa cultivated accessions generating a total of 199 scored alleles. The mean observed heterozygosity and polymorphic information content were 0.767 and 0.635, respectively. The codominant markers not only enriched the current resources of molecular markers in alfalfa, but also would facilitate targeted investigations in marker-trait association, QTL mapping, and genetic diversity analysis in alfalfa.	[Wang, Zan; Yu, Guohui; Shi, Binbin; Wang, Xuemin; Qiang, Haiping; Gao, Hongwen] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Yu, Guohui] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Northwest A&F University - China	Wang, Z (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	wangzan@cas.cn; hongwengao@hotmail.com			National Natural Science Foundation of China [31272495]; Agricultural Science and Technology Innovation Program of China [ASTIP-TAS10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program of China	This research was funded by a grant from the National Natural Science Foundation of China (No. 31272495) and the Agricultural Science and Technology Innovation Program (ASTIP-TAS10) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; [Anonymous], 2009, BMC PLANT BIOL, DOI DOI 10.1186/1471-2229-9-118; ARMSTRONG JM, 1954, CAN J BOT, V32, P531, DOI 10.1139/b54-050; Barcaccia G., 1994, Journal of Genetics and Breeding, V48, P161; BLONDON F, 1994, GENOME, V37, P264, DOI 10.1139/g94-037; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Choi HK, 2004, GENETICS, V166, P1463, DOI 10.1534/genetics.166.3.1463; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Diwan N, 1997, GENOME, V40, P887, DOI 10.1139/g97-115; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; He C, 2009, CROP SCI, V49, P2176, DOI 10.2135/cropsci2007.04.0456; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu LL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-522; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pan L, 2010, J HERED, V101, P71, DOI 10.1093/jhered/esp070; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Robins JG, 2008, CROP SCI, V48, P1780, DOI 10.2135/cropsci2008.02.0101; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Sakiroglu M, 2010, THEOR APPL GENET, V121, P403, DOI 10.1007/s00122-010-1319-4; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Silva PIT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-17; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; STANFORD EH, 1951, AGRON J, V43, P222, DOI 10.2134/agronj1951.00021962004300050004x; Teh SL, 2011, MOL BIOL REP, V38, P3903, DOI 10.1007/s11033-010-0506-3; Thrall PH, 2000, J HERED, V91, P348, DOI 10.1093/jhered/91.4.348; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang Z, 2013, MOL BIOL REP, V40, P3291, DOI 10.1007/s11033-012-2404-3; Wang ZY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-139; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xin DW, 2012, MOL BIOL REP, V39, P9047, DOI 10.1007/s11033-012-1776-8; Yi GB, 2006, THEOR APPL GENET, V114, P113, DOI 10.1007/s00122-006-0415-y; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891	54	31	38	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92029	10.1371/journal.pone.0092029	http://dx.doi.org/10.1371/journal.pone.0092029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642969	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900063
J	Wen, XJ; Huang, AM; Liu, ZL; Liu, YY; Hu, JY; Liu, J; Shuai, XT				Wen, Xiaojun; Huang, Amin; Liu, Zhonglin; Liu, Yunyun; Hu, Jingyang; Liu, Jun; Shuai, Xintao			Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA; GENE DELIVERY; IN-VITRO; APOPTOSIS; TUMORS; PROGRESSION; INHIBITOR; MIGRATION; INVASION; DISEASE	Objective: Rho-associated coiled-coil kinase 2 (ROCK2) is an attractive therapeutic target because it is overexpressed in many malignancies, including glioma. Therefore, we designed the current study to determine whether the downregulation of ROCK2 would sensitize the cytotoxic effect of temozolomide (TMZ) in U251 cells. Methods: Glycol-polyethyleneimine (PEG-PEI) was used to deliver siROCK2 to U251 cells, and the physical characteristics of the PEG-PEI/siROCK2 complex (referred to as the siROCK2 complex) were investigated. The transfection efficiency and cell uptake were determined by flow cytometry (FCM) and confocal laser microscopy (CLSM), respectively. U251 cells were then treated with 100 mM TMZ, siROCK2 complexes or their combination. The apoptosis rate and cell migration were measured by FCM and wound-healing assay, respectively. The levels of Bax, Bcl-2, cleaved caspase-3, MMP-2, and MMP-9 were detected to analyze the degrees of apoptosis and migration. Results: Our results revealed that the characteristics of the siROCK2 complexes depended closely on the N/P ratios. PEG-PEI served as a good vector for siROCK2 and exhibited low cytotoxicity toward U251 cells. The CLSM assay showed that the siROCK2 complexes were successfully uptaken and that both the protein and mRNA levels of ROCK2 were significantly suppressed. Furthermore, the combination treatment induced a higher apoptosis rate and markedly increased the gap distance of U251 cells in the wound-healing assay. Levels of the proapoptotic proteins Bax and cleaved caspase-3 were significantly increased, whereas levels of the antiapoptotic protein Bcl-2 and the migration-related proteins MMP-2 and MMP-9 were significantly reduced by the combination treatment compared with either treatment alone. Conclusions: In conclusion, our results demonstrate that the combination of TMZ and siROCK2 effectively induces apoptosis and inhibits the migration of U251 cells. Therefore, the combination of TMZ and siROCK2 complex is a potential therapeutic approach for human glioma.	[Wen, Xiaojun; Liu, Zhonglin; Hu, Jingyang; Liu, Jun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Amin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yunyun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Shuai, Xintao] Sun Yat Sen Univ, Zhongshan Sch Med, Ctr Biomed Engn, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shuai, XT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Ctr Biomed Engn, Guangzhou 510275, Guangdong, Peoples R China.	Zhonglinliu@126.com			Chinese National Natural Science Foundation [81000466]; Guangdong Province Natural Science Foundation [S2013010014550]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants to Zhonglin Liu from the Chinese National Natural Science Foundation (No. 81000466) and Guangdong Province Natural Science Foundation (S2013010014550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Das A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-36; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Erkutlu I, 2013, TUMOR BIOL, V34, P1139, DOI 10.1007/s13277-013-0655-9; Gabelloni P, 2010, NEUROSCIENCE, V168, P514, DOI 10.1016/j.neuroscience.2010.03.064; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kondraganti S, 2000, CANCER RES, V60, P6851; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Liang YR, 2012, BIOCHEM BIOPH RES CO, V421, P690, DOI 10.1016/j.bbrc.2012.03.155; Liu YY, 2013, BRAIN RES, V1490, P43, DOI 10.1016/j.brainres.2012.10.039; Neu M, 2007, J CONTROL RELEASE, V124, P69, DOI 10.1016/j.jconrel.2007.08.009; Oellers P, 2009, GLIA, V57, P499, DOI 10.1002/glia.20777; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trog D, 2006, EUR J PHARMACOL, V542, P8, DOI 10.1016/j.ejphar.2006.05.026; Vishnubhotla R, 2007, LAB INVEST, V87, P1149, DOI 10.1038/labinvest.3700674; Wang J, 2013, INT J PHARMACEUT, V458, P48, DOI 10.1016/j.ijpharm.2013.10.017; Yan B, 2006, NEUROSCI LETT, V407, P124, DOI 10.1016/j.neulet.2006.08.032; Zhang SG, 2012, J MOL NEUROSCI, V47, P346, DOI 10.1007/s12031-012-9759-8; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	23	8	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92050	10.1371/journal.pone.0092050	http://dx.doi.org/10.1371/journal.pone.0092050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642531	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900072
J	Jiao, ZJ; Bedoui, S; Brady, JL; Walter, A; Chopin, M; Carrington, EM; Sutherland, RM; Nutt, SL; Zhang, YX; Ko, HJ; Wu, L; Lew, AM; Zhan, YF				Jiao, Zhijun; Bedoui, Sammy; Brady, Jamie L.; Walter, Anne; Chopin, Michael; Carrington, Emma M.; Sutherland, Robyn M.; Nutt, Stephen L.; Zhang, Yuxia; Ko, Hyun-Ja; Wu, Li; Lew, Andrew M.; Zhan, Yifan			The Closely Related CD103(+) Dendritic Cells (DCs) and Lymphoid-Resident CD8(+) DCs Differ in Their Inflammatory Functions	PLOS ONE			English	Article							ANTIGEN CROSS-PRESENTATION; NOD-LIKE RECEPTOR; GM-CSF; T-CELLS; CUTTING EDGE; INTERLEUKIN-17A AND-17F; IN-VIVO; EXPRESSION; CD8-ALPHA(+); DIFFERENTIATION	Migratory CD103(+) and lymphoid-resident CD8(+) dendritic cells (DCs) share many attributes, such as dependence on the same transcription factors, cross-presenting ability and expression of certain surface molecules, such that it has been proposed they belong to a common sub-lineage. The functional diversity of the two DC types is nevertheless incompletely understood. Here we reveal that upon skin infection with herpes simplex virus, migratory CD103(+) DCs from draining lymph nodes were more potent at inducing Th17 cytokine production by CD4(+) T cells than CD8(+) DCs. This superior capacity to drive Th17 responses was also evident in CD103(+) DCs from uninfected mice. Their differential potency to induce Th17 differentiation was reflected by higher production of IL-1 beta and IL-6 by CD103(+) DCs compared with CD8(+) DCs upon stimulation. The two types of DCs from isolated lymph nodes also differ in expression of certain pattern recognition receptors. Furthermore, elevated levels of GM-CSF, typical of those found in inflammation, substantially increased the pool size of CD103(+) DCs in lymph nodes and skin. We argue that varied levels of GM-CSF may explain the contrasting reports regarding the positive role of GM-CSF in regulating development of CD103(+) DCs. Together, we find that these two developmentally closely-related DC subsets display functional differences and that GM-CSF has differential effect on the two types of DCs.	[Jiao, Zhijun; Brady, Jamie L.; Chopin, Michael; Carrington, Emma M.; Sutherland, Robyn M.; Nutt, Stephen L.; Zhang, Yuxia; Ko, Hyun-Ja; Lew, Andrew M.; Zhan, Yifan] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Jiao, Zhijun] Jiangsu Univ, Key Lab Med Immunol, Zhenjiang, Peoples R China; [Jiao, Zhijun] Jiangsu Univ, Dept Lab Med, Affiliated Hosp, Zhenjiang, Peoples R China; [Bedoui, Sammy; Walter, Anne] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Brady, Jamie L.; Chopin, Michael; Carrington, Emma M.; Sutherland, Robyn M.; Nutt, Stephen L.; Zhang, Yuxia; Ko, Hyun-Ja; Lew, Andrew M.; Zhan, Yifan] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Wu, Li] Tsinghua Univ, Beijing 100084, Peoples R China; [Wu, Li] Peking Univ, Joint Ctr Life Sci, Beijing 100871, Peoples R China; [Wu, Li] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Jiangsu University; Jiangsu University; University of Melbourne; University of Melbourne; Tsinghua University; Peking University; Tsinghua University	Lew, AM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	lew@wehi.edu.au; zhan@wehi.edu.au	Chopin, Michael/AAD-3661-2020; Nutt, Stephen L/C-9256-2013; Lew, Andrew/C-7248-2013	Nutt, Stephen L/0000-0002-0020-6637; Lew, Andrew/0000-0002-2198-8164; Michael, Chopin/0000-0001-8812-2763; Zhan, Yifan/0000-0001-6974-0486; BEDOUI, SAMMY/0000-0002-7443-0543	National Health and Medical Research Council of Australia (NHMRC) [575543, 637324, 1007703]; Juvenile Diabetes Research Foundation; NHMRC Independent Research Institutes [361646]; Australian Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NHMRC Independent Research Institutes(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	This work was supported by National Health and Medical Research Council of Australia (NH&MRC) program and project grants (#575543, #637324 and #1007703), Juvenile Diabetes Research Foundation, NHMRC Independent Research Institutes Infrastructure Support Scheme grant #361646, and Victorian State Government Operational Infrastructure Support and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Campbell IK, 2011, J IMMUNOL, V186, P5468, DOI 10.4049/jimmunol.1002923; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dresch C, 2011, EUR J IMMUNOL, V41, P2544, DOI 10.1002/eji.201041374; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Ouyang WJ, 2010, CYTOKINE GROWTH F R, V21, P435, DOI 10.1016/j.cytogfr.2010.10.007; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Schon MP, 1999, J IMMUNOL, V162, P6641; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540; Zhan YF, 2010, J IMMUNOL, V185, P2125, DOI 10.4049/jimmunol.0903793	53	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91126	10.1371/journal.pone.0091126	http://dx.doi.org/10.1371/journal.pone.0091126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637385	Green Published, gold			2022-12-25	WOS:000333254100017
J	Konzmann, S; Lunau, K				Konzmann, Sabine; Lunau, Klaus			Divergent Rules for Pollen and Nectar Foraging Bumblebees - A Laboratory Study with Artificial Flowers Offering Diluted Nectar Substitute and Pollen Surrogate	PLOS ONE			English	Article							DIVISION-OF-LABOR; BOMBUS-TERRESTRIS; AMINO-ACIDS; HONEY-BEES; EVOLUTION; QUALITY; PREFERENCES; HYMENOPTERA; FORAGERS; BEHAVIOR	Almost all bees collect nectar and pollen from flowers. Female bees collect pollen to provision their nest cells, whereas they use nectar for individual energy supply and nest cell provisioning. Bees fine-tune nectar foraging to the amount and to the concentration of nectar, but the individual bees' response to variability of amount and concentration of pollen reward has not yet been studied thoroughly in laboratory settings. We developed an experimental set-up in which bumblebees simultaneously collected sugar solution and pollen from artificial flowers; natural pollen was mixed with cellulose powder or glass powder as a pollen surrogate. Here we show that bumblebee (Bombus terrestris) workers do not specialise in nectar or pollen collection, but regularly collect both rewards on the same day. When offered a fixed pollen reward and varied amounts and concentrations of sugar solution, the bumblebees fine-tuned sugar solution foraging dependent on both the volume and concentration, with strong preferences for the highest concentration and the greatest volume. In the reciprocal tests, when offered a fixed sugar reward and varied amounts and concentrations of pollen mixed with a nutrient-free pollen surrogate, the bumblebees follow more an all-or-none rule for pollen, accepting all amounts and concentrations except pure surrogate. It is discussed how the bumblebees' ability to sense sugar, and their apparent inability to sense the pollen protein content, shaped their foraging behaviour. It is argued that the rarity of nectar mimicry and the frequency of pollen mimicry in natural flowers might be interpreted in the context of divergent abilities of nectar and pollen recognition in bees.	[Konzmann, Sabine; Lunau, Klaus] Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Lunau, K (corresponding author), Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany.	lunau@uni-duesseldorf.de	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201				Adeva JJG, 2012, BIOSYST ENG, V112, P304, DOI 10.1016/j.biosystemseng.2012.05.002; Arenas A, 2012, ANIM BEHAV, V83, P1023, DOI 10.1016/j.anbehav.2012.01.026; Bodi M, 2012, MATH COMP MODEL DYN, V18, P87, DOI 10.1080/13873954.2011.601420; Budde Julia, 2007, Entomologie Heute, V19, P173; BUTLER CG, 1945, J EXP BIOL, V21, P5; Calderone NW, 1996, ANIM BEHAV, V51, P631, DOI 10.1006/anbe.1996.0068; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Davies KL, 2004, ANN BOT-LONDON, V93, P75, DOI 10.1093/aob/mch007; DAY S, 1990, J APICULT RES, V29, P138, DOI 10.1080/00218839.1990.11101210; de Brito Sanchez MG, 2011, CHEM SENSES, V36, P675, DOI 10.1093/chemse/bjr040; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; Dobson HEM, 1997, J INSECT PHYSIOL, V43, P89, DOI 10.1016/S0022-1910(96)00024-8; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Edwards JR, 2011, J THEOR BIOL, V271, P64, DOI 10.1016/j.jtbi.2010.11.027; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Goyret J, 2005, NATURWISSENSCHAFTEN, V92, P440, DOI 10.1007/s00114-005-0016-7; Hagbery J, 2012, NATURWISSENSCHAFTEN, V99, P821, DOI 10.1007/s00114-012-0964-7; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Heinrich B., 2004, BUMBLEBEE EC; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; King MJ, 1996, J EXP BIOL, V199, P2317; Kitaoka TK, 2009, BEHAV ECOL SOCIOBIOL, V63, P501, DOI 10.1007/s00265-008-0684-3; KOLTERMANN R, 1971, Z VERGL PHYSIOL, V75, P49, DOI 10.1007/BF00335137; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Leonhardt SD, 2012, APIDOLOGIE, V43, P449, DOI 10.1007/s13592-011-0112-y; Linander N, 2012, CHEM SENSES, V37, P631, DOI 10.1093/chemse/bjs044; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau Klaus, 2006, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V127, P13, DOI 10.1127/0006-8152/2006/0127-0013; Mapalad KS, 2008, J EXP BIOL, V211, P2239, DOI 10.1242/jeb.016642; MICHENER C D, 1978, University of Kansas Science Bulletin, V51, P575; Michener C. D., 2000, The bees of the world; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; Neff JL, 2008, APIDOLOGIE, V39, P30, DOI 10.1051/apido:2007055; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; Plowright CMS, 1999, BEHAVIOUR, V136, P951, DOI 10.1163/156853999501667; R DEVELOPMENT CORE TEAM, 2009, R LANG ENV STAT COMP; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Robertson AW, 1999, ECOLOGY, V80, P2594, DOI 10.1890/0012-9658(1999)080[2594:BBSOMG]2.0.CO;2; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; Schmidt JO, 2006, J INSECT BEHAV, V19, P521, DOI 10.1007/s10905-006-9039-y; Sedivy C, 2008, EVOLUTION, V62, P2487, DOI 10.1111/j.1558-5646.2008.00465.x; Seeley T., 1995, WISDOM HIVE; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Siegel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033465; Smeets P, 2003, APIDOLOGIE, V34, P333, DOI 10.1051/apido:2003026; Stanley RG., 1974, POLLEN, DOI [10.1007/978-3-642-65905-8, DOI 10.1007/978-3-642-65905-8]; Thorp RW, 2000, PLANT SYST EVOL, V222, P211, DOI 10.1007/BF00984103; Townsend-Mehler JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P305, DOI 10.1007/s00265-010-1047-4; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Wacht S, 2000, J COMP PHYSIOL A, V186, P193, DOI 10.1007/s003590050019; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083	62	47	50	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91900	10.1371/journal.pone.0091900	http://dx.doi.org/10.1371/journal.pone.0091900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637406	Green Published, gold			2022-12-25	WOS:000333254100077
J	Myhrvold, CL; Janny, F; Nelson, D; Ladd, SN; Atwood, A; Sachs, JP				Myhrvold, Conor L.; Janny, Fran; Nelson, Daniel; Ladd, S. Nemiah; Atwood, Alyssa; Sachs, Julian P.			Holocene Closure of Lib Pond, Marshall Islands	PLOS ONE			English	Article							INTERTROPICAL CONVERGENCE ZONE; MODELS	Well-preserved sediment from closed water bodies of atolls such as Lib Pond are rare opportunities to reconstruct the past regional climate, which pieced together across a latitude and longitude range identify the range of movement patterns of wider scale climate phenomena such as the Intertropical Convergence Zone (ITCZ) and El Nino Southern Oscillation (ENSO). We conducted the first physico-chemical survey of Lib Pond, a shallow, closed-water saline lake located on remote and difficult to access Lib Island in the Marshall Islands at 8 degrees 18' 48.99 '' N, 167 22' 51.90 '' E in the Pacific Ocean, in July 2009. We performed a bathymetric survey, recorded salinity, dissolved oxygen, pH, and temperature profiles, monitored the tidal variability, and conducted a vegetation survey surrounding the lake. From bathymetric data we calculated the lake volume, which we used to estimate the lake's salt budget, and ultimately the residence time of water in the lake basin. We took a series of sediment cores from the lake, cores which indicate Lib Island's changing environment and climate. Radiocarbon measurements determined sediment age, and reveal significant mixing over the last 2 ka of deposition. We conclude that prior to 3 ka, Lib Island was an atoll with a central lagoon connected to the open ocean, which was then closed off from the open ocean to form the brackish system that exists today. We predict that the sediment accumulation in Lib Pond evident today will continue. As seawater is inhibited from exchanging with fresh water, Lib Pond will become a shallower lake with increasingly fresh water.	[Myhrvold, Conor L.; Janny, Fran; Nelson, Daniel; Ladd, S. Nemiah; Atwood, Alyssa; Sachs, Julian P.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Myhrvold, CL (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	conor.myhrvold@gmail.com		Ladd, S. Nemiah/0000-0002-0132-5785; Nelson, Daniel/0000-0002-2716-7770	US National Science Foundation [NSF-ESH-0639640, EAR-0745982, EAR-0823503]	US National Science Foundation(National Science Foundation (NSF))	Funding was provided to JPS by the US National Science Foundation under grants #NSF-ESH-0639640, EAR-0745982, and EAR-0823503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berner EK, 1987, GLOBAL WATER CYCLE G; CANE MA, 1984, J PHYS OCEANOGR, V14, P1864, DOI 10.1175/1520-0485(1984)014<1864:MSLDEN>2.0.CO;2; FOSBERG F R, 1990, Atoll Research Bulletin, P1; Hakanson L., 1983, PRINCIPLES LAKE SEDI; Haug G. H., 2001, Science, V293, P1304, DOI 10.1126/science.1059725; Killops SD, 2005, INTRO GEOCHEMISTRY; Knauss JA, 2005, INTRO PHYS OCEANOGRA; Kwajalein Climate Kwajalein Climate, 2007, RTS WEATH STN; Payne A. I., 1986, ECOLOGY TROPICAL LAK; Peterson FL, 1997, DEVEL SEDIM, V54, P611; PSZENNY AAP, 1982, GEOPHYS RES LETT, V9, P751, DOI 10.1029/GL009i007p00751; RASMUSSON EM, 1983, SCIENCE, V222, P1195, DOI 10.1126/science.222.4629.1195; RMI Embassy Individual Atolls-Lib Island, 2005, REP MARSH ISL EMB US; Sachs JP, 2011, SCI AM, V304, P60, DOI 10.1038/scientificamerican0311-60; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Saenger Casey, 2006, Saline Syst, V2, P8, DOI 10.1186/1746-1448-2-8; Sheldon JE, 2006, ESTUAR COAST, V29, P133, DOI 10.1007/BF02784705; Taylor JD, 2006, ZOOL J LINN SOC-LOND, V148, P421, DOI 10.1111/j.1096-3642.2006.00261.x; Trichet J, 2001, SEDIMENT GEOL, V140, P177, DOI 10.1016/S0037-0738(00)00177-9; Valencia MJ, 1977, ATOLL RES B, V197; Wetzel RG, 1972, NUTRIENTS EUTROPHICA, V1, P84; Wilcox C, 2005, J HYDROL, V301, P29, DOI 10.1016/j.jhydrol.2004.06.027; Wright VP, 1996, SEDIMENTARY ENV PROC	23	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90939	10.1371/journal.pone.0090939	http://dx.doi.org/10.1371/journal.pone.0090939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638020	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100014
J	Pina, M; Almecija, S; Alba, DM; O'Neill, MC; Moya-Sola, S				Pina, Marta; Almecija, Sergio; Alba, David M.; O'Neill, Matthew C.; Moya-Sola, Salvador			The Middle Miocene Ape Pierolapithecus catalaunicus Exhibits Extant Great Ape-Like Morphometric Affinities on Its Patella: Inferences on Knee Function and Evolution	PLOS ONE			English	Article							HISPANOPITHECUS-LAIETANUS; POSITIONAL BEHAVIOR; HIND-LIMB; LOCOMOTION; PRIMATES; QUADRUPEDALISM; CATALONIA; SKELETON; POSTURE; ISLAND	The mosaic nature of the Miocene ape postcranium hinders the reconstruction of the positional behavior and locomotion of these taxa based on isolated elements only. The fossil great ape Pierolapithecus catalaunicus (IPS 21350 skeleton; 11.9 Ma) exhibits a relatively wide and shallow thorax with moderate hand length and phalangeal curvature, dorsally-oriented metacarpophalangeal joints, and loss of ulnocarpal articulation. This evidence reveals enhanced orthograde postures without modern ape-like below-branch suspensory adaptations. Therefore, it has been proposed that natural selection enhanced vertical climbing (and not suspension per se) in Pierolapithecus catalaunicus. Although limb long bones are not available for this species, its patella (IPS 21350.37) can potentially provide insights into its knee function and thus on the complexity of its total morphological pattern. Here we provide a detailed description and morphometric analyses of IPS 21350.37, which are based on four external dimensions intended to capture the overall patellar shape. Our results reveal that the patella of Pierolapithecus is similar to that of extant great apes: proximodistally short, mediolaterally broad and anteroposteriorly thin. Previous biomechanical studies of the anthropoid knee based on the same measurements proposed that the modern great ape patella reflects a mobile knee joint while the long, narrow and thick patella of platyrrhine and especially cercopithecoid monkeys would increase the quadriceps moment arm in knee extension during walking, galloping, climbing and leaping. The patella of Pierolapithecus differs not only from that of monkeys and hylobatids, but also from that of basal hominoids (e.g., Proconsul and Nacholapithecus), which display slightly thinner patellae than extant great apes (the previously-inferred plesiomorphic hominoid condition). If patellar shape in Pierolapithecus is related to modern great ape-like knee function, our results suggest that increased knee mobility might have originally evolved in relation to enhanced climbing capabilities in great apes (such as specialized vertical climbing).	[Pina, Marta; Almecija, Sergio; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Almecija, Sergio; O'Neill, Matthew C.] SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; [Almecija, Sergio] Univ Turin, NYCEP Morphometr Grp, Turin, Italy; [Alba, David M.] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Moya-Sola, Salvador] Univ Autonoma Barcelona, ICREA, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Unitat Antropol Biol, Dept BABVE, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Turin; University of Turin; Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona	Pina, M (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain.	marta.pina@icp.cat	Alba, David/G-9716-2015; Almécija, Sergio/ABG-8129-2020; Pina, Marta/G-5974-2018	Alba, David/0000-0002-8886-5580; Almécija, Sergio/0000-0003-1373-1497; Moya-Sola, Salvador/0000-0001-8506-1061; Pina, Marta/0000-0001-9762-6402	Spanish Ministerio de Educacion [AP2010-4579]; Spanish Ministerio de Economia y Competitividad [CGL2011-27343, CGL2011-28681, RYC-2009-04533]; Generalitat de Catalunya [2009 SGR 754 GRC, BP-A 00226]; AAPA Professional Development Grant; ICREA Funding Source: Custom	Spanish Ministerio de Educacion(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); AAPA Professional Development Grant; ICREA(ICREA)	This work has been supported by the Spanish Ministerio de Educacion (AP2010-4579 to MP), the Spanish Ministerio de Economia y Competitividad [CGL2011-27343, CGL2011-28681, and RYC-2009-04533 (to DMA)], the Generalitat de Catalunya [2009 SGR 754 GRC, and BP-A 00226 (to SA)], and the AAPA Professional Development Grant (to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba DM, 2012, EVOL ANTHROPOL, V21, P254, DOI 10.1002/evan.21312; Alba DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039617; Alba DM, 2010, J HUM EVOL, V59, P143, DOI 10.1016/j.jhevol.2010.02.002; Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; Almecija S, 2014, AM J PHYS A IN PRESS; Almecija S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3888; Almecija S, 2012, AM J PHYS ANTHROPOL, V148, P436, DOI 10.1002/ajpa.22071; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Badoux D.M., 1974, P1; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun DR, 2005, SCIENCE, V308, DOI 10.1126/science.1108139; Casanovas-Vilar I, 2008, J HUM EVOL, V55, P589, DOI 10.1016/j.jhevol.2008.05.004; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; Channon AJ, 2010, AM J PHYS ANTHROPOL, V143, P403, DOI 10.1002/ajpa.21329; Channon AJ, 2010, J ANAT, V216, P446, DOI 10.1111/j.1469-7580.2009.01209.x; Crompton RH, 2010, PHILOS T R SOC B, V365, P3301, DOI 10.1098/rstb.2010.0035; Deane AS, 2008, J HUM EVOL, V55, P691, DOI 10.1016/j.jhevol.2008.05.005; Deane AS, 2010, J HUM EVOL, V59, P150, DOI 10.1016/j.jhevol.2010.04.003; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; FLEAGLE JG, 1976, FOLIA PRIMATOL, V26, P245, DOI 10.1159/000155756; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gebo DL, 1996, AM J PHYS ANTHROPOL, V101, P55, DOI 10.1002/(SICI)1096-8644(199609)101:1<55::AID-AJPA5>3.0.CO;2-C; Hammond AS, 2013, J HUM EVOL, V64, P658, DOI 10.1016/j.jhevol.2013.03.002; HARRISON T, 1986, J HUM EVOL, V15, P541, DOI 10.1016/S0047-2484(86)80073-2; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; Hurzeler J., 1958, Verhandlungen der Naturforschenden Gesellschaft in Basel, V69, P1; Isler K, 2005, AM J PHYS ANTHROPOL, V126, P66, DOI 10.1002/ajpa.10419; Isler K, 2003, THESIS U ZURICH; Jenkins F.A. Jr., 1975, P213; Jungers W.L., 1990, P87; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kohler M, 2002, AM J PHYS ANTHROPOL, V119, P297, DOI 10.1002/ajpa.10140; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McCrossin M.L., 1994, DISSERTATION; McCrossin ML, 1994, AM J PHYS ANTHR S18, V37, P142; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Moya-Sola S, 2005, SCIENCE, V308, DOI 10.1126/science.1108433; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 1999, P NATL ACAD SCI USA, V96, P313, DOI 10.1073/pnas.96.1.313; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; MoyaSola S, 1996, NATURE, V379, P156, DOI 10.1038/379156a0; Nakatsukasa M, 2012, ANTHROPOL SCI, V120, P235, DOI 10.1537/ase.120731; NISELL R, 1985, ACTA ORTHOP SCAND, V56, P1, DOI 10.3109/17453678509154159; O'Neill MC, 2013, J EXP BIOL, V216, P3709, DOI 10.1242/jeb.079665; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Patel BA, 2009, J HUM EVOL, V57, P763, DOI 10.1016/j.jhevol.2009.08.005; de los Rios MP, 2012, J HUM EVOL, V63, P497, DOI 10.1016/j.jhevol.2012.05.012; Pina M, 2012, AM J PHYS ANTHROPOL, V149, P142, DOI 10.1002/ajpa.22109; PREUSCHOFT H, 1971, FOLIA PRIMATOL, V14, P209, DOI 10.1159/000155351; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; ROSE MD, 1994, J HUM EVOL, V26, P387, DOI 10.1006/jhev.1994.1025; Rose Michael D., 1996, African Study Monographs Supplementary Issue, V24, P3; STERN JT, 1974, J BIOMECH, V7, P411, DOI 10.1016/0021-9290(74)90004-9; Susanna I, 2010, AM J PHYS ANTHROPOL, P227; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; Ward Carol V., 2007, P1011, DOI 10.1007/978-3-540-33761-4_34; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; WARD CV, 1995, J HUM EVOL, V29, P1, DOI 10.1006/jhev.1995.1045; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Zihlman AL, 2011, ANAT REC, V294, P1842, DOI 10.1002/ar.21449	64	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91944	10.1371/journal.pone.0091944	http://dx.doi.org/10.1371/journal.pone.0091944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637777	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333254100086
J	Renwick, AR; Robinson, CJ; Martin, TG; May, T; Polglase, P; Possingham, HP; Carwardine, J				Renwick, Anna R.; Robinson, Catherine J.; Martin, Tara G.; May, Tracey; Polglase, Phil; Possingham, Hugh P.; Carwardine, Josie			Biodiverse Planting for Carbon and Biodiversity on Indigenous Land	PLOS ONE			English	Article							EMISSIONS; BENEFITS	Carbon offset mechanisms have been established to mitigate climate change through changes in land management. Regulatory frameworks enable landowners and managers to generate saleable carbon credits on domestic and international markets. Identifying and managing the associated co-benefits and dis-benefits involved in the adoption of carbon offset projects is important for the projects to contribute to the broader goal of sustainable development and the provision of benefits to the local communities. So far it has been unclear how Indigenous communities can benefit from such initiatives. We provide a spatial analysis of the carbon and biodiversity potential of one offset method, planting biodiverse native vegetation, on Indigenous land across Australia. We discover significant potential for opportunities for Indigenous communities to achieve carbon sequestration and biodiversity goals through biodiverse plantings, largely in southern and eastern Australia, but the economic feasibility of these projects depend on carbon market assumptions. Our national scale cost-effectiveness analysis is critical to enable Indigenous communities to maximise the benefits available to them through participation in carbon offset schemes.	[Renwick, Anna R.; Martin, Tara G.; Possingham, Hugh P.; Carwardine, Josie] Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Robinson, Catherine J.; Martin, Tara G.; Carwardine, Josie] CSIRO Ecosyst Sci, Brisbane, Qld, Australia; [Robinson, Catherine J.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [May, Tracey] CSIRO Ecosyst Sci, Alice Springs, NT, Australia; [Polglase, Phil] CSIRO Ecosyst Sci, Crace, ACT, Australia; [Possingham, Hugh P.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Imperial College London	Renwick, AR (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	a.renwick@uq.edu.au	Carwardine, Josie/A-5801-2011; POSSINGHAM, HUGH/R-8310-2019; Martin, Tara/M-1897-2016; Possingham, Hugh/B-1337-2008; Robinson, Cathy/D-3349-2011	POSSINGHAM, HUGH/0000-0001-7755-996X; Martin, Tara/0000-0001-7165-9812; Possingham, Hugh/0000-0001-7755-996X; Robinson, Cathy/0000-0002-3453-572X; May, Tracey/0000-0002-2226-6251	CSIRO Climate Adaptation and Sustainable Agriculture Flagship; National Indigenous Climate Change Project (RIRDC) [PRJ-005438]; ARC Centre of Excellence for Environmental Decisions; NERP Research Hub for Environmental Decisions; Julius Career Award	CSIRO Climate Adaptation and Sustainable Agriculture Flagship; National Indigenous Climate Change Project (RIRDC); ARC Centre of Excellence for Environmental Decisions(Australian Research Council); NERP Research Hub for Environmental Decisions; Julius Career Award	This work was supported by the CSIRO Climate Adaptation and Sustainable Agriculture Flagship, the National Indigenous Climate Change Project (RIRDC Project No PRJ-005438), the ARC Centre of Excellence for Environmental Decisions, the NERP Research Hub for Environmental Decisions and a Julius Career Award to TGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Climate Commission, 2013, CRIT DEC GLOB ACT BU; Commonwealth of Australia (Department of Climate Change and Energy Efficiency), 2012, CARB FARM IN HDB; DCCEE, 2012, CFI METH ENV PLANT N; Dohan R, 2010, 1 NATIONS CARBON COL; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Gerrard E, 2012, ABORIG HIST MG SER, V24, P135; Goldtooth T, 2010, CARBON MARKETS VIOLA; Grainger A, 2009, CURR BIOL, V19, pR974, DOI 10.1016/j.cub.2009.10.001; Hulvey KB, 2013, NAT CLIM CHANGE, V3, P869, DOI [10.1038/nclimate1862, 10.1038/NCLIMATE1862]; Lindenmayer DB, 2012, CONSERV LETT, V5, P28, DOI 10.1111/j.1755-263X.2011.00213.x; NICC, 2011, SUMM NAT IND CLIM CH; Parker C, 2008, LITTLE GLOBAL CANOPY; Peters-Stanley M., 2012, DEV DIMENSION STATE; Polglase PJ, 2013, CLIMATIC CHANGE, V121, P161, DOI 10.1007/s10584-013-0882-5; Putz FE, 2009, GLOBAL ENVIRON CHANG, V19, P400, DOI 10.1016/j.gloenvcha.2009.07.005; Robinson C. J., 2011, INDIGENOUS IN PRESS; Robinson CJ, 2014, GEOGR RES-AUST, V52, P123, DOI 10.1111/1745-5871.12049; Robinson CJ, 2013, NICC OPPORTUNITIES R; Russell-Smith J, 2009, INT J WILDLAND FIRE, V18, P1, DOI 10.1071/WF08009; Whitehead P. J., 2009, Culture, ecology and economy of fire management in North Australian savannas: rekindling the Wurrk tradition, P287	22	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91281	10.1371/journal.pone.0091281	http://dx.doi.org/10.1371/journal.pone.0091281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637736	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100025
J	Roth, JK; Johnson, MK; Tokoglu, F; Murphy, I; Constable, RT				Roth, Jennifer K.; Johnson, Marcia K.; Tokoglu, Fuyuze; Murphy, Isabella; Constable, R. Todd			Modulating Intrinsic Connectivity: Adjacent Subregions within Supplementary Motor Cortex, Dorsolateral Prefrontal Cortex, and Parietal Cortex Connect to Separate Functional Networks during Task and Also Connect during Rest	PLOS ONE			English	Article							OBJECT WORKING-MEMORY; BRAIN ACTIVITY; DEFAULT MODE; NEURAL SYSTEM; FLUCTUATIONS; FMRI; PARCELLATION; REGIONS; ATTENTION; LOBE	Supplementary motor area (SMA), the inferior frontal junction (IFJ), superior frontal junction (SFJ) and parietal cortex are active in many cognitive tasks. In a previous study, we found that subregions of each of these major areas were differentially active in component processes of executive function during working memory tasks. In the present study, each of these subregions was used as a seed in a whole brain functional connectivity analysis of working memory and resting state data. These regions show functional connectivity to different networks, thus supporting the parcellation of these major regions into functional subregions. Many regions showing significant connectivity during the working memory residual data (with task events regressed from the data) were also significantly connected during rest suggesting that these network connections to subregions within major regions of cortex are intrinsic. For some of these connections, task demands modulate activity in these intrinsic networks. Approximately half of the connections significant during task were significant during rest, indicating that some of the connections are intrinsic while others are recruited only in the service of the task. Furthermore, the network connections to traditional 'task positive' and 'task negative' (a.k.a 'default mode') regions shift from positive connectivity to negative connectivity depending on task demands. These findings demonstrate that such task-identified subregions are part of distinct networks, and that these networks have different patterns of connectivity for task as they do during rest, engaging connections both to task positive and task negative regions. These results have implications for understanding the parcellation of commonly active regions into more specific functional networks.	[Roth, Jennifer K.] Concordia Coll New York, Dept Social Sci, Bronxville, NY 10708 USA; [Johnson, Marcia K.] Yale Univ, Dept Psychol, Sch Med, New Haven, CT 06520 USA; [Tokoglu, Fuyuze] Yale Univ, Sch Med, Dept Diagnost Radiol, Magnet Resonance Res Ctr, New Haven, CT 06510 USA; [Murphy, Isabella] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Constable, R. Todd] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Constable, R. Todd] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Roth, JK (corresponding author), Concordia Coll New York, Dept Social Sci, Bronxville, NY 10708 USA.	Jennifer.roth@concordia-ny.edu	Constable, R. Todd/ABE-8038-2021	Constable, R. Todd/0000-0001-5661-9521	NIH [R01 NS051622]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by an NIH grant, NIH R01 NS051622 (http://www.ncbi.nlm.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Dumontheil I, 2011, J COGNITIVE NEUROSCI, V23, P168, DOI 10.1162/jocn.2010.21439; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gilbert SJ, 2010, J NEUROSCI, V30, P1233, DOI 10.1523/JNEUROSCI.3220-09.2010; Giove F, 2009, MAGN RESON IMAGING, V27, P1058, DOI 10.1016/j.mri.2009.06.004; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raye CL, 2007, CORTEX, V43, P135, DOI 10.1016/S0010-9452(08)70451-9; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Rosenau BJ, 2009, J VISION, V9, p164a; Rosenau BJ, 2009, J VISION, V9, P164; Roth JK, 2007, NEUROIMAGE, V38, P617, DOI 10.1016/j.neuroimage.2007.06.037; Roth JK, 2006, CEREB CORTEX, V16, P1595, DOI 10.1093/cercor/bhj096; Roth JK, 2009, NEUROIMAGE, V48, P601, DOI 10.1016/j.neuroimage.2009.07.002; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Vandenberghe R, 2009, BEHAV BRAIN RES, V199, P171, DOI 10.1016/j.bbr.2008.12.005; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638	44	10	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90672	10.1371/journal.pone.0090672	http://dx.doi.org/10.1371/journal.pone.0090672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637793	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100007
J	Diekman, EF; van Weeghel, M; Wanders, RJA; Visser, G; Houten, SM				Diekman, Eugene F.; van Weeghel, Michel; Wanders, Ronald J. A.; Visser, Gepke; Houten, Sander M.			Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models	FASEB JOURNAL			English	Article						myopathy; rhabdomyolysis; creatine kinase; thermogenesis	ACYL-COA DEHYDROGENASE; TANDEM MASS-SPECTROMETRY; BETA-OXIDATION; AMINO-ACIDS; FOLLOW-UP; DISORDERS; BEZAFIBRATE; MICE; ACYLCARNITINE; METABOLISM	Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is an inherited disorder of mitochondrial long-chain fatty acid beta-oxidation (FAO). Patients with VLCAD deficiency may present with hypoglycemia, hepatomegaly, cardiomyopathy, and myopathy. Although several mouse models have been developed to aid in the study of the pathogenesis of long-chain FAO defects, the muscular phenotype is underexposed. To address the muscular phenotype, we used a newly developed mouse model on a mixed genetic background with a more severe defect in FAO (LCAD(-/-); VLCAD(-/-)) in addition to a validated mouse model (LCAD(-/-); VLCAD(-/-)) and compared them with wildtype (WT) mice. We found that both mouse models show a 20% reduction in energy expenditure (EE) and a 3-fold decrease in locomotor activity in the unfed state. In addition, we found a 1.7 degrees C drop in body temperature in unfed LCAD(-/-); VLCAD(-/-) mice compared with WT body temperature. We conclude that food withdrawal-induced inactivity, hypothermia, and reduction in EE are novel phenotypes associated with FAO deficiency in mice. Unexpectedly, inactivity was not explained by rhabdomyolysis, but rather reflected the overall reduced capacity of these mice to generate heat. We suggest that mice are partly protected against the negative consequence of an FAO defect.	[Diekman, Eugene F.; Visser, Gepke] UMC, Wilhelmina Childrens Hosp, Dept Metab Dis, Utrecht, Netherlands; [Diekman, Eugene F.; van Weeghel, Michel; Wanders, Ronald J. A.; Houten, Sander M.] Univ Amsterdam, Dept Clin Chem, Lab Genet Metab Dis, Amsterdam, Netherlands; [Wanders, Ronald J. A.; Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Wilhelmina Kinderziekenhuis; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai	Houten, SM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	sander.houten@mssm.edu	van Weeghel, Michel/A-2766-2010; Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; van Weeghel, Michel/0000-0002-4916-2866	Netherlands Organization for Scientific Research (Vidi) [016.086.336]; ZonMW [200320006]; Metakids	Netherlands Organization for Scientific Research (Vidi)(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development); Metakids	The authors thank M. Boek, H. te Brinke, S. Denis, and the employees of the Animal Research Institute Amsterdam for technical assistance. This work was supported by the Netherlands Organization for Scientific Research (Vidi grant 016.086.336 to SMH), ZonMW (grant 200320006) and Metakids. The authors declare no conflicts of interest.	Bakermans AJ, 2013, CARDIOVASC RES, V100, P441, DOI 10.1093/cvr/cvt212; Bakermans AJ, 2011, CIRC-CARDIOVASC IMAG, V4, P558, DOI 10.1161/CIRCIMAGING.111.963751; Bergmeyer HU, 1986, METHODS ENZYMATIC AN; Bonnefont JP, 2010, CLIN PHARMACOL THER, V88, P101, DOI 10.1038/clpt.2010.55; Bonnefont JP, 2009, NEW ENGL J MED, V360, P838, DOI 10.1056/NEJMc0806334; Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248; Casetta B, 2000, CLIN CHEM LAB MED, V38, P391, DOI 10.1515/CCLM.2000.057; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chuang CK, 2009, J CHROMATOGR A, V1216, P8947, DOI 10.1016/j.chroma.2009.10.074; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; Cox KB, 2009, LAB INVEST, V89, P1348, DOI 10.1038/labinvest.2009.86; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Liu J, 2011, PPAR RES, V2011, DOI 10.1155/2011/372854; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521; Oey NA, 2006, J INHERIT METAB DIS, V29, P71, DOI 10.1007/s10545-006-0199-x; Orngreen MC, 2014, NEUROLOGY, V82, P607, DOI 10.1212/WNL.0000000000000118; Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; Spiekerkoetter U, 2004, MUSCLE NERVE, V29, P66, DOI 10.1002/mus.10500; ter Veld F, 2009, J LIPID RES, V50, P1556, DOI 10.1194/jlr.M800221-JLR200; van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Vreken P, 1999, J INHERIT METAB DIS, V22, P302, DOI 10.1023/A:1005587617745; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8	33	6	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2891	2900		10.1096/fj.14-250241	http://dx.doi.org/10.1096/fj.14-250241			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24648546				2022-12-25	WOS:000337949400014
J	Dissanayake, D; Murakami, K; Tran, MD; Elford, AR; Millar, DG; Ohashi, PS				Dissanayake, Dilan; Murakami, Kiichi; Tran, Michael D.; Elford, Alisha R.; Millar, Douglas G.; Ohashi, Pamela S.			Peptide-Pulsed Dendritic Cells Have Superior Ability to Induce Immune-Mediated Tissue Destruction Compared to Peptide with Adjuvant	PLOS ONE			English	Article							REGULATORY T-CELLS; TOLL-LIKE RECEPTOR-2; PHASE-II TRIAL; CANCER-IMMUNOTHERAPY; TRANSGENIC MICE; VACCINATION; ANTIGEN; VIRUS; TOLERANCE; LYMPHOCYTES	Vaccines for cancer immunotherapy are of interest but in general have not yet achieved the desired therapeutic efficacy in clinical trials. We present here a novel model to evaluate vaccine strategies by following tissue destruction in a transgenic model, where a defined antigen is expressed on pancreatic islets. We found that the transfer of syngeneic antigen-pulsed dendritic cells (DCs) resulted in autoimmune cytotoxic T-lymphocyte activation that was not observed following vaccinations that were based on peptides and adjuvants. Importantly, the induction of diabetes by DC transfer is dependent upon the maturation of DCs prior to transfer. Furthermore, diabetes induction only occurred if DCs were pulsed with the immunodominant epitope in addition to at least one other peptide, suggesting greater cytolytic activity upon engagement of multiple T-cell specificities. While the tumor environment undoubtedly will be more complex than healthy tissue, the insights gained through this model provide useful information on variables that can affect CD8-mediated tissue cytolysis in vivo.	[Dissanayake, Dilan; Murakami, Kiichi; Tran, Michael D.; Elford, Alisha R.; Millar, Douglas G.; Ohashi, Pamela S.] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Dissanayake, Dilan; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Ohashi, PS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	pohashi@uhnres.utoronto.ca		Millar, Douglas/0000-0002-8640-7148; Ohashi, Pamela S./0000-0003-2915-9317; Dissanayake, Dilan/0000-0003-4270-7015	Canadian Institutes for Health Research (CIHR); CIHR; Ontario Ministry of Health and Long Term Care (OMHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by a Canadian Institutes for Health Research (CIHR) grant to P.S.O. and a CIHR studentship to D.D. P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMHLTC). The views expressed do not necessarily reflect those of the OMHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Butterfield LH, 2003, CLIN CANCER RES, V9, P5902; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Clive KS, 2012, J SURG ONCOL, V105, P452, DOI 10.1002/jso.21723; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Draube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018801; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Gross DA, 2004, J CLIN INVEST, V113, P425, DOI 10.1172/JCI200419418; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Jager E, 2000, J EXP MED, V191, P625, DOI 10.1084/jem.191.4.625; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee KH, 1999, J IMMUNOL, V163, P6292; Lin ACC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023940; Lovgren T, 2012, CANCER IMMUNOL IMMUN, V61, P817, DOI 10.1007/s00262-011-1140-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Madan RA, 2011, EXPERT REV VACCINES, V10, P141, DOI 10.1586/ERV.10.173; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OHASHI PS, 1993, J IMMUNOL, V150, P5185; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Phuphanich S, 2013, CANCER IMMUNOL IMMUN, V62, P125, DOI 10.1007/s00262-012-1319-0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Qi H, 2003, INFECT IMMUN, V71, P3337, DOI 10.1128/IAI.71.6.3337-3342.2003; Rahma OE, 2012, CANCER IMMUNOL IMMUN, V61, P373, DOI 10.1007/s00262-011-1100-9; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rong YF, 2012, CLIN EXP MED, V12, P173, DOI 10.1007/s10238-011-0159-0; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Slingluff CL, 2007, CLIN CANCER RES, V13, P6386, DOI 10.1158/1078-0432.CCR-07-0486; Slingluff CL, 2011, J CLIN ONCOL, V29, P2924, DOI 10.1200/JCO.2010.33.8053; Sommerfeldt N, 2006, CANCER RES, V66, P8258, DOI 10.1158/0008-5472.CAN-05-4201; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Vonderheide RH, 2001, CANCER RES, V61, P8366	61	10	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92380	10.1371/journal.pone.0092380	http://dx.doi.org/10.1371/journal.pone.0092380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647761	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500124
J	Fischer, J; Muller, T; Spatz, AK; Greggers, U; Grunewald, B; Menzel, R				Fischer, Johannes; Mueller, Teresa; Spatz, Anne-Kathrin; Greggers, Uwe; Gruenewald, Bernd; Menzel, Randolf			Neonicotinoids Interfere with Specific Components of Navigation in Honeybees	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ACETYLTRANSFERASE-LIKE IMMUNOREACTIVITY; DECREASES FORAGING SUCCESS; ANTENNAL LOBE NEURONS; APIS-MELLIFERA; BRAIN; BEES; LOCALIZATION; EXPOSURE; SURVIVAL	Three neonicotinoids, imidacloprid, clothianidin and thiacloprid, agonists of the nicotinic acetylcholine receptor in the central brain of insects, were applied at non-lethal doses in order to test their effects on honeybee navigation. A catch-and-release experimental design was applied in which feeder trained bees were caught when arriving at the feeder, treated with one of the neonicotinoids, and released 1.5 hours later at a remote site. The flight paths of individual bees were tracked with harmonic radar. The initial flight phase controlled by the recently acquired navigation memory (vector memory) was less compromised than the second phase that leads the animal back to the hive (homing flight). The rate of successful return was significantly lower in treated bees, the probability of a correct turn at a salient landscape structure was reduced, and less directed flights during homing flights were performed. Since the homing phase in catch-and-release experiments documents the ability of a foraging honeybee to activate a remote memory acquired during its exploratory orientation flights, we conclude that non-lethal doses of the three neonicotinoids tested either block the retrieval of exploratory navigation memory or alter this form of navigation memory. These findings are discussed in the context of the application of neonicotinoids in plant protection.	[Fischer, Johannes; Mueller, Teresa; Gruenewald, Bernd] Goethe Univ Frankfurt, Fachbereich Biowissensch, Inst Bienenkunde Oberursel, Polytech Gesell Frankfurt Main, D-60054 Frankfurt, Germany; [Spatz, Anne-Kathrin] Netzwerk Bluhende Landschaften Fischermuhle, Rosenfeld, Germany; [Greggers, Uwe; Menzel, Randolf] Free Univ Berlin, Inst Biol, Berlin, Germany	Goethe University Frankfurt; Free University of Berlin	Menzel, R (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	menzel@neurobiologie.fu-berlin.de	Grünewald, Bernd/G-2060-2012; Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	Deutsche Forschungsgemeinschaft (DFG) [ME 365/34-2]; Hertie Gemeinnutzige Stiftung; Dr. Klaus Tschira Stiftung; EU; Land Hessen, Hessisches Ministerium fur Umwelt, Ernahrung, Landwirtschaft und Verbraucherschutz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hertie Gemeinnutzige Stiftung; Dr. Klaus Tschira Stiftung; EU(European Commission); Land Hessen, Hessisches Ministerium fur Umwelt, Ernahrung, Landwirtschaft und Verbraucherschutz	The studies were financially supported by the following institutions: Deutsche Forschungsgemeinschaft (DFG grant ME 365/34-2 to RM), Hertie Gemeinnutzige Stiftung (RM), Dr. Klaus Tschira Stiftung (RM, UG), and by the EU and the Land Hessen, Hessisches Ministerium fur Umwelt, Ernahrung, Landwirtschaft und Verbraucherschutz (BG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; Barbara GS, 2005, J COMP PHYSIOL A, V191, P823, DOI 10.1007/s00359-005-0007-3; Barbara Guillaume Stephane, 2008, Invertebrate Neuroscience, V8, P19, DOI 10.1007/s10158-007-0062-2; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bortolotti L, 2003, B INSECTOL, V56, P67; Brown LA, 2006, J NEUROCHEM, V99, P608, DOI 10.1111/j.1471-4159.2006.04084.x; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; Cheeseman JF, 2012, P NATL ACAD SCI USA, V109, P7061, DOI 10.1073/pnas.1201734109; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Eisenhardt D, 2012, HONEYBEE NEUROBIOLOG, P423; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Fusca D, 2013, J COMP NEUROL, V521, P3556, DOI 10.1002/cne.23371; Gauthier M., 2012, HONEYBEE NEUROBIOLOG, P155, DOI DOI 10.1007/978-94-007-2099-213; Gauthier M, 2006, NEUROBIOL LEARN MEM, V86, P164, DOI 10.1016/j.nlm.2006.02.003; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Guez D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00037; Henry M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00062; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; HOMBERG U, 1995, CELL TISSUE RES, V279, P249, DOI 10.1007/s004410050280; Jepson James E. C., 2006, Invertebrate Neuroscience, V6, P33, DOI 10.1007/s10158-005-0013-8; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Leitinger G, 2000, J COMP NEUROL, V416, P345; Medrzycki P, 2013, B INSECTOL, V56, P59; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R., 2012, HONEYBEE NEUROBIOLOG; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SCHUSTER R, 1993, J COMP NEUROL, V335, P149, DOI 10.1002/cne.903350202; Seeley T. D, 2011, HONEYBEE DEMOCRACY; Thany SH, 2005, GENE, V344, P125, DOI 10.1016/j.gene.2004.09.010; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	51	193	205	7	256	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91364	10.1371/journal.pone.0091364	http://dx.doi.org/10.1371/journal.pone.0091364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646521	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500033
J	Kim, HS; Kim, TJ; Yoo, YM				Kim, Han Sung; Kim, Tack-Joong; Yoo, Yeong-Min			Melatonin Combined with Endoplasmic Reticulum Stress Induces Cell Death via the PI3K/Akt/mTOR Pathway in B16F10 Melanoma Cells	PLOS ONE			English	Article							INHIBITOR BAY-43-9006; SIGNALING PATHWAY; INDUCED APOPTOSIS; INDUCED AUTOPHAGY; DOWN-REGULATION; CANCER-THERAPY; UP-REGULATION; LNCAP CELLS; ER STRESS; IN-VITRO	This study investigated B16F10 melanoma cell death induced by melatonin combined with endoplasmic reticulum (ER) stress through the PI3K/Akt/mTOR pathway. Cell viability was significantly decreased after treatment with melatonin combined with ER stress from thapsigargin or tunicamycin compared to no treatment or treatment with melatonin only. Combined melatonin and ER stress also significantly reduced expression of p85 beta, p-Akt (Ser473, Thr308), and p-mTOR (Ser2448, Ser2481) compared to treatment with melatonin only. The ER stress protein p-PERK and p-eIF2 alpha were significantly increased under combined melatonin and ER stress treatment compared to no treatment or treatment with melatonin only. Combined melatonin and ER stress significantly reduced Bcl-2 protein and augmented Bax protein compared to melatonin-only treatment. Also, the combined treatment significantly lowered expression of catalase, Cu/Zn-SOD, and Mn-SOD proteins compared to melatonin only. Expression of p85 beta was significantly more decreased under treatment with melatonin and thapsigargin or tunicamycin plus the PI3K inhibitors LY294002 or wortmannin than under treatment with only melatonin or a PI3K inhibitor. The PI3K downstream target p-Akt (Ser473, Thr308) showed significantly decreased expression under treatment with melatonin and thapsigargin or tunicamycin plus PI3K inhibitors than under treatment with melatonin or PI3K inhibitors only. These results indicate that survival of B16F10 melanoma cells after combined treatment with melatonin and ER stress inducers is suppressed through regulation of the PI3K/Akt/mTOR pathway. Melatonin combined with thapsigargin or tunicamycin appears to be a promising strategy for effective melanoma treatment.	[Kim, Han Sung; Yoo, Yeong-Min] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea; [Kim, Tack-Joong] Yonsei Univ, Coll Sci & Technol, Div Biol Sci & Technol, Wonju, Gangwon Do, South Korea	Yonsei University; Yonsei University	Yoo, YM (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea.	yyeongm@hanmail.net			Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-00757]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-00757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Blask DE, 2011, J PINEAL RES, V51, P259, DOI 10.1111/j.1600-079X.2011.00888.x; Bonnefont-Rousselot D, 2011, J PINEAL RES, V50, P328, DOI 10.1111/j.1600-079X.2010.00847.x; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Cabrera J, 2010, J PINEAL RES, V49, P45, DOI 10.1111/j.1600-079X.2010.00765.x; Cos S, 2001, MELANOMA RES, V11, P197, DOI 10.1097/00008390-200104000-00016; Cui PL, 2012, J PINEAL RES, V52, P236, DOI 10.1111/j.1600-079X.2011.00933.x; de Souza AV, 2003, J PINEAL RES, V34, P242, DOI 10.1034/j.1600-079X.2003.02928.x; Fischer TW, 2006, INT J ONCOL, V29, P665; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; HELTON RA, 1993, MELANOMA RES, V3, P403, DOI 10.1097/00008390-199311000-00003; Hong Z, 2006, INT J ONCOL, V28, P661; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Joo SS, 2009, J PINEAL RES, V47, P8, DOI 10.1111/j.1600-079X.2009.00682.x; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Kadekaro AL, 2004, J PINEAL RES, V36, P204, DOI 10.1111/j.1600-079X.2004.00119.x; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kilic U, 2012, J PINEAL RES, V52, P228, DOI 10.1111/j.1600-079X.2011.00932.x; Kim CH, 2012, J PINEAL RES, V53, P289, DOI 10.1111/j.1600-079X.2012.00998.x; Kim CH, 2010, KOREAN J PHYSIOL PHA, V14, P365, DOI 10.4196/kjpp.2010.14.6.365; Kivela T, EYE LOND, V27, P243; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Liang KV, 2006, MAYO CLIN PROC, V81, P511, DOI 10.4065/81.4.511; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Min KJ, 2012, J PINEAL RES, V53, P99, DOI 10.1111/j.1600-079X.2012.00975.x; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Mori M, 2003, J CELL PHYSIOL, V195, P290, DOI 10.1002/jcp.10245; NARITA T, 1985, CANCER RES, V45, P4175; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sanchez-Hernandez I, 2012, CANCER LETT, V314, P244, DOI 10.1016/j.canlet.2011.09.037; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Su TR, 2012, MAR DRUGS, V10, P1883, DOI 10.3390/md10081883; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tan DX, 1993, ENDOCR J, V1, P57; Tirado OM, 2005, ONCOGENE, V24, P3348, DOI 10.1038/sj.onc.1208471; Uguz AC, 2012, J PINEAL RES, V53, P91, DOI 10.1111/j.1600-079X.2012.00974.x; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Weinstock MA, 2000, JAMA-J AM MED ASSOC, V284, P886, DOI 10.1001/jama.284.7.886; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Yerneni LK, 2003, MELANOMA RES, V13, P113, DOI 10.1097/00008390-200304000-00002; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zha LX, 2012, J PINEAL RES, V52, P322, DOI 10.1111/j.1600-079X.2011.00946.x	58	36	39	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92627	10.1371/journal.pone.0092627	http://dx.doi.org/10.1371/journal.pone.0092627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647338	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500150
J	Lamanna, MC; Sues, HD; Schachner, ER; Lyson, TR				Lamanna, Matthew C.; Sues, Hans-Dieter; Schachner, Emma R.; Lyson, Tyler R.			A New Large-Bodied Oviraptorosaurian Theropod Dinosaur from the Latest Cretaceous of Western North America	PLOS ONE			English	Article							HELL CREEK FORMATION; BAYAN-MANDAHU; DEPOSITIONAL-ENVIRONMENTS; INNER-MONGOLIA; CHINA; CHIROSTENOTES; MANIRAPTORA; SAURISCHIA; EVOLUTION; OSTEOLOGY	The oviraptorosaurian theropod dinosaur clade Caenagnathidae has long been enigmatic due to the incomplete nature of nearly all described fossils. Here we describe Anzu wyliei gen. et sp. nov., a new taxon of large-bodied caenagnathid based primarily on three well-preserved partial skeletons. The specimens were recovered from the uppermost Cretaceous (upper Maastrichtian) Hell Creek Formation of North and South Dakota, and are therefore among the stratigraphically youngest known oviraptorosaurian remains. Collectively, the fossils include elements from most regions of the skeleton, providing a wealth of information on the osteology and evolutionary relationships of Caenagnathidae. Phylogenetic analysis reaffirms caenagnathid monophyly, and indicates that Anzu is most closely related to Caenagnathus collinsi, a taxon that is definitively known only from a mandible from the Campanian Dinosaur Park Formation of Alberta. The problematic oviraptorosaurs Microvenator and Gigantoraptor are recovered as basal caenagnathids, as has previously been suggested. Anzu and other caenagnathids may have favored well-watered floodplain settings over channel margins, and were probably ecological generalists that fed upon vegetation, small animals, and perhaps eggs.	[Lamanna, Matthew C.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; [Sues, Hans-Dieter] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Schachner, Emma R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Lyson, Tyler R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian National Museum of Natural History	Lamanna, MC (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA.	lamannam@carnegiemnh.org		Schachner, Emma/0000-0002-8636-925X; Sues, Hans-Dieter/0000-0002-9911-7254	Carnegie Museum of Natural History; American Philosophical Society Franklin Research Grant; National Museum of Natural History Peter Buck Postdoctoral Fellowship; American Association of Anatomists Postdoctoral Fellowship	Carnegie Museum of Natural History; American Philosophical Society Franklin Research Grant; National Museum of Natural History Peter Buck Postdoctoral Fellowship; American Association of Anatomists Postdoctoral Fellowship	Funding was provided by the Carnegie Museum of Natural History (http://www.carnegiemnh.org), an American Association of Anatomists Postdoctoral Fellowship (http://www.anatomy.org/content/postdoctoral-fellowship-criteria), and an American Philosophical Society Franklin Research Grant (http://www.amphilsoc.org/grants/franklin) to E. R. S., and a National Museum of Natural History Peter Buck Postdoctoral Fellowship (http://vertebrates.si.edu/vz_buck_fell_info.html) to T. R. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin F.L., 2013, AVIAN ANCESTORS REV; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Averianov A., 2012, Journal of Stratigraphy, V36, P462; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; Balanoff AM, 2012, B AM MUS NAT HIST, P1; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; Barsbold R, 2000, NATURE, V403, P155, DOI 10.1038/35003103; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1990, P249; Barsbold R., 1983, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, P1; Barsbold R., 1976, Doklady (Proc) Acad Sci USSR (Earth Sci), V226, P221; Barsbold R., 1986, P210; Barsbold R., 1977, JOINT SOV MONG PAL E, V4, P34; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clark James M., 1999, American Museum Novitates, V3265, P1; CRACRAFT J, 1971, Journal of Paleontology, V45, P805; Currie P.J., 1990, P245; Currie PJ, 2005, LIFE O PAST, P367; CURRIE PJ, 1989, CAN J EARTH SCI, V26, P1319, DOI 10.1139/e89-111; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Dingus L, 2008, AM MUS NOVIT, P1, DOI 10.1206/442.1; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; EBERTH DA, 1993, CAN J EARTH SCI, V30, P2196, DOI 10.1139/e93-191; Elzanowski A, 1999, SM C PALEOB, P311; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; Funston GF, CANADIAN J IN PRESS; Gierlinski Gerard, 2013, P526; Gilmore C.W., 1924, GEOLOGICAL SURVEY CA, V38, p1e12; Goloboff P, 2008, CLADISTICS, V24, P91; Harris JD, 1996, CRETACEOUS RES, V17, P381, DOI 10.1006/cres.1996.0024; Hartman JH, 2002, 361 GEOL SOC AM; Hasegawa H, 2009, J ASIAN EARTH SCI, V35, P13, DOI 10.1016/j.jseaes.2008.11.010; He Tao, 2008, Vertebrata Palasiatica, V46, P178; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; [Ji Qiang 季强], 2012, [地质通报, Geological Bulletin of China], V31, P2102; Johnson KR, 2002, GEOL S AM S, P503; KING GM, 1989, ZOOL J LINN SOC-LOND, V96, P185, DOI 10.1111/j.1096-3642.1989.tb01826.x; Koppelhus, 2005, DINOSAUR PROVINCIAL; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; Kurzanov S.M., 1982, Paleontologicheskii Zhurnal, V1982, P108; Kurzanov S.M., 1987, T JOINT SOVIET MONGO, V31, P5; Kurzanov SM, 1985, PALEONTOL J, V1985, P92; Lamanna M, 2011, J VERTEBR PALEONTOL, V31, P140; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P23, DOI 10.3374/014.054.0102; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Lu J, 2002, P 5 S SOC AV PAL EV, P175; Lu JC, 2002, J VERTEBR PALEONTOL, V22, P871, DOI 10.1671/0272-4634(2002)022[0871:ANOTOF]2.0.CO;2; Lu Junchang, 2004, Bulletin of the National Science Museum Series C (Geology & Paleontology), V30, P95; Lu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080557; Lu JC, 2013, NATURWISSENSCHAFTEN, V100, P165, DOI 10.1007/s00114-012-1007-0; Lyson TR, 2010, P ROYAL SOC B, V278, P1158; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; OSMOLSKA H, 1981, Palaeontologia Polonica, P79; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Parks W.A., 1933, U TORONTO STUDIES GE, V34, p1e24; Persons IV WS, ACTA PALAEO IN PRESS; Rothschild Bruce, 2001, P331; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schachner E, 2006, J VERTEBR PALEONTOL, V26, p120A; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter Phil, 2005, Paleobios, V25, P9; Smith D., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V186, P365; Sternberg C. M., 1932, Canadian Field Naturalist, V48, P99; STERNBERG R. M., 1940, JOUR PALEONTOL, V14, P81; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Sullivan Robert M., 2011, Bulletin of the New Mexico Museum of Natural History and Science, V53, P418; Triebold M, 2000, PUBLICATIONS PALEONT, V2; Varricchio David J., 2001, P42; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Walker J.D., 2012, GEOLOGIC TIME SCALE; Wang S, 2013, ZOOTAXA, V3640, P242, DOI 10.11646/zootaxa.3640.2.7; Wei XF, 2013, ACTA GEOL SIN-ENGL, V87, P899, DOI 10.1111/1755-6724.12098; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2013, Vertebrata Palasiatica, V51, P85; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Xu Xing, 2010, Vertebrata Palasiatica, V48, P11; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Yan Y, 2007, SEDIMENT GEOL, V197, P127, DOI 10.1016/j.sedgeo.2006.09.004; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; ZHOU ZH, 2000, VERTEBRAT PALASIATIC, V38, P242; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	98	75	78	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92022	10.1371/journal.pone.0092022	http://dx.doi.org/10.1371/journal.pone.0092022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647078	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333348500073
J	Levy, AF; Zayats, M; Guerrero-Cazares, H; Quinones-Hinojosa, A; Searson, PC				Levy, Amanda F.; Zayats, Maya; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Searson, Peter C.			Influence of Basement Membrane Proteins and Endothelial Cell-Derived Factors on the Morphology of Human Fetal-Derived Astrocytes in 2D	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IN-VITRO; DIFFERENTIATION; PERICYTES; INVITRO; IMPACT	Astrocytes are the most prevalent type of glial cell in the brain, participating in a variety of diverse functions from regulating cerebral blood flow to controlling synapse formation. Astrocytes and astrocyte-conditioned media are widely used in models of the blood-brain barrier (BBB), however, very little is known about astrocyte culture in 2D. To test the hypothesis that surface coating and soluble factors influence astrocyte morphology in 2D, we quantitatively analyzed the morphology of human fetal derived astrocytes on glass, matrigel, fibronectin, collagen IV, and collagen I, and after the addition soluble factors including platelet-derived growth factor (PDGF), laminin, basic fibroblast growth factor (bFGF), and leukemia inhibitory factor (LIF). Matrigel surface coatings, as well as addition of leukemia inhibitory factor (LIF) to the media, were found to have the strongest effects on 2D astrocyte morphology, and may be important in improving existing BBB models. In addition, the novel set of quantitative parameters proposed in this paper provide a test for determining the influence of compounds on astrocyte morphology, both to screen for new endothelial cell-secreted factors that influence astrocytes, and to determine in a high-throughput way which factors are important for translation to more complex, 3D BBB models.	[Levy, Amanda F.; Zayats, Maya; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Levy, Amanda F.; Zayats, Maya; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Sch Med, Dept Neurosurg & Oncol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	searson@jhu.edu		Guerrero-Cazares, Hugo/0000-0003-1307-719X; Searson, Peter/0000-0002-5417-0828	National Institutes of Health (NIH) [1R01CA170629, 5R01NS070024]; NATIONAL CANCER INSTITUTE [R01CA170629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070024] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by in part by a National Institutes of Health (NIH) grant 1R01CA170629. AQH and HGC were supported by NIH grant 5R01NS070024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; BLACK JA, 1993, GLIA, V7, P272, DOI 10.1002/glia.440070403; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; ESTRADA C, 1990, J NEUROPATH EXP NEUR, V49, P539, DOI 10.1097/00005072-199011000-00001; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fukushima M, 2009, INT J DEV NEUROSCI, V27, P685, DOI 10.1016/j.ijdevneu.2009.07.006; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Thanabalasundaram G, 2011, INT J BIOCHEM CELL B, V43, P1284, DOI 10.1016/j.biocel.2011.05.002; Tilling T, 2002, CELL TISSUE RES, V310, P19, DOI 10.1007/s00441-002-0604-1; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wong AD, 2013, FRONTIERS NEUROENGIN, V6	30	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92165	10.1371/journal.pone.0092165	http://dx.doi.org/10.1371/journal.pone.0092165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647106	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500093
J	Matthews, LP; McCordic, JA; Parks, SE				Matthews, Leanna P.; McCordic, Jessica A.; Parks, Susan E.			Remote Acoustic Monitoring of North Atlantic Right Whales (Eubalaena glacialis) Reveals Seasonal and Diel Variations in Acoustic Behavior	PLOS ONE			English	Article							CALLING PATTERNS; SOUND PRODUCTION; POPULATION; RECORDINGS; MANAGEMENT; MIGRATION; PREY; BAY	Remote acoustic monitoring is a non-invasive tool that can be used to study the distribution, behavior, and habitat use of sound-producing species. The North Atlantic right whale (Eubalaena glacialis) is an endangered baleen whale species that produces a variety of stereotyped acoustic signals. One of these signals, the "gunshot" sound, has only been recorded from adult male North Atlantic right whales and is thought to function for reproduction, either as reproductive advertisement for females or as an agonistic signal toward other males. This study uses remote acoustic monitoring to analyze the presence of gunshots over a two-year period at two sites on the Scotian Shelf to determine if there is evidence that North Atlantic right whales may use these locations for breeding activities. Seasonal analyses at both locations indicate that gunshot sound production is highly seasonal, with an increase in the autumn. One site, Roseway West, had significantly more gunshot sounds overall and exhibited a clear diel trend in production of these signals at night. The other site, Emerald South, also showed a seasonal increase in gunshot production during the autumn, but did not show any significant diel trend. This difference in gunshot signal production at the two sites indicates variation either in the number or the behavior of whales at each location. The timing of the observed seasonal increase in gunshot sound production is consistent with the current understanding of the right whale breeding season, and our results demonstrate that detection of gunshots with remote acoustic monitoring can be a reliable way to track shifts in distribution and changes in acoustic behavior including possible mating activities.	[Matthews, Leanna P.; McCordic, Jessica A.; Parks, Susan E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Matthews, LP (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	lematthe@syr.edu	Parks, Susan E/D-2675-2014	Parks, Susan E/0000-0001-6663-627X	Right Whale Grants Program of the (U.S.) National Oceanographic and Atmospheric Administration; Office of Naval Research [N00014-03-1-0099]	Right Whale Grants Program of the (U.S.) National Oceanographic and Atmospheric Administration; Office of Naval Research(Office of Naval Research)	Right Whale Grants Program of the (U.S.) National Oceanographic and Atmospheric Administration and by Office of Naval Research grant #N00014-03-1-0099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2012, J ACOUST SOC AM, V131, P2306, DOI 10.1121/1.3682042; Au W.W.L., 2008, PRINCIPLES MARINE BI; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P155, DOI 10.3354/meps264155; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; BEST PB, 1994, J ZOOL, V232, P175, DOI 10.1111/j.1469-7998.1994.tb01567.x; Bioacoustics Research Program, 2012, RAV PROINT SOUND AN; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Bradbury Jack W., 1998, pi; Bridges AS, 2000, COPEIA, P587, DOI 10.1643/0045-8511(2000)000[0587:TVIACB]2.0.CO;2; Brown MW, 2001, J CETACEAN RES MANAG, V2, P251; Brown MW, 1995, MARINE PROTECTED ARE, P90; Cetacean and Turtle Assessment Program (CETAP), 1982, CHAR MAR MAMM TURLT; Clark C., 1983, COMMUNICATION BEHAV, P163; Clark CW, 2010, MAR MAMMAL SCI, V26, P837, DOI 10.1111/j.1748-7692.2010.00376.x; CLARK CW, 1982, ANIM BEHAV, V30, P1060, DOI 10.1016/S0003-3472(82)80196-6; Fischer FP, 1997, ECOL APPL, V7, P909, DOI 10.1890/1051-0761(1997)007[0909:QAOGQA]2.0.CO;2; Fox CG, 2001, J GEOPHYS RES-SOL EA, V106, P4183, DOI 10.1029/2000JB900404; Hamilton PK, 1998, MAR ECOL PROG SER, V171, P285, DOI 10.3354/meps171285; Hunt KE, 2006, GEN COMP ENDOCR, V148, P260, DOI 10.1016/j.ygcen.2006.03.012; IWC, 2001, J CETACEAN RES MANAG, V2, P1; Kirschel ANG, 2011, IBIS, V153, P255, DOI 10.1111/j.1474-919X.2011.01102.x; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P237; Marques Tiago A., 2011, Endangered Species Research, V13, P163, DOI 10.3354/esr00325; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; Matthews J. N., 2001, Journal of Cetacean Research and Management, V3, P271; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; McDonald MA, 2002, J CETACEAN RES MANAG, V43, P261; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2007, MAR MAMMAL SCI, V23, P856, DOI 10.1111/j.1748-7692.2007.00144.x; Mitchell E, 1986, REP INT WHAL COMMN, V10, P83; Morano JL, 2012, J ACOUST SOC AM, V132, P1207, DOI 10.1121/1.4730890; Morano JL, 2012, CONSERV BIOL, V26, P698, DOI 10.1111/j.1523-1739.2012.01866.x; Munger LM, 2008, MAR MAMMAL SCI, V24, P795, DOI 10.1111/j.1748-7692.2008.00219.x; Mussoline Sarah E., 2012, Endangered Species Research, V17, P17, DOI 10.3354/esr00411; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; Parks S. E., 2011, Endangered Species Research, V15, P63, DOI 10.3354/esr00368; Parks SE, 2005, MAR MAMMAL SCI, V21, P458, DOI 10.1111/j.1748-7692.2005.tb01244.x; Parks SE, 2005, J ACOUST SOC AM, V117, P3297, DOI 10.1121/1.1882946; Parks SE, 2003, MAR MAMMAL SCI, V19, P563, DOI 10.1111/j.1748-7692.2003.tb01321.x; Parks SE, 2012, J ACOUST SOC AM, V131, P3173, DOI 10.1121/1.3688507; Payne KB, 2003, AFR J ECOL, V41, P99, DOI 10.1046/j.1365-2028.2003.00421.x; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 2005, ANIM BEHAV, V69, P951, DOI 10.1016/j.anbehav.2004.06.025; Tellechea Javier S., 2012, Journal of Cetacean Research and Management, V12, P361; Tremain SB, 2008, WILSON J ORNITHOL, V120, P499, DOI 10.1676/07-137.1; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Winn H.E., 1986, Reports of the International Whaling Commission Special Issue, P129	52	19	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91367	10.1371/journal.pone.0091367	http://dx.doi.org/10.1371/journal.pone.0091367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646524	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500034
J	Rosskothen-Kuhl, N; Illing, RB				Rosskothen-Kuhl, Nicole; Illing, Robert-Benjamin			Gap43 Transcription Modulation in the Adult Brain Depends on Sensory Activity and Synaptic Cooperation	PLOS ONE			English	Article							LATERAL SUPERIOR OLIVE; GAP-43 MESSENGER-RNA; ELECTRICAL INTRACOCHLEAR STIMULATION; GROWTH-ASSOCIATED PROTEIN; VENTRAL COCHLEAR NUCLEUS; IN-SITU HYBRIDIZATION; C-FOS; INFERIOR COLLICULUS; AUDITORY-SYSTEM; RAT BRAIN	Brain development and learning is accompanied by morphological and molecular changes in neurons. The growth associated protein 43 (Gap43), indicator of neurite elongation and synapse formation, is highly expressed during early stages of development. Upon maturation of the brain, Gap43 is down-regulated by most neurons with the exception of subdivisions such as the CA3 region of hippocampus, the lateral superior olive (LSO) and the central inferior colliculus (CIC). Little is known about the regulation of this mRNA in adult brains. We found that the expression of Gap43 mRNA in specific neurons can be modulated by changing sensory activity of the adult brain. Using the central auditory system of rats as a model, Gap43 protein and mRNA levels were determined in LSO and CIC of hearing-experienced rats unilaterally or bilaterally deafened or unilaterally stimulated by a cochlear implant (CI). Our data indicate that Gap43 is a marker useful beyond monitoring neuronal growth and synaptogenesis, reflecting also specific patterns of synaptic activities on specific neurons. Thus, unilateral loss of input to an adult auditory system directly causes asymmetrical expression of Gap43 mRNA between LSOs or CICs on both sides of the brainstem. This consequence can be prevented by simple-patterned stimulation of a dysfunctional ear by way of a CI. We suggest that as a function of input balance and activity pattern, Gap43 mRNA expression changes as cells associate converging afferent signals.	[Rosskothen-Kuhl, Nicole; Illing, Robert-Benjamin] Univ Freiburg, Dept Otorhinolaryngol, Neurobiol Res Lab, D-79106 Freiburg, Germany	University of Freiburg	Rosskothen-Kuhl, N (corresponding author), Univ Freiburg, Dept Otorhinolaryngol, Neurobiol Res Lab, Hugstetter Str 55, D-79106 Freiburg, Germany.	nicole.rosskothen@uniklinik-freiburg.de		Rosskothen-Kuhl, Nicole/0000-0003-4724-5550				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Arndt S, 2011, OTOL NEUROTOL, V32, P39, DOI 10.1097/MAO.0b013e3181fcf271; BENDOTTI C, 1991, J NEUROSCI, V11, P600; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Bischoff P, 2013, OTOLARYGOLOGY S, VS3, DOI [10.4172/2161-119X. S3-005., DOI 10.4172/2161-119X.S3-005]; Casoli T, 2003, MICRON, V34, P415, DOI 10.1016/S0968-4328(03)00038-6; Caspary DM, 1991, NEUROBIOLOGY HEARING, VII, P141; deGroen PC, 1995, J MOL NEUROSCI, V6, P109, DOI 10.1007/BF02736770; Diolaiti D, 2007, EXP CELL RES, V313, P2980, DOI 10.1016/j.yexcr.2007.06.002; EHRET G, 1991, BRAIN RES, V567, P350, DOI 10.1016/0006-8993(91)90819-H; Firszt JB, 2012, OTOL NEUROTOL, V33, P1339, DOI 10.1097/MAO.0b013e318268d52d; Fredrich M, 2013, EUR J NEUROSCI, V38, P2041, DOI 10.1111/ejn.12200; Gerin CG, 2011, SYNAPSE, V65, P1255, DOI 10.1002/syn.20903; Grasselli G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00025; Grasselli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020791; Hildebrandt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023686; Horvath M, 2000, J COMP NEUROL, V422, P95; Illing R.B., 2010, AUDIOLOGICAL MED, V8, P63, DOI DOI 10.3109/16513860903454583; Illing RB, 1999, J COMP NEUROL, V412, P353, DOI 10.1002/(SICI)1096-9861(19990920)412:2<353::AID-CNE12>3.0.CO;2-W; Illing RB, 2002, EXP NEUROL, V175, P226, DOI 10.1006/exnr.2002.7895; Illing RB, 1997, J COMP NEUROL, V382, P116, DOI 10.1002/(SICI)1096-9861(19970526)382:1<116::AID-CNE8>3.0.CO;2-4; Illing RB, 2001, NEUROREPORT, V12, P875, DOI 10.1097/00001756-200103260-00050; Illing RB, 2012, COCHLEAR IMPLANT RES, DOI [10.5772/34440.137-166., DOI 10.5772/34440.137-166]; Jakob T, 2008, AUDIOL MED, V6, P215, DOI DOI 10.1080/16513860701875521; Jero J, 2001, ACTA OTO-LARYNGOL, V121, P585, DOI 10.1080/000164801316878863; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; KELLY JB, 1991, HEARING RES, V56, P273, DOI 10.1016/0378-5955(91)90177-B; Kelly JB, 1997, HEARING RES, V104, P112, DOI 10.1016/S0378-5955(96)00182-7; Kraus KS, 2004, J COMP NEUROL, V475, P374, DOI 10.1002/cne.20180; KRUGER L, 1993, J COMP NEUROL, V333, P417, DOI 10.1002/cne.903330308; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Mei HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041311; Meidinger MA, 2006, EUR J NEUROSCI, V23, P3187, DOI 10.1111/j.1460-9568.2006.04853.x; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; MOORE MJ, 1983, J NEUROSCI, V3, P237; Rekart JL, 2005, HIPPOCAMPUS, V15, P1, DOI 10.1002/hipo.20045; Rosskothen N, 2008, NEUROREPORT, V19, P1091, DOI 10.1097/WNR.0b013e328303bbeb; Rosskothen-Kuhl N, 2012, BRAIN RES, V1435, P40, DOI 10.1016/j.brainres.2011.11.046; Rosskothen-Kuhl N, 2010, BRAIN RES, V1347, P33, DOI 10.1016/j.brainres.2010.05.089; SAINTMARIE RL, 1990, BRAIN RES, V524, P244, DOI 10.1016/0006-8993(90)90698-B; SAINTMARIE RL, 1989, J COMP NEUROL, V279, P382; SANES DH, 1988, J NEUROSCI, V8, P682; Schwartz I.R., 1992, Springer Handbook of Auditory Research, V1, P117; Sharma N, 2010, EXP NEUROL, V223, P183, DOI 10.1016/j.expneurol.2009.04.031; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SKENE JHP, 1981, J NEUROSCI, V1, P419; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SOMMER I, 1993, EXP BRAIN RES, V95, P223; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Thompson AM, 2000, MICROSC RES TECHNIQ, V51, P330, DOI 10.1002/1097-0029(20001115)51:4<330::AID-JEMT4>3.0.CO;2-X; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Winer JA, 1998, J COMP NEUROL, V400, P147; YAO GL, 1993, MOL BRAIN RES, V18, P1, DOI 10.1016/0169-328X(93)90168-O	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92624	10.1371/journal.pone.0092624	http://dx.doi.org/10.1371/journal.pone.0092624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647228	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500149
J	Sasahira, T; Ueda, N; Yamamoto, K; Kurihara, M; Matsushima, S; Bhawal, UK; Kirita, T; Kuniyasu, H				Sasahira, Tomonori; Ueda, Nobuhiro; Yamamoto, Kazuhiko; Kurihara, Miyako; Matsushima, Sayako; Bhawal, Ujjal K.; Kirita, Tadaaki; Kuniyasu, Hiroki			Prox1 and FOXC2 Act as Regulators of Lymphangiogenesis and Angiogenesis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; GROWTH-FACTOR-D; TRANSCRIPTION FACTOR; TUMOR LYMPHANGIOGENESIS; CANCER PROGRESSION; ENDOTHELIAL-CELLS; EXPRESSION; INVASION; GENE; TRANSITION	Prospero homeobox 1 (Prox1) and forkhead box (FOX) C2 regulate angiogenesis and/or lymphangiogenesis. However, the detailed role and function of Prox1 and FOXC2 in cancer remains controversial. In the present study, we examined the expression of Prox1 and FOXC2 proteins in specimens from 163 cases with oral squamous cell carcinoma (OSCC). Furthermore, the role of Prox1 and FOXC2 in cancer cell growth and invasion was evaluated in cultured OSCC cells. Prox1 expression was significantly associated with local progression of the tumor (P = 0.0023), clinical stage (P<0.0001), lymphovessel density (LVD) (P<0.0001), nodal metastasis (P<0.0001), and worse prognosis (P<0.0001). Immunoreactivity of FOXC2 was strongly correlated with microvessel density (MVD) (P<0.0001) and poor prognosis (P = 0.0076). In vitro analysis demonstrated that Prox1 regulates cell growth, proliferation, invasion, and lymphangiogenesis by activating vascular endothelial growth factor (VEGF)-C expression. Furthermore, FOXC2 enhanced the expression level of Prox1 and promoted angiogenesis by enhancement of VEGF-A expression. Our results suggested that Prox1 and FOXC2 play key roles in OSCC progression and that further studies focusing on these proteins may yield useful insights for diagnosis and therapy of OSCC.	[Sasahira, Tomonori; Kurihara, Miyako; Matsushima, Sayako; Bhawal, Ujjal K.; Kuniyasu, Hiroki] Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 634, Japan; [Ueda, Nobuhiro; Yamamoto, Kazuhiko; Kurihara, Miyako; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 634, Japan; [Bhawal, Ujjal K.] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan	Nara Medical University; Nara Medical University; Nihon University	Kuniyasu, H (corresponding author), Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 634, Japan.	cooninh@zb4.so-net.ne.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science; http://www.jsps.go.jp/english/e-grants/index.html#. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Allred DC, 1998, MODERN PATHOL, V11, P155; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Birner P, 2001, CLIN CANCER RES, V7, P93; Currie MJ, 2004, J CLIN PATHOL, V57, P829, DOI 10.1136/jcp.2003.015644; Dadras SS, 2008, J INVEST DERMATOL, V128, P2798, DOI 10.1038/jid.2008.176; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; Elsir T, 2011, BRIT J CANCER, V104, P1747, DOI 10.1038/bjc.2011.162; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Franchi A, 2004, CANCER, V101, P973, DOI 10.1002/cncr.20454; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Harada K, 2009, J CELL SCI, V122, P3923, DOI 10.1242/jcs.052324; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kopfstein L, 2007, AM J PATHOL, V170, P1348, DOI 10.2353/ajpath.2007.060835; Kume T, 2012, J ONCOL, V2012, DOI 10.1155/2012/204593; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; Laerm A, 2007, J HEPATOL, V46, P89, DOI 10.1016/j.jhep.2006.07.033; Lahat G, 2009, CLIN CANCER RES, V15, P2637, DOI 10.1158/1078-0432.CCR-08-2442; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075388; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Matsuo Y, 2009, J SURG ONCOL, V99, P361, DOI 10.1002/jso.21245; Miettinen M, 2012, AM J SURG PATHOL, V36, P351, DOI 10.1097/PAS.0b013e318236c312; Miyahara M, 2007, CANCER-AM CANCER SOC, V110, P1287, DOI 10.1002/cncr.22900; Mydlarz Wojciech K, 2010, Expert Opin Med Diagn, V4, P53; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; Nishida N, 2011, ANN SURG ONCOL, V18, P535, DOI 10.1245/s10434-010-1274-y; Nomiya T, 2006, ONCOL REP, V15, P1497; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Sano H, 2010, BIOCHEM BIOPH RES CO, V392, P201, DOI 10.1016/j.bbrc.2010.01.015; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Sasahira T, 2008, CANCER SCI, V99, P1806, DOI 10.1111/j.1349-7006.2008.00894.x; Sasahira T, 2010, EUR J CANCER, V46, P2285, DOI 10.1016/j.ejca.2010.04.027; Schneider M, 2006, INT J ONCOL, V28, P883; Shimoda M, 2006, CLIN CANCER RES, V12, P6005, DOI 10.1158/1078-0432.CCR-06-0712; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skog M, 2011, BRIT J CANCER, V105, P1346, DOI 10.1038/bjc.2011.297; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Takahashi M, 2006, NEOPLASIA, V8, P1003, DOI 10.1593/neo.06595; Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705; Wu X, 2011, LYMPHOLOGY, V44, P35; Yoshimoto T, 2007, BIOCHEM BIOPH RES CO, V359, P258, DOI 10.1016/j.bbrc.2007.05.071	48	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92534	10.1371/journal.pone.0092534	http://dx.doi.org/10.1371/journal.pone.0092534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647631	Green Published, gold			2022-12-25	WOS:000333348500141
J	Stanic, D; Dubois, S; Chua, HK; Tonge, B; Rinehart, N; Horne, MK; Boon, WC				Stanic, Davor; Dubois, Sydney; Chua, Hui Kheng; Tonge, Bruce; Rinehart, Nicole; Horne, Malcolm K.; Boon, Wah Chin			Characterization of Aromatase Expression in the Adult Male and Female Mouse Brain. I. Coexistence with Oestrogen Receptors alpha and beta, and Androgen Receptors	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; RAT-BRAIN; GENE-EXPRESSION; STRIA TERMINALIS; BED NUCLEUS; PROTEIN EXPRESSION; PRINCIPAL NUCLEUS; SEX-DIFFERENCES	Aromatase catalyses the last step of oestrogen synthesis. There is growing evidence that local oestrogens influence many brain regions to modulate brain development and behaviour. We examined, by immunohistochemistry, the expression of aromatase in the adult male and female mouse brain, using mice in which enhanced green fluorescent protein (EGFP) is transcribed following the physiological activation of the Cyp19A1 gene. EGFP-immunoreactive processes were distributed in many brain regions, including the bed nucleus of the stria terminalis, olfactory tubercle, medial amygdaloid nucleus and medial preoptic area, with the densest distributions of EGFP-positive cell bodies in the bed nucleus and medial amygdala. Differences between male and female mice were apparent, with the density of EGFP-positive cell bodies and fibres being lower in some brain regions of female mice, including the bed nucleus and medial amygdala. EGFP-positive cell bodies in the bed nucleus, lateral septum, medial amygdala and hypothalamus co-expressed oestrogen receptor (ER) alpha and beta, or the androgen receptor (AR), although single-labelled EGFP-positive cells were also identified. Additionally, single-labelled ER alpha-, ER beta- or AR-positive cell bodies often appeared to be surrounded by EGFP-immunoreactive nerve fibres/terminals. The widespread distribution of EGFP-positive cell bodies and fibres suggests that aromatase signalling is common in the mouse brain, and that locally synthesised brain oestrogens could mediate biological effects by activating pre- and post-synaptic oestrogen alpha and beta receptors, and androgen receptors. The higher number of EGFP-positive cells in male mice may indicate that the autocrine and paracrine effects of oestrogens are more prominent in males than females.	[Stanic, Davor; Dubois, Sydney; Chua, Hui Kheng; Horne, Malcolm K.; Boon, Wah Chin] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Stanic, Davor; Horne, Malcolm K.; Boon, Wah Chin] Univ Melbourne, Dept Florey Neurosci, Parkville, Vic 3052, Australia; [Dubois, Sydney] Ecole Normale Super Lyon, Dept Biol, F-69364 Lyon, France; [Tonge, Bruce; Rinehart, Nicole] Monash Univ, Ctr Dev Psychiat & Psychol, Clayton, Vic, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic 3065, Australia; [Boon, Wah Chin] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Ecole Normale Superieure de Lyon (ENS de LYON); Monash University; St Vincent's Hospital Melbourne; Monash University	Stanic, D (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	davor.stanic@florey.edu.au	Tonge, Bruce J/T-8036-2018; Horne, Malcolm/AAL-5214-2020	Tonge, Bruce J/0000-0002-4236-9688; Horne, Malcolm/0000-0001-9427-2100; Rinehart, Nicole/0000-0001-6109-3958; Stanic, Davor/0000-0002-4310-7030	National Health and Medical Research Council of Australia [628553]; National Health and Medical Research Council of Australia, Australia Practitioner Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia, Australia Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council of Australia, Project grant (ID: 628553). Victorian Government through the Operational Infrastructure Scheme. M.K.H. supported by a National Health and Medical Research Council of Australia, Australia Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir SE, 1997, BIOL REPROD, V57, P772, DOI 10.1095/biolreprod57.4.772; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Agarwal VR, 2000, MOL CELL ENDOCRINOL, V162, P9, DOI 10.1016/S0303-7207(00)00227-6; Apostolinas S, 1999, BRAIN RES, V817, P19, DOI 10.1016/S0006-8993(98)01180-9; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; Bakker J, 2004, HORM BEHAV, V46, P1, DOI 10.1016/j.yhbeh.2004.02.003; BALTHAZART J, 1991, J NEUROBIOL, V22, P143, DOI 10.1002/neu.480220205; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Balthazart J, 2009, ANN NY ACAD SCI, V1163, P31, DOI 10.1111/j.1749-6632.2008.03637.x; Biegon A, 2010, SYNAPSE, V64, P801, DOI 10.1002/syn.20791; Boon WC, 2010, PROG BRAIN RES, V181, P209, DOI 10.1016/S0079-6123(08)81012-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Bye CR, 2012, EXP NEUROL IN PRESS; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Corbin CJ, 2009, BIOL REPROD, V81, P388, DOI 10.1095/biolreprod.109.076331; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gotsiridze T, 2007, DEV NEUROBIOL, V67, P355, DOI 10.1002/dneu.20353; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hisasue S, 2010, J SEX MED, V7, P1401, DOI 10.1111/j.1743-6109.2009.01669.x; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Horvath TL, 1997, J STEROID BIOCHEM, V61, P349; Jacobs EC, 1999, DEV NEUROSCI-BASEL, V21, P453, DOI 10.1159/000017413; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kato J, 1997, J STEROID BIOCHEM, V61, P381; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lephart ED, 2001, BRAIN RES REV, V37, P25, DOI 10.1016/S0165-0173(01)00111-4; Lu SF, 1998, ENDOCRINOLOGY, V139, P1594, DOI 10.1210/en.139.4.1594; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Meitzen J, 2013, ENDOCRINOLOGY, V154, P4293, DOI 10.1210/en.2013-1172; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Milner TA, 2010, BRAIN RES, V1351, P74, DOI 10.1016/j.brainres.2010.06.038; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; Naftolin F, 2001, EXP BIOL MED, V226, P717, DOI 10.1177/153537020222600802; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; Pardo-Bellver C, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00033; Parish CL, 2005, NEUROBIOL DIS, V19, P301, DOI 10.1016/j.nbd.2005.01.009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pease PC, 1962, ANAT REC, V142, P342; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; RESKO JA, 1993, J CLIN ENDOCR METAB, V76, P1588, DOI 10.1210/jc.76.6.1588; Resko JA, 2000, BIOL REPROD, V62, P1818, DOI 10.1095/biolreprod62.6.1818; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; Robertson KM, 2001, J ANDROL, V22, P825; Roselli CE, 2012, J NEUROENDOCRINOL, V24, P443, DOI 10.1111/j.1365-2826.2011.02260.x; ROSELLI CE, 1989, BIOL REPROD, V40, P929, DOI 10.1095/biolreprod40.5.929; Roselli CE, 2001, J STEROID BIOCHEM, V79, P247, DOI 10.1016/S0960-0760(01)00141-8; Roselli CE, 1998, BIOL REPROD, V58, P79, DOI 10.1095/biolreprod58.1.79; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; Roselli CE, 1997, BRAIN RES BULL, V44, P351, DOI 10.1016/S0361-9230(97)00214-1; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Saldanha CJ, 2005, GEN COMP ENDOCR, V141, P66, DOI 10.1016/j.ygcen.2004.11.013; Saldanha CJ, 2011, ENDOCR REV, V32, P532, DOI 10.1210/er.2011-0004; SANGHERA MK, 1991, ENDOCRINOLOGY, V129, P2834, DOI 10.1210/endo-129-6-2834; Schlinger BA, 2012, J NEUROENDOCRINOL, V24, P16, DOI 10.1111/j.1365-2826.2011.02150.x; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; Shughrue PJ, 2002, ENDOCRINOLOGY, V143, P1643, DOI 10.1210/en.143.5.1643; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Stanic D, 2011, J COMP NEUROL, V519, P1219, DOI 10.1002/cne.22608; Tsukahara S, 2011, NEUROENDOCRINOLOGY, V94, P137, DOI 10.1159/000327541; Wagner CK, 1996, J COMP NEUROL, V370, P71; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; YamadaMouri N, 1997, J STEROID BIOCHEM, V60, P325, DOI 10.1016/S0960-0760(96)00222-1; Zamboni I, 1967, J CELL BIOL, V35, p148A; Zhao CJ, 2007, J COMP NEUROL, V500, P557, DOI 10.1002/cne.21193	78	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90451	10.1371/journal.pone.0090451	http://dx.doi.org/10.1371/journal.pone.0090451			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646567	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500015
J	Xu, LH; Zeng, XC; Nie, Y; Luo, XS; Zhou, EM; Zhou, LL; Pan, YF; Li, WJ				Xu, Linghua; Zeng, Xian-Chun; Nie, Yao; Luo, Xuesong; Zhou, Enmin; Zhou, Lingli; Pan, Yunfan; Li, Wenjun			Pontibacter diazotrophicus sp nov., a Novel Nitrogen-Fixing Bacterium of the Family Cytophagaceae	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; EFFLUVIIBACTER-ROSEUS; COMMUNITY STRUCTURE; SOLAR SALTERN; DESERT SOIL; DIVERSITY; SEQUENCE; ACID	Few diazotrophs have been found to belong to the family Cytophagaceae so far. In the present study, a Gram-negative, rodshaped bacterium that forms red colonies, was isolated from sands of the Takalamakan desert. It was designated H4X(T). Phylogenetic and biochemical analysis indicated that the isolate is a new species of the genus Pontibacter. The 16S rRNA gene of H4X(T) displays 94.2-96.8% sequence similarities to those of other strains in Pontibacter. The major respiratory quinone is menaquinone-7 (MK-7). The DNA G+C content is 46.6 mol%. The major cellular fatty acids are iso-C-15:0, C-16:1 omega 5c, summed feature 3 (containing C-16:1 omega 6c and/or C-16:1 omega 7c) and summed feature 4 (comprising anteiso-C17:1B and/or iso-C17:1I). The major polar lipids are phosphatidylethanolamine (PE), one aminophospholipid (APL) and some unknown phospholipids (PLs). It is interesting to see that this bacterium can grow very well in a nitrogen-free medium. PCR amplification suggested that the bacterium possesses at least one type of nitrogenase gene. Acetylene reduction assay showed that H4X(T) actually possesses nitrogen-fixing activity. Therefore, it can be concluded that H4X(T) is a new diazotroph. We thus referred it to as Pontibacter diazotrophicus sp. nov. The type strain is H4X(T) (= CCTCC AB 2013049(T) = NRRL B-59974(T)).	[Xu, Linghua; Zeng, Xian-Chun; Nie, Yao; Zhou, Lingli; Pan, Yunfan] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Xu, Linghua; Zeng, Xian-Chun; Nie, Yao; Zhou, Lingli; Pan, Yunfan] China Univ Geosci, Dept Biol Sci & Technol, Sch Environm Studies, Wuhan 430074, Peoples R China; [Xu, Linghua] Hubei Polytech Univ, Sch Chem & Mat Engn, Huangshi, Peoples R China; [Luo, Xuesong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Zhou, Enmin; Li, Wenjun] Yunnan Univ, Minist Educ, Key Lab Microbial Divers Southwest China, Kunming, Peoples R China; [Zhou, Enmin; Li, Wenjun] Yunnan Univ, Yunnan Inst Microbiol, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China	China University of Geosciences; China University of Geosciences; Hubei Polytechnic University; Huazhong Agricultural University; Yunnan University; Yunnan University	Zeng, XC (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.	xianchun.zeng@gmail.com; xuesongluo@mail.hzau.edu.cn		Zeng, Xian-Chun/0000-0003-2675-2596	National Natural Science Foundation of China [41272257, 41072181]; China Postdoctoral Science Foundation [20110491233]; Research Program for BGEG lab staff [GBL11208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Program for BGEG lab staff	This work was supported by the National Natural Science Foundation of China (Grant no. 41272257 and no. 41072181), the China Postdoctoral Science Foundation (Grant no. 20110491233) and Research Program for BGEG lab staff (Grant no. GBL11208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benata H, 2008, SYST APPL MICROBIOL, V31, P378, DOI 10.1016/j.syapm.2008.08.002; Chowdhury SP, 2007, MICROB ECOL, V54, P82, DOI 10.1007/s00248-006-9174-1; Dai J, 2012, GENET MOL RES, V11, P2683, DOI 10.4238/2012.June.25.5; Dastager SG, 2010, INT J SYST EVOL MICR, V60, P2867, DOI 10.1099/ijs.0.019935-0; DILWORTH MJ, 1966, BIOCHIM BIOPHYS ACTA, V127, P285, DOI 10.1016/0304-4165(66)90383-7; Dwivedi V, 2013, INT J SYST EVOL MICR, V63, P309, DOI 10.1099/ijs.0.040147-0; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; Han SO, 1998, MICROB ECOL, V36, P193, DOI 10.1007/s002489900106; Joshi MN, 2012, J BACTERIOL, V194, P6329, DOI 10.1128/JB.01550-12; Joung Y, 2013, J MICROBIOL, V51, P531, DOI 10.1007/s12275-013-2324-5; Joung Y, 2011, J MICROBIOL, V49, P290, DOI 10.1007/s12275-011-0093-6; Kang JY, 2013, INT J SYST EVOL MICR, V63, P565, DOI 10.1099/ijs.0.039867-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Lacap DC, 2011, EXTREMOPHILES, V15, P31, DOI 10.1007/s00792-010-0334-3; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Ludwig W, 2007, INT J FOOD MICROBIOL, V120, P225, DOI 10.1016/j.ijfoodmicro.2007.06.023; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Nedashkovskaya OI, 2005, INT J SYST EVOL MICR, V55, P2583, DOI 10.1099/ijs.0.63819-0; Raichand R, 2011, ANTON LEEUW INT J G, V100, P129, DOI 10.1007/s10482-011-9573-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russow R, 2005, RAPID COMMUN MASS SP, V19, P3451, DOI 10.1002/rcm.2214; Singh AK, 2013, INT J SYST EVOL MICR, V63, P2829, DOI 10.1099/ijs.0.045948-0; Smibert Robert M., 1994, P607; Subhash Y, 2013, INT J SYST EVOL MICR, V63, P4524, DOI 10.1099/ijs.0.052183-0; Suresh K, 2006, INT J SYST EVOL MICR, V56, P1703, DOI 10.1099/ijs.0.64144-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang Y, 2010, INT J SYST EVOL MICR, V60, P99, DOI 10.1099/ijs.0.011395-0; Westermann J, 2008, J INTEGR PLANT BIOL, V50, P536, DOI 10.1111/j.1744-7909.2007.00626.x; Xu MB, 2012, INT J SYST EVOL MICR, V62, P665, DOI 10.1099/ijs.0.030122-0; Yeager CM, 2004, APPL ENVIRON MICROB, V70, P973, DOI 10.1128/AEM.70.2.973-983.2004; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhang L, 2008, INT J SYST EVOL MICR, V58, P1210, DOI 10.1099/ijs.0.65667-0; Zhang L, 2013, INT J SYST EVOL MICR, V63, P4462, DOI 10.1099/ijs.0.053165-0; Zhou Y, 2007, INT J SYST EVOL MICR, V57, P321, DOI 10.1099/ijs.0.64716-0	39	50	53	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92294	10.1371/journal.pone.0092294	http://dx.doi.org/10.1371/journal.pone.0092294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647674	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500108
J	Akerberg, AA; Stewart, S; Stankunas, K				Akerberg, Alexander A.; Stewart, Scott; Stankunas, Kryn			Spatial and Temporal Control of Transgene Expression in Zebrafish	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; CELL FATES; ESTROGEN-RECEPTOR; BINDING DOMAINS; GAL4 GENE; EMBRYOS; TISSUE; NOTCH; SPECIFICATION; DROSOPHILA	Transgenic zebrafish research has provided valuable insights into gene functions and cell behaviors directing vertebrate development, physiology, and disease models. Most approaches use constitutive transgene expression and therefore do not provide control over the timing or levels of transgene induction. We describe an inducible gene expression system that uses new tissue-specific zebrafish transgenic lines that express the Gal4 transcription factor fused to the estrogen-binding domain of the human estrogen receptor. We show these Gal4-ERT driver lines confer rapid, tissue-specific induction of UAS-controlled transgenes following tamoxifen exposure in both embryos and adult fish. We demonstrate how this technology can be used to define developmental windows of gene function by spatiotemporal-controlled expression of constitutively active Notch1 in embryos. Given the array of existing UAS lines, the modular nature of this system will enable many previously intractable zebrafish experiments.	[Akerberg, Alexander A.; Stewart, Scott; Stankunas, Kryn] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Akerberg, Alexander A.; Stankunas, Kryn] Univ Oregon, Dept Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Stewart, S (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	sstewart@molbio.uoregon.edu; kryn@uoregon.edu		Akerberg, Alexander/0000-0001-9385-3739	Oregon Medical Research Foundation; NIH/NICHD; University of Oregon; NIH/NHLBI [5R00HL087598]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL087598] Funding Source: NIH RePORTER	Oregon Medical Research Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Oregon; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support came from the Oregon Medical Research Foundation (SS), a NIH/NICHD Developmental Biology Training Grant (AAA), the University of Oregon (KS), and the NIH/NHLBI (5R00HL087598) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BRAND AH, 1993, DEVELOPMENT, V118, P401; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gerety SS, 2013, DEVELOPMENT, V140, P2235, DOI 10.1242/dev.091520; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; LAUGHON A, 1984, MOL CELL BIOL, V4, P260, DOI 10.1128/MCB.4.2.260; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Melby AE, 1996, DEVELOPMENT, V122, P2225; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scott EK, 2009, J NEUROCHEM, V110, P441, DOI 10.1111/j.1471-4159.2009.06161.x; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Wang YH, 2006, DIFFERENTIATION, V74, P186, DOI 10.1111/j.1432-0436.2006.00064.x; Wang YH, 2006, GENE EXPR PATTERNS, V6, P335, DOI 10.1016/j.modgep.2005.10.002; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; Yamamoto M, 2010, DEVELOPMENT, V137, P2527, DOI 10.1242/dev.051011	42	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92217	10.1371/journal.pone.0092217	http://dx.doi.org/10.1371/journal.pone.0092217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643048	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900105
J	Heinzelmann, G; Kuyucak, S				Heinzelmann, Germano; Kuyucak, Serdar			Molecular Dynamics Simulations of the Mammalian Glutamate Transporter EAAT3	PLOS ONE			English	Article							CONTROLS CATION INTERACTIONS; BINDING FREE-ENERGIES; ASPARTATE TRANSPORTER; SUBSTRATE INTERACTIONS; EXTRACELLULAR GATE; NA+ BINDING; RESIDUE; SODIUM; MECHANISM; HOMOLOG	Excitatory amino acid transporters (EAATs) are membrane proteins that enable sodium-coupled uptake of glutamate and other amino acids into neurons. Crystal structures of the archaeal homolog Glt(Ph) have been recently determined both in the inward-and outward-facing conformations. Here we construct homology models for the mammalian glutamate transporter EAAT3 in both conformations and perform molecular dynamics simulations to investigate its similarities and differences from Glt(Ph). In particular, we study the coordination of the different ligands, the gating mechanism and the location of the proton and potassium binding sites in EAAT3. We show that the protonation of the E374 residue is essential for binding of glutamate to EAAT3, otherwise glutamate becomes unstable in the binding site. The gating mechanism in the inward-facing state of EAAT3 is found to be different from that of Glt(Ph), which is traced to the relocation of an arginine residue from the HP1 segment in Glt(Ph) to the TM8 segment in EAAT3. Finally, we perform free energy calculations to locate the potassium binding site in EAAT3, and find a high-affinity site that overlaps with the Na1 and Na3 sites in Glt(Ph).	[Heinzelmann, Germano; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney	Kuyucak, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	serdar@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021; Heinzelmann, Germano/C-3460-2016	Heinzelmann, Germano/0000-0001-7168-6941; Kuyucak, Serdar/0000-0003-4315-9532	Australian Research Council [DP1092729]	Australian Research Council(Australian Research Council)	This work was supported by a grant from the Australian Research Council (DP1092729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bergles DE, 2002, J NEUROSCI, V22, P10153; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Carlsson J, 2005, J PHYS CHEM B, V109, P6448, DOI 10.1021/jp046022f; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Frillingos S, 1997, PROTEIN SCI, V6, P431; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Heinzelmann G, 2014, J PHYS CHEM B, V118, P1813, DOI 10.1021/jp412195m; Heinzelmann G, 2013, J PHYS CHEM B, V117, P5486, DOI 10.1021/jp4010423; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Jiang J, 2011, NEUROPHARMACOLOGY, V60, P172, DOI 10.1016/j.neuropharm.2010.07.019; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Lev B, 2013, PHYS CHEM CHEM PHYS, V15, P2397, DOI 10.1039/c2cp42860a; Limongelli V, 2013, P NATL ACAD SCI USA, V110, P6358, DOI 10.1073/pnas.1303186110; Minh DDL, 2005, BIOPHYS J, V89, pL25, DOI 10.1529/biophysj.105.069336; Mwaura J, 2012, ACS CHEM NEUROSCI, V3, P1073, DOI 10.1021/cn300163p; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; Roux B, 2008, J CHEM PHYS, V126; Roux B, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2931568; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Stolzenberg S, 2012, J PHYS CHEM B, V116, P5372, DOI 10.1021/jp301726s; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2005, BIOCHEMISTRY-US, V44, P3466, DOI 10.1021/bi047812i; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Tao Z, 2008, BIOCHEMISTRY-US, V47, P12923, DOI 10.1021/bi8017174; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070947; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zomot E, 2013, J BIOL CHEM, V288, P8231, DOI 10.1074/jbc.M112.438432	73	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92089	10.1371/journal.pone.0092089	http://dx.doi.org/10.1371/journal.pone.0092089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643009	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900082
J	Kohl, S; Wolters, C; Gruendler, TOJ; Vogeley, K; Klosterkotter, J; Kuhn, J				Kohl, Sina; Wolters, Carolin; Gruendler, Theo O. J.; Vogeley, Kai; Klosterkoetter, Joachim; Kuhn, Jens			Prepulse Inhibition of the Acoustic Startle Reflex in High Functioning Autism	PLOS ONE			English	Article							NORMAL SEX-DIFFERENCES; SPECTRUM DISORDERS; ASPERGERS-SYNDROME; CHILDREN; ABNORMALITIES; ADULTS; QUOTIENT; HYPERSENSITIVITY; CHILDHOOD; ATTENTION	Background: High functioning autism is an autism spectrum disorder that is characterized by deficits in social interaction and communication as well as repetitive and restrictive behavior while intelligence and general cognitive functioning are preserved. According to the weak central coherence account, individuals with autism tend to process information detail-focused at the expense of global form. This processing bias might be reflected by deficits in sensorimotor gating, a mechanism that prevents overstimulation during the transformation of sensory input into motor action. Prepulse inhibition is an operational measure of sensorimotor gating, which indicates an extensive attenuation of the startle reflex that occurs when a startling pulse is preceded by a weaker stimulus, the prepulse. Methods: In the present study, prepulse inhibition of acoustic startle was compared between 17 adults with high functioning autism and 17 sex-, age-, and intelligence-matched controls by means of electromyography. Results: Results indicate that participants with high functioning autism exhibited significantly higher startle amplitudes than the control group. However, groups did not differ with regard to PPI or habituation of startle. Discussion: These findings challenge the results of two previous studies that reported prepulse inhibition deficits in high-functioning autism and suggest that sensorimotor gating is only impaired in certain subgroups with autism spectrum disorder.	[Kohl, Sina; Wolters, Carolin; Gruendler, Theo O. J.; Vogeley, Kai; Klosterkoetter, Joachim; Kuhn, Jens] Univ Hosp Cologne, Dept Psychiat & Psychotherapy, Cologne, North Rhine Wes, Germany; [Gruendler, Theo O. J.] Univ Magdeburg, Dept Econ, D-39106 Magdeburg, Saxony Anhalt, Germany; [Gruendler, Theo O. J.] Ctr Behav Brain Sci, Magdeburg, Saxony Anhalt, Germany; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM3, Julich, North Rhine Wes, Germany	University of Cologne; Otto von Guericke University; Helmholtz Association; Research Center Julich	Kuhn, J (corresponding author), Univ Hosp Cologne, Dept Psychiat & Psychotherapy, Cologne, North Rhine Wes, Germany.	jens.kuhn@uk-koeln.de	Gruendler, Theo OJ/H-4486-2012; Vogeley, Kai/E-4860-2012	Gruendler, Theo OJ/0000-0002-5631-7352; Kohl, Sina/0000-0002-2316-7706; Vogeley, Kai/0000-0002-5891-5831	Walter and Marga Boll Foundation; German Research Foundation [KFO-219]; Center for Behavioral Brain Sciences	Walter and Marga Boll Foundation; German Research Foundation(German Research Foundation (DFG)); Center for Behavioral Brain Sciences	The authors thank the Walter and Marga Boll Foundation, the German Research Foundation (KFO-219 grant), as well as the Center for Behavioral Brain Sciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara JI, 2004, J CHILD PSYCHOL PSYC, V45, P1107, DOI 10.1111/j.1469-7610.2004.t01-1-00303.x; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Baranek GT, 2006, J CHILD PSYCHOL PSYC, V47, P591, DOI 10.1111/j.1469-7610.2005.01546.x; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Bruneau N, 1999, CLIN NEUROPHYSIOL, V110, P1927, DOI 10.1016/S1388-2457(99)00149-2; DePape AMR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044084; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gage NM, 2003, DEV BRAIN RES, V144, P201, DOI 10.1016/S0165-3806(03)00172-X; Gebhardt J, 2012, PSYCHOPHYSIOLOGY, V49, P484, DOI 10.1111/j.1469-8986.2011.01323.x; Gomes Erissandra, 2008, Pró-Fono R. Atual. Cient., V20, P279, DOI 10.1590/S0104-56872008000400013; Gowen E, 2013, J AUTISM DEV DISORD, V43, P323, DOI 10.1007/s10803-012-1574-0; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Groen WB, 2009, J AUTISM DEV DISORD, V39, P742, DOI 10.1007/s10803-008-0682-3; Guiraud JA, 2011, NEUROREPORT, V22, P845, DOI 10.1097/WNR.0b013e32834c0bec; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hitoglou M, 2010, PEDIATR NEUROL, V42, P309, DOI 10.1016/j.pediatrneurol.2009.10.009; Kanner L, 1943, NERV CHILD, V2, P217; Kemner C, 2002, J CLIN PSYCHIAT, V63, P214; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lepisto T, 2009, BIOL PSYCHOL, V82, P301, DOI 10.1016/j.biopsycho.2009.09.004; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; Matsuzaki J, 2012, NEUROREPORT, V23, P113, DOI 10.1097/WNR.0b013e32834ebf44; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Miyahara M, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00016; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Oranje B, 2013, PSYCHIAT RES, V206, P287, DOI 10.1016/j.psychres.2012.10.014; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Ouimet T, 2012, ANN NY ACAD SCI, V1252, P325, DOI 10.1111/j.1749-6632.2012.06453.x; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Schmidt K- H, 1992, WORTSCHATZTEST VOCAB; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Takarae Y, 2008, J INT NEUROPSYCH SOC, V14, P980, DOI 10.1017/S1355617708081277; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; World Health Organisation, 1993, ICD 10 CLASS MENT BE; Yuhas J, 2011, J AUTISM DEV DISORD, V41, P248, DOI 10.1007/s10803-010-1040-9	49	42	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92372	10.1371/journal.pone.0092372	http://dx.doi.org/10.1371/journal.pone.0092372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643088	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900128
J	de Mola, CL; Quispe, R; Valle, GA; Poterico, JA				Loret de Mola, Christian; Quispe, Renato; Valle, Giancarlo A.; Poterico, Julio A.			Nutritional Transition in Children under Five Years and Women of Reproductive Age: A 15-Years Trend Analysis in Peru	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DEVELOPING-COUNTRIES; OBESITY; OVERWEIGHT; UNDERWEIGHT; ANEMIA; GROWTH; BRAZIL; INCOME	Background: Rapid urbanization, increase in food availability, and changes in diet and lifestyle patterns have been changing nutritional profiles in developing nations. We aimed to describe nutritional changes in children under 5 years and women of reproductive age in Peru, during a 15-year period of rapid economic development and social policy enhancement. Materials and Methods: Trend analyses of anthropometric measures in children of preschool age and women between 1549 years, using the Peruvian National Demographic and Family Health Surveys (DHS) from 1996 to 2011. WHO growth curves were used to define stunting, underweight, wasting and overweight in children <5y. We employed the WHO BMI-age standardized curves for teenagers between 15-19y. In women >19 years, body mass index (BMI) was analyzed both categorically and as a continuous variable. To statistically analyze the trends, we used regression models: Linear and Poisson for continuous and binary outcomes, respectively. Results: We analyzed data from 123 642 women and 64 135 children, from 1996 to 2011. Decreases over time were evidenced for underweight (p<0.001), wasting (p<0.001), and stunting (p<0.001) in children under 5y. This effect was particularly noted in urban settings. Overweight levels in children reduced (p<0.001), however this reduction stopped, in urban settings, since 2005 (similar to 12%). Anemia decreased in children and women (p<0.001); with higher reduction in urban (down arrow 43%) than in rural children (down arrow 24%). BMI in women aged 15-19 years increased (p<0.001) across time, with noticeable BMI-curve shift in women older than 30 years. Moreover, obesity doubled during this period in women more than 19y. Conclusion: Nutrition transition in Peru shows different patterns for urban and rural populations. Public policies should emphasize targeting both malnutrition conditions-undernutrition/stunting, overweight/obesity and anemia-considering age and place of residence in rapid developing societies like Peru.	[Loret de Mola, Christian; Quispe, Renato; Valle, Giancarlo A.; Poterico, Julio A.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Loret de Mola, Christian] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Quispe, Renato] Univ Peruana Cayetano Heredia, CONEVID Unidad Conocimiento & Evidencia, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidade Federal de Pelotas; Universidad Peruana Cayetano Heredia	de Mola, CL (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	chlmz@yahoo.com	de Mola, Christian Loret/C-9534-2012	de Mola, Christian Loret/0000-0002-5264-5914; Valle, Giancarlo/0000-0002-4914-473X; Poterico, Julio A/0000-0001-7838-3505				Acosta A. M., 2011, IDS WORKING PAPERS, P2, DOI DOI 10.1111/j.2040-0209.2011.00367.x; Adel E, 2008, LIBYAN J MED, V3, P13, DOI 10.4176/071006; Álvarez-Dongo Doris, 2012, Rev. perú. med. exp. salud publica, V29, P303; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2008, WORLDW PREV AN 1993; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380; Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010; Creber RMM, 2010, REV PANAM SALUD PUBL, V28, P1, DOI 10.1590/S1020-49892010000700001; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; DEMOLA CL, 2012, PLOS ONE, V0007; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Eckhardt CL, 2008, EUR J CLIN NUTR, V62, P238, DOI 10.1038/sj.ejcn.1602727; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Assuncao MCF, 2007, REV SAUDE PUBL, V41, P539, DOI 10.1590/S0034-89102006005000031; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Instituto Nacional de Salud, 2012, EV IND PROGR ART NUT; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Kain Juliana, 2003, Cad. Saúde Pública, V19, pS77, DOI 10.1590/S0102-311X2003000700009; Kimbro RT, 2010, HEALTH AFFAIR, V29, P411, DOI 10.1377/hlthaff.2009.0731; Macro ORC, 2006, DEM HLTH SURV INT MA; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mispireta ML, 2007, REV PERU MED EXP SAL, V24, P129; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Pajuelo-Ramírez Jaime, 2011, Rev. perú. med. exp. salud publica, V28, P222, DOI 10.1590/s1726-46342011000200008; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Poterico Julio A., 2012, Rev. perú. med. exp. salud publica, V29, P581; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Uauy R., 2001, Journal of Nutrition, V131, P893; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; WHO, 2006, WHO CHILD GROWTH STA; WHO U World Bank, 2012, LEV TRENDS CHILD MAL; WHO/UNICEF, 2013, PROGR SAN DRINK WAT; World Health Organization, 1995, PHYS STAT US INT ANT	44	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92550	10.1371/journal.pone.0092550	http://dx.doi.org/10.1371/journal.pone.0092550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643049	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900145
J	Smith, AD; Paton, PWC; McWilliams, SR				Smith, Adam D.; Paton, Peter W. C.; McWilliams, Scott R.			Using Nocturnal Flight Calls to Assess the Fall Migration of Warblers and Sparrows along a Coastal Ecological Barrier	PLOS ONE			English	Article							BIRD MIGRATION; PASSERINE MIGRANTS; LANDBIRD MIGRANTS; MORNING FLIGHT; AUTUMN; WEATHER; RADAR; PATTERNS; BEHAVIOR; WIND	Atmospheric conditions fundamentally influence the timing, intensity, energetics, and geography of avian migration. While radar is typically used to infer the influence of weather on the magnitude and spatiotemporal patterns of nocturnal bird migration, monitoring the flight calls produced by many bird species during nocturnal migration represents an alternative methodology and provides information regarding the species composition of nocturnal migration. We used nocturnal flight call (NFC) recordings of at least 22 migratory songbirds (14 warbler and 8 sparrow species) during fall migration from eight sites along the mainland and island coasts of Rhode Island to evaluate five hypotheses regarding NFC detections. Patterns of warbler and sparrow NFC detections largely supported our expectations in that (1) NFC detections associated positively and strongly with wind conditions that influence the intensity of coastal bird migration and negatively with regional precipitation; (2) NFCs increased during conditions with reduced visibility (e. g., high cloud cover); (3) NFCs decreased with higher wind speeds, presumably due mostly to increased ambient noise; and (4) coastal mainland sites recorded five to nine times more NFCs, on average, than coastal nearshore or offshore island sites. However, we found little evidence that (5) nightly or intra-night patterns of NFCs reflected the well-documented latitudinal patterns of migrant abundance on an offshore island. Despite some potential complications in inferring migration intensity and species composition from NFC data, the acoustic monitoring of NFCs provides a viable and complementary methodology for exploring the spatiotemporal patterns of songbird migration as well as evaluating the atmospheric conditions that shape these patterns.	[Smith, Adam D.; Paton, Peter W. C.; McWilliams, Scott R.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	University of Rhode Island	Smith, AD (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	adamsmith@my.uri.edu	McWilliams, Scott R/B-8728-2013	McWilliams, Scott R/0000-0002-9727-1151	Rhode Island National Wildlife Refuge Complex [50181-9-J111]; State of Rhode Island for the Ocean Special Area Management Plan; Rhode Island Agricultural Experiment Station [5358]; Nature Conservancy grant	Rhode Island National Wildlife Refuge Complex; State of Rhode Island for the Ocean Special Area Management Plan; Rhode Island Agricultural Experiment Station; Nature Conservancy grant	This work was funded largely via Cooperative Agreement (50181-9-J111) with the Rhode Island National Wildlife Refuge Complex. Additional funding was provided by the State of Rhode Island for the Ocean Special Area Management Plan to SRM and PWCP, Rhode Island Agricultural Experiment Station to SRM (Contribution No. 5358), and a Nature Conservancy grant to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KP, 1973, ECOLOGY, V54, P1031, DOI 10.2307/1935569; ABLE KP, 1977, AUK, V94, P320; ABLE KP, 1970, BIRD BANDING, V41, P282, DOI 10.2307/4511688; Akesson S, 1996, BEHAV ECOL SOCIOBIOL, V38, P293, DOI 10.1007/s002650050245; Akesson S, 1999, ARDEA, V87, P129; AKESSON S, 1993, ORNIS SCAND, V24, P87, DOI 10.2307/3676357; ALERSTAM T, 1978, OIKOS, V30, P405, DOI 10.2307/3543491; Alerstam T, 1990, BIRD MIGRATION; Baird J., 1959, Bird-Banding, V30, P143; BAIRD JAMES, 1960, AUK, V77, P119; BINGMAN VP, 1980, AUK, V97, P465; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Bolser JA, 2013, WILSON J ORNITHOL, V125, P97, DOI 10.1676/12-057.1; Bruderer B, 1998, J AVIAN BIOL, V29, P499, DOI 10.2307/3677169; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; Dokter AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052300; Drury W. H., 1962, Ibis, V104, P449, DOI 10.1111/j.1474-919X.1962.tb08681.x; Drury W. H. Jr., 1964, Bird-Banding, V35, P69; DUNN EH, 1980, J FIELD ORNITHOL, V51, P254; Erni B, 2002, ARDEA, V90, P155; Evans W. R, 2002, FLIGHT CALLS MIGRATO; Evans William R., 2000, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V16, P151; EVANS WR, 1994, WILSON BULL, V106, P55; Evans WR, 1999, STUD AVIAN BIOL-SER, P219; Farnsworth A, 2005, AUK, V122, P733, DOI 10.1642/0004-8038(2005)122[0733:FCATVF]2.0.CO;2; Farnsworth A, 2004, J AVIAN BIOL, V35, P365, DOI 10.1111/j.0908-8857.2004.03180.x; Farnsworth A, 2007, J FIELD ORNITHOL, V78, P279, DOI 10.1111/j.1557-9263.2007.00115.x; Fitzgerald TM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1499, DOI 10.1007/s00265-008-0579-3; Fortin D, 1999, IBIS, V141, P480, DOI 10.1111/j.1474-919X.1999.tb04417.x; Gagnon F, 2011, AUK, V128, P99, DOI 10.1525/auk.2011.09161; Gagnon F, 2011, CAN J ZOOL, V89, P31, DOI 10.1139/Z10-092; Gagnon F, 2010, AUK, V127, P119, DOI 10.1525/auk.2009.09080; Gauthreaux SA, 2005, BIRDS 2 WORLDS ECOLO, P488; Gauthreaux Sidney A. Jr., 2006, P67; Geo-Marine Inc, 2010, OC WIND POW EC UNPUB, VII; GRABER RR, 1968, WILSON BULL, V80, P36; HALL G A, 1981, American Birds, V35, P135; Harrell FE, 2001, REGRESSION MODELING; Hastie TJ., 1990, GEN ADDITIVE MODELS; Huppop O, 2006, IBIS, V148, P90, DOI 10.1111/j.1474-919X.2006.00536.x; Huppop O, 2012, J AVIAN BIOL, V43, P85, DOI 10.1111/j.1600-048X.2011.05443.x; Karlsson H, 2011, IBIS, V153, P485, DOI 10.1111/j.1474-919X.2011.01130.x; Kelly JF, 2002, AUK, V119, P210, DOI 10.1642/0004-8038(2002)119[0210:DDMGBW]2.0.CO;2; Kemp MU, 2012, J THEOR BIOL, V308, P56, DOI 10.1016/j.jtbi.2012.05.026; Kerlinger P., 1989, Current Ornithology, V6, P109; La VT, 2012, CONDOR, V114, P245, DOI 10.1525/cond.2012.100193; Larkin RP, 2002, J FIELD ORNITHOL, V73, P2, DOI 10.1648/0273-8570-73.1.2; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Mizrahi D, 2010, OCEAN SPECIAL AREA M, V2; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Morris SR, 1996, CONDOR, V98, P395, DOI 10.2307/1369157; Parrish JD, 1997, CONDOR, V99, P681, DOI 10.2307/1370480; Peckford ML, 2008, J FIELD ORNITHOL, V79, P207, DOI 10.1111/j.1557-9263.2008.00165.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RALPH CJ, 1981, WILSON BULL, V93, P164; RALPH CJ, 1978, BIRD BANDING, V49, P237, DOI 10.2307/4512365; Reinert S.E., 2002, ECOLOGY BLOCK ISLAND, P151; Richardson W.J., 1990, P78; RICHARDSON W J, 1972, American Birds, V26, P10; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; RICHARDSON WJ, 1978, AUK, V95, P717; Rimmer Christopher C., 2004, Studies in Avian Biology, P123; Ruxton GD, 2010, METHODS ECOL EVOL, V1, P114, DOI 10.1111/j.2041-210X.2010.00014.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schweppenburg G. v. H. F., 1963, Journal fuer Ornithologie, V104, P191; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Smith AD, 2014, OECOLOGIA, V174, P931, DOI 10.1007/s00442-013-2834-1; Smith SB, 2007, WILSON J ORNITHOL, V119, P419, DOI 10.1676/06-073.1; Smith SB, 2010, AUK, V127, P108, DOI 10.1525/auk.2009.09139; WIEDNER DS, 1992, AUK, V109, P500; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	72	11	15	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92218	10.1371/journal.pone.0092218	http://dx.doi.org/10.1371/journal.pone.0092218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643060	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900106
J	Svobodova, I; Chaloupkova, H; Koncel, R; Bartos, L; Hradecka, L; Jebavy, L				Svobodova, Ivona; Chaloupkova, Helena; Koncel, Roman; Bartos, Ludek; Hradecka, Lenka; Jebavy, Lukas			Cortisol and Secretory Immunoglobulin A Response to Stress in German Shepherd Dogs	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; SALIVARY CORTISOL; IMMUNE-SYSTEM; COPING STYLES; BEHAVIOR; PUPPIES; IGA; PIGS; AGE; ANIMALS	The aim of the study was to determine whether cortisol and secretory Immunoglobulin A (sIgA) could be used as an indicator of acute stress in both young and adult dogs. Seventeen German shepherd puppies were exposed to the Puppy test (challenge test) at the age of seven weeks. This test has been routinely used to assess the future working ability of potential police dogs. In addition, ten adult females were subjected to 4 minutes of defense training under stressful conditions. Saliva was collected from the puppies and adult females before testing and 20 minutes after the start of testing, using a cotton swab held for 1-2 minutes in each dog's mouth. Cortisol concentrations increased after the test compared to the control sample both in puppies and the adult females. However adult females showed a significant decrease in sIgA after defense training while puppies showed a tendency of increase in sIgA. We propose that salivary cortisol could be used as an indicator of stress in puppies during early ontogeny. It is not yet clear whether sIgA could be used as a useful indicator of short-term stress in dogs.	[Svobodova, Ivona; Chaloupkova, Helena; Koncel, Roman; Bartos, Ludek; Hradecka, Lenka; Jebavy, Lukas] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague 6, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Chaloupkova, H (corresponding author), Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague 6, Czech Republic.	chaloupkovah@af.czu.cz	Chaloupková, Helena/A-7683-2019; Svobodova, Ivona/U-7957-2018	Chaloupková, Helena/0000-0003-4894-0600; Svobodova, Ivona/0000-0003-3303-981X	 [MVCR VF 20112014012]		Funding provided by grant number MVCR VF 20112014012 (URL:http://www.mvcr.cz/dotace-a-granty.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bennett A, 2010, DOMEST ANIM ENDOCRIN, V39, P171, DOI 10.1016/j.domaniend.2010.04.003; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; Erber R, 2012, STRESS, V15, P184, DOI 10.3109/10253890.2011.606855; EVANS P, 1994, BRIT J CLIN PSYCHOL, V33, P575, DOI 10.1111/j.2044-8260.1994.tb01154.x; Fahlman MM, 2001, INT J SPORTS MED, V22, P284; Fan YX, 2009, STRESS HEALTH, V25, P189, DOI 10.1002/smi.1239; HARGREAVES AL, 1990, APPL ANIM BEHAV SCI, V26, P103, DOI 10.1016/0168-1591(90)90091-Q; Horvath Z, 2007, HORM BEHAV, V52, P621, DOI 10.1016/j.yhbeh.2007.08.001; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Hucklebridge F, 1998, INT J PSYCHOPHYSIOL, V31, P69, DOI 10.1016/S0167-8760(98)00042-7; Ishiwata T, 2006, ANIM SCI J, V77, P352, DOI 10.1111/j.1740-0929.2006.00359.x; Kikkawa A, 2005, J VET MED SCI, V67, P707, DOI 10.1292/jvms.67.707; Kikkawa A, 2003, J VET MED SCI, V65, P689, DOI 10.1292/jvms.65.689; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; Lester SR, 2010, ANAT SCI EDUC, V3, P160, DOI 10.1002/ase.161; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Muneta Y, 2010, J VET MED SCI, V72, P1295, DOI 10.1292/jvms.10-0009; Ogra PL, 2010, AGEING RES REV, V9, P101, DOI 10.1016/j.arr.2009.07.007; PALAZZOLO DL, 1987, P SOC EXP BIOL MED, V185, P305; REIMERS TJ, 1990, AM J VET RES, V51, P454; Rooney NJ, 2007, PHYSIOL BEHAV, V92, P847, DOI 10.1016/j.physbeh.2007.06.011; Schafer-Somi S, 2005, RES VET SCI, V78, P143, DOI 10.1016/j.rvsc.2004.07.011; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Steiss JE, 2007, APPL ANIM BEHAV SCI, V106, P96, DOI 10.1016/j.applanim.2006.06.018; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Tomkins LM, 2011, J VET BEHAV, V6, P178, DOI 10.1016/j.jveb.2010.12.002; Tsai ML, 2012, J STRENGTH COND RES, V26, P2202, DOI 10.1519/JSC.0b013e31823a4246; van der Borg JAM, 2010, APPL ANIM BEHAV SCI, V128, P78, DOI 10.1016/j.applanim.2010.09.016; Veissier I, 1997, J ANIM SCI, V75, P356; Volkmann ER, 2006, STRESS HEALTH, V22, P11, DOI 10.1002/smi.1077; von Borell E, 2007, HORM BEHAV, V52, P130, DOI 10.1016/j.yhbeh.2007.03.014; Watamura SE, 2010, PSYCHONEUROENDOCRINO, V35, P1156, DOI 10.1016/j.psyneuen.2010.02.001; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Zaine L, 2011, BRIT J NUTR, V106, pS183, DOI 10.1017/S0007114511000559; Zeier H, 1996, BIOL PSYCHOL, V42, P413, DOI 10.1016/0301-0511(95)05170-8	46	30	30	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90820	10.1371/journal.pone.0090820	http://dx.doi.org/10.1371/journal.pone.0090820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637917	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100012
J	Symonds, MRE; Weston, MA; Robinson, RW; Guay, PJ				Symonds, Matthew R. E.; Weston, Michael A.; Robinson, Randall W.; Guay, Patrick-Jean			Comparative Analysis of Classic Brain Component Sizes in Relation to Flightiness in Birds	PLOS ONE			English	Article							INITIATION DISTANCE; PHYLOGENETIC-RELATIONSHIPS; INTERSPECIFIC VARIATION; MOLECULAR PHYLOGENY; LIFE-HISTORY; RISK-TAKING; AVIAN BRAIN; EYE SIZE; EVOLUTION; ECOLOGY	Increased encephalization has been linked to a range of behavioural traits and scenarios. However, studies of whole brain size in this context have been criticised for ignoring the role of specific brain areas in controlling behaviour. In birds, the response to potential threats is one such behaviour that may relate to the way in which the brain processes sensory information. We used a phylogenetic generalised least squares (PGLS) analyses, based on five different phylogenetic hypotheses, to analyse the relationship of relative sizes of whole brain and brain components with Flight-Initiation Distance (FID), the distance at which birds flee from an approaching human, for 41 bird species. Starting distance (the distance at which an approach to a bird commences), body mass and eye size have elsewhere been shown to be positively associated with FID, and consequently were included as covariates in our analysis. Starting distance and body mass were by far the strongest predictors of FID. Of all brain components, cerebellum size had the strongest predictor weight and was negatively associated with FID but the confidence intervals on the average estimate included zero and the overall predictor weight was low. Models featuring individual brain components were generally more strongly weighted than models featuring whole brain size. The PGLS analyses estimated there to be no phylogenetic signal in the regression models, and hence produced results equivalent to ordinary least squares regression analysis. However analyses that assumed strong phylogenetic signal produced substantially different results with each phylogeny, and overall suggest a negative relationship between forebrain size and FID. Our analyses suggest that the evolutionary assumptions of the comparative analysis, and consideration of starting distance make a profound difference to the interpretation of the effect of brain components on FID in birds.	[Symonds, Matthew R. E.; Weston, Michael A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia; [Robinson, Randall W.; Guay, Patrick-Jean] Victoria Univ, Appl Ecol Res Grp, St Albans, Vic, Australia; [Robinson, Randall W.; Guay, Patrick-Jean] Victoria Univ, Inst Sustainabil & Innovat, Coll Engn & Sci, St Albans, Vic, Australia	Deakin University; Victoria University; Victoria University	Symonds, MRE (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	matthew.symonds@deakin.edu.au	Symonds, Matthew R.E./I-6020-2018	Symonds, Matthew R.E./0000-0002-9785-6045; Robinson, Randall/0000-0001-8425-0709; Weston, Michael/0000-0002-8717-0410	Melbourne Water Corporation; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme; Faculty of Science, Engineering and the Built Environment (Deakin University) Collaborative Research Grant	Melbourne Water Corporation; Victoria University; Faculty of Health Engineering and Science Collaborative Research Grant Scheme; Faculty of Science, Engineering and the Built Environment (Deakin University) Collaborative Research Grant	This research was supported by funding from Melbourne Water Corporation and a Victoria University Fellowship and a Faculty of Health Engineering and Science Collaborative Research Grant Scheme to PJG. Write up was supported by a Faculty of Science, Engineering and the Built Environment (Deakin University) Collaborative Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Bao XK, 2010, MOL PHYLOGENET EVOL, V56, P840, DOI 10.1016/j.ympev.2010.03.038; Barton K., 2012, MUMIN MULTIMODEL INF; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; BENNETT PM, 1985, J ZOOL, V207, P151; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Burish MJ, 2004, BRAIN BEHAV EVOLUT, V63, P107, DOI 10.1159/000075674; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Chamaille-Jammes S, 2012, BEHAV ECOL SOCIOBIOL, V66, P985, DOI 10.1007/s00265-012-1354-z; Davis KE, 2008, REWEAVING TAPESTRY S; Day LB, 2005, BRAIN BEHAV EVOLUT, V66, P62, DOI 10.1159/000085048; Dumont F, 2012, ETHOLOGY, V118, P1051, DOI 10.1111/eth.12006; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2007, MOL PHYLOGENET EVOL, V43, P515, DOI 10.1016/j.ympev.2007.02.015; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Glover HK, 2011, LANDSCAPE URBAN PLAN, V103, P326, DOI 10.1016/j.landurbplan.2011.08.006; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Guay PJ, 2013, WILDLIFE RES, V40, P289, DOI 10.1071/WR13013; Guay PJ, 2013, AUSTRAL ECOL, V38, P516, DOI 10.1111/j.1442-9993.2012.02441.x; Guay PJ, 2008, AUST J ZOOL, V56, P311, DOI 10.1071/ZO08082; Guay PJ, 2013, ETHOLOGY, V119, P552, DOI 10.1111/eth.12094; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HEALY S, 1990, EVOLUTION, V44, P339, DOI 10.1111/j.1558-5646.1990.tb05203.x; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Hugall AF, 2012, NATURE, V485, P631, DOI 10.1038/nature11050; Iwaniuk AN, 2009, CAN J EXP PSYCHOL, V63, P150, DOI 10.1037/a0015678; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson KP, 2001, AUK, V118, P874, DOI 10.1642/0004-8038(2001)118[0874:AMPOTD]2.0.CO;2; Kirsch JA, 2008, CONSCIOUS COGN, V17, P475, DOI 10.1016/j.concog.2008.03.018; Kolb EM, 2013, J EXP BIOL, V216, P515, DOI 10.1242/jeb.076000; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lerner HRL, 2008, AUK, V125, P304, DOI 10.1525/auk.2008.06161; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Maddison WP, 2017, MESQUITE MODULAR SYS; Marchant S, 1990, HDB AUSTR NZ ANTAR B, V1; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2014, J EVOLUTION BIOL, V27, P34, DOI 10.1111/jeb.12272; Moller AP, 2010, J EVOLUTION BIOL, V23, P1689, DOI 10.1111/j.1420-9101.2010.02034.x; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2012, BEHAV ECOL, V23, P843, DOI 10.1093/beheco/ars040; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Orme D, 2012, CAPER COMP ANAL PHYL; Packert M, 2012, MOL PHYLOGENET EVOL, V63, P606, DOI 10.1016/j.ympev.2012.02.002; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; PORTMANN ADOLPHE, 1947, ALAUDA, V15, P1; PURVIS A, 1994, J THEOR BIOL, V167, P293, DOI 10.1006/jtbi.1994.1071; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rezende EL, 2012, COMPR PHYSIOL, V2, P639, DOI 10.1002/cphy.c100079; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; Sol D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009617; Sol D, 2009, BIOL LETTERS, V5, P130, DOI 10.1098/rsbl.2008.0621; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Symonds MRE, 2002, SYST BIOL, V51, P541, DOI 10.1080/10635150290069977; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	78	18	19	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91960	10.1371/journal.pone.0091960	http://dx.doi.org/10.1371/journal.pone.0091960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637884	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100090
J	Guan, BJ; Krokowski, D; Majumder, M; Schmotzer, CL; Kimball, SR; Merrick, WC; Koromilas, AE; Hatzoglou, M				Guan, Bo-Jhih; Krokowski, Dawid; Majumder, Mithu; Schmotzer, Christine L.; Kimball, Scot R.; Merrick, William C.; Koromilas, Antonis E.; Hatzoglou, Maria			Translational Control during Endoplasmic Reticulum Stress beyond Phosphorylation of the Translation Initiation Factor eIF2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Endoplasmic Reticulum Stress; Gene Expression; Translation Control; Unfolded Protein Response; ATF4; eIF2; Integrated Stress Response; p62; Sequestosome; Autophagy	UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; INDUCED GENE-EXPRESSION; AMINO-ACID-TRANSPORT; ER-STRESS; RIBOSOMAL-RNA; SIGNAL INTEGRATION; CELL-SURVIVAL; RAG GTPASES; S6 KINASE	Background: Chronic ER stress suppresses mTORC1 activity. Results: mTORC1-mediated suppression of translation during chronic ER stress is independent of the stress-induced eIF2-P/ATF4 signaling. Conclusion: The eIF2-P/ATF4-induced network of amino acid transporters promotes protein synthesis in part by increasing mTORC1-mediated translational control. Significance: The eIF2-P/ATF4/mTORC1 network controls protein synthesis rates during chronic ER stress and mediates the degree of stress response and survival outcomes. The accumulation of unfolded/misfolded proteins in the endoplasmic reticulum (ER) causes stress to which an unfolded protein response is activated to render cell survival or apoptosis (chronic stress). Transcriptional and translational reprogramming is tightly regulated during the unfolded protein response to ensure specific gene expression. The master regulator of this response is the PERK/eIF2/ATF4 signaling where eIF2 is phosphorylated (eIF2-P) by the kinase PERK. This signal leads to global translational shutdown, but it also enables translation of the transcription factor ATF4 mRNA. We showed recently that ATF4 induces an anabolic program through the up-regulation of selected amino acid transporters and aminoacyl-tRNA synthetases. Paradoxically, this anabolic program led cells to apoptosis during chronic ER stress in a manner that involved recovery from stress-induced protein synthesis inhibition. By using eIF2-P-deficient cells as an experimental system, we identified a communicating network of signaling pathways that contribute to the inhibition of protein synthesis during chronic ER stress. This eIF2-P-independent network includes (i) inhibition of mammalian target of rapamycin kinase protein complex 1 (mTORC1)-targeted protein phosphorylation, (ii) inhibited translation of a selective group of 5-terminal oligopyrimidine mRNAs (encoding proteins involved in the translation machinery and translationally controlled by mTORC1 signaling), and (iii) inhibited translation of non-5-terminal oligopyrimidine ribosomal protein mRNAs and ribosomal RNA biogenesis. We propose that the PERK/eIF2-P/ATF4 signaling acts as a brake in the decline of protein synthesis during chronic ER stress by positively regulating signaling downstream of the mTORC1 activity. These studies advance our knowledge on the complexity of the communicating signaling pathways in controlling protein synthesis rates during chronic stress.	[Guan, Bo-Jhih; Krokowski, Dawid; Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Schmotzer, Christine L.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Merrick, William C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Koromilas, Antonis E.] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lady Davis Institute; McGill University; McGill University	Krokowski, D (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	dmk102@case.edu; mxh8@case.edu			National Institutes of Health [R37-DK060596, R01-DK053307, R01-DK013499]; Canadian Institutes of Health Research [MOP-38160]; Quebec Breast Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R01DK013499, R37DK060596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Breast Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK060596 and R01-DK053307 (to M. H.) and R01-DK013499 (to S. R. K.). This work was also supported by Canadian Institutes of Health Research Grant MOP-38160 (to A. E. K.) and a Quebec Breast Cancer Foundation grant (to A. E. K.).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bachar-Wikstrom E, 2013, AUTOPHAGY, V9, P626, DOI 10.4161/auto.23642; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; BARBER EF, 1983, J BIOL CHEM, V258, P1851; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Buel GR, 2013, CELL METAB, V17, P633, DOI 10.1016/j.cmet.2013.04.018; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Conn CS, 2011, CELL CYCLE, V10, P1940, DOI 10.4161/cc.10.12.15858; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Dennis MD, 2013, CELL SIGNAL, V25, P2709, DOI 10.1016/j.cellsig.2013.08.038; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Iadevaia V, 2012, NUCLEIC ACIDS RES, V40, P2527, DOI 10.1093/nar/gkr1040; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Kimball SR, 2005, SEMIN CELL DEV BIOL, V16, P21, DOI 10.1016/j.semcdb.2004.11.009; Kimball SR, 2002, J NUTR, V132, P883; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Koromilas AE, 2013, FUTURE ONCOL, V9, P1005, DOI [10.2217/fon.13.49, 10.2217/FON.13.49]; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Kubica N, 2006, PROG NUCLEIC ACID RE, V81, P271, DOI 10.1016/S0079-6603(06)81007-X; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Preston AM, 2013, J CELL SCI, V126, P4253, DOI 10.1242/jcs.130336; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Reiling JH, 2008, MOL CELL, V29, P533, DOI 10.1016/j.molcel.2008.02.011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang H, 1996, J VIROL, V70, P6884, DOI 10.1128/JVI.70.10.6884-6891.1996; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	98	90	96	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12593	12611		10.1074/jbc.M113.543215	http://dx.doi.org/10.1074/jbc.M113.543215			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648524	Green Published, hybrid			2022-12-25	WOS:000335581400032
J	Cai, Y; Yang, QT; Tang, YQ; Zhang, MX; Liu, HY; Zhang, GL; Deng, QY; Huang, J; Gao, ZL; Zhou, BP; Feng, CG; Chen, XC				Cai, Yi; Yang, Qianting; Tang, Yueqiang; Zhang, Mingxia; Liu, Haiying; Zhang, Guoliang; Deng, Qunyi; Huang, Jian; Gao, Zhiliang; Zhou, Boping; Feng, Carl G.; Chen, Xinchun			Increased Complement C1q Level Marks Active Disease in Human Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; GENE-EXPRESSION; T-CELLS; PULMONARY TUBERCULOSIS; DENDRITIC CELLS; ACTIVATION; INFECTION; METAANALYSIS; DIAGNOSIS; MODULATION	Background: Complement functions as an important host defense system and complement C5 and C7 have been implicated in immunopathology of tuberculosis. However, little is known about the role of other complement components in tuberculosis. Methods: Complement gene expression in peripheral blood mononuclear cells of tuberculosis patients and controls were determined using whole genome transcriptional microarray assays. The mRNA and protein levels of three C1q components, C1qA, C1qB, and C1qC, were further validated by qRT-PCR and enzyme-linked immunosorbent assay, respectively. The percentages of C1q expression in CD14 positive cells were determined by flow cytometry. Finally, C1qC protein level was quantified in the pleural fluid of tuberculosis and non-tuberculosis pleurisy. Results: C1q expression increases significantly in the peripheral blood of patients with active tuberculosis compared to healthy controls and individuals with latent TB infection. The percentage of C1q-expressing CD14 positive cells is significantly increased in active TB patients. C1q expression in the peripheral blood correlates with sputum smear positivity in tuberculosis patients and is reduced after anti-tuberculosis chemotherapy. Notably, receiver operating characteristic analysis showed that C1qC mRNA levels in peripheral blood efficiently discriminate active from latent tuberculosis infection and healthy controls. Additionally, C1qC protein level in pleural effusion shows improved power in discriminating tuberculosis from non-tuberculosis pleurisy when compared to other inflammatory markers, such as IL-6 and TNF-alpha. Conclusions: C1q expression correlates with active disease in human tuberculosis. C1q could be a potential diagnostic marker to discriminate active tuberculosis from latent tuberculosis infection as well as tuberculosis pleurisy from non-tuberculosis pleurisy.	[Cai, Yi; Gao, Zhiliang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Qianting; Tang, Yueqiang; Zhang, Mingxia; Zhang, Guoliang; Zhou, Boping; Chen, Xinchun] Shenzhen Third Peoples Hosp, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China; [Cai, Yi; Yang, Qianting; Tang, Yueqiang; Deng, Qunyi; Huang, Jian; Chen, Xinchun] Shenzhen Third Peoples Hosp, Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen, Peoples R China; [Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Feng, Carl G.] Univ Sydney Univ, Sydney Med Sch, Dept Infect Dis & Immunol, Sydney, NSW, Australia	Sun Yat Sen University; Guangdong Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; University of Sydney	Chen, XC (corresponding author), Shenzhen Third Peoples Hosp, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China.	chenxinchun@gmail.com	Cai, Yi/AAJ-2789-2020; Zhang, Guoliang/C-7678-2017	Cai, Yi/0000-0002-1363-2328; Zhang, Guoliang/0000-0002-3617-5449; feng, carl/0000-0003-4301-4640	Twelfth-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' [2012ZX10003002]; Natural Science Foundation of China [81171535, 81273140]; Shenzhen science and technology innovation project [JCYJ20130329171031738]	Twelfth-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases''; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen science and technology innovation project	This work was supported by Twelfth-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' (2012ZX10003002), Natural Science Foundation of China Grant (81171535, 81273140), Shenzhen science and technology innovation project (JCYJ20130329171031738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/678570; [Anonymous], 2013, GLOB TUB CONTR; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Benoit ME, 2012, J IMMUNOL, V188, P5682, DOI 10.4049/jimmunol.1103760; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; CHEN A, 1994, J IMMUNOL, V153, P1430; Chen GB, 2011, J BIOL CHEM, V286, P34941, DOI 10.1074/jbc.M111.286427; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cortes-Hernandez J, 2004, EUR J IMMUNOL, V34, P3713, DOI 10.1002/eji.200425616; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Dorman SE, 2010, CLIN INFECT DIS, V50, pS173, DOI 10.1086/651488; El-Sony A, 2002, INT J TUBERC LUNG D, V6, P91; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; KOROTZER AR, 1995, EXP NEUROL, V134, P214, DOI 10.1006/exnr.1995.1051; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Lu J, 2008, CELL MOL IMMUNOL, V5, P9, DOI 10.1038/cmi.2008.2; MAEDA M, 1988, CELL TISSUE RES, V254, P543; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Merchant S, 2013, IMMUNOBIOLOGY, V218, P869, DOI 10.1016/j.imbio.2012.10.010; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mutoloki S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-336; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Ors F, 2007, J THORAC IMAG, V22, P154, DOI 10.1097/01.rti.0000213590.29472.ce; Petry F, 2001, J IMMUNOL, V167, P4033, DOI 10.4049/jimmunol.167.7.4033; Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091; Son M, 2012, P NATL ACAD SCI USA, V109, pE3160, DOI 10.1073/pnas.1212753109; Tuberculosis, 2011, NICE CLIN GUID; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044944	47	70	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92340	10.1371/journal.pone.0092340	http://dx.doi.org/10.1371/journal.pone.0092340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647646	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500120
J	Scheyer, TM; Romano, C; Jenks, J; Bucher, H				Scheyer, Torsten M.; Romano, Carlo; Jenks, Jim; Bucher, Hugo			Early Triassic Marine Biotic Recovery: The Predators' Perspective	PLOS ONE			English	Article							SULFUR MOUNTAIN FORMATION; PERMIAN MASS EXTINCTION; MONTE-SAN-GIORGIO; U-PB AGES; BRITISH-COLUMBIA; GUIZHOU PROVINCE; ANHUI PROVINCE; SOUTH CHINA; WAPITI LAKE; TIME-SCALE	Examining the geological past of our planet allows us to study periods of severe climatic and biological crises and recoveries, biotic and abiotic ecosystem fluctuations, and faunal and floral turnovers through time. Furthermore, the recovery dynamics of large predators provide a key for evaluation of the pattern and tempo of ecosystem recovery because predators are interpreted to react most sensitively to environmental turbulences. The end-Permian mass extinction was the most severe crisis experienced by life on Earth, and the common paradigm persists that the biotic recovery from the extinction event was unusually slow and occurred in a step-wise manner, lasting up to eight to nine million years well into the early Middle Triassic (Anisian) in the oceans, and even longer in the terrestrial realm. Here we survey the global distribution and size spectra of Early Triassic and Anisian marine predatory vertebrates (fishes, amphibians and reptiles) to elucidate the height of trophic pyramids in the aftermath of the end-Permian event. The survey of body size was done by compiling maximum standard lengths for the bony fishes and some cartilaginous fishes, and total size (estimates) for the tetrapods. The distribution and size spectra of the latter are difficult to assess because of preservation artifacts and are thus mostly discussed qualitatively. The data nevertheless demonstrate that no significant size increase of predators is observable from the Early Triassic to the Anisian, as would be expected from the prolonged and stepwise trophic recovery model. The data further indicate that marine ecosystems characterized by multiple trophic levels existed from the earliest Early Triassic onwards. However, a major change in the taxonomic composition of predatory guilds occurred less than two million years after the end-Permian extinction event, in which a transition from fish/amphibian to fish/reptile-dominated higher trophic levels within ecosystems became apparent.	[Scheyer, Torsten M.; Romano, Carlo; Bucher, Hugo] Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland; [Jenks, Jim] New Mexico Museum Nat Hist & Sci, Albuquerque, NM USA	University of Zurich	Scheyer, TM (corresponding author), Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland.	tscheyer@pim.uzh.ch; carlo.romano@pim.uzh.ch	Romano, Carlo/H-8903-2012; Romano, Carlo/AAG-2859-2021; Bucher, Hugo F.R./O-2212-2013	Romano, Carlo/0000-0003-4438-2736; Romano, Carlo/0000-0003-4438-2736; Bucher, Hugo F.R./0000-0001-9164-5258; Scheyer, Torsten M./0000-0002-6301-8983	The Swiss National Science Foundation [31003A_127053, 146440, 135446, 120311/135075]	The Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	The Swiss National Science Foundation (http://www.snsf.ch) is acknowledged for past and present project funding (Grant Nos. 31003A_127053 and 146440 to TMS; 135446 to HB and 120311/135075 to W. Brinkmann, Zurich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aellen M., 1972, RAPPORT GRONLANDS GE, V48, P39, DOI https://doi.org/10.34194/rapggu.v48.7308; [Anonymous], 2005, ANN U FERRARA MUSEOL; [Anonymous], 2010, ZBL GEOL PALAONTOL 2; [Anonymous], 2002, FIELDIANA GEOLOGY, DOI DOI 10.5962/BHL.TITLE.3275; [Anonymous], 2001, FIELDIANA GEOL NS, DOI DOI 10.5962/BHL.TITLE.3449; Balini M, 2012, RIV ITAL PALEONTOL S, V118, P155, DOI 10.13130/2039-4942/5996; Balini M, 2010, GEOL SOC SPEC PUBL, V334, P221, DOI 10.1144/SP334.10; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Bardet Nathalie, 1994, Historical Biology, V7, P313; Beltan L., 1979, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1979, P257; Benson RBJ, 2011, GEOL SOC SPEC PUBL, V358, P191, DOI 10.1144/SP358.13; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Benton M. J., 2005, VERTEBRATE PALEONTOL; Benton MJ, 2013, EARTH-SCI REV, V125, P199, DOI 10.1016/j.earscirev.2013.05.014; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; BIRKENMAJER K, 1979, Studia Geologica Polonica, V60, P7; Bjerager M, 2006, GEOL MAG, V143, P635, DOI 10.1017/S0016756806002020; Bjerring HC, 1999, NEW AMPHIBIOUS TETRA; Blazejowski Blazej, 2004, Polish Polar Research, V25, P153; Bohme W, 2010, SPEZIELLE ZOOLOGIE 2, P360; Brack P, 2005, EPISODES, V28, P233, DOI 10.18814/epiiugs/2005/v28i4/001; BRINKMAN DB, 1992, PALAEONTOLOGY, V35, P465; Brinkmann Winand, 2004, Schweizerische Palaeontologische Abhandlungen, V124, P1; BRUHWILER T., 2012, SPEC PAP PALAEONTOL, V88, p[22, 1]; Buchan SH, 1965, NOR POLARINST SKR, P5; BUCHER H, 1989, ECLOGAE GEOL HELV, V82, P945; Bucher H, 2013, 125 ANN ANN M GEOL S; Callaway J.M., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V178, P37; CALLAWAY JM, 1989, J PALEONTOL, V63, P930, DOI 10.1017/S0022336000036635; Camargo JA, 1995, OIKOS, V74, P538, DOI 10.2307/3546000; CARROLL RL, 1981, PHILOS T ROY SOC B, V293, P315, DOI 10.1098/rstb.1981.0079; CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Case E. C., 1936, Contributions from the Museum of Paleontology University of Michigan, V5, P1; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Chen XH, 2013, ACTA GEOL SIN-ENGL, V87, P672, DOI 10.1111/1755-6724.12078; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/NGEO1475, 10.1038/ngeo1475]; Chin K., 2002, PREDATION FOSSIL REC, V8, P43; Clement G, 1999, J VERTEBR PALEONTOL, V19, P234, DOI 10.1080/02724634.1999.10011137; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; CURRIE P J, 1981, Palaeontologia Africana, V24, P99; Cuthbertson RS, 2013, J VERTEBR PALEONTOL, V33, P831, DOI 10.1080/02724634.2013.755989; Cuthbertson RS, 2013, J VERTEBR PALEONTOL, V33, P817, DOI 10.1080/02724634.2013.756495; D-y Jiang, 2013, 125 ANN ANN M GEOL S; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Dong Z-M, 1972, I VERTEBRATE PALEONT, V9, P7; Embry AF, 1997, B CAN PETROL GEOL, V45, P415; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; Frobisch J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003733; Frobisch J, 2013, PALAEOGEOGR PALAEOCL, V372, P50, DOI 10.1016/j.palaeo.2012.10.036; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; Fv Huene, 1920, ACTA ZOOL-STOCKHOLM, V1, P433; Galfetti T, 2008, SEDIMENT GEOL, V204, P36, DOI 10.1016/j.sedgeo.2007.12.008; Galfetti T, 2007, PALAEOGEOGR PALAEOCL, V243, P394, DOI 10.1016/j.palaeo.2006.08.014; Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; Gheerbrant Emmanuel, 2005, P84; GINGERICH P D, 1981, Contributions from the Museum of Paleontology University of Michigan, V25, P235; Gingerich P. D., 2005, PLACENTAL MAMMALS OR, P234; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Ginter Michal, 2010, P1; Goudemand N, 2012, PALAEONTOLOGY, V55, P1021, DOI 10.1111/j.1475-4983.2012.01174.x; Goudemand N, 2012, GEOBIOS-LYON, V45, P199, DOI 10.1016/j.geobios.2011.06.001; Goudemand N, 2011, P NATL ACAD SCI USA, V108, P8720, DOI 10.1073/pnas.1101754108; Gradstein FM, 2004, LETHAIA, V37, P175, DOI 10.1080/00241160410006483; GRIFFITH JOHN, 1959, PROC ZOOL SOC LONDON, V132, P587; Guex J., 2010, MEM GEOL LAUSANNE, V49, P1; Guffroy S, 1956, B SOC GEOLOGIQUE FRA, V6, P847; Guinot G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3669; Guinot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044632; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hammer WR, 1987, PALEONTOLOGY AM GEOP, V41; HARLAND W.B., 1997, GEOLOGICAL SOC MEMOI, V17; Hewison RH, 2007, J TEMNOSPONDYL PALAE, V1; HOGLER J A, 1992, Palaios, V7, P108, DOI 10.2307/3514800; Hu SX, 2011, P ROY SOC B-BIOL SCI, V278, P2274, DOI 10.1098/rspb.2010.2235; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Huttenlocker AK, 2012, AM MUS NOVIT, P1; Ivanov Alexander, 2007, Bulletin of the New Mexico Museum of Natural History and Science, V41, P108; Jackson JBC, 2006, TRENDS ECOL EVOL, V21, P322, DOI 10.1016/j.tree.2006.03.017; Janvier P, 2008, MAJOR TRANSITION VER, P57; Jiang DY, 2012, J VERTEBR PALEONTOL, V32, P117; Jiang DY, 2008, PROG NAT SCI-MATER, V18, P1315, DOI 10.1016/j.pnsc.2008.01.039; Jiang DY, 2009, ACTA GEOL SIN-ENGL, V83, P451, DOI 10.1111/j.1755-6724.2009.00047.x; Jiang DY, 2005, ACTA GEOL SIN-ENGL, V79, P729; Jin Fan, 2006, Vertebrata Palasiatica, V44, P28; Kasumzadeh AA, 2000, SOSTOJANIE IZUCHENNO; Kauffman EG, 1996, GEOL SOC SP, P15, DOI 10.1144/GSL.SP.1996.001.01.02; Kelley NP, 2012, J VERTEBR PALEONTOL, V32, P120; Kelley NP, 2012, PALAEOGEOGR PALAEOCL, DOI [10.1016/j.palaeo.2012.1007.1026, DOI 10.1016/J.PALAEO.2012.1007.1026]; Ketchum HF, 2004, CAN J EARTH SCI, V41, P1, DOI 10.1139/E03-084; Klein N, 2014, ACTA PALAEONTOL POL, V59, P887, DOI 10.4202/app.2012.0147; Kogan I, 2011, B GEOL SOC DENMARK, V59, P93; Koot MB, 2013, THESIS PLYMOUTH U PL; Kosch B.F., 1990, Journal of Vertebrate Paleontology, V10, P512; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Lehman J. -P., 1956, ANN PALEONTOL, V42, P67; Lehman J.P., 1961, ANN PALEONTOL, V47, P42; LEHMAN JEAN-PIERRE, 1952, K SVENSKA VETENSKAPS AKAD HANDL, V2, P1; Lehrmann DJ, 2007, AAPG BULL, V91, P287, DOI 10.1306/10160606065; Leidy J., 1868, P ACAD NAT SCI PHILA, V20, P177; Li C., 2010, CHINESE SCI BULL, V24, P80; Li Jin-Ling, 2006, Vertebrata Palasiatica, V44, P99; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Li QG, 2009, PALAEONTOLOGY, V52, P369, DOI 10.1111/j.1475-4983.2009.00848.x; Lindemann F.-J., 1991, 5 S MES TERR EC BIOT, V364, P39; Lindemann F.-J., 2006, BOR TRIASS 2006 LONG, P94; Liu Guan-Bang, 2002, Acta Palaeontologica Sinica, V41, P27; Liu H-T, 1964, VERTEBRAT PALASIATIC, V8, P213; Long C, 2006, J PALEONTOL, V80, P583, DOI 10.1666/0022-3360(2006)80[583:GITTIP]2.0.CO;2; Lucas Spencer G., 2000, Albertiana, V24, P27; Lucas Spencer G., 1997, P423, DOI 10.1016/B978-012155210-7/50022-3; Maganuco Simone, 2009, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V36, P1; Maisch Michael W., 2010, Palaeodiversity, P151; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch MW, 2003, NEUES JAHRB GEOL P-A, V229, P317, DOI 10.1127/njgpa/229/2003/317; Maisch MW, 2003, NEUES JAHRB GEOL P-A, V227, P93, DOI 10.1127/njgpa/227/2003/93; Maisch MW, 2002, NEUES JAHRB GEOL P-A, V226, P59; Maisch MW, 2002, LETHAIA, V35, P250, DOI 10.1080/00241160260288839; Maisey, 1989, AM MUS NOVIT, V2931, P1; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; MASSARE JA, 1990, GEOL SOC AM BULL, V102, P409, DOI 10.1130/0016-7606(1990)102<0409:TAAEOT>2.3.CO;2; MASSARE JA, 1994, J VERTEBR PALEONTOL, V14, P139, DOI 10.1080/02724634.1994.10011545; Maxwell EE, 2013, GFF, V135, P85, DOI 10.1080/11035897.2012.759145; Mazin J-M, 1984, 3 S MES TERR EC, P135; Mazin J-M, 1984, 3 S MES TERR EC TURB, P141; Mazin Jean Michel, 1993, Paleontologia Lombarda, V2, P93; MAZIN JM, 1989, GEOBIOS-LYON, V22, P725, DOI 10.1016/S0016-6995(89)80069-5; MAZIN JM, 1991, CR ACAD SCI II, V313, P1207; MAZIN JM, 1981, CR ACAD SCI II, V293, P203; MAZIN JM, 1987, CR ACAD SCI II, V305, P823; McAllister J, 2003, T GEOBIOL, V20, P303; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY, V8, P1; Merriam J. C., 1904, Bulletin Geol University California, Viii, P419; Merriam John C., 1908, Memoirs of the University of California Berkeley, VNo.1; Merriam John Campbell, 1906, Berkeley University of California Publ Bull Dept Geol, V5, P75; Mork A, 1999, POLAR RES, V18, P51, DOI 10.1111/j.1751-8369.1999.tb00277.x; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Motani R, 1997, J VERTEBR PALEONTOL, V17, P39, DOI 10.1080/02724634.1997.10010951; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Motani R, 1998, NATURE, V393, P255, DOI 10.1038/30473; Motani R, 1996, J VERTEBR PALEONTOL, V16, P396, DOI 10.1080/02724634.1996.10011329; Motani R, 2000, J VERTEBR PALEONTOL, V20, P295, DOI 10.1671/0272-4634(2000)020[0295:IOIAPP]2.0.CO;2; Motani R, 1998, J VERTEBR PALEONTOL, V18, P533, DOI 10.1080/02724634.1998.10011080; Motani R, 2000, PALAEONTOLOGY, V43, P1, DOI 10.1111/1475-4983.00115; Motani R, 1997, THESIS U TORONTO TOR; Motani R, 2008, J VERTEBR PALEONTOL, V28, P900, DOI 10.1671/0272-4634(2008)28[900:HAAOMT]2.0.CO;2; Motani Ryosuke, 1999, Paludicola, V2, P174; Motani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066075; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Muller J, 2007, J VERTEBR PALEONTOL, V27, P236, DOI 10.1671/0272-4634(2007)27[236:FROATF]2.0.CO;2; Muller J, 2005, CAN J EARTH SCI, V42, P1347, DOI 10.1139/E05-030; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Mundil R, 2010, GEOL SOC SPEC PUBL, V334, P41, DOI 10.1144/SP334.3; Mutter RJ, 2008, ZOOL J LINN SOC-LOND, V154, P419, DOI 10.1111/j.1096-3642.2008.00488.x; Mutter RJ, 2007, ZOOL J LINN SOC-LOND, V149, P309; Mutter Raoul J., 2008, P103; Mutter RJ, 2008, GEOL SOC SPEC PUBL, V295, P9, DOI 10.1144/SP295.3; Mutter RJ, 2009, PALAEOGEOGR PALAEOCL, V284, P22, DOI 10.1016/j.palaeo.2009.08.024; Mutter RJ, 2006, ACTA PALAEONTOL POL, V51, P271; Mutter RJ, 2005, ECLOGAE GEOL HELV, V98, P271, DOI 10.1007/s00015-005-1164-7; Neenan JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2633; Neenan JM, 2012, J VERTEBR PALEONTOL, V32, P1350, DOI 10.1080/02724634.2012.695241; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; NICHOLLS EL, 1993, J PALEONTOL, V67, P263, DOI 10.1017/S0022336000032194; Nicholls EL, 2001, CAN J EARTH SCI, V38, P983, DOI 10.1139/e00-115; NICHOLLS EL, 1993, CAN J EARTH SCI, V30, P486, DOI 10.1139/e93-037; Nicholls Elizabeth L., 1999, Paleobios, V19, P1; Nicholls Elizabeth L., 1995, P521; Nield CM, 2006, ALCHERINGA, V30, P263, DOI 10.1080/03115510608619317; Nielsen E, 1949, PALAEOZOOLOGICA GROE, V3, P1; Nielsen E., 1935, MEDDELELSER GRONLAND, V98, P1, DOI DOI 10.1017/S1477201907002040; Nielsen E., 1942, PALAEOZOOLOGICA GROE, V1, P1; Nielsen E., 1961, P 1 INT S ARCT GEOL, P255; NIELSEN EIGIL, 1952, MEDDEL GRONLAND, V144, P1; Noetling F, 1901, NEUES JB MINERALOGIE, VXIV, P369; Obruchev DB, 1965, T PALEONTOLOGISCHESK, V108, P266; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Organ CL, 2009, NATURE, V461, P389, DOI 10.1038/nature08350; Ovtcharova M, 2006, EARTH PLANET SC LETT, V243, P463, DOI 10.1016/j.epsl.2006.01.042; Ovtcharova M, 2013, 125 ANN ANN M GEOL S; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Payne JL, 2012, ANNU REV EARTH PL SC, V40, P89, DOI 10.1146/annurev-earth-042711-105329; Peyer B., 1939, ABHANDLUNGEN SCHWEIZ, V62:, P1; PITRAT CW, 1973, PALAEOGEOGR PALAEOCL, V14, P249, DOI 10.1016/0031-0182(73)90011-4; Piveteau J., 1926, Annales de Paleontologie, V15, P53; Piveteau J., 1935, CR SEANCES SOC GEOL, V1935, P113; PIVETEAU JEAN, 1944, ANN PALEONTOL, V31, P79; Rieppel O, 2005, CAN J EARTH SCI, V42, P2081, DOI 10.1139/E05-076; RIEPPEL O, 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V221, P63; Rieppel O., 1980, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1980, P43; Rieppel O, 1999, J VERTEBR PALEONTOL, V19, P321, DOI 10.1080/02724634.1999.10011144; Rieppel O, 1998, ZOOL J LINN SOC-LOND, V124, P1; Rieppel O, 2000, HDB PALAOHERPETOLO A, V12A, P1; Rieppel Olivier, 2001, Palaeontologische Zeitschrift, V75, P207; Rieppel O, 2010, J VERTEBR PALEONTOL, V30, P1082, DOI 10.1080/02724634.2010.483548; Rieppel Olivier, 1997, P121, DOI 10.1016/B978-012155210-7/50009-0; Romano C, 2013, 125 ANN ANN M GEOL S; Romano C, 2013, NAT GEOSCI, V6, P57, DOI [10.1038/ngeo1667, 10.1038/NGEO1667]; Romano C, 2012, B GEOSCI, V87, P543, DOI 10.3140/bull.geosci.1337; Romano C, 2010, J VERTEBR PALEONTOL, V30, P1673, DOI 10.1080/02724634.2010.521962; Romano C, 2009, NEUES JAHRB GEOL P-A, V252, P17, DOI 10.1127/0077-7749/2009/0252-0017; Romanuk TN, 2011, GLOBAL ECOL BIOGEOGR, V20, P231, DOI 10.1111/j.1466-8238.2010.00579.x; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Rothschild BM, 2012, NATURWISSENSCHAFTEN, V99, P443, DOI 10.1007/s00114-012-0918-0; RUSSELL LORIS S., 1951, NATL MUS CANADA BULL, V123, P218; Ruta M, 2011, PALAEONTOLOGY, V54, P1117, DOI 10.1111/j.1475-4983.2011.01051.x; Sander P. Martin, 1998, Palaeontologische Zeitschrift, V72, P149; Sander PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019480; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sander PM, 2003, J VERTEBR PALEONTOL, V23, P799, DOI 10.1671/6; Sander PM, 1989, J VERTEBR PALEONTOL, V9, P163; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Save-Soderbergh G., 1935, Meddelelser om Gronland, V98, P1; Save-Soderburgh G., 1937, Bulletin of the Geological Institution University of Uppsala, V27, P189; Schaeffer B., 1976, Bulletin Am Mus nat Hist, V156, P515; Scheyer TM, 2012, HIST BIOL, V24, P257, DOI 10.1080/08912963.2011.621083; Scheyer TM, 2010, PALAEONTOL ELECTRON, V13; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoch R.R., 2000, ENCY PALEOHERPETOL B, P1, DOI DOI 10.1127/0077-7749/2007/0246-0001; Schoch Rainer R., 2002, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V321, P1; Schoch RR, 2011, FOSS REC, V14, P119, DOI 10.1002/mmng.201100002; Schultze Hans-Peter, 2004, P463; Sennikov AG, 2011, PALEONTOL J+, V45, P90, DOI 10.1134/S0031030111010151; Shang Qing-Hua, 2009, Vertebrata Palasiatica, V47, P178; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Shikama T., 1978, SCI REP TOHO UNIV-G, V48, P77; Spa th L.F., 1934, CATALOGUE FOSSIL C 4; Steneck RS, 2012, P NATL ACAD SCI USA, V109, P7953, DOI 10.1073/pnas.1205591109; Stensio E., 1925, KUNGLIGA SVENSKA VET, V3, P1; Stensio E, 1921, TRIASSIC FISHES SPIT; STENSIo ERIE A., 1932, MEDDELEL OM GRONLAND, V83, P1; Steyer JS, 2010, CR PALEVOL, V9, P463, DOI 10.1016/j.crpv.2010.07.007; Steyer JS, 2002, PALAEONTOLOGY, V45, P771, DOI 10.1111/1475-4983.00260; Storrs G.W., 1991, B PEABODY MUS NAT HI, V44, P1; SU DZ, 1981, VERTEBRAT PALASIATIC, V19, P107; SU T. T., 1959, VERTEBRATA PALASIATICA [CHINA], V3, P205; Sun ZY, 2009, ACTA GEOL SIN-ENGL, V83, P460, DOI 10.1111/j.1755-6724.2009.00067.x; Sun ZY, 2008, RIV ITAL PALEONTOL S, V114, P363, DOI 10.13130/2039-4942/5908; Tapanila L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0057; Theodori C, 1854, BESCHREIBUNG KOLOSSA; Thomson KS., 1977, DEV PALAEONTOLOGY ST, Vvol. 5, P377, DOI DOI 10.1016/S0920-5446(08)70332-7; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; Tichy Gottfried, 1995, Geologisch-Palaeontologische Mitteilungen, V20, P349; Tintori A., 2004, MESOZOIC FISHES, P565; Tintori A, 2014, INTEGR ZOOL, V9, P394, DOI 10.1111/1749-4877.12077; Tintori A, 2010, RIV ITAL PALEONTOL S, V116, P161, DOI 10.13130/2039-4942/5947; Tong JN, 2011, ACTA GEOL SIN-ENGL, V85, P399, DOI 10.1111/j.1755-6724.2011.00408.x; Tong JN, 2006, J PALEONTOL, V80, P146, DOI 10.1666/0022-3360(2006)080[0146:FFFTLT]2.0.CO;2; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Turner S, 2010, GEODIVERSITAS, V32, P545, DOI 10.5252/g2010n4a1; Walker Sally E., 2002, Paleontological Society Papers, V8, P119; Wang K, 1959, ACTA PAL SIN, V7, P373; Wang Nian-Zhong, 2001, Vertebrata Palasiatica, V39, P237; Wang X.F., 2003, GEOLOGY CHINA, V30, P20; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Warren Anne, 2000, Amphibian Biology, V4, P1121; Weitschat W., 1989, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V68, P179; Welles Samuel P., 1993, Paleobios, V14, P1; Wendruff AJ, 2013, CAN J EARTH SCI, V50, P904, DOI 10.1139/cjes-2013-0010; Wendruff AJ, 2012, J VERTEBR PALEONTOL, V32, P499, DOI 10.1080/02724634.2012.657317; Wild R., 1980, SCHWEIZERISCHE PALAO, V102, P1; Wiman C., 1913, B GEOL I U UPPSALA, V12, P1; Wiman C., 1916, B GEOL I U UPPSALA, V13, P209; Wiman C., 1929, B GEOLOGICAL I U UPP, V22, P183; Wiman C, 1910, B GEOLOGICAL I U UPS, V10, P124; Wiman C., 1914, B GEOLOGICAL I U UPP, V13, P1; Wiman C., 1910, B GEOLOGICAL I U UPP, V9, P34; Witzmann F, 2008, NATURWISSENSCHAFTEN, V95, P67, DOI 10.1007/s00114-007-0291-6; Witzmann F, 2010, ACTA ZOOL-STOCKHOLM, V91, P96, DOI 10.1111/j.1463-6395.2008.00385.x; Wu FX, 2011, ACTA PALAEONTOL POL, V56, P581, DOI 10.4202/app.2010.0007; Wu FX, 2009, ACTA GEOL SIN-ENGL, V83, P440, DOI 10.1111/j.1755-6724.2009.00056.x; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Yin Gongzheng, 2000, Geology Geochemistry, V28, P1; Young CC, 1972, IVPP CHINESE ACAD SC, V9, P1; YOUNG CHUNG-CHIEN, 1958, VERTEBR PALASIAT [CHINA], V2, P69; ZHANG M, 1976, SCI GEOL SINICA, P332; Zhang Qi-yue, 2010, Dizhi Tongbao, V29, P26; Zhang QY, 2008, GEOLOGICAL REV, V54, P145; Zhang Y, 2014, J ASIAN EARTH SCI, V80, P75, DOI 10.1016/j.jseaes.2013.10.032; Zhao Li-jun, 2007, Acta Palaeontologica Sinica, V46, P238	289	84	87	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e88987	10.1371/journal.pone.0088987	http://dx.doi.org/10.1371/journal.pone.0088987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647136	Green Published, Green Accepted, gold			2022-12-25	WOS:000333348500003
J	Ambayya, A; Su, AT; Osman, NH; Nik-Samsudin, NR; Khalid, K; Chang, KM; Sathar, J; Rajasuriar, JS; Yegappan, S				Ambayya, Angeli; Su, Anselm Ting; Osman, Nadila Haryani; Nik-Samsudin, Nik Rosnita; Khalid, Khadijah; Chang, Kian Meng; Sathar, Jameela; Rajasuriar, Jay Suriar; Yegappan, Subramanian			Haematological Reference Intervals in a Multiethnic Population	PLOS ONE			English	Article							BLOOD; HEMOGLOBIN; COUNT	Introduction: Similar to other populations, full blood count reference (FBC) intervals in Malaysia are generally derived from non-Malaysian subjects. However, numerous studies have shown significant differences between and within populations supporting the need for population specific intervals. Methods: Two thousand seven hundred twenty five apparently healthy adults comprising all ages, both genders and three principal races were recruited through voluntary participation. FBC was performed on two analysers, Sysmex XE-5000 and Unicel DxH 800, in addition to blood smears and haemoglobin analysis. Serum ferritin, soluble transferrin receptor and C-reactive protein assays were performed in selected subjects. All parameters of qualified subjects were tested for normality followed by determination of reference intervals, measures of central tendency and dispersion along with point estimates for each subgroup. Results: Complete data was available in 2440 subjects of whom 56% (907 women and 469 men) were included in reference interval calculation. Compared to other populations there were significant differences for haemoglobin, red blood cell count, platelet count and haematocrit in Malaysians. There were differences between men and women, and between younger and older men; unlike in other populations, haemoglobin was similar in younger and older women. However ethnicity and smoking had little impact. 70% of anemia in premenopausal women, 24% in postmenopausal women and 20% of males is attributable to iron deficiency. There was excellent correlation between Sysmex XE-5000 and Unicel DxH 800. Conclusion: Our data confirms the importance of population specific haematological parameters and supports the need for local guidelines rather than adoption of generalised reference intervals and cut-offs.	[Ambayya, Angeli; Osman, Nadila Haryani; Nik-Samsudin, Nik Rosnita; Khalid, Khadijah; Chang, Kian Meng; Sathar, Jameela; Rajasuriar, Jay Suriar; Yegappan, Subramanian] Hosp Ampang, Dept Haematol, Ampang, Selangor, Malaysia; [Su, Anselm Ting] Univ Malaysia Sarawak, Dept Community Med & Publ Hlth, Kuching, Sarawak, Malaysia	University of Malaysia Sarawak	Yegappan, S (corresponding author), Hosp Ampang, Dept Haematol, Ampang, Selangor, Malaysia.	mani14141@gmail.com	AMBAYYA, ANGELI/J-7800-2017; Su, Anselm/E-8205-2010	Su, Anselm/0000-0001-8153-3244; ambayya, angeli/0000-0001-9294-0320	Ministry of Health, Malaysia [10-277-5480]	Ministry of Health, Malaysia	This project was funded by the Ministry of Health, Malaysia (Research ID 10-277-5480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, THROMB RES, V118, P463, DOI 10.1016/j.thromres.2005.09.007; Achie LN, 2011, ASIAN J MED SCI, V3, P154; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Bull B S, 2003, Lab Hematol, V9, P1; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Hafiza Alauddin, 2012, Malays J Pathol, V34, P161; Hsieh MM, 2010, J CLIN ONCOL, V28, P1633, DOI 10.1200/JCO.2009.24.3881; Ittermann T, 2010, CLIN LAB, V56, P9; Jung H, 2010, KOREAN J LAB MED, V30, P451, DOI 10.3343/kjlm.2010.30.5.451; LEWIS SM, 1982, CLIN LAB HAEMATOL, V4, P83; Loh S P, 2010, MALAYSIAN J MED HLTH, V6, P63; Milman N, 2009, ANN HEMATOL, V88, P687, DOI 10.1007/s00277-008-0647-9; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Ministry of Health Malaysia, 2008, TRANSF PRACT GUID CL, P15; NHANES, 2007, LAB PROC MAN; Osei-Bimpong A, 2012, INT J LAB HEMATOL, V34, P91, DOI 10.1111/j.1751-553X.2011.01365.x; Pekelharing J, 2010, SYSMEX J INT, V20, P1; Roshan TM, 2009, INT J LAB HEMATOL, V31, P505, DOI 10.1111/j.1751-553X.2008.01068.x; Sirdah MM, 2008, J CLIN LAB ANAL, V22, P353, DOI 10.1002/jcla.20265; Subhashree AR, 2012, J CLIN DIAGN RES, V6, P1675, DOI 10.7860/JCDR/2012/4882.2630; Urrechaga E, 2013, INT J LAB HEMATOL, V35, P144, DOI 10.1111/ijlh.12013; Urrechaga E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603786; Urrechaga E, 2010, ANEMIA, V2010, DOI 10.1155/2010/625919; Urrechaga E, 2009, CLIN CHEM LAB MED, V47, P1411, DOI 10.1515/CCLM.2009.301; World Health Organization, 2011, HAEM CONC DIAGN ASS; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	29	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91968	10.1371/journal.pone.0091968	http://dx.doi.org/10.1371/journal.pone.0091968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642526	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000333259900052
J	Gates, KM; Molenaar, PCM; Iyer, SP; Nigg, JT; Fair, DA				Gates, Kathleen M.; Molenaar, Peter C. M.; Iyer, Swathi P.; Nigg, Joel T.; Fair, Damien A.			Organizing Heterogeneous Samples Using Community Detection of GIMME-Derived Resting State Functional Networks	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EPISODIC RETRIEVAL; BRAIN NETWORKS; GLOBAL SIGNAL; CONNECTIVITY; FMRI; ARCHITECTURE; PSYCHIATRY; PATTERNS; CHILDREN	Clinical investigations of many neuropsychiatric disorders rely on the assumption that diagnostic categories and typical control samples each have within-group homogeneity. However, research using human neuroimaging has revealed that much heterogeneity exists across individuals in both clinical and control samples. This reality necessitates that researchers identify and organize the potentially varied patterns of brain physiology. We introduce an analytical approach for arriving at subgroups of individuals based entirely on their brain physiology. The method begins with Group Iterative Multiple Model Estimation (GIMME) to assess individual directed functional connectivity maps. GIMME is one of the only methods to date that can recover both the direction and presence of directed functional connectivity maps in heterogeneous data, making it an ideal place to start since it addresses the problem of heterogeneity. Individuals are then grouped based on similarities in their connectivity patterns using a modularity approach for community detection. Monte Carlo simulations demonstrate that using GIMME in combination with the modularity algorithm works exceptionally well - on average over 97% of simulated individuals are placed in the accurate subgroup with no prior information on functional architecture or group identity. Having demonstrated reliability, we examine resting-state data of fronto-parietal regions drawn from a sample (N = 80) of typically developing and attention-deficit/hyperactivity disorder (ADHD) - diagnosed children. Here, we find 5 subgroups. Two subgroups were predominantly comprised of ADHD, suggesting that more than one biological marker exists that can be used to identify children with ADHD based from their brain physiology. Empirical evidence presented here supports notions that heterogeneity exists in brain physiology within ADHD and control samples. This type of information gained from the approach presented here can assist in better characterizing patients in terms of outcomes, optimal treatment strategies, potential gene-environment interactions, and the use of biological phenomenon to assist with mental health.	[Gates, Kathleen M.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27514 USA; [Molenaar, Peter C. M.] Penn State Univ, Dept Human Dev & Family Studies, State Coll, PA USA; [Iyer, Swathi P.; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA	University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Gates, KM (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27514 USA.	kmgates@unc.edu			NIH [R01 MH86654, K99/R00 MH091238, R01 MH096773, R21 EB015573]; Oregon Clinical and Translational Research Institute; Medical Research Foundation; NSF [1157220]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH091238, R01MH086654, R01MH096773] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1157220] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Clinical and Translational Research Institute; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported in part by NIH (http://grants.nih.gov/grants/oer.htm) grants R01 MH86654 (JTN), K99/R00 MH091238 (DAF), R01 MH096773 (DAF), and R21 EB015573 (KMG), the Oregon Clinical and Translational Research Institute (http://www.ohsu.edu/xd/research/centers-institutes/octri/) (DAF), the Medical Research Foundation (http://www.ohsu.edu/xd/about/foundation/about/medical-research-foundation/) (DAF), and and NSF grant 1157220 (http://www.nsf.gov/funding/) (PCMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltz AM, 2013, ADDICT BEHAV, V38, P2052, DOI 10.1016/j.addbeh.2012.12.023; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Conners C. K., 2008, CONNERS 3 EDITION CO, V3rd; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friedman BH, 2003, INTEGR PHYS BEH SCI, V38, P295, DOI 10.1007/BF02688859; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gates KM, 2010, NEUROIMAGE, V50, P1118, DOI 10.1016/j.neuroimage.2009.12.117; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kherif F, 2003, NEUROIMAGE, V20, P2197, DOI 10.1016/j.neuroimage.2003.08.018; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Kutner M. H., 2004, APPL LINEAR REGRESSI; LAMIELL JT, 1981, AM PSYCHOL, V36, P276, DOI 10.1037/0003-066X.36.3.276; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Miller MB, 2002, J COGNITIVE NEUROSCI, V14, P1200, DOI 10.1162/089892902760807203; Miller MB, 2007, INT J PSYCHOPHYSIOL, V63, P205, DOI 10.1016/j.ijpsycho.2006.03.019; Molenaar P.C.M., 2004, MEAS-INTERDISCIP RES, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; Molenaar PCM, 2008, DEV PSYCHOBIOL, V50, P60, DOI 10.1002/dev.20262; Mumford JA, 2014, NEUROIMAGE, V86, P573, DOI 10.1016/j.neuroimage.2013.10.020; Musser ED, 2013, J AM ACAD CHILD PSY, V52, P163, DOI 10.1016/j.jaac.2012.11.009; Nesselroade J. R., 1979, LONGITUDINAL RES STU; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nichols TT, ADDICT BIOL IN PRESS; Nikolas MA, 2013, NEUROPSYCHOLOGY, V27, P107, DOI 10.1037/a0030685; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Puig-Antich J., 1986, SCHEDULE AFFECTIVE D; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Satterthwaite TD, 2013, NEUROIMAGE, V83, P45, DOI 10.1016/j.neuroimage.2013.06.045; Seghier ML, 2008, HUM BRAIN MAPP, V29, P461, DOI 10.1002/hbm.20410; Silk T, 2005, BRIT J PSYCHIAT, V187, P282, DOI 10.1192/bjp.187.3.282; Silk TJ, 2008, BRAIN IMAGING BEHAV, V2, P123, DOI 10.1007/s11682-008-9021-8; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Talairach J., 1988, COPLANAR STEREOTAXIC; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Wechsler D, 1974, WECHSLER INTELLIGENC; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004	58	73	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91322	10.1371/journal.pone.0091322	http://dx.doi.org/10.1371/journal.pone.0091322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642753	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900018
J	Henrich, B; Rumming, M; Sczyrba, A; Velleuer, E; Dietrich, R; Gerlach, W; Gombert, M; Rahn, S; Stoye, J; Borkhardt, A; Fischer, U				Henrich, Birgit; Rumming, Madis; Sczyrba, Alexander; Velleuer, Eunike; Dietrich, Ralf; Gerlach, Wolfgang; Gombert, Michael; Rahn, Sebastian; Stoye, Jens; Borkhardt, Arndt; Fischer, Ute			Mycoplasma salivarium as a Dominant Coloniser of Fanconi Anaemia Associated Oral Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RIBOSOMAL-RNA; STREPTOCOCCUS-ANGINOSUS; PSEUDOMONAS-AERUGINOSA; MICROBIAL COMMUNITY; MOLECULAR ANALYSIS; BACTERIA PRESENT; INFECTION; HEAD; NECK	Mycoplasma salivarium belongs to the class of the smallest self-replicating Tenericutes and is predominantly found in the oral cavity of humans. In general it is considered as a non-pathogenic commensal. However, some reports point to an association with human diseases. M. salivarium was found e.g. as causative agent of a submasseteric abscess, in necrotic dental pulp, in brain abscess and clogged biliary stent. Here we describe the detection of M. salivarium on the surface of a squamous cell carcinoma of the tongue of a patient with Fanconi anaemia (FA). FA is an inherited bone marrow failure syndrome based on defective DNA-repair that increases the risk of carcinomas especially oral squamous cell carcinoma. Employing high coverage, massive parallel Roche/454-next-generation-sequencing of 16S rRNA gene amplicons we analysed the oral microbiome of this FA patient in comparison to that of an FA patient with a benign leukoplakia and five healthy individuals. The microbiota of the FA patient with leukoplakia correlated well with that of the healthy controls. A dominance of Streptococcus, Veillonella and Neisseria species was typically observed. In contrast, the microbiome of the cancer bearing FA patient was dominated by Pseudomonas aeruginosa at the healthy sites, which changed to a predominance of 98% M. salivarium on the tumour surface. Quantification of the mycoplasma load in five healthy, two tumour- and two leukoplakia-FA patients by TaqMan-PCR confirmed the prevalence of M. salivarium at the tumour sites. These new findings suggest that this mycoplasma species with its reduced coding capacity found ideal breeding grounds at the tumour sites. Interestingly, the oral cavity of all FA patients and especially samples at the tumour sites were in addition positive for Candida albicans. It remains to be elucidated in further studies whether M. salivarium can be used as a predictive biomarker for tumour development in these patients.	[Henrich, Birgit; Rahn, Sebastian] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Rumming, Madis; Velleuer, Eunike; Gombert, Michael; Borkhardt, Arndt; Fischer, Ute] Univ Dusseldorf, Dept Paediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Fac Med, Dusseldorf, Germany; [Rumming, Madis; Sczyrba, Alexander; Gerlach, Wolfgang; Stoye, Jens] Univ Bielefeld, Fac Technol, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Dietrich, Ralf] German Fanconi Anemia Help eV, Unna, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Bielefeld	Henrich, B (corresponding author), Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany.	birgit.henrich@uni-duesseldorf.de	Velleuer, Eunike/U-6355-2019	Velleuer, Eunike/0000-0003-4328-9556; Sczyrba, Alexander/0000-0002-4405-3847				Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Alcaraz LD, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2012.03857.x; Baracaldo R, 2012, J CLIN MICROBIOL, V50, P1805, DOI 10.1128/JCM.06839-11; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Do T, 2013, CLIN COSMET INVESTIG, V5, P11, DOI 10.2147/CCIDE.S31005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ENGEL L D, 1970, Journal of Periodontal Research, V5, P163; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Grisold AJ, 2008, J CLIN MICROBIOL, V46, P3860, DOI 10.1128/JCM.00807-08; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He X, 2011, MOL ORAL MICROBIOL, V26, P337, DOI 10.1111/j.2041-1014.2011.00622.x; Henrich B, 2010, J MED MICROBIOL, V59, P239, DOI 10.1099/jmm.0.013110-0; Hooper SJ, 2007, J MED MICROBIOL, V56, P1651, DOI 10.1099/jmm.0.46918-0; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hsiao WWL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-345; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; KUNDSIN RB, 1967, AM J EPIDEMIOL, V86, P579, DOI 10.1093/oxfordjournals.aje.a120767; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; LOWBURY EJL, 1970, J MED MICROBIOL, V3, P39, DOI 10.1099/00222615-3-1-39; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Magurran A., 2004, MEASURING BIOL DIVER, P1, DOI 10.2989/16085910409503825.; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; Orsted I, 2011, CLIN MICROBIOL INFEC, V17, P1047, DOI 10.1111/j.1469-0691.2011.03462.x; Panghal M, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-22; Park David R, 2005, Respir Care, V50, P742; Park DR, 2005, RESP CARE, V50, P763; Pushalkar S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-144; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sasaki M, 2005, ORAL DIS, V11, P151, DOI 10.1111/j.1601-0825.2005.01051.x; Schabereiter-Gurtner C, 2007, J CLIN MICROBIOL, V45, P906, DOI 10.1128/JCM.01344-06; Scheckenbach K, 2012, KLIN PADIATR, V224, P132, DOI 10.1055/s-0032-1308989; Shiga K, 2001, ONCOL REP, V8, P245; SO AKL, 1983, BRIT MED J, V286, P762, DOI 10.1136/bmj.286.6367.762; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Tateda M, 2000, INT J MOL MED, V6, P699; Vandecandelaere I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038401; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WATANABE T, 1986, J CLIN MICROBIOL, V23, P1034, DOI 10.1128/JCM.23.6.1034-1038.1986; Watanabe T, 1998, FEMS IMMUNOL MED MIC, V22, P241, DOI 10.1111/j.1574-695X.1998.tb01212.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	59	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92297	10.1371/journal.pone.0092297	http://dx.doi.org/10.1371/journal.pone.0092297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642836	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900119
J	Jonas, M; Eloka, O; Stephan, J; Franz, VH				Jonas, Melanie; Eloka, Owino; Stephan, Julia; Franz, Volker H.			Need for Space: The Key Distance Effect Depends on Spatial Stimulus Configurations	PLOS ONE			English	Article							S-R COMPATIBILITY; RESPONSE COMPATIBILITY; INTERFERENCE	In numerous psychological experiments, participants classify stimuli by pressing response keys. According to Lakens, Schneider, Jostmann, and Schubert (2011), classification performance is affected by physical distance between response keys - indicating a cognitive tendency to represent categories in spatial code. However, previous evidence for a key distance effect (KDE) from a color-naming Stroop task is inconclusive as to whether: (a) key separation automatically leads to an internal spatial representation of non-spatial stimulus characteristics in participants, or if the KDE rather depends on physical spatial characteristics of the stimulus configuration; (b) the KDE attenuates the Stroop interference effect. We therefore first adopted the original Stroop task in Experiment 1, confirming that wider key distance facilitated responses, but did not modulate the Stroop effect as was previously found. In Experiments 2 and 3 we controlled potential mediator variables in the original design. When we did not display instructions about stimulus-response mappings, thereby removing the unintended spatial context from the Stroop stimuli, no KDE emerged. Presenting the instructions at a central position in Experiment 4 confirmed that key separation alone is not sufficient for a KDE, but correspondence between spatial configurations of stimuli and responses is also necessary. Evidence indicates that the KDE on Stroop performance is due to known mechanisms of stimulus-response compatibility and response discriminability. The KDE does, however, not demonstrate a general disposition to represent any stimulus in spatial code.	[Jonas, Melanie; Eloka, Owino; Stephan, Julia; Franz, Volker H.] Univ Hamburg, Dept Psychol, Hamburg, Germany	University of Hamburg	Jonas, M (corresponding author), Univ Hamburg, Dept Psychol, Hamburg, Germany.	melanie.jonas@uni-hamburg.de	Franz, Volker H/K-4128-2012	Franz, Volker H/0000-0002-8457-0611	Hochschulpakt; University of Hamburg; International Graduate Research Training Group [IKG-1247]; Deutsche Forschungsgemeinschaft (DFG)	Hochschulpakt; University of Hamburg; International Graduate Research Training Group; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by funding of MJ through Hochschulpakt 2020 (HSP I, URL: http://www.bmbf.de/de/6142.php), a scholarship of the University of Hamburg (URL: http://www.uni-hamburg.de/forschung/nachwuchs/promotion/stipendienwegweiser/promotionsstipendien.html) to OE, and a research grant to VH within the International Graduate Research Training Group (No. IKG-1247) on Cross-Modal Interaction in Natural and Artificial Cognitive Systems (CINACS) from the Deutsche Forschungsgemeinschaft (DFG, URL: http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id = 968025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 2003, COGNITIVE PSYCHOL, V46, P302, DOI 10.1016/S0010-0285(02)00516-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Clark A, 2008, SUPERSIZING MIND EMB; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Franz VH, 2012, PSYCHON B REV, V19, P395, DOI 10.3758/s13423-012-0230-1; Heister G., 1990, STIMULUS RESPONSE CO, DOI DOI 10.1016/S0166-4115(08)61220-0; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; Koch I, 2011, ACTA PSYCHOL, V136, P399, DOI 10.1016/j.actpsy.2011.01.006; Lakens D, 2011, PSYCHOL SCI, V22, P887, DOI 10.1177/0956797611412391; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MILLER J, 1985, J EXP PSYCHOL HUMAN, V11, P221; Nett N, 2014, EXP PSYCHOL, V61, P142, DOI 10.1027/1618-3169/a000234; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Proctor RW, 2012, ACTA PSYCHOL, V141, P39, DOI 10.1016/j.actpsy.2012.06.005; Shimizu H, 2002, BEHAV RES METH INS C, V34, P250, DOI 10.3758/BF03195452; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Stins JF, 2000, Q J EXP PSYCHOL-A, V53, P569, DOI 10.1080/027249800390619; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vu KPL, 2002, PERCEPT PSYCHOPHYS, V64, P815, DOI 10.3758/BF03194748; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892	24	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91432	10.1371/journal.pone.0091432	http://dx.doi.org/10.1371/journal.pone.0091432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642888	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900021
J	Oku, Y; Tareyanagi, C; Takaya, S; Osaka, S; Ujiie, H; Yoshida, K; Nishiya, N; Uehara, Y				Oku, Yusuke; Tareyanagi, Chiaki; Takaya, Shinichi; Osaka, Sayaka; Ujiie, Haruki; Yoshida, Kentaro; Nishiya, Naoyuki; Uehara, Yoshimasa			Multimodal Effects of Small Molecule ROCK and LIMK Inhibitors on Mitosis, and Their Implication as Anti-Leukemia Agents	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; AURORA-A; THERAPEUTIC TARGETS; MITOTIC CHECKPOINT; MIS-SEGREGATION; KINASE; CELLS; ANEUPLOIDY; IDENTIFICATION; REGULATOR	Accurate chromosome segregation is vital for cell viability. Many cancer cells show chromosome instability (CIN) due to aberrant expression of the genes involved in chromosome segregation. The induction of massive chromosome segregation errors in such cancer cells by small molecule inhibitors is an emerging strategy to kill these cells selectively. Here we screened and characterized small molecule inhibitors which cause mitotic chromosome segregation errors to target cancer cell growth. We screened about 300 chemicals with known targets, and found that Rho-associated coiled-coil kinase (ROCK) inhibitors bypassed the spindle assembly checkpoint (SAC), which delays anaphase onset until proper kinetochore-microtubule interactions are established. We investigated how ROCK inhibitors affect chromosome segregation, and found that they induced microtubule-dependent centrosome fragmentation. Knockdown of ROCK1 and ROCK2 revealed their additive roles in centrosome integrity. Pharmacological inhibition of LIMK also induced centrosome fragmentation similar to that by ROCK inhibitors. Inhibition of ROCK or LIMK hyper-stabilized mitotic spindles and impaired Aurora-A activation. These results suggested that ROCK and LIMK are directly or indirectly involved in microtubule dynamics and activation of Aurora-A. Furthermore, inhibition of ROCK or LIMK suppressed T cell leukemia growth in vitro, but not peripheral blood mononuclear cells. They induced centrosome fragmentation and apoptosis in T cell leukemia cells. These results suggested that ROCK and LIMK can be a potential target for anti-cancer drugs.	[Oku, Yusuke; Tareyanagi, Chiaki; Takaya, Shinichi; Osaka, Sayaka; Ujiie, Haruki; Yoshida, Kentaro; Nishiya, Naoyuki; Uehara, Yoshimasa] Iwate Med Univ, Sch Pharmaceut Sci, Dept Microbial Chem Biol & Drug Discovery, Yahaba, Iwate, Japan	Iwate Medical University	Uehara, Y (corresponding author), Iwate Med Univ, Sch Pharmaceut Sci, Dept Microbial Chem Biol & Drug Discovery, Yahaba, Iwate, Japan.	yuehara@iwate-med.ac.jp	Uehara, Yoshimasa/G-1060-2014	Nishiya, Naoyuki/0000-0003-1575-9944	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23501310, 221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is in part supported by a Grant-in-Aid for Strategic Medical Science Research Center from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Bergnes G, 2005, CURR TOP MED CHEM, V5, P127, DOI 10.2174/1568026053507697; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; De Luca M, 2008, ONCOGENE, V27, P6539, DOI 10.1038/onc.2008.252; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Farrell P, 2013, MOL CANCER THER, V12, P460, DOI 10.1158/1535-7163.MCT-12-0657; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Johnson EO, 2012, J CELL SCI, V125, P1204, DOI 10.1242/jcs.092304; Jones R, 2013, INVEST NEW DRUG, V31, P1001, DOI 10.1007/s10637-013-9926-y; Katayama H, 2012, CANCER CELL, V21, P196, DOI 10.1016/j.ccr.2011.12.025; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Petrilli A, 2013, ONCOGENE; Ritchey L, 2012, CELL CYCLE, V11, P296, DOI 10.4161/cc.11.2.18734; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shan WW, 2012, CLIN CANCER RES, V18, P3352, DOI 10.1158/1078-0432.CCR-11-3058; Shimokawa H, 2002, J CARDIOVASC PHARM, V40, P749; Sumi T, 2006, EXP CELL RES, V312, P1021, DOI 10.1016/j.yexcr.2005.12.030; Tannous BA, 2013, J NATL CANC I; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tomita M, 2010, CANCER SCI, V101, P1204, DOI 10.1111/j.1349-7006.2010.01499.x; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Wysong DR, 2009, CELL CYCLE, V8, P876, DOI 10.4161/cc.8.6.7897; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150	41	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92402	10.1371/journal.pone.0092402	http://dx.doi.org/10.1371/journal.pone.0092402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642638	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900133
J	Streb, S; Zeeman, SC				Streb, Sebastian; Zeeman, Samuel C.			Replacement of the Endogenous Starch Debranching Enzymes ISA1 and ISA2 of Arabidopsis with the Rice Orthologs Reveals a Degree of Functional Conservation during Starch Synthesis	PLOS ONE			English	Article							GRANULE INITIATION; ISOAMYLASE GENE; HOMO-OLIGOMER; AMYLOPECTIN; MUTANTS; BIOSYNTHESIS; MAIZE; METABOLISM; ENDOSPERM; BREAKDOWN	This study tested the interchangeability of enzymes in starch metabolism between dicotyledonous and monocotyledonous plant species. Amylopectin - a branched glucose polymer - is the major component of starch and is responsible for its semicrystalline property. Plants synthesize starch with distinct amylopectin structures, varying between species and tissues. The structure determines starch properties, an important characteristic for cooking and nutrition, and for the industrial uses of starch. Amylopectin synthesis involves at least three enzyme classes: starch synthases, branching enzymes and debranching enzymes. For all three classes, several enzyme isoforms have been identified. However, it is not clear which enzyme(s) are responsible for the large diversity of amylopectin structures. Here, we tested whether the specificities of the debranching enzymes (ISA1 and ISA2) are major determinants of species-dependent differences in amylopectin structure by replacing the dicotyledonous Arabidopsis isoamylases (AtISA1 and AtISA2) with the monocotyledonous rice (Oryza sativa) isoforms. We demonstrate that the ISA1 and ISA2 are sufficiently well conserved between these species to form heteromultimeric chimeric Arabidopsis/rice isoamylase enzymes. Furthermore, we were able to reconstitute the endosperm-specific rice OsISA1 homomultimeric complex in Arabidopsis isa1isa2 mutants. This homomultimer was able to facilitate normal rates of starch synthesis. The resulting amylopectin structure had small but significant differences in comparison to wild-type Arabidopsis amylopectin. This suggests that ISA1 and ISA2 have a conserved function between plant species with a major role in facilitating the crystallization of pre-amylopectin synthesized by starch synthases and branching enzymes, but also influencing the final structure of amylopectin.	[Streb, Sebastian; Zeeman, Samuel C.] ETH, Dept Biol, Inst Agr Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Streb, S (corresponding author), ETH, Dept Biol, Inst Agr Sci, Zurich, Switzerland.	sstreb@ethz.ch		Streb, Sebastian/0000-0002-9095-6596; Zeeman, Samuel/0000-0002-2791-0915	Swiss National Science Foundation [3100AO-116434/1, 31003A-131074]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The work was funded by the Swiss National Science Foundation (Grant Nos. 3100AO-116434/1 and 31003A-131074) and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof S, 2013, PLANT CELL, V25, P1400, DOI 10.1105/tpc.113.109793; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Facon M, 2013, PLANT PHYSIOL, V163, P1363, DOI 10.1104/pp.113.225565; Fujita N, 1999, PLANTA, V208, P283, DOI 10.1007/s004250050560; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Hostettler C, 2011, METHODS MOL BIOL, V775, P387, DOI 10.1007/978-1-61779-237-3_21; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; MACGREGOR EA, 1993, STARCH-STARKE, V45, P232, DOI 10.1002/star.19930450705; Morell MK, 1998, ELECTROPHORESIS, V19, P2603, DOI 10.1002/elps.1150191507; Mouille G, 1996, PLANT CELL, V8, P1353; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Rahman S, 2003, GENOME, V46, P496, DOI 10.1139/g02-130; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Sundberg M, 2013, PLOS ONE IN PRESS; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	34	19	19	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92174	10.1371/journal.pone.0092174	http://dx.doi.org/10.1371/journal.pone.0092174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642810	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900098
J	Terry, RL; Kaneb, HM; Wells, DJ				Terry, Rebecca L.; Kaneb, Hannah M.; Wells, Dominic J.			Poloxomer 188 Has a Deleterious Effect on Dystrophic Skeletal Muscle Function	PLOS ONE			English	Article							MEMBRANE SEALANT POLOXAMER; MDX MICE; MUSCULAR-DYSTROPHY; BLOCK-COPOLYMERS; MOUSE; PHARMACOKINETICS; CONTRACTION; SARCOLEMMA; INJECTION; PROTECTS	Duchenne muscular dystrophy (DMD) is an X-linked, fatal muscle wasting disease for which there is currently no cure and limited palliative treatments. Poloxomer 188 (P188) is a tri-block copolymer that has been proposed as a potential treatment for cardiomyopathy in DMD patients. Despite the reported beneficial effects of P188 on dystrophic cardiac muscle function, the effects of P188 on dystrophic skeletal muscle function are relatively unknown. Mdx mice were injected intraperitoneally with 460 mg/kg or 30 mg/kg P188 dissolved in saline, or saline alone (control). The effect of single-dose and 2-week daily treatment was assessed using a muscle function test on the Tibialis Anterior (TA) muscle in situ in anaesthetised mice. The test comprises a warm up, measurement of the force-frequency relationship and a series of eccentric contractions with a 10% stretch that have previously been shown to cause a drop in maximum force in mdx mice. After 2 weeks of P188 treatment at either 30 or 460 mg/kg/day the drop in maximum force produced following eccentric contractions was significantly greater than that seen in saline treated control mice (P = 0.0001). Two week P188 treatment at either dose did not significantly change the force-frequency relationship or maximum isometric specific force produced by the TA muscle. In conclusion P188 treatment increases susceptibility to contraction-induced injury following eccentric contractions in dystrophic skeletal muscle and hence its suitability as a potential therapeutic for DMD should be reconsidered.	[Terry, Rebecca L.; Kaneb, Hannah M.; Wells, Dominic J.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Kaneb, Hannah M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Cellular & Mol Neurosci, London, England	University of London; University of London Royal Veterinary College; Imperial College London	Wells, DJ (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Royal Coll St, London, England.	dwells@rvc.ac.uk		Wells, Dominic/0000-0002-1425-6344	Wellcome Trust Integrated Veterinary Research Fellowship	Wellcome Trust Integrated Veterinary Research Fellowship	Dr Rebecca Terry was funded by a Wellcome Trust Integrated Veterinary Research Fellowship. http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; Alvarez-Lorenzo C, 2011, CURR DRUG TARGETS, V12, P1112, DOI 10.2174/138945011795906615; [Anonymous], 2013, PHAS 3 RAND STUD POL; Brockington M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014434; Broze GJ, 2001, THROMB HAEMOSTASIS, V85, P747; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Burns JW, 2011, RESUSCITATION, V82, P1453, DOI 10.1016/j.resuscitation.2011.06.007; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Chen YC, 2011, CELL BIOCHEM BIOPHYS, V60, P267, DOI 10.1007/s12013-010-9149-1; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Demina T, 2005, BIOCHEMISTRY-US, V44, P4042, DOI 10.1021/bi048373q; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Greenebaum B, 2004, BURNS, V30, P539, DOI 10.1016/j.burns.2004.02.009; Grindel JM, 2002, BIOPHARM DRUG DISPOS, V23, P87, DOI 10.1002/bdd.297; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Jewell RC, 1997, J PHARM SCI, V86, P808, DOI 10.1021/js960491e; Kabanov AV, 2003, J CONTROL RELEASE, V91, P75, DOI 10.1016/S0168-3659(03)00211-6; Krylova OO, 2003, CHEM-EUR J, V9, P3930, DOI 10.1002/chem.200204621; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; MOKRI B, 1975, NEUROLOGY, V25, P1111, DOI 10.1212/WNL.25.12.1111; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Ng R, 2008, AM J PHYSIOL-CELL PH, V295, pC146, DOI 10.1152/ajpcell.00017.2008; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Quinlan JG, 2006, NEUROMUSCULAR DISORD, V16, P855, DOI 10.1016/j.nmd.2006.09.016; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Spurney CF, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-20; Townsend D, 2010, J CLIN INVEST, V120, P1140, DOI 10.1172/JCI41329; Wang JY, 2010, LANGMUIR, V26, P12953, DOI 10.1021/la101841a; Wooddell CI, 2010, MUSCLE NERVE, V41, P487, DOI 10.1002/mus.21527; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275	33	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91221	10.1371/journal.pone.0091221	http://dx.doi.org/10.1371/journal.pone.0091221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642557	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000333259900014
J	Yang, HJ; Kim, YE; Yun, JY; Kim, HJ; Jeon, BS				Yang, Hui-Jun; Kim, Young Eun; Yun, Ji Young; Kim, Han-Joon; Jeon, Beom Seok			Identifying the Clusters within Nonmotor Manifestations in Early Parkinson's Disease by Using Unsupervised Cluster Analysis	PLOS ONE			English	Article							OLFACTORY DYSFUNCTION; PREMOTOR PHASE; HETEROGENEITY; IDENTIFICATION; SUBTYPES; MOTOR; ASSOCIATION; PROGRESSION; FEATURES; RISK	Background: Classical and data-driven classifications of Parkinson's disease (PD) are based primarily on motor symptoms, with little attention being paid to the clustering of nonmotor manifestations. Methods: Clinical data on demographic, motor and nonmotor features, including the Korean version of the sniffin' stick (KVSS) test results, and responses to the screening questionnaire of the nonmotor features were collected from 56 PD patients with disease onset within 3 years. Nonmotor subgroups were classified using unsupervised hierarchical cluster analysis (HCA). In addition to unsupervised HCA, we performed a cross-sectional analysis comparing the performance on the KVSS olfactory test with other nonmotor manifestations of the patients. Results: Forty-nine patients (87.5%) had hyposmia based on the KVSS test. HCA suggested three nonmotor clusters for all PD patients and two nonmotor clusters in de novo PD patients, without a priori assumptions about the relatedness. In the cross-sectional analysis, dream-enactment behavior was more prevalent in patients with lower olfactory scores, implying impaired olfactory function (P = 0.029 for all PD patients; P = 0.046 for de novo PD patients). Conclusion: We propose the existence of different clusters of nonmotor manifestations in early PD by using unsupervised hierarchical clustering. To our knowledge, this study is the first to report the identification of nonmotor subgroups based on unsupervised HCA of multiple nonmotor manifestations in the early stage of the disease.	[Yang, Hui-Jun] Ulsan Univ Hosp, Dept Neurol, Ulsan, South Korea; [Kim, Young Eun; Kim, Han-Joon; Jeon, Beom Seok] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Young Eun; Kim, Han-Joon; Jeon, Beom Seok] Seoul Natl Univ Hosp, Movement Disorder Ctr, Parkinson Study Grp, Neurosci Res Inst, Seoul 110744, South Korea; [Yun, Ji Young] Ewha Womans Univ, Mokdong Hosp, Dept Neurol, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University	Jeon, BS (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	brain@snu.ac.kr	Yang, Hui-Jun/M-5881-2014	Yang, Hui-Jun/0000-0002-3593-1134; Kim, Han-Joon/0000-0001-8219-9663	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A101273, A110875]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by grants of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A101273 and A110875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2011, MOVEMENT DISORD, V26, P621, DOI 10.1002/mds.23602; Berendse HW, 2011, J NEUROL SCI, V310, P21, DOI 10.1016/j.jns.2011.06.020; Berg D, 2013, EUR J NEUROL, V20, P102, DOI 10.1111/j.1468-1331.2012.03798.x; Chen HL, 2013, ENVIRON HEALTH PERSP, V121, P1245, DOI 10.1289/ehp.1306967; Cho JH, 2009, AURIS NASUS LARYNX, V36, P280, DOI 10.1016/j.anl.2008.07.005; Cramer CK, 2010, PARKINSONISM RELAT D, V16, P124, DOI 10.1016/j.parkreldis.2009.09.004; Dujardin K, 2004, J NEUROL, V251, P1383, DOI 10.1007/s00415-004-0549-2; ezankova R., 2009, STAT-US, V46, P216; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Gasparoli E, 2002, NEUROL SCI, V23, pS77, DOI 10.1007/s100720200078; Goldstein DS, 2010, NEUROLOGY, V74, P245, DOI 10.1212/WNL.0b013e3181ca014c; Graham JM, 1999, MOVEMENT DISORD, V14, P10; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Hong S.C., 1999, KOREAN J OTORHINOLAR, V42, P855; Kim HJ, 2009, J NEUROL SCI, V287, P200, DOI 10.1016/j.jns.2009.07.026; Lemer A, 2008, MOVEMENT DISORD, V23, P1076, DOI 10.1002/mds.22066; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Liepelt-Scarfone I, 2013, NEUROEPIDEMIOLOGY, V41, P174, DOI 10.1159/000353560; Morley JF, 2011, J NEUROL SCI, V310, P228, DOI 10.1016/j.jns.2011.05.030; Morley JF, 2011, MOVEMENT DISORD, V26, P2051, DOI 10.1002/mds.23792; Lloret SP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/473579; Post B, 2008, J NEUROL, V255, P716, DOI 10.1007/s00415-008-0782-1; Postuma RB, 2011, MOVEMENT DISORD, V27, P617; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Ravina B, 2013, MOVEMENT DISORD, V28, P122, DOI 10.1002/mds.25325; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Schrag A, 2006, J NEUROL NEUROSUR PS, V77, P275; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Siderowf A, 2012, MOVEMENT DISORD, V27, P406, DOI 10.1002/mds.24892; Stiasny-Kolster K, 2005, BRAIN, V128, P126, DOI 10.1093/brain/awh322; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tolosa E, 2009, NEUROLOGY, V72, pS12, DOI 10.1212/WNL.0b013e318198db11; van Rooden SM, 2009, J NEUROL NEUROSUR PS, V80, P846, DOI 10.1136/jnnp.2008.166629; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91906	10.1371/journal.pone.0091906	http://dx.doi.org/10.1371/journal.pone.0091906			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643014	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900044
J	Chou, CL; Chou, CY; Hsu, CC; Chou, YC; Chen, TJ; Chou, LF				Chou, Chia-Lin; Chou, Chia-Yu; Hsu, Chia-Chen; Chou, Yueh-Ching; Chen, Tzeng-Ji; Chou, Li-Fang			Old Habits Die Hard: A Nationwide Utilization Study of Short-Acting Nifedipine in Taiwan	PLOS ONE			English	Article							SUBLINGUAL NIFEDIPINE; MANAGEMENT; RISK; GUIDELINES; MORTALITY; SOCIETY; HEALTH; SAFETY; ADULTS; DRUGS	Background: To investigate the nationwide trend of ambulatory prescriptions of short-acting nifedipine on a PRN (pro re nata) order over a fifteen-year period in Taiwan. Methods: The systematic sampling claims datasets (0.2% sampling ratio) of ambulatory care visits within Taiwan's National Health Insurance from 1997 to 2011 were analyzed. The prescriptions of short-acting capsule-form nifedipine on a PRN order were stratified by the patient's age, the prescribing physician's specialty, and the setting of healthcare facility for each year. Results: During the study period, 8,189,681 visits were analyzed. While the utilization rate of calcium channel blockers changed with time from 2.8% (13,767/489,636) in 1997 to 5.1% (31,349/614,719) in 2011, that of short-acting nifedipine were from 1.0% (n = 5,070) to 0.2% (n = 1,246). However, short-acting capsule-form nifedipine on a PRN order still existed (from 447 prescriptions in 1997 to 784 in 2011). More than one half of these PRN nifedipines were prescribed by the internists and to the elderly patients; almost four-fifths of PRN nifedipines were prescribed during non-emergent consultations. Conclusion: The physicians in Taiwan still had the habit of prescribing short-acting nifedipines for PRN use. The reason for such practices and the impact on patients' health deserve attention.	[Chou, Chia-Lin; Hsu, Chia-Chen; Chou, Yueh-Ching] Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan; [Chou, Chia-Yu; Chou, Yueh-Ching] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan; [Chou, Chia-Yu; Chou, Yueh-Ching] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chou, Chia-Yu] Taipei Med Univ, Coll Pharm, Taipei, Taiwan; [Chou, Chia-Yu] Natl Def Med Ctr, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chou, Chia-Yu] Tzu Chi Univ, Dept Med, Hualien, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chou, Li-Fang] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; National Defense Medical Center; Tzu Chi University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chengchi University	Chou, YC (corresponding author), Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan.	ycchou@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021; Hsu, Chia-Chen/AAB-3117-2019		Taipei Veterans General Hospital [V102C-160]; National Science Council in Taiwan [NSC99-2410-H-004-029-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Taipei Veterans General Hospital (V102C-160) and National Science Council in Taiwan (NSC99-2410-H-004-029-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blaszak RT, 2001, J PEDIATR-US, V139, P34, DOI 10.1067/mpd.2001.114699; Bureau of National Health Insurance Department of Health Executive Yuan, 2011, EX YUAN NAT HLTH INS; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Egger DW, 2002, PEDIATR NEPHROL, V17, P35, DOI 10.1007/s004670200006; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fretheim A, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-21; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Furmaga EM, 2005, ADV PATIENT SAFETY R, V3; GIFFORD RW, 1991, JAMA-J AM MED ASSOC, V266, P829, DOI 10.1001/jama.266.6.829; Grise EM, 2012, STROKE, V43, P557, DOI 10.1161/STROKEAHA.111.637983; Grossman E, 2004, PROG CARDIOVASC DIS, V47, P34, DOI 10.1016/j.pcad.2004.04.006; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Hemmelgarn BR, 2008, CAN J CARDIOL, V24, P507, DOI 10.1016/S0828-282X(08)70627-5; Ishibashi Y, 1999, CLIN EXP PHARMACOL P, V26, P404, DOI 10.1046/j.1440-1681.1999.03046.x; Jung SY, 2011, NEUROLOGY, V77, P1229, DOI 10.1212/WNL.0b013e318230201a; Kizer JR, 2000, PHARMACOEPIDEM DR S, V9, P25, DOI 10.1002/(SICI)1099-1557(200001/02)9:1<25::AID-PDS469>3.0.CO;2-E; Liu JY, 2001, EUR J CLIN PHARMACOL, V57, P505, DOI 10.1007/s002280100349; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marwick C, 1996, JAMA-J AM MED ASSOC, V275, P423, DOI 10.1001/jama.275.6.423; Maxwell CJ, 2000, PHARMACOEPIDEM DR S, V9, P11, DOI 10.1002/(SICI)1099-1557(200001/02)9:1<11::AID-PDS468>3.0.CO;2-U; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Messerli FH, 1999, ARCH INTERN MED, V159, P2259, DOI 10.1001/archinte.159.19.2259; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Rehman F, 1996, AM J HYPERTENS, V9, P1035, DOI 10.1016/0895-7061(96)00172-0; Saito M, 2005, EUR J CLIN PHARMACOL, V61, P531, DOI 10.1007/s00228-005-0974-x; Stafford RS, 2006, HYPERTENSION, V48, P213, DOI 10.1161/01.HYP.0000229653.73128.b6; Su Tung-Ping, 2002, Zhonghua Yi Xue Za Zhi (Taipei), V65, P378; Yiu V, 2004, PEDIATR NEPHROL, V19, P644, DOI 10.1007/s00467-004-1444-x	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91858	10.1371/journal.pone.0091858	http://dx.doi.org/10.1371/journal.pone.0091858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637880	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100070
J	Geng, P; Li, WL; Lin, L; de Miranda, JR; Emrich, S; An, LJ; Terenius, O				Geng, Peng; Li, Wenli; Lin, Lan; de Miranda, Joachim R.; Emrich, Scott; An, Lijia; Terenius, Olle			Genetic Characterization of a Novel Iflavirus Associated with Vomiting Disease in the Chinese Oak Silkmoth Antheraea pernyi	PLOS ONE			English	Article							PICORNA-LIKE VIRUS; DEFORMED-WING-VIRUS; PHYLOGENETIC ANALYSIS; ECTROPIS-OBLIQUA; SACBROOD VIRUS; SEQUENCE; VARROA-DESTRUCTOR-VIRUS-1; IDENTIFICATION; PREDICTION; TAXONOMY	Larvae of the Chinese oak silkmoth (Antheraea pernyi) are often affected by AVD (A. pernyi vomiting disease), whose causative agent has long been suspected to be a virus. In an unrelated project we discovered a novel positive sense single-stranded RNA virus that could reproduce AVD symptoms upon injection into healthy A. pernyi larvae. The genome of this virus is 10,163 nucleotides long, has a natural poly-A tail, and contains a single, large open reading frame flanked at the 5' and 3' ends by untranslated regions containing putative structural elements for replication and translation of the virus genome. The open reading frame is predicted to encode a 3036 amino acid polyprotein with four viral structural proteins (VP1-VP4) located in the N-terminal end and the non-structural proteins, including a helicase, RNA-dependent RNA polymerase and 3C-protease, located in the C-terminal end of the polyprotein. Putative 3C-protease and autolytic cleavage sites were identified for processing the polyprotein into functional units. The genome organization, amino acid sequence and phylogenetic analyses suggest that the virus is a novel species of the genus Iflavirus, with the proposed name of Antheraea pernyi Iflavirus (ApIV).	[Geng, Peng; Li, Wenli; Lin, Lan; An, Lijia] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China; [Lin, Lan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [de Miranda, Joachim R.; Terenius, Olle] Swedish Univ Agr Sci SLU, Dept Ecol, Uppsala, Sweden; [Emrich, Scott] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA	Dalian University of Technology; Shenyang Pharmaceutical University; Swedish University of Agricultural Sciences; University of Notre Dame	Terenius, O (corresponding author), Swedish Univ Agr Sci SLU, Dept Ecol, Uppsala, Sweden.	olle.terenius@slu.se		Terenius, Olle/0000-0002-9909-1859; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	Carl Trygger foundation; Swedish research council Formas	Carl Trygger foundation; Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This project was supported by the Carl Trygger foundation and the Swedish research council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-10; Berenyi O, 2007, APPL ENVIRON MICROB, V73, P3605, DOI 10.1128/AEM.00696-07; Berman J. J., 2012, TAXONOMIC GUIDE INFE, P237, DOI DOI 10.1016/B978-0-12-415895-5.00042-8; Bonning B, 2010, INSECT VIROLOGY; BREITBURD F, 1995, J VIROL, V69, P3959, DOI 10.1128/JVI.69.6.3959-3963.1995; Ce S, 2005, LIAONING AGR SCI, V4, P39; Choe SE, 2012, VET MICROBIOL, V157, P32, DOI 10.1016/j.vetmic.2011.12.007; Christian PD, 2005, J ECON ENTOMOL, V98, P1839, DOI 10.1603/0022-0493-98.6.1839; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Hunter WB, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_28.1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 2006, J GEN VIROL, V87, P3667, DOI 10.1099/vir.0.82090-0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Millan-Leiva A, 2012, J INVERTEBR PATHOL, V109, P127, DOI 10.1016/j.jip.2011.10.009; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Roberts LO, 2009, VIRUS RES, V139, P157, DOI 10.1016/j.virusres.2008.07.017; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terio V, 2008, NEW MICROBIOL, V31, P439; van Oers MM, 2010, INSECT VIROLOGY, P231; Wang XC, 2004, J GEN VIROL, V85, P1145, DOI 10.1099/vir.0.19638-0; Wu TY, 2007, FEBS LETT, V581, P3120, DOI 10.1016/j.febslet.2007.05.070; Ye S, 2012, VIROLOGY, V428, P136, DOI 10.1016/j.virol.2012.04.002; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	37	16	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92107	10.1371/journal.pone.0092107	http://dx.doi.org/10.1371/journal.pone.0092107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637949	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100112
J	Haller, C; Berthold, M; Wobser, D; Kropec, A; Lauriola, M; Schlensak, C; Huebner, J				Haller, Christoph; Berthold, Martin; Wobser, Dominique; Kropec, Andrea; Lauriola, Marinella; Schlensak, Christian; Huebner, Johannes			Cell-Wall Glycolipid Mutations and Their Effects on Virulence of E. faecalis in a Rat Model of Infective Endocarditis	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; RESISTANT ENTEROCOCCI; BIOFILM FORMATION; IN-VITRO; FAECIUM; DISEASE	Enterococci are among the major pathogens implicated in cardiac infections and biofilm formation. E. faecalis has been shown to play an important role in infectious endocarditis. Several distinct mechanisms for biofilm formation have been identified in E. faecalis. Our group has previously characterized two distinct bacterial glucosyltransferases playing key roles in the production of the major cell wall glycolipids and leading to reduced biofilm production. To assess if this mechanism is involved in the pathogenesis of enterococcal endocarditis we compared the wild-type strain of E. faecalis 12030 with two mutants in gene EF2891 and EF2890 respectively in a rat model of infective endocarditis. The results showed less endocarditic lesions and reduced colony counts per vegetation in the two mutants. indicating that the modification of bacterial surface lipids results in significantly reduced virulence in infective endocarditis. These results underscore the important role of biofilm formation in the pathogenicity of enterococcal endocarditis and may indicate an interesting target for novel therapeutic strategies.	[Haller, Christoph; Schlensak, Christian] Univ Med Ctr Tubingen, Dept Thorac & Cardiovasc Surg, Tubingen, Germany; [Berthold, Martin; Wobser, Dominique; Kropec, Andrea; Lauriola, Marinella] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Huebner, Johannes] Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Munich	Huebner, J (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Div Pediat Infect Dis, Munich, Germany.	johannes.huebner@med.uni-muenchen.de		Huebner, Johannes/0000-0003-1232-4646; lauriola, marinella/0000-0001-9228-5389				Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Baldassarri L, 2001, MED MICROBIOL IMMUN, V190, P113, DOI 10.1007/s00430-001-0096-8; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44; Guo QY, 2006, FEMS MICROBIOL LETT, V264, P8, DOI 10.1111/j.1574-6968.2006.00378.x; Heikens E, 2011, MICROBES; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Joyanes P, 2000, EUR J CLIN MICROBIOL, V19, P124, DOI 10.1007/s100960050443; Joyanes Providencia, 1999, Clin Microbiol Infect, V5, P382, DOI 10.1111/j.1469-0691.1999.tb00160.x; Nallapareddy SR, 2011, RELATIVE CONTRIBUTIO; Paganelli F, 2011, TRENDS MICROBIOLOGY; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; SANTORO J, 1978, INFECT IMMUN, V19, P915, DOI 10.1128/IAI.19.3.915-918.1978; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Su SH, 1998, ASAIO J, V44, P770, DOI 10.1097/00002480-199811000-00003; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Werner G., 2008, EURO SURVEILL, V13, P19046	23	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91863	10.1371/journal.pone.0091863	http://dx.doi.org/10.1371/journal.pone.0091863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637922	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100072
J	Karlas, T; Petroff, D; Garnov, N; Bohm, S; Tenckhoff, H; Wittekind, C; Wiese, M; Schiefke, I; Linder, N; Schaudinn, A; Busse, H; Kahn, T; Mossner, J; Berg, T; Troltzsch, M; Keim, V; Wiegand, J				Karlas, Thomas; Petroff, David; Garnov, Nikita; Boehm, Stephan; Tenckhoff, Hannelore; Wittekind, Christian; Wiese, Manfred; Schiefke, Ingolf; Linder, Nicolas; Schaudinn, Alexander; Busse, Harald; Kahn, Thomas; Moessner, Joachim; Berg, Thomas; Troeltzsch, Michael; Keim, Volker; Wiegand, Johannes			Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and H-1-MR Spectroscopy	PLOS ONE			English	Article							FATTY LIVER-DISEASE; VISCERAL ADIPOSE-TISSUE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; FIBROSIS; DIAGNOSIS; CAP; QUANTIFICATION; MRI; ASSOCIATION	Introduction: Non-invasive assessment of steatosis and fibrosis is of growing relevance in non-alcoholic fatty liver disease (NAFLD). H-1-Magnetic resonance spectroscopy (H-1-MRS) and the ultrasound-based controlled attenuation parameter (CAP) correlate with biopsy proven steatosis, but have not been correlated with each other so far. We therefore performed a headto- head comparison between both methods. Methods: Fifty patients with biopsy-proven NAFLD and 15 healthy volunteers were evaluated with H-1-MRS and transient elastography (TE) including CAP. Steatosis was defined according to the percentage of affected hepatocytes: S1 5-33%, S2 34-66%, S3 >= 67%. Results: Steatosis grade in patients with NAFLD was S1 36%, S2 40% and S3 24%. CAP and H-1-MRS significantly correlated with histopathology and showed comparable accuracy for the detection of hepatic steatosis: areas under the receiveroperating characteristics curves were 0.93 vs. 0.88 for steatosis >= S1 and 0.94 vs. 0.88 for >= S2, respectively. Boot-strapping analysis revealed a CAP cut-off of 300 dB/m for detection of S2-3 steatosis, while retaining the lower cut-off of 215 dB/m for the definition of healthy individuals. Direct comparison between CAP and H-1-MRS revealed only modest correlation (total cohort: r = 0.63 [0.44, 0.76]; NAFLD cases: r = 0.56 [0.32, 0.74]). For detection of F2-4 fibrosis TE had sensitivity and specificity of 100% and 98.1% at a cut-off value of 8.85 kPa. Conclusion: Our data suggest a comparable diagnostic value of CAP and H-1-MRS for hepatic steatosis quantification. Combined with the simultaneous TE fibrosis assessment, CAP represents an efficient method for non-invasive characterization of NAFLD. Limited correlation between CAP and H-1-MRS may be explained by different technical aspects, anthropometry, and presence of advanced liver fibrosis.	[Karlas, Thomas; Petroff, David; Garnov, Nikita; Linder, Nicolas; Schaudinn, Alexander; Wiegand, Johannes] Leipzig Univ Med Ctr, IFB AdiposityDis, Leipzig, Germany; [Karlas, Thomas; Moessner, Joachim; Troeltzsch, Michael; Keim, Volker; Wiegand, Johannes] Univ Hosp Leipzig, Div Gastroenterol & Rheumatol, Dept Med Neurol & Dermatol, Leipzig, Germany; [Petroff, David] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany; [Garnov, Nikita; Linder, Nicolas; Schaudinn, Alexander; Busse, Harald; Kahn, Thomas] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Boehm, Stephan; Tenckhoff, Hannelore; Wiese, Manfred; Berg, Thomas; Wiegand, Johannes] Univ Hosp Leipzig, Div Gastroenterol & Rheumatol, Sect Hepatol, Dept Med Neurol & Dermatol, Leipzig, Germany; [Wittekind, Christian] Univ Hosp Leipzig, Inst Pathol, Leipzig, Germany; [Schiefke, Ingolf] Klinikum St Georg, Clin Gastroenterol & Hepatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University	Wiegand, J (corresponding author), Leipzig Univ Med Ctr, IFB AdiposityDis, Leipzig, Germany.	johannes.wiegand@medizin.uni-leipzig.de	Karlas, Thomas/I-1782-2019	Karlas, Thomas/0000-0002-8109-8526; Berg, Thomas/0000-0003-0003-6241	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, K7-40]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (Project No. K7-40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2013, EXPERT REV GASTROENT, V7, P205, DOI [10.1586/EGH.13.7, 10.1586/egh.13.7]; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Corwin A, 2012, EMERG RADIOL, V19, P141, DOI 10.1007/s10140-011-1010-3; Cournane S, 2012, PHYS MED BIOL, V57, P3901, DOI 10.1088/0031-9155/57/12/3901; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Dyson JK, 2013, J CLIN PATHOL, V66, P1033, DOI 10.1136/jclinpath-2013-201620; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Friedrich-Rust M, 2012, EUR J RADIOL, V81, pE325, DOI 10.1016/j.ejrad.2011.10.029; Guiu B, 2012, GUT, V61, P1369, DOI 10.1136/gutjnl-2011-301780; Guiu B, 2012, EUR RADIOL, V22, P855, DOI 10.1007/s00330-011-2326-9; Guiu B, 2009, J HEPATOL, V51, P1082, DOI 10.1016/j.jhep.2009.09.006; Hamilton G, 2009, J MAGN RESON IMAGING, V30, P145, DOI 10.1002/jmri.21809; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Iwasaki T, 2011, HEPATO-GASTROENTEROL, V58, P2103, DOI 10.5754/hge11263; Jin X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034198; Karlas T, 2013, BEST PRACT RES CL EN, V27, P195, DOI 10.1016/j.beem.2013.02.002; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Kumar M, 2013, J GASTROEN HEPATOL, V28, P1194, DOI 10.1111/jgh.12134; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Myers RP, 2012, J HEPATOL, V56, P564, DOI 10.1016/j.jhep.2011.10.007; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029433; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; So R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-56; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Thormer G, 2013, J MAGN RESON IMAGING, V37, P1144, DOI 10.1002/jmri.23890; Thomas E Louise, 2007, Atherosclerosis, V195, pe181, DOI 10.1016/j.atherosclerosis.2007.03.043; Le TA, 2012, HEPATOLOGY, V56, P922, DOI 10.1002/hep.25731; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wong GLH, 2013, WORLD J HEPATOL, V5, P264, DOI 10.4254/wjh.v5.i5.264; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; ZWEIG MH, 1993, CLIN CHEM, V39, P561	56	105	113	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91987	10.1371/journal.pone.0091987	http://dx.doi.org/10.1371/journal.pone.0091987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637477	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100097
J	Kwakkenbos, L; Willems, LM; Baron, M; Hudson, M; Cella, D; van den Ende, CHM; Thombs, BD				Kwakkenbos, Linda; Willems, Linda M.; Baron, Murray; Hudson, Marie; Cella, David; van den Ende, Cornelia H. M.; Thombs, Brett D.		Canadian Scleroderma Res Grp	The Comparability of English, French and Dutch Scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): An Assessment of Differential Item Functioning in Patients with Systemic Sclerosis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; VITALITY SUBSCALE; RESPONSE THEORY; DISEASE; SCALES; PROMIS; OCCUPATIONS; RELIABILITY; SEVERITY; SYMPTOMS	Objective: The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) is commonly used to assess fatigue in rheumatic diseases, and has shown to discriminate better across levels of the fatigue spectrum than other commonly used measures. The aim of this study was to assess the cross-language measurement equivalence of the English, French, and Dutch versions of the FACIT-F in systemic sclerosis (SSc) patients. Methods: The FACIT-F was completed by 871 English-speaking Canadian, 238 French-speaking Canadian and 230 Dutch SSc patients. Confirmatory factor analysis was used to assess the factor structure in the three samples. The Multiple-Indicator Multiple-Cause (MIMIC) model was utilized to assess differential item functioning (DIF), comparing English versus French and versus Dutch patient responses separately. Results: A unidimensional factor model showed good fit in all samples. Comparing French versus English patients, statistically significant, but small-magnitude DIF was found for 3 of 13 items. French patients had 0.04 of a standard deviation (SD) lower latent fatigue scores than English patients and there was an increase of only 0.03 SD after accounting for DIF. For the Dutch versus English comparison, 4 items showed small, but statistically significant, DIF. Dutch patients had 0.20 SD lower latent fatigue scores than English patients. After correcting for DIF, there was a reduction of 0.16 SD in this difference. Conclusions: There was statistically significant DIF in several items, but the overall effect on fatigue scores was minimal. English, French and Dutch versions of the FACIT-F can be reasonably treated as having equivalent scoring metrics.	[Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Kwakkenbos, Linda; Baron, Murray; Hudson, Marie; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Willems, Linda M.; van den Ende, Cornelia H. M.] Sint Maartensklin Nijmegen, Dept Rheumatol, Nijmegen, Netherlands; [Baron, Murray; Hudson, Marie; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Cella, David] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; Sint Maartens Clinic; McGill University; Northwestern University; Feinberg School of Medicine; McGill University; McGill University; McGill University	Kwakkenbos, L (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	kwakkenbosL@gmail.com	Baron, Murray/AAF-9486-2019; Pope, Janet/G-3342-2011; Kwakkenbos, Linda/GXH-2756-2022; van den Ende, Cornelia/G-9559-2011; van den Ende, Cornelia/ABG-7626-2020	Pope, Janet/0000-0003-1479-5302; Kwakkenbos, Linda/0000-0002-1573-4504; van den Ende, Cornelia/0000-0002-4352-2824; 	Dutch patient organization for patients with systemic autoimmune diseases (NVLE); Canadian Scleroderma Research Group; Canadian Institutes of Health Research (CIHR) [FRN 83518]; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); FRSQ; Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer; Actelion pharmaceuticals; Fonds de la Recherche en Sante Quebec (FRSQ); Arthritis Society	Dutch patient organization for patients with systemic autoimmune diseases (NVLE); Canadian Scleroderma Research Group; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); FRSQ(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer(Pfizer); Actelion pharmaceuticals; Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Arthritis Society	This work was supported by the Dutch patient organization for patients with systemic autoimmune diseases (NVLE) and the Canadian Scleroderma Research Group which receives grant funding from the Canadian Institutes of Health Research (CIHR) (grant #FRN 83518), the Scleroderma Society of Canada and its provincial Chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), FRSQ, the Canadian Arthritis Network (CAN), and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received educational grants from Pfizer and Actelion pharmaceuticals. Dr. Baron is the director of the Canadian Scleroderma Research Group. Dr. Kwakkenbos is supported by a Fonds de la Recherche en Sante Quebec (FRSQ) postdoctoral fellowship. Dr. Thombs is supported by an Investigator Salary Award from the Arthritis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, KELLEYS TXB RHEUMATO; Bassel M, 2011, RHEUMATOLOGY, V50, P762, DOI 10.1093/rheumatology/keq310; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Cella D, 2005, J RHEUMATOL, V32, P811; Cella D, 2011, SUPPORT CARE CANCER, V19, P1441, DOI 10.1007/s00520-010-0971-1; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Harel D, 2012, RHEUMATOLOGY, V51, P2177, DOI 10.1093/rheumatology/kes206; Hewlett S, 2007, ARTHRIT RHEUM-ARTHR, V57, P429, DOI 10.1002/art.22611; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hoogeboom TJ, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001161, 10.1136/bmjopen-2013-003563]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudson M, 2009, J RHEUMATOL, V36, P2481, DOI 10.3899/jrheum.081237; Kline R.B., 2011, PRINCIPLES PRACTICE, V4th ed., DOI [10.1177/0049124187016001004, DOI 10.1038/156278A0]; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Muthen LK., 1998, MPLUS USERS GUIDE, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nikolaus S, 2013, J CLIN EPIDEMIOL, V66, P1175, DOI 10.1016/j.jclinepi.2013.05.010; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Olson K, 2007, ONCOL NURS FORUM, V34, P93, DOI 10.1188/07.ONF.93-99; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Richards HL, 2003, ARTHRIT RHEUM-ARTHR, V49, P689, DOI 10.1002/art.11385; Sandqvist G, 2008, RHEUMATOLOGY, V47, P1708, DOI 10.1093/rheumatology/ken359; Sandqvist G, 2008, DISABIL REHABIL, V30, P27, DOI 10.1080/09638280701190083; Sandusky SB, 2009, RHEUMATOLOGY, V48, P165, DOI 10.1093/rheumatology/ken455; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Strickland G, 2012, CLIN RHEUMATOL, V31, P1215, DOI 10.1007/s10067-012-1997-1; Suarez-Almazor ME, 2007, J RHEUMATOL, V34, P1718; Teresi JA, 2006, MED CARE, V44, pS39, DOI 10.1097/01.mlr.0000245452.48613.45; Thombs BD, 2008, RHEUMATOLOGY, V47, P1559, DOI 10.1093/rheumatology/ken331; Thombs BD, 2012, CLIN EXP RHEUMATOL, V30, pS23; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038; van Lankveld WGJM, 2007, RHEUMATOLOGY, V46, P872, DOI 10.1093/rheumatology/kem008; Wigley FM, RHEUMATOLOGY, P1463; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Zumbo BD, 1999, HDB THEORY METHODS D; ZWICK R, 1997, 9705 ED TEST SERV	43	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91979	10.1371/journal.pone.0091979	http://dx.doi.org/10.1371/journal.pone.0091979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638101	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100095
J	Pyykko, OT; Lumela, M; Rummukainen, J; Nerg, O; Seppala, TT; Herukka, SK; Koivisto, AM; Alafuzoff, I; Puli, L; Savolainen, S; Soininen, H; Jaaskelainen, JE; Hiltunen, M; Zetterberg, H; Leinonen, V				Pyykko, Okko T.; Lumela, Miikka; Rummukainen, Jaana; Nerg, Ossi; Seppala, Toni T.; Herukka, Sanna-Kaisa; Koivisto, Anne M.; Alafuzoff, Irina; Puli, Lakshman; Savolainen, Sakari; Soininen, Hilkka; Jaaskelainen, Juha E.; Hiltunen, Mikko; Zetterberg, Henrik; Leinonen, Ville			Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MYELIN BASIC-PROTEIN; ALZHEIMERS-DISEASE; CSF BIOMARKERS; BETA; NEUROFILAMENT	Background: The significance of amyloid precursor protein (APP) and neuroinflammation in idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer's disease (AD) is unknown. Objective: To investigate the role of soluble APP (sAPP) and amyloid beta (Ab) isoforms, proinflammatory cytokines, and biomarkers of neuronal damage in the cerebrospinal fluid (CSF) in relation to brain biopsy Ab and hyperphosphorylated tau (HPt) findings. Methods: The study population comprised 102 patients with possible NPH with cortical brain biopsies, ventricular and lumbar CSF samples, and DNA available. The final clinical diagnoses were: 53 iNPH (91% shunt-responders), 26 AD (10 mixed iNPH+AD), and 23 others. Biopsy samples were immunostained against Ab and HPt. CSF levels of AD-related biomarkers (Ab42, p-tau, total tau), non-AD-related Ab isoforms (Ab38, Ab40), sAPP isoforms (sAPPa, sAPPb), proinflammatory cytokines (several interleukins (IL), interferon-gamma, monocyte chemoattractant protein-1, tumor necrosis factor-alpha) and biomarkers of neuronal damage (neurofilament light and myelin basic protein) were measured. All patients were genotyped for APOE. Results: Lumbar CSF levels of sAPP alpha were lower (p<0.05) in patients with shunt-responsive iNPH compared to non-iNPH patients. sAPPb showed a similar trend (p = 0.06). CSF sAPP isoform levels showed no association to Ab or HPt in the brain biopsy. Quantified Ab load in the brain biopsy showed a negative correlation with CSF levels of Ab42 in ventricular (r = 20.295, p = 0.003) and lumbar (r = 20.356, p = 0.01) samples, while the levels of Ab38 and Ab40 showed no correlation. CSF levels of proinflammatory cytokines and biomarkers of neuronal damage did not associate to the brain biopsy findings, diagnosis, or shunt response. Higher lumbar/ventricular CSF IL-8 ratios (p<0.001) were seen in lumbar samples collected after ventriculostomy compared to the samples collected before the procedure. Conclusions: The role of sAPP isoforms in iNPH seems to be independent from the amyloid cascade. No neuroinflammatory background was observed in iNPH or AD.	[Pyykko, Okko T.; Lumela, Miikka; Savolainen, Sakari; Jaaskelainen, Juha E.; Leinonen, Ville] Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland; [Nerg, Ossi; Herukka, Sanna-Kaisa; Koivisto, Anne M.; Soininen, Hilkka] Kuopio Univ Hosp, Neurol NeuroCtr, SF-70210 Kuopio, Finland; [Seppala, Toni T.; Herukka, Sanna-Kaisa; Koivisto, Anne M.; Puli, Lakshman; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio, Finland; [Rummukainen, Jaana] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Clin Neurochem Lab, Gothenburg, Sweden	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Uppsala University; University of Gothenburg	Pyykko, OT (corresponding author), Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland.	okko.pyykko@gmail.com	Seppälä, Toni T./D-4518-2015	Seppälä, Toni T./0000-0002-4940-3498; Nerg, Ossi/0000-0002-2401-9078; PULI, LAKSHMAN/0000-0001-9140-2360	Health Research Council of the Academy of Finland; The Finnish Medical Foundation; EVO/VTR grants, Kuopio University Hospital [5252614, 5772708]; University of Eastern Finland; Finnish Cultural Foundation's North Savo Regional Fund	Health Research Council of the Academy of Finland(Academy of Finland); The Finnish Medical Foundation; EVO/VTR grants, Kuopio University Hospital; University of Eastern Finland; Finnish Cultural Foundation's North Savo Regional Fund(Finnish Cultural Foundation)	This study was funded by the Health Research Council of the Academy of Finland, The Finnish Medical Foundation, EVO/VTR grants from the Kuopio University Hospital 5252614, 5772708, the strategic funding from the University of Eastern Finland, and Finnish Cultural Foundation's North Savo Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Cusimano MD, 2011, CAN J NEUROL SCI, V38, P274, DOI 10.1017/S031716710001146X; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Hamilton R, 2010, ANN NEUROL, V68, P535, DOI 10.1002/ana.22015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Koivisto AM, 2013, NEUROSURGERY, V72, P1, DOI 10.1227/NEU.0b013e31827414b3; Leinonen V, 2012, NEUROPATH APPL NEURO, V38, P72, DOI 10.1111/j.1365-2990.2011.01195.x; Leinonen V, 2008, ARCH NEUROL-CHICAGO, V65, P1304, DOI 10.1001/archneur.65.10.noc80013; Leinonen Ville, 2011, Int J Alzheimers Dis, V2011, P312526, DOI 10.4061/2011/312526; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; McGirr A, 2012, J NEUROL SCI, V321, P82, DOI 10.1016/j.jns.2012.07.062; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Patel S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-7; Pyykko OT, 2012, J NEUROL NEUROSUR PS, V83, P1119, DOI [10.1136/jnnp-2012-303849, 10.1136/jnnp-2011-303849]; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Rinne JO, 2012, ACTA NEUROPATHOL, V124, P833, DOI 10.1007/s00401-012-1051-z; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Selnes P, 2010, CEREBROSPINAL FLUID, V7; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Stoeck K, 2005, ARCH NEUROL-CHICAGO, V62, P1591, DOI 10.1001/archneur.62.10.1591; Sundstrom N, 2010, J NEUROSURG, V113, P1294, DOI 10.3171/2010.8.JNS10157; SUTTON LN, 1983, J NEUROSURG, V59, P467, DOI 10.3171/jns.1983.59.3.0467; Tarkowski E, 2003, NEUROBIOL AGING, V24, P707, DOI 10.1016/S0197-4580(02)00187-2; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Tarnaris A, 2009, BIOMARK MED, V3, P787, DOI 10.2217/BMM.09.37; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; Tullberg M, 1998, NEUROLOGY, V50, P1122, DOI 10.1212/WNL.50.4.1122; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-9; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Whitaker JN, 1998, MULT SCLER J, V4, P16, DOI 10.1191/135245898678909123; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102	44	66	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91974	10.1371/journal.pone.0091974	http://dx.doi.org/10.1371/journal.pone.0091974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638077	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100094
J	Tebbich, S; Teschke, I				Tebbich, Sabine; Teschke, Irmgard			Coping with Uncertainty: Woodpecker Finches (Cactospiza pallida) from an Unpredictable Habitat Are More Flexible than Birds from a Stable Habitat	PLOS ONE			English	Article							TOOL-USE; BEHAVIORAL DRIVE; EVOLUTION; INHIBITION; GALAPAGOS; SIZE	Behavioural flexibility is thought to be a major factor in evolution. It may facilitate the discovery and exploitation of new resources, which in turn may expose populations to novel selective forces and facilitate adaptive radiation. Darwin's finches are a textbook example of adaptive radiation. They are fast learners and show a range of unusual foraging techniques, probably as a result of their flexibility. In this study we aimed to test whether variability of the environment is correlated with flexibility. We compared woodpecker finches from a dry area (hereafter, Arid Zone), where food availability is variable, with individuals from a cloud forest (hereafter, Scalesia zone) where food abundance is stable. As parameters for flexibility, we measured neophilia and neophobia, which are two aspects of reaction to novelty, reversal learning and problem-solving. We found no differences in performance on a problem-solving task but, in line with our prediction, individuals from the Arid Zone were significantly faster reversal learners and more neophilic than their conspecifics from the Scalesia zone. The latter result supports the notion that environmental variability drives flexibility. In contrast to our prediction, Arid Zone birds were even more neophobic than birds from the Scalesia Zone. The latter result could be the consequence of differences in predation pressure between the two vegetation zones.	[Tebbich, Sabine] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Teschke, Irmgard] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany	University of Vienna; Max Planck Society	Tebbich, S (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	sabine.tebbich@univie.ac.at			FWF [V95-B17]; DFG [TE 628/1-1]; University of St. Andrews	FWF(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG)); University of St. Andrews	S. Tebbich was funded by the FWF (project number V95-B17) and I. Teschke by the DFG (project number TE 628/1-1). The University of St. Andrews provided additional funding for materials and travel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Bond AB, 2007, J COMP PSYCHOL, V121, P372, DOI 10.1037/0735-7036.121.4.372; BOWMAN ROBERT L., 1965, LIVING BIRD, V4, P29; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; Duckworth RA, 2009, EVOL ECOL, V23, P513, DOI 10.1007/s10682-008-9252-6; Dukas Reuven, 1998, P129; Eibl-Eibesfeldt I., 1962, Journal fuer Ornithologie, V103, P92, DOI 10.1007/BF01670851; Eibl-Eibesfeldt I., 1961, Zeitschrift fuer Tierpsychologie, V18, P343; Grant P.R., 1999, RECOGNITION STATES L, V2; GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; GRANT PR, 1980, AUK, V97, P227; GREENBERG R, 1984, J COMP PSYCHOL, V98, P131, DOI 10.1037/0735-7036.98.2.131; Greenberg R, 2001, CURR ORNITHOL; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Jackson MH, 1993, GALAPAGOS NATURAL HI; Kotrschal A, 2010, PLOS BIOL, V8; Lapiedra O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2893; Lefebvre L, 1997, BEHAV PROCESS, V40, P201, DOI 10.1016/S0376-6357(97)00783-3; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre Louis, 2003, P39; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Macphail EM, 1996, COGNITIVE BRAIN RES, V3, P279, DOI 10.1016/0926-6410(96)00013-4; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Odling-Smee L, 2003, ANIM BEHAV, V65, P701, DOI 10.1006/anbe.2003.2082; Plotkin H. C., 1988, ROLE BEHAV EVOLUTION; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Price T, 2008, SPECIATION BIRDS; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; Roth TC, 2010, P ROY SOC B-BIOL SCI, V277, P3187, DOI 10.1098/rspb.2010.0630; SCHLUTER D, 1984, AUK, V101, P59, DOI 10.1093/auk/101.1.59; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Sol D, 2002, ANIM BEHAV, V64, P516, DOI 10.1006/anbe.2002.4005; Sol D, 2012, ANIM BEHAV, V83, P179, DOI 10.1016/j.anbehav.2011.10.024; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; SWARTH HARRY S., 1929, PROC CALIFORNIA ACAD SCI, V18, P29; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Tebbich S, 2004, CONDOR, V106, P95, DOI 10.1650/7293; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; Teschke I, 2011, ANIM BEHAV, V82, P945, DOI 10.1016/j.anbehav.2011.07.032; Thorpe WH, 1956, LEARNING INSTINCT AN; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; West-Eberhard Mary Jane, 2003, pi	45	33	33	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91718	10.1371/journal.pone.0091718	http://dx.doi.org/10.1371/journal.pone.0091718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24638107	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100054
J	Wang, H; Megill, A; Wong, PC; Kirkwood, A; Lee, HK				Wang, Hui; Megill, Andrea; Wong, Philip C.; Kirkwood, Alfredo; Lee, Hey-Kyoung			Postsynaptic Target Specific Synaptic Dysfunctions in the CA3 Area of BACE1 Knockout Mice	PLOS ONE			English	Article							BETA-SECRETASE BACE1; NICOTINIC ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; MOSSY FIBER; FEEDFORWARD INHIBITION; RAT HIPPOCAMPUS; A-BETA; GABAERGIC INTERNEURONS; SILENT SYNAPSES; AMYLOID-BETA	Beta-amyloid precursor protein cleaving enzyme 1 (BACE1), a major neuronal beta-secretase critical for the formation of beta-amyloid (A beta) peptide, is considered one of the key therapeutic targets that can prevent the progression of Alzheimer's disease (AD). Although a complete ablation of BACE1 gene prevents Ab formation, we previously reported that BACE1 knockouts (KOs) display presynaptic deficits, especially at the mossy fiber (MF) to CA3 synapses. Whether the defect is specific to certain inputs or postsynaptic targets in CA3 is unknown. To determine this, we performed whole-cell recording from pyramidal cells (PYR) and the stratum lucidum (SL) interneurons in the CA3, both of which receive excitatory MF terminals with high levels of BACE1 expression. BACE1 KOs displayed an enhancement of paired-pulse facilitation at the MF inputs to CA3 PYRs without changes at the MF inputs to SL interneurons, which suggests postsynaptic target specific regulation. The synaptic dysfunction in CA3 PYRs was not restricted to excitatory synapses, as seen by an increase in the paired-pulse ratio of evoked inhibitory postsynaptic currents from SL to CA3 PYRs. In addition to the changes in evoked synaptic transmission, BACE1 KOs displayed a reduction in the frequency of miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs) in CA3 PYRs without alteration in mEPSCs recorded from SL interneurons. This suggests that the impairment may be more global across diverse inputs to CA3 PYRs. Our results indicate that the synaptic dysfunctions seen in BACE1 KOs are specific to the postsynaptic target, the CA3 PYRs, independent of the input type.	[Wang, Hui; Megill, Andrea; Kirkwood, Alfredo; Lee, Hey-Kyoung] Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA; [Wang, Hui; Lee, Hey-Kyoung] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol & Neurosci, Baltimore, MD USA	Johns Hopkins University; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Lee, HK (corresponding author), Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA.	heykyounglee@jhu.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	National Institute of Health [P01-NS047308, R01-AG034606]; Robert and Florence Deutsch Graduate Award; Ann G. Wylie Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, R01AG034606] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Florence Deutsch Graduate Award; Ann G. Wylie Dissertation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health grants (P01-NS047308 to PCW and H-KL; R01-AG034606 to AK), the Robert and Florence Deutsch Graduate Award (UMD to HW), and the Ann G. Wylie Dissertation Fellowship (UMD to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Giusti-Rodriguez P, 2011, J NEUROSCI, V31, P15751, DOI 10.1523/JNEUROSCI.3588-11.2011; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; LANGDON RB, 1993, J PHYSIOL-LONDON, V472, P157, DOI 10.1113/jphysiol.1993.sp019941; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maggi L, 2003, P NATL ACAD SCI USA, V100, P2059, DOI 10.1073/pnas.0437947100; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SEGUELA P, 1993, J NEUROSCI, V13, P596; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Torborg CL, 2010, J NEUROSCI, V30, P15628, DOI 10.1523/JNEUROSCI.3099-10.2010; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wang H, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/272374; Wang H, 2010, J NEUROSCI, V30, P13808, DOI 10.1523/JNEUROSCI.1070-10.2010; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92279	10.1371/journal.pone.0092279	http://dx.doi.org/10.1371/journal.pone.0092279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637500	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100137
J	Usatyuk, PV; Fu, PF; Mohan, V; Epshtein, Y; Jacobson, JR; Gomez-Cambronero, J; Wary, KK; Bindokas, V; Dudek, SM; Salgia, R; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Fu, Panfeng; Mohan, Vijay; Epshtein, Yulia; Jacobson, Jeffrey R.; Gomez-Cambronero, Julian; Wary, Kishore K.; Bindokas, Vytas; Dudek, Steven M.; Salgia, Ravi; Garcia, Joe G. N.; Natarajan, Viswanathan			Role of c-Met/Phosphatidylinositol 3-Kinase (PI3k)/Akt Signaling in Hepatocyte Growth Factor (HGF)- mediated Lamellipodia Formation, Reactive Oxygen Species (ROS) Generation, and Motility of Lung Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Cell Migration; Endothelial Cell; Hepatocyte Growth Factor; NADPH Oxidase	NADPH OXIDASE ACTIVATION; F-ACTIN; HYDROGEN-PEROXIDE; NAD(P)H OXIDASE; LEADING-EDGE; MET; MIGRATION; CORTACTIN; P47(PHOX); PATHWAY	Background: Lamellipodia structures provide a platform for the spatio-temporal localization of key components necessary for cell migration. Results: HGF activates c-Met/PI3k/Akt signaling axis, which is essential for the recruitment of actin, cortactin, p47(phox), and Rac1and ROS production in lamellipodia. Conclusion: HGF-induced spatio-temporal localization of cytoskeletal proteins and NADPH oxidase components regulate lamellipodial ROS and cell migration. Significance: This study identifies a novel role for lamellipodial ROS in cell motility. Hepatocyte growth factor (HGF) mediated signaling promotes cell proliferation and migration in a variety of cell types and plays a key role in tumorigenesis. As cell migration is important to angiogenesis, we characterized HGF-mediated effects on the formation of lamellipodia, a pre-requisite for migration using human lung microvascular endothelial cells (HLMVECs). HGF, in a dose-dependent manner, induced c-Met phosphorylation (Tyr-1234/1235, Tyr-1349, Ser-985, Tyr-1003, and Tyr-1313), activation of PI3k (phospho-Yp85) and Akt (phospho-Thr-308 and phospho-Ser-473) and potentiated lamellipodia formation and HLMVEC migration. Inhibition of c-Met kinase by SU11274 significantly attenuated c-Met, PI3k, and Akt phosphorylation, suppressed lamellipodia formation and endothelial cell migration. LY294002, an inhibitor of PI3k, abolished HGF-induced PI3k (Tyr-458), and Akt (Thr-308 and Ser-473) phosphorylation and suppressed lamellipodia formation. Furthermore, HGF stimulated p47(phox)/Cortactin/Rac1 translocation to lamellipodia and ROS generation. Moreover, inhibition of c-Met/PI3k/Akt signaling axis and NADPH oxidase attenuated HGF- induced lamellipodia formation, ROS generation and cell migration. Ex vivo experiments with mouse aortic rings revealed a role for c-Met signaling in HGF-induced sprouting and lamellipodia formation. Taken together, these data provide evidence in support of a significant role for HGF-induced c-Met/PI3k/Akt signaling and NADPH oxidase activation in lamellipodia formation and motility of lung endothelial cells.	[Usatyuk, Peter V.; Fu, Panfeng; Mohan, Vijay; Wary, Kishore K.; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Epshtein, Yulia; Jacobson, Jeffrey R.; Dudek, Steven M.; Garcia, Joe G. N.] Univ Illinois, Sect Pulm & Crit Care Med, Chicago, IL 60612 USA; [Epshtein, Yulia; Jacobson, Jeffrey R.; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Bindokas, Vytas] Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; University System of Ohio; Wright State University Dayton	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, COMRB, Room 3137,835 South Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Fu, Panfeng/F-7345-2015	Fu, Panfeng/0000-0001-8813-9258; Gomez-Cambronero, Julian/0000-0002-7581-9227; Wary, Kishore/0000-0001-8851-8565	National Institutes of Health [P01 HL098050, 2R01HL079356]; AHA [12GRNT12070159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL079356, P01HL098050, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Grants P01 HL098050 (to V. N.) and 2R01HL079356 (to K. K. W.) from the National Institutes of Health and the AHA Grant 12GRNT12070159 (to K. K. W.).	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Clavijo-Cornejo D, 2013, BIOCHIMIE, V95, P1177, DOI 10.1016/j.biochi.2013.01.005; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dossumbekova A, 2008, AM J PHYSIOL-HEART C, V295, pH2417, DOI 10.1152/ajpheart.00501.2008; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; Fountoulaki K, 2012, CARDIOLOGY, V121, P237, DOI 10.1159/000338158; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Graupera M, 2013, EXP CELL RES, V319, P1348, DOI 10.1016/j.yexcr.2013.02.021; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hodara R, 2011, ARTERIOSCL THROM VAS, V31, P2203, DOI 10.1161/ATVBAHA.111.233247; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jagadeeswaran R, 2007, AM J PHYSIOL-LUNG C, V292, pL1488, DOI 10.1152/ajplung.00147.2006; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuhlmann CRW, 2005, J THROMB HAEMOST, V3, P2089, DOI 10.1111/j.1538-7836.2005.01541.x; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawrence RE, 2010, CELL ADHES MIGR, V4, P146, DOI 10.4161/cam.4.1.10973; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Madonna R, 2013, J CARDIOVASC MED, V14, P249, DOI 10.2459/JCM.0b013e3283542017; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Martinelli R, 2013, J CELL BIOL, V201, P449, DOI 10.1083/jcb.201209077; Martinez-Palacian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053108; McKinnon H, 2006, AM J PATHOL, V168, P340, DOI 10.2353/ajpath.2006.050379; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Mishina NM, 2013, METHOD ENZYMOL, V526, P45, DOI 10.1016/B978-0-12-405883-5.00003-X; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohsawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054503; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Ruggeri RM, 2010, EUR J HISTOCHEM, V54, P118, DOI 10.4081/ejh.2010.e24; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Sala V, 2011, CELL MOL LIFE SCI, V68, P1703, DOI 10.1007/s00018-011-0633-6; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Stampoulis P, 2012, J BIOL CHEM, V287, P17848, DOI 10.1074/jbc.M111.332874; Sung BH, 2011, CURR BIOL, V21, P1460, DOI 10.1016/j.cub.2011.06.065; Taulet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041342; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Zhao YT, 2007, CELL SIGNAL, V19, P2329, DOI 10.1016/j.cellsig.2007.07.005; Zhou YJ, 2009, LIFE SCI, V85, P670, DOI 10.1016/j.lfs.2009.09.006	81	59	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13476	13491		10.1074/jbc.M113.527556	http://dx.doi.org/10.1074/jbc.M113.527556			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24634221	Green Published, hybrid			2022-12-25	WOS:000335522800044
J	Corvaglia, L; Fantini, MP; Aceti, A; Gibertoni, D; Rucci, P; Baronciani, D; Faldella, G				Corvaglia, Luigi; Fantini, Maria Pia; Aceti, Arianna; Gibertoni, Dino; Rucci, Paola; Baronciani, Dante; Faldella, Giacomo		Emilia Romagna Perinatal Network	Predictors of Full Enteral Feeding Achievement in Very Low Birth Weight Infants	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; PATENT DUCTUS-ARTERIOSUS; CLINICAL RISK INDEX; PRETERM INFANTS; ANTENATAL CORTICOSTEROIDS; PREMATURE-INFANTS; MORTALITY; AGE; TERM; MORBIDITY	Background: To elucidate the role of prenatal, neonatal and early postnatal variables in influencing the achievement of full enteral feeding (FEF) in very low birth weight (VLBW) infants and to determine whether neonatal intensive care units (NICUs) differ in this outcome. Methods: Population-based retrospective cohort study using data on 1,864 VLBW infants drawn from the "Emilia-Romagna Perinatal Network'' Registry from 2004 to 2009. The outcome of interest was time to FEF achievement. Eleven prenatal, neonatal and early postnatal variables and the study NICUs were selected as potential predictors of time to FEF. Parametric survival analysis was used to model time to FEF as a function of the predictors. Marginal effects were used to obtain adjusted estimates of median time to FEF for specific subgroups of infants. Results: Lower gestational age, exclusive formula feeding, higher CRIB II score, maternal hypertension, cesarean delivery, SGA and PDA predicted delayed FEF. NICUs proved to be heterogeneous in terms of FEF achievement. Newborns with PDA had a 4.2 days longer predicted median time to FEF compared to those without PDA; newborns exclusively formula-fed had a 1.4 days longer time to FEF compared to those fed human milk. Conclusions: The results of our study suggest that time to FEF is influenced by clinical variables and NICU-specific practices. Knowledge of the variables associated with delayed/earlier FEF achievement could help in improving specific aspects of routine clinical management of VLBW infants and to reduce practice variability.	[Corvaglia, Luigi; Aceti, Arianna; Faldella, Giacomo] Univ Bologna, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy; [Fantini, Maria Pia; Gibertoni, Dino; Rucci, Paola] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Baronciani, Dante] Direz Gen Sanita & Polit Sociali, Serv Presidi Osped, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna	Aceti, A (corresponding author), Univ Bologna, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy.	arianna.aceti2@unibo.it	Gibertoni, Dino/H-4443-2017; Aceti, Arianna/AAB-4007-2019	Gibertoni, Dino/0000-0002-1722-3724; Aceti, Arianna/0000-0001-9274-985X; Garani, Giampaolo/0000-0002-3514-2717; Rucci, Paola/0000-0002-7704-0831				Abitbol CL, 2012, NAT REV NEPHROL, V8, P265, DOI 10.1038/nrneph.2012.38; Bakker R, 2011, AM J EPIDEMIOL, V174, P797, DOI 10.1093/aje/kwr151; Bartels DB, 2005, ARCH DIS CHILD-FETAL, V90, pF53, DOI 10.1136/adc.2004.053892; Baud O, 2000, BRIT J OBSTET GYNAEC, V107, P877, DOI 10.1111/j.1471-0528.2000.tb11086.x; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Been JV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.025; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Berrington JE, 2013, ARCH DIS CHILD-FETAL, V98, pF286, DOI 10.1136/archdischild-2012-302134; BERSETH CL, 1990, J PEDIATR-US, V117, P777, DOI 10.1016/S0022-3476(05)83343-8; Bertino E, 2012, J MATERN-FETAL NEO M, V25, P67, DOI 10.3109/14767058.2012.664889; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bozzetti V, 2013, J MATERN-FETAL NEO M, V26, P1610, DOI 10.3109/14767058.2012.746303; Burrin DG, 2002, CLIN PERINATOL, V29, P65, DOI 10.1016/S0095-5108(03)00065-4; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; Cleves M, 2010, INTRO SURVIVAL ANAL; COOMBS RC, 1990, ARCH DIS CHILD-FETAL, V65, P1067, DOI 10.1136/adc.65.10_Spec_No.1067; Corpeleijn WE, 2012, NEONATOLOGY, V102, P276, DOI 10.1159/000341335; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Database VON, 2012, DAT VON MAN OP 2; Dorling J, 2005, ARCH DIS CHILD-FETAL, V90, pF359, DOI 10.1136/adc.2004.060350; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Ersch J, 2008, J PAEDIATR CHILD H, V44, P651, DOI 10.1111/j.1440-1754.2008.01375.x; Faldella G, 2011, EARLY HUM DEV, V87, pS5, DOI 10.1016/j.earlhumdev.2011.01.001; Fang S, 2001, ARCH DIS CHILD-FETAL, V85, pF42, DOI 10.1136/fn.85.1.F42; Greenwood S, 2012, J PAEDIATR CHILD H, V48, P588, DOI 10.1111/j.1440-1754.2012.02430.x; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Horbar J D, 1999, Pediatrics, V103, P350; Horbar JD, 1997, PEDIATRICS, V99, P149, DOI 10.1542/peds.99.2.149; Horbar JD, 2010, CLIN PERINATOL, V37, P29, DOI 10.1016/j.clp.2010.01.003; Hovi P, 2007, NEW ENGL J MED, V357, P617; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; ISTAT, 2011, VOL POP LEG 15 CENS; Kandasamy Y, 2009, ARCH DIS CHILD-FETAL, V94, pF78, DOI 10.1136/adc.2008.145284; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Lanigan J, 2009, P NUTR SOC, V68, P422, DOI 10.1017/S002966510999019X; Leaf A, 2012, PEDIATRICS, V129, pE1260, DOI 10.1542/peds.2011-2379; Lodha A, 2009, DEV MED CHILD NEUROL, V51, P895, DOI 10.1111/j.1469-8749.2009.03284.x; Mihatsch WA, 2002, J PEDIATR GASTR NUTR, V35, P144, DOI 10.1097/00005176-200208000-00008; Morgan J, 2011, COCHRANE DB SYST REV, V3; Mosalli R, 2010, COCHRANE DB SYST REV, V1; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Patole SK, 2007, ARCH DIS CHILD-FETAL, V92, pF53, DOI 10.1136/adc.2006.093708; Regev RH, 2004, CLIN PERINATOL, V31, P453, DOI 10.1016/j.clp.2004.04.017; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Shulman RJ, 1998, PEDIATR RES, V44, P519, DOI 10.1203/00006450-199810000-00009; Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216; Surbek D, 2012, ARCH GYNECOL OBSTET, V286, P277, DOI 10.1007/s00404-012-2339-x; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Wold SHW, 2009, ARCH DIS CHILD-FETAL, V94, pF363, DOI 10.1136/adc.2009.157800; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837	54	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92235	10.1371/journal.pone.0092235	http://dx.doi.org/10.1371/journal.pone.0092235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647523	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500102
J	Gritsun, DJ; Jones, IM; Gould, EA; Gritsun, TS				Gritsun, Dmitri J.; Jones, Ian M.; Gould, Ernest A.; Gritsun, Tamara S.			Molecular Archaeology of Flaviviridae Untranslated Regions: Duplicated RNA Structures in the Replication Enhancer of Flaviviruses and Pestiviruses Emerged via Convergent Evolution	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; STEM-LOOP STRUCTURE; 3'-UNTRANSLATED REGION; SECONDARY STRUCTURE; DENGUE VIRUS; DIRECT REPEATS; NONCODING REGION; WEB SERVER; CDNA-CLONE; VIRAL-RNA	RNA secondary structures in the 3'untranslated regions (3'UTR) of the viruses of the family Flaviviridae, previously identified as essential (promoters) or beneficial (enhancers) for replication, have been analysed. Duplicated enhancer elements are revealed as a global feature in the evolution of the 3'UTR of distantly related viruses within the genera Flavivirus and Pestivirus. For the flaviviruses, duplicated structures occur in the 3'UTR of all four distantly related ecological virus subgroups (tick-borne, mosquito-borne, no known vector and insect-specific flaviviruses (ISFV). RNA structural differences distinguish tick-borne flaviviruses with discrete pathogenetic characteristics. For Aedes-and Culex-associated ISFV, secondary RNA structures with different conformations display numerous short ssRNA direct repeats, exposed as loops and bulges. Long quadruplicate regions comprise almost the entire 3'UTR of Culex-associated ISFV. Extended duplicated sequence and associated RNA structures were also discovered in the 3'UTR of pestiviruses. In both the Flavivirus and Pestivirus genera, duplicated RNA structures were localized to the enhancer regions of the 3'UTR suggesting an adaptive role predominantly in wild-type viruses. We propose sequence reiteration might act as a scaffold for dimerization of proteins involved in assembly of viral replicase complexes. Numerous nucleotide repeats exposed as loops/bulges might also interfere with host immune responses acting as a molecular sponge to sequester key host proteins or microRNAs.	[Gritsun, Dmitri J.; Jones, Ian M.; Gritsun, Tamara S.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Gould, Ernest A.] Univ Aix Marseille, Fac Med Timone, Unite Virus Emergents, Marseille, France	University of Reading; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gritsun, TS (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	t.s.gritsun@reading.ac.uk	Jones, Ian/AAF-4986-2019	Jones, Ian/0000-0002-7738-2516	Medical Research Council grant [G0801208]; EU FP7 project SILVER [260644]; EU FP7 project PREDEMICS [278433]; MRC [G0801208] Funding Source: UKRI; Medical Research Council [G0801208] Funding Source: researchfish	Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU FP7 project SILVER; EU FP7 project PREDEMICS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council grant (G0801208) and EU FP7 projects SILVER and PREDEMICS (grant agreement numbers 260644 and 278433 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher P, 1998, J VIROL, V72, P5165, DOI 10.1128/JVI.72.6.5165-5173.1998; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charlier N, 2002, J GEN VIROL, V83, P1875, DOI 10.1099/0022-1317-83-8-1875; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; DENG RT, 1993, NUCLEIC ACIDS RES, V21, P1949, DOI 10.1093/nar/21.8.1949; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gritsun TS, 2007, VIROLOGY, V358, P258, DOI 10.1016/j.virol.2006.09.033; Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2; Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0; Gritsun TS, 2006, J GEN VIROL, V87, P2615, DOI 10.1099/vir.0.81950-0; Gritsun TS, 2006, VIROLOGY, V350, P269, DOI 10.1016/j.virol.2006.03.002; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gritsun TS, 2001, J GEN VIROL, V82, P1667, DOI 10.1099/0022-1317-82-7-1667; Gritsun TS, 1997, VIRUS RES, V49, P27, DOI 10.1016/S0168-1702(97)01451-2; Gritsun TS, 2013, MOL ARCHAEOLOGY FLAV; Gritsun TS, 2006, FLAVIVIRIDAE PATHOGE, P47; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; HEINZ FX, 2000, VIRUS TAXONOMY, P859; Hofacker IL, 2004, BIOINFORMATICS, V20, P1495, DOI 10.1093/bioinformatics/bth108; Hoshino K, 2006, VIROLOGY; Isken O, 2004, RNA, V10, P1637, DOI 10.1261/rna.7290904; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Kenny NJ, 2013, GEN COMP ENDOCR, V188, P16, DOI 10.1016/j.ygcen.2013.02.013; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Liu LH, 2009, VIROLOGY, V385, P351, DOI 10.1016/j.virol.2008.12.004; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Olsthoorn RCL, 2001, RNA, V7, P1370; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Pankraz A, 2005, J VIROL, V79, P9119, DOI 10.1128/JVI.79.14.9119-9127.2005; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; PILIPENKO EV, 1995, NUCLEIC ACIDS RES, V23, P1870, DOI 10.1093/nar/23.11.1870; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; Proutski V, 1999, VIRUS RES, V64, P107, DOI 10.1016/S0168-1702(99)00079-9; Proutski V, 1997, J GEN VIROL, V78, P1543, DOI 10.1099/0022-1317-78-7-1543; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; Romero TA, 2006, J GEN VIROL, V87, P3291, DOI 10.1099/vir.0.82182-0; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Silva PAGC, 2007, J GEN VIROL, V88, P1738, DOI 10.1099/vir.0.82811-0; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004; Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237; Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Yu HY, 1999, J VIROL, V73, P3638, DOI 10.1128/JVI.73.5.3638-3648.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92056	10.1371/journal.pone.0092056	http://dx.doi.org/10.1371/journal.pone.0092056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647143	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333348500075
J	Nance, T; Smith, KS; Anaya, V; Richardson, R; Ho, L; Pala, M; Mostafavi, S; Battle, A; Feghali-Bostwick, C; Rosen, G; Montgomery, SB				Nance, Tracy; Smith, Kevin S.; Anaya, Vanessa; Richardson, Rhea; Ho, Lawrence; Pala, Mauro; Mostafavi, Sara; Battle, Alexis; Feghali-Bostwick, Carol; Rosen, Glenn; Montgomery, Stephen B.			Transcriptome Analysis Reveals Differential Splicing Events in IPF Lung Tissue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCATION END-PRODUCTS; GROWTH-FACTOR; PULMONARY-FIBROSIS; GENE-EXPRESSION; CELL-ADHESION; HB-EGF; PERIOSTIN; BINDING; PROTEIN	Idiopathic pulmonary fibrosis (IPF) is a complex disease in which a multitude of proteins and networks are disrupted. Interrogation of the transcriptome through RNA sequencing (RNA-Seq) enables the determination of genes whose differential expression is most significant in IPF, as well as the detection of alternative splicing events which are not easily observed with traditional microarray experiments. We sequenced messenger RNA from 8 IPF lung samples and 7 healthy controls on an Illumina HiSeq 2000, and found evidence for substantial differential gene expression and differential splicing. 873 genes were differentially expressed in IPF (FDR<5%), and 440 unique genes had significant differential splicing events in at least one exonic region (FDR<5%). We used qPCR to validate the differential exon usage in the second and third most significant exonic regions, in the genes COL6A3 (RNA-Seq adjusted pval = 7.18e-10) and POSTN (RNA-Seq adjusted pval = 2.06e-09), which encode the extracellular matrix proteins collagen alpha-3(VI) and periostin. The increased gene-level expression of periostin has been associated with IPF and its clinical progression, but its differential splicing has not been studied in the context of this disease. Our results suggest that alternative splicing of these and other genes may be involved in the pathogenesis of IPF. We have developed an interactive web application which allows users to explore the results of our RNA-Seq experiment, as well as those of two previously published microarray experiments, and we hope that this will serve as a resource for future investigations of gene regulation in IPF.	[Nance, Tracy; Smith, Kevin S.; Anaya, Vanessa; Richardson, Rhea; Pala, Mauro; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Ho, Lawrence] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Mostafavi, Sara; Battle, Alexis] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Rosen, Glenn] Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA	Stanford University; University of Washington; University of Washington Seattle; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University	Nance, T (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	tracy.nance@gmail.com; grosen@stanford.edu; smontgom@stanford.edu	Pala, Mauro/AAY-4774-2020	Pala, Mauro/0000-0002-3165-5291; Montgomery, Stephen/0000-0002-5200-3903	NIH T32 training grant in Pulmonary Care and Critical Medicine; Edward Mallinckrodt Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	NIH T32 training grant in Pulmonary Care and Critical Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Tracy Nance was funded by an NIH T32 training grant in Pulmonary Care and Critical Medicine, and Stephen Montgomery is funded by the Edward Mallinckrodt Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2011, ANAL RNA SEQ DATA DI; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arafat H, 2011, SURGERY, V150, P306, DOI 10.1016/j.surg.2011.05.011; AUMAILLEY M, 1989, EXP CELL RES, V181, P463, DOI 10.1016/0014-4827(89)90103-1; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonner JC, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-15; Bozyk PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031336; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Deng N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068352; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Faull RJ, 2001, KIDNEY INT, V59, P614, DOI 10.1046/j.1523-1755.2001.059002614.x; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Huang GC, 2012, LAB INVEST, V92, P703, DOI 10.1038/labinvest.2012.3; Kass DJ, 2011, CTS-CLIN TRANSL SCI, V4, P372, DOI 10.1111/j.1752-8062.2011.00287.x; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Meltzer EB, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-70; Michaylira CZ, 2010, CANCER RES, V70, P5281, DOI 10.1158/0008-5472.CAN-10-0704; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Morra L, 2012, LUNG CANCER, V76, P183, DOI 10.1016/j.lungcan.2011.10.013; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Poumay Y, 2012, J INVEST DERMATOL, V132, P2129, DOI 10.1038/jid.2012.225; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; RStudio Inc, 2013, SHIN WEB APPL FRAM R; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Valletta D, 2012, BIOCHEM BIOPH RES CO, V426, P404, DOI 10.1016/j.bbrc.2012.08.104; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	58	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92111	10.1371/journal.pone.0092111	http://dx.doi.org/10.1371/journal.pone.0092111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647608	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000333348500087
J	Wang, MM; Bethoux, O; Bradler, S; Jacques, FMB; Cui, YY; Ren, D				Wang, Maomin; Bethoux, Olivier; Bradler, Sven; Jacques, Frederic M. B.; Cui, Yingying; Ren, Dong			Under Cover at Pre-Angiosperm Times: A Cloaked Phasmatodean Insect from the Early Cretaceous Jehol Biota	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; BODY-SIZE; WING VENATION; STICK INSECT; FOSSIL; EVOLUTION; MALES	Background: Fossil species that can be conclusively identified as stem-relatives of stick- and leaf-insects (Phasmatodea) are extremely rare, especially for the Mesozoic era. This dearth in the paleontological record makes assessments on the origin and age of the group problematic and impedes investigations of evolutionary key aspects, such as wing development, sexual size dimorphism and plant mimicry. Methodology/Principal Findings: A new fossil insect species, Cretophasmomima melanogramma Wang, Bethoux and Ren sp. nov., is described on the basis of one female and two male specimens recovered from the Yixian Formation (Early Cretaceous, ca. 126 +/- 4 mya; Inner Mongolia, NE China; known as 'Jehol biota'). The occurrence of a female abdominal operculum and of a characteristic 'shoulder pad' in the forewing allows for the interpretation of a true stem-Phasmatodea. In contrast to the situation in extant forms, sexual size dimorphism is only weakly female-biased in this species. The peculiar wing coloration, viz. dark longitudinal veins, suggests that the leaf-shaped plant organ from the contemporaneous 'gymnosperm' Membranifolia admirabilis was used as model for crypsis. Conclusions/Significance: As early as in the Early Cretaceous, some stem-Phasmatodea achieved effective leaf mimicry, although additional refinements characteristic of recent forms, such as curved fore femora, were still lacking. The diversification of small-sized arboreal insectivore birds and mammals might have triggered the acquisition of such primary defenses.	[Wang, Maomin; Cui, Yingying; Ren, Dong] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China; [Bethoux, Olivier] UPMC Paris6, MNHN, CNRS, Sorbonne Univ,CR2P, Paris, France; [Bradler, Sven] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Jacques, Frederic M. B.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Lab Palaeoecol, Xishuangbanna, Yunnan, Peoples R China; [Cui, Yingying] Tech Univ Bergakad Freiberg, Dept Palaeontol, Inst Geol, D-09596 Freiberg, Germany	Capital Normal University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Gottingen; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Technical University Freiberg	Ren, D (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Béthoux, Olivier/C-7308-2009; Jacques, Frederic MB/G-5009-2011; Bradler, Sven/D-8655-2015	Jacques, Frederic MB/0000-0002-7539-9218; Bradler, Sven/0000-0001-9307-1032	National Basic Research Program of China (973 Program) [2012CB821906]; National Science Foundation of China [31230065, 31272352, 41272006]; Beijing Municipal Commission of Education [KZ201310028033]; China Geological Survey [1212011120115]; Project of Great Wall Scholar	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); China Geological Survey(China Geological Survey); Project of Great Wall Scholar	This research is partly supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), National Science Foundation of China (grants 31230065, 31272352, 41272006), Project of Great Wall Scholar and KEY project of Beijing Municipal Commission of Education (grants KZ201310028033), China Geological Survey (grant 1212011120115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1994, ANNU REV ENTOMOL, V39, P1, DOI 10.1146/annurev.en.39.010194.000245; [Anonymous], 1971, PHYLOGENY ORTHOPTERO; BEDFORD GO, 1978, ANNU REV ENTOMOL, V23, P125, DOI 10.1146/annurev.en.23.010178.001013; Beier M., 1968, Handbuch der Zoologie Berlin, V4, P1; Bethoux O, 2007, PALEONTOL J+, V41, P338, DOI 10.1134/S0031030107030136; Bethoux O., 2001, Journal of Orthoptera Research, V10, P195, DOI 10.1665/1082-6467(2001)010[0195:VPOO]2.0.CO;2; Bethoux O, 2009, SYST ENTOMOL, V34, P599, DOI 10.1111/j.1365-3113.2009.00484.x; Bethoux Olivier, 2002, Zootaxa, V96, P1; Bethoux O, 2010, ORG DIVERS EVOL, V10, P173, DOI 10.1007/s13127-010-0005-3; Bethoux Olivier, 2008, Alavesia, V2, P219; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bradler S, 1999, COUR FOR SEKENBG, V215, P43; Bradler S., 2009, SPECIES PHYLOGENY EV, V2, P3, DOI DOI 10.17875/GUP2009-710; Bradler S, 2011, SYST ENTOMOL, V36, P218, DOI 10.1111/j.1365-3113.2010.00564.x; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; Carpenter F. M., 1992, TREATISE INVERTEBRAT; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Crampton G. C., 1916, Psyche, V23, DOI 10.1155/1916/92637; Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; Delclos X, 2008, NEUES JAHRB GEOL P-A, V247, P353, DOI 10.1127/0077-7749/2008/0247-0353; Doyle JA, 2006, J TORREY BOT SOC, V133, P169, DOI 10.3159/1095-5674(2006)133[169:SFATOO]2.0.CO;2; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Friedemann K, 2012, ACTA ZOOL-STOCKHOLM, V93, P184, DOI 10.1111/j.1463-6395.2010.00497.x; Gorochov A.V., 1993, Trudy Paleontologicheskogo Instituta, V252, P112; Gorochov A.V., 1994, PALEONTOL J+, V28, P83; Gorochov A.V, 2000, PALEONTOL J+, V34, P295; Gorochov AV, 1988, P ZOOL I RUSS ACAD S, V178, P32; Gorochov AV., 2002, HIST INSECTS, P293, DOI DOI 10.1007/0-306-47577-4; Gorokhov AV, 2005, PALEONTOL J+, V39, P178; Gottardo M, 2012, CR BIOL, V335, P594, DOI 10.1016/j.crvi.2012.07.004; Gottardo M, 2011, CR BIOL, V334, P555, DOI 10.1016/j.crvi.2011.04.003; Grimaldi David, 2005, pi; Hcchkirch Axel, 2008, Journal of Orthoptera Research, V17, P189, DOI 10.1665/1082-6467-17.2.189; Hennig W., 1981, INSECT PHYLOGENY; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jin M, 2006, GEOL J, V41, P439, DOI 10.1002/gj.1054; Kukalova-Peck J., 1991, P141; Kuzmina S. A, 1985, PALEONTOL J+, V19, P56; Labandeira CC, 2013, CURR OPIN PLANT BIOL, V16, P414, DOI 10.1016/j.pbi.2013.06.003; Mohanta TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032822; Nel A, 2010, SYST ENTOMOL, V40, P31; Nel A, 2011, ACTA PALAEONTOL POL, V56, P429, DOI 10.4202/app.2009.1108; RAGGE D. R., 1955, TRANS ROY ENT SOC LONDON, V106, P375; Rasnitsyn AP, 2007, PALEONTOL J+, V41, P341, DOI 10.1134/S0031030107030148; Redtenbacher J, 1906, PHASMIDAE AREOLATAE, P1; Ren Dong, 1997, Acta Zootaxonomica Sinica, V22, P268; Scott AC, 2004, J GEOL SOC LONDON, V161, P401, DOI 10.1144/0016-764903-118; Shang LJ, 2011, EUR J ENTOMOL, V108, P677, DOI 10.14411/eje.2011.086; SHAROV AG, 1968, T PALEONTOL I ACAD S, V118, P1; Sivinski J., 1978, Psyche (Cambridge), V85, P395, DOI 10.1155/1978/35784; Sun G, 2001, EARLY ANGIOSPERMS TH; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; Thornhill R., 1983, pi; Tilgner E, 2000, INSECT SYST EVOL, V31, P473, DOI 10.1163/187631200X00507; Tilgner EH, 1999, DEUT ENTOMOL Z, V46, P149, DOI 10.1002/mmnd.19990460203; Wang YJ, 2012, P NATL ACAD SCI USA, V109, P20514, DOI 10.1073/pnas.1205517109; Wang YJ, 2010, P NATL ACAD SCI USA, V107, P16212, DOI 10.1073/pnas.1006460107; Wedmann S, 2007, P NATL ACAD SCI USA, V104, P565, DOI 10.1073/pnas.0606937104; Wedmann S, 2010, PALAEONTOGR ABT B, V283, P175, DOI 10.1127/palb/283/2010/175; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Zeuner F. E, 1939, FOSSIL ORTHOPTERA EN; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZH, 2007, FRONTIERS BIOL CHINA, V2, P1, DOI [DOI 10.1007/S11515-007-0001-Y, 10.1007/s11515-007-0001-y]; Zhou ZY., 2009, PALAEOWORLD, V18, P1, DOI [10.1016/j.palwor.2009.01.001, DOI 10.1016/j.palwor.2009.01.001]	64	33	34	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91290	10.1371/journal.pone.0091290	http://dx.doi.org/10.1371/journal.pone.0091290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646906	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500027
J	Blanc, S; Ruggiero, F; Birot, AM; Acloque, H; Decimo, D; Lerat, E; Ohlmann, T; Samarut, J; Mey, A				Blanc, Sophie; Ruggiero, Florence; Birot, Anne-Marie; Acloque, Herve; Decimo, Didier; Lerat, Emmanuelle; Ohlmann, Theophile; Samarut, Jacques; Mey, Anne			Subcellular Localization of ENS-1/ERNI in Chick Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN ENDOGENOUS RETROVIRUS; TRANSCRIPTION FACTORS; EXPRESSION; PLURIPOTENCY; BINDING; SOX2; IDENTIFICATION; GASTRULATION; PROTEINS; GENOME	The protein of retroviral origin ENS-1/ERNI plays a major role during neural plate development in chick embryos by controlling the activity of the epigenetic regulator HP1 gamma, but its function in the earlier developmental stages is still unknown. ENS-1/ERNI promoter activity is down-regulated upon differentiation but the resulting protein expression has never been examined. In this study, we present the results obtained with custom-made antibodies to gain further insights into ENS-1 protein expression in Chicken embryonic stem cells (CES) and during their differentiation. First, we show that ENS-1 controls the activity of HP1 gamma in CES and we examined the context of its interaction with HP1 gamma. By combining immunofluorescence and western blot analysis we show that ENS-1 is localized in the cytoplasm and in the nucleus, in agreement with its role on gene's promoter activity. During differentiation, ENS-1 decreases in the cytoplasm but not in the nucleus. More precisely, three distinct forms of the ENS-1 protein co-exist in the nucleus and are differently regulated during differentiation, revealing a new level of control of the protein ENS-1. In silico analysis of the Ens-1 gene copies and the sequence of their corresponding proteins indicate that this pattern is compatible with at least three potential regulation mechanisms, each accounting only partially. The results obtained with the anti-ENS-1 antibodies presented here reveal that the regulation of ENS-1 expression in CES is more complex than expected, providing new tracks to explore the integration of ENS-1 in CES cells regulatory networks.	[Blanc, Sophie; Ruggiero, Florence; Birot, Anne-Marie; Acloque, Herve; Samarut, Jacques; Mey, Anne] Univ Lyon 1, CNRS UMR 5242, INRA USC 1370, Inst Genom Fonct Lyon,Ecole Normale Super Lyon, F-69365 Lyon, France; [Acloque, Herve] ENVT, Lab Genet Cellulaire INRA, Castanet Tolosan, France; [Decimo, Didier; Ohlmann, Theophile] Univ Lyon, Int Ctr Infectiol Res, Ecole Normale Super Lyon, CIRI,INSERM,U1111, Lyon, France; [Lerat, Emmanuelle] Univ Lyon, Lyon, France; [Lerat, Emmanuelle] Univ Lyon 1, F-69622 Villeurbanne, France; [Lerat, Emmanuelle] CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Samarut, J (corresponding author), Univ Lyon 1, CNRS UMR 5242, INRA USC 1370, Inst Genom Fonct Lyon,Ecole Normale Super Lyon, F-69365 Lyon, France.	jacques.samarut@ens-lyon.fr; anne.mey@lyon.inra.fr	ohlmann, Theophile/M-4463-2014; Ohlmann, Theophile/H-6522-2016; Samarut, Jacques/AAD-2587-2019	ohlmann, Theophile/0000-0002-2001-8916; RUGGIERO, Florence/0000-0003-2915-5359; MEY, Anne/0000-0002-2643-5702; Acloque, Herve/0000-0003-4761-1055; Decimo, Didier/0000-0002-0390-1205; LERAT, Emmanuelle/0000-0001-6757-8796	ANR (Agence Nationale pour la Recherche) Genanimal [ANR-06-GANI-007-01]; ANR Blanc [ANR-09-BLAN-0141]	ANR (Agence Nationale pour la Recherche) Genanimal(French National Research Agency (ANR)); ANR Blanc(French National Research Agency (ANR))	This work was supported by grants from the ANR (Agence Nationale pour la Recherche) Genanimal (ANR-06-GANI-007-01), from the ANR Blanc (ANR-09-BLAN-0141) http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2004, NUCLEIC ACIDS RES, V32, P2259, DOI 10.1093/nar/gkh545; Acloque H, 2001, MECH DEVELOP, V103, P79, DOI 10.1016/S0925-4773(01)00336-7; Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Caillier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015507; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lerat E, 2007, J MOL EVOL, V65, P215, DOI 10.1007/s00239-007-9001-4; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mey A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-21; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pain B, 1996, DEVELOPMENT, V122, P2339; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Pi WH, 2004, P NATL ACAD SCI USA, V101, P805, DOI 10.1073/pnas.0307698100; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; Soto Rifo R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm682; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Waltzer L, 1996, J VIROL, V70, P5909, DOI 10.1128/JVI.70.9.5909-5915.1996; Wicker T, 2005, GENOME RES, V15, P126, DOI 10.1101/gr.2438005; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	33	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92039	10.1371/journal.pone.0092039	http://dx.doi.org/10.1371/journal.pone.0092039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643087	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900068
J	Chaichana, P; Okabayashi, T; Puiprom, O; Sasayama, M; Sasaki, T; Yamashita, A; Ramasoota, P; Kurosu, T; Ikuta, K				Chaichana, Panjaporn; Okabayashi, Tamaki; Puiprom, Orapim; Sasayama, Mikiko; Sasaki, Tadahiro; Yamashita, Akifumi; Ramasoota, Pongrama; Kurosu, Takeshi; Ikuta, Kazuyoshi			Low Levels of Antibody-Dependent Enhancement in Vitro Using Viruses and Plasma from Dengue Patients	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; SECONDARY INFECTION; ENHANCING ACTIVITY; PERIPHERAL-BLOOD; IMMUNE-COMPLEXES; DISEASE SEVERITY; ACUTE-PHASE; CELLS; PATHOGENESIS	Background: The majority of dengue patients infected with any serotype of dengue virus (DENV) are asymptomatic, but the remainder may develop a wide spectrum of clinical symptoms, ranging from mild dengue fever (DF) to severe dengue hemorrhagic fever (DHF). Severe cases occur more often in patients who experience a secondary infection with a different virus serotype. A phenomenon called antibody-dependent enhancement (ADE) has been proposed to explain the onset of these severe cases, but the exact mechanism of ADE remains unclear. Methodology/Principal Finding: Virus neutralization and ADE assays were performed using ultracentrifugation supernatants of acute-phase sera from patients with secondary infections or human monoclonal antibodies (HuMAbs) as anti-DENV antibodies. Virus sources included infectious serum-derived viruses from the ultracentrifugation precipitates, laboratory-culture adapted DENV, or recombinant DENVs derived from patient sera. In contrast to the high levels of ADE observed with laboratory virus strains, low ADE was observed with autologous patient-derived viruses, when patient sera were used to provide the antibody component in the ADE assays. Similar results were obtained using samples from DF and DHF patients. Recombinant-viruses derived from DHF patients showed only minor differences in neutralization and ADE activity in the presence of HuMAbs or plasma derived from the same DHF patient. Conclusion/Significance: Serum or plasma taken from patients during the acute phase of a secondary infection showed high levels of ADE, but no neutralization activity, when assayed in the presence of laboratory-adapted virus strains. By contrast, serum or plasma from the same patient showed high levels of neutralization activity but failed to induce significant ADE when the assays were performed with autologous virus. These results demonstrate the significance of the virus source when measuring ADE. They also suggest that repeated passage of DENV in cell culture has endowed it with the capacity to induce high levels of ADE.	[Chaichana, Panjaporn; Okabayashi, Tamaki; Puiprom, Orapim; Sasayama, Mikiko] Mahidol Univ, Fac Trop Med, MOCID, Bangkok, Thailand; [Ramasoota, Pongrama] Mahidol Univ, Fac Trop Med, CEAR, Bangkok, Thailand; [Sasaki, Tadahiro; Yamashita, Akifumi; Kurosu, Takeshi; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Osaka, Japan; [Sasaki, Tadahiro; Yamashita, Akifumi; Ramasoota, Pongrama; Kurosu, Takeshi; Ikuta, Kazuyoshi] JST JICA, Sci & Technol Res Partnership Sustainable Dev SAT, Tokyo, Japan	Mahidol University; Mahidol University; Osaka University	Ikuta, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Virol, Osaka, Japan.	ikuta@biken.osaka-u.ac.jp	Ramasoota, Pongrama/W-3503-2019		Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; JST/JICA (SATREPS), Japan [08080924]	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; JST/JICA (SATREPS), Japan	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; and the JST/JICA (SATREPS; 08080924), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baclig MO, 2010, SE ASIAN J TROP MED, V41, P1352; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; da Silva Voorham JM, 2012, PLOS ONE, V7; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353; Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; King Alan D., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P718; Konishi E, 2010, J VIROL METHODS, V163, P360, DOI 10.1016/j.jviromet.2009.10.026; Kou ZH, 2011, VIROLOGY, V410, P240, DOI 10.1016/j.virol.2010.11.007; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kurosu T, 2010, BIOCHEM BIOPH RES CO, V394, P398, DOI 10.1016/j.bbrc.2010.02.181; Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Moi ML, 2013, T ROY SOC TROP MED H, V107, P51, DOI 10.1093/trstmh/trs007; Moi ML, 2011, J CLIN VIROL, V52, P225, DOI 10.1016/j.jcv.2011.07.009; Moi ML, 2011, J INFECT DIS, V203, P1405, DOI 10.1093/infdis/jir053; Paradkar PN, 2011, BIOSCIENCE REP, V31, P221, DOI 10.1042/BSR20100078; Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7; RUANGJIRACHUPORN W, 1979, CLIN EXP IMMUNOL, V36, P46; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sasaki T, 2013, ANTIVIR RES, V98, P423, DOI 10.1016/j.antiviral.2013.03.018; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Setthapramote C, 2012, BIOCHEM BIOPH RES CO, V423, P867, DOI 10.1016/j.bbrc.2012.06.057; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Srikiatkhachorn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051335; van der Schaar HM, 2009, IMMUNOBIOLOGY, V214, P613, DOI 10.1016/j.imbio.2008.11.008; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92173	10.1371/journal.pone.0092173	http://dx.doi.org/10.1371/journal.pone.0092173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642752	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900097
J	Chen, YH; Tian, J; Tian, XY; Tang, XY; Rui, K; Tong, J; Lu, LW; Xu, HX; Wang, SJ				Chen, Yanhong; Tian, Jie; Tian, Xinyu; Tang, Xinyi; Rui, Ke; Tong, Jia; Lu, Liwei; Xu, Huaxi; Wang, Shengjun			Adipose Tissue Dendritic Cells Enhances Inflammation by Prompting the Generation of Th17 Cells	PLOS ONE			English	Article							DIET-INDUCED OBESITY; BODY-MASS INDEX; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; PROSPECTIVE COHORT; MICE; LEPTIN; RISK; PATHOGENESIS	Background: Obesity has become a global challenge for public health. It has been reported that obesity is associated with chronic inflammation. However, the mechanism for the chronic inflammation contributes to obesity remains elusive. Methodology/Principal Findings: In our study, we found a novel CD11c(+) dendritic cell subset existed in murine adipose tissues which was immature phenotype. Moreover, as compared to the lean controls, the number of CD11c(+) DCs and CD4(+)IL-17(+) T cells were higher in adipose tissue of high fat diet (HFD) mice. Adipose tissues derived dendritic cells (ATDCs) displayed lower levels of CD40, CD80, CD86, MHCI and MHCII expression than splenic DCs (SPDCs). However, ATDCs showed higher levels of IL-6, TGF-beta and IL-23 secretion. Moreover, our in vitro experiments demonstrated that ATDCs were capable of promoting Th17 cell generation. Conclusions/Significance: Our results indicate the existence of CD11c(+) DCs in adipose tissues, which displays an immature phenotype but possessing pro-inflammatory function.	[Chen, Yanhong; Tian, Jie; Tian, Xinyu; Tang, Xinyi; Rui, Ke; Tong, Jia; Xu, Huaxi; Wang, Shengjun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China; [Tian, Jie; Xu, Huaxi; Wang, Shengjun] Jiangsu Univ, Sch Med Sci & Lab Med, Inst Lab Med, Zhenjiang, Peoples R China; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	Jiangsu University; Jiangsu University; University of Hong Kong; University of Hong Kong	Wang, SJ (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China.	sjwjs@mail.ujs.edu.cn	tian, jie/H-2497-2011; Lu, Liwei/C-4357-2009	Lu, Liwei/0000-0002-8634-0967	National Natural Science Foundation of China [31170849, 81072453, 31270947]; Specialized Research Fund for the Doctoral Program of Higher Education [20133227110008]; Health Department Foundation of Jiangsu Province [Z201313]; Graduate Student Research and Innovation Program of Jiangsu Province [CXZZ12_0710, CXZZ13_0700, CXLX11_0608]; Jiangsu Province "333" Project; "Qinglan" Project; Top Talent Program of Jiangsu University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Health Department Foundation of Jiangsu Province; Graduate Student Research and Innovation Program of Jiangsu Province; Jiangsu Province "333" Project; "Qinglan" Project(Jiangsu Polytech Institute); Top Talent Program of Jiangsu University	This work was supported by the National Natural Science Foundation of China (Grant No. 31170849, 81072453, 31270947), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20133227110008), Health Department Foundation of Jiangsu Province (Grant No. Z201313), Graduate Student Research and Innovation Program of Jiangsu Province (Grant No. CXZZ12_0710, CXZZ13_0700, CXLX11_0608), Jiangsu Province "333" Project and "Qinglan" Project, and Top Talent Program of Jiangsu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECH REP SER, V894, P1; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bernotiene E, 2004, ARTHRITIS RES THER, V6, pR256, DOI 10.1186/ar1174; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fransen JH, 2009, ARTHRITIS RHEUM-US, V60, P2304, DOI 10.1002/art.24719; Govindarajan G, 2008, AM J MED, V121, P366, DOI 10.1016/j.amjmed.2008.01.032; Han JW, 2008, CIRC RES, V102, P546, DOI 10.1161/CIRCRESAHA.107.161653; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Lang JE, 2008, AM J PHYSIOL-LUNG C, V294, pL1013, DOI 10.1152/ajplung.00122.2007; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Pini M, 2008, ENDOCRINOLOGY, V149, P4080, DOI 10.1210/en.2008-0327; Pini M, 2010, J LEUKOCYTE BIOL, V87, P51, DOI 10.1189/jlb.0309188; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shimazu T, 2009, INT J OBESITY, V33, P490, DOI 10.1038/ijo.2009.29; Sterry W, 2007, BRIT J DERMATOL, V157, P649, DOI 10.1111/j.1365-2133.2007.08068.x; Sumarac-Dumanovic M, 2009, INT J OBESITY, V33, P151, DOI 10.1038/ijo.2008.216; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wu H, 2009, CIRCULATION, V119, P2708; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zyromski NJ, 2008, AM J PHYSIOL-GASTR L, V295, pG552, DOI 10.1152/ajpgi.90278.2008	36	69	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92450	10.1371/journal.pone.0092450	http://dx.doi.org/10.1371/journal.pone.0092450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642966	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900142
J	Homolya, L; Fu, D; Sengupta, P; Jarnik, M; Gillet, JP; Vitale-Cross, L; Gutkind, JS; Lippincott-Schwartz, J; Arias, IM				Homolya, Laszlo; Fu, Dong; Sengupta, Prabuddha; Jarnik, Michal; Gillet, Jean-Pierre; Vitale-Cross, Lynn; Gutkind, J. Silvio; Lippincott-Schwartz, Jennifer; Arias, Irwin M.			LKB1/AMPK and PKA Control ABCB11 Trafficking and Polarization in Hepatocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SALT EXPORT PUMP; BINDING CASSETTE TRANSPORTERS; BILE-ACID TRANSPORT; CANALICULAR MEMBRANE; EXTRACELLULAR-MATRIX; LKB1; LIVER; AMPK; EXPRESSION	Polarization of hepatocytes is manifested by bile canalicular network formation and activation of LKB1 and AMPK, which control cellular energy metabolism. The bile acid, taurocholate, also regulates development of the canalicular network through activation of AMPK. In the present study, we used collagen sandwich hepatocyte cultures from control and liver-specific LKB1 knockout mice to examine the role of LKB1 in trafficking of ABCB11, the canalicular bile acid transporter. In polarized hepatocytes, ABCB11 traffics from Golgi to the apical plasma membrane and endogenously cycles through the rab 11a-myosin Vb recycling endosomal system. LKB1 knockout mice were jaundiced, lost weight and manifested impaired bile canalicular formation and intracellular trafficking of ABCB11, and died within three weeks. Using live cell imaging, fluorescence recovery after photobleaching (FRAP), particle tracking, and biochemistry, we found that LKB1 activity is required for microtubule-dependent trafficking of ABCB11 to the canalicular membrane. In control hepatocytes, ABCB11 trafficking was accelerated by taurocholate and cAMP; however, in LKB1 knockout hepatocytes, ABCB11 trafficking to the apical membrane was greatly reduced and restored only by cAMP, but not taurocholate. cAMP acted through a PKA-mediated pathway which did not activate AMPK. Our studies establish a regulatory role for LKB1 in ABCB11 trafficking to the canalicular membrane, hepatocyte polarization, and canalicular network formation.	[Homolya, Laszlo; Fu, Dong; Sengupta, Prabuddha; Jarnik, Michal; Lippincott-Schwartz, Jennifer; Arias, Irwin M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Homolya, Laszlo] Hungarian Acad Sci, Mol Cell Biol Lab, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary; [Fu, Dong] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Gillet, Jean-Pierre] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Gillet, Jean-Pierre] Belgium Univ Namur, Univ Namur, Fac Med, Lab Mol Canc Biol,Mol Physiol Res Unit URPhyM,Nam, Namur, Belgium; [Vitale-Cross, Lynn; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Namur; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Homolya, L (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	homolya.laszlo@ttk.mta.hu	Gutkind, J. Silvio/J-1201-2016; gillet, jean-pierre/A-1419-2017; Homolya, Laszlo/N-1154-2016	Gutkind, J. Silvio/0000-0002-5150-4482; gillet, jean-pierre/0000-0003-2453-590X; Homolya, Laszlo/0000-0003-1639-8140; Fu, Dong/0000-0002-6865-5033; Sengupta, Prabuddha/0000-0001-7094-6967; VItale-Cross, Lynn/0000-0001-7850-547X	Hungarian-American Enterprise Scholarship Fund (HAESF); Momentum Program of the Hungarian Academy of Sciences [LP2012-025]; Ministry of National Development/National Development Agency/Hungarian Scientific Research Fund [KTIA_OTKA_CK80283, KTIA_AIK_12-1-2012-0025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	Hungarian-American Enterprise Scholarship Fund (HAESF); Momentum Program of the Hungarian Academy of Sciences; Ministry of National Development/National Development Agency/Hungarian Scientific Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work has been supported by a scholarship from the Hungarian-American Enterprise Scholarship Fund (HAESF), grants from the Momentum Program of the Hungarian Academy of Sciences (LP2012-025), and Ministry of National Development/National Development Agency/Hungarian Scientific Research Fund (KTIA_OTKA_CK80283 and KTIA_AIK_12-1-2012-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hoffmaster KA, 2004, PHARM RES-DORDR, V21, P1294, DOI 10.1023/B:PHAM.0000033018.97745.0d; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Lam P, 2010, SEMIN LIVER DIS, V30, P125, DOI 10.1055/s-0030-1253222; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lo B, 2012, J CELL BIOL, V199, P1117, DOI 10.1083/jcb.201208080; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Orina JN, 2009, MOL CANCER THER, V8, P2057, DOI 10.1158/1535-7163.MCT-09-0256; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Swift B, 2010, MOL PHARMACEUT, V7, P491, DOI 10.1021/mp900227a; Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	29	36	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91921	10.1371/journal.pone.0091921	http://dx.doi.org/10.1371/journal.pone.0091921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643070	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000333259900048
J	Lin, CY; Li, RP; Cheng, HG; Wang, J; Shao, X				Lin, Chunye; Li, Ruiping; Cheng, Hongguang; Wang, Jing; Shao, Xiao			Tungsten Distribution in Soil and Rice in the Vicinity of the World's Largest and Longest-Operating Tungsten Mine in China	PLOS ONE			English	Article							BIOCHEMICAL-CONSTITUENTS; PLANTS; BIOAVAILABILITY; CONTAMINATION; MOLYBDENUM; SPECIATION; TOXICITY; GROWTH; METALS; MATTER	The objective of this study is to investigate tungsten (W) contamination in soil and its enrichment in rice in the area of the world's largest and longest-operating W mines in China. Root zone soil and rice plants were sampled at 15 sites in the agricultural field adjacent to W mines and analyzed for Al, Fe, Mn, Sc, and W contents and W chemical forms in the soil samples and W contents in the rice root, stem, leaf, and grain samples. Results showed that W content in the soil ranged from 3.99 to 43.7 mg kg(-1), with more than 90% of W in the residual fraction, showing its low mobility and bioavailability. Average W contents in the rice root, stem, leaf, and grain were 7.06, 2.34, 4.76, 0.17 mg kg(-1), respectively. In addition, they were linearly independent of W content and chemical forms in the soil. Average enrichment factor values were 0.39, 0.13, 0.28, and 0.01 for the root, stem, leaf, and grain, respectively. In can be concluded that W mining activity in the Dayu county contaminated the nearby agricultural soil and led to W bioaccumulation in the rice. This may pose a health risk to residents via food and soil ingestion, which should be a focus of scrutiny.	[Lin, Chunye; Li, Ruiping; Cheng, Hongguang; Shao, Xiao] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China; [Wang, Jing] Minist Land & Resources, China Land Surveying & Planning Inst, Key Lab Land Use, Beijing, Peoples R China	Beijing Normal University; Ministry of Natural Resources of the People's Republic of China	Lin, CY (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	c.lin@bnu.edu.cn			National Natural Science Foundation of China [41371441]; Ministry of Environmental Protection [201309044, 201109064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Environmental Protection	This study was supported by the National Natural Science Foundation of China (41371441, http://www.nsfc.gov.cn/), and the Ministry of Environmental Protection Funded Project (201309044, 201109064; http://www.zhb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakis Ioannis-Dimosthenis S., 2012, Plants-Basel, V1, P82, DOI 10.3390/plants1020082; Bednar AJ, 2009, CHEMOSPHERE, V75, P1049, DOI 10.1016/j.chemosphere.2009.01.039; Bibak A, 1998, J AGR FOOD CHEM, V46, P3139, DOI 10.1021/jf971103c; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; BOWEN HJM, 1960, BIOCHEM J, V77, P79, DOI 10.1042/bj0770079; Bruschweiler B, 2009, TOXICOL LETT, V189, pS219, DOI 10.1016/j.toxlet.2009.06.509; Cheng HG, 2013, POL J ENVIRON STUD, V22, P301; DAVIES EB, 1956, NATURE, V178, P866, DOI 10.1038/178866a0; Eriksson J.E, 2001, 5159 EPA; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; FU MH, 1988, J ENVIRON QUAL, V17, P146, DOI 10.2134/jeq1988.00472425001700010024x; Huang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075007; Jiang F, 2007, PLANT SOIL, V301, P37, DOI 10.1007/s11104-007-9409-z; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071176; Johnson D. R., 2009, Land Contamination & Reclamation, V17, P141, DOI 10.2462/09670513.939; Kabata-Pendias A., 2007, TRACE ELEMEN SOIL HU, DOI [10.1007/978-3-540-32714-1, DOI 10.1007/978-3-540-32714-1, 10.1007/978-3-540-32714-1_20]; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P9646, DOI 10.1021/es300606x; Koutsospyros A, 2006, J HAZARD MATER, V136, P1, DOI 10.1016/j.jhazmat.2005.11.007; Kumar A, 2011, PLANT SOIL ENVIRON, V57, P519, DOI 10.17221/345/2011-PSE; Kumar A, 2012, COMMUN SOIL SCI PLAN, V43, P1098, DOI 10.1080/00103624.2012.656171; Lin CY, 2008, J ENVIRON QUAL, V37, P1477, DOI 10.2134/jeq2007.0388; Lin CY, 2008, ENVIRON MONIT ASSESS, V137, P329, DOI 10.1007/s10661-007-9768-1; Pyatt F.B., 2004, J ENV HLTH RES, V3, P13; QUIN BF, 1976, PLANT SOIL, V45, P201, DOI 10.1007/BF00011142; QUIN BF, 1974, PLANT SOIL, V41, P177, DOI 10.1007/BF00017953; QUIN BF, 1972, NEW ZEAL J SCI, V15, P308; QUIN BF, 1972, PLANT SOIL, V37, P699, DOI 10.1007/BF01348530; Rodushkin I, 1999, SCI TOTAL ENVIRON, V231, P53, DOI 10.1016/S0048-9697(99)00080-7; Steinmaus C, 2004, ENVIRON HEALTH PERSP, V112, P766, DOI 10.1289/ehp.6592; Strigul N, 2005, CHEMOSPHERE, V61, P248, DOI 10.1016/j.chemosphere.2005.01.083; Strigul N, 2010, ECOTOX ENVIRON SAFE, V73, P1099, DOI 10.1016/j.ecoenv.2010.05.005; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; USEPA (United States Environmental Protection Agency), 2011, EXP FACT HDB 2011 ED; Wei F.S., 1990, BACKGROUND CONTENTS; Wilson B., 2009, Land Contamination & Reclamation, V17, P93, DOI 10.2462/09670513.935; Wilson B, 2006, SCI TOTAL ENVIRON, V370, P401, DOI 10.1016/j.scitotenv.2006.07.026; Wilson B, 2009, J TOXICOL ENV HEAL A, V72, P807, DOI 10.1080/15287390902800389; WILSON DO, 1966, NATURE, V209, P941, DOI 10.1038/209941a0; Zheng SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049664; Zhu HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050225	40	21	22	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91981	10.1371/journal.pone.0091981	http://dx.doi.org/10.1371/journal.pone.0091981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642612	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900054
J	Cann, CE; Adams, JE; Brown, JK; Brett, AD				Cann, Christopher E.; Adams, Judith E.; Brown, J. Keenan; Brett, Alan D.			CTXA Hip-An Extension of Classical DXA Measurements Using Quantitative CT	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CONTRAST-ENHANCED MDCT; X-RAY ABSORPTIOMETRY; PROXIMAL FEMUR; UNIVERSAL STANDARDIZATION; FEMORAL-NECK; DENSITOMETRY; OSTEOPOROSIS; CALIBRATION; SPINE	Bone mineral density (BMD) estimates for the proximal femur using Dual Energy X-ray Absorptiometry (DXA) are currently considered the standard for making a diagnosis of osteoporosis in an individual patient using BMD alone. We have compared BMD results from a commercial Quantitative CT (QCT) BMD analysis system, "CTXA Hip'', which provides clinical data for the proximal femur, to results from DXA. We have also used CTXA Hip to determine cortical and trabecular contributions to total BMD. Sixty-nine patients were scanned using 3D QCT and DXA. CTXA Hip BMD measurements for Total Hip and Femoral Neck were compared to DXA results. Twenty-two women were scanned at 0,1,2 years and CTXA Hip and DXA results analyzed for long-term reproducibility. Long-term reproducibility calculated as root-mean-square averages of SDs in vivo was 0.012 g/cm(2) (CV = 1.8%) for CTXA Total Hip and 0.011 g/cm(2) (CV = 2.0%) for CTXA Femoral Neck compared to 0.014 g/cm(2) (CV = 2.0%) and 0.016 g/cm(2) (CV = 2.7%), respectively, for DXA. The correlation of Total Hip BMD CTXA vs. DXA was R = 0.97 and for Femoral Neck was R = 0.95 (SEE 0.044 g/cm(2) in both cases). Cortical bone comprised 6265% (mean +/- SD) of total hipbone mass in osteoporotic women. CTXA Hip provides substantially the same clinical information as conventional DXA and in addition provides estimates of BMD in separate cortical and trabecular bone compartments, which may be useful in evaluation of bone strength.	[Cann, Christopher E.; Brown, J. Keenan; Brett, Alan D.] Mindways Software Inc, Austin, TX 78704 USA; [Cann, Christopher E.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Adams, Judith E.] Univ Manchester, Dept Clin Radiol, Manchester, Lancs, England	University of California System; University of California San Francisco; University of Manchester	Brett, AD (corresponding author), Mindways Software Inc, Austin, TX 78704 USA.	alan@qct.com		Brett, Alan/0000-0002-1671-9277				Adams JE, 2009, EUR J RADIOL, V71, P415, DOI 10.1016/j.ejrad.2009.04.074; [Anonymous], 2008, ACR PRACT GUID PERF; Bauer JS, 2007, AM J ROENTGENOL, V188, P1294, DOI 10.2214/AJR.06.1006; Binkley N, 2005, J BONE MINER RES, V20, P195, DOI 10.1359/JBMR.041115; Camp JJ, 2004, PRO BIOMED OPT IMAG, V5, P74, DOI 10.1117/12.535745; CANN CE, 1980, J COMPUT ASSIST TOMO, V4, P493, DOI 10.1097/00004728-198008000-00018; Curtis JR, 2008, J BONE MINER RES, V23, P1061, DOI 10.1359/JBMR.080232; Damilakis J, 2010, EUR RADIOL, V20, P2707, DOI 10.1007/s00330-010-1845-0; Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343; Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180; GENANT HK, 1994, J BONE MINER RES, V9, P1503; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; GOODSITT MM, 1992, BONE MINER, V19, P145, DOI 10.1016/0169-6009(92)90922-Z; Gruber M, 2013, EUR RADIOL, V23, P505, DOI 10.1007/s00330-012-2629-5; Guglielmi G, 2005, ACTA RADIOL, V46, P269, DOI 10.1080/02841850510012661; Hui SL, 1997, J BONE MINER RES, V12, P1463, DOI 10.1359/jbmr.1997.12.9.1463; Kang Y, 2005, COMPUT MED IMAG GRAP, V29, P533, DOI 10.1016/j.compmedimag.2005.05.002; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Keyak JH, 2011, BONE, V48, P1239, DOI 10.1016/j.bone.2011.03.682; Khoo BCC, 2012, OSTEOPOROSIS INT, V23, P1393, DOI 10.1007/s00198-011-1727-6; Khoo BCC, 2009, OSTEOPOROSIS INT, V20, P1539, DOI 10.1007/s00198-008-0820-y; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lang TF, 1997, BONE, V21, P101, DOI 10.1016/S8756-3282(97)00072-0; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Link TM, 2004, RADIOLOGY, V231, P805, DOI 10.1148/radiol.2313030325; Liu G, 1997, OSTEOPOROSIS INT, V7, P564, DOI 10.1007/BF02652563; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Nelson HD, 2010, ANN INTERN MED, V153; Papadakis AE, 2009, EUR RADIOL, V19, P172, DOI 10.1007/s00330-008-1099-2; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Prior JC, 1997, J BONE MINER RES, V12, P1851, DOI 10.1359/jbmr.1997.12.11.1851; Siris ES, 2012, OSTEOPOROSIS INT, V23, P2093, DOI 10.1007/s00198-012-1991-0; Slosman DO, 1999, J CLIN DENSITOM, V2, P37, DOI 10.1385/JCD:2:1:37; Smith JA, 1999, J CLIN DENSITOM, V2, P181, DOI 10.1385/JCD:2:2:181; US Department of Health and Human Services, 2004, BON HLTH OST REP SUR, DOI [10.2165/00002018-200932030-00004, DOI 10.2165/00002018-200932030-00004]; WAHNER HW, 1994, J BONE MINER RES, V9, P951; Yu EW, 2012, J BONE MINER RES, V27, P119, DOI 10.1002/jbmr.506	40	33	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91904	10.1371/journal.pone.0091904	http://dx.doi.org/10.1371/journal.pone.0091904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637515	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100079
J	Diaz-Riquelme, J; Martinez-Zapater, JM; Carmona, MJ				Diaz-Riquelme, Jose; Martinez-Zapater, Jose M.; Carmona, Maria J.			Transcriptional Analysis of Tendril and Inflorescence Development in Grapevine (Vitis vinifera L.)	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL TRANSITION; MERISTEM IDENTITY; BUD DEVELOPMENT; FLOWERING-TIME; ARABIDOPSIS; EXPRESSION; INTEGRATION; MICROARRAY; SIGNALS	In grapevine (Vitis vinifera L.), the lateral meristem can give rise to either tendrils or inflorescences which are determined organs. To get insights into the processes of tendril and inflorescence development, we characterized the transcriptional variation taking place in both organs. The results of the global transcriptional analyses along tendril and inflorescence development suggested that these two homologous organs initially share a common transcriptional program related to cell proliferation and growth functions. In later developmental stages they showed organ specific gene expression programs related to the particular differentiation processes taking place in each organ. In this way, tendrils showed higher transcription of genes related to photosynthesis, hormone signaling and secondary metabolism than inflorescences, while inflorescences displayed higher transcriptional activity for genes encoding transcription factors, mainly those belonging to the MADS-box gene family. The expression profiles of selected transcription factors related with inflorescence and flower meristem identity and with flower organogenesis were generally conserved with respect to their homologs in model species. Regarding tendrils, it was interesting to find that genes related with reproductive development in other species were also recruited for grapevine tendril development. These results suggest a role for those genes in the regulation of basic cellular mechanisms common to both developmental processes.	[Diaz-Riquelme, Jose; Martinez-Zapater, Jose M.] Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Logrono, Spain; [Carmona, Maria J.] Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Universidad Politecnica de Madrid	Carmona, MJ (corresponding author), Univ Politecn Madrid, Escuela Tecn Super Ingn Agron, Dept Biotecnol, Madrid, Spain.	mariajose.carmona@upm.es	CARMONA, MARIA JOSÉ CARVALHO/G-3653-2014; Martinez Zapater, Jose/I-4892-2012	CARMONA, MARIA JOSÉ CARVALHO/0000-0002-3031-2924; Martinez Zapater, Jose/0000-0001-7217-4454	Spanish Ministry of Science and Innovation (MICINN) [BIO2008-03892, BIO2011-26229]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by Projects BIO2008-03892 and BIO2011-26229 from the Spanish Ministry of Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Baggiolini M., 1952, REV ROMANDE AGR VITI, V8, p4e6, DOI DOI 10.3354/CR01048; Boss P. K., 2000, Australian Journal of Grape and Wine Research, V6, P168, DOI 10.1111/j.1755-0238.2000.tb00176.x; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Boss PK, 2002, PLANT SCI, V162, P887, DOI 10.1016/S0168-9452(02)00034-1; Boss PK, 2001, PLANT MOL BIOL, V45, P541, DOI 10.1023/A:1010634132156; Burko Y, 2013, PLANT CELL, V25, P2070, DOI 10.1105/tpc.113.113035; Buttrose M. S., 1974, Horticultural Abstracts, V44, P319; Calonje M, 2004, PLANT PHYSIOL, V135, P1491, DOI 10.1104/pp.104.040832; Carmona MJ, 2007, CAN J BOT, V85, P701, DOI 10.1139/B07-059; Carmona MJ, 2002, PLANT PHYSIOL, V130, P68, DOI 10.1104/pp.002428; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Diaz-Riquelme J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-181; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Gerrath JM, 1993, HORTIC REV, V13, P315; Gerrath JM, 1998, PHYLLOTAXIS VITACEAE, P89; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Carmona MJ, 2008, J EXP BOT, V59, P2579, DOI 10.1093/jxb/ern160; Carmona MJ, 2007, PLANT MOL BIOL, V63, P637, DOI 10.1007/s11103-006-9113-z; Jung JH, 2012, PLANT J, V69, P577, DOI 10.1111/j.1365-313X.2011.04813.x; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Lehti-Shiu MD, 2005, PLANT MOL BIOL, V58, P89, DOI 10.1007/s11103-005-4546-3; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Mandaokar A, 2003, PLANT MOL BIOL, V52, P775, DOI 10.1023/A:1025045217859; May P., 2000, Australian Journal of Grape and Wine Research, V6, P82, DOI 10.1111/j.1755-0238.2000.tb00166.x; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; MORRISON JC, 1991, BOT GAZ, V152, P304, DOI 10.1086/337894; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Nagano Y, 2001, NUCLEIC ACIDS RES, V29, P4097, DOI 10.1093/nar/29.20.4097; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; PRATT C, 1974, AM J ENOL VITICULT, V25, P131; Rausch T, 2004, BBA-PROTEINS PROTEOM, V1696, P253, DOI 10.1016/j.bbapap.2003.09.017; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shikata M, 2009, PLANT CELL PHYSIOL, V50, P2133, DOI 10.1093/pcp/pcp148; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; TUCKER SC, 1968, AM J BOT, V55, P1110, DOI 10.2307/2440479; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Viaene T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-148; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu GZ, 2010, PLANT CELL, V22, P3726, DOI 10.1105/tpc.110.075564; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yang SH, 2006, PLANT J, V45, P166, DOI 10.1111/j.1365-313X.2005.02585.x	63	27	29	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92339	10.1371/journal.pone.0092339	http://dx.doi.org/10.1371/journal.pone.0092339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637773	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100143
J	Edwards, FA; Edwards, DP; Sloan, S; Hamer, KC				Edwards, Felicity A.; Edwards, David P.; Sloan, Sean; Hamer, Keith C.			Sustainable Management in Crop Monocultures: The Impact of Retaining Forest on Oil Palm Yield	PLOS ONE			English	Article							RAIN-FOREST; SPECIES RICHNESS; TROPICAL FOREST; FUNCTIONAL DIVERSITY; HABITAT MANAGEMENT; ECOSYSTEM SERVICES; CONSERVATION VALUE; NATURAL ENEMIES; BIODIVERSITY; LANDSCAPE	Tropical agriculture is expanding rapidly at the expense of forest, driving a global extinction crisis. How to create agricultural landscapes that minimise the clearance of forest and maximise sustainability is thus a key issue. One possibility is protecting natural forest within or adjacent to crop monocultures to harness important ecosystem services provided by biodiversity spill-over that may facilitate production. Yet this contrasts with the conflicting potential that the retention of forest exports dis-services, such as agricultural pests. We focus on oil palm and obtained yields from 499 plantation parcels spanning a total of approximate to 23,000 ha of oil palm plantation in Sabah, Malaysian Borneo. We investigate the relationship between the extent and proximity of both contiguous and fragmented dipterocarp forest cover and oil palm yield, controlling for variation in oil palm age and for environmental heterogeneity by incorporating proximity to non-native forestry plantations, other oil palm plantations, and large rivers, elevation and soil type in our models. The extent of forest cover and proximity to dipterocarp forest were not significant predictors of oil palm yield. Similarly, proximity to large rivers and other oil palm plantations, as well as soil type had no significant effect. Instead, lower elevation and closer proximity to forestry plantations had significant positive impacts on oil palm yield. These findings suggest that if dipterocarp forests are exporting ecosystem service benefits or ecosystem dis-services, that the net effect on yield is neutral. There is thus no evidence to support arguments that forest should be retained within or adjacent to oil palm monocultures for the provision of ecosystem services that benefit yield. We urge for more nuanced assessments of the impacts of forest and biodiversity on yields in crop monocultures to better understand their role in sustainable agriculture.	[Edwards, Felicity A.; Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Edwards, David P.; Sloan, Sean] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld, Australia; [Edwards, David P.; Sloan, Sean] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Edwards, David P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; James Cook University; James Cook University; University of Sheffield	Edwards, FA (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	bs08f2a@leeds.ac.uk	Sloan, Sean/A-8630-2012; Edwards, David/AAC-5091-2019	Sloan, Sean/0000-0002-7834-0203; Edwards, David/0000-0001-8562-3853; Edwards, Felicity/0000-0003-1742-2763	Biotechnology and Biological Sciences Research Council; Australian Research Council; Biotechnology and Biological Sciences Research Council [1087855] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council(Australian Research Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	F.A.E was supported by a Biotechnology and Biological Sciences Research Council doctoral training grant studentship, and D. P. E and S. S. were supported by an Australian Research Council Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bhagwat SA, 2008, CONSERV BIOL, V22, P1368, DOI 10.1111/j.1523-1739.2008.01026.x; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Corley R., 2003, OIL PALM; Director of National Mapping, 1974, TAW SOILS SAB SHEET; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Edwards DP, 2012, BIOL CONSERV, V151, P60, DOI 10.1016/j.biocon.2012.01.017; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; Edwards FA, 2013, IBIS, V155, P313, DOI 10.1111/ibi.12027; ESRI, 2011, ARCGIS DESKT REL 10; FAO website, WRB MAP WORLD SOIL R; Fayle TM, 2010, BASIC APPL ECOL, V11, P337, DOI 10.1016/j.baae.2009.12.009; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Food and Agriculture Organization of the United Nations, 2013, FAOSTAT STAT DAT; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hill JK, 2011, PHILOS T R SOC B, V366, P3265, DOI 10.1098/rstb.2011.0050; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Koh LP, 2009, TRENDS ECOL EVOL, V24, P431, DOI 10.1016/j.tree.2009.03.012; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lucey JM, 2012, BIOTROPICA, V44, P368, DOI 10.1111/j.1744-7429.2011.00824.x; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Olschewski R, 2006, ECOL SOC, V11; Olschewski R, 2010, ECOL COMPLEX, V7, P314, DOI 10.1016/j.ecocom.2010.01.002; Perfecto I, 2004, ECOLOGY, V85, P2677, DOI 10.1890/03-3145; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Peterson EE, 2011, FRESHWATER BIOL, V56, P590, DOI 10.1111/j.1365-2427.2010.02507.x; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Ranganathan J, 2010, BIOL CONSERV, V143, P2909, DOI 10.1016/j.biocon.2010.04.018; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Rheinhardt R, 2012, ECOL INDIC, V23, P46, DOI 10.1016/j.ecolind.2012.03.017; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Sande SO, 2009, BIOL CONSERV, V142, P2703, DOI 10.1016/j.biocon.2009.06.023; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Schroth G, 2011, ENVIRON MANAGE, V48, P229, DOI 10.1007/s00267-011-9708-2; Senior MJM, 2013, BIODIVERS CONSERV, V22, P253, DOI 10.1007/s10531-012-0419-7; Sheldon FH, 2010, BIOL CONSERV, V143, P399, DOI 10.1016/j.biocon.2009.11.004; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Styring AR, 2011, FOREST ECOL MANAG, V261, P531, DOI 10.1016/j.foreco.2010.11.003; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008; Woodcock P, 2011, PHILOS T R SOC B, V366, P3256, DOI 10.1098/rstb.2011.0031; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Zuur Alain F., 2009, P1	74	25	26	5	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91695	10.1371/journal.pone.0091695	http://dx.doi.org/10.1371/journal.pone.0091695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638038	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333254100052
J	Francis, DM; Koveal, D; Tortajada, A; Page, R; Peti, W				Francis, Dana M.; Koveal, Dorothy; Tortajada, Antoni; Page, Rebecca; Peti, Wolfgang			Interaction of Kinase-Interaction-Motif Protein Tyrosine Phosphatases with the Mitogen-Activated Protein Kinase ERK2	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; MAP KINASE; DIFFERENTIAL REGULATION; BINDING DOMAIN; PTP-SL; DOCKING INTERACTIONS; STRUCTURAL BASIS; P38-ALPHA; SPECIFICITY; P38	The mitogen-activation protein kinase ERK2 is tightly regulated by multiple phosphatases, including those of the kinase interaction motif (KIM) PTP family (STEP, PTPSL and HePTP). Here, we use small angle X-ray scattering (SAXS) and isothermal titration calorimetry (ITC) to show that the ERK2: STEP complex is compact and that residues outside the canonical KIM motif of STEP contribute to ERK2 binding. Furthermore, we analyzed the interaction of PTPSL with ERK2 showing that residues outside of the canonical KIM motif also contribute to ERK2 binding. The integration of this work with previous studies provides a quantitative and structural map of how the members of a single family of regulators, the KIM-PTPs, differentially interact with their corresponding MAPKs, ERK2 and p38 alpha.	[Francis, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Koveal, Dorothy; Tortajada, Antoni; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Wolfgang_Peti@brown.edu	Peti, Wolfgang/L-3492-2014		American Cancer Society [RSG-08-067-01-LIB]; National Institute of Health [R01GM100910]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100910] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant RSG-08-067-01-LIB from the American Cancer Society to R. P. and by R01GM100910 from the National Institute of Health to W. P. Use of NSLS at Brookhaven National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-98CH10886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasu MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005432; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Francis DM, 2014, BIOMOL NMR ASSIGN, V8, P185, DOI 10.1007/s12104-013-9480-8; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Francis DM, 2011, J AM CHEM SOC, V133, P17138, DOI 10.1021/ja2075136; Francis DM, 2013, STRUCTURE, V21, P1612, DOI 10.1016/j.str.2013.07.003; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar GS, 2013, J BIOL CHEM, V288, P28347, DOI 10.1074/jbc.M113.499178; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Piserchio A, 2012, BIOCHEMISTRY-US, V51, P8047, DOI 10.1021/bi3012725; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tarrega C, 2002, J BIOL CHEM, V277, P2629, DOI 10.1074/jbc.M108874200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang YY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002241; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	28	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91934	10.1371/journal.pone.0091934	http://dx.doi.org/10.1371/journal.pone.0091934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637728	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100084
J	Jing, XN; Shi, QY; Bi, W; Zeng, ZF; Liang, YR; Wu, X; Xiao, SH; Liu, J; Yang, LH; Tao, EX				Jing, Xiuna; Shi, Qiaoyun; Bi, Wei; Zeng, Zhifen; Liang, Yanran; Wu, Xia; Xiao, Songhua; Liu, Jun; Yang, Lianhong; Tao, Enxiang			Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2 alpha-ATF4 Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED PROTEIN; RENAL EPITHELIAL-CELLS; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; PARKINSONS-DISEASE; INDUCED APOPTOSIS; ER STRESS; DEATH; INDUCTION	Rifampicin has been proposed as a therapeutic candidate for Parkinson's disease (PD). We previously showed that rifampicin was neuroprotective in PD models in vivo and in vitro. However, the molecular mechanisms underlying are not fully elucidated. In this study, using the comprehensive proteomic analysis, we identified that the 78 kDa glucose-regulated protein (GRP78), a hallmark of the unfolded protein response (UPR), was upregulated in rifampicin-treated PC12 cells. Western blot analysis confirmed GRP78 activation. GRP78 functions cytoprotectively in stressed cells, therefore, we hypothesized that GRP78 mediated rifampicin-induced neuroprotection. Using RNA interference, we found that GRP78 gene knockdown significantly attenuated the neuroprotective effects of rifampicin. Next, we examined three UPR transducers, namely, protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol requiring kinase alpha (IRE alpha) and activating transcription factor 6 (ATF 6), and how they regulated rifampicin-stimulated GRP78 expression. Our results showed that PERK, eukaryotic initiation factor 2 alpha (eIF2 alpha), and activating transcription factor 4 (ATF4) were activated in rifampicin-treated PC12 cells. Silencing the ATF4 gene using RNAi inhibited GRP78 stimulation. Interestingly, we did not detect significant IRE alpha activation, X-box binding protein 1 mRNA splicing, or ATF6 cleavage up to 24 h after rifampicin treatment. Taken together, our data suggested that rifampicin induced GRP78 via the PERK-eIF2 alpha-ATF4 pathway to protect neurons against rotenone-induced cell damage. Targeting molecules in this pathway could be a novel therapeutic approach for PD treatment.	[Jing, Xiuna; Bi, Wei; Zeng, Zhifen; Liang, Yanran; Wu, Xia; Xiao, Songhua; Liu, Jun; Yang, Lianhong; Tao, Enxiang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Qiaoyun] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Bi, Wei] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Stanford University; Jinan University	Tao, EX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	taoenxiang@163.com			National Natural Science Foundation of China (NSFC) [81371391]; Guangdong Provincial Department of Science and Technology [7001599, S2012010010731]; Ph.D. Programs Foundation of Ministry of Education of China [20070558257]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Science and Technology; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was funded by the the National Natural Science Foundation of China (NSFC, 81371391), and the Guangdong Provincial Department of Science and Technology (7001599; S2012010010731) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20070558257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi W, 2011, BRAIN RES, V1395, P12, DOI 10.1016/j.brainres.2011.04.019; Bradbury J, 2005, DRUG DISCOV TODAY, V10, P80, DOI 10.1016/S1359-6446(04)03340-9; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Chen SW, 2010, NEURAL REGEN RES, V5, P251, DOI 10.3969/j.issn.1673-5374.2010.04.002; Dong WJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2588; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Goldenberg-Cohen N, 2012, APOPTOSIS, V17, P278, DOI 10.1007/s10495-011-0678-x; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Hara H, 2011, NEUROCHEM INT, V58, P35, DOI 10.1016/j.neuint.2010.10.006; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Jankovic Joseph, 2008, Neuropsychiatr Dis Treat, V4, P743; Jessie K, 2010, INT J MOL SCI, V11, P4488, DOI 10.3390/ijms11114488; Jia Z, 2004, AM J PHYSIOL-RENAL, V287, pF1113, DOI 10.1152/ajprenal.00138.2004; Jiang YF, 2012, NEUROSCI LETT, V516, P182, DOI 10.1016/j.neulet.2012.03.074; Kilic U, 2004, ACTA NEUROPATHOL, V108, P65, DOI 10.1007/s00401-004-0867-6; Kong XC, 2011, BRAIN RES, V1383, P99, DOI 10.1016/j.brainres.2011.01.093; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010489; Lehotsky J, 2009, CELL MOL NEUROBIOL, V29, P917, DOI 10.1007/s10571-009-9376-4; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Oida Y, 2008, BRAIN RES, V1208, P217, DOI 10.1016/j.brainres.2008.02.068; Oida Y, 2006, BRAIN RES, V1082, P196, DOI 10.1016/j.brainres.2006.01.116; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shen CX, 2008, CHEM-BIOL INTERACT, V176, P196, DOI 10.1016/j.cbi.2008.07.014; Sun YL, 2010, NEURAL REGEN RES, V5, P85, DOI 10.3969/j.issn.1673-5374.2010.02.001; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wu HL, 2009, CARDIOVASC RES, V81, P148, DOI 10.1093/cvr/cvn262; Xu J, 2007, BRAIN RES, V1139, P220, DOI 10.1016/j.brainres.2006.12.074; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	38	22	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92110	10.1371/journal.pone.0092110	http://dx.doi.org/10.1371/journal.pone.0092110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638036	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100113
J	Song, IW; Li, WR; Chen, LY; Shen, LF; Liu, KM; Yen, JJY; Chen, YJ; Chen, YJ; Kraus, VB; Wu, JY; Lee, MTM; Chen, YT				Song, I-Wen; Li, Wei-Ru; Chen, Li-Ying; Shen, Li-Fen; Liu, Kai-Ming; Yen, Jeffrey J. Y.; Chen, Yi-Ju; Chen, Yu-Ju; Kraus, Virginia Byers; Wu, Jer-Yuarn; Lee, M. T. Michael; Chen, Yuan-Tsong			Palmitoyl Acyltransferase, Zdhhc13, Facilitates Bone Mass Acquisition by Regulating Postnatal Epiphyseal Development and Endochondral Ossification: A Mouse Model	PLOS ONE			English	Article							MT1-MMP; OSTEOPOROSIS; PROTEIN; IDENTIFICATION; ANGIOGENESIS; EXPRESSION; ISOFORMS; DISEASE; COMPLEX; 5P15.33	ZDHHC13 is a member of DHHC-containing palmitoyl acyltransferases (PATs) family of enzymes. It functions by post-translationally adding 16-carbon palmitate to proteins through a thioester linkage. We have previously shown that mice carrying a recessive Zdhhc13 nonsense mutation causing a Zdhcc13 deficiency develop alopecia, amyloidosis and osteoporosis. Our goal was to investigate the pathogenic mechanism of osteoporosis in the context of this mutation in mice. Body size, skeletal structure and trabecular bone were similar in Zdhhc13 WT and mutant mice at birth. Growth retardation and delayed secondary ossification center formation were first observed at day 10 and at 4 weeks of age, disorganization in growth plate structure and osteoporosis became evident in mutant mice. Serial microCT from 4-20 week-olds revealed that Zdhhc13 mutant mice had reduced bone mineral density. Through co-immunoprecipitation and acylbiotin exchange, MT1-MMP was identified as a direct substrate of ZDHHC13. In cells, reduction of MT1-MMP palmitoylation affected its subcellular distribution and was associated with decreased VEGF and osteocalcin expression in chondrocytes and osteoblasts. In Zdhhc13 mutant mice epiphysis where MT1-MMP was under palmitoylated, VEGF in hypertrophic chondrocytes and osteocalcin at the cartilage-bone interface were reduced based on immunohistochemical analyses. Our results suggest that Zdhhc13 is a novel regulator of postnatal skeletal development and bone mass acquisition. To our knowledge, these are the first data to suggest that ZDHHC13-mediated MT1-MMP palmitoylation is a key modulator of bone homeostasis. These data may provide novel insights into the role of palmitoylation in the pathogenesis of human osteoporosis.	[Song, I-Wen; Li, Wei-Ru; Chen, Li-Ying; Shen, Li-Fen; Liu, Kai-Ming; Yen, Jeffrey J. Y.; Wu, Jer-Yuarn; Lee, M. T. Michael; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Song, I-Wen; Chen, Yuan-Tsong] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, Kai-Ming] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yi-Ju; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Kraus, Virginia Byers] Duke Univ, Med Ctr, Dept Med, Div Rheumatol, Durham, NC 27710 USA; [Lee, M. T. Michael] RIKEN, Ctr Integrat Med Sci, Lab Int Alliance Genom Res, Yokohama, Kanagawa, Japan; [Lee, M. T. Michael] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Duke University; RIKEN; China Medical University Taiwan; Duke University	Lee, MTM (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	mikelee@ibms.sinica.edu.tw; chen0010@ibms.sinica.edu.tw	Chen, Yi-Ju/AAP-9052-2021; Song, I-Wen/AAW-9307-2020; Yen, Jeffrey Jong-Young/Q-5134-2018; Wu, Jer-Yuarn/S-7010-2018; Chen, Yu-Ju/E-9481-2015	Chen, Yi-Ju/0000-0002-7203-9188; Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Chen, Yu-Ju/0000-0002-3178-6697; SONG, I-WEN/0000-0003-1579-4328	Academia Sinica Genomic Medicine Multicenter Study [40-05-GMM]; National Research Program for Genomic Medicine, National Science Council, Taiwan (National Center for Genome Medicine) [NSC101-2319-B-001-001]	Academia Sinica Genomic Medicine Multicenter Study(Academia Sinica - Taiwan); National Research Program for Genomic Medicine, National Science Council, Taiwan (National Center for Genome Medicine)	This study was supported by the Academia Sinica Genomic Medicine Multicenter Study (40-05-GMM), the National Research Program for Genomic Medicine, National Science Council, Taiwan (National Center for Genome Medicine, NSC101-2319-B-001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Li Y, 2010, J BIOL CHEM, V285, P13022, DOI 10.1074/jbc.M109.079426; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Loro ML, 2000, J CLIN ENDOCR METAB, V85, P3908; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Manduca P, 2009, BONE, V44, P251, DOI 10.1016/j.bone.2008.10.046; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Tang Y, 2013, DEV CELL; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Yamamoto Y, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111132; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	37	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92194	10.1371/journal.pone.0092194	http://dx.doi.org/10.1371/journal.pone.0092194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637783	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100125
J	Koie, M; Okumura, K; Hisanaga, A; Kamei, T; Sasaki, K; Deng, M; Baba, A; Kohno, T; Hattori, M				Koie, Mari; Okumura, Kyoko; Hisanaga, Arisa; Kamei, Takana; Sasaki, Kazutomo; Deng, Mengyan; Baba, Atsushi; Kohno, Takao; Hattori, Mitsuharu			Cleavage within Reelin Repeat 3 Regulates the Duration and Range of the Signaling Activity of Reelin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Brain; Endosomes; Neurons; Protein Degradation; Signal Transduction; Dab1; Reelin	C-TERMINAL REGION; APOE RECEPTOR 2; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; BRAIN-DEVELOPMENT; TYROSINE PHOSPHORYLATION; LIPOPROTEIN RECEPTORS; NEURONAL MIGRATION; VLDL RECEPTOR; BINDING	Background: The physiological role of Reelin proteolysis is largely uncharacterized. Results: An uncleavable Reelin mutant remains active for a long time, and the cleaved Reelin fragment localizes differently than full-length Reelin. Conclusion: Extracellular and intracellular Reelin cleavage is required for halting downstream signaling and transport of the cleaved product. Significance: Inhibition of Reelin cleavage will be beneficial for treating neuropsychiatric diseases. Reelin is a secreted glycoprotein that plays essential roles in the brain. Reelin is specifically cleaved at two distinct sites, called N-t and C-t, with the former being the major one. N-t cleavage can occur both in the extracellular space and in the endosomes, although the physiological importance of endosomal N-t cleavage has not been investigated. In this study, we first determined the exact N-t cleavage site catalyzed by a protease secreted by cerebral cortical neurons. Cleavage occurred between Pro-1244 and Ala-1245 within Reelin repeat 3. A Reelin mutant in which Pro-1244 was replaced with aspartate (Reelin-PD) was resistant to a protease secreted by cultured cerebral cortical neurons, and its biological activity stayed active longer than that of wild-type Reelin. Interestingly, Reelin-PD remained in the intracellular compartments longer than wild-type Reelin and persistently activated downstream signaling. Therefore, N-t cleavage of Reelin is required for halting the signaling machinery in the extracellular space as well as within endosomes of target neurons. We established a monoclonal antibody specific to uncleaved Reelin protein and found that it is localized in the vicinity of Reelin-producing cells, whereas the N-terminal fragment diffuses, or is transported, to distant regions. These data demonstrate that N-t cleavage of Reelin plays critical roles in regulating the duration and range of Reelin functions both in the extracellular milieu and in the intracellular compartments.	[Koie, Mari; Okumura, Kyoko; Hisanaga, Arisa; Kamei, Takana; Sasaki, Kazutomo; Deng, Mengyan; Baba, Atsushi; Kohno, Takao; Hattori, Mitsuharu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Nagoya, Aichi 4678603, Japan	Nagoya City University	Hattori, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	mhattori@phar.nagoya-cu.ac.jp	Hattori, Mitsuharu/F-3859-2010	Hattori, Mitsuharu/0000-0002-0503-4969; Kohno, Takao/0000-0003-2557-4281; Baba, Atsushi/0000-0002-6871-7249	Ministry of Education, Culture, Sports, Science, and Technology [KAKENHI 22390016, 23123519, 22890155, 24790081]; Center for Intellectual Property Strategies of Japan Science and Technology Agency; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Intellectual Property Strategies of Japan Science and Technology Agency; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants KAKENHI 22390016 and 23123519 (to M. H.) and 22890155 and 24790081 (to T. K.), by grants from the Center for Intellectual Property Strategies of Japan Science and Technology Agency and from the Takeda Science Foundation (to M.H.).	Absil P, 2003, CELL TISSUE RES, V312, P81, DOI 10.1007/s00441-003-0701-9; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bock HH, 2004, J BIOL CHEM, V279, P33471, DOI 10.1074/jbc.M401770200; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chameau P, 2009, P NATL ACAD SCI USA, V106, P7227, DOI 10.1073/pnas.0810764106; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P1245, DOI 10.1016/j.joca.2008.02.013; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hibi T, 2009, FEBS LETT, V583, P1299, DOI 10.1016/j.febslet.2009.03.024; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hisanaga A, 2012, FEBS LETT, V586, P3349, DOI 10.1016/j.febslet.2012.07.017; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Ichihara H, 2001, MOL BRAIN RES, V97, P190, DOI 10.1016/S0169-328X(01)00307-2; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kohno S, 2009, BIOCHEM BIOPH RES CO, V380, P93, DOI 10.1016/j.bbrc.2009.01.039; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; Krstic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047793; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Ohta K, 2011, P NATL ACAD SCI USA, V108, P14962, DOI 10.1073/pnas.1100513108; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Rogers JT, 2013, J PSYCHOPHARMACOL, V27, P386, DOI 10.1177/0269881112463468; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Saez-Valero J, 2003, J NEUROSCI RES, V72, P132, DOI 10.1002/jnr.10554; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Simo S, 2013, DEV CELL, V27, P399, DOI 10.1016/j.devcel.2013.09.022; Stranahan AM, 2013, AGEING RES REV, V12, P815, DOI 10.1016/j.arr.2013.01.005; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Tinnes S, 2011, FASEB J, V25, P1002, DOI 10.1096/fj.10-168294; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Verbrugghe P, 2012, AM J MED GENET B, V159B, P392, DOI 10.1002/ajmg.b.32042; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015	55	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12922	12930		10.1074/jbc.M113.536326	http://dx.doi.org/10.1074/jbc.M113.536326			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644294	Green Published, hybrid			2022-12-25	WOS:000335581400060
J	Ramachandra, S; Linde, J; Brock, M; Guthke, R; Hube, B; Brunke, S				Ramachandra, Shruthi; Linde, Joerg; Brock, Matthias; Guthke, Reinhard; Hube, Bernhard; Brunke, Sascha			Regulatory Networks Controlling Nitrogen Sensing and Uptake in Candida albicans	PLOS ONE			English	Article							NUCLEAR-MEMBRANE PROTEIN; GERM TUBE FORMATION; TRANSCRIPTION FACTORS; GENE FAMILY; ASPARTYL PROTEINASES; NUTRIENT ACQUISITION; IRON ACQUISITION; PATHOGEN; EXPRESSION; VIRULENCE	Nitrogen is one of the key nutrients for microbial growth. During infection, pathogenic fungi like C. albicans need to acquire nitrogen from a broad range of different and changing sources inside the host. Detecting the available nitrogen sources and adjusting the expression of genes for their uptake and degradation is therefore crucial for survival and growth as well as for establishing an infection. Here, we analyzed the transcriptional response of C. albicans to nitrogen starvation and feeding with the infection-relevant nitrogen sources arginine and bovine serum albumin (BSA), representing amino acids and proteins, respectively. The response to nitrogen starvation was marked by an immediate repression of protein synthesis and an up-regulation of general amino acid permeases, as well as an up-regulation of autophagal processes in its later stages. Feeding with arginine led to a fast reduction in expression of general permeases for amino acids and to resumption of protein synthesis. The response to BSA feeding was generally slower, and was additionally characterized by an upregulation of oligopeptide transporter genes. From time-series data, we inferred network interaction models for genes relevant in nitrogen detection and uptake. Each individual network was found to be largely specific for the experimental condition (starvation or feeding with arginine or BSA). In addition, we detected several novel connections between regulator and effector genes, with putative roles in nitrogen uptake. We conclude that C. albicans adopts a particular nitrogen response network, defined by sets of specific gene-gene connections for each environmental condition. All together, they form a grid of possible gene regulatory networks, increasing the transcriptional flexibility of C. albicans.	[Ramachandra, Shruthi; Brock, Matthias] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Biochem & Physiol, Jena, Germany; [Linde, Joerg; Guthke, Reinhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Syst Biol & Bioinformat, Jena, Germany; [Ramachandra, Shruthi; Hube, Bernhard; Brunke, Sascha] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Hube, Bernhard; Brunke, Sascha] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Brock, Matthias; Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Brunke, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	sascha.brunke@hki-jena.de	Brunke, Sascha/G-1486-2012; Brock, Matthias/AAX-1430-2021	Brunke, Sascha/0000-0001-7740-4570; Brock, Matthias/0000-0003-2774-1856	German Federal Ministry of Education and Health (BMBF) Germany - Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC) [FKZ: 01EO1002]; excellent graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG) [CRC/Transregio 124]	German Federal Ministry of Education and Health (BMBF) Germany - Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC); excellent graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Federal Ministry of Education and Health (BMBF) Germany, FKZ: 01EO1002 - Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC, www.cscc.uniklinikum-jena.de). SR was supported by the excellent graduate school Jena School for Microbial Communication (JSMC; www.jsmc.uni-jena.de). JL was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) CRC/Transregio 124 'Pathogenic fungi and their human host: Networks of interaction', subproject INF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Citiulo F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002777; Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822, DOI 10.1152/ajpgi.1990.259.5.G822; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Grundmann O, 2001, J BIOL CHEM, V276, P25661, DOI 10.1074/jbc.M101068200; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horn Fabian, 2012, Front Microbiol, V3, P108, DOI 10.3389/fmicb.2012.00108; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Hube B, 2006, FUTURE MICROBIOL, V1, P209, DOI 10.2217/17460913.1.2.209; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Limjindaporn T, 2003, MOL MICROBIOL, V50, P993, DOI 10.1046/j.1365-2958.2003.03747.x; Linde J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-6; Linde J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-148; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Mayer FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002592; Mejia-Guerra MK, 2012, BBA-GENE REGUL MECH, V1819, P454, DOI 10.1016/j.bbagrm.2012.02.016; Miramon P, 2013, MED MICROBIOL IMMUN, V202, P183, DOI 10.1007/s00430-013-0288-z; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Otzen C, 2013, FEMS YEAST RES, V13, P553, DOI 10.1111/1567-1364.12057; Palmer GE, 2007, MICROBIOL-SGM, V153, P51, DOI 10.1099/mic.0.2006/001610-0; Park JY, 2003, YONSEI MED J, V44, P110, DOI 10.3349/ymj.2003.44.1.110; R Core Team, 2022, R LANG ENV STAT COMP; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Sandai D, 2012, MBIO, V3, DOI 10.1128/mBio.00495-12; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SYCHROVA H, 1994, YEAST, V10, P1647, DOI 10.1002/yea.320101214; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; Vieira N, 2010, MOL MICROBIOL, V75, P1337, DOI 10.1111/j.1365-2958.2009.07003.x; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-1; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	52	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92734	10.1371/journal.pone.0092734	http://dx.doi.org/10.1371/journal.pone.0092734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651113	Green Submitted, gold, Green Published			2022-12-25	WOS:000333352800149
J	Gan, VC; Tan, LK; Lye, DC; Pok, KY; Mok, SQ; Chua, RCR; Leo, YS; Ng, LC				Gan, Victor C.; Tan, Li-Kiang; Lye, David C.; Pok, Kwoon-Yong; Mok, Shi-Qi; Chua, Rachel Choon-Rong; Leo, Yee-Sin; Ng, Lee-Ching			Diagnosing Dengue at the Point-of-Care: Utility of a Rapid Combined Diagnostic Kit in Singapore	PLOS ONE			English	Article							TESTS; NS1; ANTIGEN; ASSAYS; SENSITIVITY; INFECTION; ACCURACY; VIRUS; SURVEILLANCE; PROPORTIONS	WHO recommendations for dengue diagnosis require laboratory facilities. Antibody-based rapid diagnostic tests (RDTs) have performed poorly, and clinical diagnosis remains the mainstay in dengue-endemic countries. We evaluated a combination antigen-antibody RDT for point-of-care testing in a high-prevalence setting. In this prospective cohort study, adults were enrolled from a tertiary infectious disease centre for evaluation of undifferentiated febrile illness from October 2011 to May 2012. SD Bioline Dengue Duo was evaluated at point-of-care against a WHO-based reference standard of viral isolation, RT-PCR, NS1-, IgM-, and IgG-ELISA. 246 adults were enrolled (median age 34 years, range 18-69), of which 197 could be confirmed definitively as either dengue or non-dengue. DENV-2 was the predominant serotype (79.5%) and the ratio of primary to secondary cases was 1:1.1. There were no test failures and minimal interobserver variation with a Fleiss' kappa of 0.983 (95% CI 0.827-1.00). Overall sensitivity and specificity were 93.9% (95% CI 88.8-96.8%) and 92.0% (95% CI 81.2-96.9%) respectively. Using WHO clinical criteria alone for diagnosis had similar sensitivities (95.9%, 95% CI 91.4-98.1%) and lower specificities (20.0%, 95% CI 11.2-33.0%). No significant difference in performance was found when testing early versus late presenters, primary versus secondary cases, or DENV-1 versus DENV-2 infections. The use of a combination RDT fulfills WHO ASSURED criteria for point-of-care testing and can enhance dengue diagnosis in an endemic setting. This has the potential to markedly improve clinical management of dengue in the field.	[Gan, Victor C.; Lye, David C.; Mok, Shi-Qi; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Tan, Li-Kiang; Pok, Kwoon-Yong; Chua, Rachel Choon-Rong; Ng, Lee-Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Lye, David C.; Leo, Yee-Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Tan Tock Seng Hospital; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gan, VC (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.	Victor.Gan@mohh.com.sg	Lye, David/ABF-4402-2021	Lye, David/0000-0003-0324-0205; Gan, Victor/0000-0002-6966-2729	Singapore National Research Foundation [NMRC/TCR/005]	Singapore National Research Foundation(National Research Foundation, Singapore)	This research is supported by the Singapore National Research Foundation under its TCR Flagship Programmes (NMRC/TCR/005) and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993; Anker M, 2011, W PACIFIC SURVEILLAN, V2, pe1; Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Kettler H., 2004, MAPPING LANDSCAPE DI; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Ministry of Health Singapore, 2012, COMM DIS SURV SING 2; Newcombe RG, 2001, STAT MED, V20, P907, DOI 10.1002/sim.906; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nga TTT, 2007, CLIN VACCINE IMMUNOL, V14, P799, DOI 10.1128/CVI.00483-06; Ooi EE, 2001, DENGUE B, V25, P41; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Peeling RW, 2009, EVALUATION COMMERCIA; Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176; Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tango T, 1998, STAT MED, V17, P891, DOI 10.1002/(SICI)1097-0258(19980430)17:8<891::AID-SIM780>3.0.CO;2-B; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization Regional Office for South-East Asia, 2011, REG OFF S E COMPR GU; Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021	37	53	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90037	10.1371/journal.pone.0090037	http://dx.doi.org/10.1371/journal.pone.0090037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646519	Green Published, gold			2022-12-25	WOS:000333348500013
J	Hack, N; Fayad, SM; Monari, EH; Akbar, U; Hardwick, A; Rodriguez, RL; Malaty, IA; Romrell, J; Shukla, AAW; McFarland, N; Ward, HE; Okun, MS				Hack, Nawaz; Fayad, Sarah M.; Monari, Erin H.; Akbar, Umer; Hardwick, Angela; Rodriguez, Ramon L.; Malaty, Irene A.; Romrell, Janet; Shukla, Aparna A. Wagle; McFarland, Nikolaus; Ward, Herbert E.; Okun, Michael S.			An Eight-Year Clinic Experience with Clozapine Use in a Parkinson's Disease Clinic Setting	PLOS ONE			English	Article							DRUG-INDUCED PSYCHOSIS; COGNITIVE IMPAIRMENT; NONMOTOR SYMPTOMS; RISK-FACTORS; MOTOR; HALLUCINATIONS; MANAGEMENT; QUETIAPINE; PATIENT	Background: To examine our eight year clinic-based experience in a Parkinson's disease expert clinical care center using clozapine as a treatment for refractory psychosis in Parkinson's disease (PD). Methods: The study was a retrospective chart review which covered eight years of clozapine registry use. Statistical T-tests, chi-square, correlations and regression analysis were used to analyze treatment response for potential associations of age, disease duration, and Hoehn & Yahr (H&Y) score, and degree of response to clozapine therapy. Results: There were 36 participants included in the analysis (32 PD, 4 parkinsonism-plus). The characteristics included 30.6% female, age 45-87 years (mean 68.3 +/- 10.15), disease duration of 17-240 months (mean 108.14 +/- 51.13) and H&Y score of 2 to 4 (mean 2.51 +/- 0.51). The overall retention rate on clozapine was 41% and the most common reasons for discontinuation were frequent blood testing (28%), nursing home (NH) placement (11%) and leucopenia (8%). Responses to clozapine across the cohort were: complete (33%), partial (33%), absent (16%), and unknown (16%). Age (r = -0.36, p < 0.01) and H&Y score (r = -0.41, p < 0.01) were shown to be related to response to clozapine therapy, but disease duration was not an associated factor (r = 0.21, p > 0.05). Conclusions: This single-center experience highlights the challenges associated with clozapine therapy in PD psychosis. Frequent blood testing remains a significant barrier for clozapine, even in patients with therapeutic benefit. Surprisingly, all patients admitted to a NH discontinued clozapine due to logistical issues of administration and monitoring within that setting. Consideration of the barriers to clozapine therapy will be important to its use and to its continued success in an outpatient setting.	[Hack, Nawaz; Fayad, Sarah M.; Monari, Erin H.; Akbar, Umer; Hardwick, Angela; Rodriguez, Ramon L.; Malaty, Irene A.; Romrell, Janet; Shukla, Aparna A. Wagle; McFarland, Nikolaus; Ward, Herbert E.; Okun, Michael S.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Fayad, Sarah M.; Ward, Herbert E.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hack, N (corresponding author), Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	nawaz@ufl.edu	Shukla, Aparna Wagle/AAN-1344-2020; Hack, Nawaz/AAH-4509-2020; Malaty, Irene/AAE-2553-2020; McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; WAGLE SHUKLA, APARNA/0000-0002-9757-9973; Hastings Monari, Erin/0000-0002-4075-3360; Hack, Nawaz/0000-0001-9867-4334; Okun, Michael/0000-0002-6247-9358				Gondim FDA, 2010, MOVEMENT DISORD, V25, P1505, DOI 10.1002/mds.22553; Chadda RK, 2013, J PHARMACOL PHARMACO, V4, P176, DOI 10.4103/0976-500X.114596; Crump K, 2011, RES SOC ADMIN PHARM, V7, P122, DOI 10.1016/j.sapharm.2010.03.006; Cubo E, 2013, NEUROLOGY, V80; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; Durif F, 2004, NEUROLOGY, V62, P381, DOI 10.1212/01.WNL.0000110317.52453.6C; Ellis T, 2000, J NEUROPSYCH CLIN N, V12, P364, DOI 10.1176/appi.neuropsych.12.3.364; Factor SA, 2003, NEUROLOGY, V60, P1756, DOI 10.1212/01.WNL.0000068010.82167.CF; Factor SA, 2001, MOVEMENT DISORD, V16, P135, DOI 10.1002/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q; Fernandez Hubert H, 2012, Cleve Clin J Med, V79 Suppl 2, pS14, DOI 10.3949/ccjm.79.s2a.03; Filia SL, 2012, AUST NZ J PSYCHIAT, V46, P225, DOI 10.1177/0004867411433210; Friedberg G, 1998, CLIN NEUROPHARMACOL, V21, P280; Friedman J, 1999, NEW ENGL J MED, V340, P757; Friedman JH, 2013, BEHAV NEUROL, V27, P469, DOI [10.1155/2013/645429, 10.3233/BEN-129016]; Friedman Joseph H, 2011, J Pharm Pract, V24, P534, DOI 10.1177/0897190011426556; Goetz CG, 1998, NEUROLOGY, V51, P811, DOI 10.1212/WNL.51.3.811; Goetz CG, 2000, NEUROLOGY, V55, P789, DOI 10.1212/WNL.55.6.789; Goldman JG, 2011, EXPERT OPIN PHARMACO, V12, P2009, DOI 10.1517/14656566.2011.587122; Hack N, 2012, ANN NEUROL, V72, P912, DOI 10.1002/ana.23697; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Hassan Anhar, 2012, Parkinsonism Relat Disord, V18 Suppl 3, pS10, DOI 10.1016/j.parkreldis.2012.06.014; Hattori N, 2013, CLIN NUCL MED, V38, P315, DOI 10.1097/RLU.0b013e3182873511; Hindle JV, 2013, J NEURAL TRANSM, V120, P649, DOI 10.1007/s00702-013-0994-0; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Liperoti R, 2005, J CLIN PSYCHIAT, V66, P1090, DOI 10.4088/JCP.v66n0901; Maher KN, 2013, J CHILD ADOL PSYCHOP, V23, P110, DOI 10.1089/cap.2011.0136; Menza M M, 1999, Ann Clin Psychiatry, V11, P141, DOI 10.1023/A:1022360027358; Merims D, 2006, CLIN NEUROPHARMACOL, V29, P331, DOI 10.1097/01.WNF.0000236769.31279.19; Michalski LS, 2009, KIDNEY INT, V75, P243, DOI 10.1038/ki.2008.464; Morgante L, 2004, CLIN NEUROPHARMACOL, V27, P153, DOI 10.1097/01.wnf.0000136891.17006.ec; Munhoz RP, 2013, PARKINSONISM RELAT D, V19, P77, DOI 10.1016/j.parkreldis.2012.07.008; Neagoe AD, 2013, GEN HOSP PSYCHIAT, V35, DOI 10.1016/j.genhosppsych.2013.03.023; Nishikawa N, 2009, PARKINSONISM RELAT D, V15, P351, DOI 10.1016/j.parkreldis.2008.08.005; Pintor L, 2012, CLIN NEUROPHARMACOL, V35, P61, DOI 10.1097/WNF.0b013e31824d5115; Poewe Werner, 2008, Pract Neurol, V8, P238, DOI 10.1136/jnnp.2008.152579; Pollak P, 2004, J NEUROL NEUROSUR PS, V75, P689, DOI 10.1136/jnnp.2003.029868; POSTMA JU, 1975, J AM GERIATR SOC, V23, P212, DOI 10.1111/j.1532-5415.1975.tb00187.x; Rabey JM, 2009, PARKINSONISM RELAT D, V15, pS105, DOI 10.1016/S1353-8020(09)70846-6; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Smith EJ, 2008, AM J PSYCHIAT, V165, P1613, DOI 10.1176/appi.ajp.2008.08081228; Stefanis N, 2010, PARKINSONISM RELAT D, V16, P550, DOI 10.1016/j.parkreldis.2010.06.010; Trosch RM, 1998, MOVEMENT DISORD, V13, P377, DOI 10.1002/mds.870130302; Weerkamp NJ, 2012, J AM GERIATR SOC, V60, P2277, DOI 10.1111/jgs.12027; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P899, DOI 10.1001/archneurol.2011.139; WOLTERS EC, 1990, NEUROLOGY, V40, P832, DOI 10.1212/WNL.40.5.832; Yoritaka A, 2013, PARKINSONISM RELAT D, V19, P725, DOI 10.1016/j.parkreldis.2013.04.001	46	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91545	10.1371/journal.pone.0091545	http://dx.doi.org/10.1371/journal.pone.0091545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646688	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500039
J	Liu, XNL; Liang, PP; Li, KC; Reder, LM				Liu, Xiaonan L.; Liang, Peipeng; Li, Kuncheng; Reder, Lynne M.			Uncovering the Neural Mechanisms Underlying Learning from Tests	PLOS ONE			English	Article							PREFRONTAL CORTEX; EPISODIC MEMORY; FUNCTIONAL ROLES; RETRIEVAL; FMRI; ACTIVATION; BRAIN; PARAHIPPOCAMPAL; RETENTION	People learn better when re-study opportunities are replaced with tests. While researchers have begun to speculate on why testing is superior to study, few studies have directly examined the neural underpinnings of this effect. In this fMRI study, participants engaged in a study phase to learn arbitrary word pairs, followed by a cued recall test (recall second half of pair when cued with first word of pair), re-study of each pair, and finally another cycle of cued recall tests. Brain activation patterns during the first test (recall) of the studied pairs predicts performance on the second test. Importantly, while subsequent memory analyses of encoding trials also predict later accuracy, the brain regions involved in predicting later memory success are more extensive for activity during retrieval (testing) than during encoding (study). Those additional regions that predict subsequent memory based on their activation at test but not at encoding may be key to understanding the basis of the testing effect.	[Liu, Xiaonan L.; Reder, Lynne M.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Liu, Xiaonan L.; Reder, Lynne M.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Liang, Peipeng; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Peipeng; Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University	Li, KC (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	lkc1955@gmail.com; reder@cmu.edu	Liang, Peipeng/A-9502-2015	Liang, Peipeng/0000-0003-3795-4134; Liu, Xiaonan/0000-0001-6021-9889; Reder, Lynne/0000-0002-6858-4466	National Natural Science Foundation of China [61105118]; Beijing Nova Program [Z12111000250000]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by the grant from the National Natural Science Foundation of China (61105118), Beijing Nova Program (No. Z12111000250000) and the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNKOPZD1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson John R, 1979, LEVELS PROCESSING HU, P385; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; Carpenter SK, 2007, PSYCHON B REV, V14, P474, DOI 10.3758/BF03194092; CARRIER M, 1992, MEM COGNITION, V20, P633, DOI 10.3758/BF03202713; Eriksson J, 2011, NEUROSCI LETT, V505, P36, DOI 10.1016/j.neulet.2011.08.061; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fletcher PC, 1998, BRAIN, V121, P1249, DOI 10.1093/brain/121.7.1249; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Gates AI, 1917, SCHOOL SOC, V6, P743; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Halamish V, 2011, J EXP PSYCHOL LEARN, V37, P801, DOI 10.1037/a0023219; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hashimoto T, 2011, NEUROBIOL LEARN MEM, V96, P143, DOI 10.1016/j.nlm.2011.03.008; Jamal NI, 2012, HUM BRAIN MAPP, V33, P235, DOI 10.1002/hbm.21208; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Keresztes A, 2013, CEREB CORTE IN PRESS; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kornell N, 2009, J EXP PSYCHOL LEARN, V35, P989, DOI 10.1037/a0015729; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manelis A, 2013, HIPPOCAMPUS, V23, P53, DOI 10.1002/hipo.22053; Manenti R, 2010, NEUROSCIENCE, V166, P501, DOI 10.1016/j.neuroscience.2009.12.037; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; McDaniel MA, 2007, PSYCHON B REV, V14, P200, DOI 10.3758/BF03194052; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pashler H, 2007, PSYCHON B REV, V14, P187, DOI 10.3758/BF03194050; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Pugh K., 2005, LEARN DISABIL RES PR, V20, P24, DOI [10.1111/j.1540-5826.2005.00117.x, DOI 10.1111/J.1540-5826.2005.00117.X]; Roediger HL, 2006, PERSPECT PSYCHOL SCI, V1, P181, DOI 10.1111/j.1745-6916.2006.00012.x; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Sommer T, 2005, NEUROPSYCHOLOGIA, V43, P732, DOI 10.1016/j.neuropsychologia.2004.08.002; Spitzer HF, 1939, J EDUC PSYCHOL, V30, P641, DOI 10.1037/h0063404; Stark CEL, 2003, J NEUROSCI, V23, P6748; Toppino TC, 2009, EXP PSYCHOL, V56, P252, DOI 10.1027/1618-3169.56.4.252; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; van den Broek GSE, 2013, NEUROIMAGE, V78, P94, DOI 10.1016/j.neuroimage.2013.03.071; Verkoeijen PPJL, 2012, PSYCHOL SCI, V23, P567, DOI 10.1177/0956797611435132; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wheeler M, 2003, MEMORY, V11, P571, DOI 10.1080/09658210244000414; Wing EA, 2013, NEUROPSYCHOLOGIA; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035	48	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92025	10.1371/journal.pone.0092025	http://dx.doi.org/10.1371/journal.pone.0092025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647122	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500074
J	Bates, SR; Quake, SR				Bates, Steven R.; Quake, Stephen R.			Mapping of Protein-Protein Interactions of E. coli RNA Polymerase with Microfluidic Mechanical Trapping	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASS-SPECTROMETRY; ALPHA-SUBUNIT; CONTACT SITE; SIGMA-FACTOR; TRANSCRIPTION ACTIVATORS; IN-VITRO; REGION 4; YEAST; COMPLEX	The biophysical details of how transcription factors and other proteins interact with RNA polymerase are of great interest as they represent the nexus of how structure and function interact to regulate gene expression in the cell. We used an in vitro microfluidic approach to map interactions between a set of ninety proteins, over a third of which are transcription factors, and each of the four subunits of E. coli RNA polymerase, and we compared our results to those of previous large-scale studies. We detected interactions between RNA polymerase and transcription factors that earlier high-throughput screens missed; our results suggest that such interactions can occur without DNA mediation more commonly than previously appreciated.	[Bates, Steven R.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, HHMI, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	quake@stanford.edu			National Science Foundation; National Institutes of Health; Howard Hughes Medical Institute	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the National Science Foundation, the National Institutes of Health, and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Arifuzzaman M, 2002, GENES CELLS, V7, P553, DOI 10.1046/j.1365-2443.2002.00545.x; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Borukhov S, 2003, CURR OPIN MICROBIOL, V6, P93, DOI 10.1016/S1369-5274(03)00036-5; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Causler B, 2004, MASS SPECTROM REV, V23, P350, DOI 10.1002/mas.10080; Collins MO, 2008, CURR OPIN BIOTECH, V19, P324, DOI 10.1016/j.copbio.2008.06.002; CUI YH, 1995, J BACTERIOL, V177, P4872, DOI 10.1128/jb.177.17.4872-4880.1995; Darwin AJ, 1998, J BACTERIOL, V180, P4192, DOI 10.1128/JB.180.16.4192-4198.1998; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kulkarni RD, 1999, BIOCHEMISTRY-US, V38, P3362, DOI 10.1021/bi982814m; Leonhartsberger S, 2001, J MOL BIOL, V307, P93, DOI 10.1006/jmbi.2000.4451; Lochowska A, 2004, MOL MICROBIOL, V53, P791, DOI 10.1111/j.1365-2958.2004.04161.x; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Mahren S, 2003, J BACTERIOL, V185, P1796, DOI 10.1128/JB.185.6.1796-1802.2003; Martin RG, 2002, MOL MICROBIOL, V43, P355, DOI 10.1046/j.1365-2958.2002.02748.x; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; Shah IM, 2004, J MOL BIOL, V343, P513, DOI 10.1016/j.jmb.2004.08.057; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TOBIN JF, 1990, J MOL BIOL, V211, P75, DOI 10.1016/0022-2836(90)90012-B; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Weber KD, 2005, J BACTERIOL, V187, P1724, DOI 10.1128/JB.187.5.1724-1731.2005; Westblade LF, 2004, J MOL BIOL, V335, P685, DOI 10.1016/j.jmb.2003.11.004; Wickstrum JR, 2004, J BACTERIOL, V186, P6277, DOI 10.1128/JB.186.18.6277-6285.2004; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	37	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91542	10.1371/journal.pone.0091542	http://dx.doi.org/10.1371/journal.pone.0091542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643045	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900026
J	Chowdhury, FZ; Estrada, LD; Murray, S; Forman, J; Farrar, JD				Chowdhury, Fatema Z.; Estrada, Leonardo D.; Murray, Sean; Forman, James; Farrar, J. David			Pharmacological Inhibition of TPL2/MAP3K8 Blocks Human Cytotoxic T Lymphocyte Effector Functions	PLOS ONE			English	Article							HUMAN CD8(+) EFFECTOR; TNF-ALPHA PRODUCTION; PROTEIN-KINASE; RHEUMATOID-ARTHRITIS; MAP KINASE; CLONAL EXPANSION; GAMMA PRODUCTION; INNATE IMMUNITY; CENTRAL MEMORY; TPL2 KINASE	CD8(+) cytotoxic T lymphocytes (CTLs) play a major role in defense against intracellular pathogens. During development, antigen-presenting cells secrete innate cytokines such as IL-12 and IFN-alpha, which drive CTL differentiation into diverse populations of effector and long-lived memory cells. Using whole transcriptome analyses, the serine/threonine protein kinase Tpl2/MAP3K8 was found to be induced by IL-12 and selectively expressed by effector memory (T-EM) CTLs. Tpl2 regulates various inflammatory pathways by activating the ERK mediated MAP kinase pathway in innate immune cells such as macrophages and dendritic cells. In this study, we found that a specific small molecule Tpl2 inhibitor blocked IFN-gamma and TNF-alpha secretion as well as cytolytic activity of human CTLs. This pathway was specific for human effector CTLs, as the Tpl2 inhibitor did not block IFN-gamma and TNF-alpha secretion from murine effector CTLs. Further, IL-12 failed to induce expression of Tpl2 in murine CTLs, and Tpl2 deficient murine CTLs did not exhibit any functional deficiency either in vitro or in vivo in response to L. monocytogenes infection. In summary, we identified a species-specific role for Tpl2 in effector function of human CTLs, which plays a major role in adaptive immune responses to intracellular pathogens and tumors.	[Chowdhury, Fatema Z.; Estrada, Leonardo D.; Murray, Sean; Forman, James; Farrar, J. David] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Farrar, J. David] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Farrar, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	David.Farrar@UTSouthwestern.edu			National Institutes of Health [AI005284, AI045764, AI056222]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056222, R01AI045764, T32AI005284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by National Institutes of Health grants (AI005284, F.Z.C.; AI045764, J.F.; and AI056222, J.D.F.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang J, 2004, J IMMUNOL, V172, P2818, DOI 10.4049/jimmunol.172.5.2818; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Graham DB, 2006, J IMMUNOL, V177, P6098, DOI 10.4049/jimmunol.177.9.6098; Gugasyan R, 2012, EMBO J, V31, P692, DOI 10.1038/emboj.2011.435; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Hirata K, 2010, BIOL PHARM BULL, V33, P1233, DOI 10.1248/bpb.33.1233; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Lawrenz M, 2012, MUCOSAL IMMUNOL, V5, P129, DOI 10.1038/mi.2011.57; Lindstrom TM, 2010, RHEUM DIS CLIN N AM, V36, P367, DOI 10.1016/j.rdc.2010.02.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Ramos HJ, 2009, BLOOD, V113, P5516, DOI 10.1182/blood-2008-11-188458; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wu JJ, 2009, BIOORG MED CHEM LETT, V19, P3485, DOI 10.1016/j.bmcl.2009.05.009; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	36	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92187	10.1371/journal.pone.0092187	http://dx.doi.org/10.1371/journal.pone.0092187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642963	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900101
J	Ferrando, ML; van Baarlen, P; Orru, G; Piga, R; Bongers, RS; Wels, M; De Greeff, A; Smith, HE; Wells, JM				Ferrando, M. Laura; van Baarlen, Peter; Orru, Germano; Piga, Rosaria; Bongers, Roger S.; Wels, Michiel; De Greeff, Astrid; Smith, Hilde E.; Wells, Jerry M.			Carbohydrate Availability Regulates Virulence Gene Expression in Streptococcus suis	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; FIBRONECTIN-BINDING PROTEIN; BACILLUS-SUBTILIS; GLYCOGEN-METABOLISM; ESCHERICHIA-COLI; EPITHELIAL-CELLS; MOUSE INTESTINE; MOLECULAR CHARACTERIZATION; HYALURONAN CONCENTRATION; CATABOLITE REPRESSION	Streptococcus suis is a major bacterial pathogen of young pigs causing worldwide economic problems for the pig industry. S. suis is also an emerging pathogen of humans. Colonization of porcine oropharynx by S. suis is considered to be a high risk factor for invasive disease. In the oropharyngeal cavity, where glucose is rapidly absorbed but dietary alpha-glucans persist, there is a profound effect of carbohydrate availability on the expression of virulence genes. Nineteen predicted or confirmed S. suis virulence genes that promote adhesion to and invasion of epithelial cells were expressed at higher levels when S. suis was supplied with the alpha-glucan starch/pullulan compared to glucose as the single carbon source. Additionally the production of suilysin, a toxin that damages epithelial cells, was increased more than ten-fold when glucose levels were low and S. suis was growing on pullulan. Based on biochemical, bioinformatics and in vitro and in vivo gene expression studies, we developed a biological model that postulates the effect of carbon catabolite repression on expression of virulence genes in the mucosa, organs and blood. This research increases our understanding of S. suis virulence mechanisms and has important implications for the design of future control strategies including the development of anti-infective strategies by modulating animal feed composition.	[Ferrando, M. Laura; van Baarlen, Peter; Piga, Rosaria; Wells, Jerry M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Ferrando, M. Laura] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Orru, Germano] Univ Cagliari, Oral Biotechnol Lab, Cagliari, Italy; [Bongers, Roger S.; Wels, Michiel] NIZO Food Res BV, Ede, Netherlands; [De Greeff, Astrid; Smith, Hilde E.] Wageningen Univ, Anim Sci Grp, Cent Vet Inst, Lelystad, Netherlands	Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; University of Cagliari; NIZO Food Research; Animal Sciences Group of Wageningen UR; Wageningen University & Research	Wells, JM (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	jerry.wells@wur.nl	van Baarlen, Peter/B-8699-2009; Ferrando, Maria Laura/M-3026-2018	van Baarlen, Peter/0000-0003-3530-5472; Ferrando, Maria Laura/0000-0002-1398-8244; Orru, Germano/0000-0003-1032-4431	Netherlands Top Institute for Food and Nutrition	Netherlands Top Institute for Food and Nutrition	The work was funded by The Netherlands Top Institute for Food and Nutrition. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Allen AG, 2004, MICROB PATHOGENESIS, V36, P327, DOI 10.1016/j.micpath.2004.02.006; Allen AG, 2001, INFECT IMMUN, V69, P2732, DOI 10.1128/IAI.69.4.2732-2735.2001; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bakker GCM, 1998, VET QUART, V20, pS59; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; Bongaerts RJM, 2000, INFECT IMMUN, V68, P7141, DOI 10.1128/IAI.68.12.7141-7143.2000; Bonifait L, 2011, VET MICROBIOL, V148, P333, DOI 10.1016/j.vetmic.2010.09.024; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chaptal V, 2006, PROTEINS, V64, P814, DOI 10.1002/prot.21001; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; EISENBERG RJ, 1974, BIOCHEM BIOPH RES CO, V57, P959, DOI 10.1016/0006-291X(74)90789-X; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; FERRARI M, 1993, MICROBIOLOGICA, V16, P381; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Ge JC, 2009, CURR MICROBIOL, V59, P248, DOI 10.1007/s00284-009-9425-8; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Gough H, 1996, ARCH ORAL BIOL, V41, P141, DOI 10.1016/0003-9969(95)00121-2; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Jobin MC, 2003, FEMS MICROBIOL LETT, V220, P113, DOI 10.1016/S0378-1097(03)00088-0; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Kouki A, 2011, J BIOL CHEM, V286, P38854, DOI 10.1074/jbc.M111.260992; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; MEURMAN JH, 1987, CARIES RES, V21, P353, DOI 10.1159/000261039; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Monedero V, 2008, RES MICROBIOL, V159, P94, DOI 10.1016/j.resmic.2007.10.002; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; MORMANN JE, 1981, CARIES RES, V15, P166; MORMANN JE, 1982, STARKE, V34, P121, DOI 10.1002/star.19820340406; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitsillides AA, 1999, RHEUMATOLOGY, V38, P1108, DOI 10.1093/rheumatology/38.11.1108; Praest BM, 1997, CLIN CHIM ACTA, V266, P117, DOI 10.1016/S0009-8981(97)00122-8; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Santi I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003787; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Seitz M, 2013, VET MICROBIOL, V167, P584, DOI 10.1016/j.vetmic.2013.09.010; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shim JH, 2009, J BACTERIOL, V191, P4835, DOI 10.1128/JB.00176-09; Si YH, 2009, VET MICROBIOL, V139, P80, DOI 10.1016/j.vetmic.2009.04.024; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 2001, INFECT IMMUN, V69, P1961, DOI 10.1128/IAI.69.3.1961-1966.2001; Smith HJ, 1996, ACTA RADIOL, V37, P2; Tan C, 2008, VET MICROBIOL, V130, P363, DOI 10.1016/j.vetmic.2008.02.025; TARAVEL FR, 1983, EUR J BIOCHEM, V130, P147; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanier G, 2007, VET MICROBIOL; Vanier G, 2007, CAN J VET RES, V71, P81; VECHT U, 1989, AM J VET RES, V50, P1037; WALKER GJ, 1971, EUR J BIOCHEM, V20, P14, DOI 10.1111/j.1432-1033.1971.tb01356.x; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang AD, 2011, VET MICROBIOL, V148, P436, DOI 10.1016/j.vetmic.2010.09.027; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072285	92	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e89334	10.1371/journal.pone.0089334	http://dx.doi.org/10.1371/journal.pone.0089334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642967	Green Published, gold			2022-12-25	WOS:000333259900003
J	Peeters, F; Oehlen, M; Ronner, J; van Os, J; Lousberg, R				Peeters, Frenk; Oehlen, Mare; Ronner, Jacco; van Os, Jim; Lousberg, Richel			Neurofeedback As a Treatment for Major Depressive Disorder - A Pilot Study	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; ALPHA ASYMMETRY; ELECTROENCEPHALOGRAPHIC ASYMMETRY; BRAIN ASYMMETRY; ANXIETY; ANTIDEPRESSANT; ENDOPHENOTYPE; SEVERITY; EMOTION	Background: There is growing interest in neurofeedback as a treatment for major depressive disorder. Reduction of asymmetry of alpha-activity between left and right prefrontal areas with neurofeedback has been postulated as effective in earlier studies. Unfortunately, methodological shortcomings limit conclusions that can be drawn from these studies. In a pilot-study, we investigated the effectiveness of reduction of asymmetry of alpha-activity with neurofeedback in depressed participants with the use of a stringent methodological approach. Methods: Nine participants meeting DSM-IV criteria for major depressive disorder were treated with a maximum of 30 neurofeedback-sessions, aimed at reducing asymmetry of alpha-activity, over a 10-week period. No changes in the use of antidepressants were allowed 6 weeks before and during the intervention. Changes in depressive symptomatology were assessed with the Quick Inventory of Depressive Symptoms, self-report version. Results: We observed response in 1 and remission in 4 out of a total of 9 participants. The effectiveness appeared largest in female participants. The mean asymmetry of alpha-activity decreased significantly over sessions in a quadratic fashion. This decrease was associated with clinical response. Conclusions: This pilot study suggests that neurofeedback aimed at a reduction of frontal asymmetry of alpha-activity may be effective as a treatment for depression. However, this was an open label pilot study. Non-specific effects of the procedure and/or a beneficial natural course may have confounded the results. Randomized controlled trials will have to establish the efficacy of neurofeedback for depression.	[Peeters, Frenk; Oehlen, Mare; van Os, Jim; Lousberg, Richel] Maastricht Univ, EURON, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands; [Ronner, Jacco] Maastricht Univ, Fac Psychol & Neurosci, Dept Instrumentat, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University; University of London; King's College London	Peeters, F (corresponding author), Maastricht Univ, EURON, Dept Psychiat & Psychol, South Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands.	f.peeters@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019	van Os, Jim/0000-0002-7245-1586; Peeters, F/0000-0002-6167-8582				Allen JJB, 2004, PSYCHOPHYSIOLOGY, V41, P269, DOI 10.1111/j.1469-8986.2003.00149.x; Allen JJB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00232; Baehr E., 1997, J NEUROTHERAPY, V2, P10, DOI DOI 10.1300/J184V02N03_02; Baehr E., 2001, J NEUROTHER, V4, P11, DOI [10.1300/J184v04n04_03, DOI 10.1300/J184V04N04_03]; BIRBAUMER N, 1988, INT J NEUROSCI, V39, P101, DOI 10.3109/00207458808985696; Blom MBJ, 2007, J AFFECT DISORDERS, V104, P119, DOI 10.1016/j.jad.2007.03.010; Bruder GE, 2001, BIOL PSYCHIAT, V49, P416, DOI 10.1016/S0006-3223(00)01016-7; Bruder GE, 1997, BIOL PSYCHIAT, V41, P939, DOI 10.1016/S0006-3223(96)00260-0; Bruder GE, 2004, NEUROPSYCHOPHARMACOL, V29, P1752, DOI 10.1038/sj.npp.1300519; Bruder GE, 2008, BIOL PSYCHIAT, V63, P1171, DOI 10.1016/j.biopsych.2007.10.009; Choi SW, 2011, NEUROPSYCHOBIOLOGY, V63, P43, DOI 10.1159/000322290; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Debener S, 2000, NEUROPSYCHOBIOLOGY, V41, P31, DOI 10.1159/000026630; Evans JR, 1999, INTRO QUANTITATIVE E; Hammond DC, 2005, J ADULT DEV, V12, P131, DOI 10.1007/s10804-005-7029-5; Hardman E, 1997, NEUROSCI LETT, V221, P117, DOI 10.1016/S0304-3940(96)13303-6; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Lofthouse N, 2012, CURR PSYCHIAT REP, V14, P536, DOI 10.1007/s11920-012-0301-z; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Peeters F, INT J PSYCH IN PRESS; Pizzagalli DA, 2002, BIOL PSYCHIAT, V52, P73, DOI 10.1016/S0006-3223(02)01313-6; Reid SA, 1998, PSYCHOPHYSIOLOGY, V35, P389, DOI 10.1111/1469-8986.3540389; Rosenfeld JP, 1996, INT J PSYCHOPHYSIOL, V23, P137, DOI 10.1016/0167-8760(96)00037-2; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Stewart JL, 2011, J AFFECT DISORDERS, V129, P167, DOI 10.1016/j.jad.2010.08.029; Stewart JL, 2010, J ABNORM PSYCHOL, V119, P502, DOI 10.1037/a0019196; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715	29	27	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91837	10.1371/journal.pone.0091837	http://dx.doi.org/10.1371/journal.pone.0091837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642756	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900039
J	Yokoyama, S; Hori, K; Tamine, KI; Fujiwara, S; Inoue, M; Maeda, Y; Funami, T; Ishihara, S; Ono, T				Yokoyama, Sumiko; Hori, Kazuhiro; Tamine, Ken-ichi; Fujiwara, Shigehiro; Inoue, Makoto; Maeda, Yoshinobu; Funami, Takahiro; Ishihara, Sayaka; Ono, Takahiro			Tongue Pressure Modulation for Initial Gel Consistency in a Different Oral Strategy	PLOS ONE			English	Article							QUALITY-OF-LIFE; FOOD CONSISTENCY; HARD PALATE; DYSPHAGIA; FORCE; VISCOSITY; VOLUME; AGE	Background: In the recent hyper-aged societies of developed countries, the market for soft diets for patients with dysphagia has been growing and numerous jelly-type foods have become available. However, interrelationships between the biomechanics of oral strategies and jelly texture remain unclear. The present study investigated the influence of the initial consistency of jelly on tongue motor kinetics in different oral strategies by measuring tongue pressure against the hard palate. Methods: Jellies created as a mixture of deacylated gellan gum and psyllium seed gum with different initial consistencies (hard, medium or soft) were prepared as test foods. Tongue pressure production while ingesting 5 ml of jelly using different oral strategies (Squeezing or Mastication) was recorded in eight healthy volunteers using an ultra-thin sensor sheet system. Maximal magnitude, duration and total integrated values (tongue work) of tongue pressure for size reduction and swallowing in each strategy were compared among initial consistencies of jelly, and between Squeezing and Mastication. Results: In Squeezing, the tongue performed more work for size reduction with increasing initial consistency of jelly by modulating both the magnitude and duration of tongue pressure over a wide area of hard palate, but tongue work for swallowing increased at the posterior-median and circumferential parts by modulating only the magnitude of tongue pressure. Conversely, in Mastication, the tongue performed more work for size reduction with increasing initial consistency of jelly by modulating both magnitude and duration of tongue pressure mainly at the posterior part of the hard palate, but tongue work as well as other tongue pressure parameters for swallowing showed no differences by type of jelly. Conclusions: These results reveal fine modulations in tongue-palate contact according to the initial consistency of jelly and oral strategies.	[Yokoyama, Sumiko; Tamine, Ken-ichi; Fujiwara, Shigehiro; Maeda, Yoshinobu; Ono, Takahiro] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan; [Hori, Kazuhiro; Inoue, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata, Japan; [Funami, Takahiro; Ishihara, Sayaka] San Ei Gen FFI Inc, Texture Design Div, Toyonaka, Osaka, Japan	Osaka University; Niigata University; San-Ei Gen F.F.I., Inc.	Ono, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan.	ono@dent.osaka-u.ac.jp		Inoue, Makoto/0000-0002-6503-2973	1 Japan Food Chemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24659859]	1 Japan Food Chemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by the research grant from the 1 Japan Food Chemical Research Foundation and the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24659859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, DYSPHAGIA, V26, P150, DOI 10.1007/s00455-010-9285-1; Arai E., 1993, JAPANESE J ORAL BIOL, V35, P312; Arai E, 1999, J JPN DYSPHAG REHABI, V3, P21; Bourne M.C., 2002, FOOD TEXTURE VISCOSI, V2nd ed., P107, DOI [10.1016/B978-012119062-0/50004-8, DOI 10.1016/B978-012119062-0/50004-8]; Brandao DM, 2010, REV ASSOC MED BRAS, V55, P38; Chen PH, 2009, DYSPHAGIA, V24, P1, DOI 10.1007/s00455-008-9156-1; Deto A, 2008, JAPANESE J DYSPHAGIA, V12, P197; Fujisaki T, 2012, SHOKUHIN TO YOUKI, V53, P30; Furuya M, 1996, J JPN PROSTHODONT SO, V40, P718; Gonzalez-Fernandez M, 2009, STROKE RECOVERY REHA, P183; HIRAI T, 1991, J PROSTHET DENT, V65, P840, DOI 10.1016/S0022-3913(05)80024-1; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; Hori K, 2006, J DENT RES, V85, P187, DOI 10.1177/154405910608500214; Hori Kazuhiro, 2005, Gerodontology, V22, P227; Hori K, 2011, DYSPHAGIA, V26, P238, DOI 10.1007/s00455-010-9292-2; Hori K, 2009, J PROSTHODONT RES, V53, P28, DOI 10.1016/j.jpor.2008.08.008; Ishihara S, 2011, FOOD HYDROCOLLOID, V25, P1016, DOI 10.1016/j.foodhyd.2010.09.022; Ishihara S, 2011, J TEXTURE STUD, V42, P254, DOI 10.1111/j.1745-4603.2010.00272.x; Ishihara S, 2011, FOOD HYDROCOLLOID, V25, P1210, DOI 10.1016/j.foodhyd.2010.11.008; Japanese Ministry of Consumers, 2009, TREATM APPR IND FOOD; Kodama S, 1984, KYUSHU DENT SOC, V38, P1128; Konaka K, 2010, EUR NEUROL, V64, P101, DOI 10.1159/000315140; Langmore Susan E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P485, DOI 10.1097/00020840-200312000-00014; Leopold NA, 1996, DYSPHAGIA, V11, P14, DOI 10.1007/BF00385794; Logemann Jeri A., 1993, Dysphagia, V8, P230, DOI 10.1007/BF01354543; Maclean J, 2009, DYSPHAGIA, V24, P314, DOI 10.1007/s00455-009-9209-0; Miller JL, 1996, DYSPHAGIA, V11, P117, DOI 10.1007/BF00417901; MORITA A, 2002, J HOME EC JPN, V53, P7; Nagaosa S, 2005, J JPN DYSPHAG REHABI, V9, P127; Nicosia MA, 2000, J GERONTOL A-BIOL, V55, pM634, DOI 10.1093/gerona/55.11.M634; Ono T, 2004, DYSPHAGIA, V19, P259, DOI 10.1007/s00455-004-0010-9; Ono T, 2007, GERODONTOLOGY, V24, P143, DOI 10.1111/j.1741-2358.2007.00172.x; Palmer JB, 1997, ARCH ORAL BIOL, V42, P429, DOI 10.1016/S0003-9969(97)00020-4; Palmer JB, 2000, AM FAM PHYSICIAN, V61, P2453; Palmer JB., 1992, DYSPHAGIA, V7, P187, DOI DOI 10.1007/BF02493469; Plowman-Prine EK, 2009, MOVEMENT DISORD, V24, P1352, DOI 10.1002/mds.22617; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Prinz JF, 1997, P ROY SOC B-BIOL SCI, V264, P1715, DOI 10.1098/rspb.1997.0238; Reimers-Neils L., 1994, DYSPHAGIA, V9, P101, DOI DOI 10.1007/BF00714596; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424; Steele CM, 2010, J SPEECH LANG HEAR R, V53, P273, DOI 10.1044/1092-4388(2009/09-0076); Stone M, 1986, Dysphagia, V1, P78; Sugita K, 2006, J ORAL BIOSCI, V48, P278, DOI 10.2330/joralbiosci.48.278; TAKAHASHI J, 1991, J TEXTURE STUD, V22, P1, DOI 10.1111/j.1745-4603.1991.tb00001.x; Tamine K, 2010, J DENT RES, V89, P1097, DOI 10.1177/0022034510370801; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Tsutsumino T, 2007, JAPANESE J DYSPHAGIA, V11, P13; Ueda Koichiro, 2004, Gerodontology, V21, P108, DOI 10.1111/j.1741-2358.2004.00016.x; Yoshikawa M, 2006, J AM GERIATR SOC, V54, P444, DOI 10.1111/j.1532-5415.2005.00619.x; Youmans SR, 2009, DYSPHAGIA, V24, P57, DOI 10.1007/s00455-008-9171-2	50	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91920	10.1371/journal.pone.0091920	http://dx.doi.org/10.1371/journal.pone.0091920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643054	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900047
J	Chen, SC; Wei, DD; Shao, RF; Dou, W; Wang, JJ				Chen, Shi-Chun; Wei, Dan-Dan; Shao, Renfu; Dou, Wei; Wang, Jin-Jun			The Complete Mitochondrial Genome of the Booklouse, Liposcelis decolor: Insights into Gene Arrangement and Genome Organization within the Genus Liposcelis	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC INFERENCE; PSOCIDS PSOCOPTERA; WEB SERVER; SEQUENCE; INSECTA; LICE; EVOLUTION; REARRANGEMENTS; SUBGENOMES	Booklice in the genus Liposcelis are pests of stored grain products. They pose a considerable economic threat to global food security and safety. To date, the complete mitochondrial genome has only been determined for a single booklouse species Liposcelis bostrychophila. Unlike most bilateral animals, which have their 37 mt genes on one circular chromosome, approximate to 15 kb in size, the mt genome of L. bostrychophila has two circular chromosomes, 8 and 8.5 kb in size. Here, we report the mt genome of another booklouse, Liposcelis decolor. The mt genome of L. decolor has the typical mt chromosome of bilateral animals, 14,405 bp long with 37 genes (13 PCGs, 22 tRNAs and 2 rRNAs). However, the arrangement of these genes in L. decolor differs substantially from that observed in L. bostrychophila and other insects. With the exception of atp8-atp6, L. decolor differs from L. bostrychophila in the arrangement of all of the other 35 genes. The variation in the mt genome organization and mt gene arrangement between the two Liposcelis species is unprecedented for closely related animals in the same genus. Furthermore, our results indicate that the two-chromosome mt genome organization observed in L. bostrychophila likely evolved recently after L. bostrychophila and L. decolor split from their most recent common ancestor.	[Chen, Shi-Chun; Wei, Dan-Dan; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Shao, Renfu] Univ Sunshine Coast, Fac Sci Educ & Engn, GeneCol Res Ctr, Maroochydore, Qld, Australia	Southwest University - China; University of the Sunshine Coast	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	wangjinjun@swu.edu.cn		Shao, Renfu/0000-0002-1686-4968	National Natural Sciences Foundation [31000860]; Program for Innovative Research Team in University [IRT0976]; Specialized Research Fund for the Doctoral Program of Higher Education [20100182120022]; Fundamental Research Funds for the Central Universities [XDJK2013C051, XDJK2013A005]	National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in University; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Sciences Foundation (31000860), the Program for Innovative Research Team in University (IRT0976), the Specialized Research Fund for the Doctoral Program of Higher Education(20100182120022), and the Fundamental Research Funds for the Central Universities (XDJK2013C051, XDJK2013A005). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Athanassiou CG, 2012, J ECON ENTOMOL, V105, P282, DOI 10.1603/EC11209; Athanassiou CG, 2010, J FOOD PROTECT, V73, P2244, DOI 10.4315/0362-028X-73.12.2244; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Cheng WX, 2007, PESTIC BIOCHEM PHYS, V89, P151, DOI 10.1016/j.pestbp.2007.05.004; Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Gibson T, 2007, J MOL EVOL, V64, P463, DOI 10.1007/s00239-006-0187-7; Grimaldi D, 2006, P ROY SOC B-BIOL SCI, V273, P625, DOI 10.1098/rspb.2005.3337; Hu F, 2009, MICRON, V40, P628, DOI 10.1016/j.micron.2009.02.006; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li FS, 2002, PSOCOPTERA CHINA, P77; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; LIENHARD C, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P117; Liu GH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-45; Liu YG, 2013, COMP BIOCHEM PHYS D, V8, P72, DOI 10.1016/j.cbd.2012.12.003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satoh TP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-479; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMON M, 1984, MOL GEN GENET, V196, P266, DOI 10.1007/BF00328059; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Watanabe KI, 1999, J MOL BIOL, V286, P645, DOI 10.1006/jmbi.1998.2523; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yan DK, 2012, GENE, V506, P117, DOI 10.1016/j.gene.2012.06.022; Yang QQ, 2013, J ECON ENTOMOL, V106, P419, DOI 10.1603/EC12163; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	12	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91902	10.1371/journal.pone.0091902	http://dx.doi.org/10.1371/journal.pone.0091902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637476	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100078
J	Olsen, JA; Balle, T; Gajhede, M; Ahring, PK; Kastrup, JS				Olsen, Jeppe A.; Balle, Thomas; Gajhede, Michael; Ahring, Philip K.; Kastrup, Jette S.			Molecular Recognition of the Neurotransmitter Acetylcholine by an Acetylcholine Binding Protein Reveals Determinants of Binding to Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; DOMAIN	Despite extensive studies on nicotinic acetylcholine receptors (nAChRs) and homologues, details of acetylcholine binding are not completely resolved. Here, we report the crystal structure of acetylcholine bound to the receptor homologue acetylcholine binding protein from Lymnaea stagnalis. This is the first structure of acetylcholine in a binding pocket containing all five aromatic residues conserved in all mammalian nAChRs. The ligand-protein interactions are characterized by contacts to the aromatic box formed primarily by residues on the principal side of the intersubunit binding interface (residues Tyr89, Trp143 and Tyr185). Besides these interactions on the principal side, we observe a cation-p interaction between acetylcholine and Trp53 on the complementary side and a water-mediated hydrogen bond from acetylcholine to backbone atoms of Leu102 and Met114, both of importance for anchoring acetylcholine to the complementary side. To further study the role of Trp53, we mutated the corresponding tryptophan in the two different acetylcholine-binding interfaces of the widespread alpha 4 beta 2 nAChR, i.e. the interfaces alpha 4(+) beta 2(2) and alpha 4(+) alpha 4(2). Mutation to alanine (W82A on the beta 2 subunit or W88A on the alpha 4 subunit) significantly altered the response to acetylcholine measured by oocyte voltage-clamp electrophysiology in both interfaces. This shows that the conserved tryptophan residue is important for the effects of ACh at alpha 4 beta 2 nAChRs, as also indicated by the crystal structure. The results add important details to the understanding of how this neurotransmitter exerts its action and improves the foundation for rational drug design targeting these receptors.	[Olsen, Jeppe A.; Gajhede, Michael; Kastrup, Jette S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Olsen, Jeppe A.] NeuroSearch AS, Ballerup, Denmark; [Balle, Thomas; Ahring, Philip K.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Ahring, Philip K.] Aniona ApS, Ballerup, Denmark	University of Copenhagen; University of Sydney	Kastrup, JS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	jsk@sund.ku.dk		Gajhede, Michael/0000-0001-9864-2287; Kastrup, Jette Sandholm/0000-0003-2654-1510; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; Drug Research Academy at the University of Copenhagen, Denmark; DANSCATT; Novo Nordisk Foundation	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; Drug Research Academy at the University of Copenhagen, Denmark; DANSCATT; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work of JAO has been co-funded by NeuroSearch A/S and the Danish Agency for Science, Technology and Innovation. Financial support has been granted from the Drug Research Academy at the University of Copenhagen, Denmark; DANSCATT and the Novo Nordisk Foundation. As an employee at NeuroSearch A/S 50% of their time, JAO participated in the following roles; study design, data collection and analysis, decision to publish, and preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blum AP, 2013, J BIOL CHEM, V288, P6991, DOI 10.1074/jbc.M112.439968; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Du J, 2012, TRENDS PHARMACOL SCI, V33, P482, DOI 10.1016/j.tips.2012.06.005; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P888, DOI 10.1016/j.jmgm.2011.01.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; Nielsen SF, 2000, J MED CHEM, V43, P2217, DOI 10.1021/jm990973d; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Ussing CA, 2013, J MED CHEM, V56, P940, DOI 10.1021/jm301409f; VERDONK ML, 1993, J COMPUT AID MOL DES, V7, P173, DOI 10.1007/BF00126443; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	31	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91232	10.1371/journal.pone.0091232	http://dx.doi.org/10.1371/journal.pone.0091232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637639	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100022
J	Zhou, XH; Liu, J				Zhou, Xionghui; Liu, Juan			Inferring Gene Dependency Network Specific to Phenotypic Alteration Based on Gene Expression Data and Clinical Information of Breast Cancer	PLOS ONE			English	Article							REGULATORY NETWORKS; MUTUAL INFORMATION; HISTOLOGIC GRADE; HIGH-RISK; B-CELLS; THERAPY; METASTASIS; MYC; SIGNATURE; SURVIVAL	Although many methods have been proposed to reconstruct gene regulatory network, most of them, when applied in the sample-based data, can not reveal the gene regulatory relations underlying the phenotypic change (e. g. normal versus cancer). In this paper, we adopt phenotype as a variable when constructing the gene regulatory network, while former researches either neglected it or only used it to select the differentially expressed genes as the inputs to construct the gene regulatory network. To be specific, we integrate phenotype information with gene expression data to identify the gene dependency pairs by using the method of conditional mutual information. A gene dependency pair (A, B) means that the influence of gene A on the phenotype depends on gene B. All identified gene dependency pairs constitute a directed network underlying the phenotype, namely gene dependency network. By this way, we have constructed gene dependency network of breast cancer from gene expression data along with two different phenotype states (metastasis and non-metastasis). Moreover, we have found the network scale free, indicating that its hub genes with high out-degrees may play critical roles in the network. After functional investigation, these hub genes are found to be biologically significant and specially related to breast cancer, which suggests that our gene dependency network is meaningful. The validity has also been justified by literature investigation. From the network, we have selected 43 discriminative hubs as signature to build the classification model for distinguishing the distant metastasis risks of breast cancer patients, and the result outperforms those classification models with published signatures. In conclusion, we have proposed a promising way to construct the gene regulatory network by using sample-based data, which has been shown to be effective and accurate in uncovering the hidden mechanism of the biological process and identifying the gene signature for phenotypic change.	[Zhou, Xionghui; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China	Wuhan University	Liu, J (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	liujuan@whu.edu.cn		Zhou, Xionghui/0000-0003-1234-1091	National Science Foundation of China [61272274, 60970063]; program for New Century Excellent Talents in Universities [NCET-10-0644]; Fundamental Research Funds for the Central Universities [2012211020208]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Science Foundation of China (61272274, 60970063), the program for New Century Excellent Talents in Universities (NCET-10-0644), and the Fundamental Research Funds for the Central Universities (2012211020208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CLARK GM, 1983, NEW ENGL J MED, V309, P1343, DOI 10.1056/NEJM198312013092240; Dehmer M, 2011, SYMMETRY-BASEL, V3, P767, DOI 10.3390/sym3040767; Dehmer M, 2011, COMPLEXITY, V17, P45, DOI 10.1002/cplx.20379; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Emmert-Streib F., 2008, INFORM THEORY STAT L; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hase T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000550; Hong SK, 2006, CELL CYCLE, V5, P801, DOI 10.4161/cc.5.8.2638; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; JOENSUU H, 1994, AM J PATHOL, V145, P1191; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moreto J, 2008, CELL SIGNAL, V20, P1092, DOI 10.1016/j.cellsig.2008.01.022; Nakagawa M, 2011, HAEMATOL-HEMATOL J, V96, P1318, DOI 10.3324/haematol.2011.041053; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Qiu P, 2009, COMPUT METH PROG BIO, V94, P177, DOI 10.1016/j.cmpb.2008.11.003; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schubert A, 2008, GYNECOL ENDOCRINOL, V24, P331, DOI 10.1080/09513590802095845; Song JM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002910; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Wu M, 2012, BRIEF BIOINFORM, V13, P150, DOI 10.1093/bib/bbr029; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040918; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhang Y, 2009, CANCER RES, V69, p598S; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	59	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92023	10.1371/journal.pone.0092023	http://dx.doi.org/10.1371/journal.pone.0092023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637666	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100101
J	Avraham, A; Cho, SS; Uhlmann, R; Polak, ML; Sandbank, J; Karni, T; Pappo, I; Halperin, R; Vaknin, Z; Sella, A; Sukumar, S; Evron, E				Avraham, Ayelet; Cho, Sean Soonweng; Uhlmann, Ronit; Polak, Mia Leonov; Sandbank, Judith; Karni, Tami; Pappo, Itzhak; Halperin, Ruvit; Vaknin, Zvi; Sella, Avishay; Sukumar, Saraswati; Evron, Ella			Tissue Specific DNA Methylation in Normal Human Breast Epithelium and in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-SUPPRESSOR; CELLS; TRIM29; ACTIVATION; PATTERNS	Cancer is a heterogeneous and tissue-specific disease. Thus, the tissue of origin reflects on the natural history of the disease and dictates the therapeutic approach. It is suggested that tissue differentiation, mediated mostly by epigenetic modifications, could guide tissue-specific susceptibility and protective mechanisms against cancer. Here we studied breast specific methylation in purified normal epithelium and its reflection in breast cancers. We established genome wide methylation profiles of various normal epithelial tissues and identified 110 genes that were differentially methylated in normal breast epithelium. A number of these genes also showed methylation alterations in breast cancers. We elaborated on one of them, TRIM29 (ATDC), and showed that its promoter was hypo-methylated in normal breast epithelium and heavily methylated in other normal epithelial tissues. Moreover, in breast carcinomas methylation increased and expression decreased whereas the reverse was noted for multiple other carcinomas. Interestingly, TRIM29 regulation in breast tumors clustered according to the PAM50 classification. Thus, it was repressed in the estrogen receptor positive tumors, particularly in the more proliferative luminal B subtype. This goes in line with previous reports indicating tumor suppressive activity of TRIM29 in estrogen receptor positive luminal breast cells in contrast to oncogenic function in pancreatic and lung cancers. Overall, these findings emphasize the linkage between breast specific epigenetic regulation and tissue specificity of cancer.	[Avraham, Ayelet; Uhlmann, Ronit; Sella, Avishay; Evron, Ella] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Oncol, Zerifin, Israel; [Cho, Sean Soonweng; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Polak, Mia Leonov; Sandbank, Judith] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Pathol, Zerifin, Israel; [Karni, Tami; Pappo, Itzhak] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Surg, Zerifin, Israel; [Halperin, Ruvit; Vaknin, Zvi] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Genecol, Zerifin, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Johns Hopkins University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University	Avraham, A (corresponding author), Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Oncol, Zerifin, Israel.	ayeleta@asaf.health.gov.il		Evron, Ella/0000-0002-1003-5042; Cho, Soonweng/0000-0002-1637-2875	Israeli Cancer Association [20130158]	Israeli Cancer Association	This study was supported by the Israeli Cancer Association grant no. 20130158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, R LANG ENV STAT COMP; Avraham A, 2010, EPIGENETICS-US, V5, P41, DOI 10.4161/epi.5.1.10724; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chang H, 2009, J CLIN PATHOL, V62, P908, DOI 10.1136/jcp.2009.067298; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Goldman M, 2013, NUCLEIC ACIDS RES, V41, P29; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huggins GS, 2006, CANCER RES, V66, P1384, DOI 10.1158/0008-5472.CAN-05-2715; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Klajic J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-456; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nacht M, 1999, CANCER RES, V59, P5464; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perou CM, 2011, COLD SPRING HARB PER, V3; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tollervey JR, 2012, EPIGENETICS-US, V7, P823, DOI 10.4161/epi.21141; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhou ZY, 2012, J CHIN MED ASSOC, V75, P269, DOI 10.1016/j.jcma.2012.04.015	35	22	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91805	10.1371/journal.pone.0091805	http://dx.doi.org/10.1371/journal.pone.0091805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651077	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800050
J	Baumgartner, FA; Toth, GB				Baumgartner, Finn A.; Toth, Gunilla B.			Abundance and Size Distribution of the Sacoglossan Elysia viridis on Co-Occurring Algal Hosts on the Swedish West Coast	PLOS ONE			English	Article							SEA SLUGS; INTRODUCED MACROALGAE; SPECIALIST HERBIVORES; PLACIDA-DENDRITICA; FEEDING ECOLOGY; ROCKY SHORES; OPISTHOBRANCHIA; MOLLUSCA; CHLOROPLASTS; ASSOCIATIONS	Sacoglossans are specialized marine herbivores that tend to have a close evolutionary relationship with their macroalgal hosts, but the widely distributed species Elysia viridis can associate with several algal species. However, most previous investigations on the field abundance and size distribution of E. viridis have focussed on Codium spp. in the British Isles, and algae from this genus are considered superior hosts for E. viridis. In the present study, we investigated the abundance and size distribution of E. viridis on 6 potential host algae with differing morphologies (the septate species Cladophora sericea, Cladophora rupestris, Chaetomorpha melagonium, and Ceramium virgatum, as well as the siphonaceous species Codium fragile and Bryopsis sp.) at 2 sites on the Swedish west coast over the course of a year. In spring, slugs were almost absent from all algal hosts. In summer and autumn, E. viridis consistently occurred on several of the algal species at both sites. The highest number of small E. viridis were found on C. sericea, intermediate numbers of significantly larger E. viridis were found on C. rupestris, while fewer, intermediate sized animals were found on C. fragile. Throughout the study period, only a few E. viridis individuals were found on C. melagonium, Bryopsis sp., and C. virgatum. Our results indicate that E. viridis is an annual species in Sweden, capable of exploiting co-occurring congeneric and intergeneric algal hosts with differing morphologies. These results corroborate previous findings that E. viridis can exploit several different algal species, but does not indicate that C. fragile is a superior host.	[Baumgartner, Finn A.; Toth, Gunilla B.] Tjarno Univ Gothenburg, Dept Biol & Environm Sci, Stromstad, Sweden		Toth, GB (corresponding author), Tjarno Univ Gothenburg, Dept Biol & Environm Sci, Stromstad, Sweden.	gunilla.toth@bioenv.gu.se	Toth, Gunilla B/E-8737-2013	Toth, Gunilla/0000-0002-1225-7773	Swedish Research Council [621-2007-5874]; Faculty of Sciences University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE); Colliander foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Sciences University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE); Colliander foundation	This work was financially supported by the Swedish Research Council through contract no. 621-2007-5874, the Faculty of Sciences University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE), and via grants from the Colliander foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner FA, 2009, MAR ECOL PROG SER, V396, P1, DOI 10.3354/meps08359; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRANDLEY BK, 1984, B MAR SCI, V34, P207; Christa G, 2013, PLANTA, V237, P559, DOI 10.1007/s00425-012-1788-6; CLARK KB, 1987, AM MALACOL BULL, V5, P259; Curtis NE, 2007, MAR BIOL, V150, P797, DOI 10.1007/s00227-006-0398-x; Curtis NE, 2006, INVERTEBR BIOL, V125, P336, DOI 10.1111/j.1744-7410.2006.00065.x; Evertsen J, 2009, MAR BIOL, V156, P847, DOI 10.1007/s00227-009-1128-y; Handeler K, 2010, MOL ECOL RESOUR, V10, P968, DOI 10.1111/j.1755-0998.2010.02853.x; Haendeler Katharina, 2007, Bonner Zoologische Beitraege, V55, P231; HINDE R, 1975, BIOL J LINN SOC, V7, P161, DOI 10.1111/j.1095-8312.1975.tb00738.x; JENSEN KR, 1989, J MOLLUS STUD, V55, P79, DOI 10.1093/mollus/55.1.79; Jensen KR, 1997, EVOL ECOL, V11, P301, DOI 10.1023/A:1018468420368; JOHANNESSON K, 1989, OIKOS, V54, P77, DOI 10.2307/3565899; Klochkova TA, 2013, MAR BIOL, V160, P155, DOI 10.1007/s00227-012-2074-7; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; Maeda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042024; MARIN A, 1992, MAR BIOL, V112, P677, DOI 10.1007/BF00346186; Marin A, 2004, SCI MAR, V68, P227, DOI 10.3989/scimar.2004.68s1227; Middlebrooks ML, 2012, THESIS U S FLORIDA T; Nohren E, 2009, ESTUAR COAST SHELF S, V84, P1, DOI 10.1016/j.ecss.2009.05.012; Pierce SK, 2012, INT REV CEL MOL BIO, V293, P123, DOI 10.1016/B978-0-12-394304-0.00009-9; Quinn GP, 2003, EXPT DESIGN DATA ANA; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; Sotka EE, 2007, MAR BIOL, V151, P1831, DOI 10.1007/s00227-007-0612-5; Thomasson MA, 2005, MAR BIOL RES, V1, P107, DOI 10.1080/17451000510019051; TROWBRIDGE CD, 1991, ECOLOGY, V72, P1880, DOI 10.2307/1940985; TROWBRIDGE CD, 1992, MAR ECOL PROG SER, V83, P207, DOI 10.3354/meps083207; TROWBRIDGE CD, 1993, J EXP MAR BIOL ECOL, V169, P233, DOI 10.1016/0022-0981(93)90195-T; Trowbridge CD, 2001, ECOL MONOGR, V71, P219, DOI 10.1890/0012-9615(2001)071[0219:HPCIMS]2.0.CO;2; Trowbridge CD, 2004, J ANIM ECOL, V73, P294, DOI 10.1111/j.0021-8790.2004.00808.x; Trowbridge CD, 2002, J MAR BIOL ASSOC UK, V82, P1029, DOI 10.1017/S0025315402006586; Trowbridge CD, 2000, J MAR BIOL ASSOC UK, V80, P1087, DOI 10.1017/S0025315400003155; TROWBRIDGE CD, 1992, MAR BIOL, V114, P443, DOI 10.1007/BF00350036; Trowbridge CD, 2008, J MAR BIOL ASSOC UK, V88, P771, DOI 10.1017/S0025315408001690; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; Williams SI, 1999, OCEANOGR MAR BIOL, V37, P87	38	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92472	10.1371/journal.pone.0092472	http://dx.doi.org/10.1371/journal.pone.0092472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647524	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500136
J	Lee, EJ; Malik, A; Pokharel, S; Ahmad, S; Mir, BA; Cho, KH; Kim, J; Kong, JC; Lee, DM; Chung, KY; Kim, SH; Choi, I				Lee, Eun Ju; Malik, Adeel; Pokharel, Smritee; Ahmad, Sarafraz; Mir, Bilal Ahmad; Cho, Kyung Hyun; Kim, Jihoe; Kong, Joon Chan; Lee, Dong-Mok; Chung, Ki Yong; Kim, Sang Hoon; Choi, Inho			Identification of Genes Differentially Expressed in Myogenin Knock-Down Bovine Muscle Satellite Cells during Differentiation through RNA Sequencing Analysis	PLOS ONE			English	Article							SKELETAL MYOBLAST DIFFERENTIATION; ENHANCER FACTOR-2 MEF2; STEM-CELLS; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CYCLE WITHDRAWAL; DNA-REPLICATION; UP-REGULATION; MCM PROTEINS; MYOD	Background: The expression of myogenic regulatory factors (MRFs) consisting of MyoD, Myf5, myogenin (MyoG) and MRF4 characterizes various phases of skeletal muscle development including myoblast proliferation, cell-cycle exit, cell fusion and the maturation of myotubes to form myofibers. Although it is well known that the function of MyoG cannot be compensated for other MRFs, the molecular mechanism by which MyoG controls muscle cell differentiation is still unclear. Therefore, in this study, RNA-Seq technology was applied to profile changes in gene expression in response to MyoG knockdown (MyoG(kd)) in primary bovine muscle satellite cells (MSCs). Results: About 61-64% of the reads of over 42 million total reads were mapped to more than 13,000 genes in the reference bovine genome. RNA-Seq analysis identified 8,469 unique genes that were differentially expressed in MyoG(kd). Among these genes, 230 were up-regulated and 224 were down-regulated by at least four-fold. DAVID Functional Annotation Cluster (FAC) and pathway analysis of all up- and down-regulated genes identified overrepresentation for cell cycle and division, DNA replication, mitosis, organelle lumen, nucleoplasm and cytosol, phosphate metabolic process, phosphoprotein phosphatase activity, cytoskeleton and cell morphogenesis, signifying the functional implication of these processes and pathways during skeletal muscle development. The RNA-Seq data was validated by real time RT-PCR analysis for eight out of ten genes as well as five marker genes investigated. Conclusions: This study is the first RNA-Seq based gene expression analysis of MyoG(kd) undertaken in primary bovine MSCs. Computational analysis of the differentially expressed genes has identified the significance of genes such as SAP30-like (SAP30L), Protein lyl-1 (LYL1), various matrix metalloproteinases, and several glycogenes in myogenesis. The results of the present study widen our knowledge of the molecular basis of skeletal muscle development and reveal the vital regulatory role of MyoG in retaining muscle cell differentiation.	[Lee, Eun Ju; Malik, Adeel; Pokharel, Smritee; Ahmad, Sarafraz; Mir, Bilal Ahmad; Cho, Kyung Hyun; Kim, Jihoe; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Bovine Genome Resources Bank, Gyongsan, South Korea; [Kong, Joon Chan; Lee, Dong-Mok] Korea Inst Ind Technol, Biomed Mfg Technol Ctr, Yeongcheon Si, South Korea; [Chung, Ki Yong] RDA, Hanwoo Expt Stn, Natl Inst Anim Sci, Pyeongchang, South Korea; [Kim, Sang Hoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea	Yeungnam University; Yeungnam University; Korea Institute of Industrial Technology (KITECH); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyung Hee University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	inhochoi@ynu.ac.kr	Mir, Bilal Ahmad/ABB-2374-2021; Malik, Adeel/ABD-4831-2020; Kim, Sang Hoon/AAJ-7334-2020	Mir, Bilal Ahmad/0000-0002-8194-5991; Malik, Adeel/0000-0002-3453-6001; Kim, Sanghoon/0000-0002-4078-6269	BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ907099]	BioGreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (Project no. PJ907099), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Al-Khalili L, 2004, ACTA PHYSIOL SCAND, V180, P395, DOI 10.1111/j.1365-201X.2004.01259.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Bentzinger CF, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt27; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Brand NJ, 1997, INT J BIOCHEM CELL B, V29, P1467, DOI 10.1016/S1357-2725(97)00084-8; Brand-Saberi B, 1999, CELL TISSUE RES, V296, P199, DOI 10.1007/s004410051281; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Cherian MG, 2000, CELL MOL BIOL, V46, P347; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Dahiya S, 2011, HUM MOL GENET, V20, P4345, DOI 10.1093/hmg/ddr362; de Oliveira MV, 2009, FEBS LETT, V583, P2975, DOI 10.1016/j.febslet.2009.08.022; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fukumoto S, 2006, J PHARMACOL SCI, V100, P195, DOI 10.1254/jphs.FMJ05004X3; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Henning MS, 2011, VIROLOGY, V415, P114, DOI 10.1016/j.virol.2011.04.006; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; Huang T, 2006, ACTA BIOCH BIOPH SIN, V38, P450, DOI 10.1111/j.1745-7270.2006.00187.x; Janot M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-483; Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81; Jung DW, 2011, ACS CHEM BIOL, V6, P553, DOI 10.1021/cb2000154; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kim JM, 2009, J ANIM BREED GENET, V126, P134, DOI 10.1111/j.1439-0388.2008.00724.x; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Knight J, 2011, PRIORITY OF DEMOCRACY: POLITICAL CONSEQUENCES OF PRAGMATISM, P1; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee DM, 2011, IN VITRO CELL DEV-AN, V47, P438, DOI 10.1007/s11626-011-9427-2; Lee EJ, 2013, PLOS ONE, DOI [10.1371/journal.pone.0079780, DOI 10.1371/J0URNAL.P0NE.0079780]; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Lindfors K, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-53; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Lu HG, 2002, J BIOL CHEM, V277, P46687, DOI 10.1074/jbc.M209643200; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; Martinez-Marmol R, 2007, CARDIOVASC RES, V76, P430, DOI 10.1016/j.cardiores.2007.08.009; Mastroyiannopoulos NP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029896; McCullagh KJA, 2008, MAMM GENOME, V19, P339, DOI 10.1007/s00335-008-9120-2; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Merkulova T, 2000, EUR J BIOCHEM, V267, P3735, DOI 10.1046/j.1432-1327.2000.01408.x; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; Mohun Tim, 1992, Current Opinion in Cell Biology, V4, P923, DOI 10.1016/0955-0674(92)90119-W; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V433, P558, DOI 10.1016/j.bbrc.2013.03.033; OLSON EN, 1991, MOL CELL BIOCHEM, V104, P7; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Qiong Wang, 2008, Frontiers of Agriculture in China, V2, P512, DOI 10.1007/s11703-008-0065-8; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Sahin F, 2010, INT J BIOL SCI, V6, P116; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Singh K, 2013, FEBS J, V280, P3991, DOI 10.1111/febs.12188; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Ugarte G, 2006, J BIOL CHEM, V281, P18473, DOI 10.1074/jbc.M600918200; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wicik Z, 2011, POL J VET SCI, V14, P643, DOI 10.2478/v10181-011-0095-7; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	118	30	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92447	10.1371/journal.pone.0092447	http://dx.doi.org/10.1371/journal.pone.0092447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647404	Green Published, gold			2022-12-25	WOS:000333348500133
J	Pang, H; Han, B; Yu, T; Peng, Z				Pang, Hui; Han, Bing; Yu, Tao; Peng, Zhen			The Complex Regulation of Tanshinone IIA in Rats with Hypertension-Induced Left Ventricular Hypertrophy	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; APELIN PROTECTS; MECHANISMS; PATHWAY; GROWTH; METALLOPROTEINASES; DEATH	Tanshinone IIA has definite protective effects on various cardiovascular diseases. However, in hypertension-induced left ventricular hypertrophy (H-LVH), the signaling pathways of tanshinone IIA in inhibition of remodeling and cardiac dysfunction remain unclear. Two-kidney, one-clip induced hypertensive rats (n = 32) were randomized to receive tanshinone IIA (5, 10, 15 mg/kg per day) or 5% glucose injection (GS). Sham-operated rats (n = 8) received 5% GS as control. Cardiac function and dimensions were assessed by using an echocardiography system. Histological determination of the fibrosis and apoptosis was performed using hematoxylin eosin, Masson's trichrome and TUNEL staining. Matrix metalloproteinase 2 (MMP2) and tissue inhibitor of matrix metalloproteinases type 2 (TIMP2) protein expressions in rat myocardial tissues were detected by immunohistochemistry. Rat cardiomyocytes were isolated by a Langendorff perfusion method. After 48 h culture, the supernatant and cardiomyocytes were collected to determine the potential related proteins impact on cardiac fibrosis and apoptosis. Compared with the sham rats, the heart tissues of H-LVH (5% GS) group suffered severely from the oxidative damage, apoptosis of cardiomyocytes and extracellular matrix (ECM) deposition. In the H-LVH group, tanshinone IIA treated decreased malondialdehyde (MDA) content and increased superoxide dismutase (SOD) activity. Tanshinone IIA inhibited cardiomyocytes apoptosis as confirmed by the reduction of TUNEL positive cardiomyocytes and the down-regulation of Caspase-3 activity and Bax/Bcl-2 ratio. Meanwhile, plasma apelin level increased with down-regulation of APJ receptor. Tanshinone IIA suppressed cardiac fibrosis through regulating the paracrine factors released by cardiomyocytes and the TGF-beta/Smads signaling pathway activity. In conclusion, our in vivo study showed that tanshinone IIA could improve heart function by enhancing myocardial contractility, inhibiting ECM deposition, and limiting apoptosis of cardiomyocytes and oxidative damage.	[Pang, Hui; Han, Bing; Yu, Tao] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Cardiovasc Med,Cent Hosp Xuzhou,Xuzhou Clin, Xuzhou, Jiangsu, Peoples R China; [Peng, Zhen] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Ultrasonog,Cent Hosp Xuzhou,Xuzhou Clin Sch, Xuzhou, Jiangsu, Peoples R China	Southeast University - China; Xuzhou Medical University; Southeast University - China; Xuzhou Medical University	Pang, H (corresponding author), Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Cardiovasc Med,Cent Hosp Xuzhou,Xuzhou Clin, Xuzhou, Jiangsu, Peoples R China.	phui81@126.com			Xuzhou Municipal Bureau of Science and Technology [XZZD1020]; Xuzhou Municipal Health Bureau [XWJ2011030]	Xuzhou Municipal Bureau of Science and Technology; Xuzhou Municipal Health Bureau	This research was supported by the Xuzhou Municipal Bureau of Science and Technology (No. XZZD1020) and Xuzhou Municipal Health Bureau (No. XWJ2011030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan P, 2011, AM J CHINESE MED, V39, P381, DOI 10.1142/S0192415X11008890; Chen Chu-Huang, 2004, Current Vascular Pharmacology, V2, P33, DOI 10.2174/1570161043476500; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Davia K, 1999, PHYSIOL GENOMICS, V1, P41, DOI 10.1152/physiolgenomics.1999.1.2.41; Diez J, 2010, HYPERTENSION, V55, P1, DOI 10.1161/HYPERTENSIONAHA.109.141887; Dixon JA, 2011, ANNU REV PHYSIOL, V73, P47, DOI 10.1146/annurev-physiol-012110-142230; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Ekhterae D, 2011, J SURG RES, V166, P59, DOI 10.1016/j.jss.2009.05.002; FANG J, 2010, DISCOVER, V31, P18, DOI DOI 10.1016/J.PHYMED.2010.06.002.PUBMED:20638255; Fedak PWM, 2008, SEMIN THORAC CARDIOV, V20, P87, DOI 10.1053/j.semtcvs.2008.04.001; Feng Jun, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P930; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Gradman Alan H, 2009, Curr Cardiol Rep, V11, P422; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; Iturrioz X, 2007, ARCH MAL COEUR VAISS, V100, P704; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Khouri MG, 2010, CIRC-CARDIOVASC IMAG, V3, P164, DOI 10.1161/CIRCIMAGING.109.883652; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Langelaan DN, 2013, BBA-BIOMEMBRANES, V1828, P1471, DOI 10.1016/j.bbamem.2013.02.005; Lewis CJ, 2004, BRIT J PHARMACOL, V141, P813, DOI 10.1038/sj.bjp.0705668; Li Yong-Sheng, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P499; Li YS, 2009, J HUAZHONG U SCI-MED, V29, P476, DOI 10.1007/s11596-009-0417-5; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Martos R, 2009, EUR J HEART FAIL, V11, P191, DOI 10.1093/eurjhf/hfn036; Narine K, 2006, TISSUE ENG, V12, P2707, DOI 10.1089/ten.2006.12.2707; Qiao ZY, 2011, MOLECULES, V16, P10002, DOI 10.3390/molecules161210002; Sadoshima J, 2006, ANTIOXID REDOX SIGN, V8, P1621, DOI 10.1089/ars.2006.8.1621; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Shah A, 2012, AM J PHYSIOL-HEART C, V302, pH2372, DOI 10.1152/ajpheart.00846.2011; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Spinale FG, 2008, CIRCULATION, V118, pS16, DOI 10.1161/CIRCULATIONAHA.108.786640; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Suzuki T, 2008, J HYPERTENS, V26, P2436, DOI 10.1097/HJH.0b013e328312c889; Tan XY, 2011, INT J BIOL SCI, V7, P383, DOI 10.7150/ijbs.7.383; Tsai WC, 2011, VASC HEALTH RISK MAN, V7, P137, DOI 10.2147/VHRM.S11235; Wang P, 2011, PHARMAZIE, V66, P517, DOI 10.1691/ph.2011.0806; [王照华 Wang Zhaohua], 2009, [华中科技大学学报. 医学版, Acta Medicinae Universitatis Scientiae et Technologiae Huazhong], V38, P500; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Yang P, 2010, J TRADIT CHIN MED, V30, P259, DOI 10.1016/S0254-6272(10)60053-2; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012; Zhang Z, 2009, CHINESE MED J-PEKING, V122, P2360, DOI 10.3760/cma.j.issn.0366-6999.2009.19.031; Zhou Dai-Xing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P936; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910	56	34	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92216	10.1371/journal.pone.0092216	http://dx.doi.org/10.1371/journal.pone.0092216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647357	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500098
J	Rathakrishnan, A; Klekamp, B; Wang, SM; Komarasamy, TV; Natkunam, SK; Sathar, J; Azizan, A; Sanchez-Anguiano, A; Manikam, R; Sekaran, SD				Rathakrishnan, Anusyah; Klekamp, Benjamin; Wang, Seok Mui; Komarasamy, Thamil Vaani; Natkunam, Santha Kumari; Sathar, Jameela; Azizan, Azliyati; Sanchez-Anguiano, Aurora; Manikam, Rishya; Sekaran, Shamala Devi			Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia	PLOS ONE			English	Article							T-CELL RESPONSES; HEMORRHAGIC-FEVER PATIENTS; DISEASE SEVERITY; VIRUS-INFECTIONS; SERUM-LEVELS; PROTEIN NS1; PATHOGENESIS; HLA; ASSOCIATIONS; EXPRESSION	Background: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. Methodology and Findings: This longitudinal descriptive study was conducted in two Malaysian hospitals where patients aged 14 and above with clinical symptoms suggestive of dengue were recruited with informed consent. Among the 504 participants, 9.3% were classified as non-dengue, 12.7% without warning signs, 77.0% with warning signs and 1.0% with severe dengue based on clinical diagnosis. Of these, 37% were misdiagnosed as non-dengue, highlighting the importance of both clinical diagnosis and laboratory findings. Thrombocytopenia, prolonged clotting time, liver enzymes, ALT and AST served as good markers for dengue progression but could not distinguish between patients with and without warning signs. HLA-A*24 and -B*57 were positively associated with Chinese and Indians patients with warning signs, respectively, whereas A*03 may be protective in the Malays. HLA-A*33 was also positively associated in patients with warning signs when compared to those without. Dengue NS1, NS2A, NS4A and NS4B were found to be important T cell epitopes; however with no apparent difference between with and without warning signs patients. Distinction between the 2 groups of patients was also not observed in any of the cytokines analyzed; nevertheless, 12 were significantly differentially expressed at the different phases of illness. Conclusion: The new dengue classification system has allowed more specific detection of dengue patients, however, none of the clinical parameters allowed distinction of patients with and without warning signs. While the HLA-A*33 may be predictive marker for development of warning signs; larger studies will be needed to support this findings.	[Rathakrishnan, Anusyah; Komarasamy, Thamil Vaani; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Klekamp, Benjamin; Azizan, Azliyati; Sanchez-Anguiano, Aurora] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA; [Wang, Seok Mui] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia; [Natkunam, Santha Kumari] Persiaran Tengku Ampuan Rahimah, Hosp Tengku Ampuan Rahimah, Klang, Selangor, Malaysia; [Sathar, Jameela] Hosp Ampang, Dept Hematol, Clin Hematol Lab, Ampang, Selangor, Malaysia; [Manikam, Rishya] Univ Malaya, Med Ctr, Dept Trauma & Emergency Med, Kuala Lumpur, Malaysia	Universiti Malaya; State University System of Florida; University of South Florida; Universiti Teknologi MARA; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Wang, Seok Mui/X-5856-2019; Sekaran, Shamala Devi/B-8482-2008; Manikam, Rishya/F-5908-2014; Rathakrishnan, Anusyah/K-4115-2014; Devi, Shamala Devi/B-9735-2010	Wang, Seok Mui/0000-0002-3631-6504; Sekaran, Shamala Devi/0000-0002-0478-0425; Rathakrishnan, Anusyah/0000-0002-5177-7624; Devi, Shamala Devi/0000-0002-0478-0425	University of Malaya [Vote PV050/2011A]; UM High Impact Research Grant UM-MOHE from the Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/E-20001-00-E000053]	University of Malaya(Universiti Malaya); UM High Impact Research Grant UM-MOHE from the Ministry of Higher Education Malaysia	This research was supported by Vote PV050/2011A from the University of Malaya as well as UM High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/E-20001-00-E000053 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang K T, 2010, Med J Malaysia, V65, P58; Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown MG, 2011, W INDIAN MED J, V60, P126; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482; FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989; Fernandez-Mestre M., 2009, Inmunologia, V28, P96; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Green SL, 1997, VET CLIN N AM-EQUINE, V13, P1; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1; Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045; Hottz E, 2011, DRUG DISCOVERY TODAY, V8, P33, DOI [10.1016/j. ddmec.2011.09.001, DOI 10.1016/J.DDMEC.2011.09.001]; Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673; Khongphatthanayothin A, 2006, JPN J INFECT DIS, V59, P186; Koraka P, 2004, J MED VIROL, V72, P445, DOI 10.1002/jmv.20007; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Kurane I, 1992, SEMIN IMMUNOL, V4, P121; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Matsuura C, 2012, T ROY SOC TROP MED H, V106, P174, DOI 10.1016/j.trstmh.2011.10.009; McNicholl J, 1998, EMERG INFECT DIS, V4, P423, DOI 10.3201/eid0403.980322; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Stephens HAF, 2010, CURR TOP MICROBIOL, V338, P99, DOI 10.1007/978-3-642-02215-9_8; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Vinomarlini G, 2011, SE ASIAN J TROP MED, V42, P94; Wanigasuriya K, 2012, USEFULNESS WHO DENGU; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2010, W PAC COUNTR HLTH IN; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662	59	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92021	10.1371/journal.pone.0092021	http://dx.doi.org/10.1371/journal.pone.0092021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647042	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500072
J	Wang, W; Cai, JY; Lin, Y; Liu, ZK; Ren, QH; Hu, L; Huang, Z; Guo, MX; Li, WX				Wang, Wei; Cai, Jinyang; Lin, Yi; Liu, Zikou; Ren, Qihao; Hu, Li; Huang, Zan; Guo, Mingxiong; Li, Wenxin			Zinc Fingers Function Cooperatively with KRAB Domain for Nuclear Localization of KRAB-Containing Zinc Finger Proteins	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; GENE ZNF268; NUCLEOLAR LOCALIZATION; RNA-BINDING; KRUPPEL; SIGNALS; COREPRESSOR; REPRESSION; EXPRESSION	Multiple nuclear localization domains have been identified in nuclear proteins, and they finely control nuclear import and functions of those proteins. ZNF268 is a typical KRAB-containing zinc finger protein (KRAB-ZFP), and previous studies have shown that the KRAB domain reinforces nuclear localization of KRAB-ZFPs by interacting with KAP1. In this study, we find that some of 24 zinc fingers of ZNF268 also possess nuclear localization activity. Results of mutagenesis studies suggest that KRAB and zinc fingers are both necessary, and they function both independently and cooperatively for the nuclear localization of ZNF268. However, the subnuclear targeting activities of KRAB and zinc fingers are different. KRAB targets proteins in nucleoplasm, but not in the nucleolus, which is mediated by interaction with KAP1, while zinc fingers target proteins in the whole nucleus uniformly. The cooperative activities of KAP1-KRAB-zinc fingers result in the precise nucleoplasmic, but not nucleolar localization of KRAB-ZFPs. Our studies reveal a novel mechanism for the subcellular localization of KRAB-ZFPs and may help us to further explore their biological functions.	[Wang, Wei; Cai, Jinyang; Lin, Yi; Liu, Zikou; Ren, Qihao; Hu, Li; Guo, Mingxiong; Li, Wenxin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Huang, Zan] Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Guo, MX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guomx@whu.edu.cn; liwxlab@whu.edu.cn	Cai, Jinyang/HCH-0290-2022; Ren, Qihao/HDN-5402-2022; LIN, YI/AAC-3335-2020	Ren, Qihao/0000-0001-5178-1829; LIN, YI/0000-0001-8209-1185; Liu, Zikou/0000-0002-0787-5083; Wang, Wei/0000-0002-6179-4188; Wang, Wei/0000-0001-7429-1013; Huang, Zan/0000-0001-5623-6950; Cai, Jinyang/0000-0002-7385-8281	National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; National Natural Science Foundation of China [30871245, 31271511]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306, National Natural Science Foundation of China Grants 30871245 and 31271511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chun JN, 2008, MOL CELLS, V26, P175; Dai C, 2007, CELL MOL BIOL LETT, V12, P362, DOI 10.2478/s11658-007-0008-z; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ito T, 2009, BIOCHEM BIOPH RES CO, V380, P28, DOI 10.1016/j.bbrc.2008.12.165; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Liu MT, 1998, VIROLOGY, V247, P62, DOI 10.1006/viro.1998.9228; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Lupo A, 2011, INT J BIOCHEM CELL B, V43, P470, DOI 10.1016/j.biocel.2010.12.020; MAEDA Y, 1992, EMBO J, V11, P3695, DOI 10.1002/j.1460-2075.1992.tb05454.x; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Medugno L, 2007, GENE, V403, P125, DOI 10.1016/j.gene.2007.07.036; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Shao HJ, 2006, INT J MOL MED, V18, P457; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sun Y, 2004, INT J MOL MED, V14, P971; Sun Y, 2003, IUBMB LIFE, V55, P127, DOI 10.1080/1521654031000110208; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wang W, 2012, J BIOL CHEM, V287, P42856, DOI 10.1074/jbc.M112.399923; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518; Zhao ZZ, 2008, ONCOL REP, V20, P1243, DOI 10.3892/or_00000136	42	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92155	10.1371/journal.pone.0092155	http://dx.doi.org/10.1371/journal.pone.0092155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647005	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500091
J	Yang, F; Zheng, TP; Gao, Y; Baskota, A; Chen, T; Ran, XW; Tian, HM				Yang, Fan; Zheng, Tianpeng; Gao, Yun; Baskota, Attit; Chen, Tao; Ran, Xingwu; Tian, Haoming			Increased Plasma DPP4 Activity Is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study	PLOS ONE			English	Article							AMIDE	Aims: To determine whether fasting plasma Dipeptidyl Peptidase 4 (DPP4) activity and active Glucagon-Like Peptide-1 (GLP-1) were predictive of the onset of metabolic syndrome. Methods: A prospective cohort study was conducted of 2042 adults (863 men and 1,179 women) aged 18-70 years without metabolic syndrome examined in 2007(baseline) and 2011(follow-up). Baseline plasma DPP4 activity was determined as the rate of cleavage of 7-amino-4-methylcoumarin (AMC) from the synthetic substrate H-glycyl-prolyl-AMC and active GLP-1 was determined by enzymoimmunoassay. Results: During an average of 4 years of follow-up, 131 men (15.2%) and 174 women (14.8%) developed metabolic syndrome. In multiple linear regression analysis, baseline DPP4 activity was an independent predictor of an increase in insulin resistance over a 4-year period (P<0.01). In multivariable-adjusted models, the odds ratio (OR) for incident metabolic syndrome comparing the highest with the lowest quartiles of DPP4 activity and active GLP-1 were 2.82, 0.45 for men and 2.48, 0.36 for women respectively. Furthermore, plasma DPP4 activity significantly improved the area under the ROC curve for predicting new-onset metabolic syndrome based on information from metabolic syndrome components (Both P<0.01). Conclusions: DPP4 activity is an important predictor of the onset of insulin resistance and metabolic syndrome in apparently healthy Chinese men and women. This finding may have important implications for understanding the aetiology of metabolic syndrome.	[Yang, Fan; Zheng, Tianpeng; Gao, Yun; Baskota, Attit; Chen, Tao; Ran, Xingwu; Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China; [Yang, Fan; Zheng, Tianpeng] Guilin Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Guangxi, Peoples R China	Sichuan University; Guilin Medical University	Tian, HM (corresponding author), Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China.	w19831120@126.com			Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This study was supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society (No. 07020470055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Kirino Y, 2012, ENDOCR J, V59, P949, DOI 10.1507/endocrj.EJ12-0158; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Luepker R. V., 2004, CARDIOVASCULAR SURVE; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Sell H, 2006, TRENDS ENDOCRIN MET, V17, P416, DOI 10.1016/j.tem.2006.10.010; von Bibra H, 2010, DIABETOLOGIA, V53, P1033, DOI 10.1007/s00125-010-1682-3; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang J, 2007, DIABETOLOGIA, V50, P1900, DOI 10.1007/s00125-007-0737-6	13	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92222	10.1371/journal.pone.0092222	http://dx.doi.org/10.1371/journal.pone.0092222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647445	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500100
J	Yi, XF; Zhang, MM; Bartlow, AW; Dong, Z				Yi, Xianfeng; Zhang, Mingming; Bartlow, Andrew W.; Dong, Zhong			Incorporating Cache Management Behavior into Seed Dispersal: The Effect of Pericarp Removal on Acorn Germination	PLOS ONE			English	Article							PEROMYSCUS-LEUCOPUS; PIGNUT HICKORY; WEEVIL LARVAE; OAK; PREDATION; SQUIRRELS; SURVIVAL; INFESTATION; MAMMALS; RODENTS	Selecting seeds for long-term storage is a key factor for food hoarding animals. Siberian chipmunks (Tamias sibiricus) remove the pericarp and scatter hoard sound acorns of Quercus mongolica over those that are insect-infested to maximize returns from caches. We have no knowledge of whether these chipmunks remove the pericarp from acorns of other species of oaks and if this behavior benefits seedling establishment. In this study, we tested whether Siberian chipmunks engage in this behavior with acorns of three other Chinese oak species, Q. variabilis, Q. aliena and Q. serrata var. brevipetiolata, and how the dispersal and germination of these acorns are affected. Our results show that when chipmunks were provided with sound and infested acorns of Quercus variabilis, Q. aliena and Q. serrata var. brevipetiolata, the two types were equally harvested and dispersed. This preference suggests that Siberian chipmunks are incapable of distinguishing between sound and insect-infested acorns. However, Siberian chipmunks removed the pericarp from acorns of these three oak species prior to dispersing and caching them. Consequently, significantly more sound acorns were scatter hoarded and more infested acorns were immediately consumed. Additionally, indoor germination experiments showed that pericarp removal by chipmunks promoted acorn germination while artificial removal showed no significant effect. Our results show that pericarp removal allows Siberian chipmunks to effectively discriminate against insect-infested acorns and may represent an adaptive behavior for cache management. Because of the germination patterns of pericarp-removed acorns, we argue that the foraging behavior of Siberian chipmunks could have potential impacts on the dispersal and germination of acorns from various oak species.	[Yi, Xianfeng] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Yi, Xianfeng; Zhang, Mingming; Dong, Zhong] Henan Univ Sci & Technol, Coll Agr, Luoyang, Henan, Peoples R China; [Bartlow, Andrew W.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Jiangxi Normal University; Henan University of Science & Technology; Utah System of Higher Education; University of Utah	Yi, XF (corresponding author), Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China.	yxfeng1975@126.com	Bartlow, Andrew/J-5435-2019	Bartlow, Andrew/0000-0002-1254-4481	Natural Science Foundation of China [31172101]; Program for New Century Excellent Talents in University [NCET-12-0693]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1404]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Integrated Management of Pest Insects and Rodents	This work was funded by the Natural Science Foundation of China (No. 31172101), the Program for New Century Excellent Talents in University (NCET-12-0693) and the State Key Laboratory of Integrated Management of Pest Insects and Rodents (ChineseIPM1404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN DC, 1993, J MAMMAL, V74, P656, DOI 10.2307/1382287; ANDERSSON C, 1992, FOREST ECOL MANAG, V50, P247, DOI 10.1016/0378-1127(92)90339-B; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Barcelos AR, 2013, INTEGR ZOOL, V8, P63, DOI 10.1111/1749-4877.12003; BARNETT RJ, 1977, AM MIDL NAT, V98, P319, DOI 10.2307/2424983; Brancalion PHS, 2011, BIOTROPICA, V43, P12, DOI 10.1111/j.1744-7429.2010.00726.x; Branco M, 2002, FOREST ECOL MANAG, V166, P159, DOI 10.1016/S0378-1127(01)00669-7; Capece PI, 2013, INTEGR ZOOL, V8, P57, DOI 10.1111/j.1749-4877.2012.00313.x; Cheng JR, 2011, CURR ZOOL, V57, P50, DOI 10.1093/czoolo/57.1.50; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Dixon MD, 1997, OECOLOGIA, V111, P201, DOI 10.1007/s004420050226; DORSEY CK, 1962, J ECON ENTOMOL, V55, P885, DOI 10.1093/jee/55.6.885; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; FOX JF, 1982, EVOLUTION, V36, P800, DOI 10.2307/2407893; Fukumoto H., 2000, J FOREST RES, V5, P31, DOI [10.1007/BF02762760, DOI 10.1007/BF02762760]; Galvez D, 2007, J TROP ECOL, V23, P381, DOI 10.1017/S0266467407003975; Hou XG, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010036; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hulme Philip E., 2002, P132; JOHNSON WC, 1985, AM MIDL NAT, V113, P319, DOI 10.2307/2425577; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Lai X, 2014, INTEGR ZOOL, V9, P246, DOI 10.1111/1749-4877.12046; Leiva MJ, 2005, FOREST ECOL MANAG, V212, P221, DOI 10.1016/j.foreco.2005.03.036; Li HJ, 2007, FOREST ECOL MANAG, V242, P511, DOI 10.1016/j.foreco.2007.01.063; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047682; Livoreil B, 1996, ETHOL ECOL EVOL, V8, P199, DOI 10.1080/08927014.1996.9522929; Meng LZ, 2012, INTEGR ZOOL, V7, P30, DOI [10.1111/j.1749-4877.2012.00273.x, 10.1111/j.1749-4877.2011.00275.x]; Munoz A, 2008, BEHAV ECOL SOCIOBIOL, V62, P913, DOI 10.1007/s00265-007-0515-y; NIXON CM, 1968, J WILDLIFE MANAGE, V32, P294, DOI 10.2307/3798974; O'Farrill G, 2013, INTEGR ZOOL, V8, P4, DOI 10.1111/j.1749-4877.2012.00316.x; Perea R, 2011, J ECOL, V99, P194, DOI 10.1111/j.1365-2745.2010.01749.x; PETERSON JK, 1983, ANN BOT-LONDON, V52, P81, DOI 10.1093/oxfordjournals.aob.a086555; R Development Core Team, 2012, R LANG ENV STAT COMP; REICHMAN OJ, 1988, ANIM BEHAV, V36, P1525, DOI 10.1016/S0003-3472(88)80223-9; Schroder T., 2002, Dendrobiology, V47, P13; SEMEL B, 1988, AM MIDL NAT, V119, P385, DOI 10.2307/2425821; Silvius KM, 2002, J TROP ECOL, V18, P707, DOI 10.1017/S0266467402002468; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; SORK VL, 1977, OECOLOGIA, V28, P289, DOI 10.1007/BF00751606; SORK VL, 1983, ECOLOGY, V64, P1049, DOI 10.2307/1937813; SORK VL, 1987, ECOLOGY, V68, P1341, DOI 10.2307/1939218; Steele MA, 2001, J MAMMAL, V82, P35, DOI 10.1644/1545-1542(2001)082&lt;0035:CMBSME&gt;2.0.CO;2; Steele MA, 1996, J MAMMAL, V77, P305, DOI 10.2307/1382802; Takahashi A, 2010, FOREST PATHOL, V40, P96, DOI 10.1111/j.1439-0329.2009.00612.x; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; WECKERLY FW, 1989, AM MIDL NAT, V122, P412, DOI 10.2307/2425929; WINSTON PW, 1956, ECOLOGY, V37, P120, DOI 10.2307/1929675; Xiao Zhishu, 2003, Acta Theriologica Sinica, V23, P312; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020; Yang YQ, 2012, PLANT ECOL, V213, P197, DOI 10.1007/s11258-011-0016-y; Yi XF, 2008, PHOTOSYNTHETICA, V46, P139, DOI 10.1007/s11099-008-0022-z; Yi XF, 2010, PLANT ECOL, V209, P291, DOI 10.1007/s11258-010-9730-0; Yi XF, 2012, ETHOLOGY, V118, P87, DOI 10.1111/j.1439-0310.2011.01989.x; Zhang HM, 2007, THESIS BEIJING GRADU	54	11	12	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92544	10.1371/journal.pone.0092544	http://dx.doi.org/10.1371/journal.pone.0092544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647670	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500142
J	Zhang, GS; Sun, HJ				Zhang, Gaosen; Sun, Henry J.			Racemization in Reverse: Evidence that D-Amino Acid Toxicity on Earth Is Controlled by Bacteria with Racemases	PLOS ONE			English	Article							D-ASPARTATE OXIDASE; PHYSIOLOGICAL-ROLE; ALANINE RACEMASE; RHODOTORULA-GRACILIS; CANDIDA-BOIDINII; ORGANIC NITROGEN; SOILS; YEAST; DETOXIFICATION; PEPTIDOGLYCAN	D-amino acids are toxic for life on Earth. Yet, they form constantly due to geochemical racemization and bacterial growth (the cell walls of which contain D-amino acids), raising the fundamental question of how they ultimately are recycled. This study provides evidence that bacteria use D-amino acids as a source of nitrogen by running enzymatic racemization in reverse. Consequently, when soils are inundated with racemic amino acids, resident bacteria consume D-as well as L-enantiomers, either simultaneously or sequentially depending on the level of their racemase activity. Bacteria thus protect life on Earth by keeping environments D-amino acid free.	[Zhang, Gaosen; Sun, Henry J.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89512 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Sun, HJ (corresponding author), Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89512 USA.	henry.sun@dri.edu		zhang, gao sen/0000-0002-1144-6919	NASA Exobiology program; NASA Astrobiology Institute	NASA Exobiology program(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute	The funding for this work was provided by the NASA Exobiology program and the NASA Astrobiology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDAG RW, 1970, AGRON J, V62, P184, DOI 10.2134/agronj1970.00021962006200020002x; Amelung W, 2006, GEODERMA, V130, P207, DOI 10.1016/j.geoderma.2005.01.017; Amelung W, 2003, J PLANT NUTR SOIL SC, V166, P677, DOI 10.1002/jpln.200321274; BADA JL, 1982, INTERDISCIPL SCI REV, V7, P30, DOI 10.1179/030801882789801304; BADA JL, 1979, NATURE, V282, P822, DOI 10.1038/282822a0; Brinton KLF, 2002, ASTROBIOLOGY, V2, P77, DOI 10.1089/153110702753621358; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; Dittmar T, 2001, GEOCHIM COSMOCHIM AC, V65, P4103, DOI 10.1016/S0016-7037(01)00688-3; Drechsel H, 1998, J PEPT SCI, V4, P147, DOI 10.1002/(SICI)1099-1387(199805)4:3<147::AID-PSC136>3.0.CO;2-C; Forsum O, 2008, NEW PHYTOL, V179, P1058, DOI 10.1111/j.1469-8137.2008.02546.x; Friedman M, 2012, METHODS MOL BIOL, V794, P337, DOI 10.1007/978-1-61779-331-8_23; Gabler M, 1999, APPL ENVIRON MICROB, V65, P3750; GRIFFIN CV, 1988, AUST J SOIL RES, V26, P531, DOI 10.1071/SR9880531; KIMBER RWL, 1994, AUST J EARTH SCI, V41, P19, DOI 10.1080/08120099408728109; LARUE TA, 1967, CAN J MICROBIOL, V13, P777, DOI 10.1139/m67-103; LEE C, 1977, LIMNOL OCEANOGR, V22, P502, DOI 10.4319/lo.1977.22.3.0502; Lester ED, 2007, SOIL BIOL BIOCHEM, V39, P704, DOI 10.1016/j.soilbio.2006.09.020; Lomstein BA, 2006, GEOCHIM COSMOCHIM AC, V70, P2970, DOI 10.1016/j.gca.2006.03.015; Martinez-Rodriguez S, 2010, CHEM BIODIVERS, V7, P1531, DOI 10.1002/cbdv.200900245; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Nagata T, 2003, LIMNOL OCEANOGR, V48, P745, DOI 10.4319/lo.2003.48.2.0745; Pedersen AGU, 2001, LIMNOL OCEANOGR, V46, P1358, DOI 10.4319/lo.2001.46.6.1358; PEROTTI ME, 1991, EUR J CELL BIOL, V55, P104; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; PUCCI MJ, 1995, J BACTERIOL, V177, P336, DOI 10.1128/jb.177.2.336-342.1995; ROGERS HJ, 1974, ANN NY ACAD SCI, V235, P29, DOI 10.1111/j.1749-6632.1974.tb43255.x; SIKORA L, 1982, MOL GEN GENET, V186, P33, DOI 10.1007/BF00422908; SIMONETTA MP, 1989, J GEN MICROBIOL, V135, P593; Smith HD, 2012, ASTROBIOLOGY, V12, P247, DOI 10.1089/ast.2010.0549; Takahashi S, 2005, YEAST, V22, P1203, DOI 10.1002/yea.1303; Uo T, 2001, J BACTERIOL, V183, P2226, DOI 10.1128/JB.183.7.2226-2233.2001; Veuger B, 2006, LIMNOL OCEANOGR, V51, P1572, DOI 10.4319/lo.2006.51.4.1572; VOLLMER A T, 1977, Great Basin Naturalist, V37, P81; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3; Yow GY, 2006, ARCH MICROBIOL, V185, P39, DOI 10.1007/s00203-005-0060-x; Yurimoto H, 2000, YEAST, V16, P1217; Yurimoto H, 2001, BIOSCI BIOTECH BIOCH, V65, P627, DOI 10.1271/bbb.65.627; ZHAO MX, 1995, J CHROMATOGR A, V690, P55, DOI 10.1016/0021-9673(94)00927-2	41	42	42	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92101	10.1371/journal.pone.0092101	http://dx.doi.org/10.1371/journal.pone.0092101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647559	Green Submitted, gold, Green Published			2022-12-25	WOS:000333348500085
J	Giachini, FR; Leite, R; Osmond, DA; Lima, VV; Inscho, EW; Webb, RC; Tostes, RC				Giachini, Fernanda R.; Leite, Romulo; Osmond, David A.; Lima, Victor V.; Inscho, Edward W.; Webb, R. Clinton; Tostes, Rita C.			Anti-Platelet Therapy with Clopidogrel Prevents Endothelial Dysfunction and Vascular Remodeling in Aortas from Hypertensive Rats	PLOS ONE			English	Article							CORONARY-ARTERY; INDUCED RELAXATION; PLATELET-FUNCTION; P2Y(1) RECEPTORS; THORACIC AORTA; ANGIOTENSIN-II; BLOOD-PRESSURE; ADP; MECHANISMS; ASPIRIN	The aim was to investigate the beneficial effects of clopidogrel in thoracic aorta function and structure and to characterize if P2Y(12) receptors contribute to these effects. Male Sprague Dawley rats were infused with angiotensin II [(Ang II) 60 ng.min(-1), 14 days] or saline (control rats) and were simultaneously treated with clopidogrel (10 mg.kg(-1).day(-1)) or vehicle. After 14 days, systolic blood pressure (mmHg) was similar in Ang II-hypertensive rats treated with clopidogrel or vehicle (199 +/- 9 vs. 190 +/- 11, respectively). Systolic blood pressure in control rats was not altered by clopidogrel treatment (128 +/- 1 vs. vehicle, 134 +/- 2). Endothelium-dependent relaxation induced by 2-MeS-ADP was decreased in aortas from vehicle-treated Ang II-hypertensive rats, compared to vehicle-treated control rats. This response was elicited via activation of P2Y(1) and P2Y(12) receptors. In the presence of L-NAME and indomethacin, 2-MeS-ADP induced contraction and this response was augmented in vehicle-treated Ang II-hypertensive rats, compared to vehicle-treated control rats. The contraction to 2-MeS-ADP was evoked by P2Y(13) and P2Y(12) receptor activation. Clopidogrel-treatment did not normalize relaxation or contractile responses induced by 2-MeS-ADP in aortas from Ang II-hypertensive rats. P2Y(1) and P2Y(12) protein expression was increased, whereas P2Y(13) receptor expression was reduced in aorta from vehicle-treated Ang II-hypertensive rats. Endothelium-dependent relaxation upon acetylcholine-stimulation was reduced in vehicle-treated Ang II-hypertensive rats, and clopidogrel treatment was effective in improving endothelial function. Clopidogrel also prevented vascular remodeling, evidenced by augmented media thickness in aortas from Ang II-hypertensive rats. Clopidogrel has beneficial effects on the aortic endothelium of Ang II-hypertensive rats, but its effects do not seem to be directly related to the presence of P2Y(12) receptors in this vessel.	[Giachini, Fernanda R.; Lima, Victor V.] Univ Fed Mato Grosso, Inst Biol Sci & Hlth, Barra Do Garcas, MT, Brazil; [Leite, Romulo] Univ Fed Ouro Preto, Sch Pharm, Ouro Preto, MG, Brazil; [Osmond, David A.; Inscho, Edward W.; Webb, R. Clinton] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Tostes, Rita C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, SP, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Ouro Preto; University System of Georgia; Augusta University; Universidade de Sao Paulo	Giachini, FR (corresponding author), Univ Fed Mato Grosso, Inst Biol Sci & Hlth, Barra Do Garcas, MT, Brazil.	fernandagiachini@hotmail.com	Giachini, Fernanda R/J-7958-2012; Tostes, Rita C/C-1025-2012	Giachini, Fernanda R/0000-0003-2688-7204; Tostes, Rita C/0000-0002-9446-0707	National Institutes of Health [HL71138, DK83685, DK44628, HL098135]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado do Mato Grosso (FAPEMAT); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvmento Cientifico e Tecnologico (CNPq); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098135, R01HL071138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083685, R01DK044628, R29DK044628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvmento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (HL71138, DK83685 and DK44628and HL098135), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Amparo a Pesquisa do Estado do Mato Grosso (FAPEMAT), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Desenvolvmento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2006, DIABETES, V55, P780, DOI 10.2337/diabetes.55.03.06.db05-1394; Arazi HC, 2012, CURR PHARM DES; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Bautista LE, 2003, J HUM HYPERTENS, V17, P223, DOI 10.1038/sj.jhh.1001537; Bender SB, 2011, J APPL PHYSIOL, V111, P1744, DOI 10.1152/japplphysiol.00946.2011; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Boyer JL, 1998, BRIT J PHARMACOL, V124, P1, DOI 10.1038/sj.bjp.0701837; Brown NJ, 1996, TRENDS CARDIOVAS MED, V6, P239, DOI 10.1016/S1050-1738(96)00091-6; Dol-Gleizes F, 1999, EUR J PHARMACOL, V367, P247, DOI 10.1016/S0014-2999(98)00985-6; GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giachini FR, 2009, CLIN SCI LOND; Gkaliagkousi E, 2010, AM J HYPERTENS, V23, P229, DOI 10.1038/ajh.2009.247; Graciano ML, 2008, AM J PHYSIOL-RENAL, V294, pF161, DOI 10.1152/ajprenal.00281.2007; Graff J, 2003, BRIT J CLIN PHARMACO, V56, P321, DOI 10.1046/j.0306-5251.2003.01873.x; Hamilos M, 2011, J THROMB THROMBOLYS, V32, P64, DOI 10.1007/s11239-011-0557-x; HELLEM AJ, 1967, THROMB DIATH HAEMOST, VS, P193; KAUL S, 1993, CIRC RES, V72, P737, DOI 10.1161/01.RES.72.4.737; Kim YC, 2005, BIOCHEM PHARMACOL, V70, P266, DOI 10.1016/j.bcp.2005.04.021; Klinkhardt U, 2003, CLIN PHARMACOL THER, V73, P232, DOI 10.1067/mcp.2003.13; LEACH CM, 1982, PROSTAGLANDINS, V24, P47, DOI 10.1016/0090-6980(82)90176-9; Lip GYH, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003186.pub3; Mitchell C, 2012, J PHARMACOL EXP THER, V343, P755, DOI 10.1124/jpet.112.198051; Palatini P, 2011, VASC HEALTH RISK MAN, V7, P725, DOI 10.2147/VHRM.S25270; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rayment SJ, 2007, FASEB J, V21, P577, DOI 10.1096/fj.06-7050com; Safar ME, 1998, HYPERTENSION, V32, P156, DOI 10.1161/01.HYP.32.1.156; Saiag B, 1996, BRIT J PHARMACOL, V118, P804, DOI 10.1111/j.1476-5381.1996.tb15471.x; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Schafer A, 2011, BASIC RES CARDIOL, V106, P485, DOI 10.1007/s00395-011-0153-4; Shechter M, 2012, PLATELETS, V23, P202, DOI 10.3109/09537104.2011.604805; Simon J, 2002, J BIOL CHEM, V277, P31390, DOI 10.1074/jbc.M110714200; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2007, VASC MED, V12, P113, DOI 10.1177/1358863X07077462; Storey RF, 2002, PLATELETS, V13, P407, DOI 10.1080/0953710021000024402; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; UMEMURA K, 1995, JPN J PHARMACOL, V67, P253, DOI 10.1254/jjp.67.253; Virdis A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/916310; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Warnholtz A, 2007, ATHEROSCLEROSIS, V194, P439, DOI 10.1016/j.atherosclerosis.2006.08.034; Wihlborg AK, 2004, ARTERIOSCL THROM VAS, V24, P1810, DOI 10.1161/01.ATV.0000142376.30582.ed; YAO SK, 1993, CIRCULATION, V88, P2888, DOI 10.1161/01.CIR.88.6.2888; Zeng CY, 2010, CLIN SCI, V118, P459, DOI 10.1042/CS20090546	44	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91890	10.1371/journal.pone.0091890	http://dx.doi.org/10.1371/journal.pone.0091890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638017	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100074
J	Tan, PC; Zaidi, SN; Azmi, N; Omar, SZ; Khong, SY				Tan, Peng Chiong; Zaidi, Syeda Nureena; Azmi, Noor; Omar, Siti Zawiah; Khong, Su Yen			Depression, Anxiety, Stress and Hyperemesis Gravidarum: Temporal and Case Controlled Correlates	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; PREGNANCY; NAUSEA	Objective: To evaluate the temporal and case-controlled correlations of anxiety, depression and stress with hyperemesis gravidarum Study Design: We performed a longitudinal cohort study of women with hyperemesis gravidarum using the Depression, Anxiety and Stress Scale (DASS-21) to evaluate psychological distress at hospitalization and in the third trimester of pregnancy (from 28 weeks gestation). Third pregnancy trimester controls were recruited from routine antenatal clinic attendees who were matched to gestational age at the second DASS-21 assessment in the HG cohort. Results: The prevalences of nausea and vomiting, depression, anxiety and stress caseness in newly hospitalised hyperemesis gravidarum women were 100% and 100%, 19%, 69% and 21% which by the third trimester had fallen to 15.7% and 9.9%, 4%, 19% and 3% and in third trimester controls were 15.9% and 14.2%, 14%, 61% and 20% respectively. Within the hyperemesis gravidarum cohort, nausea, vomiting depression, anxiety and stress reduced significantly by an absolute 84.3% (95% CI 76.2%-89.8%), 90.1% (82.8%-94.2%), 14.9% (7.2%-23.0%), 49.6% (38.6%-58.7%) and 18.2% (10.4%-26.4%) respectively between hospitalization for hyperemesis gravidarum and at the third trimester. In the third trimester, when comparing the hyperemesis gravidarum cohort to controls, the risk of nausea or vomiting was similar but depression, anxiety and stress were significantly lower: adjusted odds ratio AOR 0.10 (95% CI 0.03-0.5), 0.11 (0.05-0.23) and 0.08 (0.02-0.33) respectively. Conclusion: Our study revealed a reassuring pattern of a strong rebound from depression, anxiety and stress in women with hyperemesis gravidarum such that by the third pregnancy trimester the level of psychological distress was even lower than in controls. This observation imply that much of the psychological distress in acute hyperemesis gravidarum is self-limiting and probably in the causal pathway of hyperemesis gravidarum. Care in women with hyperemesis gravidarum should focus on the relief of nausea and vomiting.	[Tan, Peng Chiong; Zaidi, Syeda Nureena; Azmi, Noor; Omar, Siti Zawiah; Khong, Su Yen] Univ Malaya, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia	Universiti Malaya	Tan, PC (corresponding author), Univ Malaya, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia.	pctan@um.edu.my	Tan, Peng/HGD-6812-2022; TAN, PENG CHIONG/B-9917-2010; Zaidi, Syeda/CAF-2671-2022; OMAR, SITI ZAWIAH BINTI/B-9817-2010; Zaidi, Syeda/CAH-8644-2022; Su Yen, Khong/G-5036-2011; Tan, Peng Chiong/AAM-8408-2021	TAN, PENG CHIONG/0000-0001-8713-6581; Zaidi, Syeda/0000-0003-2969-896X; Zaidi, Syeda/0000-0003-2969-896X; Tan, Peng Chiong/0000-0001-8713-6581	University of Malaya [UM.C/625/1/HIR/MOHE/MED/28, H20001-00-E000066]	University of Malaya(Universiti Malaya)	A covering block research grant (UM.C/625/1/HIR/MOHE/MED/28 account no. H20001-00-E000066) was provided by the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Einarson TR, 2013, J POPUL THER CLIN PH, V20, pE171; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; McCarthy FP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027678; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Munch S, 2002, SOC WORK HEALTH CARE, V36, P59, DOI 10.1300/J010v36n01_05; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Ramli M, 2012, ASEAN J PSYCHIAT, V12, pXX; Seng JS, 2007, J PSYCHOSOM OBST GYN, V28, P209, DOI 10.1080/01674820701262044; Simpson SW, 2001, J WOMEN HEALTH GEN-B, V10, P471, DOI 10.1089/152460901300233948; Tan PC, 2006, BJOG-INT J OBSTET GY, V113, P733, DOI 10.1111/j.1471-0528.2006.00947.x; Tan PC, 2011, CURR OPIN OBSTET GYN, V23, P87, DOI 10.1097/GCO.0b013e328342d208; Tan PC, 2010, EUR J OBSTET GYN R B, V149, P153, DOI 10.1016/j.ejogrb.2009.12.031; Uguz F, 2012, GEN HOSP PSYCHIAT, V34, P398, DOI 10.1016/j.genhosppsych.2012.03.021; Verberg MFG, 2005, HUM REPROD UPDATE, V11, P527, DOI 10.1093/humupd/dmi021	18	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92036	10.1371/journal.pone.0092036	http://dx.doi.org/10.1371/journal.pone.0092036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637791	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100106
J	Zehavi, Y; Kuznetsov, O; Ovadia-Shochat, A; Juven-Gershon, T				Zehavi, Yonathan; Kuznetsov, Olga; Ovadia-Shochat, Avital; Juven-Gershon, Tamar			Core Promoter Functions in the Regulation of Gene Expression of Drosophila Dorsal Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Gene Expression; RNA Polymerase II; Transcription Regulation; Transcription; Developmental Factors; DPE (Downstream Core Promoter Element); Dorsal; Core Promoter; Gene Network	GENOME-WIDE ANALYSIS; RNA-POLYMERASE; TRANSCRIPTION FACTORS; MORPHOGEN GRADIENT; BINDING-SITES; KEY COMPONENT; TATA-BOX; DPE; ELEMENT; TWIST	Background: The Dorsal transcription factor regulates the dorsal-ventral developmental gene regulatory network by binding to enhancers. Results: The core promoters of multiple Dorsal target genes are evolutionarily conserved and functionally dependent on specific elements. Conclusion: The core promoter composition is an important determinant of the transcriptional outcome. Significance: Transcriptional regulation results from an interplay between enhancers and core promoter composition. Developmental processes are highly dependent on transcriptional regulation by RNA polymerase II. The RNA polymerase II core promoter is the ultimate target of a multitude of transcription factors that control transcription initiation. Core promoters consist of core promoter motifs, e.g. the initiator, TATA box, and the downstream core promoter element (DPE), which confer specific properties to the core promoter. Here, we explored the importance of core promoter functions in the dorsal-ventral developmental gene regulatory network. This network includes multiple genes that are activated by different nuclear concentrations of Dorsal, an NFB homolog transcription factor, along the dorsal-ventral axis. We show that over two-thirds of Dorsal target genes contain DPE sequence motifs, which is significantly higher than the proportion of DPE-containing promoters in Drosophila genes. We demonstrate that multiple Dorsal target genes are evolutionarily conserved and functionally dependent on the DPE. Furthermore, we have analyzed the activation of key Dorsal target genes by Dorsal, as well as by another Rel family transcription factor, Relish, and the dependence of their activation on the DPE motif. Using hybrid enhancer-promoter constructs in Drosophila cells and embryo extracts, we have demonstrated that the core promoter composition is an important determinant of transcriptional activity of Dorsal target genes. Taken together, our results provide evidence for the importance of core promoter composition in the regulation of Dorsal target genes.	[Zehavi, Yonathan; Kuznetsov, Olga; Ovadia-Shochat, Avital; Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Juven-Gershon, T (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	tamar.gershon@biu.ac.il	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476	Israel Science Foundation [798/10]; European Union Seventh Framework Programme Marie Curie International Reintegration Grant [256491]; National Institutes of Health [GM041249]; United States-Israel Binational Science Foundation [2009428]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041249] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); European Union Seventh Framework Programme Marie Curie International Reintegration Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Israel Science Foundation Grant 798/10 (to T.J.-G.), European Union Seventh Framework Programme Marie Curie International Reintegration Grant 256491 (to T.J.-G.) and National Institutes of Health Grant GM041249 (to James T. Kadonaga). The analysis of the transcriptional activity of Biocoid was supported by United States-Israel Binational Science Foundation Grant 2009428 (to T.J.-G. and James T. Kadonaga).	BODMER R, 1990, DEVELOPMENT, V110, P661; Bonn S, 2008, CURR OPIN GENET DEV, V18, P513, DOI 10.1016/j.gde.2008.09.005; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Copley RR, 2007, GENOME RES, V17, P1327, DOI 10.1101/gr.6490707; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; de Navascues J, 2007, DEVELOPMENT, V134, P1779, DOI 10.1242/dev.02844; Dikstein R, 2011, TRANSCR-AUSTIN, V2, P201, DOI 10.4161/trns.2.5.17271; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; GOLDBERG ML, 1979, THESIS STANFORD U; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; PAN DJ, 1991, GENE DEV, V5, P1892, DOI 10.1101/gad.5.10.1892; Papatsenko D, 2005, P NATL ACAD SCI USA, V102, P4966, DOI 10.1073/pnas.0409414102; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Reeves GT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000836; Schimmelpfeng K, 2001, MECH DEVELOP, V106, P25, DOI 10.1016/S0925-4773(01)00402-6; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; WAMPLER SL, 1990, J BIOL CHEM, V265, P21223; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	68	24	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11993	12004		10.1074/jbc.M114.550251	http://dx.doi.org/10.1074/jbc.M114.550251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24634215	Green Published, hybrid			2022-12-25	WOS:000335010600038
J	Sugumar, M; Kumar, KM; Manoharan, A; Anbarasu, A; Ramaiah, S				Sugumar, Madhan; Kumar, K. M.; Manoharan, Anand; Anbarasu, Anand; Ramaiah, Sudha			Detection of OXA-1 beta-Lactamase Gene of Klebsiella pneumoniae from Blood Stream Infections (BSI) by Conventional PCR and In-Silico Analysis to Understand the Mechanism of OXA Mediated Resistance	PLOS ONE			English	Article								Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases (ESBL) exhibit resistance to antibiotic classes. The production of ESBLs (TEM-1, TEM-2, SHV-1, OXA-1) results in resistance to ampicillin, ticarcillin, piperacillin and cephalosporins. High levels of beta-lactamases leads to development of resistance to beta-lactamase inhibitors. The present study deals with characterizing antimicrobial resistance pattern among septicemia causing K. pneumoniae and the prevalence of inhibitor resistant OXA-1 beta-lactamase genes among them. Of 151 study isolates, 59 were resistant to piperacillin/tazobactam and these isolates were further selected for blaOXA-1 screening. Amplification of beta-lactamases genes by conventional PCR showed the presence of blaOXA-1 genes among 12 K. pneumoniae (20.3%) isolates. OXA-1 beta-lactamase producing strains were found to be resistant to piperacillin/tazobactam(100%), levofloxacin (91.6%), amikacin (75%), cefoxitin (50%), ertapenem (25%), imipenem (16.6%) and meropenem (16.6%); all were susceptible to tigecycline. 3D models of OXA-1 beta-lactamase were generated and docking was performed with various beta-lactam antibiotics. Molecular docking (MD) revealed the molecular basis of drug sensitivity. MD simulation results clearly confirmed the notable loss in stability for tigecycline-blaOXA-1 complex. Findings of the present study will provide useful insights for understanding the mechanism of resistance and help with strategies for the development of new antibiotics. The conventional PCR assay designed in this study can be routinely used in clinical microbiology laboratories to determine the blaOXA-1genes.	[Sugumar, Madhan; Manoharan, Anand] Christian Med Coll & Hosp, Med Unit & Infect Dis 1, Prof Benjamin M Pulimood Labs Infect Immun & Infl, Vellore, Tamil Nadu, India; [Sugumar, Madhan; Kumar, K. M.; Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Med & Biol Comp Lab, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Vellore Institute of Technology	Manoharan, A (corresponding author), Christian Med Coll & Hosp, Med Unit & Infect Dis 1, Prof Benjamin M Pulimood Labs Infect Immun & Infl, Vellore, Tamil Nadu, India.	anandvellore@yahoo.com	Ramaiah, Sudha/T-3682-2019; Anbarasu, Anand/U-6323-2019; Anbarasu, Anand/K-4076-2017	Ramaiah, Sudha/0000-0002-4800-329X; Anbarasu, Anand/0000-0003-2216-7488	Institutional Intramural Research Grant	Institutional Intramural Research Grant	The study did not receive any extramural funding. The work formed part of the PhD dissertation of Madhan Sugumar and supported by Institutional Intramural Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BERGSTROM S, 1979, ANTIMICROB AGENTS CH, V16, P427, DOI 10.1128/AAC.16.4.427; Bert F, 2002, J ANTIMICROB CHEMOTH, V50, P11, DOI 10.1093/jac/dkf069; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunsteren W. F. V., 1996, BIOMOLECULAR SIMULAT, P1; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Karmele C, 2003, FEMS MICROBIOL LET, V223, P147; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Liao JJL, 2007, CURR TOP MED CHEM, V7, P1394; Manoharan A, 2011, INDIAN J MED MICROBI, V29, P161, DOI 10.4103/0255-0857.81799; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Navia MM, 1999, J CLIN MICROBIOL, V37, P3113, DOI 10.1128/JCM.37.10.3113-3117.1999; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHANNON K, 1990, FEMS MICROBIOL LETT, V67, P319, DOI 10.1016/0378-1097(90)90016-J; Siu LK, 2000, ANTIMICROB AGENTS CH, V44, P2034, DOI 10.1128/AAC.44.8.2034-2038.2000; Wayne PA, 2011, M100S21 CLSI, P31; ZHOU XY, 1994, ANTIMICROB AGENTS CH, V38, P1085, DOI 10.1128/AAC.38.5.1085	22	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91800	10.1371/journal.pone.0091800	http://dx.doi.org/10.1371/journal.pone.0091800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647004	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500052
J	Adachi, I				Adachi, Ikuma			Spontaneous Spatial Mapping of Learned Sequence in Chimpanzees: Evidence for a SNARC-Like Effect	PLOS ONE			English	Article							MENTAL REPRESENTATION; WORKING-MEMORY; NUMBERS; SPACE	In the last couple of decades, there has been a growing number of reports on space-based representation of numbers and serial order in humans. In the present study, to explore evolutionary origins of such representations, we examined whether our closest evolutionary relatives, chimpanzees, map an acquired sequence onto space in a similar way to humans. The subjects had been trained to perform a number sequence task in which they touched a sequence of "small'' to "large'' Arabic numerals presented in random locations on the monitor. This task was presented in sessions that also included test trials consisting of only two numerals (1 and 9) horizontally arranged. On half of the trials 1 was located to the left of 9, whereas on the other half 1 was to the right to 9. The Chimpanzees' performance was systematically influenced by the spatial arrangement of the stimuli; specifically, they responded quicker when 1 was on the left and 9 on the right compared to the other way around. This result suggests that chimpanzees, like humans, spontaneously map a learned sequence onto space.	Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan	Kyoto University	Adachi, I (corresponding author), Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan.	ikuma.adachi@gmail.com		Adachi, Ikuma/0000-0003-2856-8792	 [24000001];  [23220006];  [25730093]; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by Grant-in-Aids for Specially Promoted Research: No. 24000001 (PI: Tetsuro Matsuzawa), for Scientific Research (S): No. 23220006 (PI: Masaki Tomonaga) and for Young Scientists (B): No. 25730093 (Ikuma Adachi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biro D, 2001, Anim Cogn, V4, P193, DOI 10.1007/s100710100086; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Fias W., 2005, HDB MATH COGNITION, P43; Fias W, 2011, ATTENTION PERFORM, P133, DOI 10.1016/B978-0-12-385948-8.00010-4; Fischer MH, 2003, VIS COGN, V10, P493, DOI 10.1080/13506280244000186; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Inoue S, 2007, CURR BIOL, V17, pR1004, DOI 10.1016/j.cub.2007.10.027; Kawai N, 2000, NATURE, V403, P39, DOI 10.1038/47405; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; Muller D, 2007, MEM COGNITION, V35, P1151, DOI 10.3758/BF03193485; Shaki S, 2008, COGNITION, V108, P590, DOI 10.1016/j.cognition.2008.04.001; Tomonaga M., 1993, PRIMATE RES, V9, P67; van Dijck JP, 2013, PSYCHOL SCI, V24, P1854, DOI 10.1177/0956797613479610; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013	24	51	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90373	10.1371/journal.pone.0090373	http://dx.doi.org/10.1371/journal.pone.0090373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643044	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900006
J	Carter, A; Min, JE; Chau, W; Lima, VD; Kestler, M; Pick, N; Money, D; Montaner, JSG; Hogg, RS; Kaida, A				Carter, Allison; Min, Jeong Eun; Chau, William; Lima, Viviane D.; Kestler, Mary; Pick, Neora; Money, Deborah; Montaner, Julio S. G.; Hogg, Robert S.; Kaida, Angela			Gender Inequities in Quality of Care among HIV-Positive Individuals Initiating Antiretroviral Treatment in British Columbia, Canada (2000-2010)	PLOS ONE			English	Article							PHYSICIAN SPECIALIZATION; UPDATED RECOMMENDATIONS; HEALTH-CARE; INFECTION; THERAPY; ADHERENCE; BARRIERS; WOMEN; EXPERIENCE; MORTALITY	Objectives: We measured gender differences in "Quality of Care" (QOC) during the first year after initiation of antiretroviral therapy and investigated factors associated with poorer QOC among women. Design: QOC was estimated using the Programmatic Compliance Score (PCS), a validated metric associated with all-cause mortality, among all patients (>= 19 years) who initiated ART in British Columbia, Canada (2000-2010). Methods: PCS includes six indicators of non-compliance with treatment initiation guidelines at baseline (not having drug resistance testing before treatment; starting on a non-recommended regimen; starting therapy at CD4<200 cells/mm(3)) and during first-year follow-up (receiving <3 CD4 tests; receiving <3 viral load tests; not achieving viral suppression within six months). Summary scores range from 0-6; higher scores indicate poorer QOC. Multivariable ordinal logistic regression was used to measure if female gender was an independent predictor of poorer QOC and factors associated with poorer QOC among women. Results: QOC was determined for 3,642 patients (20% women). At baseline: 42% of women (34% men) did not have resistance testing before treatment; 17% of women (9% men) started on a non-recommended regimen (all p < 0.001). At follow-up: 17% of women (11% men) received <3 CD4; 17% of women (11% men) received <3 VL; 50% of women (41% men) did not achieve viral suppression (all p < 0.001). Overall, QOC was better among men (mean PSC = 1.54 (SD = 1.30)) compared with women (mean = 1.89 (SD = 1.37); p < 0.001). In the multivariable model, female gender (AOR = 1.16 [95% CI: 0.99-1.35]; p = 0.062) remained associated with poorer QOC after covariate adjustment. Among women, those with injection drug use history, of Aboriginal ancestry, from Vancouver Island, and who initiated ART in earlier years were more likely to have poorer QOC. Conclusions: Poorer QOC among women, especially from marginalized communities, demands that barriers undermining women's access to high-quality care be addressed to improve treatment and health for women with HIV.	[Carter, Allison; Hogg, Robert S.; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Carter, Allison; Min, Jeong Eun; Chau, William; Lima, Viviane D.; Montaner, Julio S. G.; Hogg, Robert S.; Kaida, Angela] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Kestler, Mary; Pick, Neora] BC Womens Hosp & Hlth Ctr, Oak Tree Clin, Vancouver, BC, Canada; [Money, Deborah] BC Womens Hosp & Hlth Ctr, Womens Hlth Res Inst, Vancouver, BC, Canada; [Money, Deborah] Univ British Columbia, Fac Med, Dept Obstet & Gynecol, Vancouver, BC, Canada; [Kestler, Mary; Pick, Neora; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	kangela@sfu.ca		Hogg, Robert/0000-0003-3463-5488; Carter, Allison/0000-0003-2151-2622	BC Ministry of Health (PharmaCare)	BC Ministry of Health (PharmaCare)	The Drug Treatment Program is funded by the BC Ministry of Health (PharmaCare). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad M, 2012, ANTIVIR THER, V18, P27; [Anonymous], HIV AIDS EP UPD; Backus LI, 2010, ARCH INTERN MED, V170, P1239, DOI 10.1001/archinternmed.2010.234; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Benoit C, 2007, GENDERING POPULATION; British Columbia Centre for Excellence in HIV/AIDS, 2011, BC HIV AIDS THERAPEU; Burdge DR, 2003, CAN MED ASSOC J, V168, P1671; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carter AJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17433; Cescon AM, 2011, HIV MED, V12, P352, DOI 10.1111/j.1468-1293.2010.00890.x; Csete J, 2005, VECTORS VESSELS VICT; CUNNINGHAM WE, 1995, MED CARE, V33, P739, DOI 10.1097/00005650-199507000-00009; Gahagan J, 2001, CANADIAN WOMAN STUDI, V21, P118; Gallant JE, 2002, J CLIN VIROL, V25, P317, DOI 10.1016/S1386-6532(02)00024-0; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hirschhorn LR, 2006, WOMEN HEALTH ISS, V16, P104, DOI 10.1016/j.whi.2006.02.004; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kellington S, 1999, LISTEN WOMEN ARE TAL; Kerr C. A., 2012, AM J MED QUAL, DOI 1062860611425714; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Korthuis PT, 2011, JAIDS-J ACQ IMM DEF, V56, pS83, DOI 10.1097/QAI.0b013e31820bc9a5; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; Landon BE, 2003, J GEN INTERN MED, V18, P233, DOI 10.1046/j.1525-1497.2003.20705.x; Lichtenstein B, 2006, AIDS PATIENT CARE ST, V20, P122, DOI 10.1089/apc.2006.20.122; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Lima VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047859; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McNeil D., 2011, NEW YORK TIMES; Moneyham L, 2010, J ASSOC NURSE AIDS C, V21, P467, DOI 10.1016/j.jana.2010.03.003; Moore AL, 2003, JAIDS-J ACQ IMM DEF, V32, P452, DOI 10.1097/00126334-200304010-00017; Moore AL, 2002, J ACQ IMMUN DEF SYND, V29, P197, DOI 10.1097/00042560-200202010-00015; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; Nichols F H, 2000, J Obstet Gynecol Neonatal Nurs, V29, P56, DOI 10.1111/j.1552-6909.2000.tb02756.x; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Puskas CM, 2011, CURRENT HIV AIDS REP, P1; Quinn E, 2010, LEADERSHIP ENGAGEMEN; Sargeant Sheena, 2008, BARRIERS ACCESS PRIM; Schuster MA, 2000, AM J PUBLIC HEALTH, V90, P1074, DOI 10.2105/AJPH.90.7.1074; Sherr KH, 2010, AIDS, V24, pS59, DOI 10.1097/01.aids.0000366083.75945.07; Sowell RL, 1996, NURS CONNECT, V9, P5; Stein MD, 2000, AM J PUBLIC HEALTH, V90, P1138, DOI 10.2105/AJPH.90.7.1138; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Tapp C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-86; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Turner BJ, 2003, J GEN INTERN MED, V18, P248, DOI 10.1046/j.1525-1497.2003.20122.x; Umeh OC, 2006, SEX DIFFERENCES PHAR; UNAIDS, 2010, ANN 1 HIV AIDS EST D; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703; Wuest Judith, 2002, Health Care Women Int, V23, P794, DOI 10.1080/07399330290112326; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	56	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92334	10.1371/journal.pone.0092334	http://dx.doi.org/10.1371/journal.pone.0092334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642949	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900122
J	Fan, XL; Huang, QZ; Ye, XL; Lin, Y; Chen, YT; Lin, XH; Qu, J				Fan, Xiaolan; Huang, Qinzhu; Ye, Xiaolei; Lin, Yi; Chen, Yuting; Lin, Xinhua; Qu, Jia			Drosophila USP5 Controls the Activation of Apoptosis and the Jun N-Terminal Kinase Pathway during Eye Development	PLOS ONE			English	Article							FREE POLYUBIQUITIN CHAINS; CELL-DEATH; PRONEURAL GENE; ENZYME UBA1; UBIQUITIN; JNK; MECHANISMS; DIAP1; HID; ISOPEPTIDASE	The Jun N-terminal kinase pathway plays an important role in inducing programmed cell death (apoptosis) and is activated in a variety of contexts. The deubiquitinating enzymes (DUBs) are proteases regulating the protein stability by ubiquitin-proteasome system. Here, for the first time, we report the phenotypes observed during eye development that are induced by deleting Drosophila USP5 gene, which encodes one of the USP subfamily of DUBs. usp5 mutants displayed defects in photoreceptor differentiation. Using genetic epistasis analysis and molecular markers, we show that most of these phenotypes are caused by the activation of apoptosis and JNK pathway. These data may provide a mechanistic model for understanding the mammalian usp5 gene.	[Qu, Jia] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Qu, J (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	jqu@wz.zj.cn			National Basic Research Program of China [2011CB943900]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Basic Research Program of China (No. 2011CB943900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 1997, EMBO J, V16, P4826; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Chai JJ, 2003, NAT STRUCT BIOL, V10, P892, DOI 10.1038/nsb989; Cordero-Herrera I, 2013, NUTR CANCER, V65, P718, DOI 10.1080/01635581.2013.795981; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gulino A, 2012, VITAM HORM, V88, P211, DOI 10.1016/B978-0-12-394622-5.00009-2; HADARI T, 1992, J BIOL CHEM, V267, P719; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kanda H, 2004, J BIOCHEM, V136, P1, DOI 10.1093/jb/mvh098; Kester RS, 2011, INT J DEV BIOL, V55, P109, DOI 10.1387/ijdb.103109rk; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lee TV, 2008, DEVELOPMENT, V135, P43, DOI 10.1242/dev.011288; Lee TV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002261; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Lisi S, 2000, GENETICS, V154, P669; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Oh SW, 2003, GENETICS, V163, P195; Pfleger CM, 2007, FLY, V1, P95, DOI 10.4161/fly.4285; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003; Shlevkov E, 2012, CELL DEATH DIFFER, V19, P451, DOI 10.1038/cdd.2011.113; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tsachaki M, 2012, DEV DYNAM, V241, P40, DOI 10.1002/dvdy.22738; Vanek J, 1995, Acta Chir Orthop Traumatol Cech, V62, P162; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; WILKINSON KD, 1995, ANNU REV NUTR, V15, P161, DOI 10.1146/annurev.nu.15.070195.001113; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; WOLFF T, 1991, DEVELOPMENT, V113, P825; XU T, 1993, DEVELOPMENT, V117, P1223; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Yeh TC, 2013, P NATL ACAD SCI USA, V110, P14284, DOI 10.1073/pnas.1306179110; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zachariou A, 2003, EMBO J, V22, P6642, DOI 10.1093/emboj/cdg617; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004	62	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92250	10.1371/journal.pone.0092250	http://dx.doi.org/10.1371/journal.pone.0092250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643212	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900110
J	Lui, G; Wong, RYK; Li, F; Lee, MKP; Lai, RWM; Li, TCM; Kam, JKM; Lee, N				Lui, Grace; Wong, Rity Y. K.; Li, Florence; Lee, May K. P.; Lai, Raymond W. M.; Li, Timothy C. M.; Kam, Joseph K. M.; Lee, Nelson			High Mortality in Adults Hospitalized for Active Tuberculosis in a Low HIV Prevalence Setting	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; DIAGNOSIS; DELAY; DEATH; IMPACT; CITY; TRANSMISSION; PREDICTORS; INPATIENTS	Background: This study aims to evaluate the outcomes of adults hospitalized for tuberculosis in a higher-income region with low HIV prevalence. Methods: A retrospective cohort study was conducted on all adults hospitalized for pulmonary and/or extrapulmonary tuberculosis in an acute-care hospital in Hong Kong during a two-year period. Microscopy and solid-medium culture were routinely performed. The diagnosis of tuberculosis was made by: (1) positive culture of M. tuberculosis, (2) positive M. tuberculosis PCR result, (3) histology findings of tuberculosis infection, and/or (4) typical clinico-radiological manifestations of tuberculosis which resolved after anti-TB treatment, in the absence of alternative diagnoses. Time to treatment ('early', started during initial admission; 'late', subsequent periods), reasons for delay, and short-and long-term survival were analyzed. Results: Altogether 349 patients were studied [median(IQR) age 62(48-77) years; non-HIV immunocompromised conditions 36.7%; HIV/AIDS 2.0%]. 57.9%, 16.3%, and 25.8% had pulmonary, extrapulmonary, and pulmonary-extrapulmonary tuberculosis respectively. 58.2% was smear-negative; 0.6% multidrug-resistant. 43.4% developed hypoxemia. Crude 90-day and 1-year all-cause mortality was 13.8% and 24.1% respectively. 57.6% and 35.8% received 'early' and 'late' treatment respectively, latter mostly culture-guided [median(IQR) intervals, 5(3-9) vs. 43(25-61) days]. Diagnosis was unknown before death in 6.6%. Smear-negativity, malignancy, chronic lung diseases, and prior exposure to fluoroquinolones (adjusted-OR 10.6, 95% CI 1.3-85.2) delayed diagnosis of tuberculosis. Failure to receive 'early' treatment independently predicted higher mortality (Cox-model, adjusted-HR 1.8, 95% CI 1.1-3.0). Conclusions: Mortality of hospitalized tuberculosis patients is high. Newer approaches incorporating methods for rapid diagnosis and initiation of anti-tuberculous treatment are urgently required to improve outcomes.	[Lui, Grace; Wong, Rity Y. K.; Li, Timothy C. M.; Lee, Nelson] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Li, Florence] Univ Sheffield, Fac Med, Sheffield, S Yorkshire, England; [Lee, May K. P.; Lai, Raymond W. M.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Kam, Joseph K. M.; Lee, Nelson] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; University of Sheffield; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Lee, N (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	Lee, Nelson/B-6418-2008; KAM, Kai Man/K-4546-2012; Lui, Chung Yan Grace/N-5178-2016; Lui, Grace/N-4498-2019; Hahn, Horst/G-9018-2011	Lee, Nelson/0000-0002-0783-6607; KAM, Kai Man/0000-0003-0579-0307; Lui, Chung Yan Grace/0000-0001-5242-2967; Hahn, Horst/0000-0001-9901-3861				Chen TC, 2011, INT J INFECT DIS, V15, pE211, DOI 10.1016/j.ijid.2010.11.008; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P705; Erhabor G E, 2006, Indian J Chest Dis Allied Sci, V48, P253; Farah MG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-33; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023715; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/ajrccm.165.7.2107040; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Harris TG, 2013, AM J INFECT CONTROL, V41, P155, DOI 10.1016/j.ajic.2012.02.015; Hui Z, 2012, BIOMED ENVIRON SCI, V25, P483, DOI 10.3967/0895-3988.2012.04.015; Jeon CY, 2011, INT J TUBERC LUNG D, V15, P77; Kim HJ, 2010, INT J TUBERC LUNG D, V14, P79; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lin CY, 2010, J FORMOS MED ASSOC, V109, P269, DOI 10.1016/S0929-6646(10)60052-6; Liu YC, 2010, INT J TUBERC LUNG D, V14, P72; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Malbasa Milica, 2011, Pneumologia, V60, P138; Marks SM, 2011, INT J TUBERC LUNG D, V15, P465, DOI 10.5588/ijtld.10.0259; MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Rao VK, 1999, ANN INTERN MED, V130, P404, DOI 10.7326/0003-4819-130-5-199903020-00004; Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129; Shen GH, 2012, INT J ANTIMICROB AG, V39, P201, DOI 10.1016/j.ijantimicag.2011.11.014; Shu CC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-46; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Surveillance Team Special Preventive Programme Centre for Health Protection, 2011, HIV SURV REP 2010 UP; Perrechi MCT, 2011, J BRAS PNEUMOL, V37, P783, DOI 10.1590/S1806-37132011000600012; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Tuberculosis and Chest Service Department of Health Hong Kong SAR Government, 2009, ANN REP 2009; van der Heijden YF, 2012, INT J TUBERC LUNG D, V16, P1162, DOI 10.5588/ijtld.12.0046; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; World Health Organization (WHO), 2011, WHO REP GLOB TUB CON; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	37	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92077	10.1371/journal.pone.0092077	http://dx.doi.org/10.1371/journal.pone.0092077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642794	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900078
J	Ostermann, J; Njau, B; Brown, DS; Muhlbacher, A; Thielman, N				Ostermann, Jan; Njau, Bernard; Brown, Derek S.; Muehlbacher, Axel; Thielman, Nathan			Heterogeneous HIV Testing Preferences in an Urban Setting in Tanzania: Results from a Discrete Choice Experiment	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONJOINT-ANALYSIS; RANDOMIZED-TRIAL; VOLUNTARY; ACCEPTABILITY; MOSHI; PREVENTION; CLIENTS; RISK; CARE	Background: Efforts to reduce Human Immunodeficiency Virus (HIV) transmission through treatment rely on HIV testing programs that are acceptable to broad populations. Yet, testing preferences among diverse at-risk populations in Sub-Saharan Africa are poorly understood. We fielded a population-based discrete choice experiment (DCE) to evaluate factors that influence HIV-testing preferences in a low-resource setting. Methods: Using formative work, a pilot study, and pretesting, we developed a DCE survey with five attributes: distance to testing, confidentiality, testing days (weekday vs. weekend), method for obtaining the sample for testing (blood from finger or arm, oral swab), and availability of HIV medications at the testing site. Cluster-randomization and Expanded Programme on Immunization (EPI) sampling methodology were used to enroll 486 community members, ages 18-49, in an urban setting in Northern Tanzania. Interviewer-assisted DCEs, presented to participants on iPads, were administered between September 2012 and February 2013. Results: Nearly three of five males (58%) and 85% of females had previously tested for HIV; 20% of males and 37% of females had tested within the past year. In gender-specific mixed logit analyses, distance to testing was the most important attribute to respondents, followed by confidentiality and the method for obtaining the sample for the HIV test. Both unconditional assessments of preferences for each attribute and mixed logit analyses of DCE choice patterns suggest significant preference heterogeneity among participants. Preferences differed between males and females, between those who had previously tested for HIV and those who had never tested, and between those who tested in the past year and those who tested more than a year ago. Conclusion: The findings suggest potentially significant benefits from tailoring HIV testing interventions to match the preferences of specific populations, including males and females and those who have never tested for HIV.	[Ostermann, Jan; Thielman, Nathan] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Ostermann, Jan; Brown, Derek S.; Muehlbacher, Axel] Duke Univ, Ctr Hlth Policy & Inequal Res, Durham, NC USA; [Njau, Bernard] Kilimanjaro Christian Med Coll, Dept Community Hlth, Moshi, Tanzania; [Brown, Derek S.] Washington Univ, Brown Sch, St Louis, MO USA; [Muehlbacher, Axel] Hsch Neubrandenburg, Stiftungsinst Gesundheitsokon & Med Management, Neubrandenburg, Germany; [Thielman, Nathan] Duke Univ, Sch Med, Durham, NC USA	Duke University; Duke University; Washington University (WUSTL); Duke University	Thielman, N (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	n.thielman@duke.edu	Brown, Derek S/J-3035-2013; Ostermann, Jan/GQB-4743-2022; Njau, Bernard/AAI-2152-2020; Thielman, Nathan/R-5142-2019; Mühlbacher, Axel/AAZ-6577-2020	Brown, Derek S/0000-0001-9908-9882; Thielman, Nathan/0000-0001-8152-2879; Mühlbacher, Axel/0000-0003-4402-9211; Ostermann, Jan/0000-0002-8236-9500	National Institute of Mental Health (NIMH) [R21 MH096631]; Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) [5P30 AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096631] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This publication was made possible by Grant Number R21 MH096631 from the National Institute of Mental Health (NIMH), and supported by the Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (5P30 AI064518). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIMH or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; [Anonymous], 2012, NGEN VERS 1 1 1; Baggaley R, 2012, B WORLD HEALTH ORGAN, V90, P652, DOI 10.2471/BLT.11.100818; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Bond VA, 2010, AIDS CARE, V22, P6, DOI 10.1080/09540121003720994; Bridges J, CONJOINT ANAL HLTH S; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Brown DS, 2010, VACCINE, V28, P1702, DOI 10.1016/j.vaccine.2009.12.024; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Champ P.A., 2006, VALUING ENV AMENITIE; Cherutich P, 2013, CURR HIV-AIDS REP, V10, P134, DOI 10.1007/s11904-013-0158-8; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fiorillo SP, 2012, AIDS CARE, V24, P1264, DOI 10.1080/09540121.2012.658751; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Fylkesnes K, 1999, AIDS, V13, P2469, DOI 10.1097/00002030-199912030-00019; Glick P, 2005, EVALUATION REV, V29, P331, DOI 10.1177/0193841X05276437; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Houdmont J, 2013, AIDS CARE; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Keeffe JE, 1996, B WORLD HEALTH ORGAN, V74, P525; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Knox SA, 2013, SOCIAL SCI MED; Kyaddondo D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-966; Landman Keren Z, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P24, DOI 10.1177/1545109706298479; Landman KZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003075; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Marshall DA, 2009, HEALTH ECON, V18, P1420, DOI 10.1002/hec.1437; Muhlbacher AC, 2008, PSYCHOSOC MED, V5; National Bureau of Statistics, 2011, TANZ DEM HLTH SURV 2; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Njeru MK, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-243; Ole-Nguyaine S, 2004, ANN TROP MED PARASIT, V98, P171, DOI 10.1179/000349804225003163; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Phillips KA, 2002, HEALTH SERV RES, V37, P1681, DOI 10.1111/1475-6773.01115; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Prabhu M, 2011, INT J GYNECOL OBSTET, V113, P63, DOI 10.1016/j.ijgo.2010.10.019; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Sadique MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054149; Sherr L, 2007, AIDS, V21, P851, DOI 10.1097/QAD.0b013e32805e8711; Shorter MM, 2009, JAIDS-J ACQ IMM DEF, V52, P648, DOI 10.1097/QAI.0b013e3181b31a6a; StataCorp, 2011, STAT STAT SOFTW REL, P173; TACAIDS, 2013, HIV AIDS MAL IND SUR; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Tribble AC, 2009, INT J TUBERC LUNG D, V13, P1260; Walensky RP, 2010, J ACQUIR IMMUNE DEFI; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Waters RC, 2011, JAIDS-J ACQ IMM DEF, V56, P443, DOI 10.1097/QAI.0b013e3182118f8c; WHO, 2008, MOD 7 EPI COV SURV T	62	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92100	10.1371/journal.pone.0092100	http://dx.doi.org/10.1371/journal.pone.0092100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643047	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900085
J	Marcus, JL; Glidden, DV; McMahan, V; Lama, JR; Mayer, KH; Liu, AY; Montoya-Herrera, O; Casapia, M; Hoagland, B; Grant, RM				Marcus, Julia L.; Glidden, David V.; McMahan, Vanessa; Lama, Javier R.; Mayer, Kenneth H.; Liu, Albert Y.; Montoya-Herrera, Orlando; Casapia, Martin; Hoagland, Brenda; Grant, Robert M.			Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men	PLOS ONE			English	Article							HIGH-RISK; HIV; INFECTION; PREVALENCE; TENOFOVIR; WOMEN; ACQUISITION; ACYCLOVIR	Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the effect of daily oral emtricitabine/tenofovir (FTC/TDF) PrEP on HSV-2 seroincidence and ulcer occurrence among men who have sex with men (MSM) in the iPrEx trial. Methods: HSV-2 serum testing was performed at screening and every six months. Among HSV-2-seronegative individuals, we used Cox regression models to estimate hazard ratios (HRs) of HSV-2 seroincidence associated with randomization to FTC/TDF. We used multiple imputation and Cox regression to estimate HRs for HSV-2 seroincidence accounting for drug exposure. We assessed ulcer occurrence among participants with prevalent or incident HSV-2 infection. Results: Of the 2,499 participants, 1383 (55.3%) tested HSV-2-seronegative at baseline, 892 (35.7%) tested positive, 223 (8.9%) had indeterminate tests, and one test was not done. Of the 1,347 HSV-2-seronegative participants with follow-up, 125 (9.3%) had incident HSV-2 infection (5.9 per 100 person-years). Compared with participants receiving placebo, there was no difference in HSV-2 seroincidence among participants receiving FTC/TDF (HR 1.1, 95% CI: 0.8-1.5; P = 0.64) or among participants receiving FTC/TDF with a concentration of tenofovir diphosphate >16 per million viable cells (HR 1.0, 95% CI: 0.3-3.5; P = 0.95). Among participants with HSV-2 infection, the proportion with >= 1 moderate or severe ulcer adverse event was twice as high in the placebo vs. active arm (5.9% vs. 2.9%, P = 0.02), but there were no differences in the proportions with >= 1 clinical examination during which perianal or groin ulcers were identified. Conclusions: Tenofovir in daily oral FTC/TDF PrEP may reduce the occurrence of ulcers in individuals with HSV-2 infection but does not protect against HSV-2 incidence among MSM.	[Marcus, Julia L.; McMahan, Vanessa; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Marcus, Julia L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Glidden, David V.; Grant, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Liu, Albert Y.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Montoya-Herrera, Orlando] Fdn Ecuatoriana Equidad, Guayaquil, Guayas, Ecuador; [Casapia, Martin] Asociac Civil Selva Amazon, Iquitos, Peru; [Hoagland, Brenda] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; San Francisco Department of Public Health; Fundacao Oswaldo Cruz	Grant, RM (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	robert.grant@ucsf.edu	Glidden, David/AAD-4730-2020	Casapia Morales, Wilfredo Martin/0000-0002-5972-0948; Glidden, David/0000-0001-5888-1419; Grant, Robert/0000-0002-0851-7085	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1 AI64002]; Bill and Melinda Gates Foundation; Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI064002, P30AI027763] Funding Source: NIH RePORTER	Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, as a cooperative agreement (UO1 AI64002, to Dr. Grant), by the Bill and Melinda Gates Foundation, and by the Gladstone Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; Boily MC, 2011, 18 C RETR OPP INF BO; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2013, 20 C RETR OPP INF AT; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; LeGoff J, 2008, J CLIN MICROBIOL, V46, P1914, DOI 10.1128/JCM.02332-07; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lupi O, 2011, INT J DERMATOL, V50, P709, DOI 10.1111/j.1365-4632.2010.04863.x; Okuku HS, 2011, SEX TRANSM DIS, V38, P837, DOI 10.1097/OLQ.0b013e31821a6225; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Paz-Bailey G, 2007, SEX TRANSM INFECT, V83, P16, DOI 10.1136/sti.2006.020966; Rubin DB, 2004, MULTIPLE IMPUTATION; Tan DHS, 2012, INT J WOMENS HEALTH, V4, P341, DOI 10.2147/IJWH.S27601; Tan DHS, 2011, AIDS, V25, P207, DOI 10.1097/QAD.0b013e328341ddf7; van de Laar MJW, 1998, INT J EPIDEMIOL, V27, P127, DOI 10.1093/ije/27.1.127; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	26	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91513	10.1371/journal.pone.0091513	http://dx.doi.org/10.1371/journal.pone.0091513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637511	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100039
J	Ramadas, P; Rajendran, PP; Krishnan, P; Alex, A; Siskind, E; Kadiyala, A; Jayaschandran, V; Basu, A; Bhaskaran, M; Molmenti, EP				Ramadas, Poornima; Rajendran, Prejith P.; Krishnan, Prathik; Alex, Asha; Siskind, Eric; Kadiyala, Aditya; Jayaschandran, Vivek; Basu, Amit; Bhaskaran, Madhu; Molmenti, Ernesto P.			Extended-Spectrum-Beta-Lactamase Producing Bacteria Related Urinary Tract Infection in Renal Transplant Recipients and Effect on Allograft Function	PLOS ONE			English	Article							ESCHERICHIA-COLI; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; KIDNEY-TRANSPLANTATION; UNITED-STATES; PREVALENCE; ENTEROBACTERIACEAE; SUSCEPTIBILITY; COMPLICATIONS; EPIDEMIOLOGY	Background: Urinary tract infection (UTI) is a well-recognized early complication in renal transplant recipients (RTR) and can have significant bearing on their outcome. The recent rise in incidence of extended spectrum beta lactamase (ESBL) producing bacteria causing UTI among RTR poses new and significant challenges in terms of management and outcome. Our aim is to analyze the effect of ESBL producing bacteria causing UTI in these patients and its impact on allograft function. Methods: We reviewed the medical records of 147 RTR who were followed at a tertiary care hospital affiliated transplant center between January 2007 and May 2013 and noted five RTR who developed episodes of ESBL producing bacteria related UTI during follow up. Multiple patient characteristics including demographics, immunosuppression, recurrences, allograft function and outcome were analyzed. Results: Five patients (3.4%) out of 147 had ESBL producing bacteria related UTI. We found all patients to be above 60 years of age, with three out of five being females, and all five patients had diabetes mellitus. We identified a total of 37 episodes of UTI among these five patients during this period. Two of these patients had elevated creatinine values during the episodes of UTI and three of them developed bacteremia. Of the five patients, four of them had a favorable outcome except for one patient who developed persistent allograft dysfunction. Conclusion: RTR are at a higher risk for developing ESBL producing bacteria associated UTI. Early diagnosis along with appropriate and judicious use of antibiotics will ensure long term success in allograft and patient outcome.	[Ramadas, Poornima; Rajendran, Prejith P.; Krishnan, Prathik; Alex, Asha; Jayaschandran, Vivek; Basu, Amit; Bhaskaran, Madhu; Molmenti, Ernesto P.] N Shore Univ Hosp, Transplant Program, Manhasset, NY 11030 USA; [Siskind, Eric] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Kadiyala, Aditya] N Shore Univ Hosp, Dept Nephrol, Manhasset, NY USA	Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital	Bhaskaran, M (corresponding author), N Shore Univ Hosp, Transplant Program, Manhasset, NY 11030 USA.	mbhaskar@nshs.edu	Kadiyala, Aditya/S-8056-2019	Kadiyala, Aditya/0000-0003-2553-5557; Krishnan, Prathik/0000-0001-7849-2621				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Abbott KC, 2001, AM J NEPHROL, V21, P120, DOI 10.1159/000046234; Bloom RD, 2008, CLIN J AM SOC NEPHRO, V3, pS38, DOI 10.2215/CJN.02650707; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Charfeddine Khaled, 2002, Saudi J Kidney Dis Transpl, V13, P195; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Coskun AK, 2011, TRANSPL P, V43, P813, DOI 10.1016/j.transproceed.2010.11.016; COVESMITH A, 2007, TRENDS UROL GYNECOL, V12, P31, DOI DOI 10.1002/TRE.33; Dantas SRPE, 2006, J HOSP INFECT, V63, P117, DOI 10.1016/j.jhin.2005.10.018; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Domann E, 2003, J CLIN MICROBIOL, V41, P5500, DOI 10.1128/JCM.41.12.5500-5510.2003; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; FOX BC, 1990, AM J MED, V89, P255, DOI 10.1016/0002-9343(90)90337-D; Golebiewska J, 2011, TRANSPL P, V43, P2985, DOI 10.1016/j.transproceed.2011.07.010; Goya N, 1997, INFECTION, V25, P101, DOI 10.1007/BF02113586; Grover ML, 2009, J AM BOARD FAM MED, V22, P266, DOI 10.3122/jabfm.2009.03.080123; John U, 2006, NEPHROL DIAL TRANSPL, V21, P3269, DOI 10.1093/ndt/gfl464; Kader AA, 2005, ANN SAUDI MED, V25, P239, DOI 10.5144/0256-4947.2005.239; Kawecki D, 2011, TRANSPL P, V43, P2991, DOI 10.1016/j.transproceed.2011.09.002; Kee T, 2004, TRANSPL P, V36, P2001, DOI 10.1016/j.transproceed.2004.08.121; Khanna P, 2010, SAUDI J KIDNEY DIS T, V21, P876; Leggiadro RJ, 1997, INFECT DIS CLIN N AM, V11, P875, DOI 10.1016/S0891-5520(05)70395-0; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Muller V, 1998, J UROLOGY, V159, P1826, DOI 10.1016/S0022-5347(01)63165-3; Naber KG, 2001, EUR UROL, V40, P576, DOI 10.1159/000049840; Ozcakar ZB, 2011, ACTA PAEDIATR, V100, pE61, DOI 10.1111/j.1651-2227.2011.02262.x; Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001; Patterson JE, 2000, INFECT CONT HOSP EP, V21, P455, DOI 10.1086/501787; Pinheiro HS, 2010, TRANSPL P, V42, P486, DOI 10.1016/j.transproceed.2010.02.002; Ranganathan M, 2009, TRANSPL P, V41, P162, DOI 10.1016/j.transproceed.2008.10.022; Rice JC, 2006, AM J TRANSPLANT, V6, P2375, DOI 10.1111/j.1600-6143.2006.01471.x; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P37, DOI 10.1086/498519; Rodriguez-Bano J, 2008, EXPERT REV ANTI-INFE, V6, P671, DOI 10.1586/14787210.6.5.671; Rupp ME, 2003, DRUGS, V63, P353, DOI 10.2165/00003495-200363040-00002; Saemann M, 2008, EUR J CLIN INVEST, V38, P58, DOI 10.1111/j.1365-2362.2008.02014.x; TolkoffRubin NE, 1997, INFECT DIS CLIN N AM, V11, P707, DOI 10.1016/S0891-5520(05)70381-0; Valera B, 2006, TRANSPLANT P, V38, P2414, DOI 10.1016/j.transproceed.2006.08.018; Yilmaz E, 2008, J CHEMOTHERAPY, V20, P581, DOI 10.1179/joc.2008.20.5.581	39	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91289	10.1371/journal.pone.0091289	http://dx.doi.org/10.1371/journal.pone.0091289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637786	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100026
J	Yaligar, J; Gopalan, V; Kiat, OW; Sugii, S; Shui, GH; Lam, BD; Henry, CJ; Wenk, MR; Tai, ES; Velan, SS				Yaligar, Jadegoud; Gopalan, Venkatesh; Kiat, Ong Wee; Sugii, Shigeki; Shui, Guanghou; Lam, Buu Duyen; Henry, Christiani Jeyakumar; Wenk, Markus R.; Tai, E. Shyong; Velan, S. Sendhil			Evaluation of Dietary Effects on Hepatic Lipids in High Fat and Placebo Diet Fed Rats by In Vivo MRS and LC-MS Techniques	PLOS ONE			English	Article							CHOLESTEROL ESTER HYDROLASE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; LIVER-DISEASE; UNCOUPLING PROTEIN-2; METABOLIC SYNDROME; ACID UNSATURATION; OBESITY; LYSOPHOSPHATIDYLCHOLINE; ACCUMULATION	Background & Aims: Dietary saturated fatty acids contribute to the development of fatty liver and have pathogenic link to systemic inflammation. We investigated the effects of dietary fat towards the pathogenesis of non-alcoholic fatty liver disease by longitudinal in vivo magnetic resonance spectroscopy (MRS) and in vitro liquid chromatography coupled with mass spectrometry (LC-MS). Methods: All measurements were performed on rats fed with high fat diet (HFD) and chow diet for twenty four weeks. Longitudinal MRS measurements were performed at the 12th, 18th and 24th weeks. Liver tissues were analyzed by LC-MS, histology and gene transcription studies after terminal in vivo experiments. Results: Liver fat content of HFD rats for all ages was significantly (P<0.05) higher compared to their respective chow diet fed rats. Unsaturation indices estimated from MRS and LC-MS data of chow diet fed rats were significantly higher (P<0.05) than HFD fed rats. The concentration of triglycerides 48:1, 48:2, 50:1, 50:2, 50:3, 52:1, 52:2, 52:3, 54:3 and 54:2 was significantly higher (P<0.05) in HFD rats. The concentration for some polyunsaturated triglycerides 54:7, 56:8, 56:7, 58:11, 58:10, 58:9, 58:8 and 60:10 was significantly higher (P<0.05) in chow diet fed rats compared to HFD rats. Lysophospholipid concentrations including LPC and LPE were higher in HFD rats at 24 weeks indicating the increased risk of diabetes. The expression of CD36, PPAR alpha, SCD1, SREBF1 and UCP2 were significantly upregulated in HFD rats. Conclusions: We demonstrated the early changes in saturated and unsaturated lipid composition in fatty liver by in vivo MRS and ex vivo LC-MS. The higher LPC concentration in HFD rats indicated a higher risk of developing diabetes. Early metabolic perturbations causing changes in lipid composition can be evaluated by the unsaturation index and correlated to the non alcoholic fatty liver disease.	[Yaligar, Jadegoud; Gopalan, Venkatesh; Kiat, Ong Wee; Sugii, Shigeki; Velan, S. Sendhil] ASTAR, Lab Mol Imaging, Singapore Bioimaging Consortium, Singapore, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Lam, Buu Duyen; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Lam, Buu Duyen; Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Henry, Christiani Jeyakumar; Velan, S. Sendhil] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Velan, SS (corresponding author), ASTAR, Lab Mol Imaging, Singapore Bioimaging Consortium, Singapore, Singapore.	Sendhil_Velan@sbic.a-star.edu.sg	Henry, Christiani Jeyakumar/AHB-2632-2022; Wenk, Markus Rene/D-1441-2014; Velan, S. Sendhil/B-6374-2017	Henry, Christiani Jeyakumar/0000-0002-1602-0140; Velan, S. Sendhil/0000-0002-4096-0722; Sugii, Shigeki/0000-0002-2537-9534; Shui, Guanghou/0000-0002-1621-9643; Tai, E Shyong/0000-0003-2929-8966	Singapore Bioimaging Consortium, A*STAR, Singapore; National University of Singapore, Singapore	Singapore Bioimaging Consortium, A*STAR, Singapore; National University of Singapore, Singapore(National University of Singapore)	This research was supported by the intramural funding from Singapore Bioimaging Consortium, A*STAR, Singapore & National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi Herve, 2010, WILEY INTERDISCIPLIN, V2; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bordoni A, 1998, PROSTAG LEUKOTR ESS, V58, P417, DOI 10.1016/S0952-3278(98)90163-6; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Dorfman SE, 2009, OBESITY, V17, P1200, DOI 10.1038/oby.2008.662; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Fabbrini E, 2009, OBESITY, V17, P25, DOI 10.1038/oby.2008.494; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; HORROBIN DF, 1993, AM J CLIN NUTR, V57, P732; IKAI E, 1995, J HUM HYPERTENS, V9, P101; KALOUS M, 1992, BIOCHIM BIOPHYS ACTA, V1098, P167, DOI 10.1016/S0005-2728(05)80332-9; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Nagarajan V, 2013, AM J PHYSIOL-HEART C, V304, pH1495, DOI 10.1152/ajpheart.00478.2012; Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286; Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Pratchayasakul W, 2011, LIFE SCI, V88, P619, DOI 10.1016/j.lfs.2011.02.003; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; REZNICK AZ, 1998, OXIDATIVE STRESS SKE; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Schober C, 2009, BIOORG CHEM, V37, P202, DOI 10.1016/j.bioorg.2009.09.002; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shui GH, 2013, METABOLOMICS, V9, P786, DOI 10.1007/s11306-013-0494-0; Shui GH, 2011, J CHROMATOGR A, V1218, P4357, DOI 10.1016/j.chroma.2011.05.011; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; SIMON JB, 1978, GASTROENTEROLOGY, V75, P470; SIMON JB, 1978, SCAND J CLIN LAB INV, V38, P218, DOI 10.3109/00365517809104929; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Velan SS, 2008, AM J PHYSIOL-REG I, V295, pR1060, DOI 10.1152/ajpregu.90367.2008; Velan SS, 2007, J MAGN RESON IMAGING, V25, P192, DOI 10.1002/jmri.20786; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; ZAVARONI I, 1992, J INTERN MED, V231, P235, DOI 10.1111/j.1365-2796.1992.tb00529.x; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	54	19	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91436	10.1371/journal.pone.0091436	http://dx.doi.org/10.1371/journal.pone.0091436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638096	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100034
J	Yeo, AJ; Becherel, OJ; Luff, JE; Cullen, JK; Wongsurawat, T; Jenjaroenpoon, P; Kuznetsov, VA; McKinnon, PJ; Lavin, MF				Yeo, Abrey J.; Becherel, Olivier J.; Luff, John E.; Cullen, Jason K.; Wongsurawat, Thidathip; Jenjaroenpoon, Piroon; Kuznetsov, Vladimir A.; McKinnon, Peter J.; Lavin, Martin F.			R-Loops in Proliferating Cells but Not in the Brain: Implications for AOA2 and Other Autosomal Recessive Ataxias	PLOS ONE			English	Article							STRAND BREAK REPAIR; OCULOMOTOR APRAXIA TYPE-2; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; TOPOISOMERASE-I; NEURODEGENERATIVE DISEASE; CEREBELLAR ATAXIAS; ESCHERICHIA-COLI; PAUSE SITES; SENATAXIN	Disruption of the Setx gene, defective in ataxia oculomotor apraxia type 2 (AOA2) leads to the accumulation of DNA/RNA hybrids (R-loops), failure of meiotic recombination and infertility in mice. We report here the presence of R-loops in the testes from other autosomal recessive ataxia mouse models, which correlate with fertility in these disorders. R-loops were coincident in cells showing high basal levels of DNA double strand breaks and in those cells undergoing apoptosis. Depletion of Setx led to high basal levels of R-loops and these were enhanced further by DNA damage both in vitro and in vivo in tissues with proliferating cells. There was no evidence for accumulation of R-loops in the brains of mice where Setx, Atm, Tdp1 or Aptx genes were disrupted. These data provide further evidence for genome destabilization as a consequence of disrupted transcription in the presence of DNA double strand breaks arising during DNA replication or recombination. They also suggest that R-loop accumulation does not contribute to the neurodegenerative phenotype in these autosomal recessive ataxias.	[Yeo, Abrey J.; Becherel, Olivier J.; Luff, John E.; Cullen, Jason K.; Lavin, Martin F.] QIMR Berghofer Med Res Inst, Radiat Biol & Oncol Lab, Brisbane, Qld, Australia; [Yeo, Abrey J.; Lavin, Martin F.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Becherel, Olivier J.] Univ Queensland, Sch Chem & Mol Biol, St Lucia, Qld, Australia; [Wongsurawat, Thidathip; Jenjaroenpoon, Piroon; Kuznetsov, Vladimir A.] Bioinformat Inst, Dept Genome & Gene Express Data Anal, Singapore, Singapore; [Wongsurawat, Thidathip; Kuznetsov, Vladimir A.] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumour Cell Biol, Memphis, TN 38105 USA	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; St Jude Children's Research Hospital	Lavin, MF (corresponding author), QIMR Berghofer Med Res Inst, Radiat Biol & Oncol Lab, Brisbane, Qld, Australia.	martin.lavin@qimrberghofer.edu.au	Lavin, Martin F/F-5961-2014; Wongsurawat, Thidathip/K-5590-2019; Yeo, Abrey J/D-9695-2015	Lavin, Martin F/0000-0002-5940-4769; Yeo, Abrey J/0000-0003-4470-4854; Cullen, Jason/0000-0003-4961-1673	Australian Research Council (ARC); BrAshA-T Foundation; Department of Innovation, Australian Government; University of Queensland, Australia; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); BrAshA-T Foundation; Department of Innovation, Australian Government; University of Queensland, Australia(University of Queensland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Australian Research Council (ARC) and the BrAshA-T Foundation to MFL. AJY is a recipient of the International Postgraduate Research Scholarship (IPRS) awarded by the Department of Innovation, Australian Government, and the UQCentennial and UQAdvantage scholarships awarded by the University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211; BARBI G, 1991, AM J MED GENET, V40, P44, DOI 10.1002/ajmg.1320400109; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Becherel OJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003435; Belzil VV, 2013, MOL CELL NEUROSCI, V56, P406, DOI 10.1016/j.mcn.2012.12.006; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cirillo D, 2013, RNA, V19, P129, DOI 10.1261/rna.034777.112; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guichard S, 2001, CLIN CANCER RES, V7, P3222; Hanson KA, 2012, WIRES RNA, V3, P265, DOI 10.1002/wrna.111; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kollmannsberger C, 1999, ONCOLOGY-BASEL, V56, P1, DOI 10.1159/000011923; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2013, DNA REPAIR, V12, P612, DOI 10.1016/j.dnarep.2013.04.014; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Richard P, 2013, GENE DEV, V27, P2227, DOI 10.1101/gad.224923.113; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rulten SL, 2013, DNA REPAIR, V12, P558, DOI 10.1016/j.dnarep.2013.04.008; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Vantaggiato C, 2011, BRAIN, V134, P1808, DOI 10.1093/brain/awr084; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Wong ET, 2004, ONCOLOGIST, V9, P68, DOI 10.1634/theoncologist.9-1-68; Wongsurawat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1075; Wu ZK, 2010, NUCLEIC ACIDS RES, V38, P2346, DOI 10.1093/nar/gkp1251; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	57	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90219	10.1371/journal.pone.0090219	http://dx.doi.org/10.1371/journal.pone.0090219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637776	Green Published, gold			2022-12-25	WOS:000333254100005
J	Vieira, TCRG; Cordeiro, Y; Caughey, B; Silva, JL				Vieira, Tuane C. R. G.; Cordeiro, Yraima; Caughey, Byron; Silva, Jerson L.			Heparin binding confers prion stability and impairs its aggregation	FASEB JOURNAL			English	Article						glycosaminoglycan; neurodegeneration	INTRAVENTRICULAR PENTOSAN POLYSULFATE; CREUTZFELDT-JAKOB-DISEASE; PROTEASE-RESISTANT PRP; SULFATE PROTEOGLYCANS; ALZHEIMERS-DISEASE; SYNTHETIC PEPTIDES; MAMMALIAN PRIONS; FIBRIL FORMATION; CULTURED-CELLS; CELLULAR PRP	The conversion of the prion protein (PrP) into scrapie PrP (PrPSc) is a central event in prion diseases. Several molecules work as cofactors in the conversion process, including glycosaminoglycans (GAGs). GAGs exhibit a paradoxical effect, as they convert PrP into protease-resistant PrP (PrP-res) but also exert protective activity. We compared the stability and aggregation propensity of PrP and the heparin-PrP complex through the application of different in vitro aggregation approaches, including real-time quaking-induced conversion (RT-QuIC). Transmissible spongiform encephalopathy-associated forms from mouse and hamster brain homogenates were used to seed RT-QuIC-induced fibrillization. In our study, interaction between heparin and cellular PrP (PrPC) increased thermal PrP stability, leading to an 8-fold decrease in temperature-induced aggregation. The interaction of low-molecular-weight heparin (LMWHep) with the PrP N- or C-terminal domain affected not only the extent of PrP fibrillization but also its kinetics, lowering the reaction rate constant from 1.04 to 0.29 s(-1) and increasing the lag phase from 12 to 19 h in RT-QuIC experiments. Our findings explain the protective effect of heparin in different models of prion and prion-like neurodegenerative diseases and establish the groundwork for the development of therapeutic strategies based on GAGs.	[Vieira, Tuane C. R. G.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonncia Magnet Nucl Jiri Jonas, Inst Bioqum Med Leopoldo Meis, Inst Nacl Ciencia Tecnol Biol Estrutural E Bioima, Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Far, Rio De Janeiro, Brazil; [Caughey, Byron] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, US Natl Inst Hlth, Hamilton, MT 59840 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim, Bloco E Sala 10, BR-21941590 Rio De Janeiro, RJ, Brazil.	tuane@bioqmed.ufrj.br; jerson@bioqmed.ufrj.br	SILVA, JERSON Lima/GRF-1442-2022; Cordeiro, Yraima/J-7619-2012; Silva, Jerson/J-8984-2014; Vieira, Tuane CRG/F-4550-2014	SILVA, JERSON Lima/0000-0001-9523-9441; Cordeiro, Yraima/0000-0003-4278-212X; Silva, Jerson/0000-0001-9523-9441; Vieira, Tuane CRG/0000-0002-3574-5411	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CNPq; Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); FAPERJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001087] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank A. Hughson for purifying the recombinant PrP and for preparing the brain homogenate samples and G. and L. Raymond for technical assistance. T.C.R.G.V. received a postdoctoral fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through the Science Without Borders Internship Program and from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). This work was supported by grants from CNPq, Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program) and FAPERJ.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Adjou KT, 2003, J GEN VIROL, V84, P2595, DOI 10.1099/vir.0.19073-0; Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Cortijo-Arellano M, 2008, BIOCHEM BIOPH RES CO, V368, P238, DOI 10.1016/j.bbrc.2008.01.049; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Dudas B, 2008, NEURODEGENER DIS, V5, P200, DOI 10.1159/000113702; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Harrison PM, 1999, J MOL BIOL, V286, P593, DOI 10.1006/jmbi.1998.2497; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Honda H, 2012, NEUROPATHOLOGY, V32, P124, DOI 10.1111/j.1440-1789.2011.01245.x; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaneko K, 1997, J MOL BIOL, V270, P574, DOI 10.1006/jmbi.1997.1135; KANEKO K, 1995, P NATL ACAD SCI USA, V92, P11160, DOI 10.1073/pnas.92.24.11160; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Kong QZ, 2013, CELL REP, V4, P248, DOI 10.1016/j.celrep.2013.06.030; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; Larramendy-Gozalo C, 2007, J GEN VIROL, V88, P1062, DOI 10.1099/vir.0.82286-0; Lee KS, 2007, P NATL ACAD SCI USA, V104, P9551, DOI 10.1073/pnas.0703910104; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Leveugle B, 1998, J NEUROCHEM, V70, P736; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Ma Q, 2002, THROMB RES, V105, P447, DOI 10.1016/S0049-3848(02)00050-6; Martins PM, 2013, PRION, V7, P136, DOI 10.4161/pri.23111; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Perez M, 1998, BIOCHEM J, V335, P369, DOI 10.1042/bj3350369; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rumjon A, 2012, INT J NEPHROL RENOV, V5, P37, DOI 10.2147/IJNRD.S19165; Schatzl HM, 1997, J MOL BIOL, V265, P257, DOI 10.1006/jmbi.1996.0791; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Terada T, 2010, ACTA NEUROL SCAND, V121, P127, DOI 10.1111/j.1600-0404.2009.01272.x; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Whittle IR, 2006, ACTA NEUROCHIR, V148, P677, DOI 10.1007/s00701-006-0772-y; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhu H, 2001, MOL MED, V7, P517, DOI 10.1007/BF03401857	80	46	46	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2667	2676		10.1096/fj.13-246777	http://dx.doi.org/10.1096/fj.13-246777			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24648544	Green Published			2022-12-25	WOS:000339883600024
J	Song, HW; Wohltmann, M; Tan, M; Ladenson, JH; Turk, J				Song, Haowei; Wohltmann, Mary; Tan, Min; Ladenson, Jack H.; Turk, John			Group VIA Phospholipase A2 Mitigates Palmitate-induced beta-Cell Mitochondrial Injury and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Apoptosis; Cardiolipin; Diabetes; ER Stress; Lipid Peroxidation; Mass Spectrometry (MS); Mitochondrial Apoptosis; Oxidative Stress; Pancreatic Islets; Reactive Oxygen Species (ROS)	ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; NITRIC-OXIDE SYNTHASE; CYTOCHROME-C RELEASE; CALCIUM-INDEPENDENT PHOSPHOLIPASE-A2; TRANSFECTED INSULINOMA CELLS; HUMAN PANCREATIC-ISLETS; OXIDATIVE STRESS; LIPID-PEROXIDATION; ELECTROSPRAY-IONIZATION	Background: Lipid-induced -cell loss contributes to type 2 diabetes mellitus (T2DM). Results: Palmitate-induced -cell lipid oxidation, mitochondrial dysfunction, and apoptosis correlate inversely with expression of iPLA(2), which associates with mitochondria, generates monolysocardiolipin, and lowers oxidized phospholipid content. Conclusion: iPLA(2) mitigates palmitate-induced -cell mitochondrial injury and apoptosis and may facilitate repair of oxidized lipids. Significance: Understanding lipid-induced -cell loss could lead to T2DM therapies. Palmitate (C16:0) induces apoptosis of insulin-secreting -cells by processes that involve generation of reactive oxygen species, and chronically elevated blood long chain free fatty acid levels are thought to contribute to -cell lipotoxicity and the development of diabetes mellitus. Group VIA phospholipase A(2) (iPLA(2)) affects -cell sensitivity to apoptosis, and here we examined iPLA(2) effects on events that occur in -cells incubated with C16:0. Such events in INS-1 insulinoma cells were found to include activation of caspase-3, expression of stress response genes (C/EBP homologous protein and activating transcription factor 4), accumulation of ceramide, loss of mitochondrial membrane potential, and apoptosis. All of these responses were blunted in INS-1 cells that overexpress iPLA(2), which has been proposed to facilitate repair of oxidized mitochondrial phospholipids, e.g. cardiolipin (CL), by excising oxidized polyunsaturated fatty acid residues, e.g. linoleate (C18:2), to yield lysophospholipids, e.g. monolysocardiolipin (MLCL), that can be reacylated to regenerate the native phospholipid structures. Here the MLCL content of mouse pancreatic islets was found to rise with increasing iPLA(2) expression, and recombinant iPLA(2) hydrolyzed CL to MLCL and released oxygenated C18:2 residues from oxidized CL in preference to native C18:2. C16:0 induced accumulation of oxidized CL species and of the oxidized phospholipid (C18:0/hydroxyeicosatetraenoic acid)-glycerophosphoethanolamine, and these effects were blunted in INS-1 cells that overexpress iPLA(2), consistent with iPLA(2)-mediated removal of oxidized phospholipids. C16:0 also induced iPLA(2) association with INS-1 cell mitochondria, consistent with a role in mitochondrial repair. These findings indicate that iPLA(2) confers significant protection of -cells against C16:0-induced injury.	[Song, Haowei; Wohltmann, Mary; Tan, Min; Turk, John] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA; [Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	jturk@dom.wustl.edu			National Institutes of Health [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R37DK034388, P30DK020579, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Abaraviciene SM, 2008, CELL MOL LIFE SCI, V65, P2256, DOI 10.1007/s00018-008-8100-8; Abaraviciene SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002182; ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q; Andersen AD, 2009, AM J PHYSIOL-CELL PH, V296, pC1227, DOI 10.1152/ajpcell.00370.2008; Balazy M, 2003, AGEING RES REV, V2, P191, DOI 10.1016/S1568-1637(02)00065-X; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chen X, 2008, J LIPID RES, V49, P832, DOI 10.1194/jlr.M700598-JLR200; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cummings BS, 2002, AM J PHYSIOL-RENAL, V283, pF492, DOI 10.1152/ajprenal.00022.2002; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Guo Y, 2012, EUR J LIPID SCI TECH, V114, P233, DOI 10.1002/ejlt.201100309; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P491, DOI 10.1016/j.jasms.2004.12.015; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jeon MJ, 2012, EXP MOL MED, V44, P562, DOI 10.3858/emm.2012.44.9.064; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Keanei DC, 2011, CLIN SCI, V120, P195, DOI 10.1042/CS20100282; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Korper S, 2003, EXP HEMATOL, V31, P815, DOI 10.1016/S0301-472X(03)00199-1; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Leonardi O, 2003, EUR J ENDOCRINOL, V149, P99, DOI 10.1530/eje.0.1490099; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Liu W, 2011, FREE RADICAL BIO MED, V50, P166, DOI 10.1016/j.freeradbiomed.2010.10.709; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma BJ, 1999, J LIPID RES, V40, P1837; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Ma ZA, 2012, CURR DIABETES REV, V8, P69; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; Ma ZM, 2001, LIPIDS, V36, P689, DOI 10.1007/s11745-001-0774-9; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Martinez J, 2001, ARCH BIOCHEM BIOPHYS, V392, P257, DOI 10.1006/abbi.2001.2439; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Michalska M, 2010, BIOSCIENCE REP, V30, P445, DOI 10.1042/BSR20090138; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Montero J, 2010, BBA-BIOENERGETICS, V1797, P1217, DOI 10.1016/j.bbabio.2010.02.010; Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0; O'Donnell VB, 2011, BBA-MOL CELL BIOL L, V1811, P818, DOI 10.1016/j.bbalip.2011.07.018; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pappan KL, 2005, J BIOL CHEM, V280, P9023, DOI 10.1074/jbc.M409706200; PARADIES G, 1993, ARCH BIOCHEM BIOPHYS, V307, P91, DOI 10.1006/abbi.1993.1565; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Rachek LI, 2006, DIABETES, V55, P1022, DOI 10.2337/diabetes.55.04.06.db05-0865; Ramanadham S, 2004, DIABETES, V53, pS179, DOI 10.2337/diabetes.53.2007.S179; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; ROBINSON NC, 1980, BIOCHEMISTRY-US, V19, P3656, DOI 10.1021/bi00557a003; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Salamon Z, 1997, J BIOENERG BIOMEMBR, V29, P211, DOI 10.1023/A:1022401825287; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Song HW, 2012, J BIOL CHEM, V287, P5528, DOI 10.1074/jbc.M111.285114; Song HW, 2010, J BIOL CHEM, V285, P33843, DOI 10.1074/jbc.M110.153197; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; SPOONER PJR, 1992, BIOCHEMISTRY-US, V31, P10129, DOI 10.1021/bi00156a037; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Ushmorov A, 1999, BLOOD, V93, P2342, DOI 10.1182/blood.V93.7.2342.407k09_2342_2352; VANKUIJK FJGM, 1987, TRENDS BIOCHEM SCI, V12, P31, DOI 10.1016/0968-0004(87)90014-4; Veluthakal R, 2005, APOPTOSIS, V10, P841, DOI 10.1007/s10495-005-0431-4; VIK SB, 1977, BIOCHEMISTRY-US, V16, P5755, DOI 10.1021/bi00645a016; Wang WF, 2011, BBA-MOL BASIS DIS, V1812, P1532, DOI 10.1016/j.bbadis.2011.07.016; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Wiederkehr A, 2009, DIABETES, V58, P2185, DOI 10.2337/db09-0967; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Won JS, 2004, J NEUROCHEM, V88, P583, DOI 10.1046/j.1471-4159.2003.02165.x; Xu M, 2011, J BIOL CHEM, V286, P11141, DOI 10.1074/jbc.M110.196543; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang WY, 2012, MOL PLANT, V5, P452, DOI 10.1093/mp/ssr118; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	110	24	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14194	14210		10.1074/jbc.M114.561910	http://dx.doi.org/10.1074/jbc.M114.561910			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24648512	Green Published, hybrid			2022-12-25	WOS:000335984600046
J	Hung, KC; Huang, HJ; Lin, MW; Lei, YP; Lin, AMY				Hung, Kai-Chih; Huang, Hui-Ju; Lin, Ming-Wei; Lei, Yen-Ping; Lin, Anya Maan-yuh			Roles of Autophagy in MPP+-Induced Neurotoxicity In Vivo: The Involvement of Mitochondria and alpha-Synuclein Aggregation	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; INDUCED OXIDATIVE INJURY; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; UP-REGULATION; CELL-DEATH; STRESS; APOPTOSIS; BRAIN; NEURODEGENERATION	Macroautophagy (also known as autophagy) is an intracellular self-eating mechanism and has been proposed as both neuroprotective and neurodestructive in the central nervous system (CNS) neurodegenerative diseases. In the present study, the role of autophagy involving mitochondria and alpha-synuclein was investigated in MPP+ (1-methyl-4-phenylpyridinium)- induced oxidative injury in chloral hydrate-anesthetized rats in vivo. The oxidative mechanism underlying MPP+-induced neurotoxicity was identified by elevated lipid peroxidation and heme oxygenase-1 levels, a redox-regulated protein in MPP+-infused substantia nigra (SN). At the same time, MPP+ significantly increased LC3-II levels, a hallmark protein of autophagy. To block MPP+-induced autophagy in rat brain, Atg7siRNA was intranigrally infused 4 d prior to MPP+ infusion. Western blot assay showed that in vivo Atg7siRNA transfection not only reduced Atg7 levels in the MPP+-infused SN but attenuated MPP+-induced elevation in LC3-II levels, activation of caspase 9 and reduction in tyrosine hydroxylase levels, indicating that autophagy is pro-death. The immunostaining study demonstrated co-localization of LC3 and succinate dehydrogenase (a mitochondrial complex II) as well as LC3 and alpha-synuclein, suggesting that autophagy may engulf mitochondria and alpha-synuclein. Indeed, in vivo Atg7siRNA transfection mitigated MPP+-induced reduction in cytochrome c oxidase. In addition, MPP+-induced autophagy differentially altered the alpha-synuclein aggregates in the infused SN. In conclusion, autophagy plays a prodeath role in the MPP+-induced oxidative injury by sequestering mitochondria in the rat brain. Moreover, our data suggest that the benefits of autophagy depend on the levels of alpha-synuclein aggregates in the nigrostriatal dopaminergic system of the rat brain.	[Hung, Kai-Chih] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan; [Huang, Hui-Ju; Lin, Anya Maan-yuh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lei, Yen-Ping] Natl Yang Ming Univ, Dept Nursing, Taipei 112, Taiwan; [Lin, Anya Maan-yuh] Natl Yang Ming Univ, Dept Pharmacol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, AMY (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	myalin@vghtpe.gov.tw			 [NSC101-2320-B-010-044];  [V103-C-060]	; 	The authors report the following sources of funding: NSC101-2320-B-010-044 and V103-C-060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cai ZL, 2009, NEUROREPORT, V20, P569, DOI 10.1097/WNR.0b013e32832986c4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chang CF, 2012, J PINEAL RES, V52, P312, DOI 10.1111/j.1600-079X.2011.00945.x; Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050; CHIUEH CC, 1983, J PHARMACOL EXP THER, V225, P529; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Hochfeld WE, 2013, ACTA PHARMACOL SIN, V34, P600, DOI 10.1038/aps.2012.189; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Janda E, 2012, MOL NEUROBIOL, V46, P639, DOI 10.1007/s12035-012-8318-1; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; KIKUGAWA K, 1989, ADV EXP MED BIOL, V266, P345; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li LY, 2011, NEUROSCI LETT, V489, P62, DOI 10.1016/j.neulet.2010.11.068; Lin AMY, 2004, NEUROCHEM INT, V44, P99, DOI 10.1016/S0197-0186(03)00113-X; Lin AMY, 2007, TOXICOL APPL PHARM, V224, P138, DOI 10.1016/j.taap.2007.06.016; Liu KY, 2013, NEUROCHEM RES, V38, P201, DOI 10.1007/s11064-012-0909-8; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Paxinos G, 1986, RAT BRAIN STEREOTAXI, V27, P121; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007; Shivalingappa PC, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/424285; SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Tzeng YW, 2010, FREE RADICAL BIO MED, V49, P839, DOI 10.1016/j.freeradbiomed.2010.06.004; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xilouri M, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001803; Yu HC, 2010, NEUROPATH APPL NEURO, V36, P612, DOI 10.1111/j.1365-2990.2010.01107.x; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036377	52	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91074	10.1371/journal.pone.0091074	http://dx.doi.org/10.1371/journal.pone.0091074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646838	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500022
J	Kuo, MS; Auriau, J; Pierre-Eugene, C; Issad, T				Kuo, Mei-Shiue; Auriau, Johanna; Pierre-Eugene, Cecile; Issad, Tarik			Development of a Human Breast-Cancer Derived Cell Line Stably Expressing a Bioluminescence Resonance Energy Transfer (BRET)-Based Phosphatidyl Inositol-3 Phosphate (PIP3) Biosensor	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; BINDING PROTEINS IGFBPS; FACTOR-I-RECEPTOR; INSULIN-RECEPTOR; ACTIVATION STATE; TYROSINE PHOSPHORYLATION; SUBCUTANEOUS INJECTION; TARGETING PI3K; GLARGINE	Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates PI3K. Activated PI3K uses PIP2 to generate PIP3, which recruit Akt to the plasma membrane through its pleckstrin homology (PH) domain, permitting its activation by PDKs. Activated Akt controls important biological functions, including cell metabolism, proliferation and survival. The PI3K pathway is therefore an attractive target for drug discovery. However, current assays for measurement of PIP3 production are technically demanding and not amenable to high-throughput screening. We have established a MCF-7-derived breast cancer cell line, that stably co-expresses the PH domain of Akt fused to Renilla luciferase and YFP fused to a membrane localization signal. This BRET biosensor pair permits to monitor, in real time, in living cells, PIP3 production at the plasma membrane upon stimulation by different ligands, including insulin, the insulin analogue glargine, IGF1, IGF2 and EGF. Moreover, several known inhibitors that target different steps of the PI3K/Akt pathway caused inhibition of ligand-induced BRET. Cetuximab, a humanized anti-EGF receptor monoclonal antibody used for the treatment of cancer, completely inhibited EGF-induced BRET, and the tyrosine kinase inhibitor tyrphostine AG1024 inhibited insulin effect on PIP3 production. Moreover, the effects of insulin and IGF1 were inhibited by molecules that inhibit PI3K catalytic activity or the interaction between PIP3 and the PH domain of Akt. Finally, we showed that human serum induced a dose-dependent increase in BRET signal, suggesting that this stable clone may be used as a prognostic tool to evaluate the PI3K stimulatory activity present in serum of human patients. We have thus established a cell line, suitable for the screening and/or the study of molecules with stimulatory or inhibitory activities on the PI3K/Akt pathway that will constitute a new tool for translational research in diabetes and cancer.	[Kuo, Mei-Shiue; Auriau, Johanna; Pierre-Eugene, Cecile; Issad, Tarik] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Kuo, Mei-Shiue; Auriau, Johanna; Pierre-Eugene, Cecile; Issad, Tarik] INSERM, U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Issad, T (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France.	tarik.issad@inserm.fr		Issad, Tarik/0000-0002-2638-6330	French CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de Sante et de Recherche Medicale)	French CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de Sante et de Recherche Medicale)	This work was supported by the French CNRS (Centre National de la Recherche Scientifique) and the INSERM (Institut National de Sante et de Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agin A, 2007, DIABETES METAB, V33, P205, DOI 10.1016/j.diabet.2006.12.002; ARTEAGA CL, 1994, CANCER RES, V54, P4703; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Blanquart C, 2006, MOL PHARMACOL, V70, P1802, DOI 10.1124/mol.106.026989; Blanquart C, 2009, BIOCHEM BIOPH RES CO, V387, P748, DOI 10.1016/j.bbrc.2009.07.105; Bolli GB, 2012, DIABETES CARE, V35, P2626, DOI 10.2337/dc12-0270; Boubekeur S, 2011, J BIOL CHEM, V286, P19373, DOI 10.1074/jbc.M111.222984; Boute N, 2001, MOL PHARMACOL, V60, P640; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; DECUPIS A, 1995, BRIT J PHARMACOL, V116, P2391; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fardini Y, 2014, FASEB J, V28, P1010, DOI 10.1096/fj.13-238378; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Frost VJ, 1996, J CLIN ENDOCR METAB, V81, P2216, DOI 10.1210/jc.81.6.2216; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; IMAI Y, 1982, CANCER RES, V42, P4394; ISSAD T, 1995, EUR J BIOCHEM, V234, P108, DOI 10.1111/j.1432-1033.1995.108_c.x; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kanwal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069150; KAREY KP, 1988, CANCER RES, V48, P4083; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Lahlou N, 2002, DIABETES, V51, P1980, DOI 10.2337/diabetes.51.6.1980; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Mayer Doris, 2010, Archives of Physiology and Biochemistry, V116, P73, DOI 10.3109/13813451003631439; Merlin JL, 2002, ANN ONCOL, V13, P1743, DOI 10.1093/annonc/mdf263; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; MILAZZO G, 1992, CANCER RES, V52, P3924; Moses SA, 2009, CANCER RES, V69, P5073, DOI 10.1158/0008-5472.CAN-08-3839; Nouaille S, 2006, EMBO REP, V7, P512, DOI 10.1038/sj.embor.7400668; Panasiti V, 2011, J AM ACAD DERMATOL, V64, P865, DOI 10.1016/j.jaad.2010.03.035; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Patil N, 2012, BIOL-TARGETS THER, V6, P221, DOI 10.2147/BTT.S24217; Pierre-Eugene C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041992; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak MN, 1998, BREAST CANCER RES TR, V47, P209, DOI 10.1023/A:1005950916707; ROOS W, 1986, P NATL ACAD SCI USA, V83, P991, DOI 10.1073/pnas.83.4.991; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1993, BIOCHEM J, V290, P419, DOI 10.1042/bj2900419; Stephen RL, 2001, J BIOL CHEM, V276, P40080, DOI 10.1074/jbc.M105892200; SYMONS JA, 1991, J EXP MED, V174, P1251, DOI 10.1084/jem.174.5.1251; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Toyoshima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1745; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; Zhang Y, 1996, EXP EYE RES, V63, P265, DOI 10.1006/exer.1996.0115	61	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92737	10.1371/journal.pone.0092737	http://dx.doi.org/10.1371/journal.pone.0092737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647478	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500154
J	Liu, DH; Wei, LL; Guo, T; Tan, WF				Liu, Donghua; Wei, Lili; Guo, Ting; Tan, Weifen			Detection of DOPA-Melanin in the Dimorphic Fungal Pathogen Penicillium marneffei and Its Effect on Macrophage Phagocytosis In Vitro	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FONSECAEA-PEDROSOI; PARACOCCIDIOIDES-BRASILIENSIS; INFECTION; MELANIZATION; GENE; SUSCEPTIBILITY; BIOSYNTHESIS; TYROSINASE; RESISTANCE	The fungal pathogen Penicillium marneffei produces melanin-like pigment in vitro. The synthetic pathway of melanin and its possible influence in the protective yeast cells surviving within macrophage cells are not known. In this work, P. marneffei produced brown black pigment in the presence of L-DOPA and black particles were extracted from yeast cells treated with proteolytic enzymes, denaturant and concentrated hot acid. Kojic acid inhibited the brown-black pigment production of P. marneffei yeast grown on brain heart infusion agar. Transmitting electron microscopy showed spherical granular electron-dense particles with an average diameter of 100 nm in a beaded arrangement in the innermost cell wall. Electron-paramagnetic resonance revealed that the black particles contain a stable free radical compound. The UV-visible and Fourier transform infrared spectra of particles extracted from P. marneffei and synthetic DOPA-melanin showed a high degree of similarity. Melanized yeast cells decreased phagocytosis by macrophage cells and increased resistance to intracellular digestion in vitro. These results indicate that P. marneffei can synthesize DOPA-melanin or melanin-like compounds in vitro and suggest that the DOPA-melanin pathway is associated with cell wall structure and enhances the resistance to phagocytosis by macrophages.	[Liu, Donghua; Wei, Lili; Guo, Ting; Tan, Weifen] Guangxi Med Univ, Dept Dermatol & Venereol, Affiliated Hosp 1, Nanning, Peoples R China	Guangxi Medical University	Liu, DH (corresponding author), Guangxi Med Univ, Dept Dermatol & Venereol, Affiliated Hosp 1, Nanning, Peoples R China.	ldhgxmu@163.com	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		National Natural Science Foundation of China [81160191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81160191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Paes R, 2009, MICROBES INFECT, V11, P554, DOI 10.1016/j.micinf.2009.03.002; Cao CW, 2011, EMERG INFECT DIS, V17, P209, DOI 10.3201/eid1702.100718; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Franzen AJ, 2008, J STRUCT BIOL, V162, P75, DOI 10.1016/j.jsb.2007.11.004; Franzen AJ, 2006, MICROSC RES TECHNIQ, V69, P729, DOI 10.1002/jemt.20344; Gomez BL, 2001, INFECT IMMUN, V69, P5760, DOI 10.1128/IAI.69.9.5760-5767.2001; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; Kahn V, 1995, PIGM CELL RES, V8, P234, DOI 10.1111/j.1600-0749.1995.tb00669.x; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Liu DH, 2011, MYCOSES, V54, P113, DOI 10.1111/j.1439-0507.2009.01786.x; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 2004, FEMS MICROBIOL LETT, V239, P187, DOI 10.1016/j.femsle.2004.08.040; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Pal AK, 2013, MED MYCOL IN PRESS; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Rosas AL, 2001, MYCOPATHOLOGIA, V151, P53, DOI 10.1023/A:1010977107089; Sajjan S, 2010, J MICROBIOL BIOTECHN, V20, P1513, DOI 10.4014/jmb.1002.02006; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Thirach S, 2007, MED MYCOL, V45, P409, DOI 10.1080/13693780701381271; Ustianowski AP, 2008, CURR OPIN INFECT DIS, V21, P31, DOI 10.1097/QCO.0b013e3282f406ae; Volling K, 2011, CELL MICROBIOL, V13, P1130, DOI 10.1111/j.1462-5822.2011.01605.x; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0; Youngchim S, 1999, MED MYCOL, V37, P445, DOI 10.1046/j.1365-280X.1999.00235.x; Youngchim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063764; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	35	28	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92610	10.1371/journal.pone.0092610	http://dx.doi.org/10.1371/journal.pone.0092610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647795	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500148
J	Zhao, TT; Zhang, HJ; Lu, XG; Huang, XR; Zhang, WK; Wang, H; Lan, HY; Li, P				Zhao, Ting Ting; Zhang, Hao Jun; Lu, Xiao Guang; Huang, Xiao Ru; Zhang, Wei Ku; Wang, Hua; Lan, Hui Yao; Li, Ping			Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-beta/Smad3 Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; RENAL FIBROSIS; DIVERSE ROLES; NEPHROPATHY; RECEPTOR; MICRORNA; SMAD3; INFLAMMATION; ACTIVATION	Objective: Increasing evidence shows that TGF-beta 1 is a key mediator in diabetic nephropathy (DN) and induces renal fibrosis positively by Smad3 but negatively by Smad7. However, treatment of DN by blocking the TGF-beta/Smad pathway remains limited. The present study investigated the anti-fibrotic effect of a traditional Chinese medicine, Chaihuang-Yishen granule (CHYS), on DN. Research Design and Methods: Protective role of CHYS in DN was examined in an accelerated type 1 DN induced by streptozotocin in uninephrectomized Wistar rats. CHYS, at a dose of 0.56 g/kg body weight, was administered by a daily gastric gavage for 20 weeks and the therapeutic effect and potential mechanisms of CHYS on diabetic kidney injury were examined. Results: Treatment with CHYS attenuated diabetic kidney injury by significantly inhibiting 24-h proteinuria and progressive renal fibrosis including glomerulosclerotic index, tubulointerstitial fibrosis index, and upregulation of extracellular matrix (collagen I, IV, and fibronectin), despite the same levels of blood glucose. Further studies revealed that inhibition of renal fibrosis in CHYS-treated diabetic rats was associated with inhibition of TGF-beta 1/Smad3 signaling as demonstrated by upregulation of Smad7 but downregulation of TGF-beta 1, TGF-beta receptors, activation of Smad3, and expression of miRNA-21. Conclusions: CHYS may be a therapeutic agent for DN. CHYS attenuates DN by blocking TGF-beta/Smad3-mediated renal fibrosis.	[Zhao, Ting Ting; Zhang, Hao Jun; Lu, Xiao Guang; Zhang, Wei Ku; Wang, Hua; Li, Ping] China Japan Friendship Hosp, Inst Clin Med Sci, Dept Pharmacol, Beijing, Peoples R China; [Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao Ru; Lan, Hui Yao] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China	China-Japan Friendship Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong	Lan, HY (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	hylan@cuhk.edu.hk; lp8675@163.com	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755	National Natural Scientific Foundation of China [30973911, 81173422]; International S&T Cooperation Program of China [2011DFA31860]; Municipal Science and Technology R & D funding of basic research, Shenzhen [JC201104220290A]; Research Grant Council of Hong Kong [CUHK5/CRF/09, CUHK3/CRF/12R]; Focused Investment Scheme A and B from the Chinese University of Hong Kong	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; Municipal Science and Technology R & D funding of basic research, Shenzhen; Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Focused Investment Scheme A and B from the Chinese University of Hong Kong	This work was supported by the National Natural Scientific Foundation of China [grant number: 30973911, 81173422 to PL]; International S&T Cooperation Program of China [grant number: 2011DFA31860 to PL]; Municipal Science and Technology R & D funding of basic research, Shenzhen (Major Program JC201104220290A to HYL); the Research Grant Council of Hong Kong (CUHK5/CRF/09 and CUHK3/CRF/12R to HYL); and the Focused Investment Scheme A and B from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Critchley JAJH, 2002, CHINESE MED J-PEKING, V115, P129; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hong SW, 2001, AM J PATHOL, V158, P1653; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang CM, 2002, DIABETES, V51, P3577, DOI 10.2337/diabetes.51.12.3577; Huang XR, 2008, J AM SOC NEPHROL, V19, P233, DOI 10.1681/ASN.2007040484; International Diabetes Federation, 2013, COMPL DIAB; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Li P, 2007, NEPHROLOGY, V12, P466, DOI 10.1111/j.1440-1797.2007.00828.x; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Patel V, 2012, CURR OPIN NEPHROL HY, V21, P410, DOI 10.1097/MNH.0b013e328354e559; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhang HT, 2011, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2011-69; Zhao T, 2012, J PHARMACEUT BIOMED, V60, P32, DOI 10.1016/j.jpba.2011.11.010; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	38	51	60	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90807	10.1371/journal.pone.0090807	http://dx.doi.org/10.1371/journal.pone.0090807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646636	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500017
J	Doneva, SP; Cole, GG				Doneva, Silviya P.; Cole, Geoff G.			The Role of Attention in a Joint-Action Effect	PLOS ONE			English	Article							ACTION CO-REPRESENTATION; INFLUENCE FREDS ACTION; SELECTIVE ATTENTION; MIRROR NEURONS; INHIBITION; RETURN; TASK; APPEARANCE; PERCEPTION; EXECUTION	The most common explanation for joint-action effects has been the action co-representation account in which observation of another's action is represented within one's own action system. However, recent evidence has shown that the most prominent of these joint-action effects (i.e., the Social Simon effect), can occur when no co-actor is present. In the current work we examined whether another joint-action phenomenon (a movement congruency effect) can be induced when a participant performs their part of the task with a different effector to that of their co-actor and when a co-actor's action is replaced by an attention-capturing luminance signal. Contrary to what is predicted by the action co-representation account, results show that the basic movement congruency effect occurred in both situations. These findings challenge the action co-representation account of this particular effect and suggest instead that it is driven by bottom-up mechanisms.	[Doneva, Silviya P.; Cole, Geoff G.] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England	University of Essex	Doneva, SP (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.	sdoneva@essex.ac.uk						Atmaca S, 2008, SOC NEUROSCI-UK, V3, P410, DOI 10.1080/17470910801900908; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Cole GG, 2012, PSYCHOL RES-PSYCH FO, V76, P736, DOI 10.1007/s00426-011-0395-7; Cole GG, 2010, Q J EXP PSYCHOL, V63, P147, DOI 10.1080/17470210902853522; Cole GG, 2009, VIS COGN, V17, P755, DOI 10.1080/13506280802611582; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dolk T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00084; Fine JM, 2013, J EXP PSYCHOL HUMAN, V39, P1541, DOI 10.1037/a0031953; Fine JM, 2011, EXP BRAIN RES, V211, P459, DOI 10.1007/s00221-011-2707-y; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frischen A, 2009, COGNITION, V111, P212, DOI 10.1016/j.cognition.2009.02.003; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Hayes SJ, 2010, PSYCHOL RES-PSYCH FO, V74, P302, DOI 10.1007/s00426-009-0250-2; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; Hommel B, 1996, Q J EXP PSYCHOL-A, V49, P546, DOI 10.1080/027249896392496; Hommel B, 2009, PSYCHOL SCI, V20, P794, DOI 10.1111/j.1467-9280.2009.02367.x; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Kingstone A, 1999, PERCEPT PSYCHOPHYS, V61, P1046, DOI 10.3758/BF03207612; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lepsien J, 2002, J COGNITIVE NEUROSCI, V14, P127, DOI 10.1162/089892902317236795; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liepelt R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00086; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Mayer AR, 2004, NEUROIMAGE, V23, P534, DOI 10.1016/j.neuroimage.2004.06.027; Mayer AR, 2004, J COGNITIVE NEUROSCI, V16, P1262, DOI 10.1162/0898929041920531; Muller NG, 2007, J COGNITIVE NEUROSCI, V19, P587, DOI 10.1162/jocn.2007.19.4.587; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Muller BCN, 2011, NEUROPSYCHOLOGIA, V49, P1373, DOI 10.1016/j.neuropsychologia.2011.01.022; Ondobaka S, 2012, PSYCHOL SCI, V23, P30, DOI 10.1177/0956797611424163; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Prime DJ, 2006, BRAIN RES, V1072, P161, DOI 10.1016/j.brainres.2005.11.081; Prime DJ, 2004, PSYCHOL SCI, V15, P272, DOI 10.1111/j.0956-7976.2004.00665.x; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; Richardson MJ, 2009, NEUROSCI LETT, V449, P117, DOI 10.1016/j.neulet.2008.10.092; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Romero V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044761; Ruz M., 2002, PSICOLOGICA, V23, P283, DOI DOI 10.1080/09084282.2010.547774; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Skarratt PA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00196; Skarratt PA, 2010, ACTA PSYCHOL, V134, P48, DOI 10.1016/j.actpsy.2009.12.003; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Van der Lubbe RHJ, 2005, J COGNITIVE NEUROSCI, V17, P1829, DOI 10.1162/089892905775008634; Vlainic E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00208; Wascher E, 2004, PSYCHOPHYSIOLOGY, V41, P716, DOI 10.1111/j.1469-8986.2004.00198.x; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Welsh TN, 2007, PSYCHON B REV, V14, P950, DOI 10.3758/BF03194127; Welsh TN, 2009, BRAIN COGNITION, V71, P64, DOI 10.1016/j.bandc.2009.04.001; Welsh TN, 2009, BRAIN RES, V1248, P141, DOI 10.1016/j.brainres.2008.10.077; Welsh TN, 2005, NEUROSCI LETT, V385, P99, DOI 10.1016/j.neulet.2005.05.013; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	62	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91336	10.1371/journal.pone.0091336	http://dx.doi.org/10.1371/journal.pone.0091336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24642806	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000333259900019
J	Mountzios, G; Aivazi, D; Kostopoulos, I; Kourea, HP; Kouvatseas, G; Timotheadou, E; Zebekakis, P; Efstratiou, I; Gogas, H; Vamvouka, C; Chrisafi, S; Stofas, A; Pentheroudakis, G; Koutras, A; Galani, E; Bafaloukos, D; Fountzilas, G				Mountzios, Giannis; Aivazi, Dimitra; Kostopoulos, Ioannis; Kourea, Helen P.; Kouvatseas, George; Timotheadou, Eleni; Zebekakis, Pantelis; Efstratiou, Ioannis; Gogas, Helen; Vamvouka, Chrisanthi; Chrisafi, Sofia; Stofas, Anastasios; Pentheroudakis, George; Koutras, Angelos; Galani, Eleni; Bafaloukos, Dimitrios; Fountzilas, George			Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes	PLOS ONE			English	Article							FACTOR-I RECEPTOR; THERAPEUTIC TARGET; PHASE-III; RISK; SURVIVAL; IGF-1; CELLS; IGF1R; ASSOCIATION; EPIRUBICIN	Introduction: We sought to determine the level of protein expression of the critical components of the insulin-like growth factor receptor (IGFR) pathway and to evaluate their prognostic significance across the different early breast cancer subtypes. Patients and Methods: Archival tumor tissue from 1,021 women with early, node positive breast cancer, who were prospectively evaluated within two randomized clinical trials, was used to construct tissue microarrays that were stained for hormone receptors (HR), Ki67, HER2, epidermal growth factor receptor (EGFR) and cytokeratins 5/6, to classify tumors into five immunophenotypical subgroups. Immunohistochemical (IHC) expression of IGF1R-alpha and beta subunits, IGF2R and IGF-binding protein 2 (IGFBP2) was assessed using the immunoreactive score (IRS). Repeated internal cross-validation was performed to examine the statistical validity of the cut off points for all biomarkers. Results: After a median follow-up time of 105.4 months, overall 370 women (36.2%) had relapsed and 270 (26.4%) had died. Tumors expressing IGF1R-alpha above the median IRS were significantly more frequently HR positive (luminal A+B+HER2), as compared to HER2-enriched and triple negative ones (p<0.001 for both comparisons). IGF2R was overexpressed significantly more frequently in HR negative tumors (p = 0.001) and had an inverse correlation with all other biomarkers. Patients with luminal A and B tumors with high IGF1R-alpha and negative EGFR expression (N = 190) had significantly higher 4-year survival rates, as compared to the rest (log-rank p = 0.046), as did patients with luminal A and B tumors with high IGF1R-alpha and low IGF2R expression, as compared to the rest (N = 91), (log-rank p = 0.035). After adjustment for significant variables, patients in the latter group had a relative 45% reduction in the risk of death, as compared to the rest (p = 0.035). Conclusion: Aberrant expression of components of the IGF1R pathway is associated with better clinical outcomes in women with luminal A and B, node positive, early breast cancer.	[Mountzios, Giannis] 251 Airforce Gen Hosp, Dept Med Oncol, Athens, Greece; [Aivazi, Dimitra; Chrisafi, Sofia; Fountzilas, George] Aristotle Univ Thessaloniki, Mol Oncol Lab, Sch Med, Hellen Fdn Canc Res, GR-54006 Thessaloniki, Greece; [Kostopoulos, Ioannis] Aristotle Univ Thessaloniki, Dept Pathol, Sch Med, GR-54006 Thessaloniki, Greece; [Kourea, Helen P.] Univ Hosp Patras, Dept Pathol, Rion, Greece; [Kouvatseas, George] Hlth Data Specialists Ltd, Athens, Greece; [Timotheadou, Eleni; Fountzilas, George] Aristotle Univ Thessaloniki, Dept Med Oncol, Sch Med, Papageorgiou Hosp, GR-54006 Thessaloniki, Greece; [Zebekakis, Pantelis] Aristotle Univ Thessaloniki, Dept Internal Med 1, Sch Med, AHEPA Hosp, GR-54006 Thessaloniki, Greece; [Efstratiou, Ioannis] Papageorgiou Hosp, Dept Pathol, Thessaloniki, Greece; [Gogas, Helen] Univ Athens, Sch Med, Dept Med 1, Laiko Gen Hosp, GR-11527 Athens, Greece; [Vamvouka, Chrisanthi] Evangelismos Med Ctr, Dept Pathol, Athens, Greece; [Stofas, Anastasios] Natl & Kapodistrian Univ Athens, Dept Pathol, Athens 11528, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Koutras, Angelos] Univ Patras, Sch Med, Dept Med, Div Oncol,Univ Hosp, GR-26110 Patras, Greece; [Galani, Eleni] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Bafaloukos, Dimitrios] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University of Patras; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Ahepa University Hospital; Papageorgiou Hospital; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Evangelismos Hospital; National & Kapodistrian University of Athens; University Hospital Ioannina; University of Patras	Mountzios, G (corresponding author), 251 Airforce Gen Hosp, Dept Med Oncol, Athens, Greece.	gmountzios@gmail.com	TIMOTHEADOU, ELENI/AAM-6301-2020; Fountzilas, George/ABF-2139-2020; Mountzios, Giannis/ABE-1197-2020; Chrisafi, Sofia/AAH-2823-2020	Fountzilas, George/0000-0001-8045-2186	internal Hellenic Co-operative Oncology Group (HeCOG) research grant [HE R_10/10]	internal Hellenic Co-operative Oncology Group (HeCOG) research grant	The study did not have any external funding. The study was supported in part by an internal Hellenic Co-operative Oncology Group (HeCOG) research grant (HE R_10/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNETERRE J, 1990, CANCER RES, V50, P6931; Browne BC, 2012, BREAST CANCER RES TR, V136, P717, DOI 10.1007/s10549-012-2260-9; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Diallo-Danebrock R, 2007, CLIN CANCER RES, V13, P488, DOI 10.1158/1078-0432.CCR-06-1842; Doyle SL, 2012, AM J GASTROENTEROL, V107, P196, DOI 10.1038/ajg.2011.417; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037946; Franks SE, 2012, ONCOGENE, V31, P3298, DOI 10.1038/onc.2011.486; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Gallicchio L, 2013, J CANCER RES CLIN, V139, P837, DOI 10.1007/s00432-013-1391-7; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hartog H, 2012, ANTICANCER RES, V32, P1309; Hermani A, 2013, CELL SIGNAL, V25, P1395, DOI 10.1016/j.cellsig.2013.02.018; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Kim JS, 2012, CANCER-AM CANCER SOC, V118, P2454, DOI 10.1002/cncr.26492; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Lin MZ, 2014, ONCOGENE, V33, P85, DOI 10.1038/onc.2012.538; Llanos AA, 2013, BREAST CANCER RES TR, V138, P571, DOI 10.1007/s10549-013-2452-y; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; Martin EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049067; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Mountzios G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054048; Muendlein A, 2013, J CANCER RES CLIN, V139, P491, DOI 10.1007/s00432-012-1355-3; Nahta Rita, 2012, Chemother Res Pract, V2012, P648965, DOI 10.1155/2012/648965; Nielsen TO, 2004, CANCER RES, V64, P286, DOI 10.1158/0008-5472.CAN-03-1242; PAPA V, 1993, CANCER RES, V53, P3736; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; RAILO MJ, 1994, EUR J CANCER, V30A, P307, DOI 10.1016/0959-8049(94)90247-X; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Shimizu C, 2004, HUM PATHOL, V35, P1537, DOI 10.1016/j.humpath.2004.09.005; Shin AS, 2007, BREAST CANCER RES TR, V105, P55, DOI 10.1007/s10549-006-9427-1; Soria JC, 2013, EUR J CANCER, V49, P1799, DOI 10.1016/j.ejca.2013.01.003; Ueda S, 2006, CANCER SCI, V97, P597, DOI 10.1111/j.1349-7006.2006.00228.x; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Warner E, 2011, NEW ENGL J MED, V365, P1025, DOI 10.1056/NEJMcp1101540; Werner H, 2012, LANCET ONCOL, V13, pE537, DOI 10.1016/S1470-2045(12)70362-5; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8	48	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91407	10.1371/journal.pone.0091407	http://dx.doi.org/10.1371/journal.pone.0091407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637962	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100032
J	Polzin, K; Rokas, A				Polzin, Kenneth; Rokas, Antonis			Evaluating Rare Amino Acid Substitutions (RGC_CAMs) in a Yeast Model Clade	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; REPLACEMENTS; PHYLOGENETICS; COELOMATA; SEQUENCES; HOMOPLASY; EVOLUTION; ANIMALS; GENUS	When inferring phylogenetic relationships, not all sites in a sequence alignment are equally informative. One recently proposed approach that takes advantage of this inequality relies on sites that contain amino acids whose replacement requires multiple substitutions. Identifying these so-called RGC_CAM substitutions (after Rare Genomic Changes as Conserved Amino acids-Multiple substitutions) requires that, first, at any given site in the amino acid sequence alignment, there must be a minimum of two different amino acids; second, each amino acid must be present in at least two taxa; and third, the amino acids must require a minimum of two nucleotide substitutions to replace each other. Although theory suggests that RGC_CAM substitutions are expected to be rare and less likely to be homoplastic, the informativeness of RGC_CAM substitutions has not been extensively evaluated in biological data sets. We investigated the quality of RGC_CAM substitutions by examining their degree of homoplasy and internode certainty in nearly 2.7 million aligned amino acid sites from 5,261 proteins from five species belonging to the yeast Saccharomyces sensu stricto clade whose phylogeny is well-established. We identified 2,647 sites containing RGC_CAM substitutions, a number that contrasts sharply with the 100,887 sites containing RGC_non-CAM substitutions (i.e., changes between amino acids that require only a single nucleotide substitution). We found that RGC_CAM substitutions had significantly lower homoplasy than RGC_non-CAM ones; specifically RGC_CAM substitutions showed a per-site average homoplasy index of 0.100, whereas RGC_non-CAM substitutions had a homoplasy index of 0.215. Internode certainty values were also higher for sites containing RGC_CAM substitutions than for RGC_non-CAM ones. These results suggest that RGC_ CAM substitutions possess a strong phylogenetic signal and are useful markers for phylogenetic inference despite their rarity.	[Polzin, Kenneth; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Rokas, A (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	Graduate Program in Biological Sciences at Vanderbilt University; National Science Foundation [DEB-0844968]	Graduate Program in Biological Sciences at Vanderbilt University; National Science Foundation(National Science Foundation (NSF))	KP was funded by the Graduate Program in Biological Sciences at Vanderbilt University. Research in AR's laboratory is supported by the National Science Foundation (DEB-0844968). This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Cracraft J., 2004, ASSEMBLING TREE LIFE; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hittinger CT, 2013, TRENDS GENET, V29, P309, DOI 10.1016/j.tig.2013.01.002; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Kitching I. J., 1998, CLADISTICS THEORY PR; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Rogozin IB, 2007, MOL BIOL EVOL, V24, P2594, DOI 10.1093/molbev/msm218; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rokas A, 1999, INSECT MOL BIOL, V8, P527, DOI 10.1046/j.1365-2583.1999.00149.x; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Salichos L, 2014, MOL BIOL EV IN PRESS; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92213	10.1371/journal.pone.0092213	http://dx.doi.org/10.1371/journal.pone.0092213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637883	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100128
J	Sukackaite, R; Jensen, MR; Mas, PJ; Blackledge, M; Buonomo, SB; Hart, DJ				Sukackaite, Rasa; Jensen, Malene Ringkjobing; Mas, Philippe J.; Blackledge, Martin; Buonomo, Sara B.; Hart, Darren J.			Structural and Biophysical Characterization of Murine Rif1 C Terminus Reveals High Specificity for DNA Cruciform Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Directed Evolution; DNA Replication; Intrinsically Disordered Proteins; NMR	SUSCEPTIBILITY PROTEIN BRCA1; AMINO-ACID-SEQUENCE; NUCLEAR-MATRIX; ENERGY CONTENT; END RESECTION; WEB SERVER; REPLICATION; BINDING; REPAIR; REGIONS	Background: Mammalian Rif1 is a regulator of DNA replication timing and repair. Results: We characterized DNA binding by Rif1 C terminus and identified the critical residues. Conclusion: Rif1 shows a highly selective binding of DNA cruciform structures. Significance: This is a step forward in the understanding of Rif1 functions. Mammalian Rif1 is a key regulator of DNA replication timing, double-stranded DNA break repair, and replication fork restart. Dissecting the molecular functions of Rif1 is essential to understand how it regulates such diverse processes. However, Rif1 is a large protein that lacks well defined functional domains and is predicted to be largely intrinsically disordered; these features have hampered recombinant expression of Rif1 and subsequent functional characterization. Here we applied ESPRIT (expression of soluble proteins by random incremental truncation), an in vitro evolution-like approach, to identify high yielding soluble fragments encompassing conserved regions I and II (CRI and CRII) at the C-terminal region of murine Rif1. NMR analysis showed CRI to be intrinsically disordered, whereas CRII is partially folded. CRII binds cruciform DNA with high selectivity and micromolar affinity and thus represents a functional DNA binding domain. Mutational analysis revealed an -helical region of CRII to be important for cruciform DNA binding and identified critical residues. Thus, we present the first structural study of the mammalian Rif1, identifying a domain that directly links its function to DNA binding. The high specificity of Rif1 for cruciform structures is significant given the role of this key protein in regulating origin firing and DNA repair.	[Sukackaite, Rasa; Mas, Philippe J.; Hart, Darren J.] European Mol Biol Lab, Grenoble Outstat, F-38042 Grenoble, France; [Sukackaite, Rasa; Mas, Philippe J.; Hart, Darren J.] Univ Grenoble Alpes, Unit Virus Host Cell Interact, EMBL, CNRS, F-38042 Grenoble, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] Univ Grenoble Alpes, Inst Biol Struct IBS, F-38027 Grenoble, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] IBS, CEA, DSV, F-38027 Grenoble, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] CNRS, IBS, F-38027 Grenoble, France; [Sukackaite, Rasa; Buonomo, Sara B.] European Mol Biol Lab, Monterotondo Outstat, I-00015 Monterotondo, Italy	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL)	Buonomo, SB (corresponding author), European Mol Biol Lab, Monterotondo Outstat, Adriano Buzzati Traverso Campus,Via Ramarini 32, I-00015 Monterotondo, Italy.	sara.buonomo@embl.it; hart@embl.fr	; Hart, Darren/C-4858-2015	Buonomo, Sara/0000-0002-0177-2884; Hart, Darren/0000-0002-3502-2002; Jensen, Malene R./0000-0003-0419-2196; Mas, Philippe/0000-0002-8060-0289	EMBL Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions COFUND [229597]; French Agence Nationale de la Recherche (ANR) through ANR JCJC Protein Disorder; ANR MALZ TAUSTRUCT; TGIR-RMN-THC [FR3050 CNRS]	EMBL Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions COFUND; French Agence Nationale de la Recherche (ANR) through ANR JCJC Protein Disorder(French National Research Agency (ANR)); ANR MALZ TAUSTRUCT(French National Research Agency (ANR)); TGIR-RMN-THC	This work was supported by an EMBL Interdisciplinary Postdoc (EIPOD) under Marie Curie Actions COFUND (229597) (to R. S.). This work was also supported by the French Agence Nationale de la Recherche (ANR) through ANR JCJC Protein Disorder (to M.R.J.); ANR MALZ TAUSTRUCT (to M. B); and TGIR-RMN-THC FR3050 CNRS. D.J.H. is an inventor on an EMBL patent for the ESPRIT technology used to express Rif1 fragments.	Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Assenberg R, 2008, BIOCHEM J, V411, P553, DOI 10.1042/BJ20071613; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Rivera-Mulia JC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-3; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; Grasser KD, 1998, EUR J BIOCHEM, V253, P787, DOI 10.1046/j.1432-1327.1998.2530787.x; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hart DJ, 2013, CURR OPIN STRUC BIOL, V23, P403, DOI 10.1016/j.sbi.2013.03.004; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Karsten R., 1997, BIF FUTURA, V12, P20; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Naseem R, 2006, BIOCHEM J, V395, P529, DOI 10.1042/BJ20051646; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Scheich C, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-12; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sreesankar E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-255; Sturdy A, 2004, J MOL BIOL, V340, P469, DOI 10.1016/j.jmb.2004.05.005; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yumerefendi H, 2010, J STRUCT BIOL, V172, P66, DOI 10.1016/j.jsb.2010.02.021; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	41	24	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13903	13911		10.1074/jbc.M114.557843	http://dx.doi.org/10.1074/jbc.M114.557843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24634216	hybrid, Green Published			2022-12-25	WOS:000335984600022
J	Calinescu, O; Paulino, C; Kuhlbrandt, W; Fendler, K				Calinescu, Octavian; Paulino, Cristina; Kuehlbrandt, Werner; Fendler, Klaus			Keeping It Simple, Transport Mechanism and pH Regulation in Na (+)/H (+) Exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Electrophysiology; Membrane Transport; pH Regulation; Sodium Proton Exchange; EcNhaA; MjNhaP1; Cation Proton Antiporter; Solid Supported Membrane	NA+/H+ ANTIPORTER; METHANOCOCCUS-JANNASCHII; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; MEMBRANE; RESIDUES; BINDING; MODELS; NHAA; NHE1	Background: Na+/H+ exchangers have a pronounced pH dependence previously explained by pH sensors. Results: Electrophysiological investigation of NhaP1 from Methanocaldococcus jannaschii (MjNhaP1), a prototype of electroneutral Na+/H+ exchangers, allowed its kinetic characterization. Conclusion: The pH dependence of Na+/H+ exchangers is an inherent property of their transport mechanism. Significance: The proposed mechanism of transport and pH regulation applies to all Na+/H+ exchangers. Na+/H+ exchangers are essential for regulation of intracellular proton and sodium concentrations in all living organisms. We examined and experimentally verified a kinetic model for Na+/H+ exchangers, where a single binding site is alternatively occupied by Na+ or one or two H+ ions. The proposed transport mechanism inherently down-regulates Na+/H+ exchangers at extreme pH, preventing excessive cytoplasmic acidification or alkalinization. As an experimental test system we present the first electrophysiological investigation of an electroneutral Na+/H+ exchanger, NhaP1 from Methanocaldococcus jannaschii (MjNhaP1), a close homologue of the medically important eukaryotic NHE Na+/H+ exchangers. The kinetic model describes the experimentally observed substrate dependences of MjNhaP1, and the transport mechanism explains alkaline down-regulation of MjNhaP1. Because this model also accounts for acidic down-regulation of the electrogenic NhaA Na+/H+ exchanger from Escherichia coli (EcNhaA, shown in a previous publication) we conclude that it applies generally to all Na+/H+ exchangers, electrogenic as well as electroneutral, and elegantly explains their pH regulation. Furthermore, the electrophysiological analysis allows insight into the electrostatic structure of the translocation complex in electroneutral and electrogenic Na+/H+ exchangers.	[Calinescu, Octavian; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Paulino, Cristina; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society; Max Planck Society	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Max von Laue Str 3, D-60438 Frankfurt, Germany.	klaus.fendler@biophys.mpg.de	Paulino, Cristina/ABB-7205-2021; Paulino, Cristina/A-2192-2016; Calinescu, Octavian/P-4278-2014	Paulino, Cristina/0000-0001-7017-109X; Paulino, Cristina/0000-0001-7017-109X; Calinescu, Octavian/0000-0001-8003-0442; Kuhlbrandt, Werner/0000-0002-2013-4810; Fendler, Klaus/0000-0002-5699-7060	Deutsche Forschungsgemeinschaft [SFB 807]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 807.	Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Garcia-Celma JJ, 2007, LANGMUIR, V23, P10074, DOI 10.1021/la701188f; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; Hellmer J, 2003, FEBS LETT, V542, P32, DOI 10.1016/S0014-5793(03)00332-6; Hellmer J, 2002, FEBS LETT, V527, P245, DOI 10.1016/S0014-5793(02)03244-1; Hisamitsu T, 2007, FEBS J, V274, P4326, DOI 10.1111/j.1742-4658.2007.05962.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Klingenberg M, 2005, BIOCHEMISTRY-US, V44, P8563, DOI 10.1021/bi050543r; KLINGENBERG M, 1992, STUDY ENZYMES, P367; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; STEIN WD, 1977, MOL CELL BIOCHEM, V15, P27, DOI 10.1007/BF01731287; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200	23	29	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13168	13176		10.1074/jbc.M113.542993	http://dx.doi.org/10.1074/jbc.M113.542993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24644283	hybrid, Green Published			2022-12-25	WOS:000335522800018
J	Haraguchi, T; Tominaga, M; Matsumoto, R; Sato, K; Nakano, A; Yamamoto, K; Ito, K				Haraguchi, Takeshi; Tominaga, Motoki; Matsumoto, Rie; Sato, Kei; Nakano, Akihiko; Yamamoto, Keiichi; Ito, Kohji			Molecular Characterization and Subcellular Localization of Arabidopsis Class VIII Myosin, ATM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arabidopsis; ATPases; Kinetics; Molecular Motors; Myosin	INTRACELLULAR FREE MG2+; DUTY RATIO MOTOR; SMOOTH-MUSCLE; KINETIC MECHANISM; FLUORESCENT INDICATOR; PLANT MYOSIN; 2ND-MESSENGER ROLE; ADP DISSOCIATION; SKELETAL-MUSCLE; ATP HYDROLYSIS	Background: Molecular properties of class VIII myosin are not characterized. Results:Arabidopsis class VIII myosin, ATM1, has low enzymatic activity and high affinity for actin and is primarily localized at the cell cortex. Conclusion: Our data suggest that ATM1 functions as a tension sensor/generator. Significance: This is the first report of enzymatic and motile properties of class VIII myosin. Land plants possess myosin classes VIII and XI. Although some information is available on the molecular properties of class XI myosins, class VIII myosins are not characterized. Here, we report the first analysis of the enzymatic properties of class VIII myosin. The motor domain of Arabidopsis class VIII myosin, ATM1 (ATM1-MD), and the motor domain plus one IQ motif (ATM1-1IQ) were expressed in a baculovirus system and characterized. ATM1-MD and ATM1-1IQ had low actin-activated Mg2+-ATPase activity (V-max = 4 s(-1)), although their affinities for actin were high (K-actin = 4 m). The actin-sliding velocities of ATM1-MD and ATM1-1IQ were 0.02 and 0.089 m/s, respectively, from which the value for full-length ATM1 is calculated to be approximate to 0.2 m/s. The results of actin co-sedimentation assay showed that the duty ratio of ATM1 was approximate to 90%. ADP dissociation from the actinATM1 complex (acto-ATM1) was extremely slow, which accounts for the low actin-sliding velocity, low actin-activated ATPase activity, and high duty ratio. The rate of ADP dissociation from acto-ATM1 was markedly biphasic with fast and slow phase rates (5.1 and 0.41 s(-1), respectively). Physiological concentrations of free Mg2+ modulated actin-sliding velocity and actin-activated ATPase activity by changing the rate of ADP dissociation from acto-ATM1. GFP-fused full-length ATM1 expressed in Arabidopsis was localized to plasmodesmata, plastids, newly formed cell walls, and actin filaments at the cell cortex. Our results suggest that ATM1 functions as a tension sensor/generator at the cell cortex and other structures in Arabidopsis.	[Haraguchi, Takeshi; Matsumoto, Rie; Yamamoto, Keiichi; Ito, Kohji] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; [Tominaga, Motoki; Nakano, Akihiko] RIKEN, Ctr Adv Photon, Live Cell Mol Imaging Res Team, Wako, Saitama 3510198, Japan; [Tominaga, Motoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sato, Kei; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Chiba University; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Ito, K (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan.	k-ito@faculty.chiba-u.jp	Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014; Ito, Kohji/K-8441-2017	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Ito, Kohji/0000-0001-9573-432X; Haraguchi, Takeshi/0000-0001-7542-1473	Japan Society for the Promotion of Science KAKENHI [21570159, 20001009, 23770060]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 21570159, 20001009, and 23770060.	ALTURA BM, 1993, EUR J PHARM-MOLEC PH, V246, P299, DOI 10.1016/0922-4106(93)90046-C; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Avisar D, 2008, J VIROL, V82, P2836, DOI 10.1128/JVI.02246-07; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; DAI LJ, 1992, AM J PHYSIOL, V262, pF1100; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Delva P, 2004, J MEMBRANE BIOL, V199, P163, DOI 10.1007/s00232-004-0686-7; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; GOLDSTEIN DA, 1979, BIOPHYS J, V26, P235, DOI 10.1016/S0006-3495(79)85247-9; Golomb L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-3; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hachikubo Y, 2007, PLANT CELL PHYSIOL, V48, P886, DOI 10.1093/pcp/pcm054; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Hashimoto K, 2005, PLANT CELL PHYSIOL, V46, P782, DOI 10.1093/pcp/pci085; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Iotti S, 2008, MAGNESIUM RES, V21, P157, DOI 10.1684/mrh.2008.0142; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; Ito K, 2003, J BIOL CHEM, V278, P31049, DOI 10.1074/jbc.M304138200; Ito K, 2007, J BIOL CHEM, V282, P19534, DOI 10.1074/jbc.M611802200; Ito K, 2009, P NATL ACAD SCI USA, V106, P21585, DOI 10.1073/pnas.0910787106; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, P NATL ACAD SCI USA, V94, P14332, DOI 10.1073/pnas.94.26.14332; Kambara T, 2006, J BIOL CHEM, V281, P37291, DOI 10.1074/jbc.M603823200; KNIGHT AE, 1993, J MOL BIOL, V231, P148, DOI 10.1006/jmbi.1993.1266; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Mitsuda N, 2004, PLANT CELL PHYSIOL, V45, P845, DOI 10.1093/pcp/pch101; MURPHY E, 1989, P NATL ACAD SCI USA, V86, P2981, DOI 10.1073/pnas.86.8.2981; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; OKADA K, 1992, AM J PHYSIOL, V263, pC873, DOI 10.1152/ajpcell.1992.263.4.C873; Peremyslov V, 2011, PLANT PHYSIOL, V155, P1191, DOI 10.1104/pp.110.170720; PETERSEN A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P169, DOI 10.1016/0304-4165(90)90112-A; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reichelt S, 1999, PLANT J, V19, P555, DOI 10.1046/j.1365-313X.1999.00553.x; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; RIJKERS GT, 1993, BIOCHEM J, V289, P373, DOI 10.1042/bj2890373; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sattarzadeh A, 2008, CELL MOTIL CYTOSKEL, V65, P457, DOI 10.1002/cm.20271; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SINGH J, 1995, MOL CELL BIOCHEM, V149, P175, DOI 10.1007/BF01076575; Sparkes I, 2011, MOL PLANT, V4, P805, DOI 10.1093/mp/ssr063; Tashiro M, 1997, BIOPHYS J, V73, P3358, DOI 10.1016/S0006-3495(97)78360-7; Thaler M., 1991, THESIS U WURZBURG GE; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Tominaga M, 2013, DEV CELL, V27, P345, DOI 10.1016/j.devcel.2013.10.005; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Weghuber J, 2006, FEBS J, V273, P1198, DOI 10.1111/j.1742-4658.2006.05157.x; WESTERBLAD H, 1992, EXP PHYSIOL, V77, P733, DOI 10.1113/expphysiol.1992.sp003639; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Wojtaszek P, 2005, FUNCT PLANT BIOL, V32, P721, DOI 10.1071/FP05004; YAMAMOTO K, 1994, P JPN ACAD B-PHYS, V70, P175, DOI 10.2183/pjab.70.175; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; YAZAKI Y, 1988, PLANT CELL PHYSIOL, V29, P919; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; YOKOTA E, 1994, PROTOPLASMA, V177, P153, DOI 10.1007/BF01378989; Yoshimura M, 2001, J BIOL CHEM, V276, P39600, DOI 10.1074/jbc.M105080200	92	26	28	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12343	12355		10.1074/jbc.M113.521716	http://dx.doi.org/10.1074/jbc.M113.521716			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24637024	Green Published, hybrid			2022-12-25	WOS:000335581400013
J	Sui, XW; Kiser, PD; Che, T; Carey, PR; Golczak, M; Shi, WX; von Lintig, J; Palczewski, K				Sui, Xuewu; Kiser, Philip D.; Che, Tao; Carey, Paul R.; Golczak, Marcin; Shi, Wuxian; von Lintig, Johannes; Palczewski, Krzysztof			Analysis of Carotenoid Isomerase Activity in a Prototypical Carotenoid Cleavage Enzyme, Apocarotenoid Oxygenase ( ACO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotene; Carotenoid; Enzyme Catalysis; Enzyme Inactivation; Enzyme Mechanisms; Enzyme Structure; Vitamin A	IN-VITRO CHARACTERIZATION; BETA-CAROTENE; RETINOID ISOMERASE; KEY RESIDUES; ALL-TRANS; RESONANCE RAMAN; VISUAL CYCLE; VITAMIN-A; RPE65; ISOMEROHYDROLASE	Background: Isomerase activity for Synechocystis apocarotenoid oxygenase (ACO) has not been verified biochemically. Results: ACO exclusively produces all-trans-retinal from all-trans-apo-8-carotenol and is inhibited by linear polyoxyethylene detergents. Conclusion: ACO cleaves but does not isomerize all-trans-8-apocarotenol. Significance: This study clarifies the activity of and influence of detergent on ACO, a classical non-isomerizing member of the carotenoid cleavage enzyme family. Carotenoid cleavage enzymes (CCEs) constitute a group of evolutionarily related proteins that metabolize a variety of carotenoid and non-carotenoid substrates. Typically, these enzymes utilize a non-heme iron center to oxidatively cleave a carbon-carbon double bond of a carotenoid substrate. Some members also isomerize specific double bonds in their substrates to yield cis-apocarotenoid products. The apocarotenoid oxygenase from Synechocystis has been hypothesized to represent one such member of this latter category of CCEs. Here, we developed a novel expression and purification protocol that enabled production of soluble, native ACO in quantities sufficient for high resolution structural and spectroscopic investigation of its catalytic mechanism. High performance liquid chromatography and Raman spectroscopy revealed that ACO exclusively formed all-trans products. We also found that linear polyoxyethylene detergents previously used for ACO crystallization strongly inhibited the apocarotenoid oxygenase activity of the enzyme. We crystallized the native enzyme in the absence of apocarotenoid substrate and found electron density in the active site that was similar in appearance to the density previously attributed to a di-cis-apocarotenoid intermediate. Our results clearly demonstrated that ACO is in fact a non-isomerizing member of the CCE family. These results indicate that careful selection of detergent is critical for the success of structural studies aimed at elucidating structures of CCE-carotenoid/retinoid complexes.	[Sui, Xuewu; Kiser, Philip D.; Golczak, Marcin; von Lintig, Johannes; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Che, Tao; Carey, Paul R.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Shi, Wuxian] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kiser, PD (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	pdk7@case.edu		von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health from the National Center for Research Resources [GM103403]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020551, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, R01GM054072, P41GM103403, R56GM054072, P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Leslie T. Webster, Jr., and members of the Palczewski laboratory (Case Western Reserve University) for valuable comments on the manuscript. We also thank Dr. Zhaoyang (John) Feng (Case Western Reserve University) for providing equipment used for this study. A portion of this work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which is supported by National Institutes of Health Grant GM103403 from the National Center for Research Resources. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract number DE-AC02-06CH11357. Some data for this study were measured at beamline X29 of the National Synchrotron Light Source.	Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; BRAIMAN M, 1980, BIOCHEMISTRY-US, V19, P5421, DOI 10.1021/bi00564a042; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; CALLENDER R, 1977, ANNU REV BIOPHYS BIO, V6, P33, DOI 10.1146/annurev.bb.06.060177.000341; Chander P, 2012, J BIOL CHEM, V287, P30552, DOI 10.1074/jbc.M112.364596; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Frisch M., 2016, GAUSSIAN 16 REVISION; Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Maeda T, 2011, MOL PHARMACOL, V80, P943, DOI 10.1124/mol.111.074732; Matthews BW, 2009, PROTEIN SCI, V18, P494, DOI 10.1002/pro.61; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAGAO A, 1994, FASEB J, V8, P968, DOI 10.1096/fasebj.8.12.8088462; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Poliakov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049975; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SHARMA RV, 1976, BIOCHEM J, V158, P377, DOI 10.1042/bj1580377; Solomon EI, 2003, P NATL ACAD SCI USA, V100, P3589, DOI 10.1073/pnas.0336792100; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2012, BIOCHEMISTRY-US, V51, P4217, DOI 10.1021/bi300144n; Takahashi Y, 2011, FEBS J, V278, P973, DOI 10.1111/j.1742-4658.2011.08019.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; TEETER MM, 1991, ANNU REV BIOPHYS BIO, V20, P577, DOI 10.1146/annurev.bb.20.060191.003045; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Voolstra O, 2010, J BIOL CHEM, V285, P2130, DOI 10.1074/jbc.M109.056101; Wang XY, 2010, CURR BIOL, V20, P93, DOI 10.1016/j.cub.2009.12.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	63	26	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12286	12299		10.1074/jbc.M114.552836	http://dx.doi.org/10.1074/jbc.M114.552836			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648526	hybrid, Green Published			2022-12-25	WOS:000335581400009
J	Neuhauser, B; Ludewig, U				Neuhaeuser, Benjamin; Ludewig, Uwe			Uncoupling of Ionic Currents from Substrate Transport in the Plant Ammonium Transporter AtAMT1; 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ammonia; Electrophysiology; Membrane Transport; Plant; Proton Transport	ESCHERICHIA-COLI; CHANNEL AMTB; DEPROTONATION MECHANISM; CRYSTAL-STRUCTURE; PROTEINS; NH4+; ARRANGEMENT; SELECTIVITY; AFFINITY; BINDING	Background: The substrate transported by AMT/Rh proteins (NH3/NH<sub arrange="stack">4<sup arrange="stack">+/NH<sub arrange="stack">3<sup arrange="stack">+H+) is strongly disputed. Results: In the net NH<sub arrange="stack">4<sup arrange="stack">+ transporter AtAMT1;2 mutations led to a change in coupling of NH3 and H+ transport. Conclusion: AMT/Rh proteins might share a general mechanism of NH3 transport with different H+ coupling ratios. Significance: Different NH3/H+ coupling ratios in AMT/Rh proteins can explain the contrasting results for their transported substrate (NH3/NH<sub arrange="stack">4<sup arrange="stack">+/NH<sub arrange="stack">3<sup arrange="stack">+H+). The ammonium flux across prokaryotic, plant, and animal membranes is regulated by structurally related ammonium transporters (AMT) and/or related Rhesus (Rh) glycoproteins. Several plant AMT homologs, such as AtAMT1;2 from Arabidopsis, elicit ionic, ammonium-dependent currents when expressed in oocytes. By contrast, functional evidence for the transport of NH3 and the lack of coupled ionic currents has been provided for many Rh proteins. Furthermore, despite high resolution structures the transported substrate in many bacterial homologs, such as AmtB from Escherichia coli, is still unclear. In a heterologous genetic screen in yeast, AtAMT1;2 mutants with reduced transport activity were identified based on the resistance of yeast to the toxic transport analog methylamine. When expressed in oocytes, the reduced transport capacity was confirmed for either of the mutants Q67K, M72I,and W145S. Structural alignments suggest that these mutations were dispersed at subunit contact sites of trimeric AMTs, without direct contact to the pore lumen. Surprisingly, and in contrast to the wild type AtAMT1;2 transporter, ionic currents were not associated with the substrate transport in these mutants. Whether these data suggest that the wild type AtAMT1;2 functions as H+/NH3 co-transporter, as well as how the strict substrate coupling with protons is lost by the mutations, is discussed.	[Neuhaeuser, Benjamin; Ludewig, Uwe] Univ Hohenheim, Inst Crop Sci, D-70593 Stuttgart, Germany	University Hohenheim	Neuhauser, B (corresponding author), Univ Hohenheim, Inst Crop Sci, Fruwirthstr 20, D-70593 Stuttgart, Germany.	benjamin.neuhaeuser@uni-hohenheim.de		Neuhauser, Benjamin/0000-0002-2391-0598	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially supported by grants from the Deutsche Forschungsgemeinschaft.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Besserer A, 2012, PLANT CELL, V24, P3463, DOI 10.1105/tpc.112.101758; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Furuichi T, 2010, PLANT J, V64, P47, DOI 10.1111/j.1365-313X.2010.04309.x; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Hall JA, 2013, J BIOL CHEM, V288, P14080, DOI 10.1074/jbc.M113.457952; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Loque D, 2004, J EXP BOT, V55, P1293, DOI 10.1093/jxb/erh147; Loque D, 2009, J BIOL CHEM, V284, P24988, DOI 10.1074/jbc.M109.020842; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Martinez-Torres A, 2001, P NATL ACAD SCI USA, V98, P1947, DOI 10.1073/pnas.031584898; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Ortiz-Ramirez C, 2011, J BIOL CHEM, V286, P31113, DOI 10.1074/jbc.M111.261693; Sogaard R, 2009, PFLUG ARCH EUR J PHY, V458, P733, DOI 10.1007/s00424-009-0665-z; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	34	22	25	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11650	11655		10.1074/jbc.C114.552802	http://dx.doi.org/10.1074/jbc.C114.552802			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24634212	Green Published, hybrid			2022-12-25	WOS:000335010600008
J	Yamashiro, S; Gokhin, DS; Sui, ZH; Bergeron, SE; Rubenstein, PA; Fowler, VM				Yamashiro, Sawako; Gokhin, David S.; Sui, Zhenhua; Bergeron, Sarah E.; Rubenstein, Peter A.; Fowler, Velia M.			Differential Actin-regulatory Activities of Tropomodulin1 and Tropomodulin3 with Diverse Tropomyosin and Actin Isoforms*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cytoskeleton; Protein Chemistry; Protein-Protein Interactions; Tropomyosin; Actin Capping; Actin-binding Proteins; Tropomodulin	SKELETAL-MUSCLE FIBERS; ALPHA-TROPOMYOSIN; TROPOMODULIN/TROPOMYOSIN INTERACTIONS; BINDING-PROPERTIES; CAPPING PROTEIN; COILED-COIL; YEAST ACTIN; GENE FAMILY; N-TERMINUS; END	Background: Tropomodulins (Tmods) cap pointed ends of actin filaments in a tropomyosin (TM)-dependent manner. Results: Tmod1 and Tmod3 similarly cap actin filaments with diverse TM and actin isoforms, but only Tmod3 sequesters - and (cyto)-actin monomers. Conclusion: Isoform-specific actin monomer sequestration by Tmod3 may provide a mechanism for actin remodeling in TM-deficient regions of cells. Significance: Defining the actin-regulatory activities of Tmods illuminates cytoskeletal dynamics. Tropomodulins (Tmods) are F-actin pointed end capping proteins that interact with tropomyosins (TMs) and cap TM-coated filaments with higher affinity than TM-free filaments. Here, we tested whether differences in recognition of TM or actin isoforms by Tmod1 and Tmod3 contribute to the distinct cellular functions of these Tmods. We found that Tmod3 bound approximate to 5-fold more weakly than Tmod1 to /TM, TM5b, and TM5NM1. However, surprisingly, Tmod3 was as effective as Tmod1 at capping pointed ends of skeletal muscle -actin ((sk)-actin) filaments coated with /TM, TM5b, or TM5NM1. Tmod3 only capped TM-coated (sk)-actin filaments more weakly than Tmod1 in the presence of recombinant TM2, which is unacetylated at its NH2 terminus, binds F-actin weakly, and has a disabled Tmod-binding site. Moreover, both Tmod1 and Tmod3 were similarly effective at capping pointed ends of platelet /cytoplasmic ((cyto))-actin filaments coated with TM5NM1. In the absence of TMs, both Tmod1 and Tmod3 had similarly weak abilities to nucleate /(cyto)-actin filament assembly, but only Tmod3 could sequester cytoplasmic - and (cyto)-actin (but not (sk)-actin) monomers and prevent polymerization under physiological conditions. Thus, differences in TM binding by Tmod1 and Tmod3 do not appear to regulate the abilities of these Tmods to cap TM-(sk)-actin or TM-/(cyto)-actin pointed ends and, thus, are unlikely to determine selective co-assembly of Tmod, TM, and actin isoforms in different cell types and cytoskeletal structures. The ability of Tmod3 to sequester - and (cyto)-actin (but not (sk)-actin) monomers in the absence of TMs suggests a novel function for Tmod3 in regulating actin remodeling or turnover in cells.	[Yamashiro, Sawako; Gokhin, David S.; Sui, Zhenhua; Fowler, Velia M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Yamashiro, Sawako] Tohoku Univ, Lab Single Mol Cell Biol, Sendai, Miyagi 9808578, Japan; [Bergeron, Sarah E.; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Scripps Research Institute; Tohoku University; University of Iowa	Fowler, VM (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd,CB163, La Jolla, CA 92037 USA.	velia@scripps.edu		Yamashiro, Sawako/0000-0002-5980-0470; Rubenstein, Peter/0000-0003-1225-4414; Fowler, Velia/0000-0002-3161-8802	National Institutes of Health [R01-HL083464, R01-DC008803]; Muscular Dystrophy Association; Japan Society for the Promotion of Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL083464 (to V. M. F.) and R01-DC008803 (to P. A. R.). This work was also supported by a development grant from the Muscular Dystrophy Association (to D. S. G.) and grants-in-aid for young scientists and for scientific research on innovative areas from the Japan Society for the Promotion of Science (to S. Y.).	Almenar-Queralt A, 1999, J CELL SCI, V112, P1111; BABCOCK GG, 1994, J BIOL CHEM, V269, P27510; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Bunnell TM, 2011, CRIT REV EUKAR GENE, V21, P255, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.30; CARLIER MF, 1994, ADV EXP MED BIOL, V358, P71; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; FOWLER VM, 1987, J BIOL CHEM, V262, P12792; FOWLER VM, 1985, J CELL BIOL, V100, P47, DOI 10.1083/jcb.100.1.47; Gokhin DS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103069; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2002, BIOPHYS J, V82, P2580, DOI 10.1016/S0006-3495(02)75600-2; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hitchcock-DeGregori SE, 2001, BIOCHEMISTRY-US, V40, P2104, DOI 10.1021/bi002421z; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Ilkovski B, 2008, J NEUROPATH EXP NEUR, V67, P867, DOI 10.1097/NEN.0b013e318183a44f; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2008, CELL MOL LIFE SCI, V65, P563, DOI 10.1007/s00018-007-7347-9; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2008, ADV EXP MED BIOL, V644, P283; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON H, 1988, BIOCHIM BIOPHYS ACTA, V953, P95, DOI 10.1016/0167-4838(88)90013-1; Maytum R, 2004, J BIOL CHEM, V279, P18203, DOI 10.1074/jbc.M311636200; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Moroz NA, 2013, J BIOL CHEM, V288, P4899, DOI 10.1074/jbc.M112.434522; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Ochala J, 2014, FASEB J, V28, P408, DOI 10.1096/fj.13-239640; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Perrin BJ, 2010, CYTOSKELETON, V67, P630, DOI 10.1002/cm.20475; PINDER JC, 1983, J CELL BIOL, V96, P768, DOI 10.1083/jcb.96.3.768; PINDER JC, 1978, J SUPRAMOL STR CELL, V8, P439, DOI 10.1002/jss.400080406; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Prins KW, 2011, J CELL SCI, V124, P951, DOI 10.1242/jcs.079848; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Shuster CB, 1996, CELL MOTIL CYTOSKEL, V35, P175; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; Sung LA, 2000, BLOOD, V95, P1473, DOI 10.1182/blood.V95.4.1473.004k50_1473_1480; TemmGrove CJ, 1996, CELL MOTIL CYTOSKEL, V33, P223, DOI 10.1002/(SICI)1097-0169(1996)33:3<223::AID-CM6>3.0.CO;2-B; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Tzima E, 2000, EUR J BIOCHEM, V267, P4720, DOI 10.1046/j.1432-1327.2000.01525.x; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; URSITTI JA, 1994, J CELL SCI, V107, P1633; Uversky VN, 2011, J MOL RECOGNIT, V24, P647, DOI 10.1002/jmr.1093; Vera C, 2000, ARCH BIOCHEM BIOPHYS, V378, P16, DOI 10.1006/abbi.2000.1802; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; YANG YZ, 1979, J BIOL CHEM, V254, P7137; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005	77	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11616	11629		10.1074/jbc.M114.555128	http://dx.doi.org/10.1074/jbc.M114.555128			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24644292	hybrid, Green Published			2022-12-25	WOS:000335010600005
J	Ugonna, K; Bingle, CD; Plant, K; Wilson, K; Everard, ML				Ugonna, Kelechi; Bingle, Colin D.; Plant, Karen; Wilson, Kirsty; Everard, Mark L.			Macrophages Are Required for Dendritic Cell Uptake of Respiratory Syncytial Virus from an Infected Epithelium	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; DIFFERENTIATION; INFANTS; DISEASE	We have previously shown that the respiratory syncytial virus [RSV] can productively infect monocyte derived dendritic cells [MoDC] and remain dormant within the same cells for prolonged periods. It is therefore possible that infected dendritic cells act as a reservoir within the airways of individuals between annual epidemics. In the present study we explored the possibility that sub-epithelial DCs can be infected with RSV from differentiated bronchial epithelium and that in turn RSV from DCs can infect the epithelium. A dual co-culture model was established in which a differentiated primary airway epithelium on an Air Liquid Interface (ALI) was cultured on a transwell insert and MoDCs were subsequently added to the basolateral membrane of the insert. Further experiments were undertaken using a triple co-culture model in which in which macrophages were added to the apical surface of the differentiated epithelium. A modified RSV [rr-RSV] expressing a red fluorescent protein marker of replication was used to infect either the MoDCs or the differentiated epithelium and infection of the reciprocal cell type was assessed using confocal microscopy. Our data shows that primary epithelium became infected when rr-RSV infected MoDCs were introduced onto the basal surface of the transwell insert. MoDCs located beneath the epithelium did not become infected with virus from infected epithelial cells in the dual co-culture model. However when macrophages were present on the apical surface of the primary epithelium infection of the basal MoDCs occurred. Our data suggests that RSV infected dendritic cells readily transmit infection to epithelial cells even when they are located beneath the basal layer. However macrophages appear to be necessary for the transmission of infection from epithelial cells to basal dendritic cells.	[Ugonna, Kelechi] Sheffield Childrens Hosp, Dept Resp Med, Sheffield, S Yorkshire, England; [Bingle, Colin D.; Plant, Karen; Wilson, Kirsty] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England; [Everard, Mark L.] Univ Western Australia, Princess Margaret Hosp, Sch Paediat & Child Hlth, Subiaco, WA, Australia	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Western Australia	Everard, ML (corresponding author), Univ Western Australia, Princess Margaret Hosp, Sch Paediat & Child Hlth, Subiaco, WA, Australia.	mark.everard@uwa.edu.au		Bingle, Colin/0000-0002-5405-6988; Everard, Mark/0000-0003-1571-261X	Sheffield Children's Hospital Research Committee	Sheffield Children's Hospital Research Committee	The study was funded by the Sheffield Children's Hospital Research Committee. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Bataki EL, 2005, CLIN EXP IMMUNOL, V140, P470, DOI 10.1111/j.1365-2249.2005.02780.x; Bingle CD, 2010, HISTOCHEM CELL BIOL, V133, P505, DOI 10.1007/s00418-010-0683-0; Blank F, 2007, AM J RESP CELL MOL, V36, P669, DOI 10.1165/rcmb.2006-0234OC; Blank F, 2011, IMMUNOBIOLOGY, V216, P86, DOI 10.1016/j.imbio.2010.02.006; Condon TV, 2011, J LEUKOCYTE BIOL, V90, P883, DOI 10.1189/jlb.0311134; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; ENGLUND JA, 1994, PEDIATR INFECT DIS J, V13, P449, DOI 10.1097/00006454-199405000-00037; Everard ML, 2006, CURR ALLERGY ASTHM R, V6, P97, DOI 10.1007/s11882-006-0046-z; EVERARD ML, 1992, EUR J PEDIATR, V151, P638, DOI 10.1007/BF01957564; Everard ML, 2009, TXB PAEDIAT RESP MED, P491; GILCHRIST S, 1994, J INFECT DIS, V170, P986, DOI 10.1093/infdis/170.4.986; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Johansen J, 1997, APMIS, V105, P303, DOI 10.1111/j.1699-0463.1997.tb00573.x; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Jones A, 2001, EFFECT RSV HUMAN BON; MIDULLA F, 1993, J INFECT DIS, V168, P1515, DOI 10.1093/infdis/168.6.1515; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Neyt K, 2013, IMMUNOL REV, V255, P57, DOI 10.1111/imr.12100; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; PANUSKA JR, 1990, J CLIN INVEST, V86, P113, DOI 10.1172/JCI114672; PARROTT RH, 1973, AM J EPIDEMIOL, V98, P289, DOI 10.1093/oxfordjournals.aje.a121558; Rivera-Toledo E, 2012, VIRUSES-BASEL, V4, P3270, DOI 10.3390/v4123270; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Rothen-Rutishauser B, 2008, EXPERT OPIN DRUG MET, V4, P1075, DOI [10.1517/17425255.4.8.1075, 10.1517/17425255.4.8.1075 ]; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	30	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91855	10.1371/journal.pone.0091855	http://dx.doi.org/10.1371/journal.pone.0091855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651119	Green Published, Green Accepted, gold			2022-12-25	WOS:000333352800051
J	Hara, S; Umeyama, K; Yokoo, T; Nagashima, H; Nagata, M				Hara, Satoshi; Umeyama, Kazuhiro; Yokoo, Takashi; Nagashima, Hiroshi; Nagata, Michio			Diffuse Glomerular Nodular Lesions in Diabetic Pigs Carrying a Dominant-Negative Mutant Hepatocyte Nuclear Factor 1-Alpha, an Inheritant Diabetic Gene in Humans	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; TRANSGENIC PIGS; NEPHROPATHY; MICE; GLOMERULOSCLEROSIS; DEFICIENCY; STRESS; MODEL; BETA; LOCALIZATION	Glomerular nodular lesions, known as Kimmelstiel-Wilson nodules, are a pathological hallmark of progressive human diabetic nephropathy. We have induced severe diabetes in pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha (HNF1 alpha) P291fsinsC, a maturity-onset diabetes of the young type-3 (MODY3) gene in humans. In this model, glomerular pathology revealed that formation of diffuse glomerular nodules commenced as young as 1 month of age and increased in size and incidence until the age of 10 months, the end of the study period. Immunohistochemistry showed that the nodules consisted of various collagen types (I, III, IV, V and VI) with advanced glycation end-product (AGE) and N-epsilon-carboxymethyl-lysine (CML) deposition, similar to those in human diabetic nodules, except for collagen type I. Transforming growth factor-beta (TGF-beta) was also expressed exclusively in the nodules. The ultrastructure of the nodules comprised predominant interstitial-type collagen deposition arising from the mesangial matrices. Curiously, these nodules were found predominantly in the deep cortex. However, diabetic pigs failed to show any of the features characteristic of human diabetic nephropathy; e. g., proteinuria, glomerular basement membrane thickening, exudative lesions, mesangiolysis, tubular atrophy, interstitial fibrosis, and vascular hyalinosis. The pigs showed only Armanni-Ebstein lesions, a characteristic tubular manifestation in human diabetes. RT-PCR analysis showed that glomeruli in wild-type pigs did not express endogenous HNF1 alpha and HNF1 beta, indicating that mutant HNF1 alpha did not directly contribute to glomerular nodular formation in diabetic pigs. In conclusion, pigs harboring the dominant-negative mutant human MODY3 gene showed reproducible and distinct glomerular nodules, possibly due to AGE- and CML-based collagen accumulation. Although the pathology differed in several respects from that of human glomerular nodular lesions, the somewhat acute and constitutive formation of nodules in this mammalian model might provide information facilitating identification of the principal mechanism underlying diabetic nodular sclerosis.	[Hara, Satoshi; Nagata, Michio] Univ Tsukuba, Dept Kidney & Vasc Pathol, Tsukuba, Ibaraki, Japan; [Umeyama, Kazuhiro; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res, Kawasaki, Kanagawa, Japan; [Yokoo, Takashi] Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med, Tokyo, Japan; [Hara, Satoshi] Kanazawa Univ, Sch Med, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa 920, Japan	University of Tsukuba; Meiji University; Jikei University; Kanazawa University	Nagata, M (corresponding author), Univ Tsukuba, Dept Kidney & Vasc Pathol, Tsukuba, Ibaraki, Japan.	nagatam@md.tsukuba.ac.jp	hara, satoshi/AAA-3930-2020	Nagashima, Hiroshi/0000-0001-9940-8783	Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science [23500505]	Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science	This work was partially supported by Grants-in-Aid for Scientific Research (C) (#23500505) from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Fukami K, 2004, KIDNEY INT, V66, P2137, DOI 10.1111/j.1523-1755.2004.66004.x; Furuichi K, 2011, NEPHROL DIAL TRANSPL, V26, P3124, DOI 10.1093/ndt/gfr125; GLICK AD, 1992, HUM PATHOL, V23, P1373, DOI 10.1016/0046-8177(92)90057-A; Heaf JG, 2001, SCAND J UROL NEPHROL, V35, P233; Hong D, 2007, DIABETES RES CLIN PR, V78, P189, DOI 10.1016/j.diabres.2007.03.024; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Inagi R, 2006, DIABETES, V55, P356, DOI 10.2337/diabetes.55.02.06.db05-0702; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kimmelstiel P, 1936, AM J PATHOL, V12, P83; Kosugi T, 2009, AM J PATHOL, V174, P1221, DOI 10.2353/ajpath.2009.080605; Larsen MO, 2002, AM J PHYSIOL-ENDOC M, V282, pE1342, DOI 10.1152/ajpendo.00564.2001; MAKINO H, 1994, DIABETIC MED, V11, P304, DOI 10.1111/j.1464-5491.1994.tb00276.x; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; NERLICH A, 1991, AM J PATHOL, V139, P889; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Renner S, 2001, NATURE, V414, P813; Renner S, 2013, DIABETES, V62, P1505, DOI 10.2337/db12-1065; RITCHIE S, 1957, AM J PATHOL, V33, P1035; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Umeyama K, 2013, J REPROD DEVELOP, V59, P599, DOI 10.1262/jrd.2013-069; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; YAN SD, 1994, J BIOL CHEM, V269, P9889; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	35	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92219	10.1371/journal.pone.0092219	http://dx.doi.org/10.1371/journal.pone.0092219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647409	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500099
J	Lee, J; Kang, Y; Shin, SC; Park, H; Lee, H				Lee, Jungeun; Kang, Yoonjee; Shin, Seung Chul; Park, Hyun; Lee, Hyoungseok			Combined Analysis of the Chloroplast Genome and Transcriptome of the Antarctic Vascular Plant Deschampsia antarctica Desv	PLOS ONE			English	Article							POACEAE; SEQUENCE; PHYLOGENY; ALIGNMENT; GENE; MITOCHONDRIA; EVOLUTION	Background: Antarctic hairgrass (Deschampsia antarctica Desv.) is the only natural grass species in the maritime Antarctic. It has been researched as an important ecological marker and as an extremophile plant for studies on stress tolerance. Despite its importance, little genomic information is available for D. antarctica. Here, we report the complete chloroplast genome, transcriptome profiles of the coding/noncoding genes, and the posttranscriptional processing by RNA editing in the chloroplast system. Results: The complete chloroplast genome of D. antarctica is 135,362 bp in length with a typical quadripartite structure, including the large (LSC: 79,881 bp) and small (SSC: 12,519 bp) single-copy regions, separated by a pair of identical inverted repeats (IR: 21,481 bp). It contains 114 unique genes, including 81 unique protein-coding genes, 29 tRNA genes, and 4 rRNA genes. Sequence divergence analysis with other plastomes from the BEP clade of the grass family suggests a sister relationship between D. antarctica, Festuca arundinacea and Lolium perenne of the Poeae tribe, based on the whole plastome. In addition, we conducted high-resolution mapping of the chloroplast-derived transcripts. Thus, we created an expression profile for 81 protein-coding genes and identified ndhC, psbJ, rps19, psaJ, and psbA as the most highly expressed chloroplast genes. Small RNA-seq analysis identified 27 small noncoding RNAs of chloroplast origin that were preferentially located near the 5'- or 3'-ends of genes. We also found >30 RNA-editing sites in the D. antarctica chloroplast genome, with a dominance of C-to-U conversions. Conclusions: We assembled and characterized the complete chloroplast genome sequence of D. antarctica and investigated the features of the plastid transcriptome. These data may contribute to a better understanding of the evolution of D. antarctica within the Poaceae family for use in molecular phylogenetic studies and may also help researchers understand the characteristics of the chloroplast transcriptome.	[Lee, Jungeun; Kang, Yoonjee; Shin, Seung Chul; Park, Hyun; Lee, Hyoungseok] Korea Polar Res Inst, Div Life Sci, Inchon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Park, H (corresponding author), Korea Polar Res Inst, Div Life Sci, Inchon, South Korea.	soulaid@kopri.re.kr; hpark@kopri.re.kr		Lee, Hyoungseok/0000-0002-5831-6345	Functional Genomics on Polar Organisms grant [PE13020]; Basic Research Program [PE13120]; Korea Polar Research Institute (KOPRI)	Functional Genomics on Polar Organisms grant; Basic Research Program; Korea Polar Research Institute (KOPRI)	This work was supported by Functional Genomics on Polar Organisms grant (PE13020) and the Basic Research Program (PE13120) funded by Korea Polar Research Institute (KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi M, 2002, PHYSIOL PLANTARUM, V115, P479, DOI 10.1034/j.1399-3054.2002.1150401.x; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Davis JI, 2007, ALISO J SYSTEMATIC E, V23; Souto DPF, 2006, PLANT SYST EVOL, V261, P1, DOI 10.1007/s00606-006-0425-x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Grosskopf D, 1996, CURR GENET, V29, P556, DOI 10.1007/BF02426960; Hand ML, 2013, G3-GENES GENOM GENET, V3, P607, DOI 10.1534/g3.112.005264; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; HSIAO C, 1995, THEOR APPL GENET, V90, P389, DOI 10.1007/BF00221981; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; NADOT S, 1994, PLANT SYST EVOL, V191, P27, DOI 10.1007/BF00985340; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Perez-Torres E, 2004, FUNCT PLANT BIOL, V31, P731, DOI 10.1071/FP03082; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Soreng R. J., 2000, Grasses: systematics and evolution., P61; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiong FSS, 2000, AM J BOT, V87, P700, DOI 10.2307/2656856; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38; Zhang YR, 2012, AUST J BOT, V60, P461, DOI 10.1071/BT12073; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	41	37	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92501	10.1371/journal.pone.0092501	http://dx.doi.org/10.1371/journal.pone.0092501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647560	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500138
J	Nagata, JM; Cohen, CR; Young, SL; Wamuyu, C; Armes, MN; Otieno, BO; Leslie, HH; Dandu, M; Stewart, CC; Bukusi, EA; Weiser, SD				Nagata, Jason M.; Cohen, Craig R.; Young, Sera L.; Wamuyu, Catherine; Armes, Mary N.; Otieno, Benard O.; Leslie, Hannah H.; Dandu, Madhavi; Stewart, Christopher C.; Bukusi, Elizabeth A.; Weiser, Sheri D.			Descriptive Characteristics and Health Outcomes of the Food by Prescription Nutrition Supplementation Program for Adults Living with HIV in Nyanza Province, Kenya	PLOS ONE			English	Article							BODY-MASS INDEX; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; WEIGHT-LOSS; INSECURITY; HIV/AIDS; UNDERNUTRITION; CONSUMPTION; COMMUNITY; SURVIVAL	Background: The clinical effects and potential benefits of nutrition supplementation interventions for persons living with HIV remain largely unreported, despite awareness of the multifaceted relationship between HIV infection and nutrition. We therefore examined descriptive characteristics and nutritional outcomes of the Food by Prescription (FBP) nutrition supplementation program in Nyanza Province, Kenya. Methods: Demographic, health, and anthropometric data were gathered from a retrospective cohort of 1,017 non-pregnant adult patients who enrolled into the FBP program at a Family AIDS Care and Education Services (FACES) site in Nyanza Province between July 2009 and July 2011. Our primary outcome was FBP treatment success defined as attainment of BMI>20, and we used Cox proportional hazards to assess socio-demographic and clinical correlates of FBP treatment success. Results: Mean body mass index was 16.4 upon enrollment into the FBP program. On average, FBP clients gained 2.01 kg in weight and 0.73 kg/m(2) in BMI over follow-up (mean 100 days), with the greatest gains among the most severely undernourished (BMI <16) clients (p < 0.001). Only 13.1% of clients attained a BMI>20, though 44.5% achieved a BMI increase >= 0.5. Greater BMI at baseline, younger age, male gender, and not requiring highly active antiretroviral therapy (HAART) were associated with a higher rate of attainment of BMI>20. Conclusion: This study reports significant gains in weight and BMI among patients enrolled in the FBP program, though only a minority of patients achieved stated programmatic goals of BMI>20. Future research should include well-designed prospective studies that examine retention, exit reasons, mortality outcomes, and long-term sustainability of nutrition supplementation programs for persons living with HIV.	[Nagata, Jason M.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Young, Sera L.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Wamuyu, Catherine; Armes, Mary N.; Otieno, Benard O.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Family AIDS Care & Educ Serv, Nairobi, Kenya; [Leslie, Hannah H.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Dandu, Madhavi] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA; [Stewart, Christopher C.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Weiser, Sheri D.] Univ Calif San Francisco, Div HIV AIDS, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; Kenya Medical Research Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nagata, JM (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	jasonmnagata@gmail.com		Nagata, Jason/0000-0002-6541-0604; Leslie, Hannah Hogan/0000-0002-7464-3645; Young, Sera/0000-0002-1763-1218	University of California, San Francisco Pathways Explore Grant; Northern California Association; National Institutes of Health [R01 MH095683]; National Institute of Mental Health [K01 MH098902]; University of California, San Francisco Library Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098902, R01MH095683] Funding Source: NIH RePORTER	University of California, San Francisco Pathways Explore Grant(University of California System); Northern California Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of California, San Francisco Library Open Access Publishing Fund(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the University of California, San Francisco Pathways Explore Grant, the University of California, San Francisco Library Open Access Publishing Fund, and the Phi Beta Kappa, Northern California Association, Scholarship (JN), the National Institutes of Health R01 MH095683 (SW), and the National Institute of Mental Health K01 MH098902 (SY).	Agnarson AM, 2007, AIDS, V21, P1225, DOI 10.1097/QAD.0b013e32810f2dad; Anema A, 2012, PUBLIC HEALTH NUTR, V15, P938, DOI 10.1017/S136898001100125X; Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; de Waal A, 2003, LANCET, V362, P1234, DOI 10.1016/S0140-6736(03)14548-5; FAO, 2000, STATE FOOD INSECURIT; Food and Nutrition Technical Assistance II Project (FANTA-2), 2009, REV KEN FOOD PRESCR; Ivers LC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-33; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Keithley JK, 2002, JPEN-PARENTER ENTER, V26, P6, DOI 10.1177/014860710202600106; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Koethe JR, 2009, CLIN INFECT DIS, V49, P787, DOI 10.1086/605285; Kuria EN, 2010, PUBLIC HEALTH NUTR, V13, P475, DOI 10.1017/S1368980009990826; Laraia BA, 2006, J NUTR, V136, P177, DOI 10.1093/jn/136.1.177; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Leathers Howard D., 2009, WORLD FOOD PROBLEM E; Leyna GH, 2010, PUBLIC HEALTH NUTR, V13, P1438, DOI 10.1017/S1368980010000327; Mahlungulu S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004536.pub2; Marchione TJ, 2005, J NUTR, V135, P886, DOI 10.1093/jn/135.4.886; Nagata JM, 2013, AIDS CARE, V25, P1491, DOI 10.1080/09540121.2013.775399; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; Nagata JM, 2011, J ETHNOPHARMACOL, V135, P501, DOI 10.1016/j.jep.2011.03.051; Nagata JM, 2009, ECON HUM BIOL, V7, P96, DOI 10.1016/j.ehb.2009.02.002; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Ndekha MJ, 2009, BMJ-BRIT MED J, P338; Powell-Tuck J, 2003, CLIN NUTR, V22, P307, DOI 10.1016/S0261-5614(03)00009-8; Rabeneck L, 1998, J AM DIET ASSOC, V98, P434, DOI 10.1016/S0002-8223(98)00099-6; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Sadler K, 2012, MEASURING IMPACT COS, P29; Schwenk A, 1999, CLIN NUTR, V18, P371, DOI 10.1016/S0261-5614(99)80018-1; Shevitz AH, 1999, AIDS, V13, P1351, DOI 10.1097/00002030-199907300-00012; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; World Health Organisation, 2003, NUTR REQ PEOPL LIV H; World Health Organisation, 2007, WHO CAS DEF HIV SURV	37	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91403	10.1371/journal.pone.0091403	http://dx.doi.org/10.1371/journal.pone.0091403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646586	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500036
J	Khalaj, N; Abu Osman, NA; Mokhtar, AH; Mehdikhani, M; Abas, WAW				Khalaj, Nafiseh; Abu Osman, Noor Azuan; Mokhtar, Abdul Halim; Mehdikhani, Mahboobeh; Abas, Wan Abu Bakar Wan			Balance and Risk of Fall in Individuals with Bilateral Mild and Moderate Knee Osteoarthritis	PLOS ONE			English	Article							BIODEX STABILITY SYSTEM; POSTURAL SWAY; ELDERLY PERSONS; PROPRIOCEPTION; STRENGTH; PAIN; ARTHRITIS; GAIT	Balance is essential for mobility and performing activities of daily living. People with knee osteoarthritis display impairment in knee joint proprioception. Thus, the aim of this study was to evaluate balance and risk of fall in individuals with bilateral mild and moderate knee osteoarthritis. Sixty subjects aged between 50 and 70 years volunteered in this study. They were categorized into three groups which were healthy (n = 20), mild (n = 20) and moderate (n = 20) bilateral knee osteoarthritis groups. Dynamic and static balance and risk of fall were assessed using Biodex Stability System. In addition, Timed Up and Go test was used as a clinical test for balance. Results of this study illustrated that there were significant differences in balance (dynamic and static) and risk of fall between three groups. In addition, the main (most significant) difference was found to be between healthy group and moderate group. Furthermore, on clinical scoring of balance, the "Timed Up and Go" test, all three groups showed significant difference. In conclusion, bilateral knee osteoarthritis impaired the balance and increased the risk of fall, particularly in people with moderate knee osteoarthritis.	[Khalaj, Nafiseh; Abu Osman, Noor Azuan; Mehdikhani, Mahboobeh; Abas, Wan Abu Bakar Wan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Mokhtar, Abdul Halim] Univ Malaya, Fac Med, Dept Sport Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Khalaj, N (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	nafisehkhalaj@hotmail.com	MOKHTAR, ABDUL HALIM/B-8102-2010; Khalaj, Nafiseh/P-4935-2016; ABU OSMAN, NOOR AZUAN/B-9265-2010	MOKHTAR, ABDUL HALIM/0000-0001-8057-313X; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421	UM/MOHE/HIR [D000010-16001]	UM/MOHE/HIR	This study was supported by UM/MOHE/HIR Project No. D000010-16001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BL, 1998, J ATHL TRAINING, V33, P323; Aydog E, 2006, CLIN RHEUMATOL, V25, P462, DOI 10.1007/s10067-005-0074-4; Baert IAC, 2013, CLIN RHEUMATOL, V32, P1365, DOI 10.1007/s10067-013-2285-4; Bascuas I, 2013, ORTHOPEDICS, V36, pE6, DOI 10.3928/01477447-20121217-11; Cachupe WJC, 2001, MEASUREMENTS PHYS ED, V5, P97, DOI [DOI 10.1207/S15327841MPEE0502_, 10.1207/S15327841MPEE0502_3, DOI 10.1207/S15327841MPEE0502_3]; Fisher NM, 1997, SCAND J REHABIL MED, V29, P213; Hassan BS, 2002, ANN RHEUM DIS, V61, P422, DOI 10.1136/ard.61.5.422; Hassan BS, 2001, ANN RHEUM DIS, V60, P612, DOI 10.1136/ard.60.6.612; Hill KD, 2013, J CLIN GERONTOL GERI, V4, P22, DOI 10.1016/j.jcgg.2012.10.003; Hinman RS, 2002, RHEUMATOLOGY, V41, P1388, DOI 10.1093/rheumatology/41.12.1388; Hsieh RL, 2013, ARCH PHYS MED REHAB, V94, P340, DOI 10.1016/j.apmr.2012.09.022; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Jadelis K, 2001, J AM GERIATR SOC, V49, P884, DOI 10.1046/j.1532-5415.2001.49178.x; Kiss RM, 2011, J ELECTROMYOGR KINES, V21, P695, DOI 10.1016/j.jelekin.2011.07.011; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Masui T, 2006, J ORTHOP SCI, V11, P353, DOI 10.1007/s00776-006-1034-9; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Morrow JR, 2010, MEASUREMENT EVALUATI; Pandya NK, 2007, GAIT POSTURE, V25, P106, DOI 10.1016/j.gaitpost.2006.02.001; Pandya NK, 2005, CLIN ORTHOP RELAT R, P150, DOI 10.1097/01.blo.0000150316.97009.f2; Petrella M, 2012, REV BRAS REUMATOL, V52, P507, DOI 10.1590/S0482-50042012000400004; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Sharma L, 2003, ARTHRITIS RHEUM-US, V48, P3359, DOI 10.1002/art.11420; Sharma L, 1997, ARTHRITIS RHEUM, V40, P1518, DOI 10.1002/art.1780400821; Sibley KM, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-33; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Wegener L, 1997, J ORTHOP SPORT PHYS, V25, P13, DOI 10.2519/jospt.1997.25.1.13; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	28	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92270	10.1371/journal.pone.0092270	http://dx.doi.org/10.1371/journal.pone.0092270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642715	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900116
J	Li, RZ; Wu, FG; Ruonala, R; Sapkota, D; Hu, ZH; Mu, XQ				Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Hu, Zihua; Mu, Xiuqian			Isl1 and Pou4f2 Form a Complex to Regulate Target Genes in Developing Retinal Ganglion Cells	PLOS ONE			English	Article							ELEGANS HOMEOPROTEINS UNC-86; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; CAENORHABDITIS-ELEGANS; DOMAIN FACTORS; LIM DOMAIN; RNA-SEQ; DIFFERENTIATION; HOMEODOMAIN; EXPRESSION	Precise regulation of gene expression during biological processes, including development, is often achieved by combinatorial action of multiple transcription factors. The mechanisms by which these factors collaborate are largely not known. We have shown previously that Isl1, a Lim-Homeodomain transcription factor, and Pou4f2, a class IV POU domain transcription factor, co-regulate a set of genes required for retinal ganglion cell (RGC) differentiation. Here we further explore how these two factors interact to precisely regulate gene expression during RGC development. By GST pulldown assays, co-immunoprecipitation, and electrophoretic mobility shift assays, we show that Isl1 and Pou4f2 form a complex in vitro and in vivo, and identify the domains within these two proteins that are responsible for this interaction. By luciferase assay, in situ hybridization, and RNA-seq, we further demonstrate that the two factors contribute quantitatively to gene expression in the developing RGCs. Although each factor alone can activate gene expression, both factors are required to achieve optimal expression levels. Finally, we discover that Isl1 and Pou4f2 can interact with other POU and Lim-Homeodomain factors respectively, indicating the interactions between these two classes of transcription factors are prevalent in development and other biological processes.	[Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Hu, Zihua; Mu, Xiuqian] SUNY Buffalo, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY 14260 USA; [Sapkota, Darshan; Mu, Xiuqian] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Ctr Computat Res, Buffalo, NY 14260 USA; [Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Mu, Xiuqian] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp, Buffalo, NY 14260 USA; [Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Hu, Zihua; Mu, Xiuqian] SUNY Buffalo, SUNY Eye Inst, Buffalo, NY 14260 USA; [Mu, Xiuqian] Roswell Pk Canc Inst, CCSG Canc Genet Program, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Mu, XQ (corresponding author), SUNY Buffalo, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY 14260 USA.	xmu@buffalo.edu	Mu, Xiuqian/I-9146-2014	Mu, Xiuqian/0000-0002-8003-7529; Sapkota, Darshan/0000-0003-3773-2910	National Eye Institute [EY020545]; Whitehall Foundation; Research to Prevent Blindness; Department of Ophthalmology of University at Buffalo; NATIONAL CANCER INSTITUTE [P30CA016056, P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020545] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Whitehall Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Department of Ophthalmology of University at Buffalo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, http://www.nei.nih.gov, EY020545, to XM; the Whitehall Foundation, http://www.whitehall.org, to XM; and Research to Prevent Blindness, https://www.rpbusa.org/rpb/, an Unrestricted Grant from to the Department of Ophthalmology of University at Buffalo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cepko CL, 1996, CURR OPIN NEUROBIOL, V6, P542, DOI 10.1016/S0959-4388(96)80062-6; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Duggan A, 1998, DEVELOPMENT, V125, P4107; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hwang SB, 2003, J MOL BIOL, V333, P237, DOI 10.1016/j.jmb.2003.08.055; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Johnson K G, 2000, Results Probl Cell Differ, V31, P157; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; LICHTSTEINER S, 1995, EMBO J, V14, P3937, DOI 10.1002/j.1460-2075.1995.tb00065.x; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Martin SE, 2005, DIFFERENTIATION, V73, P18, DOI 10.1111/j.1432-0436.2005.07301004.x; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Mu XQ, 2001, DEVELOPMENT, V128, P2569; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rockelein I, 2000, MOL CELL BIOL, V20, P4806, DOI 10.1128/MCB.20.13.4806-4813.2000; Rohrig S, 2000, EMBO J, V19, P3694, DOI 10.1093/emboj/19.14.3694; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sapkota D, 2011, EXP EYE RES, V93, P796, DOI 10.1016/j.exer.2011.10.003; Schonemann MD, 1998, ADV EXP MED BIOL, V449, P39; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076347; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Smit DJ, 2000, EUR J BIOCHEM, V267, P6413, DOI 10.1046/j.1432-1327.2000.01737.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trieu M, 1999, J NEUROSCI, V19, P6549; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zaffran S, 2005, BIOCHEM BIOPH RES CO, V334, P361, DOI 10.1016/j.bbrc.2005.06.090; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069	52	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92105	10.1371/journal.pone.0092105	http://dx.doi.org/10.1371/journal.pone.0092105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643061	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900086
J	Milutinovic, PS; Englert, JM; Crum, LT; Mason, NS; Ramsgaard, L; Enghild, JJ; Sparvero, LJ; Lotze, MT; Oury, TD				Milutinovic, Pavle S.; Englert, Judson M.; Crum, Lauren T.; Mason, Neale S.; Ramsgaard, Lasse; Enghild, Jan J.; Sparvero, Louis J.; Lotze, Michael T.; Oury, Tim D.			Clearance Kinetics and Matrix Binding Partners of the Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; REPERFUSION INJURY; RAGE; BLOCKADE; PURIFICATION; ACTIVATION; EXPRESSION; PROTEIN; HMGB1	Elucidating the sites and mechanisms of sRAGE action in the healthy state is vital to better understand the biological importance of the receptor for advanced glycation end products (RAGE). Previous studies in animal models of disease have demonstrated that exogenous sRAGE has an anti-inflammatory effect, which has been reasoned to arise from sequestration of pro-inflammatory ligands away from membrane-bound RAGE isoforms. We show here that sRAGE exhibits in vitro binding with high affinity and reversibly to extracellular matrix components collagen I, collagen IV, and laminin. Soluble RAGE administered intratracheally, intravenously, or intraperitoneally, does not distribute in a specific fashion to any healthy mouse tissue, suggesting against the existence of accessible sRAGE sinks and receptors in the healthy mouse. Intratracheal administration is the only effective means of delivering exogenous sRAGE to the lung, the organ in which RAGE is most highly expressed; clearance of sRAGE from lung does not differ appreciably from that of albumin.	[Milutinovic, Pavle S.; Crum, Lauren T.; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Englert, Judson M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Mason, Neale S.] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA; [Ramsgaard, Lasse; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Sparvero, Louis J.; Lotze, Michael T.] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Oury, TD (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	tdoury@pitt.edu		Enghild, Jan Johannes/0000-0001-9292-9172	NIH [R21 HL095495]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095495, T32HL094295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant R21 HL095495 to Tim D. Oury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; BRETT J, 1993, AM J PATHOL, V143, P1699; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Chuong C, 2009, J CELL PHYSIOL, V221, P430, DOI 10.1002/jcp.21873; Dahlin K, 2004, AM J RESP CELL MOL, V31, P309, DOI 10.1165/rcmb.2003-0423OC; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; EFFROS RM, 1983, AM REV RESPIR DIS, V127, pS59; Englert J, 2009, THESIS U PITTSBURGH; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Frommhold D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-56; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hastings RH, 2004, AM J PHYSIOL-LUNG C, V286, pL679, DOI 10.1152/ajplung.00205.2003; HASTINGS RH, 1992, J APPL PHYSIOL, V73, P1310, DOI 10.1152/jappl.1992.73.4.1310; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; John TA, 2001, J PHYSIOL-LONDON, V533, P547, DOI 10.1111/j.1469-7793.2001.0547a.x; Kataoka K, 2012, ONCOL LETT, V3, P1149, DOI 10.3892/ol.2012.612; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Marsche G, 2007, FASEB J, V21, P3075, DOI 10.1096/fj.07-8316com; Miller AL, 2012, J INFECT DIS, V205, P1311, DOI 10.1093/infdis/jir826; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; NEEPER M, 1992, J BIOL CHEM, V267, P14998; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Pullerits R, 2006, ARTHRITIS RHEUM, V54, P3898, DOI 10.1002/art.22217; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; Sarkany Z, 2011, J BIOL CHEM, V286, P37525, DOI 10.1074/jbc.M111.223438; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Sourris KC, 2010, DIABETOLOGIA, V53, P2442, DOI 10.1007/s00125-010-1837-2; Steiner J, 2011, CLIN CHEM LAB MED, V49, P409, DOI 10.1515/CCLM.2011.083; Sternberg DI, 2008, J THORAC CARDIOV SUR, V136, P1576, DOI 10.1016/j.jtcvs.2008.05.032; Teismann P, 2012, NEUROBIOL AGING, V33, P2478, DOI 10.1016/j.neurobiolaging.2011.12.006; VLASSARA H, 1989, J CLIN INVEST, V84, P1813, DOI 10.1172/JCI114366; VLASSARA H, 1988, DIABETES, V37, P456, DOI 10.2337/diabetes.37.4.456; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; WAUTIER JL, 1994, P NATL ACAD SCI USA, V91, P7742, DOI 10.1073/pnas.91.16.7742; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC	50	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e88259	10.1371/journal.pone.0088259	http://dx.doi.org/10.1371/journal.pone.0088259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642901	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333259900002
J	Sauque, V; Rabal-Garces, R; Sola-Almagro, C; Cuenca-Bescos, G				Sauque, Victor; Rabal-Garces, Raquel; Sola-Almagro, Cristina; Cuenca-Bescos, Gloria			Bone Accumulation by Leopards in the Late Pleistocene in the Moncayo Massif (Zaragoza, NE Spain)	PLOS ONE			English	Article							CROCUTA-SPELAEA GOLDFUSS; PANTHERA-PARDUS LINNAEUS; MULTIPLE CARNIVORE TAXA; WOLVES CANIS-LUPUS; SPOTTED HYENA; MIDDLE PLEISTOCENE; FEEDING ECOLOGY; HAMMERSTONE PERCUSSION; FAUNAL ASSEMBLAGE; 1823 POPULATION	Eating habits of Panthera pardus are well known. When there are caves in its territory, prey accumulates inside them. This helps to prevent its kill from being stolen by other predators like hyenas. Although the leopard is an accumulator of bones in caves, few studies have been conducted on existing lairs. There are, however, examples of fossil vertebrate sites whose main collecting agent is the leopard. During the Late Pleistocene, the leopard was a common carnivore in European faunal associations. Here we present a new locality of Quaternary mammals with a scarce human presence, the cave of Los Rincones (province of Zaragoza, Spain); we show the leopard to be the main accumulator of the bones in the cave, while there are no interactions between humans and leopards. For this purpose, a taphonomic analysis is performed on different bone-layers of the cave.	[Sauque, Victor; Rabal-Garces, Raquel; Cuenca-Bescos, Gloria] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Sola-Almagro, Cristina] Univ Zaragoza, Fac Filosofia & Letras, Zaragoza, Spain	University of Zaragoza; University of Zaragoza	Sauque, V (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	vsauque@gmail.com	Gloria, Cuenca-Bescós/A-3616-2013	Gloria, Cuenca-Bescós/0000-0001-5125-9651; Sauque, Victor/0000-0001-5379-5087	Government of Aragon [Exp. 50/2006, 132/2010]	Government of Aragon(Gobierno de Aragon)	Victor Sauque is beneficiary of a predoctoral grant from the Government of Aragon. The Government of Aragon has partially subsidized our geological activities in Los Rincones (Exp. 50/2006, 132/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1975, J ZOOL, V175, P15; ALADOS CL, 1996, ECOLOGIA COMPORTAMIE; Altuna J., 1972, Munibe, V24, P1; Altuna J., 1980, Munibe, V32, P317; Altuna J, 1981, RESTOS OSEOS YACIMIE, V223, P269; [Anonymous], 2006, TRABAJOS PREHIST; [Anonymous], 2001, AFRICAN PREDATORS; [Anonymous], 2010, ZONA ARQUEOLOGICA; [Anonymous], [No title captured]; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Arrizabalaga A., 2000, MUNIBE ANTROPOLOGIA, V42, P193; Azorit Concepcion, 2002, Anales de Biologia (Murcia), V24, P107; Barrientos Luis Mariano, 1997, Quercus, V139, P14; Ruiz CB, 2011, QUATERN INT, V243, P105, DOI 10.1016/j.quaint.2011.02.021; Binford L.R., 1981, BONES ANCIENT MEN MO; Blasco MF, 1997, J ANTHROPOL RES, V53, P177, DOI 10.1086/jar.53.2.3631276; Blasco MF, 1997, BOLSKAN REV ARQUEOLO, P9; Blasco R, 2011, J ARCHAEOL SCI, V38, P3373, DOI 10.1016/j.jas.2011.07.023; Blumenschine R.J., 1993, BONES BEHAV, DOI 10.1016/j.jhevol.2017.08.004; BLUMENSCHINE RJ, 1986, J HUM EVOL, V15, P639, DOI 10.1016/S0047-2484(86)80002-1; Brain C.K., 1993, Transvaal Museum Monograph, V8, P257; Brain C. K., 1981, HUNTERS HUNTED INTRO; BRAIN CK, 1970, NATURE, V225, P1112, DOI 10.1038/2251112a0; BUNN HT, 1986, J HUM EVOL, V15, P673, DOI 10.1016/S0047-2484(86)80004-5; Burke A, 2003, QUATERNARY RES, V59, P459, DOI 10.1016/S0033-5894(03)00059-0; Caceres I., 2002, THESIS U ROVIRA VIRG; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Carranza J., 2011, ENCICLOPEDIA VIRTUAL; Carrion JS, 2001, PALAEOGEOGR PALAEOCL, V176, P193, DOI 10.1016/S0031-0182(01)00338-8; Castanos P, 1990, ANTROPOLOGIA ARKEOLO, V42, P253; Castel Jean-Christophe, 2004, Revue de Paleobiologie, V23, P675; Castel Jean-Christophe, 2010, Revue de Paleobiologie, V29, P411; Clevenger A.P., 1991, ECOLOGIA PARDO ESPAN; Clot A., 1980, THESIS U P SABATIER; Coard R, 1999, J ARCHAEOL SCI, V26, P1369, DOI 10.1006/jasc.1999.0438; Cooper SM, 1999, AFR J ECOL, V37, P149, DOI 10.1046/j.1365-2028.1999.00161.x; CRUZURIBE K, 1991, J FIELD ARCHAEOL, V18, P467, DOI 10.2307/530408; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; Curio E., 1976, ETHOLOGY PREDATION; D'Errico F, 2002, J ARCHAEOL SCI, V29, P211, DOI 10.1006/jasc.2001.0687; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; Daura J, 2013, QUATERNARY SCI REV, V60, P26, DOI 10.1016/j.quascirev.2012.10.042; Davis S, 2002, REV PORTUGUESA ARQUE, V5/2, P29; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; de Ruiter DJ, 2000, J ARCHAEOL SCI, V27, P665, DOI 10.1006/jasc.1999.0470; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; DELIBES M, 1980, ACTA THERIOL, V25, P309, DOI 10.4098/AT.arch.80-28; Delpech F, 1980, B ASS FRANCAISE ET S, V1, P268; Diedrich CG, 2012, J ARCHAEOL SCI, V39, P1749, DOI 10.1016/j.jas.2012.01.013; Diedrich CG, 2011, QUATERN INT, V233, P171, DOI 10.1016/j.quaint.2010.02.027; Diedrich CG, 2013, QUATERNARY SCI REV, V76, P167, DOI 10.1016/j.quascirev.2013.05.009; Diedrich CG, 2012, HIST BIOL, V24, P161, DOI 10.1080/08912963.2011.591491; Diedrich CG, 2011, HIST BIOL, V23, P237, DOI 10.1080/08912963.2010.530348; Diedrich CG, 2012, HIST BIOL, V24, P63, DOI 10.1080/08912963.2011.552718; Diedrich CG, 2011, HIST BIOL, V23, P335, DOI 10.1080/08912963.2011.552719; Diedrich CG, 2009, QUATERNARY RES, V71, P361, DOI 10.1016/j.yqres.2008.12.006; Diez JC, 1999, J HUM EVOL, V37, P623, DOI 10.1006/jhev.1999.0346; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M., 1994, TRABAJOS PREHIST, V51, P15, DOI DOI 10.3989/TP.1994.V51.I1.462; Dominguez-Rodrigo M., 1994, QUADERNOS PREHISTORI, V16, P9; Dominguez-Rodrigo Manuel, 2010, Journal of Taphonomy, V8, P155; Dominguez-Rodrigo Manuel, 2007, P255; Eisenmann V., 1986, EQUIDS ANCIENT WORLD, P67; Elosegui MM, 2009, PARDO PIRINEOS; Esteban-Nadal M, 2012, J ARCHAEOL SCI, V39, P3208, DOI 10.1016/j.jas.2012.05.004; Falgueres C., 2005, MUNIBE, V57, P93; Fernandez H., 2001, OSTEOLOGIE COMP PETI; Fitzgibbon C. D., 1995, SERENGETI, P274; FITZGIBBON CD, 1989, J ZOOL, V218, P99, DOI 10.1111/j.1469-7998.1989.tb02528.x; Fosse P., 2010, ZONA ARQUELOGICA ACT, V13, P108; Fosse P., 1997, PALEO, V9, P15, DOI [10.3406/pal.1997.1227, DOI 10.3406/PAL.1997.1227]; Garcia N, 2001, ANTHROPOLOGIE, V105, P83; Garcia N, 1998, GEOBIOS-LYON, V31, P659, DOI 10.1016/S0016-6995(98)80053-3; Gil-Sanchez JM, 2006, ACTA THERIOL, V51, P85, DOI 10.1007/BF03192659; Gisbert M., 2009, CUEVAS SIMAS PROVINC; Granados J.E., 2001, Galemys, V13, P3; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL LONDON, V270, P1; Hillson S., 1992, MAMMAL BONES TEETH I; Jackson P., 1996, BIOL CONSERVATION; Jedrzejewska B., 1998, PREDATION VERTEBRATE; JordaPardo J. F., 2011, Boletin de la Real Sociedad Espanola de Historia Natural, Seccion Geologica, V105, P137; Kingdon J., 1977, E AFRICAN MAMMALS A; Kruuk H., 1972, SPOTTED HYENA STUDY; Kuhn BF, 2010, INT J OSTEOARCHAEOL, V20, P15, DOI 10.1002/oa.996; Kurten B, 1976, CAVE BEAR STORY LIFE; LEROUX PG, 1989, AFR J ECOL, V27, P167; Arsuaga JL, 2012, QUATERN INT, V275, P55, DOI 10.1016/j.quaint.2012.04.019; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; Marchal F, 2009, CR PALEVOL, V8, P493, DOI 10.1016/j.crpv.2009.03.004; Marean CW, 1998, CURR ANTHROPOL, V39, pS79, DOI 10.1086/204691; MARIEZKURRENA K, 1983, Munibe, V35, P149; Mateos-Quesada P, 2000, TROFEO, V376, P124; Mateos-Quesada P., 2011, ENCICLOPEDIA VIRTUAL; Mech D., 2003, WOLVES BEHAV ECOLOGY; Mills G, 1998, HYANAS STATUS SURVEY; Mills MGL, 1990, KALAHARI HYAENAS COM; MITCHELL B. L., 1965, ZOOL AFRICANA, V1, P297; Monchot Herve, 2005, Paleorient, V31, P27; Monchot H, 2009, QUATERNAIRE, V20, P239, DOI 10.4000/quaternaire.5166; Montoya P., 1999, Estudios Geologicos (Madrid), V55, P127; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Morris P., 1978, P483; Myers N., 1986, P437; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Noe-Nygaard N, 2005, J ARCHAEOL SCI, V32, P855, DOI 10.1016/j.jas.2005.01.004; Nohemi Sala M. T., 2011, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V105, P67; Nowak RM, 1999, MAMMALS WORLD; Okarma H, 1997, WOLF OKOLOGIE VERHAL, P1; Pales L., 1971, ATLAS OSTEOLOGIQUE S; Perez Ripoll M., 1988, ARCH PREHISTORIA LEV, V18, P83; Perez-Barberia F.J., 2010, ENCICLOPEDIA VIRTUAL; PEREZBARBERIA FJ, 1994, J ZOOL, V233, P649; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2002, INT J OSTEOARCHAEOL, V12, P127, DOI 10.1002/oa.594; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Pinto Llona AC, 2005, TAFONOMI PALEOECOLOG; POCOCK R. I., 1932, PROC ZOOL SOC LONDON, V1932, P543; Pons-Moya J., 1985, Paleontologia i Evolucio, V18, P39; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Prendergast Mary E., 2008, Journal of Taphonomy, V6, P301; Quam RM, 2001, J HUM EVOL, V41, P385, DOI 10.1006/jhev.2001.0486; Rabal-Garces R, 2013, THESIS U ZARAGOZA; Rabal-Garces R, 2012, LETHAIA, V45, P96, DOI 10.1111/j.1502-3931.2011.00260.x; Rivals F, 2006, INT J OSTEOARCHAEOL, V16, P249, DOI 10.1002/oa.822; RODRIGUEZ CF, 1995, J ARCHAEOL SCI, V22, P597, DOI 10.1016/S0305-4403(95)80145-6; Rodriguez-Hidalgo A, 2013, J ARCHAEOL SCI, V40, P3031, DOI 10.1016/j.jas.2013.03.006; ROGERS L, 1981, NAT HIST, V90, P64; ROGERS LL, 1987, WILDLIFE MONOGR, P1; Sala N., 2012, THESIS U COMPLUTENSE; Sala N, 2013, J ARCHAEOL SCI, V40, P1389, DOI 10.1016/j.jas.2012.10.018; Saladie P, 2009, THESIS U ROVIRA VIRG; Saladie P, 2011, INT J OSTEOARCHAEOL, DOI [10.1002/oa.1237, DOI 10.1002/0A.1237]; Salazar-Garcia DC, 2013, QUAT INT IN PRESS; Sauque V, 2013, QUATERNAIRE, V24, P35; Schaller G. B., 1972, SERENGETI LION STUDY; Selvaggio M.M., 1994, THESIS RUTGERS U; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Shipman P., 1983, BAR International Series, V163, P31; SHIPMAN P, 1984, PALEOBIOLOGY, V10, P358, DOI 10.1017/S0094837300008320; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Simons JW, 1966, KENYA B CAVE EXPLORA, V1, P51; Steyn V, 2006, S AFR J WILDL RES, V36, P189; Stiner Mary C., 2004, Revue de Paleobiologie, V23, P771; Stiner Mary C., 1999, Ursus, V11, P41; Stiner MC, 1998, J HUM EVOL, V34, P303, DOI 10.1006/jhev.1997.0198; Stiner MC., 1996, GEOARCHAEOLOGY, V11, P279, DOI [10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:43.0.CO;2-Z, DOI 10.1002/(SICI)1520-6548(199607)11:4<279::AID-GEA1>3.0.CO;2-Z]; SUTCLIFFE AJ, 1970, NATURE, V227, P1110, DOI 10.1038/2271110a0; Sutcliffe AJ., 1973, T CAVE RES GROUP G B, V15, P41; Testu A., 2011, QUATERNAIRE, V4, P271; Torres T, 1988, SPECIAL PUBLICATION, V99, P1; Turner A., 1997, BIG CATS THEIR FOSSI; Utrilla P., 2010, ZONA ARQUEOL, V13, P376; Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105; VIGAL CR, 1988, CAN J ZOOL, V66, P2836, DOI 10.1139/z88-410; Vigne, 2003, ARCHAEOFAUNA, V12, P157; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Villa P, 2000, J ANTHROPOL RES, V56, P187, DOI 10.1086/jar.56.2.3631362; Villa Paola, 2004, Revue de Paleobiologie, V23, P705; Villa P, 2010, J ARCHAEOL SCI, V37, P919, DOI 10.1016/j.jas.2009.11.025; Villaluenga Aritza, 2009, Munibe (Antropologia - Arkeologia), V60, P17; Voorhies M, 1969, 1 NEBR CONTR GEOL, V1; Walker R., 1985, GUIDE POSTCRANIAL BO; Yravedra Jose, 2011, Journal of Taphonomy, V9, P37; Yravedra Jose, 2010, Journal of Taphonomy, V8, P301	171	28	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92144	10.1371/journal.pone.0092144	http://dx.doi.org/10.1371/journal.pone.0092144			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642667	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900095
J	Wenneras, C; Hagberg, L; Andersson, R; Hynsjo, L; Lindahl, A; Okroj, M; Blom, AM; Johansson, P; Andreasson, B; Gottfries, J; Wold, AE				Wenneras, Christine; Hagberg, Lars; Andersson, Rune; Hynsjo, Lars; Lindahl, Anders; Okroj, Marcin; Blom, Anna M.; Johansson, Peter; Andreasson, Bjorn; Gottfries, Johan; Wold, Agnes E.			Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients	PLOS ONE			English	Article							SERUM ALPHA-FETOPROTEIN; C4B-BINDING PROTEIN; IMMUNE-SYSTEM; DISEASES; BLOOD; TRANSPLANTATION; BACTEREMIA; ACTIVATION; CITRULLINE; MORTALITY	Background: Invasive infections and sterile tissue damage can both give rise to systemic inflammation with fever and production of inflammatory mediators. This makes it difficult to diagnose infections in patients who are already inflamed, e.g. due to cell and tissue damage. For example, fever in patients with hematological malignancies may depend on infection, lysis of malignant cells, and/or chemotherapy-induced mucosal damage. We hypothesized that it would be possible to distinguish patterns of inflammatory mediators characterizing infectious and non-infectious causes of inflammation, respectively. Analysis of a broad range of parameters using a multivariate method of pattern recognition was done for this purpose. Methods: In this prospective study, febrile (>38 degrees C) neutropenic patients (n = 42) with hematologic malignancies were classified as having or not having a microbiologically defined infection by an infectious disease specialist. In parallel, blood was analyzed for 116 biomarkers, and 23 clinical variables were recorded for each patient. Using O-PLS (orthogonal projection to latent structures), a model was constructed based on these 139 variables that could separate the infected from the non-infected patients. Non-discriminatory variables were discarded until a final model was reached. Finally, the capacity of this model to accurately classify a validation set of febrile neutropenic patients (n = 10) as infected or non-infected was tested. Results: A model that could segregate infected from non-infected patients was achieved based on discrete differences in the levels of 40 variables. These variables included acute phase proteins, cytokines, measures of coagulation, metabolism, organ stress and iron turn-over. The model correctly identified the infectious status of nine out of ten subsequently recruited febrile neutropenic hematology patients. Conclusions: It is possible to separate patients with infectious inflammation from those with sterile inflammation based on inflammatory mediator patterns. This strategy could be developed into a decision-making tool for diverse clinical applications.	[Wenneras, Christine; Johansson, Peter; Andreasson, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Dept Hematol & Coagulat, Gothenburg, Sweden; [Wenneras, Christine; Hagberg, Lars; Andersson, Rune; Wold, Agnes E.] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Hynsjo, Lars; Lindahl, Anders] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Okroj, Marcin; Blom, Anna M.] Lund Univ, Dept Lab Med, Malmo, Sweden; [Johansson, Peter; Andreasson, Bjorn] Uddevalla Cent Hosp, Dept Internal Med, Uddevalla, Sweden; [Gottfries, Johan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Lund University; Voestalpine AG; University of Gothenburg	Wenneras, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Hematol & Coagulat, Gothenburg, Sweden.	christine.wenneras@microbio.gu.se	Lindahl, Anders/H-9550-2014; Blom, Anna/AFS-7369-2022; Gottfries, Johan/M-3445-2016; Blom, Anna/B-9607-2009	Lindahl, Anders/0000-0003-2871-5166; Gottfries, Johan/0000-0001-7135-4664; Blom, Anna/0000-0002-1348-1734; Wold, Agnes/0000-0001-9196-5040; Andersson, Rune/0000-0002-8133-1199	Vastra Gotaland Region Research Foundation [93900]; Cancer and Allergy Foundation [149781]; LUA-ALF [71580]; Strategic ALF Transplantation [74080]; IngaBritt and Arne Lundberg Foundation [332/07]	Vastra Gotaland Region Research Foundation; Cancer and Allergy Foundation; LUA-ALF; Strategic ALF Transplantation; IngaBritt and Arne Lundberg Foundation	This work was supported by grants from Vastra Gotaland Region Research Foundation (grant number: 93900); Cancer and Allergy Foundation (grant number: 149781); LUA-ALF (grant number: 71580); Strategic ALF Transplantation (grant number: 74080), and the IngaBritt and Arne Lundberg Foundation (grant number: 332/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas F, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-62; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; BLOOMER JR, 1977, GASTROENTEROLOGY, V72, P479; Bodey GP, 2009, J ANTIMICROB CHEMOTH, V63, pI3, DOI 10.1093/jac/dkp074; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; CHRISTIANSEN M, 1994, SCAND J CLIN LAB INV, V54, P215, DOI 10.3109/00365519409088427; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Feld R, 2008, INT J ANTIMICROB AG, V32, pS30, DOI 10.1016/j.ijantimicag.2008.06.017; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Hamilton MA, 2012, MINERVA ANESTESIOL, V78, P1039; Hermans PWM, 2005, CLIN INFECT DIS, V41, pS453, DOI 10.1086/431996; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Komori H, 2012, J BIOL CHEM, V287, P30688, DOI 10.1074/jbc.M112.353771; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Liamis G, 2011, J INFECTION, V63, P327, DOI 10.1016/j.jinf.2011.07.013; Lin MY, 2008, ANTIMICROB AGENTS CH, V52, P3188, DOI 10.1128/AAC.01553-07; Martin M, 2009, J VASC SURG, V50, P100, DOI 10.1016/j.jvs.2008.12.033; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Panel C, 1990, J INFECT DIS, V161, P397; Parkins MD, 2007, J ANTIMICROB CHEMOTH, V60, P613, DOI 10.1093/jac/dkm212; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Robertson CM, 2006, MICROBES INFECT, V8, P1382, DOI 10.1016/j.micinf.2005.12.016; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Skovbjerg S, 2009, CLIN MICROBIOL INFEC, V15, P680, DOI 10.1111/j.1469-0691.2009.02796.x; Trauner M, 1999, J GASTROEN HEPATOL, V14, P946, DOI 10.1046/j.1440-1746.1999.01982.x; van der Velden WJFM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015156; Vischer UM, 1999, CRIT REV ONCOL HEMAT, V30, P93, DOI 10.1016/S1040-8428(98)00045-6; Vokurka S, 2013, MED SCI MONITOR, V19, P81, DOI 10.12659/MSM.883755; Wold S., 1989, Intelligent Instruments & Computers, V7, P197	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92319	10.1371/journal.pone.0092319	http://dx.doi.org/10.1371/journal.pone.0092319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642872	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900120
J	Cai, JR; Yu, XF; Xu, RD; Fang, Y; Qian, XQ; Liu, SP; Teng, J; Ding, XQ				Cai, Jieru; Yu, Xiaofang; Xu, Rende; Fang, Yi; Qian, Xiaoqin; Liu, Shaopeng; Teng, Jie; Ding, Xiaoqiang			Maximum Efficacy of Mesenchymal Stem Cells in Rat Model of Renal Ischemia-Reperfusion Injury: Renal Artery Administration with Optimal Numbers	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EFFICIENCY; SURVIVAL; DELIVERY; THERAPY; FAILURE	Backgrounds: Despite the potential therapeutic benefits, cell therapy in renal ischemia-reperfusion (I/R) injury is currently limited by low rates of cell engraftment after systemic delivery. In this study, we investigate whether locally administration through renal artery can enhance the migration and therapeutic potential of mesenchymal stem cells (MSCs) in ischemic kidney. Methods: The model of renal I/R injury was induced by 45 min occlusion of the left renal pedicle and right nephrectomy in rat. Followed by reperfusion, graded doses of CM-Dil labeled MSCs were implanted via three routes: tail vein (TV), carotid artery (CA), and renal artery (RA). Renal blood flow was evaluated by color and spectral Doppler ultrasound at 1 h and 24 h post-I/R. All the samples were collected for analysis at 24 h post-I/R. Results: After injection of 1x10(6) MSCs, RA group showed obviously increased renal retention of grafted MSCs compared with TV and CA group; however, the renal function was even further deteriorated. When graded doses of MSCs, the maximal therapeutic efficiency was achieved with renal artery injection of 1x10(5) MSCs, which was significantly better than TV and CA group of 1x10(6) MSCs. In addition, further fluorescent microscopic and ultrasonic examination confirmed that the aggravated renal dysfunction in RA group was due to renal hypoperfusion caused by cell occlusion. Conclusion: Administration route and dosage are two critical factors determining the efficiency of cell therapy and 1x10(5) MSCs injected through renal artery produces the most dramatic improvement in renal function and morphology in rat model of renal I/R injury.	[Cai, Jieru; Yu, Xiaofang; Fang, Yi; Liu, Shaopeng; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Xu, Rende] Shanghai Jiao Tong Univ, Renji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Qian, Xiaoqin] Fudan Univ, Zhongshan Hosp, Dept Ultrasonog, Shanghai 200433, Peoples R China; [Teng, Jie] Fudan Univ, Zhongshan Hosp, Blood Purificat Ctr, Shanghai 200433, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Teng, J (corresponding author), Fudan Univ, Zhongshan Hosp, Blood Purificat Ctr, Shanghai 200433, Peoples R China.	teng.jie@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn			Major Project of Basic Research of Technology Committee in Shanghai of China [12DJ1400200]; Mingdao Plan of Fudan University [EZF152404/001/004]	Major Project of Basic Research of Technology Committee in Shanghai of China; Mingdao Plan of Fudan University	This work was supported by Major Project of Basic Research of Technology Committee in Shanghai of China (12DJ1400200) and Mingdao Plan of Fudan University (Grant NO: EZF152404/001/004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2012, CELL TRANSPLANT, V21, P2009, DOI 10.3727/096368912X640448; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; da Cunha MGMCM, 2013, EUR SURG RES, V51, P58, DOI 10.1159/000354389; De Martino M, 2010, TRANSPL P, V42, P1331, DOI 10.1016/j.transproceed.2010.03.079; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Fiorina P, 2006, J AM SOC NEPHROL, V17, P716, DOI 10.1681/ASN.2005090954; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Shih YC, 2013, PLAST RECONSTR SURG, V132, p940E, DOI 10.1097/PRS.0b013e3182a806ce; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Turetschek K, 1996, J ULTRAS MED, V15, P517; Yu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062703; Zhang QW, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/859643; Zhuo W, 2013, TRANSPL P, V45, P503, DOI 10.1016/j.transproceed.2012.07.162	29	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92347	10.1371/journal.pone.0092347	http://dx.doi.org/10.1371/journal.pone.0092347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637784	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100144
J	Woo, SL; Xu, H; Li, HG; Zhao, Y; Hu, X; Zhao, JJ; Guo, X; Guo, T; Botchlett, R; Qi, T; Pei, Y; Zheng, J; Xu, YM; An, XF; Chen, LL; Chen, LL; Li, QF; Xiao, XQ; Huo, YQ; Wu, CD				Woo, Shih-Lung; Xu, Hang; Li, Honggui; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Guo, Xin; Guo, Ting; Botchlett, Rachel; Qi, Ting; Pei, Ya; Zheng, Juan; Xu, Yiming; An, Xiaofei; Chen, Lulu; Chen, Lili; Li, Qifu; Xiao, Xiaoqiu; Huo, Yuqing; Wu, Chaodong			Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SYSTEMIC INSULIN-RESISTANCE; RECEPTOR-GAMMA ACTIVATION; GENE-EXPRESSION PROFILES; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; DIABETES-MELLITUS; GLUCOSE-PRODUCTION; MICE; TISSUE; GLUCONEOGENESIS	Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin resistance. To better understand the pathophysiology of obesity-associated NAFLD, the present study examined the involvement of liver and adipose tissues in metformin actions on reducing hepatic steatosis and inflammation during obesity. C57BL/6J mice were fed a high-fat diet (HFD) for 12 weeks to induce obesity-associated NAFLD and treated with metformin (150 mg/kg/d) orally for the last four weeks of HFD feeding. Compared with HFD-fed control mice, metformin-treated mice showed improvement in both glucose tolerance and insulin sensitivity. Also, metformin treatment caused a significant decrease in liver weight, but not adiposity. As indicated by histological changes, metformin treatment decreased hepatic steatosis, but not the size of adipocytes. In addition, metformin treatment caused an increase in the phosphorylation of liver AMP-activated protein kinase (AMPK), which was accompanied by an increase in the phosphorylation of liver acetyl-CoA carboxylase and decreases in the phosphorylation of liver c-Jun N-terminal kinase 1 (JNK1) and in the mRNA levels of lipogenic enzymes and proinflammatory cytokines. However, metformin treatment did not significantly alter adipose tissue AMPK phosphorylation and inflammatory responses. In cultured hepatocytes, metformin treatment increased AMPK phosphorylation and decreased fat deposition and inflammatory responses. Additionally, in bone marrow-derived macrophages, metformin treatment partially blunted the effects of lipopolysaccharide on inducing the phosphorylation of JNK1 and nuclear factor kappa B (NF-kappa B) p65 and on increasing the mRNA levels of proinflammatory cytokines. Taken together, these results suggest that metformin protects against obesity-associated NAFLD largely through direct effects on decreasing hepatocyte fat deposition and on inhibiting inflammatory responses in both hepatocytes and macrophages.	[Woo, Shih-Lung; Xu, Hang; Li, Honggui; Zhao, Yan; Hu, Xiang; Zhao, Jiajia; Guo, Xin; Guo, Ting; Botchlett, Rachel; Qi, Ting; Pei, Ya; Zheng, Juan; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Hu, Xiang; Zheng, Juan; Chen, Lulu] Huazhong Univ Sci & Technol, Dept Endocrinol, Union Hosp, Tongji Coll Med, Wuhan 430074, Hubei, Peoples R China; [Zhao, Jiajia; Chen, Lili] Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Coll Med, Wuhan 430074, Hubei, Peoples R China; [Xu, Yiming; Huo, Yuqing] Georgia Regents Univ, Vasc Biol Ctr, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA USA; [An, Xiaofei; Huo, Yuqing] Peking Univ, Ctr Drug Discovery, Key Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Li, Qifu; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China; [Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China	Texas A&M University System; Texas A&M University College Station; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Georgia; Augusta University; Peking University; University Town of Shenzhen; Chongqing Medical University; Chongqing Medical University	Huo, YQ (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, GA USA.	YHUO@gru.edu; cdwu@tamu.edu	zhao, yan/N-6096-2014; Xiao, Xiaoqiu/K-7672-2019	Xiao, Xiaoqiu/0000-0002-4568-8772; Xu, Yiming/0000-0002-9537-3664; Xu, Yiming/0000-0002-8866-7859; Li, Qifu/0000-0003-3904-410X	American Diabetes Association (ADA) [1-10-JF-54, 1-13-BS-214-BR, 1-10-BS-76]; American Heart Association (AHA) [12BGIA9050003, 10GRNT4400005]; National Institutes of Health (NIH) [1R01DK095828, 1R01DK095862, R01HL095556-01, R21HL108922]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108922, R01HL095556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095862, R01DK095828] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by American Diabetes Association (ADA) grants 1-10-JF-54, 1-13-BS-214-BR (to C. W.), and 1-10-BS-76 (to Y.H.), American Heart Association (AHA) 12BGIA9050003 (to C. W.), 10GRNT4400005 (to Y.H). and National Institutes of Health (NIH) grants 1R01DK095828 and 1R01DK095862 (to C. W.), R01HL095556-01 and R21HL108922 (to Y.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2006, GASTROENTEROLOGY, V130, P1848, DOI 10.1053/j.gastro.2006.03.041; Anthony J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077946; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen YM, 2013, NUTR RES, V33, P332, DOI 10.1016/j.nutres.2013.02.003; Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Guo X, 2013, J NUTR BIOCHEM, V24, P770, DOI 10.1016/j.jnutbio.2012.04.007; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Kim S, 2005, J NUTR, V135, P33, DOI 10.1093/jn/135.1.33; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Klein-Wieringa IR, 2013, J IMMUNOL, V191, P1356, DOI 10.4049/jimmunol.1203074; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Neuschwander-Tetri BA, 2010, NAT REV GASTRO HEPAT, V7, P243, DOI 10.1038/nrgastro.2010.50; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; PERRIELLO G, 1994, DIABETES, V43, P920, DOI 10.2337/diabetes.43.7.920; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shin N. R., 2013, GUT; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Tajima K, 2013, AM J PHYSIOL-ENDOC M, V305, pE987, DOI 10.1152/ajpendo.00133.2013; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	48	120	132	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91111	10.1371/journal.pone.0091111	http://dx.doi.org/10.1371/journal.pone.0091111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638078	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100016
J	Ren, YC; Chen, L; Niu, QH; Hui, FL				Ren, Yongcheng; Chen, Liang; Niu, Qiuhong; Hui, Fengli			Description of Scheffersomyces henanensis sp nov., a New D-Xylose-Fermenting Yeast Species Isolated from Rotten Wood	PLOS ONE			English	Article							RPB1 SEQUENCES; RIBOSOMAL DNA; FERMENTATION; ETHANOL; PHYLOGENY; STRAIN; FOREST; FRASS; GUT	Two strains of a D-xylose-fermenting yeast species were isolated from rotten wood samples collected from the Baotianman Nature Reserve in Henan Province, central China. These strains formed hat-shaped ascospores in conjugated and deliquescent asci. Multilocus phylogenetic analysis that included the nearly complete small subunit (SSU), the internal transcribed spacer (ITS) region and the D1/D2 domain of the large subunit (LSU) rRNA genes, as well as RNA polymerase II largest subunit (RPB1) gene demonstrated that the two strains represent a novel yeast species closely related to Scheffersomyces segobiensis. A sequence comparison of xylose reductase (XYL1) gene, which was recently recommended for rapid identification of cryptic species in the Scheffersomyces clade, revealed a significant sequence divergence of 25 nucleotides between the novel strains and their closest relative S. segobiensis, supporting their classification as a distinct species. Furthermore, these new strains can be clearly distinguished from S. segobiensis by a number of morphological and physiological characteristics. Therefore, a novel yeast species, Scheffersomyces henanensis sp. nov., is proposed to accommodate these strains. The type strain is BY-41(T) (= CICC 1974(T) = CBS 12475(T)).	[Ren, Yongcheng; Chen, Liang; Niu, Qiuhong; Hui, Fengli] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China	Nanyang Normal College	Hui, FL (corresponding author), Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China.	huifl@126.com		liang, CHEN/0000-0001-7429-4505	National Natural Science Foundation of China [31370073]; Research Planning Project of Basic and Advanced Technology of Henan Province, China [122300410032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Planning Project of Basic and Advanced Technology of Henan Province, China	This work was supported by the National Natural Science Foundation of China (31370073) and the Research Planning Project of Basic and Advanced Technology of Henan Province, China (122300410032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Agbogbo FK, 2007, J IND MICROBIOL BIOT, V34, P723, DOI 10.1007/s10295-007-0247-z; Agbogbo FK, 2006, BIOTECHNOL LETT, V28, P2065, DOI 10.1007/s10529-006-9192-6; BARNETT JA, 2000, YEASTS CHARACTERISTI; Cadete RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043135; Chandel AK, 2011, BIOTECHNOL MOL BIOL, V6; DUPREEZ JC, 1983, BIOTECHNOL LETT, V5, P357, DOI 10.1007/BF01141138; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hahn-Hagerdal B, 2004, APPL BIOCHEM BIOTECH, V113, P1207; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; JEFFRIES TW, 1985, TRENDS BIOTECHNOL, V3, P208, DOI 10.1016/0167-7799(85)90048-4; JEFFRIES TW, 1994, ENZYME MICROB TECH, V16, P922, DOI 10.1016/0141-0229(94)90001-9; Jindamorakot S, 2007, FEMS YEAST RES, V7, P1409, DOI 10.1111/j.1567-1364.2007.00305.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Limtong S, 2007, INT J SYST EVOL MICR, V57, P419, DOI 10.1099/ijs.0.64539-0; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; RAMIREZ C, 1984, MYCOPATHOLOGIA, V88, P83, DOI 10.1007/BF00436436; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos R, 2011, ANTON LEEUW INT J G, V99, P635, DOI 10.1007/s10482-010-9536-z; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suh SO, 2013, INT J SYST EVOL MICR, V63, P4330, DOI 10.1099/ijs.0.053009-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Thanh VN, 2003, FEMS YEAST RES, V4, P113, DOI 10.1016/S1567-1356(03)00079-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbina H, 2013, MYCOLOGIA, V105, P650, DOI 10.3852/12-094; Urbina H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039128; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; White T., 1990, PCR PROTOCOLS GUIDE, P315; YAMADA Y, 1973, J GEN APPL MICROBIOL, V19, P59, DOI 10.2323/jgam.19.59; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9	35	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92315	10.1371/journal.pone.0092315	http://dx.doi.org/10.1371/journal.pone.0092315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647466	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500114
J	Andreassen, KV; Hjuler, ST; Furness, SG; Sexton, PM; Christopoulos, A; Nosjean, O; Karsdal, MA; Henriksen, K				Andreassen, Kim Vietz; Hjuler, Sara Toftegaard; Furness, Sebastian G.; Sexton, Patrick M.; Christopoulos, Arthur; Nosjean, Olivier; Karsdal, Morten Asser; Henriksen, Kim			Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ADENYLATE-CYCLASE; REGIONAL-DISTRIBUTION; RAT OSTEOCLASTS; BINDING-SITES; KINASE-C; ACTIVATION; INTERNALIZATION; CELLS; PHARMACOLOGY	Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the differences between sCT and hCT on the human calcitonin receptor (CT(a)R) with respect to activation of cAMP signaling, beta-arrestin recruitment, ligand binding kinetics and internalization. The study was conducted using mammalian cell lines heterologously expressing the human CT(a) receptor. CT(a)R downstream signaling was investigated with dose response profiles for cAMP production and beta-arrestin recruitment for sCT and hCT during short term (<2 hours) and prolonged (up to 72 hours) stimulation. CT(a)R kinetics and internalization was investigated with radio-labeled sCT and hCT ligands on cultured cells and isolated membrane preparations from the same cell line. We found that sCT and hCT are equipotent during short-term stimulations with differences manifesting themselves only during long-term stimulation with sCT inducing a prolonged activation up to 72 hours, while hCT loses activity markedly earlier. The prolonged sCT stimulation of both cAMP accumulation and beta-arrestin recruitment was attenuated, but not abrogated by acid wash, suggesting a role for sCT activated internalized receptors. We have demonstrated a novel phenomenon, namely that two distinct CT(a)R downstream signaling activation patterns are activated by two related ligands, thereby highlighting qualitatively different signaling responses in vitro that could have implications for sCT use in vivo.	[Andreassen, Kim Vietz; Hjuler, Sara Toftegaard; Karsdal, Morten Asser; Henriksen, Kim] Nord Biosci AS, Herlev, Denmark; [Furness, Sebastian G.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Furness, Sebastian G.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Clayton, Vic 3800, Australia; [Nosjean, Olivier] Inst Rech Servier, Croissy Sur Seine, France	Nordic Bioscience; Monash University; Monash University; Servier; Institut de Recherches Internationales Servier	Andreassen, KV (corresponding author), Nord Biosci AS, Herlev, Denmark.	kan@nordicbioscience.com	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Furness, Sebastian/Q-9068-2018	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Furness, Sebastian/0000-0001-8655-8221; Karsdal, Morten/0000-0001-5026-8740	Danish Research Foundation; Danish Ministry for Science, Technology and Education	Danish Research Foundation; Danish Ministry for Science, Technology and Education	Partly funded by Danish Research Foundation and the Danish Ministry for Science, Technology and Education. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVINTE T, 1993, J BIOL CHEM, V268, P6415; Azria M, 1989, CALCITONINS; CHAKRABORTY M, 1994, P NATL ACAD SCI USA, V91, P2115, DOI 10.1073/pnas.91.6.2115; CHAKRABORTY M, 1991, SCIENCE, V251, P1078, DOI 10.1126/science.1847755; CHAMBERS TJ, 1986, J CLIN ENDOCR METAB, V63, P1080, DOI 10.1210/jcem-63-5-1080; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; DEL FA, 2008, ARCH BIOCHEM BIOPHYS, V473, P147; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Feigh M, 2012, BRIT J PHARMACOL, V167, P151, DOI 10.1111/j.1476-5381.2012.01979.x; Feigh M, 2011, DIABETES OBES METAB, V13, P911, DOI 10.1111/j.1463-1326.2011.01425.x; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FINDLAY DM, 1984, ENDOCRINOLOGY, V115, P78, DOI 10.1210/endo-115-1-78; FISCHER JA, 1981, P NATL ACAD SCI-BIOL, V78, P7801, DOI 10.1073/pnas.78.12.7801; FISCHER JA, 1981, LIFE SCI, V29, P663, DOI 10.1016/0024-3205(81)90018-7; Henriksen K, 2010, EXPERT OPIN BIOL TH, V10, P1617, DOI 10.1517/14712598.2010.526104; Henriksen K, 2009, BIOCHEM BIOPH RES CO, V378, P804, DOI 10.1016/j.bbrc.2008.11.145; Hilton JM, 2000, J ENDOCRINOL, V166, P213, DOI 10.1677/joe.0.1660213; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; HOUSSAMI S, 1995, MOL PHARMACOL, V47, P798; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; KUESTNER RE, 1994, MOL PHARMACOL, V46, P246; Mack CM, 2011, DIABETES OBES METAB, V13, P1105, DOI 10.1111/j.1463-1326.2011.01465.x; MICHELANGELI VP, 1983, J CYCLIC NUCL PROT, V9, P129; NICHOLSON GC, 1987, ENDOCRINOLOGY, V120, P1902, DOI 10.1210/endo-120-5-1902; Pham V, 2005, J BIOL CHEM, V280, P28610, DOI 10.1074/jbc.M503272200; Pham VI, 2004, J PEPT SCI, V10, P179, DOI 10.1002/psc.541; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; SCHNEIDER HG, 1990, ACTA ENDOCRINOL-COP, V122, P255, DOI 10.1530/acta.0.1220255; SCHNEIDER HG, 1988, MOL CELL ENDOCRINOL, V58, P9, DOI 10.1016/0303-7207(88)90048-2; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; SU YJ, 1992, ENDOCRINOLOGY, V131, P1497, DOI 10.1210/en.131.3.1497; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677; Young Andrew, 2005, Adv Pharmacol, V52, P47, DOI 10.1016/S1054-3589(05)52003-9; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9	37	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92042	10.1371/journal.pone.0092042	http://dx.doi.org/10.1371/journal.pone.0092042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643196	Green Published, gold			2022-12-25	WOS:000333259900070
J	Maguire, S; Estabel, J; Ingham, N; Pearson, S; Ryder, E; Carragher, DM; Walker, N; Bussell, J; Chan, WI; Keane, TM; Adams, DJ; Scudamore, CL; Lelliott, CJ; Ramirez-Solis, R; Karp, NA; Steel, KP; White, JK; Gerdin, AK				Maguire, Simon; Estabel, Jeanne; Ingham, Neil; Pearson, Selina; Ryder, Edward; Carragher, Damian M.; Walker, Nicolas; Bussell, James; Chan, Wai-In; Keane, Thomas M.; Adams, David J.; Scudamore, Cheryl L.; Lelliott, Christopher J.; Ramirez-Solis, Ramiro; Karp, Natasha A.; Steel, Karen P.; White, Jacqueline K.; Gerdin, Anna-Karin		Sanger MGP Slc25a21 Project Team	Targeting of Slc25a21 Is Associated with Orofacial Defects and Otitis Media Due to Disrupted Expression of a Neighbouring Gene	PLOS ONE			English	Article							ALPHA-AMINOADIPIC ACIDURIA; TRANSPORTER FAMILY SLC25; LOCUS-CONTROL REGION; REGULATORY ELEMENTS; MOLAR OLIGODONTIA; GENOME-WIDE; PAX9 GENE; MOUSE; IDENTIFICATION; MICE	Homozygosity for Slc25a21(tm1a(KOMP)Wtsi) results in mice exhibiting orofacial abnormalities, alterations in carpal and rugae structures, hearing impairment and inflammation in the middle ear. In humans it has been hypothesised that the 2oxoadipate mitochondrial carrier coded by SLC25A21 may be involved in the disease 2-oxoadipate acidaemia. Unexpectedly, no 2-oxoadipate acidaemia-like symptoms were observed in animals homozygous for Slc25a21(tm1a(KOMP)Wtsi) despite confirmation that this allele reduces Slc25a21 expression by 71.3%. To study the complete knockout, an allelic series was generated using the loxP and FRT sites typical of a Knockout Mouse Project allele. After removal of the critical exon and neomycin selection cassette, Slc25a21 knockout mice homozygous for the Slc25a21(tm1b(KOMP)Wtsi) and Slc25a21(tm1d(KOMP)Wtsi) alleles were phenotypically indistinguishable from wild-type. This led us to explore the genomic environment of Slc25a21 and to discover that expression of Pax9, located 3' of the target gene, was reduced in homozygous Slc25a21(tm1a(KOMP)Wtsi) mice. We hypothesize that the presence of the selection cassette is the cause of the down regulation of Pax9 observed. The phenotypes we observed in homozygous Slc25a21(tm1a(KOMP)Wtsi) mice were broadly consistent with a hypomorphic Pax9 allele with the exception of otitis media and hearing impairment which may be a novel consequence of Pax9 down regulation. We explore the ramifications associated with this particular targeted mutation and emphasise the need to interpret phenotypes taking into consideration all potential underlying genetic mechanisms.	[Maguire, Simon; Estabel, Jeanne; Ingham, Neil; Pearson, Selina; Ryder, Edward; Carragher, Damian M.; Walker, Nicolas; Bussell, James; Keane, Thomas M.; Adams, David J.; Lelliott, Christopher J.; Ramirez-Solis, Ramiro; Karp, Natasha A.; Steel, Karen P.; White, Jacqueline K.; Gerdin, Anna-Karin; Sanger MGP Slc25a21 Project Team] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Walker, Nicolas] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, Cambs, England; [Chan, Wai-In] Cambridge Inst Med Res, Dept Haematol, Cambridge, Cambs, England; [Scudamore, Cheryl L.] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of London; University of London Royal Veterinary College	White, JK (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	jkw@sanger.ac.uk	Ryder, Edward/AAK-1243-2021; Ismail, Ozama/AFQ-9517-2022; Carragher, Damian/E-6673-2016; Carragher, Damian/O-4183-2019	Ryder, Edward/0000-0002-1799-9899; Carragher, Damian/0000-0003-4341-4943; Carragher, Damian/0000-0003-4341-4943; Adams, David/0000-0001-9490-0306; Scudamore, Cheryl/0000-0002-7101-1714; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Keane, Thomas/0000-0001-7532-6898; Ismail, Ozama/0000-0002-0871-3924; Vancollie, Valerie/0000-0003-1547-1975; Karp, Natasha/0000-0002-8404-2907	Wellcome Trust [098051]; European Union [282510]; Medical Research Council [G0901338, MC_UP_1502/1, G0300212, MC_qA137918] Funding Source: researchfish; MRC [G0300212, MC_qA137918, MC_UP_1502/1, G0901338] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant no 098051 to WTSI) (http://www.wellcome.ac.uk/) and the European Union's Seventh Framework program under grant agreement number 282510 - BLUEPRINT (NW) (www.blueprint-epigenome.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Das P, 2003, AM J MED GENET A, V118A, P35, DOI 10.1002/ajmg.a.10011; DURAN M, 1984, J INHERIT METAB DIS, V7, P61, DOI 10.1007/BF01805803; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; FISCHER MH, 1980, AM J MED GENET, V5, P35, DOI 10.1002/ajmg.1320050106; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Mataki S, 1991, STUDIES TRANSPORT ME, P298; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Ovchinnikov D, 2009, COLD SPRING HARB PRO; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Peters H, 1997, MAMM GENOME, V8, P62, DOI 10.1007/s003359900351; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PRZYREMBEL H, 1976, CLIN CHIM ACTA, V66, P227, DOI 10.1016/0009-8981(76)90060-7; Ryder E, 2013, MAMM GENOME, V24, P286, DOI 10.1007/s00335-013-9467-x; Santagati F, 2003, GENETICS, V165, P235; Sasaki Y, 2007, ARCH ORAL BIOL, V52, P260, DOI 10.1016/j.archoralbio.2006.09.012; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tyrer HE, 2013, CURR ALLERGY ASTHM R, V13, P501, DOI 10.1007/s11882-013-0360-1; van der Weyden L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-224; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; WILSON RW, 1975, PEDIATR RES, V9, P522, DOI 10.1203/00006450-197506000-00002	38	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91807	10.1371/journal.pone.0091807	http://dx.doi.org/10.1371/journal.pone.0091807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642684	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900037
J	Maurya, SR; Mahalakshmi, R				Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan			Cysteine Residues Impact the Stability and Micelle Interaction Dynamics of the Human Mitochondrial beta-Barrel Anion Channel hVDAC-2	PLOS ONE			English	Article							MEMBRANE-PROTEIN VDAC; DETERGENT CONCENTRATION; ESCHERICHIA-COLI; BAK ACTIVATION; APOPTOSIS; ISOFORMS; SINGLE; UREA; TARGET; ENERGY	The anti-apoptotic 19-stranded transmembrane human voltage dependent anion channel isoform 2 (hVDAC-2) beta-barrel stability is crucial for anion transport in mitochondria. The role of the unusually high number of cysteine residues in this isoform is poorly understood. Using a Cys-less construct of hVDAC-2, we haveinvestigated the contribution of cysteines to channel function, barrel stability and its influence on the strength of protein-micelle interactions. We observe that despite the overall preservation in barrel structure upon cysteine mutation, subtle local variations in the mode of interaction of the barrel with its refolded micellar environment arise, which may manifest itself in the channel activity of both the proteins. Fluorescence measurements of the Trp residues in hVDAC-2 point to possible differences in the association of the barrel with lauryldimethylamine oxide (LDAO) micelles. Upon replacement of cysteines in hVDAC-2, our data suggests greater barrel rigidity by way of intra-protein interactions. This, in turn, lowers the equilibrium barrel thermodynamic parameters in LDAO by perturbingthe stability of the protein-micelle complex. In addition to this, we also find a difference in the cooperativity of unfolding upon increasing the LDAO concentration, implying the importance of micelle concentration and micelle-protein ratios on the stability of this barrel. Our results indicate that the nine cysteine residues of hVDAC-2 are the key in establishing strong(er) barrel interactions with its environment and also impart additional malleability to the barrel scaffold.	[Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India.	maha@iiserb.ac.in	Maurya, Svetlana/H-3664-2018; Mahalakshmi, Radhakrishnan/B-3143-2008	Maurya, Svetlana/0000-0002-4700-2711; Mahalakshmi, Radhakrishnan/0000-0003-1549-7550	Department of Biotechnology (DBT), Govt. of India [BT/01/IYBA/2009]; Council of Scientific and Industrial Research, India; DBT, Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); DBT, Govt. of India(Department of Biotechnology (DBT) India)	This work is supported by the Department of Biotechnology (DBT), Govt. of India award number BT/01/IYBA/2009. SRM is supported by a senior research fellowship from Council of Scientific and Industrial Research, India. R. M. is a recipient of the Ramalingaswami Fellowship from DBT, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1986, BIOPOLYMERS, V25, P1623, DOI 10.1002/bip.360250906; Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Canchi DR, 2013, ANNU REV PHYS CHEM, V64, P273, DOI 10.1146/annurev-physchem-040412-110156; Chaturvedi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079351; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2007, METHOD CELL BIOL, V80, P241, DOI 10.1016/S0091-679X(06)80012-9; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1438, DOI 10.1016/j.bbamem.2011.11.014; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Franzin CM, 2007, J AM CHEM SOC, V129, P8078, DOI 10.1021/ja0728371; GREENE RF, 1974, J BIOL CHEM, V249, P5388; HERRMANN KW, 1962, J PHYS CHEM-US, V66, P295, DOI 10.1021/j100808a025; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Kaufmann TC, 2006, DETERGENT PROTEIN DE; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Lakowicz J.R., 1991, TOPICS FLUORESCENCE, V2; Lazarou M, 2010, J BIOL CHEM, V285, P36876, DOI 10.1074/jbc.M110.159301; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Maurya SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087701; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; Menzel VA, 2009, BIOSCIENCE REP, V29, P351, DOI 10.1042/BSR20080123; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Mudiyanselage APKKK, 2013, BIOCHEMISTRY-US, V52, P6127, DOI 10.1021/bi4007176; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Plotz M, 2012, CELL DEATH DIFFER, V19, P1928, DOI 10.1038/cdd.2012.71; Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Ren DC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000274; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Sheshadri S, 1999, PROTEIN SCI, V8, P1689, DOI 10.1110/ps.8.8.1689; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Stangl M, 2012, BIOPHYS J, V103, P2455, DOI 10.1016/j.bpj.2012.11.004; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Tan EHL, 1996, BIOPHYS J, V70, P2385, DOI 10.1016/S0006-3495(96)79806-5; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Venkatesu P, 2007, ARCH BIOCHEM BIOPHYS, V466, P106, DOI 10.1016/j.abb.2007.07.004; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhang XP, 2012, PROTEIN CELL, V3, P790, DOI 10.1007/s13238-012-2069-7	71	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92183	10.1371/journal.pone.0092183	http://dx.doi.org/10.1371/journal.pone.0092183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642864	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900099
J	Scholer, J; Krischik, V				Scholer, Jamison; Krischik, Vera			Chronic Exposure of Imidacloprid and Clothianidin Reduce Queen Survival, Foraging, and Nectar Storing in Colonies of Bombus impatiens	PLOS ONE			English	Article							COORDINATED AGRICULTURAL PROJECT; HONEY-BEE; NEONICOTINOID INSECTICIDES; TERRESTRIS HYMENOPTERA; PESTICIDE EXPOSURE; NATIONAL RESEARCH; NOSEMA-CERANAE; TOXICITY; APIDAE; RISK	In an 11-week greenhouse study, caged queenright colonies of Bombus impatiens Cresson, were fed treatments of 0 (0 ppb actual residue I, imidacloprid; C, clothianidin), 10 (14 I, 9 C), 20 (16 I, 17 C), 50 (71 I, 39 C) and 100 (127 I, 76 C) ppb imidacloprid or clothianidin in sugar syrup (50%). These treatments overlapped the residue levels found in pollen and nectar of many crops and landscape plants, which have higher residue levels than seed-treated crops (less than 10 ppb, corn, canola and sunflower). At 6 weeks, queen mortality was significantly higher in 50 ppb and 100 ppb and by 11 weeks in 20 ppb-100 ppb neonicotinyl-treated colonies. The largest impact for both neonicotinyls starting at 20 (16 I, 17 C) ppb was the statistically significant reduction in queen survival (37% I, 56% C) ppb, worker movement, colony consumption, and colony weight compared to 0 ppb treatments. Bees at feeders flew back to the nest box so it appears that only a few workers were collecting syrup in the flight box and returning the syrup to the nest. The majority of the workers sat immobilized for weeks on the floor of the flight box without moving to fed at sugar syrup feeders. Neonicotinyl residues were lower in wax pots in the nest than in the sugar syrup that was provided. At 10 (14) ppb I and 50 (39) ppb C, fewer males were produced by the workers, but queens continued to invest in queen production which was similar among treatments. Feeding on imidacloprid and clothianidin can cause changes in behavior (reduced worker movement, consumption, wax pot production, and nectar storage) that result in detrimental effects on colonies (queen survival and colony weight). Wild bumblebees depending on foraging workers can be negatively impacted by chronic neonicotinyl exposure at 20 ppb.	[Scholer, Jamison; Krischik, Vera] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Krischik, V (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	krisc001@umn.edu			USDA SARE [00015590]; grant "Mitigating pollinator decline" [MN LCCMR 221G]; University of Minnesota Experiment Station (MAES) project [MN 17-027]	USDA SARE(United States Department of Agriculture (USDA)); grant "Mitigating pollinator decline"; University of Minnesota Experiment Station (MAES) project	Research was supported by a USDA SARE (00015590) grant "The role of imidacloprid systemic insecticide on colony collapse disorder of honey bees and decline of bumblebee pollinators", 2010 MN LCCMR 221G grant "Mitigating pollinator decline", and University of Minnesota Experiment Station (MAES) project MN 17-027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Averill AL, 2011, AM BEE J, V151, P1187; Baldwin J, 2003, DELTA FARM PRES 1211; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cnaani J, 2002, INSECT SOC, V49, P164, DOI 10.1007/s00040-002-8297-8; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; EFSA Panel on Biological Hazards, 2012, EFSA Journal, V10, P2724; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Elston C, 2013, APIDOLOGIE, V44, P563, DOI 10.1007/s13592-013-0206-9; Fischer DL, 2007, BAYER CROPSCIENCE; Frazier J, 2011, AM BEE J, V151, P779; Frazier M, 2008, AM BEE J, V148, P521; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gradish AE, 2010, PEST MANAG SCI, V66, P142, DOI 10.1002/ps.1846; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Incerti Francesca, 2003, Bulletin of Insectology, V56, P159; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Minnesota Department of Agriculture, 2013, PEST SAL DAT 2009; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MORSE RA, 2003, BEECULTURE, V128, P1; Paine TD, 2011, BIOL CONTROL, V56, P175, DOI 10.1016/j.biocontrol.2010.08.007; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilatic H, 2012, WIDELY USED PESTICID; Prichard AM, 2009, NOT DEC IN REEV CHEM; Rossler W., 2012, HONEYBEE NEUROBIOLOG, P141, DOI [DOI 10.1007/978-94-007-2099-2, 10.1007/978-94-007-2099-2]; SAS, 2010, SAS ENT GUID 4 3; SAS, 2010, JMP PRO 9 0 2; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott-Dupree CD, 2001, IMPACT GAUCHO TI 435; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Tome HVV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038406; USDA APHIS, 2003, AS LONGH BEETL COOP; USDA ARS, 2011, COL COLL DIS PROGR R; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; van der Steen JJM, 2008, APIDOLOGIE, V39, P273, DOI 10.1051/apido:2008006; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vaughan M, 2006, 35 USDA NAT AGR CTR; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winter K, 2006, IMPORTATION NONNATIV	73	51	51	3	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91573	10.1371/journal.pone.0091573	http://dx.doi.org/10.1371/journal.pone.0091573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643057	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900027
J	Thompson, AA; Byrne, PA; Henriques, DYP				Thompson, Aidan A.; Byrne, Patrick A.; Henriques, Denise Y. P.			Visual Targets Aren't Irreversibly Converted to Motor Coordinates: Eye-Centered Updating of Visuospatial Memory in Online Reach Control	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; REFERENCE FRAMES; HAND COORDINATION; GUIDED REACH; MOVEMENTS; SPACE; TRANSFORMATIONS; GAZE; INFORMATION; REPRESENTATION	Counter to current and widely accepted hypotheses that sensorimotor transformations involve converting target locations in spatial memory from an eye-fixed reference frame into a more stable motor-based reference frame, we show that this is not strictly the case. Eye-centered representations continue to dominate reach control even during movement execution; the eye-centered target representation persists after conversion to a motor-based frame and is continuously updated as the eyes move during reach, and is used to modify the reach plan accordingly during online control. While reaches are known to be adjusted online when targets physically shift, our results are the first to show that similar adjustments occur in response to changes in representations of remembered target locations. Specifically, we find that shifts in gaze direction, which produce predictable changes in the internal (specifically eye-centered) representation of remembered target locations also produce mid-transport changes in reach kinematics. This indicates that representations of remembered reach targets (and visuospatial memory in general) continue to be updated relative to gaze even after reach onset. Thus, online motor control is influenced dynamically by both the external and internal updating mechanisms.	[Thompson, Aidan A.; Byrne, Patrick A.; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Thompson, Aidan A.; Henriques, Denise Y. P.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Henriques, DYP (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	deniseh@yorku.ca		Byrne, Patrick/0000-0002-5276-5393	Natural Sciences and Engineering Research Council; Canadian Foundation for Innovation New Opportunities Fund; Ontario Graduate Scholarships Science and Technology program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation New Opportunities Fund(Canada Foundation for Innovation); Ontario Graduate Scholarships Science and Technology program	This work was funded by the Natural Sciences and Engineering Research Council (through a Discovery Grant to DYPH and a post-graduate scholarship to AAT), the Canadian Foundation for Innovation New Opportunities Fund (DYPH), and the Ontario Graduate Scholarships Science and Technology program (AAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Byrne PA, 2010, J NEUROPHYSIOL, V103, P3054, DOI 10.1152/jn.01008.2009; Chen Y, 2011, NEUROPSYCHOLOGIA, V49, P49, DOI 10.1016/j.neuropsychologia.2010.10.031; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2002, PROG BRAIN RES, V140, P329; HOGAN N, 1984, J NEUROSCI, V4, P2745; Izawa J, 2008, J NEUROSCI, V28, P11360, DOI 10.1523/JNEUROSCI.3063-08.2008; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Khan AZ, 2001, VISION RES, V41, P1743, DOI 10.1016/S0042-6989(01)00079-7; McGovern NN, 2011, J IMMUNOL, V186, P453, DOI 10.4049/jimmunol.1002213; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Medendorp WP, 2002, NEUROREPORT, V13, P633, DOI 10.1097/00001756-200204160-00019; Poljac E, 2003, EXP BRAIN RES, V151, P501, DOI 10.1007/s00221-003-1498-1; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Sorrento GU, 2008, J NEUROPHYSIOL, V99, P2968, DOI 10.1152/jn.90225.2008; Thompson AA, 2008, J NEUROPHYSIOL, V100, P2507, DOI 10.1152/jn.90599.2008; Van Pelt S, 2007, J NEUROPHYSIOL, V97, P1209, DOI 10.1152/jn.00882.2006	26	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92455	10.1371/journal.pone.0092455	http://dx.doi.org/10.1371/journal.pone.0092455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643008	gold, Green Published			2022-12-25	WOS:000333259900143
J	Gyllensten, H; Hakkarainen, KM; Hagg, S; Carlsten, A; Petzold, M; Rehnberg, C; Jonsson, AK				Gyllensten, Hanna; Hakkarainen, Katja M.; Hagg, Staffan; Carlsten, Anders; Petzold, Max; Rehnberg, Clas; Jonsson, Anna K.			Economic Impact of Adverse Drug Events - A Retrospective Population-Based Cohort Study of 4970 Adults	PLOS ONE			English	Article							COSTS; ADMISSIONS	Background: The aim was to estimate the direct costs caused by ADEs, including costs for dispensed drugs, primary care, other outpatient care, and inpatient care, and to relate the direct costs caused by ADEs to the societal COI (direct and indirect costs), for patients with ADEs and for the entire study population. Methods: We conducted a population-based observational retrospective cohort study of ADEs identified from medical records. From a random sample of 5025 adults in a Swedish county council, 4970 were included in the analyses. During a three-month study period in 2008, direct and indirect costs were estimated from resource use identified in the medical records and from register data on costs for resource use. Results: Among 596 patients with ADEs, the average direct costs per patient caused by ADEs were USD 444.9 [95% CI: 264.4 to 625.3], corresponding to USD 21 million per 100 000 adult inhabitants per year. Inpatient care accounted for 53.9% of all direct costs caused by ADEs. For patients with ADEs, the average societal cost of illness was USD 6235.0 [5442.8 to 7027.2], of which direct costs were USD 2830.1 [2260.7 to 3399.4] (45%), and indirect costs USD 3404.9 [2899.3 to 3910.4] (55%). The societal cost of illness was higher for patients with ADEs compared to other patients. ADEs caused 9.5% of all direct healthcare costs in the study population. Conclusions: Healthcare costs for patients with ADEs are substantial across different settings; in primary care, other outpatient care and inpatient care. Hence the economic impact of ADEs will be underestimated in studies focusing on inpatient ADEs alone. Moreover, the high proportion of indirect costs in the societal COI for patients with ADEs suggests that the observed costs caused by ADEs would be even higher if including indirect costs. Additional studies are needed to identify interventions to prevent and manage ADEs.	[Gyllensten, Hanna; Hakkarainen, Katja M.; Carlsten, Anders] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Gyllensten, Hanna; Hakkarainen, Katja M.] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Social Med, Gothenburg, Sweden; [Hagg, Staffan; Jonsson, Anna K.] Linkoping Univ, Fac Hlth Sci, Dept Drug Res Clin Pharmacol, Linkoping, Sweden; [Hagg, Staffan] Jonkoping Cty Council, Futurum Acad Hlth & Care, Jonkoping, Sweden; [Carlsten, Anders] Med Prod Agcy, Uppsala, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat Occupat & Environm Med, Akad Stat, Gothenburg, Sweden; [Rehnberg, Clas] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Jonsson, Anna K.] Cty Council Ostergotland, Dept Clin Pharmacol, Linkoping, Sweden	University of Gothenburg; Linkoping University; Futurum; Medical Products Agency; University of Gothenburg; Karolinska Institutet; City Council Ostergotland	Gyllensten, H (corresponding author), Nord Sch Publ Hlth NHV, Gothenburg, Sweden.	hanna.gyllensten@nhv.se	Hägg, Staffan/G-5612-2013; Gyllensten, Hanna/H-7378-2016	Hägg, Staffan/0000-0002-5137-8420; Gyllensten, Hanna/0000-0001-6890-5162; Rehnberg, Clas/0000-0001-5326-450X	National Corporation of Swedish Pharmacies (Apoteket AB); Region Vastra Gotaland; Ostergotland County Council	National Corporation of Swedish Pharmacies (Apoteket AB); Region Vastra Gotaland; Ostergotland County Council	The research was funded by an unrestricted grant from the National Corporation of Swedish Pharmacies (Apoteket AB). Additional funding was received from Region Vastra Gotaland and Ostergotland County Council. The study sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The research was conducted independently from the sponsor.	Anell Anders, 2012, Health Syst Transit, V14, P1; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Gyllensten H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002574; Gyllensten H, 2012, DRUG SAFETY, V35, P207, DOI 10.2165/11597090-000000000-00000; Hakkarainen KM, 2013, BR J CLIN P IN PRESS, DOI [10.1111/bcp.12314, DOI 10.1111/BCP.12314:IN]; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Hohl CM, 2011, ANN EMERG MED, V58, P270, DOI 10.1016/j.annemergmed.2011.01.003; Hoonhout LHF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-27; Howard RL, 2003, QUAL SAF HEALTH CARE, V12, P280, DOI 10.1136/qhc.12.4.280; Hug BL, 2012, JT COMM J QUAL PATIE, V38, P120, DOI 10.1016/S1553-7250(12)38016-1; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Nordic Centre for Classifications in Health Care, NORD CTR CLASS HLTH; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Rodriguez-Monguio R, 2003, PHARMACOECONOMICS, V21, P623, DOI 10.2165/00019053-200321090-00002; Segel J. E., 2006, RTI UNC CTR EXCELLEN, P1; Statistics Sweden, STAT FOLKM EFT REG C; Statistics Sweden, 2013, STAT GEN GRUND MAN S; Sveriges Riksbank, SVER RIKSB ARSG VAL; Swedish Tax Agency, 2007, SKATT SVER SKATT ARS; Tafreshi MJ, 1999, ANN PHARMACOTHER, V33, P1252, DOI 10.1345/aph.19062	21	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92061	10.1371/journal.pone.0092061	http://dx.doi.org/10.1371/journal.pone.0092061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637879	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100109
J	Preti, MG; Makris, N; Papadimitriou, G; Lagana, MM; Griffanti, L; Clerici, M; Nemni, R; Westin, CF; Baselli, G; Baglio, F				Preti, Maria Giulia; Makris, Nikos; Papadimitriou, George; Lagana, Maria Marcella; Griffanti, Ludovica; Clerici, Mario; Nemni, Raffaello; Westin, Carl-Fredrik; Baselli, Giuseppe; Baglio, Francesca			A Novel Approach of Groupwise fMRI-Guided Tractography Allowing to Characterize the Clinical Evolution of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; BRAIN ACTIVATION; DIFFUSION; DTI; RECOMMENDATIONS; DISCONNECTION; DEMENTIA	Guiding diffusion tract-based anatomy by functional magnetic resonance imaging (fMRI), we aim to investigate the relationship between structural connectivity and functional activity in the human brain. To this purpose, we introduced a novel groupwise fMRI-guided tractographic approach, that was applied on a population ranging between prodromic and moderate stages of Alzheimer's disease (AD). The study comprised of 15 subjects affected by amnestic mild cognitive impairment (aMCI), 14 diagnosed with AD and 14 elderly healthy adults who were used as controls. By creating representative (ensemble) functionally guided tracts within each group of participants, our methodology highlighted the white matter fiber connections involved in verbal fluency functions for a specific population, and hypothesized on brain compensation mechanisms that potentially counteract or reduce cognitive impairment symptoms in prodromic AD. Our hope is that this fMRI-guided tractographic approach could have potential impact in various clinical studies, while investigating white/gray matter connectivity, in both health and disease.	[Preti, Maria Giulia; Lagana, Maria Marcella; Griffanti, Ludovica; Clerici, Mario; Nemni, Raffaello; Baglio, Francesca] Fdn Don Carlo Gnocchi ONLUS, IRCCS, Milan, Italy; [Preti, Maria Giulia; Griffanti, Ludovica; Baselli, Giuseppe] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Makris, Nikos; Papadimitriou, George] Harvard Univ, Sch Med, Dept Psychiat,Massachusetts Gen Hosp, Ctr Neural Syst Invest,Ctr Morphometr Anal,Athino, Boston, MA 02115 USA; [Makris, Nikos; Papadimitriou, George] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging,Dept Neur, Ctr Neural Syst Invest,Ctr Morphometr Anal,Sch Me, Boston, MA USA; [Makris, Nikos] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat,Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Makris, Nikos] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Clerici, Mario; Nemni, Raffaello] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Westin, Carl-Fredrik] Brigham & Womens Hosp, Dept Radiol, Lab Math Imaging, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	IRCCS Fondazione Don Carlo Gnocchi Onlus; Polytechnic University of Milan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; University of Milan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Preti, MG (corresponding author), Fdn Don Carlo Gnocchi ONLUS, IRCCS, Milan, Italy.	gpreti@dongnocchi.it	Lagana, Maria Marcella/L-8050-2016; Griffanti, Ludovica/ABA-4218-2020; Preti, Maria Giulia/X-9430-2019; Baglio, Francesca/K-2808-2016; baglio, francesca/AAX-6298-2020	Lagana, Maria Marcella/0000-0001-7848-1711; Griffanti, Ludovica/0000-0002-0540-9353; Preti, Maria Giulia/0000-0002-5323-5327; Baglio, Francesca/0000-0002-6145-5274; baglio, francesca/0000-0002-6145-5274; Clerici, Mario/0000-0001-5920-6191	Ricerca Corrente; Italian Ministry of Health; National Institutes of Health (NIH) [R01MH074794, P41EB015902, R01AG042512, R01DA027804, R21NS079905, R21NS077059]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077059, R21NS079905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027804] Funding Source: NIH RePORTER	Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by 2011-2012 Ricerca Corrente, Italian Ministry of Health (http://www.salute.gov.it/portale/temi/p2_5. jsp?lingua = italiano&area = Ricerca%20sanita ria&menu = corrente), National Institutes of Health (NIH) R01MH074794, NIH P41EB015902, NIH R01AG042512, NIH R01DA027804, NIH R21NS079905 and NIH R21NS077059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Basho S, 2007, NEUROPSYCHOLOGIA, V45, P1697, DOI 10.1016/j.neuropsychologia.2007.01.007; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jackowski M, 2005, MED IMAGE ANAL, V9, P427, DOI 10.1016/j.media.2005.05.008; Jansen A, 2005, HUM BRAIN MAPP, V24, P165, DOI 10.1002/hbm.20077; Kim DS, 2005, ANN NY ACAD SCI, V1064, P1, DOI 10.1196/annals.1340.005; Kleiser R, 2010, NEURORADIOLOGY, V52, P37, DOI 10.1007/s00234-009-0539-2; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lagana M., 2010, COMPUT INTEL NEUROSC; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Magni E, 1996, EUR J NEUROL, V3, P98; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Neufang S, 2011, J ALZHEIMERS DIS, V25, P309, DOI 10.3233/JAD-2011-102154; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pihlajamaki M, 2008, AM J GERIAT PSYCHIAT, V16, P283, DOI 10.1097/JGP.0b013e318162a0a9; Preti MG, 2012, IEEE ENG MED BIO, P2283, DOI 10.1109/EMBC.2012.6346418; Preti MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035856; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Schlosser RGM, 2007, SCHIZOPHR RES, V89, P1, DOI 10.1016/j.schres.2006.09.007; Smits M, 2007, AM J NEURORADIOL, V28, P1354, DOI 10.3174/ajnr.A0538; Staempfli P, 2008, NEUROIMAGE, V39, P119, DOI 10.1016/j.neuroimage.2007.08.025; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058887	39	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92026	10.1371/journal.pone.0092026	http://dx.doi.org/10.1371/journal.pone.0092026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637718	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100102
J	Stahl-Pehe, A; Lange, K; Bachle, C; Castillo, K; Holl, RW; Rosenbauer, J				Stahl-Pehe, Anna; Lange, Karin; Baechle, Christina; Castillo, Katty; Holl, Reinhard W.; Rosenbauer, Joachim			Mental Health Problems among Adolescents with Early-Onset and Long-Duration Type 1 Diabetes and Their Association with Quality of Life: A Population-Based Survey	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; GERMAN HEALTH; CHILD HEALTH; SELF-REPORTS; PARENT; PREVALENCE; INTERVIEW; STRENGTHS; IMPACT	Objective: To evaluate mental health problems and associations between mental health problems and health-related quality of life in adolescents with type 1 diabetes in comparison with the general population. Method: A total of 629 11-to 17-year-olds with early-onset and long-lasting type 1 diabetes and their parents completed comprehensive questionnaires. Mental health was assessed using the parent-and self-report versions of the Strengths and Difficulties Questionnaire (SDQ). The Revised Children's Quality of Life Questionnaire (KINDL-R) was used to measure quality of life. The comparison group (n = 6,813) was a representative sample from the German KiGGS study. Results: The proportion of youths with mental health problems (defined as abnormal SDQ total difficulties score) was, based on self-reports, 4.4% in the patient group and 2.9% in the general population (adjusted OR = 1.61, p = 0.044); and based on proxy reports, 7.9% in the patient group and 7.2% in the general population (OR = 1.05, p = 0.788). Youths with type 1 diabetes and self-reported mental health problems scored worse in the KINDL-R subscales of physical well-being (adjusted average difference beta = -16.74, p < 0.001) and family (beta = -11.09, p = 0.017), and in the KINDL-R total score (beta = -8.09, p < 0.001), than peers with self-reported mental health problems. The quality of life of diabetic adolescents and proxy-reported mental health problems did not differ from peers with proxy-reported mental health problems adjusted for confounders. Conclusions: Compared with the general population with mental health problems, the quality of life of adolescents with type 1 diabetes who report mental health problems is more severely impaired. This observation calls for early prevention and intervention as part of pediatric diabetes long-term care.	[Stahl-Pehe, Anna; Baechle, Christina; Castillo, Katty; Rosenbauer, Joachim] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr DDZ, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Lange, Karin] Hannover Med Sch, Med Psychol Unit, Hannover, Germany; [Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Hannover Medical School; Ulm University	Stahl-Pehe, A (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr DDZ, Inst Biometr & Epidemiol, Dusseldorf, Germany.	anna.stahl@ddz.uni-duesseldorf.de		Holl, Reinhard/0000-0003-1395-4842; Stahl-Pehe, Anna/0000-0002-5281-6023	Competence Network for Diabetes Mellitus; Federal Ministry of Education and Research [01GI0802, 01GI1109A]; German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia	Competence Network for Diabetes Mellitus; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia	The study was supported by the Competence Network for Diabetes Mellitus (www.kompetenznetz-diabetes-mellitus.net/index.php/en) funded by the Federal Ministry of Education and Research (support code 01GI0802, 01GI1109A). The German Diabetes Center is institutionally funded by the German Ministry of Health and the Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2012, J AM ACAD CHILD PSY, V51, P1261, DOI 10.1016/j.jaac.2012.09.010; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950; Boe T, 2012, SOC PSYCH PSYCH EPID, V47, P1557, DOI 10.1007/s00127-011-0462-9; Bot M, 2011, EPIDEMIOL PSYCH SCI, V20, P357, DOI 10.1017/S2045796011000540; Bullinger M, 2008, EUR CHILD ADOLES PSY, V17, P125, DOI 10.1007/s00787-008-1014-z; de Wit M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-10; Delamater AM, 2009, PEDIATR DIABETES, V10, P175, DOI 10.1111/j.1399-5448.2009.00580.x; Erhart M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-77; Essau CA, 2012, INT J METH PSYCH RES, V21, P232, DOI 10.1002/mpr.1364; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Goodman R, 2012, SDQ SCORING INSTRUCT; Graue M, 2003, ACTA PAEDIATR, V92, P1190, DOI 10.1080/08035250310005657; Helgeson VS, 2007, J PEDIATR PSYCHOL, V32, P794, DOI 10.1093/jpepsy/jsm020; Helm Dieter, 2010, Central European Journal of Public Health, V18, P3; Holling H, 2008, EUR CHILD ADOLES PSY, V17, P34, DOI 10.1007/s00787-008-1004-1; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kulzer B, 2013, DIABETOL STOFFWECHS, V8, P198, DOI 10.1055/s-0033-1335785; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lange M, 2007, BUNDESGESUNDHEITSBLA, V50, P578, DOI 10.1007/s00103-007-0219-5; Marzelli MJ, 2014, DIABETES, V63, P343, DOI 10.2337/db13-0179; Moore SM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-50; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Perna L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-199; Persson S, 2013, DIABETOLOGIA, V56, P1254, DOI 10.1007/s00125-013-2870-8; Rajmil L, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-103; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Rothenberger A, 2008, EUR CHILD ADOLES PSY, V17, P99, DOI 10.1007/s00787-008-1011-2; Salardi S, 2012, DIABETES CARE, V35, P829, DOI 10.2337/dc11-1489; Speight J, 2013, MED J AUSTRALIA, V198, P16, DOI 10.5694/mja12.11489; Stahl A, 2012, DIABETES CARE, V35, P1736, DOI 10.2337/dc11-2438; Stahl-Pehe A, 2014, PEDIATR DIABETES, V15, P436, DOI 10.1111/pedi.12096; Stevanovic D, 2013, QUAL LIFE RES, V22, P333, DOI 10.1007/s11136-012-0158-y; Olives EV, 2013, QUAL LIFE RES, V22, P613, DOI 10.1007/s11136-012-0167-x; Wake M, 2000, DIABETIC MED, V17, P700, DOI 10.1046/j.1464-5491.2000.00360.x	41	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92473	10.1371/journal.pone.0092473	http://dx.doi.org/10.1371/journal.pone.0092473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4XD	24637957	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100150
J	Tanabe, K; Yamazaki, H; Inaguma, Y; Asada, A; Kimura, T; Takahashi, J; Taoka, M; Ohshima, T; Furuichi, T; Isobe, T; Nagata, K; Shirao, T; Hisanaga, S				Tanabe, Kazuya; Yamazaki, Hiroyuki; Inaguma, Yutaka; Asada, Akiko; Kimura, Taeko; Takahashi, Junya; Taoka, Masato; Ohshima, Toshio; Furuichi, Teiichi; Isobe, Toshiaki; Nagata, Koh-ichi; Shirao, Tomoaki; Hisanaga, Shin-ichi			Phosphorylation of Drebrin by Cyclin-Dependent Kinase 5 and Its Role in Neuronal Migration	PLOS ONE			English	Article							REGULATES ACTIN POLYMERIZATION; CDK5 ACTIVATOR P35; BIPOLAR TRANSITION; PROTEIN; COMPLEX; GROWTH; BINDING; CELLS	Cyclin-dependent kinase 5 (Cdk5)-p35 is a proline-directed Ser/Thr kinase which plays a key role in neuronal migration, neurite outgrowth, and spine formation during brain development. Dynamic remodeling of cytoskeletons is required for all of these processes. Cdk5-p35 phosphorylates many cytoskeletal proteins, but it is not fully understood how Cdk5-p35 regulates cytoskeletal reorganization associated with neuronal migration. Since actin filaments are critical for the neuronal movement and process formation, we aimed to find Cdk5 substrates among actin-binding proteins. In this study, we isolated actin gels from mouse brain extracts, which contain many actin-binding proteins, and phosphorylated them by Cdk5-p35 in vitro. Drebrin, a side binding protein of actin filaments and well known for spine formation, was identified as a phosphorylated protein. Drebrin has two isoforms, an embryonic form drebrin E and an adult type long isoform drebrin A. Ser142 was identified as a common phosphorylation site to drebrin E and A and Ser342 as a drebrin A-specific site. Phosphorylated drebrin is localized at the distal area of total drebrin in the growth cone of cultured primary neurons. By expressing nonphosphorylatable or phosphorylation mimicking mutants in developing neurons in utero, the reversible phosphorylation/dephosphorylation reaction of drebrin was shown to be involved in radial migration of cortical neurons. These results suggest that Cdk5-p35 regulates neuronal migration through phosphorylation of drebrin in growth cone processes.	[Tanabe, Kazuya; Asada, Akiko; Kimura, Taeko; Takahashi, Junya; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Yamazaki, Hiroyuki; Shirao, Tomoaki] Gunma Univ, Grad Sch Med, Dept Neurobiol & Behav, Maebashi, Gunma, Japan; [Inaguma, Yutaka; Nagata, Koh-ichi] Inst Dev Res, Kasugai, Aichi, Japan; [Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 19203, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Furuichi, Teiichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo Metropolitan University; Gunma University; Tokyo Metropolitan University; Waseda University; Tokyo University of Science	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	hisanaga-shinichi@tmu.ac.jp	Furuichi, Teiichi/B-5086-2014; Isobe, Toshiaki/Q-9279-2017; Shirao, Tomoaki/I-9257-2016	Furuichi, Teiichi/0000-0002-9676-1888; Taoka, Masato/0000-0001-5554-4951; Shirao, Tomoaki/0000-0003-4323-028X	Ministry of Education, Science and Culture, Japan [19057007, 20370047]	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants-in-aid from the Ministry of Education, Science and Culture, Japan (19057007 and 20370047 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chew CS, 2005, AM J PHYSIOL-GASTR L, V289, pG320, DOI 10.1152/ajpgi.00002.2005; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dun XP, 2012, MOL CELL NEUROSCI, V49, P341, DOI 10.1016/j.mcn.2012.01.006; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Honda T, 2011, NEUROCHEM RES, V36, P1270, DOI 10.1007/s11064-011-0407-4; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ishikawa R, 2007, BIOCHEM BIOPH RES CO, V359, P398, DOI 10.1016/j.bbrc.2007.05.123; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2013, GENES CELLS, V18, P176, DOI 10.1111/gtc.12029; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishimura YV, 2012, MED MOL MORPHOL, V45, P1, DOI 10.1007/s00795-011-0557-0; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Paglini G, 1998, J NEUROSCI, V18, P9858; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Taguchi K, 2005, J NEUROSCI RES, V81, P218, DOI 10.1002/jnr.20555; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; Tsutsumi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010260; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Xie MJ, 2013, CEREB CORTEX, V23, P1410, DOI 10.1093/cercor/bhs123; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007	50	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92291	10.1371/journal.pone.0092291	http://dx.doi.org/10.1371/journal.pone.0092291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637538	gold, Green Published, Green Submitted			2022-12-25	WOS:000333254100138
J	Zhang, GY; Zou, XY; Miao, S; Chen, JJ; Du, T; Zhong, L; Ju, GQ; Liu, GH; Zhu, YJ				Zhang, Guangyuan; Zou, Xiangyu; Miao, Shuai; Chen, Jinjun; Du, Tao; Zhong, Liang; Ju, Guanqun; Liu, Guohua; Zhu, Yingjian			The Anti-Oxidative Role of Micro-Vesicles Derived from Human Wharton-Jelly Mesenchymal Stromal Cells through NOX2/gp91(phox) Suppression in Alleviating Renal Ischemia-Reperfusion Injury in Rats	PLOS ONE			English	Article							GENERATING NADPH OXIDASES; ACUTE KIDNEY INJURY; STEM-CELLS; OXIDATIVE STRESS; IN-VIVO; MICROVESICLES; PROTECT; MICROPARTICLES; INDUCTION; INCREASES	Oxidative stress is known as one of the main contributors in renal ischemia/reperfusion injury (IRI). Here we hypothesized that Micro-vesicles (MVs) derived from human Wharton Jelly mesenchymal stromal cells (hWJMSCs) could protect kidney against IRI through mitigating oxidative stress. MVs isolated from hWJMSCs conditioned medium were injected intravenously in rats immediately after unilateral kidney ischemia for 60 min. The animals were sacrificed at 24h, 48h and 2 weeks respectively after reperfusion. Our results show that the expression of NOX2 and reactive oxygen species (ROS) in injured kidney tissues was declined and the oxidative stress was alleviated in MVs group at 24h and 48h in parallel with the reduced apoptosis and enhanced proliferation of cells. IRI-initiated fibrosis was abrogated by MVs coincident with renal function amelioration at 2 weeks. NOX2 was also found down-regulated by MVs both in human umbilical vein endothelial cells (HUVEC) and NRK-52E cell line under hypoxia injury model in vitro. In conclusion, a single administration of hWJMSC-MVs might protect the kidney by alleviation of the oxidative stress in the early stage of kidney IRI through suppressing NOX2 expression. Moreover, it could reduce the fibrosis and improved renal function.	[Zhang, Guangyuan; Zou, Xiangyu; Miao, Shuai; Du, Tao; Ju, Guanqun; Liu, Guohua; Zhu, Yingjian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Chen, Jinjun] Shanghai Jiao Tong Univ, Sch Med, Tissue Engn Ctr, Shanghai Key Lab Tissue Engn, Shanghai 200030, Peoples R China; [Du, Tao] Henan Prov Peoples Hosp, Dept Urol, Zhengzhou, Peoples R China; [Zhong, Liang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University; Shanghai Jiao Tong University	Liu, GH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	liuguohua_sjtu@163.com; zhuyingjian_sjtu@126.com	Zhang, Guangyuan/AAD-5494-2020		Research Program of Science and Technology Commission of Shanghai Municipality [10411967200]; Shanghai Song-Jiang Health Bureau [2011PD06]; National Natural Science Foundation of China [81170642]; Shanghai Shen Kang Plat-form Grant [SHDC12007206]	Research Program of Science and Technology Commission of Shanghai Municipality; Shanghai Song-Jiang Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Shen Kang Plat-form Grant	This study is supported by grants from the Research Program of Science and Technology Commission of Shanghai Municipality (10411967200) and Shanghai Song-Jiang Health Bureau (2011PD06) and National Natural Science Foundation of China(81170642) and Shanghai Shen Kang Plat-form Grant (SHDC12007206). The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy VE, 2002, CRIT CARE CLIN, V18, P203, DOI 10.1016/S0749-0704(01)00002-1; Armitage ME, 2009, J MOL MED, V87, P1071, DOI 10.1007/s00109-009-0544-2; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bernard A, 2010, J TRAUMA, V69, P320, DOI 10.1097/TA.0b013e3181e401f0; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Cho KA, 2012, CELL BIOL INT, V36, P1267, DOI 10.1042/CBI20110634; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kalinowski L, 2004, ACTA BIOCHIM POL, V51, P459; Kaminski KA, 2002, INT J CARDIOL, V86, P41, DOI 10.1016/S0167-5273(02)00189-4; Kleikers PWM, 2012, J MOL MED, V90, P1391, DOI 10.1007/s00109-012-0963-3; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; Liu L, 2010, NEUROSCIENCE, V167, P1115, DOI 10.1016/j.neuroscience.2010.01.057; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Milwid JM, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/392050; Modlinger P, 2006, HYPERTENSION, V47, P238, DOI 10.1161/01.HYP.0000200023.02195.73; Mokarizadeh A, 2012, IMMUNOL LETT, V147, P47, DOI 10.1016/j.imlet.2012.06.001; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Shinomol GK, 2007, NEUROTOXICOLOGY, V28, P798, DOI 10.1016/j.neuro.2007.03.002; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Siriussawakul A, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/819382; Steinberg BE, 2007, SCI STKE 2007, V2007, DOI 10.1126/stke.3792007pe11; Sukpat S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459196; Tsuda H, 2013, CELL TRANSPLANT; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Villanueva S, 2013, CLIN SCI, V125, P199, DOI 10.1042/CS20120644; Wang FW, 2013, J CELL BIOCH; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366; Xagorari A, 2013, INT J CLIN EXP PATHO, V6, P831; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194; Zhuo WL, 2011, UROL INT, V86, P191, DOI 10.1159/000319366	59	96	101	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92129	10.1371/journal.pone.0092129	http://dx.doi.org/10.1371/journal.pone.0092129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637475	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100117
J	Harada, J; Mizoguchi, T; Tsukatani, Y; Yokono, M; Tanaka, A; Tamiaki, H				Harada, Jiro; Mizoguchi, Tadashi; Tsukatani, Yusuke; Yokono, Makio; Tanaka, Ayumi; Tamiaki, Hitoshi			Chlorophyllide a Oxidoreductase Works as One of the Divinyl Reductases Specifically Involved in Bacteriochlorophyll a Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Evolution; Microbiology; Photosynthesis; Photosynthetic Pigments; Reductase; BciA; BciB; DVR; Photosynthetic Bacteria; Purple Bacteria	HELIOBACTERIUM-MODESTICALDUM; CHROMOSOMAL INSERTION; ARABIDOPSIS-THALIANA; 8-VINYL REDUCTASE; IDENTIFICATION; PROTOCHLOROPHYLLIDE; DERIVATIVES; MUTAGENESIS; EVOLUTION; MONOVINYL	Background: An unknown third divinyl-chlorophyllide a reductase (DVR) was proposed among phototrophs. Results: The double mutant lacking the conventional DVR and chlorophyllide a reductase (COR) of a purple bacterium uniquely accumulated divinyl-chlorophyllide a. Conclusion: An additional activity of COR corresponds to the third DVR, which is conserved among other photosynthetic bacteria. Significance: COR is suggested to be the evolutionarily oldest DVR among three DVRs. Bacteriochlorophyll a is widely distributed among anoxygenic photosynthetic bacteria. In bacteriochlorophyll a biosynthesis, the reduction of the C8 vinyl group in 8-vinyl-chlorophyllide a is catalyzed to produce chlorophyllide a by an 8-vinyl reductase called divinyl reductase (DVR), which has been classified into two types, BciA and BciB. However, previous studies demonstrated that mutants lacking the DVR still synthesize normal bacteriochlorophyll a with the C8 ethyl group and suggested the existence of an unknown third DVR. Meanwhile, we recently observed that chlorophyllide a oxidoreductase (COR) of a purple bacterium happened to show the 8-vinyl reduction of 8-vinyl-chlorophyllide a in vitro. In this study, we made a double mutant lacking BciA and COR of the purple bacterium Rhodobacter sphaeroides in order to investigate whether the mutant still produces pigments with the C8 ethyl group or if COR actually works as the third DVR. The single mutant deleting BciA or COR showed production of the C8 ethyl group pigments, whereas the double mutant accumulated 8-vinyl-chlorophyllide, indicating that there was no enzyme other than BciA and COR functioning as the unknown third DVR in Rhodobacter sphaeroides (note that this bacterium has no bciB gene). Moreover, some COR genes derived from other groups of anoxygenic photosynthetic bacteria were introduced into the double mutant, and all of the complementary strains produced normal bacteriochlorophyll a. This observation indicated that COR of these bacteria performs two functions, reductions of the C8 vinyl group and the C7=C8 double bond, and that such an activity is probably conserved in the widely ranging groups.	[Harada, Jiro] Kurume Univ, Dept Med Biochem, Sch Med, Kurume, Fukuoka 8300011, Japan; [Mizoguchi, Tadashi; Tsukatani, Yusuke; Tamiaki, Hitoshi] Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan; [Yokono, Makio; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Tsukatani, Yusuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tanaka, Ayumi] Japan Sci & Technol Agcy, CREST, Sapporo, Hokkaido 0600819, Japan	Kurume University; Ritsumeikan University; Hokkaido University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Harada, J (corresponding author), Kurume Univ, Dept Med Biochem, Sch Med, Asahi Machi 67, Kurume, Fukuoka 8300011, Japan.	jiro_harada@med.kurume-u.ac.jp; tamiaki@fc.ritsumei.ac.jp	Tanaka, Ayumi/D-9003-2012; Yokono, Makio/N-8425-2015; Tsukatani, Yusuke/A-6448-2014	Yokono, Makio/0000-0002-4813-2120; Tsukatani, Yusuke/0000-0003-2831-8996	Japan Society for the Promotion of Science [22245030, 24590366, 24750169, 24107002]; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25650092, 24107002, 24550201] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (A) 22245030 (to H. T.), Grant-in-Aid for Scientific Research (C) 24590366 (to T. M.), Grant-in-Aid for Scientific Research for Young Scientists (B) 24750169 (to J. H.), and Grant-in-Aid for Scientific Research on Innovative Areas "Artificial Photosynthesis (AnApple)" 24107002 (to H. T.) from the Japan Society for the Promotion of Science.; Supported by a PRESTO (Precursory Research for Embryonic Science and Technology) fellowship from the Japan Science and Technology Agency. Present address: Earth-Life Science Institute (ELSI), Tokyo Institute of Technology, Meguro-ku, Tokyo 152-8550, Japan.	BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Canniffe DP, 2013, BIOCHEM J, V450, P397, DOI 10.1042/BJ20121723; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harada J, 2008, PHOTOSYNTH RES, V95, P213, DOI 10.1007/s11120-007-9254-1; Harada J, 2008, PHOTOCH PHOTOBIO SCI, V7, P1179, DOI 10.1039/b802435a; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; Islam MR, 2008, PLANT PHYSIOL, V148, P1068, DOI 10.1104/pp.108.123117; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Ito H, 2014, PLANT CELL PHYSIOL, V55, P593, DOI 10.1093/pcp/pct203; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda S, 2002, BIOCHEMISTRY-US, V41, P11211, DOI 10.1021/bi0258492; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Mizoguchi T, 2006, FEBS LETT, V580, P6644, DOI 10.1016/j.febslet.2006.11.020; Mizoguchi T, 2012, BIOORGAN MED CHEM, V20, P6803, DOI 10.1016/j.bmc.2012.09.054; Muller AH, 2011, ANAL BIOCHEM, V419, P271, DOI 10.1016/j.ab.2011.08.028; Nagashima S., 2013, ADV BOT RES GENOME E, P152; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Nakanishi H, 2005, PLANT CELL PHYSIOL, V46, P467, DOI 10.1093/pcp/pci053; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; SAEKI K, 1991, J BIOL CHEM, V266, P12889; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; Saunders AH, 2013, BIOCHEMISTRY-US, V52, P8442, DOI 10.1021/bi401172b; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; SUZUKI JY, 1995, J BIOL CHEM, V270, P3732, DOI 10.1074/jbc.270.8.3732; Swingley Wesley D., 2009, V28, P17; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tsukatani Y, 2013, BBA-BIOENERGETICS, V1827, P1200, DOI 10.1016/j.bbabio.2013.06.007; Tsukatani Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01217; Walker JS, 2003, RAPID COMMUN MASS SP, V17, P1125, DOI 10.1002/rcm.1015	40	20	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12716	12726		10.1074/jbc.M113.546739	http://dx.doi.org/10.1074/jbc.M113.546739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24637023	hybrid, Green Published			2022-12-25	WOS:000335581400043
J	Eram, MS; Bustos, SP; Lima-Fernandes, E; Siarheyeva, A; Senisterra, G; Hajian, T; Chau, I; Duan, SL; Wu, H; Dombrovski, L; Schapira, M; Arrowsmith, CH; Vedadi, M				Eram, Mohammad S.; Bustos, Susan P.; Lima-Fernandes, Evelyne; Siarheyeva, Alena; Senisterra, Guillermo; Hajian, Taraneh; Chau, Irene; Duan, Shili; Wu, Hong; Dombrovski, Ludmila; Schapira, Matthieu; Arrowsmith, Cheryl H.; Vedadi, Masoud			Trimethylation of Histone H3 Lysine 36 by Human Methyltransferase PRDM9 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Enzyme Inhibitors; Enzyme Kinetics; Epigenetics; Histone Methylation; Methyltransferase	SINGLE-NUCLEOTIDE POLYMORPHISMS; RECOMBINATION HOT-SPOTS; ZINC-FINGER PROTEIN; MEIOTIC RECOMBINATION; MEISETZ GENE; PR DOMAIN; METHYLATION; BINDING; FAMILY; REPAIR	Background: Histone methyltransferase PRDM9 marks recombination hot spots and is implicated in sterility and cancers. Results: We identified histone H3K36 as a new methylation mark for PRDM9. Conclusion: PRDM9 is a highly active histone methyltransferase that trimethylates H3K4 and H3K36. Significance: Discovering PRDM9 as a H3K36 methyltransferase could lead to identifying the roles that PRDM9 may play in human fertility and susceptibility to cancer. PRDM9 (PR domain-containing protein 9) is a meiosis-specific protein that trimethylates H3K4 and controls the activation of recombination hot spots. It is an essential enzyme in the progression of early meiotic prophase. Disruption of the PRDM9 gene results in sterility in mice. In human, several PRDM9 SNPs have been implicated in sterility as well. Here we report on kinetic studies of H3K4 methylation by PRDM9 in vitro indicating that PRDM9 is a highly active histone methyltransferase catalyzing mono-, di-, and trimethylation of the H3K4 mark. Screening for other potential histone marks, we identified H3K36 as a second histone residue that could also be mono-, di-, and trimethylated by PRDM9 as efficiently as H3K4. Overexpression of PRDM9 in HEK293 cells also resulted in a significant increase in trimethylated H3K36 and H3K4 further confirming our in vitro observations. Our findings indicate that PRDM9 may play critical roles through H3K36 trimethylation in cells.	[Eram, Mohammad S.; Bustos, Susan P.; Lima-Fernandes, Evelyne; Siarheyeva, Alena; Senisterra, Guillermo; Hajian, Taraneh; Chau, Irene; Wu, Hong; Dombrovski, Ludmila; Schapira, Matthieu; Arrowsmith, Cheryl H.; Vedadi, Masoud] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Schapira, Matthieu; Vedadi, Masoud] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, MaRS Ctr, South Tower,101 Coll St,7th Floor,Rm 714, Toronto, ON M5G 1L7, Canada.	m.vedadi@utoronto.ca		Arrowsmith, Cheryl/0000-0002-4971-3250; Hajian, Taraneh/0000-0002-3248-6266; Lima Fernandes, Evelyne/0000-0002-3628-9745	AbbVie [1097737]; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust Grant [092809/Z/10/Z]; National Research Fund, Luxembourg; European Commission	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust Grant(Wellcome Trust); National Research Fund, Luxembourg(Luxembourg National Research Fund); European Commission(European CommissionEuropean Commission Joint Research Centre)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada through the Ontario Genomics Institute [OGI-055], GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust Grant 092809/Z/10/Z.; Recipient of a Post-doctoral fellowship by the National Research Fund, Luxembourg, and in part by the Marie Curie Actions of the European Commission (FP7-COFUND).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Allali-Hassani A, 2012, J BIOMOL SCREEN, V17, P71, DOI 10.1177/1087057111422256; Anand Mt, 2012, J Hum Reprod Sci, V5, P266, DOI 10.4103/0974-1208.106339; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BORUN TW, 1972, J BIOL CHEM, V247, P4288; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Feichtinger J, 2012, ONCOTARGET, V3, P843; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HEMPEL K, 1968, NATURWISSENSCHAFTEN, V55, P37, DOI 10.1007/BF00593411; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; HUANG S, 1994, CELL, V78, P9, DOI 10.1016/0092-8674(94)90565-7; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Irie S, 2009, J ANDROL, V30, P426, DOI 10.2164/jandrol.108.006262; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kim KC, 2003, CANCER RES, V63, P7619; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Miyamoto T, 2008, J ASSIST REPROD GEN, V25, P553, DOI 10.1007/s10815-008-9270-x; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Newbold RF, 2010, ANTICANCER RES, V30, P3309; Nimura K, 2010, J MOL MED, V88, P1213, DOI 10.1007/s00109-010-0668-4; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V27, P479, DOI 10.1016/S0006-291X(67)80010-X; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Wu YX, 2008, J MOL CELL CARDIOL, V44, P47, DOI 10.1016/j.yjmcc.2007.06.008; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	61	75	76	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12177	12188		10.1074/jbc.M113.523183	http://dx.doi.org/10.1074/jbc.M113.523183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24634223	hybrid, Green Published			2022-12-25	WOS:000335010600053
J	Kaucsar, T; Bodor, C; Godo, M; Szalay, C; Revesz, C; Nemeth, Z; Mozes, M; Szenasi, G; Rosivall, L; Soti, C; Hamar, P				Kaucsar, Tamas; Bodor, Csaba; Godo, Maria; Szalay, Csaba; Revesz, Csaba; Nemeth, Zalan; Mozes, Miklos; Szenasi, Gabor; Rosivall, Laszlo; Soti, Csaba; Hamar, Peter			LPS-Induced Delayed Preconditioning Is Mediated by Hsp90 and Involves the Heat Shock Response in Mouse Kidney	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; MOLECULAR CHAPERONES; EXPRESSION; PROTEINS; STRESS; INDUCTION; PROTECTS; CELLS; HSP70; INOS	Introduction: We and others demonstrated previously that preconditioning with endotoxin (LPS) protected from a subsequent lethal LPS challenge or from renal ischemia-reperfusion injury (IRI). LPS is effective in evoking the heat shock response, an ancient and essential cellular defense mechanism, which plays a role in resistance to, and recovery from diseases. Here, by using the pharmacological Hsp90 inhibitor novobiocin (NB), we investigated the role of Hsp90 and the heat shock response in LPS-induced delayed renal preconditioning. Methods: Male C57BL/6 mice were treated with preconditioning (P: 2 mg/kg, ip.) and subsequent lethal (L: 10 mg/kg, ip.) doses of LPS alone or in combination with NB (100 mg/kg, ip.). Controls received saline (C) or NB. Results: Preconditioning LPS conferred protection from a subsequent lethal LPS treatment. Importantly, the protective effect of LPS preconditioning was completely abolished by a concomitant treatment with NB. LPS induced a marked heat shock protein increase as demonstrated by Western blots of Hsp70 and Hsp90. NB alone also stimulated Hsp70 and Hsp90 mRNA but not protein expression. However, Hsp70 and Hsp90 protein induction in LPS-treated mice was abolished by a concomitant NB treatment, demonstrating a NB-induced impairment of the heat shock response to LPS preconditioning. Conclusion: LPS-induced heat shock protein induction and tolerance to a subsequent lethal LPS treatment was prevented by the Hsp90 inhibitor, novobiocin. Our findings demonstrate a critical role of Hsp90 in LPS signaling, and a potential involvement of the heat shock response in LPS-induced preconditioning.	[Kaucsar, Tamas; Bodor, Csaba; Godo, Maria; Szalay, Csaba; Revesz, Csaba; Nemeth, Zalan; Mozes, Miklos; Szenasi, Gabor; Rosivall, Laszlo; Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary; [Soti, Csaba] Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary; [Rosivall, Laszlo] Semmelweis Univ, Hungarian Acad Sci, Nephrol Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Soti, C (corresponding author), Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary.	csaba@med.semmelweis-univ.hu; hamar.peter@med.semmelweis-univ.hu	Szénási, Gábor/K-3136-2017; Szenasi, Gabor/ABH-2591-2021; Hamar, Peter/A-8996-2010; Kaucsár, Tamás/H-4904-2016; Revesz, Csaba/AAA-5722-2022; Sőti, Csaba/O-6070-2017	Szénási, Gábor/0000-0002-7350-6091; Hamar, Peter/0000-0002-1095-3564; Kaucsár, Tamás/0000-0003-4460-1265; Sőti, Csaba/0000-0002-4057-7678	Hungarian Research Fund [OTKA K 81972, NF69278, ETT 07-011/2009]; Bolyai Research Scholarship of the Hungarian Academy of Sciences; Merit Prize of the Semmelweis University	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Merit Prize of the Semmelweis University	Support was provided to P. Hamar from the Hungarian Research Fund: OTKA K 81972, NF69278, ETT 07-011/2009. C. S. and P. H. acknowledge support from the Bolyai Research Scholarship of the Hungarian Academy of Sciences and the Merit Prize of the Semmelweis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Beck FX, 2000, AM J PHYSIOL-RENAL, V279, pF203, DOI 10.1152/ajprenal.2000.279.2.F203; BEESON PB, 1946, P SOC EXP BIOL MED, V61, P248; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chatterjee A, 2008, AM J PHYSIOL-LUNG C, V294, pL755, DOI 10.1152/ajplung.00350.2007; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Ding XZ, 2010, PROSTAG OTH LIPID M, V92, P1, DOI 10.1016/j.prostaglandins.2009.12.006; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Edelman DA, 2007, J SURG RES, V140, P171, DOI 10.1016/j.jss.2006.12.560; Elliott GT, 1998, J MOL CELL CARDIOL, V30, P3, DOI 10.1006/jmcc.1997.0586; Fintha A, 2013, AM J PATHOL, V182, P388, DOI 10.1016/j.ajpath.2012.10.009; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Hausenloy DJ, 2012, HEART METAB, V54, P5; Hauser GJ, 1996, AM J PHYSIOL-HEART C, V271, pH2529, DOI 10.1152/ajpheart.1996.271.6.H2529; He K, 2013, KIDNEY INT; He X, 2013, LAB INVEST, V93, P168, DOI 10.1038/labinvest.2012.160; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Kelly KJ, 2005, CONTRIB NEPHROL, V148, P86, DOI 10.1159/000086054; Kim MG, 2014, KIDNEY INT, V85, P62, DOI 10.1038/ki.2013.277; Lee J, 2013, HISTOL HISTOPATHOL, V28, P1223, DOI 10.14670/HH-28.1223; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; Naito M, 2008, J AM SOC NEPHROL, V19, P1321, DOI 10.1681/ASN.2007121368; Nakada J, 2005, SHOCK, V24, P482, DOI 10.1097/01.shk.0000180980.63247.a9; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Njemini R, 2003, SCAND J IMMUNOL, V58, P664, DOI 10.1111/j.1365-3083.2003.01341.x; O'Neill S, 2012, EXPERT OPIN INV DRUG, V21, P1535, DOI 10.1517/13543784.2012.713939; Pare JM, 2013, MOL BIOL CELL, V24, P2303, DOI 10.1091/mbc.E12-12-0892; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Sharma D, 2009, PROTEIN PEPTIDE LETT, V16, P571, DOI 10.2174/092986609788490230; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Suganuma T, 2002, J PHARMACOL EXP THER, V303, P656, DOI 10.1124/jpet.102.035758; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Toyoda T, 2000, J NEUROSURG, V92, P435, DOI 10.3171/jns.2000.92.3.0435; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2008, NOVART FDN SYMP, V291, P79; Triantafilou M, 2008, NOVART FDN SYMP, V291, P137; Triantafilou Martha, 2008, Novartis Found Symp, V291, P74; Vladic N, 2011, AM J PHYSIOL-HEART C, V301, pH2130, DOI 10.1152/ajpheart.01078.2010; Yoshida K, 1996, MOL CELL BIOCHEM, V159, P73	53	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92004	10.1371/journal.pone.0092004	http://dx.doi.org/10.1371/journal.pone.0092004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646925	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500069
J	Robinson, J; Cinner, JE; Graham, NAJ				Robinson, Jan; Cinner, Joshua E.; Graham, Nicholas A. J.			The Influence of Fisher Knowledge on the Susceptibility of Reef Fish Aggregations to Fishing	PLOS ONE			English	Article							BROWN-MARBLED GROUPER; SPAWNING AGGREGATIONS; RESOURCE-MANAGEMENT; SITE FIDELITY; HOME-RANGE; ISLAND; VULNERABILITY; CONSERVATION; CATCHABILITY; RESIDENCY	Reef fishes that exhibit predictable aggregating behaviour are often considered vulnerable to overexploitation. However, fisher knowledge of this behaviour is often heterogeneous and, coupled with socioeconomic factors that constrain demand for or access to aggregated fish, will influence susceptibility to fishing. At two case study locations in Papua New Guinea, Ahus and Karkar islands, we conducted interview-based surveys to examine how local context influenced heterogeneity in knowledge of fish aggregations. We then explored the role of fisher knowledge in conferring susceptibility to fishing relative to socioeconomic drivers of fishing effort. Local heterogeneity in knowledge of aggregating behaviour differed between our case studies. At Ahus, variable access rights among fishers and genders to the main habitats were sources of heterogeneity in knowledge. By contrast, knowledge was more homogenous at Karkar and the sole source of variation was gear type. Differences between locations in the susceptibility of aggregations to fishing depended primarily on socioeconomic drivers of fishing effort rather than catchability. While Ahus fishers were knowledgeable of fish aggregations and used more selective gears, Karkar fishers were less constrained by tenure in their access to aggregation habitat. However, fishing effort was greater at Ahus and likely related to high dependency on fishing, greater access to provincial capital markets than Karkar and a weakening of customary management. Moreover, highly efficient fishing techniques have emerged at Ahus to exploit the non-reproductive aggregating behaviour of target species. Understanding how knowledge is structured within fishing communities and its relation to socioeconomic drivers of fishing effort is important if customary practices for conservation, such as tambu areas, are to be supported. The findings of this study call for a holistic approach to assessing the risks posed to reef fish aggregations by fishing, grounded in the principals of fisheries science and emerging social-ecological thinking.	[Robinson, Jan; Cinner, Joshua E.; Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University	Robinson, J (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	jan.robinson@my.jcu.edu.au	Cinner, Joshua e/E-8966-2011; Graham, Nicholas AJ/C-8360-2014; Cinner, Joshua/AAA-6823-2021	Cinner, Joshua e/0000-0003-2675-9317; Graham, Nicholas AJ/0000-0002-0304-7467; 	Australian Research Council	Australian Research Council(Australian Research Council)	This study was funded by the Australian Research Council (www.coralcoe.org.au). The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; ArreguinSanchez F, 1996, REV FISH BIOL FISHER, V6, P221; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Aswani S, 2008, HUM ECOL, V36, P325, DOI 10.1007/s10745-007-9159-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijoux JP, 2013, MAR ECOL PROG SER, V475, P233, DOI 10.3354/meps10113; Carrier James, 1987, QUESTION COMMONS CUL, P143; CARRIER JG, 1982, ANTHROPOS, V77, P904; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; Christie P, 1997, COAST MANAGE, V25, P155, DOI 10.1080/08920759709362316; Cinner JE, 2007, CORAL REEFS, V26, P1035, DOI 10.1007/s00338-007-0213-2; Cinner JE, 2005, CONSERV BIOL, V19, P1714, DOI 10.1111/j.1523-1739.2005.00209.x-i1; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Claro R, 2009, FISH RES, V99, P7, DOI 10.1016/j.fishres.2009.04.004; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; Colding J, 2001, ECOL APPL, V11, P584; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Corpuz VT, 1985, ICLARM Q, V8, P12; Crona BI, 2006, ECOL SOC, V11; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; Daw TM, 2011, ENVIRON CONSERV, V38, P75, DOI 10.1017/S0376892910000901; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; Domeier ML, 1997, B MAR SCI, V60, P698; Ebisawa A, 2006, ICHTHYOL RES, V53, P269, DOI 10.1007/s10228-006-0345-3; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Froese R, 2013, FISHBASE; Grandcourt EM, 2006, FISH RES, V78, P203, DOI 10.1016/j.fishres.2005.11.021; Hamilton RJ, 2011, BIOL CONSERV, V144, P1850, DOI 10.1016/j.biocon.2011.03.024; Hamilton R.J., 2004, 404 TNC PAC ISL COUN; Heyman WD, 2008, B MAR SCI, V83, P531; Hitt S, 2011, ENVIRON BIOL FISH, V92, P525, DOI 10.1007/s10641-011-9875-2; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Johannes R. E., 2000, SPC TRADITIONAL MARI, P22; Johannes R.E., 1981, WORDS LAGOON FISHING; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Kaunda-Arara B, 2004, ENVIRON BIOL FISH, V70, P363, DOI 10.1023/B:EBFI.0000035428.59802.af; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; Matlin M., 2005, COGNITION, V6th ed.; Matos-Caraballo D, 2006, B MAR SCI, V79, P1; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nanami A, 2009, FISHERIES SCI, V75, P1109, DOI 10.1007/s12562-009-0136-7; Newman SJ, 2001, MAR FRESHWATER RES, V52, P843, DOI 10.1071/MF99131; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Parish J.D., 1987, P405; Parrish JK, 1999, ENVIRON BIOL FISH, V55, P157, DOI 10.1023/A:1007472602017; Patrick WS, 2010, FISH B-NOAA, V108, P305; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; Rhodes KL, 2012, CORAL REEFS, V31, P443, DOI 10.1007/s00338-012-0875-2; Rhodes KL, 2008, FISH B-NOAA, V106, P194; Robinson J, 2008, B MAR SCI, V83, P415; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Samoilys MA, 2006, P 10 INT COR REEF S, V1, P1335; Wilberg MJ, 2010, REV FISH SCI, V18, P7, DOI 10.1080/10641260903294647	61	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91296	10.1371/journal.pone.0091296	http://dx.doi.org/10.1371/journal.pone.0091296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646910	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500028
J	Verhagen, M; van Roekel, E; Engels, RCME				Verhagen, Maaike; van Roekel, Eeske; Engels, Rutger C. M. E.			Involvement of the BDNF Gene in Loneliness in Adolescence: A Report of Opposite Gene Effects in Boys and Girls	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; FACTOR VAL(66)MET POLYMORPHISM; REDUCED HIPPOCAMPAL VOLUMES; RECEPTOR GENE; ENVIRONMENT INTERACTIONS; INDIVIDUAL-DIFFERENCES; MAJOR DEPRESSION; PARENTAL SUPPORT; SOCIAL-ISOLATION; HEALTHY-SUBJECTS	Previous research has shown that loneliness has a heritable component and that genes within the serotonin-, dopamine-, and oxytocin systems are related to loneliness in adolescence. In the present study, the relation between the BDNF Val66Met polymorphism and loneliness in adolescent boys and girls was examined in a longitudinal study spanning five annual waves (N = 305). Latent growth curve modeling (LGCM) was used to examine the baseline level and the change in loneliness over time. The main finding was that the BDNF gene was not related to loneliness in the total sample. A BDNF by sex interaction was found, in that Met carrying girls had the highest levels of loneliness at baseline, whereas in boys the ValVal genotype was related to higher levels of loneliness. Our results underline the importance of sex-stratified analyses when examining effects of the BDNF genotype and the necessity of conducting gene studies to intermediate phenotypes of loneliness.	[Verhagen, Maaike; van Roekel, Eeske; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van Roekel, Eeske] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands	Radboud University Nijmegen; University of Groningen	Verhagen, M (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.verhagen@bsi.ru.nl	van Roekel, Eeske/E-7889-2012	van Roekel, Eeske/0000-0002-0829-8089; Engels, Rutger/0000-0003-1944-9126				Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chou KL, 2014, AM J GERIAT PSYCHIAT, V22, P510, DOI 10.1016/j.jagp.2012.11.002; Cicchetti D, 1996, DEV PSYCHOPATHOL, V8, P597, DOI 10.1017/S0954579400007318; de Geus E, 2008, BIOL PSYCHOL, V79, P1, DOI 10.1016/j.biopsycho.2008.04.002; Doane LD, 2010, PSYCHONEUROENDOCRINO, V35, P430, DOI 10.1016/j.psyneuen.2009.08.005; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Duncan T, 2006, INTRO LATENT VARIABL; Dunn EC, 2014, J AFFECT DISORDERS, V152, P243, DOI 10.1016/j.jad.2013.09.018; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Gardner WL, 2005, PERS SOC PSYCHOL B, V31, P1549, DOI 10.1177/0146167205277208; Gasic GP, 2009, AM J MED GENET B, V150B, P762, DOI 10.1002/ajmg.b.30944; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hajek T, 2012, WORLD J BIOL PSYCHIA, V13, P178, DOI 10.3109/15622975.2011.580005; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Hilt LM, 2007, NEUROSCI LETT, V429, P12, DOI 10.1016/j.neulet.2007.09.053; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MARCOEN A, 1987, J YOUTH ADOLESCENCE, V16, P561, DOI 10.1007/BF02138821; Marcoen A., 1993, ADOLESCENCE ITS SOCI, P197; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Montag C, 2008, NEUROIMAGE, V42, P1554, DOI 10.1016/j.neuroimage.2008.06.008; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Mueller SC, 2013, J AM ACAD CHILD PSY, V52, P184, DOI 10.1016/j.jaac.2012.11.016; Mukherjee P, 2011, PSYCHIAT RES-NEUROIM, V191, P182, DOI 10.1016/j.pscychresns.2010.10.001; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Outhred T, 2012, BRAIN BEHAV, V2, P778, DOI 10.1002/brb3.99; Perlman D., 1981, PARKINSONISM RELATED, VVol. 3, P31; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Qualter P, 2013, J ABNORM CHILD PSYCH, V41, P325, DOI 10.1007/s10802-012-9676-x; Rotenberg KJ, 2010, PERS SOC PSYCHOL B, V36, P1086, DOI 10.1177/0146167210374957; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007; Scharfman HE, 2005, TRENDS NEUROSCI, V28, P79, DOI 10.1016/j.tins.2004.12.005; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Shalev I, 2009, PSYCHONEUROENDOCRINO, V34, P382, DOI 10.1016/j.psyneuen.2008.09.017; Sublette ME, 2008, PROG NEURO-PSYCHOPH, V32, P1652, DOI 10.1016/j.pnpbp.2008.06.009; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; van der Vorst H, 2005, ADDICTION, V100, P1464, DOI 10.1111/j.1360-0443.2005.01193.x; van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012; van Roekel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077689; van Roekel E, 2013, PSYCHIAT GENET, V23, P204, DOI 10.1097/YPG.0b013e328363f631; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; van Roekel E, 2010, J CHILD PSYCHOL PSYC, V51, P747, DOI 10.1111/j.1469-7610.2010.02225.x; van Wingen G, 2010, NEUROIMAGE, V50, P1212, DOI 10.1016/j.neuroimage.2010.01.058; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002	65	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92768	10.1371/journal.pone.0092768	http://dx.doi.org/10.1371/journal.pone.0092768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647525	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500155
J	Wu, HJ; Yiu, WH; Li, RX; Wong, DWL; Leung, JCK; Chan, LYY; Zhang, Y; Lian, QZ; Lin, M; Tse, HF; Lai, KN; Tang, SCW				Wu, Hao Jia; Yiu, Wai Han; Li, Rui Xi; Wong, Dickson W. L.; Leung, Joseph C. K.; Chan, Loretta Y. Y.; Zhang, Yuelin; Lian, Qizhou; Lin, Miao; Tse, Hung Fat; Lai, Kar Neng; Tang, Sydney C. W.			Mesenchymal Stem Cells Modulate Albumin-Induced Renal Tubular Inflammation and Fibrosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; ANTIINFLAMMATORY PROTEIN TSG-6; CHRONIC KIDNEY-DISEASE; RAT REMNANT KIDNEY; EPITHELIAL-CELLS; DIABETIC-NEPHROPATHY; STROMAL CELLS; TNF-ALPHA; INTERSTITIAL FIBROSIS; IGA NEPHROPATHY	Bone marrow-derived mesenchymal stem cells (BM-MSCs) have recently shown promise as a therapeutic tool in various types of chronic kidney disease (CKD) models. However, the mechanism of action is incompletely understood. As renal prognosis in CKD is largely determined by the degree of renal tubular injury that correlates with residual proteinuria, we hypothesized that BM-MSCs may exert modulatory effects on renal tubular inflammation and epithelial-to-mesenchymal transition (EMT) under a protein-overloaded milieu. Using a co-culture model of human proximal tubular epithelial cells (PTECs) and BM-MSCs, we showed that concomitant stimulation of BM-MSCs by albumin excess was a prerequisite for them to attenuate albumin-induced IL-6, IL-8, TNF-alpha, CCL-2, CCL-5 overexpression in PTECs, which was partly mediated via deactivation of tubular NF-kappa B signaling. In addition, albumin induced tubular EMT, as shown by E-cadherin loss and alpha-SMA, FN and collagen IV overexpression, was also prevented by BM-MSC co-culture. Albumin-overloaded BM-MSCs per se retained their tri-lineage differentiation capacity and overexpressed hepatocyte growth factor (HGF) and TNF alpha-stimulating gene (TSG)-6 via P38 and NF-kappa B signaling. Albumin-induced tubular CCL-2, CCL-5 and TNF-alpha overexpression were suppressed by recombinant HGF treatment, while the upregulation of alpha-SMA, FN and collagen IV was attenuated by recombinant TSG-6. Neutralizing HGF and TSG-6 abolished the anti-inflammatory and anti-EMT effects of BM-MSC co-culture in albumin-induced PTECs, respectively. In vivo, albumin-overloaded mice treated with mouse BM-MSCs had markedly reduced BUN, tubular CCL-2 and CCL-5 expression, alpha-SMA and collagen IV accumulation independent of changes in proteinuria. These data suggest anti-inflammatory and anti-fibrotic roles of BM-MSCs on renal tubular cells under a protein overloaded condition, probably mediated via the paracrine action of HGF and TSG-6.	[Wu, Hao Jia; Yiu, Wai Han; Li, Rui Xi; Wong, Dickson W. L.; Leung, Joseph C. K.; Chan, Loretta Y. Y.; Lin, Miao; Lai, Kar Neng; Tang, Sydney C. W.] Univ Hong Kong, Queen Mary Hosp, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yuelin; Lian, Qizhou; Tse, Hung Fat] Univ Hong Kong, Queen Mary Hosp, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lian, Qizhou] Univ Hong Kong, Queen Mary Hosp, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Tang, SCW (corresponding author), Univ Hong Kong, Queen Mary Hosp, Div Nephrol, Hong Kong, Hong Kong, Peoples R China.	scwtang@hku.hk	Lian, Qizhou/Y-1613-2019; Tse, Hung-Fat/C-4426-2009; Tang, Sydney Chi Wai/C-4411-2009; Wong, Dickson/F-8855-2013	Tse, Hung-Fat/0000-0002-9578-7808; Tang, Sydney Chi Wai/0000-0002-6862-1941; Wong, Dickson/0000-0002-4798-2908; Wu, Haojia/0000-0002-7866-2544; Lian, Qizhou/0000-0001-8189-7160; Tse, Hung Fat/0000-0003-4665-7887	Research Grants Council of Hong Kong [HKU 778212]; National Basic Research Program of China 973 program [2012CB517600, 2012CB517606]; HKU Seed Funding for Basic Research; Hong Kong Society of Nephrology Research; Endowment Fund; Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd.	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China 973 program(National Basic Research Program of China); HKU Seed Funding for Basic Research(University of Hong Kong); Hong Kong Society of Nephrology Research; Endowment Fund; Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd.	General Research Fund of the Research Grants Council (Grant number: HKU 778212) of Hong Kong, the National Basic Research Program of China 973 program no. 2012CB517600 (no. 2012CB517606), HKU Seed Funding for Basic Research, and the Hong Kong Society of Nephrology Research Grant 2010; W.H.Y. is partially supported by an Endowment Fund established for the "Yu Professorship in Nephrology" awarded to S.C.W.T. and the Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of the results from this study was presented in abstract form at the American Society of Nephrology Renal Week, Nov 10-13, 2011, Philadelphia, PA, USA.	Abbate M, 2008, J AM SOC NEPHROL, V19, P1158, DOI 10.1681/ASN.2007060686; Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Donadelli R, 2003, J AM SOC NEPHROL, V14, P2436, DOI 10.1097/01.ASN.0000089564.55411.7F; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Imberti B, 2007, J AM SOC NEPHROL, V18, P2921, DOI 10.1681/ASN.2006121318; Lai KN, 2007, KIDNEY INT, V71, P526, DOI 10.1038/sj.ki.5002091; Lai KN, 2006, NEPHROL DIAL TRANSPL, V21, P1188, DOI 10.1093/ndt/gfk085; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lin M, 2013, KIDNEY INT, V83, P887, DOI 10.1038/ki.2013.11; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Molitoris BA, 1996, KIDNEY INT, V49, P1592, DOI 10.1038/ki.1996.231; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Tang S, 1999, J AM SOC NEPHROL, V10, P69; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Tang S, 2002, KIDNEY INT, V61, P1655, DOI 10.1046/j.1523-1755.2002.00301.x; Tang S, 2001, AM J KIDNEY DIS, V37, P94, DOI 10.1053/ajkd.2001.20593; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tang SCW, 2010, KIDNEY INT, V77, P543, DOI 10.1038/ki.2009.499; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Togel F, 2009, J CELL MOL MED, V13, P2109, DOI 10.1111/j.1582-4934.2008.00641.x; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Zhang YL, 2012, CELL TRANSPLANT, V21, P2225, DOI 10.3727/096368912X653020	42	54	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90883	10.1371/journal.pone.0090883	http://dx.doi.org/10.1371/journal.pone.0090883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646687	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500019
J	Iwasaki, K; Sudo, H; Yamada, K; Ito, M; Iwasaki, N				Iwasaki, Koji; Sudo, Hideki; Yamada, Katsuhisa; Ito, Manabu; Iwasaki, Norimasa			Cytotoxic Effects of the Radiocontrast Agent Iotrolan and Anesthetic Agents Bupivacaine and Lidocaine in Three-Dimensional Cultures of Human Intervertebral Disc Nucleus Pulposus Cells: Identification of the Apoptotic Pathways	PLOS ONE			English	Article							LUMBAR DISC; CASPASE 3; DEGENERATION; TOXICITY; PUNCTURE	Background: Discography and discoblock are imaging procedures used to diagnose discogenic low back pain. Although needle puncture of the intervertebral disc (IVD) itself induces disc degeneration, the agents used in these procedures may also have harmful effects on IVD cells. The purpose of this study was to analyze whether radiocontrast agents and local anesthetic agents have detrimental effects on human nucleus pulposus (NP) cells. Methods: Healthy human NP cells were cultured for 7 days in three-dimensional (3D) cell-alginate bead composites, and were then exposed to clinically relevant doses of a radiocontrast agent (iotrolan) or local anesthetic (lidocaine or bupivacaine). Cell viability and apoptosis were measured by confocal microscopy and flow cytometry. On the basis of caspase expression profiles, the apoptotic pathways activated by the agents were identified by Western blot analysis. Results: The radiocontrast agent iotrolan did not affect NP cell viability or induce apoptosis. In contrast, both the anesthetic agents significantly decreased cell viability and increased the apoptotic cell number in a time-and dose-dependent manner. After 120 min, 2% lidocaine and 0.5% bupivacaine decreased percent live cells to 13% and 10%, respectively (p<0.05). The number of apoptotic cells was doubled by increasing lidocaine dosage from 1% to 2% (23% and 42%) and bupivacaine from 0.25% to 0.50% (25% and 48%) (p<0.05). Western blot analysis revealed that both anesthetic agents upregulated cleaved caspase-3 and caspase-8, whereas only bupivacaine upregulated cleaved caspase-9. Conclusions/Significance: The present study demonstrates that iotrolan does not affect the viability of healthy human NP cells. In contrast, the two anesthetic agents commonly used in discography or discoblock may cause extensive damage to IVDs by inducing apoptotic cell death.	[Iwasaki, Koji; Yamada, Katsuhisa; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Sudo, Hideki; Ito, Manabu] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Sudo, Hideki/G-2748-2012	Iwasaki, Koji/0000-0002-4525-9150	Nakatomi Foundation; Takeda Science Foundation	Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from the Nakatomi Foundation and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayda-Bruno M, 2013, EUR SPINE J; Cai XY, 2014, SPINE J, V14, P483, DOI 10.1016/j.spinee.2013.06.041; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Chu CR, 2006, ARTHROSCOPY, V22, P693, DOI 10.1016/j.arthro.2006.05.006; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; GMEINWIESER JK, 1995, EUR RADIOL, V5, pS30, DOI 10.1007/BF02343258; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Gruber HE, 2012, SPINE J, V12, P329, DOI 10.1016/j.spinee.2012.02.003; Lee H, 2010, SPINE J, V10, P159, DOI 10.1016/j.spinee.2009.08.445; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Masuda K, 2003, J ORTHOP RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2; McLure H A, 2005, Minerva Anestesiol, V71, P59; Miyazaki T, 2011, KNEE SURG SPORT TR A, V19, P1198, DOI 10.1007/s00167-010-1369-9; MIYAZAWA T, 1990, INVEST RADIOL, V25, P999, DOI 10.1097/00004424-199009000-00008; Moon JH, 2012, SPINE J, V12, P665, DOI 10.1016/j.spinee.2012.06.009; Ohtori Seiji, 2009, Spine (Phila Pa 1976), V34, P1345, DOI 10.1097/BRS.0b013e3181a401bf; Park JB, 2005, J BONE JOINT SURG AM, V87A, P1338, DOI 10.2106/JBJS.D.02527; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Press W R, 1989, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V128, P126; Quero L, 2011, SPINE J, V11, P46, DOI 10.1016/j.spinee.2010.11.001; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Ringel K, 1989, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V128, P153; Singh J, 2008, J NUCL MED TECHNOL, V36, P69, DOI 10.2967/jnmt.107.047621; Sudo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058806; Sudo H, 2011, ARTHRITIS RHEUM-US, V63, P1648, DOI 10.1002/art.30251; Sudo H, 2010, J ORTHOP RES, V28, P1608, DOI 10.1002/jor.21185; WEINSTEIN J, 1988, SPINE, V13, P1344, DOI 10.1097/00007632-198812000-00002; Yamada K, 2014, AM J PATHOL, V184, P753, DOI 10.1016/j.ajpath.2013.11.010	29	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92442	10.1371/journal.pone.0092442	http://dx.doi.org/10.1371/journal.pone.0092442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642945	Green Published, gold			2022-12-25	WOS:000333259900141
J	Balasanyan, V; Arnold, DB				Balasanyan, Varuzhan; Arnold, Don B.			Actin and Myosin-Dependent Localization of mRNA to Dendrites	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; ZIPCODE-BINDING-PROTEIN; AXON INITIAL SEGMENT; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CYTOPLASMIC DYNEIN; STAUFEN PROTEIN; KINESIN MOTOR; TRANSPORT; VA	The localization of mRNAs within axons and dendrites allows neurons to manipulate protein levels in a time and location dependent manner and is essential for processes such as synaptic plasticity and axon guidance. However, an essential step in the process of mRNA localization, the decision to traffic to dendrites and/or axons, remains poorly understood. Here we show that Myosin Va and actin filaments are necessary for the dendritic localization of the mRNA binding protein Staufen 1 and of mRNA encoding the microtubule binding protein Map2. Blocking the function or expression of Myosin Va or depolymerizing actin filaments leads to localization of Staufen 1 and of Map2 mRNA in both axons and dendrites. Furthermore, interaction with Myosin Va plays an instructive role in the dendritic localization of Hermes 1, an RNA binding protein. Wild-type Hermes 1 localizes to both axons and dendrites, whereas Hermes 1 fused with a Myosin Va binding peptide, localizes specifically to dendrites. Thus, our results suggest that targeting of mRNAs to the dendrites is mediated by a mechanism that is dependent on actin and Myosin Va.	[Balasanyan, Varuzhan; Arnold, Don B.] Univ So Calif, Dept Biol, Program Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California	Arnold, DB (corresponding author), Univ So Calif, Dept Biol, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.	darnold@usc.edu			NIH [NS041963]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant NS041963 to DBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam S, 2012, CELL REPORTS, V2, P89, DOI 10.1016/j.celrep.2012.05.018; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Arnold DB, 2013, J NEUROCHEM; Arnold DB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe49; Aronov S, 2002, J CELL SCI, V115, P3817, DOI 10.1242/jcs.00058; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bassell GJ, 1998, J NEUROSCI, V18, P251; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bianco A, 2010, CURR BIOL, V20, P1487, DOI 10.1016/j.cub.2010.07.016; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Doyle M, 2012, GENE DEV, V26, P110, DOI 10.1101/gad.184945.111; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim-Ha Jeongsil, 1993, Development (Cambridge), V119, P169; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Monshausen M, 2001, J NEUROCHEM, V76, P155, DOI 10.1046/j.1471-4159.2001.00061.x; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nalavadi VC, 2012, J NEUROSCI, V32, P15133, DOI 10.1523/JNEUROSCI.2006-12.2012; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Salerno VP, 2008, CELL MOTIL CYTOSKEL, V65, P422, DOI 10.1002/cm.20272; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Watanabe K, 2012, CELL REP, V2, P1546, DOI 10.1016/j.celrep.2012.11.015; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	57	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92349	10.1371/journal.pone.0092349	http://dx.doi.org/10.1371/journal.pone.0092349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637809	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100145
J	Reaves, DK; Fagan-Solis, KD; Dunphy, K; Oliver, SD; Scott, DW; Fleming, JM				Reaves, Denise K.; Fagan-Solis, Katerina D.; Dunphy, Karen; Oliver, Shannon D.; Scott, David W.; Fleming, Jodie M.			The Role of Lipolysis Stimulated Lipoprotein Receptor in Breast Cancer and Directing Breast Cancer Cell Behavior	PLOS ONE			English	Article							PROTEIN; LEPTIN	The claudin-low molecular subtype of breast cancer is of particular interest for clinically the majority of these tumors are poor prognosis, triple negative, invasive ductal carcinomas. Claudin-low tumors are characterized by cancer stem cell-like features and low expression of cell junction and adhesion proteins. Herein, we sought to define the role of lipolysis stimulated lipoprotein receptor (LSR) in breast cancer and cancer cell behavior as LSR was recently correlated with tumor-initiating features. We show that LSR was expressed in epithelium, endothelium, and stromal cells within the healthy breast tissue, as well as in tumor epithelium. In primary breast tumor bioposies, LSR expression was significantly correlated with invasive ductal carcinomas compared to invasive lobular carcinomas, as well as ER alpha positive tumors and breast cancer cell lines. LSR levels were significantly reduced in claudin-low breast cancer cell lines and functional studies illustrated that reintroduction of LSR into a claudin-low cell line suppressed the EMT phenotype and reduced individual cell migration. However, our data suggest that LSR may promote collective cell migration. Re-introduction of LSR in claudin-low breast cancer cell lines reestablished tight junction protein expression and correlated with transepithelial electrical resistance, thereby reverting claudin-low lines to other intrinsic molecular subtypes. Moreover, overexpression of LSR altered gene expression of pathways involved in transformation and tumorigenesis as well as enhanced proliferation and survival in anchorage independent conditions, highlighting that reestablishment of LSR signaling promotes aggressive/tumor initiating cell behaviors. Collectively, these data highlight a direct role for LSR in driving aggressive breast cancer behavior.	[Reaves, Denise K.; Fagan-Solis, Katerina D.; Oliver, Shannon D.; Fleming, Jodie M.] N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA; [Dunphy, Karen] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Scott, David W.] Univ N Carolina, Dept Cell Physiol & Cell Biol, Chapel Hill, NC USA	University of North Carolina; North Carolina Central University; University of Massachusetts System; University of Massachusetts Amherst; University of North Carolina; University of North Carolina Chapel Hill	Fleming, JM (corresponding author), N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA.	Jodie.fleming@nccu.edu		Fleming, Jodie/0000-0003-0297-5197	NIGMS Support of Competitive Research (SCORE) Pilot Project Award [5SC2CA176585-02]; NCI Comprehensive Minority Institution/Cancer Center Partnership [U54 CA156735-03]; NATIONAL CANCER INSTITUTE [R21CA175783, U54CA156735, SC2CA176585, T32CA009156] Funding Source: NIH RePORTER	NIGMS Support of Competitive Research (SCORE) Pilot Project Award; NCI Comprehensive Minority Institution/Cancer Center Partnership; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIGMS Support of Competitive Research (SCORE) Pilot Project Award (5SC2CA176585-02) and the NCI Comprehensive Minority Institution/Cancer Center Partnership (U54 CA156735-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, FEBS J, V279, P4361, DOI 10.1111/febs.12026; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; Biglia N, 2013, EJSO-EUR J SURG ONC, V39, P455, DOI 10.1016/j.ejso.2013.02.007; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Dunphy KA, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-74; Fleming JM, 2013, J MOL ENDOCRINOL, V50, P79, DOI 10.1530/JME-12-0201; Fleming JM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-46; Fleming JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3215; Fleming JM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-266; Fleming JM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-27; Furuse M, 2012, ANN NY ACAD SCI, V1257, P54, DOI 10.1111/j.1749-6632.2012.06486.x; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Iwamoto N, 2013, CELL STRUCT FUNCT; Korhonen T, 2013, BREAST; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Macek R, 2003, CELL MOL BIOL, V49, P1; Martin TA, 2007, J CELL BIOCHEM, V101, P155, DOI 10.1002/jcb.21162; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Neal-Perry G, 2010, MATURITAS, V67, P34, DOI 10.1016/j.maturitas.2010.04.016; Papatheodorou P, 2013, MBIO, V4, DOI 10.1128/mBio.00244-13; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2011, COLD SPRING HARB PER, V3; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Scully S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025819; Spina A, 2013, FRONT BIOSCI-LANDMRK, V18, P133, DOI 10.2741/4092; Stenger C, 2010, FASEB J, V24, P4218, DOI 10.1096/fj.10-160440; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Webb PG, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-19; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017	41	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91747	10.1371/journal.pone.0091747	http://dx.doi.org/10.1371/journal.pone.0091747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637461	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100058
J	Yoon, JH; Choudhury, JR; Park, J; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise			A Role for DNA Polymerase theta in Promoting Replication through Oxidative DNA Lesion, Thymine Glycol, in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA Damage; DNA Polymerase; DNA Repair; DNA Replication; DNA Polymerase; Lesion Bypass; Thymine Glycol	EPSTEIN-BARR-VIRUS; LOW-FIDELITY; TRANSLESION SYNTHESIS; STABLE REPLICATION; PLASMID ORIGIN; LATENT ORIGIN; DUPLEX DNA; BYPASS; PROTEIN; DAMAGE	Background: Little is known of biological functions of DNA polymerase (pol) in human cells. Results: pol promotes replication through the common oxidation product, thymine glycol, in human cells. Conclusion: pol active site can accommodate the considerable distortion imposed by thymine glycol at the extension step. Significance: pol may function in translesion synthesis opposite a variety of DNA lesions. The biological functions of human DNA polymerase (pol) , an A family polymerase, have remained poorly defined. Here we identify a role of pol in translesion synthesis (TLS) in human cells. We show that TLS through the thymine glycol (TG) lesion, the most common oxidation product of thymine, occurs via two alternative pathways, in one of which, polymerases and function together and mediate error-free TLS, whereas in the other, pol functions in an error-prone manner. Human pol is comprised of an N-terminal ATPase/helicase domain, a large central domain, and a C-terminal polymerase domain; however, we find that only the C-terminal polymerase domain is required for TLS opposite TG in human cells. In contrast to TLS mediated by pol and pol, in which pol would elongate the chain from the TG:A base pair formed by pol action, the ability of pol alone to carry out the nucleotide insertion step, as well as the subsequent extension step that presents a considerable impediment due to displacement of the 5 template base, suggests that the pol active site can accommodate highly distorting DNA lesions.	[Yoon, Jung-Hoon; Choudhury, Jayati Roy; Park, Jeseong; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	l.prakash@utmb.edu		Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	National Institutes of Health NIEHS Center [P30-ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020833, P30ES006676, R01ES012411] Funding Source: NIH RePORTER	National Institutes of Health NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Richard Hodge (University of Texas Medical Branch at Galveston) for providing TG containing DNAs, Dr. Thomas Wood (University of Texas Medical Branch at Galveston) for sequencing the TLS products, and Dr. Narottam Acharya for initial biochemical studies with pol theta. The TG containing DNAs were constructed by Dr. Richard Hodge in the Synthetic Organic Chemistry Core Laboratory at the University of Texas Medical Branch at Galveston, supported by National Institutes of Health NIEHS Center Grant P30-ES06676.	ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BREIMER LH, 1985, BIOCHEMISTRY-US, V24, P4018, DOI 10.1021/bi00336a032; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5398, DOI 10.1021/bi00391a027; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; FRENKEL K, 1981, BIOCHEMISTRY-US, V20, P7566, DOI 10.1021/bi00529a035; Hogg M, 2011, J MOL BIOL, V405, P642, DOI 10.1016/j.jmb.2010.10.041; Johnson RE, 2003, GENE DEV, V17, P77, DOI 10.1101/gad.1048303; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; KAO JY, 1993, J BIOL CHEM, V268, P17787; Kung HC, 1997, J BIOL CHEM, V272, P9227; Kusumoto R, 2002, BIOCHEMISTRY-US, V41, P6090, DOI 10.1021/bi025549k; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Maga G, 2002, J MOL BIOL, V319, P359, DOI 10.1016/S0022-2836(02)00325-X; McNulty JM, 1998, CHEM RES TOXICOL, V11, P666, DOI 10.1021/tx970225w; MIDDLETON T, 1992, J VIROL, V66, P489, DOI 10.1128/JVI.66.1.489-495.1992; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Shirakata M, 1998, J BIOCHEM-TOKYO, V123, P175; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; TEOULE R, 1977, RADIAT RES, V72, P190, DOI 10.2307/3574690; Wang JD, 2006, MOL CELL BIOL, V26, P1124, DOI 10.1128/MCB.26.3.1124-1134.2006; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yoon JH, 2012, MBIO, V3, DOI 10.1128/mBio.00271-12; Yoon JH, 2012, P NATL ACAD SCI USA, V109, P7799, DOI 10.1073/pnas.1204105109; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004	39	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13177	13185		10.1074/jbc.M114.556977	http://dx.doi.org/10.1074/jbc.M114.556977			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24648516	hybrid, Green Published			2022-12-25	WOS:000335522800019
J	Agunbiade, TA; Coates, BS; Datinon, B; Djouaka, R; Sun, WL; Tamo, M; Pittendrigh, BR				Agunbiade, Tolulope A.; Coates, Brad S.; Datinon, Benjamin; Djouaka, Rousseau; Sun, Weilin; Tamo, Manuele; Pittendrigh, Barry R.			Genetic Differentiation among Maruca vitrata F. (Lepidoptera: Crambidae) Populations on Cultivated Cowpea and Wild Host Plants: Implications for Insect Resistance Management and Biological Control Strategies	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; LEGUME POD BORER; AFRICAN ARMYWORM; MIGRATION; SOFTWARE; COTTON; SUSTAINABILITY; BUTTERFLIES; SPECIATION; NOCTUIDAE	Maruca vitrata Fabricius (Lepidoptera: Crambidae) is a polyphagous insect pest that feeds on a variety of leguminous plants in the tropics and subtropics. The contribution of host-associated genetic variation on population structure was investigated using analysis of mitochondrial cytochrome oxidase 1 (cox1) sequence and microsatellite marker data from M. vitrata collected from cultivated cowpea (Vigna unguiculata L. Walp.), and alternative host plants Pueraria phaseoloides (Roxb.) Benth. var. javanica (Benth.) Baker, Loncocarpus sericeus (Poir), and Tephrosia candida (Roxb.). Analyses of microsatellite data revealed a significant global FST estimate of 0.05 (P <= 0.001). The program STRUCTURE estimated 2 genotypic clusters (co-ancestries) on the four host plants across 3 geographic locations, but little geographic variation was predicted among genotypes from different geographic locations using analysis of molecular variance (AMOVA; among group variation -0.68%) or F-statistics (F-ST(Loc) = 20.01; P = 0.62). These results were corroborated by mitochondrial haplotype data (phi(Loc)(ST) = 0.05; P = 0.92). In contrast, genotypes obtained from different host plants showed low but significant levels of genetic variation (F-ST(Host) = 0.04; P = 0.01), which accounted for 4.08% of the total genetic variation, but was not congruent with mitochondrial haplotype analyses (phi(Host)(ST) = 0.06; P = 0.27). Variation among host plants at a location and host plants among locations showed no consistent evidence for M. vitrata population subdivision. These results suggest that host plants do not significantly influence the genetic structure of M. vitrata, and this has implications for biocontrol agent releases as well as insecticide resistance management (IRM) for M. vitrata in West Africa.	[Agunbiade, Tolulope A.; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Coates, Brad S.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Datinon, Benjamin; Djouaka, Rousseau; Tamo, Manuele] Int Inst Trop Agr, Cotonou, Benin	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Agunbiade, TA (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	agunbia1@illinois.edu		Coates, Brad/0000-0001-8908-1529; Tamo, Manuele/0000-0002-5863-7421	Howard Hughes Medical Institute; Legumes Innovation Lab; Bureau for Economic Growth, Agriculture, and Trade, US Agency for International Development [EDH-A-00-07-00005]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project) [3625-22000-017-00]; Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA [3543]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Legumes Innovation Lab; Bureau for Economic Growth, Agriculture, and Trade, US Agency for International Development(United States Agency for International Development (USAID)); United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project); Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA	This project has been made possible through the International Student Research Fellowship to Tolulope A. Agunbiade by the Howard Hughes Medical Institute. This project was also supported by the Legumes Innovation Lab, formerly known as the Dry Grains Pulses Collaborative Research Support Program (CRSP), by the Bureau for Economic Growth, Agriculture, and Trade, US Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. A portion of research data collection and analysis was supported by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project 3625-22000-017-00) and the Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA (Project 3543). The opinions expressed are those of the authors and do not necessarily reflect the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney MR, 2007, J COTTON SCI, V11, P35; Agunbiade TA, 2012, B ENTOMOL RES, V102, P589, DOI 10.1017/S0007485312000156; ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; Altieri M. A., 1982, Crop Protection, V1, P405, DOI 10.1016/0261-2194(82)90023-0; Altieri Miguel A., 1993, P257; Arodokoun D, 1996, THESIS U LAVAL QUEBE; Arodokoun D. Y., 2003, Insect Science and its Application, V23, P103; Ba Niango Malick, 2009, International Journal of Tropical Insect Science, V29, P109, DOI 10.1017/S174275840999021X; Benjamini Y, 2001, ANN STAT, V29, P1165; Bianchi FJJA, 2008, BIOL CONTROL, V46, P400, DOI 10.1016/j.biocontrol.2008.04.010; Bottenberg H., 1997, Advances in cowpea research, P271; Bourguet D, 2000, P ROY SOC B-BIOL SCI, V267, P117, DOI 10.1098/rspb.2000.0975; Calcagno V, 2007, J EVOLUTION BIOL, V20, P1720, DOI 10.1111/j.1420-9101.2007.01391.x; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DENBOER MH, 1978, J ZOOL, V185, P539; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Downham MCA, 2002, CHALLENGES OPPORTUNI, P124; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fatokun CA, 2002, CHALLENGES OPPORTUNI, P81; Feder Jeffrey L., 1998, P408; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Futuyma D.J., 1983, P227; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gourdine JS, 2005, J ENTOMOL SCI, V40, P96, DOI 10.18474/0749-8004-40.1.96; Gurr G, 2005, PLANT PROVIDED FOOD, P267; Gurr GM, 1999, INT J PEST MANAGE, V45, P81, DOI 10.1080/096708799227851; Huesing Joseph, 2011, GM Crops, V2, P211, DOI 10.4161/gmcr.2.3.18689; Jackson RE, 2008, ENTOMOL EXP APPL, V126, P89, DOI 10.1111/j.1570-7458.2007.00653.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lavandero B, 2006, BASIC APPL ECOL, V7, P236, DOI 10.1016/j.baae.2005.09.004; Lee JC, 2008, BIOCONTROL, V53, P289, DOI 10.1007/s10526-007-9070-8; Leumann C, 1994, THESIS ETH ZURICH SW; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; MERRETT PJ, 1986, B ENTOMOL RES, V76, P247, DOI 10.1017/S0007485300014723; Mitter C., 1991, P35; Murdock LL, 2002, WORKSH GEN TRANSF CO; Nason JD, 2002, EVOLUTION, V56, P1475, DOI 10.1111/j.0014-3820.2002.tb01459.x; Olivieri I, 2008, EVOL APPL, V1, P112, DOI 10.1111/j.1752-4571.2007.00010.x; Onstad D. W., 2012, ENVIRON ENTOMOL, V41, P1045; Onstad DW, 2003, J ECON ENTOMOL, V96, P1872, DOI 10.1603/0022-0493-96.6.1872; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; Strong D.R., 1984, INSECTS PLANTS COMMU; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; Tamo M., 1997, Advances in cowpea research, P259; Tamo M, 2003, BIOL CONTROL IPM SYS, P256; Tamo M, 2012, IMPR LIV COWP VAL CH, P249; Tan SJ, 2001, CHINESE SCI BULL, V46, P1804, DOI 10.1007/BF02900555; Taylor T.A., 1978, P193; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waage JK, 1991, P 1 WORKSH EC FDN SU; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wratten S. D., 1995, P117; Wu K, 2004, CROP PROT, V23, P523, DOI 10.1016/j.cropro.2003.10.009; Zhang TZ, 2000, CHINESE SCI BULL, V45, P119	75	17	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92072	10.1371/journal.pone.0092072	http://dx.doi.org/10.1371/journal.pone.0092072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647356	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500079
J	Ferguson, L; Grant, AD; Lewis, J; Kielmann, K; Watson-Jones, D; Vusha, S; Ong'ech, JO; Ross, DA				Ferguson, Laura; Grant, Alison D.; Lewis, James; Kielmann, Karina; Watson-Jones, Deborah; Vusha, Sophie; Ong'ech, John O.; Ross, David A.			Linking Women Who Test HIV-Positive in Pregnancy-Related Services to HIV Care and Treatment Services in Kenya: A Mixed Methods Prospective Cohort Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; FOLLOW-UP; ANTENATAL CARE; TREATMENT INITIATION; BEHAVIOR-CHANGE; PREVENTION; PROGRAM; ACCESS	Introduction: There has been insufficient attention to long-term care and treatment for pregnant women diagnosed with HIV. Objective and Methods: This prospective cohort study of 100 HIV-positive women recruited within pregnancy-related services in a district hospital in Kenya employed quantitative methods to assess attrition between women testing HIV-positive in pregnancy-related services and accessing long-term HIV care and treatment services. Qualitative methods were used to explore barriers and facilitators to navigating these services. Structured questionnaires were administered to cohort participants at enrolment and 90+ days later. Participants' medical records were monitored prospectively. Semi-structured qualitative interviews were carried out with a sub-set of 19 participants. Findings: Only 53/100 (53%) women registered at an HIV clinic within 90 days of HIV diagnosis, of whom 27/53 (51%) had a CD4 count result in their file. 11/27 (41%) women were eligible for immediate antiretroviral therapy (ART); only 6/11 (55%) started ART during study follow-up. In multivariable logistic regression analysis, factors associated with registration at the HIV clinic within 90 days of HIV diagnosis were: having cared for someone with HIV (aOR:3.67(95% CI:1.22, 11.09)), not having to pay for transport to the hospital (aOR: 2.73(95% CI: 1.09, 6.84)), and having received enough information to decide to have an HIV test (aOR: 3.61(95% CI: 0.83, 15.71)). Qualitative data revealed multiple factors underlying high patient drop-out related to women's social support networks (e.g. partner's attitude to HIV status), interactions with health workers (e.g. being given unclear/incorrect HIV-related information) and health services characteristics (e.g. restricted opening hours, long waiting times). Conclusion: HIV testing within pregnancy-related services is an important entry point to HIV care and treatment services, but few women successfully completed the steps needed for assessment of their treatment needs within three months of diagnosis. Programmatic recommendations include simplified pathways to care, better-tailored counselling, integration of ART into antenatal services, and facilitation of social support.	[Ferguson, Laura] Univ So Calif, Inst Global Hlth, Los Angeles, CA 90089 USA; [Ferguson, Laura; Lewis, James; Ross, David A.] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Ferguson, Laura; Vusha, Sophie; Ong'ech, John O.] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Grant, Alison D.; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Kielmann, Karina] Queen Margaret Univ, Inst Int Hlth & Dev, Edinburgh, Midlothian, Scotland; [Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Ong'ech, John O.] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Southern California; University of London; London School of Hygiene & Tropical Medicine; University of Nairobi; University of London; London School of Hygiene & Tropical Medicine; Queen Margaret University; National Institute of Medical Research; University of Nairobi	Ferguson, L (corresponding author), Univ So Calif, Inst Global Hlth, Los Angeles, CA 90089 USA.	laurafer@usc.edu	Lewis, James/F-6333-2013; Ferguson, Laura/AAO-9694-2021	Ferguson, Laura/0000-0002-1340-793X	Economic and Social Research Council (UK)/Medical Research Council UK; UK Department for International Development-supported Evidence for Action on HIV Treatment and Care Systems Research Programme; Parkes Foundation; University of London Central Research Fund; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Economic and Social Research Council (UK)/Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development-supported Evidence for Action on HIV Treatment and Care Systems Research Programme; Parkes Foundation; University of London Central Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding to support this work came from the Economic and Social Research Council (UK)/Medical Research Council UK (www.esrc.ac.uk; www.mrc.ac.uk), the UK Department for International Development-supported Evidence for Action on HIV Treatment and Care Systems Research Programme (www.evidence4action.org), the Parkes Foundation (www.parkesfoundation.org.uk) and the University of London Central Research Fund (www.london.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams E, 2010, INT AIDS C VIENN AUS; Balira R, 2010, IMPLEMENTATION PREVE; Chen JY, 2010, JAIDS-J ACQ IMM DEF, V54, P102, DOI 10.1097/QAI.0b013e3181c080bf; Chi BH, 2007, JAIDS-J ACQ IMM DEF, V45, P125, DOI 10.1097/QAI.0b013e318050d28f; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ferguson L, 2012, JAIDS-J ACQ IMM DEF, V60, pE90, DOI 10.1097/QAI.0b013e318253258a; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Hensen B, 2012, TROP MED INT HEALTH, V17, P59, DOI 10.1111/j.1365-3156.2011.02893.x; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Larsson EC, 2012, HEALTH POLICY PLANN, V27, P69, DOI 10.1093/heapol/czr009; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Macintyre K, 2001, AIDS EDUC PREV, V13, P160, DOI 10.1521/aeap.13.2.160.19736; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Ministry of Health Republic of Kenya, 2010, NAT REC PREV MOTH CH; Ministry of Health Republic of Kenya, 2009, NAT GUID PREV MOTH T; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Muchedzi A, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-38; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; Palekar R, 2008, AIDS BEHAV, V12, P903, DOI 10.1007/s10461-007-9325-5; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Tonwe-Gold B, 2009, TROP MED INT HEALTH, V14, P204, DOI 10.1111/j.1365-3156.2008.02182.x; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091; Wettstein C, 2012, AIDS ACQUIRED IMMUNE; WHO, 2012, US ANT DRUGS TREAT P; World Health Organisation, 2021, CONSOLIDATED GUIDELI	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89764	10.1371/journal.pone.0089764	http://dx.doi.org/10.1371/journal.pone.0089764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646492	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500009
J	Greshake, B; Bayer, PE; Rausch, H; Reda, J				Greshake, Bastian; Bayer, Philipp E.; Rausch, Helge; Reda, Julia			openSNP-A Crowdsourced Web Resource for Personal Genomics	PLOS ONE			English	Article							DATABASE; CANCER; ISSUES	Genome-Wide Association Studies are widely used to correlate phenotypic traits with genetic variants. These studies usually compare the genetic variation between two groups to single out certain Single Nucleotide Polymorphisms ( SNPs) that are linked to a phenotypic variation in one of the groups. However, it is necessary to have a large enough sample size to find statistically significant correlations. Direct-To-Consumer (DTC) genetic testing can supply additional data: DTC-companies offer the analysis of a large amount of SNPs for an individual at low cost without the need to consult a physician or geneticist. Over 100,000 people have already been genotyped through Direct-To-Consumer genetic testing companies. However, this data is not public for a variety of reasons and thus cannot be used in research. It seems reasonable to create a central open data repository for such data. Here we present the web platform openSNP, an open database which allows participants of Direct-To-Consumer genetic testing to publish their genetic data at no cost along with phenotypic information. Through this crowdsourced effort of collecting genetic and phenotypic information, openSNP has become a resource for a wide area of studies, including Genome-Wide Association Studies. openSNP is hosted at http://www.opensnp.org, and the code is released under MIT-license at http://github.com/gedankenstuecke/snpr.	[Greshake, Bastian] Biodivers & Climate Res Ctr, Mol Ecol Grp, Frankfurt, Germany; [Greshake, Bastian] Goethe Univ Frankfurt, Dept Appl Bioinformat, Inst Cell Biol & Neurosci, D-60054 Frankfurt, Germany; [Bayer, Philipp E.] Univ Queensland, Sch Land Crop & Food Sci, Brisbane, Qld, Australia; [Bayer, Philipp E.] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Genom, Brisbane, Qld, Australia; [Rausch, Helge] Hsch Tech & Wirtschaft, Berlin, Germany; [Reda, Julia] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany	Goethe University Frankfurt; University of Queensland; University of Queensland; Johannes Gutenberg University of Mainz	Greshake, B (corresponding author), Biodivers & Climate Res Ctr, Mol Ecol Grp, Frankfurt, Germany.	info@opensnp.org	Greshake, Bastian/ABF-7171-2020; Bayer, Philipp Emanuel/L-4481-2018	Greshake, Bastian/0000-0002-9925-9623; Bayer, Philipp Emanuel/0000-0001-8530-3067	German Wikimedia Foundation	German Wikimedia Foundation	The study was partially funded by 5000(sic) from the German Wikimedia Foundation (http://www.wikimedia.de/wiki/Hauptseite) in the context of their WissensWert contest, which funds projects for the use of open licenses to create a more open culture (2011) (http://de.wikipedia.org/wiki/Wikipedia:WissensWert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	23andMe, 2011, 23ANDME 2011 STAT DA; Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; andMe, 2012, 23ANDME PRIV STAT; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Bove R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059707; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Cariaso M, 2011, NUCL ACIDS RES; Caulfield T, 2012, ANNU REV MED, V63, P23, DOI 10.1146/annurev-med-062110-123753; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darst BF, 2013, HLTH COMMUN; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hauskeller C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2317; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hogarth S, 2008, ANNU REV GENOM HUM G, V9, P161, DOI 10.1146/annurev.genom.9.081307.164319; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Joh EE, 2011, NATURE REV GENETICS, V12, P3113; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lee SSJ, 2009, AM J BIOETHICS, V9, P35, DOI 10.1080/15265160902874452; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; McGowan ML, 2010, NEW GENET SOC, V29, P261, DOI 10.1080/14636778.2010.507485; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Molloy JC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001195; Njiaju UO, 2012, BREAST J, V18, P436, DOI 10.1111/j.1524-4741.2012.01274.x; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pinkerton CR, 2002, EUR J CANCER, V38, P1051, DOI 10.1016/S0959-8049(02)00021-7; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sweeney L, 2013, CISC VIS NETW IND GL; Tanzi RE, 2012, COLD SPRING HARBOR P, V2; Wasson K, 2009, AM J BIOETHICS, V9, P56, DOI 10.1080/15265160902893965; Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549; Wolinsky H, 2005, EMBO REP, V6, P805, DOI 10.1038/sj.embor.7400508; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030309	42	48	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89204	10.1371/journal.pone.0089204	http://dx.doi.org/10.1371/journal.pone.0089204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647222	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500004
J	Kang, KR; Chen, L; Zhao, X; Qin, CF; Zhan, ZW; Wang, JH; Li, WM; Dzakah, EE; Huang, WJ; Shu, YL; Jiang, T; Cao, WC; Xie, MQ; Luo, XC; Tang, SX				Kang, Keren; Chen, Li; Zhao, Xiang; Qin, Chengfeng; Zhan, Zanwu; Wang, Jihua; Li, Wenmei; Dzakah, Emmanuel E.; Huang, Weijuang; Shu, Yuelong; Jiang, Tao; Cao, Wuchun; Xie, Mingquan; Luo, Xiaochun; Tang, Shixing			Development of Rapid Immunochromatographic Test for Hemagglutinin Antigen of H7 Subtype in Patients Infected with Novel Avian Influenza A (H7N9) Virus	PLOS ONE			English	Article							TRANSMISSION; OUTBREAK	Background: Since human infection with the novel H7N9 avian influenza virus was identified in China in March 2013, the relatively high mortality rate and possibility of human-to-human transmission have highlighted the urgent need for sensitive and specific assays for diagnosis of H7N9 infection. Methodology/Principal Findings: We developed a rapid diagnostic test for the novel avian influenza A (H7N9) virus using anti-hemagglutinin (HA) monoclonal antibodies specifically targeting H7 in an immunochromatographic assay system. The assay limit of detection was 10 3.5 pfu/ml or 10 3 TCID50 of H7N9 virus. The assay specifically detected H7N9 viral isolates and recombinant HA proteins of H7 subtypes including H7N7 and H7N9, but did not react with non-H7 subtypes including H1N1, H3N2, H5N1, H5N9, and H9N2. The detection sensitivity was 59.4% (19/32) for H7N9 patients confirmed by RT-PCR. Moreover, the highest sensitivity of 61.5% (16/26) was obtained when testing H7N9 positive sputum samples while 35.7% (5/14) of nasopharyngeal swabs and 20% (2/10) of fecal samples tested positive. No false positive detection was found when testing 180 H7N9 negative samples. Conclusions/Significance: Our novel rapid assay can specifically detect H7 HA antigen, facilitating rapid diagnosis for prevention and control of the on-going H7N9 epidemic.	[Kang, Keren; Dzakah, Emmanuel E.; Xie, Mingquan; Luo, Xiaochun] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Kang, Keren; Chen, Li; Zhan, Zanwu; Wang, Jihua; Li, Wenmei; Tang, Shixing] Guangzhou Wondfo Biotech Co Ltd, Natl Engn Lab Point Of Care Tests, Guangzhou, Guangdong, Peoples R China; [Zhao, Xiang; Huang, Weijuang; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Qin, Chengfeng; Jiang, Tao; Cao, Wuchun] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China	South China University of Technology; Chinese Center for Disease Control & Prevention; Beijing Institute of Microbiology & Epidemiology	Tang, SX (corresponding author), Guangzhou Wondfo Biotech Co Ltd, Natl Engn Lab Point Of Care Tests, Guangzhou, Guangdong, Peoples R China.	tang.shixing@wondfo.com.cn	Qin, Cheng-Feng/I-6839-2019; Luo, Xiao-Chun/E-2377-2012	Qin, Cheng-Feng/0000-0002-0632-2807; Luo, Xiao-Chun/0000-0001-9554-370X; Dzakah, Emmanuel/0000-0002-7475-6420	National Major Science & Technology Projects for Infectious Disease Control and Prevention [2013ZX10004804]	National Major Science & Technology Projects for Infectious Disease Control and Prevention	This study was supported by the National Major Science & Technology Projects for Infectious Disease Control and Prevention (2013ZX10004804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas C, 2013, EURO SURVEILL, V18; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; China Food and Drug Administration, 2013, AUTH PCR KITS H7N9 C; Editorial team, 2007, EURO SURVEILL, V12; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; National Health and Family Planning Commission of the People's Republic of China, 2013, NEW CAS CHIN; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; WHO, 2013, REAL TIM RT PCR PROT; WHO Global Alert and Response, 2013, HUM INF AV INFL A H7; Wulff Niels H, 2012, J Clin Bioinforma, V2, P5, DOI 10.1186/2043-9113-2-5	17	20	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92306	10.1371/journal.pone.0092306	http://dx.doi.org/10.1371/journal.pone.0092306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647358	gold, Green Published, Green Submitted			2022-12-25	WOS:000333348500112
J	Zhang, M; Guo, R; Shi, S; Miao, Y; Zhang, YF; Li, B				Zhang, Min; Guo, Rui; Shi, Shuo; Miao, Yin; Zhang, Yifan; Li, Biao			Baculovirus Vector-Mediated Transfer of Sodium Iodide Symporter and Plasminogen Kringle 5 Genes for Tumor Radioiodide Therapy	PLOS ONE			English	Article							IONIZING-RADIATION; ANGIOGENESIS INHIBITORS; PROSTATE-CANCER; IN-VIVO; EXPRESSION; CELLS; PROMOTER; RADIOTHERAPY; XENOGRAFTS; ACTIVATION	Background: Both tumor cells and their supporting endothelial cells should be considered for targeted cell killing when designing cancer treatments. Here we investigated the feasibility of combining radioiodide and antiangiogenic therapies after baculovirus-mediated transfer of genes encoding the sodium iodide symporter (NIS) and plasminogen kringle 5 (K5). Methods: A recombinant baculovirus containing the NIS gene under control of the human telomerase reverse transcriptase (hTERT) promoter and the K5 gene driven by the early growth response 1 (Egr1) promoter was developed. Dual-luciferase reporter assay was performed to confirm the activation of hTERT transcription. NIS and K5 gene expression were identified by Western blot and Real-Time PCR. Functional NIS activity in baculovirus-infected Hela cells was confirmed by the uptake of (125)vertical bar and cytotoxicity of (131)vertical bar. The apoptotic effect of (131)vertical bar-induced K5 on baculovirus-infected human umbilical vein endothelial cells (HUVECs) was analyzed by a flow cytometry-based assay. In vivo, NIS reporter gene imaging and therapeutic experiments with (131)vertical bar were performed. Finally, the microvessel density (MVD) in tumors after treatment was determined by CD31 immunostaining. Results: The activation of hTERT transcription was specifically up-regulated in tumor cells. NIS gene expression markedly increased in baculovirus-infected HeLa cells, but not in MRC5 cells. The Hela cells showed a significant increase of (125) vertical bar uptake, which was inhibited by NaClO4, and a notably decreased cell survival rate by (131)vertical bar treatment. Expression of the K5 gene induced by (131)vertical bar was elevated in a dose-and time-dependent manner and resulted in the apoptosis of HUVECs. Furthermore, (131)vertical bar SPECT imaging clearly showed cervical tumor xenografts infected with recombinant baculovirus. Following therapy, tumor growth was significantly retarded. CD31 immunostaining confirmed a significant decrease of MVD. Conclusion: The recombinant baculovirus supports a promising strategy of NIS-based raidoiodide therapy combined with K5-based antiangiogenic therapy by targeting both the tumor and its supporting vessels.	[Zhang, Min; Guo, Rui; Shi, Shuo; Miao, Yin; Zhang, Yifan; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn	Zhang, Yifan/AGT-8799-2022	Yifan, Zhang/0000-0001-6488-6232; Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81071181]; Shanghai Outstanding Academic Leaders Project [11XD1403700]; Shanghai Health Bureau Youth Foundation [2010Y021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project; Shanghai Health Bureau Youth Foundation	This work was supported by grants from the National Natural Science Foundation of China (No. 81071181,http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700, http://www.stcsm.gov.cn/) and Shanghai Health Bureau Youth Foundation (2010Y021,http://www.smhb.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland A, 2000, CANCER RES, V60, P3484; Camphausen K, 2002, EXPERT OPIN BIOL TH, V2, P477; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cengic N, 2005, J CLIN ENDOCR METAB, V90, P4457, DOI 10.1210/jc.2004-2140; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; Dwyer RM, 2005, MOL THER, V12, P835, DOI 10.1016/j.ymthe.2005.05.013; Dwyer RM, 2005, CLIN CANCER RES, V11, P1483, DOI 10.1158/1078-0432.CCR-04-1636; Gorski DH, 1999, CANCER RES, V59, P3374; Gorski DH, 1998, CANCER RES, V58, P5686; Guo R, 2010, NUCL MED COMMUN, V31, P916, DOI 10.1097/MNM.0b013e32833dedd7; Haberkorn U, 2001, J NUCL MED, V42, P317; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Kaikkonen MU, 2006, GENE THER, V13, P304, DOI 10.1038/sj.gt.3302657; Kawashita Y, 2005, GENE THER, V12, P1633, DOI 10.1038/sj.gt.3302531; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kim SH, 2008, HUM GENE THER, V19, P951, DOI [10.1089/hum.2008.030, 10.1089/hgt.2008.030]; Koga S, 2000, HUM GENE THER, V11, P1397, DOI 10.1089/10430340050057477; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; Minemura K, 2000, ENDOCRINOLOGY, V141, P1814, DOI 10.1210/en.141.5.1814; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Scholz IV, 2005, GENE THER, V12, P272, DOI 10.1038/sj.gt.3302410; Shin JH, 2004, EUR J NUCL MED MOL I, V31, P425, DOI 10.1007/s00259-003-1394-8; Spitzweg C, 2000, CANCER RES, V60, P6526; Takahashi T, 1997, HUM GENE THER, V8, P827, DOI 10.1089/hum.1997.8.7-827; Takakura M, 1999, CANCER RES, V59, P551; WEICHSELBAUM RR, 1994, CANCER RES, V54, P4266; Zhu XP, 2010, MED PHYS, V37, P2974, DOI 10.1118/1.3431999	32	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92326	10.1371/journal.pone.0092326	http://dx.doi.org/10.1371/journal.pone.0092326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647588	Green Published, gold, Green Submitted			2022-12-25	WOS:000333348500118
J	Zhu, XM; Huang, SX; Zhang, LL; Wu, YM; Chen, YW; Tao, YX; Wang, YS; He, SG; Shen, SB; Wu, J; Li, BJ; Guo, XZ; He, L; Ma, G				Zhu, Xuming; Huang, Sixia; Zhang, Lingling; Wu, Yumei; Chen, Yingwei; Tao, Yixin; Wang, Yushu; He, Shigang; Shen, Sanbing; Wu, Ji; Li, Baojie; Guo, Xizhi; He, Lin; Ma, Gang			Constitutive Activation of Ectodermal beta-Catenin Induces Ectopic Outgrowths at Various Positions in Mouse Embryo and Affects Abdominal Ventral Body Wall Closure	PLOS ONE			English	Article							GENETIC INTERACTION; VERTEBRATE LIMB; MORPHOGENESIS; INITIATION; IDENTITY; SIGNALS; RIDGE; FGF10; TBX4; MICE	Vertebrate limbs originate from the lateral plate mesoderm (LPM) and the overlying ectoderm. While normal limb formation in defined regions has been well studied, the question of whether other positions retain limb-forming potential has not been fully investigated in mice. By ectopically activating beta-catenin in the ectoderm with Msx2-cre, we observed that local tissue outgrowths were induced, which either progressed into limb-like structure within the inter-limb flank or formed extra tissues in other parts of the mouse embryo. In the presumptive abdominal region of severely affected embryos, ectopic limb formation was coupled with impaired abdominal ventral body wall (AVBW) closure, which indicates the existence of a potential counterbalance of limb formation and AVBW closure. At the molecular level, constitutive beta-catenin activation was sufficient to trigger, but insufficient to maintain the ectopic expression of a putative limb-inducing factor, Fgf8, in the ectoderm. These findings provide new insight into the mechanism of limb formation and AVBW closure, and the crosstalk between the Wnt/beta-catenin pathway and Fgf signal.	[Zhu, Xuming; Huang, Sixia; Zhang, Lingling; Tao, Yixin; Wang, Yushu; He, Shigang; Shen, Sanbing; Wu, Ji; Li, Baojie; Guo, Xizhi; He, Lin; Ma, Gang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Wu, Yumei; Chen, Yingwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol,Luwan Branch, Shanghai 200030, Peoples R China; [He, Shigang] Shanghai Jiao Tong Univ, Dept Biomed Engn, Shanghai 200030, Peoples R China; [Shen, Sanbing] Natl Univ Ireland Galway, Sch Med, Regenerat Med Inst, Galway, Ireland	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ollscoil na Gaillimhe-University of Galway	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	xzguo2005@gmail.com; helinhelin3@gmail.com; magang2004@gmail.com	Zhu, Xuming/ABC-6380-2021; Shen, Sanbing/E-3750-2015; zhang, lingling/HDM-2189-2022	Zhu, Xuming/0000-0003-1148-4162; Huang, Sixia/0000-0003-3591-1085; Zhang, Lingling/0000-0002-9390-8880; Shen, Sanbing/0000-0002-8217-9811; Guo, Xizhi/0000-0001-8047-6049	973 Programs [2013CB967401, 2011CBA00803, 2012CB966903, 2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [91127047, 81121001]; Natural Science Foundation of Shanghai [13ZR1421100]; Shanghai Leading Academic Discipline Project [B205]	973 Programs(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 Programs (2013CB967401, 2011CBA00803, 2012CB966903, 2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (91127047, 81121001), the Natural Science Foundation of Shanghai (13ZR1421100), and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huang SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045904; Hunter AGW, 2011, AM J MED GENET A, V155A, P2045, DOI 10.1002/ajmg.a.34161; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Lin CX, 2008, DEVELOPMENT, V135, P2815, DOI 10.1242/dev.020586; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Soshnikova N, 2003, GENE DEV, V17, P1963, DOI 10.1101/gad.263003; Sun J, 2007, BIOCHEM BIOPH RES CO, V360, P238, DOI 10.1016/j.bbrc.2007.06.049; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tamura K, 2001, J ANAT, V199, P195, DOI 10.1017/S0021878201008081; Tanaka M, 2000, DEVELOPMENT, V127, P4011; Zhu XM, 2012, DEV BIOL, V365, P328, DOI 10.1016/j.ydbio.2012.02.019	22	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92092	10.1371/journal.pone.0092092	http://dx.doi.org/10.1371/journal.pone.0092092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647475	Green Published, Green Submitted, gold			2022-12-25	WOS:000333348500082
J	Li, C; Yu, DG; Williams, GR; Wang, ZH				Li, Chen; Yu, Deng-Guang; Williams, Gareth R.; Wang, Zhuan-Hua			Fast-Dissolving Core-Shell Composite Microparticles of Quercetin Fabricated Using a Coaxial Electrospray Process	PLOS ONE			English	Article							DUAL DRUG-RELEASE; SOLID DISPERSIONS; DELIVERY; ENHANCEMENT; ATOMIZATION; PARTICLES; SYSTEM	This study reports on novel fast-dissolving core-shell composite microparticles of quercetin fabricated using coaxial electrospraying. A PVC-coated concentric spinneret was developed to conduct the electrospray process. A series of analyses were undertaken to characterize the resultant particles in terms of their morphology, the physical form of their components, and their functional performance. Scanning and transmission electron microscopies revealed that the microparticles had spherical morphologies with clear core-shell structure visible. Differential scanning calorimetry and X-ray diffraction verified that the quercetin active ingredient in the core and sucralose and sodium dodecyl sulfate (SDS) excipients in the shell existed in the amorphous state. This is believed to be a result of second-order interactions between the components; these could be observed by Fourier transform infrared spectroscopy. In vitro dissolution and permeation studies showed that the microparticles rapidly released the incorporated quercetin within one minute, and had permeation rates across the sublingual mucosa around 10 times faster than raw quercetin.	[Li, Chen; Wang, Zhuan-Hua] Shanxi Univ, Inst Biotechnol, Taiyuan, Peoples R China; [Yu, Deng-Guang] Shanghai Univ Sci & Technol, Sch Mat & Engn, Shanghai 201800, Peoples R China; [Williams, Gareth R.] UCL Sch Pharm, London, England	Shanxi University; University of Shanghai for Science & Technology; University of London; University College London	Yu, DG (corresponding author), Shanghai Univ Sci & Technol, Sch Mat & Engn, Shanghai 201800, Peoples R China.	ydg017@gmail.com; zhwang@sxu.edu.cn	Williams, Gareth/A-5980-2013; Yu, Deng-Guang/W-1686-2019	Williams, Gareth/0000-0002-3066-2860; Yu, Deng-Guang/0000-0001-7825-4498	Natural Sciences Foundation of China [51373101, 30970611, 31171659]; Natural Science Foundation of Shanghai [13ZR1428900]; Shanghai Municipal Education Commission [13ZZ113]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the Natural Sciences Foundation of China (Nos. 51373101, 30970611 and 31171659), the Natural Science Foundation of Shanghai (No. 13ZR1428900) and the Key Project of the Shanghai Municipal Education Commission (No. 13ZZ113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050713; Beig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068237; Bikiaris DN, 2011, EXPERT OPIN DRUG DEL, V8, P1501, DOI 10.1517/17425247.2011.618181; Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013; Chaturvedi A, 2011, CURR DRUG DELIV, V8, P373, DOI 10.2174/156720111795768022; Chaudhuri RG, 2012, CHEM REV, V112, P2373, DOI 10.1021/cr100449n; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Cui WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068771; Ding L, 2005, J CONTROL RELEASE, V102, P395, DOI 10.1016/j.jconrel.2004.10.011; Douroumis D, 2011, EXPERT OPIN DRUG DEL, V8, P665, DOI 10.1517/17425247.2011.566553; Enayati M, 2010, J R SOC INTERFACE, V7, P667, DOI 10.1098/rsif.2009.0348; George MC, 2009, ANGEW CHEM INT EDIT, V48, P8606, DOI 10.1002/anie.200904089; Grotz VL, 2009, REGUL TOXICOL PHARM, V55, P1, DOI 10.1016/j.yrtph.2009.05.011; Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025; Li HL, 2009, J CONTROL RELEASE, V133, P238, DOI 10.1016/j.jconrel.2008.10.002; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; Li WB, 2013, MATER LETT, V93, P125, DOI 10.1016/j.matlet.2012.11.064; Li XY, 2013, INT J MOL SCI, V14, P21647, DOI 10.3390/ijms141121647; Liang XL, 2012, ANGEW CHEM INT EDIT, V51, P8034, DOI 10.1002/anie.201203456; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Lu XF, 2011, PROG POLYM SCI, V36, P671, DOI 10.1016/j.progpolymsci.2010.07.010; Moghe AK, 2008, POLYM REV, V48, P353, DOI 10.1080/15583720802022257; Nagaraju T, 2013, CURR DRUG DELIV, V10, P96, DOI 10.2174/1567201811310010016; Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374; Nicolazzo JA, 2005, J CONTROL RELEASE, V105, P1, DOI 10.1016/j.jconrel.2005.01.024; Park CG, 2014, ACTA BIOMATER, V10, P77, DOI 10.1016/j.actbio.2013.08.026; Pongpeerapat A, 2006, PHARM RES, V23, P2566, DOI 10.1007/s11095-006-9089-z; Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486; Roscigno P, 2003, LANGMUIR, V19, P9638, DOI 10.1021/la034928r; Saigal N, 2008, EXPERT OPIN THER PAT, V18, P769, DOI 10.1517/13543776.18.7.769; Salata OV, 2005, CURR NANOSCI, V1, P25, DOI 10.2174/1573413052953192; Slater SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020802; Song BT, 2012, ACTA BIOMATER, V8, P1901, DOI 10.1016/j.actbio.2012.01.020; Webster TJ, 2006, INT J NANOMED, V1, P115, DOI 10.2147/nano.2006.1.2.115; Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022; Wu YQ, 2008, J BIOMAT SCI-POLYM E, V19, P573, DOI 10.1163/156856208784089616; Xie JW, 2006, BIOMATERIALS, V27, P3321, DOI 10.1016/j.biomaterials.2006.01.034; Yu DG, 2013, ACTA BIOMATER, V9, P5665, DOI 10.1016/j.actbio.2012.10.021; Yu DG, 2013, RSC ADV, V3, P17775, DOI 10.1039/c3ra43222j; Yu DG, 2013, RSC ADV, V3, P4652, DOI 10.1039/c3ra40334c; Yu DG, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/10/105606; Yu DG, 2011, INT J NANOMED, V6, P3271, DOI 10.2147/IJN.S27468; Yu DG, 2010, INT J PHARMACEUT, V400, P158, DOI 10.1016/j.ijpharm.2010.08.010; Yu DG, 2009, DRUG DEV IND PHARM, V35, P1530, DOI 10.3109/03639040903059359; Yu DG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055104; Yu DG, 2009, J PHARM PHARMACOL, V61, P323, DOI 10.1211/jpp/61.03.0006	47	37	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92106	10.1371/journal.pone.0092106	http://dx.doi.org/10.1371/journal.pone.0092106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643072	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900087
J	Lu, X; Zhang, FY; Shen, Q; Jiang, WM; Pan, QF; Lv, ZY; Yan, TX; Fu, XQ; Wang, YL; Qian, HM; Tang, KX				Lu, Xu; Zhang, Fangyuan; Shen, Qian; Jiang, Weimin; Pan, Qifang; Lv, Zongyou; Yan, Tingxiang; Fu, Xueqing; Wang, Yuliang; Qian, Hongmei; Tang, Kexuan			Overexpression of Allene Oxide Cyclase Improves the Biosynthesis of Artemisinin in Artemisia annua L.	PLOS ONE			English	Article							JASMONIC ACID; ARABIDOPSIS-THALIANA; TRANSGENIC TOBACCO; ENZYME; CHROMATOGRAPHY; INDUCTION; DEFENSE; PLANTS	Jasmonates (JAs) are important signaling molecules in plants and play crucial roles in stress responses, secondary metabolites' regulation, plant growth and development. In this study, the promoter of AaAOC, which was the key gene of jasmonate biosynthetic pathway, had been cloned. GUS staining showed that AaAOC was expressed ubiquitiously in A. annua. AaAOC gene was overexpressed under control of 35S promoter. RT-Q-PCR showed that the expression levels of AaAOC were increased from 1.6- to 5.2-fold in AaAOC-overexpression transgenic A. annua. The results of GC-MS showed that the content of endogenous jasmonic acid (JA) was 2- to 4.7-fold of the control level in AaAOC-overexpression plants. HPLC showed that the contents of artemisinin, dihydroartemisinic acid and artemisinic acid were increased significantly in AaAOC-overexpression plants. RT-Q-PCR showed that the expression levels of FPS (farnesyl diphosphate synthase), CYP71AV1 (cytochrome P450 dependent hydroxylase) and DBR2 (double bond reductase 2) were increased significantly in AaAOC-overexpression plants. All data demonstrated that increased endogenous JA could significantly promote the biosynthesis of artemisinin in AaAOC-overexpression transgenic A. annua.	[Lu, Xu; Zhang, Fangyuan; Shen, Qian; Jiang, Weimin; Pan, Qifang; Lv, Zongyou; Yan, Tingxiang; Fu, Xueqing; Wang, Yuliang; Qian, Hongmei; Tang, Kexuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Lu, Xu] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China	Shanghai Jiao Tong University; China Pharmaceutical University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn	Tang, Kexuan/E-3555-2013; SHEN, QIAN/O-6347-2015	Tang, Kexuan/0000-0002-8748-9624; Wang, Yuliang/0000-0001-6174-6365; SHEN, QIAN/0000-0002-4621-4659; Jiang, Weimin/0000-0002-2546-5256	China "863" Program [2011AA100605]	China "863" Program(National High Technology Research and Development Program of China)	China "863" Program (grant no. 2011AA100605), the URL of funder's website: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2006, J BIOL CHEM, V281, P31528, DOI 10.1074/jbc.M604820200; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Engelberth J, 2003, ANAL BIOCHEM, V312, P242, DOI 10.1016/S0003-2697(02)00466-9; Ferreira JFS, 2009, PHYTOCHEM ANALYSIS, V20, P91, DOI 10.1002/pca.1101; Gu XC, 2012, PLANT CELL REP, V31, P2247, DOI 10.1007/s00299-012-1334-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang KJ, 2009, PLANTA, V229, P1057, DOI 10.1007/s00425-009-0896-4; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liu DH, 2010, RUSS J PLANT PHYSL+, V57, P882, DOI 10.1134/S102144371006018X; Liu WS, 2013, PLANT BIOTECHNOL J, V11, P43, DOI 10.1111/pbi.12005; Lu X, 2012, MOL BIOL REP, V39, P9521, DOI 10.1007/s11033-012-1816-4; Maes L, 2011, NEW PHYTOL, V189, P176, DOI 10.1111/j.1469-8137.2010.03466.x; Muller A, 2002, PLANTA, V216, P44, DOI 10.1007/s00425-002-0866-6; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tretner C, 2008, J EXP BOT, V59, P2847, DOI 10.1093/jxb/ern145; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Weathers PJ, 2006, IN VITRO CELL DEV-PL, V42, P309, DOI 10.1079/IVP2006782; Yang DH, 2011, J EXP BOT, V62, P641, DOI 10.1093/jxb/erq298; Zhang L, 2009, BIOTECHNOL APPL BIOC, V52, P199, DOI 10.1042/BA20080068; Ziegler J, 2000, J BIOL CHEM, V275, P19132, DOI 10.1074/jbc.M002133200	29	19	19	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91741	10.1371/journal.pone.0091741	http://dx.doi.org/10.1371/journal.pone.0091741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642483	gold, Green Published, Green Submitted			2022-12-25	WOS:000333259900032
J	Nandi, S; Chanda, S; Bagchi, P; Nayak, MK; Bhowmick, R; Chawla-Sarkar, M				Nandi, Satabdi; Chanda, Shampa; Bagchi, Parikshit; Nayak, Mukti Kant; Bhowmick, Rahul; Chawla-Sarkar, Mamta			MAVS Protein Is Attenuated by Rotavirus Nonstructural Protein 1	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; INTERFERON-REGULATORY-FACTORS; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; RIG-I; VIRAL EVASION; NSP1; INFECTION; RNA; DEGRADATION	Rotavirus is the single, most important agent of infantile gastroenteritis in many animal species, including humans. In developing countries, rotavirus infection attributes approximately 500,000 deaths annually. Like other viruses it establishes an intimate and complex interaction with the host cell to counteract the antiviral responses elicited by the cell. Among various pattern recognition receptors (PAMPs) of the host, the cytosolic RNA helicases interact with viral RNA to activate the Mitochondrial Antiviral Signaling protein (MAVS), which regulates cellular interferon response. With an aim to identify the role of different PAMPs in rotavirus infected cell, MAVS was found to degrade in a time dependent and strain independent manner. Rotavirus non-structural protein 1 (NSP1) which is a known IFN antagonist, interacted with MAVS and degraded it in a strain independent manner, resulting in a complete loss of RNA sensing machinery in the infected cell. To best of our knowledge, this is the first report on NSP1 functionality where a signaling protein is targeted unanimously in all strains. In addition NSP1 inhibited the formation of detergent resistant MAVS aggregates, thereby averting the antiviral signaling cascade. The present study highlights the multifunctional role of rotavirus NSP1 and reinforces the fact that the virus orchestrates the cellular antiviral response to its own benefit by various back up strategies.	[Nandi, Satabdi; Chanda, Shampa; Bagchi, Parikshit; Nayak, Mukti Kant; Bhowmick, Rahul; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India.	chawlam70@gmail.com	Bhowmick, Rahul/AAD-4433-2022	Bhowmick, Rahul/0000-0002-5412-1209	Indian Council of Medical Research (ICMR), India; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan	The study was financially supported by Indian Council of Medical Research (ICMR), India and Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Arnold MM, 2013, J VIROL, V87, P9813, DOI 10.1128/JVI.01146-13; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Bagchi P, 2013, VIROLOGY, V444, P41, DOI 10.1016/j.virol.2013.07.003; Bagchi P, 2013, J VIROL, V87, P2358, DOI 10.1128/JVI.02479-12; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bhowmick R, 2013, J VIROL, V87, P6840, DOI 10.1128/JVI.00734-13; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Feng N, 2009, J VIROL, V83, P6987, DOI 10.1128/JVI.00585-09; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Graff JW, 2002, J VIROL, V76, P9545, DOI 10.1128/JVI.76.18.9545-9550.2002; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; HUA J, 1993, VIROLOGY, V196, P372, DOI 10.1006/viro.1993.1492; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Qi BC, 2007, INT J BIOCHEM CELL B, V39, P287, DOI 10.1016/j.biocel.2006.08.016; Qin L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-526; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; Rollo EE, 1999, J IMMUNOL, V163, P4442; Sen A, 2013, J VIROL; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	43	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92126	10.1371/journal.pone.0092126	http://dx.doi.org/10.1371/journal.pone.0092126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643253	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900091
J	Bi, N; Cao, JZ; Song, YM; Shen, J; Liu, WY; Fan, J; He, J; Shi, YK; Zhang, X; Lu, N; Zhan, QM; Wang, LH				Bi, Nan; Cao, Jianzhong; Song, Yongmei; Shen, Jie; Liu, Wenyang; Fan, Jing; He, Jie; Shi, Yuankai; Zhang, Xun; Lu, Ning; Zhan, Qimin; Wang, Luhua			A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy	PLOS ONE			English	Article							REDUCED EXPRESSION; PROGNOSTIC VALUE; GROWTH; OVEREXPRESSION; MIR-150; CLUSTER; TUMORS	Small-cell lung cancer (SCLC) is one of the most aggressive cancers, yet the molecular mechanisms underlying its devastating clinical outcome remain elusive. In this study, we investigated whether microRNA (miRNA) expression profiles can predict the clinical outcomes of SCLC patients. A total of 82 patients with limited SCLC, who were treated with surgical resection and adjuvant chemotherapy, were enrolled in this study. First, we surveyed the expression of 924 miRNAs from 42 SCLC patients to discover survival-relevant miRNAs and develop prognostic models, which were then validated in an independent cohort of 40 cases using quantitative real-time PCR. We found that the miR-150/miR-886-3p signature was significantly correlated with the overall survival (OS) of SCLC patients (p = 0.02) in the training set, and both miRNA expression levels were much lower in the SCLC samples than normal lung samples. The miRNA signature also proved to be a significant predictor of survival in the validation set. Patients with high-risk miRNA signatures had poor overall survival (p = 0.005) and progression-free survival (p = 0.017) compared with those with low-risk scores. These findings retained statistical significance after adjusting for age, gender and smoking status (HR: 0.26, 95%: CI 0.10-0.69, p = 0.007), which suggested it may be an independent predictor of survival. In summary, we developed a prognostic miR-150/miR-886-3p signature and validated expression in an independent dataset of resectable SCLC. These preliminary results indicated that miRNAs may serve as promising molecular prognostic markers and new therapeutic targets for SCLC.	[Bi, Nan; Cao, Jianzhong; Shen, Jie; Liu, Wenyang; Wang, Luhua] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Radiat Oncol, Beijing 100730, Peoples R China; [Bi, Nan; Cao, Jianzhong; Song, Yongmei; Shen, Jie; Liu, Wenyang; Fan, Jing; He, Jie; Shi, Yuankai; Zhang, Xun; Lu, Ning; Zhan, Qimin; Wang, Luhua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Song, Yongmei; Fan, Jing; Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [He, Jie] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Thorac Surg, Beijing 100730, Peoples R China; [Shi, Yuankai] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhang, Xun; Lu, Ning] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn; wlhwq@yahoo.com	bi, nan/GWV-5745-2022; Zhang, Xun/HHM-9059-2022; Liu, Wen-Yang/AAI-7264-2020	Zhang, Xun/0000-0001-5411-2727; Liu, Wen-Yang/0000-0002-6978-7169; song, yongmei/0000-0002-7789-0158	973 National Key Fundamental Research Program of China [2009CB521801, 2010CB912800]; National Natural Science Foundation of China [81021061, 81071830]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 National Key Fundamental Research Program of China (2009CB521801, 2010CB912800) and the National Natural Science Foundation of China (81021061, 81071830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, CLIN CANC RES, V16, P610; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cao J, 2013, CANC RES; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; COOK RM, 1993, CURR PROB CANCER, V17, P71; Crivellari G, 2007, ONCOLOGIST, V12, P79, DOI 10.1634/theoncologist.12-1-79; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lee HW, 2012, PATHOL INT, V62, P583, DOI 10.1111/j.1440-1827.2012.02845.x; Lee JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021300; Li YJ, 2012, ONCOL REP, V27, P129, DOI 10.3892/or.2011.1466; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Ma YL, 2012, GUT, V61, P1447, DOI 10.1136/gutjnl-2011-301122; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Ou SHI, 2009, J THORAC ONCOL, V4, P300, DOI 10.1097/JTO.0b013e318194a355; Pizzini S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-589; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Shiao TH, 2011, J THORAC ONCOL, V6, P195, DOI 10.1097/JTO.0b013e3181f94abb; Simon G, 2001, Chest Surg Clin N Am, V11, P165; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Treppendahl MB, 2012, BLOOD, V119, P206, DOI 10.1182/blood-2011-06-362541; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Xiong Y, PLOS ONE, V6; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhao LJ, 2009, INT J RADIAT ONCOL, V74, P1385, DOI 10.1016/j.ijrobp.2008.10.065; Zhu H, 2011, CANCER-AM CANCER SOC, V117, P5423, DOI 10.1002/cncr.26206	45	30	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91388	10.1371/journal.pone.0091388	http://dx.doi.org/10.1371/journal.pone.0091388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637927	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100031
J	Gupta, D; Rani, M; Khan, N; Jameel, S				Gupta, Deepti; Rani, Manjusha; Khan, Nabab; Jameel, Shahid			HIV-1 Infected Peripheral Blood Mononuclear Cells Modulate the Fibrogenic Activity of Hepatic Stellate Cells through Secreted TGF-beta and JNK Signaling	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR-BETA; C-VIRUS; LIVER FIBROSIS; HIV; PROLIFERATION; EXPRESSION; TRANSDUCTION; ACTIVATION; MECHANISMS	Background and Aims: Patients with liver disease infected with the human immunodeficiency virus (HIV) exhibit accelerated progression of hepatic fibrosis and liver cirrhosis compared to uninfected individuals. We studied the effects of soluble factors secreted by HIV-infected peripheral blood mononuclear cells (PBMCs) on hepatic stellate cells (HSCs), which are central mediators of liver fibrosis. Methods: An in vitro model was used in which a HSC line, LX2, was treated with culture supernatants of human PBMCs infected with macrophage tropic (R5) or T cell tropic (X4) strains of HIV-1. Quantitative reverse transcription PCR (qRT-PCR) and western blotting were used to assess the expression of fibrogenic and proinflammatory markers; LX2 proliferation and intracellular signaling pathways were also studied. A qRT-PCR based miRNome array was used for comparative miRNA profiling of LX2 cells treated with infected PBMC culture supernatants. Results: Pro-fibrogenic, angiogenic and proinflammatory markers, and proliferation of LX2 cells were increased following exposure to culture supernatants from HIV-1 infected PBMCs. The profiling of miRNAs in LX2 cells treated with culture supernatants from HIV-1 R5- or X4-infected PBMCs showed 66 and 22 miRNAs respectively, to be significantly altered compared to mock-treated LX2 cells. While different sets of miRNAs were altered in the two cases, bioinformatics analyses predicted these to be associated with common pathways, including TGF-beta signaling and extracellular matrix receptor interaction pathways. Conclusions: HIV infection creates a favorable milieu for the activation of hepatic stellate cells and increased hepatic fibrosis. We identify some regulatory molecules important for these effects.	[Gupta, Deepti; Rani, Manjusha; Khan, Nabab; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Wellcome Trust DBT India Alliance, Hyderabad, Andhra Pradesh, India.	shahid@icgeb.res.in	khan, Nabab/Z-3970-2019; Gupta, Deepti/U-1777-2019	khan, Nabab/0000-0002-8563-5341; Gupta, Deepti/0000-0001-7931-0017	Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was funded by grants from the Department of Biotechnology (DBT) and Indian Council of Medical Research (ICMR). Senior Research Fellowship was awarded the ICMR to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; BREEN EC, 1990, J IMMUNOL, V144, P480; Breitkopf K, 2005, ALCOHOL CLIN EXP RES, V29, p121S, DOI 10.1097/01.alc.0000189284.98684.22; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Guo GH, 2009, HEPATOB PANCREAT DIS, V8, P59; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033659; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Hung KS, 2005, BIOCHEM BIOPH RES CO, V336, P324, DOI 10.1016/j.bbrc.2005.08.085; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawada N, 2011, HEPATOL RES, V41, P199, DOI 10.1111/j.1872-034X.2011.00776.x; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Kluwe J, 2007, OCTOBER, V13, P1324, DOI [10.1038/nm1663, DOI 10.1038/NM1663]; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOTZ M, 1993, ANN NY ACAD SCI, V685, P501, DOI 10.1111/j.1749-6632.1993.tb35912.x; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; MOLINA JM, 1989, J CLIN INVEST, V84, P733, DOI 10.1172/JCI114230; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Nunoya J-J, 2013, J INFECT DIS, P1; Patel P, 2014, PLOS ONE IN PRESS; Roe Barbara, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000847; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Sherman KE, 2007, HEPATOLOGY, V45, P1566, DOI 10.1002/hep.21722; Tahiri M, 2013, WORLD J HEPATOL, V5, P584, DOI 10.4254/wjh.v5.i10.584; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiercinska-Drapalo A, 2004, VIRAL IMMUNOL, V17, P109, DOI 10.1089/088282404322875502; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	48	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91569	10.1371/journal.pone.0091569	http://dx.doi.org/10.1371/journal.pone.0091569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637780	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100045
J	Wang, F; Li, DL; Wang, ZY; Dong, AR; Liu, LH; Wang, BY; Chen, QL; Liu, XH				Wang, Feng; Li, Danlei; Wang, Zhiying; Dong, Airong; Liu, Lihong; Wang, Buyong; Chen, Qiaoli; Liu, Xiaohan			Transcriptomic Analysis of the Rice White Tip Nematode, Aphelenchoides besseyi (Nematoda: Aphelenchoididae)	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; HORIZONTAL GENE-TRANSFER; ROOT-LESION NEMATODE; RNA INTERFERENCE; PHARYNGEAL GLAND; EFFECTOR PROTEIN; IDENTIFICATION; SEQUENCE; CLASSIFICATION; EXPRESSION	Background: The rice white tip nematode Aphelenchoides besseyi, a devastating nematode whose genome has not been sequenced, is distributed widely throughout almost all the rice-growing regions of the world. The aims of the present study were to define the transcriptome of A. besseyi and to identify parasite-related, mortality-related or host resistance-overcoming genes in this nematode. Methodology and Principal Findings: Using Solexa/Illumina sequencing, we profiled the transcriptome of mixed-stage populations of A. besseyi. A total of 51,270 transcripts without gaps were produced based on high-quality clean reads. Of all the A. besseyi transcripts, 9,132 KEGG Orthology assignments were annotated. Carbohydrate-active enzymes of glycoside hydrolases (GHs), glycosyltransferases (GTs), carbohydrate esterases (CEs) and carbohydrate-binding modules (CBMs) were identified. The presence of the A. besseyi GH45 cellulase gene was verified by in situ hybridization. Given that 13 unique A. besseyi potential effector genes were identified from 41 candidate effector homologs, further studies of these homologs are merited. Finally, comparative analyses were conducted between A. besseyi contigs and Caenorhabditis elegans genes to look for orthologs of RNAi phenotypes, neuropeptides and peptidases. Conclusions and Significance: The present results provide comprehensive insight into the genetic makeup of A. besseyi. Many of this species' genes are parasite related, nematode mortality-related or necessary to overcome host resistance. The generated transcriptome dataset of A. besseyi reported here lays the foundation for further studies of the molecular mechanisms related to parasitism and facilitates the development of new control strategies for this species.	[Wang, Feng; Li, Danlei; Wang, Zhiying; Dong, Airong; Liu, Lihong; Wang, Buyong; Chen, Qiaoli; Liu, Xiaohan] Northeast Forestry Univ, Coll Forestry, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Li, DL (corresponding author), Northeast Forestry Univ, Coll Forestry, Harbin, Heilongjiang, Peoples R China.	danleili@nefu.edu.cn	liu, li/HGC-0900-2022		Research Fund for the Doctoral Program of Higher Education of China [20100062120002]; Heilongjiang Postdoctoral Fund (China) [LBH-Z11248]; China State Scholarship Fund [2009660509]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Heilongjiang Postdoctoral Fund (China); China State Scholarship Fund	This work was financed by the Research Fund for the Doctoral Program of Higher Education of China (project 20100062120002), the Heilongjiang Postdoctoral Fund (China; project LBH-Z11248) and the China State Scholarship Fund (2009660509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Bakhetia M, 2005, TRENDS PLANT SCI, V10, P362, DOI 10.1016/j.tplants.2005.06.007; Cantacessi C, 2011, BIOTECHNOL ADV, V29, P261, DOI 10.1016/j.biotechadv.2010.11.005; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; de Boer JM, 1998, J NEMATOL, V30, P309; De Meutter J, 2003, MOL PLANT PATHOL, V4, P271, DOI [10.1046/j.1364-3703.2003.00176.x, 10.1046/J.1364-3703.2003.00176.X]; Duncan LW, 2006, PLANT NEMATOLOGY, P123, DOI [10.1079/9781845930561.0123, 10.1079/9781780641515.0144]; Elling AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-58; FORTUNER R, 1975, PLANT NEMATOLOGY, V44, P1; Fu Z, 2012, PHYTOPATHOLOGY, V102, P804, DOI 10.1094/PHYTO-12-11-0336; Geldhof P, 2007, PARASITOLOGY, V134, P609, DOI 10.1017/S0031182006002071; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haegeman A, 2013, MOL PLANT PATHOL, V14, P379, DOI 10.1111/mpp.12014; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jacob J, 2008, MOL GENET GENOMICS, V280, P1, DOI 10.1007/s00438-008-0340-7; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Jones JT, 2005, NEMATOLOGY, V7, P641, DOI 10.1163/156854105775142919; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karim N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-525; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2014, NEMATOLOGY, V16, P99, DOI 10.1163/15685411-00002748; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 2008, WORMBOOK, V25, P1, DOI [10.1895/wormbook.1.142.1, DOI 10.1895/W0RMB00K.1.142.1]; Lin BR, 2013, MOL PLANT MICROBE IN, V26, P55, DOI 10.1094/MPMI-05-12-0114-FI; Lin M.S., 2004, RICE SCI, V12, P289; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rajan, 1990, Indian Journal of Nematology, V19, P10; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; Roze E, 2008, MOL PLANT PATHOL, V9, P1, DOI [10.1111/j.1364-3703.2007.00435.x, 10.1111/J.1364-3703.2007.00435.X]; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Silva G. S. da, 1992, Informe Agropecuario (Belo Horizonte), V16, P57; Tiwari S. P., 2003, Advances in nematology, P103; Togashi K, 2001, NEMATOLOGY, V3, P17, DOI 10.1163/156854101300106847; Tsay T. T., 1995, Plant Pathology Bulletin, V4, P180; Tytgat T, 2004, MOL PLANT MICROBE IN, V17, P846, DOI 10.1094/MPMI.2004.17.8.846; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Wang F, 2012, INT J MOL SCI, V13, P8819, DOI 10.3390/ijms13078819; Wang K. M., 1993, Plant Protection Bulletin (Taichung), V35, P14; Yoshida K, 2009, J NEMATOL, V41, P17; Yu P. C., 2004, Plant Pathology Bulletin, V13, P35	63	27	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91591	10.1371/journal.pone.0091591	http://dx.doi.org/10.1371/journal.pone.0091591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637831	gold, Green Submitted, Green Published			2022-12-25	WOS:000333254100047
J	Chua, CEL; Tang, BL				Chua, Christelle En Lin; Tang, Bor Luen			Engagement of the Small GTPase Rab31 Protein and Its Effector, Early Endosome Antigen 1, Is Important for Trafficking of the Ligand-bound Epidermal Growth Factor Receptor from the Early to the Late Endosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Endosomes; Epidermal Growth Factor Receptor (EGFR); Rab; Trafficking	TRANS-GOLGI NETWORK; NUCLEOTIDE EXCHANGE FACTOR; EARLY ENDOCYTIC PATHWAY; EGF RECEPTOR; INTRACELLULAR TRAFFICKING; MEMBRANE TRAFFICKING; BREAST-CANCER; EEA1; EXPRESSION; BINDING	Background: Rab31 is a member of the Rab5 subfamily of Rab GTPases. Results: Manipulation of Rab31 and interacting partners affects trafficking of the EGF receptor (EGFR) to the late endosome. Conclusion: Rab31, with its regulator and effector, plays an important role in the trafficking of the EGFR from the early to the late endosome. Significance: Evidence is provided for Rab31 being a key regulator of endocytic traffic of the EGFR. Rab31 is a member of the Rab5 subfamily of Rab GTPases. Although localized largely to the trans-Golgi network, it shares common guanine nucleotide exchange factors and effectors with other Rab5 subfamily members that have been implicated in endocytic membrane traffic. We investigated whether Rab31 also has a role in the trafficking of the ligand-bound EGF receptor (EGFR) internalized through receptor-mediated endocytosis. We found that loss of Rab31 inhibits, but overexpression enhances, EGFR trafficking to the late endosomes and that the effect of Rab31 silencing could be specifically rescued by overexpression of a silencing-resistant form of Rab31. Rab31 was found to interact with the EGFR by coimmunoprecipitation and affinity pulldown analyses, and the primarily trans-Golgi network-localized Rab31 has increased colocalization with the EGFR in A431 cells 30 min after pulsing with EGF. A glycerol gradient sedimentation assay suggested that Rab31 is sequestered into a high molecular weight complex after stimulation with EGF, as was early endosome antigen 1 (EEA1), a factor responsible for endosomal tethering and fusion events. We found that loss of EEA1 reduced the interaction between Rab31 and the EGFR and abrogated the effect of Rab31 overexpression on the trafficking of the EGFR. Likewise, loss of GAPex5, a Rab31 guanine nucleotide exchange factor that has a role in ubiquitination and degradation of the EGFR, reduced the interaction of Rab31 with the EGFR and its effect on EGFR trafficking. Taken together, our results suggest that Rab31 is an important regulator of endocytic trafficking of the EGFR and functions in an EGFR trafficking complex that includes EEA1 and GAPex5.	[Chua, Christelle En Lin; Tang, Bor Luen] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119228, Singapore; [Chua, Christelle En Lin; Tang, Bor Luen] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Chua, CEL (corresponding author), Natl Univ Singapore, Dept Biochem, Block MD7,8 Med Dr,01-05, Singapore 117597, Singapore.	g0901904@nus.edu.sg; bchtbl@nus.edu.sg	Tang, Bor Luen/E-4548-2012	Tang, Bor Luen/0000-0002-1925-636X	National University of Singapore Graduate School for Integrative Sciences and Engineering (NGS)	National University of Singapore Graduate School for Integrative Sciences and Engineering (NGS)	This work was supported by the National University of Singapore Graduate School for Integrative Sciences and Engineering (NGS).	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Ceresa BP, 2006, HISTOL HISTOPATHOL, V21, P987, DOI 10.14670/HH-21.987; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Grismayer B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-62; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kajiho H, 2011, J BIOL CHEM, V286, P24364, DOI 10.1074/jbc.M110.172445; Kauppi M, 2002, J CELL SCI, V115, P899; Kotzsch M, 2008, BREAST CANCER RES TR, V111, P229, DOI 10.1007/s10549-007-9782-6; Kunkle BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064140; Li L, 2001, J BIOL CHEM, V276, P5265, DOI 10.1074/jbc.M003883200; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; Mills IG, 2001, J CELL SCI, V114, P1959; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Ng EL, 2007, BIOCHEM BIOPH RES CO, V361, P751, DOI 10.1016/j.bbrc.2007.07.076; Ng EL, 2009, J CELL PHYSIOL, V221, P716, DOI 10.1002/jcp.21911; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Segev N., 2001, SCI STKE, V2001, pre11; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P33, DOI 10.1016/j.semcdb.2010.11.005; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Tong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064817; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Yang X, 2012, BIOCHEM BIOPH RES CO, V421, P651, DOI 10.1016/j.bbrc.2012.04.049; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	46	31	30	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12375	12389		10.1074/jbc.M114.548321	http://dx.doi.org/10.1074/jbc.M114.548321			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24644286	Green Published, hybrid			2022-12-25	WOS:000335581400016
J	Yao, Q; Liu, BQ; Li, H; McGarrigle, D; Xing, BW; Zhou, MT; Wang, Z; Zhang, JJ; Huang, XY; Guo, L				Yao, Qi; Liu, Bing-Qian; Li, Hui; McGarrigle, Deirdre; Xing, Bo-Wen; Zhou, Mao-Tian; Wang, Zhe; Zhang, J. Jillian; Huang, Xin-Yun; Guo, Lin			C-terminal Src Kinase ( Csk)-mediated Phosphorylation of Eukaryotic Elongation Factor 2 ( eEF2) Promotes Proteolytic Cleavage and Nuclear Translocation of eEF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Nuclear Translocation; Phosphorylation; Sumoylation; Translation Elongation Factors; Csk; Nuclear Pleomorphism; Proteolytic Cleavage	PROTEIN-TYROSINE KINASE; FACTOR-II; RABBIT RETICULOCYTES; FAMILY KINASES; CELL-CYCLE; CSK GENE; CANCER; SUMO; OVEREXPRESSION; IDENTIFICATION	Background: The C-terminal Src kinase (Csk) is known as a tumor suppressor, but Src-independent function is unclear. Results: eEF2 is a new protein substrate of Csk. Conclusion: eEF2 phosphorylation and SUMOylation promote its proteolytic cleavage and nuclear localization. Significance: Our findings suggest that a tyrosine kinase can be both a tumor suppressor and a promoter through regulation of different substrate proteins. Protein-tyrosine kinase C-terminal Src kinase (Csk) was originally purified as a kinase for phosphorylating Src and other Src family kinases. The phosphorylation of a C-terminal tyrosine residue of Src family kinases suppresses their kinase activity. Therefore, most physiological studies regarding Csk function have been focused on Csk as a negative regulator of Src family tyrosine kinases and as a potential tumor suppressor. Paradoxically, the protein levels of Csk were elevated in some human carcinomas. In this report, we show that eukaryotic elongation factor 2 (eEF2) is a new protein substrate of Csk and could locate in the nucleus. We demonstrate that Csk-mediated phosphorylation of eEF2 has no effect on its cytoplasmic function in regulating protein translation. However, phosphorylation of eEF2 enhances its proteolytic cleavage and the nuclear translocation of the cleaved eEF2 through a SUMOylation-regulated process. Furthermore, we show that cleaved fragments of eEF2 can induce nuclear morphological changes and aneuploidy similar to those in cancer cells, suggesting that there is an additional mechanism for Csk in tumorigenesis through regulation of eEF2 subcellular localization.	[Yao, Qi; Liu, Bing-Qian; Li, Hui; Xing, Bo-Wen; Zhou, Mao-Tian; Wang, Zhe; Guo, Lin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [McGarrigle, Deirdre; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA	Wuhan University; Cornell University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu; guol@whu.edu.cn	Wang, Zhe/GZB-1109-2022	Wang, Zhe/0000-0001-7071-3370	National Institutes of Health [HL091525]; National Science Foundation of China [31028015, 31221061]; National Basic Research Program of China [2013CB911102]; 111 Project of China [B06018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 111 Project of China(Ministry of Education, China - 111 Project); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL091525 (to X.-Y. H.). This work was also supported by National Science Foundation of China Grants 31028015 and 31221061, National Basic Research Program of China Grant 2013CB911102, and the 111 Project of China Grant B06018 (to L. G.).	Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Benistant C, 2001, CANCER RES, V61, P1415; Bermek E, 1978, Prog Nucleic Acid Res Mol Biol, V21, P63, DOI 10.1016/S0079-6603(08)60267-6; BOLEN JB, 1993, ONCOGENE, V8, P2025; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Chen CY, 2011, CANCER SCI, V102, P1582, DOI 10.1111/j.1349-7006.2011.01975.x; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Duesberg P, 2004, IUBMB LIFE, V56, P65, DOI 10.1080/15216540410001667902; Duprez E, 1999, J CELL SCI, V112, P381; Gevaert K, 2005, PROTEOMICS, V5, P3589, DOI 10.1002/pmic.200401217; GIOVANE A, 1987, BIOCHEM J, V244, P337, DOI 10.1042/bj2440337; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; HINCKE MT, 1992, BIOCHEM J, V282, P877, DOI 10.1042/bj2820877; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kimura M, 2013, J BIOL CHEM, V288, P24540, DOI 10.1074/jbc.M113.489286; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lee SS, 2006, J BIOL CHEM, V281, P8183, DOI 10.1074/jbc.M508120200; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Miller MA, 2000, ONCOGENE, V19, P3925, DOI 10.1038/sj.onc.1203714; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Miura Y, 2007, J BIOCHEM, V142, P145, DOI 10.1093/jb/mvm118; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nakagawa T, 2000, INT J CANCER, V88, P384, DOI 10.1002/1097-0215(20001101)88:3<384::AID-IJC10>3.3.CO;2-2; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; OKADA M, 1991, J BIOL CHEM, V266, P24249; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Parrado J, 1999, FREE RADICAL BIO MED, V26, P362, DOI 10.1016/S0891-5849(98)00202-0; PRICE NT, 1991, FEBS LETT, V282, P253, DOI 10.1016/0014-5793(91)80489-P; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sedek M, 2013, BIOCHEM J, V453, P231, DOI 10.1042/BJ20121375; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; WATANABE N, 1995, JPN J CLIN ONCOL, V25, P5; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	57	15	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12666	12678		10.1074/jbc.M113.546481	http://dx.doi.org/10.1074/jbc.M113.546481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24648518	hybrid, Green Published			2022-12-25	WOS:000335581400038
J	Kleisner, K; Chvatalova, V; Flegr, J				Kleisner, Karel; Chvatalova, Veronika; Flegr, Jaroslav			Perceived Intelligence Is Associated with Measured Intelligence in Men but Not Women	PLOS ONE			English	Article							4TH DIGIT RATIO; MATING SUCCESS; TESTOSTERONE; PERSONALITY; BEAUTY; CUES; ATTRACTIVENESS; IMPRESSIONS; SCHIZOTYPY; ACCURACY	Background: The ability to accurately assess the intelligence of other persons finds its place in everyday social interaction and should have important evolutionary consequences. Methodology/Principal Findings: We used static facial photographs of 40 men and 40 women to test the relationship between measured IQ, perceived intelligence, and facial shape. Both men and women were able to accurately evaluate the intelligence of men by viewing facial photographs. In addition to general intelligence, figural and fluid intelligence showed a significant relationship with perceived intelligence, but again, only in men. No relationship between perceived intelligence and IQ was found for women. We used geometric morphometrics to determine which facial traits are associated with the perception of intelligence, as well as with intelligence as measured by IQ testing. Faces that are perceived as highly intelligent are rather prolonged with a broader distance between the eyes, a larger nose, a slight upturn to the corners of the mouth, and a sharper, pointing, less rounded chin. By contrast, the perception of lower intelligence is associated with broader, more rounded faces with eyes closer to each other, a shorter nose, declining corners of the mouth, and a rounded and massive chin. By contrast, we found no correlation between morphological traits and real intelligence measured with IQ test, either in men or women. Conclusions: These results suggest that a perceiver can accurately gauge the real intelligence of men, but not women, by viewing their faces in photographs; however, this estimation is possibly not based on facial shape. Our study revealed no relation between intelligence and either attractiveness or face shape.	[Kleisner, Karel; Chvatalova, Veronika; Flegr, Jaroslav] Charles Univ Prague, Dept Philosophy & Hist Sci, Fac Sci, Prague, Czech Republic	Charles University Prague	Kleisner, K (corresponding author), Charles Univ Prague, Dept Philosophy & Hist Sci, Fac Sci, Prague, Czech Republic.	karel.kleisner@natur.cuni.cz	Kleisner, Karel/M-2718-2017; Flegr, Jaroslav/AAG-7568-2021; Chvatalova, Veronika/Z-4109-2019; Flegr, Jaroslav/A-1564-2008	Kleisner, Karel/0000-0002-3277-8365; Flegr, Jaroslav/0000-0002-0822-0126; Chvatalova, Veronika/0000-0002-9601-492X; Flegr, Jaroslav/0000-0002-0822-0126	Czech Grant Agency [GACR P407/11/1464]; Charles University in Prague [UNCE 204004]	Czech Grant Agency(Grant Agency of the Czech Republic); Charles University in Prague	This research was supported by Czech Grant Agency project GACR P407/11/1464 (www.gacr.cz) and by Charles University in Prague project UNCE 204004 (www.cuni.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthauer R, 2001, INTELLIGENZ STRUKTUR; Anderson LD, 1921, J APPL PSYCHOL, V5, P152, DOI 10.1037/h0075189; BORKENAU P, 1995, J PERS, V63, P1, DOI 10.1111/j.1467-6494.1995.tb00799.x; BORKENAU P, 1993, J PERS SOC PSYCHOL, V65, P546, DOI 10.1037/0022-3514.65.3.546; Borkenau P, 2004, J PERS SOC PSYCHOL, V86, P599, DOI 10.1037/0022-3514.86.4.599; Brand A, 2012, J GEN PSYCHOL, V139, P260, DOI 10.1080/00221309.2012.703711; Burke D, 2010, EVOL PSYCHOL-US, V8, P573, DOI 10.1177/147470491000800404; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Cattell R. B., 1971, ABILITIES THEIR STRU; Denny K, 2008, INTELLIGENCE, V36, P616, DOI 10.1016/j.intell.2008.01.003; DeYoung CG, 2012, J RES PERS, V46, P63, DOI 10.1016/j.jrp.2011.12.003; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Gelman A, 2009, AM SCI, V97, P310, DOI 10.1511/2009.79.310; Greengross G, 2011, INTELLIGENCE, V39, P188, DOI 10.1016/j.intell.2011.03.006; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Kanazawa S, 2004, INTELLIGENCE, V32, P227, DOI 10.1016/j.intell.2004.03.003; Kanazawa S, 2011, INTELLIGENCE, V39, P7, DOI 10.1016/j.intell.2010.11.003; Kleisner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053285; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Miller G, 2000, Novartis Found Symp, V233, P260; Miller G, 2000, ANN NY ACAD SCI, V907, P62; Miller G., 2011, MATING MIND SEXUAL C; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Moore F. R., 2011, J EVOLUTIONARY PSYCH, V9, P205, DOI [10.1556/JEP.9.2011.3.2, DOI 10.1556/JEP.9.2011.3.2]; Murphy NA, 2003, J PERS, V71, P465, DOI 10.1111/1467-6494.7103008; Murphy NA, 2007, PERS SOC PSYCHOL B, V33, P325, DOI 10.1177/0146167206294871; Murphy NA, 2011, INTELLIGENCE, V39, P54, DOI 10.1016/j.intell.2010.10.001; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D, 2006, J RES PERS, V40, P876, DOI 10.1016/j.jrp.2005.09.004; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Penke L, 2011, EVOLUTIONARY PSYCHOL; Plhakova A., 2005, TEST STRUKTURY INTEL; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Prokosch MD, 2005, INTELLIGENCE, V33, P203, DOI 10.1016/j.intell.2004.07.007; Reynolds DJ, 2001, PERS SOC PSYCHOL B, V27, P187, DOI 10.1177/0146167201272005; Rohlf J., 2008, TPSRELW VERSION 1 46; Rohlf J.F., 2004, TPSSUPER VERSION 1 1; Rohlf J. F., 2009, TPSREGR VERSION 1 36; Roney JR, 2006, P ROY SOC B-BIOL SCI, V273, P2169, DOI 10.1098/rspb.2006.3569; Rule NO, 2010, PLOS ONE, V5; Samochowiec J, 2010, SOC PSYCHOL PERS SCI, V1, P206, DOI 10.1177/1948550610372145; SCHAEFER K, 2006, PSYCHOL SCI, V48, P178; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Todorov A., 2011, OXFORD HDB FACE PERC, P631, DOI 10.1093/oxfordhb/9780199559053.013.0032; Zebrowitz L. A., 1997, READING FACES WINDOW; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	52	50	53	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e81237	10.1371/journal.pone.0081237	http://dx.doi.org/10.1371/journal.pone.0081237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651120	Green Published, gold, Green Submitted			2022-12-25	WOS:000333352800001
J	Barta, ML; Hickey, JM; Anbanandam, A; Dyer, K; Hammel, M; Hefty, PS				Barta, Michael L.; Hickey, John M.; Anbanandam, Asokan; Dyer, Kevin; Hammel, Michal; Hefty, P. Scott			Atypical Response Regulator ChxR from Chlamydia trachomatis Is Structurally Poised for DNA Binding	PLOS ONE			English	Article							X-RAY-SCATTERING; 2-COMPONENT SIGNAL-TRANSDUCTION; RNA-POLYMERASE INTERACTION; SMALL-ANGLE SCATTERING; MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL MACROMOLECULES; TRANSCRIPTIONAL ACTIVATOR; OMPR/PHOB-SUBFAMILY; HELICOBACTER-PYLORI; ESCHERICHIA-COLI	ChxR is an atypical two-component signal transduction response regulator (RR) of the OmpR/PhoB subfamily encoded by the obligate intracellular bacterial pathogen Chlamydia trachomatis. Despite structural homology within both receiver and effector domains to prototypical subfamily members, ChxR does not require phosphorylation for dimer formation, DNA binding or transcriptional activation. Thus, we hypothesized that ChxR is in a conformation optimal for DNA binding with limited interdomain interactions. To address this hypothesis, the NMR solution structure of the ChxR effector domain was determined and used in combination with the previously reported ChxR receiver domain structure to generate a full-length dimer model based upon SAXS analysis. Small-angle scattering of ChxR supported a dimer with minimal interdomain interactions and effector domains in a conformation that appears to require only subtle reorientation for optimal major/minor groove DNA interactions. SAXS modeling also supported that the effector domains were in a head-to-tail conformation, consistent with ChxR recognizing tandem DNA repeats. The effector domain structure was leveraged to identify key residues that were critical for maintaining protein - nucleic acid interactions. In combination with prior analysis of the essential location of specific nucleotides for ChxR recognition of DNA, a model of the full-length ChxR dimer bound to its cognate cis-acting element was generated.	[Barta, Michael L.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Hickey, John M.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Anbanandam, Asokan] Univ Kansas, Del Shankel Struct Biol Ctr, Lawrence, KS 66045 USA; [Dyer, Kevin; Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of Kansas; University of Kansas; University of Kansas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hefty, PS (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	pshefty@ku.edu		Hammel, Michal/0000-0002-5610-9289	NIH [AIR01079083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079083, R03AI078179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH AIR01079083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Bauler LD, 2014, J BACTERIOL; Bernado Pau, 2012, Methods Mol Biol, V896, P107, DOI 10.1007/978-1-4614-3704-8_7; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Biersmith BH, 2011, J MOL BIOL, V408, P616, DOI 10.1016/j.jmb.2011.03.013; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Blanco AG, 2011, EMBO J, V30, P3776, DOI 10.1038/emboj.2011.271; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Chen YH, 2004, J BACTERIOL, V186, P1493, DOI 10.1128/JB.186.5.1493-1502.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano WL., 2002, PYMOL MOL GRAPHICS S; Delany I, 2002, J BACTERIOL, V184, P4800, DOI 10.1128/JB.184.17.4800-4810.2002; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Goddard T. D., 2008, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gupta SS, 2009, J BIOL CHEM, V284, P6536, DOI 10.1074/jbc.M804592200; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hickey JM, 2011, J BIOL CHEM, V286, P32606, DOI 10.1074/jbc.M111.220574; Hickey JM, 2011, J BACTERIOL, V193, P389, DOI 10.1128/JB.00833-10; Hickey JM, 2009, ACTA CRYSTALLOGR F, V65, P791, DOI 10.1107/S1744309109025184; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; King-Scott J, 2007, J BIOL CHEM, V282, P37717, DOI 10.1074/jbc.M705081200; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Koo IC, 2006, P NATL ACAD SCI USA, V103, P750, DOI 10.1073/pnas.0509690103; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu X, 2013, P NATL ACAD SCI US; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MAKINO K, 1993, GENE DEV, V7, P149, DOI 10.1101/gad.7.1.149; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Narayanan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030102; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Okamura H, 2000, J MOL BIOL, V295, P1225, DOI 10.1006/jmbi.1999.3379; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; TSUNG K, 1990, P NATL ACAD SCI USA, V87, P5940, DOI 10.1073/pnas.87.15.5940; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	80	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91760	10.1371/journal.pone.0091760	http://dx.doi.org/10.1371/journal.pone.0091760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646934	gold, Green Submitted, Green Published			2022-12-25	WOS:000333348500050
J	Deboeck, G; Taboada, D; Hagan, G; Treacy, C; Page, K; Sheares, K; Naeije, R; Pepke-Zaba, J				Deboeck, Gael; Taboada, Dolores; Hagan, Guy; Treacy, Carmen; Page, Kathy; Sheares, Karen; Naeije, Robert; Pepke-Zaba, Joanna			Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; ARTERIAL-HYPERTENSION; NONINVASIVE MEASUREMENT; EXERCISE; SURVIVAL; HEMODYNAMICS; GUIDELINES; DIAGNOSIS; REST	Purpose: The 6 minutes walk test (6MWT) is often shown to be the best predictor of mortality in pulmonary hypertension (PH) probably because it challenges the failing heart to deliver adequate cardiac output. We hypothesised that the 6MWT elicits maximal cardiac output as measured during a maximal cardiopulmonary exercise testing (CPET). Methods: 18 patients with chronic thromboembolic pulmonary hypertension (n = 12) or pulmonary arterial hypertension (n = 6) and 10 healthy subjects performed a 6MWT and CPET with measurements of cardiac output (non invasive rebreathing device) before and directly after exercise. Heart rate was measured during 6MWT with a cardiofrequence meter. Results: Cardiac output and heart rate measured at the end of the 6MWT were linearly related to 6MW distance (mean +/- SD: 490 +/- 87 m). Patients with a high NT-pro-BNP achieve a maximum cardiac output during the 6MWT, while in normal subjects and in patients with a low-normal NT-proBNP, cardiac output at the end of a 6MWT was lower than achieved at maximum exercise during a CPET. In both cases, heart rate is the major determinant of exercise-induced increase in cardiac output. However, stroke volume increased during CPET in healthy subjects, not in PH patients. Conclusion: Maximal cardiac output is elicited by 6MWT in PH patients with failing right ventricle. Cardiac output increase is dependent on chronotropic response in patients with PH.	[Deboeck, Gael] Univ Libre Bruxelles, Dept Cardiol, Erasmus Univ Hosp, Brussels, Belgium; [Taboada, Dolores; Hagan, Guy; Treacy, Carmen; Page, Kathy; Sheares, Karen; Pepke-Zaba, Joanna] Papworth Hosp, Pulm Vasc Dis Unit, Cambridge, England; [Naeije, Robert] Univ Libre Bruxelles, Fac Med, Dept Physiol, Brussels, Belgium	Universite Libre de Bruxelles; Papworth Hospital; Universite Libre de Bruxelles	Deboeck, G (corresponding author), Univ Libre Bruxelles, Dept Cardiol, Erasmus Univ Hosp, Brussels, Belgium.	gael.deboeck@ulb.ac.be	Pepke-Zaba, Joanna/AGW-3073-2022		European Respiratory Society [LTRF21-2010]; Cambridge biomedical centre	European Respiratory Society; Cambridge biomedical centre	Dr Gael Deboeck is the recipient of a European Respiratory Society Fellowship (LTRF21-2010). The authors acknowledge the support of the Cambridge biomedical centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni P, 2005, J AM COLL CARDIOL, V46, P1779, DOI 10.1016/j.jacc.2005.08.005; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Deboeck G, 2005, EUR RESPIR J, V26, P667, DOI 10.1183/09031936.05.00031505; Deboeck G, 2004, EUR RESPIR J, V23, P747, DOI 10.1183/09031936.04.00111904; Deboeck G, 2013, EUR J PREV CARD 0319, V19; Deboeck G, 2012, EUR RESPIR J, V40, P1410, DOI 10.1183/09031936.00217911; Farina S, 2014, AM J CARDIOL, V113, P546, DOI 10.1016/j.amjcard.2013.10.017; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; Frantz RP, 2012, J HEART LUNG TRANSPL, V31, P811, DOI 10.1016/j.healun.2012.04.005; Frost AE, 2005, VASC PHARMACOL, V43, P36, DOI 10.1016/j.vph.2005.03.003; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; Hall JE., 2011, TXB MED PHYSL; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Lang CC, 2007, AM J CARDIOL, V99, P404, DOI 10.1016/j.amjcard.2006.08.047; LASKEY WK, 1993, J AM COLL CARDIOL, V21, P406, DOI 10.1016/0735-1097(93)90682-Q; Lee WTN, 2011, THORAX, V66, P810, DOI 10.1136/thx.2011.159228; LIPKIN DP, 1986, BRIT MED J, V292, P653, DOI 10.1136/bmj.292.6521.653; Mainguy V, 2013, EUR RESPIR J, V42, P425, DOI 10.1183/09031936.00107012; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Naeije R, 2010, CHEST, V137, P1258, DOI 10.1378/chest.10-0351; NOOTENS M, 1995, AM J CARDIOL, V75, P374, DOI 10.1016/S0002-9149(99)80557-8; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Provencher S, 2006, EUR RESPIR J, V27, P114, DOI 10.1183/09031936.06.00042705; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Stringer WW, 1997, J APPL PHYSIOL, V82, P908, DOI 10.1152/jappl.1997.82.3.908; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Vella CA, 2005, BRIT J SPORT MED, V39, P190, DOI 10.1136/bjsm.2004.013037; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A; Wensel R, 2013, INT J CARDIOL, V167, P1193, DOI 10.1016/j.ijcard.2012.03.135	30	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92324	10.1371/journal.pone.0092324	http://dx.doi.org/10.1371/journal.pone.0092324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647561	Green Submitted, Green Published, gold			2022-12-25	WOS:000333348500117
J	Case, AJ; Naruoka, Y; Chen, XM; Garland-Campbell, KA; Zemetra, RS; Carter, AH				Case, Austin J.; Naruoka, Yukiko; Chen, Xianming; Garland-Campbell, Kimberly A.; Zemetra, Robert S.; Carter, Arron H.			Mapping Stripe Rust Resistance in a BrundageXCoda Winter Wheat Recombinant Inbred Line Population	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; F-SP TRITICI; PUCCINIA-STRIIFORMIS; HIGH-TEMPERATURE; CHROMOSOMAL LOCATION; SEEDLING RESISTANCE; COMMON WHEAT; LINKAGE MAPS; AESTIVUM L.; GENE SR2	A recombinant inbred line (RIL) mapping population developed from a cross between winter wheat (Triticum aestivum L.) cultivars Coda and Brundage was evaluated for reaction to stripe rust (caused by Puccinia striiformis f. sp. tritici). Two hundred and sixty eight RIL from the population were evaluated in replicated field trials in a total of nine site-year locations in the U. S. Pacific Northwest. Seedling reaction to stripe rust races PST-100, PST-114 and PST-127 was also examined. A linkage map consisting of 2,391 polymorphic DNA markers was developed covering all chromosomes of wheat with the exception of 1D. Two QTL on chromosome 1B were associated with adult plant and seedling reaction and were the most significant QTL detected. Together these QTL reduced adult plant infection type from a score of seven to a score of two reduced disease severity by an average of 25% and provided protection against race PST-100, PST-114 and PST-127 in the seedling stage. The location of these QTL and the race specificity provided by them suggest that observed effects at this locus are due to a complementation of the previously known but defeated resistances of the cultivar Tres combining with that of Madsen (the two parent cultivars of Coda). Two additional QTL on chromosome 3B and one on 5B were associated with adult plant reaction only, and a single QTL on chromosome 5D was associated with seedling reaction to PST-114. Coda has been resistant to stripe rust since its release in 2000, indicating that combining multiple resistance genes for stripe rust provides durable resistance, especially when all-stage resistance genes are combined in a fashion to maximize the number of races they protect against. Identified molecular markers will allow for an efficient transfer of these genes into other cultivars, thereby continuing to provide excellent resistance to stripe rust.	[Case, Austin J.; Naruoka, Yukiko; Carter, Arron H.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Chen, Xianming; Garland-Campbell, Kimberly A.] ARS, Wheat Genet Qual Physiol & Dis Res Unit, USDA, Pullman, WA USA; [Zemetra, Robert S.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Washington State University; United States Department of Agriculture (USDA); Oregon State University	Carter, AH (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ahcarter@wsu.edu	Carter, Arron/E-9631-2019	Carter, Arron/0000-0002-8019-6554; Garland-Campbell, Kimberly/0000-0003-4747-3270	Washington State University Hatch Project [0232]; Washington Grain Alliance; National Research Initiative Competitive Grants CAP project from the USDA National Institute of Food and Agriculture [2011-68002-30029]	Washington State University Hatch Project; Washington Grain Alliance; National Research Initiative Competitive Grants CAP project from the USDA National Institute of Food and Agriculture	This project was supported by Washington State University Hatch Project 0232, the Washington Grain Alliance, and the National Research Initiative Competitive Grants CAP project 2011-68002-30029 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Allan RE, 2000, CROP SCI, V40, P578, DOI 10.2135/cropsci2000.0028rcv; Bansal UK, 2011, THEOR APPL GENET, V122, P1461, DOI 10.1007/s00122-011-1545-4; Bariana HS, 2007, DEV PLANT BREED, V12, P723; Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Basten J.C., 1997, QTL CARTOGRAPHER REF; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chen X. M., 1994, Phytopathology, V84, P1116; Chen XM, 2010, CAN J PLANT PATHOL, V32, P315, DOI 10.1080/07060661.2010.499271; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1993, PHYTOPATHOLOGY, V83, P382, DOI 10.1094/Phyto-83-382; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P1428, DOI 10.1094/Phyto-82-1428; Chen XM, 2002, PLANT DIS, V86, P39, DOI 10.1094/PDIS.2002.86.1.39; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P573, DOI 10.1094/Phyto-85-573; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; GALLUN RL, 1977, J HERED, V68, P223, DOI 10.1093/oxfordjournals.jhered.a108818; GERECHTERAMITAI ZK, 1989, EUPHYTICA, V43, P187, DOI 10.1007/BF00037912; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Haldane JBS, 1919, J GENET, V8, P299; Holland JB, 2002, PL BRED RE, V22, P9; Johnson EB, 2008, EUPHYTICA, V163, P193, DOI 10.1007/s10681-007-9628-7; Kolmer JA., 2009, WHEAT SCI TRADE, P89, DOI [10.1002/9780813818832.ch5, DOI 10.1002/9780813818832.CH5]; Kong L, 2005, PLANT BREEDING, V124, P525, DOI 10.1111/j.1439-0523.2005.01139.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Leonard JM, 2008, THEOR APPL GENET, V116, P261, DOI 10.1007/s00122-007-0664-4; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Li Q, 2011, THEOR APPL GENET, V122, P189, DOI 10.1007/s00122-010-1435-1; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Line R. F., 1992, USDA TECHNICAL B, V1788; LINE RF, 1995, PLANT DIS, V79, P1254; Liu XM, 2005, THEOR APPL GENET, V110, P1473, DOI 10.1007/s00122-005-1982-z; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Luo P.G., 2007, CAN J PLANT PATHOL, V30, P1; MACER RCF, 1975, T BRIT MYCOL SOC, V65, P351; Mago R, 2011, THEOR APPL GENET, V122, P735, DOI 10.1007/s00122-010-1482-7; McIntosh RA, 1996, EUPHYTICA, V89, P401; McIntosh RA, 2011, ANN WHEAT NEWSLETTER; Melichar JPE, 2008, THEOR APPL GENET, V117, P391, DOI 10.1007/s00122-008-0783-6; METZGER RJ, 1970, CROP SCI, V10, P567, DOI 10.2135/cropsci1970.0011183X001000050035x; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Pahalawatta V, 2005, PHYTOPATHOLOGY, V95, P427, DOI 10.1094/PHYTO-95-0427; PAN C. L., 1940, JOUR AMER SOC AGRON, V32, P107; PAYNE P I, 1986, Genetica Agraria, V40, P231; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Quincke MC, 2011, THEOR APPL GENET, V122, P1339, DOI 10.1007/s00122-011-1535-6; Riera-Lizarazu O, 2000, GENETICS, V156, P327; Saari EE, 1985, DIS DISTRIBUTION EPI, P259, DOI DOI 10.1016/B978-0-12-148402-6.50017-1; Santra DK, 2008, THEOR APPL GENET, V117, P793, DOI 10.1007/s00122-008-0820-5; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Singh RP, 2000, CROP SCI, V40, P1148, DOI 10.2135/cropsci2000.4041148x; SORRELLS ME, 1987, CROP SCI, V27, P1314, DOI 10.2135/cropsci1987.0011183X002700060060x; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Spielmeyer W, 2003, CROP SCI, V43, P333, DOI 10.2135/cropsci2003.0333; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Vazquez MD, 2012, THEOR APPL GENET, V124, P1, DOI 10.1007/s00122-011-1681-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan AM, 2012, PLANT DIS, V96, P67, DOI 10.1094/PDIS-02-11-0119; Wang LM, 2009, CEREAL RES COMMUN, V37, P209, DOI 10.1556/CRC.37.2009.2.7; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang S, 2012, WINDOWS QTL CARTOGRA; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; Zemetra RS, 1998, CROP SCI, V38, P1404, DOI 10.2135/cropsci1998.0011183X003800050056x; Zemetra RS, 2003, CROP SCI, V43, P1884, DOI 10.2135/cropsci2003.1884; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; [No title captured]	78	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91758	10.1371/journal.pone.0091758	http://dx.doi.org/10.1371/journal.pone.0091758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642574	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900035
J	Fernandez-Higuero, JA; Salvador, AM; Martin, C; Milicua, JCG; Arrondo, JLR				Fernandez-Higuero, Jose A.; Salvador, Ana M.; Martin, Cesar; Milicua, Jose Carlos G.; Arrondo, Jose L. R.			Human LDL Structural Diversity Studied by IR Spectroscopy	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; TRANSFORM INFRARED-SPECTROSCOPY; DEFECTIVE APOLIPOPROTEIN B-100; PLASMA-LIPOPROTEINS; SECONDARY STRUCTURE; RISK-FACTOR; PARTICLE; CHOLESTEROL; RECEPTOR	Lipoproteins are responsible for cholesterol traffic in humans. Low density lipoprotein (LDL) delivers cholesterol from liver to peripheral tissues. A misleading delivery can lead to the formation of atherosclerotic plaques. LDL has a single protein, apoB-100, that binds to a specific receptor. It is known that the failure associated with a deficient protein-receptor binding leads to plaque formation. ApoB-100 is a large single lipid-associated polypeptide difficulting the study of its structure. IR spectroscopy is a technique suitable to follow the different conformational changes produced in apoB-100 because it is not affected by the size of the protein or the turbidity of the sample. We have analyzed LDL spectra of different individuals and shown that, even if there are not big structural changes, a different pattern in the intensity of the band located around 1617 cm 21 related with strands embedded in the lipid monolayer, can be associated with a different conformational rearrangement that could affect to a protein interacting region with the receptor.	[Fernandez-Higuero, Jose A.; Salvador, Ana M.; Martin, Cesar; Arrondo, Jose L. R.] Univ Basque Country, CSIC, Unidad Biofis, EHU, E-48080 Bilbao, Spain; [Fernandez-Higuero, Jose A.; Salvador, Ana M.; Martin, Cesar; Milicua, Jose Carlos G.; Arrondo, Jose L. R.] Univ Basque Country, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Arrondo, JLR (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, EHU, E-48080 Bilbao, Spain.	joseluis.arrondo@ehu.es	martin, cesar/L-1303-2014	martin, cesar/0000-0002-4087-8729; Salvador Ibanez, Ana Maria/0000-0003-2170-6419; Fernandez-Higuero, Jose Angel/0000-0002-4143-5532	MINECO [BFU 2006-14423]; Programa INNPACTO [NuIPT-2011-0817-010000]	MINECO(Spanish Government); Programa INNPACTO	This work has been supported in part by MINECO grant (BFU 2006-14423) and Programa INNPACTO (grant NuIPT-2011-0817-010000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; BANEULOS S, 1995, J BIOL CHEM, V270, P9192; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; Chapman MJ, 1998, EUR HEART J, V19, pA24; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Ensign W, 2006, CLIN CHEM, V52, P1722, DOI 10.1373/clinchem.2005.059949; Fernandez-Higuero JA, 2011, ANAL BIOCHEM, V417, P283, DOI 10.1016/j.ab.2011.06.004; Fruchart JC, 1997, CURR MED RES OPIN, V13, P603, DOI 10.1185/03007999709113334; GOORMAGHTIGH E, 1993, BIOCHEMISTRY-US, V32, P6104, DOI 10.1021/bi00074a023; GRIFFIN BA, 1994, ATHEROSCLEROSIS, V106, P241, DOI 10.1016/0021-9150(94)90129-5; Griffin BA, 1999, P NUTR SOC, V58, P163, DOI 10.1079/PNS19990022; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Koivuniemi A, 2008, BBA-PROTEINS PROTEOM, V1784, P1668, DOI 10.1016/j.bbapap.2008.06.007; KRAUSS RM, 1982, J LIPID RES, V23, P97; Krilov D, 2009, SPECTROCHIM ACTA A, V73, P701, DOI 10.1016/j.saa.2009.03.015; Kumar V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018841; LAGGNER P, 1981, J BIOL CHEM, V256, P1832; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lamarche B, 1999, DIABETES METAB, V25, P199; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lund-Katz S, 1998, BIOCHEMISTRY-US, V37, P12867, DOI 10.1021/bi980828m; Lunin VY, 2001, ACTA CRYSTALLOGR D, V57, P108, DOI 10.1107/S0907444900014608; McNamara JR, 1996, J LIPID RES, V37, P1924; MISEREZ AR, 1995, ARTERIOSCL THROM VAS, V15, P1719, DOI 10.1161/01.ATV.15.10.1719; MUSLINER TA, 1988, CLIN CHEM, V34, pB78; Nara M, 2002, CHEM PHYS LIPIDS, V117, P1, DOI 10.1016/S0009-3084(02)00003-8; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NIGON F, 1991, J LIPID RES, V32, P1741; OTVOS JD, 1991, CLIN CHEM, V37, P377; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Rajman I, 1996, ATHEROSCLEROSIS, V125, P231; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1999, J LIPID RES, V40, P1401; Segrest JP, 2001, J LIPID RES, V42, P1346; Sninsky JJ, 2013, J INVESTIG MED; SPIN JM, 1995, BIOPHYS J, V68, P2115, DOI 10.1016/S0006-3495(95)80392-9; Tanfani F, 1997, BIOCHEM J, V322, P765, DOI 10.1042/bj3220765; TYBJAERGHANSEN A, 1995, SCAND J CLIN LAB INV, V55, P57; Vakkilainen J, 2003, CIRCULATION, V107, P1733, DOI 10.1161/01.CIR.0000057982.50167.6E; Vecino AJ, 2012, BBA-BIOMEMBRANES, V1818, P3158, DOI 10.1016/j.bbamem.2012.08.015; Vieira OV, 1996, J LIPID RES, V37, P2715; Wang L, 2006, P NATL ACAD SCI USA, V103, P6871, DOI 10.1073/pnas.0602213103; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301; Werner RM, 1998, CAN J CARDIOL, V14, p3B	58	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92426	10.1371/journal.pone.0092426	http://dx.doi.org/10.1371/journal.pone.0092426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642788	Green Published, gold, Green Submitted			2022-12-25	WOS:000333259900137
J	Johansson, SE; Larsen, SS; Povlsen, GK; Edvinsson, L				Johansson, Sara Ellinor; Larsen, Stine Schmidt; Povlsen, Gro Klitgaard; Edvinsson, Lars			Early MEK1/2 Inhibition after Global Cerebral Ischemia in Rats Reduces Brain Damage and Improves Outcome by Preventing Delayed Vasoconstrictor Receptor Upregulation	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; CARDIAC-ARREST; BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; NEURONAL DAMAGE; CO2 REACTIVITY; ADULT RATS; RECOVERY; DEATH; ACTIVATION	Background: Global cerebral ischemia following cardiac arrest is associated with increased cerebral vasoconstriction and decreased cerebral blood flow, contributing to delayed neuronal cell death and neurological detriments in affected patients. We hypothesize that upregulation of contractile ETB and 5-HT1B receptors, previously demonstrated in cerebral arteries after experimental global ischemia, are a key mechanism behind insufficient perfusion of the post-ischemic brain, proposing blockade of this receptor upregulation as a novel target for prevention of cerebral hypoperfusion and delayed neuronal cell death after global cerebral ischemia. The aim was to characterize the time-course of receptor upregulation and associated neuronal damage after global ischemia and investigate whether treatment with the MEK1/2 inhibitor U0126 can prevent cerebrovascular receptor upregulation and thereby improve functional outcome after global cerebral ischemia. Incomplete global cerebral ischemia was induced in Wistar rats and the time-course of enhanced contractile responses and the effect of U0126 in cerebral arteries were studied by wire myography and the neuronal cell death by TUNEL. The expression of ETB and 5-HT1B receptors was determined by immunofluorescence. Results: Enhanced vasoconstriction peaked in fore-and midbrain arteries 3 days after ischemia. Neuronal cell death appeared initially in the hippocampus 3 days after ischemia and gradually increased until 7 days post-ischemia. Treatment with U0126 normalised cerebrovascular ETB and 5-HT1B receptor expression and contractile function, reduced hippocampal cell death and improved survival rate compared to vehicle treated animals. Conclusions: Excessive cerebrovascular expression of contractile ETB and 5-HT1B receptors is a delayed response to global cerebral ischemia peaking 3 days after the insult, which likely contributes to the development of delayed neuronal damage. The enhanced cerebrovascular contractility can be prevented by treatment with the MEK1/2 inhibitor U0126, diminishes neuronal damage and improves survival rate, suggesting MEK1/2 inhibition as a novel strategy for early treatment of neurological consequences following global cerebral ischemia.	[Johansson, Sara Ellinor; Larsen, Stine Schmidt; Povlsen, Gro Klitgaard; Edvinsson, Lars] Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Edvinsson, Lars] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden	University of Copenhagen; Lund University	Johansson, SE (corresponding author), Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	sara.ellinor.johansson@regionh.dk		Edvinsson, Lars/0000-0002-1805-1346	Lundbeck Foundation (Lundbeck Foundation Center for Neurovascular Signaling, LUCENS); Danish Research Council for Health and Disease	Lundbeck Foundation (Lundbeck Foundation Center for Neurovascular Signaling, LUCENS)(Lundbeckfonden); Danish Research Council for Health and Disease	This work was financially supported by the Lundbeck Foundation (Lundbeck Foundation Center for Neurovascular Signaling, LUCENS) and Danish Research Council for Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg SAS, 2006, J CEREBR BLOOD F MET, V26, P846, DOI 10.1038/sj.jcbfm.9600236; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buunk G, 1996, INTENS CARE MED, V22, P1191, DOI 10.1007/BF01709335; Dragancea I, 2013, RESUSCITATION, V84, P337, DOI 10.1016/j.resuscitation.2012.09.015; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; Hosomi Naohisa, 2007, J Stroke Cerebrovasc Dis, V16, P103, DOI 10.1016/j.jstrokecerebrovasdis.2006.12.001; HOSSMANN KA, 1973, Z NEUROL, V204, P281, DOI 10.1007/BF00316009; Hossmann KA, 1997, SHOCK, V8, P95, DOI 10.1097/00024382-199708000-00004; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041852; KAGSTROM E, 1983, J CEREBR BLOOD F MET, V3, P170, DOI 10.1038/jcbfm.1983.24; KARLSSON BR, 1994, ACTA ANAESTH SCAND, V38, P248, DOI 10.1111/j.1399-6576.1994.tb03883.x; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Larsen CC, 2011, J NEUROSURG, V114, P1143, DOI 10.3171/2010.6.JNS1018; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; MATSUMOTO M, 1990, STROKE, V21, P1470, DOI 10.1161/01.STR.21.10.1470; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; MILLER CL, 1980, STROKE, V11, P542, DOI 10.1161/01.STR.11.5.542; MRSULJA BB, 1976, ACTA NEUROPATHOL, V36, P1, DOI 10.1007/BF00685142; NEMOTO EM, 1975, STROKE, V6, P425, DOI 10.1161/01.STR.6.4.425; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Petrovic M, 2011, VOJNOSANIT PREGL, V68, P495, DOI 10.2298/VSP1106495P; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Povlsen GK, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-34; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Safar P, 2002, CRIT CARE MED, V30, pS140, DOI 10.1097/00003246-200204001-00004; Satoh K, 2011, BRAIN RES, V1382, P266, DOI 10.1016/j.brainres.2011.01.049; SCHMIDTKASTNER R, 1986, J NEUROL, V233, P367, DOI 10.1007/BF00313924; Schmitz B, 1997, J CEREBR BLOOD F MET, V17, P1202, DOI 10.1097/00004647-199711000-00009; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; SMITH ML, 1988, ACTA NEUROPATHOL, V76, P253, DOI 10.1007/BF00687772; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; TAKASU A, 1995, RESUSCITATION, V30, P69, DOI 10.1016/0300-9572(95)00864-P; WISNIEWSKI HM, 1995, ACTA NEUROPATHOL, V90, P432; Zeng YS, 2000, NEUROSCI RES, V37, P113, DOI 10.1016/S0168-0102(00)00107-3; Zhan LX, 2013, MOL NEUROBIOL, V48, P109, DOI 10.1007/s12035-013-8436-4; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035	38	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92417	10.1371/journal.pone.0092417	http://dx.doi.org/10.1371/journal.pone.0092417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642693	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900134
J	Laventie, BJ; Guerin, F; Mourey, L; Tawk, MY; Jover, E; Maveyraud, L; Prevost, G				Laventie, Benoit-Joseph; Guerin, Frederic; Mourey, Lionel; Tawk, Mira Y.; Jover, Emmanuel; Maveyraud, Laurent; Prevost, Gilles			Residues Essential for Panton-Valentine Leukocidin S Component Binding to Its Cell Receptor Suggest Both Plasticity and Adaptability in Its Interaction Surface	PLOS ONE			English	Article							PORE-FORMING TOXINS; STAPHYLOCOCCAL ALPHA-TOXIN; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HEPTAMERIC TRANSMEMBRANE PORE; GAMMA-HEMOLYSIN; CRYSTAL-STRUCTURE; LUKE-LUKD; CONFORMATIONAL-CHANGES; NECROTIZING PNEUMONIA; LEUKOTOXIN FAMILY	Panton-Valentine leukocidin (PVL), a bicomponent staphylococcal leukotoxin, is involved in the poor prognosis of necrotizing pneumonia. The present study aimed to elucidate the binding mechanism of PVL and in particular its cell-binding domain. The class S component of PVL, LukS-PV, is known to ensure cell targeting and exhibits the highest affinity for the neutrophil membrane (K-d similar to 10(-10) M) compared to the class F component of PVL, LukF-PV (K-d similar to 10(-9) M). Alanine scanning mutagenesis was used to identify the residues involved in LukS-PV binding to the neutrophil surface. Nineteen single alanine mutations were performed in the rim domain previously described as implicated in cell membrane interactions. Positions were chosen in order to replace polar or exposed charged residues and according to conservation between leukotoxin class S components. Characterization studies enabled to identify a cluster of residues essential for LukS-PV binding, localized on two loops of the rim domain. The mutations R73A, Y184A, T244A, H245A and Y250A led to dramatically reduced binding affinities for both human leukocytes and undifferentiated U937 cells expressing the C5a receptor. The three-dimensional structure of five of the mutants was determined using X-ray crystallography. Structure analysis identified residues Y184 and Y250 as crucial in providing structural flexibility in the receptor-binding domain of LukS-PV.	[Laventie, Benoit-Joseph; Tawk, Mira Y.; Jover, Emmanuel; Prevost, Gilles] Univ Strasbourg CHRU, Federat Med Translat Strasbourg, EA Virulence Bacterienne Precoce 7290, Inst Bacteriol, Strasbourg, France; [Guerin, Frederic; Mourey, Lionel; Maveyraud, Laurent] CNRS, IPBS, Toulouse, France; [Guerin, Frederic; Mourey, Lionel; Maveyraud, Laurent] Univ Toulouse 3, Univ Toulouse, IPBS, F-31062 Toulouse, France	CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Maveyraud, L (corresponding author), CNRS, IPBS, Toulouse, France.	laurent.maveyraud@ipbs.fr; prevost@unistra.fr	LAVENTIE, Benoît-Joseph/H-5260-2011; Maveyraud, Laurent/C-6066-2011; Mourey, Lionel/B-5662-2009	LAVENTIE, Benoît-Joseph/0000-0003-0205-0944; Maveyraud, Laurent/0000-0003-4610-8319; Mourey, Lionel/0000-0002-8259-1259	Direction de la Recherche et des Etudes Doctorales [EA4438]; French Ministery of Superior Education and Research	Direction de la Recherche et des Etudes Doctorales; French Ministery of Superior Education and Research	This work was supported by grants from EA4438 to GP (Direction de la Recherche et des Etudes Doctorales, and BJL was awarded by the French Ministery of Superior Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Aman MJ, 2010, J BIOMOL STRUCT DYN, V28, P1; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheung GYC, 2012, EXPERT OPIN THER TAR, V16, P601, DOI 10.1517/14728222.2012.682573; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; COONEY J, 1993, INFECT IMMUN, V61, P768, DOI 10.1128/IAI.61.2.768-771.1993; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; Freer JH., 2006, COMPREHENSIVE SOURCE, P590, DOI 10.1016/B978-012088445-2/50037-8; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Girgis DO, 2005, INVEST OPHTH VIS SCI, V46, P2064, DOI 10.1167/iovs.04-0897; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Gravet A, 2001, J CLIN MICROBIOL, V39, P4349, DOI 10.1128/JCM.39.12.4349-4356.2001; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Joubert O, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/25935; Joubert O, 2006, BIOCHEM J, V396, P381, DOI 10.1042/BJ20051878; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P541, DOI 10.1271/bbb.61.541; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Morinaga N, 2003, MICROBIOL IMMUNOL, V47, P81, DOI 10.1111/j.1348-0421.2003.tb02789.x; Moussa LB, 1999, FEBS LETT, V461, P280, DOI 10.1016/S0014-5793(99)01453-2; Nariya H, 1997, FEBS LETT, V415, P96, DOI 10.1016/S0014-5793(97)01100-9; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; PREVOST G, 1995, FEBS LETT, V376, P135, DOI 10.1016/0014-5793(95)01260-9; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Roblin P, 2008, PROTEINS, V71, P485, DOI 10.1002/prot.21900; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; VecseySemjen B, 1997, J BIOL CHEM, V272, P5709, DOI 10.1074/jbc.272.9.5709; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Viero G, 2008, CELL MOL LIFE SCI, V65, P312, DOI 10.1007/s00018-007-7491-2; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOODIN AM, 1960, BIOCHEM J, V75, P158, DOI 10.1042/bj0750158; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	59	15	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92094	10.1371/journal.pone.0092094	http://dx.doi.org/10.1371/journal.pone.0092094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643034	Green Published, Green Submitted, gold			2022-12-25	WOS:000333259900084
J	Martin, PKM; Stilhano, RS; Samoto, VY; Takiya, CM; Peres, GB; Michelacci, YMCD; da Silva, FH; Pereira, VG; D'Almeida, V; Marques, FLN; Otake, AH; Chammas, R; Han, SW				Matsumoto Martin, Priscila Keiko; Stilhano, Roberta Sessa; Samoto, Vivian Yochiko; Takiya, Christina Maeda; Peres, Giovani Bravin; Correa da Silva Michelacci, Yara Maria; da Silva, Flavia Helena; Pereira, Vanessa Goncalves; D'Almeida, Vania; Navarro Marques, Fabio Luiz; Otake, Andreia Hanada; Chammas, Roger; Han, Sang Won			Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human alpha-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; IMMUNE-RESPONSE; GENE-THERAPY; LYSOSOMAL STORAGE; INDOLEAMINE 2,3-DIOXYGENASE; NITRIC-OXIDE; BLOOD-CELLS; MICE; PROLIFERATION; IMPROVES	Mucopolysaccharidosis type I (MPSI) is an autosomal recessive disease that leads to systemic lysosomal storage, which is caused by the absence of alpha-L-iduronidase (IDUA). Enzyme replacement therapy is recognized as the best therapeutic option for MPSI; however, high titers of anti-IDUA antibody have frequently been observed. Due to the immunosuppressant properties of MSC, we hypothesized that MSC modified with the IDUA gene would be able to produce IDUA for a long period of time. Sleeping Beauty transposon vectors were used to modify MSC because these are basically less-immunogenic plasmids. For cell transplantation, 4x10(6) MSC-KO-IDUA cells (MSC from KO mice modified with IDUA) were injected into the peritoneum of KO-mice three times over intervals of more than one month. The total IDUA activities from MSC-KO-IDUA before cell transplantation were 9.6, 120 and 179 U for the first, second and third injections, respectively. Only after the second cell transplantation, more than one unit of IDUA activity was detected in the blood of 3 mice for 2 days. After the third cell transplantation, a high titer of anti-IDUA antibody was detected in all of the treated mice. Anti-IDUA antibody response was also detected in C57Bl/6 mice treated with MSC-WT-IDUA. The antibody titers were high and comparable to mice that were immunized by electroporation. MSC-transplanted mice had high levels of TNF-alpha and infiltrates in the renal glomeruli. The spreading of the transplanted MSC into the peritoneum of other organs was confirmed after injection of In-111-labeled MSC. In conclusion, the antibody response against IDUA could not be avoided by MSC. On the contrary, these cells worked as an adjuvant that favored IDUA immunization. Therefore, the humoral immunosuppressant property of MSC is questionable and indicates the danger of using MSC as a source for the production of exogenous proteins to treat monogenic diseases.	[Matsumoto Martin, Priscila Keiko; Stilhano, Roberta Sessa; da Silva, Flavia Helena; Han, Sang Won] Univ Fed Sao Paulo, Res Ctr Gene Therapy, Sao Paulo, Brazil; [Matsumoto Martin, Priscila Keiko; Stilhano, Roberta Sessa; Han, Sang Won] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Samoto, Vivian Yochiko; Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Peres, Giovani Bravin; Correa da Silva Michelacci, Yara Maria] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [da Silva, Flavia Helena] Univ Fed Rio Grande do Sul, Dept Genet, Sao Paulo, Brazil; [Pereira, Vanessa Goncalves; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Navarro Marques, Fabio Luiz] Univ Sao Paulo, Nucl Med Ctr, Sao Paulo, Brazil; [Otake, Andreia Hanada; Chammas, Roger] Univ Sao Paulo, Sch Med, Dept Radiol & Oncol, Expt Oncol Lab, Sao Paulo, Brazil; [Otake, Andreia Hanada; Chammas, Roger] Canc Inst Sao Paulo State, Translat Invest Ctr Oncol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Sul; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Han, SW (corresponding author), Univ Fed Sao Paulo, Res Ctr Gene Therapy, Sao Paulo, Brazil.	sang.han@unifesp.br	Peres, Giovani B/D-4553-2013; D'Almeida, Vânia/AAV-3955-2020; STILHANO, roberta/F-6923-2015; Marques, Fabio LN/C-4153-2012; Otake, Andréia H./F-5131-2016; D'Almeida, Vania/AAB-7115-2020; Chammas, Roger/A-8004-2011; Takiya, Christina/AAU-5959-2021; Navarro Marques, Fabio Luiz/ABI-7774-2020	Peres, Giovani B/0000-0003-3890-5334; D'Almeida, Vânia/0000-0003-0947-5312; STILHANO, roberta/0000-0002-0653-5968; Marques, Fabio LN/0000-0001-7383-926X; Otake, Andréia H./0000-0003-1303-1220; Chammas, Roger/0000-0003-0342-8726; Takiya, Christina/0000-0002-8019-628X; Navarro Marques, Fabio Luiz/0000-0001-7383-926X	FAPESP [08/56529-1, 2008/56530-0, 2009/52235-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	PKMM and RSS were recipients of FAPESP scholarships (08/56529-1 and 2008/56530-0, respectively), and this work was financially supported by FAPESP (grant # 2009/52235-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Baldo G, 2013, MOL GENET METAB, V109, P33, DOI 10.1016/j.ymgme.2013.03.005; BECKER W, 1986, KLIN WOCHENSCHR, V64, P141, DOI 10.1007/BF01732640; Behmer O.A., 1976, MANUAL TECNICAS HIST, V1st; Belay E, 2010, STEM CELLS, V28, P1760, DOI 10.1002/stem.501; Bhaumik S, 2001, EXP CELL RES, V266, P44, DOI 10.1006/excr.2001.5201; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Chung S, 2007, MOL GENET METAB, V90, P181, DOI 10.1016/j.ymgme.2006.08.001; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Comoli P, 2008, NEPHROL DIAL TRANSPL, V23, P1196, DOI 10.1093/ndt/gfm740; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; da Silva Flavia Helena, 2012, Genet Vaccines Ther, V10, P2, DOI 10.1186/1479-0556-10-2; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Di Domenico C, 2006, HUM GENE THER, V17, P1112; Dickson P, 2008, J CLIN INVEST, V118, P2868, DOI 10.1172/JCI34676; Dierenfeld AD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001380; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; GOEDEMANS WT, 1987, J NUCL MED, V28, P1020; Grassel Susanne, 2012, Methods Mol Biol, V879, P203, DOI 10.1007/978-1-61779-815-3_14; HOPPER KE, 1986, J LEUKOCYTE BIOL, V39, P435, DOI 10.1002/jlb.39.4.435; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Kakavanos R, 2003, LANCET, V361, P1608, DOI 10.1016/S0140-6736(03)13311-9; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kobayashi H, 2005, MOL THER, V11, P776, DOI 10.1016/j.ymthe.2004.10.006; MCKUSICK VA, 1965, MEDICINE, V44, P445, DOI 10.1097/00005792-196511000-00001; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Parise CB, 2008, VACCINE, V26, P3812, DOI 10.1016/j.vaccine.2008.05.029; Ponder KP, 2008, J CLIN INVEST, V118, P2686, DOI 10.1172/JCI36521; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Roca M, 2010, EUR J NUCL MED MOL I, V37, P835, DOI 10.1007/s00259-010-1393-5; Sacramento CB, 2010, J GENE MED, V12, P310, DOI 10.1002/jgm.1434; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Scriver C.R., 1995, METABOLIC MOL BASES; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Yoshida H, 2002, ARTHRITIS RHEUM, V46, P2235, DOI 10.1002/art.10441; Youd M, 2010, CLIN EXP IMMUNOL, V161, P176, DOI 10.1111/j.1365-2249.2010.04158.x; Zhang HY, 2010, EXPERT OPIN BIOL TH, V10, P701, DOI 10.1517/14712591003769816	44	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92420	10.1371/journal.pone.0092420	http://dx.doi.org/10.1371/journal.pone.0092420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642723	Green Submitted, gold, Green Published			2022-12-25	WOS:000333259900135
J	May, O; Yu, HY; Riederer, B; Manns, MP; Seidler, U; Bachmann, O				May, Oliver; Yu, Haoyang; Riederer, Brigitte; Manns, Michael P.; Seidler, Ursula; Bachmann, Oliver			Short-Term Regulation of Murine Colonic NBCe1-B (Electrogenic Na+/HCO3- Cotransporter) Membrane Expression and Activity by Protein Kinase C	PLOS ONE			English	Article							MUCOSAL BICARBONATE SECRETION; RENAL NA-HCO3 COTRANSPORTER; /OH-EXCHANGE ACTIVITY; PKC-EPSILON; NA+-HCO3-COTRANSPORTER; SURFACE EXPRESSION; DOWN-REGULATION; CACO-2 CELLS; CAMP; INHIBITION	The colonic mucosa actively secretes HCO3-, and several lines of evidence point to an important role of Na+/HCO3- cotransport (NBC) as a basolateral HCO3- import pathway. We could recently demonstrate that the predominant NBC isoform in murine colonic crypts is electrogenic NBCe1-B, and that secretagogues cause NBCe1 exocytosis, which likely represents a component of NBC activation. Since protein kinase C (PKC) plays a key role in the regulation of ion transport by trafficking events, we asked whether it is also involved in the observed NBC activity increase. Crypts were isolated from murine proximal colon to assess PKC activation as well as NBC function and membrane abundance using fluorometric pH(i) measurements and cell surface biotinylation, respectively. PKC isoform translocation and phosphorylation occurred in response to PMA-, as well as secretagogue stimulation. The conventional and novel PKC inhibitors Go6976 or Go6850 did not alter NBC function or surface expression by themselves, but stimulation with forskolin (10(-5) M) or carbachol (10(-4) M) in their presence led to a significant decrease in NBC-mediated proton flux, and biotinylated NBCe1. Our data thus indicate that secretagogues lead to PKC translocation and phosphorylation in murine colonic crypts, and that PKC is necessary for the increase in NBC transport rate and membrane abundance caused by cholinergic and cAMP-dependent stimuli.	[May, Oliver; Yu, Haoyang; Riederer, Brigitte; Manns, Michael P.; Seidler, Ursula; Bachmann, Oliver] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Hannover Medical School	Bachmann, O (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	bachmann.oliver@mh-hannover.de	Bachmann, Oliver/AAV-4258-2021; Seidler, Ursula/HII-8049-2022	Bachmann, Oliver/0000-0002-6830-2975; Seidler, Ursula/0000-0002-9600-2769	Deutsche Forschungsgemeinschaft [SFB621-C10];  [SFB621-C9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (www.dfg.de) to O. Bachmann (SFB621-C10). Brigitte Riederer was funded by the SFB621-C9 grant to U. Seidler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; Bachmann O, 2006, AM J PHYSIOL-GASTR L, V291, pG650, DOI 10.1152/ajpgi.00376.2005; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Bachmann O, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-70; Broughman JR, 2006, AM J PHYSIOL-GASTR L, V291, pG318, DOI 10.1152/ajpgi.00355.2005; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chen M, 2012, J PHYSL; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Edelstein J, 2011, CELL SIGNAL, V23, P239, DOI 10.1016/j.cellsig.2010.09.008; Espiritu DJD, 2004, J MEMBRANE BIOL, V199, P39, DOI 10.1007/s00232-004-0675-x; Glaser S, 2003, AM J PHYSIOL-GASTR L, V284, pG683, DOI 10.1152/ajpgi.00302.2002; Gross E, 2003, J PHYSIOL-LONDON, V549, P673, DOI 10.1113/jphysiol.2003.042226; Gross E, 2002, AM J PHYSIOL-RENAL, V283, pF876, DOI 10.1152/ajprenal.00148.2002; Hegyi P, 2005, AM J PHYSIOL-CELL PH, V288, pC1030, DOI 10.1152/ajpcell.00430.2003; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; Jacob P, 2000, GASTROENTEROLOGY, V119, P406, DOI 10.1053/gast.2000.9358; Kim HW, 2010, MOL CELL BIOL, V30, P5406, DOI 10.1128/MCB.00217-10; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATTHEWS JB, 1993, AM J PHYSIOL, V265, pC1109, DOI 10.1152/ajpcell.1993.265.4.C1109; Odes HS, 1996, PHARMACOLOGY, V53, P60, DOI 10.1159/000139415; Orsenigo MN, 2002, EXP PHYSIOL, V87, P299, DOI 10.1113/eph8702319; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Perry C, 2006, AM J PHYSIOL-RENAL, V290, pF417, DOI 10.1152/ajprenal.00395.2004; Perry C, 2008, AMJPHYSIOL CELL PHYS; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Qu F, 2011, J CELL BIOCHEM, V112, P902, DOI 10.1002/jcb.22999; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Ruiz OS, 1997, KIDNEY INT, V51, P1069, DOI 10.1038/ki.1997.149; Ruiz OS, 1996, KIDNEY INT, V49, P696, DOI 10.1038/ki.1996.98; RUIZ OS, 1992, AM J PHYSIOL, V262, pF560, DOI 10.1152/ajprenal.1992.262.4.F560; Saksena S, 2005, J BIOL CHEM, V280, P11859, DOI 10.1074/jbc.M411553200; Saksena S, 2002, AM J PHYSIOL-CELL PH, V283, pC1492, DOI 10.1152/ajpcell.00473.2001; Schmitt BM, 1999, AM J PHYSIOL-RENAL, V276, pF27, DOI 10.1152/ajprenal.1999.276.1.F27; SINGH AK, 2013, J PHYSL; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; Tang J, 2010, J BIOL CHEM, V285, P34072, DOI 10.1074/jbc.M110.137380; Tuo BG, 2004, AM J PHYSIOL-GASTR L, V286, pG814, DOI 10.1152/ajpgi.00251.2003; Yamada H, 1996, AM J PHYSIOL-RENAL, V271, pF1068, DOI 10.1152/ajprenal.1996.271.5.F1068; Yu HY, 2009, AM J PHYSIOL-GASTR L, V297, pG1223, DOI 10.1152/ajpgi.00157.2009	45	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92275	10.1371/journal.pone.0092275	http://dx.doi.org/10.1371/journal.pone.0092275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24642792	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900118
J	Liu, ZS; Jiang, RF; Yuan, ST; Wang, N; Feng, Y; Hu, GL; Zhu, XM; Huang, K; Ma, JL; Xu, GT; Liu, QH; Xue, ZG; Fan, GP				Liu, Zhenshan; Jiang, Rongfeng; Yuan, Songtao; Wang, Na; Feng, Yun; Hu, Ganlu; Zhu, Xianmin; Huang, Kevin; Ma, Jieliang; Xu, Guotong; Liu, Qinghuai; Xue, Zhigang; Fan, Guoping			Integrated Analysis of DNA Methylation and RNA Transcriptome during In Vitro Differentiation of Human Pluripotent Stem Cells into Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							GENOME-WIDE MAPS; GENE-EXPRESSION; PROGENITOR CELLS; VISUAL FUNCTION; RPE; STATES; DEMETHYLATION; INACTIVATION; INSTABILITY; RESTRICTION	Using the paradigm of in vitro differentiation of hESCs/iPSCs into retinal pigment epithelial (RPE) cells, we have recently profiled mRNA and miRNA transcriptomes to define a set of RPE mRNA and miRNA signature genes implicated in directed RPE differentiation. In this study, in order to understand the role of DNA methylation in RPE differentiation, we profiled genome-scale DNA methylation patterns using the method of reduced representation bisulfite sequencing (RRBS). We found dynamic waves of de novo methylation and demethylation in four stages of RPE differentiation. Integrated analysis of DNA methylation and RPE transcriptomes revealed a reverse-correlation between levels of DNA methylation and expression of a subset of miRNA and mRNA genes that are important for RPE differentiation and function. Gene Ontology (GO) analysis suggested that genes undergoing dynamic methylation changes were related to RPE differentiation and maturation. We further compared methylation patterns among human ESC- and iPSC-derived RPE as well as primary fetal RPE (fRPE) cells, and discovered that specific DNA methylation pattern is useful to classify each of the three types of RPE cells. Our results demonstrate that DNA methylation may serve as biomarkers to characterize the cell differentiation process during the conversion of human pluripotent stem cells into functional RPE cells.	[Liu, Zhenshan; Jiang, Rongfeng; Wang, Na; Feng, Yun; Hu, Ganlu; Zhu, Xianmin; Ma, Jieliang; Xue, Zhigang] Tongji Univ, Sch Med, Tongji Hosp, Dept Regenerat Med,Translat Ctr Stem Cell Res, Shanghai 200092, Peoples R China; [Huang, Kevin; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Yuan, Songtao; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Xu, Guotong] Tongji Univ, Sch Med, Tongji Eye Inst, Shanghai 200092, Peoples R China; [Xu, Guotong] Tongji Univ, Sch Med, Dept Regenerat Med, Shanghai 200092, Peoples R China; [Fan, Guoping] Tongji Univ, Sch Life Sci & Technol, Adv Inst Translat Med, Shanghai 200092, Peoples R China; [Liu, Zhenshan; Xue, Zhigang] Tongji Univ, Suzhou Inst, Suzhou, Jiangsu, Peoples R China	Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nanjing Medical University; Tongji University; Tongji University; Tongji University; Tongji University	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn; Xuezhigang75@gmail.com; Gfan@mednet.ucla.edu	Albertini, David/AAD-3856-2021; Zhu, Xianmin/M-6437-2017	Albertini, David/0000-0001-6536-2828; Zhu, Xianmin/0000-0003-1405-9700; Liu, Qinghuai/0000-0003-1605-1964	NIH [GM081621]; International Science & Technology Cooperation Program of China [2011DFB30010]; National Natural Science Foundation of China [81271258]; Natural Science Foundation of Jiangsu Province of China [DK2011321]; Ministry of Science and Technology 973 Basic Research program in China [2011CB965102, 2011CB966204, 2012CB966303]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Ministry of Science and Technology 973 Basic Research program in China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM081621, International Science & Technology Cooperation Program of China (2011DFB30010), National Natural Science Foundation of China (81271258), Natural Science Foundation of Jiangsu Province of China (DK2011321), and Ministry of Science and Technology 973 Basic Research program in China (2011CB965102, 2011CB966204, and 2012CB966303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Ghazi NG, 2002, EYE, V16, P411, DOI 10.1038/sj.eye.6700197; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037224; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Khavari DA, 2010, CELL CYCLE, V9, P3880, DOI 10.4161/cc.9.19.13385; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao RR, 2004, BIOL REPROD, V71, P1772, DOI 10.1095/biolreprod.104.030395; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tompkins JD, 2012, P NATL ACAD SCI USA, V109, P12544, DOI 10.1073/pnas.1209620109; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	66	19	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91416	10.1371/journal.pone.0091416	http://dx.doi.org/10.1371/journal.pone.0091416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638073	Green Published, Green Submitted, gold			2022-12-25	WOS:000333254100033
J	Zafra, MP; Mazzeo, C; Gamez, C; Marco, AR; de Zulueta, A; Sanz, V; Bilbao, I; Ruiz-Cabello, J; Zubeldia, JM; del Pozo, V				Paz Zafra, Ma; Mazzeo, Carla; Gamez, Cristina; Rodriguez Marco, Ainara; de Zulueta, Ana; Sanz, Veronica; Bilbao, Izaskun; Ruiz-Cabello, Jesus; Zubeldia, Jose M.; del Pozo, Victoria			Gene Silencing of SOCS3 by siRNA Intranasal Delivery Inhibits Asthma Phenotype in Mice	PLOS ONE			English	Article							SMALL INTERFERING RNA; AIRWAY HYPERRESPONSIVENESS; IMMUNE-RESPONSES; INFLAMMATION; SUPPRESSOR; EXPRESSION; CELLS; THERAPY; RHOA	Suppresors of cytokine signaling (SOCS) proteins regulate cytokine responses and control immune balance. Several studies have confirmed that SOCS3 is increased in asthmatic patients, and SOCS3 expression is correlated with disease severity. The objective of this study was to evaluate if delivering of SOCS3 short interfering RNA (siRNA) intranasally in lungs could be a good therapeutic approach in an asthma chronic mouse model. Our results showed that intranasal treatment with SOCS3-siRNA led to an improvement in the eosinophil count and the normalization of hyperresponsiveness to methacholine. Concomitantly, this treatment resulted in an improvement in mucus secretion, a reduction in lung collagen, which are prominent features of airway remodeling. The mechanism implies JAK/STAT and RhoA/Rho-kinase signaling pathway, because we found a decreasing in STAT3 phosphorylation status and down regulation of RhoA/Rho-kinase protein expression. These results might lead to a new therapy for the treatment of chronic asthma.	[Paz Zafra, Ma; Mazzeo, Carla; Gamez, Cristina; Rodriguez Marco, Ainara; de Zulueta, Ana; Sanz, Veronica; del Pozo, Victoria] IIS Fdn Jimenez Diaz, Dept Immunol, Madrid, Spain; [Paz Zafra, Ma; Mazzeo, Carla; Gamez, Cristina; de Zulueta, Ana; Sanz, Veronica; Bilbao, Izaskun; Ruiz-Cabello, Jesus; del Pozo, Victoria] CIBER Enfermedades Resp, Madrid, Spain; [Bilbao, Izaskun; Ruiz-Cabello, Jesus] Ctr Nacl Invest Cardiovasc, Adv Imaging Unit, Madrid, Spain; [Bilbao, Izaskun; Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid, Spain; [Zubeldia, Jose M.] Hosp Gen Gregorio Maranon, Allergy Sect, Madrid, Spain; [Zubeldia, Jose M.] Hosp Gen Gregorio Maranon, Expt Med Unit, Madrid, Spain	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital	del Pozo, V (corresponding author), IIS Fdn Jimenez Diaz, Dept Immunol, Madrid, Spain.	vpozo@fjd.es	Zafra, Maria Paz/ABH-4756-2020; Ruiz-Cabello, Jesus/A-9570-2012; Zubeldia, Jose M./H-3518-2016; Mazzeo, Carla/M-1976-2014; Gamez, Cristina/AAA-6000-2021	Zafra, Maria Paz/0000-0001-9303-0097; Ruiz-Cabello, Jesus/0000-0001-8681-5056; Zubeldia, Jose M./0000-0003-3110-274X; Mazzeo, Carla/0000-0001-7916-8209; Gamez, Cristina/0000-0001-5412-9318	CIBER de Enfermedades Respiratorias; Spain's Health Research Fund, a Carlos III Institute of Health initiative; Conchita Rabago Foundation;  [PS09/00153];  [PI12/00691]	CIBER de Enfermedades Respiratorias; Spain's Health Research Fund, a Carlos III Institute of Health initiative; Conchita Rabago Foundation; ; 	This study was supported by grants PS09/00153 and PI12/00691 and CIBER de Enfermedades Respiratorias; from Spain's Health Research Fund, a Carlos III Institute of Health initiative; and fellowship grants from the Conchita Rabago Foundation (PZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2004, CLIN EXP IMMUNOL, V135, P505, DOI 10.1111/j.1365-2249.2004.02405.x; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Chiba Y, 2010, PHARMACOL RES, V61, P188, DOI 10.1016/j.phrs.2009.10.003; Chiba Y, 2009, AM J RESP CELL MOL, V40, P159, DOI 10.1165/rcmb.2008-0162OC; Collison A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-29; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hausding M, 2011, INT IMMUNOL, V23, P1, DOI 10.1093/intimm/dxq451; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Horiuchi Y, 2006, CLIN EXP DERMATOL, V31, P100, DOI 10.1111/j.1365-2230.2005.01979.x; Kasaian MT, 2013, AM J RESP CELL MOL, V49, P37, DOI 10.1165/rcmb.2012-0500OC; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Lopez E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/917015; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; Manuyakorn W, 2013, ASIAN PAC J ALLERGY, V31, P3; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moriwaki A, 2011, AM J RESP CELL MOL, V44, P448, DOI 10.1165/rcmb.2009-0051OC; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020; Zhu M, 2011, EUR RESPIR J, V38, P841, DOI 10.1183/09031936.00125010	33	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91996	10.1371/journal.pone.0091996	http://dx.doi.org/10.1371/journal.pone.0091996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637581	Green Published, gold			2022-12-25	WOS:000333254100099
J	Schuler, N; Palm, J; Kaiser, M; Betten, D; Furtwangler, R; Rube, C; Graf, N; Rube, CE				Schuler, Nadine; Palm, Jan; Kaiser, Mareike; Betten, Dominik; Furtwaengler, Rhoikos; Ruebe, Christian; Graf, Norbert; Ruebe, Claudia E.			DNA-Damage Foci to Detect and Characterize DNA Repair Alterations in Children Treated for Pediatric Malignancies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SQUAMOUS-CELL CARCINOMA; STRAND BREAK REPAIR; FANCONI-ANEMIA; NORMAL-TISSUES; RADIOSENSITIVITY; PATHWAY; ATM; HETEROCHROMATIN; REPLICATION	Purpose: In children diagnosed with cancer, we evaluated the DNA damage foci approach to identify patients with double-strand break (DSB) repair deficiencies, who may overreact to DNA-damaging radio-and chemotherapy. In one patient with Fanconi anemia (FA) suffering relapsing squamous cell carcinomas of the oral cavity we also characterized the repair defect in biopsies of skin, mucosa and tumor. Methods and Materials: In children with histologically confirmed tumors or leukemias and healthy control-children DSB repair was investigated by counting gamma H2AX-, 53BP1- and pATM-foci in blood lymphocytes at defined time points after ex-vivo irradiation. This DSB repair capacity was correlated with treatment-related normal-tissue responses. For the FA patient the defective repair was also characterized in tissue biopsies by analyzing DNA damage response proteins by light and electron microscopy. Results: Between tumor-children and healthy control-children we observed significant differences in mean DSB repair capacity, suggesting that childhood cancer is based on genetic alterations affecting DNA repair. Only 1 out of 4 patients with grade-4 normal-tissue toxicities revealed an impaired DSB repair capacity. The defective DNA repair in FA patient was verified in irradiated blood lymphocytes as well as in non-irradiated mucosa and skin biopsies leading to an excessive accumulation of heterochromatin-associated DSBs in rapidly cycling cells. Conclusions: Analyzing human tissues we show that DSB repair alterations predispose to cancer formation at younger ages and affect the susceptibility to normal-tissue toxicities. DNA damage foci analysis of blood and tissue samples allows one to detect and characterize DSB repair deficiencies and enables identification of patients at risk for high-grade toxicities. However, not all treatment-associated normal-tissue toxicities can be explained by DSB repair deficiencies.	[Schuler, Nadine; Palm, Jan; Kaiser, Mareike; Betten, Dominik; Ruebe, Christian; Ruebe, Claudia E.] Univ Saarland, Dept Radiat Oncol, Homburg, Germany; [Furtwaengler, Rhoikos; Graf, Norbert] Univ Saarland, Dept Pediat Hematol & Oncol, Homburg, Germany	Saarland University; Saarland University	Rube, CE (corresponding author), Univ Saarland, Dept Radiat Oncol, Homburg, Germany.	claudia.ruebe@uks.eu	Graf, Norbert/H-1328-2011; Furtwängler, Rhoikos/V-3519-2018	Graf, Norbert/0000-0002-2248-323X; Furtwängler, Rhoikos/0000-0002-1967-8343; Palm, Jan/0000-0003-1122-1557	Deutsche Krebshilfe [109774]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by "Deutsche Krebshilfe'' (grant no. 109774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolling T, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-10; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2012, MUTAT RES-FUND MOL M, V736, P39, DOI 10.1016/j.mrfmmm.2011.05.017; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lorat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038165; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Marinoglou Konstantina, 2012, Yale Journal of Biology and Medicine, V85, P469; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Raabe A, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-65; Romick-Rosendale LE, 2013, MUTAT RES-FUND MOL M, V743, P78, DOI 10.1016/j.mrfmmm.2013.01.001; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rube CE, 2010, INT J RADIAT ONCOL, V78, P359, DOI 10.1016/j.ijrobp.2009.08.052; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	30	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91319	10.1371/journal.pone.0091319	http://dx.doi.org/10.1371/journal.pone.0091319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637877	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100028
J	Tsai, HC; Huang, CY; Su, HL; Tang, CH				Tsai, Hsiao-Chi; Huang, Chun-Yin; Su, Hong-Lin; Tang, Chih-Hsin			CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; FOCAL ADHESION KINASE; DRUG-RESISTANCE; SURVIVIN EXPRESSION; MALIGNANT-MELANOMA; PROGNOSTIC-FACTOR; FACTOR CTGF/CCN2; GENE-EXPRESSION; CANCER CELLS; LUNG-CANCER	Osteosarcoma (OS) is the most common form of malignant bone tumor and is an aggressive malignant neoplasm exhibiting osteoblastic differentiation. Cisplatin is one of the most efficacious antitumor drugs for osteosarcoma patients. However, treatment failures are common due to the development of chemoresistance. CCN2 (also known as CTGF), is a secreted protein that binds to integrins, modulates the invasive behavior of certain human cancer cells. However, the effect of CCN2 in cisplatin-mediated chemotherapy is still unknown. Here, we found that CCN2 was upregulated in human osteosarcoma cells after treatment with cisplatin. Moreover, overexpression of CCN2 increased the resistance to cisplatin-mediated cell apoptosis. In contrast, reduction of CCN2 by CCN2 shRNA promoted the chemotherapeutic effect of cisplatin. We also found that CCN2 provided resistance to cisplatin-induced apoptosis through upregulation of Bcl-xL and survivin. Knockdown of Bcl-xL or survivin removed the CCN2-mediated resistance to apoptosis induced by cisplatin. On the other hand, CCN2 also promoted FAK, MEK, and ERK survival signaling pathways to enhance tumor survival during cisplatin treatment. In a mouse xenograft model, overexpression of CCN2 promoted resistance to cisplatin. However, knockdown of CCN2 increased the therapeutic effect of cisplatin. Therefore, our data suggest that CCN2 might be a critical oncogene of human osteosarcoma for cisplatin-resistance and supported osteosarcoma cell growth in vivo and in vitro.	[Tsai, Hsiao-Chi; Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Huang, Chun-Yin] China Med Univ, Beigang Hosp, Dept Orthopaed Surg, Taichung, Yun Lin County, Taiwan; [Huang, Chun-Yin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Su, HL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	suhonglin@gmail.com; chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Demers MJ, 2009, J CELL BIOCHEM, V107, P639, DOI 10.1002/jcb.22131; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Huang WC, 2011, BIOMEDICINE-TAIWAN, V1, P2, DOI 10.1016/j.biomed.2011.10.001; Janeway KA, 2010, LANCET ONCOL, V11, P670, DOI 10.1016/S1470-2045(10)70062-0; Karczmarek-Borowska B, 2005, FOLIA HISTOCHEM CYTO, V43, P237; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kubo M, 1998, BRIT J DERMATOL, V139, P192; Liang XJ, 2009, CELL BIOL INT, V33, P119, DOI 10.1016/j.cellbi.2008.10.013; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Moritani NH, 2003, CANCER LETT, V192, P205, DOI 10.1016/S0304-3835(02)00718-8; Osaka E, 2006, ACTA HISTOCHEM CYTOC, V39, P95, DOI 10.1267/ahc.06005; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Spina A, 2013, J CELL PHYSIOL, V228, P198, DOI 10.1002/jcp.24124; Sridhar SS, 2005, MOL CANCER THER, V4, P677, DOI 10.1158/1535-7163.MCT-04-0297; Trieb K, 2003, EUR J SURG ONCOL, V29, P379, DOI 10.1053/ejso.2002.1415; Wang MY, 2009, CANCER RES, V69, P3482, DOI 10.1158/0008-5472.CAN-08-2524; Wang WJ, 2006, J SURG ONCOL, V93, P578, DOI 10.1002/jso.20507; Wang ZX, 2010, BONE, V47, P445, DOI 10.1016/j.bone.2010.05.027; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Wilkins RM, 2003, ANN SURG ONCOL, V10, P498, DOI 10.1245/ASO.2003.03.061; Xie D, 2001, CANCER RES, V61, P8917; Yatomi M, 2007, ANTICANCER RES, V27, P3235; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Zaffaroni N, 2002, DRUG RESIST UPDATE, V5, P65, DOI 10.1016/S1368-7646(02)00049-3; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	44	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e90159	10.1371/journal.pone.0090159	http://dx.doi.org/10.1371/journal.pone.0090159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24637722	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100003
J	Xu, SG; Zhu, JZ; Wu, ZY				Xu, Shuguang; Zhu, Jingzhi; Wu, Zhiyong			Loss of Dab2 Expression in Breast Cancer Cells Impairs Their Ability to Deplete TGF-beta and Induce Tregs Development via TGF-beta	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; TUMOR-SUPPRESSOR; TRANSFORMING GROWTH-FACTOR-BETA-1; MEDIATED ENDOCYTOSIS; PERIPHERAL-BLOOD; DOWN-REGULATION; CUTTING EDGE; RECEPTOR; MECHANISMS	Dab2 is a multifunctional adapter protein which is frequently under-expressed in a variety of cancers. It is implicated in many critical functions, including several signaling pathways, cell arrangement, differentiation of stem cells, and receptor endocytosis. Transforming growth factor-beta (TGF-beta) is a secreted multifunctional protein that controls several developmental processes and pathogenesis of many diseases. It has been documented that Dab2 played an important role in TGF-beta receptors endocytosis. Here, we present evidence that re-expression of Dab2 in SK-BR-3 cell partially restored its ability to deplete TGF-beta in surrounding medium by normalizing the trafficking of TGF-beta receptors. We also demonstrate that the difference in TGF-beta depletions produced by Dab2 expression was sufficient to impact on the conversion of naive CD4+ T cells to regulatory T cells (Tregs), and thus inhibited the proliferation of T cells. This work revealed a critical result that breast cancer cell was deficient in Dab2 expression and related receptor endocytosis-mediated TGF-beta depletion, which may contribute to the accumulation of TGF-beta in tumor microenvironment and the induction of immune tolerance.	[Xu, Shuguang; Zhu, Jingzhi; Wu, Zhiyong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wu, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Surg, Shanghai, Peoples R China.	zhiyongwu@gmail.com						ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Anders RA, 1996, J BIOL CHEM, V271, P21758, DOI 10.1074/jbc.271.36.21758; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; cells T, J IMMUNOL, V173, P6526; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; DALAL BI, 1993, AM J PATHOL, V143, P381; Desruisseau S, 2006, BRIT J CANCER, V94, P239, DOI 10.1038/sj.bjc.6602920; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Dumont N, 2000, BREAST CANCER RES, V2, P125, DOI 10.1186/bcr44; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Fulop V, 1998, ONCOGENE, V17, P419, DOI 10.1038/sj.onc.1201955; GORSCH SM, 1992, CANCER RES, V52, P6949; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grau AM, 2008, BREAST CANCER RES TR, V112, P335, DOI 10.1007/s10549-007-9845-8; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Koumoundourou D, 2007, ANTICANCER RES, V27, P2613; LAIHO M, 1987, J BIOL CHEM, V262, P17467; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; MACCALLUM J, 1994, BRIT J CANCER, V69, P1006, DOI 10.1038/bjc.1994.197; Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z; Martin JC, 2010, BRIT J CANCER, V103, P1716, DOI 10.1038/sj.bjc.6605975; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MASSAGUE J, 1986, J CELL PHYSIOL, V128, P216, DOI 10.1002/jcp.1041280212; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayorga ME, 2011, STEM CELLS DEV, V20, P681, DOI 10.1089/scd.2010.0151; MCCUNE BK, 1992, HUM PATHOL, V23, P13, DOI 10.1016/0046-8177(92)90004-M; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; O'Brien PJ, 2008, BIOL-TARGETS THER, V2, P563; Oluwadara O, 2011, BIOINFORMATION, V5, P285, DOI 10.6026/97320630005285; Paiva CE, 2010, ANN ONCOL, V21, P734, DOI 10.1093/annonc/mdp518; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Penheiter SG, 2010, MOL BIOL CELL, V21, P4009, DOI 10.1091/mbc.E09-12-1019; Petrausch U, 2009, J IMMUNOL, V183, P3682, DOI 10.4049/jimmunol.0900560; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sheng ZJ, 2000, GENOMICS, V70, P381, DOI 10.1006/geno.2000.6383; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Tong JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-253; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Tseng CP, 1998, ENDOCRINOLOGY, V139, P3542, DOI 10.1210/en.139.8.3542; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; WALKER RA, 1992, EUR J CANCER, V28A, P641, DOI 10.1016/S0959-8049(05)80116-9; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Wang ZK, 2012, CANCER IMMUNOL IMMUN, V61, P911, DOI 10.1007/s00262-011-1158-4; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22; Zwaagstra JC, 2001, J BIOL CHEM, V276, P27237, DOI 10.1074/jbc.M100033200	69	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91709	10.1371/journal.pone.0091709	http://dx.doi.org/10.1371/journal.pone.0091709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24638085	Green Submitted, Green Published, gold			2022-12-25	WOS:000333254100053
J	Wu, H; Jiang, TL; Huang, XB; Lin, HJ; Wang, HW; Wang, L; Niu, HX; Feng, J				Wu, Hui; Jiang, Tinglei; Huang, Xiaobin; Lin, Hongjun; Wang, Hongwei; Wang, Lei; Niu, Hongxing; Feng, Jiang			A Test of Rensch's Rule in Greater Horseshoe Bat (Rhinolophus ferrumequinum) with Female-Biased Sexual Size Dimorphism	PLOS ONE			English	Article							WING MORPHOLOGY; WATER STRIDER; BODY-SIZE; ALLOMETRY; SELECTION; CHIROPTERA; EVOLUTION; MAMMALIA; BERGMANN; FAILS	Sexual size dimorphism (SSD) is widespread within the animal kingdom. Rensch's rule describes a relationship between SSD and body size: SSD increases with body size when males are the larger sex, and decreases with body size when females are the larger sex. Rensch's rule is well supported for taxa that exhibit male-biased SSD but patterns of allometry among taxa with female-biased size dimorphism are mixed, there is evidence both for and against the rule. Furthermore, most studies have investigated Rensch's rule across a variety of taxa; but among-population studies supporting Rensch's rule are lacking, especially in taxa that display only slight SSD. Here, we tested whether patterns of intraspecific variation in SSD in greater horseshoe bats conform to Rensch's rule, and evaluated the contribution of latitude to Rensch's rule. Our results showed SSD was consistently female-biased in greater horseshoe bats, although female body size was only slightly larger than male body size. The slope of major axis regression of log(10) (male) on log(10) (female) was significantly different from 1. Forearm length for both sexes of greater horseshoe bats was significantly negatively correlated with latitude, and males displayed a slightly but nonsignificant steeper latitudinal cline in body size than females. We suggest that variation in patterns of SSD among greater horseshoe bat populations is consistent with Rensch's rule indicating that males were the more variable sex. Males did not have a steeper body size-latitude relationship than females suggesting that sex-specific latitudinal variation in body size may not be an important contributing factor to Rensch's rule. Future research on greater horseshoe bats might best focus on more comprehensive mechanisms driving the pattern of female-biased SSD variation.	[Wu, Hui; Jiang, Tinglei; Huang, Xiaobin; Lin, Hongjun; Wang, Hongwei; Wang, Lei; Feng, Jiang] NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchu, Peoples R China; [Wu, Hui; Jiang, Tinglei; Feng, Jiang] NE Normal Univ, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Niu, Hongxing] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Henan Normal University	Jiang, TL (corresponding author), NE Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchu, Peoples R China.	jiangtl730@nenu.edu.cn; fengj@nenu.edu.cn	Lin, Hongjun/G-8462-2011; Jiang, Tinglei/GQQ-9485-2022; Wu, Hao/AGE-4639-2022	Lin, Hongjun/0000-0003-1125-0681; Yang, Xiaofei/0000-0002-5118-7755; Wu, Hao/0000-0003-2340-9258	National Natural Science Foundation of China [31030011, 31100280, 31270414]; Research Fund for the Doctoral Program of Higher Education of China [20110043120015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This project was supported by grants from the National Natural Science Foundation of China (Grant No. 31030011, 31100280, 31270414), Research Fund for the Doctoral Program of Higher Education of China (20110043120015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Altingham J., 1996, BATS BIOL BEHAV; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; Andersson Malte, 1994; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Benda Petr, 2007, Acta Societatis Zoologicae Bohemicae, V71, P71; Benda Petr, 2011, Acta Societatis Zoologicae Bohemicae, V75, P159; Benda Pets, 2006, Acta Societatis Zoologicae Bohemicae, V70, P1; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Brunet-Rossinni Anja K., 2009, P315; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Cox Robert M., 2007, P38; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; Darwin C, 1990, DESCENT MAN SELECTIO; Davis CM, 2008, BIOL J LINN SOC, V95, P141, DOI 10.1111/j.1095-8312.2008.01035.x; de Camargo NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049734; DeBlase A, 1980, FIELD M NAT HIST; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FINDLEY JS, 1972, J MAMMAL, V53, P429, DOI 10.2307/1379035; Frydlova P, 2010, BIOL J LINN SOC, V100, P293, DOI 10.1111/j.1095-8312.2010.01430.x; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Hayssen V, 1996, J MAMMAL, V77, P476, DOI 10.2307/1382823; Herczeg G, 2010, J ANIM ECOL, V79, P581, DOI 10.1111/j.1365-2656.2010.01665.x; HUGHES PM, 1991, J EXP BIOL, V161, P285; KAWAI K, 2007, MAMMAL SCI, V47, P239; KOENIG WD, 1986, AM NAT, V127, P403, DOI 10.1086/284491; KRYSTUFEK B, 1993, ACTA THERIOL, V38, P67, DOI 10.4098/AT.arch.93-6; Kunz TH, 2006, BAT ECOLOGY; Lengkeek W, 2008, CAN J ZOOL, V86, P1173, DOI 10.1139/Z08-103; Liao WB, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-10; Lindenfors P, 2007, SEX SIZE GENDER ROLE, P19; Lison F, 2014, ACTA ZOOL-STOCKHOLM, V95, P137, DOI 10.1111/azo.12012; Mateju J, 2013, FRONT ZOOL, V10, P1, DOI 10.1186/1742-9994-10-27; Matthews LH, 1937, ZOOL SOC LOND, P224; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Polak J, 2010, EVOL ECOL, V24, P1255, DOI 10.1007/s10682-010-9354-9; Preatoni D, 2000, ATTI MUS CIV ST NAT, V11, P89; R Core Team, 2021, R LANG ENV STAT COMP; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; Ransome R.D., 1991, P88; RANSOME RD, 1968, J ZOOL, V154, P77; Rossiter SJ, 2006, MOL ECOL, V15, P3035, DOI 10.1111/j.1365-294X.2006.02987.x; Serrano-Meneses MA, 2008, J EVOLUTION BIOL, V21, P1259, DOI 10.1111/j.1420-9101.2008.01567.x; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; SINHA Y P, 1973, Mammalia, V37, P603, DOI 10.1515/mamm.1973.37.4.603; Smith AT, 2010, GUIDE ESTIMATES PRB; Smith RJ, 2002, INT J PRIMATOL, V23, P1095, DOI 10.1023/A:1019654100876; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Stefen C, 2012, ACTA THERIOL, P1; Stephens PR, 2009, EVOLUTION, V63, P910, DOI 10.1111/j.1558-5646.2008.00597.x; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; Storz JF, 2001, BIOL J LINN SOC, V72, P17, DOI 10.1006/bijl.2000.0482; Stuart-Fox D, 2009, EVOL ECOL, V23, P425, DOI 10.1007/s10682-008-9242-8; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tubaro PL, 2003, BIOL J LINN SOC, V80, P519, DOI 10.1046/j.1095-8312.2003.00252.x; Webb TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000897; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Wu Y., 2009, FAUNA HEBEI; Xiao Z, 1988, FAUNA LIAONING	68	49	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e86085	10.1371/journal.pone.0086085	http://dx.doi.org/10.1371/journal.pone.0086085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465886	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500109
J	Tang, Y; He, H; Cheng, N; Song, YL; Ding, WJ; Zhang, YF; Zhang, WH; Zhang, J; Peng, H; Jiang, H				Tang, Yi; He, Hua; Cheng, Ning; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Wenhao; Zhang, Jie; Peng, Heng; Jiang, Hua			PDGF, NT-3 and IGF-2 in Combination Induced Transdifferentiation of Muscle-Derived Stem Cells into Schwann Cell-Like Cells	PLOS ONE			English	Article							DIFFERENTIATION; REGENERATION	Muscle-derived stem cells (MDSCs) are multipotent stem cells with a remarkable long-term self-renewal and regeneration capacity. Here, we show that postnatal MDSCs could be transdifferentiated into Schwann cell-like cells upon the combined treatment of three neurotrophic factors (PDGF, NT-3 and IGF-2). The transdifferentiation of MDSCs was initially induced by Schwann cell (SC) conditioned medium. MDSCs adopted a spindle-like morphology similar to SCs after the transdifferentiation. Immunocytochemistry and immunoblot showed clearly that the SC markers S100, GFAP and p75 were expressed highly only after the transdifferentiation. Flow cytometry assay showed that the portion of S100 expressed cells was more than 60 percent and over one fourth of the transdifferentiated cells expressed all the three SC markers, indicating an efficient transdifferentiation. We then tested neurotrophic factors in the conditioned medium and found it was PDGF, NT-3 and IGF-2 in combination that conducted the transdifferentiation. Our findings demonstrate that it is possible to use specific neurotrophic factors to transdifferentiate MDSCs into Schwann cell-like cells, which might be therapeutically useful for clinical applications.	[Tang, Yi; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Jie; Jiang, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China; [Tang, Yi] 411 Hosp CPLA, Dept Plast Surg, Shanghai, Peoples R China; [He, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Cheng, Ning] Second Mil Med Univ, Changhai Hosp, Dept Transfus, Shanghai, Peoples R China; [Zhang, Wenhao] Shanghai Jiao Tong Univ, XinHua Hosp, Dept Hematol, Sch Med, Shanghai 200030, Peoples R China; [Peng, Heng] Hong Kong Baptist Univ, Dept Math, Kowloon, Hong Kong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Hong Kong Baptist University	Jiang, H (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China.	lmiao.simm@gmail.com	Peng, Heng/B-7152-2009; Johnson, William/N-1972-2017	Peng, Heng/0000-0001-7807-8527; Johnson, William/0000-0002-3823-4094	National Natural Science Foundation of China [81100950]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81100950. Website http://www.nsfc.gov.cn no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Cheng HL, 1999, ENDOCRINOLOGY, V140, P4478, DOI 10.1210/en.140.10.4478; Cohen RI, 1999, J EXP BIOL, V202, P461; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; GUENARD V, 1992, J NEUROSCI, V12, P3310; Ide C, 1996, NEUROSCI RES, V25, P101; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Keilhoff G, 2000, NEUROREPORT, V11, P3805, DOI 10.1097/00001756-200011270-00042; Keilhoff G, 1999, J NEUROSCI METH, V89, P17, DOI 10.1016/S0165-0270(99)00034-5; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192; Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Zhao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041506	22	62	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e73402	10.1371/journal.pone.0073402	http://dx.doi.org/10.1371/journal.pone.0073402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24637790	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800001
J	Kim, JA; Choi, HJ; Kwon, YK; Ryu, DH; Kwon, TH; Hwang, GS				Kim, Ju-Ae; Choi, Hyo-Jung; Kwon, Yong-Kook; Ryu, Do Hyun; Kwon, Tae-Hwan; Hwang, Geum-Sook			H-1 NMR-Based Metabolite Profiling of Plasma in a Rat Model of Chronic Kidney Disease	PLOS ONE			English	Article							EXPERIMENTAL CHRONIC UREMIA; AMINO-ACID-METABOLISM; SKELETAL-MUSCLE; GLUTAMINE FORMATION; SERUM METABOLITES; PROXIMAL TUBULE; PROTEIN; ALANINE; CITRATE; COTRANSPORTER	Chronic kidney disease (CKD) is characterized by the gradual loss of the kidney function to excrete wastes and fluids from the blood. H-1 NMR-based metabolomics was exploited to investigate the altered metabolic pattern in rats with CKD induced by surgical reduction of the renal mass (i.e., 5/6 nephrectomy (5/6 Nx)), particularly for identifying specific metabolic biomarkers associated with early of CKD. Plasma metabolite profiling was performed in CKD rats (at 4- or 8-weeks after 5/6 Nx) compared to sham-operated rats. Principle components analysis (PCA), partial least squares-discriminant analysis (PLS-DA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) score plots showed a significant separation between the groups. The resulting metabolic profiles demonstrated significantly increased plasma levels of organic anions, including citrate, beta-hydroxybutyrate, lactate, acetate, acetoacetate, and formate in CKD. Moreover, levels of alanine, glutamine, and glutamate were significantly higher. These changes were likely to be associated with complicated metabolic acidosis in CKD for counteracting systemic metabolic acidosis or increased protein catabolism from muscle. In contrast, levels of VLDL/LDL (CH2)(n) and N-acetylglycoproteins were decreased. Taken together, the observed changes of plasma metabolite profiles in CKD rats provide insights into the disturbed metabolism in early phase of CKD, in particular for the altered metabolism of acid-base and/or amino acids.	[Kim, Ju-Ae; Kwon, Yong-Kook; Hwang, Geum-Sook] Korea Basic Sci Inst, Integrated Metabol Res Grp, Seoul Ctr, Seoul, South Korea; [Kim, Ju-Ae; Ryu, Do Hyun] Sungkyunkwan Univ, Dept Chem, Suwon, South Korea; [Choi, Hyo-Jung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea; [Kwon, Yong-Kook; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Basic Science Institute (KBSI); Sungkyunkwan University (SKKU); Kyungpook National University; Chungnam National University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea.	thkwon@knu.ac.kr; gshwang@kbsi.re.kr	Ryu, Do Hyun/ADI-9819-2022; Kwon, Tae-Hwan/ABA-1981-2020		National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning, Korea [2010-0019393, 2010-0019394, 2013R1A1A2007266, 2013M3A9B6046418]; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea [A111345]; Korea Basic Science Institute [T33409]; Creative Allied Project (CAP); Kyungpook National University Research Fund	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Korea; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea; Korea Basic Science Institute; Creative Allied Project (CAP); Kyungpook National University Research Fund	This study was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea (2010-0019393, 2010-0019394, 2013R1A1A2007266, and 2013M3A9B6046418); the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Korea (A111345), Korea Basic Science Institute (T33409), the Creative Allied Project (CAP), and Kyungpook National University Research Fund, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A RJ, 2000, KIDNEY, P455; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; ALPERN RJ, 1990, PHYSIOL REV, V70, P79, DOI 10.1152/physrev.1990.70.1.79; ALPERN RJ, 1995, KIDNEY INT, V47, P1205, DOI 10.1038/ki.1995.171; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BOUBY N, 1993, KIDNEY INT, V44, P676, DOI 10.1038/ki.1993.300; BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; CHARLES J.C., 2005, HOSP PHYS, V1, P37; Choi HJ, 2012, J PROTEOME RES, V11, P3816, DOI 10.1021/pr300309d; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi JY, 2011, NEPHROL DIAL TRANSPL, V26, P1304, DOI 10.1093/ndt/gfq554; CONDON JR, 1971, CLIN CHIM ACTA, V32, P333, DOI 10.1016/0009-8981(71)90433-5; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; FARBER MO, 1976, CLIN SCI MOL MED, V50, P165, DOI 10.1042/cs0500165; GARBER AJ, 1976, J BIOL CHEM, V251, P826; GARBER AJ, 1978, J CLIN INVEST, V62, P633, DOI 10.1172/JCI109170; GARBER AJ, 1978, J CLIN INVEST, V62, P623, DOI 10.1172/JCI109169; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Hong YS, 2010, ARCH PHARM RES, V33, P1091, DOI 10.1007/s12272-010-0716-1; Hwang GS, 2010, AM J PHYSIOL-RENAL, V298, pF461, DOI 10.1152/ajprenal.00389.2009; Jang ZH, 2012, MOL BIOSYST, V8, P2001, DOI 10.1039/c2mb25073j; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590, DOI 10.1152/ajprenal.1985.249.4.F590; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kim CD, 2010, TRANSPLANTATION, V90, P748, DOI 10.1097/TP.0b013e3181edd69a; Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kwon TH, 2002, AM J PHYSIOL-RENAL, V282, pF341, DOI 10.1152/ajprenal.00104.2001; Kwon TH, 1998, AM J PHYSIOL-RENAL, V275, pF724, DOI 10.1152/ajprenal.1998.275.5.F724; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF257, DOI 10.1152/ajprenal.1999.277.2.F257; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; MADDOX DA, 1986, J CLIN INVEST, V77, P1639, DOI 10.1172/JCI112481; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Roderick PJ, 2007, COCHRANE DB SYST REV, V1; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; Weiner ID, 2011, CORE CONCEPTS DISORD, P203; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014	46	89	100	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85445	10.1371/journal.pone.0085445	http://dx.doi.org/10.1371/journal.pone.0085445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24647444	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500046
J	Knowles, SE; Toms, G; Sanders, C; Bee, P; Lovell, K; Rennick-Egglestone, S; Coyle, D; Kennedy, CM; Littlewood, E; Kessler, D; Gilbody, S; Bower, P				Knowles, Sarah E.; Toms, Gill; Sanders, Caroline; Bee, Penny; Lovell, Karina; Rennick-Egglestone, Stefan; Coyle, David; Kennedy, Catriona M.; Littlewood, Elizabeth; Kessler, David; Gilbody, Simon; Bower, Peter			Qualitative Meta-Synthesis of User Experience of Computerised Therapy for Depression and Anxiety	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; STEPPED CARE; SELF-HELP; ACCEPTABILITY; ETHNOGRAPHY; MANAGEMENT; BARRIERS; SYSTEM; AGENTS	Objective: Computerised therapies play an integral role in efforts to improve access to psychological treatment for patients with depression and anxiety. However, despite recognised problems with uptake, there has been a lack of investigation into the barriers and facilitators of engagement. We aimed to systematically review and synthesise findings from qualitative studies of computerised therapies, in order to identify factors impacting on engagement. Method: Systematic review and meta-synthesis of qualitative studies of user experiences of computer delivered therapy for depression and/or anxiety. Results: 8 studies were included in the review. All except one were of desktop based cognitive behavioural treatments. Black and minority ethnic and older participants were underrepresented, and only one study addressed users with a comorbid physical health problem. Through synthesis, we identified two key overarching concepts, regarding the need for treatments to be sensitive to the individual, and the dialectal nature of user experience, with different degrees of support and anonymity experienced as both positive and negative. We propose that these factors can be conceptually understood as the 'non-specific' or 'common' factors of computerised therapy, analogous to but distinct from the common factors of traditional face-to-face therapies. Conclusion: Experience of computerised therapy could be improved through personalisation and sensitisation of content to individual users, recognising the need for users to experience a sense of 'self' in the treatment which is currently absent. Exploiting the common factors of computerised therapy, through enhancing perceived connection and collaboration, could offer a way of reconciling tensions due to the dialectal nature of user experience. Future research should explore whether the findings are generalisable to other patient groups, to other delivery formats (such as mobile technology) and other treatment modalities beyond cognitive behaviour therapy. The proposed model could aid the development of enhancements to current packages to improve uptake and support engagement.	[Knowles, Sarah E.; Toms, Gill; Sanders, Caroline; Bower, Peter] Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England; [Bee, Penny; Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Rennick-Egglestone, Stefan] Univ Nottingham, Mixed Real Lab, Sch Comp Sci, Nottingham NG7 2RD, England; [Coyle, David] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Kennedy, Catriona M.] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Littlewood, Elizabeth; Gilbody, Simon] Univ York, Mental Hlth & Addict Res Grp, York YO10 5DD, N Yorkshire, England; [Kessler, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Manchester; University of Manchester; University of Nottingham; University of Bristol; University of Birmingham; University of York - UK; University of Bristol	Knowles, SE (corresponding author), Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England.	sarah.knowles@manchester.ac.uk	Coyle, David/P-3920-2019; Sanders, Taren/N-9511-2018; Lovell, Karina S E/E-6410-2012; Lonsdale, Chris/T-8710-2017; Bower, Peter/A-1508-2011; Bee, Penny E/O-8822-2014; Gilbody, Simon/AAY-3720-2021; Kessler, david/ABB-6489-2021; Sanders, Caroline/G-8021-2014	Coyle, David/0000-0002-5103-0379; Sanders, Taren/0000-0002-4504-6008; Lovell, Karina S E/0000-0001-8821-895X; Lonsdale, Chris/0000-0002-2523-5565; Bower, Peter/0000-0001-9558-3349; Bee, Penny E/0000-0002-5600-0400; Gilbody, Simon/0000-0002-8236-6983; Sanders, Caroline/0000-0002-0539-928X; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Kennedy, Catriona/0000-0003-3510-9113; Cliff, Dylan/0000-0001-6863-3996; Knowles, Sarah/0000-0002-0863-5866	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council [G0401181] Funding Source: researchfish; National Institute for Health Research [06/43/504, SPCR-040, 06/43/05] Funding Source: researchfish	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded as part of the UK National Institute of Health Research (NIHR) School for Primary Care Research. The research team were independent from the funding agency. The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advocat J, 2010, SOC SCI MED, V70, P485, DOI 10.1016/j.socscimed.2009.10.051; [Anonymous], 1994, QUAL HEALTH RES, DOI [10.1177/104973239400400102, DOI 10.1177/104973239400400102]; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Bate P., 2007, J APPL BEHAV SCI, V43, P41, DOI [10.1177/0021886306297014, DOI 10.1177/0021886306297014]; Bickmore T, 2010, HARVARD REV PSYCHIAT, V18, P119, DOI 10.3109/10673221003707538; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Bradley KL., 2012, INT J MENT HEALTH PR, V14, P23, DOI [10.1080/14623730.2012.665337, DOI 10.1080/14623730.2012.665337]; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Cavanagh Kate, 2009, Cognitive Behaviour Therapy, V38, P235, DOI 10.1080/16506070802561256; Chambers DA, 2013, GEN HOSP PSYCHIAT, V35, P329, DOI 10.1016/j.genhosppsych.2013.03.006; Coyle D, 2007, INTERACT COMPUT, V19, P545, DOI 10.1016/j.intcom.2007.02.001; Coyle D, 2008, ONTORACT 2008: FIRST INTERNATIONAL WORKSHOP ON ONTOLOGIES IN INTERACTIVE SYSTEMS, PROCEEDINGS, P18, DOI 10.1109/ONTORACT.2008.12; Dehn DM, 2000, INT J HUM-COMPUT ST, V52, P1, DOI 10.1006/ijhc.1999.0325; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Doherty G., 2012, P 2012 ACM ANN C HUM, P1421, DOI DOI 10.1145/2207676.2208602; Farzanfar R, 2007, COMPUT HUM BEHAV, V23, P1167, DOI 10.1016/j.chb.2004.11.015; Gerhards SAH, 2011, J AFFECT DISORDERS, V129, P117, DOI 10.1016/j.jad.2010.09.012; Green KE, 2009, PROF PSYCHOL-RES PR, V40, P96, DOI 10.1037/a0012847; Helgadottir FD, 2009, BEHAV CHANGE, V26, P245, DOI 10.1375/bech.26.4.245; Hind D, 2010, PSYCHOL HEALTH, V25, P699, DOI 10.1080/08870440902842739; Iloabachie C, 2011, GEN HOSP PSYCHIAT, V33, P543, DOI 10.1016/j.genhosppsych.2011.08.004; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Klein B, 2008, J APPL PSYCHOL, V4; Knowles SE, 2012, 2012 C PRIM CAR MENT; Lambert MJ, 2005, J CLIN PSYCHOL, V61, P855, DOI 10.1002/jclp.20130; Layard R, 2006, DEPRESSION REPORT; Malpass A, 2009, SOC SCI MED, V68, P154, DOI 10.1016/j.socscimed.2008.09.068; Marks I, 2009, ANNU REV CLIN PSYCHO, V5, P121, DOI 10.1146/annurev.clinpsy.032408.153538; Mitchell J., 2005, PRIMARY CARE MENTAL, V3, P27; Mitchell N, 2007, COUNS PSYCHOTHER RES, V7, P144, DOI 10.1080/14733140701565987; NHS Confederation Mental Health Network, 2013, E MENT HLTH WHATS AL; NICE, 2009, DEPR AD UPD NICE CLI; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Peck DF, 2010, CLIN PSYCHOL PSYCHOT, V17, P147, DOI 10.1002/cpp.669; Pilgrim D, 2009, HEALTH-LONDON, V13, P235, DOI 10.1177/1363459308099686; Prevost S., 2000, EMBODIED CONVERSATIO, DOI DOI 10.7551/MITPRESS/2697.001.0001; Reeves B, 1996, CSLI PUBLICATIONS ST; Richards DA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-3; Rosser BA, 2009, J TELEMED TELECARE, V15, P327, DOI 10.1258/jtt.2009.090116; Ryan RM, 2011, COUNS PSYCHOL, V39, P193, DOI 10.1177/0011000009359313; Sanders C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-220; Schneider J, 2012, COMPUTERISED CBT COM; Simon GE, 2009, LANCET, V374, P594, DOI 10.1016/S0140-6736(09)61415-X; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; STRUPP H, 1978, HDB PSYCHOTHERAPY BE; The King's Fund, 2011, PAT CTR CAR KINGS FU; Timmermans S, 2003, SOCIOL HEALTH ILL, V25, P97, DOI 10.1111/1467-9566.00342; Titov N, 2010, COMPUTER DELIVERED C; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224; Watkins DC, 2011, J TELEMED TELECARE, V17, P378, DOI 10.1258/jtt.2011.110105	51	143	148	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84323	10.1371/journal.pone.0084323	http://dx.doi.org/10.1371/journal.pone.0084323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24643129	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000012
J	Rhodes, JR; Lunney, D; Callaghan, J; McAlpine, CA				Rhodes, Jonathan R.; Lunney, Daniel; Callaghan, John; McAlpine, Clive A.			A Few Large Roads or Many Small Ones? How to Accommodate Growth in Vehicle Numbers to Minimise Impacts on Wildlife	PLOS ONE			English	Article							NEW-SOUTH-WALES; OF-FIT TESTS; PHASCOLARCTOS-CINEREUS; PORT STEPHENS; HOME-RANGE; MORTALITY; CONSERVATION; POPULATION; KOALAS; MODELS	Roads and vehicular traffic are among the most pervasive of threats to biodiversity because they fragmenting habitat, increasing mortality and opening up new areas for the exploitation of natural resources. However, the number of vehicles on roads is increasing rapidly and this is likely to continue into the future, putting increased pressure on wildlife populations. Consequently, a major challenge is the planning of road networks to accommodate increased numbers of vehicles, while minimising impacts on wildlife. Nonetheless, we currently have few principles for guiding decisions on road network planning to reduce impacts on wildlife in real landscapes. We addressed this issue by developing an approach for quantifying the impact on wildlife mortality of two alternative mechanisms for accommodating growth in vehicle numbers: (1) increasing the number of roads, and (2) increasing traffic volumes on existing roads. We applied this approach to a koala (Phascolarctos cinereus) population in eastern Australia and quantified the relative impact of each strategy on mortality. We show that, in most cases, accommodating growth in traffic through increases in volumes on existing roads has a lower impact than building new roads. An exception is where the existing road network has very low road density, but very high traffic volumes on each road. These findings have important implications for how we design road networks to reduce their impacts on biodiversity.	[Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Rhodes, Jonathan R.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, NERP Environm Decis Hub, Brisbane, Qld, Australia; [Lunney, Daniel] Off Environm & Heritage New South Wales, Hurstville, NSW, Australia; [Lunney, Daniel] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Callaghan, John] Australian Koala Fdn, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Office of Environment & Heritage - New South Wales; University of Sydney	Rhodes, JR (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	j.rhodes@uq.edu.au	Rhodes, Jonathan/C-4841-2008	Rhodes, Jonathan/0000-0001-6746-7412; Beale, Mathew/0000-0002-4740-3187; Fisher, Matthew/0000-0002-1862-6402; Rhodes, Johanna/0000-0002-1338-7860; McAlpine, Clive/0000-0003-0457-8144; Lunney, Dan/0000-0002-5771-0746	Australian Research Council [C00107594]	Australian Research Council(Australian Research Council)	This work was supported by funding from: An Australian Research Council Linkage Project with contributions from the Australian Koala Foundation and New South Wales Government (project number: C00107594, www.arc.gov.au). The Australian Research Council Centre of Excellence for Environmental Decisions (www.arc.gov.au). The National Environmental Research Program Environmental Decisions Hub (http://www.environment.gov.au/topics/science-and-research/national-environmental-research-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Cork SJ, 2000, CONSERV BIOL, V14, P660, DOI 10.1046/j.1523-1739.2000.99389.x; DECC, 2008, NSW 2008 KOAL REC PL; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dovers SR, 1996, BIODIVERS CONSERV, V5, P1143, DOI 10.1007/BF00051569; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Efron B., 1994, INTRO BOOTSTRAP; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; FAHRIG L, 2009, ECOL SOC, V14; Fields G, 2009, INT J SUSTAIN TRANSP, V3, P360, DOI 10.1080/15568310802260013; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Goosem Miriam, 1997, P241; Grosman PD, 2011, ECOL MODEL, V222, P1423, DOI 10.1016/j.ecolmodel.2011.01.022; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; HINDELL MA, 1987, AUST WILDLIFE RES, V14, P349, DOI 10.1071/WR9870349; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Road Federation, 2011, WORLD ROAD STAT 2011; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jaeger Jochen A.G., 2006, P151; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Knott Tiffany, 1998, Pacific Conservation Biology, V4, P354; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Lunney D, 2000, CONSERV BIOL, V14, P669, DOI 10.1046/j.1523-1739.2000.99386.x; Lunney D, 2010, NATURAL HIST SYDNEY; Lunney D, PAC CONSERV IN PRESS; Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melzer A, 1995, ASPECTS ECOLOGY KOAL; Mitchell P., 1990, P171; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Natural Resource Management Ministerial Council, 2009, NAT KOAL CONS MAN ST; OSIUS G, 1992, J AM STAT ASSOC, V87, P1145, DOI 10.2307/2290653; Phillips S, 2000, WILDLIFE RES, V27, P1, DOI 10.1071/WR98054; Pittman J, 1993, PROBABILITY; Polak T, J APPL ECOL IN PRESS; Port Stephens Council, 2001, PORT STEPH COUNC C 1; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Ramp D, 2006, J WILDLIFE MANAGE, V70, P1615, DOI 10.2193/0022-541X(2006)70[1615:TEORFO]2.0.CO;2; Reed P.C., 1990, P55; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Roger E, 2011, POPUL ECOL, V53, P215, DOI 10.1007/s10144-010-0209-6; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Slooten E, 2000, CONSERV BIOL, V14, P1264, DOI 10.1046/j.1523-1739.2000.00099-411.x; Spellerberg IF, 2002, ECOLOGICAL EFFECTS R, DOI DOI 10.1201/9781482279931; Stewart-Oaten Allan, 1996, P17, DOI 10.1016/B978-012627255-0/50004-5; Sushinsky JR, 2013, GLOBAL CHANGE BIOL, V19, P401, DOI 10.1111/gcb.12055; Taylor BD, 2003, WILDLIFE RES, V30, P529, DOI 10.1071/WR01062; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van Langevelde F, 2004, LANDSCAPE ECOL, V19, P895, DOI 10.1007/s10980-004-0464-z; van Langevelde F, 1997, HABITAT FRAGMENTATIO, P171; van Langevelde F, 2009, ECOL SOC, V14; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; White NA, 1999, WILDLIFE RES, V26, P731, DOI 10.1071/WR98002; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	74	56	58	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91093	10.1371/journal.pone.0091093	http://dx.doi.org/10.1371/journal.pone.0091093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646891	Green Published, gold			2022-12-25	WOS:000333348500024
J	Sanders, T; Cliff, DP; Lonsdale, C				Sanders, Taren; Cliff, Dylan P.; Lonsdale, Chris			Measuring Adolescent Boys' Physical Activity: Bout Length and the Influence of Accelerometer Epoch Length	PLOS ONE			English	Article							ACTIVITY PATTERNS; CHILDREN; HEALTH; LEVEL	Objectives: Accurate, objective measurement is important for understanding adolescents' physical activity (PA) behaviour. When using accelerometry to objectively measure PA, a decision must be made regarding how frequently data is recorded (i.e., epoch length). The purpose of this study was to examine i) PA bout length, and ii) the effect of variations in accelerometer epoch length on PA estimates during physical education (PE) and leisure time in adolescent boys. Design: Cross-sectional study. Methods: Year 9 boys (N = 133; mean age +/- SD = 14.36 +/- 0.48 years) wore accelerometers during two PE lessons, and for a period of seven consecutive days. Data were reintegrated from 1s into longer periods of 2, 5, 10, 30, and 60 seconds. ANOVAs were used to test for differences in PA estimates between epochs in leisure time and PE. Results: The mean length of vigorous PA (VPA) bouts was 3.5 +/- 2.0 seconds for PE and 2.5 +/- 1.7 seconds for leisure time, and mean length of moderate PA (MPA) bouts was 2.3 +/- 0.5 seconds for PE and 2.9 +/- 0.5 seconds for leisure time. During PE, estimates of MVPA, MPA, and light PA (LPA) increased as epoch increased from 1 second to 60 seconds, while VPA and sedentary behaviour estimates decreased. During leisure time, estimates of all PA intensities decreased as epoch increased from 1 second to 60 seconds, with the exception of sedentary behaviour, which increased as epoch length increased. Conclusion: The context in which PA occurs can influence PA bout length measurement and the effect of variations in epoch length on PA estimates. Researchers measuring PA with accelerometry should be conscious of the possible influence of context on PA estimates.	[Sanders, Taren; Lonsdale, Chris] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Cliff, Dylan P.] Univ Wollongong, Interdisciplinary Educ Res Inst, Sch Educ, Wollongong, NSW, Australia	Western Sydney University; University of Wollongong	Lonsdale, C (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	c.lonsdale@uws.edu.au	Coyle, David/P-3920-2019; Sanders, Taren/N-9511-2018; Lovell, Karina S E/E-6410-2012; Lonsdale, Chris/T-8710-2017; Bower, Peter/A-1508-2011; Bee, Penny E/O-8822-2014; Gilbody, Simon/AAY-3720-2021; Kessler, david/ABB-6489-2021; Sanders, Caroline/G-8021-2014	Coyle, David/0000-0002-5103-0379; Sanders, Taren/0000-0002-4504-6008; Lovell, Karina S E/0000-0001-8821-895X; Lonsdale, Chris/0000-0002-2523-5565; Bower, Peter/0000-0001-9558-3349; Bee, Penny E/0000-0002-5600-0400; Gilbody, Simon/0000-0002-8236-6983; Sanders, Caroline/0000-0002-0539-928X; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Kennedy, Catriona/0000-0003-3510-9113; Cliff, Dylan/0000-0001-6863-3996; Knowles, Sarah/0000-0002-0863-5866	University of Western Sydney; National Heart Foundation of Australia [PH 11S 6025]; Medical Research Council [G0401181] Funding Source: researchfish; National Institute for Health Research [06/43/504, SPCR-040, 06/43/05] Funding Source: researchfish	University of Western Sydney; National Heart Foundation of Australia(National Heart Foundation of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the University of Western Sydney's support for Bachelor of Health Science (Honours) research projects. Dylan Cliff is funded by a National Heart Foundation of Australia Postdoctoral Research Fellowship (PH 11S 6025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph Software Department, 2012, ACT 6 US MAN; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Berman N, 1998, AM J HUM BIOL, V10, P289, DOI 10.1002/(SICI)1520-6300(1998)10:3<289::AID-AJHB4>3.0.CO;2-E; Blaes A, 2011, AM J HUM BIOL, V23, P353, DOI 10.1002/ajhb.21142; Carson V, 2014, INT J OBESITY, V38, P16, DOI 10.1038/ijo.2013.135; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Dencker M, 2012, J SPORT MED PHYS FIT, V52, P115; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P.S., 1997, MED SCI SPORT EXER S, V29, P45, DOI DOI 10.1097/00005768-199705001-00256; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Gabriel KP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-53; Gutin B, 2008, OBESITY, V16, P2193, DOI 10.1038/oby.2008.348; Holman RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025733; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Obeid J, 2011, APPL PHYSIOL NUTR ME, V36, P291, DOI [10.1139/h11-002, 10.1139/H11-002]; Rowls AV., 2006, CITESEER, V4, P52; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sayers A, 2011, J CLIN ENDOCR METAB, V96, pE793, DOI 10.1210/jc.2010-2550; Sirard JR, 2009, J PHYS ACT HEALTH, V6, pS148, DOI 10.1123/jpah.6.s1.s148; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tabachnick B.G., 2001, USING MULTIVARIATE S, V4th ed.; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Vanhelst J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-26; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	37	143	148	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92040	10.1371/journal.pone.0092040	http://dx.doi.org/10.1371/journal.pone.0092040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643129	Green Submitted, Green Published, gold			2022-12-25	WOS:000333259900069
J	Chen, C; Sia, I; Ma, HM; Tai, BC; Cheong, A; Fong, NP; Tan, SYJ; Chan, KM; Tan, BY; Menon, E; Ee, CH; Lee, KK; Ng, YS; Teo, YY; Ma, S; Heng, D; Koh, GCH				Chen, Cynthia; Sia, Isaac; Ma, Hon-Ming; Tai, Bee Choo; Cheong, Angela; Fong, Ngan Phoon; Tan, Shi Yu Julia; Chan, Kin Ming; Tan, Boon Yeow; Menon, Edward; Ee, Chye Hua; Lee, Kok Keng; Ng, Yee Sien; Teo, Yik Ying; Ma, Stefan; Heng, Derrick; Koh, Gerald Choon-Huat			The Synergistic Effect of Functional Status and Comorbidity Burden on Mortality: A 16-Year Survival Analysis	PLOS ONE			English	Article							NURSING-HOME USE; OLDER-ADULTS; BARTHEL INDEX; HIP FRACTURE; FRAILTY; PREVALENCE; DISABILITY; ACCUMULATION; MORBIDITY; DISEASES	Objectives: The relationship between disability and comorbidity on mortality is widely perceived as additive in clinical models of frailty. Design: National data were retrospectively extracted from medical records of community hospital. Data Sources: There were of 12,804 acutely-disabled patients admitted for inpatient rehabilitation in Singapore rehabilitation community hospitals from 1996 through 2005 were followed up for death till 31 December 2011. Outcome Measure: Cox proportional-hazards regression to assess the interaction of comorbidity and disability at discharge on all-cause mortality. Results: During a median follow-up of 10.9 years, there were 8,565 deaths (66.9%). The mean age was 73.0 (standard deviation: 11.5) years. Independent risk factors of mortality were higher comorbidity (p<0.001), severity of disability at discharge (p<0.001), being widowed (adjusted hazard ratio [aHR]: 1.38, 95% confidence interval [CI]:1.25-1.53), low socioeconomic status (aHR: 1.40, 95%CI:1.29-1.53), discharge to nursing home (aHR: 1.14, 95%CI:1.05-1.22) and re-admission into acute care (aHR: 1.54, 95%CI:1.45-1.65). In the main effects model, those with high comorbidity had an aHR = 2.41 (95%CI:2.13-2.72) whereas those with total disability had an aHR = 2.28 (95%CI:2.12-2.46). In the interaction model, synergistic interaction existed between comorbidity and disability (p<0.001) where those with high comorbidity and total disability had much higher aHR = 6.57 (95%CI:5.15-8.37). Conclusions: Patients with greater comorbidity and disability at discharge, discharge to nursing home or re-admission into acute care, lower socioeconomic status and being widowed had higher mortality risk. Our results identified predictive variables of mortality that map well onto the frailty cascade model. Increasing comorbidity and disability interacted synergistically to increase mortality risk.	[Chen, Cynthia; Tai, Bee Choo; Cheong, Angela; Fong, Ngan Phoon; Teo, Yik Ying; Koh, Gerald Choon-Huat] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Sia, Isaac] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Ma, Hon-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ma, Hon-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Therapeut, Hong Kong, Hong Kong, Peoples R China; [Tan, Shi Yu Julia; Koh, Gerald Choon-Huat] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Chan, Kin Ming] Ang Mo Kio Thye Hua Kwan Hosp, Med Serv, Singapore, Singapore; [Tan, Boon Yeow] St Lukes Hosp, Med Serv, Singapore, Singapore; [Menon, Edward] St Andrews Community Hosp, Med Serv, Singapore, Singapore; [Ee, Chye Hua; Lee, Kok Keng] Bright Vis Hosp, Singapore, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Ma, Stefan; Heng, Derrick] Minist Hlth, Singapore, Singapore	National University of Singapore; State University System of Florida; University of Florida; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Ministry of Health-Singapore	Koh, GCH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	gerald_koh@nuhs.edu.sg	CHEN, CYNTHIA/O-6203-2016; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022; Rogawski, Michael/B-6353-2009	Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261; HSIEH, WU-SHIUN/0000-0002-0609-3311; Koh, Choon Huat Gerald/0000-0002-6453-6897; TSAO, PO-NIEN/0000-0002-6114-1769; Matt, Lucas/0000-0003-3235-5140; Rogawski, Michael/0000-0002-3296-8193; Sia, Isaac/0000-0001-8449-1799; Ng, Yee-Sien/0000-0003-1377-5852	National University of Singapore (NUS) Start-Up Grant; NUS Provost Matching Grant; NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research [HSRG/0006/2013]; Singapore National Medical Research Council Research Fellowship; Schulich Graduate Scholarship, University of Western Ontario	National University of Singapore (NUS) Start-Up Grant(National University of Singapore); NUS Provost Matching Grant; NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research(Ministry of Education, SingaporeNational University of Singapore); Singapore National Medical Research Council Research Fellowship(National Medical Research Council, Singapore); Schulich Graduate Scholarship, University of Western Ontario	This study was supported by a National University of Singapore (NUS) Start-Up Grant, the NUS Provost Matching Grant, the NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research Grant Number HSRG/0006/2013, Singapore National Medical Research Council Research Fellowship and Schulich Graduate Scholarship, University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, PRINCIPLES GERIATRIC; Bernardini Judith, 2004, Adv Perit Dial, V20, P125; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P356, DOI 10.1016/j.jamda.2009.11.008; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Lee J, 2007, NEUROCHEM RES, V32, P635, DOI 10.1007/s11064-006-9138-3; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Ministry of Health (MOH), 2004, HEALTHC SERV ELD INF; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Ravindrarajah R, ARCH GERONTOLOGY GER; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; Rudberg MA, 1996, J GERONTOL A-BIOL, V51, pM189, DOI 10.1093/gerona/51A.5.M189; Schiller JS, 2012, VITAL HLTH STAT, V10, P67; Seo Nam Sook, 2006, Taehan Kanho Hakhoe Chi, V36, P514; Shah S, 2000, CLIN REHABIL, V14, P551, DOI 10.1191/0269215500cr360oa; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHINAR D, 1987, ARCH PHYS MED REHAB, V68, P723; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Song XW, 2007, AGING CLIN EXP RES, V19, P145; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Woo J, 2014, AGE, V36, P923, DOI 10.1007/s11357-013-9590-3	41	94	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106248	10.1371/journal.pone.0106248	http://dx.doi.org/10.1371/journal.pone.0106248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25229608	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500134
J	Hu, YS; Young, AJ; Ehli, EA; Nowotny, D; Davies, PS; Droke, EA; Soundy, TJ; Davies, GE				Hu, Yueshan; Young, Alan J.; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Droke, Elizabeth A.; Soundy, Timothy J.; Davies, Gareth E.			Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; FATTY LIVER-DISEASE; DOUBLE-BLIND; BODY-WEIGHT; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCHIZOPHRENIA; CLOZAPINE; GLUCOSE	Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain. Metformin was reported to produce significant attenuation of antipsychotic-induced weight gain in patients, while the study of preventing olanzapine-induced weight gain in an animal model is absent. Berberine, an herbal alkaloid, was shown in our previous studies to prevent fat accumulation in vitro and in vivo. Utilizing a well-replicated rat model of olanzapine-induced weight gain, here we demonstrated that two weeks of metformin or berberine treatment significantly prevented the olanzapine-induced weight gain and white fat accumulation. Neither metformin nor berberine treatment demonstrated a significant inhibition of olanzapine-increased food intake. But interestingly, a significant loss of brown adipose tissue caused by olanzapine treatment was prevented by the addition of metformin or berberine. Our gene expression analysis also demonstrated that the weight gain prevention efficacy of metformin or berberine treatment was associated with changes in the expression of multiple key genes controlling energy expenditure. This study not only demonstrates a significant preventive efficacy of metformin and berberine treatment on olanzapine-induced weight gain in rats, but also suggests a potential mechanism of action for preventing olanzapine-reduced energy expenditure.	[Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA; [Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Hu, Yueshan; Ehli, Erik A.; Soundy, Timothy J.; Davies, Gareth E.] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Sioux Falls, SD USA; [Young, Alan J.] S Dakota State Univ, Dept Vet & Biomed Sci, Coll Agr & Biol Sci, Brookings, SD 57007 USA; [Droke, Elizabeth A.] S Dakota State Univ, Dept Hlth & Nutr Sci, Coll Educ & Human Sci, Brookings, SD 57007 USA; [Davies, Gareth E.] S Dakota State Univ, Coll Pharm, Dept Pharm Practice, Brookings, SD 57007 USA	University of South Dakota; South Dakota State University; South Dakota State University; South Dakota State University	Hu, YS (corresponding author), Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA.	Yueshan.Hu@avera.org		Xiang, Zou/0000-0003-3925-0296	Avera Research Institute	Avera Research Institute	Avera Research Institute sponsored this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; Boyda HN, 2014, PROG NEURO-PSYCHOPH, V48, P170, DOI 10.1016/j.pnpbp.2013.10.006; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Case M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-72; Chen CH, 2008, PROG NEURO-PSYCHOPH, V32, P925, DOI 10.1016/j.pnpbp.2007.11.013; Citrome L, 2011, CLIN DRUG INVEST, V31, P455, DOI 10.2165/11589060-000000000-00000; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Faulkner G, 2006, CAN J PSYCHIAT, V51, P502, DOI 10.1177/070674370605100805; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Feng S, 2012, NEUROENDOCRINOL LETT, V33, P493; Gilles M, 2010, CLIN NEUROPHARMACOL, V33, P248, DOI 10.1097/WNF.0b013e3181f0ec33; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Hu Y, 2012, PHARMACOGENOMICS J, V12, P372, DOI 10.1038/tpj.2011.24; Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Hu YS, 2010, FITOTERAPIA, V81, P259, DOI 10.1016/j.fitote.2009.09.012; Ikegami M, 2013, EUR J PHARM; Jarskog LF, 2007, ANNU REV MED, V58, P49, DOI 10.1146/annurev.med.58.060904.084114; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Kluge M, 2007, J CLIN PSYCHOPHARM, V27, P662, DOI 10.1097/jcp.0b013e31815a8872; Kreuzer P, 2012, NERVENARZT, V83, P630, DOI 10.1007/s00115-011-3310-y; Kudoh A, 2004, ANESTH ANALG, V98, P111, DOI 10.1213/01.ANE.0000093313.16711.5E; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee MS, 2011, J NUTR, V141, P1947, DOI 10.3945/jn.111.146050; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Liebig M, 2010, OBESITY, V18, P1952, DOI 10.1038/oby.2010.17; Lindenmayer JP, 2003, AM J PSYCHIAT, V160, P290, DOI 10.1176/appi.ajp.160.2.290; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Makino T, 2009, BIOL PHARM BULL, V32, P1741, DOI 10.1248/bpb.32.1741; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newcomer JW, 2006, CAN J PSYCHIAT, V51, P480, DOI 10.1177/070674370605100803; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Praharaj SK, 2011, BRIT J CLIN PHARMACO, V71, P377, DOI 10.1111/j.1365-2125.2010.03783.x; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saddichha S, 2008, SCHIZOPHR RES, V101, P266, DOI 10.1016/j.schres.2008.01.004; Schreiner A, 2012, J CLIN PSYCHOPHARM, V32, P449, DOI 10.1097/JCP.0b013e31825cccad; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Shirzadi AA, 2006, HARVARD REV PSYCHIAT, V14, P152, DOI 10.1080/10673220600748486; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Smith G. C., 2011, Archives of Physiology and Biochemistry, V117, P241, DOI 10.3109/13813455.2011.576681; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Thakore JH, 2004, BRIT J PSYCHIAT, V184, pS76, DOI 10.1192/bjp.184.47.s76; Toalson Patrick, 2004, Prim Care Companion J Clin Psychiatry, V6, P152; Tschoner A, 2007, INT J CLIN PRACT, V61, P1356, DOI 10.1111/j.1742-1241.2007.01416.x; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; Wu RR, 2008, AM J PSYCHIAT, V165, P352, DOI 10.1176/appi.ajp.2007.07010079; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	66	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93310	10.1371/journal.pone.0093310	http://dx.doi.org/10.1371/journal.pone.0093310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24676355	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600170
J	Chen, CY; Chen, HL; Chou, HC; Tsao, PN; Hsieh, WS; Chang, MH				Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei			Weight-Based Policy of Hepatitis B Vaccination in Very Low Birth Weight Infants in Taiwan: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; IMMUNE-RESPONSE; PRETERM INFANTS; INFECTION; PREVENTION; EFFICACY; IMMUNOGENICITY; GLOBULIN; BORN	Background: The current recommendation of giving the first dose of hepatitis B vaccine to very low birth weight (VLBW) infants at 30 days of chronologic age usually is not practical, because most VLBW infants are not medically stable at that age. We use an alternative body-weight-based protocol, and evaluate its efficacy in an endemic area under a universal immunization program. Methods: The immunogenicity of the current hepatitis B vaccination strategy in 155 VLBW preterm infants was evaluated at age 2 to 13 years, with parental consent. All of the infants were born between 1995 and 2006, and received their first dose of hepatitis B vaccine when they reached 2,000-2,200 g, irrespective of chronological age. Hepatitis B immunoglobulin (HBIG) was given at birth to infants born to HBsAg(+)/HBeAg(+) mothers. Results: All 155 of the recruited children were HBsAg and anti-HBc negative. The anti-HBs seropositivity rate (geometric mean titer) was 84.1% (146.5 mIU/mL) for children under 3 years, 73.5% (68.8 mIU/mL) for 4-to 7-year-olds, 27.7% (55.4 mIU/mL) for 8-to 11-year-olds and 20% (6.0 mIU/mL) for children >= 12 years of age. More than 90% of these children received the first vaccination after 30 days of age, half (51%) at 60 to 90 days, and 29 children (18.6%) after 90 days of age. Of the 26 infants born to HBsAg(+) mothers, 6/6 infants of HBeAg(+) mothers received HBIG at birth, and 12/20 infants of HBeAg(-) mothers received HBIG. None of the 26 infants became infected. Conclusions: Delaying hepatitis B vaccinations in VLBW preterm infants until they reach a weight of 2,000 g, with the administration of HBIG at birth for infants of HBsAg(+) mothers provided adequate immunogenicity and protection in a highly endemic area. Weight-based policy of hepatitis B vaccination is an effective and practical alternative strategy for VLBW infants.	[Chen, Chien-Yi] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	changmh@ntu.edu.tw	CHEN, CYNTHIA/O-6203-2016; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022; Rogawski, Michael/B-6353-2009	Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261; HSIEH, WU-SHIUN/0000-0002-0609-3311; Koh, Choon Huat Gerald/0000-0002-6453-6897; TSAO, PO-NIEN/0000-0002-6114-1769; Matt, Lucas/0000-0003-3235-5140; Rogawski, Michael/0000-0002-3296-8193; Sia, Isaac/0000-0001-8449-1799; Ng, Yee-Sien/0000-0003-1377-5852	National Taiwan University Hospital [NTUH.98-M1230]; Center for Disease Control, Department of Health, Taiwan [DOH98-DC-10181]	National Taiwan University Hospital(National Taiwan University); Center for Disease Control, Department of Health, Taiwan	This study was supported by grant from the National Taiwan University Hospital (NTUH.98-M1230), and partially from the Center for Disease Control, Department of Health, Taiwan (DOH98-DC-10181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1983, HEPATOLOGY, V3, P135; BEASLEY RP, 1983, LANCET, V2, P1099; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; HALL CB, 1994, PEDIATRICS, V94, P403; HALL CB, 1992, PEDIATRICS, V89, P795; Hsu HM, 1999, J INFECT DIS, V179, P367, DOI 10.1086/314585; Huang FY, 1997, ARCH DIS CHILD-FETAL, V77, pF135, DOI 10.1136/fn.77.2.F135; Kesler K, 1998, PEDIATR INFECT DIS J, V17, P116, DOI 10.1097/00006454-199802000-00007; Khalak R, 1998, PEDIATRICS, V101, P597, DOI 10.1542/peds.101.4.597; Kim SC, 1997, PEDIATRICS, V99, P534, DOI 10.1542/peds.99.4.534; Kirmani KI, 2002, PEDIATRICS, V109, P498, DOI 10.1542/peds.109.3.498; LAU YL, 1992, J PEDIATR-US, V121, P962, DOI 10.1016/S0022-3476(05)80352-X; LEE CY, 1991, PEDIATR INFECT DIS J, V10, P299, DOI 10.1097/00006454-199104000-00007; LEE PI, 1995, J PEDIATR-US, V126, P716, DOI 10.1016/S0022-3476(95)70398-5; Linder N, 2002, INFECTION, V30, P136, DOI 10.1007/s15010-002-2068-3; Linder N, 2000, ARCH DIS CHILD-FETAL, V83, pF24, DOI 10.1136/fn.83.1.F24; Losonsky GA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e14; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; Patel DM, 1997, J PEDIATR-US, V131, P641, DOI 10.1016/S0022-3476(97)70078-7; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Saari TN, 2003, PEDIATRICS, V112, P193, DOI 10.1542/peds.112.1.193	24	94	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92271	10.1371/journal.pone.0092271	http://dx.doi.org/10.1371/journal.pone.0092271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	25229608	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100136
J	Hu, Y; Zhu, Q; Tang, LL				Hu, Yu; Zhu, Qin; Tang, Lili			MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression	PLOS ONE			English	Article							DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; S6 KINASE; MICRORNA; PATHWAY; GROWTH; AKT; TRANSLATION; APOPTOSIS	MicroRNAs (miRNAs) play an important role in human tumorigenesis as oncogenes or tumor suppressors. miR-99a has been reported as a tumor suppressor gene in various cancers in humans. However, only limited information about the function of miR-99a in human breast cancers is available. Here we investigated the expression of miR-99a in breast cancer tissue specimens and its antitumor activity in breast cancer cells. We initially identified that the expression of miR-99a was significantly reduced in four breast cancer cell lines. More importantly, we found downregulation of miR-99a in breast cancer specimens from ten different patients. We then analyzed the mechanism of miR-99a in inhibiting tumorigenesis. Cell-based assays that showed overexpression of miR-99a not only reduced breast cancer cell viability by inducing accumulation of cells at sub-G1 phase and cell apoptosis, but also inhibited tumorigenicity in vivo. As a critical miR-99a target, we have shown that the function of mammalian target of rapamycin (mTOR) was greatly inhibited by miR-99a-based Luciferase report assay; overexpression of miR-99a reduced the expression of mTOR and its downstream phosphorylated proteins (p-4E-BP1 and p-S6K1). Similar to restoring miR-99a expression, mTOR downregulation suppressed cell viability and increased cell apoptosis, whereas restoration of mTOR expression significantly reversed the inhibitory effects of miR-99a on the mTOR/p-4E-BP1/p-S6K1 signal pathway and the miR-99a antitumor activity. In clinical specimens and cell lines, mTOR was commonly overexpressed and its protein levels were statistically inversely correlated with miR-99a expression. Taken together, these results have demonstrated that miR-99a antitumor activity is achieved by targeting the mTOR/p-4E-BP1/p-S6K1 pathway in human breast cancer cells. This study suggests a potential therapeutic strategy to effectively control breast cancer development.	[Hu, Yu; Tang, Lili] Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China; [Zhu, Qin] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, LL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China.	lilitangxy@126.com		Xiang, Zou/0000-0003-3925-0296				Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cui L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-546; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; TELFORD WG, 1992, CYTOMETRY, V13, P137, DOI 10.1002/cyto.990130205; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhou J, 2010, MOL MED REP, V3, P387, DOI 10.3892/mmr_00000269	45	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92099	10.1371/journal.pone.0092099	http://dx.doi.org/10.1371/journal.pone.0092099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24676355	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100111
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	25521114	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	25521114	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	25521114	Green Published, Green Submitted, gold			2022-12-25	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521114	Green Submitted, Green Published, gold			2022-12-25	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Chen, Xin-Zu/K-2988-2019; Xue, Charlie C/F-1244-2014; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; Xue, Charlie/0000-0001-6937-9088; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061763, R01HD038329, R01HD018269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25521114	Green Submitted, Green Published, gold			2022-12-25	WOS:000339954800038
